PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cheng, AM; Handa, P; Tateya, S; Schwartz, J; Tang, CR; Mitra, P; Oram, JF; Chait, A; Kim, F				Cheng, Andrew M.; Handa, Priya; Tateya, Sanshiro; Schwartz, Jay; Tang, Chongren; Mitra, Poulami; Oram, John F.; Chait, Alan; Kim, Francis			Apolipoprotein A-I Attenuates Palmitate-Mediated NF-kappa B Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; DIET-INDUCED OBESITY; CAVEOLIN-1 EXPRESSION; INFLAMMATORY RESPONSE; HDL; CHOLESTEROL; ATHEROSCLEROSIS; MICE; LIPOPOLYSACCHARIDE; VIVO	While high-density lipoprotein (HDL) is known to protect against a wide range of inflammatory stimuli, its anti-inflammatory mechanisms are not well understood. Furthermore, HDL's protective effects against saturated dietary fats have not been previously described. In this study, we used endothelial cells to demonstrate that while palmitic acid activates NF-kappa B signaling, apolipoprotein A-I, (apoA-I), the major protein component of HDL, attenuates palmitate-induced NF-kappa B activation. Further, vascular NF-kappa B signaling (IL-6, MCP-1, TNF-alpha) and macrophage markers (CD68, CD11c) induced by 24 weeks of a diabetogenic diet containing cholesterol (DDC) is reduced in human apoA-I overexpressing transgenic C57BL/6 mice compared to age-matched WT controls. Moreover, WT mice on DDC compared to a chow diet display increased gene expression of lipid raft markers such as Caveolin-1 and Flotillin-1, and inflammatory Toll-like receptors (TLRs) (TLR2, TLR4) in the vasculature. However apoA-I transgenic mice on DDC show markedly reduced expression of these genes. Finally, we show that in endothelial cells TLR4 is recruited into lipid rafts in response to palmitate, and that apoA-I prevents palmitate-induced TLR4 trafficking into lipid rafts, thereby blocking NF-kappa B activation. Thus, apoA-I overexpression might be a useful therapeutic tool against vascular inflammation.	[Cheng, Andrew M.; Handa, Priya; Tateya, Sanshiro; Schwartz, Jay; Tang, Chongren; Mitra, Poulami; Oram, John F.; Chait, Alan; Kim, Francis] Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Cheng, AM (corresponding author), Univ Washington, Dept Med, Diabet & Obes Ctr Excellence, Seattle, WA 98105 USA.	fkim@u.washington.edu			National Institutes of Health [DK073878, HL94352, HL92969, HL055362]; Cardiovascular Postdoctoral Training grant [T32 HL07828]; John L. Locke, Jr, Charitable Trust; Kenneth H. Cooper Endowed Professorship in Preventive Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094352, R01HL055362, T32HL007828, P01HL092969, R56HL094352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, R01DK073878, P30DK035816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cardiovascular Postdoctoral Training grant; John L. Locke, Jr, Charitable Trust; Kenneth H. Cooper Endowed Professorship in Preventive Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants DK073878 (to F.K.), and HL94352 and HL92969 (to A.C.), HL055362 (to J.O.), Cardiovascular Postdoctoral Training grant T32 HL07828 (A.M.C.) and by grants from the John L. Locke, Jr, Charitable Trust and from the Kenneth H. Cooper Endowed Professorship in Preventive Cardiology (to F.K.). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bursill CA, 2010, ARTERIOSCL THROM VAS, V30, P1773, DOI 10.1161/ATVBAHA.110.211342; Chen JX, 2008, LAB INVEST, V88, P1316, DOI 10.1038/labinvest.2008.92; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; Fernandez-Hernando C, 2009, CELL METAB, V10, P48, DOI 10.1016/j.cmet.2009.06.003; Fessler MB, 2011, J IMMUNOL, V187, P1529, DOI 10.4049/jimmunol.1100253; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; Getz GS, 2010, CURR PHARM DESIGN, V16, P3173; Haas MJ, 2011, CURR OPIN INFECT DIS, V24, P265, DOI 10.1097/QCO.0b013e328344b724; Kim F, 2005, ARTERIOSCL THROM VAS, V25, P989, DOI 10.1161/01.ATV.0000160549.60980.a8; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kim SJ, 2011, J NUTR BIOCH; MENDEZ AJ, 1991, J BIOL CHEM, V266, P10104; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Murphy AJ, 2011, BIOCHIM BIOPHYS ACTA; Murphy AJ, 2008, ARTERIOSCL THROM VAS, V28, P2071, DOI 10.1161/ATVBAHA.108.168690; Murphy AJ, 2011, ARTERIOSCL THROM VAS, V31, P1333, DOI 10.1161/ATVBAHA.111.226258; Murphy AJ, 2010, CLIN EXP PHARMACOL P, V37, P710, DOI 10.1111/j.1440-1681.2009.05338.x; Navab M, 2001, ARTERIOSCL THROM VAS, V21, P481, DOI 10.1161/01.ATV.21.4.481; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Park SH, 2003, INT J BIOCHEM CELL B, V35, P168, DOI 10.1016/S1357-2725(02)00173-5; Peterson SJ, 2008, J LIPID RES, V49, P1658, DOI 10.1194/jlr.M800046-JLR200; Peterson SJ, 2007, J PHARMACOL EXP THER, V322, P514, DOI 10.1124/jpet.107.119479; Puranik R, 2008, ATHEROSCLEROSIS, V196, P240, DOI 10.1016/j.atherosclerosis.2007.05.008; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Saemann MD, 2010, EUR J CLIN INVEST, V40, P1131, DOI 10.1111/j.1365-2362.2010.02361.x; Smythies LE, 2010, AM J PHYSIOL-CELL PH, V298, pC1538, DOI 10.1152/ajpcell.00467.2009; Soong G, 2004, J CLIN INVEST, V113, P1482, DOI 10.1172/JCI200420773; Subramanian S, 2008, ARTERIOSCLER THROMB; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Terasaka N, 2008, J CLIN INVEST, V118, P3701, DOI 10.1172/JCI35470; Tiruppathi C, 2008, J BIOL CHEM, V283, P4210, DOI 10.1074/jbc.M703153200; Tolle M, 2008, ARTERIOSCL THROM VAS, V28, P1542, DOI 10.1161/ATVBAHA.107.161042; Triantafilou M, 2002, J CELL SCI, V115, P2603; Triantafilou M, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/186093; Van Linthout S, 2011, J MOL MED, V89, P151, DOI 10.1007/s00109-010-0690-6; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Wong SW, 2009, J BIOL CHEM, V284, P27384, DOI 10.1074/jbc.M109.044065; Yang NH, 2007, CARDIOVASC RES, V76, P167, DOI 10.1016/j.cardiores.2007.05.028; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869; Zhu XW, 2010, J LIPID RES, V51, P3196, DOI 10.1194/jlr.M006486	42	64	65	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33917	10.1371/journal.pone.0033917	http://dx.doi.org/10.1371/journal.pone.0033917			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479476	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100082
J	Delgado, TC; Barosa, C; Nunes, PM; Cerdan, S; Geraldes, CFGC; Jones, JG				Delgado, Teresa C.; Barosa, Cristina; Nunes, Patricia M.; Cerdan, Sebastian; Geraldes, Carlos F. G. C.; Jones, John G.			Resolving the Sources of Plasma Glucose Excursions following a Glucose Tolerance Test in the Rat with Deuterated Water and [U-C-13]Glucose	PLOS ONE			English	Article							INSULIN-RESISTANCE; ORAL GLUCOSE; LIVER; LOAD; H-2; GLUCONEOGENESIS; CARBOHYDRATE; VALIDATION; METABOLISM; (H2O)-H-2	Sources of plasma glucose excursions (PGE) following a glucose tolerance test enriched with [U-C-13]glucose and deuterated water were directly resolved by C-13 and H-2 Nuclear Magnetic Resonance spectroscopy analysis of plasma glucose and water enrichments in rat. Plasma water H-2-enrichment attained isotopic steady-state within 2-4 minutes following the load. The fraction of PGE derived from endogenous sources was determined from the ratio of plasma glucose position 2 and plasma water H-2-enrichments. The fractional gluconeogenic contributions to PGE were obtained from plasma glucose positions 2 and 5 H-2-positional enrichment ratios and load contributions were estimated from plasma [U-C-13]glucose enrichments. At 15 minutes, the load contributed 26 +/- 5% of PGE while 14 +/- 2% originated from gluconeogenesis in healthy control rats. Between 15 and 120 minutes, the load contribution fell whereas the gluconeogenic contribution remained constant. High-fat fed animals had significant higher 120-minute blood glucose (173 +/- 6 mg/dL vs. 139 +/- 10 mg/dL, p<0.05) and gluconeogenic contributions to PGE (59 +/- 5 mg/dL vs. 38 +/- 3 mg/dL, p<0.01) relative to standard chow-fed controls. In summary, the endogenous and load components of PGE can be resolved during a glucose tolerance test and these measurements revealed that plasma glucose synthesis via gluconeogenesis remained active during the period immediately following a glucose load. In rats that were placed on high-fat diet, the development of glucose intolerance was associated with a significantly higher gluconeogenic contribution to plasma glucose levels after the load.	[Delgado, Teresa C.; Barosa, Cristina; Nunes, Patricia M.; Geraldes, Carlos F. G. C.; Jones, John G.] Ctr Neurosci & Cell Biol, Intermediary Metab Grp, Coimbra, Portugal; [Delgado, Teresa C.; Barosa, Cristina; Nunes, Patricia M.; Geraldes, Carlos F. G. C.; Jones, John G.] Ctr Neurosci & Cell Biol, Inorgan Biochem & Mol Imaging Grp, Coimbra, Portugal; [Delgado, Teresa C.; Cerdan, Sebastian] Inst Invest Biomed Madrid Alberto Sols CSIC UAM, Lab Imaging & Spect Magnet Resonance, Madrid, Spain	Universidade de Coimbra; Universidade de Coimbra; Consejo Superior de Investigaciones Cientificas (CSIC)	Delgado, TC (corresponding author), Ctr Neurosci & Cell Biol, Intermediary Metab Grp, Coimbra, Portugal.	jones@cnc.uc.pt	de Oliveira, Maria Cristina Barosa/A-6377-2014; Delgado, Teresa C/L-1681-2014; Delgado, Teresa/ABF-9171-2020; Jones, John/A-8684-2010	de Oliveira, Maria Cristina Barosa/0000-0001-7819-2434; Delgado, Teresa C/0000-0001-9204-581X; Delgado, Teresa/0000-0001-9204-581X; Jones, John/0000-0002-3745-3885; Nunes, Patricia/0000-0003-4740-8268; Cerdan, Sebastian/0000-0001-9965-0270; Geraldes, Carlos/0000-0002-0837-8329	Portuguese Foundation for Science and Technology [POCI/SAUsimilar toOSM/65140/2006]; National Programme for Scientific re-equipment [REDE/1517/RMN/2005]; POCI (FEDER); Portuguese Foundation for Science and Technology; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/46197/2008]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); National Programme for Scientific re-equipment; POCI (FEDER)(European Commission); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology)	The authors acknowledge financial support from the Portuguese Foundation for Science and Technology (research grant POCI/SAU similar to OSM/65140/2006). The NMR spectrometers are part of the National NMR Network and were purchased in the framework of the National Programme for Scientific re-equipment, contract REDE/1517/RMN/2005, with funds from POCI 2010 (FEDER) and the Portuguese Foundation for Science and Technology. T. C. D. held a fellowship from the Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BPD/46197/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allick G, 2006, AM J PHYSIOL-ENDOC M, V290, pE1212, DOI 10.1152/ajpendo.00279.2005; Bock G, 2007, DIABETES, V56, P1703, DOI 10.2337/db06-1776; Boku A, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-78; Burgess SC, 2003, ANAL BIOCHEM, V318, P321, DOI 10.1016/S0003-2697(03)00158-1; Burgess SC, 2001, ANAL BIOCHEM, V289, P187, DOI 10.1006/abio.2000.4930; COBELLI C, 1984, AM J PHYSIOL, V247, pR488, DOI 10.1152/ajpregu.1984.247.3.R488; Edgerton DS, 2006, J CLIN INVEST, V116, P521, DOI 10.1172/JCI27073; Gupta N, 2002, AM J PHYSIOL-ENDOC M, V283, pE1002, DOI 10.1152/ajpendo.00091.2002; GUTNIAK M, 1986, DIABETES CARE, V9, P244, DOI 10.2337/diacare.9.3.244; Jin ES, 2005, AM J PHYSIOL-ENDOC M, V288, pE654, DOI 10.1152/ajpendo.00365.2004; Jin ES, 2003, J BIOL CHEM, V278, P28427, DOI 10.1074/jbc.M302134200; Jones JG, 2001, AM J PHYSIOL-ENDOC M, V281, pE848, DOI 10.1152/ajpendo.2001.281.4.E848; Jones JG, 2001, MAGN RESON MED, V45, P156, DOI 10.1002/1522-2594(200101)45:1<156::AID-MRM1020>3.0.CO;2-Z; KATZ J, 1975, EUR J BIOCHEM, V60, P91, DOI 10.1111/j.1432-1033.1975.tb20979.x; LEE HB, 1985, J NUCL MED, V26, P72; Li L, 2006, ANN NUTR METAB, V50, P499, DOI 10.1159/000098141; Mari A, 2003, COMPUT METH PROG BIO, V71, P269, DOI 10.1016/S0169-2607(02)00097-4; MCMAHON M, 1989, J CLIN ENDOCR METAB, V68, P647, DOI 10.1210/jcem-68-3-647; NIEWOEHNER CB, 1984, AM J PHYSIOL, V246, pE89, DOI 10.1152/ajpendo.1984.246.1.E89; Perdigoto R, 2003, NMR BIOMED, V16, P189, DOI 10.1002/nbm.826; RADZIUK J, 1978, AM J PHYSIOL, V234, pE84, DOI 10.1152/ajpendo.1978.234.1.E84; RADZIUK J, 1987, Diabetes Metabolism Reviews, V3, P231; RIZZA RA, 1981, AM J PHYSIOL, V240, pE630, DOI 10.1152/ajpendo.1981.240.6.E630; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sena CM, 2007, DIABETES METAB, V33, P296, DOI 10.1016/j.diabet.2007.03.002; SMADJA C, 1990, BIOCHEM J, V270, P505, DOI 10.1042/bj2700505; SMADJA C, 1988, AM J PHYSIOL, V254, pE407, DOI 10.1152/ajpendo.1988.254.4.E407; Soares AF, 2010, METAB ENG, V12, P552, DOI 10.1016/j.ymben.2010.08.002; Soares AF, 2009, MAGN RESON MED, V61, P1, DOI 10.1002/mrm.21830; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Stevic R, 2007, AGE AGEING, V36, P459, DOI 10.1093/ageing/afm076	31	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34042	10.1371/journal.pone.0034042	http://dx.doi.org/10.1371/journal.pone.0034042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479514	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100105
J	Fantoni, C; Caudek, C; Domini, F				Fantoni, Carlo; Caudek, Corrado; Domini, Fulvio			Perceived Surface Slant Is Systematically Biased in the Actively-Generated Optic Flow	PLOS ONE			English	Article							STRUCTURE-FROM-MOTION; VISUAL-PERCEPTION; 3-D STRUCTURE; 3-DIMENSIONAL STRUCTURE; TEMPORAL INTEGRATION; DEPTH-PERCEPTION; LARGE-FIELD; ORIENTATION; STEREO; INFORMATION	Humans make systematic errors in the 3D interpretation of the optic flow in both passive and active vision. These systematic distortions can be predicted by a biologically-inspired model which disregards self-motion information resulting from head movements (Caudek, Fantoni, & Domini 2011). Here, we tested two predictions of this model: (1) A plane that is stationary in an earth-fixed reference frame will be perceived as changing its slant if the movement of the observer's head causes a variation of the optic flow; (2) a surface that rotates in an earth-fixed reference frame will be perceived to be stationary, if the surface rotation is appropriately yoked to the head movement so as to generate a variation of the surface slant but not of the optic flow. Both predictions were corroborated by two experiments in which observers judged the perceived slant of a random-dot planar surface during egomotion. We found qualitatively similar biases for monocular and binocular viewing of the simulated surfaces, although, in principle, the simultaneous presence of disparity and motion cues allows for a veridical recovery of surface slant.	[Domini, Fulvio] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Caudek, Corrado] Univ Florence, Dipartimento Psicol, Florence, Italy; [Fantoni, Carlo; Caudek, Corrado; Domini, Fulvio] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst UniTn, Rovereto, Italy	Brown University; University of Florence; Istituto Italiano di Tecnologia - IIT	Fantoni, C (corresponding author), Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst UniTn, Rovereto, Italy.	carlo.fantoni@iit.it	Caudek, Corrado/E-3621-2010	Caudek, Corrado/0000-0002-1404-0420				[Anonymous], 2000, MIXED EFFECTS MODELS; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Backus BT, 1999, PERCEPTION, V28, P217, DOI 10.1068/p2753; Banks MS, 1998, VISION RES, V38, P187, DOI 10.1016/S0042-6989(97)00179-X; CAUDEK C, 1993, J EXP PSYCHOL HUMAN, V19, P32, DOI 10.1037/0096-1523.19.1.32; Caudek C, 2002, VISION RES, V42, P1213, DOI 10.1016/S0042-6989(02)00052-4; Caudek C, 1998, J EXP PSYCHOL HUMAN, V24, P609, DOI 10.1037/0096-1523.24.2.609; Caudek C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018731; CLOCKSIN WF, 1980, PERCEPTION, V9, P253, DOI 10.1068/p090253; Colas F, 2007, BIOL CYBERN, V97, P461, DOI 10.1007/s00422-007-0183-z; Cornilleau-Peres V, 2002, VISION RES, V42, P1403, DOI 10.1016/S0042-6989(01)00298-X; Di Luca M, 2010, VISION RES, V50, P1519, DOI 10.1016/j.visres.2010.05.006; Di Luca M, 2007, VISION RES, V47, P1335, DOI 10.1016/j.visres.2006.10.029; DIJKSTRA TMH, 1995, VISION RES, V35, P453, DOI 10.1016/0042-6989(94)00147-E; Domini F, 1998, J EXP PSYCHOL HUMAN, V24, P1273, DOI 10.1037/0096-1523.24.4.1273; Domini F, 1997, J EXP PSYCHOL HUMAN, V23, P1111; Domini F, 1999, J EXP PSYCHOL HUMAN, V25, P426; Domini F, 2003, TRENDS COGN SCI, V7, P444, DOI 10.1016/j.tics.2003.08.007; Domini F, 2003, VISION RES, V43, P1753, DOI 10.1016/S0042-6989(03)00181-0; Domini F, 2003, PERCEPT PSYCHOPHYS, V65, P48, DOI 10.3758/BF03194782; Domini F, 2002, J EXP PSYCHOL HUMAN, V28, P816, DOI 10.1037//0096-1523.28.4.816; Domini F, 1998, PERCEPT PSYCHOPHYS, V60, P747, DOI 10.3758/BF03206060; Domini F, 1998, PERCEPT PSYCHOPHYS, V60, P1164, DOI 10.3758/BF03206166; Domini F, 2006, VISION RES, V46, P1707, DOI 10.1016/j.visres.2005.11.018; Dyde RT, 2008, J VISION, V8, DOI 10.1167/8.14.5; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; Fantoni C, 2008, VISION RES, V48, P1196, DOI 10.1016/j.visres.2008.01.026; Fantoni C, 2008, VISION RES, V48, P16; Fantoni C, 2010, J VISION, V10, DOI 10.1167/10.5.12; Fantoni C, 2008, J VISION, V8, DOI 10.1167/8.7.29; FOLEY JM, 1980, PSYCHOL REV, V87, P411, DOI 10.1037/0033-295X.87.5.411; Foster R, 2011, ACTA PSYCHOL, V136, P300, DOI 10.1016/j.actpsy.2010.12.003; Freeman TCA, 1996, VISION RES, V36, P317, DOI 10.1016/0042-6989(95)00083-C; GARDING J, 1995, VISION RES, V35, P703, DOI 10.1016/0042-6989(94)00162-F; Gibson J.J., 1966, SENSES CONSIDERED PE; Gibson JJ, 1950, PERCEPTION VISUAL WO; HILDRETH EC, 1990, PERCEPT PSYCHOPHYS, V48, P19, DOI 10.3758/BF03205008; Jaekl PM, 2005, EXP BRAIN RES, V163, P388, DOI 10.1007/s00221-004-2191-8; Jain A., 2010, J VISION, V10, p[30, 1], DOI 10.1167/10.14.30; Jain A, 2011, P NATL ACAD SCI USA, V108, P1663, DOI 10.1073/pnas.1016211108; KOENDERINK JJ, 1975, OPT ACTA, V22, P773, DOI 10.1080/713819112; KOENDERINK JJ, 1995, IMAGE VISION COMPUT, V13, P321, DOI 10.1016/0262-8856(95)99719-H; Koenderink JJ, 1978, KYBERNETIK, P224; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Landy MS, 2011, SENSORY CUE INTEGRAT; LITER JC, 1993, PERCEPTION, V22, P1441, DOI 10.1068/p221441; Liter JC, 1998, J EXP PSYCHOL HUMAN, V24, P1257, DOI 10.1037/0096-1523.24.4.1257; LONGUETHIGGINS HC, 1980, PROC R SOC SER B-BIO, V208, P385, DOI 10.1098/rspb.1980.0057; Mon-Williams M, 2000, EXP BRAIN RES, V133, P407, DOI 10.1007/s002210000410; NORMAN JF, 1993, PERCEPT PSYCHOPHYS, V53, P279, DOI 10.3758/BF03205183; RICHARDS W, 1985, J OPT SOC AM A, V2, P343, DOI 10.1364/JOSAA.2.000343; ROGERS BJ, 1995, PERCEPTION, V24, P155, DOI 10.1068/p240155; ROGERS S, 1992, PERCEPT PSYCHOPHYS, V52, P446, DOI 10.3758/BF03206704; Sherrington C.S., 1906, INTEGRATIVE ACTION N, Vfirst, DOI 10.1037/13798-000; Tassinari H, 2008, PERCEPTION, V37, P79, DOI 10.1068/p5501; TODD JT, 1990, PERCEPT PSYCHOPHYS, V48, P419, DOI 10.3758/BF03211585; Todd JT, 1999, PERCEPT PSYCHOPHYS, V61, P1577, DOI 10.3758/BF03213119; ULLMAN S, 1984, PERCEPTION, V13, P255, DOI 10.1068/p130255; ULLMAN S, 1979, PROC R SOC SER B-BIO, V203, P405, DOI 10.1098/rspb.1979.0006; ULLMAN S, 1986, Spatial Vision, V1, P263, DOI 10.1163/156856886X00070; van Boxtel JJA, 2003, J VISION, V3, P318, DOI 10.1167/3.5.1; von Helmholtz H, 2002, HDB PHYSL OPTICS; Wexler M, 2005, TRENDS COGN SCI, V9, P431, DOI 10.1016/j.tics.2005.06.018; Wexler M, 2005, P NATL ACAD SCI USA, V102, P1246, DOI 10.1073/pnas.0409241102; Wexler M, 2003, PSYCHOL SCI, V14, P340, DOI 10.1111/1467-9280.14491; Wexler M, 2001, VISION RES, V41, P3023, DOI 10.1016/S0042-6989(01)00190-0; Wexler M, 2002, TRENDS COGN SCI, V6, P497, DOI 10.1016/S1364-6613(02)02023-5; Wexler M, 2001, NATURE, V409, P85, DOI 10.1038/35051081; Zhong H, 2006, VISION RES, V46, P3494, DOI 10.1016/j.visres.2006.04.003	69	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33911	10.1371/journal.pone.0033911	http://dx.doi.org/10.1371/journal.pone.0033911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UC	22479473	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100080
J	Kalfa, N; Fukami, M; Philibert, P; Audran, F; Pienkowski, C; Weill, J; Pinto, G; Manouvrier, S; Polak, M; Ogata, T; Sultan, C				Kalfa, Nicolas; Fukami, Maki; Philibert, Pascal; Audran, Francoise; Pienkowski, Catherine; Weill, Jacques; Pinto, Graziella; Manouvrier, Sylvie; Polak, Michel; Ogata, Totsumo; Sultan, Charles			Screening of MAMLD1 Mutations in 70 Children with 46,XY DSD: Identification and Functional Analysis of Two New Mutations	PLOS ONE			English	Article							CONTIGUOUS GENE SYNDROME; STEROIDOGENIC FACTOR-I; STRUCTURE PREDICTION; MYOTUBULAR MYOPATHY; HYPOSPADIAS; CXORF6; XQ28; POLYMORPHISMS; DISORDERS; GENITALIA	More than 50% of children with severe 46,XY disorders of sex development (DSD) do not have a definitive etiological diagnosis. Besides gonadal dysgenesis, defects in androgen biosynthesis, and abnormalities in androgen sensitivity, the Mastermind-like domain containing 1 (MAMLD1) gene, which was identified as critical for the development of male genitalia, may be implicated. The present study investigated whether MAMLD1 is implicated in cases of severe 46, XY DSD and whether routine sequencing of MAMLD1 should be performed in these patients. Seventy children with severe non-syndromic 46, XY DSD of unknown etiology were studied. One hundred and fifty healthy individuals were included as controls. Direct sequencing of the MAMLD1, AR, SRD5A2 and NR5A1 genes was performed. The transactivation function of the variant MAMLD1 proteins was quantified by the luciferase method. Two new mutations were identified: p.S143X (c.428C>A) in a patient with scrotal hypospadias with microphallus and p.P384L (c.1151C>T) in a patient with penile hypospadias with microphallus. The in vitro functional study confirmed no residual transactivating function of the p.S143X mutant and a significantly reduced transactivation function of the p.P384L protein (p = 0.0032). The p.P359S, p.N662S and p.H347Q variants are also reported with particularly high frequency of the p.359T- p.662G haplotype in the DSD patients. Severe undervirilization in XY newborns can reveal mutations of MAMLD1. MAMLD1 should be routinely sequenced in these patients with otherwise normal AR, SRD5A2 and NR5A1genes.	[Kalfa, Nicolas; Philibert, Pascal; Audran, Francoise; Sultan, Charles] CHU Montpellier, Hop Lapeyronie, Serv Hormonol, Montpellier, France; [Sultan, Charles] CHU Montpellier, UM1, Montpellier, France; [Kalfa, Nicolas; Sultan, Charles] CHU Montpellier, Hop Lapeyronie, Serv Chirurg & Urol Pediat, Montpellier, France; [Fukami, Maki; Ogata, Totsumo] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Pienkowski, Catherine] CHU Toulouse, Hop Enfants, Unite Endocrinol Pediat, Toulouse, France; [Weill, Jacques] CHU Lille, Hop Jeanne de Flandre, Pediat Clin, F-59037 Lille, France; [Pinto, Graziella; Polak, Michel] Hop Necker Enfants Malad, APHP, Unite Endocrinol Pediat, Paris, France; [Manouvrier, Sylvie] CHU Lille, Hop Jeanne de Flandre, Serv Genet Clin, F-59037 Lille, France; [Sultan, Charles] Hop Arnaud de Villeneuve, Serv Pediat, Unite Endocrinol & Gynecol Pediat, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; National Center for Child Health & Development - Japan; CHU de Toulouse; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Montpellier	Kalfa, N (corresponding author), CHU Montpellier, Hop Lapeyronie, Serv Hormonol, Montpellier, France.	c-sultan@chu-montpellier.fr	Fukami, Maki/ABE-4694-2020; Kalfa, Nicolas/AAZ-8096-2021; Kalfa, Nicolas/AAC-9287-2020; Philibert, Pascal/C-6728-2008	Fukami, Maki/0000-0001-9971-4035; Kalfa, Nicolas/0000-0001-5472-4096; Philibert, Pascal/0000-0001-6384-521X; Ogata, Tsutomu/0000-0001-7178-9991	Programme Hospitalier de Recherch Clinique Inter-Regional (PHRC) [UF 8270]; Fondation pour la Recherche Medicale [FRM110309]; Grants-in-Aid for Scientific Research [22227002] Funding Source: KAKEN	Programme Hospitalier de Recherch Clinique Inter-Regional (PHRC); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was funded by a Programme Hospitalier de Recherch Clinique Inter-Regional (PHRC number UF 8270) provided by CHU de Montpellier and by a grant from Fondation pour la Recherche Medicale FRM110309. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch O, 1999, CYTOGENET CELL GENET, V85, P310, DOI 10.1159/000015284; Chen YG, 2010, EUR J MED GENET, V53, P122, DOI 10.1016/j.ejmg.2010.03.005; Choi JH, 2008, J PEDIATR ENDOCR MET, V21, P545; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Coutant R, 2007, J CLIN ENDOCR METAB, V92, P2868, DOI 10.1210/jc.2007-0024; Fisch H, 2010, J PEDIATR UROL, V6, P37, DOI 10.1016/j.jpurol.2009.05.005; Fukami M, 2008, J BIOL CHEM, V283, P5525, DOI 10.1074/jbc.M703289200; Fukami M, 2006, NAT GENET, V38, P1369, DOI 10.1038/ng1900; Hu LJ, 1996, HUM MOL GENET, V5, P139, DOI 10.1093/hmg/5.1.139; Kalfa N, 2011, J PEDIATR UROL, V7, P585, DOI 10.1016/j.jpurol.2011.09.005; Kalfa N, 2008, EUR J ENDOCRINOL, V159, P453, DOI 10.1530/EJE-08-0085; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Laporte J, 1997, GENOMICS, V41, P458, DOI 10.1006/geno.1997.4662; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; Maimoun L, 2011, J CLIN ENDOCR METAB, V96, P296, DOI 10.1210/jc.2010-1024; Martinez-Frias ML, 2004, BIRTH DEFECTS RES A, V70, P75, DOI 10.1002/bdra.10149; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Morel Y, 2002, EUR J PEDIATR, V161, P49, DOI 10.1007/s00431-001-0854-z; Nelson P, 2007, DIALOGUES PEDIAT URO, V28, P2; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Ogata T, 2009, HORM RES, V71, P245, DOI 10.1159/000208797; Paulozzi LJ, 1997, PEDIATRICS, V100, P831, DOI 10.1542/peds.100.5.831; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Philibert P, 2010, FERTIL STERIL, V94, P472, DOI 10.1016/j.fertnstert.2009.03.057; Philibert P, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-28; Quigley C A, 1994, Curr Ther Endocrinol Metab, V5, P342; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sadovsky Y, 2000, REV REPROD, V5, P136; Shibata Y, 2010, UROLOGY, V76, P78, DOI 10.1016/j.urology.2010.02.043; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thyen U, 2006, HORM RES, V66, P195, DOI 10.1159/000094782; Welsh M, 2010, INT J ANDROL, V33, pE144, DOI 10.1111/j.1365-2605.2009.00978.x; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	34	25	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32505	10.1371/journal.pone.0032505	http://dx.doi.org/10.1371/journal.pone.0032505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479329	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100012
J	Shimizu, Y; Kihara, T; Haghparast, SMA; Yuba, S; Miyake, J				Shimizu, Yuji; Kihara, Takanori; Haghparast, Seyed Mohammad Ali; Yuba, Shunsuke; Miyake, Jun			Simple Display System of Mechanical Properties of Cells and Their Dispersion	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; LASER OPTICAL TWEEZERS; ATOMIC-FORCE; SURGERY SIMULATION; ACTIN; CYTOSKELETON; MICROSCOPY; STIFFNESS; CULTURE	The mechanical properties of cells are unique indicators of their states and functions. Though, it is difficult to recognize the degrees of mechanical properties, due to small size of the cell and broad distribution of the mechanical properties. Here, we developed a simple virtual reality system for presenting the mechanical properties of cells and their dispersion using a haptic device and a PC. This system simulates atomic force microscopy (AFM) nanoindentation experiments for floating cells in virtual environments. An operator can virtually position the AFM spherical probe over a round cell with the haptic handle on the PC monitor and feel the force interaction. The Young's modulus of mesenchymal stem cells and HEK293 cells in the floating state was measured by AFM. The distribution of the Young's modulus of these cells was broad, and the distribution complied with a log-normal pattern. To represent the mechanical properties together with the cell variance, we used log-normal distribution-dependent random number determined by the mode and variance values of the Young's modulus of these cells. The represented Young's modulus was determined for each touching event of the probe surface and the cell object, and the haptic device-generating force was calculated using a Hertz model corresponding to the indentation depth and the fixed Young's modulus value. Using this system, we can feel the mechanical properties and their dispersion in each cell type in real time. This system will help us not only recognize the degrees of mechanical properties of diverse cells but also share them with others.	[Shimizu, Yuji; Kihara, Takanori; Haghparast, Seyed Mohammad Ali; Miyake, Jun] Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, Toyonaka, Osaka 560, Japan; [Yuba, Shunsuke] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Amagasaki, Hyogo, Japan	Osaka University; National Institute of Advanced Industrial Science & Technology (AIST)	Shimizu, Y (corresponding author), Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, Toyonaka, Osaka 560, Japan.	takanori.kihara@gmail.com			Okinawa Prefecture, Japan; Graduate School of Engineering Science, Osaka University, Japan	Okinawa Prefecture, Japan; Graduate School of Engineering Science, Osaka University, Japan	This study was supported by grants from Okinawa Prefecture, Japan (http://www.pref.okinawa.jp/english/index.html) (research project of industrialization of medical innovation and technology to J.M.) and Graduate School of Engineering Science, Osaka University, Japan (http://www.es.osaka-u.ac.jp/eng/index.html) (Multidisciplinary Research Laboratory System to T.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOX GEP, 1958, ANN MATH STAT, V29, P610, DOI 10.1214/aoms/1177706645; Bro-Nielsen M, 1998, P IEEE, V86, P490, DOI 10.1109/5.662874; Burdea GC, 2003, VIURTUAL REALITY TEC; Choi C, 2009, INT J MED ROBOT COMP, V5, P257, DOI 10.1002/rcs.256; Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001; Costa Kevin D., 2006, V319, P331; Cotin S, 1999, IEEE T VIS COMPUT GR, V5, P62, DOI 10.1109/2945.764872; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; DAI JW, 1995, BIOPHYS J, V68, P988, DOI 10.1016/S0006-3495(95)80274-2; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fager PJ, 2004, INT J MED ROBOT COMP, V1, P36, DOI 10.1581/mrcas.2004.010102; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fouchard J, 2011, CELL ADHES MIGR, V5, P16, DOI 10.4161/cam.5.1.13281; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003; Kagiwada H, 2010, CYTOSKELETON, V67, P496, DOI 10.1002/cm.20460; Kato K, 2003, BIOTECHNIQUES, V35, P1014, DOI 10.2144/03355rr01; Kihara T, 2011, BIOCHEM BIOPH RES CO, V409, P1, DOI 10.1016/j.bbrc.2011.04.022; Kotobuki N, 2005, TISSUE ENG, V11, P663, DOI 10.1089/ten.2005.11.663; Kuroda Y, 2005, COMPUT METH PROG BIO, V80, P216, DOI 10.1016/j.cmpb.2005.09.001; Ladjal H, 2009, P IEEE INT C INT ROB, P1326; Ladjal H, 2010, IEEE-ASME T MECH, V15, P1; Lulevich V, 2006, LANGMUIR, V22, P8151, DOI 10.1021/la060561p; Maloney JM, 2010, BIOPHYS J, V99, P2479, DOI 10.1016/j.bpj.2010.08.052; Mathur AB, 2000, BIOPHYS J, V78, P1725, DOI 10.1016/S0006-3495(00)76724-5; Matzke R, 2001, NAT CELL BIOL, V3, P607, DOI 10.1038/35078583; Nagayama M, 2001, CELL MOTIL CYTOSKEL, V50, P173, DOI 10.1002/cm.10008; NASH GB, 1989, BLOOD, V74, P855, DOI 10.1182/blood.V74.2.855.bloodjournal742855; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Sugitate T, 2009, CURR APPL PHYS, V9, pE291, DOI 10.1016/j.cap.2009.06.020; Titushkin I, 2006, BIOPHYS J, V90, P2582, DOI 10.1529/biophysj.105.073775; Trickey WR, 2004, J ORTHOPAED RES, V22, P131, DOI 10.1016/S0736-0266(03)00150-5; Van Vliet KJ, 2003, ACTA MATER, V51, P5881, DOI 10.1016/j.actamat.2003.09.001	34	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34305	10.1371/journal.pone.0034305	http://dx.doi.org/10.1371/journal.pone.0034305			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479595	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100147
J	Song, KY; An, KA; Yang, G; Huang, JP				Song, Kunyu; An, Kenan; Yang, Guang; Huang, Jiping			Risk-Return Relationship in a Complex Adaptive System	PLOS ONE			English	Article							PHASE-TRANSITIONS; DECISION-MAKING; MINORITY GAME; EQUILIBRIUM; BEHAVIOR; PARADOX	For survival and development, autonomous agents in complex adaptive systems involving the human society must compete against or collaborate with others for sharing limited resources or wealth, by using different methods. One method is to invest, in order to obtain payoffs with risk. It is a common belief that investments with a positive risk-return relationship (namely, high risk high return and vice versa) are dominant over those with a negative risk-return relationship (i.e., high risk low return and vice versa) in the human society; the belief has a notable impact on daily investing activities of investors. Here we investigate the risk-return relationship in a model complex adaptive system, in order to study the effect of both market efficiency and closeness that exist in the human society and play an important role in helping to establish traditional finance/economics theories. We conduct a series of computer-aided human experiments, and also perform agent-based simulations and theoretical analysis to confirm the experimental observations and reveal the underlying mechanism. We report that investments with a negative risk-return relationship have dominance over those with a positive risk-return relationship instead in such a complex adaptive systems. We formulate the dynamical process for the system's evolution, which helps to discover the different role of identical and heterogeneous preferences. This work might be valuable not only to complexity science, but also to finance and economics, to management and social science, and to physics.	[Song, Kunyu] Fudan Univ, Dept Phys, State Key Lab Surface Phys, Shanghai 200433, Peoples R China; Fudan Univ, Minist Educ, Key Lab Micro & Nano Photon Struct, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Song, KY (corresponding author), Fudan Univ, Dept Phys, State Key Lab Surface Phys, Shanghai 200433, Peoples R China.	jphuang@fudan.edu.cn	huang, jiping/G-7865-2011		National Natural Science Foundation of China [10874025, 11075035]; Chinese National Key Basic Research Special Fund [2011CB922004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Key Basic Research Special Fund(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China under Grant Nos. 10874025 and 11075035, and by Chinese National Key Basic Research Special Fund under Grant No. 2011CB922004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; BOWMAN EH, 1980, SLOAN MANAGE REV, V21, P17; Cavagna A, 2010, P NATL ACAD SCI USA, V107, P11865, DOI 10.1073/pnas.1005766107; Challet D, 1997, PHYSICA A, V246, P407, DOI 10.1016/S0378-4371(97)00419-6; FAMA EF, 1973, J POLIT ECON, V81, P607, DOI 10.1086/260061; Farmer JD, 2009, NATURE, V460, P685, DOI 10.1038/460685a; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Hart M, 2001, PHYSICA A, V298, P537, DOI 10.1016/S0378-4371(01)00245-X; Holland J. H., 1992, ADAPTATION NATURAL A; Johnson NF, 2005, LECT NOTES ECON MATH, P55; Laureti P, 2004, PHYSICA A, V331, P651, DOI 10.1016/j.physa.2003.07.002; RUEFLI TW, 1990, MANAGE SCI, V36, P368, DOI 10.1287/mnsc.36.3.368; Savit R, 1999, PHYS REV LETT, V82, P2203, DOI 10.1103/PhysRevLett.82.2203; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Takano Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009368; Wang W, 2009, P NATL ACAD SCI USA, V106, P8423, DOI 10.1073/pnas.0811782106; Zhao L, 2011, P NATL ACAD SCI USA, V108, P15058, DOI 10.1073/pnas.1105239108	17	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33588	10.1371/journal.pone.0033588	http://dx.doi.org/10.1371/journal.pone.0033588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UC	22479416	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339100060
J	Cheng, WL; Tsai, MM; Tsai, CY; Huang, YH; Chen, CY; Chi, HC; Tseng, YH; Chao, IW; Lin, WC; Wu, SM; Liang, Y; Liao, CJ; Lin, YH; Chung, IH; Chen, WJ; Lin, PY; Wang, CS; Lin, KH				Cheng, Wan-Li; Tsai, Ming-Ming; Tsai, Chung-Ying; Huang, Ya-Hui; Chen, Cheng-Yi; Chi, Hsiang-Cheng; Tseng, Yi-Hsin; Chao, Im-Wai; Lin, Wei-Chi; Wu, Sheng-Ming; Liang, Ying; Liao, Chia-Jung; Lin, Yang-Hsiang; Chung, I-Hsiao; Chen, Wei-Jan; Lin, Paul Y.; Wang, Chia-Siu; Lin, Kwang-Huei			Glyoxalase-I Is a Novel Prognosis Factor Associated with Gastric Cancer Progression	PLOS ONE			English	Article							PEROXIDASE COMPLEX; EXPRESSION; OVEREXPRESSION; PROTEIN; CARCINOMA; ANTIBODY; GENE; METHYLGLYOXAL; INHIBITOR; ESTROGEN	Glyoxalase I (GLO1), a methylglyoxal detoxification enzyme, is implicated in the progression of human malignancies. The role of GLO1 in gastric cancer development or progression is currently unclear. The expression of GLO1 was determined in primary gastric cancer specimens using quantitative polymerase chain reaction, immunohistochemistry (IHC), and western blotting analyses. GLO1 expression was higher in gastric cancer tissues, compared with that in adjacent noncancerous tissues. Elevated expression of GLO1 was significantly associated with gastric wall invasion, lymph node metastasis, and pathological stage, suggesting a novel role of GLO1 in gastric cancer development and progression. The 5-year survival rate of the lower GLO1 expression groups was significantly greater than that of the higher expression groups (log rank P = 0.0373) in IHC experiments. Over-expression of GLO1 in gastric cancer cell lines increases cell proliferation, migration and invasiveness. Conversely, down-regulation of GLO1 with shRNA led to a marked reduction in the migration and invasion abilities. Our data strongly suggest that high expression of GLO1 in gastric cancer enhances the metastasis ability of tumor cells in vitro and in vivo, and support its efficacy as a potential marker for the detection and prognosis of gastric cancer.	[Cheng, Wan-Li; Tsai, Ming-Ming; Tsai, Chung-Ying; Chen, Cheng-Yi; Chi, Hsiang-Cheng; Tseng, Yi-Hsin; Chao, Im-Wai; Lin, Wei-Chi; Wu, Sheng-Ming; Liao, Chia-Jung; Lin, Yang-Hsiang; Chung, I-Hsiao; Lin, Kwang-Huei] Chang Gung Univ, Dept Biochem, Tao Yuan, Taiwan; [Tsai, Ming-Ming] Chang Gung Univ Sci & Technol, Dept Nursing, Tao Yuan, Taiwan; [Huang, Ya-Hui] Chang Gung Mem Hosp, Med Res Ctr, Tao Yuan, Taiwan; [Liang, Ying] Chang Gung Univ, Prote Core Lab, Tao Yuan, Taiwan; [Chen, Wei-Jan] Chang Gung Mem Hosp, Cardiovasc Div 1, Tao Yuan, Taiwan; [Lin, Paul Y.] Chang Gung Mem Hosp, Dept Pathol, Chiayi, Taiwan; [Wang, Chia-Siu] Chang Gung Mem Hosp, Dept Gen Surg, Chiayi, Taiwan	Chang Gung University; Chang Gung University of Science & Technology; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Cheng, WL (corresponding author), Chang Gung Univ, Dept Biochem, Tao Yuan, Taiwan.	khlin@mail.cgu.edu.tw			Chang-Gung University, Taoyuan, Taiwan [NMRPD 150311, NMRPD170441-42, CMRPG 640042-43, CMRPG 670291-93]; National Science Council of the Republic of China (NSC) [95-2314-B-182-027, 97-2314-B-182-009-MY2, 99-2314-B-182-022]	Chang-Gung University, Taoyuan, Taiwan; National Science Council of the Republic of China (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Chang-Gung University, Taoyuan, Taiwan (NMRPD 150311, NMRPD170441-42, CMRPG 640042-43, CMRPG 670291-93) and the National Science Council of the Republic of China (NSC 95-2314-B-182-027, 97-2314-B-182-009-MY2, 99-2314-B-182-022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antognelli C, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-115; Bair WB, 2010, MELANOMA RES, V20, P85, DOI 10.1097/CMR.0b013e3283364903; Bedogni B, 2009, PIGM CELL MELANOMA R, V22, P166, DOI 10.1111/j.1755-148X.2009.00553.x; Ceradini DJ, 2008, J BIOL CHEM, V283, P10930, DOI 10.1074/jbc.M707451200; Chen CD, 2007, PROTEOMICS, V7, P155, DOI 10.1002/pmic.200600663; Cheng WL, 2011, ANN ONCOL, V22, P2267, DOI 10.1093/annonc/mdq739; Cheng WL, 2008, INT J CANCER, V123, P1787, DOI 10.1002/ijc.23746; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Department of Health Taiwan, 2010, CAUS DEATH STAT; GOULDING H, 1995, HUM PATHOL, V26, P291, DOI 10.1016/0046-8177(95)90060-8; Greene FLPA, 2002, AJCC CANC STAGING MA, P99; Griffiths EA, 2005, EUR J CANCER, V41, P2792, DOI 10.1016/j.ejca.2005.09.008; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; Huang YH, 2006, ENDOCRINOLOGY, V147, P2481, DOI 10.1210/en.2005-1166; Japanese Gastric Cancer A, 1998, GASTRIC CANCER, V1, P10, DOI DOI 10.1007/PL00011681]; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kavarana MJ, 1999, J MED CHEM, V42, P221, DOI 10.1021/jm9708036; Konno H, 2003, CANCER SCI, V94, P735, DOI 10.1111/j.1349-7006.2003.tb01511.x; Lin KH, 2002, ENDOCRINOLOGY, V143, P467, DOI 10.1210/en.143.2.467; Liu XE, 2004, WORLD J GASTROENTERO, V10, P352; Mao XY, 2007, WORLD J GASTROENTERO, V13, P3466, DOI 10.3748/wjg.v13.i25.3466; Nikolsky Y, 2005, TOXICOL LETT, V158, P20, DOI 10.1016/j.toxlet.2005.02.004; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Ranganathan S, 1999, GENE, V240, P149, DOI 10.1016/S0378-1119(99)00420-5; Rohwer N, 2009, BRIT J CANCER, V100, P772, DOI 10.1038/sj.bjc.6604919; Rohwer N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012038; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Sakamoto H, 2000, BLOOD, V95, P3214, DOI 10.1182/blood.V95.10.3214; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Thornalley PJ, 2011, SEMIN CELL DEV BIOL, V22, P318, DOI 10.1016/j.semcdb.2011.02.006; Thornalley PJ, 1996, BIOCHEM PHARMACOL, V51, P1365, DOI 10.1016/0006-2952(96)00059-7; THORNALLEY PJ, 1995, CRIT REV ONCOL HEMAT, V20, P99, DOI 10.1016/1040-8428(94)00149-N; Tsai MS, 2007, STEM CELLS, V25, P2511, DOI 10.1634/stemcells.2007-0023; Tsujimoto H, 2010, GASTRIC CANCER, V13, P212, DOI 10.1007/s10120-010-0568-x; Wang Chia-Siu, 2002, Chang Gung Med J, V25, P216; Wang CS, 2004, BRIT J CANCER, V91, P1924, DOI 10.1038/sj.bjc.6602213; Westermarck J, 1999, FASEB J, V13, P781, DOI 10.1096/fasebj.13.8.781; Wu CC, 2005, PROTEOMICS, V5, P3173, DOI 10.1002/pmic.200401133; Yao JC, 2004, CLIN CANCER RES, V10, P4109, DOI 10.1158/1078-0432.CCR-03-0628; Zhang DH, 2005, MOL CELL PROTEOMICS, V4, P1686, DOI 10.1074/mcp.M400221-MCP200	43	53	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34352	10.1371/journal.pone.0034352	http://dx.doi.org/10.1371/journal.pone.0034352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479608	gold, Green Submitted, Green Published			2022-12-27	WOS:000304523400076
J	Baruffini, E; Serafini, F; Ferrero, I; Lodi, T				Baruffini, Enrico; Serafini, Fausta; Ferrero, Iliana; Lodi, Tiziana			Overexpression of DNA Polymerase Zeta Reduces the Mitochondrial Mutability Caused by Pathological Mutations in DNA Polymerase Gamma in Yeast	PLOS ONE			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; COLI SHUTTLE VECTORS; LARGE RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; INDUCED MUTAGENESIS; REV1 PROTEIN; RESISTANCE MUTATIONS; DEPLETION SYNDROMES; COMPLEX-FORMATION; GENE-EXPRESSION	In yeast, DNA polymerase zeta (Rev3 and Rev7) and Rev1, involved in the error-prone translesion synthesis during replication of nuclear DNA, localize also in mitochondria. We show that overexpression of Rev3 reduced the mtDNA extended mutability caused by a subclass of pathological mutations in Mip1, the yeast mitochondrial DNA polymerase orthologous to human Pol gamma. This beneficial effect was synergistic with the effect achieved by increasing the dNTPs pools. Since overexpression of Rev3 is detrimental for nuclear DNA mutability, we constructed a mutant Rev3 isoform unable to migrate into the nucleus: its overexpression reduced mtDNA mutability without increasing the nuclear one.	[Baruffini, Enrico; Serafini, Fausta; Ferrero, Iliana; Lodi, Tiziana] Univ Parma, Dept Genet, I-43100 Parma, Italy	University of Parma	Baruffini, E (corresponding author), Univ Parma, Dept Genet, I-43100 Parma, Italy.	enrico.baruffini@nemo.unipr.it	lodi, tiziana/A-5993-2012; Baruffini, Enrico/C-1057-2015; Baruffini, Enrico/AAL-2608-2020	lodi, tiziana/0000-0002-7294-8971; Baruffini, Enrico/0000-0002-8280-7849; Baruffini, Enrico/0000-0002-8280-7849	Fondazione Telethon-Italy [GGP07019]	Fondazione Telethon-Italy(Fondazione Telethon)	This work was supported by the Fondazione Telethon-Italy [GGP07019], http://www.telethon.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya N, 2005, MOL CELL BIOL, V25, P9734, DOI 10.1128/MCB.25.21.9734-9740.2005; Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Atanassova N, 2011, HUM MOL GENET, V20, P1212, DOI 10.1093/hmg/ddq565; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Baruffini E, 2007, BIOCHIM BIOPHYS ACTA, V1772, P225; Baruffini E, 2006, HUM MOL GENET, V15, P2846, DOI 10.1093/hmg/ddl219; Baruffini E, 2011, MITOCHONDRION, V11, P182, DOI 10.1016/j.mito.2010.09.007; Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023; Baruffini E, 2010, MITOCHONDRION, V10, P183, DOI 10.1016/j.mito.2009.10.002; Baruffini E, 2009, J BIOTECHNOL, V143, P247, DOI 10.1016/j.jbiotec.2009.08.007; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074; Chiappini F, 2009, CURR HIV RES, V7, P244, DOI 10.2174/157016209787581409; CHIT NW, 1994, J BIOL CHEM, V269, P29993; CODON AC, 1995, APPL ENVIRON MICROB, V61, P630; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; CUI Z, 1989, CURR GENET, V16, P273, DOI 10.1007/BF00422114; de Padula M, 2004, NUCLEIC ACIDS RES, V32, P5003, DOI 10.1093/nar/gkh831; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Dujon B., 1981, MOL BIOL YEAST SACCH, P505; Euro L, 2011, NUCLEIC ACIDS RES, V39, P9072, DOI 10.1093/nar/gkr618; Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279; Gibson BR, 2008, LETT APPL MICROBIOL, V46, P636, DOI 10.1111/j.1472-765X.2008.02360.x; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Graziewicz MA, 2004, NAT STRUCT MOL BIOL, V11, P770, DOI 10.1038/nsmb805; Graziewicz MA, 2004, NUCLEIC ACIDS RES, V32, P397, DOI 10.1093/nar/gkh213; Graziewicz MA, 2007, HUM MOL GENET, V16, P2729, DOI 10.1093/hmg/ddm227; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Haracska L, 2003, MOL CELL BIOL, V23, P1453, DOI 10.1128/MCB.23.4.1453-1459.2003; Hisama FM, 2005, AM J MED GENET A, V135A, P217, DOI 10.1002/ajmg.a.30672; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang ME, 2002, GENETICS, V160, P1409; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Kaiser C., 1994, METHODS YEAST GENETI; Kalifa L, 2007, DNA REPAIR, V6, P1732, DOI 10.1016/j.dnarep.2007.06.005; Kaniak A, 2009, DNA REPAIR, V8, P318, DOI 10.1016/j.dnarep.2008.11.004; Kasiviswanathan R, 2011, J BIOL CHEM, DOI [10.1074/jbc.M111.306852jbc.M111.306852, DOI 10.1074/JBC.M111.306852JBC.M111.306852]; KUENZI MT, 1974, J BACTERIOL, V117, P80; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; Lawrence CW, 1996, CANCER SURV, V28, P21; Lawrence CW, 2000, COLD SPRING HARB SYM, V65, P61, DOI 10.1101/sqb.2000.65.61; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lebedeva MA, 2007, CELL CYCLE, V6, P2048, DOI 10.4161/cc.6.16.4572; LECRENIER N, 1995, MOL GEN GENET, V249, P1, DOI 10.1007/BF00290229; Lee JC, 2001, FEMS YEAST RES, V1, P57; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Lucas P, 2004, MITOCHONDRION, V4, P13, DOI 10.1016/j.mito.2004.04.001; Mieczkowski PA, 1997, MOL GEN GENET, V253, P655, DOI 10.1007/s004380050369; Mookerjee SA, 2006, MUTAT RES-FUND MOL M, V595, P91, DOI 10.1016/j.mrfmmm.2005.10.006; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202; Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200; Rajpal DK, 2000, MUTAT RES-DNA REPAIR, V461, P133, DOI 10.1016/S0921-8777(00)00047-1; Saneto RP, 2010, SEIZURE-EUR J EPILEP, V19, P140, DOI 10.1016/j.seizure.2010.01.002; Sembongi H, 2007, HUM MOL GENET, V16, P2306, DOI 10.1093/hmg/ddm182; Sherman F, 1986, LAB COURSE MANUAL ME; Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71; SINGHAL RK, 1992, MOL GEN GENET, V236, P17, DOI 10.1007/BF00279638; SOR F, 1984, NUCLEIC ACIDS RES, V12, P8313, DOI 10.1093/nar/12.22.8313; SOR F, 1982, NUCLEIC ACIDS RES, V10, P6571, DOI 10.1093/nar/10.21.6571; Spinazzola A, 2009, J INHERIT METAB DIS, V32, P143, DOI 10.1007/s10545-008-1038-z; Stewart JD, 2010, HEPATOLOGY, V52, P1791, DOI 10.1002/hep.23891; Stricker S, 2009, J NEUROL NEUROSUR PS, V80, P1181, DOI 10.1136/jnnp.2008.166066; Stuart GR, 2006, HUM MOL GENET, V15, P363, DOI 10.1093/hmg/ddi454; Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4; Stumpf JD, 2010, HUM MOL GENET, V19, P2123, DOI 10.1093/hmg/ddq089; Szczepanowska K, 2010, HUM MOL GENET, V19, P3516, DOI 10.1093/hmg/ddq267; Taylor SD, 2005, MOL BIOL CELL, V16, P3010, DOI 10.1091/mbc.E05-01-0053; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Vanderstraeten S, 1998, J BIOL CHEM, V273, P23690, DOI 10.1074/jbc.273.37.23690; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Yamanaka H, 2007, J INFECT DIS, V195, P1419, DOI 10.1086/513872; Zhang HS, 2006, GENETICS, V172, P2683, DOI 10.1534/genetics.105.051029; Zhao XL, 1998, MOL CELL, V2, P329, DOI 10.1016/S1097-2765(00)80277-4	81	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34322	10.1371/journal.pone.0034322	http://dx.doi.org/10.1371/journal.pone.0034322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470557	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000096
J	Chouvenc, T; Su, NY				Chouvenc, Thomas; Su, Nan-Yao			When Subterranean Termites Challenge the Rules of Fungal Epizootics	PLOS ONE			English	Article							RETICULITERMES-FLAVIPES ISOPTERA; BIOLOGICAL-CONTROL AGENTS; METARHIZIUM-ANISOPLIAE; COPTOTERMES-FORMOSANUS; DISEASE RESISTANCE; DEFENSE-MECHANISMS; RHINOTERMITIDAE; INSECT; ANTIFUNGAL; EVOLUTION	Over the past 50 years, repeated attempts have been made to develop biological control technologies for use against economically important species of subterranean termites, focusing primarily on the use of the entomopathogenic fungus Metarhizium anisopliae. However, no successful field implementation of biological control has been reported. Most previous work has been conducted under the assumption that environmental conditions within termite nests would favor the growth and dispersion of entomopathogenic agents, resulting in an epizootic. Epizootics rely on the ability of the pathogenic microorganism to self-replicate and disperse among the host population. However, our study shows that due to multilevel disease resistance mechanisms, the incidence of an epizootic within a group of termites is unlikely. By exposing groups of 50 termites in planar arenas containing sand particles treated with a range of densities of an entomopathogenic fungus, we were able to quantify behavioral patterns as a function of the death ratios resulting from the fungal exposure. The inability of the fungal pathogen M. anisopliae to complete its life cycle within a Coptotermes formosanus (Isoptera: Rhinotermitidae) group was mainly the result of cannibalism and the burial behavior of the nest mates, even when termite mortality reached up to 75%. Because a subterranean termite colony, as a superorganism, can prevent epizootics of M. anisopliae, the traditional concepts of epizootiology may not apply to this social insect when exposed to fungal pathogens, or other pathogen for which termites have evolved behavioral and physiological means of disrupting their life cycle.	[Chouvenc, Thomas; Su, Nan-Yao] Univ Florida, Dept Entomol & Nematol, Ft Lauderdale, FL 33314 USA	State University System of Florida; University of Florida	Chouvenc, T (corresponding author), Univ Florida, Dept Entomol & Nematol, Ft Lauderdale, FL 33314 USA.	tomchouv@ufl.edu	su, nan/GRS-5213-2022		United States Department of Agriculture - Agricultural Research Service [58-6435-8-276]; University of Florida [00094648]	United States Department of Agriculture - Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); University of Florida(University of Florida)	This study was supported by a grant from the United States Department of Agriculture - Agricultural Research Service under the grant agreement no. 58-6435-8-276 and by a research opportunity seed fund from the University of Florida under the grant agreement no. 00094648. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1982, PARASITOLOGY, V84, P3, DOI 10.1017/S0031182000053592; Baer B, 2005, INSECT SOC, V52, P298, DOI 10.1007/s00040-005-0809-x; Bulmer MS, 2010, INSECT MOL BIOL, V19, P669, DOI 10.1111/j.1365-2583.2010.01023.x; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Chouvenc T, 2012, INSECT SOC, V59, P119, DOI 10.1007/s00040-011-0197-3; Chouvenc T, 2008, J ECON ENTOMOL, V101, P885, DOI 10.1603/0022-0493(2008)101[885:IBTSTR]2.0.CO;2; Chouvenc T, 2011, FLA ENTOMOL, V94, P817, DOI 10.1653/024.094.0413; Chouvenc T, 2011, BIOL CONTROL, V59, P69, DOI 10.1016/j.biocontrol.2011.06.015; Chouvenc T, 2010, FLA ENTOMOL, V93, P467, DOI 10.1653/024.093.0327; Chouvenc T, 2010, J ECON ENTOMOL, V103, P1327, DOI 10.1603/EC09407; Chouvenc T, 2009, SOCIOBIOLOGY, V54, P723; Chouvenc T, 2009, J INVERTEBR PATHOL, V101, P234, DOI 10.1016/j.jip.2009.05.008; Chouvenc T, 2009, J INVERTEBR PATHOL, V101, P130, DOI 10.1016/j.jip.2009.04.005; Cotter SC, 2010, BEHAV ECOL, V21, P663, DOI 10.1093/beheco/arq070; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Cremer S, 2009, PHILOS T R SOC B, V364, P129, DOI 10.1098/rstb.2008.0166; Culliney TW, 2000, B ENTOMOL RES, V90, P9, DOI 10.1017/S0007485300000031; Ebert D, 1997, P ROY SOC B-BIOL SCI, V264, P985, DOI 10.1098/rspb.1997.0136; ELKINTON JS, 1990, ANNU REV ENTOMOL, V35, P571, DOI 10.1146/annurev.en.35.010190.003035; EMERSON ALFRED E., 1939, AMER MIDLAND NAT, V21, P182, DOI 10.2307/2420380; FUXA J. R., 1987, EPIZOOTIOLOGY INSECT; Grace JK, 2003, SOCIOBIOLOGY, V41, P115; GRACE JK, 1992, SOCIOBIOLOGY, V20, P23; HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453; Hamilton C, 2012, DEV COMP IMMUNOL, V36, P372, DOI 10.1016/j.dci.2011.07.008; Hamilton C, 2011, J INSECT PHYSIOL, V57, P1259, DOI 10.1016/j.jinsphys.2011.05.016; HANEL H, 1981, Z ANGEW ENTOMOL, V92, P9; Holldobler B., 2009, SUPERORGANISM; Hughes WOH, 2004, P ROY SOC B-BIOL SCI, V271, pS104, DOI 10.1098/rsbl.2003.0115; Hughes WOH, 2002, P ROY SOC B-BIOL SCI, V269, P1811, DOI 10.1098/rspb.2002.2113; Husseneder Claudia, 2009, P361; Jaccoud DB, 1999, ENTOMOL EXP APPL, V93, P51, DOI 10.1023/A:1003830625680; Kaya, 1993, INSECT PATHOLOGY; Keller S, 2003, BIOCONTROL, V48, P307, DOI 10.1023/A:1023646207455; KELLER S., 1989, INSECT FUNGUS INTERA, P240, DOI DOI 10.1016/B978-0-12-751800-8.50016-1; KING EG, 1969, ANN ENTOMOL SOC AM, V62, P536, DOI 10.1093/aesa/62.3.536; KREJZOVA R, 1971, Entomophaga, V16, P221, DOI 10.1007/BF02371172; Lacey LA, 2001, BIOL CONTROL, V21, P230, DOI 10.1006/bcon.2001.0938; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; Li HF, 2010, ENVIRON ENTOMOL, V39, P1601, DOI 10.1603/EN09262; Loeck Alci E., 1994, Anais da Sociedade Entomologica do Brasil, V23, P359; Mankowski ME, 2005, BIOCONTROL SCI TECHN, V15, P367, DOI 10.1080/09583150400016951; Myles TG, 2002, SOCIOBIOLOGY, V40, P243; Pie MR, 2004, J THEOR BIOL, V226, P45, DOI 10.1016/j.jtbi.2003.08.002; RATH AC, 1992, MYCOL RES, V96, P378, DOI 10.1016/S0953-7562(09)80956-8; Reber A, 2011, J EVOLUTION BIOL, V24, P954, DOI 10.1111/j.1420-9101.2011.02230.x; Rosengaus RB, 1998, BEHAV ECOL SOCIOBIOL, V44, P125, DOI 10.1007/s002650050523; Rosengaus RB, 1998, J CHEM ECOL, V24, P1697, DOI 10.1023/A:1020872729671; Rosengaus RB, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P165, DOI 10.1007/978-90-481-3977-4_7; Rosengaus RB, 2007, NATURWISSENSCHAFTEN, V94, P25, DOI 10.1007/s00114-006-0151-9; SAS Institute, 2002, SAS STAT US GUID VER, VSixth; Shimizu S, 2003, APPL ENTOMOL ZOOL, V38, P125, DOI 10.1303/aez.2003.125; SMYTHE RV, 1965, J INVERTEBR PATHOL, V7, P423, DOI 10.1016/0022-2011(65)90116-3; Staples JA, 2000, 86 CSIRO DIV ENT; Steinhaus E. A., 1949, PRINCIPLES INSECT PA; Su NY, 2009, ANN ENTOMOL SOC AM, V102, P1158, DOI 10.1603/008.102.0626; SU NY, 1986, SOCIOBIOLOGY, V12, P299; Su NY, 2005, J ECON ENTOMOL, V98, P2143, DOI 10.1603/0022-0493-98.6.2143; SU NY, 1993, ENVIRON ENTOMOL, V22, P1113, DOI 10.1093/ee/22.5.1113; TAMASHIRO M, 1973, Environmental Entomology, V2, P721, DOI 10.1093/ee/2.4.721; Ugelvig LV, 2010, P ROY SOC B-BIOL SCI, V277, P2821, DOI 10.1098/rspb.2010.0644; Walker TN, 2011, ECOL ENTOMOL, V36, P588, DOI 10.1111/j.1365-2311.2011.01312.x; Wang CL, 2004, BIOL CONTROL, V30, P523, DOI 10.1016/j.biocontrol.2004.02.007; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301; Yanagawa A, 2007, BIOCONTROL, V52, P75, DOI 10.1007/s10526-006-9020-x; Yanagawa A, 2011, J INVERTEBR PATHOL, V107, P100, DOI 10.1016/j.jip.2011.03.003; Yoshimura T., 1998, JPN J ENV ENTOMOL ZO, V9, P16	67	58	62	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34484	10.1371/journal.pone.0034484	http://dx.doi.org/10.1371/journal.pone.0034484			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470575	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000114
J	Milicic, A; Kaur, R; Reyes-Sandoval, A; Tang, CK; Honeycutt, J; Perrie, Y; Hill, AVS				Milicic, Anita; Kaur, Randip; Reyes-Sandoval, Arturo; Tang, Choon-Kit; Honeycutt, Jared; Perrie, Yvonne; Hill, Adrian V. S.			Small Cationic DDA:TDB Liposomes as Protein Vaccine Adjuvants Obviate the Need for TLR Agonists in Inducing Cellular and Humoral Responses	PLOS ONE			English	Article							EXOGENOUS SOLUBLE-ANTIGEN; DENDRITIC CELLS; IMMUNE-RESPONSE; CORD FACTOR; CPG-DNA; MACROPINOCYTOSIS; IMMUNIZATION; TUBERCULOSIS; ACTIVATION; INDUCTION	Most subunit vaccines require adjuvants in order to induce protective immune responses to the targeted pathogen. However, many of the potent immunogenic adjuvants display unacceptable local or systemic reactogenicity. Liposomes are spherical vesicles consisting of single (unilamellar) or multiple (multilamellar) phospholipid bi-layers. The lipid membranes are interleaved with an aqueous buffer, which can be utilised to deliver hydrophilic vaccine components, such as protein antigens or ligands for immune receptors. Liposomes, in particular cationic DDA:TDB vesicles, have been shown in animal models to induce strong humoral responses to the associated antigen without increased reactogenicity, and are currently being tested in Phase I human clinical trials. We explored several modifications of DDA:TDB liposomes - including size, antigen association and addition of TLR agonists - to assess their immunogenic capacity as vaccine adjuvants, using Ovalbumin (OVA) protein as a model protein vaccine. Following triple homologous immunisation, small unilamellar vesicles (SUVs) with no TLR agonists showed a significantly higher capacity for inducing spleen CD8 IFN gamma responses against OVA in comparison with the larger multilamellar vesicles (MLVs). Antigen-specific antibody reponses were also higher with SUVs. Addition of the TLR3 and TLR9 agonists significantly increased the adjuvanting capacity of MLVs and OVA-encapsulating dehydration-rehydration vesicles (DRVs), but not of SUVs. Our findings lend further support to the use of liposomes as protein vaccine adjuvants. Importantly, the ability of DDA: TDB SUVs to induce potent CD8 T cell responses without the need for adding immunostimulators would avoid the potential safety risks associated with the clinical use of TLR agonists in vaccines adjuvanted with liposomes.	[Milicic, Anita; Reyes-Sandoval, Arturo; Tang, Choon-Kit; Honeycutt, Jared; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England; [Kaur, Randip; Perrie, Yvonne] Aston Univ, Aston Pharm Sch, Birmingham B4 7ET, W Midlands, England	University of Oxford; Jenner Institute; Aston University	Milicic, A (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	anita.milicic@ndm.ox.ac.uk	Reyes-Sandoval, Arturo/B-4264-2011	Perrie, Yvonne/0000-0001-8497-2541; Reyes-Sandoval, Arturo/0000-0002-2648-1696	Wellcome Trust [EF113/Z/07/Z]; Singapore Agency for Science, Technology and Research (A*STAR); TB Vaccine Initiative (NewTBVAC) [HEALTH-F3-2009-241745]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Singapore Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); TB Vaccine Initiative (NewTBVAC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Wellcome Trust Strategic grant (grant no. EF113/Z/07/Z; www.wellcome.ac.uk), the Singapore Agency for Science, Technology and Research (A*STAR) personal fellowship to CKT (www.a-star.edu.sg), and the TB Vaccine Initiative (NewTBVAC) (grant no. HEALTH-F3-2009-241745; http://www.tbvi.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; ALVING CR, 1992, BIOCHIM BIOPHYS ACTA, V1113, P307, DOI 10.1016/0304-4157(92)90004-T; ALVING CR, 1995, IMMUNOL REV, V145, P5, DOI 10.1111/j.1600-065X.1995.tb00075.x; Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Bal SM, 2011, VACCINE, V29, P1045, DOI 10.1016/j.vaccine.2010.11.061; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Brunel F, 1999, VACCINE, V17, P2192, DOI 10.1016/S0264-410X(98)00492-7; Christensen D, 2011, EXPERT REV VACCINES, V10, P513, DOI [10.1586/erv.11.17, 10.1586/ERV.11.17]; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; DAVIS D, 1987, IMMUNOLOGY, V61, P229; de Cassan SC, 2011, J IMMUNOL, V187, P2602, DOI 10.4049/jimmunol.1101004; Dow SW, 1999, J IMMUNOL, V163, P1552; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652; Gluck R, 1995, VACCINE DESIGN SUBUN, P347; GREGORIADIS G, 1974, LANCET, V1, P1313, DOI 10.1016/S0140-6736(74)90682-5; GREGORIADIS G, 1990, IMMUNOL TODAY, V11, P89, DOI 10.1016/0167-5699(90)90034-7; GREGORIADIS G, 1994, J DRUG TARGET, V2, P351, DOI 10.3109/10611869408996809; Gregoriadis G, 1971, BIOCHEM J, V124, P58; Gregoriadis G, VACCINE ADJUVANTS PR, P137; Gursel I, 2001, J IMMUNOL, V167, P3324, DOI 10.4049/jimmunol.167.6.3324; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Henriksen-Lacey M, 2011, J CONTROL RELEASE, V154, P131, DOI 10.1016/j.jconrel.2011.05.019; Holten-Andersen L, 2004, INFECT IMMUN, V72, P1608, DOI 10.1128/IAI.72.3.1608-1617.2004; Jain AK, 2007, J DRUG TARGET, V15, P417, DOI 10.1080/10611860701453653; KAHL LP, 1989, J IMMUNOL, V142, P4441; Kaur R, 2011, J CONTROL RELEASE; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; KIRBY C, 1984, BIO-TECHNOL, V2, P979, DOI 10.1038/nbt1184-979; Korsholm KS, 2007, IMMUNOLOGY, V121, P216, DOI 10.1111/j.1365-2567.2007.02560.x; Larsen KC, 2009, VACCINE, V27, P5589, DOI 10.1016/j.vaccine.2009.07.025; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; NAIR S, 1992, J EXP MED, V175, P609, DOI 10.1084/jem.175.2.609; Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5; Norbury CC, 1997, EUR J IMMUNOL, V27, P280, DOI 10.1002/eji.1830270141; RAHMAN YE, 1974, J LAB CLIN MED, V83, P640; SELTZER SE, 1988, INVEST RADIOL, V23, P131, DOI 10.1097/00004424-198802000-00009; SHEK PN, 1982, IMMUNOLOGY, V47, P627; Tanaka Y, 2004, BIOCONJUGATE CHEM, V15, P35, DOI 10.1021/bc034134o; Taneichi M, 2006, BIOCONJUGATE CHEM, V17, P899, DOI 10.1021/bc060024g; Wells JW, 2008, J IMMUNOL, V181, P3422, DOI 10.4049/jimmunol.181.5.3422; Zaks K, 2006, J IMMUNOL, V176, P7335, DOI 10.4049/jimmunol.176.12.7335	46	39	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34255	10.1371/journal.pone.0034255	http://dx.doi.org/10.1371/journal.pone.0034255			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470545	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000304489000084
J	Reinert, RB; Kantz, J; Misfeldt, AA; Poffenberger, G; Gannon, M; Brissova, M; Powers, AC				Reinert, Rachel B.; Kantz, Jeannelle; Misfeldt, Amanda Ackermann; Poffenberger, Greg; Gannon, Maureen; Brissova, Marcela; Powers, Alvin C.			Tamoxifen-Induced Cre-loxP Recombination Is Prolonged in Pancreatic Islets of Adult Mice	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; BETA-CELL REGENERATION; STEM-CELLS; IN-VIVO; EFFICIENT RECOMBINATION; PROGENITOR-CELL; ENDOCRINE-CELLS; SCROTAL HERNIAS; INDUCIBLE FORM; ALPHA-CELLS	Tamoxifen (Tm)-inducible Cre recombinases are widely used to perform gene inactivation and lineage tracing studies in mice. Although the efficiency of inducible Cre-loxP recombination can be easily evaluated with reporter strains, the precise length of time that Tm induces nuclear translocation of CreER(Tm) and subsequent recombination of a target allele is not well defined, and difficult to assess. To better understand the timeline of Tm activity in vivo, we developed a bioassay in which pancreatic islets with a Tm-inducible reporter (from Pdx1(PB)-CreER(Tm);R26R(lacZ) mice) were transplanted beneath the renal capsule of adult mice previously treated with three doses of 1 mg Tm, 8 mg Tm, or corn oil vehicle. Surprisingly, recombination in islet grafts, as assessed by expression of the beta-galactosidase (beta-gal) reporter, was observed days or weeks after Tm treatment, in a dose-dependent manner. Substantial recombination occurred in islet grafts long after administration of 3x8 mg Tm: in grafts transplanted 48 hours after the last Tm injection, 77.9 +/- 0.4% of beta-cells were beta-gal+; in beta-cells placed after 1 week, 46.2 +/- 5.0% were beta-gal+; after 2 weeks, 26.3 +/- 7.0% were beta-gal+; and after 4 weeks, 1.9 +/- 0.9% were beta-gal+. Islet grafts from mice given 361 mg Tm showed lower, but notable, recombination 48 hours (4.9 +/- 1.7%) and 1 week (4.5 +/- 1.9%) after Tm administration. These results show that Tm doses commonly used to induce Cre-loxP recombination may continue to label significant numbers of cells for weeks after Tm treatment, possibly confounding the interpretation of time-sensitive studies using Tm-dependent models. Therefore, investigators developing experimental approaches using Tm-inducible systems should consider both maximal recombination efficiency and the length of time that Tm-induced Cre-loxP recombination occurs.	[Reinert, Rachel B.; Kantz, Jeannelle; Misfeldt, Amanda Ackermann; Gannon, Maureen; Powers, Alvin C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA; [Poffenberger, Greg; Gannon, Maureen; Brissova, Marcela; Powers, Alvin C.] Vanderbilt Univ, Sch Med, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN 37212 USA; [Gannon, Maureen] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Gannon, Maureen; Powers, Alvin C.] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Reinert, RB (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.	al.powers@vanderbilt.edu	Gannon, Maureen A/F-9060-2012	Reinert, Rachel/0000-0001-7778-4219	Juvenile Diabetes Research Foundation International; Department of Veterans Affairs; National Institutes of Health (NIH) [DK66636, DK69603, DK63439, DK62641, DK72473, DK089572, R56 DK071052, F30 DK085932, T32 GM07347, CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; Vanderbilt Mouse Metabolic Phenotyping Center [DK59637]; Vanderbilt Diabetes Research and Training Center [DK20593]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK066636, R21DK062641, P30DK058404, R21DK063439, U01DK072473, U2CDK059637, R33DK066636, P30DK020593, P60DK020593, U24DK059637, U01DK089572, R56DK071052, R01DK069603, F30DK085932, R01DK068764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000666] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Mouse Metabolic Phenotyping Center; Vanderbilt Diabetes Research and Training Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the Juvenile Diabetes Research Foundation International, the Department of Veterans Affairs, the National Institutes of Health (NIH) (grant nos. DK66636, DK69603, DK63439, DK62641, DK72473, DK089572, R56 DK071052, F30 DK085932, T32 GM07347), the Vanderbilt Mouse Metabolic Phenotyping Center (DK59637), and the Vanderbilt Diabetes Research and Training Center (DK20593). Islet isolation was performed in collaboration with the Vanderbilt Islet Procurement and Analysis Core (supported by the Vanderbilt DRTC). Image acquisition was performed in part through the use of the Vanderbilt University Medical Center Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouna S, 2010, ORGANOGENESIS, V6, P125, DOI 10.4161/org.6.2.10374; Anastassiadis K, 2010, METHOD ENZYMOL, V477, P109, DOI 10.1016/S0076-6879(10)77007-5; Badea TC, 2003, J NEUROSCI, V23, P2314; Badea TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007859; Blaine SA, 2010, DEVELOPMENT, V137, P2289, DOI 10.1242/dev.048421; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; BONNEVIENIELSEN V, 1982, DIABETES METAB, V8, P271; Brake Rachael L, 2004, Genet Mol Res, V3, P456; Brennand K, 2007, PLOS BIOL, V5, P1520, DOI 10.1371/journal.pbio.0050163; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; Buelow B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003264; Burns KA, 2007, CEREB CORTEX, V17, P2585, DOI 10.1093/cercor/bhl164; Burrows H, 1934, BRIT J SURG, V21, P507, DOI 10.1002/bjs.1800218314; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Deanesly R, 1933, J PHYSIOL-LONDON, V78, P155, DOI 10.1113/jphysiol.1933.sp002994; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dorrell C, 2011, GENE DEV, V25, P1193, DOI 10.1101/gad.2029411; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; FURR BJA, 1984, PHARMACOL THERAPEUT, V25, P127, DOI 10.1016/0163-7258(84)90043-3; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gardener WU, 1936, AM J ANAT, V59, P459, DOI 10.1002/aja.1000590307; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Hall ME, 2011, AM J PHYSIOL-HEART C, V301, pH253, DOI 10.1152/ajpheart.00786.2010; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HAZARY S, 1960, ANAT REC, V136, P437, DOI 10.1002/ar.1091360402; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; Kopinke D, 2011, DEVELOPMENT, V138, P431, DOI 10.1242/dev.053843; Kopinke D, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-38; Kopp JL, 2011, CELL CYCLE, V10, P1921, DOI 10.4161/cc.10.12.16010; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kushner JA, 2010, CELL METAB, V11, P2, DOI 10.1016/j.cmet.2009.12.005; LAVINE RL, 1971, DIABETES, V20, P134, DOI 10.2337/diab.20.3.134; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; LIEN EA, 1991, CANCER RES, V51, P4837; Liu H, 2010, ENDOCRINOLOGY, V151, P520, DOI 10.1210/en.2009-0992; Liu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013533; Long MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005435; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Murtaugh LC, 2011, CELL STEM CELL, V8, P244, DOI 10.1016/j.stem.2011.02.010; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Nakamura K, 2011, BIOMED RES-TOKYO, V32, P167, DOI 10.2220/biomedres.32.167; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Remedi MS, 2009, CELL METAB, V9, P140, DOI 10.1016/j.cmet.2008.12.005; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Salpeter SJ, 2011, ENDOCRINOLOGY, V152, P2589, DOI 10.1210/en.2010-1372; Salpeter SJ, 2010, DEVELOPMENT, V137, P3205, DOI 10.1242/dev.054304; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sangiorgi E, 2009, P NATL ACAD SCI USA, V106, P7101, DOI 10.1073/pnas.0902508106; Scholten D, 2010, GASTROENTEROLOGY, V139, P987, DOI 10.1053/j.gastro.2010.05.005; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Strobel O, 2007, P NATL ACAD SCI USA, V104, P4419, DOI 10.1073/pnas.0605248104; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Yang YQ, 2010, P NATL ACAD SCI USA, V107, P20358, DOI 10.1073/pnas.1012257107; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zhang HJ, 2005, GENESIS, V42, P210, DOI 10.1002/gene.20137; Zhang HJ, 2006, MOL ENDOCRINOL, V20, P1853, DOI 10.1210/me.2006-0056; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	78	91	91	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33529	10.1371/journal.pone.0033529	http://dx.doi.org/10.1371/journal.pone.0033529			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470452	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000022
J	Dumbacher, JP; Rathbun, GB; Smit, HA; Eiseb, SJ				Dumbacher, John P.; Rathbun, Galen B.; Smit, Hanneline A.; Eiseb, Seth J.			Phylogeny and Taxonomy of the Round-Eared Sengis or Elephant-Shrews, Genus Macroscelides (Mammalia, Afrotheria, Macroscelidea)	PLOS ONE			English	Article							GENETIC SPECIES CONCEPT; UTILIZATION DISTRIBUTIONS; UDZUNGWA MOUNTAINS; GIANT SENGI; HOME RANGES; MITOCHONDRIAL; SPECIATION; DIVERSITY; SEQUENCES; TANZANIA	The round-eared sengis or elephant-shrews (genus Macroscelides) exhibit striking pelage variation throughout their ranges. Over ten taxonomic names have been proposed to describe this variation, but currently only two taxa are recognized (M. proboscideus proboscideus and M. p. flavicaudatus). Here, we review the taxonomic history of Macroscelides, and we use data on the geographic distribution, morphology, and mitochondrial DNA sequence to evaluate the current taxonomy. Our data support only two taxa that correspond to the currently recognized subspecies M. p. proboscideus and M. p. flavicaudatus. Mitochondrial haplotypes of these two taxa are reciprocally monophyletic with over 13% uncorrected sequence divergence between them. PCA analysis of 14 morphological characters (mostly cranial) grouped the two taxa into non-overlapping clusters, and body mass alone is a relatively reliable distinguishing character throughout much of Macroscelides range. Although fieldworkers were unable to find sympatric populations, the two taxa were found within 50 km of each other, and genetic analysis showed no evidence of gene flow. Based upon corroborating genetic data, morphological data, near sympatry with no evidence of gene flow, and differences in habitat use, we elevate these two forms to full species.	[Dumbacher, John P.; Rathbun, Galen B.] Calif Acad Sci, Dept Vertebrate Zool & Anthropol, San Francisco, CA 94118 USA; [Smit, Hanneline A.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Smit, Hanneline A.] Univ Stellenbosch, Dept Bot & Zool, Matieland, South Africa; [Eiseb, Seth J.] Natl Museum Namibia, Windhoek, Namibia	California Academy of Sciences; University of California System; University of California Berkeley; Stellenbosch University	Dumbacher, JP (corresponding author), Calif Acad Sci, Dept Vertebrate Zool & Anthropol, San Francisco, CA 94118 USA.	jdumbacher@calacademy.org	; Dumbacher, John/B-5280-2009	Eiseb, Seth Johannes/0000-0002-0408-4999; Dumbacher, John/0000-0001-8942-1554	California Academy of Sciences; Department of Ornithology and Mammalogy; Namibia Ministry of Environment and Tourism	California Academy of Sciences; Department of Ornithology and Mammalogy; Namibia Ministry of Environment and Tourism	Funding was provided by the California Academy of Sciences in-house funds and Department of Ornithology and Mammalogy gift funds (http://www.calacademy.org/). Those who provided the funds to the academy or allocated the funds to the authors' department had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Mike Griffin for guidance in focusing our efforts to appropriate localities in Namibia, and for initial specimen collection. John Irish was invaluable in assisting us in finding historical farm (known elsewhere as ranch) names, and providing centroid coordinates of farm properties. We greatly appreciate the hospitality and logistical support of Danica Shaw and staff of the NamibRand Nature Reserve. Similarly, we are indebted to Susan and Anton Horn of Zwartmodder Farm, and J. Albi Bruekner of Gorassis Farm, for their gracious hospitality. Paula Jenkins and Louise Tomsett provided GBR access to the collection of sengis at The Natural History Museum in London, as did Teresa Kearney at the Ditsong National Museum of Natural History in Pretoria. We appreciate Moe Flannery's help with import permits and cataloging specimens at CAS, and Tiffany Bozic for assistance with fieldwork. Assistance with laboratory work at CAS was provided by Monica McDonald, Amber Bifolk, Carmen DeLeon, and Zach Hanna. James Patton and Patricia Holroyd provided useful insights into cranial morphology. We thank the Namibia Ministry of Environment and Tourism for supporting our work with research and export permits.	Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bannikova AA, 2011, ZOOTAXA, P1; Beaver BV, 2001, J AM VET MED ASSOC, V218, P669, DOI 10.2460/javma.2001.218.669; Borisenko AV, 2008, MOL ECOL RESOUR, V8, P471, DOI 10.1111/j.1471-8286.2007.01998.x; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Coetzee C. G., 1969, Scientific Papers Namib Desert Research Station, VNo. 40, P23; CORBET GB, 1968, B BRIT MUS NAT HIST, V16, P47; Cracraft J., 1983, Current Ornithology, V1, P159; De Blase A. F., 1981, MANUAL MAMMALOGY KEY; Desmet P., 1999, KAROO ECOLOGICAL PAT; Dumbacher JP, 2003, MOL PHYLOGENET EVOL, V29, P540, DOI 10.1016/S1055-7903(03)00135-0; Dumbacher JP, 2001, P ROY SOC B-BIOL SCI, V268, P1971, DOI 10.1098/rspb.2001.1717; Edwards SV, 2005, P NATL ACAD SCI USA, V102, P6550, DOI 10.1073/pnas.0501846102; Francis CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012575; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hedges SB, 2001, P NATL ACAD SCI USA, V98, P1, DOI 10.1073/pnas.98.1.1; Hoesch W., 1959, Natur und Volk, V89, P53; Hoesch W., 1960, Bonner Zoologische Beitraege, V10, P263; HOESCH W., 1956, BONN ZOOL BEITR, V7, P59; HOESCH W., 1956, BONN ZOOL BEITR, V7, P8; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; KERLEY GIH, 1995, MAMMAL REV, V25, P39, DOI 10.1111/j.1365-2907.1995.tb00436.x; Kingdon J., 1974, E AFRICAN MAMMALS AT, V2, P341; Kizirian D, 2004, MOL PHYLOGENET EVOL, V32, P1072, DOI 10.1016/j.ympev.2004.05.001; Lichtenstein H., 1831, DARSTELLUNG NEUER OD; LUNDHOLM B. G., 1955, ANN TRANSVAAL MUS, V22, P279; MAYR E., 1953, METHODS PRINCIPLES S; Mendelsohn J, 2002, PLANTS ANIMALS ATLAS; Murata Y, 2003, MOL PHYLOGENET EVOL, V28, P253, DOI 10.1016/S1055-7903(03)00035-6; Ogilby W., 1838, P ZOOL SOC LOND, V1838, P5; PATTERSON BRYAN, 1965, BULL MUS COMP ZOOL HARVARD UNIV, V133, P297; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rathbun GB, 2009, AFR J ECOL, V47, P1, DOI 10.1111/j.1365-2028.2009.01102.x; Rathbun GB, 2006, J ZOOL, V269, P391, DOI 10.1111/j.1469-7998.2006.00087.x; Rathbun GB, 2009, MACROSCELIDES LOCATI; Roberts A., 1951, MAMMALS S AFRICA; Rovero F, 2008, J ZOOL, V274, P126, DOI 10.1111/j.1469-7998.2007.00363.x; Rovero Francesco, 2006, Journal of East African Natural History, V95, P111, DOI 10.2982/0012-8317(2006)95[111:APNGSE]2.0.CO;2; SAUER E G F, 1973, Zeitschrift fuer Saeugetierkunde, V38, P65; Schubert M, 2009, BEHAV ECOL SOCIOBIOL, V64, P257, DOI 10.1007/s00265-009-0842-2; Seiffert ER, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-224; Shaw G., 1800, GEN ZOOLOGY SYSTEM 2, VI; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Smit HA, 2008, J MAMMAL, V89, P1257, DOI 10.1644/07-MAMM-A-254.1; Smit HA, 2007, MOL ECOL, V16, P2680, DOI 10.1111/j.1365-294X.2007.03334.x; Smit H.A., 2007, Afrotherian Conservation, V5, P5; Smit HA, 2008, PHYLOGEOGRAPHY 3 SO; Smit HA, 2010, J BIOGEOGR, V37, P857, DOI 10.1111/j.1365-2699.2009.02249.x; SMITH A., 1829, ZOOLOGICAL J LONDON, V4, P433; Smith A, 1838, MAMMALIA PLATE 10; Sorenson MD, 1996, P NATL ACAD SCI USA, V93, P15239, DOI 10.1073/pnas.93.26.15239; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Springer MS, 1999, SYST BIOL, V48, P65, DOI 10.1080/106351599260445; Stresemann E., 1961, Journal fuer Ornithologie, V102, P490; Swofford D., 2003, PHYLOGENETIC ANAL US; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017	61	18	19	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e32410	10.1371/journal.pone.0032410	http://dx.doi.org/10.1371/journal.pone.0032410			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479325	gold, Green Published			2022-12-27	WOS:000303894900009
J	Fournier, JP; Lapeyre-Mestre, M; Sommet, A; Dupouy, J; Poutrain, JC; Montastruc, JL				Fournier, Jean-Pascal; Lapeyre-Mestre, Maryse; Sommet, Agnes; Dupouy, Julie; Poutrain, Jean-Christophe; Montastruc, Jean-Louis			Laboratory Monitoring of Patients Treated with Antihypertensive Drugs and Newly Exposed to Non Steroidal Anti-Inflammatory Drugs: A Cohort Study	PLOS ONE			English	Article							GENERAL-PRACTICE; AMBULATORY-CARE; INHIBITORS; PATTERNS	Background: Drug-Drug Interactions between Non Steroidal Anti-Inflammatory Drugs (NSAIDs) and Angiotensin Converting Enzyme Inhibitors (ACEIs), Angiotensin Receptor Blocker (ARBs) or diuretics can lead to renal failure and hyperkalemia. Thus, monitoring of serum creatinine and potassium is recommended when a first dispensing of NSAID occur in patients treated with these drugs. Methods: We conducted a pharmacoepidemiological retrospective cohort study using data from the French Health Insurance Reimbursement Database to evaluate the proportion of serum creatinine and potassium laboratory monitoring in patients treated with ACEI, ARB or diuretic and receiving a first dispensing of NSAID. We described the first dispensing of NSAID among 3,500 patients of a 4-year cohort (6,633 patients treated with antihypertensive drugs) and analyzed serum creatinine and potassium laboratory monitoring within the 3 weeks after the first NSAID dispensing. Results: General Practitioners were the most frequent prescribers of NSAIDs (85.5%, 95% CI: 84.3-86.6). The more commonly prescribed NSAIDs were ibuprofen (20%), ketoprofen (15%), diclofenac (15%) and piroxicam (12%). Serum creatinine and potassium monitoring was 10.7%(95% CI: 9.5-11.8) in patients treated by ACEIs, ARBs or diuretics. Overall, monitoring was more frequently performed to women aged over 60, treated with digoxin or glucose lowering drugs, but not to patients treated with ACEIs, ARBs or diuretics. Monitoring was more frequent when NSAIDs' prescribers were cardiologists or anesthesiologists. Conclusion: Monitoring of serum creatinine and potassium of patients treated with ACEIs, ARBs or diuretics and receiving a first NSAID dispensing is insufficiently performed and needs to be reinforced through specific interventions.	[Fournier, Jean-Pascal; Lapeyre-Mestre, Maryse; Sommet, Agnes; Dupouy, Julie; Montastruc, Jean-Louis] Univ Toulouse 3, Fac Med, Lab Pharmacol Med & Clin, F-31062 Toulouse, France; [Fournier, Jean-Pascal; Lapeyre-Mestre, Maryse; Sommet, Agnes; Dupouy, Julie; Montastruc, Jean-Louis] Fac Med Toulouse, INSERM, UMR1027, F-31073 Toulouse, France; [Fournier, Jean-Pascal; Dupouy, Julie; Poutrain, Jean-Christophe] Univ Toulouse 3, Fac Med, Dept Univ Med Gen, F-31062 Toulouse, France; [Lapeyre-Mestre, Maryse; Sommet, Agnes; Montastruc, Jean-Louis] Ctr Hosp Univ Toulouse, Serv Pharmacol Clin, Ctr Midi Pyrenees Pharmacovigilance Pharmacoepid, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse	Fournier, JP (corresponding author), Univ Toulouse 3, Fac Med, Lab Pharmacol Med & Clin, F-31062 Toulouse, France.	jean-pascal.fournier@univ-tlse3.fr	Fournier, Jean-Pascal/GVU-6024-2022; Lapeyre-Mestre, Maryse/C-8710-2012; Dupouy, Julie/AAD-7436-2019	Lapeyre-Mestre, Maryse/0000-0002-5494-5873; Dupouy, Julie/0000-0001-7801-286X; Fournier, Jean-Pascal/0000-0002-9971-0672				[Anonymous], 2009, REV PRESCRIRE, V29, P50; Bootsma JEM, 2011, DRUG SAFETY, V34, P605, DOI 10.2165/11587250-000000000-00000; Brefel-Courbon C, 2009, PAIN, V141, P14, DOI 10.1016/j.pain.2008.04.026; BROCHIER ML, 1993, EUR HEART J, V14, P951, DOI 10.1093/eurheartj/14.7.951; Clinard F, 2001, PHARMACOEPIDEM DR S, V10, P329, DOI 10.1002/pds.623; Goldman RE, 2010, J EVAL CLIN PRACT, V16, P1136, DOI 10.1111/j.1365-2753.2009.01282.x; Hargreaves K, 2005, AUST DENT J, V50, pS14, DOI 10.1111/j.1834-7819.2005.tb00378.x; Holdgate A, 2004, BRIT MED J, V328, P1401, DOI 10.1136/bmj.38119.581991.55; Langley C, 1998, FAM PRACT, V15, P105, DOI 10.1093/fampra/15.2.105; Loboz KK, 2005, BRIT J CLIN PHARMACO, V59, P239, DOI 10.1111/j.0306-5251.2004.2188.x; Lugardon S, 2006, THERAPIE, V61, P109, DOI 10.2515/therapie:2006029; Martin-Latry K, 2010, PHARMACOEPIDEM DR S, V19, P256, DOI 10.1002/pds.1912; McDowelll SE, 2011, DRUG SAFETY, V34, P1049, DOI 10.2165/11593980-000000000-00000; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Mikhail SS, 2007, MED J AUSTRALIA, V187, P160, DOI 10.5694/j.1326-5377.2007.tb01175.x; Olyaei AJ, 2008, CLIN NEPHROTOXINS RE, P419; Raebel MA, 2007, PHARMACOEPIDEM DR S, V16, P55, DOI 10.1002/pds.1217; Saint-Salvi B, 2009, THESAURUS INTERACTIO; Schedlbauer A, 2009, J AM MED INFORM ASSN, V16, P531, DOI 10.1197/jamia.M2910; Vitry AI, 2007, BRIT J CLIN PHARMACO, V63, P709, DOI 10.1111/j.1365-2125.2006.02809.x; Weingart SN, 2011, DRUG SAFETY, V34, P587, DOI 10.2165/11589360-000000000-00000	21	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34187	10.1371/journal.pone.0034187	http://dx.doi.org/10.1371/journal.pone.0034187			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479557	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900067
J	Hong, F; Saiman, Y; Si, CP; Mosoian, A; Bansal, MB				Hong, Feng; Saiman, Yedidya; Si, Chuanping; Mosoian, Arevik; Bansal, Meena B.			X4 Human Immunodeficiency Virus Type 1 gp120 Promotes Human Hepatic Stellate Cell Activation and Collagen I Expression through Interactions with CXCR4	PLOS ONE			English	Article							LIVER FIBROSIS; C VIRUS; ANTIRETROVIRAL-THERAPY; HIV-INFECTION; COINFECTED PATIENTS; TGF-BETA; PROGRESSION; PROTEINS; PROLIFERATION; INDIVIDUALS	Background & Aims: Patients coinfected with HIV-1 and HCV develop more rapid liver fibrosis than patients monoinfected with HCV. HIV RNA levels correlate with fibrosis progression implicating HIV directly in the fibrotic process. While activated hepatic stellate cells (HSCs) express the 2 major HIV chemokine coreceptors, CXCR4 and CCR5, little is known about the profibrogenic effects of the HIV-1 envelope protein, gp120, on HSCs. We therefore examined the in vitro impact of X4 gp120 on HSC activation, collagen I expression, and underlying signaling pathways and examined the in vivo expression of gp120 in HIV/HCV coinfected livers. Methods: Primary human HSCs and LX-2 cells, a human HSC line, were challenged with X4 gp120 and expression of fibrogenic markers assessed by qRT-PCR and Western blot +/2 either CXCR4-targeted shRNA or anti-CXCR4 neutralizing antibody. Downstream intracellular signaling pathways were evaluated with Western blot and pre-treatment with specific pathway inhibitors. Gp120 immunostaining was performed on HIV/HCV coinfected liver biopsies. Results: X4 gp 120 significantly increased expression of alpha-smooth muscle actin (a-SMA) and collagen I in HSCs which was blocked by pre-incubation with either CXCR4-targeted shRNA or anti-CXCR4 neutralizing antibody. Furthermore, X4 gp120 promoted Extracellular signal-regulated kinase (ERK) 1/2 phosphorylation and pretreatment with an ERK inhibitor attenuated HSC activation and collagen I expression. Sinusoidal staining for gp120 was evident in HIV/HCV coinfected livers. Conclusions: X4 HIV-1 gp120 is pro-fibrogenic through its interactions with CXCR4 on activated HSCs. The availability of small molecule inhibitors to CXCR4 make this a potential anti-fibrotic target in HIV/HCV coinfected patients.	[Hong, Feng; Saiman, Yedidya; Mosoian, Arevik; Bansal, Meena B.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Hong, Feng; Si, Chuanping] Jining Med Coll, Dept Immunol, Jining, Peoples R China	Icahn School of Medicine at Mount Sinai; Jining Medical University	Hong, F (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	meena.bansal@mssm.edu		si, chuanping/0000-0002-4460-3896	NIH [DK6047402, DK071745, R56DK092128]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK060474, R56DK092128, R03DK071745] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH DK6047402, DK071745, and R56DK092128 (M.B.B.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Balasubramanian A, 2003, J BIOL CHEM, V278, P35755, DOI 10.1074/jbc.M302889200; Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Blackard JT, 2006, J MED VIROL, V78, P202, DOI 10.1002/jmv.20528; Brau N, 2006, J HEPATOL, V44, P47, DOI 10.1016/j.jhep.2005.07.006; Bruno R, 2010, GUT, V59, P513, DOI 10.1136/gut.2008.163287; Cummins NW, 2010, J INFECT DIS, V201, P1273, DOI 10.1086/651434; DallaPiazza M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-116; de Ledinghen V, 2008, J VIRAL HEPATITIS, V15, P427, DOI 10.1111/j.1365-2893.2007.00962.x; Doms RW, 2004, NEW ENGL J MED, V351, P743, DOI 10.1056/NEJMp048058; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Friedman SL, 2001, HEPATIC STELLATE CEL, P307; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Guo GH, 2009, HEPATOB PANCREAT DIS, V8, P59; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; HOUSSET C, 1993, J HEPATOL, V19, P252, DOI 10.1016/S0168-8278(05)80579-3; HUFERT FT, 1993, J ACQ IMMUN DEF SYND, V6, P772; Klasse PJ, 2004, VIROLOGY, V323, P1, DOI 10.1016/j.virol.2004.03.003; Kucia M, 2004, J MOL HISTOL, V35, P233; Lin W, 2008, GASTROENTEROLOGY, V134, P803, DOI 10.1053/j.gastro.2008.01.005; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Mann DA, 2010, J HEPATOL, V52, P949, DOI 10.1016/j.jhep.2010.02.005; Mazzocca A, 2004, J BIOL CHEM; Mendeni M, 2011, CLIN INFECT DIS, V52, P1164, DOI 10.1093/cid/cir071; Mohsen AH, 2003, GUT, V52, P1035, DOI 10.1136/gut.52.7.1035; Munshi N, 2003, J INFECT DIS, V188, P1192, DOI 10.1086/378643; NAVIKAS V, 1994, CLIN EXP IMMUNOL, V96, P59; De Obanos MP, 2006, J CELL PHYSIOL, V209, P580, DOI 10.1002/jcp.20790; Popik W, 2000, VIROLOGY, V276, P1, DOI 10.1006/viro.2000.0581; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; Schulze-Krebs A, 2005, GASTROENTEROLOGY, V129, P246, DOI 10.1053/j.gastro.2005.03.089; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Sherman KE, 2010, HEPATOLOGY, V52, p401A, DOI 10.1002/hep.23394; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Vlahakis SR, 2003, J INFECT DIS, V188, P1455, DOI 10.1086/379738; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	42	25	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33659	10.1371/journal.pone.0033659	http://dx.doi.org/10.1371/journal.pone.0033659			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479424	gold, Green Published, Green Submitted			2022-12-27	WOS:000303894900035
J	Kalay, Z; Fujiwara, TK; Kusumi, A				Kalay, Ziya; Fujiwara, Takahiro K.; Kusumi, Akihiro			Confining Domains Lead to Reaction Bursts: Reaction Kinetics in the Plasma Membrane	PLOS ONE			English	Article							SINGLE-MOLECULE TRACKING; INTRACELLULAR ENVIRONMENTS; SIGNAL-TRANSDUCTION; RATE LAWS; DIFFUSION; PROTEIN; CELLS; PHOSPHATASES; ORGANIZATION; COMPARTMENTS	Confinement of molecules in specific small volumes and areas within a cell is likely to be a general strategy that is developed during evolution for regulating the interactions and functions of biomolecules. The cellular plasma membrane, which is the outermost membrane that surrounds the entire cell, was considered to be a continuous two-dimensional liquid, but it is becoming clear that it consists of numerous nano-meso-scale domains with various lifetimes, such as raft domains and cytoskeleton-induced compartments, and membrane molecules are dynamically trapped in these domains. In this article, we give a theoretical account on the effects of molecular confinement on reversible bimolecular reactions in a partitioned surface such as the plasma membrane. By performing simulations based on a lattice-based model of diffusion and reaction, we found that in the presence of membrane partitioning, bimolecular reactions that occur in each compartment proceed in bursts during which the reaction rate is sharply and briefly increased even though the asymptotic reaction rate remains the same. We characterized the time between reaction bursts and the burst amplitude as a function of the model parameters, and discussed the biological significance of the reaction bursts in the presence of strong inhibitor activity.	[Kalay, Ziya; Fujiwara, Takahiro K.; Kusumi, Akihiro] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan; [Kusumi, Akihiro] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan	Kyoto University; Kyoto University	Kalay, Z (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan.	zkalay@icems.kyoto-u.ac.jp; akusumi@frontier.kyoto-u.ac.jp	Fujiwara, Takahiro/G-2755-2012	Fujiwara, Takahiro/0000-0001-5576-759X; Kalay, Ziya/0000-0003-4103-1623	World Premier International Research Center (WPI) Initiative of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT	World Premier International Research Center (WPI) Initiative of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported in part by the World Premier International Research Center (WPI) Initiative of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and Grants-in-aid from the MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083; Chaudhuri A, 2011, P NATL ACAD SCI USA, V108, P14825, DOI 10.1073/pnas.1100007108; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Costa MN, 2011, J BIOTECHNOL, V151, P261, DOI 10.1016/j.jbiotec.2010.12.009; Costa MN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006316; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Fange D, 2010, P NATL ACAD SCI USA, V107, P19820, DOI 10.1073/pnas.1006565107; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Grecco HE, 2011, CELL, V144, P897, DOI 10.1016/j.cell.2011.01.029; Grima R, 2006, BIOPHYS CHEM, V124, P1, DOI 10.1016/j.bpc.2006.04.019; Grima R, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3427244; Grima R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-101; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Kalay Z, KUSUMI CELLULAR DOMA, P3; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kenkre VM, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051907; KLARLUND JK, 1985, CELL, V41, P707, DOI 10.1016/S0092-8674(85)80051-9; Krishnamurthy S, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-13; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Kusumi A, 2011, TRENDS BIOCHEM SCI, V36, P604, DOI 10.1016/j.tibs.2011.08.001; LEREA KM, 1989, BIOCHEMISTRY-US, V28, P9286, DOI 10.1021/bi00450a008; Lifshitz E.M, 1980, STAT PHYS 1, V5; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Mears M, 2011, MACROMOL RAPID COMM, V32, P1411, DOI 10.1002/marc.201100076; Melo E, 2006, BIOPHYS CHEM, V123, P77, DOI 10.1016/j.bpc.2006.05.003; Mocciaro A, 2010, J CELL SCI, V123, P2867, DOI 10.1242/jcs.074815; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; NABI IR, 2011, CELLULAR MEMBRANE DO; Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006; POWLES JG, 1992, P ROY SOC LOND A MAT, V436, P391, DOI 10.1098/rspa.1992.0025; RILEY MR, 1995, BIOPHYS J, V68, P1716, DOI 10.1016/S0006-3495(95)80349-8; RYAN TA, 1988, SCIENCE, V239, P61, DOI 10.1126/science.2962287; Saxton MJ, 2002, J CHEM PHYS, V116, P203, DOI 10.1063/1.1424317; Schnell S, 2004, PROG BIOPHYS MOL BIO, V85, P235, DOI 10.1016/j.pbiomolbio.2004.01.012; Schoen I, 2009, P NATL ACAD SCI USA, V106, P21649, DOI 10.1073/pnas.0901313106; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Treanor B, 2010, IMMUNITY, V32, P187, DOI 10.1016/j.immuni.2009.12.005; Tyson JJ, 2008, J R SOC INTERFACE, V5, pS1, DOI 10.1098/rsif.2008.0179.focus; Wang G, 2007, J PHYS CHEM C, V111, P11921, DOI 10.1021/jp070152h	44	38	38	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e32948	10.1371/journal.pone.0032948	http://dx.doi.org/10.1371/journal.pone.0032948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479350	Green Submitted, Green Published, gold			2022-12-27	WOS:000303894900015
J	Sousa, A; Dal Poz, MR; Carvalho, CL				Sousa, Angelica; Dal Poz, Mario R.; Carvalho, Cristiana Leite			Monitoring Inequalities in the Health Workforce: The Case Study of Brazil 1991-2005	PLOS ONE			English	Article							INFANT-MORTALITY; HUMAN-RESOURCES; CHILD HEALTH; ECONOMETRIC-ANALYSIS; TRENDS; CHALLENGES; COUNTRIES; COVERAGE; PROGRESS; NEWBORN	Introduction: Both the quantity and the distribution of health workers in a country are fundamental for assuring equitable access to health services. Using the case of Brazil, we measure changes in inequalities in the distribution of the health workforce and account for the sources of inequalities at sub-national level to identify whether policies have been effective in decreasing inequalities and increasing the density of health workers in the poorest areas between 1991 and 2005. Methods: With data from Datasus 2005 and the 1991 and 2000 Census we measure the Gini and the Theil T across the 4,267 Brazilian Minimum Comparable Areas (MCA) for 1991, 2000 and 2005 to investigate changes in inequalities in the densities of physicians; nurse professionals; nurse associates; and community health workers by states, poverty quintiles and urban-rural stratum to account for the sources of inequalities. Results: We find that inequalities have increased over time and that physicians and nurse professionals are the categories of health workers, which are more unequally distributed across MCA. The poorest states experience the highest shortage of health workers (below the national average) and have the highest inequalities in the distribution of physicians plus nurse professionals (above the national average) in the three years. Most of the staff in poor areas are unskilled health workers. Most of the overall inequalities in the distribution of health workers across MCA are due to inequalities within states, poverty quintiles and rural-urban stratum. Discussion: This study highlights some critical issues in terms of the geographical distribution of health workers, which are accessible to the poor and the new methods have given new insights to identify critical geographical areas in Brazil. Eliminating the gap in the health workforce would require policies and interventions to be conducted at the state level focused in poor and rural areas.	[Sousa, Angelica; Dal Poz, Mario R.] WHO, Dept Hlth Syst Policies & Workforce, CH-1211 Geneva, Switzerland; [Sousa, Angelica] Harvard Univ, Sch Publ Hlth, Ctr Populat & Dev Studies, Boston, MA 02115 USA; [Dal Poz, Mario R.] Univ State Rio Janeiro, Inst Social Med, Rio De Janeiro, Brazil; [Carvalho, Cristiana Leite] Pontif Catholic Univ, Sch Dent, Minas Gerais, Brazil	World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health	Sousa, A (corresponding author), WHO, Dept Hlth Syst Policies & Workforce, CH-1211 Geneva, Switzerland.	sousaa@who.int	, Dal Poz/D-3564-2009	, Dal Poz/0000-0002-3005-3280; Sousa, Angelica/0000-0002-0006-9310				Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Anand S PD, 2010, HUMAN RESOURCES HLTH; Anand S, 2008, LANCET, V372, P1774, DOI 10.1016/S0140-6736(08)61363-X; Anand S, 2007, LANCET, V369, P1277, DOI 10.1016/S0140-6736(07)60599-6; Barros AJD, 2005, REACHING POOR HLTH N; Barros FC, 2010, AM J PUBLIC HEALTH, V100, P1877, DOI 10.2105/AJPH.2010.196816; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Farahani M, 2009, SOC SCI MED, V68, P1918, DOI 10.1016/j.socscimed.2009.03.023; Girardi S. N., 2011, TRABALHO SAUDE ABORD, P171; Girardi SN, 2011, SURVEY HIST WORK GRA; Guanais Frederico C, 2010, BMJ, V341, pc6542, DOI 10.1136/bmj.c6542; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2003, CENS DEM 2000 MICR A; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2002, CENS DEM 1991 MICR A; Instituto de Pesquisa Economica Aplicada (IPEA), 2008, DAD MACR REG; IPEA, 2010, OBJ DES MIL REL NAC; Jenkins S. P., 1999, STATA TECHNICAL B, V48, P4; Matijasevich A, 2008, AM J PUBLIC HEALTH, V98, P692, DOI 10.2105/AJPH.2006.093492; Ministerio da Saude, 2011, SIST INF ORC PUBL SA; Ministerio da Saude Departamento de Informatica do SUS (DATASUS), 2005, IND DAD BAS CONS PRO; Ministerio da Saude Departamento de Informatica do SUS (DATASUS), 2005, SIST INF AT BAS; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Duarte CMR, 2007, CAD SAUDE PUBLICA, V23, P1511, DOI 10.1590/S0102-311X2007000700002; Rede Interagencial de Informacoes para a Saude-Ripsa, 2008, IND BAS SAUD BRAS CO; Scheffler RM, 2008, B WORLD HEALTH ORGAN, V86, P516, DOI 10.2471/BLT.07.046474; Sergio L, 2011, CARTA CAPITAL, V651, P34; Sousa A, 2011, TRABALHO SAUDE ABORD, P319; Sousa A, 2010, INT J EQUITY HEALTH, V9, DOI 10.1186/1475-9276-9-21; Sousa MF, 2009, CIENC SAUDE COLETIVA, P14; *STATACORP, 2005, STAT STAT SOFTW; Victora CG, 2010, HEALTH POLICY PLANN, V25, P253, DOI 10.1093/heapol/czp065; Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X; Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4; Volpe FM, 2009, REV PANAM SALUD PUBL, V26, P478, DOI 10.1590/S1020-49892009001200002; World Health Organization, 2006, WORLD HLTH REP WORK	35	31	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33399	10.1371/journal.pone.0033399	http://dx.doi.org/10.1371/journal.pone.0033399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	940MY	22479392	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900026
J	Valdes, VJ; Athie, A; Salinas, LS; Navarro, RE; Vaca, L				Valdes, Victor J.; Athie, Alejandro; Salinas, Laura S.; Navarro, Rosa E.; Vaca, Luis			CUP-1 Is a Novel Protein Involved in Dietary Cholesterol Uptake in Caenorhabditis elegans	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; C-ELEGANS; BENZODIAZEPINE-RECEPTOR; RNA INTERFERENCE; STRESS RESISTANCE; NEMATODE; TRANSPORT; STEROLS; IDENTIFICATION; REQUIREMENT	Sterols transport and distribution are essential processes in all multicellular organisms. Survival of the nematode Caenorhabditis elegans depends on dietary absorption of sterols present in the environment. However the general mechanisms associated to sterol uptake in nematodes are poorly understood. In the present work we provide evidence showing that a previously uncharacterized transmembrane protein, designated Cholesterol Uptake Protein-1 (CUP-1), is involved in dietary cholesterol uptake in C. elegans. Animals lacking CUP-1 showed hypersensitivity to cholesterol limitation and were unable to uptake cholesterol. A CUP-1-GFP fusion protein colocalized with cholesterol-rich vesicles, endosomes and lysosomes as well as the plasma membrane. Additionally, by FRET imaging, a direct interaction was found between the cholesterol analog DHE and the transmembrane "cholesterol recognition/interaction amino acid consensus" (CRAC) motif present in C. elegans CUP-1. In-silico analysis identified two mammalian homologues of CUP-1. Most interestingly, CRAC motifs are conserved in mammalian CUP-1 homologous. Our results suggest a role of CUP-1 in cholesterol uptake in C. elegans and open up the possibility for the existence of a new class of proteins involved in sterol absorption in mammals.	[Valdes, Victor J.; Athie, Alejandro; Salinas, Laura S.; Navarro, Rosa E.; Vaca, Luis] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Valdes, VJ (corresponding author), Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biol Celular & Desarrollo, Ciudad Univ, Mexico City 04510, DF, Mexico.	rnavarro@ifc.unam.mx; lvaca@ifc.unam.mx	Athie, Alejandro/L-9942-2017; Valdes, Julian/C-1840-2017	Athie, Alejandro/0000-0003-0827-7605; Valdes, Julian/0000-0001-6157-1358; Navarro, Rosa/0000-0003-4992-4450; Vaca, Luis/0000-0003-2266-4847	Instituto de Ciencia y Tecnologia del DF (ICyTDF); Direccion General de Asuntos del Personal Academico (DGAPA); CONACyT [103856-Q]; PAPIIT [IN225509]	Instituto de Ciencia y Tecnologia del DF (ICyTDF); Direccion General de Asuntos del Personal Academico (DGAPA); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT))	This project was supported by grants from Instituto de Ciencia y Tecnologia del DF ( ICyTDF), Direccion General de Asuntos del Personal Academico (DGAPA) and CONACyT to VL and CONACyT 103856-Q and PAPIIT IN225509 to NRE. CONACyT supported VV. This study was performed in partial fulfillment of the requirement for the PhD degree in Biomedical Sciences of VV at the Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betters JL, 2010, FEBS LETT, V584, P2740, DOI 10.1016/j.febslet.2010.03.030; Branicky R, 2010, DEV DYNAM, V239, P1365, DOI 10.1002/dvdy.22234; Chang TY, 2006, ANNU REV CELL DEV BI, V22, P129, DOI 10.1146/annurev.cellbio.22.010305.104656; Chitwood DJ, 1999, CRIT REV BIOCHEM MOL, V34, P273, DOI 10.1080/10409239991209309; Davies JP, 2000, GENOMICS, V65, P137, DOI 10.1006/geno.2000.6151; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Eaton S, 2008, NAT REV MOL CELL BIO, V9, P437, DOI 10.1038/nrm2414; Entchev EV, 2005, SEMIN CELL DEV BIOL, V16, P175, DOI 10.1016/j.semcdb.2005.01.004; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; HIEB WF, 1968, SCIENCE, V160, P778, DOI 10.1126/science.160.3829.778; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; Jeong J, 2002, J CLIN INVEST, V110, P591, DOI 10.1172/JCI200216506; JOHNSTONE IL, 1994, BIOESSAYS, V16, P171, DOI 10.1002/bies.950160307; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurzchalia TV, 2003, NAT CELL BIOL, V5, P684, DOI 10.1038/ncb0803-684; Lee Eun-Young, 2009, V462, P167, DOI 10.1007/978-1-60327-115-8_11; Lee EY, 2005, BIOCHEM BIOPH RES CO, V328, P929, DOI 10.1016/j.bbrc.2005.01.050; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; Li J, 2004, DEVELOPMENT, V131, P5741, DOI 10.1242/dev.01408; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Martin R, 2010, ORG BIOMOL CHEM, V8, P739, DOI 10.1039/b918488k; Matyash V, 2004, PLOS BIOL, V2, P1561, DOI 10.1371/journal.pbio.0020280; Matyash V, 2001, MOL BIOL CELL, V12, P1725, DOI 10.1091/mbc.12.6.1725; McIntosh A, 2008, LIPIDS, V43, P1185, DOI 10.1007/s11745-008-3194-1; Merris M, 2004, J LIPID RES, V45, P2044, DOI 10.1194/jlr.M400100-JLR200; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Patel DS, 2008, DEVELOPMENT, V135, P2239, DOI 10.1242/dev.016972; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Rasband WS, 2011, IMAGEJ, P1997; RAZIN S, 1975, J BACTERIOL, V124, P570, DOI 10.1128/JB.124.1.570-572.1975; Reis RJS, 2011, AGING-US, V3, P125, DOI 10.18632/aging.100275; Santel A, 2006, GENE THER, V13, P1222, DOI 10.1038/sj.gt.3302777; Shim YH, 2002, MOL REPROD DEV, V61, P358, DOI 10.1002/mrd.10099; SLOTTE JP, 1989, BIOCHIM BIOPHYS ACTA, V1005, P303, DOI 10.1016/0005-2760(89)90053-2; Smith MM, 2007, BBA-GEN SUBJECTS, V1770, P1345, DOI 10.1016/j.bbagen.2007.06.004; Stepek G, 2010, INT J PARASITOL, V40, P533, DOI 10.1016/j.ijpara.2009.10.007; Sym M, 2000, CURR BIOL, V10, P527, DOI 10.1016/S0960-9822(00)00468-1; Tamura K, 2011, MOL BIOL EVOL; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; Vinci G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002883; Walkley SU, 2004, BBA-MOL CELL BIOL L, V1685, P48, DOI 10.1016/j.bbalip.2004.08.011; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wolfrum C, 2007, NAT BIOTECHNOL, V25, P1149, DOI 10.1038/nbt1339; Wustner D, 2010, TRAFFIC, V11, P440, DOI 10.1111/j.1600-0854.2010.01040.x; Yochem J, 1999, DEVELOPMENT, V126, P597	56	22	27	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33962	10.1371/journal.pone.0033962	http://dx.doi.org/10.1371/journal.pone.0033962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479487	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900052
J	Yuan, GH; Wang, CK; Ma, CL; Chen, N; Tian, QH; Zhang, TL; Fu, W				Yuan, Guohong; Wang, Chongkai; Ma, Chaolai; Chen, Ning; Tian, Qinghe; Zhang, Tonglin; Fu, Wei			Oncogenic Function of DACT1 in Colon Cancer through the Regulation of beta-catenin	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; GLYCOGEN-SYNTHASE KINASE-3-BETA; SIGNALING PATHWAY; DOWN-REGULATION; NUCLEAR EXPORT; WNT; APC; IDENTIFICATION; ACTIVATION; EXPRESSION	The Wnt/beta-catenin signaling pathway plays important roles in the progression of colon cancer. DACT1 has been identified as a modulator of Wnt signaling through its interaction with Dishevelled (Dvl), a central mediator of both the canonical and noncanonical Wnt pathways. However, the functions of DACT1 in the WNT/beta-catenin signaling pathway remain unclear. Here, we present evidence that DACT1 is an important positive regulator in colon cancer through regulating the stability and sublocation of beta-catenin. We have shown that DACT1 promotes cancer cell proliferation in vitro and tumor growth in vivo and enhances the migratory and invasive potential of colon cancer cells. Furthermore, the higher expression of DACT1 not only increases the nuclear and cytoplasmic fractions of beta-catenin, but also increases its membrane-associated fraction. The overexpression of DACT1 leads to the increased accumulation of nonphosphorylated beta-catenin in the cytoplasm and particularly in the nuclei. We have demonstrated that DACT1 interacts with GSK-3 beta and beta-catenin. DACT1 stabilizes beta-catenin via DACT1-induced effects on GSK-3 beta and directly interacts with beta-catenin proteins. The level of phosphorylated GSK-3 beta at Ser9 is significantly increased following the elevated expression of DACT1. DACT1 mediates the subcellular localization of beta-catenin via increasing the level of phosphorylated GSK-3 beta at Ser9 to inhibit the activity of GSK-3 beta. Taken together, our study identifies DACT1 as an important positive regulator in colon cancer and suggests a potential strategy for the therapeutic control of the beta-catenin-dependent pathway.	[Yuan, Guohong; Wang, Chongkai; Ma, Chaolai; Chen, Ning; Tian, Qinghe; Zhang, Tonglin; Fu, Wei] Peking Univ, Dept Gen Surg, Hosp 3, Beijing 100871, Peoples R China	Peking University	Yuan, GH (corresponding author), Peking Univ, Dept Gen Surg, Hosp 3, Beijing 100871, Peoples R China.	wei.fu0720@sohu.com			National Science Foundation of China [30770440]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Science Foundation of China, No. 30770440. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERLE H, 1994, J CELL SCI, V107, P3655; ASHTONRICKARDT PG, 1989, ONCOGENE, V4, P1169; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chen YP, 2008, J BIOL CHEM, V283, P17969, DOI 10.1074/jbc.M802917200; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Cox RT, 1998, CURR BIOL, V8, pR140, DOI 10.1016/S0960-9822(98)70081-8; Dale TC, 1998, BIOCHEM J, V329, P209; Dominguez I, 2000, DEVELOPMENT, V127, P861; Eleftheriou A, 2001, J BIOL CHEM, V276, P25883, DOI 10.1074/jbc.M102656200; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Hamada Fumihiko, 2009, Kaibogaku Zasshi, V84, P111; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Henderson BR, 2002, EMBO REP, V3, P834, DOI 10.1093/embo-reports/kvf181; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Johnson M, 2009, CELL SIGNAL, V21, P339, DOI 10.1016/j.cellsig.2008.11.004; Katoh M, 2003, INT J ONCOL, V22, P907; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Marikawa Y, 1998, MECH DEVELOP, V77, P75, DOI 10.1016/S0925-4773(98)00134-8; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Salomon D, 1997, J CELL BIOL, V139, P1325, DOI 10.1083/jcb.139.5.1325; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wang CK, 2011, THESIS PEKING U; Wiechens N, 2001, CURR BIOL, V11, P18, DOI 10.1016/S0960-9822(00)00045-2; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Yanagawa S, 2002, EMBO J, V21, P1733, DOI 10.1093/emboj/21.7.1733; Yang ZQ, 2010, MOL CARCINOGEN, V49, P508, DOI 10.1002/mc.20622; Yau TO, 2005, ONCOGENE, V24, P1607, DOI 10.1038/sj.onc.1208340; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200	48	22	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e34004	10.1371/journal.pone.0034004	http://dx.doi.org/10.1371/journal.pone.0034004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470507	Green Published, Green Submitted, gold			2022-12-27	WOS:000303857100064
J	Chunco, AJ; Jobe, T; Pfennig, KS				Chunco, Amanda J.; Jobe, Todd; Pfennig, Karin S.			Why Do Species Co-Occur? A Test of Alternative Hypotheses Describing Abiotic Differences in Sympatry versus Allopatry Using Spadefoot Toads	PLOS ONE			English	Article							CHARACTER DISPLACEMENT; POSITIVE INTERACTIONS; IMPROVE PREDICTION; DISTRIBUTIONS; HYBRIDIZATION; MODELS; COMPETITION; DIVERGENCE; SELECTION; CLIMATE	Areas of co-occurrence between two species (sympatry) are often thought to arise in regions where abiotic conditions are conducive to both species and are therefore intermediate between regions where either species occurs alone (allopatry). Depending on historical factors or interactions between species, however, sympatry might not differ from allopatry, or, alternatively, sympatry might actually be more extreme in abiotic conditions relative to allopatry. Here, we evaluate these three hypothesized patterns for how sympatry compares to allopatry in abiotic conditions. We use two species of congeneric spadefoot toads, Spea multiplicata and S. bombifrons, as our study system. To test these hypotheses, we created ecological niche models (specifically using MAXENT) for both species to create a map of the joint probability of occurrence of both species. Using the results of these models, we identified three types of locations: two where either species was predicted to occur alone (i.e., allopatry for S. multiplicata and allopatry for S. bombifrons) and one where both species were predicted to co-occur (i.e., sympatry). We then compared the abiotic environment between these three location types and found that sympatry was significantly hotter and drier than the allopatric regions. Thus, sympatry was not intermediate between the alternative allopatric sites. Instead, sympatry occurred at one extreme of the conditions occupied by both species. We hypothesize that biotic interactions in these extreme environments facilitate co-occurrence. Specifically, hybridization between S. bombifrons females and S. multiplicata males may facilitate co-occurrence by decreasing development time of tadpoles. Additionally, the presence of alternative food resources in more extreme conditions may preclude competitive exclusion of one species by the other. This work has implications for predicting how interacting species will respond to climate change, because species interactions may facilitate survival in extreme habitats.	[Chunco, Amanda J.] Univ N Carolina, Dept Geog, Chapel Hill, NC 27515 USA; [Jobe, Todd] Signal Innovat Grp Inc, Durham, NC USA; [Pfennig, Karin S.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chunco, AJ (corresponding author), Univ N Carolina, Dept Geog, Chapel Hill, NC 27515 USA.	chunco@email.unc.edu	Chunco, Amanda J./AAI-8938-2020	Chunco, Amanda/0000-0002-8265-327X	Seeding Postdoctoral Innovators in Research and Education grant from the Minority Opportunities in Research division of the National Institute of General Medical Sciences/National Institutes of Health (NIH) [K12GM000678]; University of North Carolina (UNC) Graduate Student Opportunity Fund; National Science Foundation; NIH Director's New Innovator Award; UNC at Cahpel Hill's Libraries; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678] Funding Source: NIH RePORTER	Seeding Postdoctoral Innovators in Research and Education grant from the Minority Opportunities in Research division of the National Institute of General Medical Sciences/National Institutes of Health (NIH); University of North Carolina (UNC) Graduate Student Opportunity Fund; National Science Foundation(National Science Foundation (NSF)); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC at Cahpel Hill's Libraries; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported primarily by the Seeding Postdoctoral Innovators in Research and Education grant K12GM000678 from the Minority Opportunities in Research division of the National Institute of General Medical Sciences/National Institutes of Health (NIH) and the University of North Carolina (UNC) Graduate Student Opportunity Fund to AJC, with additional support provided by a grant from the National Science Foundation and a NIH Director's New Innovator Award to KP. The UNC at Cahpel Hill's Libraries provided financial support for open access publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AM, 1999, COPEIA, P515, DOI 10.2307/1447502; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bragg AN, 1965, GNOMES NIGHT SPADEFO; Brito JC, 2009, BIOL CONSERV, V142, P3020, DOI 10.1016/j.biocon.2009.08.001; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Chapman AD, 2006, GLOBAL BIODIVERSITY; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; Darwin C, 1859, ORIGIN SPECIES MEANS; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elliott L., 2009, FROGS TOADS N AM COM; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Figueroa ME, 2003, J ECOL, V91, P616, DOI 10.1046/j.1365-2745.2003.00794.x; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Griggs R. F., 1914, B TORREY BOT CLUB, V41, P25, DOI [10.2307/2479433, DOI 10.2307/2479433]; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Groning J, 2008, Q REV BIOL, V83, P257, DOI 10.1086/590510; Guisan A, 1998, J VEG SCI, V9, P65, DOI 10.2307/3237224; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Heikkinen RK, 2007, GLOBAL ECOL BIOGEOGR, V16, P754, DOI 10.1111/j.1466-8238.2007.00345.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; Krebs C. J., 1978, ECOLOGY ANAL DISTRIB, V3rd; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Martinez-Freiria F, 2008, DIVERS DISTRIB, V14, P452, DOI 10.1111/j.1472-4642.2007.00446.x; Merriam C.H., 1984, NATL GEOGRAPHIC MAGA, V6, P229; PFENNIG D, 1990, OECOLOGIA, V85, P101, DOI 10.1007/BF00317349; Pfennig DW, 2007, EVOLUTION, V61, P257, DOI 10.1111/j.1558-5646.2007.00034.x; Pfennig DW, 2000, EVOLUTION, V54, P1738; Pfennig DW, 2006, ECOLOGY, V87, P769, DOI 10.1890/05-0787; PFENNIG DW, 1992, EVOLUTION, V46, P1408, DOI 10.1111/j.1558-5646.1992.tb01133.x; Pfennig DW, 2002, EVOLUTION, V56, P1217; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Pfennig KS, 2007, EVOL ECOL RES, V9, P341; Pfennig KS, 2009, Q REV BIOL, V84, P253, DOI 10.1086/605079; Pfennig KS, 2005, EVOLUTION, V59, P2200; Pfennig KS, 2003, EVOLUTION, V57, P2842; Pfennig KS, 2002, EVOLUTION, V56, P1840; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; R Development Core Team, 2005, R LANG ENV STAT COMP; Rice AM, 2008, J EVOLUTION BIOL, V21, P696, DOI 10.1111/j.1420-9101.2008.01518.x; Rodriguez MA, 2005, ACTA OECOL, V28, P65, DOI 10.1016/j.actao.2005.02.006; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; SATTLER PW, 1985, COPEIA, P324; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Simovich M., 1985, THESIS U CALIFORNIA; Stebbins R.C., 1985, FIELD GUIDE W REPTIL, V2nd; Swenson NG, 2006, J EVOLUTION BIOL, V19, P717, DOI 10.1111/j.1420-9101.2005.01066.x; Walls SC, 2009, GLOBAL CHANGE BIOL, V15, P1903, DOI 10.1111/j.1365-2486.2009.01867.x; Williams JW, 2007, FRONT ECOL ENVIRON, V5, P475, DOI 10.1890/070037; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	58	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32748	10.1371/journal.pone.0032748	http://dx.doi.org/10.1371/journal.pone.0032748			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479337	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100017
J	Dementhon, K; El-Kirat-Chatel, S; Noel, T				Dementhon, Karine; El-Kirat-Chatel, Sofiane; Noel, Thierry			Development of an In Vitro Model for the Multi-Parametric Quantification of the Cellular Interactions between Candida Yeasts and Phagocytes	PLOS ONE			English	Article							FLUORESCENCE QUENCHING TECHNIQUE; NEUTROPHIL EXTRACELLULAR TRAPS; MURINE MACROPHAGES; ALBICANS YEAST; FLOW-CYTOMETRY; WALL PROTEINS; TRANSCRIPTIONAL RESPONSE; SACCHAROMYCES-CEREVISIAE; CRYPTOCOCCUS-NEOFORMANS; IMMUNE-SYSTEM	We developed a new in vitro model for a multi-parameter characterization of the time course interaction of Candida fungal cells with J774 murine macrophages and human neutrophils, based on the use of combined microscopy, fluorometry, flow cytometry and viability assays. Using fluorochromes specific to phagocytes and yeasts, we could accurately quantify various parameters simultaneously in a single infection experiment: at the individual cell level, we measured the association of phagocytes to fungal cells and phagocyte survival, and monitored in parallel the overall phagocytosis process by measuring the part of ingested fungal cells among the total fungal biomass that changed over time. Candida albicans, C. glabrata, and C. lusitaniae were used as a proof of concept: they exhibited species-specific differences in their association rate with phagocytes. The fungal biomass uptaken by the phagocytes differed significantly according to the Candida species. The measure of the survival of fungal and immune cells during the interaction showed that C. albicans was the more aggressive yeast in vitro, destroying the vast majority of the phagocytes within five hours. All three species of Candida were able to survive and to escape macrophage phagocytosis either by the intraphagocytic yeast-to-hyphae transition (C. albicans) and the fungal cell multiplication until phagocytes burst (C. glabrata, C. lusitaniae), or by the avoidance of phagocytosis (C. lusitaniae). We demonstrated that our model was sensitive enough to quantify small variations of the parameters of the interaction. The method has been conceived to be amenable to the high-throughput screening of mutants in order to unravel the molecular mechanisms involved in the interaction between yeasts and host phagocytes.	[Dementhon, Karine; El-Kirat-Chatel, Sofiane; Noel, Thierry] Univ Bordeaux, UMR 5234, Bordeaux, France; [Dementhon, Karine; El-Kirat-Chatel, Sofiane; Noel, Thierry] CNRS, UMR 5234, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Dementhon, K (corresponding author), Univ Bordeaux, UMR 5234, Bordeaux, France.	thierry.noel@u-bordeaux2.fr	El-Kirat-Chatel, Sofiane/H-7728-2016	El-Kirat-Chatel, Sofiane/0000-0001-5877-5640; Noel, Thierry/0000-0003-0320-1126; DEMENTHON, Karine/0000-0003-0974-3663	French Ministere de l'Enseignement Superieur et de la Recherche; University of Bordeaux; Centre National de la Recherche Scientifique	French Ministere de l'Enseignement Superieur et de la Recherche; University of Bordeaux; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	Sofiane El-Kirat-Chatel PhD was supported by the French Ministere de l'Enseignement Superieur et de la Recherche. This work was supported by grants from the University of Bordeaux and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BJERKNES R, 1984, BLUT, V49, P315, DOI 10.1007/BF00320205; Brieland J, 2001, INFECT IMMUN, V69, P5046, DOI 10.1128/IAI.69.8.5046-5055.2001; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Busetto S, 2004, CYTOM PART A, V58A, P201, DOI 10.1002/cyto.a.20014; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; CHAKA W, 1995, CLIN DIAGN LAB IMMUN, V2, P753, DOI 10.1128/CDLI.2.6.753-759.1995; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; de Groot PWJ, 2008, EUKARYOT CELL, V7, P1951, DOI 10.1128/EC.00284-08; DOOLEY DC, 1982, EXP HEMATOL, V10, P591; Ebanks RO, 2006, PROTEOMICS, V6, P2147, DOI 10.1002/pmic.200500100; Fernandez-Arenas E, 2009, CELL MICROBIOL, V11, P560, DOI 10.1111/j.1462-5822.2008.01274.x; Fradin C, 2005, MOL MICROBIOL, V56, P397, DOI 10.1111/j.1365-2958.2005.04557.x; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gales A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000714; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Ghosh S, 2009, INFECT IMMUN, V77, P1596, DOI 10.1128/IAI.01452-08; Hed J, 1986, Methods Enzymol, V132, P198; Heilmann CJ, 2011, MICROBIOLOGY; Hiller E, 2011, INT J MED MICROBIOL, V301, P384, DOI 10.1016/j.ijmm.2011.04.004; Hoch HC, 2005, MYCOLOGIA, V97, P580, DOI 10.3852/mycologia.97.3.580; Ibata-Ombetta S, 2003, J BIOL CHEM, V278, P13086, DOI 10.1074/jbc.M210680200; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Keppler-Ross S, 2010, EUKARYOT CELL, V9, P1776, DOI 10.1128/EC.00156-10; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Lehmann AK, 2000, J IMMUNOL METHODS, V243, P229, DOI 10.1016/S0022-1759(00)00237-4; LICHTENFELS R, 1994, J IMMUNOL METHODS, V172, P227, DOI 10.1016/0022-1759(94)90110-4; Lohse MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001473; LOIKE JD, 1983, J IMMUNOL METHODS, V57, P373, DOI 10.1016/0022-1759(83)90097-2; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Luo G, 2010, J INFECT DIS, V201, P1718, DOI 10.1086/652407; MAEDA H, 1967, J BIOCHEM-TOKYO, V62, P276, DOI 10.1093/oxfordjournals.jbchem.a128660; Marr KA, 2001, CLIN DIAGN LAB IMMUN, V8, P1240, DOI 10.1128/CDLI.8.6.1240-1247.2001; Martinez-Esparza M, 2007, CLIN MICROBIOL INFEC, V13, P384, DOI 10.1111/j.1469-0691.2007.01663.x; Martinez-Esparza M, 2006, J IMMUNOL METHODS, V314, P90, DOI 10.1016/j.jim.2006.06.004; Martinez-Esparza M, 2009, INT J MED MICROBIOL, V299, P453, DOI 10.1016/j.ijmm.2008.12.001; McKenzie CGJ, 2010, INFECT IMMUN, V78, P1650, DOI 10.1128/IAI.00001-10; Mora-Montes HM, 2011, INFECT IMMUN, V79, P1961, DOI 10.1128/IAI.01282-10; Mora-Montes HM, 2010, J BIOL CHEM, V285, P12087, DOI 10.1074/jbc.M109.081513; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Poulain D, 2004, CURR OPIN MICROBIOL, V7, P342, DOI 10.1016/j.mib.2004.06.011; Roetzer A, 2010, CELL MICROBIOL, V12, P199, DOI 10.1111/j.1462-5822.2009.01391.x; Rubin-Bejerano I, 2007, CELL HOST MICROBE, V2, P55, DOI 10.1016/j.chom.2007.06.002; Schindler B, 2008, MED MYCOL, V46, P251, DOI 10.1080/13693780701837157; Scott AJ, 2000, MED MYCOL, V38, P15, DOI 10.1080/mmy.38.1.15.22; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Seider K, 2010, CURR OPIN MICROBIOL, V13, P392, DOI 10.1016/j.mib.2010.05.001; Sheth CC, 2011, MED MYCOL; Uppuluri P, 2007, MOL MICROBIOL, V64, P1572, DOI 10.1111/j.1365-2958.2007.05760.x; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Villena SN, 2008, CELL MICROBIOL, V10, P1274, DOI 10.1111/j.1462-5822.2008.01125.x; Weingart CL, 1999, INFECT IMMUN, V67, P4264, DOI 10.1128/IAI.67.8.4264-4267.1999; Wheeler RT, 2006, PLOS PATHOG, V2, P328, DOI 10.1371/journal.ppat.0020035; Zhang B, 2003, J BIOL CHEM, V278, P28443, DOI 10.1074/jbc.M210727200	56	45	46	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32621	10.1371/journal.pone.0032621	http://dx.doi.org/10.1371/journal.pone.0032621			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479332	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100015
J	Shen, HC; Li, YQ; Liao, YD; Zhang, TH; Liu, Q; Du, JJ				Shen, Hongchang; Li, Yongqiu; Liao, Yida; Zhang, Tiehong; Liu, Qi; Du, Jiajun			Lower Blood Calcium Associates with Unfavorable Prognosis and Predicts for Bone Metastasis in NSCLC	PLOS ONE			English	Article							FATAL PROSTATE-CANCER; DAIRY-PRODUCTS; SERUM-CALCIUM; ENDOPLASMIC-RETICULUM; PROSPECTIVE COHORT; RISK; CA2+; SUPPLEMENTATION; METAANALYSIS; HOMEOSTASIS	Ionized calcium was involved in various cellular signal pathways, and regulates many cellular processes, including those relevant to tumorigenesis. We hypothesis that imbalance of calcium homeostasis is correlated with development of lung carcinomas. We collected the clinical data of 1084 patients with non small cell lung cancer (NSCLC) treated in Shandong Provincial Hospital, Shandong University. Logistic regression was used to determine the association between calcium levels and clinical characteristics, and COX regression and Kaplan-Meier model were applied to analyze risk factors on overall survival. Blood electrolytes were tested before treatment; and nearly 16% patients with NSCLC were complained with decreased blood calcium, which is more frequent than that in other electrolytes. Further, Multivariate logistic regression analysis disclosed that there were significant correlation between blood calcium decrease and moderate and poor differentiation (P = 0.012, OR = 1.926 (1.203-4.219)), squamous cell carcinoma (P = 0.024, OR = 1.968(1.094-3.540)), and bone metastasis (P = 0.032, OR = 0.396(0.235-0.669)). In multivariate COX regression analysis, advanced lymph node stage and decreased blood calcium were significantly and independent, unfavorable prognostic factors (P<0.001). Finally, the Kaplan-Meier Survival curve revealed that blood calcium decrease was associated with shorter survival (Log-rank; chi(2) = 26.172, P<0.001). Our finding indicates that lower blood calcium levels are asscociated with a higher risk of unfavorable prognosis and bone metastasis of NSCLC.	[Shen, Hongchang; Liao, Yida; Zhang, Tiehong] Shandong Univ, Prov Hosp, Biobank Ctr, Jinan 250100, Peoples R China; [Shen, Hongchang; Liao, Yida; Liu, Qi; Du, Jiajun] Shandong Univ, Prov Hosp, Inst Oncol, Jinan 250100, Peoples R China; [Li, Yongqiu] Shandong Univ, Prov Hosp, Dept Med Adm, Jinan 250100, Peoples R China; [Zhang, Tiehong] Shandong Univ, Prov Hosp, Dept Thorac Surg, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University	Shen, HC (corresponding author), Shandong Univ, Prov Hosp, Biobank Ctr, Jinan 250100, Peoples R China.	liuqi66@sdu.edu.cn; dujiajun@sdu.edu.cn			Provincial Natural Science Foundation of Shandong [ZR2010HM067, ZR2011HM077]; Provincial Science and Technology Foundation of Shandong [2010RKGA2007]	Provincial Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province); Provincial Science and Technology Foundation of Shandong	This work was supported by Provincial Natural Science Foundation of Shandong (ZR2010HM067 and ZR2011HM077) and Provincial Science and Technology Foundation of Shandong (2010RKGA2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2007, CANCER EPIDEM BIOMAR, V16, P2623, DOI 10.1158/1055-9965.EPI-07-0601; Almquist M, 2007, CANCER CAUSE CONTROL, V18, P595, DOI 10.1007/s10552-007-9001-0; Baron JA, 2005, CANCER EPIDEM BIOMAR, V14, P586, DOI 10.1158/1055-9965.EPI-04-0319; Bentle MS, 2006, J BIOL CHEM, V281, P33684, DOI 10.1074/jbc.M603678200; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Bikle DD, 2004, J STEROID BIOCHEM, V89-90, P355, DOI 10.1016/j.jsbmb.2004.03.020; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; Gao X, 2005, JNCI-J NATL CANCER I, V97, P1768, DOI 10.1093/jnci/dji402; Giovannucci E, 2006, CANCER EPIDEM BIOMAR, V15, P203, DOI 10.1158/1055-9965.EPI-05-0586; Giovannucci E, 1998, CANCER CAUSE CONTROL, V9, P567, DOI 10.1023/A:1008835903714; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; Govindasamy A, 2002, ONCOGENE, V21, P7839; Guillaume L, 2001, J BIOL CHEM, V276, P47608; Halthur C, 2009, CANCER CAUSE CONTROL, V20, P1205, DOI 10.1007/s10552-009-9342-y; Huang JB, 2004, CANCER RES, V64, P2482, DOI 10.1158/0008-5472.CAN-03-3501; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kesse E, 2006, BRIT J NUTR, V95, P539, DOI 10.1079/BJN20051670; Liao JH, 2006, CANCER RES, V66, P9065, DOI 10.1158/0008-5472.CAN-06-0317; Lipskaia L, 2004, BIOL CELL, V96, P55, DOI 10.1016/j.biolcel.2003.11.001; Patton AM, 2003, CURR PHARM DESIGN, V9, P543, DOI 10.2174/1381612033391559; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Prins GS, 2008, STEROIDS, V73, P233, DOI 10.1016/j.steroids.2007.10.013; Rizzuto R, 2003, ONCOGENE, V22, P8619, DOI 10.1038/sj.onc.1207105; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rodriguez C, 2003, CANCER EPIDEM BIOMAR, V12, P597; Severi G, 2006, J NATL CANCER I, V98, P794, DOI 10.1093/jnci/djj215; Skinner HG, 2008, CANCER EPIDEM BIOMAR, V17, P2302, DOI 10.1158/1055-9965.EPI-08-0365; Skinner HG, 2009, CANCER EPIDEM BIOMAR, V18, P575, DOI 10.1158/1055-9965.EPI-08-0915; Subhas C, 2003, CANCER RES, V63, P67	30	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34264	10.1371/journal.pone.0034264	http://dx.doi.org/10.1371/journal.pone.0034264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479582	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339100142
J	Davies, EC; Chandler, CIR; Innocent, SHS; Kalumuna, C; Terlouw, DJ; Lalloo, DG; Staedke, SG; Haaland, A				Davies, Emma C.; Chandler, Clare I. R.; Innocent, Simeon H. S.; Kalumuna, Charles; Terlouw, Dianne J.; Lalloo, David G.; Staedke, Sarah G.; Haaland, Ane			Designing Adverse Event Forms for Real-World Reporting: Participatory Research in Uganda	PLOS ONE			English	Article							DRUG-REACTIONS; PHARMACOVIGILANCE; MALARIA; AFRICA; TRIALS; SAFETY; KENYA; SIAYA	The wide- scale roll- out of artemisinin combination therapies ( ACTs) for the treatment of malaria should be accompanied by continued surveillance of their safety. Post- marketing pharmacovigilance ( PV) relies on adverse event ( AE) reporting by clinicians, but as a large proportion of treatments are provided by non- clinicians in low- resource settings, the effectiveness of such PV systems is limited. To facilitate reporting, AE forms should be easily completed; however, most are challenging for lower- level health workers and non- clinicians to complete. Through participatory research, we sought to develop user- friendly AE report forms to capture information on events associated with ACTs. Following situation analysis, we undertook workshops with community medicine distributors and health workers in Jinja, Uganda, to develop a reporting form based on experiences and needs of users, and communication and visual perception principles. Participants gave feedback for revisions of subsequent versions. We then conducted 8 pretesting sessions with 77 potential end users to test and refine passive and active versions of the form. The development process resulted in a form that included a pictorial storyboard to communicate the rationale for the information needed and facilitate rapport between the reporter and the respondent, and a diary format to record the drug administration and event details in chronological relation to each other. Successive rounds of pretesting used qualitative and quantitative feedback to refine the form, with the final round showing over 80% of the form completed correctly by potential end users. We developed novel AE report forms that can be used by non- clinicians to capture pharmacovigilance data for anti- malarial drugs. The participatory approach was effective for developing forms that are intuitive for reporters, and motivating for respondents. The forms, or their key components, could be adapted for use in other low- literacy settings to improve quality and quantity of drug safety reports as new medicines are scaled- up.	[Davies, Emma C.; Terlouw, Dianne J.; Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Chandler, Clare I. R.; Staedke, Sarah G.] London Sch Hyg & Trop Med, London WC1, England; [Innocent, Simeon H. S.] Univ Cambridge, Cambridge, England; [Kalumuna, Charles] Uganda Malaria Surveillance Project, Kampala, Uganda; [Haaland, Ane] Univ Oslo Haaland Commun, Oslo, Norway	Liverpool School of Tropical Medicine; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; University of Oslo	Davies, EC (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	ecdavies@ymail.com		Chandler, Clare/0000-0001-6499-7522; Lalloo, David/0000-0001-7680-2200; Terlouw, Anja/0000-0001-5327-8995	ACT Consortium; Bill AMP; Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine	ACT Consortium; Bill AMP; Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine	This research is supported by the ACT Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine (http://www.actconsortium.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayi IO, 2008, PATIENT EDUC COUNS; [Anonymous], MED ANTHR Q; Basch E, 2010, NEW ENGL J MED, V362, P865, DOI 10.1056/NEJMp0911494; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Blenkinsopp A, 2007, BRIT J CLIN PHARMACO, V63, P148, DOI 10.1111/j.1365-2125.2006.02746.x; Bukirwa H, 2008, TROP MED INT HEALTH, V13, P1143, DOI 10.1111/j.1365-3156.2008.02119.x; Charles C, 1999, SOC SCI MED, V49, P651, DOI 10.1016/S0277-9536(99)00145-8; Chetley A, 2007, IMPROVE USE MED CONS; Cornwall A, 1995, SOC SCI MED, V41, P1667, DOI 10.1016/0277-9536(95)00127-S; Das J, 2011, IMPACT RECALL PERIOD; Edwards IR, 2008, DRUG SAFETY, V31, P961, DOI 10.2165/00002018-200831110-00001; ETKIN NL, 1992, MED ANTHROPOL Q, V6, P99, DOI 10.1525/maq.1992.6.2.02a00010; European Medicines Agency, 1995, ICH TOP E 2 A CLIN S; Haaland A, 1984, PRETESTING COMMUNICA; Haaland A., 2006, QUALITY INFORM FIELD; Haaland Ane, 2001, REPORTING PICTURES C; Kamat Vinay R, 2009, Anthropol Med, V16, P293, DOI 10.1080/13648470903246854; Kelly JM, 2001, AM J PUBLIC HEALTH, V91, P1617, DOI 10.2105/AJPH.91.10.1617; Kuemmerle A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-57; Mead N, 2000, SOC SCI MED, V51, P1087, DOI 10.1016/S0277-9536(00)00098-8; Mehta U, 2007, DRUG SAFETY, V30, P899, DOI 10.2165/00002018-200730100-00008; Mehta Ushma, 2010, Expert Rev Clin Pharmacol, V3, P509, DOI 10.1586/ecp.10.37; Oshikoya KA, 2009, ARCH DIS CHILD, V94, P469, DOI 10.1136/adc.2008.152629; Rowe SY, 2007, TROP MED INT HEALTH, V12, P651, DOI 10.1111/j.1365-3156.2007.01824.x; Staedke SG, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-107; Stergachis A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-148; Talisuna AO, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-50; UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. Community Directed Treatment with Ivermectin, 1996, COMM DIR TREATM IV R; World Health Organization, 2007, PRACT HDB PHARM ANT; World Health Organization (WHO) and Medicines for Malaria Venture (MMV), 2009, PHARM GUID COUNTR PA	30	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32704	10.1371/journal.pone.0032704	http://dx.doi.org/10.1371/journal.pone.0032704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948SR	22479335	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000304523400007
J	Eura, Y; Yanamoto, H; Arai, Y; Okuda, T; Miyata, T; Kokame, K				Eura, Yuka; Yanamoto, Hiroji; Arai, Yuji; Okuda, Tomohiko; Miyata, Toshiyuki; Kokame, Koichi			Derlin-1 Deficiency Is Embryonic Lethal, Derlin-3 Deficiency Appears Normal, and Herp Deficiency Is Intolerant to Glucose Load and Ischemia in Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; MEMBRANE-PROTEIN; UBIQUITIN-LIGASE; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; CEREBRAL-ISCHEMIA; BETA-PROTEIN; DEGRADATION; ER	Accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER) causes a cellular condition called ER stress. To overcome ER stress, unfolded proteins are eliminated by an ER-associated degradation (ERAD) system. To explore the physiological requirements for ERAD-related membrane proteins in mammals, we generated Derlin-1-, Derlin-3-, and Herp-deficient mice by gene targeting. Complete loss of Derlin-1 caused embryonic lethality at around E7-E8 (early somite stages). In contrast, Derlin-3- and Herp-deficient mice were born alive with the expected Mendelian frequency, and were superficially indistinguishable from wild-type mice. However, in the Derlin-3- and Herp-deficient mouse organs, the expression levels of ERAD-related proteins were affected under both normal and ER stress conditions; specific effects differed among the organs. Degradation of ERAD substrates was reduced in the Herp-deficient liver, and Herp-deficient mice exhibited impaired glucose tolerance and vulnerability to brain ischemic injury, both of which are known to be implicated in ER stress. Our findings indicate that ERAD or uncharacterized functions involving Derlin-1 are essential in early embryonic development. Derlin-3- and Herp-deficient mice may become useful model animals for investigations of the physiological contribution of ERAD under stressful or pathological conditions.	[Eura, Yuka; Okuda, Tomohiko; Miyata, Toshiyuki; Kokame, Koichi] Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan; [Yanamoto, Hiroji] Natl Cerebral & Cardiovasc Ctr, Lab Neurol & Neurosurg, Suita, Osaka, Japan; [Arai, Yuji] Natl Cerebral & Cardiovasc Ctr, Dept Biosci & Genet, Suita, Osaka, Japan	National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan	Eura, Y (corresponding author), Natl Cerebral & Cardiovasc Ctr, Dept Mol Pathogenesis, Suita, Osaka, Japan.	kame@ri.ncvc.go.jp	Eura, Yuka/C-4632-2013; Yanamoto, Hiroji/ABF-7320-2020; yanamoto, hiroji/ABB-3923-2020	Kokame, Koichi/0000-0002-9654-6299	Ministry of Health, Labour, and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; National Institute of Biomedical Innovation (NIBIO) of Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Biomedical Innovation (NIBIO) of Japan(National Institute of Biomedical Innovation)	This work was supported by grants-in-aid from the Ministry of Health, Labour, and Welfare of Japan; from the Ministry of Education, Culture, Sports, Science and Technology of Japan; from Japan Society for the Promotion of Science, grants-in-aid-for JSPS Fellows; and from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Chigurupati S, 2009, J BIOL CHEM, V284, P18323, DOI 10.1074/jbc.M109.020891; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; DeGracia DJ, 2004, J NEUROCHEM, V91, P1, DOI 10.1111/j.1471-4159.2004.02703.x; Dougan SK, 2011, MOL CELL BIOL, V31, P1145, DOI 10.1128/MCB.00967-10; Francisco AB, 2010, J BIOL CHEM, V285, P13694, DOI 10.1074/jbc.M109.085340; Freeman H, 2006, CELL METAB, V3, P35, DOI 10.1016/j.cmet.2005.10.008; Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Iwawaki T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013052; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Kny M, 2011, J BIOL CHEM, V286, P5151, DOI 10.1074/jbc.M110.134551; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Liang GQ, 2008, HUM MOL GENET, V17, P1109, DOI 10.1093/hmg/ddm383; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Oda Y, 2006, J CELL BIOL, V172, P383, DOI 10.1083/jcb.200507057; Ogawa S, 2007, ANTIOXID REDOX SIGN, V9, P573, DOI 10.1089/ars.2006.1516; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Sai X, 2002, J BIOL CHEM, V277, P12915, DOI 10.1074/jbc.M112372200; Sai XR, 2003, FEBS LETT, V553, P151, DOI 10.1016/S0014-5793(03)01009-3; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200; Yamamoto H, 2011, J BIOL CHEM, V286, P26158, DOI 10.1074/jbc.M111.256446; Yanamoto H, 2004, BRAIN RES, V1019, P178, DOI 10.1016/j.brainres.2004.05.105; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	46	44	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34298	10.1371/journal.pone.0034298	http://dx.doi.org/10.1371/journal.pone.0034298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479592	Green Published, Green Submitted, gold			2022-12-27	WOS:000304523400069
J	Fesel, C; Barreto, M; Ferreira, RC; Costa, N; Venda, LL; Pereira, C; Carvalho, C; Moraes-Fontes, MF; Ferreira, CM; Vasconcelos, C; Viana, JF; Santos, E; Martins, B; Demengeot, J; Vicente, AM				Fesel, Constantin; Barreto, Marta; Ferreira, Ricardo C.; Costa, Nuno; Venda, Lara L.; Pereira, Clara; Carvalho, Claudia; Moraes-Fontes, Maria Francisca; Ferreira, Carlos M.; Vasconcelos, Carlos; Viana, Joao F.; Santos, Eugenia; Martins, Berta; Demengeot, Jocelyne; Vicente, Astrid M.			Compensatory T-Cell Regulation in Unaffected Relatives of SLE Patients, and Opposite IL-2/CD25-Mediated Effects Suggested by Coreferentiality Modeling	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTIBODY REPERTOIRES; AUTOREACTIVE REPERTOIRES; AUTOIMMUNE-DISEASE; ALLELIC EXPRESSION; ADOPTIVE TRANSFER; PERIPHERAL-BLOOD; GLOBAL ANALYSIS; PRONE MICE; EX-VIVO	In human systemic lupus erythematosus (SLE), diverse autoantibodies accumulate over years before disease manifestation. Unaffected relatives of SLE patients frequently share a sustained production of autoantibodies with indiscriminable specificity, usually without ever acquiring the disease. We studied relations of IgG autoantibody profiles and peripheral blood activated regulatory T-cells (aTregs), represented by CD4(+)CD25(bright) T-cells that were regularly 70-90% Foxp3(+). We found consistent positive correlations of broad-range as well as specific SLE-associated IgG with aTreg frequencies within unaffected relatives, but not patients or unrelated controls. Our interpretation: unaffected relatives with shared genetic factors compensated pathogenic effects by aTregs engaged in parallel with the individual autoantibody production. To study this further, we applied a novel analytic approach named coreferentiality that tests the indirect relatedness of parameters in respect to multivariate phenotype data. Results show that independently of their direct correlation, aTreg frequencies and specific SLE-associated IgG were likely functionally related in unaffected relatives: they significantly parallelled each other in their relations to broad-range immunoblot autoantibody profiles. In unaffected relatives, we also found coreferential effects of genetic variation in the loci encoding IL-2 and CD25. A model of CD25 functional genetic effects constructed by coreferentiality maximization suggests that IL-2-CD25 interaction, likely stimulating aTregs in unaffected relatives, had an opposed effect in SLE patients, presumably triggering primarily T-effector cells in this group. Coreferentiality modeling as we do it here could also be useful in other contexts, particularly to explore combined functional genetic effects.	[Fesel, Constantin; Barreto, Marta; Ferreira, Ricardo C.; Costa, Nuno; Venda, Lara L.; Pereira, Clara; Moraes-Fontes, Maria Francisca; Demengeot, Jocelyne; Vicente, Astrid M.] Gulbenkian Inst Sci, Oeiras, Portugal; [Ferreira, Carlos M.; Santos, Eugenia] Assoc Doentes Com Lupus, Lisbon, Portugal; [Viana, Joao F.] EPE, Ctr Hosp Lisboa Ocidental, Lisbon, Portugal; [Pereira, Clara; Carvalho, Claudia; Vasconcelos, Carlos; Martins, Berta] Inst Ciencias Biomed Abel Salazar, Oporto, Portugal; [Barreto, Marta; Vicente, Astrid M.] IP, Inst Nacl Saude Dr Ricardo Jorge, Lisbon, Portugal; [Ferreira, Ricardo C.] Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Dept Med Genet,Cambridge Inst Med Res, Cambridge, England; [Venda, Lara L.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Moraes-Fontes, Maria Francisca; Ferreira, Carlos M.; Santos, Eugenia] Hosp Santa Maria, Clin Univ Med 2, Lisbon, Portugal; [Vasconcelos, Carlos] EPE, Unidade Imunol Clin, Hosp Santo Antonio, Oporto, Portugal	Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Universidade do Porto; Instituto Nacional de Saude Dr. Ricardo Jorge; University of Cambridge; University of Oxford; Universidade de Lisboa; Hospital Santa Maria	Fesel, C (corresponding author), Gulbenkian Inst Sci, Oeiras, Portugal.	cfesel@igc.gulbenkian.pt	demengeot, jocelyne/K-8072-2014; Barreto, Marta/F-5591-2012; Vicente, Astrid/F-8692-2014; Alves-Pereira, Clara F./G-2985-2011; vasconcelos, carlos S/C-9728-2009	demengeot, jocelyne/0000-0002-4761-614X; Barreto, Marta/0000-0001-6464-548X; Vicente, Astrid/0000-0001-7134-8037; Alves-Pereira, Clara F./0000-0002-9519-2310; Carvalho, Claudia/0000-0002-1937-6177; Ferreira, Ricardo C./0000-0001-5733-3285; Vasconcelos, Carlos/0000-0002-8073-5028; Silva, Berta/0000-0001-6579-5068; Fesel, Constantin/0000-0003-3537-5243	Fundaco para a Ciencia e a Tecnologia (FCT), Portugal [POCTI/SAU-MMO/59913/2004]	Fundaco para a Ciencia e a Tecnologia (FCT), Portugal	This work was supported by Fundaco para a Ciencia e a Tecnologia (FCT), Portugal, by the research grant POCTI/SAU-MMO/59913/2004 and postdoctoral fellowships to CF and MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Barreto M, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-5; Bayley JP, 2003, EUR J IMMUNOL, V33, P2142, DOI 10.1002/eji.200323976; Bonelli M, 2008, ANN RHEUM DIS, V67, P664, DOI 10.1136/ard.2007.074690; Bonelli M, 2010, ANN RHEUM DIS, V69, P65, DOI 10.1136/ard.2009.117135; Bonelli M, 2009, J IMMUNOL, V182, P1689, DOI 10.4049/jimmunol.182.3.1689; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavanillas ML, 2010, EUR J HUM GENET, V18, P794, DOI 10.1038/ejhg.2010.15; Craig WY, 1999, J RHEUMATOL, V26, P914; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; Crispin JC, 2008, AUTOIMMUN REV, V7, P256, DOI 10.1016/j.autrev.2007.11.020; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; Deshmukh US, 2005, CLIN IMMUNOL, V117, P112, DOI 10.1016/j.clim.2005.07.002; Dorner T, 2005, CLIN EXP MED, V4, P159, DOI 10.1007/s10238-004-0051-2; Fedetz M, 2003, J RHEUMATOL, V30, P435; Fedetz M, 2009, TISSUE ANTIGENS, V74, P244, DOI 10.1111/j.1399-0039.2009.01298.x; Ferreira R, 2005, J AUTOIMMUN, V25, P155, DOI 10.1016/j.jaut.2005.05.004; Fesel C, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-5; Fesel C, 1998, EUR J IMMUNOL, V28, P3616, DOI 10.1002/(SICI)1521-4141(199811)28:11&lt;3616::AID-IMMU3616&gt;3.0.CO;2-B; Fesel C, 2011, PLOS ONE IN PRESS; FRITZLER MJ, 1985, CLIN IMMUNOL IMMUNOP, V36, P120, DOI 10.1016/0090-1229(85)90045-5; Gaipl US, 2006, CURR TOP MICROBIOL, V305, P161, DOI 10.1007/3-540-29714-6_8; Grinberg-Bleyer Y, 2010, J EXP MED, V207, P1871, DOI 10.1084/jem.20100209; HAURY M, 1994, SCAND J IMMUNOL, V39, P79, DOI 10.1111/j.1365-3083.1994.tb03343.x; Hayashi T, 2005, INT J EXP PATHOL, V86, P289, DOI 10.1111/j.0959-9673.2005.00438.x; Heinlen LD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009599; Heinlen LD, 2003, LUPUS, V12, P335, DOI 10.1191/0961203303lu377xx; Hoffmann SC, 2001, TRANSPLANTATION, V72, P1444, DOI 10.1097/00007890-200110270-00019; Horwitz DA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2894; Hsu WT, 2006, CLIN EXP IMMUNOL, V145, P513, DOI 10.1111/j.1365-2249.2006.03173.x; Humrich JY, 2010, P NATL ACAD SCI USA, V107, P204, DOI 10.1073/pnas.0903158107; Johnson AE, 1996, LANCET, V347, P367, DOI 10.1016/S0140-6736(96)90539-5; Kattah NH, 2010, IMMUNOL REV, V233, P126, DOI 10.1111/j.0105-2896.2009.00863.x; Lee JH, 2006, IMMUNOLOGY, V117, P280, DOI 10.1111/j.1365-2567.2005.02306.x; Lin YJ, 2008, CLIN IMMUNOL, V129, P36, DOI 10.1016/j.clim.2008.05.011; Liu MF, 2004, SCAND J IMMUNOL, V59, P198, DOI 10.1111/j.0300-9475.2004.01370.x; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Matesanz F, 2004, J NEUROIMMUNOL, V148, P212, DOI 10.1016/j.jneuroim.2003.12.001; Matesanz F, 2001, J NEUROIMMUNOL, V119, P101, DOI 10.1016/S0165-5728(01)00354-X; Matesanz F, 2000, EUR J IMMUNOL, V30, P3516, DOI 10.1002/1521-4141(2000012)30:12<3516::AID-IMMU3516>3.0.CO;2-S; McClain MT, 2005, NAT MED, V11, P85, DOI 10.1038/nm1167; Mesquita D, 2011, SCAND J RHEUMATOL, V40, P41, DOI 10.3109/03009742.2010.489229; Michel M, 2001, MEDICINE, V80, P153, DOI 10.1097/00005792-200105000-00001; Miyara M, 2005, J IMMUNOL, V175, P8392, DOI 10.4049/jimmunol.175.12.8392; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; MOUTHON L, 1995, P NATL ACAD SCI USA, V92, P3839, DOI 10.1073/pnas.92.9.3839; Nambiar MP, 2003, ARTHRITIS RHEUM, V48, P1948, DOI 10.1002/art.11072; NOBREGA A, 1993, EUR J IMMUNOL, V23, P2851, DOI 10.1002/eji.1830231119; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Press W., 1994, NUMERICAL RECIPES C; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Santos-Lima EC, 2001, EUR J IMMUNOL, V31, P634, DOI 10.1002/1521-4141(200102)31:2&lt;634::AID-IMMU634&gt;3.0.CO;2-H; Scalapino KJ, 2006, J IMMUNOL, V177, P1451, DOI 10.4049/jimmunol.177.3.1451; Scalapino KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006031; Scheinecker C, 2010, J AUTOIMMUN, V35, P269, DOI 10.1016/j.jaut.2010.06.018; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Sharshar T, 1998, EUR J IMMUNOL, V28, P2344, DOI 10.1002/(SICI)1521-4141(199808)28:08<2344::AID-IMMU2344>3.0.CO;2-T; Silva SC, 2004, J NEUROIMMUNOL, V152, P176, DOI 10.1016/j.jneuroim.2004.03.015; Stahl D, 2000, J IMMUNOL METHODS, V240, P1, DOI 10.1016/S0022-1759(00)00185-X; Suen JL, 2009, IMMUNOLOGY, V127, P196, DOI 10.1111/j.1365-2567.2008.02937.x; Sundblad A, 1997, J AUTOIMMUN, V10, P193, DOI 10.1006/jaut.1996.0116; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Valencia X, 2007, J IMMUNOL, V178, P2579, DOI 10.4049/jimmunol.178.4.2579; van der Linden MW, 2001, J RHEUMATOL, V28, P284; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958	71	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33992	10.1371/journal.pone.0033992	http://dx.doi.org/10.1371/journal.pone.0033992			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479496	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400048
J	Georghiou, SB; Magana, M; Garfein, RS; Catanzaro, DG; Catanzaro, A; Rodwell, TC				Georghiou, Sophia B.; Magana, Marisa; Garfein, Richard S.; Catanzaro, Donald G.; Catanzaro, Antonino; Rodwell, Timothy C.			Evaluation of Genetic Mutations Associated with Mycobacterium tuberculosis Resistance to Amikacin, Kanamycin and Capreomycin: A Systematic Review	PLOS ONE			English	Review							GENOTYPE MTBDR ASSAY; 2ND-LINE ANTITUBERCULOSIS DRUGS; MOLECULAR BEACON ASSAY; RIBOSOMAL-RNA GENE; RAPID DETECTION; ISONIAZID RESISTANCE; RIFAMPIN RESISTANCE; CROSS-RESISTANCE; SOUTH-AFRICA; STREPTOMYCIN RESISTANCE	Background: Rapid molecular diagnostics for detecting multidrug-resistant and extensively drug-resistant tuberculosis (M/XDR-TB) primarily identify mutations in Mycobacterium tuberculosis (Mtb) genes associated with drug resistance. Their accuracy, however, is dependent largely on the strength of the association between a specific mutation and the phenotypic resistance of the isolate with that mutation, which is not always 100%. While this relationship is well established and reliable for first-line anti-TB drugs, rifampin and isoniazid, it is less well-studied and understood for second-line, injectable drugs, amikacin (AMK), kanamycin (KAN) and capreomycin (CAP). Methodology/Principal Findings: We conducted a systematic review of all published studies evaluating Mtb mutations associated with resistance to AMK, KAN, CAP in order to characterize the diversity and frequency of mutations as well as describe the strength of the association between specific mutations and phenotypic resistance in global populations. Our objective was to determine the potential utility and reliability of these mutations as diagnostic markers for detecting AMK, KAN and CAP resistance. Mutation data was reviewed for 1,585 unique clinical isolates from four continents and over 18 countries. Mutations in the rrs, tlyA, eis promoter and gidB genes were associated with AMK, KAN and/or CAP resistance. Conclusions/Significance: The rrs A1401G mutation was present in the majority of AMK, KAN and CAP resistant Mtb strains reviewed, but was also found in 7% of CAP susceptible strains. The 1401 mutation alone, however, was not found with sufficient frequency to detect more than 70-80% of global Mtb strains resistant to AMK and CAP, and 60% of strains resistant to KAN. Additional mutations in the rrs, eis promoter, tlyA and gidB genes appear to be associated with resistance and could improve sensitivity and specificity of future diagnostics.	[Georghiou, Sophia B.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Magana, Marisa; Catanzaro, Antonino] Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA; [Garfein, Richard S.; Rodwell, Timothy C.] Univ Calif San Diego, Sch Med, Div Global Publ Hlth, La Jolla, CA 92093 USA; [Catanzaro, Donald G.] Univ Calif San Diego, Dept Family & Prevent Med, Hlth Serv Res Ctr, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Georghiou, SB (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	trodwell@ucsd.edu	Catanzaro, Donald/AAA-4932-2019	Catanzaro, Donald/0000-0003-1760-0574; Georghiou, Sophia/0000-0003-0099-903X	NIAID [K01AI083784, U01AI082229]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI083784, U01AI082229] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID grants # K01AI083784 to Dr. Timothy Rodwell and # U01AI082229 to Dr. Antonio Catanzaro, Dr. Marisa Magana, Dr. Richard Garfein, and Dr. Donald Catanzaro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alangaden GJ, 1998, ANTIMICROB AGENTS CH, V42, P1295, DOI 10.1128/AAC.42.5.1295; Alcaide F, 2011, ENFERM INFEC MICR CL, V29, P34, DOI 10.1016/S0213-005X(11)70016-7; [Anonymous], 2008, GUID PROGR MAN DRUG; [Anonymous], 2011, GLOB TUB CONTR; [Anonymous], 1997, COMMITTEE LAB SERVIC, V72, P597; Banerjee R, 2010, J CLIN MICROBIOL, V48, P3779, DOI 10.1128/JCM.01236-10; Blaschitz M, 2011, J ANTIMICROB CHEMOTH, V66, P1243, DOI 10.1093/jac/dkr070; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bravo LTC, 2009, J CLIN MICROBIOL, V47, P3985, DOI 10.1128/JCM.01229-09; Brossier F, 2010, J CLIN MICROBIOL, V48, P1683, DOI 10.1128/JCM.01947-09; Calver AD, 2010, EMERG INFECT DIS, V16, P264, DOI 10.3201/eid1602.090968; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Cavusoglu C, 2006, J CLIN MICROBIOL, V44, P2338, DOI 10.1128/JCM.00425-06; Djelouadji Zoheira, 2009, BMC Res Notes, V2, P239, DOI 10.1186/1756-0500-2-239; Drobniewski FA, 1998, J MED MICROBIOL, V47, P189, DOI 10.1099/00222615-47-3-189; Engstrom A, 2011, J ANTIMICROB CHEMOTH, V66, P1247, DOI 10.1093/jac/dkr109; Evans J, 2009, J ANTIMICROB CHEMOTH, V63, P11, DOI 10.1093/jac/dkn433; Evans J, 2010, J ANTIMICROB CHEMOTH, V65, P897, DOI 10.1093/jac/dkq047; Feuerriegel S, 2009, ANTIMICROB AGENTS CH, V53, P3353, DOI 10.1128/AAC.00050-09; Hillemann D, 2005, J CLIN MICROBIOL, V43, P3699, DOI 10.1128/JCM.43.8.3699-3703.2005; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Hillemann D, 2009, J CLIN MICROBIOL, V47, P1767, DOI 10.1128/JCM.00081-09; HONORE N, 1995, ANTIMICROB AGENTS CH, V39, P769, DOI 10.1128/AAC.39.3.769; Huang WL, 2011, J CLIN MICROBIOL, V49, P2502, DOI 10.1128/JCM.00197-11; Ioerger TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007778; Isola D, 2005, J MICROBIOL METH, V62, P113, DOI 10.1016/j.mimet.2005.02.004; Johansen SK, 2006, MOL CELL, V23, P173, DOI 10.1016/j.molcel.2006.05.044; Johnson R, 2006, CURR ISSUES MOL BIOL, V8, P97; Jugheli L, 2009, ANTIMICROB AGENTS CH, V53, P5064, DOI 10.1128/AAC.00851-09; Jureen P, 2010, J CLIN MICROBIOL, V48, P1853, DOI 10.1128/JCM.00240-10; Jureen P, 2006, J CLIN MICROBIOL, V44, P1925, DOI 10.1128/JCM.02210-05; Kam KM, 2010, INT J TUBERC LUNG D, V14, P282; Kent PTaK, GP PUBLIC HLTH MYCOB; Khanna A, 2010, ANTIMICROB AGENTS CH, V54, P4789, DOI 10.1128/AAC.00661-10; Kleeberg HHKH HP, 1980, LAB MAN TUB METH, P2; Kontsevaya I, 2011, J CLIN MICROBIOL, V49, P2832, DOI 10.1128/JCM.01889-10; Kruuner A, 2003, ANTIMICROB AGENTS CH, V47, P2971, DOI 10.1128/AAC.47.9.2971-2973.2003; Lacoma A, 2008, J CLIN MICROBIOL, V46, P3660, DOI 10.1128/JCM.00618-08; Leung KL, 2010, J APPL MICROBIOL, V109, P2087, DOI 10.1111/j.1365-2672.2010.04840.x; Ling DI, 2008, EUR RESPIR J, V32, P1165, DOI 10.1183/09031936.00061808; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P3192, DOI 10.1128/AAC.49.8.3192-3197.2005; Maus CE, 2005, ANTIMICROB AGENTS CH, V49, P571, DOI 10.1128/AAC.49.2.571-577.2005; Miotto P, 2008, J CLIN MICROBIOL, V46, P393, DOI 10.1128/JCM.01066-07; Miotto P, 2006, J CLIN MICROBIOL, V44, P2485, DOI 10.1128/JCM.00083-06; Nebenzahl-Guimaraes H, 2009, Recent Pat DNA Gene Seq, V3, P172; Nikolayevskyy V, 2009, BMC CLIN PATHOL, V9, DOI 10.1186/1472-6890-9-2; O'Grady J, 2011, CURR OPIN PULM MED, V17, P134, DOI 10.1097/MCP.0b013e3283452346; Organization WH, 2011, WHO TUB; Perdigao J, 2010, J ANTIMICROB CHEMOTH, V65, P224, DOI 10.1093/jac/dkp452; Pfyffer GE, 1999, J CLIN MICROBIOL, V37, P3179, DOI 10.1128/JCM.37.10.3179-3186.1999; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Shah NS, 2011, EMERG INFECT DIS, V17, P510, DOI 10.3201/eid1703.101363; Sharma D, 2007, J MOL BIOL, V374, P1065, DOI 10.1016/j.jmb.2007.10.003; Sirgel FA, 2011, MICROB DRUG RESIST; Somoskovi A, 2006, J CLIN MICROBIOL, V44, P4459, DOI 10.1128/JCM.01506-06; Springer B, 2001, ANTIMICROB AGENTS CH, V45, P2877, DOI 10.1128/AAC.45.10.2877-2884.2001; Stavrum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004540; Sugawara I, 2009, INDIAN J EXP BIOL, V47, P520; Sun ZG, 2008, INT J ANTIMICROB AG, V31, P115, DOI 10.1016/j.ijantimicag.2007.10.014; Suzuki M, 1998, JPN J PHARMACOL, V77, P177, DOI 10.1254/jjp.77.177; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; TRNKA L, 1970, ANTIBIOT CHEMOTHER, V16, P369; Valvatne H, 2009, J ANTIMICROB CHEMOTH, V64, P694, DOI 10.1093/jac/dkp292; van Ingen J, 2010, J CLIN MICROBIOL, V48, P2749, DOI 10.1128/JCM.00652-10; Van Rie A, 2010, EXPERT REV MOL DIAGN, V10, P937, DOI [10.1586/erm.10.67, 10.1586/ERM.10.67]; Varma-Basil M, 2004, J CLIN MICROBIOL, V42, P5512, DOI 10.1128/JCM.42.12.5512-5516.2004; Via LE, 2010, J CLIN MICROBIOL, V48, P402, DOI 10.1128/JCM.01476-09; Vo SK, 2010, J CLIN MICROBIOL, V48, P2934, DOI 10.1128/JCM.00201-10; Wakata A, 1998, ENVIRON MOL MUTAGEN, V32, P84, DOI 10.1002/(SICI)1098-2280(1998)32:1<84::AID-EM10>3.0.CO;2-K; Watterson SA, 1998, J CLIN MICROBIOL, V36, P1969, DOI 10.1128/JCM.36.7.1969-1973.1998; Wong SY, 2011, ANTIMICROB AGENTS CH, V55, P2515, DOI 10.1128/AAC.01814-10; World Health Organization, 2010, GLOB TUB CONTR; Zaunbrecher MA, 2009, P NATL ACAD SCI USA, V106, P20004, DOI 10.1073/pnas.0907925106; Zhao Ming-cai, 2004, Sichuan Da Xue Xue Bao Yi Xue Ban, V35, P313	78	171	187	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33275					12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479378	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400018
J	Ge, SC; He, QS; Granfors, K				Ge, Shichao; He, Qiushui; Granfors, Kaisa			HLA-B27 Modulates Intracellular Growth of Salmonella Pathogenicity Island 2 Mutants and Production of Cytokines in Infected Monocytic U937 Cells	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; III SECRETION SYSTEM; IFN-GAMMA; FACTOR-ALPHA; TYPHIMURIUM; GENES; PATHOGENESIS; MACROPHAGES; ENTERITIDIS; VIRULENCE	Background: Salmonella enterica serovar Enteritidis PT4 KS8822/88 replicates rapidly in HLA-B27-transfected human monocytic U937 cells. In this process, Salmonella pathogenicity island 2 (SPI-2) genes play a crucial role. Our previous study indicated that 118 Salmonella genes, including 8 SPI-2 genes were affected by HLA-B27 antigen during Salmonella infection of U937 cells. Methods/Principal Findings: To further investigate Salmonella replication in HLA-B27-positive U937 monocytic cells, two SPI-2 genes, ssaS and sscA up-regulated most during Salmonella infection of HLA-B27-transfected U937 cells, were mutated by using one-step gene disruption method. Intracellular survival and replication of the mutants in the U937 cells was compared to that of the wild type strain. Surprisingly, the two mutated strains replicated significantly more than the wild type bacteria in HLA-B27-transfected cells. Secretion of tumor necrosis factor alpha (TNF-alpha) and interleukin 10 (IL-10) was significantly induced during the infection of HLA-B27-transfected U937 cells with the mutants. The results indicated that the certain SPI-2 genes in wild type bacteria suppress Salmonella intracellular growth and production of cytokines in infected HLA-B27-transfected cells. HLA-B27-associated modulation of Salmonella SPI-2 genes and cytokine production may have importance in the persistent infection of the bacteria and the pathogenesis of reactive arthritis. Conclusions: The study provides evidence that certain virulence factors of pathogens can reduce the intracellular growth in the host cells. We suggest that the limiting intracellular growth might be a strategy for persistence of bacteria in host cells, keeping a balance between pathogenic growth and pathogenesis.	[Ge, Shichao; He, Qiushui; Granfors, Kaisa] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Turku, Finland; [He, Qiushui] Univ Turku, Dept Pediat, Turku, Finland	Finland National Institute for Health & Welfare; University of Turku	Ge, SC (corresponding author), Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Turku, Finland.	shichaoge2004@yahoo.com.cn			Academy of Finland; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This study was supported by grants from the Academy of Finland and the Sigrid Juselius Foundation to Kaisa Granfors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeten D, 2001, ARTHRITIS RHEUM-US, V44, P186, DOI 10.1002/1529-0131(200101)44:1<186::AID-ANR25>3.0.CO;2-B; Beutler BA, 1999, J RHEUMATOL, V26, P16; Cirillo DM, 1998, MOL MICROBIOL, V30, P175, DOI 10.1046/j.1365-2958.1998.01048.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Keyser F, 2003, RHEUM DIS CLIN N AM, V29, P463, DOI 10.1016/S0889-857X(03)00052-8; Ekman P, 2000, ARTHRITIS RHEUM-US, V43, P1527, DOI 10.1002/1529-0131(200007)43:7<1527::AID-ANR17>3.3.CO;2-7; Ekman P, 2002, INFECT IMMUN, V70, P1609, DOI 10.1128/IAI.70.3.1609-1614.2002; Ekman P, 1999, INFECT IMMUN, V67, P3670, DOI 10.1128/IAI.67.7.3670-3673.1999; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Feng XH, 2003, MOL MICROBIOL, V48, P1131, DOI 10.1046/j.1365-2958.2003.03502.x; Galan JE, 1996, ANNU REV CELL DEV BI, V12, P221, DOI 10.1146/annurev.cellbio.12.1.221; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Ge SC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-456; Granfors K, 1998, ARTHRITIS RHEUM, V41, P855, DOI 10.1002/1529-0131(199805)41:5<855::AID-ART12>3.0.CO;2-J; Granfors Kaisa, 2002, Arthritis Rheum, V46, P606, DOI 10.1002/art.10041; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; JUNG HC, 1995, J CLIN INVEST, V95, P55, DOI 10.1172/JCI117676; Laitio P, 1997, EUR J IMMUNOL, V27, P1331, DOI 10.1002/eji.1830270606; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; LeirisaloRepo M, 1997, ANN RHEUM DIS, V56, P516, DOI 10.1136/ard.56.9.516; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; Maini RN, 2004, ARTHRITIS RES THER, V6, pS1, DOI 10.1186/ar994; MAKIIKOLA O, 1992, LANCET, V339, P1096, DOI 10.1016/0140-6736(92)90675-S; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; NAKANO Y, 1990, J IMMUNOL, V144, P1935; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Ochman H, 1996, P NATL ACAD SCI USA, V93, P7800, DOI 10.1073/pnas.93.15.7800; Penttinen MA, 2004, ARTHRITIS RHEUM, V50, P2255, DOI 10.1002/art.20336; Raupach B, 2003, J IMMUNOL, V170, P6133, DOI 10.4049/jimmunol.170.12.6133; Sahlberg AS, 2007, ARTHRITIS RHEUM, V56, P2652, DOI 10.1002/art.22746; Sahlberg AS, 2009, ADV EXP MED BIOL, V649, P235; Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593; Sieper J, 1996, IMMUNOL TODAY, V17, P160, DOI 10.1016/0167-5699(96)80612-8; SIEPER J, 1995, ARTHRITIS RHEUM, V38, P1547, DOI 10.1002/art.1780381105; Solano C, 2002, MOL MICROBIOL, V43, P793, DOI 10.1046/j.1365-2958.2002.02802.x; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Thompson JA, 2011, MICROBIOL-SGM, V157, P2084, DOI 10.1099/mic.0.048926-0; Tierrez A, 2005, CELL MICROBIOL, V7, P901, DOI 10.1111/j.1462-5822.2005.00540.x; TITE JP, 1991, J IMMUNOL, V147, P3161; Uchiya K, 2004, INFECT IMMUN, V72, P1964, DOI 10.1128/IAI.72.4.1964-1973.2004; Vahamiko S, 2005, ARTHRITIS RES THER, V7, P136, DOI 10.1186/ar1762; Valdivia RH, 1997, SCIENCE, V277, P2007, DOI 10.1126/science.277.5334.2007; Wesemann DR, 2003, J IMMUNOL, V171, P5313, DOI 10.4049/jimmunol.171.10.5313; Zahrt TC, 2001, P NATL ACAD SCI USA, V98, P12706, DOI 10.1073/pnas.221272198	48	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34093	10.1371/journal.pone.0034093	http://dx.doi.org/10.1371/journal.pone.0034093			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470519	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000062
J	Ma, ZL; Qin, Y; Wang, G; Li, XD; He, RR; Chuai, ML; Kurihara, H; Yang, XS				Ma, Zheng-lai; Qin, Yang; Wang, Guang; Li, Xiao-di; He, Rong-rong; Chuai, Manli; Kurihara, Hiroshi; Yang, Xuesong			Exploring the Caffeine-Induced Teratogenicity on Neurodevelopment Using Early Chick Embryo	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; GENE-EXPRESSION; CONSUMPTION; PREGNANCY; BRAIN; CREST; CELLS; RISK	Caffeine consumption is worldwide. It has been part of our diet for many centuries; indwelled in our foods, drinks, and medicines. It is often perceived as a "legal drug'', and though it is known to have detrimental effects on our health, more specifically, disrupt the normal fetal development following excessive maternal intake, much ambiguity still surrounds the precise mechanisms and consequences of caffeine-induced toxicity. Here, we employed early chick embryos as a developmental model to assess the effects of caffeine on the development of the fetal nervous system. We found that administration of caffeine led to defective neural tube closures and expression of several abnormal morphological phenotypes, which included thickening of the cephalic mesenchymal tissues and scattering of somites. Immunocytochemistry of caffeine-treated embryos using neural crest cell markers also demonstrated uncharacteristic features; HNK1 labeled migratory crest cells exhibited an incontinuous dorsal-ventral migration trajectory, though Pax7 positive cells of the caffeine-treated groups were comparatively similar to the control. Furthermore, the number of neurons expressing neurofilament and the degree of neuronal branching were both significantly reduced following caffeine administration. The extent of these effects was dose-dependent. In conclusion, caffeine exposure can result in malformations of the neural tube and induce other teratogenic effects on neurodevelopment, although the exact mechanism of these effects requires further investigation.	[Ma, Zheng-lai; Wang, Guang; Chuai, Manli; Yang, Xuesong] Jinan Univ, Key Lab Regenerat Med, Minist Educ, Coll Med, Guangzhou, Guangdong, Peoples R China; [Qin, Yang; Li, Xiao-di; He, Rong-rong; Kurihara, Hiroshi] Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Ma, ZL (corresponding author), Jinan Univ, Key Lab Regenerat Med, Minist Educ, Coll Med, Guangzhou, Guangdong, Peoples R China.	Hiroshi_Kurihara@163.com; yang_xuesong@126.com	Wang, Guang/AAC-4624-2019	HE, Rong-Rong/0000-0001-5505-5672; Li, Xiaodi/0000-0002-7109-6770	NSFC [30971493, 31071054]; "973 Project'' [2010CB529702]; Fundamental Research Funds for the Central Universities [21610601]	NSFC(National Natural Science Foundation of China (NSFC)); "973 Project''(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	Funding: NSFC (30971493 and 31071054); "973 Project'' (2010CB529702); the Fundamental Research Funds for the Central Universities (21610601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chung YN, 2008, CHILD NERV SYST, V24, P105, DOI 10.1007/s00381-007-0440-4; GALLI C, 1975, PHARMACOL RES COMMUN, V7, P217, DOI 10.1016/0031-6989(75)90021-1; GRAHAM DM, 1978, NUTR REV, V36, P97, DOI 10.1111/j.1753-4887.1978.tb03717.x; Hall BK, 2008, J BIOSCIENCES, V33, P781, DOI 10.1007/s12038-008-0098-4; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Kawakami A, 1997, MECH DEVELOP, V66, P119, DOI 10.1016/S0925-4773(97)00097-X; KIMMEL CA, 1984, FUND APPL TOXICOL, V4, P240, DOI 10.1016/0272-0590(84)90125-8; KUCERA P, 1987, TERATOGEN CARCIN MUT, V7, P427, DOI 10.1002/tcm.1770070502; Kuczkowski KM, 2009, REV ESP ANEST REANIM, V56, P612, DOI 10.1016/S0034-9356(09)70477-3; Kuczkowski KM, 2009, ANN FR ANESTH, V28, P605, DOI 10.1016/j.annfar.2009.04.011; Kuczkowski KM, 2009, ARCH GYNECOL OBSTET, V280, P695, DOI 10.1007/s00404-009-0991-6; Marret S, 1997, BRAIN RES, V773, P213, DOI 10.1016/S0006-8993(97)00938-4; MARTIN TR, 1987, AM J EPIDEMIOL, V126, P813, DOI 10.1093/oxfordjournals.aje.a114718; McCauley DW, 2002, GENE, V287, P129, DOI 10.1016/S0378-1119(01)00894-0; Minarcik J C, 2003, Orthod Craniofac Res, V6, P210, DOI 10.1046/j.1601-6335.2003.00268.x; MOASE CE, 1990, TERATOLOGY, V42, P171, DOI 10.1002/tera.1420420208; NAROD SA, 1991, AM J OBSTET GYNECOL, V164, P1109, DOI 10.1016/0002-9378(91)90597-K; Rana N, 2010, ZEBRAFISH, V7, P69, DOI 10.1089/zeb.2009.0631; Sahir N, 2000, DEV BRAIN RES, V121, P213, DOI 10.1016/S0165-3806(00)00037-7; Sahir N, 2004, J MOL NEUROSCI, V24, P201, DOI 10.1385/JMN:24:2:201; Sauka-Spengler T, 2008, METHOD CELL BIOL, V87, P237, DOI 10.1016/S0091-679X(08)00212-4; Schmidt RJ, 2010, BIRTH DEFECTS RES A, V88, P560, DOI 10.1002/bdra.20681; Schmidt RJ, 2009, BIRTH DEFECTS RES A, V85, P879, DOI 10.1002/bdra.20624; Stevenson RE, 2004, BIRTH DEFECTS RES A, V70, P554, DOI 10.1002/bdra.20062; TANAKA H, 1987, BIOL NEONATE, V51, P332, DOI 10.1159/000242672; WILKINSON JM, 1994, TERATOGEN CARCIN MUT, V14, P205, DOI 10.1002/tcm.1770140502; Yang XS, 2008, DEVELOPMENT, V135, P3521, DOI 10.1242/dev.023416	28	27	28	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34278	10.1371/journal.pone.0034278	http://dx.doi.org/10.1371/journal.pone.0034278			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470550	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000089
J	Maksimov, P; Zerweck, J; Maksimov, A; Hotop, A; Gross, U; Spekker, K; Daubener, W; Werdermann, S; Niederstrasser, O; Petri, E; Mertens, M; Ulrich, RG; Conraths, FJ; Schares, G				Maksimov, Pavlo; Zerweck, Johannes; Maksimov, Aline; Hotop, Andrea; Gross, Uwe; Spekker, Katrin; Daeubener, Walter; Werdermann, Sandra; Niederstrasser, Olaf; Petri, Eckhardt; Mertens, Marc; Ulrich, Rainer G.; Conraths, Franz J.; Schares, Gereon			Analysis of Clonal Type-Specific Antibody Reactions in Toxoplasma gondii Seropositive Humans from Germany by Peptide-Microarray	PLOS ONE			English	Article							LINKED IMMUNOSORBENT ASSAYS; IMMUNOGLOBULIN-G ANTIBODIES; IMMUNOCOMPROMISED PATIENTS; CONGENITAL TOXOPLASMOSIS; POLYMORPHIC PEPTIDES; ANTIGEN MICROARRAYS; SYNTHETIC PEPTIDES; PREGNANT-WOMEN; SOUTH-AMERICA; STRAINS	Background: Different clonal types of Toxoplasma gondii are thought to be associated with distinct clinical manifestations of infections. Serotyping is a novel technique which may allow to determine the clonal type of T. gondii humans are infected with and to extend typing studies to larger populations which include infected but non-diseased individuals. Methodology: A peptide-microarray test for T. gondii serotyping was established with 54 previously published synthetic peptides, which mimic clonal type-specific epitopes. The test was applied to human sera (n = 174) collected from individuals with an acute T. gondii infection (n = 21), a latent T. gondii infection (n = 53) and from T. gondii-seropositive forest workers (n = 100). Findings: The majority (n = 124; 71%) of all T. gondii seropositive human sera showed reactions against synthetic peptides with sequences specific for clonal type II (type II peptides). Type I and type III peptides were recognized by 42% (n = 73) or 16% (n = 28) of the human sera, respectively, while type II-III, type I-III or type I-II peptides were recognized by 49% (n = 85), 36% (n = 62) or 14% (n = 25) of the sera, respectively. Highest reaction intensities were observed with synthetic peptides mimicking type II-specific epitopes. A proportion of the sera (n = 22; 13%) showed no reaction with type-specific peptides. Individuals with acute toxoplasmosis reacted with a statistically significantly higher number of peptides as compared to individuals with latent T. gondii infection or seropositive forest workers. Conclusions: Type II-specific reactions were overrepresented and higher in intensity in the study population, which was in accord with genotyping studies on T. gondii oocysts previously conducted in the same area. There were also individuals with type I-or type III-specific reactions. Well-characterized reference sera and further specific peptide markers are needed to establish and to perform future serotyping approaches with higher resolution.	[Maksimov, Pavlo; Maksimov, Aline; Conraths, Franz J.; Schares, Gereon] Friedrich Loeffler Inst, Inst Epidemiol, Fed Res Inst Anim Hlth, Wusterhausen, Germany; [Zerweck, Johannes] JPT Peptide Technol GmbH, Berlin, Germany; [Hotop, Andrea; Gross, Uwe] Univ Med Ctr Gottingen, Dept Med Microbiol, German Natl Consulting Lab Toxoplasmosis, Gottingen, Germany; [Spekker, Katrin; Daeubener, Walter] Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, D-40225 Dusseldorf, Germany; [Werdermann, Sandra] Inst Arbeits & Sozialhyg Stiftung, Kyritz, Germany; [Niederstrasser, Olaf] BG Kliniken Bergmannstrost, Halle, Germany; [Petri, Eckhardt] Novartis Vaccines & Diagnost, Marburg, Germany; [Mertens, Marc; Ulrich, Rainer G.] Friedrich Loeffler Inst, Inst Novel & Emerging Infect Dis, Fed Res Inst Anim Hlth, Greifswald, Germany	Friedrich Loeffler Institute; University of Gottingen; Heinrich Heine University Dusseldorf; Novartis; Friedrich Loeffler Institute	Maksimov, P (corresponding author), Friedrich Loeffler Inst, Inst Epidemiol, Fed Res Inst Anim Hlth, Wusterhausen, Germany.	pavlo.maksimov@fli.bund.de; gereon.schares@fli.bund.de	Schares, Gereon R.M./F-9850-2019; Maksimov, Pavlo/AAC-3916-2019	Schares, Gereon R.M./0000-0002-3217-289X; Maksimov, Pavlo/0000-0002-9457-0658; Conraths, Franz/0000-0002-7400-9409	German Federal Ministry of Education and Research [01KI0765, 01KI1002F, 01KI0764, 01KI1002E, 01KI0766, 01KI1002B]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The study was supported by the German Federal Ministry of Education and Research (Toxonet01 and Toxonet02) by funds to Dr. Schares (01KI0765; 01KI1002F), Dr. Daubener (01KI0764; 01KI1002E) and Dr. Gross (01KI0766; 01KI1002B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg D, 2002, INT J PARASITOL, V32, P27, DOI 10.1016/S0020-7519(01)00301-0; Ajzenberg D, 2009, J INFECT DIS, V199, P1155, DOI 10.1086/597477; Andresen H, 2009, CURR PROTEOMICS, V6, P1; Beghetto E, 2003, INT J PARASITOL, V33, P163, DOI 10.1016/S0020-7519(02)00256-4; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Carme B, 2009, EMERG INFECT DIS, V15, P656, DOI 10.3201/eid1504.081306; CESBRONDELAUW MF, 1994, PARASITOL TODAY, V10, P293, DOI 10.1016/0169-4758(94)90078-7; Dominguez-Almendros S, 2011, ALLERGOL IMMUNOPATH, V39, P295, DOI 10.1016/j.aller.2011.05.002; Dubey JP, 2003, J PARASITOL, V89, P1060, DOI 10.1645/GE-124R; Frank R, 1996, Methods Mol Biol, V66, P149; FRIENDLY M, 1994, J AM STAT ASSOC, V89, P190, DOI DOI 10.2307/2291215; Golkar M, 2008, DIAGN MICR INFEC DIS, V61, P31, DOI 10.1016/j.diagmicrobio.2007.09.003; Grigg ME, 2003, MICROBES INFECT, V5, P685, DOI 10.1016/S1286-4579(03)00088-1; Grigg ME, 2001, J INFECT DIS, V184, P633, DOI 10.1086/322800; Herrmann DC, 2010, INT J PARASITOL, V40, P285, DOI 10.1016/j.ijpara.2009.08.001; Hiszczynska-Sawicka E, 2003, PROTEIN EXPRES PURIF, V27, P150, DOI 10.1016/S1046-5928(02)00593-4; Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032; Hosseininejad M, 2009, VET PARASITOL, V164, P315, DOI 10.1016/j.vetpar.2009.05.029; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Howe DK, 1997, J CLIN MICROBIOL, V35, P1411, DOI 10.1128/JCM.35.6.1411-1414.1997; Jacobs D, 1999, CLIN DIAGN LAB IMMUN, V6, P24, DOI 10.1128/CDLI.6.1.24-29.1999; Jamieson SE, 2009, MEM I OSWALDO CRUZ, V104, P162, DOI 10.1590/S0074-02762009000200006; Janitschke Klaus, 2003, Clin Lab, V49, P239; Jones JL, 2001, OBSTET GYNECOL SURV, V56, P296, DOI 10.1097/00006254-200105000-00025; Khan A, 2005, J CLIN MICROBIOL, V43, P5881, DOI 10.1128/JCM.43.12.5881-5887.2005; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Kong JT, 2003, J INFECT DIS, V187, P1484, DOI 10.1086/374647; Lecordier L, 2000, CLIN DIAGN LAB IMMUN, V7, P607, DOI 10.1128/CDLI.7.4.607-611.2000; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Melnyk O, 2002, BIOCONJUGATE CHEM, V13, P713, DOI 10.1021/bc015584o; Mertens M, 2011, MED MICROBIOL IMMUN, V200, P263, DOI 10.1007/s00430-011-0203-4; Mezzasoma L, 2002, CLIN CHEM, V48, P121; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morisset S, 2008, MICROBES INFECT, V10, P742, DOI 10.1016/j.micinf.2008.04.001; Nahtman T, 2007, J IMMUNOL METHODS, V328, P1, DOI 10.1016/j.jim.2007.07.015; Ngo Y, 2009, J IMMUNOL METHODS, V343, P68, DOI 10.1016/j.jim.2008.12.004; Nowakowska D, 2006, J CLIN MICROBIOL, V44, P1382, DOI 10.1128/JCM.44.4.1382-1389.2006; Pamelard F, 2009, METHODS MOL BIOL, V570, P413, DOI 10.1007/978-1-60327-394-7_24; Panse S, 2004, MOL DIVERS, V8, P291, DOI 10.1023/B:MODI.0000036240.39384.eb; PARMLEY SF, 1994, J PARASITOL, V80, P293, DOI 10.2307/3283761; Peyron F, 2006, MICROBES INFECT, V8, P2333, DOI 10.1016/j.micinf.2006.03.023; Redlich A, 1998, PARASITOL RES, V84, P700, DOI 10.1007/s004360050473; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; Schares G, 2008, VET PARASITOL, V152, P34, DOI 10.1016/j.vetpar.2007.12.004; Sibley LD, 2009, PHILOS T R SOC B, V364, P2749, DOI 10.1098/rstb.2009.0087; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Sousa S, 2008, CLIN VACCINE IMMUNOL, V15, P1380, DOI 10.1128/CVI.00186-08; Sousa S, 2010, VET PARASITOL, V169, P24, DOI 10.1016/j.vetpar.2009.12.025; Sousa S, 2009, CLIN VACCINE IMMUNOL, V16, P1158, DOI 10.1128/CVI.00092-09; Su CL, 2002, P NATL ACAD SCI USA, V99, P10753, DOI 10.1073/pnas.172117099; Suzuki Y, 2002, J INFECT DIS, V185, pS58, DOI 10.1086/337999; Suzuki Y, 1999, IMMUNOBIOLOGY, V201, P255, DOI 10.1016/S0171-2985(99)80066-7; Vigil A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011447; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T; Xiao JC, 2009, MICROBES INFECT, V11, P1011, DOI 10.1016/j.micinf.2009.07.007	56	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34212	10.1371/journal.pone.0034212	http://dx.doi.org/10.1371/journal.pone.0034212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470537	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000076
J	Puritz, JB; Addison, JA; Toonen, RJ				Puritz, Jonathan B.; Addison, Jason A.; Toonen, Robert J.			Next-Generation Phylogeography: A Targeted Approach for Multilocus Sequencing of Non-Model Organisms	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; MARBLED MURRELETS; NUCLEAR-DNA; GENE; POPULATIONS; RECOMBINATION; AMPLIFICATION; PHYLOGENIES; EVOLUTION; INTRONS	The field of phylogeography has long since realized the need and utility of incorporating nuclear DNA (nDNA) sequences into analyses. However, the use of nDNA sequence data, at the population level, has been hindered by technical laboratory difficulty, sequencing costs, and problematic analytical methods dealing with genotypic sequence data, especially in non-model organisms. Here, we present a method utilizing the 454 GS-FLX Titanium pyrosequencing platform with the capacity to simultaneously sequence two species of sea star (Meridiastra calcar and Parvulastra exigua) at five different nDNA loci across 16 different populations of 20 individuals each per species. We compare results from 3 populations with traditional Sanger sequencing based methods, and demonstrate that this next-generation sequencing platform is more time and cost effective and more sensitive to rare variants than Sanger based sequencing. A crucial advantage is that the high coverage of clonally amplified sequences simplifies haplotype determination, even in highly polymorphic species. This targeted next-generation approach can greatly increase the use of nDNA sequence loci in phylogeographic and population genetic studies by mitigating many of the time, cost, and analytical issues associated with highly polymorphic, diploid sequence markers.	[Puritz, Jonathan B.; Toonen, Robert J.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Addison, Jason A.] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 6E1, Canada	University of Hawaii System; University of Hawaii Manoa; University of New Brunswick	Puritz, JB (corresponding author), Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	jpuritz@gmail.com	Toonen, Rob/V-6230-2019; Puritz, Jonathan B/C-9289-2011; Toonen, Rob/K-2891-2012	Toonen, Rob/0000-0001-6339-4340; Puritz, Jonathan B/0000-0003-1404-4680; Toonen, Rob/0000-0001-6339-4340	National Science Foundation [Bio-OCE 0623699]; Office Of The Director [0903833] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	Funding for this project came from the National Science Foundation Bio-OCE 0623699. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Avise J, 2004, MOL MARKERS NATURAL; Avise JC, 1998, MOL ECOL, V7, P371, DOI 10.1046/j.1365-294x.1998.00391.x; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bowen BW, 2005, MOL ECOL, V14, P2389, DOI 10.1111/j.1365-294X.2005.02598.x; Congdon BC, 2000, EVOLUTION, V54, P974; Creer S, 2005, CLADISTICS, V21, P390, DOI 10.1111/j.1096-0031.2005.00072.x; Creer S, 2007, EVOL BIOINFORM, V3, P99; Drummond A. J., 2011, GENEIOUS 5 4; Duret L, 2001, TRENDS GENET, V17, P172, DOI 10.1016/S0168-9525(01)02236-3; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Friesen Vicki, 2000, P274; Friesen VL, 1997, MOL ECOL, V6, P1047, DOI 10.1046/j.1365-294X.1997.00277.x; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Hare MP, 2001, TRENDS ECOL EVOL, V16, P700, DOI 10.1016/S0169-5347(01)02326-6; Hoelzer GA, 1997, EVOLUTION, V51, P622, DOI 10.1111/j.1558-5646.1997.tb02451.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huang ZS, 2008, MOL ECOL, V17, P1930, DOI 10.1111/j.1365-294X.2008.03730.x; Jarman SN, 2002, MAR BIOTECHNOL, V4, P347, DOI 10.1007/s10126-002-0029-6; KARL SA, 1993, MOL BIOL EVOL, V10, P342; KARL SA, 1992, SCIENCE, V256, P100, DOI 10.1126/science.1348870; Keever CC, 2009, EVOLUTION, V63, P3214, DOI 10.1111/j.1558-5646.2009.00801.x; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Leamon JH, 2003, ELECTROPHORESIS, V24, P3769, DOI 10.1002/elps.200305646; Mallarino R, 2005, MOL PHYLOGENET EVOL, V34, P625, DOI 10.1016/j.ympev.2004.10.021; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mattick JS, 2001, MOL BIOL EVOL, V18, P1611, DOI 10.1093/oxfordjournals.molbev.a003951; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Prychitko TM, 2003, MOL BIOL EVOL, V20, P762, DOI 10.1093/molbev/msg080; Prychitko TM, 2000, MOL BIOL EVOL, V17, P1101, DOI 10.1093/oxfordjournals.molbev.a026391; Salem Rany M., 2005, Human Genomics, V2, P39; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; SLADE RW, 1994, MOL BIOL EVOL, V11, P341; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Zhang DX, 2003, MOL ECOL, V12, P563, DOI 10.1046/j.1365-294X.2003.01773.x; Zieler H, 2002, INSECT MOL BIOL, V11, P87, DOI 10.1046/j.0962-1075.2001.00312.x	45	36	36	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34241	10.1371/journal.pone.0034241	http://dx.doi.org/10.1371/journal.pone.0034241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470543	Green Submitted, Green Published, gold			2022-12-27	WOS:000304489000082
J	Chen, KC; Wang, TY; Chan, CH				Chen, Kuang-Chi; Wang, Tse-Yi; Chan, Chen-Hsiung			Associations between HIV and Human Pathways Revealed by Protein-Protein Interactions and Correlated Gene Expression Profiles	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTED PATIENTS; PANCREATIC-CANCER; HOST INTERACTIONS; MYELOID-LEUKEMIA; LUNG-CANCER; DATA FUSION; NETWORKS; ENRICHMENT; RISK	Background: AIDS is one of the most devastating diseases in human history. Decades of studies have revealed host factors required for HIV infection, indicating that HIV exploits host processes for its own purposes. HIV infection leads to AIDS as well as various comorbidities. The associations between HIV and human pathways and diseases may reveal non-obvious relationships between HIV and non-HIV-defining diseases. Principal Findings: Human biological pathways were evaluated and statistically compared against the presence of HIV host factor related genes. All of the obtained scores comparing HIV targeted genes and biological pathways were ranked. Different rank results based on overlapping genes, recovered virus-host interactions, co-expressed genes, and common interactions in human protein-protein interaction networks were obtained. Correlations between rankings suggested that these measures yielded diverse rankings. Rank combination of these ranks led to a final ranking of HIV-associated pathways, which revealed that HIV is associated with immune cell-related pathways and several cancer-related pathways. The proposed method is also applicable to the evaluation of associations between other pathogens and human pathways and diseases. Conclusions: Our results suggest that HIV infection shares common molecular mechanisms with certain signaling pathways and cancers. Interference in apoptosis pathways and the long-term suppression of immune system functions by HIV infection might contribute to tumorigenesis. Relationships between HIV infection and human pathways of disease may aid in the identification of common drug targets for viral infections and other diseases.	[Chen, Kuang-Chi; Chan, Chen-Hsiung] Tzu Chi Univ, Dept Med Informat, Hualien, Taiwan; [Wang, Tse-Yi] Acad Sinica, Inst Informat Sci, Taipei, Taiwan	Tzu Chi University; Academia Sinica - Taiwan	Chen, KC (corresponding author), Tzu Chi Univ, Dept Med Informat, Hualien, Taiwan.	frankch@mail.tcu.edu.tw			National Science Council (NSC), Taiwan [NSC-100-2221-E-320-006, NSC99-2113-M-320-001-MY2]; Tzu Chi University	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); Tzu Chi University	KCC was supported by National Science Council (NSC), Taiwan, grant No. NSC-100-2221-E-320-006. CHC was supported by Tzu Chi University and National Science Council (NSC), Taiwan, grant No. NSC99-2113-M-320-001-MY2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts S, 2006, NAT BIOTECHNOL, V24, P537, DOI 10.1038/nbt1203; Bonnet F, 2009, CLIN INFECT DIS, V48, P633, DOI 10.1086/596766; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brown JN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003664; Brunner TB, 2008, J CLIN ONCOL, V26, P2699, DOI 10.1200/JCO.2007.15.2355; Calderwood MA, 2007, P NATL ACAD SCI USA, V104, P7606, DOI 10.1073/pnas.0702332104; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chow WA, 2009, LANCET ONCOL, V10, P61, DOI 10.1016/S1470-2045(08)70334-6; Chugh P, 2007, J MOL BIOL, V366, P67, DOI 10.1016/j.jmb.2006.11.011; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; de la Fuente C, 2003, CURR HIV RES, V1, P131; Deregibus MC, 2002, J BIOL CHEM, V277, P25195, DOI 10.1074/jbc.M200921200; Dickerson JE, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-80; Dyer MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040032; Dyer MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012089; Engels EA, 2006, J CLIN ONCOL, V24, P1383, DOI 10.1200/JCO.2005.03.4413; Estrada V, 2006, METABOLISM, V55, P940, DOI 10.1016/j.metabol.2006.02.024; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Gale RP, 2011, LEUKEMIA; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hsu DF, 2010, LECT NOTES ARTIF INT, V6334, P42, DOI 10.1007/978-3-642-15314-3_5; Hsu DF, 2005, INFORM RETRIEVAL, V8, P449, DOI 10.1007/s10791-005-6994-4; Hsu DF, 2006, ADV DATA MINING TECH; Hyrcza MD, 2007, J VIROL, V81, P3477, DOI 10.1128/JVI.01552-06; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kang TW, 2011, NATURE; Kao CY, 2004, B INT CHINESE STAT A, V2004, P37; Kim RJ, 2006, OBESITY, V14, P994, DOI 10.1038/oby.2006.114; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kwan CK, 2011, CLIN MICROBIOL REV, V24, P351, DOI 10.1128/CMR.00042-10; Mallewa JE, 2008, J ANTIMICROB CHEMOTH, V62, P648, DOI 10.1093/jac/dkn251; Manfredi R, 2004, EUR J MED RES, V9, P537; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Navratil V, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-13; Pinney JW, 2009, AIDS, V23, P549, DOI 10.1097/QAD.0b013e328325a495; Sadaie AR, 2004, ANTIVIR RES, V61, P1, DOI 10.1016/j.antiviral.2003.09.004; Schlaberg R, 2008, LEUKEMIA LYMPHOMA, V49, P1155, DOI 10.1080/10428190802074601; Serraino D, 2009, CLIN INFECT DIS, V49, DOI 10.1086/600823; Serrano M, 2011, NATURE, V479, P481, DOI 10.1038/479481a; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sutton L, 2001, BRIT J HAEMATOL, V112, P900, DOI 10.1046/j.1365-2141.2001.02661.x; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xie L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002037; Yang JM, 2005, J CHEM INF MODEL, V45, P1134, DOI 10.1021/ci050034w; Yi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003288; Zhang JL, 2007, J CLIN INVEST, V117, P473, DOI 10.1172/JCI28971; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Ziegler J L, 1985, Front Radiat Ther Oncol, V19, P99	59	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34240	10.1371/journal.pone.0034240	http://dx.doi.org/10.1371/journal.pone.0034240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479575	gold, Green Published, Green Submitted			2022-12-27	WOS:000303894900073
J	Gong, HB; Kovar, JL; Baker, B; Zhang, AH; Cheung, L; Draney, DR; Correa, IR; Xu, MQ; Olive, DM				Gong, Haibiao; Kovar, Joy L.; Baker, Brenda; Zhang, Aihua; Cheung, Lael; Draney, Daniel R.; Correa, Ivan R., Jr.; Xu, Ming-Qun; Olive, D. Michael			Near-Infrared Fluorescence Imaging of Mammalian Cells and Xenograft Tumors with SNAP-Tag	PLOS ONE			English	Article							LABELED MONOCLONAL-ANTIBODIES; IN-VIVO; FUSION PROTEINS; LIVE CELLS; RECEPTOR EXPRESSION; CANCER MODELS; LIVING CELLS; PROBES; ACTIVATION; BRIGHT	Fluorescence in the near-infrared (NIR) spectral region is suitable for in vivo imaging due to its reduced background and high penetration capability compared to visible fluorescence. SNAP(f) is a fast-labeling variant of SNAP-tag that reacts with a fluorescent dye-conjugated benzylguanine (BG) substrate, leading to covalent attachment of the fluorescent dye to the SNAP(f). This property makes SNAP(f) a valuable tool for fluorescence imaging. The NIR fluorescent substrate BG-800, a conjugate between BG and IRDye 800CW, was synthesized and characterized in this study. HEK293, MDA-MB-231 and SK-OV-3 cells stably expressing SNAP(f)-Beta-2 adrenergic receptor (SNAP(f)-ADR beta 2) fusion protein were created. The ADR beta 2 portion of the protein directs the localization of the protein to the cell membrane. The expression of SNAP(f)-ADR beta 2 in the stable cell lines was confirmed by the reaction between BG-800 substrate and cell lysates. Microscopic examination confirmed that SNAP(f)-ADR beta 2 was localized on the cell membrane. The signal intensity of the labeled cells was dependent on the BG-800 concentration. In vivo imaging study showed that BG-800 could be used to visualize xenograph tumors expressing SNAP(f)-ADR beta 2. However, the background signal was relatively high, which may be a reflection of non-specific accumulation of BG-800 in the skin. To address the background issue, quenched substrates that only fluoresce upon reaction with SNAP-tag were synthesized and characterized. Although the fluorescence was successfully quenched, in vivo imaging with the quenched substrate CBG-800-PEG-QC1 failed to visualize the SNAP(f)-ADR beta 2 expressing tumor, possibly due to the reduced reaction rate. Further improvement is needed to apply this system for in vivo imaging.	[Gong, Haibiao; Kovar, Joy L.; Cheung, Lael; Draney, Daniel R.; Olive, D. Michael] LI COR Biosci, Lincoln, NE 68504 USA; [Baker, Brenda; Zhang, Aihua; Correa, Ivan R., Jr.; Xu, Ming-Qun] New England Biolabs Inc, Ipswich, MA USA	New England Biolabs	Gong, HB (corresponding author), LI COR Biosci, Lincoln, NE 68504 USA.	herbert.gong@licor.com		Correa, Ivan/0000-0002-3169-6878				Adams KE, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717137; Barrett T, 2007, CLIN CANCER RES, V13, P6639, DOI 10.1158/1078-0432.CCR-07-1119; Bojkowska K, 2011, CHEM BIOL, V18, P805, DOI 10.1016/j.chembiol.2011.03.014; Chen HX, 2005, ANAL BIOCHEM, V338, P136, DOI 10.1016/j.ab.2004.11.015; Eckhardt M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022007; Filonov GS, 2011, NAT BIOTECHNOL, V29, P757, DOI 10.1038/nbt.1918; Gautier A, 2008, CHEM BIOL, V15, P128, DOI 10.1016/j.chembiol.2008.01.007; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gong H, 2008, CANCER RES, V68, P7386, DOI 10.1158/0008-5472.CAN-08-1545; Gong HB, 2011, TALANTA, V84, P941, DOI 10.1016/j.talanta.2011.02.035; Gong HB, 2010, NEOPLASIA, V12, P139, DOI 10.1593/neo.91446; Gong H, 2009, ANAL BIOCHEM, V386, P59, DOI 10.1016/j.ab.2008.11.031; Gong HB, 2006, MOL ENDOCRINOL, V20, P279, DOI 10.1210/me.2005-0205; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Kampmeier F, 2010, EUR J NUCL MED MOL I, V37, P1926, DOI 10.1007/s00259-010-1482-5; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Kiyose K, 2010, J AM CHEM SOC, V132, P15846, DOI 10.1021/ja105937q; Kobayashi H, 2011, ACCOUNTS CHEM RES, V44, P83, DOI 10.1021/ar1000633; Kobayashi H, 2010, CHEM REV, V110, P2620, DOI 10.1021/cr900263j; Komatsu T, 2011, J AM CHEM SOC, V133, P6745, DOI 10.1021/ja200225m; Kosaka N, 2009, BIOCONJUGATE CHEM, V20, P1367, DOI 10.1021/bc9001344; Kovar JL, 2007, ANAL BIOCHEM, V367, P1, DOI 10.1016/j.ab.2007.04.011; Kovar JL, 2009, ANAL BIOCHEM, V384, P254, DOI 10.1016/j.ab.2008.09.050; Koyama Y, 2007, NEOPLASIA, V9, P1021, DOI 10.1593/neo.07787; Lin MZ, 2009, CHEM BIOL, V16, P1169, DOI 10.1016/j.chembiol.2009.10.009; MARSHALL MV, 2010, MOL IMAGING BIOL; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Peng XX, 2009, ANAL BIOCHEM, V388, P220, DOI 10.1016/j.ab.2009.02.024; Sampath L, 2007, J NUCL MED, V48, P1501, DOI 10.2967/jnumed.107.042234; Shcherbo D, 2007, NAT METHODS, V4, P741, DOI 10.1038/NMETH1083; Shcherbo D, 2010, NAT METHODS, V7, P827, DOI [10.1038/NMETH.1501, 10.1038/nmeth.1501]; Shu XK, 2009, SCIENCE, V324, P804, DOI 10.1126/science.1168683; Srikun D, 2010, J AM CHEM SOC, V132, P4455, DOI 10.1021/ja100117u; Stohr K, 2010, ANAL CHEM, V82, P8186, DOI 10.1021/ac101521y; Sun XL, 2011, CHEMBIOCHEM, V12, P2217, DOI 10.1002/cbic.201100173; Tomat E, 2008, J AM CHEM SOC, V130, P15776, DOI 10.1021/ja806634e; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Zhang CJ, 2011, ORG LETT, V13, P4160, DOI 10.1021/ol201430x	40	23	24	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34003	10.1371/journal.pone.0034003	http://dx.doi.org/10.1371/journal.pone.0034003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479502	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100094
J	Ionta, S; Perruchoud, D; Draganski, B; Blanke, O				Ionta, Silvio; Perruchoud, David; Draganski, Bogdan; Blanke, Olaf			Body Context and Posture Affect Mental Imagery of Hands	PLOS ONE			English	Article							DEVELOPMENTAL-COORDINATION-DISORDER; MOTOR IMAGERY; SPATIAL TRANSFORMATIONS; EGOCENTRIC TRANSFORMATIONS; CORPOREAL AWARENESS; VISUAL-IMAGERY; ROTATION; REPRESENTATIONS; OBJECTS; SELF	Different visual stimuli have been shown to recruit different mental imagery strategies. However the role of specific visual stimuli properties related to body context and posture in mental imagery is still under debate. Aiming to dissociate the behavioural correlates of mental processing of visual stimuli characterized by different body context, in the present study we investigated whether the mental rotation of stimuli showing either hands as attached to a body (hands-on-body) or not (hands-only), would be based on different mechanisms. We further examined the effects of postural changes on the mental rotation of both stimuli. Thirty healthy volunteers verbally judged the laterality of rotated hands-only and hands-on-body stimuli presented from the dorsum- or the palm-view, while positioning their hands on their knees (front postural condition) or behind their back (back postural condition). Mental rotation of hands-only, but not of hands-on-body, was modulated by the stimulus view and orientation. Additionally, only the hands-only stimuli were mentally rotated at different speeds according to the postural conditions. This indicates that different stimulus-related mechanisms are recruited in mental rotation by changing the bodily context in which a particular body part is presented. The present data suggest that, with respect to hands-only, mental rotation of hands-on-body is less dependent on biomechanical constraints and proprioceptive input. We interpret our results as evidence for preferential processing of visual- rather than kinesthetic-based mechanisms during mental transformation of hands-on-body and hands-only, respectively.	[Ionta, Silvio; Perruchoud, David; Blanke, Olaf] Ecole Polytech Fed Lausanne, Brain Mind Inst, Cognit Neurosci Lab, CH-1015 Lausanne, Switzerland; [Draganski, Bogdan] Univ Lausanne, CHUV, Dept Clin Neurosci, LREN, CH-1015 Lausanne, Switzerland; [Draganski, Bogdan] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Draganski, Bogdan] Humboldt Univ, D-10099 Berlin, Germany; [Draganski, Bogdan] Charite, Mind Brain Inst, D-10099 Berlin, Germany; [Blanke, Olaf] Univ Hosp, Dept Neurol, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Max Planck Society; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Geneva	Ionta, S (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Cognit Neurosci Lab, CH-1015 Lausanne, Switzerland.	silvio.ionta@epfl.ch	Draganski, Bogdan/C-3096-2016; ionta, silvio/AGB-3634-2022	Draganski, Bogdan/0000-0002-5159-5919; ionta, silvio/0000-0003-2078-4861	Swiss Federal Institute of Technology Lausanne (EPFL)	Swiss Federal Institute of Technology Lausanne (EPFL)	This work was supported by the Swiss Federal Institute of Technology Lausanne (EPFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MA, 2006, J EXP PSYCHOL GEN, V135, P327, DOI 10.1037/0096-3445.135.3.327; Berlucchi G, 1997, TRENDS NEUROSCI, V20, P560, DOI 10.1016/S0166-2236(97)01136-3; Blanke O, 2005, BRAIN RES REV, V50, P184, DOI 10.1016/j.brainresrev.2005.05.008; Blanke O, 2005, J NEUROSCI, V25, P550, DOI 10.1523/JNEUROSCI.2612-04.2005; BONDA E, 1995, P NATL ACAD SCI USA, V92, P11180, DOI 10.1073/pnas.92.24.11180; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; COOPER LA, 1975, J EXP PSYCHOL HUMAN, V104, P48, DOI 10.1037/0096-1523.1.1.48; Creem SH, 2001, COGNITION, V81, P41, DOI 10.1016/S0010-0277(01)00118-4; Creem-Regehr SH, 2007, NEUROIMAGE, V35, P916, DOI 10.1016/j.neuroimage.2006.11.057; de Lange FP, 2006, NEUROIMAGE, V33, P609, DOI 10.1016/j.neuroimage.2006.07.017; de Lange FP, 2005, J COGNITIVE NEUROSCI, V17, P97, DOI 10.1162/0898929052880039; DECETY J, 1989, BEHAV BRAIN RES, V34, P35, DOI 10.1016/S0166-4328(89)80088-9; Devlin AL, 2010, AGING NEUROPSYCHOL C, V17, P709, DOI 10.1080/13825585.2010.510554; Dragovic M, 2004, LATERALITY, V9, P411, DOI 10.1080/13576500342000248; Fiorio M, 2006, BRAIN, V129, P47, DOI 10.1093/brain/awh630; Fiorio M, 2007, NEUROPSYCHOLOGIA, V45, P2346, DOI 10.1016/j.neuropsychologia.2007.02.005; Funk M, 2008, J INT NEUROPSYCH SOC, V14, P81, DOI 10.1017/S1355617708080041; Ganis G, 2000, CEREB CORTEX, V10, P175, DOI 10.1093/cercor/10.2.175; Gawryszewski LG, 2007, BRAZ J MED BIOL RES, V40, P377, DOI 10.1590/S0100-879X2007000300013; Gerardin E, 2000, CEREB CORTEX, V10, P1093, DOI 10.1093/cercor/10.11.1093; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Harris IM, 2002, NEUROPSYCHOLOGY, V16, P524, DOI 10.1037//0894-4105.16.4.524; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P414, DOI 10.1017/S0048577202001105; Ionta S, 2007, EXP BRAIN RES, V183, P1, DOI 10.1007/s00221-007-1020-2; Ionta S, 2009, EXP BRAIN RES, V195, P207, DOI 10.1007/s00221-009-1770-0; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jola C., 2005, SPAT COGN COMPUT, V5, P217; Katschnig P, 2010, MOVEMENT DISORD, V25, P1061, DOI 10.1002/mds.23047; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Kosslyn SM, 1998, PSYCHOPHYSIOLOGY, V35, P151, DOI 10.1017/S0048577298001516; Lopez C, 2011, BRAIN RES REV; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Lust JM, 2006, CHILD CARE HLTH DEV, V32, P649, DOI 10.1111/j.1365-2214.2006.00683.x; Michelon P, 2006, J NEUROPHYSIOL, V95, P811, DOI 10.1152/jn.00488.2005; Munzert J, 2009, PROG BRAIN RES, V174, P219, DOI 10.1016/S0079-6123(09)01318-1; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Overney LS, 2009, BRAIN TOPOGR, V22, P27, DOI 10.1007/s10548-008-0065-2; Overney  LS, 2005, COGNITIVE BRAIN RES, V25, P722, DOI 10.1016/j.cogbrainres.2005.09.024; PARSONS LM, 1994, J EXP PSYCHOL HUMAN, V20, P709, DOI 10.1037/0096-1523.20.4.709; PARSONS LM, 1987, J EXP PSYCHOL GEN, V116, P172, DOI 10.1037/0096-3445.116.2.172; PARSONS LM, 1987, COGNITIVE PSYCHOL, V19, P178, DOI 10.1016/0010-0285(87)90011-9; Parsons LM, 1998, J NEUROSCI, V18, P6539; Petit LS, 2003, BRAIN COGNITION, V51, P95, DOI 10.1016/S0278-2626(02)00526-2; RATCLIFF G, 1979, NEUROPSYCHOLOGIA, V17, P49, DOI 10.1016/0028-3932(79)90021-6; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Rumiati RI, 2001, CORTEX, V37, P730, DOI 10.1016/S0010-9452(08)70626-9; Schwabe L, 2009, HUM BRAIN MAPP, V30, P1801, DOI 10.1002/hbm.20764; Schwoebel J, 2005, J COGNITIVE NEUROSCI, V17, P543, DOI 10.1162/0898929053467587; SEKIYAMA K, 1982, PERCEPT PSYCHOPHYS, V32, P89, DOI 10.3758/BF03204268; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Sirigu A, 2001, J COGNITIVE NEUROSCI, V13, P910, DOI 10.1162/089892901753165827; Steenbergen B, 2007, NEUROPSYCHOLOGIA, V45, P3324, DOI 10.1016/j.neuropsychologia.2007.07.002; Steggemann Y, 2011, BRAIN COGNITION, V76, P97, DOI 10.1016/j.bandc.2011.02.013; ter Horst AC, 2010, EXP BRAIN RES, V203, P347, DOI 10.1007/s00221-010-2235-1; Thayer ZC, 2001, NEUROREPORT, V12, P3433, DOI 10.1097/00001756-200111160-00011; Tomasino B, 2004, J COGNITIVE NEUROSCI, V16, P878, DOI 10.1162/089892904970753; Tomasino B, 2003, BRAIN COGNITION, V51, P368, DOI 10.1016/S0278-2626(02)00570-5; Urgesi C, 2007, NAT NEUROSCI, V10, P30, DOI 10.1038/nn1815; Williams J, 2006, CHILD CARE HLTH DEV, V32, P633, DOI 10.1111/j.1365-2214.2006.00688.x; Wohlschlager A, 1998, J EXP PSYCHOL HUMAN, V24, P397, DOI 10.1037/0096-1523.24.2.397; Wraga M, 2005, NEUROPSYCHOLOGIA, V43, P1351, DOI 10.1016/j.neuropsychologia.2004.11.028; Wraga M, 2000, J EXP PSYCHOL LEARN, V26, P151, DOI 10.1037/0278-7393.26.1.151; Zacks J, 1999, NEUROPSYCHOLOGIA, V37, P1029, DOI 10.1016/S0028-3932(99)00012-3; Zacks J. M., 2000, Spatial Cognition and Computation, V2, P315, DOI 10.1023/A:1015584100204; Zacks J. M., 2005, SPAT COGN COMPUT, V5, P271, DOI [10.1207/s15427633scc0504_1, DOI 10.1207/s15427633scc0504_1]; Zacks Jeffrey M, 2005, Behav Cogn Neurosci Rev, V4, P96, DOI 10.1177/1534582305281085; Zacks JM, 2002, NEUROIMAGE, V16, P857, DOI 10.1006/nimg.2002.1129	68	47	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34382	10.1371/journal.pone.0034382	http://dx.doi.org/10.1371/journal.pone.0034382			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UC	22479618	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100153
J	Isachenko, V; Mallmann, P; Petrunkina, AM; Rahimi, G; Nawroth, F; Hancke, K; Felberbaum, R; Genze, F; Damjanoski, I; Isachenko, E				Isachenko, Vladimir; Mallmann, Peter; Petrunkina, Anna M.; Rahimi, Gohar; Nawroth, Frank; Hancke, Katharina; Felberbaum, Ricardo; Genze, Felicitas; Damjanoski, Ilija; Isachenko, Evgenia			Comparison of In Vitro- and Chorioallantoic Membrane (CAM)-Culture Systems for Cryopreserved Medulla-Contained Human Ovarian Tissue	PLOS ONE			English	Article							MONOZYGOTIC TWINS DISCORDANT; SHORT-TERM TRANSPLANTATION; FERTILITY PRESERVATION; GENE-EXPRESSION; VITRIFICATION; FOLLICLES; MODEL; CANCER; AUTOTRANSPLANTATION; ACTIVATION	At present, there are three ways to determine effectively the quality of the cryopreservation procedure using ovarian tissue before the re-implantation treatment: evaluation of follicles after post-thawing xenotransplantation to SCID mouse, in-vitro culture in a large volume of culture medium under constant agitation and culture on embryonic chorio-allantoic membrane within a hen's eggs. The aim of this study was to compare the two methods, culture in vitro and culture on embryonic chorioallantoic membrane (CAM) of cryopreserved human ovarian medulla-contained and medulla-free cortex. Ovarian fragments were divided into small pieces (1.5-2.0x1.0-1.2x0.8-1.5) of two types, cortex with medulla and medulla-free cortex, frozen, thawed and randomly divided into the following four groups. Group 1: medulla-free cortex cultured in vitro for 8 days in large volume of medium with mechanical agitation, Group 2: medulla-containing cortex cultured in vitro, Group 3: medulla-free cortex cultured in CAM-system for 5 days, Group 4: medulla-containing cortex cultured in CAM-system. The efficacy of the tissue culture was evaluated by the development of follicles and by intensiveness of angiogenesis in the tissue (von Willebrand factor and Desmin). For Group 1, 2, 3 and 4, respectively 85%, 85%, 87% and 84% of the follicles were morphologically normal (P>0.1). The immunohistochemical analysis showed that angiogenesis detected by von Willebrand factor was lower in groups 1 and 3 (medulla-free cortex). Neo-vascularisation (by Desmin) was observed only in ovarian tissue of Group 4 (medulla-contained cortex after CAM-culture). It appears that the presence of medulla in ovarian pieces is beneficial for post-thaw development of cryopreserved human ovarian tissue. For medical practice it is recommended for evaluation of post-warming ovarian tissue to use the CAM-system as a valuable alternative to xenotransplantation and for cryopreservation of these tissues to prepare ovarian medulla-contained strips.	[Isachenko, Vladimir; Mallmann, Peter; Rahimi, Gohar; Isachenko, Evgenia] Univ Cologne, Res Grp Reprod Med, Dept Obstet & Gynecol, D-50931 Cologne, Germany; [Isachenko, Vladimir; Mallmann, Peter; Rahimi, Gohar; Isachenko, Evgenia] Univ Cologne, IVF Lab, Dept Obstet & Gynecol, CAM Xenotransplantat Grp, D-50931 Cologne, Germany; [Petrunkina, Anna M.] Univ Vet Med, Unit Reprod Med Clin, Hannover, Germany; [Petrunkina, Anna M.] Univ Cambridge, Lab Flow Cytometry, Cambridge Inst Med Res, Cambridge, England; [Nawroth, Frank] Ctr Endocrinol & Reprod Med Barkhof, Dept Reprod Med, Hamburg, Germany; [Hancke, Katharina] Univ Ulm, Univ Maternal Hosp, Dept Obstet & Gynecol, Ulm, Germany; [Felberbaum, Ricardo] Univ Ulm, Univ Maternal Hosp Kempten, Dept Obstet & Gynecol, Kempten, Germany; [Genze, Felicitas; Damjanoski, Ilija] Univ Ulm, Univ Hosp Urol, Ulm, Germany	University of Cologne; University of Cologne; University of Veterinary Medicine Hannover, Foundation; University of Cambridge; Ulm University; Ulm University; Ulm University	Isachenko, V (corresponding author), Univ Cologne, Res Grp Reprod Med, Dept Obstet & Gynecol, D-50931 Cologne, Germany.	v.isachenko@yahoo.com						ALLES JU, 1988, AM J CLIN PATHOL, V89, P463, DOI 10.1093/ajcp/89.4.463; Altekruse SF, 2010, CANC STAT REV; Andersen CY, 2008, HUM REPROD, V23, P2266, DOI 10.1093/humrep/den244; [Anonymous], 2010, CANC GERM 2005 2006; Aubard Y, 1999, HUM REPROD, V14, P2149, DOI 10.1093/humrep/14.8.2149; AUERBACH R, 1974, DEV BIOL, V41, P391, DOI 10.1016/0012-1606(74)90316-9; Baird DT, 1999, ENDOCRINOLOGY, V140, P462, DOI 10.1210/en.140.1.462; Berube M, 2005, MOL VIS, V11, P1101; Brey EA, 2004, ANN BIOMED ENG, V32, P1100, DOI 10.1114/B:ABME.0000036646.17362.c4; Cushman RA, 2002, HUM REPROD, V17, P48, DOI 10.1093/humrep/17.1.48; Delgado-Rosas F, 2009, HUM REPROD, V24, P1142, DOI 10.1093/humrep/dep008; Demeestere I, 2007, ONCOLOGIST, V12, P1437, DOI 10.1634/theoncologist.12-12-1437; DIAZFLORES L, 1991, HISTOL HISTOPATHOL, V6, P269; DISSEN GA, 1994, ENDOCRINOLOGY, V134, P1146, DOI 10.1210/en.134.3.1146; Dittrich R, 2010, Minerva Ginecol, V62, P63; Dolmans MM, 2007, REPRODUCTION, V134, P253, DOI 10.1530/REP-07-0131; Donnez J, 2006, HUM REPROD, V21, P183, DOI 10.1093/humrep/dei268; Donnez J, 2004, LANCET, V364, P1405, DOI 10.1016/S0140-6736(04)17222-X; Donnez J, 1998, HUM REPROD UPDATE, V4, P248, DOI 10.1093/humupd/4.3.248; Donnez J, 2006, HUM REPROD UPDATE, V12, P519, DOI 10.1093/humupd/dml032; Donnez J, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2010.11.041; Ernst E, 2010, HUM REPROD, V25, P1280, DOI 10.1093/humrep/deq033; Gigli I, 2005, MOL REPROD DEV, V71, P480, DOI 10.1002/mrd.20338; Gook DA, 2003, HUM REPROD, V18, P1772, DOI 10.1093/humrep/deg365; Gosden R G, 2002, Reprod Biomed Online, V4 Suppl 1, P64; GOSDEN RG, 1994, HUM REPROD, V9, P597, DOI 10.1093/oxfordjournals.humrep.a138556; Gosden RG, 2000, MOL CELL ENDOCRINOL, V163, P125, DOI 10.1016/S0303-7207(99)00248-8; Gosden Roger G, 2005, J Natl Cancer Inst Monogr, P60; Hovatta O, 2005, REPROD BIOMED ONLINE, V10, P729, DOI 10.1016/S1472-6483(10)61116-9; Isachenko E, 2010, FERTILITY CRYOPRESER, V157-168, P157; Isachenko E, 2008, CRYOLETTERS, V29, P301; Isachenko E, 2009, FERTIL STERIL, V91, P1556, DOI 10.1016/j.fertnstert.2008.09.068; Isachenko V, 2008, CRYOLETTERS, V29, P261; Isachenko V, 2010, GEBURTSH FRAUENHEILK, V70, P561, DOI 10.1055/s-0030-1250075; Isachenko V, 2009, REPRODUCTION, V138, P319, DOI 10.1530/REP-09-0039; Isachenko V, 2008, FRAUENARZT, V49, P518; Isachenko V, 2010, FERTILITY CRYOPRESER, P213; Isachenko V, 2008, REPROD BIOMED ONLINE, V16, P336, DOI 10.1016/S1472-6483(10)60593-7; Isachenko V, 2007, CRYOBIOLOGY, V55, P261, DOI 10.1016/j.cryobiol.2007.08.008; Isachenko V, 2006, REPROD BIOMED ONLINE, V13, P228, DOI 10.1016/S1472-6483(10)60620-7; Isachenko V, 2009, CRYOLETTERS, V30, P449; JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906; Katoh M, 2001, CELLS TISSUES ORGANS, V169, P125, DOI 10.1159/000047870; Kawanami Oichi, 2000, Journal of Nippon Medical School, V67, P118, DOI 10.1272/jnms.67.118; KhanDawood FS, 1996, BIOL REPROD, V54, P734, DOI 10.1095/biolreprod54.3.734; Kim SS, 2002, FERTIL STERIL, V78, P77, DOI 10.1016/S0015-0282(02)03144-8; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Kristensen SG, 2011, HUM REPROD, V26, P157, DOI 10.1093/humrep/deq318; Kunzi-Rapp K, 2001, J UROLOGY, V166, P1502, DOI 10.1016/S0022-5347(05)65820-X; Kunzi-Rapp K, 1999, ARCH DERMATOL RES, V291, P290, DOI 10.1007/s004030050410; Leng T, 2004, RETINA-J RET VIT DIS, V24, P427, DOI 10.1097/00006982-200406000-00014; Lotz L, 2011, FERTIL STERIL, V95, P2612, DOI 10.1016/j.fertnstert.2011.05.003; Martinez-Madrid B, 2009, FERTIL STERIL, V91, P285, DOI 10.1016/j.fertnstert.2007.11.026; Meirow D, 2005, NEW ENGL J MED, V353, P318, DOI 10.1056/NEJMc055237; Meirow D, 2001, HUM REPROD UPDATE, V7, P535, DOI 10.1093/humupd/7.6.535; Meirow D, 2007, LEUKEMIA LYMPHOMA, V48, P1569, DOI 10.1080/10428190701471957; Muller AM, 2002, EXP GERONTOL, V37, P713, DOI 10.1016/S0531-5565(02)00010-4; Nakada K, 1998, J MUSCLE RES CELL M, V19, P169, DOI 10.1023/A:1005312729381; Nap AW, 2004, HUM REPROD, V19, P2180, DOI 10.1093/humrep/deh408; NEHLS V, 1992, CELL TISSUE RES, V270, P469, DOI 10.1007/BF00645048; Nisolle M, 2000, FERTIL STERIL, V74, P122, DOI 10.1016/S0015-0282(00)00548-3; Oktay K, 1998, HUM REPROD, V13, P1133, DOI 10.1093/humrep/13.5.1133; Oktay K, 2000, NEW ENGL J MED, V342, P1919, DOI 10.1056/NEJM200006223422516; Oktay K, 2011, FERTIL STERIL, V95, DOI 10.1016/j.fertnstert.2010.07.1072; Paynter SJ, 1999, CRYOBIOLOGY, V38, P301, DOI 10.1006/cryo.1999.2170; Rahimi G, 2004, REPROD BIOMED ONLINE, V9, P187, DOI 10.1016/S1472-6483(10)62128-1; Rahimi G, 2009, CRYOLETTERS, V30, P300; Rahimi G, 2010, EUR J OBSTET GYN R B, V149, P63, DOI 10.1016/j.ejogrb.2009.11.015; Revel A, 2011, HUM REPROD, V26, P1097, DOI 10.1093/humrep/der063; Ribatti Domenico, 2000, Current Pharmaceutical Biotechnology, V1, P73, DOI 10.2174/1389201003379040; Rosendahl M, 2011, REPROD BIOMED ONLINE, V22, P162, DOI 10.1016/j.rbmo.2010.10.015; Roux C, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.12.022; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sanchez-Serrano M, 2010, FERTIL STERIL, V93, DOI 10.1016/j.fertnstert.2009.09.046; Schmidt KT, 2011, FERTIL STERIL, V95, P695, DOI 10.1016/j.fertnstert.2010.07.1080; Schmidt KLT, 2005, HUM REPROD, V20, P3539, DOI 10.1093/humrep/dei250; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Silber SJ, 2008, HUM REPROD, V23, P1531, DOI 10.1093/humrep/den032; Silber SJ, 2007, NEW ENGL J MED, V356, P1382, DOI 10.1056/NEJMc066574; Smitz JEJ, 2002, REPRODUCTION, V123, P185, DOI 10.1530/rep.0.1230185; Starke RD, 2011, BLOOD, V117, P1071, DOI 10.1182/blood-2010-01-264507; Valdes TI, 2002, J BIOMED MATER RES, V62, P273, DOI 10.1002/jbm.10152; VERHOEVEN D, 1988, VIRCHOWS ARCH B, V54, P263; von Willebrand AE, 1926, FIN LAKARESALLSK HAN, V67, P7; von Wolff M, 2011, ARCH GYNECOL OBSTET, V284, P427, DOI 10.1007/s00404-011-1874-1; von Wolff M, 2009, EUR J CANCER, V45, P1547, DOI 10.1016/j.ejca.2009.01.029; Weissman A, 1999, BIOL REPROD, V60, P1462, DOI 10.1095/biolreprod60.6.1462; Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801	88	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32549	10.1371/journal.pone.0032549	http://dx.doi.org/10.1371/journal.pone.0032549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479331	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339100014
J	Kerner, A; Park, J; Williams, A; Lin, XXNN				Kerner, Alissa; Park, Jihyang; Williams, Audra; Lin, Xiaoxia Nina			A Programmable Escherichia coli Consortium via Tunable Symbiosis	PLOS ONE			English	Article							ANTHRANILATE SYNTHASE; EXPRESSION; SYSTEM; FERMENTATION; COOPERATION; TRYPTOPHAN; EVOLUTION; PROTEIN	Synthetic microbial consortia that can mimic natural systems have the potential to become a powerful biotechnology for various applications. One highly desirable feature of these consortia is that they can be precisely regulated. In this work we designed a programmable, symbiotic circuit that enables continuous tuning of the growth rate and composition of a synthetic consortium. We implemented our general design through the cross-feeding of tryptophan and tyrosine by two E. coli auxotrophs. By regulating the expression of genes related to the export or production of these amino acids, we were able to tune the metabolite exchanges and achieve a wide range of growth rates and strain ratios. In addition, by inverting the relationship of growth/ratio vs. inducer concentrations, we were able to "program" the co-culture for pre-specified attributes with the proper addition of inducing chemicals. This programmable proof-of-concept circuit or its variants can be applied to more complex systems where precise tuning of the consortium would facilitate the optimization of specific objectives, such as increasing the overall efficiency of microbial production of biofuels or pharmaceuticals.	[Kerner, Alissa; Lin, Xiaoxia Nina] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Kerner, Alissa; Park, Jihyang; Williams, Audra; Lin, Xiaoxia Nina] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Lin, Xiaoxia Nina] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kerner, A (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	ninalin@umich.edu			Cellular Biotechnology Training Program at the University of Michigan; National Science Foundation [EEC 0926926, CBET 1055227]	Cellular Biotechnology Training Program at the University of Michigan; National Science Foundation(National Science Foundation (NSF))	This work was supported by a fellowship AK received from the Cellular Biotechnology Training Program (http://www.cbtp.umich.edu/) at the University of Michigan and partly by National Science Foundation grants received by XNL (EEC 0926926, CBET 1055227). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA S, 1982, APPL ENVIRON MICROB, V43, P289, DOI 10.1128/AEM.43.2.289-297.1982; AZUMA S, 1993, APPL MICROBIOL BIOT, V39, P471, DOI 10.1007/BF00205035; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bongaerts J, 2001, METAB ENG, V3, P289, DOI 10.1006/mben.2001.0196; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Brenner K, 2007, P NATL ACAD SCI USA, V104, P17300, DOI 10.1073/pnas.0704256104; Brenner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016791; CALIGIURI MG, 1991, J BIOL CHEM, V266, P8328; Daims H, 2006, TRENDS BIOTECHNOL, V24, P483, DOI 10.1016/j.tibtech.2006.09.002; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Doroshenko V, 2007, FEMS MICROBIOL LETT, V275, P312, DOI 10.1111/j.1574-6968.2007.00894.x; Eiteman Mark A, 2008, J Biol Eng, V2, P3, DOI 10.1186/1754-1611-2-3; Eiteman MA, 2009, BIOTECHNOL BIOENG, V102, P822, DOI 10.1002/bit.22103; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fu N, 2009, ENZYME MICROB TECH, V45, P210, DOI 10.1016/j.enzmictec.2009.04.006; Harcombe W, 2010, EVOLUTION, V64, P2166, DOI 10.1111/j.1558-5646.2010.00959.x; Hillesland KL, 2010, P NATL ACAD SCI USA, V107, P2124, DOI 10.1073/pnas.0908456107; Lee SK, 2005, APPL ENVIRON MICROB, V71, P6856, DOI 10.1128/AEM.71.11.6856-6862.2005; Lee SK, 2007, APPL ENVIRON MICROB, V73, P5711, DOI 10.1128/AEM.00791-07; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Pittard J, 2005, MOL MICROBIOL, V55, P16, DOI 10.1111/j.1365-2958.2004.04385.x; Shou WY, 2007, P NATL ACAD SCI USA, V104, P1877, DOI 10.1073/pnas.0610575104; Spraggon G, 2001, P NATL ACAD SCI USA, V98, P6021, DOI 10.1073/pnas.111150298; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Weber W, 2007, P NATL ACAD SCI USA, V104, P10435, DOI 10.1073/pnas.0701382104	27	59	62	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34032	10.1371/journal.pone.0034032	http://dx.doi.org/10.1371/journal.pone.0034032			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479509	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100100
J	Reynaud, E; El Khoury-Malhame, M; Rossier, J; Blin, O; Khalfa, S				Reynaud, Emmanuelle; El Khoury-Malhame, Myriam; Rossier, Jerome; Blin, Olivier; Khalfa, Stephanie			Neuroticism Modifies Psychophysiological Responses to Fearful Films	PLOS ONE			English	Article							EMOTIONAL STATES; FACIAL EMG; PERSONALITY; STIMULI; FMRI; SUSCEPTIBILITY; AMYGDALA; SADNESS; STRESS; EXTRAVERSION	Background: Neuroticism is a personality component frequently found in anxious and depressive psychiatric disorders. The influence of neuroticism on negative emotions could be due to its action on stimuli related to fear and sadness, but this remains debated. Our goal was thus to better understand the impact of neuroticism through verbal and physiological assessment in response to stimuli inducing fear and sadness as compared to another negative emotion (disgust). Methods: Fifteen low neurotic and 18 high neurotic subjects were assessed on an emotional attending task by using film excerpts inducing fear, disgust, and sadness. We recorded skin conductance response (SCR) and corrugator muscle activity (frowning) as indices of emotional expression. Results: SCR was larger in high neurotic subjects than in low neurotics for fear relative to sadness and disgust. Moreover, corrugator activity and SCR were larger in high than in low neurotic subjects when fear was induced. Conclusion: After decades of evidence that individuals higher in neuroticism experience more intense emotional reactions to even minor stressors, our results indicate that they show greater SCR and expressive reactivity specifically to stimuli evoking fear rather than to those inducing sadness or disgust. Fear processing seems mainly under the influence of neuroticism. This modulation of autonomic activity by neurotics in response to threat/fear may explain their increased vulnerability to anxious psychopathologies such as PTSD (post traumatic stress disorder).	[Reynaud, Emmanuelle; El Khoury-Malhame, Myriam; Blin, Olivier; Khalfa, Stephanie] CNRS, UMR 7289, INT, Marseille, France; [Reynaud, Emmanuelle; El Khoury-Malhame, Myriam; Khalfa, Stephanie] Univ Mediterranean Aix Marseille 2, Fac Life & Hlth Sci, Dept Neurosci, F-13284 Marseille 07, France; [Rossier, Jerome] Univ Lausanne, Inst Psychol, Lausanne, Switzerland; [Blin, Olivier] Timone Hosp, APHM, Unit Clin Pharmacol & Therapeut Evaluat CIC UPCET, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Lausanne; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Reynaud, E (corresponding author), CNRS, UMR 7289, INT, Marseille, France.	manreynaud@yahoo.fr	Rossier, Jérôme/A-3494-2009; Khoury-Malhame, Myriam EL/AAH-5668-2019; Blin, Olivier/P-6960-2016	Rossier, Jérôme/0000-0002-9924-3672; Khoury-Malhame, Myriam EL/0000-0002-3397-9337; 	French national research council CNRS	French national research council CNRS(French National Research Agency (ANR)Centre National de la Recherche Scientifique (CNRS))	This research was promoted and funded by the French national research council CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez RP, 2008, J NEUROSCI, V28, P6211, DOI 10.1523/JNEUROSCI.1246-08.2008; Barrett J, 2009, PSYCHOL MED, V39, P255, DOI 10.1017/S0033291708003516; Bartlett DL, 1996, HDB MUSIC PSYCHOL, P343; Canli T, 2002, BRAIN COGNITION, V50, P414, DOI 10.1016/S0278-2626(02)00517-1; Canli T, 2001, BEHAV NEUROSCI, V115, P33, DOI 10.1037//0735-7044.115.1.33; Charney DS, 2004, AM J PSYCHIAT, V161, P195, DOI 10.1176/appi.ajp.161.2.195; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Costa P.T., 1992, PSYCHOL ASSESSMENT R, V396; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Cottraux J, 1985, EVALUATION CLIN PSYC; Cox BJ, 2004, BEHAV RES THER, V42, P105, DOI 10.1016/S0005-7967(03)00105-0; Craske MG., 1999, ANXIETY DISORDERS PS; Craske MG, 2009, BIOL PSYCHIAT, V65, P220, DOI 10.1016/j.biopsych.2008.07.020; Cremers HR, 2010, NEUROIMAGE, V49, P963, DOI 10.1016/j.neuroimage.2009.08.023; Eisenberger NI, 2005, COGN AFFECT BEHAV NE, V5, P169, DOI 10.3758/CABN.5.2.169; Eysenck H.J., 1967, BIOL BASIS PERSONALI; FOWLES DC, 1981, PSYCHOPHYSIOLOGY, V18, P232, DOI 10.1111/j.1469-8986.1981.tb03024.x; FRIDLUND AJ, 1986, PSYCHOPHYSIOLOGY, V23, P567, DOI 10.1111/j.1469-8986.1986.tb00676.x; Gomez P, 2005, BIOL PSYCHOL, V68, P223, DOI 10.1016/j.biopsycho.2004.06.003; Haas BW, 2008, NEUROIMAGE, V42, P385, DOI 10.1016/j.neuroimage.2008.04.027; Haas BW, 2007, BEHAV NEUROSCI, V121, P249, DOI 10.1037/0735-7044.121.2.249; Hagemann D, 2003, BRAIN COGNITION, V52, P79, DOI 10.1016/S0278-2626(03)00011-3; Hansenne M, 1999, J PSYCHIATR RES, V33, P31, DOI 10.1016/S0022-3956(98)00036-3; Hecht H, 1998, J AFFECT DISORDERS, V51, P33, DOI 10.1016/S0165-0327(98)00154-2; Hu SQ, 2003, PERCEPT MOTOR SKILL, V97, P1091, DOI 10.2466/PMS.97.7.1091-1099; Kelly MM, 2009, BEHAV RES THER, V47, P331, DOI 10.1016/j.brat.2009.01.008; Kreibig SD, 2007, PSYCHOPHYSIOLOGY, V44, P787, DOI 10.1111/j.1469-8986.2007.00550.x; LARSEN RJ, 1991, J PERS SOC PSYCHOL, V61, P132, DOI 10.1037/0022-3514.61.1.132; LARSEN RJ, 1989, PERS INDIV DIFFER, V10, P1221, DOI 10.1016/0191-8869(89)90233-X; Norris CJ, 2007, PSYCHOPHYSIOLOGY, V44, P823, DOI 10.1111/j.1469-8986.2007.00551.x; OATLEY K, 1992, ANNU REV PSYCHOL, V43, P55, DOI 10.1146/annurev.ps.43.020192.000415; Palomba D, 2000, INT J PSYCHOPHYSIOL, V36, P45, DOI 10.1016/S0167-8760(99)00099-9; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Reuter M, 2004, BEHAV NEUROSCI, V118, P462, DOI 10.1037/0735-7044.118.3.462; Robinson MD, 2007, PERS INDIV DIFFER, V42, P1221, DOI 10.1016/j.paid.2006.09.027; Schneider TR, 2004, J EXP SOC PSYCHOL, V40, P795, DOI 10.1016/j.jesp.2004.04.005; Schweitzer M.B., 1990, MANUEL INVENTAIRE AN; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Stein JL, 2007, NEUROIMAGE, V36, P736, DOI 10.1016/j.neuroimage.2007.03.022; Stewart ME, 2005, PERS INDIV DIFFER, V38, P1085, DOI 10.1016/j.paid.2004.07.007; TRANEL D, 1994, PSYCHOPHYSIOLOGY, V31, P427, DOI 10.1111/j.1469-8986.1994.tb01046.x; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465; Williams LM, 2001, NEUROIMAGE, V14, P1070, DOI 10.1006/nimg.2001.0904; Wilson GD, 2000, PERS INDIV DIFFER, V29, P1077, DOI 10.1016/S0191-8869(99)00255-X; Wolf K, 2005, SCAND J PSYCHOL, V46, P403, DOI 10.1111/j.1467-9450.2005.00471.x; Zelenski JM, 1999, J PERS, V67, P761, DOI 10.1111/1467-6494.00072	46	32	32	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32413	10.1371/journal.pone.0032413	http://dx.doi.org/10.1371/journal.pone.0032413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UC	22479326	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100010
J	Bramen, JE; Hranilovich, JA; Dahl, RE; Chen, J; Rosso, C; Forbes, EE; Dinov, ID; Worthman, CM; Sowell, ER				Bramen, Jennifer E.; Hranilovich, Jennifer A.; Dahl, Ronald E.; Chen, Jessie; Rosso, Carly; Forbes, Erika E.; Dinov, Ivo D.; Worthman, Carol M.; Sowell, Elizabeth R.			Sex Matters during Adolescence: Testosterone-Related Cortical Thickness Maturation Differs between Boys and Girls	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; CEREBRAL-CORTEX; ADULT MALE; CATECHOLAMINE INNERVATION; GEOMETRICALLY ACCURATE; FRONTAL-CORTEX; NEURON NUMBER; TEMPORAL-LOBE; BRAIN GROWTH; GRAY-MATTER	Age-related changes in cortical thickness have been observed during adolescence, including thinning in frontal and parietal cortices, and thickening in the lateral temporal lobes. Studies have shown sex differences in hormone-related brain maturation when boys and girls are age-matched, however, because girls mature 1-2 years earlier than boys, these sex differences could be confounded by pubertal maturation. To address puberty effects directly, this study assessed sex differences in testosterone-related cortical maturation by studying 85 boys and girls in a narrow age range and matched on sexual maturity. We expected that testosterone-by-sex interactions on cortical thickness would be observed in brain regions known from the animal literature to be high in androgen receptors. We found sex differences in associations between circulating testosterone and thickness in left inferior parietal lobule, middle temporal gyrus, calcarine sulcus, and right lingual gyrus, all regions known to be high in androgen receptors. Visual areas increased with testosterone in boys, but decreased in girls. All other regions were more impacted by testosterone levels in girls than boys. The regional pattern of sex-by-testosterone interactions may have implications for understanding sex differences in behavior and adolescent-onset neuropsychiatric disorders.	[Bramen, Jennifer E.; Hranilovich, Jennifer A.; Chen, Jessie; Rosso, Carly; Sowell, Elizabeth R.] Childrens Hosp Los Angeles, Dev Cognit Neuroimaging Lab, Los Angeles, CA 90027 USA; [Dahl, Ronald E.] Univ Calif Berkeley, Inst Human Dev, Dept Publ Hlth, Berkeley, CA 94720 USA; [Forbes, Erika E.] Univ Pittsburgh, Western Psychiat Inst & Clin, Dept Psychiat, Pittsburgh, PA 15213 USA; [Worthman, Carol M.] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Bramen, Jennifer E.] Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Staglin Ctr Cognit Neurosci, Los Angeles, CA 90024 USA; [Dinov, Ivo D.] Univ Calif Los Angeles, Dept Neurol, Lab Neuro Imaging, Los Angeles, CA 90024 USA; [Sowell, Elizabeth R.] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA	Children's Hospital Los Angeles; University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Emory University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California	Bramen, JE (corresponding author), Childrens Hosp Los Angeles, Dev Cognit Neuroimaging Lab, Los Angeles, CA 90027 USA.	esowell@chla.usc.edu	Bramen, Jennifer/GRS-4796-2022; Hranilovich, Jennifer/AAA-3770-2021; Dahl, Ronald/AAW-8714-2021; Forbes, Erika/J-2445-2015	Bramen, Jennifer/0000-0001-8967-0008; Hranilovich, Jennifer/0000-0001-6260-4123; Worthman, Carol M/0000-0002-5397-2298; dahl, ronald/0000-0002-1794-7132; Dinov, Ivo/0000-0003-3825-4375; Forbes, Erika/0000-0003-0659-7744	National Institute of Drug Abuse [R01 DA017831, R01 DA018910]; National Institute of Mental Health [R01 MH087563]; National Institute of Child Development Health and Human Development [RO1 HD053893-01]; Undergraduate Research Scholars; Hilton Family Foundation; National Institutes of Health through the National Institute of Health Roadmap for Medical Research; Center for Computational Biology [U54 RR021813]; NIH/NCRR [5 P41 RR013642]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053893] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR021813, P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA018910] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Development Health and Human Development; Undergraduate Research Scholars; Hilton Family Foundation; National Institutes of Health through the National Institute of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Computational Biology; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Drug Abuse Grants R01 DA017831 awarded to ERS and R01 DA018910 awarded to RED. Support for this research was also provided by the National Institute of Mental Health Grants R01 MH087563 and National Institute of Child Development Health and Human Development RO1 HD053893-01 awarded to ERS and the Undergraduate Research Scholars grant to JAH, supported by the Hilton Family Foundation. Additional support was provided by the National Institutes of Health through the National Institute of Health Roadmap for Medical Research, grant U54 RR021813 entitled Center for Computational Biology and NIH/NCRR 5 P41 RR013642 awarded to AWT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED EI, 2008, NAT NEUROSCI; Bauer M, 2005, MOL PSYCHIATR, V10, P456, DOI 10.1038/sj.mp.4001647; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bramen JE, 2010, CEREB CORTEX; Bramen JE, 2011, CEREB CORTEX, V21, P636, DOI 10.1093/cercor/bhq137; Chu Annie, 2009, J Online Learn Teach, V5, P1; Chu A, 2009, J STAT SOFTW, V30, P1; Cooke BM, 2006, NEUROSCIENCE, V138, P997, DOI 10.1016/j.neuroscience.2005.06.018; Cross CP, 2011, PSYCHOL BULL, V137, P97, DOI 10.1037/a0021591; Dahl RE, 2009, DEV PSYCHOPATHOL, V21, P1, DOI 10.1017/S0954579409000017; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dinov I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013070; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Forbes EE, 2010, J AM ACAD CHILD PSY, V49, P162, DOI 10.1016/j.jaac.2009.11.006; Gaub M, 1997, J AM ACAD CHILD PSY, V36, P1036, DOI 10.1097/00004583-199708000-00011; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giedd JN, 1996, J COMP NEUROL, V366, P223, DOI 10.1002/(SICI)1096-9861(19960304)366:2<223::AID-CNE3>3.0.CO;2-7; Halpern D., 2013, SEX DIFFERENCES COGN, V4th; Halpern DF, 2001, BRAIN COGNITION, V45, P392, DOI 10.1006/brcg.2001.1287; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hankin BL, 2007, CHILD DEV, V78, P279, DOI 10.1111/j.1467-8624.2007.00997.x; King JA, 2000, BEHAV BRAIN RES, V107, P35, DOI 10.1016/S0166-4328(99)00113-8; KOLB B, 1991, J NEUROENDOCRINOL, V3, P95, DOI 10.1111/j.1365-2826.1991.tb00245.x; Kritzer M, 2004, CEREB CORTEX, V14, P268, DOI 10.1093/cercor/bhg127; Kritzer MF, 1999, CEREB CORTEX, V9, P507, DOI 10.1093/cercor/9.5.507; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Lu LH, 2007, CEREB CORTEX, V17, P1092, DOI 10.1093/cercor/bhl019; Markham JA, 2002, NEUROBIOL AGING, V23, P579, DOI 10.1016/S0197-4580(02)00004-0; MARSHALL WA, 1968, ANNU REV MED, V19, P283, DOI 10.1146/annurev.me.19.020168.001435; Marshall WA, 1986, HUMAN GROWTH, P171, DOI DOI 10.1007/978-1-4899-0522-2_8; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; MUNOZCUETO JA, 1990, BRAIN RES, V515, P64; Neufang S, 2008, CEREB CORTEX; Nunez JL, 2003, J NEUROBIOL, V56, P293, DOI 10.1002/neu.10236; Nunez JL, 2002, J NEUROBIOL, V52, P312, DOI 10.1002/neu.10092; Nunez JL, 2000, DEV BRAIN RES, V125, P83, DOI 10.1016/S0165-3806(00)00126-7; Nunez JL, 2001, J COMP NEUROL, V436, P32; Peper JS, 2009, PSYCHONEUROENDOCRINO, V34, P332, DOI 10.1016/j.psyneuen.2008.09.012; Raznahan A, 2010, P NATL ACAD SCI USA, V107, P16988, DOI 10.1073/pnas.1006025107; REID SNM, 1992, J COMP NEUROL, V321, P448, DOI 10.1002/cne.903210311; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Rex DE, 2003, NEUROIMAGE, V19, P1033, DOI 10.1016/S1053-8119(03)00185-X; Rosas HD, 2002, NEUROLOGY, V58, P695, DOI 10.1212/WNL.58.5.695; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Schulz KM, 2004, HORM BEHAV, V45, P242, DOI 10.1016/j.yhbeh.2003.12.007; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Siddiqui A, 1997, DEV BRAIN RES, V98, P247, DOI 10.1016/S0165-3806(96)00171-X; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sowell ER, 1998, DEV NEUROPSYCHOL, V14, P599, DOI 10.1080/87565649809540731; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; STEWART J, 1994, BRAIN RES, V646, P157, DOI 10.1016/0006-8993(94)90070-1; STEWART J, 1994, BRAIN RES, V654, P149, DOI 10.1016/0006-8993(94)91581-4; Venkatesan C, 1999, J COMP NEUROL, V415, P240; WEISSMAN MM, 1993, J AFFECT DISORDERS, V29, P77, DOI 10.1016/0165-0327(93)90025-F; Worthman CM, 1997, AM J PHYS ANTHROPOL, V104, P1; Yurgelun-Todd DA, 2003, PERCEPT MOTOR SKILL, V96, P3, DOI 10.2466/pms.2003.96.1.3; Yurgelun-Todd D, 2007, CURR OPIN NEUROBIOL, V17, P251, DOI 10.1016/j.conb.2007.03.009; Zhang L, 1999, NEUROSCIENCE, V94, P251, DOI 10.1016/S0306-4522(99)00234-1	71	104	102	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33850	10.1371/journal.pone.0033850	http://dx.doi.org/10.1371/journal.pone.0033850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479458	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000304523400041
J	Dyhrman, ST; Jenkins, BD; Rynearson, TA; Saito, MA; Mercier, ML; Alexander, H; Whitney, LP; Drzewianowski, A; Bulygin, VV; Bertrand, EM; Wu, ZJ; Benitez-Nelson, C; Heithoff, A				Dyhrman, Sonya T.; Jenkins, Bethany D.; Rynearson, Tatiana A.; Saito, Mak A.; Mercier, Melissa L.; Alexander, Harriet; Whitney, LeAnn P.; Drzewianowski, Andrea; Bulygin, Vladimir V.; Bertrand, Erin M.; Wu, Zhijin; Benitez-Nelson, Claudia; Heithoff, Abigail			The Transcriptome and Proteome of the Diatom Thalassiosira pseudonana Reveal a Diverse Phosphorus Stress Response	PLOS ONE			English	Article							EMILIANIA-HUXLEYI PRYMNESIOPHYCEAE; RNA-BINDING PROTEINS; ALKALINE-PHOSPHATASE; CHLAMYDOMONAS-REINHARDTII; GENE-EXPRESSION; PUF FAMILY; MARINE; POLYPHOSPHATE; BIOSYNTHESIS; OCEAN	Phosphorus (P) is a critical driver of phytoplankton growth and ecosystem function in the ocean. Diatoms are an abundant class of marine phytoplankton that are responsible for significant amounts of primary production. With the control they exert on the oceanic carbon cycle, there have been a number of studies focused on how diatoms respond to limiting macro and micronutrients such as iron and nitrogen. However, diatom physiological responses to P deficiency are poorly understood. Here, we couple deep sequencing of transcript tags and quantitative proteomics to analyze the diatom Thalassiosira pseudonana grown under P-replete and P-deficient conditions. A total of 318 transcripts were differentially regulated with a false discovery rate of < 0.05, and a total of 136 proteins were differentially abundant (p < 0.05). Significant changes in the abundance of transcripts and proteins were observed and coordinated for multiple biochemical pathways, including glycolysis and translation. Patterns in transcript and protein abundance were also linked to physiological changes in cellular P distributions, and enzyme activities. These data demonstrate that diatom P deficiency results in changes in cellular P allocation through polyphosphate production, increased P transport, a switch to utilization of dissolved organic P through increased production of metalloenzymes, and a remodeling of the cell surface through production of sulfolipids. Together, these findings reveal that T. pseudonana has evolved a sophisticated response to P deficiency involving multiple biochemical strategies that are likely critical to its ability to respond to variations in environmental P availability.	[Dyhrman, Sonya T.; Alexander, Harriet; Heithoff, Abigail] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Jenkins, Bethany D.; Whitney, LeAnn P.] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA; [Jenkins, Bethany D.; Rynearson, Tatiana A.; Mercier, Melissa L.; Drzewianowski, Andrea] Univ Rhode Isl, Grad Sch Oceanog, Kingston, RI 02881 USA; [Saito, Mak A.; Bulygin, Vladimir V.; Bertrand, Erin M.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Wu, Zhijin] Brown Univ, Dept Community Hlth, Ctr Stat Sci, Providence, RI 02912 USA; [Benitez-Nelson, Claudia] Univ S Carolina, Marine Sci Program, Dept Earth & Ocean Sci, Columbia, SC 29208 USA	Woods Hole Oceanographic Institution; University of Rhode Island; University of Rhode Island; Woods Hole Oceanographic Institution; Brown University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Dyhrman, ST (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	sdyhrman@whoi.edu	wu, zhijin/J-2282-2014; wu, zhijin/J-4995-2016; Saito, Mak/ADT-4986-2022	wu, zhijin/0000-0002-9596-9134; Saito, Mak/0000-0001-6040-9295; Benitez-Nelson, Claudia/0000-0002-1004-5048; Alexander, Harriet/0000-0003-1308-8008	National Science Foundation (NSF); Environmental Genomics; NSF Biological Oceanography Program [OCE-0723667]; NSF Chemical Oceanography Program [OCE-0549794, OCE-0526800]; G. B. Moore Foundation [OCE-0752291]; NSF-EPSCoR [NSF-0554548, NSF-1004057]; University of Rhode Island; Center for Microbial Oceanography: Research and Education; Joint Genome Institute/DOE Community Sequencing Program [CSP795793]; Directorate For Geosciences [1061094, 0962208] Funding Source: National Science Foundation; Division Of Ocean Sciences [1316036, 1060884] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Environmental Genomics; NSF Biological Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NSF Chemical Oceanography Program(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); G. B. Moore Foundation; NSF-EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); University of Rhode Island; Center for Microbial Oceanography: Research and Education; Joint Genome Institute/DOE Community Sequencing Program; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by the National Science Foundation (NSF) Environmental Genomics and NSF Biological Oceanography Program through grant OCE-0723667 to Dr. Dyhrman, Dr. Jenkins, Dr. Saito, and Dr. Rynearson, the NSF Chemical Oceanography Program through grant OCE-0549794 to Dr. Dyhrman and OCE-0526800 to Dr. Jenkins, the G. B. Moore Foundation and OCE-0752291 to Dr. Saito, NSF-EPSCoR ( NSF-0554548 & NSF-1004057) to the University of Rhode Island, the Center for Microbial Oceanography: Research and Education, and the Joint Genome Institute/DOE Community Sequencing Program (CSP795793) to Dr. Jenkins, Dr. Dyhrman, Dr. Rynearson and Dr. Saito. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; AMMERMAN JW, 1985, SCIENCE, V227, P1338, DOI 10.1126/science.227.4692.1338; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Benitez-Nelson CR, 2000, EARTH-SCI REV, V51, P109, DOI 10.1016/S0012-8252(00)00018-0; Benning C, 1998, ANNU REV PLANT PHYS, V49, P53, DOI 10.1146/annurev.arplant.49.1.53; BRZOSKA P, 1989, FEMS MICROBIOL LETT, V63, P115, DOI 10.1016/0168-6445(89)90015-6; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Diaz J, 2008, SCIENCE, V320, P652, DOI 10.1126/science.1151751; DUFF SMG, 1989, PLANT PHYSIOL, V90, P1275, DOI 10.1104/pp.90.4.1275; Dyhrman ST, 2006, LIMNOL OCEANOGR, V51, P1381, DOI 10.4319/lo.2006.51.3.1381; Dyhrman ST, 2009, NAT GEOSCI, V2, P696, DOI 10.1038/NGEO639; Dyhrman ST, 2007, OCEANOGRAPHY, V20, P110, DOI 10.5670/oceanog.2007.54; Dyhrman ST, 2006, APPL ENVIRON MICROB, V72, P252, DOI 10.1128/AEM.72.1.252-260.2006; Dyhrman ST, 2003, J PLANKTON RES, V25, P1215, DOI 10.1093/plankt/fbg086; Dyhrman ST, 1999, APPL ENVIRON MICROB, V65, P3205; Dyhrman ST, 1997, J PHYCOL, V33, P602, DOI 10.1111/j.0022-3646.1997.00602.x; Fedoroff NV, 2002, CURR OPIN PLANT BIOL, V5, P452, DOI 10.1016/S1369-5266(02)00280-7; Fournier ML, 2010, MOL CELL PROTEOMICS, V9, P271, DOI 10.1074/mcp.M900415-MCP200; Franks PJS, 2009, J PLANKTON RES, V31, P1299, DOI 10.1093/plankt/fbp069; Grossman A, 2000, PROTIST, V151, P201, DOI 10.1078/1434-4610-00020; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guler S, 2000, J BACTERIOL, V182, P543, DOI 10.1128/JB.182.2.543-545.2000; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Karl D. M., 2002, BIOGEOCHEMISTRY MARI, P249, DOI DOI 10.1016/B978-012323841-2/50008-7]; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Le Bihan T, 2011, J PROTEOMICS, V74, P2060, DOI 10.1016/j.jprot.2011.05.028; Li QY, 2006, BIOCHEM BIOPH RES CO, V340, P95, DOI 10.1016/j.bbrc.2005.11.144; Lomas MW, 2010, BIOGEOSCIENCES, V7, P695, DOI 10.5194/bg-7-695-2010; Lu XN, 2005, MOL CELL PROTEOMICS, V4, P1948, DOI 10.1074/mcp.M500138-MCP200; Luo HW, 2009, P NATL ACAD SCI USA, V106, P21219, DOI 10.1073/pnas.0907586106; Martin P, 2011, ISME J, V5, P1057, DOI 10.1038/ismej.2010.192; Mather RL, 2008, NAT GEOSCI, V1, P439, DOI 10.1038/ngeo232; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Moustafa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009688; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nowrousian M, 2010, EUKARYOT CELL, V9, P1300, DOI 10.1128/EC.00123-10; Nunn BL, 2009, AQUAT MICROB ECOL, V55, P241, DOI 10.3354/ame01284; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Orchard ED, 2010, LIMNOL OCEANOGR, V55, P2161, DOI 10.4319/lo.2010.55.5.2161; Paytan A, 2007, CHEM REV, V107, P563, DOI 10.1021/cr0503613; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; PERRY MJ, 1976, LIMNOL OCEANOGR, V21, P88, DOI 10.4319/lo.1976.21.1.0088; PRICE N M, 1988, Biological Oceanography, V6, P443; QianWu J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-1-r3, 10.1186/gb-2008-9-5-220]; Riegman R, 2000, J PHYCOL, V36, P87, DOI 10.1046/j.1529-8817.2000.99023.x; Riekhof WR, 2005, ARCH BIOCHEM BIOPHYS, V441, P96, DOI 10.1016/j.abb.2005.07.001; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Ruttenberg KC, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002837; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Saito MA, 2011, P NATL ACAD SCI USA, V108, P2184, DOI 10.1073/pnas.1006943108; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tetu SG, 2009, ISME J, V3, P835, DOI 10.1038/ismej.2009.31; Thamatrakoln K, 2012, ENVIRON MICROBIOL, V14, P67, DOI 10.1111/j.1462-2920.2011.02468.x; THEODOROU ME, 1991, PLANT PHYSIOL, V95, P1089, DOI 10.1104/pp.95.4.1089; Thompson DK, 2002, APPL ENVIRON MICROB, V68, P881, DOI 10.1128/AEM.68.2.881-892.2002; Van Mooy BAS, 2008, LIMNOL OCEANOGR, V53, P78, DOI 10.4319/lo.2008.53.1.0078; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wu ZJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-564; Wurch LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028949; Wurch LL, 2011, ENVIRON MICROBIOL, V13, P468, DOI 10.1111/j.1462-2920.2010.02351.x; Xu Y, 2006, J PHYCOL, V42, P835, DOI 10.1111/j.1529-8817.2006.00243.x; Yamaguchi H, 2005, J PLANKTON RES, V27, P603, DOI 10.1093/plankt/fbi027; Young CL, 2010, AQUAT GEOCHEM, V16, P563, DOI 10.1007/s10498-009-9087-y; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	69	213	218	7	223	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33768	10.1371/journal.pone.0033768	http://dx.doi.org/10.1371/journal.pone.0033768			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479440	Green Submitted, gold, Green Published			2022-12-27	WOS:000304523400035
J	Kallberg, E; Vogl, T; Liberg, D; Olsson, A; Bjork, P; Wikstrom, P; Bergh, A; Roth, J; Ivars, F; Leanderson, T				Kallberg, Eva; Vogl, Thomas; Liberg, David; Olsson, Anders; Bjork, Per; Wikstrom, Pernilla; Bergh, Anders; Roth, Johannes; Ivars, Fredrik; Leanderson, Tomas			S100A9 Interaction with TLR4 Promotes Tumor Growth	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; ANTI-ANGIOGENIC AGENT; SUPPRESSOR-CELLS; TGF-BETA; TRANSGENIC ADENOCARCINOMA; AUTOIMMUNE-DISEASE; IN-VIVO; PROTEINS; MOUSE; IDENTIFICATION	By breeding TRAMP mice with S100A9 knock-out (S100A9(-/-)) animals and scoring the appearance of palpable tumors we observed a delayed tumor growth in animals devoid of S100A9 expression. CD11b(+) S100A9 expressing cells were not observed in normal prostate tissue from control C57BL/6 mice but were readily detected in TRAMP prostate tumors. Also, S100A9 expression was observed in association with CD68(+) macrophages in biopsies from human prostate tumors. Delayed growth of TRAMP tumors was also observed in mice lacking the S100A9 ligand TLR4. In the EL-4 lymphoma model tumor growth inhibition was observed in S100A9(-/-) and TLR4(-/-), but not in RAGE(-/-) animals lacking an alternative S100A9 receptor. When expression of immune-regulating genes was analyzed using RT-PCR the only common change observed in mice lacking S100A9 and TLR4 was a down-regulation of TGF beta expression in splenic CD11b(+) cells. Lastly, treatment of mice with a small molecule (ABR-215050) that inhibits S100A9 binding to TLR4 inhibited EL4 tumor growth. Thus, S100A9 and TLR4 appear to be involved in promoting tumor growth in two different tumor models and pharmacological inhibition of S100A9-TLR4 interactions is a novel and promising target for anti-tumor therapies.	[Kallberg, Eva; Ivars, Fredrik; Leanderson, Tomas] Lund Univ, Immunol Grp, Lund, Sweden; [Vogl, Thomas; Roth, Johannes] Univ Munster, Inst Immunol, Munster, Germany; [Liberg, David; Olsson, Anders; Bjork, Per] Act Biotech AB, Lund, Sweden; [Wikstrom, Pernilla; Bergh, Anders] Umea Univ, Dept Med Biosci, Umea, Sweden	Lund University; University of Munster; Umea University	Kallberg, E (corresponding author), Lund Univ, Immunol Grp, Lund, Sweden.	tomas.leanderson@med.lu.se			Swedish Cancer Foundation; Swedish Science Council; Active Biotech	Swedish Cancer Foundation; Swedish Science Council; Active Biotech	TL, PW and AB are supported by grants from the Swedish Cancer Foundation and the Swedish Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation, or preparation of the manuscript.; The authors have read the journals policy and have the following conflicts: TL is a part time employee and DL, AO and PB are full time employees of Active Biotech that develops ABR-215050 for the treatment of prostate cancer. FI has a research grant from Active Biotech. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ATTIA MAM, 1966, CANCER RES, V26, P1787; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Bratt O, 2009, BRIT J CANCER, V101, P1233, DOI 10.1038/sj.bjc.6605322; Chen R, 2008, ONCOGENE, V27, P225, DOI 10.1038/sj.onc.1210907; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Chung SC, 2009, EUR J CANCER, V45, P174, DOI 10.1016/j.ejca.2008.10.010; Degl'Innocenti E, 2005, EUR J IMMUNOL, V35, P66, DOI 10.1002/eji.200425531; Dolcetti L, 2010, EUR J IMMUNOL, V40, P22, DOI 10.1002/eji.200939903; Flavell RA, 2010, NAT REV IMMUNOL, V10, P554, DOI 10.1038/nri2808; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Ge RR, 2006, CLIN CANCER RES, V12, P4315, DOI 10.1158/1078-0432.CCR-06-0162; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Greifenberg V, 2009, EUR J IMMUNOL, V39, P2865, DOI 10.1002/eji.200939486; Halin S, 2009, NEOPLASIA, V11, P177, DOI 10.1593/neo.81338; Hermani A, 2005, CLIN CANCER RES, V11, P5146, DOI 10.1158/1078-0432.CCR-05-0352; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Isaacs JT, 2006, PROSTATE, V66, P1768, DOI 10.1002/pros.20509; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Marigo I, 2008, IMMUNOL REV, V222, P162, DOI 10.1111/j.1600-065X.2008.00602.x; Martiniello-Wilks R, 2003, ANTICANCER RES, V23, P2633; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nam JS, 2008, CANCER RES, V68, P3835, DOI 10.1158/0008-5472.CAN-08-0215; Olsson A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-107; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Pili R, 2011, J CLIN ONCOL, V29, P4022, DOI 10.1200/JCO.2011.35.6295; Ribechini E, 2010, MED MICROBIOL IMMUN, V199, P273, DOI 10.1007/s00430-010-0151-4; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Suzuki E, 2007, CANCER RES, V67, P2351, DOI 10.1158/0008-5472.CAN-06-2389; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Turovskaya O, 2008, CARCINOGENESIS, V29, P2035, DOI 10.1093/carcin/bgn188; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Wikstrom P, 2005, PROSTATE, V62, P148, DOI 10.1002/pros.20123; Yanamandra K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005562; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895	47	97	102	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34207	10.1371/journal.pone.0034207	http://dx.doi.org/10.1371/journal.pone.0034207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470535	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000074
J	Havemann, F; Glaser, J; Heinz, M; Struck, A				Havemann, Frank; Glaeser, Jochen; Heinz, Michael; Struck, Alexander			Identifying Overlapping and Hierarchical Thematic Structures in Networks of Scholarly Papers: A Comparison of Three Approaches	PLOS ONE			English	Article							COMMUNITIES; MAPS	The aim of this paper is to introduce and assess three algorithms for the identification of overlapping thematic structures in networks of papers. We implemented three recently proposed approaches to the identification of overlapping and hierarchical substructures in graphs and applied the corresponding algorithms to a network of 492 information-science papers coupled via their cited sources. The thematic substructures obtained and overlaps produced by the three hierarchical cluster algorithms were compared to a content-based categorisation, which we based on the interpretation of titles, abstracts, and keywords. We defined sets of papers dealing with three topics located on different levels of aggregation: h-index, webometrics, and bibliometrics. We identified these topics with branches in the dendrograms produced by the three cluster algorithms and compared the overlapping topics they detected with one another and with the three predefined paper sets. We discuss the advantages and drawbacks of applying the three approaches to paper networks in research fields.	[Havemann, Frank; Heinz, Michael; Struck, Alexander] Humboldt Univ, Inst Bibliotheks & Informat Wissensch, D-10099 Berlin, Germany; [Glaeser, Jochen] Tech Univ Berlin, Zentrum Tech & Gesell, Berlin, Germany	Humboldt University of Berlin; Technical University of Berlin	Havemann, F (corresponding author), Humboldt Univ, Inst Bibliotheks & Informat Wissensch, D-10099 Berlin, Germany.	Frank.Havemann@ibi.hu-berlin.de		Struck, Alexander/0000-0002-1173-9228	Bundesministerium fur Bildung und Forschung (BMBF)	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	Bundesministerium fur Bildung und Forschung (BMBF, http://www.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; AMSTERDAMSKA O, 1989, SCIENTOMETRICS, V15, P449, DOI 10.1007/BF02017065; [Anonymous], ARXIV11105813; [Anonymous], 2010, P 4 SNA KDD WORKSH; Ball B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036103; Baumes J, 2005, LECT NOTES COMPUT SC, V3495, P27; Baumes J., 2005, IADIS AC, V5, P97; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Friggeri A., 2011, ARXIV11022623; Ghosh S., 2011, P ACM C WORLD WID WE, P39; Glaser J., 2006, WISSENSCHAFTLICHE PR, VVol. 906; Gregory S, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/02/P02017; Gregory S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/10/103018; Havemann F, 2010, ASONAM C OD DENM AUG; Havemann F, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01023; Janssens F, 2008, SCIENTOMETRICS, V75, P607, DOI 10.1007/s11192-007-2002-7; Janssens F, 2009, INFORM PROCESS MANAG, V45, P683, DOI 10.1016/j.ipm.2009.06.003; Kim Y, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026110; Klavans R, 2011, J AM SOC INF SCI TEC, V62, P1, DOI 10.1002/asi.21444; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Lee C, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066107; MARSHAKOVA IV, 1973, NAUCH-TEKHN INFORM 2, P3; Mitesser O, 2008, P WIS 2008 4 INT C W; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; SMALL H, 1973, J AM SOC INFORM SCI, V24, P265, DOI 10.1002/asi.4630240406; SULLIVAN D, 1977, SOC STUD SCI, V7, P223, DOI 10.1177/030631277700700205; Tibely G, 2012, PHYSICA A, V391, P1831, DOI 10.1016/j.physa.2011.09.040; van Raan AFJ, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P19; Xiaohua Wang, 2009, Physica A, V388, P5045, DOI 10.1016/j.physa.2009.08.032; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752; Zitt M, 2005, SCIENTOMETRICS, V63, P373, DOI 10.1007/s11192-005-0218-y	38	7	10	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33255	10.1371/journal.pone.0033255	http://dx.doi.org/10.1371/journal.pone.0033255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	940MY	22479376	Green Submitted, Green Published, gold			2022-12-27	WOS:000303894900020
J	Place, SP; Smith, BW				Place, Sean P.; Smith, Bryan W.			Effects of Seawater Acidification on Cell Cycle Control Mechanisms in Strongylocentrotus purpuratus Embryos	PLOS ONE			English	Article							SEA-URCHIN EGGS; ACID-BASE-BALANCE; PROTEIN-SYNTHESIS; INTRACELLULAR PH; PSAMMECHINUS-MILIARIS; OCEAN ACIDIFICATION; STRESS-RESPONSE; MESSENGER-RNA; CARBONIC-ACID; ACTIVATION	Previous studies have shown fertilization and development of marine species can be significantly inhibited when the pH of sea water is artificially lowered. Little mechanistic understanding of these effects exists to date, but previous work has linked developmental inhibition to reduced cleavage rates in embryos. To explore this further, we tested whether common cell cycle checkpoints were involved using three cellular biomarkers of cell cycle progression: (1) the onset of DNA synthesis, (2) production of a mitotic regulator, cyclin B, and (3) formation of the mitotic spindle. We grew embryos of the purple sea urchin, Strongylocentrotus purpuratus, in seawater artifically buffered to a pH of similar to 7.0, 7.5, and 8.0 by CO2 infusion. Our results suggest the reduced rates of mitotic cleavage are likely unrelated to common cell cycle checkpoints. We found no significant differences in the three biomarkers assessed between pH treatments, indicating the embryos progress through the G(1)/S, G(2)/M and metaphase/anaphase transitions at relatively similar rates. These data suggest low pH environments may not impact developmental programs directly, but may act through secondary mechanisms such as cellular energetics.	[Place, Sean P.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; Univ S Carolina, Environm & Sustainabil Program, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Place, SP (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	places@mailbox.sc.edu			University of South Carolina	University of South Carolina	These studies were supported by a start-up grant to SPP by the University of South Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMON A, 1994, CELL, V77, P1037, DOI 10.1016/0092-8674(94)90443-X; Burnett L, 2002, BIOL BULL, V203, P42, DOI 10.2307/1543456; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2011, P ROY SOC B-BIOL SCI, V278, P2376, DOI 10.1098/rspb.2010.2404; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Clark D, 2009, MAR BIOL, V156, P1125, DOI 10.1007/s00227-009-1155-8; CohenFix O, 1997, CURR OPIN CELL BIOL, V9, P800, DOI 10.1016/S0955-0674(97)80080-4; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Dickson A., 2007, PICES SPEC PUBL; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Ducibella T, 2006, SEMIN CELL DEV BIOL, V17, P324, DOI 10.1016/j.semcdb.2006.02.010; Dupont S, 2010, ECOTOXICOLOGY, V19, P449, DOI 10.1007/s10646-010-0463-6; EPEL D, 1974, DEV BIOL, V40, P245, DOI 10.1016/0012-1606(74)90127-4; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; FANG F, 1991, CELL, V66, P731, DOI 10.1016/0092-8674(91)90117-H; Fangue NA, 2010, LIMNOL OCEANOGR-METH, V8, P441, DOI 10.4319/lom.2010.8.441; Foltz KR, 2004, METHOD CELL BIOL, V74, P39; GRAINGER JL, 1979, DEV BIOL, V68, P396, DOI 10.1016/0012-1606(79)90213-6; Hamdoun A, 2007, P NATL ACAD SCI USA, V104, P1745, DOI 10.1073/pnas.0610108104; Hardwick KG, 1998, TRENDS GENET, V14, P1, DOI 10.1016/S0168-9525(97)01340-1; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; HUMPHREYS T, 1971, DEV BIOL, V26, P201, DOI 10.1016/0012-1606(71)90122-9; Ishikawa K, 2006, DNA CELL BIOL, V25, P406, DOI 10.1089/dna.2006.25.406; Jacobs HW, 1998, GENE DEV, V12, P3741, DOI 10.1101/gad.12.23.3741; JOHNSON CH, 1983, DEV BIOL, V98, P493, DOI 10.1016/0012-1606(83)90378-0; JOHNSON JD, 1976, NATURE, V262, P661, DOI 10.1038/262661a0; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; KNOBLICH JA, 1993, EMBO J, V12, P65, DOI 10.1002/j.1460-2075.1993.tb05632.x; Kurihara H, 2004, MAR POLLUT BULL, V49, P721, DOI 10.1016/j.marpolbul.2004.05.005; Kurihara H, 2004, MAR ECOL PROG SER, V274, P161, DOI 10.3354/meps274161; Lange BMH, 2002, CURR OPIN CELL BIOL, V14, P35, DOI 10.1016/S0955-0674(01)00291-5; Martin S, 2011, J EXP BIOL, V214, P1357, DOI 10.1242/jeb.051169; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Mikhailov A, 2002, CURR BIOL, V12, pR331, DOI 10.1016/S0960-9822(02)00833-3; Miles H, 2007, MAR POLLUT BULL, V54, P89, DOI 10.1016/j.marpolbul.2006.09.021; Moulin L, 2011, MAR POLLUT BULL, V62, P48, DOI 10.1016/j.marpolbul.2010.09.012; MURRAY AW, 1995, CURR OPIN GENET DEV, V5, P5, DOI 10.1016/S0959-437X(95)90046-2; O'Donnell MJ, 2010, MAR ECOL PROG SER, V398, P157, DOI 10.3354/meps08346; Pace DA, 2006, J EXP BIOL, V209, P158, DOI 10.1242/jeb.01962; PAGANO G, 1985, TERATOGEN CARCIN MUT, V5, P101, DOI 10.1002/tcm.1770050204; Pearce AK, 2001, TRENDS CELL BIOL, V11, P426, DOI 10.1016/S0962-8924(01)02119-5; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; PINES J, 1990, NATURE, V346, P760, DOI 10.1038/346760a0; Portner HO, 2000, J EXP BIOL, V203, P2417; Rieder CL, 2000, CURR BIOL, V10, P1067, DOI 10.1016/S0960-9822(00)00678-3; Robbins LL, 2002, 20101280 US GEOL SUR; ROSENBLATT J, 1992, P NATL ACAD SCI USA, V89, P2824, DOI 10.1073/pnas.89.7.2824; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; Runft LL, 2002, DEV BIOL, V245, P237, DOI 10.1006/dbio.2002.0600; Shackelford RE, 1999, ENVIRON HEALTH PERSP, V107, P5, DOI 10.2307/3434468; SHEN SS, 1979, NATURE, V282, P87, DOI 10.1038/282087a0; SPICER JI, 1995, MAR BIOL, V124, P71, DOI 10.1007/BF00349148; SPICER JI, 1988, MAR BIOL, V99, P527, DOI 10.1007/BF00392560; STEINHARDT R, 1977, DEV BIOL, V58, P185, DOI 10.1016/0012-1606(77)90084-7; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Stumpp M, 2011, COMP BIOCHEM PHYS A, V160, P320, DOI 10.1016/j.cbpa.2011.06.023; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; THNG JPH, 1990, CELL, V63, P313, DOI 10.1016/0092-8674(90)90164-A; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Truchot J-P, 1987, ZOOPHYSIOLOGY, V20; VACQUIER VD, 1995, DEV GROWTH DIFFER, V37, P1; VACQUIER VD, 1986, TRENDS BIOCHEM SCI, V11, P77, DOI 10.1016/0968-0004(86)90270-7; Voronina E, 2003, DEV BIOL, V256, P258, DOI 10.1016/S0012-1606(02)00134-3; Wen LZ, 2006, J CELL SCI, V119, P3491, DOI 10.1242/jcs.03082; WHEATLY MG, 1989, J EXP BIOL, V143, P33; Whitaker M, 2006, PHYSIOL REV, V86, P25, DOI 10.1152/physrev.00023.2005; Whitaker M., 1985, IONIC SIGNALING SEA, P167; WHITAKER MJ, 1982, Q REV BIOPHYS, V15, P593, DOI 10.1017/S0033583500003760; Whiteley NM, 2001, J EXP BIOL, V204, P1003; WINKLER MM, 1980, NATURE, V287, P558, DOI 10.1038/287558a0	74	17	17	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34068	10.1371/journal.pone.0034068	http://dx.doi.org/10.1371/journal.pone.0034068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479526	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900059
J	Williams, DM; Martin, RM; Smith, GD; Alberti, KGMM; Ben-Shlomo, Y; McCarthy, A				Williams, Dylan M.; Martin, Richard M.; Smith, George Davey; Alberti, K. G. M. M.; Ben-Shlomo, Yoav; McCarthy, Anne			Associations of Infant Nutrition with Insulin Resistance Measures in Early Adulthood: Evidence from the Barry-Caerphilly Growth (BCG) Study	PLOS ONE			English	Article							BLOOD-PRESSURE; GLUCOSE-TOLERANCE; MATHEMATICAL APPROACH; LATER LIFE; RISK; SENSITIVITY; ADIPOSITY; RELEASE; YOUTH	Background: Previous studies suggest that over-nutrition in early infancy may programme long-term susceptibility to insulin resistance. Objective: To assess the association of breast milk and quantity of infant formula and cows' milk intake during infancy with insulin resistance measures in early adulthood. Design: Long-term follow-up of the Barry Caerphilly Growth cohort, into which mothers and their offspring had originally been randomly assigned, between 1972-1974, to receive milk supplementation or not. Participants were the offspring, aged 23-27 years at follow-up (n = 679). Breastfeeding and formula/cows' milk intake was recorded prospectively by nurses. The main outcomes were insulin sensitivity (ISI0) and insulin secretion (CIR30). Results: 573 (84%) individuals had valid glucose and insulin results and complete covariate information. There was little evidence of associations of breastfeeding versus any formula/cows' milk feeding or of increasing quartiles of formula/cows' milk consumption during infancy (<3 months) with any outcome measure in young adulthood. In fully adjusted models, the differences in outcomes between breastfeeding versus formula/cows' milk feeding at 3 months were: fasting glucose (-0.07 mmol/l; 95% CI: -0.19, 0.05); fasting insulin (8.0%; -8.7, 27.6); ISI0 (-6.1%; -11.3, 12.1) and CIR30 (3.8%; -19.0, 32.8). There was also little evidence that increasing intakes of formula/cows' milk at 3 months were associated with fasting glucose (increase per quartile of formula/cows' milk intake = 0.00 mmol/l; -0.03, 0.03); fasting insulin (0.8%; -3.2, 5.1); ISI (0) (-0.9%; -5.1, 3.5) and CIR30 (-2.6%; -8.4, 3.6). Conclusions: We found no evidence that increasing consumption of formula/cows' milk in early infancy was associated with insulin resistance in young adulthood.	[Williams, Dylan M.; Martin, Richard M.; Smith, George Davey; Ben-Shlomo, Yoav] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Alberti, K. G. M. M.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Endocrinol & Metab, London, England; [McCarthy, Anne] Hlth Res Board, Child Hlth Epidemiol Div, Dublin, Ireland	University of Bristol; Imperial College London; Health Research Board - Ireland	Williams, DM (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	dylan.williams@bristol.ac.uk	Ben-Shlomo, Yoav/ABD-2004-2021; Davey Smith, George/A-7407-2013	Ben-Shlomo, Yoav/0000-0001-6648-3007; Davey Smith, George/0000-0002-1407-8314; Martin, Richard/0000-0002-7992-7719; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Williams, Dylan/0000-0002-3825-2487; s, hema/0000-0002-3440-9475	United Kingdom Department of Health and Social Security; British Heart Foundation; Diabetes UK; British Lung Foundation; Wellcome Trust [WT083431MA]; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	United Kingdom Department of Health and Social Security; British Heart Foundation(British Heart Foundation); Diabetes UK(Diabetes UK); British Lung Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The BCG study was originally funded by the United Kingdom Department of Health and Social Security. The follow-up was funded by grants from the British Heart Foundation, Diabetes UK and British Lung Foundation. DW is funded by a Wellcome Trust 4-year PhD studentship [WT083431MA]. The views expressed in this paper are those of the authors and not necessarily those of any funding body or others whose support is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN L, 1993, CLIN CHEM, V39, P578; [Anonymous], 2009, DIABETES CARE, V32, pS6, DOI 10.2337/dc09-S006; Bastard JP, 2007, DIABETES METAB, V33, P261, DOI 10.1016/j.diabet.2007.02.004; Bolling K, 2007, INFANT FEEDING SURVE; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Department of Health and Social Security, 1974, PRES DAY PRACT INF F; ELWOOD PC, 1981, ARCH DIS CHILD, V56, P831, DOI 10.1136/adc.56.11.831; FALL CHD, 1995, BRIT MED J, V310, P428, DOI 10.1136/bmj.310.6977.428; Goodwin RD, 2003, PREV MED, V36, P698, DOI 10.1016/S0091-7435(03)00042-2; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Lawlor DA, 2005, ARCH DIS CHILD, V90, P582, DOI 10.1136/adc.2004.055335; Lebovitz HE, 2006, DIABETES OBES METAB, V8, P237, DOI 10.1111/j.1463-1326.2005.00521.x; Lebovitz HE, 2005, DIABETES CARE, V28, P2322, DOI 10.2337/diacare.28.9.2322; Lucas A, 1998, J NUTR, V128, p401S, DOI 10.1093/jn/128.2.401S; Martin RM, 2005, AM J EPIDEMIOL, V161, P15, DOI 10.1093/aje/kwh338; Martin RM, 2003, AM J CLIN NUTR, V77, P1489, DOI 10.1093/ajcn/77.6.1489; Mayer-Davis EJ, 2008, DIABETES CARE, V31, P470, DOI 10.2337/dc07-1321; Mayer-Davis EJ, 2006, DIABETES CARE, V29, P2231, DOI 10.2337/dc06-0974; Montgomery AA, 2000, LANCET, V355, P2136, DOI 10.1016/S0140-6736(00)02385-0; Nissinen A, 2004, DIABETOLOGIA, V47, P1245, DOI 10.1007/s00125-004-1433-4; Owen CG, 2005, PEDIATRICS, V115, P1367, DOI 10.1542/peds.2004-1176; Owen CG, 2008, AM J CLIN NUTR, V88, P305, DOI 10.1093/ajcn/88.2.305; Owen CG, 2006, AM J CLIN NUTR, V84, P1043, DOI 10.1093/ajcn/84.5.1043; Ravelli ACJ, 2000, ARCH DIS CHILD, V82, P248, DOI 10.1136/adc.82.3.248; Singhal A, 2003, LANCET, V361, P1089, DOI 10.1016/S0140-6736(03)12895-4; Singhal A, 2001, LANCET, V357, P413, DOI 10.1016/S0140-6736(00)04004-6; SLUITER WJ, 1976, DIABETES, V25, P245, DOI 10.2337/diabetes.25.4.245; SLUITER WJ, 1976, DIABETES, V25, P241, DOI 10.2337/diabetes.25.4.241; Ten S, 2004, J CLIN ENDOCR METAB, V89, P2526, DOI 10.1210/jc.2004-0276	30	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34161	10.1371/journal.pone.0034161	http://dx.doi.org/10.1371/journal.pone.0034161			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479550	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900065
J	Al-Ghouleh, A; Johal, R; Sharquie, IK; Emara, M; Harrington, H; Shakib, F; Ghaemmaghami, AM				Al-Ghouleh, Abeer; Johal, Ramneek; Sharquie, Inas K.; Emara, Mohammed; Harrington, Helen; Shakib, Farouk; Ghaemmaghami, Amir M.			The Glycosylation Pattern of Common Allergens: The Recognition and Uptake of Der p 1 by Epithelial and Dendritic Cells Is Carbohydrate Dependent	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; MITE ALLERGEN; MANNOSE RECEPTOR; MASS-SPECTROMETRY; N-GLYCANS; DC-SIGN; EXPRESSION; TSLP; OLIGOSACCHARIDES; INFLAMMATION	Allergens are initiators of both innate and adaptive immune responses. They are recognised at the site of entry by epithelial and dendritic cells (DCs), both of which activate innate inflammatory circuits that can collectively induce Th2 immune responses. In an attempt to have a better understanding of the role of carbohydrates in the recognition and uptake of allergens by the innate immune system, we defined common glycosylation patterns in major allergens. This was done using labelled lectins and showed that allergens like Der p 1 (Dermatophagoides pteronyssinus group 1), Fel d 1 (Felis domisticus), Ara h 1 (Arachis hypogaea), Der p 2 (Dermatophagoides pteronyssinus group 2), Bla g 2 (Blattella germanica) and Can f 1 (Canis familiaris) are glycosylated and that the main dominant sugars on these allergens are 1-2, 1-3 and 1-6 mannose. These observations are in line with recent reports implicating the mannose receptor (MR) in allergen recognition and uptake by DCs and suggesting a major link between glycosylation and allergen recognition. We then looked at TSLP (Thymic Stromal Lymphopoietin) cytokine secretion by lung epithelia upon encountering natural Der p 1 allergen. TSLP is suggested to drive DC maturation in support of allergic hypersensitivity reactions. Our data showed an increase in TSLP secretion by lung epithelia upon stimulation with natural Der p 1 which was carbohydrate dependent. The deglycosylated preparation of Der p 1 exhibited minimal uptake by DCs compared to the natural and hyperglycosylated recombinant counterparts, with the latter being taken up more readily than the other preparations. Collectively, our data indicate that carbohydrate moieties on allergens play a vital role in their recognition by innate immune cells, implicating them in downstream deleterious Th2 cell activation and IgE production.	[Al-Ghouleh, Abeer; Johal, Ramneek; Sharquie, Inas K.; Emara, Mohammed; Harrington, Helen; Shakib, Farouk; Ghaemmaghami, Amir M.] Univ Nottingham, Sch Mol Med Sci, Div Immunol, Queens Med Ctr, Nottingham NG7 2RD, England	University of Nottingham	Al-Ghouleh, A (corresponding author), Univ Nottingham, Sch Mol Med Sci, Div Immunol, Queens Med Ctr, Nottingham NG7 2RD, England.	Amir.Ghaemmaghami@nottingham.ac.uk	Ghaemmaghami, Amir/AAP-2968-2020; Ghaemmaghami, Amir/S-2627-2019; Sharquie, Inas K/Q-8037-2019; Emara, Mohamed M./C-8220-2013	Ghaemmaghami, Amir/0000-0003-3160-8759; Sharquie, Inas K/0000-0002-4953-7365; Emara, Mohamed M./0000-0001-7708-9435				Adams EW, 2008, CHEMBIOCHEM, V9, P294, DOI 10.1002/cbic.200700310; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Aoki R, 2010, J AGR FOOD CHEM, V58, P7986, DOI 10.1021/jf100793d; Buhling F, 2002, CELLULAR PEPTIDASES, V2, P241; Cereghino JL, 2000, FEMS MICROBIOL REV, V24, P45, DOI 10.1111/j.1574-6976.2000.tb00532.x; Chaudhuri N, 2008, PAEDIATR RESPIR REV, V9, P236, DOI 10.1016/j.prrv.2008.03.002; Chunsheng J, 2008, J ALLERGY CLIN IMMUN, V121, P185; Comeau MR, 2010, MUCOSAL IMMUNOL, V3, P138, DOI 10.1038/mi.2009.134; Commins SP, 2010, CURR ALLERGY ASTHM R, V10, P29, DOI 10.1007/s11882-009-0079-1; Deslee G, 2002, J ALLERGY CLIN IMMUN, V110, P763, DOI 10.1067/mai.2002.129121; Emara M, 2012, J BIOL CHEM, V287, P5756, DOI 10.1074/jbc.M111.312520; Emara M, 2011, J BIOL CHEM, V286, P13033, DOI 10.1074/jbc.M111.220657; Erbacher A, 2009, HUM IMMUNOL, V70, P308, DOI 10.1016/j.humimm.2009.02.005; Fotisch K, 2001, GLYCOCONJUGATE J, V18, P373, DOI 10.1023/A:1014860030380; FRIEND SL, 1994, EXP HEMATOL, V22, P321; Furmonaviciene R, 2005, ATTEMPT DEFINE ALLER, P4201; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Ghaemmaghami AM, 2002, CLIN EXP ALLERGY, V32, P1468, DOI 10.1046/j.1365-2745.2002.01504.x; Goll DE, CALPAIN SYSTEM, P731; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; He R, 2010, ANN NY ACAD SCI, V1183, P13, DOI 10.1111/j.1749-6632.2009.05128.x; Horlock C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r30; Hsu SC, 2010, J BIOL CHEM, V285, P7903, DOI 10.1074/jbc.M109.058370; Huby RDJ, WHY ARE SOME PROTEIN, P235; ISHIHARA H, 1979, J BIOL CHEM, V254, P715; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jacquenet S, 2009, J ALLERGY CLIN IMMUN, V124, P603, DOI 10.1016/j.jaci.2009.06.014; Jacquet A, 2002, CLIN EXP ALLERGY, V32, P1048, DOI 10.1046/j.1365-2222.2002.01437.x; Jutel M, 2011, ALLERGY, V66, P725, DOI 10.1111/j.1398-9995.2011.02589.x; Kashyap M, 2011, J IMMUNOLOGY; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Kerrigan AM, 2009, IMMUNOBIOLOGY, V214, P562, DOI 10.1016/j.imbio.2008.11.003; Kimura Y, 2008, BIOSCI BIOTECH BIOCH, V72, P485, DOI 10.1271/bbb.70572; Kolarich D, 2000, ANAL BIOCHEM, V285, P64, DOI 10.1006/abio.2000.4737; Lanfranco MF, 2008, MOL BIOCHEM PARASIT, V161, P91, DOI 10.1016/j.molbiopara.2008.06.005; Lauer I, 2004, BIOCHEM J, V383, P327, DOI 10.1042/BJ20041062; Leonard R, 2005, J BIOL CHEM, V280, P7932, DOI 10.1074/jbc.M410407200; Linhart B, 2011, VACCINE; LIPNIUNAS P, 1992, ANAL BIOCHEM, V200, P58, DOI 10.1016/0003-2697(92)90277-E; Malik A, 2008, INT J BIOL MACROMOL, V42, P185, DOI 10.1016/j.ijbiomac.2007.11.004; Meno K, 2005, J IMMUNOL, V175, P3835, DOI 10.4049/jimmunol.175.6.3835; Miyata M, 2009, EUR J IMMUNOL, V39, P3078, DOI 10.1002/eji.200939302; Okano M, 2001, J ALLERGY CLIN IMMUN, V108, P101, DOI 10.1067/mai.2001.115757; Okano M, 1999, J IMMUNOL, V163, P6712; Perlin AS, 2006, ADV CARBOHYD CHEM BI, V60, P183, DOI 10.1016/S0065-2318(06)60005-X; Plasencia MD, 2008, J AM SOC MASS SPECTR, V19, P1706, DOI 10.1016/j.jasms.2008.07.020; Poltl G, 2007, MOL IMMUNOLOGICAL CH, P220; Ray RJ, 1996, EUR J IMMUNOL, V26, P10, DOI 10.1002/eji.1830260103; Reche PA, 2001, J IMMUNOL, V167, P336, DOI 10.4049/jimmunol.167.1.336; Rochman I, 2007, J IMMUNOL, V178, P6720, DOI 10.4049/jimmunol.178.11.6720; Rochman Y, 2008, CURR OPIN PHARMACOL, V8, P249, DOI 10.1016/j.coph.2008.03.002; Royer PJ, 2010, J IMMUNOL, V185, P1522, DOI 10.4049/jimmunol.1000774; Schaible B, 2010, RESP PHYSIOL NEUROBI, V174, P235, DOI 10.1016/j.resp.2010.08.006; Seppala U, 2009, MOL IMMUNOL, V46, P2014, DOI 10.1016/j.molimm.2009.03.005; Shakib F, 2008, TRENDS IMMUNOL, V29, P633, DOI 10.1016/j.it.2008.08.007; Smagur J, 2009, BIOL CHEM, V390, P361, DOI 10.1515/BC.2009.042; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Staudacher E, 1999, BBA-GEN SUBJECTS, V1473, P216, DOI 10.1016/S0304-4165(99)00181-6; Tanaka J, 2009, CLIN EXP ALLERGY, V39, P89, DOI 10.1111/j.1365-2222.2008.03151.x; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; THORPE PE, 1988, CANCER RES, V48, P6396; van Oort E, 2002, EUR J BIOCHEM, V269, P671, DOI 10.1046/j.0014-2956.2001.02700.x; van Ree R, 2000, BETA 1 2 XYLOSE ALPH, P11451; Wang YH, 2009, CLIN EXP ALLERGY, V39, P798, DOI 10.1111/j.1365-2222.2009.03241.x; Wangi JK, 2008, CELL MOL IMMUNOL, V5, P99, DOI 10.1038/cmi.2008.12; Wills-Karp M, 2010, MUCOSAL IMMUNOL, V3, P104, DOI 10.1038/mi.2009.138; Ying S, 2005, J IMMUNOL, V174, P8183, DOI 10.4049/jimmunol.174.12.8183; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	70	58	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33929	10.1371/journal.pone.0033929	http://dx.doi.org/10.1371/journal.pone.0033929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479478	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100083
J	Kawamoto, T; Ohga, N; Akiyama, K; Hirata, N; Kitahara, S; Maishi, N; Osawa, T; Yamamoto, K; Kondoh, M; Shindoh, M; Hida, Y; Hida, K				Kawamoto, Taisuke; Ohga, Noritaka; Akiyama, Kosuke; Hirata, Naoya; Kitahara, Shuji; Maishi, Nako; Osawa, Takahiro; Yamamoto, Kazuyuki; Kondoh, Miyako; Shindoh, Masanobu; Hida, Yasuhiro; Hida, Kyoko			Tumor-Derived Microvesicles Induce Proangiogenic Phenotype in Endothelial Cells via Endocytosis	PLOS ONE			English	Article							MEMBRANE-VESICLES; CANCER PROGRESSION; SUBSTRATE GIRDIN; MESSENGER-RNA; ANGIOGENESIS; MELANOMA; VEGF; ABNORMALITIES; COMMUNICATION; MECHANISMS	Background: Increasing evidence indicates that tumor endothelial cells (TEC) differ from normal endothelial cells (NEC). Our previous reports also showed that TEC were different from NEC. For example, TEC have chromosomal abnormality and proangiogenic properties such as high motility and proliferative activity. However, the mechanism by which TEC acquire a specific character remains unclear. To investigate this mechanism, we focused on tumor-derived microvesicles (TMV). Recent studies have shown that TMV contain numerous types of bioactive molecules and affect normal stromal cells in the tumor microenvironment. However, most of the functional mechanisms of TMV remain unclear. Methodology/Principal Findings: Here we showed that TMV isolated from tumor cells were taken up by NEC through endocytosis. In addition, we found that TMV promoted random motility and tube formation through the activation of the phosphoinositide 3-kinase/Akt pathway in NEC. Moreover, the effects induced by TMV were inhibited by the endocytosis inhibitor dynasore. Our results indicate that TMV could confer proangiogenic properties to NEC partly via endocytosis. Conclusion: We for the first time showed that endocytosis of TMV contributes to tumor angiogenesis. These findings offer new insights into cancer therapies and the crosstalk between tumor and endothelial cells mediated by TMV in the tumor microenvironment.	[Kawamoto, Taisuke; Ohga, Noritaka; Akiyama, Kosuke; Hirata, Naoya; Maishi, Nako; Osawa, Takahiro; Yamamoto, Kazuyuki; Kondoh, Miyako; Hida, Kyoko] Hokkaido Univ, Dept Vasc Biol, Grad Sch Dent Med, Sapporo, Hokkaido, Japan; [Kitahara, Shuji] Tokyo Womens Med Univ, Sch Med, Dept Anat & Dev Biol, Tokyo, Japan; [Shindoh, Masanobu] Hokkaido Univ, Dept Oral Pathol & Biol, Grad Sch Dent Med, Sapporo, Hokkaido, Japan; [Hida, Yasuhiro] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Sapporo, Hokkaido, Japan	Hokkaido University; Tokyo Women's Medical University; Hokkaido University; Hokkaido University	Kawamoto, T (corresponding author), Hokkaido Univ, Dept Vasc Biol, Grad Sch Dent Med, Sapporo, Hokkaido, Japan.	khida@den.hokudai.ac.jp	Hida, Yasuhiro/A-7761-2012; Hida, Kyoko/AAE-3183-2020; Hida, Kyoko/A-8444-2012; Kitahara, Shuji/AAA-4632-2020; Shindoh, Masanobu/A-4799-2012; Maishi, Nako/A-8403-2012	Hida, Yasuhiro/0000-0003-1759-4215; Hida, Kyoko/0000-0002-7968-6062; Kitahara, Shuji/0000-0002-2904-0319; Shindoh, Masanobu/0000-0002-7782-5823; 	Ministry of Education, Science, and Culture of Japan [20390506, 21659458, 21591655, 23792306]; Akiyama Foundation; Grants-in-Aid for Scientific Research [11J08458] Funding Source: KAKEN	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Akiyama Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan to K. Hida (#20390506 and #21659458), Y. Hida (#21591655), N. Ohga (#23792306) and the Akiyama Foundation ( K. Hida). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 2009, AM J PATHOL, V175, P2657, DOI 10.2353/ajpath.2009.090202; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Baj-Krzyworzeka M, 2006, CANCER IMMUNOL IMMUN, V55, P808, DOI 10.1007/s00262-005-0075-9; Camussi G, 2011, AM J CANCER RES, V1, P98; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Cohen MB, 2009, J CELL BIOCHEM, V106, P363, DOI 10.1002/jcb.22022; Dolo V, 1999, ANN NY ACAD SCI, V878, P497, DOI 10.1111/j.1749-6632.1999.tb07707.x; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fujioka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016324; Ginestra A, 1998, ANTICANCER RES, V18, P3433; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Hong BS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-556; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Kim CW, 2002, CANCER RES, V62, P6312; Kitahara S, 2010, MED MOL MORPHOL, V43, P26, DOI 10.1007/s00795-009-0481-8; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kurosu T, 2011, BRIT J CANCER, V104, P819, DOI 10.1038/bjc.2011.20; Lima LG, 2009, CANCER LETT, V283, P168, DOI 10.1016/j.canlet.2009.03.041; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Martinez MC, 2005, AM J PHYSIOL-HEART C, V288, pH1004, DOI 10.1152/ajpheart.00842.2004; Matsuda K, 2010, BIOCHEM BIOPH RES CO, V394, P947, DOI 10.1016/j.bbrc.2010.03.089; McDonald DM, 2002, CANCER RES, V62, P5381; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Muraki C, 2011, INT J CANC; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Neumann S, 2009, TRAFFIC, V10, P334, DOI 10.1111/j.1600-0854.2008.00872.x; Ohga N, 2012, AM J PATHOL; Ohga N, 2009, CANCER SCI, V100, P1963, DOI 10.1111/j.1349-7006.2009.01255.x; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; St Croix B, 2000, SCIENCE, V289, P1197; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Wang F.Z., 2011, MOL CELL BIOCHEM; Weng L, 2010, CANCER SCI, V101, P836, DOI 10.1111/j.1349-7006.2010.01487.x; Wickenden JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2558; Wysoczynski M, 2009, INT J CANCER, V125, P1595, DOI 10.1002/ijc.24479	44	73	74	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34045	10.1371/journal.pone.0034045	http://dx.doi.org/10.1371/journal.pone.0034045			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479517	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100106
J	Oakley, AJ; Bhatia, S; Ecroyd, H; Garner, B				Oakley, Aaron J.; Bhatia, Surabhi; Ecroyd, Heath; Garner, Brett			Molecular Dynamics Analysis of Apolipoprotein-D - Lipid Hydroperoxide Interactions: Mechanism for Selective Oxidation of Met-93	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEINS; METHIONINE OXIDATION; ARACHIDONIC-ACID; FORCE-FIELDS; PROTEINS; RESIDUES; MODEL; SIMULATIONS; REDUCTION; SULFOXIDE	Background: Recent studies suggest reduction of radical-propagating fatty acid hydroperoxides to inert hydroxides by interaction with apolipoprotein-D (apoD) Met93 may represent an antioxidant function for apoD. The nature and structural consequences of this selective interaction are unknown. Methodology/Principal Findings: Herein we used molecular dynamics (MD) analysis to address these issues. Long-timescale simulations of apoD suggest lipid molecules are bound flexibly, with the molecules free to explore multiple conformations in a binding site at the entrance to the classical lipocalin ligand-binding pocket. Models of 5s-12s- and 15s-hydroperoxyeicosatetraenoic acids were created and the lipids found to wrap around Met93 thus providing a plausible mechanism by which eicosatetraenoic acids bearing hydroperoxides on different carbon atoms can interact with Met93 to yield Met93 sulfoxide (Met93SO). Simulations of glycosylated apoD indicated that a second solvent exposed Met at position 49 was shielded by a triantennerary N-glycan attached to Asn45 thereby precluding lipid interactions. MD simulations of apoD showed B-factors of the loop containing Met93SO were higher in the oxidized protein, indicating increased flexibility that is predicted to destabilize the protein and promote self-association. Conclusions/Significance: These studies provide novel insights into the mechanisms that may contribute to the antioxidant function of apoD and the structural consequences that result if Met93SO is not redox-cycled back to its native state.	[Oakley, Aaron J.; Ecroyd, Heath; Garner, Brett] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Oakley, Aaron J.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia; [Bhatia, Surabhi] Neurosci Res Australia, Sydney, NSW, Australia; [Ecroyd, Heath; Garner, Brett] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia	University of Wollongong; University of Wollongong; Neuroscience Research Australia; University of Wollongong	Oakley, AJ (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia.	aarono@uow.edu.au; brettg@uow.edu.au	Ecroyd, Heath/E-7140-2015; Oakley, Aaron/A-9464-2013	Oakley, Aaron/0000-0002-4764-014X; Ecroyd, Heath/0000-0001-7574-0044	Australian National Health and Medical Research Council [1003886]; Australian Research Council Future Fellowships [FT0991986, FT0990287, FT110100586]; award under the Merit Allocation Scheme on the NCI National Facility at the Australian National University	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowships(Australian Research Council); award under the Merit Allocation Scheme on the NCI National Facility at the Australian National University	This research was supported by the Australian National Health and Medical Research Council (ID# 1003886), the Australian Research Council Future Fellowships (BG: ID# FT0991986, AJO: ID# FT0990287, HE: ID# FT110100586) and by an award under the Merit Allocation Scheme on the NCI National Facility at the Australian National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia S, 2012, BIOCHEM J, V442, P713, DOI 10.1042/BJ20111166; Butterfield DA, 2010, BBA-MOL CELL BIOL L, V1801, P924, DOI 10.1016/j.bbalip.2010.02.005; CABRAL JHM, 1995, FEBS LETT, V366, P53, DOI 10.1016/0014-5793(95)00484-Q; Chao CC, 1997, P NATL ACAD SCI USA, V94, P2969, DOI 10.1073/pnas.94.7.2969; Colombo G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004296; DILLEY WG, 1990, BREAST CANCER RES TR, V16, P253, DOI 10.1007/BF01806333; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Flower DR, 1996, BIOCHEM J, V318, P1; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Ganfornina MD, 2008, AGING CELL, V7, P506, DOI 10.1111/j.1474-9726.2008.00395.x; Garner B, 1998, J BIOL CHEM, V273, P6080, DOI 10.1074/jbc.273.11.6080; Garner B, 1998, J BIOL CHEM, V273, P6088, DOI 10.1074/jbc.273.11.6088; Greenberg ME, 2008, J BIOL CHEM, V283, P2385, DOI 10.1074/jbc.M707348200; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kim WS, 2009, J NEUROCHEM, V109, P1053, DOI 10.1111/j.1471-4159.2009.06031.x; Lea O A, 1988, Steroids, V52, P337, DOI 10.1016/0039-128X(88)90135-3; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Meli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019093; Muffat J, 2008, P NATL ACAD SCI USA, V105, P7088, DOI 10.1073/pnas.0800896105; Nasreen A, 2006, PROTEIN SCI, V15, P190, DOI 10.1110/ps.051775606; Nomura T, 2009, BIOPOLYMERS, V91, P78, DOI 10.1002/bip.21084; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pratico D, 2010, BBA-MOL CELL BIOL L, V1801, P930, DOI 10.1016/j.bbalip.2010.01.009; Rassart E, 2000, BBA-PROTEIN STRUCT M, V1482, P185, DOI 10.1016/S0167-4838(00)00162-X; SCHINDLER PA, 1995, PROTEIN SCI, V4, P791; Strader ML, 2002, J PHYS CHEM A, V106, P1074, DOI 10.1021/jp013658n; Terrisse L, 1998, J NEUROCHEM, V71, P1643; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Vogt M, 2001, J MOL RECOGNIT, V14, P79, DOI 10.1002/1099-1352(200101/02)14:1<79::AID-JMR521>3.0.CO;2-4; VOGT W, 1995, FREE RADICAL BIO MED, V18, P93, DOI 10.1016/0891-5849(94)00158-G; Wong YQ, 2010, P NATL ACAD SCI USA, V107, P1977, DOI 10.1073/pnas.0910136107	37	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34057	10.1371/journal.pone.0034057	http://dx.doi.org/10.1371/journal.pone.0034057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479522	gold, Green Published			2022-12-27	WOS:000305339100111
J	Rao, NA; Saraswathy, S; Pararajasegaram, G; Bhat, SP				Rao, Narsing A.; Saraswathy, Sindhu; Pararajasegaram, Geeta; Bhat, Suraj P.			Small Heat Shock Protein alpha A-Crystallin Prevents Photoreceptor Degeneration in Experimental Autoimmune Uveitis	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; B-CRYSTALLIN; ACUTE-INFLAMMATION; IMMUNE-RESPONSES; UVEORETINITIS; INVOLVEMENT; MODULATION; GENES; TLR4	The small heat shock protein, alpha A-crystallin null (alpha A(-/-)) mice are known to be more prone to retinal degeneration than the wild type mice in Experimental Autoimmune Uveoretinitis (EAU). In this report we demonstrate that intravenous administration of alpha A preserves retinal architecture and prevents photoreceptor damage in EAU. Interestingly, only alpha A and not alpha B-crystallin (alpha B), a closely related small heat shock protein works, pointing to molecular specificity in the observed retinal protection. The possible involvement of alpha A in retinal protection through immune modulation is corroborated by adaptive transfer experiments, (employing alpha A(-/-) and wild type mice with EAU as donors and Rag2(-/-) as the recipient mice), which indicate that alpha A protects against the autoimmune challenge by modulating the systemic B and T cell immunity. We show that alpha A administration causes marked reduction in Th1 cytokines (TNF-alpha, IL-12 and IFN-gamma), both in the retina and in the spleen; notably, IL-17 was only reduced in the retina suggesting local intervention. Importantly, expression of Toll-like receptors and their associated adaptors is also inhibited suggesting that alpha A protection, against photoreceptor loss in EAU, is associated with systemic suppression of both the adaptive and innate immune responses.	[Rao, Narsing A.; Saraswathy, Sindhu; Pararajasegaram, Geeta] Univ So Calif, Doheny Eye Inst, Los Angeles, CA 90089 USA; [Bhat, Suraj P.] Univ Calif Los Angeles, Jules Stein Eye Inst, Brain Res Inst, Los Angeles, CA 90024 USA; [Bhat, Suraj P.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA	Doheny Eye Institute; University of Southern California; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Rao, NA (corresponding author), Univ So Calif, Doheny Eye Inst, Los Angeles, CA 90089 USA.	nrao@usc.edu	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257; Bhat, Suraj P/0000-0003-4707-5870	National Institutes of Health, Bethesda, Maryland [E Y017347, EY019506, EY03040, EY06044]; Research to Prevent Blindness, Inc., New York, New York; NATIONAL EYE INSTITUTE [R01EY019506, R01EY006044, P30EY003040] Funding Source: NIH RePORTER	National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc., New York, New York(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by grants E Y017347, EY019506 and EY03040 to (NR) and EY06044 (to SB) from the National Institutes of Health, Bethesda, Maryland; and by a grant from Research to Prevent Blindness, Inc., New York, New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2003, BIOCHEM SOC T, V31, P637, DOI 10.1042/BST0310637; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Bhat SP, 2003, PROG DRUG RES, V60, P205; Brady JP, 1997, P NATL ACAD SCI USA, V94, P884, DOI 10.1073/pnas.94.3.884; Caspi Rachel R, 2003, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1506s53; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Du LP, 2009, OCUL IMMUNOL INFLAMM, V17, P249, DOI 10.1080/09273940902999356; Fan HG, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/704706; Feng Y, 2010, AM J PHYSIOL-CELL PH, V299, pC760, DOI 10.1152/ajpcell.00155.2010; Forrester JV, 1998, CURR EYE RES, V17, P426, DOI 10.1080/02713689808951224; Henderson B, 2010, J LEUKOCYTE BIOL, V88, P445, DOI 10.1189/jlb.1209779; Hohki S, 2010, EXP EYE RES, V91, P162, DOI 10.1016/j.exer.2010.04.009; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1080, P173, DOI 10.1016/0167-4838(91)90146-Q; Keino H, 2010, BRIT J OPHTHALMOL, V94, P802, DOI 10.1136/bjo.2009.171314; Kulkarni R, 2010, CELL TISSUE RES; Larson T, 2011, EXPERT OPIN EMERG DR, V16, P309, DOI 10.1517/14728214.2011.537824; Liu G, 2010, CLIN EXP IMMUNOL, V160, P168, DOI 10.1111/j.1365-2249.2010.04091.x; Liu GW, 2007, IMMUNOLOGY, V122, P149, DOI 10.1111/j.1365-2567.2007.02651.x; Masilamoni JG, 2006, BBA-MOL BASIS DIS, V1762, P284, DOI 10.1016/j.bbadis.2005.11.007; Masilamoni JG, 2005, BRAIN RES BULL, V67, P235, DOI 10.1016/j.brainresbull.2005.07.002; Masilamoni JG, 2005, BBA-MOL BASIS DIS, V1740, P411, DOI 10.1016/j.bbadis.2004.11.002; Metzger DW, 2010, CYTOKINE, V52, P102, DOI 10.1016/j.cyto.2010.06.011; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Rao NA, 2008, INVEST OPHTH VIS SCI, V49, P1161, DOI 10.1167/iovs.07-1259; Roelofs MF, 2006, J IMMUNOL, V176, P7021, DOI 10.4049/jimmunol.176.11.7021; Romi F, 2011, EUR NEUROL, V66, P65, DOI 10.1159/000329373; Saraswathy S, 2010, INVEST OPHTH VIS SCI, V51, P3680, DOI 10.1167/iovs.09-4575; Saraswathy S, 2009, INVEST OPHTH VIS SCI, V50, P5559, DOI 10.1167/iovs.08-2842; Scirocco A, 2010, J CELL PHYSIOL, V223, P442, DOI 10.1002/jcp.22053; Shechter R, 2008, J CELL BIOL, V183, P393, DOI 10.1083/jcb.200804010; Somasundaram T, 2000, J BIOL CHEM, V275, P17154, DOI 10.1074/jbc.M000304200; SRINIVASAN AN, 1992, J BIOL CHEM, V267, P23337; Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje; van Noort JM, 2010, J NEUROPATH EXP NEUR, V69, P694, DOI 10.1097/NEN.0b013e3181e4939c; Yoshimura T, 2008, INT IMMUNOL, V20, P209, DOI 10.1093/intimm/dxm135; Yoshimura T, 2009, RHEUMATOLOGY, V48, P347, DOI 10.1093/rheumatology/ken489	37	30	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33582	10.1371/journal.pone.0033582	http://dx.doi.org/10.1371/journal.pone.0033582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479415	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100059
J	Shvedova, AA; Kapralov, AA; Feng, WH; Kisin, ER; Murray, AR; Mercer, RR; St Croix, CM; Lang, MA; Watkins, SC; Konduru, NV; Allen, BL; Conroy, J; Kotchey, GP; Mohamed, BM; Meade, AD; Volkov, Y; Star, A; Fadeel, B; Kagan, VE				Shvedova, Anna A.; Kapralov, Alexandr A.; Feng, Wei Hong; Kisin, Elena R.; Murray, Ashley R.; Mercer, Robert R.; St Croix, Claudette M.; Lang, Megan A.; Watkins, Simon C.; Konduru, Nagarjun V.; Allen, Brett L.; Conroy, Jennifer; Kotchey, Gregg P.; Mohamed, Bashir M.; Meade, Aidan D.; Volkov, Yuri; Star, Alexander; Fadeel, Bengt; Kagan, Valerian E.			Impaired Clearance and Enhanced Pulmonary Inflammatory/Fibrotic Response to Carbon Nanotubes in Myeloperoxidase-Deficient Mice	PLOS ONE			English	Article							TOXICITY	Advancement of biomedical applications of carbonaceous nanomaterials is hampered by their biopersistence and pro-inflammatory action in vivo. Here, we used myeloperoxidase knockout B6.129X1-MPO (MPO k/o) mice and showed that oxidation and clearance of single walled carbon nanotubes (SWCNT) from the lungs of these animals after pharyngeal aspiration was markedly less effective whereas the inflammatory response was more robust than in wild-type C57Bl/6 mice. Our results provide direct evidence for the participation of MPO - one of the key-orchestrators of inflammatory response - in the in vivo pulmonary oxidative biodegradation of SWCNT and suggest new ways to control the biopersistence of nanomaterials through genetic or pharmacological manipulations.	[Shvedova, Anna A.; Kisin, Elena R.; Murray, Ashley R.; Mercer, Robert R.] NIOSH, Pathol & Physiol Res Branch, Hlth Effects Lab Div, Morgantown, WV 26505 USA; [Kapralov, Alexandr A.; Feng, Wei Hong; Konduru, Nagarjun V.; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Radical & Antioxidant Hlth, Pittsburgh, PA USA; [Kapralov, Alexandr A.; Feng, Wei Hong; St Croix, Claudette M.; Konduru, Nagarjun V.; Kagan, Valerian E.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Lang, Megan A.; Watkins, Simon C.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA USA; [Lang, Megan A.; Watkins, Simon C.] Univ Pittsburgh, Dept Physiol, Pittsburgh, PA 15261 USA; [Conroy, Jennifer; Mohamed, Bashir M.; Volkov, Yuri] Trinity Coll Dublin, Dept Clin Med, Dublin, Ireland; [Volkov, Yuri] Trinity Coll Dublin, Ctr Res Adapt Nanostruct & Nanodevices, Dublin, Ireland; [Meade, Aidan D.] Dublin Inst Technol, Coll Sci & Hlth, Sch Phys, Dublin, Ireland; [Allen, Brett L.; Kotchey, Gregg P.; Star, Alexander] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Fadeel, Bengt] Karolinska Inst, Inst Environm Med, Div Mol Toxicol, Stockholm, Sweden	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Trinity College Dublin; Trinity College Dublin; Technological University Dublin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Karolinska Institutet	Shvedova, AA (corresponding author), NIOSH, Pathol & Physiol Res Branch, Hlth Effects Lab Div, Morgantown, WV 26505 USA.	kagan@pitt.edu	St Croix, Claudette/AAA-3338-2022; Meade, Aidan/A-5092-2013; Watkins, Simon/ABG-2590-2021; Mohamed, Bashir/H-3065-2019; Mohamed, Bashir/AAG-8996-2019; Kotchey, Gregg P./S-1953-2019; Star, Alexander/C-3399-2013; Volkov, Yuri/N-6774-2014	Meade, Aidan/0000-0003-0353-9768; Watkins, Simon/0000-0003-4092-1552; Star, Alexander/0000-0001-7863-5987; Kagan, Valerian E./0000-0002-7245-1885; Volkov, Yuri/0000-0001-7406-518X; Kotchey, Gregg/0000-0002-6915-4353; M. Mohamed, Bashir/0000-0003-2146-1589; McIntyre, Jennifer/0000-0001-6418-8960; Kapralov, Oleksandr/0000-0002-3006-916X	National Institute for Occupational Safety and Health [OH008282]; National Institutes of Health [HL70755, HL094488, U19AI068021]; National Institute of Environmental Health Sciences [R01ES019304]; National Library of Medicine [LM007994-05]; National Occupational Research Agenda [927000Y, 927Z1LU]; Nanotechnology Research Center [927ZJHF]; National Science Foundation CAREER [0449117]; Air Force Office of Scientific Research [FA9550-09-1-0478]; 7th Framework Program of the European Commission [EC-FP7-NANOMMUNE-214281]; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Science Foundation of Ireland, Strategic Research Cluster BioNanointeract; Centre for Research on Adaptive Nanostructures and Nanodevices, Higher Education Authority (Ireland); Programme for Research in Third-Level Institutions (PRTLI) (Ireland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070755, R01HL094488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH008282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019304] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007994] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Occupational Research Agenda; Nanotechnology Research Center; National Science Foundation CAREER(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); 7th Framework Program of the European Commission(European Commission); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Science Foundation of Ireland, Strategic Research Cluster BioNanointeract(Science Foundation Ireland); Centre for Research on Adaptive Nanostructures and Nanodevices, Higher Education Authority (Ireland)(Science Foundation Ireland); Programme for Research in Third-Level Institutions (PRTLI) (Ireland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	National Institute for Occupational Safety and Health OH008282, National Institutes of Health HL70755, HL094488, U19AI068021, National Institute of Environmental Health Sciences R01ES019304, National Library of Medicine LM007994-05, National Occupational Research Agenda 927000Y, 927Z1LU, Nanotechnology Research Center 927ZJHF, National Science Foundation CAREER 0449117, Air Force Office of Scientific Research FA9550-09-1-0478, 7th Framework Program of the European Commission (EC-FP7-NANOMMUNE-214281), Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning and by the Science Foundation of Ireland, Strategic Research Cluster BioNanointeract and Centre for Research on Adaptive Nanostructures and Nanodevices, Higher Education Authority (Ireland) and Programme for Research in Third-Level Institutions (PRTLI) (Ireland). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BL, 2008, NANO LETT, V8, P3899, DOI 10.1021/nl802315h; Allen BL, 2009, J AM CHEM SOC, V131, P17194, DOI 10.1021/ja9083623; Allen RC, 2011, INFECT IMMUN, V79, P474, DOI 10.1128/IAI.00910-09; Brennan ML, 2001, J CLIN INVEST, V107, P419, DOI 10.1172/JCI8797; Cheng QH, 2010, J PHYS CHEM C, V114, P4857, DOI 10.1021/jp911202d; Gasser M, 2010, J NANOBIOTECHNOL, V8, DOI 10.1186/1477-3155-8-31; Giordani S, 2006, J PHYS CHEM B, V110, P15708, DOI 10.1021/jp0626216; Gorelik O.P, 2000, NASACR2000208926; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kagan VE, 2010, NAT NANOTECHNOL, V5, P354, DOI [10.1038/NNANO.2010.44, 10.1038/nnano.2010.44]; KANNO J, 2010, TOXICOLOGIST, V114, pA1397; Kisin ER, 2011, TOXICOL APPL PHARM, V252, P1, DOI 10.1016/j.taap.2011.02.001; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Kotchey GP, 2011, ACS NANO, V5, P2098, DOI 10.1021/nn103265h; Liu J, 1998, SCIENCE, V280, P1253, DOI 10.1126/science.280.5367.1253; Monopoli MP, 2011, J AM CHEM SOC, V133, P2525, DOI 10.1021/ja107583h; Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008; O'Brien PJ, 2000, CHEM-BIOL INTERACT, V129, P113, DOI 10.1016/S0009-2797(00)00201-5; Panasenko OM, 2005, BIOCHEMISTRY-MOSCOW+, V70, P998, DOI 10.1007/s10541-005-0215-z; Park EJ, 2011, ARCH TOXICOL, V85, P1121, DOI 10.1007/s00204-011-0655-8; Sakamoto Y, 2009, J TOXICOL SCI, V34, P65, DOI 10.2131/jts.34.65; Scott CD, 2003, J NANOSCI NANOTECHNO, V3, P63, DOI 10.1166/jnn.2003.164; Shvedova AA, 2008, AM J PHYSIOL-LUNG C, V295, pL552, DOI 10.1152/ajplung.90287.2008; Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005; Shvedova AA, 2010, ANNU REV PHARMACOL, V50, P63, DOI 10.1146/annurev.pharmtox.010909.105819; SUTHERLAND K, 1993, J CLIN INVEST, V92, P2360, DOI 10.1172/JCI116841; Vallhov H, 2006, NANO LETT, V6, P1682, DOI 10.1021/nl060860z; Vlasova II, 2011, RUSS J BIOORG CHEM+, V37, P453, DOI 10.1134/S1068162011040157; Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228; Zhao Y, 2011, J PHYS CHEM A, V115, P9536, DOI 10.1021/jp112324d	32	129	131	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e30923	10.1371/journal.pone.0030923	http://dx.doi.org/10.1371/journal.pone.0030923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479306	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000305339100003
J	Aung, KM; Boldbaatar, D; Umemiya-Shirafuji, R; Liao, M; Tsuji, N; Xuan, XA; Suzuki, H; Kume, A; Galay, RL; Tanaka, T; Fujisaki, K				Aung, Kyaw Min; Boldbaatar, Damdinsuren; Umemiya-Shirafuji, Rika; Liao, Min; Tsuji, Naotoshi; Xuan Xuenan; Suzuki, Hiroshi; Kume, Aiko; Galay, Remil Linggatong; Tanaka, Tetsuya; Fujisaki, Kozo			HlSRB, a Class B Scavenger Receptor, Is Key to the Granulocyte-Mediated Microbial Phagocytosis in Ticks	PLOS ONE			English	Article							ORNITHODOROS-MOUBATA ACARI; ESCHERICHIA-COLI; IXODES-RICINUS; HARD TICK; TGF-BETA; HEMOCYTES; CD36; IMMUNE; ANGIOGENESIS; RECOGNITION	Ixodid ticks transmit various pathogens of deadly diseases to humans and animals. However, the specific molecule that functions in the recognition and control of pathogens inside ticks is not yet to be identified. Class B scavenger receptor CD36 (SRB) participates in internalization of apoptotic cells, certain bacterial and fungal pathogens, and modified low-density lipoproteins. Recently, we have reported on recombinant HlSRB, a 50-kDa protein with one hydrophobic SRB domain from the hard tick, Haemaphysalis longicornis. Here, we show that HlSRB plays vital roles in granulocyte-mediated phagocytosis to invading Escherichia coli and contributes to the first-line host defense against various pathogens. Data clearly revealed that granulocytes that up-regulated the expression of cell surface HlSRB are almost exclusively involved in hemocyte-mediated phagocytosis for E. coli in ticks, and post-transcriptional silencing of the HlSRB-specific gene ablated the granulocytes' ability to phagocytose E. coli and resulted in the mortality of ticks due to high bacteremia. This is the first report demonstrating that a scavenger receptor molecule contributes to hemocyte-mediated phagocytosis against exogenous pathogens, isolated and characterized from hematophagous arthropods.	[Aung, Kyaw Min; Galay, Remil Linggatong; Tanaka, Tetsuya; Fujisaki, Kozo] Yamaguchi Univ, Dept Pathol & Prevent Vet Sci, United Grad Sch Vet Sci, Yamaguchi, Japan; [Aung, Kyaw Min; Boldbaatar, Damdinsuren; Umemiya-Shirafuji, Rika; Liao, Min; Kume, Aiko; Galay, Remil Linggatong; Tanaka, Tetsuya; Fujisaki, Kozo] Kagoshima Univ, Fac Agr, Dept Frontier Vet Med, Lab Emerging Infect Dis, Kagoshima 890, Japan; [Tsuji, Naotoshi] Natl Inst Anim Hlth, Parasit Dis Lab, Tsukuba, Ibaraki 305, Japan; [Xuan Xuenan; Suzuki, Hiroshi] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan	Yamaguchi University; Kagoshima University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Obihiro University of Agriculture & Veterinary Medicine	Aung, KM (corresponding author), Yamaguchi Univ, Dept Pathol & Prevent Vet Sci, United Grad Sch Vet Sci, Yamaguchi, Japan.	tick@ms.kagoshima-u.ac.jp	Umemiya-Shirafuji, Rika/AFT-5139-2022; Galay, Remil/AAN-4392-2021	Umemiya-Shirafuji, Rika/0000-0001-7641-5526; Galay, Remil/0000-0001-9749-8308; Damdinsuren, Boldbaatar/0000-0002-0541-3766	Japan Society for the Promotion of Science; Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology); Grants-in-Aid for Scientific Research [21380190] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant- in- Aid for Scientific Research (A) from the Japan Society for the Promotion of Science and KMA is supported by the Japanese Government (Ministry of Education, Culture, Sports, Science, and Technology) scholarship for PhD study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028407; Aung KM, 2011, PARASITOL RES, V108, P273, DOI 10.1007/s00436-010-2053-1; Baines D, 2008, CAN J MICROBIOL, V54, P984, DOI 10.1139/W08-090; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Borovickova B, 2005, EXP APPL ACAROL, V35, P317, DOI 10.1007/s10493-004-2209-8; Ceraul SM, 2002, J MED ENTOMOL, V39, P376, DOI 10.1603/0022-2585-39.2.376; DOLP RM, 1970, J MED ENTOMOL, V7, P277, DOI 10.1093/jmedent/7.3.277; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; FUJISAKI K, 1975, Applied Entomology and Zoology, V10, P30; FUJISAKI K, 1978, NATL I ANIM HEALTH Q, V18, P27; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Gudderra NP, 2002, J INSECT PHYSIOL, V48, P269, DOI 10.1016/S0022-1910(02)00050-1; Habeeb Salwa M., 2008, American-Eurasian Journal of Agricultural & Environmental Sciences, V3, P829; Inoue N, 2001, J MED ENTOMOL, V38, P514, DOI 10.1603/0022-2585-38.4.514; Kadota K, 2003, J MED ENTOMOL, V40, P770, DOI 10.1603/0022-2585-40.6.770; Kletsas D, 1998, EUR J CELL BIOL, V75, P362, DOI 10.1016/S0171-9335(98)80069-1; KUHN KH, 1994, CELL TISSUE RES, V277, P493, DOI 10.1007/BF00300222; Lackie A.M., 1988, Advances in Insect Physiology, V21, P85, DOI 10.1016/S0065-2806(08)60123-X; Liao M, 2008, INSECT BIOCHEM MOLEC, V38, P285, DOI 10.1016/j.ibmb.2007.11.006; MAENO Y, 1994, EXP PARASITOL, V79, P383, DOI 10.1006/expr.1994.1100; Marmaras VJ, 2009, CELL SIGNAL, V21, P186, DOI 10.1016/j.cellsig.2008.08.014; Matsuo T, 2004, EXP PARASITOL, V108, P67, DOI 10.1016/j.exppara.2004.07.014; Matsuo T, 2007, J VET MED SCI, V69, P317, DOI 10.1292/jvms.69.317; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; Ottaviani E, 2004, PROG MOLEC, V34, P1; Ottaviani E, 2001, COMP BIOCHEM PHYS C, V129, P295, DOI 10.1016/S1532-0456(01)00211-3; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Pereira LS, 2001, EXP PARASITOL, V99, P66, DOI 10.1006/expr.2001.4657; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Sommers CH, 2008, J FOOD SCI, V73, pM87, DOI 10.1111/j.1750-3841.2007.00647.x; Sonenshine D.E., 1991, BIOL TICKS, V1, P3; Sonenshine DE, 2008, FRONT BIOSCI-LANDMRK, V13, P7046, DOI 10.2741/3209; Sonenshine DE, 1991, BIOL TICKS, V1, P55; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Yang XQ, 2011, FOOD MICROBIOL, V28, P1478, DOI 10.1016/j.fm.2011.08.013	38	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33504	10.1371/journal.pone.0033504	http://dx.doi.org/10.1371/journal.pone.0033504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479406	gold, Green Published, Green Submitted			2022-12-27	WOS:000304523400025
J	Khan, DR; Dube, D; Gall, L; Peynot, N; Ruffini, S; Laffont, L; Le Bourhis, D; Degrelle, S; Jouneau, A; Duranthon, V				Khan, Daulat Raheem; Dube, Delphine; Gall, Laurence; Peynot, Nathalie; Ruffini, Sylvie; Laffont, Ludivine; Le Bourhis, Daniel; Degrelle, Severine; Jouneau, Alice; Duranthon, Veronique			Expression of Pluripotency Master Regulators during Two Key Developmental Transitions: EGA and Early Lineage Specification in the Bovine Embryo	PLOS ONE			English	Article							STEM-CELLS; GENE-EXPRESSION; PREIMPLANTATION EMBRYOS; SELF-RENEWAL; MOUSE; NANOG; OCT4; DIFFERENTIATION; SOX2; FERTILIZATION	Pluripotency genes are implicated in mouse embryonic genome activation (EGA) and pluripotent lineage specification. Moreover, their expression levels have been correlated with embryonic term development. In bovine, however, little information is available about dynamics of pluripotency genes during these processes. In this study, we charted quantitative and/or qualitative spatio-temporal expression patterns of transcripts and proteins of pluripotency genes (OCT4, SOX2 and NANOG) and mRNA levels of some of their downstream targets in bovine oocytes and early embryos. Furthermore, to correlate expression patterns of these genes with term developmental potential, we used cloned embryos, having similar in vitro but different full term development rates. Our findings affirm: firstly, the core triad of pluripotency genes is probably not implicated in bovine EGA since their proteins were not detected during pre-EGA phase, despite the transcripts for OCT4 and SOX2 were present. Secondly, an earlier ICM specification of transcripts and proteins of SOX2 and NANOG makes them pertinent candidates of bovine pluripotent lineage specification than OCT4. Thirdly, embryos with low term development potential have higher transcription rates; nevertheless, precarious balance between pluripotency genes is maintained. This balance presages normal in vitro development but, probably higher transcription rate disturbs it at later stage that abrogates term development.	[Khan, Daulat Raheem; Dube, Delphine; Gall, Laurence; Peynot, Nathalie; Ruffini, Sylvie; Laffont, Ludivine; Le Bourhis, Daniel; Degrelle, Severine; Jouneau, Alice; Duranthon, Veronique] INRA, UMR Biol Dev & Reprod 1198, Jouy En Josas, France; [Khan, Daulat Raheem; Dube, Delphine; Gall, Laurence; Peynot, Nathalie; Ruffini, Sylvie; Laffont, Ludivine; Le Bourhis, Daniel; Degrelle, Severine; Jouneau, Alice; Duranthon, Veronique] ENVA, Maisons Alfort, France; [Le Bourhis, Daniel] UNCEIA, Serv Tech, Maisons Alfort, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ecole Nationale Veterinaire d'Alfort (ENVA); Ecole Nationale Veterinaire d'Alfort (ENVA)	Khan, DR (corresponding author), INRA, UMR Biol Dev & Reprod 1198, Jouy En Josas, France.	veronique.duranthon@jouy.inra.fr	Degrelle, Severine/AAC-1726-2020; Duranthon, Véronique/D-8855-2019	Degrelle, Severine/0000-0001-6263-4875; Duranthon, Véronique/0000-0001-8120-7481; Jouneau, Alice/0000-0001-5985-9862	PHysiologie Animale et Systeme d'Elevage (PHASE) department of Institut National de la Recherche Agronomique (INRA), France; Higher Education Commission (HEC) of Pakistan; INRA PHASE department	PHysiologie Animale et Systeme d'Elevage (PHASE) department of Institut National de la Recherche Agronomique (INRA), France; Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan); INRA PHASE department	The funds for this research were provided by the PHysiologie Animale et Systeme d'Elevage (PHASE) department of Institut National de la Recherche Agronomique (INRA), France. Dr. Khan had a PhD scholarship from the Higher Education Commission (HEC) of Pakistan and the INRA PHASE department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Berg DK, 2011, DEV CELL, V20, P244, DOI 10.1016/j.devcel.2011.01.003; Betts DH, 2001, THERIOGENOLOGY, V55, P171, DOI 10.1016/S0093-691X(00)00453-2; Beyhan Z, 2007, DEV BIOL, V305, P637, DOI 10.1016/j.ydbio.2007.01.041; Bui LC, 2009, REPRODUCTION, V138, P289, DOI 10.1530/REP-09-0042; Cao SB, 2009, J EXP ZOOL PART A, V311A, P368, DOI 10.1002/jez.535; Dahl JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009150; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Degrelle SA, 2005, DEV BIOL, V288, P448, DOI 10.1016/j.ydbio.2005.09.043; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Foygel K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004109; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Hall VJ, 2009, DEV DYNAM, V238, P2014, DOI 10.1002/dvdy.22027; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; He SY, 2006, MOL REPROD DEV, V73, P1512, DOI 10.1002/mrd.20525; Hue I, 2001, DEV GENES EVOL, V211, P157, DOI 10.1007/s004270100138; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kato Y, 2010, INT J DEV BIOL, V54, P1623, DOI 10.1387/ijdb.103203yk; Keramari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013952; Kirchhof N, 2000, BIOL REPROD, V63, P1698, DOI 10.1095/biolreprod63.6.1698; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Kurosaka S, 2004, BIOL REPROD, V71, P1578, DOI 10.1095/biolreprod.104.029322; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Li XP, 2005, MOL REPROD DEV, V72, P152, DOI 10.1002/mrd.20346; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Martinez-Barbera JP, 2000, DEV BIOL, V223, P422, DOI 10.1006/dbio.2000.9757; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Pan H, 2010, BIOL REPROD; Pan H, 2011, BIOL REPROD, V85, P409, DOI 10.1095/biolreprod.111.090886; Pant D, 2009, CLONING STEM CELLS, V11, P355, DOI 10.1089/clo.2008.0078; PARRISH JJ, 1986, THERIOGENOLOGY, V25, P591, DOI 10.1016/0093-691X(86)90143-3; PAVLOK A, 1989, REPROD NUTR DEV, V29, P611, DOI 10.1051/rnd:19890510; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Renard JP, 2007, THERIOGENOLOGY, V68, pS196, DOI 10.1016/j.theriogenology.2007.05.060; ROBERTSON I., 1998, MANUAL INT EMBRYO TR; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shi W, 2003, DIFFERENTIATION, V71, P91, DOI 10.1046/j.1432-0436.2003.710201.x; Smith SL, 2005, P NATL ACAD SCI USA, V102, P17582, DOI 10.1073/pnas.0508952102; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; van Eijk MJT, 1999, BIOL REPROD, V60, P1093, DOI 10.1095/biolreprod60.5.1093; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Weisheit G, 2002, DEV GENES EVOL, V212, P403, DOI 10.1007/s00427-002-0258-8; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	57	80	81	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34110	10.1371/journal.pone.0034110	http://dx.doi.org/10.1371/journal.pone.0034110			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479535	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400056
J	Unsworth, RKF; Rasheed, MA; Chartrand, KM; Roelofs, AJ				Unsworth, Richard K. F.; Rasheed, Michael A.; Chartrand, Kathryn M.; Roelofs, Anthony J.			Solar Radiation and Tidal Exposure as Environmental Drivers of Enhalus acoroides Dominated Seagrass Meadows	PLOS ONE			English	Article							ZOSTERA-CAPRICORNI; PHOTOSYNTHETIC TOLERANCES; THALASSIA-HEMPRICHII; COMMUNITY STRUCTURE; SEASONAL-CHANGES; CAIRNS HARBOR; BIOMASS; DESICCATION; QUEENSLAND; RESPONSES	There is strong evidence of a global long-term decline in seagrass meadows that is widely attributed to anthropogenic activity. Yet in many regions, attributing these changes to actual activities is difficult, as there exists limited understanding of the natural processes that can influence these valuable ecosystem service providers. Being able to separate natural from anthropogenic causes of seagrass change is important for developing strategies that effectively mitigate and manage anthropogenic impacts on seagrass, and promote coastal ecosystems resilient to future environmental change. The present study investigated the influence of environmental and climate related factors on seagrass biomass in a large approximate to 250 ha meadow in tropical north east Australia. Annual monitoring of the intertidal Enhalus acoroides (L.f.) Royle seagrass meadow over eleven years revealed a declining trend in above-ground biomass (54% significant overall reduction from 2000 to 2010). Partial Least Squares Regression found this reduction to be significantly and negatively correlated with tidal exposure, and significantly and negatively correlated with the amount of solar radiation. This study documents how natural long-term tidal variability can influence long-term seagrass dynamics. Exposure to desiccation, high UV, and daytime temperature regimes are discussed as the likely mechanisms for the action of these factors in causing this decline. The results emphasise the importance of understanding and assessing natural environmentally-driven change when interpreting the results of seagrass monitoring programs.	[Unsworth, Richard K. F.] Swansea Univ, Coll Sci, Ctr Sustainable Aquat Res, Swansea, W Glam, Wales; [Rasheed, Michael A.; Chartrand, Kathryn M.; Roelofs, Anthony J.] Fisheries Queensland, No Fisheries Ctr, Cairns, Australia	Swansea University	Unsworth, RKF (corresponding author), Swansea Univ, Coll Sci, Ctr Sustainable Aquat Res, Swansea, W Glam, Wales.	r.k.f.unsworth@swansea.ac.uk	Chartrand, Kathryn/B-7695-2014; Rasheed, Michael Alan/ABA-7716-2020; Unsworth, Richard K.F./C-1266-2009; Rasheed, Michael/B-7698-2014	Chartrand, Kathryn/0000-0002-0030-961X; Rasheed, Michael Alan/0000-0002-8316-7644; Unsworth, Richard K.F./0000-0003-0036-9724; Rasheed, Michael/0000-0002-8316-7644				Anthony KRN, 2007, MAR BIOL, V151, P1623, DOI 10.1007/s00227-006-0573-0; Bjork M, 1999, MAR ECOL PROG SER, V191, P121, DOI 10.3354/meps191121; BOM, 2011, AUSTR FED BUR MET; BROUNS JJWM, 1986, AQUAT BOT, V25, P21, DOI 10.1016/0304-3770(86)90038-0; BROUNS JJWM, 1987, AQUAT BOT, V27, P333, DOI 10.1016/0304-3770(87)90073-8; Burdick DM, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P79, DOI 10.1016/B978-044450891-1/50005-0; Campbell SJ, 2006, J EXP MAR BIOL ECOL, V330, P455, DOI 10.1016/j.jembe.2005.09.017; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Chartrand KM, 2009, DPI F PUBLICATION; COLES RG, 1993, AUST J MAR FRESH RES, V44, P193; Collier CJ, 2012, MAR POLLUT BULL, V65, P342, DOI 10.1016/j.marpolbul.2011.06.017; Collier CJ, 2011, LIMNOL OCEANOGR, V56, P2200, DOI 10.4319/lo.2011.56.6.2200; Demmig-Adams B, 2004, PHOTOCHEMISTRY CAROT; Erftemeijer PLA, 2006, MAR POLLUT BULL, V52, P1553, DOI 10.1016/j.marpolbul.2006.09.006; ERFTEMEIJER PLA, 1994, OECOLOGIA, V99, P45, DOI 10.1007/BF00317082; Figueroa FL, 2002, MAR ECOL PROG SER, V230, P59, DOI 10.3354/meps230059; Haapkyla J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016893; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Hall MO, 1999, ESTUARIES, V22, P445, DOI 10.2307/1353210; Hemminga MA, SEAGRASS ECOLOGY; IPCC, 2007, CLIM CHANG 2007 PHYS; Kahn AE, 2009, AQUAT BOT, V90, P195, DOI 10.1016/j.aquabot.2008.07.003; KIRKMAN H, 1978, AQUAT BOT, V5, P63, DOI 10.1016/0304-3770(78)90047-5; Koch MS, 2007, J EXP MAR BIOL ECOL, V341, P91, DOI 10.1016/j.jembe.2006.10.004; McArthur LC, 2006, ECOL MODEL, V196, P163, DOI 10.1016/j.ecolmodel.2006.02.030; McKenzie LJ, 2001, GLOBAL SEAGRASS RESEARCH METHODS, P101, DOI 10.1016/B978-044450891-1/50006-2; MCKENZIE LJ, 1994, AUST J MAR FRESH RES, V45, P1337, DOI 10.1071/MF9941337; MELLORS JE, 1991, AQUAT BOT, V42, P67, DOI 10.1016/0304-3770(91)90106-F; NIENHUIS PH, 1989, NETH J SEA RES, V23, P197, DOI 10.1016/0077-7579(89)90014-8; Ort DR, 2001, PLANT PHYSIOL, V125, P29, DOI 10.1104/pp.125.1.29; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; POLLARD PC, 1993, AUST J MAR FRESH RES, V44, P127; RALPH PJ, 1995, AQUAT BOT, V51, P55, DOI 10.1016/0304-3770(95)00456-A; Rasheed MA, 2004, J EXP MAR BIOL ECOL, V310, P13, DOI 10.1016/j.jembe.2004.03.022; Rasheed MA, 1999, J EXP MAR BIOL ECOL, V235, P183, DOI 10.1016/S0022-0981(98)00158-0; Rasheed MA, 2011, MAR ECOL PROG SER, V422, P93, DOI 10.3354/meps08925; Seddon S, 2000, AQUAT BOT, V66, P297, DOI 10.1016/S0304-3770(99)00080-7; Short FT, 1999, AQUAT BOT, V63, P169, DOI 10.1016/S0304-3770(98)00117-X; Stapel J, 1997, MAR ECOL PROG SER, V148, P251, DOI 10.3354/meps148251; Tanaka Y, 2004, MAR ECOL PROG SER, V284, P117, DOI 10.3354/meps284117; Taylor HA, 2011, MAR POLLUT BULL, V63, P431, DOI 10.1016/j.marpolbul.2011.04.039; Terrados J, 1998, ESTUAR COAST SHELF S, V46, P757, DOI 10.1006/ecss.1997.0304; TROCINE RP, 1981, PLANT PHYSIOL, V68, P74, DOI 10.1104/pp.68.1.74; Unsworth RKF, 2007, MAR FRESHWATER RES, V58, P1008, DOI 10.1071/MF07058; Unsworth RKF, 2010, OCEAN COAST MANAGE, V53, P218, DOI 10.1016/j.ocecoaman.2010.04.002; Unsworth RKF, 2010, CONSERV LETT, V3, P63, DOI 10.1111/j.1755-263X.2010.00101.x; Unsworth RKF, 2009, AQUAT BIOL, V5, P85, DOI 10.3354/ab00139; Valentine JF, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P463; Waycott M., 2007, CLIMATE CHANGE GREAT, P193; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WORREST RC, 1989, ENVIRON CONSERV, V16, P261, DOI 10.1017/S0376892900009358; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	52	25	25	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34133	10.1371/journal.pone.0034133	http://dx.doi.org/10.1371/journal.pone.0034133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479541	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000304523400057
J	Han, J; Chen, JN; Zhang, ZG; Li, HG; Ding, YG; Du, H; Shao, CK				Han, Jing; Chen, Jian-ning; Zhang, Zhi-gang; Li, Hai-gang; Ding, Yun-gang; Du, Hong; Shao, Chun-kui			Sequence Variations of Latent Membrane Protein 2A in Epstein-Barr Virus-Associated Gastric Carcinomas from Guangzhou, Southern China	PLOS ONE			English	Article							T-CELL RESPONSES; NASOPHARYNGEAL CARCINOMA; GENE-EXPRESSION; STUMP CANCER; CTL EPITOPES; EBV; LMP2A; PREVALENCE; ADENOCARCINOMAS; IDENTIFICATION	Latent membrane protein 2A (LMP2A), expressed in most Epstein-Barr virus (EBV)-associated malignancies, has been demonstrated to be responsible for the maintenance of latent infection and epithelial cell transformation. Besides, it could also act as the target for a CTL-based therapy for EBV-associated malignancies. In the present study, sequence variations of LMP2A in EBV-associated gastric carcinoma (EBVaGC) and healthy EBV carriers from Guangzhou, southern China, where nasopharyngeal carcinoma (NPC) is endemic, were investigated. Widespread sequence variations in the LMP2A gene were found, with no sequence identical to the B95.8 prototype. No consistent mutation was detected in all isolates. The immunoreceptor tyrosine-based activation motif (ITAM) and PY motifs in the amino terminus of LMP2A were strictly conserved, suggesting their important roles in virus infection; while 8 of the 17 identified CTL epitopes in the transmembrane region of LMP2A were affected by at least one point mutation, which may implicate that the effect of LMP2A polymorphisms should be considered when LMP2A-targeted immunotherapy is conducted. The polymorphisms of LMP2A in EBVaGC in gastric remnant carcinoma (GRC) were for the first time investigated in the world. The LMP2A sequence variations in EBVaGC in GRC were somewhat different from those in EBVaGC in conventional gastric carcinoma. The sequence variations of LMP2A in EBVaGC were similar to those in throat washing of healthy EBV carriers, indicating that these variations are due to geographic-associated polymorphisms rather than EBVaGC-associated mutations. This, to our best knowledge, is the first detailed investigation of LMP2A polymorphisms in EBVaGC in Guangzhou, southern China, where NPC is endemic.	[Han, Jing; Chen, Jian-ning; Zhang, Zhi-gang; Ding, Yun-gang; Shao, Chun-kui] Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Li, Hai-gang] Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 2, Guangzhou 510275, Guangdong, Peoples R China; [Du, Hong] Guangzhou First Municipal Peoples Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; South China University of Technology	Han, J (corresponding author), Zhengzhou Univ, Henan Key Lab Tumor Pathol, Dept Pathol, Affiliated Hosp 1, Zhengzhou, Henan Province, Peoples R China.	chunkuishao2011@163.com			National Natural Science Foundation of China [30672409, 81071893]; Guangdong Natural Science Foundation [8151008901000132, 05001748]; Guangdong Science and Technology Project [2009B060700034]; Guangzhou Science and Technology Project, Guangdong Province, China [11C22060745]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Science and Technology Project; Guangzhou Science and Technology Project, Guangdong Province, China	This work was supported by the National Natural Science Foundation of China (Nos. 30672409 and 81071893; http://www.nsfc.gov.cn/), the Guangdong Natural Science Foundation (Nos. 8151008901000132 and 05001748; http://gdsf.gdstc.gov.cn/), the Guangdong Science and Technology Project (No. 2009B060700034; http://pro4.gdstc.gov.cn/stms/main.jsp), and the Guangzhou Science and Technology Project (No. 11C22060745; http://www.gzsi.gov.cn/), Guangdong Province, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba S, 2008, CANCER SCI, V99, P195, DOI 10.1111/j.1349-7006.2007.00674.x; Baas IO, 1998, J CLIN PATHOL, V51, P662, DOI 10.1136/jcp.51.9.662; BUSSON P, 1995, J GEN VIROL, V76, P139, DOI 10.1099/0022-1317-76-1-139; Chang MS, 2000, PATHOL INT, V50, P486, DOI 10.1046/j.1440-1827.2000.01072.x; Chen JN, 2011, VIRUS RES, V160, P191, DOI 10.1016/j.virusres.2011.06.011; Chen JN, 2010, J MED VIROL, V82, P658, DOI 10.1002/jmv.21731; DECAMPOSLIMA PO, 1993, SCIENCE, V260, P98, DOI 10.1126/science.7682013; DECAMPOSLIMA PO, 1994, J EXP MED, V179, P1297, DOI 10.1084/jem.179.4.1297; EPSTEIN MA, 1964, LANCET, V1, P702, DOI 10.1016/s0140-6736(64)91524-7; Fox CP, 2010, BLOOD, V116, P3695, DOI 10.1182/blood-2010-06-292268; FRANKEN M, 1995, J VIROL, V69, P8011, DOI 10.1128/JVI.69.12.8011-8019.1995; Fruehling S, 1997, VIROLOGY, V235, P241, DOI 10.1006/viro.1997.8690; Fukuda M, 2004, J VIROL, V78, P1697, DOI 10.1128/JVI.78.4.1697-1705.2004; Hino R, 2008, CANCER RES, V68, P1427, DOI 10.1158/0008-5472.CAN-07-3027; Hino R, 2009, CANCER RES, V69, P2766, DOI 10.1158/0008-5472.CAN-08-3070; Ikeda A, 2003, J VIROL, V77, P5529, DOI 10.1128/JVI.77.9.5529-5534.2003; International Agency for Research on Cancer WHO, 1997, IARC MON EV CARC RIS, V70, P255; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Khanna R, 1999, IMMUNOL REV, V170, P49, DOI 10.1111/j.1600-065X.1999.tb01328.x; Kong QL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000940; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee JH, 2009, J GASTROEN HEPATOL, V24, P354, DOI 10.1111/j.1440-1746.2009.05775.x; Lee SP, 1997, J IMMUNOL, V158, P3325; Liu GY, 2009, CELL MOL IMMUNOL, V6, P423, DOI 10.1038/cmi.2009.54; Longnecker R, 2000, ADV CANCER RES, V79, P175, DOI 10.1016/S0065-230X(00)79006-3; LUNG ML, 1990, VIROLOGY, V177, P44, DOI 10.1016/0042-6822(90)90458-4; LUNG ML, 1991, VIROLOGY, V185, P67, DOI 10.1016/0042-6822(91)90754-Y; Luo B, 2005, WORLD J GASTROENTERO, V11, P629, DOI 10.3748/wjg.v11.i5.629; Meij P, 2002, INT J CANCER, V99, P93, DOI 10.1002/ijc.10309; MILLER CL, 1994, P NATL ACAD SCI USA, V91, P772, DOI 10.1073/pnas.91.2.772; Murphy G, 2009, GASTROENTEROLOGY, V137, P824, DOI 10.1053/j.gastro.2009.05.001; Redchenko IV, 1999, J VIROL, V73, P334, DOI 10.1128/JVI.73.1.334-342.1999; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; ROWE M, 1987, EMBO J, V6, P2743, DOI 10.1002/j.1460-2075.1987.tb02568.x; Safatle-Ribeiro AV, 1998, DIGEST DIS, V16, P159, DOI 10.1159/000016860; Saiki Y, 1996, LAB INVEST, V75, P67; Scholle F, 2000, J VIROL, V74, P10681, DOI 10.1128/JVI.74.22.10681-10689.2000; Sinning C, 2007, EJSO-EUR J SURG ONC, V33, P133, DOI 10.1016/j.ejso.2006.09.006; Snyder MD, 2006, TRAFFIC, V7, P993, DOI 10.1111/j.1600-0854.2006.00450.x; Sugiura M, 1996, BRIT J CANCER, V74, P625, DOI 10.1038/bjc.1996.412; Tanaka M, 1999, VIRUS GENES, V19, P103, DOI 10.1023/A:1008171006400; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; TOKUNAGA M, 1993, AM J PATHOL, V143, P1250; Uozaki H, 2008, INT J CLIN EXP PATHO, V1, P198; van Beek J, 2006, AM J SURG PATHOL, V30, P59, DOI 10.1097/01.pas.0000176428.06629.1e; van Beek J, 2004, J CLIN ONCOL, V22, P664, DOI 10.1200/JCO.2004.08.061; Wang B, 2009, CELL MOL IMMUNOL, V6, P97, DOI 10.1038/cmi.2009.13; Wang XA, 2010, J GEN VIROL, V91, P2564, DOI 10.1099/vir.0.021881-0; Whitney BM, 2002, J MED VIROL, V67, P359, DOI 10.1002/jmv.10073; YAMAMOTO N, 1994, CANCER, V74, P805, DOI 10.1002/1097-0142(19940801)74:3<805::AID-CNCR2820740304>3.0.CO;2-L; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zeng MS, 2005, J VIROL, V79, P15323, DOI 10.1128/JVI.79.24.15323-15330.2005; zur Hausen A, 2000, CANCER RES, V60, P2745	54	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34276	10.1371/journal.pone.0034276	http://dx.doi.org/10.1371/journal.pone.0034276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470549	Green Submitted, Green Published, gold			2022-12-27	WOS:000304489000088
J	Hoch, DB; Watson, AJ; Linton, DA; Bello, HE; Senelly, M; Milik, MT; Baim, MA; Jethwani, K; Fricchione, GL; Benson, H; Kvedar, JC				Hoch, Daniel B.; Watson, Alice J.; Linton, Deborah A.; Bello, Heather E.; Senelly, Marco; Milik, Mariola T.; Baim, Margaret A.; Jethwani, Kamal; Fricchione, Gregory L.; Benson, Herbert; Kvedar, Joseph C.			The Feasibility and Impact of Delivering a Mind-Body Intervention in a Virtual World	PLOS ONE			English	Article							RELAXATION RESPONSE; BEHAVIORAL TREATMENT; INTERNET; MEDITATION; PROGRAM; DISEASE; STRESS; TRIAL	Introduction: Mind-body medical approaches may ameliorate chronic disease. Stress reduction is particularly helpful, but face-to-face delivery systems cannot reach all those who might benefit. An online, 3-dimensional virtual world may be able to support the rich interpersonal interactions required of this approach. In this pilot study, we explore the feasibility of translating a face-to-face stress reduction program into an online virtual setting and estimate the effect size of the intervention. Methods and Findings: Domain experts in virtual world technology joined with mind body practitioners to translate an existing 8 week relaxation response-based resiliency program into an 8-week virtual world-based program in Second Life (TM) (SL). Twenty-four healthy volunteers with at least one month's experience in SL completed the program. Each subject filled out the Perceived Stress Scale (PSS) and the Symptom Checklist 90-Revised (SCL-90-R) before and after taking part. Participants took part in one of 3 groups of about 10 subjects. The participants found the program to be helpful and enjoyable. Many reported that the virtual environment was an excellent substitute for the preferred face-to-face approach. On quantitative measures, there was a general trend toward decreased perceived stress, (15.7 to 15.0), symptoms of depression, (57.6 to 57.0) and anxiety (56.8 to 54.8). There was a significant decrease of 2.8 points on the SCL-90-R Global Severity Index (p < 0.05). Conclusions: This pilot project showed that it is feasible to deliver a typical mind-body medical intervention through a virtual environment and that it is well received. Moreover, the small reduction in psychological distress suggests further research is warranted. Based on the data collected for this project, a randomized trial with less than 50 subjects would be appropriately powered if perceived stress is the primary outcome.	[Hoch, Daniel B.; Milik, Mariola T.; Baim, Margaret A.; Fricchione, Gregory L.; Benson, Herbert] Benson Henry Inst Mind Body Med, Boston, MA USA; [Jethwani, Kamal; Kvedar, Joseph C.] Partners Healthcare, Ctr Connected Hlth, Boston, MA USA; [Hoch, Daniel B.; Watson, Alice J.; Jethwani, Kamal; Fricchione, Gregory L.; Kvedar, Joseph C.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hoch, Daniel B.; Baim, Margaret A.; Jethwani, Kamal; Fricchione, Gregory L.; Benson, Herbert; Kvedar, Joseph C.] Harvard Univ, Sch Med, Boston, MA USA; [Bello, Heather E.] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Linton, Deborah A.] Hlth 20, San Francisco, CA USA; [Senelly, Marco] OneVis Solut Inc, Austin, TX USA	Partners Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Hoch, DB (corresponding author), Benson Henry Inst Mind Body Med, Boston, MA USA.	dhoch@partners.org		Hoch, Daniel/0000-0002-4294-024X; Milik, Mariola/0000-0002-5859-4935	Partners Healthcare Information Systems Research Council	Partners Healthcare Information Systems Research Council	This research was supported by a grant from the Partners Healthcare Information Systems Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard L, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1192; BEARY JF, 1974, PSYCHOSOM MED, V36, P115, DOI 10.1097/00006842-197403000-00003; Bee PE, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-60; BENSON H, 1975, LANCET, V2, P380, DOI 10.1016/S0140-6736(75)92895-0; BENSON H, 1978, PSYCHOTHER PSYCHOSOM, V30, P229, DOI 10.1159/000287304; BENSON H, 1974, PSYCHIATRY, V37, P37, DOI 10.1080/00332747.1974.11023785; BENSON H, 1978, J HUM STRESS, V4, P38, DOI 10.1080/0097840X.1978.9934985; Boulos MNK, 2007, HEALTH INFO LIBR J, V24, P233, DOI [10.1111/j.1471-1842.2007.00733.x, 10.1111/J.1471-1842.2007.00733.x]; Cannon WB., BODILY CHANGES PAIN, DOI [10.1037/10013-000, DOI 10.1037/10013-000]; Carlbring P, 2003, J BEHAV THER EXP PSY, V34, P129, DOI 10.1016/S0005-7916(03)00026-0; CAUDILL M, 1991, CLIN J PAIN, V7, P305, DOI 10.1097/00002508-199112000-00009; Christensen H, 2004, BRIT MED J, V328, P265, DOI 10.1136/bmj.37945.566632.EE; Cohen S, 2011, J APPL SOCI IN PRESS; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Cuijpers P, 2008, J BEHAV MED, V31, P169, DOI 10.1007/s10865-007-9144-1; DOMAR AD, 1990, FERTIL STERIL, V53, P246; Esch Tobias, 2003, Med Sci Monit, V9, pRA23; GOODALE IL, 1990, OBSTET GYNECOL, V75, P649; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Holzel BK, 2010, SOC COGN AFFECT NEUR, V5, P11, DOI 10.1093/scan/nsp034; HOFFMAN JW, 1982, SCIENCE, V215, P190, DOI 10.1126/science.7031901; Jacobs GD, 1996, BIOFEEDBACK SELF-REG, V21, P121, DOI 10.1007/BF02284691; JACOBS GD, 1993, BEHAV MODIF, V17, P498, DOI 10.1177/01454455930174005; Jacobs GD, 2001, J ALTERN COMPLEM MED, V7, pS93; Jacobs GD, 1996, AM J MED, V100, P212, DOI 10.1016/S0002-9343(97)89461-2; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lazar SW, 2000, NEUROREPORT, V11, P1581, DOI 10.1097/00001756-200005150-00041; Mandle C L, 1996, J Cardiovasc Nurs, V10, P4; Samuelson M, 2010, J ALTERN COMPLEM MED, V16, P187, DOI 10.1089/acm.2009.0142; Stefano GB, 2001, PHARMACOL RES, V43, P199, DOI 10.1006/phrs.2000.0765; WALLACE RK, 1971, AM J PHYSIOL, V221, P795, DOI 10.1152/ajplegacy.1971.221.3.795	31	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33843	10.1371/journal.pone.0033843	http://dx.doi.org/10.1371/journal.pone.0033843			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948FM	22470483	gold, Green Published			2022-12-27	WOS:000304489000039
J	Qi, X; Flick, MJ; Frederick, M; Chu, Z; Mason, R; Delay, M; Thornton, S				Qi, Xiaoyang; Flick, Matthew J.; Frederick, Malinda; Chu, Zhengtao; Mason, Rachel; DeLay, Monica; Thornton, Sherry			Saposin C Coupled Lipid Nanovesicles Specifically Target Arthritic Mouse Joints for Optical Imaging of Disease Severity	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; NEAR-INFRARED FLUORESCENCE; EARLY RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; EFFECTOR PHASE; MODEL; RECEPTOR; NEUTROPHIL; ACTIVATION; THERAPY	Rheumatoid arthritis is a chronic inflammatory disease affecting approximately 1% of the population and is characterized by cartilage and bone destruction ultimately leading to loss of joint function. Early detection and intervention of disease provides the best hope for successful treatment and preservation of joint mobility and function. Reliable and non-invasive techniques that accurately measure arthritic disease onset and progression are lacking. We recently developed a novel agent, SapC-DOPS, which is composed of the membrane-associated lysosomal protein saposin C (SapC) incorporated into 1,2-dioleoyl-sn-glycero-3-phospho-L-serine (DOPS) lipid nanovesicles. SapC-DOPS has a high fusogenic affinity for phosphatidylserine-enriched microdomains on surfaces of target cell membranes. Incorporation of a far-red fluorophore, CellVue Maroon (CVM), into the nanovesicles allows for in vivo non-invasive visualization of the agent in targeted tissue. Given that phosphatidylserine is present only on the inner leaflet of healthy plasma membranes but is "flipped'' to the outer leaflet upon cell damage, we hypothesized that SapC-DOPS would target tissue damage associated with inflammatory arthritis due to local surface-exposure of phosphatidylserine. Optical imaging with SapC-DOPS-CVM in two distinct models of arthritis, serum-transfer arthritis (e.g., K/BxN) and collagen-induced arthritis (CIA) revealed robust SapC-DOPS-CVM specific localization to arthritic paws and joints in live animals. Importantly, intensity of localized fluorescent signal correlated with macroscopic arthritic disease severity and increased with disease progression. Flow cytometry of cells extracted from arthritic joints demonstrated that SapC-DOPS-CVM localized to an average of 7-8% of total joint cells and primarily to CD11b+Gr-1+ cells. Results from the current studies strongly support the application of SapC-DOPS-CVM for advanced clinical and research applications including: detecting early arthritis onset, assessing disease progression real-time in live subjects, and providing novel information regarding cell types that may mediate arthritis progression within joints.	[Qi, Xiaoyang; Chu, Zhengtao] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Internal Med,Div Hematol Oncol, Cincinnati, OH 45221 USA; [Qi, Xiaoyang; Flick, Matthew J.; Frederick, Malinda; Chu, Zhengtao; Mason, Rachel; DeLay, Monica; Thornton, Sherry] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH USA; [Qi, Xiaoyang; Frederick, Malinda] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Internal Med,Div Human Genet, Cincinnati, OH USA; [Frederick, Malinda; Mason, Rachel; DeLay, Monica; Thornton, Sherry] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Internal Med,Div Rheumatol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Qi, X (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Dept Internal Med,Div Hematol Oncol, Cincinnati, OH 45221 USA.	sherry.thornton@cchmc.org			Institutional Clinical and Translational Science Award; National Institutes of Health/National Center for Research Resources (NIH/NCRR) [5UL1RR026314-02]; Cincinnati Rheumatic Disease Core Center [NIH AR47363]; NATIONAL CANCER INSTITUTE [R01CA158372] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR026314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR047363] Funding Source: NIH RePORTER	Institutional Clinical and Translational Science Award; National Institutes of Health/National Center for Research Resources (NIH/NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Center for Research Resources (NCRR)); Cincinnati Rheumatic Disease Core Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by an Institutional Clinical and Translational Science Award, National Institutes of Health/National Center for Research Resources (NIH/NCRR) grant number 5UL1RR026314-02 and the Cincinnati Rheumatic Disease Core Center grant NIH AR47363. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KE, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717137; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Cascao R, 2010, AUTOIMMUN REV, V9, P531, DOI 10.1016/j.autrev.2009.12.013; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Chen WT, 2005, ARTHRITIS RES THER, V7, pR310, DOI 10.1186/ar1483; Cho YG, 2007, AUTOIMMUN REV, V7, P65, DOI 10.1016/j.autrev.2007.08.001; Egan CE, 2008, IMMUNOL RES, V40, P35, DOI 10.1007/s12026-007-0061-8; Elliott ER, 2011, J IMMUNOL, V187, P4319, DOI 10.4049/jimmunol.1100341; Fadeel B, 2010, BIOCHEM BIOPH RES CO, V396, P7, DOI 10.1016/j.bbrc.2010.02.106; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Fischer T, 2010, ACAD RADIOL, V17, P375, DOI 10.1016/j.acra.2009.09.016; Flick MJ, 2007, J CLIN INVEST, V117, P3224, DOI 10.1172/JCI30134; Foster W, 2011, EUR J CLIN INVEST; Fouque-Aubert A, 2010, JOINT BONE SPINE, V77, P212, DOI 10.1016/j.jbspin.2009.08.009; Golovko Daniel, 2011, Int J Clin Rheumtol, V6, P67, DOI 10.2217/ijr.10.105; Gompels LL, 2011, ARTHRITIS RHEUM-US, V63, P107, DOI 10.1002/art.30082; Gompels LL, 2010, RHEUMATOLOGY, V49, P1436, DOI 10.1093/rheumatology/keq012; Grant EP, 2002, J EXP MED, V196, P1461, DOI 10.1084/jem.20020205; Hansch A, 2004, ARTHRITIS RHEUM-US, V50, P961, DOI 10.1002/art.20112; Hoek RM, 2010, ARTHRITIS RHEUM-US, V62, P1036, DOI 10.1002/art.27347; Holmdahl R, 2002, AGEING RES REV, V1, P135, DOI 10.1016/S0047-6374(01)00371-2; Jakus Z, 2009, J EXP MED, V206, P577, DOI 10.1084/jem.20081859; Kaimal V, 2011, MOL IMAGING BIOL, V13, P886, DOI 10.1007/s11307-010-0417-7; Katz JD, 2009, ANN NY ACAD SCI, V1154, P10, DOI 10.1111/j.1749-6632.2009.04381.x; KEFFER J, 1991, EMBO J, V10, P4025, DOI 10.1002/j.1460-2075.1991.tb04978.x; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Kubassova O, 2009, ANN NY ACAD SCI, V1154, P207, DOI 10.1111/j.1749-6632.2009.04392.x; Kyburz D, 2003, SPRINGER SEMIN IMMUN, V25, P79, DOI 10.1007/s00281-003-0131-5; Latham KA, 2005, J IMMUNOL, V174, P3978, DOI 10.4049/jimmunol.174.7.3978; Link TM, 2011, INT J CLIN RHEUMATOL, V6, P1; Marshall Milton V, 2010, Open Surg Oncol J, V2, P12; Miesel R, 1996, FREE RADICAL BIO MED, V20, P75, DOI 10.1016/0891-5849(95)02026-8; Monach PA, 2010, ARTHRITIS RHEUM-US, V62, P753, DOI 10.1002/art.27238; Moura RA, 2011, RHEUMATOLOGY, V50, P278, DOI 10.1093/rheumatology/keq338; Nandakumar KS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2089; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Paulos CM, 2004, ADV DRUG DELIVER REV, V56, P1205, DOI 10.1016/j.addr.2004.01.012; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Qi XY, 2009, CLIN CANCER RES, V15, P5840, DOI 10.1158/1078-0432.CCR-08-3285; Qi XY, 2001, J BIOL CHEM, V276, P27010, DOI 10.1074/jbc.M101075200; Raichel L, 2008, EUR J IMMUNOL, V38, P2905, DOI 10.1002/eji.200838545; Sasmono RT, 2007, J LEUKOCYTE BIOL, V82, P111, DOI 10.1189/jlb.1206713; Sevick-Muraca EM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2953185; Silverman GJ, 2008, IMMUNOL REV, V223, P175, DOI 10.1111/j.1600-065X.2008.00627.x; Sokka T, 2009, RHEUM DIS CLIN N AM, V35, P713, DOI 10.1016/j.rdc.2009.10.004; Thornton S, 2002, CLIN IMMUNOL, V105, P155, DOI 10.1006/clim.2002.5227; van Dam GM, 2011, NAT MED, V17, P1315, DOI 10.1038/nm.2472; van den Berg WB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2803; Weinmann P, 2007, CLIN EXP RHEUMATOL, V25, P885; Wright HL, 2010, RHEUMATOLOGY, V49, P1618, DOI 10.1093/rheumatology/keq045	50	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33966	10.1371/journal.pone.0033966	http://dx.doi.org/10.1371/journal.pone.0033966			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470501	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000047
J	Chen, LL; Chung, WC; Lin, CP; Kuo, CH				Chen, Ling-Ling; Chung, Wan-Chia; Lin, Chan-Pin; Kuo, Chih-Horng			Comparative Analysis of Gene Content Evolution in Phytoplasmas and Mycoplasmas	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; DELETIONAL BIAS; BACTERIAL; IDENTIFICATION; DATABASE; INSECT; PYROPHOSPHATASE; ENCYCLOPEDIA; AGALACTIAE; INFERENCE	Phytoplasmas and mycoplasmas are two groups of important pathogens in the bacterial class Mollicutes. Because of their economical and clinical importance, these obligate pathogens have attracted much research attention. However, difficulties involved in the empirical study of these bacteria, particularly the fact that phytoplasmas have not yet been successfully cultivated outside of their hosts despite decades of attempts, have greatly hampered research progress. With the rapid advancements in genome sequencing, comparative genome analysis provides a new approach to facilitate our understanding of these bacteria. In this study, our main focus is to investigate the evolution of gene content in phytoplasmas, mycoplasmas, and their common ancestor. By using a phylogenetic framework for comparative analysis of 12 complete genome sequences, we characterized the putative gains and losses of genes in these obligate parasites. Our results demonstrated that the degradation of metabolic capacities in these bacteria has occurred predominantly in the common ancestor of Mollicutes, prior to the evolutionary split of phytoplasmas and mycoplasmas. Furthermore, we identified a list of genes that are acquired by the common ancestor of phytoplasmas and are conserved across all strains with complete genome sequences available. These genes include several putative effectors for the interactions with hosts and may be good candidates for future functional characterization.	[Chen, Ling-Ling; Chung, Wan-Chia; Kuo, Chih-Horng] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Lin, Chan-Pin] Natl Taiwan Univ, Dept Plant Pathol & Microbiol, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Chen, LL (corresponding author), Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan.	chk@gate.sinica.edu.tw	Chen, Ling-Ling/AAY-3547-2021; Kuo, Chih-Horng/E-2045-2013	Kuo, Chih-Horng/0000-0002-2857-0529; Lin, Chan-Pin/0000-0002-9951-687X	National Science Council of Taiwan [NSC 99-2313-B-001-006-MY2]; Academia Sinica	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	Funding for this work was provided by research grants from the National Science Council of Taiwan (NSC 99-2313-B-001-006-MY2) and Academia Sinica to CHK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bai XD, 2004, FEMS MICROBIOL LETT, V235, P249, DOI [10.1111/j.1574-6968.2004.tb09596.x, 10.1016/j.femsle.2004.04.043]; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Bai XD, 2009, MOL PLANT MICROBE IN, V22, P18, DOI 10.1094/MPMI-22-1-0018; Barre A, 2004, NUCLEIC ACIDS RES, V32, pD307, DOI 10.1093/nar/gkh114; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; Burse A, 2004, APPL ENVIRON MICROB, V70, P693, DOI 10.1128/AEM.70.2.693-703.2004; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caspi R, 2010, NUCLEIC ACIDS RES, V38, pD473, DOI 10.1093/nar/gkp875; CHEN J, 1990, J BACTERIOL, V172, P5686, DOI 10.1128/jb.172.10.5686-5689.1990; Chopra-Dewasthaly R, 2005, INT J MED MICROBIOL, V294, P447, DOI 10.1016/j.ijmm.2004.09.010; Christensen NM, 2005, TRENDS PLANT SCI, V10, P526, DOI 10.1016/j.tplants.2005.09.008; Economou A, 1998, MOL MICROBIOL, V27, P511, DOI 10.1046/j.1365-2958.1998.00713.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Firrao G, 2004, INT J SYST EVOL MICR, V54, P1243, DOI 10.1099/ijs.0.02854-0; Florez LA, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap012; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUNDERSEN DE, 1994, J BACTERIOL, V176, P5244, DOI 10.1128/JB.176.17.5244-5254.1994; Hoelzle K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-194; Hogenhout SA, 2008, MOL PLANT PATHOL, V9, P403, DOI 10.1111/J.1364-3703.2008.00472.X; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P422, DOI 10.1016/j.pbi.2011.05.003; Hogenhout SA, 2010, PHYTOPLASMAS: GENOMES, PLANT HOSTS AND VECTORS, P19; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulsen T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r31; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kosaka T, 2008, GENOME RES, V18, P442, DOI 10.1101/gr.7136508; Kube M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-306; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Kuo CH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-108; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; Kuo CH, 2009, GENOME BIOL EVOL, V1, P145, DOI 10.1093/gbe/evp016; Kuo CH, 2009, GENOME RES, V19, P1450, DOI 10.1101/gr.091785.109; Lammers CR, 2010, MICROBIOL-SGM, V156, P849, DOI 10.1099/mic.0.035790-0; Lee IM, 1998, PHYTOPATHOLOGY, V88, P1359, DOI 10.1094/PHYTO.1998.88.12.1359; Lee IM, 2000, ANNU REV MICROBIOL, V54, P221, DOI 10.1146/annurev.micro.54.1.221; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; MacLean AM, 2011, PLANT PHYSIOL, V157, P831, DOI 10.1104/pp.111.181586; Maniloff J, 1996, P NATL ACAD SCI USA, V93, P10004, DOI 10.1073/pnas.93.19.10004; Minion FC, 2004, J BACTERIOL, V186, P7123, DOI 10.1128/JB.186.21.7123-7133.2004; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Namba S, 2011, J GEN PLANT PATHOL, V77, P345, DOI 10.1007/s10327-011-0341-y; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; Nouvel LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-86; Novichkov PS, 2009, J BACTERIOL, V191, P65, DOI 10.1128/JB.01237-08; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; OSAWA S, 1990, P ROY SOC B-BIOL SCI, V241, P19, DOI 10.1098/rspb.1990.0060; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; Sheppard K, 2008, NUCLEIC ACIDS RES, V36, P1813, DOI 10.1093/nar/gkn015; Souza RC, 2007, GENET MOL BIOL, V30, P169, DOI 10.1590/S1415-47572007000200002; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Strauss E, 2009, SCIENCE, V325, P388, DOI 10.1126/science.325_388; Sugio A, 2011, ANNU REV PHYTOPATHOL, V49, P175, DOI 10.1146/annurev-phyto-072910-095323; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Wei W, 2008, P NATL ACAD SCI USA, V105, P11827, DOI 10.1073/pnas.0805237105; Westberg J, 2004, GENOME RES, V14, P221, DOI 10.1101/gr.1673304; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	72	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34407	10.1371/journal.pone.0034407	http://dx.doi.org/10.1371/journal.pone.0034407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479625	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900090
J	Liou, YJ; Wang, HH; Lee, MTM; Wang, SC; Chiang, HL; Chen, CC; Lin, CH; Chung, MS; Kuo, CC; Liao, DL; Wu, CK; Liu, CM; Liu, YL; Hwu, HG; Lai, IC; Tsai, SJ; Chen, CH; Liu, HF; Chou, YC; Chen, CH; Chen, YT; Hong, CJ; Wu, JY				Liou, Ying-Jay; Wang, Hui-Hung; Lee, Ming-Ta Michael; Wang, Sheng-Chang; Chiang, Hung-Lun; Chen, Cheng-Chung; Lin, Ching-Hua; Chung, Ming-Shun; Kuo, Chien-Cheng; Liao, Ding-Lieh; Wu, Ching-Kuan; Liu, Chih-Min; Liu, Yu-Li; Hwu, Hai-Gwo; Lai, I-Ching; Tsai, Shih-Jen; Chen, Chia-Hsiang; Liu, Hui-Fen; Chou, Yi-Chun; Chen, Chien-Hsiun; Chen, Yuan-Tsong; Hong, Chen-Jee; Wu, Jer-Yuarn			Genome-Wide Association Study of Treatment Refractory Schizophrenia in Han Chinese	PLOS ONE			English	Article							TREATMENT-RESISTANT SCHIZOPHRENIA; KAPPA-B P50; INFLAMMATORY RESPONSE SYSTEM; TYPICAL NEUROLEPTICS; TRANSCRIPTION FACTOR; COMMON VARIANTS; RECEPTOR GENE; LINKAGE; SUSCEPTIBILITY; ACTIVATION	We report the first genome-wide association study of a joint analysis using 795 Han Chinese individuals with treatment-refractory schizophrenia (TRS) and 806 controls. Three loci showed suggestive significant association with TRS were identified. These loci include: rs10218843 (P = 3.04x10(-7)) and rs11265461 (P = 1.94x10(-7)) are adjacent to signaling lymphocytic activation molecule family member 1 (SLAMF1); rs4699030 (P = 1.94x10(-6)) and rs230529 (P = 1.74x10(-7)) are located in the gene nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (NFKB1); and rs13049286 (P = 3.05x10(-5)) and rs3827219 (P = 1.66x10(-5)) fall in receptor-interacting serine/threonine-protein kinase 4 (RIPK4). One isolated single nucleotide polymorphism (SNP), rs739617 (P = 3.87x10(-5)) was also identified to be associated with TRS. The -94delATTG allele (rs28362691) located in the promoter region of NFKB1 was identified by resequencing and was found to associate with TRS (P = 4.85x10(-6)). The promoter assay demonstrated that the -94delATTG allele had a significant lower promoter activity than the -94insATTG allele in the SH-SY5Y cells. This study suggests that rs28362691 in NFKB1 might be involved in the development of TRS.	[Liou, Ying-Jay; Tsai, Shih-Jen; Hong, Chen-Jee] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Liou, Ying-Jay; Chiang, Hung-Lun] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Wang, Hui-Hung; Lee, Ming-Ta Michael; Chiang, Hung-Lun; Liu, Hui-Fen; Chou, Yi-Chun; Chen, Chien-Hsiun; Chen, Yuan-Tsong; Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Lee, Ming-Ta Michael; Chen, Chien-Hsiun; Wu, Jer-Yuarn] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Wang, Sheng-Chang; Chen, Chia-Hsiang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Mental Hlth & Addict Med, Zhunan, Taiwan; [Chen, Cheng-Chung; Lin, Ching-Hua] Kaohsiung Kai Suan Psychiat Hosp, Kaohsiung, Taiwan; [Chung, Ming-Shun; Kuo, Chien-Cheng] Execut Yuan, Jianan Mental Hosp, Dept Hlth, Taipei, Taiwan; [Liao, Ding-Lieh] Execut Yuan, Bali Psychiat Ctr, Dept Hlth, Taipei, Taiwan; [Wu, Ching-Kuan] Tsyr Huey Mental Hosp, Kaohsiung, Taiwan; [Liu, Chih-Min; Hwu, Hai-Gwo] Natl Taiwan Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Liu, Chih-Min; Hwu, Hai-Gwo] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Hwu, Hai-Gwo] Natl Taiwan Univ, Coll Sci, Dept Psychol, Taipei 10764, Taiwan; [Lai, I-Ching] Yuli Vet Hosp, Hualien, Taiwan; [Tsai, Shih-Jen; Hong, Chen-Jee] Natl Yang Ming Univ, Dept Med, Taipei 112, Taiwan; [Chen, Yuan-Tsong] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Hong, Chen-Jee] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; China Medical University Taiwan; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Yang Ming Chiao Tung University; Duke University; National Yang Ming Chiao Tung University	Liou, YJ (corresponding author), Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan.	cjhong@vghtpe.gov.tw; jywu@ibms.sinica.edu.tw	Chen, Chien Hsiun/Q-3826-2018; Wu, Jer-Yuarn/S-7010-2018; Wang, Sheng-Chang/G-9350-2011; Liu, Yu-Li/E-3829-2010; Chen, Chia-Hsiang/E-3939-2010; Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X; HWU, HAI-GWO/0000-0002-2582-2807; LIU, CHIH-MIN/0000-0001-7016-8990; Chen, Chia-Hsiang/0000-0002-8232-2403	National Science Council, Taiwan [NSC-99-3112-B-001-022, NSC-99-3112-B-001-023]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the National Research Program for Genomic Medicine, National Science Council, Taiwan (NSC-99-3112-B-001-022 NSC-99-3112-B-001-023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkelai A, 2011, INT J NEUROPSYCHOPH, P1; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Bahr C, 2000, J BIOL CHEM, V275, P36350, DOI 10.1074/jbc.M004771200; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Berger SB, 2010, NAT IMMUNOL, V11, P920, DOI 10.1038/ni.1931; BILDER RM, 1994, J CLIN PSYCHIAT, V55, P53; Cannons JL, 2004, IMMUNITY, V21, P693, DOI 10.1016/j.immuni.2004.09.012; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Chen F, 1999, CLIN CHEM, V45, P7; Chien IC, 2004, PSYCHIAT CLIN NEUROS, V58, P611, DOI 10.1111/j.1440-1819.2004.01311.x; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Chung B, 2005, J IMMUNOL, V174, P3153, DOI 10.4049/jimmunol.174.6.3153; Conley RR, 2001, BIOL PSYCHIAT, V50, P898, DOI 10.1016/S0006-3223(01)01271-9; Crow TJ, 2007, AM J PSYCHIAT, V164, P13, DOI 10.1176/appi.ajp.164.1.13; de Chaldee M, 1999, AM J MED GENET, V88, P452, DOI 10.1002/(SICI)1096-8628(19991015)88:5<452::AID-AJMG2>3.0.CO;2-0; Duan JB, 2004, AM J HUM GENET, V75, P624, DOI 10.1086/424887; Elkis H, 2007, PSYCHIAT CLIN N AM, V30, P511, DOI 10.1016/j.psc.2007.04.001; Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Gottesman I.I., 1991, SCHIZOPHRENIA GENESI; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Hashimoto R, 2011, NEUROPSYCHOPHARMACOL, V36, P1921, DOI 10.1038/npp.2011.78; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Hyman SE, 2008, NATURE, V455, P890, DOI 10.1038/nature07454; Inayama Y, 1996, AM J MED GENET, V67, P103, DOI 10.1002/(SICI)1096-8628(19960216)67:1<103::AID-AJMG18>3.0.CO;2-S; Ji XF, 2008, NEUROSCI LETT, V435, P95, DOI 10.1016/j.neulet.2008.01.083; Joober R, 1999, J PSYCHIATR NEUROSCI, V24, P141; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; KATILA H, 1994, SCHIZOPHR RES, V12, P29, DOI 10.1016/0920-9964(94)90081-7; Koga M, 2009, HUM MOL GENET, V18, P2483, DOI 10.1093/hmg/ddp166; Kohlrausch FB, 2008, PHARMACOGENET GENOM, V18, P599, DOI 10.1097/FPC.0b013e328301a763; Lee M, 2010, PSYCHIAT RES; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; Lin A, 1998, SCHIZOPHR RES, V32, P9, DOI 10.1016/S0920-9964(98)00034-6; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; LIOU HC, 1992, EMBO J, V11, P3003, DOI 10.1002/j.1460-2075.1992.tb05370.x; Maes M, 2000, EUR NEUROPSYCHOPHARM, V10, P119, DOI 10.1016/S0924-977X(99)00062-0; Maes M, 2002, SCHIZOPHR RES, V54, P281, DOI 10.1016/S0920-9964(00)00094-3; Mah S, 2006, MOL PSYCHIATR, V11, P471, DOI 10.1038/sj.mp.4001785; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Quiroga MF, 2004, J IMMUNOL, V173, P4120, DOI 10.4049/jimmunol.173.6.4120; RICE NR, 1992, CELL, V71, P243, DOI 10.1016/0092-8674(92)90353-E; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Saha S, 2005, PLOS MED, V2, P413, DOI 10.1371/journal.pmed.0020141; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; SHAIKH S, 1994, LANCET, V343, P1045; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; Shishodia S, 2004, BIOCHEM PHARMACOL, V68, P1071, DOI 10.1016/j.bcp.2004.04.026; Song XQ, 2009, BIOL PSYCHIAT, V65, P481, DOI 10.1016/j.biopsych.2008.10.018; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; STERN RG, 1993, PSYCHIAT CLIN N AM, V16, P313; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; TEN RM, 1992, EMBO J, V11, P195, DOI 10.1002/j.1460-2075.1992.tb05042.x; Ueda S, 2008, J NEUROSCI RES, V86, P3052, DOI 10.1002/jnr.21763; VANKAMMEN DP, 1990, CLIN NEUROPHARMACOL, V13, pS16; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	64	45	46	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33598	10.1371/journal.pone.0033598	http://dx.doi.org/10.1371/journal.pone.0033598			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479419	Green Submitted, Green Published, gold			2022-12-27	WOS:000303894900032
J	Seebohm, G; Neumann, S; Theiss, C; Novkovic, T; Hill, EV; Tavare, JM; Lang, F; Hollmann, M; Manahan-Vaughan, D; Strutz-Seebohm, N				Seebohm, Guiscard; Neumann, Sebastian; Theiss, Carsten; Novkovic, Tanja; Hill, Elaine V.; Tavare, Jeremy M.; Lang, Florian; Hollmann, Michael; Manahan-Vaughan, Denise; Strutz-Seebohm, Nathalie			Identification of a Novel Signaling Pathway and Its Relevance for GluA1 Recycling	PLOS ONE			English	Article							AMPA RECEPTOR TRAFFICKING; HIPPOCAMPAL-NEURONS; RAB GTPASES; PHOSPHORYLATION; INSULIN; ENDOCYTOSIS; ENDOSOMES	We previously showed that the serum-and glucocorticoid-inducible kinase 3 (SGK3) increases the AMPA-type glutamate receptor GluA1 protein in the plasma membrane. The activation of AMPA receptors by NMDA-type glutamate receptors eventually leads to postsynaptic neuronal plasticity. Here, we show that SGK3 mRNA is upregulated in the hippocampus of new-born wild type Wistar rats after NMDA receptor activation. We further demonstrate in the Xenopus oocyte expression system that delivery of GluA1 protein to the plasma membrane depends on the small GTPase RAB11. This RAB-dependent GluA1 trafficking requires phosphorylation and activation of phosphoinositol-3-phosphate-5-kinase (PIKfyve) and the generation of PI(3,5)P-2. In line with this mechanism we could show PIKfyve mRNA expression in the hippocampus of wild type C57/BL6 mice and phosphorylation of PIKfyve by SGK3. Incubation of hippocampal slices with the PIKfyve inhibitor YM201636 revealed reduced CA1 basal synaptic activity. Furthermore, treatment of primary hippocampal neurons with YM201636 altered the GluA1 expression pattern towards reduced synaptic expression of GluA1. Our findings demonstrate for the first time an involvement of PIKfyve and PI(3,5)P-2 in NMDA receptor-triggered synaptic GluA1 trafficking. This new regulatory pathway of GluA1 may contribute to synaptic plasticity and memory.	[Seebohm, Guiscard; Strutz-Seebohm, Nathalie] Ruhr Univ Bochum, Dept Biochem 1, Cat Channel Grp, Bochum, Germany; [Neumann, Sebastian] Ruhr Univ Bochum, Dept Biochem Mol Neurobiochem 2, Bochum, Germany; [Theiss, Carsten] Ruhr Univ Bochum, Dept Anat & Mol Embryol, Bochum, Germany; [Novkovic, Tanja; Manahan-Vaughan, Denise] Ruhr Univ Bochum, Dept Neurophysiol, Bochum, Germany; [Hill, Elaine V.; Tavare, Jeremy M.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Lang, Florian] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Hollmann, Michael] Ruhr Univ Bochum, Dept Biochem Receptor Biochem 1, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; University of Bristol; Eberhard Karls University of Tubingen; Ruhr University Bochum	Seebohm, G (corresponding author), Ruhr Univ Bochum, Dept Biochem 1, Cat Channel Grp, Univ Str 150, Bochum, Germany.	naestrutz@hotmail.com		Manahan-Vaughan, Denise/0000-0002-9283-9609; Hollmann, Michael/0000-0001-8000-7787; Neumann, Sebastian/0000-0003-3706-9012	Deutsche Forschungsgemeinschaft [DFG-STR 1156/1-1]; Medical Research Council [G7708269] Funding Source: researchfish; MRC [G7708269] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG-STR 1156/1-1 to NSS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.-	Ahmadian G, 2004, EMBO J, V23, P1040, DOI 10.1038/sj.emboj.7600126; Alesutan IS, 2010, CELL PHYSIOL BIOCHEM, V25, P187, DOI 10.1159/000276569; Appleby VJ, 2011, J NEUROCHEM, V116, P530, DOI 10.1111/j.1471-4159.2010.07133.x; Arendt KL, 2010, NAT NEUROSCI, V13, P36, DOI 10.1038/nn.2462; Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; Choquet D, 2010, EUR J NEUROSCI, V32, P250, DOI 10.1111/j.1460-9568.2010.07350.x; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Gehring EM, 2009, BIOCHEM BIOPH RES CO, V390, P952, DOI 10.1016/j.bbrc.2009.10.084; Gehring EM, 2009, CELL PHYSIOL BIOCHEM, V24, P361, DOI 10.1159/000257428; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Ho CY, 2012, TRAFFIC, V13, P1, DOI 10.1111/j.1600-0854.2011.01246.x; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Keifer J, 2010, EUR J NEUROSCI, V32, P269, DOI 10.1111/j.1460-9568.2010.07339.x; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kessler A, 2000, DIABETOLOGIA, V43, P1518, DOI 10.1007/s001250051563; Klaus F, 2009, NEUROCHEM INT, V54, P372, DOI 10.1016/j.neuint.2009.01.002; Klaus F, 2009, BIOCHEM BIOPH RES CO, V381, P407, DOI 10.1016/j.bbrc.2009.02.053; Lessmann V, 1997, BRAIN RES, V763, P111; Lisman J., 2006, SCI STKE, V2006, pr; Mukhopadhyay A, 1997, J CELL BIOL, V136, P1227, DOI 10.1083/jcb.136.6.1227; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Sbrissa D, 2004, ENDOCRINOLOGY, V145, P4853, DOI 10.1210/en.2004-0489; Seebohm G, 2003, MOL PHARMACOL, V64, P70, DOI 10.1124/mol.64.1.70; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Strutz-Seebohm N, 2005, J PHYSIOL-LONDON, V565, P381, DOI 10.1113/jphysiol.2004.079582; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Yang YL, 2008, P NATL ACAD SCI USA, V105, P11388, DOI 10.1073/pnas.0802978105	36	22	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33889	10.1371/journal.pone.0033889	http://dx.doi.org/10.1371/journal.pone.0033889			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470488	Green Published, Green Submitted, gold			2022-12-27	WOS:000303857100055
J	Mathews, SC; Mallidi, J; Kulkarni, K; Toth, PP; Jones, SR				Mathews, Simon C.; Mallidi, Jaya; Kulkarni, Krishnaji; Toth, Peter P.; Jones, Steven R.			Achieving Secondary Prevention Low-Density Lipoprotein Particle Concentration Goals Using Lipoprotein Cholesterol-Based Data	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; MAGNETIC-RESONANCE SPECTROSCOPY; ISCHEMIC-HEART-DISEASE; CARDIOVASCULAR-DISEASE; POSITION STATEMENT; RISK; SIZE; ATHEROSCLEROSIS; THERAPY; NUMBER	Background: Epidemiologic studies suggest that LDL particle concentration (LDL-P) may remain elevated at guideline recommended LDL cholesterol goals, representing a source of residual risk. We examined the following seven separate lipid parameters in achieving the LDL-P goal of < 1000 nmol/L goal for very high risk secondary prevention: total cholesterol to HDL cholesterol ratio, TC/HDL, < 3; a composite of ATP-III very high risk targets, LDL-C < 70 mg/dL, non-HDL-C < 100 mg/dL and TG < 150 mg/dL; a composite of standard secondary risk targets, LDL-C < 100, non-HDL-C < 130, TG < 150; LDL phenotype; HDL-C >= 40; TG < 150; and TG/HDL-C < 3. Methods: We measured ApoB, ApoAI, ultracentrifugation lipoprotein cholesterol and NMR lipoprotein particle concentration in 148 unselected primary and secondary prevention patients. Results: TC/ HDL- C < 3 effectively discriminated subjects by LDL-P goal (F = 84.1, p < 10(-6)). The ATP- III very high risk composite target (LDL-C < 70, nonHDL-C < 100, TG < 150) was also effective (F = 42.8, p < 10(-5)). However, the standard secondary prevention composite (LDL-C < 100, non-HDL-C < 130, TG < 150) was also effective but yielded higher LDL-P than the very high risk composite (F = 42.0, p < 10(-5)) with upper 95% confidence interval of LDL-P less than 1000 nmol/ L. TG < 150 and TG/HDL-C < 3 cutpoints both significantly discriminated subjects but the LDL-P upper 95% confidence intervals fell above goal of 1000 nmol/ L (F = 15.8, p = 0.0001 and F = 9.7, p = 0.002 respectively). LDL density phenotype neared significance ( F = 2.85, p = 0.094) and the HDL-C cutpoint of 40 mg/dL did not discriminate (F = 0.53, p = 0.47) alone or add discriminatory power to ATP-III targets. Conclusions: A simple composite of ATP-III very high risk lipoprotein cholesterol based treatment targets or TC/HDL-C ratio < 3 most effectively identified subjects meeting the secondary prevention target level of LDL- P < 1000 nmol/L, providing a potential alternative to advanced lipid testing in many clinical circumstances.	[Mathews, Simon C.; Jones, Steven R.] Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD 21218 USA; [Mallidi, Jaya] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Mallidi, Jaya] Tufts Univ, Dept Internal Med, Baystate Med Ctr, Springfield, MA USA; [Kulkarni, Krishnaji] Atherotech Diagnost Lab, Birmingham, AL USA; [Toth, Peter P.] CGH Med Ctr, Sterling, IL USA; [Toth, Peter P.] Univ Illinois, Sch Med, Peoria, IL USA	Johns Hopkins University; Johns Hopkins University; Baystate Medical Center; Tufts University; University of Illinois System; University of Illinois Peoria	Mathews, SC (corresponding author), Johns Hopkins Univ, Dept Med, Div Cardiol, Baltimore, MD 21218 USA.	sjones64@jhmi.edu	Mathews, Simon/AAU-9176-2020; Toth, Peter/GMW-6552-2022		Atherotech Diagnostics	Atherotech Diagnostics	The costs of acquisition and subsequent analysis of blood specimens was supported by a grant from Atherotech Diagnostics (http://www.atherotech. com). Dr. Kulkarni, Director of Research for Atherotech, collaborated in the analysis of the specimens and provided advice and guidance concerning the laboratory methods used in obtaining data. The statistical analysis, interpretation of the data and preparation of the manuscript took place independent of any involvement with the funding organization, Atherotech. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Barter PJ, 2006, J INTERN MED, V259, P247, DOI 10.1111/j.1365-2796.2006.01616.x; Blake GJ, 2002, CIRCULATION, V106, P1930, DOI 10.1161/01.CIR.0000033222.75187.B9; Boizel R, 2000, DIABETES CARE, V23, P1679, DOI 10.2337/diacare.23.11.1679; Brunzell JD, 2008, J AM COLL CARDIOL, V51, P1512, DOI 10.1016/j.jacc.2008.02.034; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Contois JH, 2009, CLIN CHEM, V55, P407, DOI 10.1373/clinchem.2008.118356; Cromwell WC, 2007, J CLIN LIPIDOL, V1, P583, DOI 10.1016/j.jacl.2007.10.001; Cromwell WC, 2006, AM J CARDIOL, V98, P1599, DOI 10.1016/j.amjcard.2006.07.036; Cromwell William C, 2009, Curr Cardiol Rep, V11, P468; El Harchaoui K, 2007, J AM COLL CARDIOL, V49, P547, DOI 10.1016/j.jacc.2006.09.043; Gardner CD, 1996, JAMA-J AM MED ASSOC, V276, P875, DOI 10.1001/jama.276.11.875; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; KULKARNI KR, 1994, J LIPID RES, V35, P159; Kulkarni KR, 2006, CLIN LAB MED, V26, P787, DOI 10.1016/j.cll.2006.07.004; Kuller L, 2002, ARTERIOSCL THROM VAS, V22, P1175, DOI 10.1161/01.ATV.0000022015.97341.3A; Lamarche B, 2001, CAN J CARDIOL, V17, P859; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; McLaughlin T, 2003, ANN INTERN MED, V139, P802, DOI 10.7326/0003-4819-139-10-200311180-00007; McPherson R, 2006, CAN J CARDIOL, V22, P913, DOI 10.1016/S0828-282X(06)70310-5; Mora S, 2007, ATHEROSCLEROSIS, V192, P211, DOI 10.1016/j.atherosclerosis.2006.05.007; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Nielsen LB, 1996, ATHEROSCLEROSIS, V123, P1, DOI 10.1016/0021-9150(96)05802-9; O'Keefe JH, 2004, J AM COLL CARDIOL, V43, P2142, DOI 10.1016/j.jacc.2004.03.046; Otvos James D, 2002, Clin Lab, V48, P171; Otvos JD, 2006, CIRCULATION, V113, P1556, DOI 10.1161/CIRCULATIONAHA.105.565135; Otvos JD, 2002, AM J CARDIOL, V90, p22I; Rosenson RS, 2002, AM J CARDIOL, V90, P89, DOI 10.1016/S0002-9149(02)02427-X; Sniderman AD, 2008, J CLIN LIPIDOL, V2, P36, DOI 10.1016/j.jacl.2007.12.006; St-Pierre AC, 2005, ARTERIOSCL THROM VAS, V25, P553, DOI 10.1161/01.ATV.0000154144.73236.f4; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890	32	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33692	10.1371/journal.pone.0033692	http://dx.doi.org/10.1371/journal.pone.0033692			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479428	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400028
J	Weisinger, RM; Marinelli, RJ; Wrenn, SJ; Harbury, PB				Weisinger, Rebecca M.; Marinelli, Robert J.; Wrenn, S. Jarrett; Harbury, Pehr B.			Mesofluidic Devices for DNA-Programmed Combinatorial Chemistry	PLOS ONE			English	Article							IN-VITRO SELECTION; CELLULOSE MEMBRANES; INHIBITORS; MOLECULES; LIGANDS; LIBRARY; PAPER	Hybrid combinatorial chemistry strategies that use DNA as an information-carrying medium are proving to be powerful tools for molecular discovery. In order to extend these efforts, we present a highly parallel format for DNA-programmed chemical library synthesis. The new format uses a standard microwell plate footprint and is compatible with commercially available automation technology. It can accommodate a wide variety of combinatorial synthetic schemes with up to 384 different building blocks per chemical step. We demonstrate that fluidic routing of DNA populations in the highly parallel format occurs with excellent specificity, and that chemistry on DNA arrayed into 384 well plates proceeds robustly, two requirements for the high-fidelity translation and efficient in vitro evolution of small molecules.	[Weisinger, Rebecca M.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Weisinger, Rebecca M.; Marinelli, Robert J.; Wrenn, S. Jarrett; Harbury, Pehr B.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University	Weisinger, RM (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	harbury@cmgm.stanford.edu			NIH [DP OD000429]; Gabilan Stanford Graduate Fellowship; Stanford University; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000429] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabilan Stanford Graduate Fellowship; Stanford University(Stanford University); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by an NIH Pioneer Award (DP OD000429 to P.B.H.). R. M. W. was partially supported by the Gabilan Stanford Graduate Fellowship. S.J.W. was partially supported by the Stanford University Medical Scientist Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrilho E, 2009, ANAL CHEM, V81, P5990, DOI 10.1021/ac900847g; Chan TR, 2004, ORG LETT, V6, P2853, DOI 10.1021/ol0493094; Clark MA, 2010, CURR OPIN CHEM BIOL, V14, P396, DOI 10.1016/j.cbpa.2010.02.017; Clark MA, 2009, NAT CHEM BIOL, V5, P647, DOI 10.1038/nchembio.211; Duckworth BP, 2007, ANGEW CHEM INT EDIT, V46, P8819, DOI 10.1002/anie.200701942; Gartner ZJ, 2001, J AM CHEM SOC, V123, P6961, DOI 10.1021/ja015873n; Halpin DR, 2004, PLOS BIOL, V2, P1015, DOI 10.1371/journal.pbio.0020173; Halpin DR, 2004, PLOS BIOL, V2, P1022, DOI 10.1371/journal.pbio.0020174; Heine N, 2003, TETRAHEDRON, V59, P9919, DOI 10.1016/j.tet.2003.10.044; Heine N, 2001, TETRAHEDRON LETT, V42, P227, DOI 10.1016/S0040-4039(00)01960-2; Kleiner RE, 2010, J AM CHEM SOC, V132, P11779, DOI 10.1021/ja104903x; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Mannocci L, 2010, BIOCONJUGATE CHEM, V21, P1836, DOI 10.1021/bc100198x; Martinez AW, 2008, P NATL ACAD SCI USA, V105, P19606, DOI 10.1073/pnas.0810903105; Rolland JP, 2004, J AM CHEM SOC, V126, P2322, DOI 10.1021/ja031657y; Schwabacher AW, 1998, J ORG CHEM, V63, P1727, DOI 10.1021/jo971802o; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; van Reis RD, 2006, CHARGED FILTRATION M; Wrenn SJ, 2007, J AM CHEM SOC, V129, P13137, DOI 10.1021/ja073993a	19	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32299	10.1371/journal.pone.0032299	http://dx.doi.org/10.1371/journal.pone.0032299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479318				2022-12-27	WOS:000304523400004
J	Wu, WT; Li, H; Wang, HB; Zhao, XY; Gao, ZQ; Qiao, R; Zhang, W; Qian, J; Wang, JC; Chen, HY; Wei, QY; Han, BH; Lu, DR				Wu, Wenting; Li, Huan; Wang, Huibo; Zhao, Xueying; Gao, Zhiqiang; Qiao, Rong; Zhang, Wei; Qian, Ji; Wang, Jiucun; Chen, Hongyan; Wei, Qingyi; Han, Baohui; Lu, Daru			Effect of Polymorphisms in XPD on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							REPAIR GENE XPD; SINGLE NUCLEOTIDE POLYMORPHISMS; PROGNOSTIC-FACTORS; EXCISION-REPAIR; SURVIVAL; CISPLATIN; RISK; ASSOCIATION; POPULATION; CARCINOMA	Purpose: Xeroderma pigmentosum group D (XPD) codes for a DNA helicase involved in nucleotide excision repair thatremoves platinum-induced DNA damage. Genetic polymorphisms of XPD may affect DNA repair capacity and lead to individual differences in the outcome of patients after chemotherapy. This study aims to identify whether XPD polymorphisms affect clinical efficacy among advanced non-small cell lung cancer (NSCLC) patients treated with platinum-based chemotherapy. Experimental Design: 353 stage III-IV NSCLC patients receiving platinum-based chemotherapy as the first-line treatment were enrolled in this study. Four potentially functional XPD polymorphisms (Arg(156)Arg, Asp(312)Asn, Asp(711)Asp and Lys(751)Gln) were genotyped by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry or PCR-based sequencing. Results: Variant genotypes of XPD Asp(312)Asn, Asp(711)Asp and Lys(751)Gln were significantly associated with poorer NSCLC survival (P = 0.006, 0.006, 0.014, respectively, by log-rank test). The most common haplotype GCA (in order of Asp(312)Asn, Asp(711)Asp and Lys(751)Gln) also exhibited significant risk effect on NSCLC survival (log-rank P = 0.001). This effect was more predominant for patients with stage IIIB disease (P = 2.21 x 10(-4), log-rank test). Increased risks for variant haplotypes of XPD were also observed among patients with performance status of 0-1 and patients with adenocarcinoma. However, no significant associations were found between these polymorphisms, chemotherapy response and PFS. Conclusions: Our study provides evidence for the predictive role of XPD Asp(312)Asn, Asp(711)Asp and Lys(751)Gln polymorphisms/haplotype on NSCLC prognosis in inoperable advanced NSCLC patients treated with platinum-based chemotherapy.	[Wu, Wenting; Li, Huan; Zhao, Xueying; Qian, Ji; Wang, Jiucun; Chen, Hongyan; Lu, Daru] Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn,Ctr Fudan VARI Genet Epi, Shanghai 200433, Peoples R China; [Wu, Wenting; Li, Huan; Zhao, Xueying; Qian, Ji; Wang, Jiucun; Chen, Hongyan; Lu, Daru] Fudan Univ, Inst Genet, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Wu, Wenting] Univ Calif San Diego, Dept Psychiat, Beyster Ctr Genom Psychiat Dis, La Jolla, CA 92093 USA; [Gao, Zhiqiang; Qiao, Rong; Zhang, Wei; Han, Baohui] Shanghai Jiao Tong Univ, Dept Resp Dis, Shanghai Chest Hosp, Shanghai 200030, Peoples R China; [Wang, Huibo] Univ Alabama Birmingham, Ctr Comprehens Canc, Div Hematol & Oncol, Birmingham, AL 35294 USA; [Wei, Qingyi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Fudan University; Fudan University; University of California System; University of California San Diego; Shanghai Jiao Tong University; University of Alabama System; University of Alabama Birmingham; University of Texas System; UTMD Anderson Cancer Center	Wu, WT (corresponding author), Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn,Ctr Fudan VARI Genet Epi, Shanghai 200433, Peoples R China.	xkyyhan@gmail.com; drlu@fudan.edu.cn	wu, wenting/Q-4979-2016	wu, wenting/0000-0003-0982-771X	China National High-Tech Research and Development Program [2012AA02A517, 2012AA02A518]; Shanghai Science and Technology Research Program [06DZ19501, 09JC1402200, 10410709100]; Scientific and technological support plans from Jiangsu province [BE2010715]; Natural Science Foundation of China [30800622]; Shanghai Subject Chief Scientist for Public Health [08GWD07]	China National High-Tech Research and Development Program(National High Technology Research and Development Program of China); Shanghai Science and Technology Research Program; Scientific and technological support plans from Jiangsu province; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Subject Chief Scientist for Public Health	This work was supported in part by China National High-Tech Research and Development Program Grant (2012AA02A517, 2012AA02A518), Shanghai Science and Technology Research Program (06DZ19501, 09JC1402200, 10410709100), Scientific and technological support plans from Jiangsu province (BE2010715), Natural Science Foundation of China (30800622) and Shanghai Subject Chief Scientist for Public Health 08GWD07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma K, 2007, CANCER SCI, V98, P1336, DOI 10.1111/j.1349-7006.2007.00557.x; Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037; Butkiewicz D, 2001, CARCINOGENESIS, V22, P593, DOI 10.1093/carcin/22.4.593; Chng W, 2006, LEUKEMIA, V20, P807, DOI 10.1038/sj.leu.2404172; de las Penas R, 2006, ANN ONCOL, V17, P668, DOI 10.1093/annonc/mdj135; Dybdahl M, 1999, CANCER EPIDEM BIOMAR, V8, P77; Einhorn LH, 2008, J CLIN ONCOL, V26, P3485, DOI 10.1200/JCO.2008.17.2056; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Gandara DR, 2009, J CLIN ONCOL, V27, P3540, DOI 10.1200/JCO.2008.20.8793; Gao WM, 2003, CARCINOGENESIS, V24, P1671, DOI 10.1093/carcin/bgg115; Gurubhagavatula S, 2004, J CLIN ONCOL, V22, P2594, DOI 10.1200/JCO.2004.08.067; Heist RS, 2008, J CLIN ONCOL, V26, P5596, DOI 10.1200/JCO.2008.18.0406; Isla D, 2004, ANN ONCOL, V15, P1194, DOI 10.1093/annonc/mdh319; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Laine JP, 2007, DNA REPAIR, V6, P1264, DOI 10.1016/j.dnarep.2007.02.010; Liang G, 2003, INT J CANCER, V105, P669, DOI 10.1002/ijc.11136; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Lunn RM, 2000, CARCINOGENESIS, V21, P551, DOI 10.1093/carcin/21.4.551; Monaco Regina, 2009, J Carcinog, V8, P12, DOI 10.4103/1477-3163.54918; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Park DJ, 2001, CANCER RES, V61, P8654; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; Ring BZ, 2009, MODERN PATHOL, V22, P1032, DOI 10.1038/modpathol.2009.60; Ryu JS, 2004, LUNG CANCER, V44, P311, DOI 10.1016/j.lungcan.2003.11.019; Seker H, 2001, CANCER RES, V61, P7430; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Spitz MR, 2001, CANCER RES, V61, P1354; Sturgis EM, 2002, ARCH OTOLARYNGOL, V128, P1084, DOI 10.1001/archotol.128.9.1084; Wakefield J, 2007, AM J HUM GENET, V81, P208, DOI 10.1086/519024; Winsey SL, 2000, CANCER RES, V60, P5612; Wolfe KJ, 2007, PHARMACOGENET GENOM, V17, P897, DOI 10.1097/FPC.0b013e3280115e63; Wu Q, 2005, EMBO REP, V6, P551, DOI 10.1038/sj.embor.7400418; Wu WT, 2009, CLIN CANCER RES, V15, P3889, DOI 10.1158/1078-0432.CCR-08-2715; Yao CY, 2009, ASIAN PAC J CANCER P, V10, P859; Yin M, 2011, LUNG CANCER, V72, P370, DOI 10.1016/j.lungcan.2010.10.011	35	196	203	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33200	10.1371/journal.pone.0033200	http://dx.doi.org/10.1371/journal.pone.0033200			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479369	Green Submitted, gold, Green Published			2022-12-27	WOS:000304523400013
J	Hallett, RM; Kondratyev, MK; Giacomelli, AO; Nixon, AML; Girgis-Gabardo, A; Ilieva, D; Hassell, JA				Hallett, Robin M.; Kondratyev, Maria K.; Giacomelli, Andrew O.; Nixon, Allison M. L.; Girgis-Gabardo, Adele; Ilieva, Dora; Hassell, John A.			Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast Cancer	PLOS ONE			English	Article							STEM-CELLS; PROSPECTIVE IDENTIFICATION; WNT PATHWAY; IN-VITRO; EXPRESSION; RESISTANCE; SUBPOPULATION; CHEMOTHERAPY; PROTEINS; LEUKEMIA	Background: Recent evidence suggests that human breast cancer is sustained by a minor subpopulation of breast tumor-initiating cells (BTIC), which confer resistance to anticancer therapies and consequently must be eradicated to achieve durable breast cancer cure. Methods/Findings: To identify signaling pathways that might be targeted to eliminate BTIC, while sparing their normal stem and progenitor cell counterparts, we performed global gene expression profiling of BTIC- and mammary epithelial stem/progenitor cell- enriched cultures derived from mouse mammary tumors and mammary glands, respectively. Such analyses suggested a role for the Wnt/Beta-catenin signaling pathway in maintaining the viability and or sustaining the self-renewal of BTICs in vitro. To determine whether the Wnt/Beta-catenin pathway played a role in BTIC processes we employed a chemical genomics approach. We found that pharmacological inhibitors of Wnt/beta-catenin signaling inhibited sphere- and colony-formation by primary breast tumor cells and primary mammary epithelial cells, as well as by tumorsphere- and mammosphere-derived cells. Serial assays of self-renewal in vitro revealed that the Wnt/Beta-catenin signaling inhibitor PKF118-310 irreversibly affected BTIC, whereas it functioned reversibly to suspend the self-renewal of mammary epithelial stem/progenitor cells. Incubation of primary tumor cells in vitro with PKF118-310 eliminated their capacity to subsequently seed tumor growth after transplant into syngeneic mice. Administration of PKF118-310 to tumor-bearing mice halted tumor growth in vivo. Moreover, viable tumor cells harvested from PKF118-310 treated mice were unable to seed the growth of secondary tumors after transplant. Conclusions: These studies demonstrate that inhibitors of Wnt/beta-catenin signaling eradicated BTIC in vitro and in vivo and provide a compelling rationale for developing such antagonists for breast cancer therapy.	[Hallett, Robin M.; Kondratyev, Maria K.; Giacomelli, Andrew O.; Nixon, Allison M. L.; Girgis-Gabardo, Adele; Ilieva, Dora; Hassell, John A.] McMaster Univ, Ctr Funct Gen, Dept Biochem & Biomed Sci, Hamilton, ON, Canada	McMaster University	Hallett, RM (corresponding author), McMaster Univ, Ctr Funct Gen, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	Hassell@mcmaster.ca		Nixon, Allison/0000-0002-5540-4534	Canadian Stem Cell Network; Ontario Institute for Cancer Research; Canadian Breast Cancer Foundation	Canadian Stem Cell Network; Ontario Institute for Cancer Research; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was generously supported by grants from the Canadian Stem Cell Network, the Ontario Institute for Cancer Research and the Canadian Breast Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Binnerts ME, 2009, MOL BIOL CELL, V20, P3552, DOI 10.1091/mbc.E08-12-1252; BLOOM HJG, 1957, BRIT J CANCER, V11, P359, DOI 10.1038/bjc.1957.43; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Ghods AJ, 2007, STEM CELLS, V25, P1645, DOI 10.1634/stemcells.2006-0624; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Hallett RM, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-120; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Howe LR, 2004, CANCER BIOL THER, V3, P36, DOI 10.4161/cbt.3.1.561; Kang MK, 2007, STEM CELLS DEV, V16, P837, DOI 10.1089/scd.2007.0006; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Klarmann GJ, 2008, EPIGENETICS-US, V3, P59, DOI 10.4161/epi.3.2.5899; Kondratyev M, 2012, ONCOGENE, V31, P93, DOI 10.1038/onc.2011.212; Kurpios NA, 2009, DEV BIOL, V325, P106, DOI 10.1016/j.ydbio.2008.09.033; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Lobo NA, 2007, ANN REV CELL DEV BIO; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sachs Pullan, 1996, EPITHELIAL CELL CULT; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Singh SK, 2003, CANCER RES, V63, P5821; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Stingl J, 2008, J PATHOL; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Ugolini F, 2001, ONCOGENE, V20, P5810, DOI 10.1038/sj.onc.1204706; WONG GT, 1994, MOL CELL BIOL, V14, P6278, DOI 10.1128/MCB.14.9.6278; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Wulf GG, 2001, BLOOD, V98, P1166, DOI 10.1182/blood.V98.4.1166; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364	59	74	78	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33976	10.1371/journal.pone.0033976	http://dx.doi.org/10.1371/journal.pone.0033976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470504	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000049
J	Murk, K; Wittenmayer, N; Michaelsen-Preusse, K; Dresbach, T; Schoenenberger, CA; Korte, M; Jockusch, BM; Rothkegel, M				Murk, Kai; Wittenmayer, Nina; Michaelsen-Preusse, Kristin; Dresbach, Thomas; Schoenenberger, Cora-Ann; Korte, Martin; Jockusch, Brigitte M.; Rothkegel, Martin			Neuronal Profilin Isoforms Are Addressed by Different Signalling Pathways	PLOS ONE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; DENDRITIC SPINE MORPHOLOGY; GLUTAMATE RECEPTORS; SCAFFOLDING PROTEIN; NEUROTROPHIC FACTOR; SYNAPTIC VESICLES; PHOSPHOLIPASE-C; ACTIN; CYTOSKELETON; PLASTICITY	Profilins are prominent regulators of actin dynamics. While most mammalian cells express only one profilin, two isoforms, PFN1 and PFN2a are present in the CNS. To challenge the hypothesis that the expression of two profilin isoforms is linked to the complex shape of neurons and to the activity-dependent structural plasticity, we analysed how PFN1 and PFN2a respond to changes of neuronal activity. Simultaneous labelling of rodent embryonic neurons with isoform-specific monoclonal antibodies revealed both isoforms in the same synapse. Immunoelectron microscopy on brain sections demonstrated both profilins in synapses of the mature rodent cortex, hippocampus and cerebellum. Both isoforms were significantly more abundant in postsynaptic than in presynaptic structures. Immunofluorescence showed PFN2a associated with gephyrin clusters of the postsynaptic active zone in inhibitory synapses of embryonic neurons. When cultures were stimulated in order to change their activity level, active synapses that were identified by the uptake of synaptotagmin antibodies, displayed significantly higher amounts of both isoforms than non-stimulated controls. Specific inhibition of NMDA receptors by the antagonist APV in cultured rat hippocampal neurons resulted in a decrease of PFN2a but left PFN1 unaffected. Stimulation by the brain derived neurotrophic factor (BDNF), on the other hand, led to a significant increase in both synaptic PFN1 and PFN2a. Analogous results were obtained for neuronal nuclei: both isoforms were localized in the same nucleus, and their levels rose significantly in response to KCl stimulation, whereas BDNF caused here a higher increase in PFN1 than in PFN2a. Our results strongly support the notion of an isoform specific role for profilins as regulators of actin dynamics in different signalling pathways, in excitatory as well as in inhibitory synapses. Furthermore, they suggest a functional role for both profilins in neuronal nuclei.	[Murk, Kai; Michaelsen-Preusse, Kristin; Korte, Martin; Jockusch, Brigitte M.; Rothkegel, Martin] TU Braunschweig, Inst Zool, Braunschweig, Germany; [Wittenmayer, Nina; Dresbach, Thomas] Univ Gottingen, Dept Anat & Cell Biol, Ctr Anat, Gottingen, Germany; [Schoenenberger, Cora-Ann] Univ Basel, ME Muller Inst Struct Biol, Basel, Switzerland	Braunschweig University of Technology; University of Gottingen; University of Basel	Murk, K (corresponding author), Univ Bristol, Sch Med Sci, Dept Biochem, MRC Synapt Plast, Bristol BS8 1TD, Avon, England.	m.rothkegel@tu-bs.de		Michaelsen-Preusse, Kristin/0000-0002-7838-5882; , Martin/0000-0001-5041-4429; Murk, Kai/0000-0002-6573-4529	Deutsche Forschungsgemeinschaft; Fonds der Chemischen Industrie; Maurice E. Mueller Institute	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Maurice E. Mueller Institute	This study was financially supported by grants from the Deutsche Forschungsgemeinschaft (www.dfg.de) (MR, MK, TD, BMJ), the Fonds der Chemischen Industrie (fonds.vci.de) (BMJ), and the Maurice E. Mueller Institute (CAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Birbach A, 2006, EXP CELL RES, V312, P2279, DOI 10.1016/j.yexcr.2006.03.026; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Charrier C, 2006, J NEUROSCI, V26, P8502, DOI 10.1523/JNEUROSCI.1758-06.2006; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Gareus R, 2006, J BIOL CHEM, V281, P2803, DOI 10.1074/jbc.M503528200; Gartner A, 2006, J NEUROSCI, V26, P3496, DOI 10.1523/JNEUROSCI.3792-05.2006; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; Giesemann T, 2003, J NEUROSCI, V23, P8330; GOLDSCHMIDTCLERMONT PJ, 1990, SCIENCE, V247, P1575, DOI 10.1126/science.2157283; GOLDSCHMIDTCLERMONT PJ, 1991, SCIENCE, V251, P1231, DOI 10.1126/science.1848725; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Hanus C, 2006, J NEUROSCI, V26, P4586, DOI 10.1523/JNEUROSCI.5123-05.2006; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; Jockusch BM, 2007, REV PHYSIOL BIOCH P, V159, P131, DOI 10.1007/112_2007_704; Jockusch BM, 2004, NEUROREPORT, V15, P1535, DOI 10.1097/01.wnr.0000131673.92694.58; KIRSCH J, 1995, J NEUROSCI, V15, P4148; Kneussel M, 2007, BIOL CELL, V99, P297, DOI 10.1042/BC20060120; Korte M, 2008, SCIENCE, V319, P1627, DOI 10.1126/science.1155748; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Lambrechts A, 2006, J CELL SCI, V119, P1570, DOI 10.1242/jcs.02884; Lamprecht R, 2006, NAT NEUROSCI, V9, P481, DOI 10.1038/nn1672; Lederer M, 2005, J CELL SCI, V118, P331, DOI 10.1242/jcs.01618; Mammoto A, 1998, BIOCHEM BIOPH RES CO, V243, P86, DOI 10.1006/bbrc.1997.8068; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Mayboroda O, 1997, CELL MOTIL CYTOSKEL, V37, P166, DOI 10.1002/(SICI)1097-0169(1997)37:2<166::AID-CM9>3.0.CO;2-6; Mei F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021568; Michaelsen K, 2010, P NATL ACAD SCI USA, V107, P15780, DOI 10.1073/pnas.1004406107; Miyagi Y, 2002, J NEUROSCI, V22, P803, DOI 10.1523/JNEUROSCI.22-03-00803.2002; Mondin M, 2010, J BIOL CHEM, V285, P40060, DOI 10.1074/jbc.M110.140442; Murk K, 2009, J CELL SCI, V122, P957, DOI 10.1242/jcs.041715; Neuhoff H, 2005, EUR J NEUROSCI, V21, P15, DOI 10.1111/j.1460-9568.2004.03814.x; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010; Rawe VY, 2006, HUM REPROD, V21, P1143, DOI 10.1093/humrep/dei480; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rostaing P, 2006, EUR J NEUROSCI, V24, P3463, DOI 10.1111/j.1460-9568.2006.05234.x; Schoenenberger CA, 2005, J STRUCT BIOL, V152, P157, DOI 10.1016/j.jsb.2005.09.003; Schroeder U, 2009, J MOL BIOL, V386, P1368, DOI 10.1016/j.jmb.2008.11.023; Schubert V, 2006, J CELL BIOL, V172, P453, DOI 10.1083/jcb.200506136; Sharma A, 2005, EXP CELL RES, V309, P185, DOI 10.1016/j.yexcr.2005.05.014; Skare P, 2003, EXP CELL RES, V286, P12, DOI 10.1016/S0014-4827(03)00102-2; Smolinsky B, 2008, J BIOL CHEM, V283, P17370, DOI 10.1074/jbc.M800985200; Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tao-Cheng JH, 2006, NEUROSCIENCE, V141, P1217, DOI 10.1016/j.neuroscience.2006.04.061; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Witke W, 1998, EMBO J, V17, P967, DOI 10.1093/emboj/17.4.967; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Wittenmayer N, 2009, P NATL ACAD SCI USA, V106, P13564, DOI 10.1073/pnas.0905819106; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; ZIRRGIEBEL U, 1995, J NEUROCHEM, V65, P2241	55	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34167	10.1371/journal.pone.0034167	http://dx.doi.org/10.1371/journal.pone.0034167			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470532	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000071
J	Ficko-Blean, E; Stuart, CP; Suits, MD; Cid, M; Tessier, M; Woods, RJ; Boraston, AB				Ficko-Blean, Elizabeth; Stuart, Christopher P.; Suits, Michael D.; Cid, Melissa; Tessier, Matthew; Woods, Robert J.; Boraston, Alisdair B.			Carbohydrate Recognition by an Architecturally Complex alpha-N-Acetylglucosaminidase from Clostridium perfringens	PLOS ONE			English	Article							BINDING MODULE; CELL-CARCINOMA; MUCUS LAYERS; MUCIN; SIALIDASE; ACETYLGALACTOSAMINIDASES; ALGORITHMS; EXPRESSION; DYNAMICS; TISSUES	CpGH89 is a large multimodular enzyme produced by the human and animal pathogen Clostridium perfringens. The catalytic activity of this exo-alpha-D-N-acetylglucosaminidase is directed towards a rare carbohydrate motif, N-acetyl-beta-D-glucosamine-alpha-1,4-D-galactose, which is displayed on the class III mucins deep within the gastric mucosa. In addition to the family 89 glycoside hydrolase catalytic module this enzyme has six modules that share sequence similarity to the family 32 carbohydrate-binding modules (CBM32s), suggesting the enzyme has considerable capacity to adhere to carbohydrates. Here we suggest that two of the modules, CBM32-1 and CBM32-6, are not functional as carbohydrate-binding modules (CBMs) and demonstrate that three of the CBMs, CBM32-3, CBM32-4, and CBM32-5, are indeed capable of binding carbohydrates. CBM32-3 and CBM32-4 have a novel binding specificity for N-acetyl-beta-D-glucosamine-alpha-1,4-D-galactose, which thus complements the specificity of the catalytic module. The X-ray crystal structure of CBM32-4 in complex with this disaccharide reveals a mode of recognition that is based primarily on accommodation of the unique bent shape of this sugar. In contrast, as revealed by a series of X-ray crystal structures and quantitative binding studies, CBM32-5 displays the structural and functional features of galactose binding that is commonly associated with CBM family 32. The functional CBM32s that CpGH89 contains suggest the possibility for multivalent binding events and the partitioning of this enzyme to highly specific regions within the gastrointestinal tract.	[Ficko-Blean, Elizabeth; Stuart, Christopher P.; Suits, Michael D.; Cid, Melissa; Boraston, Alisdair B.] Univ Victoria, Victoria, BC, Canada; [Tessier, Matthew; Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Woods, Robert J.] Natl Univ Ireland, Sch Chem, Galway, Ireland	University of Victoria; University System of Georgia; University of Georgia; Ollscoil na Gaillimhe-University of Galway	Ficko-Blean, E (corresponding author), Univ Victoria, Victoria, BC, Canada.	boraston@uvic.ca	Woods, Robert/F-4962-2015; Ficko-Blean, Elizabeth/N-1746-2013	Woods, Robert/0000-0002-2400-6293; Ficko-Blean, Elizabeth/0000-0002-3915-4715; Boraston, Alisdair/0000-0001-6417-0592	Canadian Institutes of Health Research [FRN 68913]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institutes of Health Research grant (FRN 68913). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKAMATSU T, 1990, HISTOCHEM J, V22, P416, DOI 10.1007/BF01003461; Ashida H, 2008, GLYCOBIOLOGY, V18, P727, DOI 10.1093/glycob/cwn053; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Boraston AB, 2003, J MOL BIOL, V327, P659, DOI 10.1016/S0022-2836(03)00152-9; Boraston AB, 2001, BIOCHEMISTRY-US, V40, P14679, DOI 10.1021/bi015760g; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Case D.A., 2022, AMBER 2020; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ficko-Blean E, 2005, ACTA CRYSTALLOGR F, V61, P834, DOI 10.1107/S1744309105024012; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Ficko-Blean E, 2009, J MOL BIOL, V390, P208, DOI 10.1016/j.jmb.2009.04.066; Ficko-Blean E, 2009, J BIOL CHEM, V284, P9876, DOI 10.1074/jbc.M808954200; FUJIMORI Y, 1995, HUM PATHOL, V26, P725, DOI 10.1016/0046-8177(95)90219-8; Fujita M, 2011, J BIOL CHEM, V286, P6479, DOI 10.1074/jbc.M110.206722; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Higgins MA, 2011, J MOL BIOL, V411, P1017, DOI 10.1016/j.jmb.2011.06.035; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KIJIMA H, 1989, ACTA PATHOL JAPON, V39, P235; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; KOCHETKOV NK, 1976, EUR J BIOCHEM, V67, P129, DOI 10.1111/j.1432-1033.1976.tb10641.x; Koutsioulis D, 2008, GLYCOBIOLOGY, V18, P799, DOI 10.1093/glycob/cwn069; LESUFFLEUR T, 1994, CRIT REV ONCOL HEMAT, V17, P153, DOI 10.1016/1040-8428(94)90053-1; MATSUZAWA K, 1992, HUM PATHOL, V23, P925, DOI 10.1016/0046-8177(92)90407-T; McCalmont TH, 2011, J CUTAN PATHOL, V38, P540, DOI 10.1111/j.1600-0560.2011.01732.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Morris RJ, 2002, ACTA CRYSTALLOGR D, V58, P968, DOI 10.1107/S0907444902005462; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakajima K, 2003, J HISTOCHEM CYTOCHEM, V51, P1689, DOI 10.1177/002215540305101213; Nakamura N, 1998, J HISTOCHEM CYTOCHEM, V46, P793, DOI 10.1177/002215549804600702; Nakayama J, 1999, P NATL ACAD SCI USA, V96, P8991, DOI 10.1073/pnas.96.16.8991; Newstead SL, 2008, J BIOL CHEM, V283, P9080, DOI 10.1074/jbc.M710247200; Newstead SL, 2005, ACTA CRYSTALLOGR D, V61, P1483, DOI 10.1107/S0907444905026132; Onufriev A, 2000, J PHYS CHEM B, V104, P3712, DOI 10.1021/jp994072s; OTA H, 1992, HISTOCHEM J, V24, P86, DOI 10.1007/BF01082444; Ota H, 2001, AM J CLIN PATHOL, V115, P69; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; TSUTSUMI Y, 1984, ARCH PATHOL LAB MED, V108, P917; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Woods Group, 2005, COMPL CARB RES CTR; Zhang MX, 2001, J HISTOCHEM CYTOCHEM, V49, P587, DOI 10.1177/002215540104900505	59	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33524	10.1371/journal.pone.0033524	http://dx.doi.org/10.1371/journal.pone.0033524			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479408	gold, Green Published, Green Submitted			2022-12-27	WOS:000303894900030
J	Roperto, S; Borzacchiello, G; Esposito, I; Riccardi, M; Urraro, C; Luca, R; Corteggio, A; Tate, R; Cermola, M; Paciello, O; Roperto, F				Roperto, Sante; Borzacchiello, Giuseppe; Esposito, Iolanda; Riccardi, Marita; Urraro, Chiara; Luca, Roberta; Corteggio, Annunziata; Tate, Rosarita; Cermola, Michele; Paciello, Orlando; Roperto, Franco			Productive Infection of Bovine Papillomavirus Type 2 in the Placenta of Pregnant Cows Affected with Urinary Bladder Tumors	PLOS ONE			English	Article							TRANSPLACENTAL TRANSMISSION; BETA-RECEPTOR; E5; PDGF; DNA; ONCOPROTEINS; EXPRESSION; GENOTYPES; CATTLE; VIRUS	Papillomaviruses (PVs) are believed to be highly epitheliotropic as they usually establish productive infections within stratified epithelia. In vitro, various PVs appear to complete their entire life-cycle in different trophoblastic cell lines. In this study, infection by and protein expression of bovine papillomavirus type 2 (BPV-2) in the uterine and chorionic epithelium of the placenta has been described in four cows suffering from naturally occurring papillomavirus-associated urothelial bladder tumors. E5 oncoprotein was detected both by Western blot analysis and immunohistochemically. It appears to be complexed and perfectly co-localized with the activated platelet-derived growth factor beta receptor (PDGF beta R) by laser scanning confocal microscopy. The activated PDGF beta R might be involved in organogenesis and neo-angiogenesis rather than in cell transformation during pregnancy. The major capsid protein, L1, believed to be only expressed in productive papillomavirus infection has been detected by Western blot analysis. Immunohistochemical investigations confirmed the presence of L1 protein both in the cytoplasm and nuclei of cells of the uterine and chorionic epithelium. Trophoblastic cells appear to be the major target for L1 protein expression. Finally, the early protein E2, required for viral DNA replication and known to be expressed during a productive infection, has been detected by Western blot and immunohistochemically. Electron microscopic investigations detected viral particles in nuclei of uterine and chorionic epithelium. This study shows that both active and productive infections by BPV-2 in the placenta of pregnant cows can occur in vivo.	[Roperto, Sante; Borzacchiello, Giuseppe; Esposito, Iolanda; Riccardi, Marita; Urraro, Chiara; Luca, Roberta; Corteggio, Annunziata; Paciello, Orlando; Roperto, Franco] Univ Naples Federico II, Dept Pathol & Anim Hlth, Naples, Italy; [Tate, Rosarita; Cermola, Michele] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, I-80125 Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Roperto, S (corresponding author), Univ Naples Federico II, Dept Pathol & Anim Hlth, Naples, Italy.	sante.roperto@unina.it	Vecchio, Domenico/I-4102-2013; riccardi, marita georgia/AAD-3454-2020; Corteggio, Annunziata/AAL-5277-2021	Vecchio, Domenico/0000-0002-8766-7224; riccardi, marita georgia/0000-0002-9097-8939; roperto, sante/0000-0001-6210-5519; Corteggio, Annunziata/0000-0002-9017-317X; Borzacchiello, Giuseppe/0000-0003-3943-2604	Ministero Italiano dell'Universita e della Ricerca Scientifica (MIUR); Ministero Italiano delle Politiche Agricole, Agroalimentari e Forestali (MIPAAF); Ministero della Salute; Assessorato alla Sanita della Regione Basilicata and della Regione Campania	Ministero Italiano dell'Universita e della Ricerca Scientifica (MIUR)(Ministry of Education, Universities and Research (MIUR)); Ministero Italiano delle Politiche Agricole, Agroalimentari e Forestali (MIPAAF); Ministero della Salute(Ministry of Health, Italy); Assessorato alla Sanita della Regione Basilicata and della Regione Campania	This work was sponsored by grants from the Ministero Italiano dell'Universita e della Ricerca Scientifica (MIUR), Ministero Italiano delle Politiche Agricole, Agroalimentari e Forestali (MIPAAF), Ministero della Salute, and Assessorato alla Sanita della Regione Basilicata and della Regione Campania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson ML, 2007, THERIOGENOLOGY, V68, P474, DOI 10.1016/j.theriogenology.2007.04.001; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; [Anonymous], 2007, IARC MON EV CARC RIS; Bodaghi S, 2005, J CLIN MICROBIOL, V43, P5428, DOI 10.1128/JCM.43.11.5428-5434.2005; Borzacchiello G, 2006, ONCOGENE, V25, P1251, DOI 10.1038/sj.onc.1209152; Borzacchiello G, 2003, J GEN VIROL, V84, P2921, DOI 10.1099/vir.0.19412-0; Borzacchiello G, 2007, CANCER LETT, V250, P82, DOI 10.1016/j.canlet.2006.09.022; Boulenouar S, 2010, CARCINOGENESIS, V31, P473, DOI 10.1093/carcin/bgp281; Castellsague X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-74; de Freitas AC, 2003, BRAZ J MICROBIOL, V34, P76, DOI 10.1590/S1517-83822003000500026; DESROCHERS A, 1994, CAN VET J, V35, P646; Eppel W, 2000, OBSTET GYNECOL, V96, P337, DOI 10.1016/S0029-7844(00)00953-4; Favre M, 1998, J INVEST DERMATOL, V111, P333, DOI 10.1046/j.1523-1747.1998.00312.x; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Gomez LM, 2008, HUM REPROD, V23, P709, DOI 10.1093/humrep/dem404; Graham SV, 2006, PAPILLOMAVIRUS RES N; Hartl B, 2011, J GEN VIROL, V92, P2437, DOI 10.1099/vir.0.033670-0; Hermonat PL, 1998, HUM PATHOL, V29, P170, DOI 10.1016/S0046-8177(98)90228-3; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Koskimaa HM, 2012, J PEDIATR-US, V160, P837, DOI 10.1016/j.jpeds.2011.10.027; Liu Y, 2001, VIROLOGY, V290, P99, DOI 10.1006/viro.2001.1135; MACLACHLAN NJ, 2002, TUMORS DOMESTIC ANIM; Maxie M. G., 2007, J KENNEDY PALMERS PA, P518; Misdorp W, 2002, VET QUART, V24, P1; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Morris WE, 2010, CAN VET J, V51, P877; Ohlsson R, 1999, DEV BIOL, V212, P124, DOI 10.1006/dbio.1999.9306; PETTI L, 1991, EMBO J, V10, P845, DOI 10.1002/j.1460-2075.1991.tb08017.x; Rombaldi RL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-106; Roperto S, 2010, J COMP PATHOL, V142, P95, DOI 10.1016/j.jcpa.2009.08.156; Roperto S, 2008, J GEN VIROL, V89, P3027, DOI 10.1099/vir.0.2008/004457-0; Roperto S, 2011, J GEN VIROL, V92, P1787, DOI 10.1099/vir.0.031740-0; Sarkola M, 2008, ACTA OBSTET GYN SCAN, V87, P1181, DOI 10.1080/00016340802468308; Shafti-Keramat S, 2009, VIROLOGY, V393, P1, DOI 10.1016/j.virol.2009.07.036; Smith Elaine M, 2010, Infect Dis Obstet Gynecol, V2010, P326369, DOI 10.1155/2010/326369; SPARKOWSKI J, 1995, EMBO J, V14, P3055, DOI 10.1002/j.1460-2075.1995.tb07308.x; Syrjanen S, 2010, APMIS, V118, P494, DOI 10.1111/j.1600-0463.2010.02620.x; Talbert-Slagle K, 2009, VIROLOGY, V384, P345, DOI 10.1016/j.virol.2008.09.033; TSENG CJ, 1992, AM J OBSTET GYNECOL, V166, P35, DOI 10.1016/0002-9378(92)91825-U; Van den Akker NMS, 2008, DEV DYNAM, V237, P494, DOI 10.1002/dvdy.21436; Weyn C, 2011, VIROLOGY, V412, P146, DOI 10.1016/j.virol.2010.12.056; Weyn C, 2011, J INFECT DIS, V203, P341, DOI 10.1093/infdis/jiq056; Yaguiu A, 2008, GENET MOL RES, V7, P487, DOI 10.4238/vol7-2gmr436; Yoo HS, 2010, J REPROD DEVELOP, V56, pS53, DOI 10.1262/jrd.1056S53; You H, 2008, PLACENTA, V29, P30, DOI 10.1016/j.placenta.2007.08.005; Zuo Z, 2011, AM J CLIN PATHOL, V136, P260, DOI 10.1309/AJCP93JMIUEKRPIW; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	47	35	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33569	10.1371/journal.pone.0033569	http://dx.doi.org/10.1371/journal.pone.0033569			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479413	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900031
J	Shakhov, AN; Singh, VK; Bone, F; Cheney, A; Kononov, Y; Krasnov, P; Bratanova-Toshkova, TK; Shakhova, VV; Young, JS; Weil, MM; Panoskaltsis-Mortari, A; Orschell, CM; Baker, PS; Gudkov, A; Feinstein, E				Shakhov, Alexander N.; Singh, Vijay K.; Bone, Frederick; Cheney, Alec; Kononov, Yevgeniy; Krasnov, Peter; Bratanova-Toshkova, Troitza K.; Shakhova, Vera V.; Young, Jason; Weil, Michael M.; Panoskaltsis-Mortari, Angela; Orschell, Christie M.; Baker, Patricia S.; Gudkov, Andrei; Feinstein, Elena			Prevention and Mitigation of Acute Radiation Syndrome in Mice by Synthetic Lipopeptide Agonists of Toll-Like Receptor 2 (TLR2)	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FACTOR-KAPPA-B; IONIZING-RADIATION; CELL-PROLIFERATION; GROWTH-FACTOR; VITAMIN-E; G-CSF; RADIOPROTECTION; MOUSE; ACTIVATION	Bacterial lipoproteins (BLP) induce innate immune responses in mammals by activating heterodimeric receptor complexes containing Toll-like receptor 2 (TLR2). TLR2 signaling results in nuclear factor-kappaB (NF-kappa B)-dependent upregulation of anti-apoptotic factors, anti-oxidants and cytokines, all of which have been implicated in radiation protection. Here we demonstrate that synthetic lipopeptides (sLP) that mimic the structure of naturally occurring mycoplasmal BLP significantly increase mouse survival following lethal total body irradiation (TBI) when administered between 48 hours before and 24 hours after irradiation. The TBI dose ranges against which sLP are effective indicate that sLP primarily impact the hematopoietic (HP) component of acute radiation syndrome. Indeed, sLP treatment accelerated recovery of bone marrow (BM) and spleen cellularity and ameliorated thrombocytopenia of irradiated mice. sLP did not improve survival of irradiated TLR2-knockout mice, confirming that sLP-mediated radioprotection requires TLR2. However, sLP was radioprotective in chimeric mice containing TLR2-null BM on a wild type background, indicating that radioprotection of the HP system by sLP is, at least in part, indirect and initiated in non-BM cells. sLP injection resulted in strong transient induction of multiple cytokines with known roles in hematopoiesis, including granulocyte colony-stimulating factor (G-CSF), keratinocyte chemoattractant (KC) and interleukin-6 (IL-6). sLP-induced cytokines, particularly G-CSF, are likely mediators of the radioprotective/mitigative activity of sLP. This study illustrates the strong potential of LP-based TLR2 agonists for anti-radiation prophylaxis and therapy in defense and medical scenarios.	[Shakhov, Alexander N.; Bone, Frederick; Cheney, Alec; Kononov, Yevgeniy; Krasnov, Peter; Bratanova-Toshkova, Troitza K.; Shakhova, Vera V.; Young, Jason; Baker, Patricia S.; Gudkov, Andrei; Feinstein, Elena] Cleveland BioLabs Inc, Buffalo, NY USA; [Singh, Vijay K.] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Radiat Countermeasures Program, Bethesda, MD 20814 USA; [Singh, Vijay K.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Radiat Biol, Bethesda, MD 20814 USA; [Weil, Michael M.] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Panoskaltsis-Mortari, Angela] Univ Minnesota, Dept Pediat, Div Hematol Oncol & Blood & Marrow Transplant, Minneapolis, MN 55455 USA; [Panoskaltsis-Mortari, Angela] Univ Minnesota, Dept Med, Div Pulm Allergy & Crit Care Med, Minneapolis, MN 55455 USA; [Orschell, Christie M.] Indiana Univ Sch Med, Indianapolis, IN USA; [Gudkov, Andrei] Roswell Pk Canc Inst, Buffalo, NY 14263 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; Uniformed Services University of the Health Sciences - USA; Colorado State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Indiana University System; Indiana University Bloomington; Roswell Park Cancer Institute	Shakhov, AN (corresponding author), Cleveland BioLabs Inc, Buffalo, NY USA.	ashakhov@cbiolabs.com	Singh, Vijay/GWZ-8972-2022	Singh, Vijay/0000-0002-6631-3849; Gudkov, Andrei/0000-0003-2548-0154	National Institute of Allergy and Infectious Diseases [HHSN266200500043C]; Defense Advanced Research Projects Agency [W911NF-05-C-0001]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was partially supported by National Institute of Allergy and Infectious Diseases, contract # HHSN266200500043C. Defense Advanced Research Projects Agency contract # W911NF-05-C-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Akazawa T, 2004, CANCER RES, V64, P757, DOI 10.1158/0008-5472.CAN-03-1518; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Andreassen CN, 2003, SEMIN RADIAT ONCOL, V13, P62, DOI 10.1053/srao.2003.50006; Benjamin GC, 2009, ASSESSING MED PREPAR; Burdelya LG, 2011, INT J RAD ONCOL BIOL; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Dodd Mi., 2001, MANAGING SIDE EFFECT; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; Gratwohl A, 1998, BLOOD, V92, P765; Greenberger JS, 2009, IN VIVO, V23, P323; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; HIMES SR, 1993, ONCOGENE, V8, P3189; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Hudak S, 1998, EXP HEMATOL, V26, P515; ISLAM A, 1989, J MED, V20, P193; ITO Y, 1984, MICROBIOL IMMUNOL, V28, P847, DOI 10.1111/j.1348-0421.1984.tb00740.x; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kiura K, 2006, FEMS IMMUNOL MED MIC, V46, P78, DOI 10.1111/j.1574-695X.2005.00002.x; Kiura K, 2006, FEMS IMMUNOL MED MIC, V48, P44, DOI 10.1111/j.1574-695X.2006.00119.x; Koenig KL, 2005, ANN EMERG MED, V45, P643, DOI 10.1016/j.annemergmed.2005.01.020; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; LEIGH BR, 1995, RADIAT RES, V142, P12, DOI 10.2307/3578961; MacVittie Thomas J, 2002, Mil Med, V167, P68; MALICK MA, 1978, EXPERIENTIA, V34, P1216, DOI 10.1007/BF01922966; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; NETA R, 1991, J EXP MED, V173, P1177, DOI 10.1084/jem.173.5.1177; NETA R, 1986, J IMMUNOL, V136, P2483; Pellmar Terry C, 2005, Radiat Res, V163, P115, DOI 10.1667/RR3283; Potten CS, 2001, CELL GROWTH DIFFER, V12, P265; POTTEN CS, 1992, CANCER METAST REV, V11, P179, DOI 10.1007/BF00048063; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Schill T, 2012, EXP DERMATOL, V21, P91, DOI 10.1111/j.1600-0625.2011.01386.x; Schmidt J, 2007, BRIT J CANCER, V97, P598, DOI 10.1038/sj.bjc.6603903; Seed TM, 2003, PHYS GUIDE TERRORIST, P339; Shibata K, 2000, J IMMUNOL, V165, P6538, DOI 10.4049/jimmunol.165.11.6538; Singh VK, 2006, EXP MOL PATHOL, V81, P55, DOI 10.1016/j.yexmp.2005.11.002; Singh VK, 2005, EXP MOL PATHOL, V78, P156, DOI 10.1016/j.yexmp.2004.10.003; Srinivasan V, 2002, INT J RADIAT BIOL, V78, P535, DOI [10.1080/095530002317577358, 10.1080/09553000110112435]; Srinivasan V, 1997, ADV EXP MED BIOL, V400, P791; Stickney DR, 2007, INT IMMUNOPHARMACOL, V7, P500, DOI 10.1016/j.intimp.2006.12.005; Takeda K, 2002, J ENDOTOXIN RES, V8, P459, DOI 10.1179/096805102125001073; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tsujimoto H, 2005, J LEUKOCYTE BIOL, V78, P888, DOI 10.1189/jlb.0105051; WADDICK KG, 1991, BLOOD, V77, P2364; Wang Y, 2004, CANCER RES, V64, P6240, DOI 10.1158/0008-5472.CAN-04-0591; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Weiss JF, 2003, TOXICOLOGY, V189, P1, DOI 10.1016/S0300-483X(03)00149-5; Weiss JF, 2000, ANN NY ACAD SCI, V899, P44, DOI 10.1111/j.1749-6632.2000.tb06175.x; Whitnall MH, 2000, INT J IMMUNOPHARMACO, V22, P1, DOI 10.1016/S0192-0561(99)00059-4; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; ZSEBO KM, 1992, P NATL ACAD SCI USA, V89, P9464, DOI 10.1073/pnas.89.20.9464	55	55	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33044	10.1371/journal.pone.0033044	http://dx.doi.org/10.1371/journal.pone.0033044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479357	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900016
J	Polonelli, L; Ciociola, T; Magliani, W; Zanello, PP; D'Adda, T; Galati, S; De Bernardis, F; Arancia, S; Gabrielli, E; Pericolini, E; Vecchiarelli, A; Arruda, DC; Pinto, MR; Travassos, LR; Pertinhez, TA; Spisni, A; Conti, S				Polonelli, Luciano; Ciociola, Tecla; Magliani, Walter; Zanello, Pier Paolo; D'Adda, Tiziana; Galati, Serena; De Bernardis, Flavia; Arancia, Silvia; Gabrielli, Elena; Pericolini, Eva; Vecchiarelli, Anna; Arruda, Denise C.; Pinto, Marcia R.; Travassos, Luiz R.; Pertinhez, Thelma A.; Spisni, Alberto; Conti, Stefania			Peptides of the Constant Region of Antibodies Display Fungicidal Activity	PLOS ONE			English	Article							FUNGAL-INFECTIONS; CRYPTIC PEPTIDES; CDRS	Synthetic peptides with sequences identical to fragments of the constant region of different classes (IgG, IgM, IgA) of antibodies (Fc-peptides) exerted a fungicidal activity in vitro against pathogenic yeasts, such as Candida albicans, Candida glabrata, Cryptococcus neoformans, and Malassezia furfur, including caspofungin and triazole resistant strains. Alanine-substituted derivatives of fungicidal Fc-peptides, tested to evaluate the critical role of each residue, displayed unaltered, increased or decreased candidacidal activity in vitro. An Fc-peptide, included in all human IgGs, displayed a therapeutic effect against experimental mucosal and systemic candidiasis in mouse models. It is intriguing to hypothesize that some Fc-peptides may influence the antifungal immune response and constitute the basis for devising new antifungal agents.	[Polonelli, Luciano; Ciociola, Tecla; Magliani, Walter; Zanello, Pier Paolo; Conti, Stefania] Univ Parma, Dipartimento Patol & Med Lab, Sez Microbiol, I-43100 Parma, Italy; [D'Adda, Tiziana] Univ Parma, Dipartimento Patol & Med Lab, Sez Anat & Istol Patol, I-43100 Parma, Italy; [Galati, Serena] Univ Parma, Dipartimento Genet Biol Microrganismi Antropol, I-43100 Parma, Italy; [De Bernardis, Flavia; Arancia, Silvia] Ist Super Sanita, Dipartimento Malattie Infettive Parassitarie & Im, I-00161 Rome, Italy; [Gabrielli, Elena; Pericolini, Eva; Vecchiarelli, Anna] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, Sez Microbiol, I-06100 Perugia, Italy; [Arruda, Denise C.; Travassos, Luiz R.] Univ Fed Sao Paulo, Unidade Oncol Expt, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Arruda, Denise C.; Travassos, Luiz R.] Univ Fed Sao Paulo, Disciplina Biol Celular, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil; [Pinto, Marcia R.] Univ Sao Paulo, Dept Microbiol, BR-05508 Sao Paulo, Brazil; [Pertinhez, Thelma A.; Spisni, Alberto] Univ Parma, Dipartimento Med Sperimentale, I-43100 Parma, Italy	University of Parma; University of Parma; University of Parma; Istituto Superiore di Sanita (ISS); University of Perugia; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; University of Parma	Polonelli, L (corresponding author), Univ Parma, Dipartimento Patol & Med Lab, Sez Microbiol, I-43100 Parma, Italy.	stefania.conti@unipr.it	Spisni, Alberto/AAY-7778-2020; Pinto, Marcia Ribeiro/X-7362-2019; Travassos, Luiz R/J-3631-2012; Arruda, Denise C/E-2184-2013; Pericolini, Eva/AAZ-5848-2021; DE BERNARDIS, FLAVIA/C-9589-2016; , Denise/AAD-1162-2022; Galati, Serena/AAC-2865-2019; Ciociola, Tecla/AFN-5212-2022; Travassos, Luiz/V-2467-2019; Ciociola, Tecla/HCH-2453-2022; Conti, Stefania/N-3558-2015	Pinto, Marcia Ribeiro/0000-0001-6726-9459; Arruda, Denise C/0000-0002-8807-8835; DE BERNARDIS, FLAVIA/0000-0001-9440-8629; Galati, Serena/0000-0002-7901-8646; Ciociola, Tecla/0000-0001-6499-2545; Conti, Stefania/0000-0001-9973-8352; Arancia, Silvia/0000-0002-1451-0189; Vecchiarelli, Anna/0000-0002-3185-6720; Pericolini, Eva/0000-0002-5299-8197	Italian Ministry of Health [40H39]	Italian Ministry of Health(Ministry of Health, Italy)	The work has been supported by funding from the Italian Ministry of Health in the frame of the National AIDS Research Program (grant number 40H39). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autelitano DJ, 2006, DRUG DISCOV TODAY, V11, P306, DOI 10.1016/j.drudis.2006.02.003; BISTONI F, 1986, INFECT IMMUN, V51, P668, DOI 10.1128/IAI.51.2.668-674.1986; Calderone RA., 2002, CANDIDA CANDIDIASIS; Cenci E, 2006, J LEUKOCYTE BIOL, V79, P40, DOI 10.1189/jlb.0205113; COHEN S, 1964, ADV IMMUNOL, V4, P287, DOI 10.1016/S0065-2776(08)60710-5; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Gabrielli E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008187; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Leventakos K, 2010, CLIN INFECT DIS, V50, P405, DOI 10.1086/649879; Magliani W, 2009, CURR MED CHEM, V16, P2305, DOI 10.2174/092986709788453104; Ng JH, 2006, IDRUGS, V9, P343; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Pertinhez TA, 2009, MOL PHARMACEUT, V6, P1036, DOI 10.1021/mp900024z; Pimenta DC, 2007, PEPTIDES, V28, P2403, DOI 10.1016/j.peptides.2007.10.005; Polonelli L, 2003, INFECT IMMUN, V71, P6205, DOI 10.1128/IAI.71.11.6205-6212.2003; Polonelli L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002371; Samir P, 2011, AAPS J, V13, P152, DOI 10.1208/s12248-011-9252-2; SINGH NP, 1988, EXP CELL RES, V237, P123; Tortorano AM, 2006, INT J ANTIMICROB AG, V27, P359, DOI 10.1016/j.ijantimicag.2006.01.002; Ueki N, 2007, BIOPOLYMERS, V88, P190, DOI 10.1002/bip.20687; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823	22	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e34105	10.1371/journal.pone.0034105	http://dx.doi.org/10.1371/journal.pone.0034105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470523	gold, Green Published, Green Submitted			2022-12-27	WOS:000303857100067
J	Cheng, JC; Auersperg, N; Leung, PCK				Cheng, Jung-Chien; Auersperg, Nelly; Leung, Peter C. K.			EGF-Induced EMT and Invasiveness in Serous Borderline Ovarian Tumor Cells: A Possible Step in the Transition to Low-Grade Serous Carcinoma Cells?	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN EXPRESSION; ACTIVATED PROTEIN-KINASE; PROGNOSTIC-SIGNIFICANCE; SURFACE EPITHELIUM; DOWN-REGULATION; FACTOR RECEPTOR; T-ANTIGEN; CANCER	In high-grade ovarian cancer cultures, it has been shown that epidermal growth factor (EGF) induces cell invasion by activating an epithelial-mesenchymal transition (EMT). However, the effect of EGF on serous borderline ovarian tumors (SBOT) and low-grade serous carcinomas (LGC) cell invasion remains unknown. Here, we show that EGF receptor (EGFR) was expressed, that EGF treatment increased cell migration and invasion in two cultured SBOT cell lines, SBOT3.1 and SV40 large T antigen-infected SBOT cells (SBOT4-LT), and in two cultured LGC cell lines, MPSC1 and SV40 LT/ST-immortalized LGC cells (ILGC). However, EGF induced down-regulation of E-cadherin and concurrent up-regulation of N-cadherin in SBOT cells but not in LGC cells. In SBOT cells, the expression of the transcriptional repressors of E-cadherin, Snail, Slug and ZEB1 were increased by EGF treatment. Treatment with EGF led to the activation of the downstream ERK1/2 and PI3K/Akt. The MEK1 inhibitor PD98059 diminished the EGF-induced cadherin switch and the up-regulation of Snail, Slug and ZEB1 and the EGFmediated increase in SBOT cell migration and invasion. The PI3K inhibitor LY294002 had similar effects, but it could not block the EGF-induced up-regulation of N-cadherin and ZEB1. This study demonstrates that EGF induces SBOT cell migration and invasion by activating EMT, which involves the activation of the ERK1/2 and PI3K/Akt pathways and, subsequently, Snail, Slug and ZEB1 expression. Moreover, our results suggest that there are EMT-independent mechanisms that mediate the EGF-induced LGC cell migration and invasion.	[Cheng, Jung-Chien; Auersperg, Nelly; Leung, Peter C. K.] Univ British Columbia, Dept Obstet & Gynecol, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia	Cheng, JC (corresponding author), Univ British Columbia, Dept Obstet & Gynecol, Child & Family Res Inst, Vancouver, BC V5Z 1M9, Canada.	peter.leung@ubc.ca	Cheng, Jung-Chien/T-4258-2019	Cheng, Jung-Chien/0000-0002-5399-9327; Leung, Peter/0000-0003-3152-3800	Canadian Institutes of Health Research; Child & Family Research Institute Senior Investigator Award; BC Foundation for Non-Animal Research-Evelyn Martin Memorial Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Child & Family Research Institute Senior Investigator Award; BC Foundation for Non-Animal Research-Evelyn Martin Memorial Fellowship	This work was supported by an operating grant from the Canadian Institutes of Health Research to PCKL. PCKL is the recipient of a Child & Family Research Institute Senior Investigator Award. JCC is the recipient of BC Foundation for Non-Animal Research-Evelyn Martin Memorial Fellowship. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Barr S, 2008, CLIN EXP METASTAS, V25, P685, DOI 10.1007/s10585-007-9121-7; Bartlett JMS, 1996, BRIT J CANCER, V73, P301, DOI 10.1038/bjc.1996.53; BERCHUCK A, 1990, CANCER RES, V50, P4087; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; Castellvi J, 2006, CANCER-AM CANCER SOC, V107, P1801, DOI 10.1002/cncr.22195; Cheng JC, 2011, ONCOGENE, V30, P3930, DOI 10.1038/onc.2011.117; Cheng JC, 2011, ONCOGENE, V30, P1020, DOI 10.1038/onc.2010.486; Cheng JC, 2010, MOL ENDOCRINOL, V24, P1569, DOI 10.1210/me.2010-0034; Cho EY, 2006, PATHOL INT, V56, P62, DOI 10.1111/j.1440-1827.2006.01925.x; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Darai E, 1997, HUM PATHOL, V28, P922, DOI 10.1016/S0046-8177(97)90007-1; Ellerbroek SM, 2001, CANCER RES, V61, P1855; Eltabbakh GH, 1997, GYNECOL ONCOL, V65, P218, DOI 10.1006/gyno.1997.4661; Farley J, 2009, GYNECOL ONCOL, V113, P341, DOI 10.1016/j.ygyno.2009.02.009; Gershenson DM, 1998, CANCER, V83, P2157, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2157::AID-CNCR14>3.0.CO;2-D; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Krall JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015945; Kuwabara Y, 2008, CANCER SCI, V99, P1933, DOI 10.1111/j.1349-7006.2008.00946.x; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Nielsen JS, 2004, INT J GYNECOL CANCER, V14, P1086, DOI 10.1111/j.1048-891X.2004.14606.x; Niikura H, 1997, INT J GYNECOL PATHOL, V16, P60, DOI 10.1097/00004347-199701000-00010; O'Neill CJ, 2005, AM J SURG PATHOL, V29, P1034; Pohl G, 2005, CANCER RES, V65, P1994, DOI 10.1158/0008-5472.CAN-04-3625; RUBIN SC, 1993, AM J OBSTET GYNECOL, V168, P162, DOI 10.1016/S0002-9378(12)90907-2; Sablina AA, 2008, CANCER METAST REV, V27, P137, DOI 10.1007/s10555-008-9116-0; Sayan AE, 2009, P NATL ACAD SCI USA, V106, P14884, DOI 10.1073/pnas.0902042106; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Shih IM, 2005, CLIN CANCER RES, V11, P7273, DOI 10.1158/1078-0432.CCR-05-0755; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Steffensen KD, 2008, INT J ONCOL, V33, P195; Sundfeldt K, 1997, INT J CANCER, V74, P275, DOI 10.1002/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.3.CO;2-V; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; VEATCH AL, 1994, INT J CANCER, V58, P393, DOI 10.1002/ijc.2910580315; Vergara D, 2010, CANCER LETT, V291, P59, DOI 10.1016/j.canlet.2009.09.017; Woo MMM, 2008, INT J GYNECOL CANCER, V18, P1234, DOI 10.1111/j.1525-1438.2007.01171.x; Woo MM, 2008, GYNECOL ONCOL, V111, P125, DOI 10.1016/j.ygyno.2008.06.021; Woo MMM, 2007, IN VITRO CELL DEV-AN, V43, P7, DOI 10.1007/s11626-006-9002-4; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhou HY, 2007, ENDOCRINOLOGY, V148, P5195, DOI 10.1210/en.2007-0361	46	50	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34071	10.1371/journal.pone.0034071	http://dx.doi.org/10.1371/journal.pone.0034071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479527	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339100113
J	Guven, SC; Laska, M				Guven, Selcuk Can; Laska, Matthias			Olfactory Sensitivity and Odor Structure-Activity Relationships for Aliphatic Carboxylic Acids in CD-1 Mice	PLOS ONE			English	Article							REPRESENTATIONS; DISCRIMINATION; BULB; MAP	Using a conditioning paradigm, the olfactory sensitivity of CD-1 mice for a homologous series of aliphatic n-carboxylic acids (ethanoic acid to n-octanoic acid) and several of their isomeric forms was investigated. With all 14 odorants, the animals significantly discriminated concentrations as low as 0.03 ppm (parts per million) from the solvent, and with four odorants the best-scoring animals even detected concentrations as low as 3 ppt (parts per trillion). Analysis of odor structure-activity relationships showed that the correlation between olfactory detection thresholds of the mice for the unbranched carboxylic acids and carbon chain length can best be described as a U-shaped function with the lowest threshold values at n-butanoic acid. A significant positive correlation between olfactory detection thresholds and carbon chain length of the carboxylic acids with their branching next to the functional carboxyl group was found. In contrast, no such correlation was found for carboxylic acids with their branching at the distal end of the carbon chain relative to the functional carboxyl group. Finally, a significant correlation was found between olfactory detection thresholds and the position of the branching of the carboxylic acids. Across-species comparisons suggest that mice are more sensitive for short-chained (C-2 to C-4) aliphatic n-carboxylic acids than other mammalian species, but not for longer-chained ones (C-5 to C-8). Further comparisons suggest that odor structure-activity relationships are both substance class- and species-specific.	[Guven, Selcuk Can; Laska, Matthias] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden	Linkoping University	Guven, SC (corresponding author), Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden.	malas@ifm.liu.se		Laska, Matthias/0000-0001-5583-2697				Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; BRETTING H, 1972, Zeitschrift fuer Saeugetierkunde, V37, P286; Brown R.E., 1985, SOCIAL ODOURS MAMMAL, P345, DOI [10.1016/0376-6357(86)90097-5, DOI 10.1016/0376-6357(86)90097-5]; Cometto-Muniz JE, 2010, EXP BRAIN RES, V207, P75, DOI 10.1007/s00221-010-2430-0; Deiss V, 1997, PHYSIOL BEHAV, V61, P209, DOI 10.1016/S0031-9384(96)00402-7; Doty R. L., 2003, HDB OLFACTION GUSTAT, P203, DOI DOI 10.1201/9780203911457; Dykyi J, 2001, LANDOLT BORNSTEIN NU, V20; Gilad Y, 2004, PLOS BIOL, V2, P120, DOI 10.1371/journal.pbio.0020005; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Hastings L., 2003, HDB OLFACTION GUSTAT, P385; Johnson BA, 2000, J COMP NEUROL, V426, P330, DOI 10.1002/1096-9861(20001016)426:2<330::AID-CNE12>3.0.CO;2-5; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Johnson BA, 2009, J COMP NEUROL, V514, P658, DOI 10.1002/cne.22046; Joshi D, 2006, CHEM SENSES, V31, P655, DOI 10.1093/chemse/bjl006; Kosaka T, 2005, NEUROSCIENCE, V131, P611, DOI 10.1016/j.neuroscience.2004.11.050; Larsson L, 2011, NEUROSCI RES, V71, P355, DOI 10.1016/j.neures.2011.08.009; Laska M, 2000, CHEM SENSES, V25, P47, DOI 10.1093/chemse/25.1.47; Laska M, 2006, BEHAV BRAIN RES, V167, P349, DOI 10.1016/j.bbr.2005.09.022; Laska M, 2004, CHEM SENSES, V29, P101, DOI 10.1093/chemse/bjh010; LASKA M, 1990, J COMP PHYSIOL A, V166, P395; Laska M, 2008, J COMP PHYSIOL A, V194, P971, DOI 10.1007/s00359-008-0370-y; Laska M, 2009, J EXP ZOOL PART A, V311A, P278, DOI 10.1002/jez.527; Mandairon N, 2009, J NEUROSCI METH, V180, P296, DOI 10.1016/j.jneumeth.2009.04.008; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; MOULTON D. G., 1960, ANIMAL BEHAVIOUR, V8, P117, DOI 10.1016/0003-3472(60)90019-1; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; NEUHAUS W, 1953, Z VERGL PHYSIOL, V35, P527; PASSE DH, 1985, NEUROSCI BIOBEHAV R, V9, P431, DOI 10.1016/0149-7634(85)90021-1; Pearce J. M., 2008, ANIMAL LEARNING COGN, V3rd; Pho V, 2005, BEHAV BRAIN RES, V161, P245, DOI 10.1016/j.bbr.2005.02.011; SCHMIDT C, 1982, Z SAUGETIERKD, V47, P162; SCHMIDT U, 1975, Zeitschrift fuer Saeugetierkunde, V40, P269; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Stephan H., 1988, P1; van Gemert LJV., 2003, COMPILATIONS ODOUR T; Wallen H, 2012, AMINO ACIDS, V42, P1475, DOI 10.1007/s00726-011-0951-x; Weast RC., 1987, HDB CHEM PHYS, V68; Zhang XH, 2007, GENOMICS, V89, P441, DOI 10.1016/j.ygeno.2007.01.002; Zou DJ, 2004, SCIENCE, V304, P1976, DOI 10.1126/science.1093468	41	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34301	10.1371/journal.pone.0034301	http://dx.doi.org/10.1371/journal.pone.0034301			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479594	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100146
J	Leijs, R; van Nes, EH; Watts, CH; Cooper, SJB; Humphreys, WF; Hogendoorn, K				Leijs, Remko; van Nes, Egbert H.; Watts, Chris H.; Cooper, Steven J. B.; Humphreys, William F.; Hogendoorn, Katja			Evolution of Blind Beetles in Isolated Aquifers: A Test of Alternative Modes of Speciation	PLOS ONE			English	Article							MITOCHONDRIAL-DNA PHYLOGEOGRAPHY; SUBTERRANEAN DIVING BEETLES; SYMPATRIC SPECIATION; ECOLOGICAL SPECIATION; MATHEMATICAL-MODELS; ADAPTIVE RADIATION; YILGARN REGION; ARID ZONE; DYTISCIDAE; COLEOPTERA	Evidence is growing that not only allopatric but also sympatric speciation can be important in the evolution of species. Sympatric speciation has most convincingly been demonstrated in laboratory experiments with bacteria, but field-based evidence is limited to a few cases. The recently discovered plethora of subterranean diving beetle species in isolated aquifers in the arid interior of Australia offers a unique opportunity to evaluate alternative modes of speciation. This naturally replicated evolutionary experiment started 10-5 million years ago, when climate change forced the surface species to occupy geographically isolated subterranean aquifers. Using phylogenetic analysis, we determine the frequency of aquifers containing closely related sister species. By comparing observed frequencies with predictions from different statistical models, we show that it is very unlikely that the high number of sympatrically occurring sister species can be explained by a combination of allopatric evolution and repeated colonisations alone. Thus, diversification has occurred within the aquifers and likely involved sympatric, parapatric and/or microallopatric speciation.	[Leijs, Remko; Watts, Chris H.; Cooper, Steven J. B.] S Australian Museum, Adelaide, SA 5000, Australia; [Leijs, Remko; Cooper, Steven J. B.; Humphreys, William F.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Leijs, Remko] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA, Australia; [van Nes, Egbert H.] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, Wageningen, Netherlands; [Humphreys, William F.] Western Australian Museum, Welshpool, WA, Australia; [Humphreys, William F.] Univ Western Australia, Sch Anim Biol, Nedlands, WA 6009, Australia; [Hogendoorn, Katja] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia	University of Adelaide; Flinders University South Australia; Wageningen University & Research; Western Australian Museum; University of Western Australia; University of Adelaide	Leijs, R (corresponding author), S Australian Museum, Adelaide, SA 5000, Australia.	remko.leijs@samuseum.sa.gov.au	Cooper, Steven JB/I-6291-2012; van Nes, Egbert H/F-2681-2011	Leijs, Remko/0000-0001-6909-5659; van Nes, Egbert/0000-0002-6345-104X	Australian Research Council [A00106441, DP0663675, DP0346583]; Australian Biological Resources Study	Australian Research Council(Australian Research Council); Australian Biological Resources Study	This research was supported by Australian Research Council grants to SJBC, CHW and WFH (A00106441 and DP0663675) and RL (DP0346583), and by Australian Biological Resources Study grants to CHW and WFH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Babik W, 2009, MOL ECOL, V18, P3629, DOI 10.1111/j.1365-294X.2009.04306.x; Balke M, 2004, MOL PHYLOGENET EVOL, V32, P866, DOI 10.1016/j.ympev.2004.03.014; Bistrom O., 1997, Entomologica Basiliensia, V19, P57; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Butlin RK, 2008, PHILOS T R SOC B, V363, P2997, DOI 10.1098/rstb.2008.0076; Claessen D, 2000, AM NAT, V155, P219, DOI 10.1086/303315; Claessen D, 2002, EVOL ECOL RES, V4, P189; Cooper SJB, 2002, INVERTEBR SYST, V16, P589, DOI 10.1071/IT01039; Cooper SJB, 2008, INVERTEBR SYST, V22, P195, DOI 10.1071/IS07039; Cooper SJB, 2007, MOL ECOL, V16, P1533, DOI 10.1111/j.1365-294X.2007.03261.x; Coyne J.A., 2004, SPECIATION; Darwin C, 1859, ORIGING SPECIES MEAN; Davy-Bowker John, 2002, Aquatic Ecology, V36, P435, DOI 10.1023/A:1016550127986; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fairchild GW, 2000, FRESHWATER BIOL, V44, P523, DOI 10.1046/j.1365-2427.2000.00601.x; Fitzpatrick BM, 2008, J EVOLUTION BIOL, V21, P1452, DOI 10.1111/j.1420-9101.2008.01611.x; Fitzpatrick BM, 2009, J EVOLUTION BIOL, V22, P2342, DOI 10.1111/j.1420-9101.2009.01833.x; Fukami T, 2007, NATURE, V446, P436, DOI 10.1038/nature05629; Gavrilets S, 2003, EVOLUTION, V57, P2197; Gavrilets S, 2007, MOL ECOL, V16, P2893, DOI 10.1111/j.1365-294X.2007.03305.x; Gavrilets S, 2007, MOL ECOL, V16, P2910, DOI 10.1111/j.1365-294X.2007.03304.x; Gillespie R, 2004, SCIENCE, V303, P356, DOI 10.1126/science.1091875; Guzik MT, 2008, INVERTEBR SYST, V22, P205, DOI 10.1071/IS07040; Guzik MT, 2009, MOL ECOL, V18, P3683, DOI 10.1111/j.1365-294X.2009.04296.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Humphreys W.F., 2001, Records of the Western Australian Museum Supplement, V64, P63; Humphreys WF, 2009, HYDROBIOLOGIA, V626, P79, DOI 10.1007/s10750-009-9738-4; Juan C, 2010, MOL ECOL, V19, P3865, DOI 10.1111/j.1365-294X.2010.04759.x; Larson D. J., 2000, PREDACEOUS DIVING BE; Larson DJ, 1997, AUST J ENTOMOL, V36, P269, DOI 10.1111/j.1440-6055.1997.tb01469.x; Leys R, 2005, BIOL LETTERS, V1, P496, DOI 10.1098/rsbl.2005.0358; Leys R, 2003, EVOLUTION, V57, P2819, DOI 10.1111/j.0014-3820.2003.tb01523.x; Leys R, 2008, INVERTEBR SYST, V22, P217, DOI 10.1071/IS07034; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Martin Helene A., 1998, Proceedings of the Linnean Society of New South Wales, V119, P115; Mims MC, 2010, MOL ECOL, V19, P940, DOI 10.1111/j.1365-294X.2010.04529.x; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; Schluter D, 2001, TRENDS ECOL EVOL, V16, P283, DOI 10.1016/S0169-5347(01)02186-3; Stein R, 1986, SILICLASTIC SEDIMENT, P1437; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Taylor EB, 1999, BIOL J LINN SOC, V66, P271, DOI 10.1111/j.1095-8312.1999.tb01891.x; Vamosi JC, 2007, DIVERS DISTRIB, V13, P1, DOI 10.1111/j.1472-4642.2006.00299.x; Watts CHS, 2009, T ROY SOC SOUTH AUST, V133, P62, DOI 10.1080/03721426.2009.10887112; WATTS CHS, 1985, P ACAD NAT SCI PHILA, V137, P22; Watts CHS, 2002, CHECKLIST GUIDES IDE	50	31	34	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34260	10.1371/journal.pone.0034260	http://dx.doi.org/10.1371/journal.pone.0034260			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479581	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100141
J	Nielsen, M; Cucchiaro, J; Mohamedally, J				Nielsen, Mark; Cucchiaro, Jessica; Mohamedally, Jumana			When the Transmission of Culture Is Child's Play	PLOS ONE			English	Article							YOUNG-CHILDREN; OVER-IMITATION; TOOL USE; CHIMPANZEES; OVERIMITATION; PRETENSE; ORIGINS; PEOPLE; SCOPE	Background: Humans frequently engage in arbitrary, conventional behavior whose primary purpose is to identify with cultural in-groups. The propensity for doing so is established early in human ontogeny as children become progressively enmeshed in their own cultural milieu. This is exemplified by their habitual replication of causally redundant actions shown to them by adults. Yet children seemingly ignore such actions shown to them by peers. How then does culture get transmitted intra-generationally? Here we suggest the answer might be 'in play'. Principal Findings: Using a diffusion chain design preschoolers first watched an adult retrieve a toy from a novel apparatus using a series of actions, some of which were obviously redundant. These children could then show another child how to open the apparatus, who in turn could show a third child. When the adult modeled the actions in a playful manner they were retained down to the third child at higher rates than when the adult seeded them in a functionally oriented way. Conclusions: Our results draw attention to the possibility that play might serve a critical function in the transmission of human culture by providing a mechanism for arbitrary ideas to spread between children.	[Nielsen, Mark; Cucchiaro, Jessica; Mohamedally, Jumana] Univ Queensland, Sch Psychol, Early Cognit Dev Ctr, Brisbane, Qld, Australia	University of Queensland	Nielsen, M (corresponding author), Univ Queensland, Sch Psychol, Early Cognit Dev Ctr, Brisbane, Qld, Australia.	nielsen@psy.uq.edu.au	Nielsen, Mark/A-6792-2013	Nielsen, Mark/0000-0002-0402-8372	Australian Research Council [DP110100602]	Australian Research Council(Australian Research Council)	The authors gratefully acknowledge the support of the Australian Research Council (Discovery Project DP110100602) whose funding supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd R., 1985, CULTURE EVOLUTIONARY; Bretherton I., 1984, SYMBOLIC PLAY DEV SO, P271, DOI [10.1016/b978-0-12-132680-7.50014-4, DOI 10.1016/B978-0-12-132680-7.50014-4]; Carpenter M, 2008, J EXP CHILD PSYCHOL, V101, P225, DOI 10.1016/j.jecp.2008.09.005; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Csibra G., 2006, ATTENTION PERFORM, VXXI, P249; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; Flynn E, 2008, PHILOS T R SOC B, V363, P3541, DOI 10.1098/rstb.2008.0136; Flynn E, 2008, SOC DEV, V17, P699, DOI 10.1111/j.1467-9507.2007.00453.x; Flynn E, 2010, LEARN BEHAV, V38, P284, DOI 10.3758/LB.38.3.284; Gergely G., 2006, ROOTS HUMAN SOCIALIT, P229; Gergely G., 2005, INTERACT STUD, V6, P463, DOI [10.1075/is.6.3.10ger, DOI 10.1075/IS.6.3.10GER]; Gergely G, 2007, DEVELOPMENTAL SCI, V10, P139, DOI 10.1111/j.1467-7687.2007.00576.x; Haight WL, 1999, CHILD DEV, V70, P1477, DOI 10.1111/1467-8624.00107; HARRIS PL, 1993, MONOGRAPHS SOC RES C, V58; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Henrich J, 2010, NATURE, V466, P29, DOI 10.1038/466029a; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Kenward B, J EXPT CHIL IN PRESS; Kenward B, 2011, P ROY SOC B-BIOL SCI, V278, P1239, DOI 10.1098/rspb.2010.1399; LESLIE AM, 1987, PSYCHOL REV, V94, P412, DOI 10.1037/0033-295X.94.4.412; LILLARD AS, 1993, CHILD DEV, V64, P372, DOI 10.1111/j.1467-8624.1993.tb02915.x; Lyons DE, 2007, P NATL ACAD SCI USA, V104, P19751, DOI 10.1073/pnas.0704452104; Lyons DE, 2011, PHILOS T R SOC B, V366, P1158, DOI 10.1098/rstb.2010.0335; MCCUNENICOLICH L, 1981, CHILD DEV, V52, P785, DOI 10.2307/1129078; McGuigan N, J COMP PSYC IN PRESS; McGuigan N, 2011, BRIT J PSYCHOL, V102, P1, DOI 10.1348/000712610X493115; McGuigan N, 2010, EUR J DEV PSYCHOL, V7, P561, DOI 10.1080/17405620902858125; NAGELL K, 1993, J COMP PSYCHOL, V107, P174, DOI 10.1037/0735-7036.107.2.174; Nielsen M, J COMP PSYC IN PRESS; Nielsen M, 2006, DEV PSYCHOL, V42, P555, DOI 10.1037/0012-1649.42.3.555; Nielsen M, 2011, DEV PSYCHOL, V47, P1050, DOI 10.1037/a0023866; Nielsen M, 2010, AUST J PSYCHOL, V62, P67, DOI 10.1080/00049530902758613; Nielsen M, 2010, PSYCHOL SCI, V21, P729, DOI 10.1177/0956797610368808; Over H, J COMP PSYC IN PRESS; Perner J, 1991, UNDERSTANDING REPRES; Rakoczy H, 2005, EMORY S COG, P69; Rakoczy H, 2008, MIND LANG, V23, P499, DOI 10.1111/j.1468-0017.2008.00357.x; Rakoczy H, 2007, NEW DIR CHILD ADOLES, V115, P53, DOI 10.1002/cad.182; Schmidt MFH, 2011, DEVELOPMENTAL SCI, V14, P530, DOI 10.1111/j.1467-7687.2010.01000.x; Searle, 1995, CONSTRUCTION SOCIAL; Smith P. K., 2010, CHILDREN AND PLAY; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; Vygotsky L.S., 1978, MIND SOC DEV HIGHER, P79, DOI DOI 10.2307/J.CTVJF9VZ4.11; Whiten A, 2005, NATURE, V437, P52, DOI 10.1038/nature04023; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Zmyj N, INFANT CHIL IN PRESS	47	32	32	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34066	10.1371/journal.pone.0034066	http://dx.doi.org/10.1371/journal.pone.0034066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UC	22479524	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100112
J	Nutter, S; Cheung, M; Adler-Shohet, FC; Krusel, K; Vogel, K; Meyers, H				Nutter, Sandra; Cheung, Michele; Adler-Shohet, Felice C.; Krusel, Kathryn; Vogel, Kate; Meyers, Hildy			Evaluation of Indirect Fluorescent Antibody Assays Compared to Rapid Influenza Diagnostic Tests for the Detection of Pandemic Influenza A (H1N1) pdm09	PLOS ONE			English	Article							NEW-YORK-CITY; ANTIGEN TEST; VIRUS; IDENTIFICATION; PERFORMANCE; CHILDREN	Performance of indirect fluorescent antibody (IFA) assays and rapid influenza diagnostic tests (RIDT) during the 2009 H1N1 pandemic was evaluated, along with the relative effects of age and illness severity on test accuracy. Clinicians and laboratories submitted specimens on patients with respiratory illness to public health from April to mid October 2009 for polymerase chain reaction (PCR) testing as part of pandemic H1N1 surveillance efforts in Orange County, CA; IFA and RIDT were performed in clinical settings. Sensitivity and specificity for detection of the 2009 pandemic H1N1 strain, now officially named influenza A(H1N1) pdm09, were calculated for 638 specimens. Overall, approximately 30% of IFA tests and RIDTs tested by PCR were falsely negative (sensitivity 71% and 69%, respectively). Sensitivity of RIDT ranged from 45% to 84% depending on severity and age of patients. In hospitalized children, sensitivity of IFA (75%) was similar to RIDT (84%). Specificity of tests performed on hospitalized children was 94% for IFA and 80% for RIDT. Overall sensitivity of RIDT in this study was comparable to previously published studies on pandemic H1N1 influenza and sensitivity of IFA was similar to what has been reported in children for seasonal influenza. Both diagnostic tests produced a high number of false negatives and should not be used to rule out influenza infection.	[Nutter, Sandra; Krusel, Kathryn] Orange Cty Hlth Care Agcy, Publ Hlth Lab, Santa Ana, CA 92705 USA; [Adler-Shohet, Felice C.] Childrens Hosp Orange Cty, Div Infect Dis, Orange, CA 92668 USA; [Vogel, Kate] St Joseph Hosp, Clin Lab, Orange, CA USA	Childrens Hospital of Orange County	Nutter, S (corresponding author), Orange Cty Hlth Care Agcy, Publ Hlth Lab, Santa Ana, CA 92705 USA.	snutter@ochca.com	Adler-Shohet, Felice C/GYD-5038-2022					Bakerman P, 2011, J CLIN MICROBIOL, V49, P3673, DOI 10.1128/JCM.05255-11; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1029; Cruz AT, 2010, PEDIATRICS, V125, pE645, DOI 10.1542/peds.2009-3060; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Ganzenmueller T, 2010, J MED MICROBIOL, V59, P713, DOI 10.1099/jmm.0.017244-0; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Hawkes M, 2010, PEDIATRICS, V125, pE639, DOI 10.1542/peds.2009-2669; Higgins AD, 2010, J CLIN MICROBIOL, V48, P2677, DOI 10.1128/JCM.00978-10; Kok J, 2010, J CLIN MICROBIOL, V48, P290, DOI 10.1128/JCM.01465-09; Landry ML, 2010, J CLIN MICROBIOL, V48, P957, DOI 10.1128/JCM.01678-09; Landry ML, 2011, CURR OPIN PEDIATR, V23, P91, DOI 10.1097/MOP.0b013e328341ebd9; Leonardi GP, 2010, AM J CLIN PATHOL, V134, P910, DOI 10.1309/AJCPR7LTR5UUUYDT; Leonardi GP, 2010, J CLIN MICROBIOL, V48, P1189, DOI 10.1128/JCM.01657-09; Louie JK, 2010, EMERG INFECT DIS, V16, P824, DOI [10.3201/eid1605.091794, 10.3201/eid1605.091797]; Miroballi Y, 2010, ARCH PEDIAT ADOL MED, V164, P24, DOI 10.1001/archpediatrics.2009.259; Pollock NR, 2009, CLIN INFECT DIS, V49, pE66, DOI 10.1086/644502; Sandora TJ, 2010, PEDIATR INFECT DIS J, V29, P261, DOI 10.1097/INF.0b013e3181be9f9c; Uyeki T, 2009, NEW ENGL J MED, V361, pe114; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164	20	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33097	10.1371/journal.pone.0033097	http://dx.doi.org/10.1371/journal.pone.0033097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479360	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339100032
J	Schonrath, K; Klein-Szanto, AJ; Braunewell, KH				Schoenrath, Katharina; Klein-Szanto, Andres J.; Braunewell, Karl H.			The putative Tumor Suppressor VILIP-1 Counteracts Epidermal Growth Factor-Induced Epidermal-Mesenchymal Transition in Squamous Carcinoma Cells	PLOS ONE			English	Article							VISININ-LIKE PROTEIN-1; E-CADHERIN EXPRESSION; C6 GLIOMA-CELLS; CANCER-CELLS; IN-VITRO; TRANSFORMING GROWTH-FACTOR-BETA-1; KERATINOCYTE MIGRATION; TRANSCRIPTION FACTORS; ELEVATING AGENTS; EPITHELIAL-CELLS	Epithelial-mesenchymal transition (EMT) is a crucial step for the acquisition of invasive properties of carcinoma cells during tumor progression. Epidermal growth factor (EGF)-treatment of squamous cell carcinoma (SCC) cells provokes changes in the expression of lineage markers, morphological changes, and a higher invasive and metastatic potential. Here we show that chronic stimulation with EGF induces EMT in skin-derived SCC cell lines along with the down-regulation of the epithelial marker E-cadherin, and of the putative tumor suppressor VILIP-1 (visinin-like protein 1). In esophageal squamous cell carcinoma and non-small cell lung carcinoma the loss of VILIP-1 correlates with clinicopathological features related to enhanced invasiveness. VILIP-1 has previously been shown to suppress tumor cell invasion via enhancing cAMP-signaling in a murine SCC model. In mouse skin SCC cell lines the VILIP-1-negative tumor cells have low cAMP levels, whereas VILIP-1-positive SCCs possess high cAMP levels, but low invasive properties. We show that in VILIP-1-negative SCCs, Snail1, a transcriptional repressor involved in EMT, is up-regulated. Snail1 expression is reduced by ectopic VILIP-1-expression in VILIP-1-negative SCC cells, and application of the general adenylyl cyclase inhibitor 2',3'-dideoxyadenosine attenuated this effect. Conversely, EGF-stimulation of VILIP-1-positive SCC cells leads to the down-regulation of VILIP-1 and the induction of Snail1 expression. The induction of Snail is inhibited by elevated cAMP levels. The role of cAMP in EMT was further highlighted by its suppressive effect on the EGF-induced enhancement of migration in VILIP-1-positive SCC cells. These findings indicate that VILIP-1 is involved in EMT of SCC by regulating the transcription factor Snail1 in a cAMP-dependent manner.	[Schoenrath, Katharina; Braunewell, Karl H.] Charite, Inst Neurophysiol, Signal Transduct Res Grp, D-13353 Berlin, Germany; [Klein-Szanto, Andres J.] Fox Chase Canc Ctr, Dept Pathol, Philadelphia, PA 19111 USA; [Braunewell, Karl H.] Ruhr Univ Bochum, Inst Neurophysiol, Bochum, Germany; [Braunewell, Karl H.] So Res Inst, Dept Biochem & Mol Biol, Mol & Cellular Neurosci Lab, Birmingham, AL 35255 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Fox Chase Cancer Center; Ruhr University Bochum	Schonrath, K (corresponding author), Charite, Inst Neurophysiol, Signal Transduct Res Grp, D-13353 Berlin, Germany.	braunewell@sri.org			Deutsche Krebshilfe; National Institutes of Health [CA107257, CA06927]; NATIONAL CANCER INSTITUTE [R01CA107257, P30CA006927] Funding Source: NIH RePORTER	Deutsche Krebshilfe(Deutsche Krebshilfe); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by a grant from Deutsche Krebshilfe to KHB. AJK-S was supported from the National Institutes of Health CA107257, CA06927 and by an appropriation from the Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2006, AM J PHYSIOL-CELL PH, V290, pC1532, DOI 10.1152/ajpcell.00478.2005; Bachelder RE, 2005, J CELL BIOL, V168, P29, DOI 10.1083/jcb.200409067; Brackmann M, 2005, J CELL SCI, V118, P2495, DOI 10.1242/jcs.02376; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Braunewell KH, 1997, J NEUROCHEM, V68, P2129; Braunewell KH, 1997, NEUROSCI LETT, V234, P139, DOI 10.1016/S0304-3940(97)00696-4; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; De Craene B, 2005, CELL SIGNAL, V17, P535, DOI 10.1016/j.cellsig.2004.10.011; Deeb G, 2004, MODERN PATHOL, V17, P430, DOI 10.1038/modpathol.3800041; Dursun P, 2007, INT J GYNECOL CANCER, V17, P843, DOI 10.1111/j.1525-1438.2007.00876.x; Ellenrieder V, 2001, CANCER RES, V61, P4222; Fu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001698; Fujimoto K, 2001, EXP CELL RES, V266, P239, DOI 10.1006/excr.2000.5229; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Gilcrease MZ, 2007, CANCER LETT, V247, P1, DOI 10.1016/j.canlet.2006.03.031; Grandoch M, 2009, BRIT J CANCER, V101, P2038, DOI 10.1038/sj.bjc.6605439; Guerrico AMG, 2005, ONCOGENE, V24, P2307, DOI 10.1038/sj.onc.1208476; Hayashi H, 2009, THROMB HAEMOSTASIS, V102, P327, DOI 10.1160/TH08-12-0781; Hemavathy K, 2000, GENE, V257, P1, DOI 10.1016/S0378-1119(00)00371-1; Higashikawa K, 2009, INT J CANCER, V124, P2837, DOI 10.1002/ijc.24280; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Hoot KE, 2008, J CLIN INVEST, V118, P2722, DOI 10.1172/JCI33713; Houslay MD, 2010, NAT BIOTECHNOL, V28, P38, DOI 10.1038/nbt0110-38; Huber O, 1999, J CELL SCI, V112, P4415; Hudson LG, 2007, MOL CARCINOGEN, V46, P257, DOI 10.1002/mc.20257; IWASAKI T, 1994, J INVEST DERMATOL, V102, P891, DOI 10.1111/1523-1747.ep12383031; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Karmakar S, 2004, J REPROD IMMUNOL, V64, P9, DOI 10.1016/j.jri.2004.04.005; Kim A, 2009, EXP CELL RES, V315, P3325, DOI 10.1016/j.yexcr.2009.05.024; Kolosionek E, 2009, MOL BIOL CELL, V20, P4751, DOI 10.1091/mbc.E09-01-0019; Lee MY, 2008, CLIN CANCER RES, V14, P4743, DOI 10.1158/1078-0432.CCR-08-0234; Lin L, 2002, BIOCHEM BIOPH RES CO, V296, P827, DOI 10.1016/S0006-291X(02)00943-9; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lyle KS, 2008, CELL SIGNAL, V20, P1104, DOI 10.1016/j.cellsig.2008.01.018; Mahloogi H, 2003, CANCER RES, V63, P4997; McCawley LJ, 2000, MOL PHARMACOL, V58, P145, DOI 10.1124/mol.58.1.145; Mukai M, 2000, FEBS LETT, V484, P69, DOI 10.1016/S0014-5793(00)02129-3; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Pursiheimo JP, 2002, FEBS LETT, V521, P157, DOI 10.1016/S0014-5793(02)02864-8; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Santibanez JF, 2003, INT J CANCER, V107, P715, DOI 10.1002/ijc.11457; Schonrath K, 2011, MOL CARCINOGEN, V50, P319, DOI 10.1002/mc.20707; Shin SY, 2010, CANCER RES, V70, P6715, DOI 10.1158/0008-5472.CAN-10-1377; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tian Zhen, 2002, Shanghai Kou Qiang Yi Xue, V11, P350; Wickborn C, 2006, MOL CARCINOGEN, V45, P572, DOI 10.1002/mc.20201; Yokoyama K, 2001, ORAL ONCOL, V37, P65, DOI 10.1016/S1368-8375(00)00059-2; Zhang AH, 2006, AM J PHYSIOL-RENAL, V291, pF1332, DOI 10.1152/ajprenal.00131.2006	51	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33116	10.1371/journal.pone.0033116	http://dx.doi.org/10.1371/journal.pone.0033116			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479362	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100033
J	Tarasiuk, A; Reznor, G; Greenberg-Dotan, S; Reuveni, H				Tarasiuk, Ariel; Reznor, Gally; Greenberg-Dotan, Sari; Reuveni, Haim			Financial Incentive Increases CPAP Acceptance in Patients from Low Socioeconomic Background	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; OBSTRUCTIVE SLEEP-APNEA; HEALTH-CARE UTILIZATION; APNOEA/HYPOPNOEA SYNDROME; MEDICATION ADHERENCE; COST-EFFECTIVENESS; RISK-FACTOR; MORTALITY; HYPOPNEA; BENEFITS	Objective: We explored whether financial incentives have a role in patients' decisions to accept (purchase) a continuous positive airway pressure (CPAP) device in a healthcare system that requires cost sharing. Design: Longitudinal interventional study. Patients: The group receiving financial incentive (n = 137, 50.8 +/- 10.6 years, apnea/hypopnea index (AHI) 38.7 +/- 19.9 events/hr) and the control group (n = 121, 50.9 +/- 10.3 years, AHI 39.9 +/- 22) underwent attendant titration and a two-week adaptation to CPAP. Patients in the control group had a co-payment of $330-660; the financial incentive group paid a subsidized price of $55. Results: CPAP acceptance was 43% greater (p = 0.02) in the financial incentive group. CPAP acceptance among the low socioeconomic strata (n = 113) (adjusting for age, gender, BMI, tobacco smoking) was enhanced by financial incentive (OR, 95% CI) (3.43, 1.09-10.85), age (1.1, 1.03-1.17), AHI (>30 vs. <30) (4.87, 1.56-15.2), and by family/friends who had positive experience with CPAP (4.29, 1.05-17.51). Among average/high-income patients (n = 145) CPAP acceptance was affected by AHI (>30 vs. <30) (3.16, 1.14-8.75), living with a partner (8.82, 1.03-75.8) but not by the financial incentive. At one-year follow-up CPAP adherence was similar in the financial incentive and control groups, 35% and 39%, respectively (p = 0.82). Adherence rate was sensitive to education (+yr) (1.28, 1.06-1.55) and AHI (>30 vs. <30) (5.25, 1.34-18.5). Conclusions: Minimizing cost sharing reduces a barrier for CPAP acceptance among low socioeconomic status patients. Thus, financial incentive should be applied as a policy to encourage CPAP treatment, especially among low socioeconomic strata patients.	[Tarasiuk, Ariel; Reznor, Gally; Greenberg-Dotan, Sari; Reuveni, Haim] Ben Gurion Univ Negev, Fac Hlth Sci, Sleep Wake Disorders Unit, Dept Physiol,Soroka Univ,Med Ctr, Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center	Tarasiuk, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Sleep Wake Disorders Unit, Dept Physiol,Soroka Univ,Med Ctr, Beer Sheva, Israel.	tarasiuk@bgu.ac.il			Israel Institute for Health Policy and Health Services Research [A/147/2003]	Israel Institute for Health Policy and Health Services Research	This study was supported by a grant from the Israel Institute for Health Policy and Health Services Research, award no. A/147/2003. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarrak M, 2005, SLEEP, V28, P1306, DOI 10.1093/sleep/28.10.1306; Aloia MS, 2005, J CLIN SLEEP MED, V1, P346; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Martinez-Garcia MA, 2009, AM J RESP CRIT CARE, V180, P36, DOI 10.1164/rccm.200808-1341OC; Ayas NT, 2006, ARCH INTERN MED, V166, P977, DOI 10.1001/archinte.166.9.977; Bandura A., 1986, SOCIAL FDN THOUGHT A; Braithwaite RS, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000234; Brin YS, 2005, ISR MED ASSOC J, V7, P13; Chernew ME, 2008, HEALTH AFFAIR, V27, P103, DOI 10.1377/hlthaff.27.1.103; Chernew ME, 2010, HEALTH AFFAIR, V29, P530, DOI 10.1377/hlthaff.2009.0119; Choudhry NK, 2007, HEALTH AFFAIR, V26, P186, DOI 10.1377/hlthaff.26.1.186; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Fendrick A Mark, 2010, Am J Manag Care, V16, pS314; Fendrick AM, 2001, AM J MANAG CARE, V7, P861; Gay P, 2006, SLEEP, V29, P381, DOI 10.1093/sleep/29.3.381; Giuffrida A, 1997, BRIT MED J, V315, P703, DOI 10.1136/bmj.315.7110.703; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Greenberg Harly, 2004, Sleep Breath, V8, P185, DOI 10.1055/s-2004-860895; Guest JF, 2008, THORAX, V63, P860, DOI 10.1136/thx.2007.086454; Heisler M, 2004, MED CARE, V42, P626, DOI 10.1097/01.mlr.0000129352.36733.cc; Hoy CJ, 1999, AM J RESP CRIT CARE, V159, P1096, DOI 10.1164/ajrccm.159.4.9808008; Ip MSM, 2004, AM J RESP CRIT CARE, V169, P348, DOI 10.1164/rccm.200306-767OC; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; KUMP K, 1994, AM J RESP CRIT CARE, V150, P735, DOI 10.1164/ajrccm.150.3.8087345; Kushida CA, 2006, SLEEP, V29, P375, DOI 10.1093/sleep/29.3.375; Lettieri CJ, 2009, ANN INTERN MED, V151, P696, DOI 10.7326/0003-4819-151-10-200911170-00006; Maciejewski ML, 2010, HEALTH AFFAIR, V29, P2002, DOI 10.1377/hlthaff.2010.0571; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mahoney JJ, 2005, AM J MANAG CARE, V11, pS170; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marti S, 2002, EUR RESPIR J, V20, P1511, DOI 10.1183/09031936.02.00306502; McArdle N, 2001, THORAX, V56, P513, DOI 10.1136/thorax.56.7.513; McDaid C, 2009, Health Technol Assess, V13, piii, DOI 10.3310/hta13040; McDaid C, 2009, HEALTH TECHNOL ASSES, V13, P1; McDaid C, 2009, HEALTH TECHNOL ASSES, V13, P143, DOI DOI 10.3310/HTA13040; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Olsen S, 2008, EUR RESPIR J, V32, P710, DOI 10.1183/09031936.00127507; Platt AB, 2009, SLEEP, V32, P799, DOI 10.1093/sleep/32.6.799; Popescu G, 2001, THORAX, V56, P727, DOI 10.1136/thorax.56.9.727; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Reuveni H, 2008, EUR RESPIR J, V31, P273, DOI 10.1183/09031936.00097907; Reuveni H, 2004, SLEEP, V27, P1518, DOI 10.1093/sleep/27.8.1518; Reuveni H, 2002, HEALTH POLICY, V62, P1, DOI 10.1016/S0168-8510(02)00011-8; Simon-Tuval T, 2009, SLEEP, V32, P545, DOI 10.1093/sleep/32.4.545; Smith S, 2004, SLEEP MED, V5, P359, DOI 10.1016/j.sleep.2003.12.007; Stepnowsky CJ, 2002, SLEEP, V25, P758, DOI 10.1093/sleep/25.7.758; Sutherland K, 2008, MED CARE RES REV, V65, p36S, DOI 10.1177/1077558708324235; Tarasiuk A, 2008, J AM GERIATR SOC, V56, P247, DOI 10.1111/j.1532-5415.2007.01544.x; Tarasiuk A, 2006, CHEST, V130, P766, DOI 10.1378/chest.130.3.766; Weatherly HLA, 2009, INT J TECHNOL ASSESS, V25, P26, DOI 10.1017/S0266462309090047; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; Weaver TE, 2007, SLEEP, V30, P711, DOI 10.1093/sleep/30.6.711	54	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33178	10.1371/journal.pone.0033178	http://dx.doi.org/10.1371/journal.pone.0033178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UC	22479368	gold, Green Published			2022-12-27	WOS:000305339100037
J	Liu, X; Silverstein, PS; Singh, V; Shah, A; Qureshi, N; Kumar, A				Liu, Xun; Silverstein, Peter S.; Singh, Vijeta; Shah, Ankit; Qureshi, Nilofer; Kumar, Anil			Methamphetamine Increases LPS-Mediated Expression of IL-8, TNF-alpha and IL-1 beta in Human Macrophages through Common Signaling Pathways	PLOS ONE			English	Article							NF-KAPPA-B; DOPAMINE-RECEPTORS; DENDRITIC CELLS; BINDING PROTEIN; HIV-INFECTION; KINASE; DEATH; ACTIVATION; MECHANISMS; APOPTOSIS	The use of methamphetamine (MA) has increased in recent years, and is a major health concern throughout the world. The use of MA has been associated with an increased risk of acquiring HIV-1, along with an increased probability of the acquisition of various sexually transmitted infections. In order to determine the potential effects of MA exposure in the context of an infectious agent, U937 macrophages were exposed to various combinations of MA and bacterial lipopolysaccharide (LPS). Treatment with MA alone caused significant increases in the levels of TNF-alpha, while treatment with both MA and LPS resulted in significant increases in TNF-alpha, IL-1 beta and the chemokine IL-8. The increases in cytokine or chemokine levels seen when cells were treated with both LPS and MA were generally greater than those increases observed when cells were treated with only LPS. Treatment with chemical inhibitors demonstrated that the signal transduction pathways including NF-kB, MAPK, and P13-Akt were involved in mediating the increased inflammatory response. As discussed in the paper, these pathways appear to be utilized by both MA and LPS, in the induction of these inflammatory mediators. Since these pathways are involved in the induction of inflammation in response to other pathogens, this suggests that MA-exacerbated inflammation may be a common feature of infectious disease in MA abusers.	[Liu, Xun; Silverstein, Peter S.; Singh, Vijeta; Shah, Ankit; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Sch Med, Kansas City, MO 64110 USA; [Qureshi, Nilofer] Univ Missouri, Sch Med, Shock Trauma Res Ctr, Kansas City, MO 64108 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Liu, X (corresponding author), Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Sch Med, Kansas City, MO 64110 USA.	kumaran@umkc.edu	KUMAR, ANIL/ACD-8340-2022; Boothapati, Anil Kumar/HHS-1813-2022	SHAH, ANKIT/0000-0002-9771-8777	National Institute on Drug Abuse [DA025528, DA025011]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025528, R01DA025011] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute on Drug Abuse grants DA025528 and DA025011 to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreakos E, 2004, BLOOD, V103, P2229, DOI 10.1182/blood-2003-04-1356; Andreakos E, 2003, BLOOD, V101, P983, DOI 10.1182/blood-2002-06-1835; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Chen J, 2009, EUR J NEUROSCI, V29, P287, DOI 10.1111/j.1460-9568.2008.06590.x; Degenhardt L, INT J DRUG POLICY, V21, P347; Dos Santos S, 2007, ANN NY ACAD SCI, V1096, P70, DOI 10.1196/annals.1397.071; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Fleckenstein AE, 2009, NEUROPHARMACOLOGY, V56, P133, DOI 10.1016/j.neuropharm.2008.07.002; Gaskill PJ, 2009, AM J PATHOL, V175, P1148, DOI 10.2353/ajpath.2009.081067; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Kawai T, NAT IMMUNOL, V11, P373; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Lee MY, 2006, J CELL PHYSIOL, V208, P399, DOI 10.1002/jcp.20674; Liang H, 2008, AM J PATHOL, V172, P1617, DOI 10.2353/ajpath.2008.070971; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mahajan SD, 2006, MOL DIAGN THER, V10, P257, DOI 10.1007/BF03256465; Mannoury la Cour C, MOL PHARM, V79, P91; Nair MPN, 2009, J NEUROIMMUNE PHARM, V4, P129, DOI 10.1007/s11481-008-9128-0; Nair VD, 2003, BIOCHEM J, V373, P25, DOI 10.1042/BJ20030017; OAS, 2007, METH AB; Ojaniemi M, 2003, EUR J IMMUNOL, V33, P597, DOI 10.1002/eji.200323376; Qureshi N, 2003, J IMMUNOL, V171, P1515, DOI 10.4049/jimmunol.171.3.1515; Ragin AB, 2009, J NEUROVIROL, V15, P275, DOI 10.1080/13550280902913271; Rau TF, NEUROPHARMACOLOGY, V61, P677; Rawson RA, ANN REV PUBLIC HLTH, V31, P385; Reynolds JL, 2009, J CLIN IMMUNOL, V29, P646, DOI 10.1007/s10875-009-9309-5; Reynolds JL, IMMUNOL INVEST, V40, P481; Riddle EL, 2006, AAPS J, V8, pE413, DOI 10.1007/BF02854914; Riviere GJ, 2000, J PHARMACOL EXP THER, V292, P1042; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Takeuchi Y, 2003, J NEUROCHEM, V85, P729, DOI 10.1046/j.1471-4159.2003.01711.x; Talloczy Z, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040028; Tipton DA, TOXICOL IN VITRO, V24, P921; Valjent E, 2000, J NEUROSCI, V20, P8701; Xu WJ, 2005, SYNAPSE, V58, P110, DOI 10.1002/syn.20185; Zanassi P, 2001, J BIOL CHEM, V276, P11487, DOI 10.1074/jbc.M007631200	38	33	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33822	10.1371/journal.pone.0033822	http://dx.doi.org/10.1371/journal.pone.0033822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479453	Green Published, Green Submitted, gold			2022-12-27	WOS:000304523400038
J	Haber, M; Platt, DE; Bonab, MA; Youhanna, SC; Soria-Hernanz, DF; Martinez-Cruz, B; Douaihy, B; Ghassibe-Sabbagh, M; Rafatpanah, H; Ghanbari, M; Whale, J; Balanovsky, O; Wells, RS; Comas, D; Tyler-Smith, C; Zalloua, PA				Haber, Marc; Platt, Daniel E.; Bonab, Maziar Ashrafian; Youhanna, Sonia C.; Soria-Hernanz, David F.; Martinez-Cruz, Begona; Douaihy, Bouchra; Ghassibe-Sabbagh, Michella; Rafatpanah, Hoshang; Ghanbari, Mohsen; Whale, John; Balanovsky, Oleg; Wells, R. Spencer; Comas, David; Tyler-Smith, Chris; Zalloua, Pierre A.		Genographic Consortium	Afghanistan's Ethnic Groups Share a Y-Chromosomal Heritage Structured by Historical Events	PLOS ONE			English	Article							SHORT TANDEM REPEATS; GENETIC LANDSCAPE; MUTATION-RATE; POPULATION; STR; DIVERSITY; EXPANSIONS; HAPLOTYPES; DISTANCES; HEARTLAND	Afghanistan has held a strategic position throughout history. It has been inhabited since the Paleolithic and later became a crossroad for expanding civilizations and empires. Afghanistan's location, history, and diverse ethnic groups present a unique opportunity to explore how nations and ethnic groups emerged, and how major cultural evolutions and technological developments in human history have influenced modern population structures. In this study we have analyzed, for the first time, the four major ethnic groups in present-day Afghanistan: Hazara, Pashtun, Tajik, and Uzbek, using 52 binary markers and 19 short tandem repeats on the non-recombinant segment of the Y-chromosome. A total of 204 Afghan samples were investigated along with more than 8,500 samples from surrounding populations important to Afghanistan's history through migrations and conquests, including Iranians, Greeks, Indians, Middle Easterners, East Europeans, and East Asians. Our results suggest that all current Afghans largely share a heritage derived from a common unstructured ancestral population that could have emerged during the Neolithic revolution and the formation of the first farming communities. Our results also indicate that inter-Afghan differentiation started during the Bronze Age, probably driven by the formation of the first civilizations in the region. Later migrations and invasions into the region have been assimilated differentially among the ethnic groups, increasing inter-population genetic differences, and giving the Afghans a unique genetic diversity in Central Asia.	[Haber, Marc; Youhanna, Sonia C.; Douaihy, Bouchra; Ghassibe-Sabbagh, Michella; Zalloua, Pierre A.] Lebanese Amer Univ, Beirut, Lebanon; [Haber, Marc; Soria-Hernanz, David F.; Martinez-Cruz, Begona; Comas, David] Pompeu Fabra Univ, Evolutionary Biol Inst, Barcelona, Spain; [Platt, Daniel E.] IBM TJ Watson Res Ctr, Yorktown Hts, NY USA; [Bonab, Maziar Ashrafian; Whale, John] Univ Portsmouth, Sch Biol Sci, Portsmouth, Hants, England; [Rafatpanah, Hoshang; Ghanbari, Mohsen] Mashhad Univ Med Sci, Mashhad, Iran; [Balanovsky, Oleg] Russian Acad Med Sci, Med Genet Res Ctr, Moscow, Russia; [Soria-Hernanz, David F.; Wells, R. Spencer] Natl Geog Soc, Genog Project, Washington, DC USA; [Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Zalloua, Pierre A.] Harvard Univ, Harvard Sch Publ Hlth, Boston, MA 02115 USA	Lebanese American University; Pompeu Fabra University; International Business Machines (IBM); University of Portsmouth; Mashhad University Medical Science; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; National Geographic Society; Wellcome Trust Sanger Institute; Harvard University; Harvard T.H. Chan School of Public Health	Haber, M (corresponding author), Lebanese Amer Univ, Beirut, Lebanon.	pierre.zalloua@lau.edu.lb	Ghanbari, Mohsen/AAH-1340-2020; Ghassibe, Michella/A-7256-2011; Cooper, Alan/E-8171-2012; Comas, David/D-5382-2014; Bonab, Maziar Ashrafian/AAG-1686-2019; Rafatpanah, Houshang/O-7391-2018; Santos, Fabrício Rodrigues/H-2370-2011; Haak, Wolfgang/C-2362-2014; Ghassibe-Sabbagh, Michella/AAG-5710-2019; Haber, Marc/Y-5090-2019; Balanovsky, Oleg/G-1549-2014; Haber, Marc/D-2553-2012	Ghanbari, Mohsen/0000-0002-9476-7143; Cooper, Alan/0000-0002-7738-7851; Comas, David/0000-0002-5075-0956; Rafatpanah, Houshang/0000-0002-1061-5864; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Haak, Wolfgang/0000-0003-2475-2007; Ghassibe-Sabbagh, Michella/0000-0003-2107-9929; Haber, Marc/0000-0003-1000-1448; Haber, Marc/0000-0003-1000-1448; mele, marta/0000-0001-8874-6453; Royyuru, Ajay/0000-0003-4440-4755; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; youhanna, sonia/0000-0002-9376-8478; zalloua, pierre/0000-0002-8494-5081; Martinez-Cruz, Begona/0000-0003-1268-6620; Ashrafian Bonab, Maziar/0000-0002-9833-7976; Quintana-Murci, Lluis/0000-0003-2429-6320; Douaihy, Bouchra/0000-0001-7600-3409	Wellcome Trust; National Geographic Society; IBM; Waitt Family Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); National Geographic Society(National Geographic Society); IBM(International Business Machines (IBM)); Waitt Family Foundation	We thank the sample donors for taking part in this study. We also thank Dr. Christopher Thornton and Mr. Brian Johnsrud for their insightful comments. CTS is supported by The Wellcome Trust. The Genographic Project is supported by funding from the National Geographic Society, IBM, and the Waitt Family Foundation. Members of the Genographic Consortium: Janet S. Ziegle (Applied Biosystems, Foster City, California, United States); Li Jin & Shilin Li (Fudan University, Shanghai, China); Pandikumar Swamikrishnan (IBM, Somers, New York, United States); Asif Javed, Laxmi Parida & Ajay K. Royyuru (IBM, Yorktown Heights, New York, United States); Lluis Quintana-Murci (Institut Pasteur, Paris, France); R. John Mitchell (La Trobe University, Melbourne, Victoria, Australia); Syama Adhikarla, ArunKumar GaneshPrasad, Ramasamy Pitchappan & Arun Varatharajan Santhakumari (Madurai Kamaraj University, Madurai, Tamil Nadu, India); Angela Hobbs & Himla Soodyall (National Health Laboratory Service, Johannesburg, South Africa); Elena Balanovska (Research Centre for Medical Genetics, Russian Academy of Medical Sciences, Moscow, Russia); Daniela R. Lacerda & Fabricio R. Santos (Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil); Pedro Paulo Vieira (Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil); Jaume Bertranpetit & Marta Mele (Universitat Pompeu Fabra, Barcelona, Spain); Christina J. Adler, Alan Cooper, Clio S. I. Der Sarkissian & Wolfgang Haak (University of Adelaide, South Australia, Australia); Matthew E. Kaplan & Nirav C. Merchant (University of Arizona, Tucson, Arizona, United States); Colin Renfrew (University of Cambridge, Cambridge, United Kingdom); Andrew C. Clarke & Elizabeth A. Matisoo-Smith (University of Otago, Dunedin, New Zealand); Matthew C. Dulik, Jill B. Gaieski, Amanda C. Owings, Theodore G. Schurr & Miguel G. Vilar (University of Pennsylvania, Philadelphia, Pennsylvania, United States).	Alakoc YD, 2010, FORENSIC SCI INT-GEN, V4, pE135, DOI 10.1016/j.fsigen.2010.01.016; Balamurugan K, 2010, LEGAL MED, V12, P265, DOI 10.1016/j.legalmed.2010.05.008; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; BANDELT HJ, 1995, GENETICS, V141, P743; Batini C, 2011, MOL BIOL EVOL, V28, P2603, DOI 10.1093/molbev/msr089; Berti A, 2005, J FORENSIC SCI, V50, P1494; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; Chaix R, 2004, AM J HUM GENET, V75, P1113, DOI 10.1086/425938; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Di Cristofaro J, 2012, FORENSIC SCI INT-GEN, V6, pE44, DOI 10.1016/j.fsigen.2011.03.004; DUPREE L, 1964, SCIENCE, V146, P638, DOI 10.1126/science.146.3644.638; Dupree L., 1980, AFGHANISTAN-UK; El-Sibai M, 2009, ANN HUM GENET, V73, P568, DOI 10.1111/j.1469-1809.2009.00538.x; Elizabeth E, 2007, PERSEPOLIS PUNJAB EX; Emadi Hafizullah, 2005, CULTURE CUSTOMS AFGH; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Firasat S, 2007, EUR J HUM GENET, V15, P121, DOI 10.1038/sj.ejhg.5201726; Gimbutas M., 1970, INDOEUROPEAN INDOEUR, P155; Gomes V, 2010, HUM GENET, V127, P603, DOI 10.1007/s00439-010-0808-5; Gusmao L, 2006, FORENSIC SCI INT, V157, P187, DOI 10.1016/j.forsciint.2005.04.002; Haber M, 2011, EUR J HUM GENET, V19, P334, DOI 10.1038/ejhg.2010.177; Heyer E, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-49; Johanson Lars, 1998, TURKIC LANGUAGES; Jolliffe I, 1986, PRINCIPAL COPONENTS; Kovatsi L, 2009, FORENSIC SCI INT-GEN, V4, pE19, DOI 10.1016/j.fsigen.2009.01.001; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lacau H, 2011, LEGAL MED-TOKYO, V13, P103, DOI 10.1016/j.legalmed.2010.11.004; Library of Congress. Federal Research Division, 2001, AFGH COUNTR STUD, Vxlv; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Martinez-Cruz B, 2011, EUR J HUM GENET, V19, P216, DOI 10.1038/ejhg.2010.153; MONMONIER MS, 1973, GEOGR ANAL, V5, P245; Perez-Lezaun A, 1999, AM J HUM GENET, V65, P208, DOI 10.1086/302451; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Rebala K, 2011, FORENSIC SCI INT-GEN, V5, pE17, DOI 10.1016/j.fsigen.2009.10.011; Roewer L, 2008, INT J LEGAL MED, V122, P219, DOI 10.1007/s00414-007-0222-2; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Thangaraj K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015283; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; Volgyi A, 2009, FORENSIC SCI INT-GEN, V3, pE27, DOI 10.1016/j.fsigen.2008.04.006; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wilber D. N., 1962, AFGHANISTAN ITS PEOP; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yadav B, 2011, FORENSIC SCI INT-GEN, V5, pE63, DOI 10.1016/j.fsigen.2010.09.012; Zalloua PA, 2008, AM J HUM GENET, V83, P633, DOI 10.1016/j.ajhg.2008.10.012; Zerjal T, 2002, AM J HUM GENET, V71, P466, DOI 10.1086/342096; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105	50	36	36	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34288	10.1371/journal.pone.0034288	http://dx.doi.org/10.1371/journal.pone.0034288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470552	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000091
J	Martin, TA; Jayanthi, S; McCoy, MT; Brannock, C; Ladenheim, B; Garrett, T; Lehrmann, E; Becker, KG; Cadet, JL				Martin, Tracey A.; Jayanthi, Subramaniam; McCoy, Michael T.; Brannock, Christie; Ladenheim, Bruce; Garrett, Tiffany; Lehrmann, Elin; Becker, Kevin G.; Cadet, Jean Lud			Methamphetamine Causes Differential Alterations in Gene Expression and Patterns of Histone Acetylation/Hypoacetylation in the Rat Nucleus Accumbens	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; DOPAMINE-MEDIATED BEHAVIORS; INDUCED NEURONAL APOPTOSIS; INDUCED LOCOMOTOR-ACTIVITY; TRANSCRIPTIONAL REPRESSION; C-JUN; INDUCED REINSTATEMENT; CHOLECYSTOKININ-LIKE; FACTOR RECEPTORS; NUCLEOSOMAL DNA	Methamphetamine (METH) addiction is associated with several neuropsychiatric symptoms. Little is known about the effects of METH on gene expression and epigenetic modifications in the rat nucleus accumbens (NAC). Our study investigated the effects of a non-toxic METH injection (20 mg/kg) on gene expression, histone acetylation, and the expression of the histone acetyltransferase (HAT), ATF2, and of the histone deacetylases (HDACs), HDAC1 and HDAC2, in that structure. Microarray analyses done at 1, 8, 16 and 24 hrs after the METH injection identified METH-induced changes in the expression of genes previously implicated in the acute and longterm effects of psychostimulants, including immediate early genes and corticotropin-releasing factor (Crf). In contrast, the METH injection caused time-dependent decreases in the expression of other genes including Npas4 and cholecystokinin (Cck). Pathway analyses showed that genes with altered expression participated in behavioral performance, cell-to-cell signaling, and regulation of gene expression. PCR analyses confirmed the changes in the expression of c-fos, fosB, Crf, Cck, and Npas4 transcripts. To determine if the METH injection caused post-translational changes in histone markers, we used western blot analyses and identified METH-mediated decreases in histone H3 acetylated at lysine 9 (H3K9ac) and lysine 18 (H3K18ac) in nuclear sub-fractions. In contrast, the METH injection caused time-dependent increases in acetylated H4K5 and H4K8. The changes in histone acetylation were accompanied by decreased expression of HDAC1 but increased expression of HDAC2 protein levels. The histone acetyltransferase, ATF2, showed significant METH-induced increased in protein expression. These results suggest that METH-induced alterations in global gene expression seen in rat NAC might be related, in part, to METH-induced changes in histone acetylation secondary to changes in HAT and HDAC expression. The causal role that HATs and HDACs might play in METH-induced gene expression needs to be investigated further.	[Martin, Tracey A.; Jayanthi, Subramaniam; McCoy, Michael T.; Brannock, Christie; Ladenheim, Bruce; Garrett, Tiffany; Cadet, Jean Lud] NIDA, Mol Neuropsychiat Res Branch, NIH, Baltimore, MD 21224 USA; [Lehrmann, Elin; Becker, Kevin G.] NIA, Gene Express & Genom Unit, Intramural Res Program, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Martin, TA (corresponding author), NIDA, Mol Neuropsychiat Res Branch, NIH, Baltimore, MD 21224 USA.	jcadet@intra.nida.nih.gov	Jayanthi, Subramaniam/ABI-4023-2020	Becker, Kevin/0000-0002-6794-6656; Jayanthi, Subramaniam/0000-0002-5209-303X; Lehrmann, Elin/0000-0002-9869-9475	National Institutes of Health (NIDA); National Institutes of Health (NIA); NATIONAL INSTITUTE ON AGING [ZICAG000616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000552, ZIADA000551] Funding Source: NIH RePORTER	National Institutes of Health (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by the National Institutes of Health (Intramural Research Programs of NIDA and NIA). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHAFIZ HA, 1992, MOL ENDOCRINOL, V6, P2079, DOI 10.1210/me.6.12.2079; Archer TK, 2008, EXPERT OPIN THER TAR, V12, P1457, DOI [10.1517/14728222.12.10.1301 , 10.1517/14728220802384047, 10.1517/14728222.12.11.1457 , 10.1517/14728220802384013]; Barr AM, 2006, J PSYCHIATR NEUROSCI, V31, P301; Beato M, 1996, J MOL MED, V74, P711, DOI 10.1007/s001090050076; Beinfeld MC, 2003, LIFE SCI, V72, P747, DOI 10.1016/S0024-3205(02)02330-5; Belotserkovskaya R, 2004, BBA-GENE STRUCT EXPR, V1677, P87, DOI 10.1016/j.bbaexp.2003.09.017; Berger SL, 2010, COLD SH Q B, V75, P23, DOI 10.1101/sqb.2010.75.044; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; Bruhat A, 2007, NUCLEIC ACIDS RES, V35, P1312, DOI 10.1093/nar/gkm038; Cadet JL, 2011, DOSE-RESPONSE, V9, P165, DOI 10.2203/dose-response.10-011.Cadet; Cadet JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015643; Cadet JL, 2009, NEUROTOX RES, V15, P252, DOI 10.1007/s12640-009-9026-0; Cadet JL, 2001, SYNAPSE, V41, P40, DOI 10.1002/syn.1058; Cadet JL, 2010, CNS NEUROL DISORD DR; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; COLE BJ, 1989, PSYCHOPHARMACOLOGY, V99, P27, DOI 10.1007/BF00634448; CRAWLEY JN, 1985, PSYCHOPHARMACOL BULL, V21, P523; CRAWLEY JN, 1994, PEPTIDES, V15, P731, DOI 10.1016/0196-9781(94)90104-X; CRAWLEY JN, 1992, J NEUROSCI, V12, P3380; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; DECESARE D, 1995, ONCOGENE, V11, P365; DESOUZA EB, 1985, J NEUROSCI, V5, P3189; EMSON PC, 1980, LIFE SCI, V26, P2157, DOI 10.1016/0024-3205(80)90603-7; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Frankel PS, 2007, PHARMACOL BIOCHEM BE, V86, P511, DOI 10.1016/j.pbb.2007.01.012; Fukamauchi F, 1996, NEUROCHEM INT, V28, P391, DOI 10.1016/0197-0186(95)00104-2; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hall DA, 2008, PSYCHOPHARMACOLOGY, V195, P469, DOI 10.1007/s00213-007-0923-8; Holahan MR, 1997, PSYCHOPHARMACOLOGY, V130, P189, DOI 10.1007/s002130050228; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; HURD YL, 1992, BRAIN RES, V578, P317, DOI 10.1016/0006-8993(92)90264-A; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jayanthi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006092; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kawasaki H, 2000, Nucleic Acids Symp Ser, P259; Khan ANH, 2008, IMMUNOL RES, V40, P164, DOI 10.1007/s12026-007-0085-0; Koob GF, 2010, CURR OPIN INVEST DR, V11, P63; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; LEE DY, 1993, CELL, V72, P73, DOI 10.1016/0092-8674(93)90051-Q; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Lu L, 2003, J NEUROCHEM, V84, P1378, DOI 10.1046/j.1471-4159.2003.01635.x; Luscher C, 2011, NEURON, V69, P650, DOI 10.1016/j.neuron.2011.01.017; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; McCoy MT, 2011, PSYCHOPHARMACOLOGY, V215, P353, DOI 10.1007/s00213-010-2146-7; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Miller L, 2011, PHYSIOL BEHAV, V104, P312, DOI 10.1016/j.physbeh.2011.03.026; Moffett MC, 2007, PSYCHOPHARMACOLOGY, V190, P171, DOI 10.1007/s00213-006-0625-7; MORLEY JE, 1982, LIFE SCI, V31, P1459, DOI 10.1016/0024-3205(82)90007-8; Morrison BE, 2007, CELL MOL LIFE SCI, V64, P2258, DOI 10.1007/s00018-007-7035-9; Murr R, 2010, ADV GENET, V70, P101, DOI [10.1016/B978-0-12-380866-0.60005-8, 10.1016/S0065-2660(10)70005-5]; Mutskov V, 1998, MOL CELL BIOL, V18, P6293, DOI 10.1128/MCB.18.11.6293; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Northrup DL, 2011, IMMUNITY, V34, P830, DOI 10.1016/j.immuni.2011.06.002; Osley MA, 2006, RES PRO CEL, V41, P47, DOI 10.1007/006; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Primus RJ, 1997, NEUROPSYCHOPHARMACOL, V17, P308, DOI 10.1016/S0893-133X(97)00071-7; Rando OJ, 2007, CURR OPIN CELL BIOL, V19, P250, DOI 10.1016/j.ceb.2007.04.006; Razin SV, 2007, J MOL BIOL, V369, P597, DOI 10.1016/j.jmb.2007.04.003; Renthal W, 2009, SEMIN CELL DEV BIOL, V20, P387, DOI 10.1016/j.semcdb.2009.01.005; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Sarnyai Z, 2001, PHARMACOL REV, V53, P209; SAWCHENKO PE, 1993, CIBA F SYMP, V172, P5; Sawchenko PE, 1993, CIBA F SYMP, V172, P21; Schepers RJF, 2003, CLIN CHEM, V49, P121, DOI 10.1373/49.1.121; SEROOGY KB, 1987, EXP BRAIN RES, V68, P277; SEROOGY KB, 1989, J COMP NEUROL, V279, P397, DOI 10.1002/cne.902790306; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shalev U, 2010, BRAIN RES, V1314, P15, DOI 10.1016/j.brainres.2009.07.028; Sng JCG, 2005, NEUROSCI LETT, V386, P150, DOI 10.1016/j.neulet.2005.06.003; Thiriet N, 2005, J NEUROSCI, V25, P5273, DOI 10.1523/JNEUROSCI.4893-04.2005; Thomas DM, 2004, J NEUROCHEM, V88, P380, DOI 10.1046/j.1471-4159.2003.02182.x; Ura K, 1997, EMBO J, V16, P2096, DOI 10.1093/emboj/16.8.2096; VACCARINO FJ, 1989, BEHAV NEUROSCI, V103, P831, DOI 10.1037/0735-7044.103.4.831; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; van Dam H, 2001, ONCOGENE, V20, P2453, DOI 10.1038/sj.onc.1204239; VANDERHAEGHEN JJ, 1980, P NATL ACAD SCI-BIOL, V77, P1190, DOI 10.1073/pnas.77.2.1190; Verdone Loredana, 2006, Briefings in Functional Genomics & Proteomics, V5, P209, DOI 10.1093/bfgp/ell028; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; WEISS F, 1989, PSYCHOPHARMACOLOGY, V99, P409, DOI 10.1007/BF00445568; WEISS F, 1988, PHARMACOL BIOCHEM BE, V30, P309, DOI 10.1016/0091-3057(88)90460-1; Winter S, 2010, ESSAYS BIOCHEM, V48, P45, DOI [10.1042/bse0480045, 10.1042/BSE0480045]; Xi ZX, 2009, NEUROSCIENCE, V161, P392, DOI 10.1016/j.neuroscience.2009.03.060; YOSHIKAWA T, 1994, PEPTIDES, V15, P471, DOI 10.1016/0196-9781(94)90208-9; ZABORSZKY L, 1985, NEUROSCIENCE, V14, P427, DOI 10.1016/0306-4522(85)90302-1; Zhou Y, 1996, J PHARMACOL EXP THER, V279, P351	91	87	90	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34236	10.1371/journal.pone.0034236	http://dx.doi.org/10.1371/journal.pone.0034236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470541	Green Submitted, gold, Green Published			2022-12-27	WOS:000304489000080
J	Spruijt, NE; ReijmanHinze, J; Hens, G; Vander Poorten, V; van der Molen, ABM				Spruijt, Nicole E.; ReijmanHinze, Judith; Hens, Greet; Vander Poorten, Vincent; van der Molen, Aebele B. Mink			In Search of the Optimal Surgical Treatment for Velopharyngeal Dysfunction in 22q11.2 Deletion Syndrome: A Systematic Review	PLOS ONE			English	Review							OBSTRUCTIVE SLEEP-APNEA; PHARYNGEAL FLAP SURGERY; SUBMUCOUS CLEFT-PALATE; CARDIO-FACIAL SYNDROME; VELOCARDIOFACIAL SYNDROME; SPHINCTER PHARYNGOPLASTY; FURLOW PALATOPLASTY; ARTICULATION SKILLS; SPEECH OUTCOMES; WALL-MOTION	Background: Patients with the 22q11.2 deletion syndrome (22qDS) and velopharyngeal dysfunction (VPD) tend to have residual VPD following surgery. This systematic review seeks to determine whether a particular surgical procedure results in superior speech outcome or less morbidity. Methodology/Principal Findings: A combined computerized and hand-search yielded 70 studies, of which 27 were deemed relevant for this review, reporting on a total of 525 patients with 22qDS and VPD undergoing surgery for VPD. All studies were levels 2c or 4 evidence. The methodological quality of these studies was assessed using criteria based on the Cochrane Collaboration's tool for assessing risk of bias. Heterogeneous groups of patients were reported on in the studies. The surgical procedure was often tailored to findings on preoperative imaging. Overall, 50% of patients attained normal resonance, 48% attained normal nasal emissions scores, and 83% had understandable speech postoperatively. However, 5% became hyponasal, 1% had obstructive sleep apnea (OSA), and 17% required further surgery. There were no significant differences in speech outcome between patients who underwent a fat injection, Furlow or intravelar veloplasty, pharyngeal flap pharyngoplasty, Honig pharyngoplasty, or sphincter pharyngoplasty or Hynes procedures. There was a trend that a lower percentage of patients attained normal resonance after a fat injection or palatoplasty than after the more obstructive pharyngoplasties (11-18% versus 44-62%, p = 0.08). Only patients who underwent pharyngeal flaps or sphincter pharyngoplasties incurred OSA, yet this was not statistically significantly more often than after other procedures (p = 0.25). More patients who underwent a palatoplasty needed further surgery than those who underwent a pharyngoplasty (50% versus 7-13%, p = 0.03). Conclusions/Significance: In the heterogeneous group of patients with 22qDS and VPD, a grade C recommendation can be made to minimize the morbidity of further surgery by choosing to perform a pharyngoplasty directly instead of only a palatoplasty.	[Spruijt, Nicole E.; van der Molen, Aebele B. Mink] Univ Med Ctr, Dept Plast Surg, Utrecht, Netherlands; [ReijmanHinze, Judith] Free Univ Amsterdam, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Amsterdam, Netherlands; [Hens, Greet; Vander Poorten, Vincent] Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Louvain, Belgium	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam	Spruijt, NE (corresponding author), Univ Med Ctr, Dept Plast Surg, Utrecht, Netherlands.	mvdmolen.ea@planet.nl	Vander Poorten, Vincent/AEM-1939-2022	Hens, Greet/0000-0001-9690-7376; Vander Poorten, Vincent/0000-0003-1341-829X				Abyholm F, 2005, CLEFT PALATE-CRAN J, V42, P501; Agarwal T, 2003, J CRANIOFAC SURG, V14, P630, DOI 10.1097/00001665-200309000-00006; ARGAMASO RV, 1980, PLAST RECONSTR SURG, V66, P214, DOI 10.1097/00006534-198008000-00007; ARGAMASO RV, 1994, CLEFT PALATE-CRAN J, V31, P287, DOI 10.1597/1545-1569(1994)031<0287:TOAVIW>2.3.CO;2; Armour A, 2005, PLAST RECONSTR SURG, V115, P45, DOI 10.1097/01.PRS.0000145635.87742.AF; Arneja JS, 2008, PLAST RECONSTR SURG, V122, P845, DOI 10.1097/PRS.0b013e3181811a83; BARONE CM, 1994, PLAST RECONSTR SURG, V93, P279, DOI 10.1097/00006534-199402000-00007; Baylis AL, 2008, CLEFT PALATE-CRAN J, V45, P193, DOI 10.1597/06-012.1; Brandao GR, 2011, J CRANIOFAC SURG, V22, P1736, DOI 10.1097/SCS.0b013e31822e624f; Canady JW, 2007, PLAST RECONSTR SURG, V120, P506, DOI 10.1097/01.prs.0000267434.76665.11; Chegar BE, 2007, ARCH FACIAL PLAST S, V9, P252, DOI 10.1001/archfaci.9.4.252; Conley SF, 1997, AM J OTOLARYNG, V18, P38, DOI 10.1016/S0196-0709(97)90047-8; D'Antonio LL, 2001, PLAST RECONSTR SURG, V107, P1077, DOI 10.1097/00006534-200104010-00033; D'Antonio LL, 2001, CLEFT PALATE-CRAN J, V38, P455, DOI 10.1597/1545-1569(2001)038<0455:AOSCIC>2.0.CO;2; DAVISON PM, 1990, BRIT J PLAST SURG, V43, P187, DOI 10.1016/0007-1226(90)90160-2; Devriendt K, 1998, J MED GENET, V35, P789, DOI 10.1136/jmg.35.9.789-a; Dyce O, 2002, ARCH OTOLARYNGOL, V128, P1408, DOI 10.1001/archotol.128.12.1408; Eliez S, 2000, EUR CHILD ADOLES PSY, V9, P109, DOI 10.1007/s007870050005; Furlow LT, 2005, PLAST RECONSTR SURG, V116, P81, DOI 10.1097/01.PRS.0000169696.79882.DD; Gerdes M, 1999, AM J MED GENET, V85, P127, DOI 10.1002/(SICI)1096-8628(19990716)85:2<127::AID-AJMG6>3.0.CO;2-F; Ghanem AM, 2011, MOL SYNDROMOL, V1, P209; Goldberg S, 2005, PEDIATR PULM, V40, P205, DOI 10.1002/ppul.20230; GOLDINGKUSHNER KJ, 1990, CLEFT PALATE J, V27, P337, DOI 10.1597/1545-1569(1990)027<0337:SFTRON>2.3.CO;2; Goorhuis-Brouwer SM, 2003, CLEFT PALATE-CRAN J, V40, P190, DOI 10.1597/1545-1569(2003)040<0190:SLIICW>2.0.CO;2; Graham W P 3rd, 1973, Cleft Palate J, V10, P176; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Huang MHS, 1998, PLAST RECONSTR SURG, V101, P613, DOI 10.1097/00006534-199803000-00007; Husein M, 2004, J OTOLARYNGOL, V33, P222, DOI 10.2310/7070.2004.03082; Jackson AT, 2005, PLAST RECONSTR SURG, V115, P53, DOI 10.1097/01.PRS.0000145636.34356.D8; Karling J, 1999, CLEFT PALATE-CRAN J, V36, P166, DOI 10.1597/1545-1569(1999)036<0166:AOPWAA>2.3.CO;2; Karling J, 1999, CLEFT PALATE-CRAN J, V36, P154, DOI 10.1597/1545-1569(1999)036<0154:CBTTOP>2.3.CO;2; Keuning KHDM, 2009, INT J ORAL MAX SURG, V38, P1137, DOI 10.1016/j.ijom.2009.06.017; Kobrynski LJ, 2007, LANCET, V370, P1443, DOI 10.1016/S0140-6736(07)61601-8; KRAVATH RE, 1980, J PEDIATR-US, V96, P645, DOI 10.1016/S0022-3476(80)80730-X; Lam E, 2007, PLAST RECONSTR SURG, V120, P495, DOI 10.1097/01.prs.0000267438.18295.e4; Leuchter I, 2009, EUR ARCH OTORHINOLAR; LEWIS MB, 1980, CLEFT PALATE J, V17, P301; Lin KY, 1999, CLEFT PALATE-CRAN J, V36, P73, DOI 10.1597/1545-1569(1999)036<0073:LTOAOT>2.3.CO;2; LIPSON AH, 1991, J MED GENET, V28, P596, DOI 10.1136/jmg.28.9.596; Losken A, 2006, PLAST RECONSTR SURG, V117, P1493, DOI 10.1097/01.prs.0000206377.14083.ce; Losken A, 2003, PLAST RECONSTR SURG, V112, P1755, DOI 10.1097/01.PRS.0000090720.33554.8B; MACKENZIESTEPNER K, 1987, PLAST RECONSTR SURG, V80, P347, DOI 10.1097/00006534-198709000-00002; MARSH JL, 1980, PLAST RECONSTR SURG, V65, P592, DOI 10.1097/00006534-198005000-00009; Marsh JL, 2003, J CRANIOFAC SURG, V14, P621, DOI 10.1097/00001665-200309000-00004; MARSH JL, 1989, CLEFT PALATE J, V26, P46; McDonald-McGinn DM, 2011, MEDICINE, V90, P1, DOI 10.1097/MD.0b013e3182060469; Meek MF, 2003, ANN PLAS SURG, V50, P13, DOI 10.1097/00000637-200301000-00003; Mehendale FV, 2004, CLEFT PALATE-CRAN J, V41, P124, DOI 10.1597/01-110; Milczuk HA, 2007, CLEFT PALATE-CRAN J, V44, P412, DOI 10.1597/05-136.1; Mink van der Molen AB, 2008, J PLAST RECONSTR AES; Nicolas L, 2011, INT J PEDIAT OTORHIN; PEAT BG, 1994, PLAST RECONSTR SURG, V93, P948, DOI 10.1097/00006534-199404001-00008; Perkins JA, 2005, PLAST RECONSTR SURG, V116, P72, DOI 10.1097/01.PRS.0000169694.29082.69; Persson C, 2006, INT J LANG COMM DIS, V41, P313, DOI 10.1080/13682820500361497; Phillips B., 1998, OXFORD CTR EVIDENCE; Pryor LS, 2006, CLEFT PALATE-CRAN J, V43, P222, DOI 10.1597/04-115.1; Reade MC, 2008, CRIT CARE, V12, DOI 10.1186/cc6941; RISKI JE, 1979, CLEFT PALATE J, V16, P421; Rottgers SA, 2011, ANN PLAS SURG, V66, P479, DOI 10.1097/SAP.0b013e3182185ccb; Rouillon I, 2009, ARCH OTOLARYNGOL, V135, P652, DOI 10.1001/archoto.2009.64; Saitta SC, 2004, HUM MOL GENET, V13, P417, DOI 10.1093/hmg/ddh041; Scherer NJ, 1999, AM J MED GENET, V88, P714, DOI 10.1002/(SICI)1096-8628(19991215)88:6<714::AID-AJMG24>3.0.CO;2-B; SCHMELZEISEN R, 1992, PLAST RECONSTR SURG, V90, P774, DOI 10.1097/00006534-199211000-00006; Seagle MB, 2002, ANN PLAS SURG, V48, P464, DOI 10.1097/00000637-200205000-00003; SHER AE, 1986, INT J PEDIATR OTORHI, V11, P135, DOI 10.1016/S0165-5876(86)80008-8; SHPRINTZEN RJ, 1980, PLAST RECONSTR SURG, V66, P570, DOI 10.1097/00006534-198010000-00011; SHPRINTZEN RJ, 1988, INT ANESTHESIOL CLIN, V26, P79, DOI 10.1097/00004311-198802610-00016; Shprintzen RJ, 2008, DEV DISABIL RES REV, V14, P3, DOI 10.1002/ddrr.2; Sie KCY, 2008, ARCH OTOLARYNGOL, V134, P757, DOI 10.1001/archotol.134.7.757; Sie KCY, 2007, FACIAL PLAST SURG, V23, P128, DOI 10.1055/s-2007-979282; Sie KCY, 2001, PLAST RECONSTR SURG, V108, P17, DOI 10.1097/00006534-200107000-00004; Sie KCY, 1998, LARYNGOSCOPE, V108, P1211, DOI 10.1097/00005537-199808000-00021; Solot C, 2011, MOL SYNDROMOL, V1, P195; Sommerlad BC, 2002, CLEFT PALATE-CRAN J, V39, P295, DOI 10.1597/1545-1569(2002)039<0295:PRRR>2.0.CO;2; Spruijt NE, 2011, CLEFT PALATE CRANIOF; Swanson EW, 2011, PLAST RECONSTR SURG, V127, P2045, DOI 10.1097/PRS.0b013e31820e91e6; Tatum Sherard A 3rd, 2002, Arch Facial Plast Surg, V4, P73, DOI 10.1001/archfaci.4.2.73; Van Lierde KM, 2007, INT J PEDIATR OTORHI, V71, P721, DOI 10.1016/j.ijporl.2007.01.009; Vandevoort MJ, 2001, BRIT J PLAST SURG, V54, P192, DOI 10.1054/bjps.2000.3524; Wang GM, 2009, J CRANIOFAC SURG, V20, P1934, DOI 10.1097/SCS.0b013e3181b6cc9c; Widdershoven JCC, 2008, J PLAST RECONSTR AES, V61, P1016, DOI 10.1016/j.bjps.2008.02.007; Widdershoven JCC, CLEFT PALAT IN PRESS; Widdershoven JCC, 2008, ARCH OTOLARYNGOL, V134, P1159, DOI 10.1001/archotol.134.11.1159; Witt P, 1999, BRIT J PLAST SURG, V52, P613, DOI 10.1054/bjps.1999.3168; Witt PD, 1998, PLAST RECONSTR SURG, V101, P1457, DOI 10.1097/00006534-199805000-00004; Witt PD, 1998, PLAST RECONSTR SURG, V101, P1184, DOI 10.1097/00006534-199804050-00002; WITT PD, 1995, CLEFT PALATE-CRAN J, V32, P179, DOI 10.1597/1545-1569(1995)032<0179:MOTHV>2.3.CO;2; Ysunza A, 2004, INT J PEDIATR OTORHI, V68, P1499, DOI 10.1016/j.ijporl.2004.06.010; Ysunza A, 2002, PLAST RECONSTR SURG, V110, P1401, DOI 10.1097/01.PRS.0000029349.16221.FB; Ysunza A, 2001, PLAST RECONSTR SURG, V107, P9, DOI 10.1097/00006534-200101000-00002; Ysunza A, 2011, INT J PEDIATR OTORHI, V75, P1255, DOI 10.1016/j.ijporl.2011.07.001; Ysunza A, 2009, INT J PEDIATR OTORHI, V73, P1572, DOI 10.1016/j.ijporl.2009.08.007; ZWITMAN DH, 1982, CLEFT PALATE J, V19, P40	93	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34332	10.1371/journal.pone.0034332	http://dx.doi.org/10.1371/journal.pone.0034332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470558	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000097
J	Altshuler, AE; Penn, AH; Yang, JA; Kim, GR; Schmid-Schonbein, GW				Altshuler, Angelina E.; Penn, Alexander H.; Yang, Jessica A.; Kim, Ga-Ram; Schmid-Schoenbein, Geert W.			Protease Activity Increases in Plasma, Peritoneal Fluid, and Vital Organs after Hemorrhagic Shock in Rats	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; MATRIX METALLOPROTEINASES; ISCHEMIA-REPERFUSION; INTESTINAL ISCHEMIA; CYTOTOXIC MEDIATORS; LUNG INJURY; PERMEABILITY; ACTIVATION; TRAUMA; INHIBITION	Hemorrhagic shock (HS) is associated with high mortality. A severe decrease in blood pressure causes the intestine, a major site of digestive enzymes, to become permeable - possibly releasing those enzymes into the circulation and peritoneal space, where they may in turn activate other enzymes, e. g. matrix metalloproteinases (MMPs). If uncontrolled, these enzymes may result in pathophysiologic cleavage of receptors or plasma proteins. Our first objective was to determine, in compartments outside of the intestine (plasma, peritoneal fluid, brain, heart, liver, and lung) protease activities and select protease concentrations after hemorrhagic shock (2 hours ischemia, 2 hours reperfusion). Our second objective was to determine whether inhibition of proteases in the intestinal lumen with a serine protease inhibitor (ANGD), a process that improves survival after shock in rats, reduces the protease activities distant from the intestine. To determine the protease activity, plasma and peritoneal fluid were incubated with small peptide substrates for trypsin-, chymotrypsin-, and elastase-like activities or with casein, a substrate cleaved by multiple proteases. Gelatinase activities were determined by gelatin gel zymography and a specific MMP-9 substrate. Immunoblotting was used to confirm elevated pancreatic trypsin in plasma, peritoneal fluid, and lung and MMP-9 concentrations in all samples after hemorrhagic shock. Caseinolytic, trypsin-, chymotrypsin-, elastase-like, and MMP-9 activities were all significantly (p<0.05) upregulated after hemorrhagic shock regardless of enteral pretreatment with ANGD. Pancreatic trypsin was detected by immunoblot in the plasma, peritoneal space, and lungs after hemorrhagic shock. MMP-9 concentrations and activities were significantly upregulated after hemorrhagic shock in plasma, peritoneal fluid, heart, liver, and lung. These results indicate that protease activities, including that of trypsin, increase in sites distant from the intestine after hemorrhagic shock. Proteases, including pancreatic proteases, may be shock mediators and potential targets for therapy in shock.	[Altshuler, Angelina E.; Penn, Alexander H.; Yang, Jessica A.; Kim, Ga-Ram; Schmid-Schoenbein, Geert W.] Univ Calif San Diego, Dept Bioengn, Inst Engn Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Altshuler, AE (corresponding author), Univ Calif San Diego, Dept Bioengn, Inst Engn Med, La Jolla, CA 92093 USA.	aaltshul@ucsd.edu	Altshuler, Angelina/I-8023-2012	Kotov, Jessica Amy/0000-0002-1205-5178; Penn, Alexander/0000-0002-0774-1835	National Institutes of Health (NIH) [GM-85072]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL105373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085072] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) GM-85072. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUBRY M, 1976, BIOCHIM BIOPHYS ACTA, V438, P221, DOI 10.1016/0005-2744(76)90238-2; BOHLEN HG, 1975, AM J PHYSIOL, V229, P1159, DOI 10.1152/ajplegacy.1975.229.5.1159; Chang M, 2011, SHOCK; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; Davis GE, 2010, J MOL CELL CARDIOL, V48, P454, DOI 10.1016/j.yjmcc.2009.09.002; Deitch EA, 2003, SHOCK, V19, P452, DOI 10.1097/01.shk.0000048899.46342.f6; Deitch EA, 2010, ANN NY ACAD SCI, V1207, pE103, DOI 10.1111/j.1749-6632.2010.05713.x; DeLano FA, 2008, HYPERTENSION, V52, P415, DOI 10.1161/HYPERTENSIONAHA.107.104356; Doerner AM, 2011, INT J CLIN EXP MED, V4, P67; Duncan ME, 1998, EUR J BIOCHEM, V258, P37, DOI 10.1046/j.1432-1327.1998.2580037.x; Fitzal F, 2002, J VASC RES, V39, P320, DOI 10.1159/000065544; GEARING AJH, 1995, J LEUKOCYTE BIOL, V57, P774, DOI 10.1002/jlb.57.5.774; Ishimaru K, 2004, SHOCK, V22, P467, DOI 10.1097/01.shk.0000142253.31006.8c; Kunugi S, 2010, LAB INVEST; KUROIWA K, 1989, CLIN CHEM, V35, P2169; Lalu MM, 2005, EUR HEART J, V26, P27, DOI 10.1093/eurheratj/ehi007; LARGMAN C, 1986, DIGEST DIS SCI, V31, P961, DOI 10.1007/BF01303217; Malinoski DJ, 2009, J TRAUMA, V67, P445, DOI 10.1097/TA.0b013e3181b5dc11; Mitsuoka H, 2000, SHOCK, V14, P522, DOI 10.1097/00024382-200014050-00005; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Penn AH, 2011, SHOCK; Penn AH, 2008, AM J PHYSIOL-HEART C, V294, pH1779, DOI 10.1152/ajpheart.00902.2007; Penn AH, 2007, SHOCK, V27, P296, DOI 10.1097/01.shk.0000235139.20775.7f; Rosario HS, 2004, AM J PATHOL, V164, P1707, DOI 10.1016/S0002-9440(10)63729-7; ROUMEN RMH, 1993, ARCH SURG-CHICAGO, V128, P453; Rushing GD, 2008, ANN SURG, V247, P929, DOI 10.1097/SLA.0b013e31816757f7; Sato H, 2008, MED SCI MONITOR, V14, pBR79; Schonbeck U, 1998, J IMMUNOL, V161, P3340; Shi Han-ping, 2004, Chin J Traumatol, V7, P36; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; STAUB NC, 1981, ANNU REV MED, V32, P291, DOI 10.1146/annurev.me.32.020181.001451; Sun ZW, 1998, SHOCK, V10, P203, DOI 10.1097/00024382-199809000-00009; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Tien H, 2007, CAN J SURG, V50, P202; TODD TRJ, 1978, J APPL PHYSIOL, V45, P298, DOI 10.1152/jappl.1978.45.2.298; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Waldow T, 2009, J SURG RES, V152, P198, DOI 10.1016/j.jss.2008.03.014; Watkins AC, 2008, J TRAUMA, V64, P126, DOI 10.1097/TA.0b013e3181574a8a; WHITTAM JH, 1973, CRYOBIOLOGY, V10, P240, DOI 10.1016/0011-2240(73)90037-0; ZINGARELLI B, 1994, AM J PHYSIOL, V266, pH1512, DOI 10.1152/ajpheart.1994.266.4.H1512	40	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e32672	10.1371/journal.pone.0032672	http://dx.doi.org/10.1371/journal.pone.0032672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479334	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900010
J	Karbowski, J				Karbowski, Jan			Approximate Invariance of Metabolic Energy per Synapse during Development in Mammalian Brains	PLOS ONE			English	Article							CEREBRAL GLUCOSE-UTILIZATION; CELLULAR SCALING RULES; POSTNATAL-DEVELOPMENT; VISUAL-CORTEX; TRANSMITTER RELEASE; PYRAMIDAL NEURONS; SYNAPTOGENESIS; LIFE; MATURATION; PLASTICITY	During mammalian development the cerebral metabolic rate correlates qualitatively with synaptogenesis, and both often exhibit bimodal temporal profiles. Despite these non-monotonic dependencies, it is found based on empirical data for different mammals that regional metabolic rate per synapse is approximately conserved from birth to adulthood for a given species (with a slight deviation from this constancy for human visual and temporal cortices during adolescence). A typical synapse uses about (7 +/- 2).10(3) glucose molecules per second in primate cerebral cortex, and about five times of that amount in cat and rat visual cortices. A theoretical model for brain metabolic expenditure is used to estimate synaptic signaling and neural spiking activity during development. It is found that synaptic efficacy is generally inversely correlated with average firing rate, and, additionally, synapses consume a bulk of metabolic energy, roughly 50-90% during most of the developmental process (except human temporal cortex <50%). Overall, these results suggest a tight regulation of brain electrical and chemical activities during the formation and consolidation of neural connections. This presumably reflects strong energetic constraints on brain development.	Polish Acad Sci, Inst Biocybernet & Biomed Engn, Warsaw, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences	Karbowski, J (corresponding author), Polish Acad Sci, Inst Biocybernet & Biomed Engn, Warsaw, Poland.	jkarbowski@mimuw.edu.pl		Karbowski, Jan/0000-0001-5560-4723	Polish Ministry of Science and Education [NN 518 409238]; EU [FP7-PEOPLE-2007-IRG-210538]	Polish Ministry of Science and Education(Ministry of Science and Higher Education, Poland); EU(European Commission)	The work was supported by the grant from the Polish Ministry of Science and Education (NN 518 409238), and by the Marie Curie Actions EU grant FP7-PEOPLE-2007-IRG-210538. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGHAJANIAN G. K., 1967, BRAIN RES, V6, P716, DOI 10.1016/0006-8993(67)90128-X; AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Allman J.M., 1999, EVOLVING BRAINS; Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; BOURGEOIS JP, 1993, J NEUROSCI, V13, P2801; BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Chechik G, 1999, NEURAL COMPUT, V11, P2061, DOI 10.1162/089976699300016089; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; CHUGANI HT, 1991, J CEREBR BLOOD F MET, V11, P35, DOI 10.1038/jcbfm.1991.4; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Frick A, 2007, J PHYSIOL-LONDON, V585, P103, DOI 10.1113/jphysiol.2007.141788; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gonzalez-Burgos G, 2008, CEREB CORTEX, V18, P626, DOI 10.1093/cercor/bhm095; Herculano-Houzel S, 2007, P NATL ACAD SCI USA, V104, P3562, DOI 10.1073/pnas.0611396104; Herculano-Houzel S, 2006, P NATL ACAD SCI USA, V103, P12138, DOI 10.1073/pnas.0604911103; Herculano-Houzel S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017514; Herndon JG, 1999, J COMP NEUROL, V409, P567; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; JACOBS B, 1995, CEREB CORTEX, V5, P222, DOI 10.1093/cercor/5.3.222; JAHR CE, 1990, J NEUROSCI, V10, P3178; Kaas JonH., 2000, BRAIN MIND, V1, P7, DOI DOI 10.1023/A:1010028405318; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Karbowski J, 2004, J COMPUT NEUROSCI, V17, P347, DOI 10.1023/B:JCNS.0000044876.28268.18; Karbowski J, 2003, J COMPUT NEUROSCI, V15, P347, DOI 10.1023/A:1027467911225; Karbowski J, 2001, PHYS REV LETT, V86, P3674, DOI 10.1103/PhysRevLett.86.3674; Karbowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026709; Karbowski J, 2009, J COMPUT NEUROSCI, V27, P415, DOI 10.1007/s10827-009-0153-7; Karbowski J, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-18; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kinnala A, 1996, ARCH DIS CHILD-FETAL, V74, pF153, DOI 10.1136/fn.74.3.F153; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Le Be JV, 2006, P NATL ACAD SCI USA, V103, P13214, DOI 10.1073/pnas.0604691103; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; McGlashan TH, 2000, ARCH GEN PSYCHIAT, V57, P637, DOI 10.1001/archpsyc.57.7.637; MITCHISON G, 1992, TRENDS NEUROSCI, V15, P122, DOI 10.1016/0166-2236(92)90352-9; Montgomery JM, 2004, TRENDS NEUROSCI, V27, P744, DOI 10.1016/j.tins.2004.10.006; Moore AH, 2000, DEV BRAIN RES, V120, P141, DOI 10.1016/S0165-3806(00)00005-5; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; NEHLIG A, 1988, J NEUROSCI, V8, P2321; Noda A, 2002, BRAIN RES, V936, P76, DOI 10.1016/S0006-8993(02)02558-1; Pakkenberg B, 1997, J COMP NEUROL, V384, P312, DOI 10.1002/(SICI)1096-9861(19970728)384:2<312::AID-CNE10>3.0.CO;2-K; RAKIC P, 1994, PROG BRAIN RES, V102, P227; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Silberberg G, 2005, TRENDS NEUROSCI, V28, P541, DOI 10.1016/j.tins.2005.08.004; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; VANOOYEN A, 1994, J THEOR BIOL, V167, P27, DOI 10.1006/jtbi.1994.1047; VanOoyen A, 2003, DEV COGN NEUROSCI, P1; Volgushev M, 2004, J NEUROPHYSIOL, V92, P212, DOI 10.1152/jn.01166.2003; Wen Q, 2005, PLOS COMPUT BIOL, V1, P617, DOI 10.1371/journal.pcbi.0010078; WINFIELD DA, 1981, BRAIN RES, V206, P166, DOI 10.1016/0006-8993(81)90110-4; Yoshimura Y, 1999, NEUROSCIENCE, V88, P347, DOI 10.1016/S0306-4522(98)00382-0; ZECEVIC N, 1989, DEV BRAIN RES, V50, P11, DOI 10.1016/0165-3806(89)90124-7; Zecevic N, 1991, CEREB CORTEX, V1, P510, DOI 10.1093/cercor/1.6.510; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	75	12	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33425	10.1371/journal.pone.0033425	http://dx.doi.org/10.1371/journal.pone.0033425			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479396	gold, Green Published, Green Submitted			2022-12-27	WOS:000303894900028
J	Kawashima, M; Kawakita, T; Inaba, T; Okada, N; Ito, M; Shimmura, S; Watanabe, M; Shinmura, K; Tsubota, K				Kawashima, Motoko; Kawakita, Tetsuya; Inaba, Takaaki; Okada, Naoko; Ito, Masataka; Shimmura, Shigeto; Watanabe, Mitsuhiro; Shinmura, Ken; Tsubota, Kazuo			Dietary Lactoferrin Alleviates Age-Related Lacrimal Gland Dysfunction in Mice	PLOS ONE			English	Article							BOVINE LACTOFERRIN; DRY EYE; GASTROINTESTINAL-TRACT; OXIDATIVE DAMAGE; PROTEIN PROFILES; MITOCHONDRIAL; RESTRICTION; DNA; CHOLESTEROL; DISEASE	Background: Decrease in lacrimal gland secretory function is related to age-induced dry eye disease. Lactoferrin, the main glycoprotein component of tears, has multiple functions, including anti-inflammatory effects and the promotion of cell growth. We investigated how oral administration of lactoferrin affects age-related lacrimal dysfunction. Methods and Findings: Twelve-month-old male C57BL/6Cr Slc mice were randomly divided into a control fed group and an oral lactoferrin treatment group. Tear function was measured at a 6-month time-point. After euthanasia, the lacrimal glands were subjected to histological examination with 8-hydroxy-2'-deoxyguanosine (8-OHdG) antibodies, and serum concentrations of 8-OHdG and hexanoyl-lysine adduct (HEL) were evaluated. Additionally, monocyte chemotactic protein-1(MCP-1) and tumor necrosis factor-alpha (TNF-alpha) gene expression levels were determined by real-time PCR. The volume of tear secretion was significantly larger in the treated group than in the control. Lactoferrin administration reduced inflammatory cell infiltration and the MCP-1 and TNF-alpha expression levels. Serum concentrations of 8-OHdG and HEL in the lactoferrin group were lower than those in the control group and were associated with attenuated 8-OHdG immunostaining of the lacrimal glands. Conclusion: Oral lactoferrin administration preserves lacrimal gland function in aged mice by attenuating oxidative damage and suppressing subsequent gland inflammation.	[Kawashima, Motoko; Kawakita, Tetsuya; Inaba, Takaaki; Okada, Naoko; Shimmura, Shigeto; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Shinmura, Ken] Keio Univ, Sch Med, Div Geriatr Med, Dept Internal Med, Tokyo, Japan; [Ito, Masataka] Natl Def Med Coll, Dept Ophthalmol, Saitama, Japan	Keio University; Keio University; National Defense Medical College - Japan	Kawashima, M (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	motoko-k@a3.keio.jp; tsubota@z3.keio.jp	Shinmura, Ken/L-9168-2013; Shimmura, Shigeto/J-4678-2013; 岡田, 直子/GRI-9555-2022	岡田, 直子/0000-0002-3378-5778; Shinmura, Ken/0000-0002-1419-3574	NRL Pharma, Kawasaki, Japan	NRL Pharma, Kawasaki, Japan	Financial support was provided by NRL Pharma, Kawasaki, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Benna S, 2006, ARTERIOSCL THROM VAS, V26, P218, DOI 10.1161/01.ATV.0000193626.22269.45; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baveye S, 1999, CLIN CHEM LAB MED, V37, P281, DOI 10.1515/CCLM.1999.049; Brock JH, 2002, BIOCHEM CELL BIOL, V80, P1, DOI 10.1139/o01-212; Burrow H, 2011, MED CHEM, V7, P224, DOI 1573-4064/11 $58.00+.00; Conneely OM, 2001, J AM COLL NUTR, V20, p389S, DOI 10.1080/07315724.2001.10719173; DANJO Y, 1994, ACTA OPHTHALMOL, V72, P433; Dogru M, 2007, OPHTHALMOLOGY, V114, P2366, DOI 10.1016/j.ophtha.2007.06.027; Draper CE, 1999, EXP EYE RES, V68, P265, DOI 10.1006/exer.1998.0605; Draper CE, 1998, J AUTONOM NERV SYST, V69, P173, DOI 10.1016/S0165-1838(98)00026-5; Fischer R, 2007, INT IMMUNOPHARMACOL, V7, P1387, DOI 10.1016/j.intimp.2007.05.019; Flanagan JL, 2009, BIOCHIMIE, V91, P35, DOI 10.1016/j.biochi.2008.07.007; Fritsche KL, 2001, J AM COLL NUTR, V20, p396S, DOI 10.1080/07315724.2001.10719174; Fujihara T, 1998, J OCUL PHARMACOL TH, V14, P99, DOI 10.1089/jop.1998.14.99; Fujihara T, 2000, CORNEA, V19, P207, DOI 10.1097/00003226-200003000-00015; GILLETTE TE, 1980, AM J OPHTHALMOL, V90, P30, DOI 10.1016/S0002-9394(14)75074-3; Green-Church KB, 2008, MOL VIS, V14, P456; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P259, DOI 10.1042/bj1990259; Hadziahmetovic M, 2011, INVEST OPHTH VIS SCI, V52, P959, DOI 10.1167/iovs.10-6207; Hayashida K, 2004, J VET MED SCI, V66, P149, DOI 10.1292/jvms.66.149; Higuchi A, 2011, FREE RADICAL BIO MED, V51, P2210, DOI 10.1016/j.freeradbiomed.2011.09.025; Hudson EK, 1998, FREE RADICAL RES, V29, P573, DOI 10.1080/10715769800300611; JENSEN OL, 1986, ACTA OPHTHALMOL, V64, P83; Kanyshkova TG, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1, DOI 10.1023/A:1002817226110; Kawashima M, 2010, BIOCHEM BIOPH RES CO, V397, P724, DOI 10.1016/j.bbrc.2010.06.018; Kushibiki S, 2009, ANIM SCI J, V80, P258, DOI 10.1111/j.1740-0929.2009.00642.x; Kuwata H, 1998, BIOCHEM J, V334, P321, DOI 10.1042/bj3340321; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Legrand D, 2005, CELL MOL LIFE SCI, V62, P2549, DOI 10.1007/s00018-005-5370-2; Li N, 2005, J PROTEOME RES, V4, P2052, DOI 10.1021/pr0501970; Lindmark-Mansson H, 2000, BRIT J NUTR, V84, pS103; MCCOLLUM CJ, 1994, CORNEA, V13, P505; MCGILL JI, 1984, BRIT J OPHTHALMOL, V68, P316, DOI 10.1136/bjo.68.5.316; Merono T, 2011, EUR J CLIN INVEST, V41, P479, DOI 10.1111/j.1365-2362.2010.02429.x; Morimoto-Tochigi A, 2010, INVEST OPHTH VIS SCI, V51, P4395, DOI 10.1167/iovs.09-4573; NAGASAKO Y, 1993, J DAIRY SCI, V76, P1876, DOI 10.3168/jds.S0022-0302(93)77520-7; OBATA H, 1995, OPHTHALMOLOGY, V102, P678, DOI 10.1016/S0161-6420(95)30971-2; Ogawa Y, 2001, INVEST OPHTH VIS SCI, V42, P111; Ohashi Y, 2003, AM J OPHTHALMOL, V136, P291, DOI 10.1016/S0002-9394(03)00203-4; Ono T, 2011, BRIT J NUTR, V105, P200, DOI 10.1017/S0007114510003259; Pattamatta U, 2009, INVEST OPHTH VIS SCI, V50, P1636, DOI 10.1167/iovs.08-1882; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Rios JD, 2005, EXP EYE RES, V80, P477, DOI 10.1016/j.exer.2004.10.012; Shimmura S, 1998, INVEST OPHTH VIS SCI, V39, P1346; Shoji H, 2007, PEDIATR RES, V61, P89, DOI 10.1203/01.pdr.0000250198.22735.20; Takeuchi T, 2004, BRIT J NUTR, V91, P533, DOI 10.1079/BJN20041090; Takeuchi T, 2006, EXP PHYSIOL, V91, P1033, DOI 10.1113/expphysiol.2006.034876; Toyokuni S, 1996, FREE RADICAL BIO MED, V20, P859, DOI 10.1016/0891-5849(95)02184-1; Tsubota A, 2008, J HEPATOL, V48, P486, DOI 10.1016/j.jhep.2007.11.013; Yamada M, 2005, BRIT J OPHTHALMOL, V89, P803, DOI 10.1136/bjo.2004.055822	51	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33148	10.1371/journal.pone.0033148	http://dx.doi.org/10.1371/journal.pone.0033148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479365	gold, Green Published, Green Submitted			2022-12-27	WOS:000303894900018
J	Lang, ML; Kanost, MR; Gorman, MJ				Lang, Minglin; Kanost, Michael R.; Gorman, Maureen J.			Multicopper Oxidase-3 Is a Laccase Associated with the Peritrophic Matrix of Anopheles gambiae	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BILIRUBIN OXIDASE; TOBACCO HORNWORM; FUNGAL LACCASES; MANDUCA-SEXTA; SPECIFICITY; MIDGUT; SYSTEM; REDOX; IDENTIFICATION	The multicopper oxidase (MCO) family of enzymes includes laccases, which oxidize a broad range of substrates including polyphenols and phenylendiamines; ferroxidases, which oxidize ferrous iron; and several other oxidases with specific substrates such as ascorbate, bilirubin or copper. The genome of Anopheles gambiae, a species of mosquito, encodes five putative multicopper oxidases. Of these five, only AgMCO2 has known enzymatic and physiological functions: it is a highly conserved laccase that functions in cuticle pigmentation and tanning by oxidizing dopamine and dopamine derivatives. AgMCO3 is a mosquito-specific gene that is expressed predominantly in adult midguts and Malpighian tubules. To determine its enzymatic function, we purified recombinant AgMCO3 and analyzed its activity. AgMCO3 oxidized hydroquinone (a p-diphenol), the five o-diphenols tested, 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS), and p-phenylenediamine, but not ferrous iron. The catalytic efficiencies of AgMCO3 were similar to those of cuticular laccases (MCO2 orthologs), except that AgMCO3 oxidized all of the phenolic substrates with similar efficiencies whereas the MCO2 isoforms were less efficient at oxidizing catechol or dopa. These results demonstrate that AgMCO3 can be classified as a laccase and suggest that AgMCO3 has a somewhat broader substrate specificity than MCO2 orthologs. In addition, we observed AgMCO3 immunoreactivity in the peritrophic matrix, which functions as a selective barrier between the blood meal and midgut epithelial cells, protecting the midgut from mechanical damage, pathogens, and toxic molecules. We propose that AgMCO3 may oxidize toxic molecules in the blood meal leading to detoxification or to cross-linking of the molecules to the peritrophic matrix, thus targeting them for excretion.	[Lang, Minglin; Kanost, Michael R.; Gorman, Maureen J.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Lang, Minglin] Agr Univ Hebei, Coll Life Sci, Baoding, Peoples R China	Kansas State University; Hebei Agricultural University	Lang, ML (corresponding author), Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA.	mgorman@ksu.edu		Kanost, Michael/0000-0002-6827-0061; Gorman, Maureen/0000-0003-2005-6223	National Institute of Allergy and Infectious Diseases [R01AI070864]; National Institutes of Health [P20-RR017686]; National Institutes of Health from IDeA Networks of Biomedical Research Excellence (INBRE) of National Center for Research Resources [P20 RR-016464]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464, P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070864] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from IDeA Networks of Biomedical Research Excellence (INBRE) of National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant Number R01AI070864 from the National Institute of Allergy and Infectious Diseases. The Center of Biomedical Research Excellence (COBRE) Confocal Microfluorometry and Microscopy Core Facility is supported by Kansas State University and the National Institutes of Health Grant P20-RR017686. The Nevada Proteomics Center is supported by National Institutes of Health Grant Number P20 RR-016464 from the IDeA Networks of Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; Baez S, 1997, BIOCHEM J, V324, P25, DOI 10.1042/bj3240025; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Barbehenn RV, 2001, ARCH INSECT BIOCHEM, V47, P86, DOI 10.1002/arch.1039; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Benedict M. Q., 1997, The molecular biology of insect disease vectors: a methods manual., P3; Bertrand T, 2002, BIOCHEMISTRY-US, V41, P7325, DOI 10.1021/bi0201318; Bettedi L, 2011, J EXP BIOL, V214, P971, DOI 10.1242/jeb.051664; Chen HJ, 2004, BLOOD, V103, P3933, DOI 10.1182/blood-2003-09-3139; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Corena MD, 2005, J EXP BIOL, V208, P3263, DOI 10.1242/jeb.01739; Coy MR, 2010, INSECT BIOCHEM MOLEC, V40, P723, DOI 10.1016/j.ibmb.2010.07.004; Devenport M, 2006, BIOCHEMISTRY-US, V45, P9540, DOI 10.1021/bi0605991; Dinglasan RR, 2009, INSECT BIOCHEM MOLEC, V39, P125, DOI 10.1016/j.ibmb.2008.10.010; Dittmer NT, 2010, INSECT BIOCHEM MOLEC, V40, P179, DOI 10.1016/j.ibmb.2010.02.006; Dittmer NT, 2004, INSECT BIOCHEM MOLEC, V34, P29, DOI 10.1016/j.ibmb.2003.08.003; Eggert C, 1996, APPL ENVIRON MICROB, V62, P1151, DOI 10.1128/AEM.62.4.1151-1158.1996; Gorman MJ, 2008, INSECT BIOCHEM MOLEC, V38, P817, DOI 10.1016/j.ibmb.2008.07.001; Gorman MJ, 2012, INSECT BIOCHEM MOLEC, V42, P193, DOI 10.1016/j.ibmb.2011.11.010; Gupta N, 2010, J MOL CATAL B-ENZYM, V62, P230, DOI 10.1016/j.molcatb.2009.10.012; Hattori M, 2005, J INSECT PHYSIOL, V51, P1359, DOI 10.1016/j.jinsphys.2005.08.010; Hegedus D, 2009, ANNU REV ENTOMOL, V54, P285, DOI 10.1146/annurev.ento.54.110807.090559; Kallio JP, 2009, J MOL BIOL, V392, P895, DOI 10.1016/j.jmb.2009.06.053; Kallio JP, 2011, FEBS J, V278, P2283, DOI 10.1111/j.1742-4658.2011.08146.x; Kuraishi T, 2011, P NATL ACAD SCI USA, V108, P15966, DOI 10.1073/pnas.1105994108; Matera I, 2008, INORG CHIM ACTA, V361, P4129, DOI 10.1016/j.ica.2008.03.091; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Parkinson NM, 2003, COMP BIOCHEM PHYS C, V134, P513, DOI 10.1016/S1532-0456(03)00041-3; Pascoa V, 2002, INSECT BIOCHEM MOLEC, V32, P517, DOI 10.1016/S0965-1748(01)00130-8; Quintanar L, 2007, ACCOUNTS CHEM RES, V40, P445, DOI 10.1021/ar600051a; Sakurai T, 2007, CHEM REC, V7, P220, DOI 10.1002/tcr.20125; Shao L, 2001, ARCH INSECT BIOCHEM, V47, P119, DOI 10.1002/arch.1042; Sidjanski S, 1997, J PARASITOL, V83, P686, DOI 10.2307/3284247; Tadesse MA, 2008, ORG BIOMOL CHEM, V6, P868, DOI 10.1039/b716002j; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; THOMAS BR, 1989, INSECT BIOCHEM, V19, P611, DOI 10.1016/0020-1790(89)90095-4; WHITEHEAD DL, 1960, NATURE, V185, P610, DOI 10.1038/185610a0; Xu F, 1996, BIOCHEMISTRY-US, V35, P7608, DOI 10.1021/bi952971a; Xu F, 1996, BBA-PROTEIN STRUCT M, V1292, P303, DOI 10.1016/0167-4838(95)00210-3; Zhukhlistova NE, 2008, CRYSTALLOGR REP+, V53, P92, DOI 10.1134/S1063774508010124	40	27	28	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33985	10.1371/journal.pone.0033985	http://dx.doi.org/10.1371/journal.pone.0033985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479493	Green Submitted, Green Published, gold			2022-12-27	WOS:000303894900055
J	Li, H; Liu, WZ; Liang, PJ				Li, Hao; Liu, Wen-Zhong; Liang, Pei-Ji			Adaptation-Dependent Synchronous Activity Contributes to Receptive Field Size Change of Bullfrog Retinal Ganglion Cell	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; TRACER-COUPLING SIZE; HORIZONTAL CELLS; VISUAL-ADAPTATION; MAMMALIAN RETINA; AMACRINE CELLS; DOPAMINERGIC MODULATION; CORRELATED ACTIVITIES; CONTRAST ADAPTATION; DIMMING DETECTORS	Nearby retinal ganglion cells of similar functional subtype have a tendency to discharge spikes in synchrony. The synchronized activity is involved in encoding some aspects of visual input. On the other hand, neurons always continuously adjust their activities in adaptation to some features of visual stimulation, including mean ambient light, contrast level, etc. Previous studies on adaptation were primarily focused on single neuronal activity, however, it is also intriguing to investigate the adaptation process in population neuronal activities. In the present study, by using multi-electrode recording system, we simultaneously recorded spike discharges from a group of dimming detectors (OFF-sustained type ganglion cells) in bullfrog retina. The changes in receptive field properties and synchronization strength during contrast adaptation were analyzed. It was found that, when perfused using normal Ringer's solution, single neuronal receptive field size was reduced during contrast adaptation, which was accompanied by weakening in synchronization strength between adjacent neurons' activities. When dopamine (1 mu M) was applied, the adaptation-related receptive field area shrinkage and synchronization weakening were both eliminated. The activation of D1 receptor was involved in the adaptation-related modulation of synchronization and receptive field. Our results thus suggest that the size of single neuron's receptive field is positively related to the strength of its synchronized activity with its neighboring neurons, and the dopaminergic pathway is responsible for the modulation of receptive field property and synchronous activity of the ganglion cells during the adaptation process.	[Li, Hao; Liu, Wen-Zhong; Liang, Pei-Ji] Shanghai Jiao Tong Univ, Dept Biomed Engn, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Li, H (corresponding author), Shanghai Jiao Tong Univ, Dept Biomed Engn, Shanghai 200030, Peoples R China.	pjliang@sjtu.edu.cn			National Basic Research Program of China [2005CB724301]; National Foundation of Natural Science of China [61075108]	National Basic Research Program of China(National Basic Research Program of China); National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2005CB724301) and the National Foundation of Natural Science of China (61075108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; BLOOMFIELD SA, 1995, VISUAL NEUROSCI, V12, P985, DOI 10.1017/S0952523800009524; Bloomfield SA, 1997, VISUAL NEUROSCI, V14, P1153, DOI 10.1017/S0952523800011846; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; Camp AJ, 2009, J NEUROSCI, V29, P5009, DOI 10.1523/JNEUROSCI.0219-09.2009; Dedek K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001714; Demb JB, 2008, J PHYSIOL-LONDON, V586, P4377, DOI 10.1113/jphysiol.2008.156638; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; DONG CJ, 1991, J PHYSIOL-LONDON, V440, P291, DOI 10.1113/jphysiol.1991.sp018709; DONNER K, 1981, J PHYSIOL-LONDON, V319, P131, DOI 10.1113/jphysiol.1981.sp013896; DONNER K, 1987, VISION RES, V27, P1211, DOI 10.1016/0042-6989(87)90196-9; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; HAMPSON ECGM, 1994, P ROY SOC B-BIOL SCI, V255, P67, DOI 10.1098/rspb.1994.0010; HAMPSON ECGM, 1992, J NEUROSCI, V12, P4911; He SG, 2000, J COMP NEUROL, V418, P33, DOI 10.1002/(SICI)1096-9861(20000228)418:1<33::AID-CNE3>3.0.CO;2-J; HIDAKA S, 1993, NEUROREPORT, V5, P29, DOI 10.1097/00001756-199310000-00007; Hu EH, 2010, J PHYSIOL-LONDON, V588, P4145, DOI 10.1113/jphysiol.2010.193268; Hu EH, 2003, J NEUROSCI, V23, P6768; Ishikane H, 1999, VISUAL NEUROSCI, V16, P1001, DOI 10.1017/S0952523899166033; Jin X, 2005, BRAIN RES, V1055, P156, DOI 10.1016/j.brainres.2005.07.006; Jing W, 2010, COGN NEURODYNAMICS, V4, P179, DOI 10.1007/s11571-010-9119-8; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; KRAMER SG, 1971, INVEST OPHTH VISUAL, V10, P438; LASATER EM, 1987, P NATL ACAD SCI USA, V84, P7319, DOI 10.1073/pnas.84.20.7319; Lesica NA, 2004, J NEUROSCI, V24, P10731, DOI 10.1523/JNEUROSCI.3059-04.2004; Lesica NA, 2007, NEURON, V55, P479, DOI 10.1016/j.neuron.2007.07.013; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Li Yao, 2011, ACTA BIOPHYS SIN, V27, P211; Liu X, 2007, BRAIN RES, V1177, P37, DOI 10.1016/j.brainres.2007.07.001; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; Mills SL, 2007, VISUAL NEUROSCIENCE, V24; Ribelayga C, 2008, NEURON, V59, P790, DOI 10.1016/j.neuron.2008.07.017; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Singer W, 2009, COGN NEURODYNAMICS, V3, P189, DOI 10.1007/s11571-009-9087-z; STIRLING RV, 1987, J COMP NEUROL, V258, P477, DOI 10.1002/cne.902580402; STRAZNICKY C, 1988, ANAT EMBRYOL, V178, P143, DOI 10.1007/BF02463648; TERANISHI T, 1994, NEUROSCIENCE, V59, P217, DOI 10.1016/0306-4522(94)90112-0; Trong PK, 2008, NAT NEUROSCI, V11, P1343, DOI 10.1038/nn.2199; Volgyi B, 2005, J COMP NEUROL, V492, P66, DOI 10.1002/cne.20700; Wang GL, 2006, IEEE T BIO-MED ENG, V53, P1195, DOI 10.1109/TBME.2006.873397; Wark B, 2009, NEURON, V61, P750, DOI 10.1016/j.neuron.2009.01.019; WITKOVSKY P, 1993, P NATL ACAD SCI USA, V90, P5667, DOI 10.1073/pnas.90.12.5667; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; WITKOVSKY P, 1991, PROG RETIN RES, V11, P247, DOI 10.1016/0278-4327(91)90031-V; WITKOVSKY P, 1990, VISUAL NEUROSCI, V5, P405, DOI 10.1017/S0952523800000493; YAMADA M, 1992, VISION RES, V32, P1801, DOI 10.1016/0042-6989(92)90041-G; Zhang AJ, 2011, J COMP NEUROL, V519, P2125, DOI 10.1002/cne.22604; Zhang AJ, 2009, J NEUROSCI, V29, P789, DOI 10.1523/JNEUROSCI.4984-08.2009; Zhang AJ, 2004, INVEST OPHTH VIS SCI, V45, pU537; Zhang DQ, 2007, J NEUROSCI, V27, P692, DOI 10.1523/JNEUROSCI.4478-06.2007; Zhang PM, 2004, J NEUROSCI METH, V135, P55, DOI 10.1016/j.jneumeth.2003.12.001	60	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34336	10.1371/journal.pone.0034336	http://dx.doi.org/10.1371/journal.pone.0034336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479604	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900082
J	Ngamskulrungroj, P; Chang, Y; Roh, J; Kwon-Chung, KJ				Ngamskulrungroj, Popchai; Chang, Yun; Roh, Jamin; Kwon-Chung, Kyung J.			Differences in Nitrogen Metabolism between Cryptococcus neoformans and C. gattii, the Two Etiologic Agents of Cryptococcosis	PLOS ONE			English	Article							D-PROLINE ASSIMILATION; SACCHAROMYCES-CEREVISIAE; VANCOUVER-ISLAND; MOLECULAR CHARACTERIZATION; RAPID IDENTIFICATION; VAR. GRUBII; EPIDEMIOLOGIC DIFFERENCES; ASPERGILLUS-FUMIGATUS; THREONINE ALDOLASE; CANDIDA-ALBICANS	Two members of the Cryptococcus neoformans-gattii species complex, the etiologic agents of cryptococcosis, can be differentiated by biological, biochemical, serological and molecular typing techniques. Based on their differences in carbon and nitrogen utilization patterns, cost effective and very specific diagnostic tests using D-proline and canvanine-glycine-bromthymol blue (CGB) media have been formulated and are widely used for identification of the two species. However, these methods have yet to be tested for strains with confirmed molecular types to assess the degree of specificity for each molecular type in the two species. We collected global isolates of every major molecular type available and tested their patterns of nitrogen utilization. We confirmed specificity of the CGB test to be 100% regardless of molecular type while the D-proline test yielded 8-38% false negative results in three of the four C. gattii molecular types, VGI-VGIII. The utilization pattern of a new set of amino acids: D-alanine, L-tryptophan and L-phenylalanine, showed species specificity comparable to that of D-proline. We discovered that the transcription factor Gat1 (Are1) regulates the utilization of nitrogen differently between C. neoformans and C. gattii strains. Unlike in C. neoformans, expression of the genes encoding glycine decarboxylase complex in C. gatti was only partially suppressed by nitrogen catabolite repression in the presence of ammonium. GAT1 in C. neoformans controlled the induction of three of the four genes encoding the glycine decarboxylase complex when glycine was used as the sole nitrogen source while in C. gattii its regulation of these genes was less stringent. Moreover, while virulence of C. neoformans strains in mice was not affected by Gat1, the transcription factor positively influenced the virulence of C. gattii strain.	[Ngamskulrungroj, Popchai; Chang, Yun; Roh, Jamin; Kwon-Chung, Kyung J.] NIAID, Mol Microbiol Sect, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Ngamskulrungroj, Popchai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Mahidol University	Ngamskulrungroj, P (corresponding author), NIAID, Mol Microbiol Sect, Lab Clin Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	june_kwon-chung@nih.gov	Ngamskulrungroj, Popchai/N-8545-2019; Ngamskulrungroj, Popchai/ABE-7699-2021	Ngamskulrungroj, Popchai/0000-0001-5162-5498; 	National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000744] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funds from the intramural program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT JE, 1978, SABOURAUDIA, V16, P167; BENNETT JE, 1977, AM J EPIDEMIOL, V105, P582, DOI 10.1093/oxfordjournals.aje.a112423; Boekhout T, 2001, MICROBIOL-UK, V147, P891, DOI 10.1099/00221287-147-4-891; Bovers M, 2008, REV IBEROAM MICOL, V25, pS4, DOI 10.1016/S1130-1406(08)70019-6; Byrnes EJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000850; Casadevall A, 2003, CURR OPIN MICROBIOL, V6, P332, DOI 10.1016/S1369-5274(03)00082-1; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Chen JH, 2008, EMERG INFECT DIS, V14, P755, DOI 10.3201/eid1405.071312; Choi YH, 2010, FEMS YEAST RES, V10, P769, DOI 10.1111/j.1567-1364.2010.00648.x; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; DUFAIT R, 1987, MYCOSES, V30, P483, DOI 10.1111/j.1439-0507.1987.tb03833.x; ELLIS DH, 1990, J CLIN MICROBIOL, V28, P1642, DOI 10.1128/JCM.28.7.1642-1644.1990; Franzot SP, 1999, J CLIN MICROBIOL, V37, P838, DOI 10.1128/JCM.37.3.838-840.1999; Fraser JA, 2005, NATURE, V437, P1360, DOI 10.1038/nature04220; FU YH, 1987, MOL CELL BIOL, V7, P1691, DOI 10.1128/MCB.7.5.1691; Gerik KJ, 2005, MOL MICROBIOL, V58, P393, DOI 10.1111/j.1365-2958.2005.04843.x; Heitman J., 2011, CRYPTOCOCCUS HUMAN P, P620; Hensel M, 1998, MOL GEN GENET, V258, P553, DOI 10.1007/s004380050767; Kastanos EK, 1997, BIOCHEMISTRY-US, V36, P14956, DOI 10.1021/bi971610n; Kidd SE, 2004, P NATL ACAD SCI USA, V101, P17258, DOI 10.1073/pnas.0402981101; Klein KR, 2009, J CLIN MICROBIOL, V47, P3669, DOI 10.1128/JCM.01072-09; Kmetzsch L, 2011, FUNGAL GENET BIOL, V48, P192, DOI 10.1016/j.fgb.2010.07.011; Kurtzman CP, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P1; Kwon-Chung Kyung J., 2002, Taxon, V51, P804, DOI 10.2307/1555045; Kwon-Chung KJ, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P3; KWONCHUNG KJ, 1975, MYCOLOGIA, V67, P1197, DOI 10.2307/3758842; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P942, DOI 10.2307/3758813; KWONCHUNG KJ, 1984, AM J EPIDEMIOL, V120, P123, DOI 10.1093/oxfordjournals.aje.a113861; KWONCHUNG KJ, 1978, INT J SYST BACTERIOL, V28, P616, DOI 10.1099/00207713-28-4-616; KWONCHUNG KJ, 1982, J CLIN MICROBIOL, V15, P535, DOI 10.1128/JCM.15.3.535-537.1982; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P1869, DOI 10.1128/IAI.60.5.1869-1874.1992; Leal AL, 2008, MED MYCOL, V46, P377, DOI 10.1080/13693780701824429; Lee IR, 2011, GENETICS, V188, P309, DOI 10.1534/genetics.111.128538; LEVITZ SM, 1991, REV INFECT DIS, V13, P1163; Limjindaporn T, 2003, MOL MICROBIOL, V50, P993, DOI 10.1046/j.1365-2958.2003.03747.x; Litvintseva AP, 2006, GENETICS, V172, P2223, DOI 10.1534/genetics.105.046672; Ma HS, 2009, P NATL ACAD SCI USA, V106, P12980, DOI 10.1073/pnas.0902963106; MacDougall L, 2007, EMERG INFECT DIS, V13, P42, DOI 10.3201/eid1301.060827; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; McClelland CA, 2005, FUNGAL GENET BIOL, V42, P904, DOI 10.1016/j.fgb.2005.07.003; McNeil JB, 1997, GENE, V186, P13, DOI 10.1016/S0378-1119(96)00670-1; McNeil JB, 2000, YEAST, V16, P167, DOI 10.1002/(SICI)1097-0061(20000130)16:2&lt;167::AID-YEA519&gt;3.0.CO;2-1; McTaggart L, 2011, J CLIN MICROBIOL, V49, P2522, DOI 10.1128/JCM.00502-11; Meyer W, 2003, EMERG INFECT DIS, V9, P189; Meyer W, 2009, MED MYCOL, V47, P561, DOI 10.1080/13693780902953886; MITCHELL AP, 1984, MOL CELL BIOL, V4, P2758, DOI 10.1128/MCB.4.12.2758; Monschau N, 1997, FEMS MICROBIOL LETT, V150, P55, DOI 10.1016/S0378-1097(97)00096-7; Nagarajan L, 1997, J BIOL CHEM, V272, P4444, DOI 10.1074/jbc.272.7.4444; Narasipura SD, 2005, MOL MICROBIOL, V55, P1782, DOI 10.1111/j.1365-2958.2005.04503.x; Ngamskulrungroj P, 2011, CLIN MICROBIOL INFEC, V17, P251, DOI 10.1111/j.1469-0691.2010.03222.x; Ngamskulrungroj P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016076; Ngamskulrungroj P, 2009, INFECT IMMUN, V77, P4584, DOI 10.1128/IAI.00565-09; Ngamskulrungroj P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005862; Nishikawa MM, 1996, J MED VET MYCOL, V34, P365; Granados DP, 2006, FEMS YEAST RES, V6, P636, DOI 10.1111/j.1567-1364.2006.00090.x; PERFECT JR, 1993, J CLIN MICROBIOL, V31, P3305, DOI 10.1128/JCM.31.12.3305-3309.1993; PHILPOT CM, 1977, SABOURAUDIA, V15, P141; Piper MDW, 2002, FEMS YEAST RES, V2, P59, DOI 10.1016/S1567-1356(01)00061-7; POLACHECK I, 1980, J BACTERIOL, V142, P15, DOI 10.1128/JB.142.1.15-20.1980; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; Rao GVS, 2003, J TOXICOL ENV HEAL A, V66, P1441, DOI 10.1080/15287390306417; ROSS J, 1988, J GEN MICROBIOL, V134, P1131; SALKIN IF, 1982, J CLIN MICROBIOL, V15, P169, DOI 10.1128/JCM.15.1.169-171.1982; SEGAL E, 1976, J CLIN MICROBIOL, V4, P157; Sinclair DA, 1996, MOL MICROBIOL, V19, P611, DOI 10.1046/j.1365-2958.1996.419947.x; Snoeijers SS, 1999, MOL GEN GENET, V261, P653, DOI 10.1007/s004380050008; Sugui JA, 2010, J CLIN MICROBIOL, V48, P220, DOI 10.1128/JCM.01556-09; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Williamson Peter R., 1997, Frontiers in Bioscience, V2, pE99; WILLIAMSON PR, 1994, J BACTERIOL, V176, P656, DOI 10.1128/jb.176.3.656-664.1994; Wong KH, 2008, EUKARYOT CELL, V7, P917, DOI 10.1128/EC.00076-08; Zaragoza O, 2003, INFECT IMMUN, V71, P6155, DOI 10.1128/IAI.71.11.6155-6164.2003	72	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34258	10.1371/journal.pone.0034258	http://dx.doi.org/10.1371/journal.pone.0034258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479580	Green Submitted, Green Published, gold			2022-12-27	WOS:000303894900075
J	Bolton, M; Horvath, DJ; Li, BR; Cortado, H; Newsom, D; White, P; Partida-Sanchez, S; Justice, SS				Bolton, Michael; Horvath, Dennis J., Jr.; Li, Birong; Cortado, Hanna; Newsom, David; White, Peter; Partida-Sanchez, Santiago; Justice, Sheryl S.			Intrauterine Growth Restriction Is a Direct Consequence of Localized Maternal Uropathogenic Escherichia coli Cystitis	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; DENDRITIC CELLS; ASYMPTOMATIC BACTERIURIA; PRETERM BIRTH; PREGNANCY; PYELONEPHRITIS; DISSEMINATION; INTERLEUKIN-6; EXPRESSION; OUTCOMES	Despite the continually increasing rates of adverse perinatal outcomes across the globe, the molecular mechanisms that underlie adverse perinatal outcomes are not completely understood. Clinical studies report that 10% of pregnant women will experience a urinary tract infection (UTI) and there is an association of UTIs with adverse perinatal outcomes. We introduced bacterial cystitis into successfully outbred female mice at gestational day 14 to follow pregnancy outcomes and immunological responses to determine the mechanisms that underlie UTI-mediated adverse outcomes. Outbred fetuses from mothers experiencing localized cystitis displayed intrauterine growth restriction (20-80%) as early as 48 hours post-infection and throughout the remainder of normal gestation. Robust infiltration of cellular innate immune effectors was observed in the uteroplacental tissue following introduction of UTI despite absence of viable bacteria. The magnitude of serum proinflammatory cytokines is elevated in the maternal serum during UTI. This study demonstrates that a localized infection can dramatically impact the immunological status as well as the function of non-infected distal organs and tissues. This model can be used as a platform to determine the mechanism(s) by which proinflammatory changes occur between non-contiguous genitourinary organs	[Bolton, Michael] Nationwide Childrens Hosp, Dept Pediat, Infect Dis Sect, Columbus, OH USA; [Bolton, Michael; Horvath, Dennis J., Jr.; Li, Birong; Cortado, Hanna; Newsom, David; White, Peter; Partida-Sanchez, Santiago; Justice, Sheryl S.] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Res Inst, Columbus, OH USA; [White, Peter; Partida-Sanchez, Santiago; Justice, Sheryl S.] Ohio State Univ, Sch Med, Dept Pediat, Columbus, OH 43210 USA; [White, Peter; Partida-Sanchez, Santiago; Justice, Sheryl S.] Ohio State Univ, Sch Med, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Justice, Sheryl S.] Ohio State Univ, Sch Med, Div Urol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Bolton, M (corresponding author), Nationwide Childrens Hosp, Dept Pediat, Infect Dis Sect, Columbus, OH USA.	Santiago.Partida-Sanchez@nationwidechildrens.org; Sheryl_Justice@nationwidechildrens.org	Justice, Sheryl/E-3329-2011; Partida-Sanchez, Santiago/B-7523-2008; White, Peter/E-4301-2011	Justice, Sheryl/0000-0002-7059-3759; Partida-Sanchez, Santiago/0000-0003-2996-9440; White, Peter/0000-0002-5218-5903	National Institutes of Health [1R01AI092117-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092117] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in part supported by National Institutes of Health 1R01AI092117-01A1 to SP. No additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 1996, EUR RESPIR J, V9, P1713, DOI 10.1183/09031936.96.09081713; Andrews WW, 2000, AM J PERINAT, V17, P357, DOI 10.1055/s-2000-13448; Blois S, 2004, AM J REPROD IMMUNOL, V51, P40, DOI 10.1046/j.8755-8920.2003.00120.x; Blois SM, 2008, J MOL MED, V86, P837, DOI 10.1007/s00109-008-0342-2; Blois SM, 2007, BIOL REPROD, V77, P590, DOI 10.1095/biolreprod.107.060632; Blois SM, 2004, BIOL REPROD, V70, P1018, DOI 10.1095/biolreprod.103.022640; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Colatrella A, 2010, BEST PRACT RES CL EN, V24, P635, DOI 10.1016/j.beem.2010.05.003; CUNNINGHAM FG, 1973, OBSTET GYNECOL, V42, P112; Dasanayake AP, 2008, MCN-AM J MATERN-CHIL, V33, P45, DOI 10.1097/01.NMC.0000305657.24613.47; Eichenwald EC, 2008, NEW ENGL J MED, V358, P1700, DOI 10.1056/NEJMra0707601; Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009; Engel D, 2006, INFECT IMMUN, V74, P6100, DOI 10.1128/IAI.00881-06; Gilstrap LC, 2001, OBSTET GYN CLIN N AM, V28, P581, DOI 10.1016/S0889-8545(05)70219-9; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; HANDWERGER S, 1992, TRENDS ENDOCRIN MET, V3, P91, DOI 10.1016/1043-2760(92)90019-W; Haraoka M, 1999, J INFECT DIS, V180, P1220, DOI 10.1086/315006; HEDGES S, 1991, INFECT IMMUN, V59, P421, DOI 10.1128/IAI.59.1.421-427.1991; Hirahara F, 1998, FERTIL STERIL, V70, P246, DOI 10.1016/S0015-0282(98)00164-2; Horvath DJ, 2011, MICROBES INFECT, V13, P426, DOI 10.1016/j.micinf.2010.12.004; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Hunstad DA, 2010, ANNU REV MICROBIOL, V64, P203, DOI 10.1146/annurev.micro.112408.134258; Ingersoll MA, 2008, CELL MICROBIOL, V10, P2568, DOI 10.1111/j.1462-5822.2008.01230.x; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100; KASS EH, 1960, ARCH INTERN MED, V105, P194, DOI 10.1001/archinte.1960.00270140016003; Kaul AK, 1999, INFECT IMMUN, V67, P5958, DOI 10.1128/IAI.67.11.5958-5966.1999; Kruger T, 2004, J AM SOC NEPHROL, V15, P613, DOI 10.1097/01.ASN.0000114553.36258.91; Lee AK, 1998, INFECT IMMUN, V66, P3964, DOI 10.1128/IAI.66.8.3964-3967.1998; Lumbiganon P, 2009, OBSTET GYNECOL, V113, P339, DOI 10.1097/AOG.0b013e318195c2a2; MADINGER NE, 1989, AM J OBSTET GYNECOL, V161, P657, DOI 10.1016/0002-9378(89)90373-6; Mazor-Dray E, 2009, J MATERN-FETAL NEO M, V22, P124, DOI 10.1080/14767050802488246; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Munn M B, 1999, J Matern Fetal Med, V8, P151; Murray SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012418; NAEYE RL, 1979, NEW ENGL J MED, V300, P819, DOI 10.1056/NEJM197904123001503; Nagaeva O, 2002, AM J REPROD IMMUNOL, V47, P203, DOI 10.1034/j.1600-0897.2002.01065.x; Pararas MV, 2006, EUR J CLIN MICROBIOL, V25, P562, DOI 10.1007/s10096-006-0190-3; Pennell CE, 2007, AM J OBSTET GYNECOL, V196, P107, DOI 10.1016/j.ajog.2006.03.109; Prados MB, 2011, J REPROD IMMUNOL, V89, P207, DOI 10.1016/j.jri.2011.01.021; Randolph GJ, 2008, CURR OPIN LIPIDOL, V19, P462, DOI 10.1097/MOL.0b013e32830d5f09; Ratajczak CK, 2008, PEDIATR RES, V64, P581, DOI 10.1203/PDR.0b013e31818718d2; Reedy NJ, 2007, J MIDWIFERY WOM HEAL, V52, P281, DOI 10.1016/j.jmwh.2007.02.022; ROMERO R, 1989, OBSTET GYNECOL, V73, P576; Rosen DA, 2007, PLOS MED, V4, P1949, DOI 10.1371/journal.pmed.0040329; SCHIEVE LA, 1994, AM J PUBLIC HEALTH, V84, P405, DOI 10.2105/AJPH.84.3.405; Schilling JD, 2002, INFECT IMMUN, V70, P7042, DOI 10.1128/IAI.70.12.7042-7049.2002; Sheiner E, 2009, J MATERN-FETAL NEO M, V22, P423, DOI 10.1080/14767050802360783; Sheu JN, 2006, CYTOKINE, V36, P276, DOI 10.1016/j.cyto.2007.02.006; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; Stock S, 2010, SEMIN FETAL NEONAT M, V15, P336, DOI 10.1016/j.siny.2010.06.006; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Sukhikh GT, 2002, B EXP BIOL MED+, V134, P107, DOI 10.1023/A:1021117826014; Toldi G, 2011, AM J REPROD IMMUNOLO; Vargas Roberto, 2010, Rev Obstet Gynecol, V3, P92; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Vergnes JN, 2007, AM J OBSTET GYNECOL, V196, p[135, e131]; Vickers MH, 2005, ENDOCRINOLOGY, V146, P4211, DOI 10.1210/en.2005-0581	58	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33897	10.1371/journal.pone.0033897	http://dx.doi.org/10.1371/journal.pone.0033897			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470490	gold, Green Submitted, Green Published			2022-12-27	WOS:000303857100056
J	Ananworanich, J; Schuetz, A; Vandergeeten, C; Sereti, I; de Souza, M; Rerknimitr, R; Dewar, R; Marovich, M; van Griensven, F; Sekaly, R; Pinyakorn, S; Phanuphak, N; Trichavaroj, R; Rutvisuttinunt, W; Chomchey, N; Paris, R; Peel, S; Valcour, V; Maldarelli, F; Chomont, N; Michael, N; Phanuphak, P; Kim, JH				Ananworanich, Jintanat; Schuetz, Alexandra; Vandergeeten, Claire; Sereti, Irini; de Souza, Mark; Rerknimitr, Rungsun; Dewar, Robin; Marovich, Mary; van Griensven, Frits; Sekaly, Rafick; Pinyakorn, Suteeraporn; Phanuphak, Nittaya; Trichavaroj, Rapee; Rutvisuttinunt, Wiriya; Chomchey, Nitiya; Paris, Robert; Peel, Sheila; Valcour, Victor; Maldarelli, Frank; Chomont, Nicolas; Michael, Nelson; Phanuphak, Praphan; Kim, Jerome H.		RV	Impact of Multi-Targeted Antiretroviral Treatment on Gut T Cell Depletion and HIV Reservoir Seeding during Acute HIV Infection	PLOS ONE			English	Article							IMMUNE ACTIVATION; THERAPY; RALTEGRAVIR; PERSISTENCE; DYNAMICS; RISK; INTENSIFICATION; INTERRUPTION; RESTORATION; REPLICATION	Background: Limited knowledge exists on early HIV events that may inform preventive and therapeutic strategies. This study aims to characterize the earliest immunologic and virologic HIV events following infection and investigates the usage of a novel therapeutic strategy. Methods and Findings: We prospectively screened 24,430 subjects in Bangkok and identified 40 AHI individuals. Thirty Thais were enrolled (8 Fiebig I, 5 Fiebig II, 15 Fiebig III, 2 Fiebig IV) of whom 15 completed 24 weeks of megaHAART (tenofovir/emtricitabine/efavirenz/raltegravir/maraviroc). Sigmoid biopsies were completed in 24/30 at baseline and 13/15 at week 24. At baseline, the median age was 29 years and 83% were MSM. Most were symptomatic (87%), and were infected with R5-tropic (77%) CRF01_AE (70%). Median CD4 was 406 cells/mm(3). HIV RNA was 5.5 log(10) copies/ml. Median total blood HIV DNA was higher in Fiebig III (550 copy/10(6) PBMC) vs. Fiebig I (8 copy/10(6) PBMC) (p = 0.01) while the median %CD4+CCR5+ gut T cells was lower in Fiebig III (19%) vs. Fiebig I (59%) (p = 0.0008). After 24 weeks of megaHAART, HIV RNA levels of,50 copies were achieved in 14/15 in blood and 13/13 in gut. Total blood HIV DNA at week 0 predicted reservoir size at week 24 (p<0.001). Total HIV DNA declined significantly and was undetectable in 3 of 15 in blood and 3 of 7 in gut. Frequency of CD4+CCR5+ gut T cells increased from 41% at baseline to 64% at week 24 (p>0.050); subjects with less than 40% at baseline had a significant increase in CD4+CCR5+ T cells from baseline to week 24 (14% vs. 71%, p = 0.02). Conclusions: Gut T cell depletion and HIV reservoir seeding increases with progression of AHI. MegaHAART was associated with immune restoration and reduced reservoir size. Our findings could inform research on strategies to achieve HIV drug-free remission.	[Ananworanich, Jintanat; Pinyakorn, Suteeraporn; Phanuphak, Nittaya; Chomchey, Nitiya; Valcour, Victor; Phanuphak, Praphan; Kim, Jerome H.] SE Asia Res Collaborat Hawaii, Bangkok, Thailand; [Ananworanich, Jintanat; Pinyakorn, Suteeraporn; Phanuphak, Nittaya; Chomchey, Nitiya; Phanuphak, Praphan] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Ananworanich, Jintanat; Pinyakorn, Suteeraporn] HIV NAT, Bangkok, Thailand; [Ananworanich, Jintanat; Rerknimitr, Rungsun; Phanuphak, Praphan] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand; [Ananworanich, Jintanat; Schuetz, Alexandra; de Souza, Mark; Trichavaroj, Rapee; Rutvisuttinunt, Wiriya; Paris, Robert; Kim, Jerome H.] Armed Forces Res Inst Med Sci US Component, Dept Retrovirol, Bangkok, Thailand; [Schuetz, Alexandra; de Souza, Mark; Marovich, Mary; Paris, Robert; Peel, Sheila; Michael, Nelson; Kim, Jerome H.] US Mil HIV Res Program, Rockville, MD USA; [Vandergeeten, Claire; Sekaly, Rafick; Chomont, Nicolas] Vaccine & Gene Therapy Inst, Port St Lucie, FL USA; [Sereti, Irini] NIAID, Immunoregulat Lab, Clin & Mol Retrovirol Sect, Bethesda, MD 20892 USA; [Dewar, Robin] NCI, Virus Isolat & Serol Lab, Appl & Dev Res Directorate, Sci Applicat Int Corp,Frederick Inc,Frederick Can, Frederick, MD 21701 USA; [van Griensven, Frits] Minist Publ Hlth, Dept Dis Control, Thailand Minist Publ Hlth, US Ctr Dis Control & Prevent Collaborat, Amphur Muang, Nonthaburi, Thailand; [Valcour, Victor] Univ Calif San Francisco, Memory & Aging Ctr, San Francisco, CA 94143 USA; [Maldarelli, Frank] NIH, In Vivo Biol Grp, Magnuson Clin Ctr, Bethesda, MD 20892 USA	Thai Red Cross Society; Chulalongkorn University; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Walter Reed Army Institute of Research (WRAIR); Vaccine & Gene Therapy Institute of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); Ministry of Public Health - Thailand; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA	Ananworanich, J (corresponding author), SE Asia Res Collaborat Hawaii, Bangkok, Thailand.	jintanat.a@searchthailand.org	Maldarelli, Frank/O-2428-2016; Chomont, Nicolas/ABG-2545-2020; Ananworanich, Jintanat/AAC-6348-2021; Phanuphak, Nittaya/AAA-8579-2019	Chomont, Nicolas/0000-0001-9747-5018; Ananworanich, Jintanat/0000-0003-1369-3224; Ratto-Kim, Silvia/0000-0003-2025-6399; Sereti, Irini/0000-0002-0076-0224	UCLA CFAR [5P30 AI028697]; United States Military HIV Research Program, Walter Reed Army Institute of Research, Rockville, Maryland [W81XWH-07-2-0067]; federal funds from the National Cancer Institute [HHSN261200800001E]; National Institute of Allergy and Infectious Diseases; National Institute of Mental Health [NH-R21MH089341]; Vaccine and Gene Therapy Institute; Gilead (Truvada(R), Atripla(R)); Merck (Sustiva(R), Isentress(R)); Pfizer (Selzentry(R)); Monogram Biosciences; Abbott; Gilead; ViiV; NATIONAL CANCER INSTITUTE [ZIABC011466, ZIABC011464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	UCLA CFAR; United States Military HIV Research Program, Walter Reed Army Institute of Research, Rockville, Maryland; federal funds from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Vaccine and Gene Therapy Institute; Gilead (Truvada(R), Atripla(R)); Merck (Sustiva(R), Isentress(R)); Pfizer (Selzentry(R)); Monogram Biosciences; Abbott(Abbott Laboratories); Gilead(Gilead Sciences); ViiV; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank our study participants and staff from the Thai Red Cross AIDS Research Centre and the Silom Community Clinic in Bangkok for their valuable contributions to this study. We thank Ms. Piraporn June Ohata and Ms. Varaporn Pothipala for their help in preparing this manuscript. SEARCH is a research collaboration between the Thai Red Cross AIDS Research Centre (TRCARC), the University of Hawaii and the Department of Retrovirology, U.S. Army Medical Component, Armed Forces Research Institute of Medical Sciences (AFRIMS). We also thank the UCLA CFAR Mucosal Immunology Core Laboratory, funded by UCLA CFAR grant 5P30 AI028697 for their support and guidance regarding the isolation of MMC.; The United States Military HIV Research Program, Walter Reed Army Institute of Research, Rockville, Maryland funded the study under a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the United States Department of Defense. This project has been funded in whole or in part with federal funds from the National Cancer Institute (Contract No. HHSN261200800001E), the National Institute of Allergy and Infectious Diseases and the National Institute of Mental Health (NH-R21MH089341). The study was also funded in part by the Vaccine and Gene Therapy Institute. Antiretroviral therapy was supported by Gilead (Truvada (R), Atripla (R)), Merck (Sustiva (R), Isentress (R)) and Pfizer (Selzentry (R)). Monogram Biosciences supported the Trofile (R) test. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; JA has received speaker's fee and/or honorarium from Abbott, Gilead and ViiV. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ananworanich J, 2008, JAIDS-J ACQ IMM DEF, V49, P151, DOI 10.1097/QAI.0b013e318183a96d; Bell SK, 2010, J INFECT DIS, V202, pS278, DOI 10.1086/655655; Boulware DR, 2011, J INFECT DIS, V203, P1637, DOI 10.1093/infdis/jir134; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Calmy A, 2009, AIDS, V23, P929, DOI 10.1097/QAD.0b013e32832995fa; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Ciccone EJ, 2010, MUCOSAL IMMUNOL, V3, P172, DOI 10.1038/mi.2009.129; Cohen MS, 2010, J INFECT DIS, V202, pS270, DOI 10.1086/655651; d'Ettorre G, 2011, CURR HIV RES, V9, P148, DOI 10.2174/157016211795945296; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Heredia A, 2007, AIDS, V21, P1317, DOI 10.1097/QAD.0b013e32815278ea; Hicks CB, 2007, CLIN EXP IMMUNOL, V149, P211, DOI 10.1111/j.1365-2249.2007.03437.x; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kijak GH, 2007, VIROLOGY, V358, P178, DOI 10.1016/j.virol.2006.07.055; Koup RA, 2011, NAT REV IMMUNOL, V11, P65, DOI 10.1038/nri2890; Ling B, 2007, AIDS, V21, P2377, DOI 10.1097/QAD.0b013e3282f08b32; MARKOWITZ M, 2011, 18 C RETR OPP INF BO; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Neaton JD, 2010, CURR OPIN HIV AIDS, V5, P480, DOI 10.1097/COH.0b013e32833ed75d; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Rosenberg ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010555; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Salgado M, 2011, CLIN IMMUNOL, V139, P110, DOI 10.1016/j.clim.2011.02.008; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sedaghat AR, 2009, ANTIVIR THER, V14, P263; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Tincati C, 2009, ANTIVIR THER, V14, P321; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Verhoeven D, 2008, J VIROL, V82, P4016, DOI 10.1128/JVI.02164-07; Working Group on Antiretroviral Therapy and Medical Management of HIV-infected Adults and Adolescents, 2011, GUID US ANT AG HIV I; Yukl SA, 2010, J INFECT DIS, V202, P1553, DOI 10.1086/656722; Yukl SA, 2010, AIDS, V24, P2450, DOI 10.1097/QAD.0b013e32833ef7bb	39	240	244	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33948	10.1371/journal.pone.0033948	http://dx.doi.org/10.1371/journal.pone.0033948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479485	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100089
J	Deng, Y; Gu, XY; Zhao, XD; Luo, J; Luo, ZX; Wang, LJ; Fu, Z; Yang, XQ; Liu, EM				Deng, Yu; Gu, Xiaoyang; Zhao, Xiaodong; Luo, Jian; Luo, Zhengxiu; Wang, Lijia; Fu, Zhou; Yang, Xiqiang; Liu, Enmei			High Viral Load of Human Bocavirus Correlates with Duration of Wheezing in Children with Severe Lower Respiratory Tract Infection	PLOS ONE			English	Article							YOUNG-CHILDREN; HOSPITALIZED CHILDREN; FREQUENT DETECTION; VIRUS; PARVOVIRUS; RNA	Background: Human bocavirus (HBoV) is a newly discovered parvovirus and increasing evidences are available to support its role as an etiologic agent in lower respiratory tract infection (LRTI). The objective of this study is to assess the impact of HBoV viral load on clinical characteristics in children who were HBoV positive and suffered severe LRTI. Methods: Lower respiratory tract aspirates from 186 hospitalized children with severe LRTI were obtained by bronchoscopy. HBoVs were detected by real-time PCR and other 10 infectious agents were examined using PCR and/or direct fluorescent assay. Results: Thirty-one patients (24.6%) were tested positive for HBoV in the respiratory tract aspirates. Fifteen samples had a high viral load (>10(4) copies/mL) and the other sixteen samples had a low viral load (<10(4) copies/mL). The duration of presented wheezing and hospitalization was longer in children with high viral load of HBoV than that in children with low viral load. The days of wheezing showed a correlation with viral load of HBoV. Conclusion: We confirmed that HBoV was frequently detected in patients with severe LRTI. Wheezing was one of the most common symptoms presented by patients with positive HBoV. A high HBoV viral load could be an etiologic agent for LRTI, which led to more severe lower respiratory tract symptom, longer duration of wheezing and hospitalization.	[Deng, Yu; Luo, Jian; Luo, Zhengxiu; Fu, Zhou; Liu, Enmei] Chongqing Med Univ, Childrens Hosp, Dept Resp Med, Chongqing, Peoples R China; [Zhao, Xiaodong; Yang, Xiqiang] Chongqing Med Univ, Childrens Hosp, Dept Nephrol & Immunol Med, Chongqing, Peoples R China; [Wang, Lijia] Chongqing Med Univ, Key Lab Child Dev & Disorders, Minist Educ, Lab Childrens Resp Med, Chongqing, Peoples R China; [Gu, Xiaoyang] PLA, Bethune Int Peace Hosp, Paediat Unit, Shijiazhuang, Hebei Province, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Deng, Y (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Resp Med, Chongqing, Peoples R China.	emliu186@126.com			National Natural Science Foundation of China [NSFC 30972698]; China Special Grant for the Prevention and Control of Infection Diseases [2009ZX10004-204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Special Grant for the Prevention and Control of Infection Diseases	This work was supported by National Natural Science Foundation of China (NSFC 30972698) and China Special Grant for the Prevention and Control of Infection Diseases (2009ZX10004-204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Arnold JC, 2006, CLIN INFECT DIS, V43, P283, DOI 10.1086/505399; Bastien N, 2006, EMERG INFECT DIS, V12, P848, DOI 10.3201/eid1205.051424; Brieu N, 2008, PEDIATR INFECT DIS J, V27, P969, DOI 10.1097/INF.0b013e31817acfaa; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Choi EH, 2006, CLIN INFECT DIS, V43, P585, DOI 10.1086/506350; Christensen A, 2010, J CLIN VIROL, V49, P158, DOI 10.1016/j.jcv.2010.07.016; Chung JY, 2008, J CLIN VIROL, V43, P223, DOI 10.1016/j.jcv.2008.06.008; Chung JY, 2006, EMERG INFECT DIS, V12, P1254, DOI 10.3201/eid1708.060261; COLLINS PL, 1990, J GEN VIROL, V71, P3015, DOI 10.1099/0022-1317-71-12-3015; Dakhama A, 1999, AM J RESP CRIT CARE, V159, P1316, DOI 10.1164/ajrccm.159.4.9807085; Dijkman R, 2009, J VIROL, V83, P7739, DOI 10.1128/JVI.00614-09; Fan J, 1996, J CLIN MICROBIOL, V34, P1914, DOI 10.1128/JCM.34.8.1914-1917.1996; Foulongne V, 2006, EMERG INFECT DIS, V12, P862, DOI 10.3201/eid1205.051523; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Gagliardi TB, 2009, EPIDEMIOL INFECT, V137, P1032, DOI 10.1017/S0950268808001842; Garcia-Garcia ML, 2008, PEDIATR INFECT DIS J, V27, P358, DOI 10.1097/INF.0b013e3181626d2a; Jartti T, 2012, REV MED VIROL, V22, P46, DOI 10.1002/rmv.720; Kahn JS, 2008, J INFECT DIS, V198, P41, DOI 10.1086/588674; KARRON RA, 1994, J CLIN MICROBIOL, V32, P484, DOI 10.1128/JCM.32.2.484-488.1994; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Lehtoranta L, 2012, INT J PEDIATR OTORHI, V76, P206, DOI 10.1016/j.ijporl.2011.10.025; Longtin J, 2008, EMERG INFECT DIS, V14, P217, DOI 10.3201/eid1402.070851; Ma XM, 2006, J CLIN MICROBIOL, V44, P1132, DOI 10.1128/JCM.44.3.1132-1134.2006; Maggi F, 2007, J CLIN VIROL, V38, P321, DOI 10.1016/j.jcv.2007.01.008; Martin ET, 2010, J INFECT DIS, V201, P1625, DOI 10.1086/652405; Martin ET, 2009, J CLIN MICROBIOL, V47, P4131, DOI 10.1128/JCM.01508-09; MURRAY PR, 1975, MAYO CLIN PROC, V50, P339; Murray PR, 1980, MANUAL CLIN MICROBIO, V6th; Naghipour M, 2007, J MED VIROL, V79, P539, DOI 10.1002/jmv.20815; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Sloots TP, 2006, J CLIN VIROL, V35, P99, DOI 10.1016/j.jcv.2005.09.008; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; von Linstow ML, 2008, PEDIATR INFECT DIS J, V27, P897, DOI 10.1097/INF.0b013e3181757b16; Wang K, 2010, J CLIN VIROL, V47, P148, DOI 10.1016/j.jcv.2009.11.015; Weissbrich B, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-109; Yu D, 2010, CLIN MICROBIOL INFEC, V16, P1399, DOI [10.1111/j.1469-0691.2010.03147.x, 10.1111/j.1469-0691.2009.03147.x]	39	41	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34353	10.1371/journal.pone.0034353	http://dx.doi.org/10.1371/journal.pone.0034353			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479609	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100152
J	Glas, J; Seiderer, J; Wagner, J; Olszak, T; Fries, C; Tillack, C; Friedrich, M; Beigel, F; Stallhofer, J; Steib, C; Wetzke, M; Goke, B; Ochsenkun, T; Diegelmann, J; Czamara, D; Brand, S				Glas, Juergen; Seiderer, Julia; Wagner, Johanna; Olszak, Torsten; Fries, Christoph; Tillack, Cornelia; Friedrich, Matthias; Beigel, Florian; Stallhofer, Johannes; Steib, Christian; Wetzke, Martin; Goeke, Burkhard; Ochsenkuehn, Thomas; Diegelmann, Julia; Czamara, Darina; Brand, Stephan			Analysis of IL12B Gene Variants in Inflammatory Bowel Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTERFERON-GAMMA PRODUCTION; ACTIVE CROHNS-DISEASE; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; INTESTINAL INFLAMMATION; PSORIATIC-ARTHRITIS; IL23R GENES; RISK LOCI; IL-23	Background: IL12B encodes the p40 subunit of IL-12, which is also part of IL-23. Recent genome-wide association studies identified IL12B and IL23R as susceptibility genes for inflammatory bowel disease (IBD). However, the phenotypic effects and potential gene-gene interactions of IL12B variants are largely unknown. Methodology/Principal Findings: We analyzed IL12B gene variants regarding association with Crohn's disease (CD) and ulcerative colitis (UC). Genomic DNA from 2196 individuals including 913 CD patients, 318 UC patients and 965 healthy, unrelated controls was analyzed for four SNPs in the IL12B gene region (rs3212227, rs17860508, rs10045431, rs6887695). Our analysis revealed an association of the IL12B SNP rs6887695 with susceptibility to IBD (p = 0.035; OR 1.15 [95% CI 1.01-1.31] including a trend for rs6887695 for association with CD (OR 1.41; [0.99-1.31], p = 0.066) and UC (OR 1.18 [0.97-1.43], p = 0.092). CD patients, who were homozygous C/C carriers of this SNP, had significantly more often non-stricturing, non-penetrating disease than carriers of the G allele (p = 6.8x10(-5); OR = 2.84, 95% CI 1.66-4.84), while C/C homozygous UC patients had less often extensive colitis than G allele carriers (p = 0.029; OR = 0.36, 95% CI 0.14-0.92). In silico analysis predicted stronger binding of the minor C allele of rs6887695 to the transcription factor ROR alpha which is involved in Th17 differentiation. Differences regarding the binding to the major and minor allele sequence of rs6887695 were also predicted for the transcription factors HSF1, HSF2, MZF1 and Oct-1. Epistasis analysis revealed weak epistasis of the IL12B SNP rs6887695 with several SNPs (rs11889341, rs7574865, rs7568275, rs8179673, rs10181656, rs7582694) in the STAT4 gene which encodes the major IL-12 downstream transcription factor STAT4 (p < 0.05) but there was no epistasis between IL23R and IL12B variants. Conclusions/Significance: The IL12B SNP rs6887695 modulates the susceptibility and the phenotype of IBD, although the effect on IBD susceptibilty is less pronounced than that of IL23R gene variants.	[Glas, Juergen; Seiderer, Julia; Wagner, Johanna; Olszak, Torsten; Fries, Christoph; Tillack, Cornelia; Friedrich, Matthias; Beigel, Florian; Stallhofer, Johannes; Steib, Christian; Wetzke, Martin; Goeke, Burkhard; Ochsenkuehn, Thomas; Diegelmann, Julia; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Glas, Juergen; Wagner, Johanna; Fries, Christoph; Friedrich, Matthias; Wetzke, Martin; Diegelmann, Julia] LMU, Dept Prevent Dent & Periodontol, Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; [Olszak, Torsten] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol, Boston, MA 02115 USA; [Wetzke, Martin] Hannover Med Sch, Dept Pediat, D-3000 Hannover, Germany; [Czamara, Darina] Max Planck Inst Psychiat, D-80804 Munich, Germany	University of Munich; University of Munich; RWTH Aachen University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Hannover Medical School; Max Planck Society	Glas, J (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	julia.diegelmann@med.uni-muenchen.de; stephan.brand@med.uni-muenchen.de	Wetzke, Martin/HDM-2614-2022	Stallhofer, Johannes/0000-0001-8698-6103	Broad Medical Foundation [IBD-0126R2]; Ludwig-Maximilians-University Munich (FoFoLe) [422]; Robert-Bosch-Foundation; Else Kroner-Fresenius-Stiftung [81/08//EKMS08/01, 2010_EKES.32]; DFG [BR 1912/6-1]; Ludwig-Maximilians-University Munich (Excellence Initiative)	Broad Medical Foundation; Ludwig-Maximilians-University Munich (FoFoLe); Robert-Bosch-Foundation; Else Kroner-Fresenius-Stiftung; DFG(German Research Foundation (DFG)); Ludwig-Maximilians-University Munich (Excellence Initiative)	J. Glas was supported by a grant from the Broad Medical Foundation (IBD-0126R2). J. Seiderer and J. Diegelmann were supported by grants from the Ludwig-Maximilians-University Munich (FoFoLe Nr. 422; Habilitationsstipendium, LMUExcellent to J.S. and Promotionsstipendium to J.D.); J. Seiderer was also supported by the Robert-Bosch-Foundation and the Else Kroner-Fresenius-Stiftung (81/08//EKMS08/01). S. Brand was supported by grants from the DFG (BR 1912/6-1), the Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium 2010; 2010_EKES.32), and by grants of Ludwig-Maximilians-University Munich (Excellence Initiative, Investment Funds 2008 and FoFoLe program). J. Wagner was supported by a grant from the Ludwig-Maximilians-University Munich (FoFoLe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Begovich AB, 2007, HUM IMMUNOL, V68, P934, DOI 10.1016/j.humimm.2007.09.005; Beynon V, 2008, INFLAMM BOWEL DIS, V14, P1033, DOI 10.1002/ibd.20441; Brand S, 2006, J CELL BIOCHEM, V97, P709, DOI 10.1002/jcb.20672; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; CHAN SH, 1991, J EXP MED, V173, P869, DOI 10.1084/jem.173.4.869; Chang M, 2008, ARTHRITIS RHEUM-US, V58, P1877, DOI 10.1002/art.23492; Chelbi ST, 2012, HUM MOL GENET   0131; Ciric B, 2009, J IMMUNOL, V182, P5296, DOI 10.4049/jimmunol.0900036; Dambacher J, 2009, GUT, V58, P1207, DOI 10.1136/gut.2007.130112; Danoy P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001195; Delerive P, 2001, EMBO REP, V2, P42, DOI 10.1093/embo-reports/kve007; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Ferguson LR, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/539461; Festen EAM, 2010, AM J GASTROENTEROL, V105, P395, DOI 10.1038/ajg.2009.576; Filer C, 2008, ARTHRITIS RHEUM-US, V58, P3705, DOI 10.1002/art.24128; Flach CF, 2007, INFECT IMMUN, V75, P2343, DOI 10.1128/IAI.01900-06; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Glas JN, 2009, AM J GASTROENTEROL, V104, P1737, DOI 10.1038/ajg.2009.163; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Glas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029309; Glas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019319; Glas J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010373; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hirota T, 2005, J ALLERGY CLIN IMMUN, V116, P789, DOI 10.1016/j.jaci.2005.06.010; Huffmeier U, 2009, J INVEST DERMATOL, V129, P355, DOI 10.1038/jid.2008.233; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Marquez A, 2008, INFLAMM BOWEL DIS, V14, P1192, DOI 10.1002/ibd.20463; Monteleone G, 2005, GASTROENTEROLOGY, V128, P687, DOI 10.1053/j.gastro.2004.12.042; Morahan G, 2007, TISSUE ANTIGENS, V69, P234, DOI 10.1111/j.1399-0039.2006.773_3.x; Morgan K, 1997, INT J BIOCHEM CELL B, V29, P1501, DOI 10.1016/S1357-2725(97)00118-0; Muller-Berghaus J, 2004, GENES IMMUN, V5, P431, DOI 10.1038/sj.gene.6364102; Nair RP, 2008, J INVEST DERMATOL, V128, P1653, DOI 10.1038/sj.jid.5701255; Neurath MF, 2007, NAT MED, V13, P26, DOI 10.1038/nm0107-26; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Parronchi P, 1997, AM J PATHOL, V150, P823; Peter I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-63; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Smith RL, 2008, J INVEST DERMATOL, V128, P1325, DOI 10.1038/sj.jid.5701140; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Tanaka KI, 2007, J BIOL CHEM, V282, P23240, DOI 10.1074/jbc.M704081200; Torkvist L, 2010, INFLAMM BOWEL DIS, V16, P907, DOI 10.1002/ibd.21105; Tug E, 2009, J INVEST ALLERG CLIN, V19, P21; van der Heide F, 2010, AM J GASTROENTEROL, V105, P1165, DOI 10.1038/ajg.2009.659; Wang K, 2009, AM J HUM GENET, V84, P399, DOI 10.1016/j.ajhg.2009.01.026; Yamazaki K, 2009, GUT, V58, P228, DOI 10.1136/gut.2007.140764; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zwiers A, 2011, J IMMUNOL, V186, P3572, DOI 10.4049/jimmunol.1001330	62	47	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34349	10.1371/journal.pone.0034349	http://dx.doi.org/10.1371/journal.pone.0034349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479607	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100151
J	McKay, JA; Groom, A; Potter, C; Coneyworth, LJ; Ford, D; Mathers, JC; Relton, CL				McKay, Jill A.; Groom, Alexandra; Potter, Catherine; Coneyworth, Lisa J.; Ford, Dianne; Mathers, John C.; Relton, Caroline L.			Genetic and Non-Genetic Influences during Pregnancy on Infant Global and Site Specific DNA Methylation: Role for Folate Gene Variants and Vitamin B-12	PLOS ONE			English	Article							FOLIC-ACID USE; PROMOTER METHYLATION; PLASMA HOMOCYSTEINE; BIRTH; DIETARY; MTHFR; IGF2; HYPERMETHYLATION; POLYMORPHISMS; ASSOCIATIONS	Inter-individual variation in patterns of DNA methylation at birth can be explained by the influence of environmental, genetic and stochastic factors. This study investigates the genetic and non-genetic determinants of variation in DNA methylation in human infants. Given its central role in provision of methyl groups for DNA methylation, this study focuses on aspects of folate metabolism. Global (LUMA) and gene specific (IGF2, ZNT5, IGFBP3) DNA methylation were quantified in 430 infants by Pyrosequencing (R). Seven polymorphisms in 6 genes (MTHFR, MTRR, FOLH1, C beta S, RFC1, SHMT) involved in folate absorption and metabolism were analysed in DNA from both infants and mothers. Red blood cell folate and serum vitamin B-12 concentrations were measured as indices of vitamin status. Relationships between DNA methylation patterns and several covariates viz. sex, gestation length, maternal and infant red cell folate, maternal and infant serum vitamin B-12, maternal age, smoking and genotype were tested. Length of gestation correlated positively with IGF2 methylation (rho = 0.11, p = 0.032) and inversely with ZNT5 methylation (rho = -0.13, p = 0.017). Methylation of the IGFBP3 locus correlated inversely with infant vitamin B-12 concentration (rho = -0.16, p = 0.007), whilst global DNA methylation correlated inversely with maternal vitamin B-12 concentrations (rho = 0.18, p = 0.044). Analysis of common genetic variants in folate pathway genes highlighted several associations including infant MTRR 66G>A genotype with DNA methylation (chi(2) = 8.82, rho = 0.003) and maternal MTHFR 677C>T genotype with IGF2 methylation (chi(2) = 2.77, p = 0.006). These data support the hypothesis that both environmental and genetic factors involved in one-carbon metabolism influence DNA methylation in infants. Specifically, the findings highlight the importance of vitamin B-12 status, infant MTRR genotype and maternal MTHFR genotype, all of which may influence the supply of methyl groups for DNA methylation. In addition, gestational length appears to be an important determinant of infant DNA methylation patterns.	[McKay, Jill A.; Mathers, John C.] Newcastle Univ, Human Nutr Res Ctr, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Groom, Alexandra; Potter, Catherine; Relton, Caroline L.] Newcastle Univ, Inst Med Genet, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Coneyworth, Lisa J.; Ford, Dianne] Newcastle Univ, Inst Cell & Mol Biol, Human Nutr Res Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	McKay, JA (corresponding author), Newcastle Univ, Human Nutr Res Ctr, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	jill.mckay@ncl.ac.uk	Relton, Caroline/AAC-5904-2019	Mathers, John/0000-0003-3406-3002; McKay, Jill Ann/0000-0002-2711-0301; Relton, Caroline/0000-0003-2052-4840	European Nutrigenomics Organisation (NuGO); Biotechnology and Biological Sciences Research Council (BBSRC) [BH081097]; NuGO [CT-2004-505944]; BBSRC [BB/F007981/1, BB/G007993/1] Funding Source: UKRI; MRC [G0700718, G0900686] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F007981/1, BB/G007993/1] Funding Source: researchfish; Medical Research Council [G0700718, G0900686] Funding Source: researchfish	European Nutrigenomics Organisation (NuGO); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NuGO; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by The European Nutrigenomics Organisation (NuGO): linking genomics, nutrition and health research. NuGO was a FP6 European funded Network of Excellence (CT-2004-505944). The authors also acknowledge support from the Biotechnology and Biological Sciences Research Council (BBSRC) through grant no. BH081097. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2011, BIRTH DEFECTS RES A; Adkins RM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-47; Aguilera O, 2010, J APPL PHYSL; Ba Y, 2011, EUR J CLIN NUTR, V65, P480, DOI 10.1038/ejcn.2010.294; Bjornsson HT, 2008, JAMA-J AM MED ASSOC, V299, P2877, DOI 10.1001/jama.299.24.2877; Bock C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn122; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bollati V, 2009, MECH AGEING DEV, V130, P234, DOI 10.1016/j.mad.2008.12.003; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Byun HM, 2009, HUM MOL GENET; Chase DS, 1998, J MED GENET, V35, P413, DOI 10.1136/jmg.35.5.413; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; de Vogel S, 2009, CANCER EPIDEM BIOMAR, V18, P3086, DOI 10.1158/1055-9965.EPI-09-0289; Demendi C, 2011, EUR J OBSTET GYNECOL; Devlin AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012201; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Fryer AA, 2011, EPIGENETICS-US, V6, P86, DOI 10.4161/epi.6.1.13392; Fryer Anthony A, 2009, Epigenetics, V4, P394; Gemma C, 2009, OBESITY, V17, P1032, DOI 10.1038/oby.2008.605; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Guerrero-Preston R, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12378; Hanson M, 2011, PROG BIOPHYS MOL BIO, V106, P272, DOI 10.1016/j.pbiomolbio.2010.12.008; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kile ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013730; Launay JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007959; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; Mathers JC, 2009, NUTRIENTS AND EPIGENETICS, P175, DOI 10.1201/9781420063561.ch8; Mathers JC, 2009, ADV EXP MED BIOL, V646, P119, DOI 10.1007/978-1-4020-9173-5_13; McKay JA, 2011, EFFECT MATERNAL POST; McKay JA, 2011, MOL NUTR FO IN PRESS; McKay JA, 2011, GENES NUTR, V6, P189, DOI 10.1007/s12263-010-0199-1; Michels KB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025254; Minelli C, 2004, AM J EPIDEMIOL, V160, P445, DOI 10.1093/aje/kwh228; Neuhouser ML, 2011, CANCER EPIDEM BIOMAR, V20, P1912, DOI 10.1158/1055-9965.EPI-10-1352; Niihout HF, 2008, VITAM HORM, V79, P45, DOI 10.1016/S0083-6729(08)00402-0; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Pavanello S, 2009, INT J CANCER, V125, P1692, DOI 10.1002/ijc.24492; Pufulete M, 2005, BRIT J CANCER, V92, P838, DOI 10.1038/sj.bjc.6602439; Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998; Relton CL, 2005, BRIT J NUTR, V93, P593, DOI 10.1079/BJN20041395; Relton CL, 2004, J MED GENET, V41, P256, DOI 10.1136/jmg.2003.010694; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Schneider E, 2010, NUCL ACIDS RES; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Sohn KJ, 2009, INT J CANCER, V124, P1999, DOI 10.1002/ijc.24003; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Taberlay PC, 2011, PROG DRUG RES, V67, P1, DOI 10.1007/978-3-7643-8989-5_1; Tao MH, 2009, CANCER EPIDEM BIOMAR, V18, P998, DOI 10.1158/1055-9965.EPI-08-0916; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; THOMPSON RF, 2010, AGING CELL; Tobi EW, 2011, EPIGENETICS-US, V6, P171, DOI 10.4161/epi.6.2.13516; Ulrich CM, 2008, NUTR REV, V66, pS27, DOI 10.1111/j.1753-4887.2008.00062.x; Unterberger A, 2009, J MED PRIMATOL, V38, P219, DOI 10.1111/j.1600-0684.2008.00320.x; van den Donk M, 2007, CANCER EPIDEM BIOMAR, V16, P327, DOI 10.1158/1055-9965.EPI-06-0810; Wakeling LA, 2009, AGE DORDR; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Wettergren Y, 2010, MOL MED, V16, P425, DOI 10.2119/molmed.2009.00156; White Helen E, 2006, Clin Chem, V52, P1005, DOI 10.1373/clinchem.2005.065086; Yang HH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009355; Zhang DD, 2010, AM J HUM GENET, V86, P411, DOI 10.1016/j.ajhg.2010.02.005	68	100	106	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33290	10.1371/journal.pone.0033290	http://dx.doi.org/10.1371/journal.pone.0033290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479380	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100040
J	Estecha, A; Aguilera-Montilla, N; Sanchez-Mateos, P; Puig-Kroger, A				Estecha, Ana; Aguilera-Montilla, Noemi; Sanchez-Mateos, Paloma; Puig-Kroeger, Amaya			RUNX3 Regulates Intercellular Adhesion Molecule 3 (ICAM-3) Expression during Macrophage Differentiation and Monocyte Extravasation	PLOS ONE			English	Article							T-LYMPHOCYTES; TRANSCRIPTION FACTORS; CALCIUM MOBILIZATION; IMMUNE-RESPONSES; COUNTER-RECEPTOR; DENDRITIC CELLS; GENE; BINDING; LFA-1; PROMOTERS	The adhesion molecule ICAM-3 belongs to the immunoglobulin gene superfamily and functions as a ligand for the beta 2 integrins LFA-1, Mac-1 and alpha(d)beta(2). The expression of ICAM-3 is restricted to cells of the hematopoietic lineage. We present evidences that the ICAM-3 gene promoter exhibits a leukocyte-specific activity, as its activity is significantly higher in ICAM-3(+) hematopoietic cell lines. The activity of the ICAM-3 gene promoter is dependent on the occupancy of RUNX cognate sequences both in vitro and in vivo, and whose integrity is required for RUNX responsiveness and for the cooperative actions of RUNX with transcription factors of the Ets and C/ EBP families. Protein analysis revealed that ICAM-3 levels diminish upon monocyte-derived macrophage differentiation, monocyte transendothelial migration and dendritic cell maturation, changes that correlate with an increase in RUNX3. Importantly, disruption of RUNX-binding sites led to enhanced promoter activity, and small interfering RNA-mediated reduction of RUNX3 expression resulted in increased ICAM-3 mRNA levels. Altogether these results indicate that the ICAM-3 gene promoter is negatively regulated by RUNX transcription factors, which contribute to the leukocyte-restricted and the regulated expression of ICAM-3 during monocyte-to-macrophage differentiation and monocyte extravasation.	[Estecha, Ana; Sanchez-Mateos, Paloma; Puig-Kroeger, Amaya] Hosp Gen Univ Gregorio Maranon, Lab Inmunooncol, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Aguilera-Montilla, Noemi] CSIC, Ctr Invest Biol, Madrid, Spain	General University Gregorio Maranon Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Estecha, A (corresponding author), Hosp Gen Univ Gregorio Maranon, Lab Inmunooncol, Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain.	apuig.hgugm@salud.madrid.org	Puig, Amaya/B-6164-2015; Aguilera-Montilla, Noemi/G-4277-2015; Sanchez-Mateos, Paloma/E-8931-2013	Puig, Amaya/0000-0003-2943-9757; Aguilera-Montilla, Noemi/0000-0002-6925-6069; Sanchez-Mateos, Paloma/0000-0001-6589-4445	Instituto de Salud Carlos III [PI08/1208, PI11/00165, CP06/00199]; Ministerio de Educacion y Ciencia (Spanish Ministry of Education and Science) [SAF2010/16102]; Ministerio de Sanidad y Consumo (Spanish Ministry of Health)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Educacion y Ciencia (Spanish Ministry of Education and Science)(Spanish Government); Ministerio de Sanidad y Consumo (Spanish Ministry of Health)	This work was supported by grants PI08/1208 and PI11/00165 from Instituto de Salud Carlos III to APK and grant SAF2010/16102 from Ministerio de Educacion y Ciencia (Spanish Ministry of Education and Science) to PSM. APK is supported by Ministerio de Sanidad y Consumo (Spanish Ministry of Health), Instituto de Salud Carlos III (CP06/00199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arman M, 2009, MOL IMMUNOL, V46, P2226, DOI 10.1016/j.molimm.2009.04.018; Berney SM, 1999, J LEUKOCYTE BIOL, V65, P867, DOI 10.1002/jlb.65.6.867; Bleijs DA, 1999, EUR J IMMUNOL, V29, P2248, DOI 10.1002/(SICI)1521-4141(199907)29:07<2248::AID-IMMU2248>3.0.CO;2-9; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; CAMPANERO MR, 1993, J CELL BIOL, V123, P1007, DOI 10.1083/jcb.123.4.1007; DEFOUGEROLLES AR, 1995, EUR J IMMUNOL, V25, P1008, DOI 10.1002/eji.1830250422; DEFOUGEROLLES AR, 1994, J EXP MED, V179, P619, DOI 10.1084/jem.179.2.619; DEFOUGEROLLES AR, 1993, J EXP MED, V177, P1187, DOI 10.1084/jem.177.4.1187; DEFOUGEROLLES AR, 1991, J EXP MED, V174, P253, DOI 10.1084/jem.174.1.253; DEFOUGEROLLES AR, 1992, J EXP MED, V175, P185, DOI 10.1084/jem.175.1.185; delPozo MA, 1997, J CELL BIOL, V137, P493; Djuretic IM, 2007, NAT IMMUNOL, V8, P145, DOI 10.1038/ni1424; Dominguez-Soto A, 2005, IMMUNOBIOLOGY, V210, P133, DOI 10.1016/j.imbio.2005.05.008; Estecha A, 2009, J CELL SCI, V122, P3492, DOI 10.1242/jcs.053157; FAWCETT J, 1992, NATURE, V360, P481, DOI 10.1038/360481a0; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Gregory CD, 1998, BIOCHEM SOC T, V26, P644, DOI 10.1042/bst0260644; HERNANDEZCASELLES T, 1993, EUR J IMMUNOL, V23, P2799, DOI 10.1002/eji.1830231112; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Jimenez D, 2005, J BIOL CHEM, V280, P5854, DOI 10.1074/jbc.M412104200; JUAN M, 1994, J EXP MED, V179, P1747, DOI 10.1084/jem.179.6.1747; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; Montoya MC, 2002, NAT IMMUNOL, V3, P159, DOI 10.1038/ni753; Ning YM, 1999, J BIOL CHEM, V274, P30624, DOI 10.1074/jbc.274.43.30624; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; PINOOTIN MR, 1995, TISSUE ANTIGENS, V46, P32, DOI 10.1111/j.1399-0039.1995.tb02473.x; Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050; Puig-Kroger A, 2000, J BIOL CHEM, V275, P28507, DOI 10.1074/jbc.M004323200; Puig-Kroger A, 2003, BLOOD, V102, P3252, DOI 10.1182/blood-2003-02-0618; Puig-Kroger A, 2006, J IMMUNOL, V177, P2107, DOI 10.4049/jimmunol.177.4.2107; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Serrador JM, 1997, J CELL BIOL, V138, P1409, DOI 10.1083/jcb.138.6.1409; Serrano-Gomez D, 2008, J BIOL CHEM, V283, P3889, DOI 10.1074/jbc.M706004200; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; STARLING GC, 1995, EUR J IMMUNOL, V25, P2528, DOI 10.1002/eji.1830250918; SUN WW, 1995, J VIROL, V69, P4941, DOI 10.1128/JVI.69.8.4941-4949.1995; VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; VILELLA R, 1990, TISSUE ANTIGENS, V36, P203, DOI 10.1111/j.1399-0039.1990.tb01830.x; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhong WX, 2009, CELL MOL BIOL LETT, V14, P587, DOI 10.2478/s11658-009-0023-3	44	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33313	10.1371/journal.pone.0033313	http://dx.doi.org/10.1371/journal.pone.0033313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479382	Green Published, gold			2022-12-27	WOS:000304523400019
J	Boichard, D; Chung, H; Dassonneville, R; David, X; Eggen, A; Fritz, S; Gietzen, KJ; Hayes, BJ; Lawley, CT; Sonstegard, TS; Van Tassell, CP; VanRaden, PM; Viaud-Martinez, KA; Wiggans, GR				Boichard, Didier; Chung, Hoyoung; Dassonneville, Romain; David, Xavier; Eggen, Andre; Fritz, Sebastien; Gietzen, Kimberly J.; Hayes, Ben J.; Lawley, Cynthia T.; Sonstegard, Tad S.; Van Tassell, Curtis P.; VanRaden, Paul M.; Viaud-Martinez, Karine A.; Wiggans, George R.		Bovine LD Consortium	Design of a Bovine Low-Density SNP Array Optimized for Imputation	PLOS ONE			English	Article							MISSING GENOTYPES; PREDICTION; SELECTION; MARKERS; PANELS; MODEL	The Illumina BovineLD BeadChip was designed to support imputation to higher density genotypes in dairy and beef breeds by including single-nucleotide polymorphisms (SNPs) that had a high minor allele frequency as well as uniform spacing across the genome except at the ends of the chromosome where densities were increased. The chip also includes SNPs on the Y chromosome and mitochondrial DNA loci that are useful for determining subspecies classification and certain paternal and maternal breed lineages. The total number of SNPs was 6,909. Accuracy of imputation to Illumina BovineSNP50 genotypes using the BovineLD chip was over 97% for most dairy and beef populations. The BovineLD imputations were about 3 percentage points more accurate than those from the Illumina GoldenGate Bovine3K BeadChip across multiple populations. The improvement was greatest when neither parent was genotyped. The minor allele frequencies were similar across taurine beef and dairy breeds as was the proportion of SNPs that were polymorphic. The new BovineLD chip should facilitate low-cost genomic selection in taurine beef and dairy cattle.	[Boichard, Didier; Dassonneville, Romain] Natl Inst Agr Res INRA, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France; [Chung, Hoyoung] Natl Inst Anim Sci, Anim Genet Improvement Div, Seonghwan, Cheonan, South Korea; [Chung, Hoyoung; Sonstegard, Tad S.; Van Tassell, Curtis P.] ARS, Bovine Funct Genom Lab, USDA, Beltsville, MD USA; [Dassonneville, Romain] Inst Elevage, Paris, France; [David, Xavier; Fritz, Sebastien] Natl Assoc Livestock & Artificial Inseminat Coope, Paris, France; [Eggen, Andre; Gietzen, Kimberly J.; Lawley, Cynthia T.; Viaud-Martinez, Karine A.] Illumina, San Diego, CA USA; [Hayes, Ben J.] Dept Primary Ind Victoria, Biosci Res Div, Melbourne, Vic, Australia; [Hayes, Ben J.] Dairy Futures Cooperat Res Ctr, Bundoora, Vic, Australia; [Hayes, Ben J.] La Trobe Univ, Bundoora, Vic, Australia; [VanRaden, Paul M.; Wiggans, George R.] ARS, Anim Improvement Programs Lab, USDA, Beltsville, MD USA	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; National Institute of Animal Science, Republic of Korea; United States Department of Agriculture (USDA); Illumina; Victorian Department of Environment & Primary Industries; La Trobe University; United States Department of Agriculture (USDA)	Boichard, D (corresponding author), Natl Inst Agr Res INRA, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France.	ben.hayes@dpi.vic.gov.au	Hayes, Ben J/L-3308-2016; Van Tassell, Curtis P./O-4247-2019; Boichard, Didier/AAD-8675-2020	Hayes, Ben J/0000-0002-5606-3970; Van Tassell, Curtis P./0000-0002-8416-2087; Boichard, Didier/0000-0003-0361-2961; Lawley, Cynthia/0000-0001-7001-4705; FRITZ, Sebastien/0000-0002-3378-1048	National Research Agency (ANR); Apisgene; Dairy Futures Cooperative Research Centre; Beef Genetic Technologies Cooperative Research Centre; Department of Primary Industries Victoria; Dairy Australia; Agriculture and Food Research Initiative from U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture [2009-65205-05635]; USDA Agricultural Research Service [1265-31000-096-00D, 1265-31000-098-00D]	National Research Agency (ANR)(French National Research Agency (ANR)); Apisgene; Dairy Futures Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Beef Genetic Technologies Cooperative Research Centre; Department of Primary Industries Victoria; Dairy Australia(Dairy Australia); Agriculture and Food Research Initiative from U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture; USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The National Research Agency (ANR) and Apisgene funded the French BovineSNP50 data. The Dairy Futures Cooperative Research Centre, Beef Genetic Technologies Cooperative Research Centre, Department of Primary Industries Victoria, and Dairy Australia funded the Australian dairy and beef genotyping. This project was also supported by Agriculture and Food Research Initiative Competitive Grant no. 2009-65205-05635 from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture and by Projects 1265-31000-096-00D and 1265-31000-098-00D from the USDA Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Daetwyler HD, 2011, GENETICS, V189, P317, DOI 10.1534/genetics.111.128082; Dassonneville R, 2011, J DAIRY SCI, V94, P3679, DOI 10.3168/jds.2011-4299; Dassonneville R, 2012, J DAIRY SCI IN PRESS; Druet T, 2010, J DAIRY SCI, V93, P5443, DOI 10.3168/jds.2010-3255; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Edwards CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015922; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Heffner EL, 2011, PLANT GENOME-US, V4, P65, DOI [10.3835/plantgenome2010.12.0029, 10.3835/plantgenome.2010.12.0029]; Hickey JM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-12; Johnston J., 2011, INTERBULL B; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meuwissen THE, 2001, GENETICS, V157, P1819; Pryce JE, 2012, ANIM PROD SCI, V52, P107, DOI 10.1071/AN11098; Pryce JE, 2010, J DAIRY SCI, V93, P5455, DOI 10.3168/jds.2010-3256; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Van Eenennaam AL, 2011, J ANIM SCI, V89, P307, DOI 10.2527/jas.2010-3223; VanRaden PM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-10; Weigel KA, 2010, J DAIRY SCI, V93, P2229, DOI 10.3168/jds.2009-2849; Wiggans GR, 2012, J DAIRY SCI, V95, P1552, DOI 10.3168/jds.2011-4985; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866	22	128	134	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34130	10.1371/journal.pone.0034130	http://dx.doi.org/10.1371/journal.pone.0034130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470530	Green Submitted, gold, Green Published			2022-12-27	WOS:000304489000069
J	Homman-Ludiye, J; Merson, TD; Bourne, JA				Homman-Ludiye, Jihane; Merson, Tobias D.; Bourne, James A.			The Early Postnatal Nonhuman Primate Neocortex Contains Self-Renewing Multipotent Neural Progenitor Cells	PLOS ONE			English	Article							STEM-CELLS; ADULT NEUROGENESIS; VISUAL-CORTEX; SUBVENTRICULAR ZONE; MAMMALIAN BRAIN; MOUSE-BRAIN; NEURONS; GENERATION; ASTROCYTES; MARMOSET	The postnatal neocortex has traditionally been considered a non-neurogenic region, under non-pathological conditions. A few studies suggest, however, that a small subpopulation of neural cells born during postnatal life can differentiate into neurons that take up residence within the neocortex, implying that postnatal neurogenesis could occur in this region, albeit at a low level. Evidence to support this hypothesis remains controversial while the source of putative neural progenitors responsible for generating new neurons in the postnatal neocortex is unknown. Here we report the identification of self-renewing multipotent neural progenitor cells (NPCs) derived from the postnatal day 14 (PD14) marmoset monkey primary visual cortex (V1, striate cortex). While neuronal maturation within V1 is well advanced by PD14, we observed cells throughout this region that co-expressed Sox2 and Ki67, defining a population of resident proliferating progenitor cells. When cultured at low density in the presence of epidermal growth factor (EGF) and/or fibroblast growth factor 2 (FGF-2), dissociated V1 tissue gave rise to multipotent neurospheres that exhibited the ability to differentiate into neurons, oligodendrocytes and astrocytes. While the capacity to generate neurones and oligodendrocytes was not observed beyond the third passage, astrocyte-restricted neurospheres could be maintained for up to 6 passages. This study provides the first direct evidence for the existence of multipotent NPCs within the postnatal neocortex of the nonhuman primate. The potential contribution of neocortical NPCs to neural repair following injury raises exciting new possibilities for the field of regenerative medicine.	[Homman-Ludiye, Jihane; Merson, Tobias D.; Bourne, James A.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Merson, Tobias D.] Univ Melbourne, Florey Neurosci Inst, Melbourne, Vic, Australia; [Merson, Tobias D.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic, Australia	Australian Regenerative Medicine Institute; Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Homman-Ludiye, J (corresponding author), Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia.	tmerson@unimelb.edu.au; james.bourne@monash.edu	Merson, Tobias D/D-5375-2015; Bourne, James/B-5265-2018	Merson, Tobias D/0000-0002-7246-3608; Bourne, James/0000-0002-0902-3108; Homman-Ludiye, Jihane/0000-0001-6689-1457	National Health and Medical Research Council; NHMRC/MSRA; State Government of Victoria; Australian Government	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NHMRC/MSRA(National Health and Medical Research Council (NHMRC) of Australia); State Government of Victoria; Australian Government(Australian GovernmentCGIAR)	This work was supported by the National Health and Medical Research Council and an RD Wright Fellowship (NHMRC) to JB and Betty Cuthbert Fellowship (NHMRC/MSRA) to TM. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Bernier PJ, 2002, P NATL ACAD SCI USA, V99, P11464, DOI 10.1073/pnas.172403999; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Bloch J, 2011, J COMP NEUROL, V519, P775, DOI 10.1002/cne.22547; Bourne JA, 2006, CEREB CORTEX, V16, P405, DOI 10.1093/cercor/bhi119; Bourne JA, 2005, CEREB CORTEX, V15, P740, DOI 10.1093/cercor/bhh175; Brazel CY, 2005, AGING CELL, V4, P197, DOI 10.1111/j.1474-9726.2005.00158.x; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Cameron HA, 2008, BIOL PSYCHIAT, V63, P650, DOI 10.1016/j.biopsych.2007.09.023; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Decimo I, 2011, STEM CELLS, V29, P2062, DOI 10.1002/stem.766; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; FRITSCHY JM, 1986, DEV BRAIN RES, V29, P173, DOI 10.1016/0165-3806(86)90093-3; Garcia-Moreno F, 2012, CEREB CORTEX, V22, P482, DOI 10.1093/cercor/bhr312; GAREY LJ, 1983, BEHAV BRAIN RES, V10, P3, DOI 10.1016/0166-4328(83)90145-6; Goldshmit Y, 2010, J NEUROTRAUM, V27, P1321, DOI 10.1089/neu.2010.1294; Gould E, 1999, SCIENCE, V286, P548, DOI 10.1126/science.286.5439.548; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Gritti A, 1996, J NEUROSCI, V16, P1091; KAPLAN MS, 1981, J COMP NEUROL, V195, P323, DOI 10.1002/cne.901950211; Kim WR, 2011, EUR J NEUROSCI, V33, P599, DOI 10.1111/j.1460-9568.2010.07557.x; Koketsu D, 2003, J NEUROSCI, V23, P937; Kornack DR, 2001, SCIENCE, V294, P2127, DOI 10.1126/science.1065467; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Merson TD, 2006, J NEUROSCI, V26, P11359, DOI 10.1523/JNEUROSCI.2247-06.2006; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; MISSLER M, 1993, J COMP NEUROL, V333, P53, DOI 10.1002/cne.903330105; Palazzi X, 2008, MARMOSET BRAIN STERE, P1, DOI [10.1007/978-0-387-78385-7_1, DOI 10.1007/978-0-387-78385-7_1]; Palmer TD, 1999, J NEUROSCI, V19, P8487; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rakic P, 2002, NAT REV NEUROSCI, V3, P65, DOI 10.1038/nrn700; Rakic P, 2002, CLIN NEUROSCI RES, V2, P29, DOI 10.1016/S1566-2772(02)00005-1; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sawamoto K, 2011, J COMP NEUROL, V519, P690, DOI 10.1002/cne.22543; Sirko S, 2009, BRAIN, V132, P2252, DOI 10.1093/brain/awp043; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Takemura NU, 2005, NEUROSCIENCE, V134, P121, DOI 10.1016/j.neuroscience.2005.04.033; Vessal M, 2010, J NEUROSCI, V30, P8613, DOI 10.1523/JNEUROSCI.5272-09.2010; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008	47	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34383	10.1371/journal.pone.0034383	http://dx.doi.org/10.1371/journal.pone.0034383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470566	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000105
J	Huizinga, R; Easton, AS; Donachie, AM; Guthrie, J; van Rijs, W; Heikema, A; Boon, L; Samsom, JN; Jacobs, BC; Willison, HJ; Goodyear, CS				Huizinga, Ruth; Easton, Alistair S.; Donachie, Anne M.; Guthrie, Jim; van Rijs, Wouter; Heikema, Astrid; Boon, Louis; Samsom, Janneke N.; Jacobs, Bart C.; Willison, Hugh J.; Goodyear, Carl S.			Sialylation of Campylobacter jejuni Lipo-Oligosaccharides: Impact on Phagocytosis and Cytokine Production in Mice	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; DENDRITIC CELLS; CLINICAL-FEATURES; ANTIBODIES; LIPOOLIGOSACCHARIDES; SIALOADHESIN; DETERMINANT; INFECTIONS; ACTIVATION; SIGLECS	Background: Guillain-Barre syndrome (GBS) is a post-infectious polyradiculoneuropathy, frequently associated with antecedent Campylobacter jejuni (C. jejuni) infection. The presence of sialic acid on C. jejuni lipo-oligosaccharide (LOS) is considered a risk factor for development of GBS as it crucially determines the structural homology between LOS and gangliosides, explaining the induction of cross-reactive neurotoxic antibodies. Sialylated C. jejuni are recognised by TLR4 and sialoadhesin; however, the functional implications of these interactions in vivo are unknown. Methodology/Principal Findings: In this study we investigated the effects of bacterial sialylation on phagocytosis and cytokine secretion by mouse myeloid cells in vitro and in vivo. Using fluorescently labelled GM1a/GD1a ganglioside-mimicking C. jejuni strains and corresponding (Cst-II-mutant) control strains lacking sialic acid, we show that sialylated C. jejuni was more efficiently phagocytosed in vitro by BM-M Phi, but not by BM-DC. In addition, LOS sialylation increased the production of IL-10, IL-6 and IFN-beta by both BM-M Phi and BM-DC. Subsequent in vivo experiments revealed that sialylation augmented the deposition of fluorescent bacteria in splenic DC, but not macrophages. In addition, sialylation significantly amplified the production of type I interferons, which was independent of pDC. Conclusions/Significance: These results identify novel immune stimulatory effects of C. jejuni sialylation, which may be important in inducing cross-reactive humoral responses that cause GBS.	[Huizinga, Ruth; van Rijs, Wouter; Jacobs, Bart C.] Univ Med Ctr Rotterdam, Dept Immunol, Erasmus MC, Rotterdam, Netherlands; [Easton, Alistair S.; Donachie, Anne M.; Willison, Hugh J.; Goodyear, Carl S.] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Guthrie, Jim] So Gen Hosp, Dept Bacteriol, Glasgow G51 4TF, Lanark, Scotland; [van Rijs, Wouter; Jacobs, Bart C.] Univ Med Ctr Rotterdam, Dept Neurol, Erasmus MC, Rotterdam, Netherlands; [Heikema, Astrid] Univ Med Ctr Rotterdam, Dept Microbiol, Erasmus MC, Rotterdam, Netherlands; [Boon, Louis] Bioceros BV, Utrecht, Netherlands; [Samsom, Janneke N.] Univ Med Ctr Rotterdam, Div Gastroenterol & Nutr, Erasmus MC, Dept Paediat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Glasgow; University of Glasgow; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Bioceros B.V.; Erasmus University Rotterdam; Erasmus MC	Huizinga, R (corresponding author), Univ Med Ctr Rotterdam, Dept Immunol, Erasmus MC, Rotterdam, Netherlands.	Carl.Goodyear@glasgow.ac.uk	Jacobs, Bart/ABE-2210-2021; Boon, Laurence/HCI-3629-2022; willison, hugh/HCI-7819-2022; Samsom, Janneke/C-5304-2013	Boon, Louis/0000-0002-0937-9171; Goodyear, Carl/0000-0001-5926-5941	EFIS-IL; Pathological Society; Arthritis Research UK [17653]	EFIS-IL; Pathological Society; Arthritis Research UK(Versus Arthritis)	This work was financially supported by an EFIS-IL Fellowship (to RH) and a Pathological Society of Great Britain and Ireland pilot project grant (to ASE). CSG is supported by an Arthritis Research UK Non-clinical Career Development Fellowship (No. 17653). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2002, INFECT IMMUN, V70, P1202, DOI 10.1128/IAI.70.3.1202-1208.2002; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Bax M, 2011, INFECT IMMUN, V79, P2681, DOI 10.1128/IAI.00009-11; BLASER MJ, 1983, INFECT IMMUN, V39, P908, DOI 10.1128/IAI.39.2.908-916.1983; Braun D, 2002, INT IMMUNOL, V14, P411, DOI 10.1093/intimm/14.4.411; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; de Zoete MR, 2010, INFECT IMMUN, V78, P1229, DOI 10.1128/IAI.00897-09; Ekstein D, 2005, NEUROLOGY, V65, P456, DOI 10.1212/01.wnl.0000171858.82527.4c; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06; Goodyear CS, 1999, J CLIN INVEST, V104, P697, DOI 10.1172/JCI6837; Guerry P, 2000, INFECT IMMUN, V68, P6656, DOI 10.1128/IAI.68.12.6656-6662.2000; Halstead SK, 2004, BRAIN, V127, P2109, DOI 10.1093/brain/awh231; Heikema AP, 2010, INFECT IMMUN, V78, P3237, DOI 10.1128/IAI.01273-09; Houliston RS, 2007, BIOCHEMISTRY-US, V46, P8164, DOI 10.1021/bi700685s; Jacobs BC, 1996, ANN NEUROL, V40, P181, DOI 10.1002/ana.410400209; Janssen R, 2008, CLIN MICROBIOL REV, V21, P505, DOI 10.1128/CMR.00055-07; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Koga M, 2005, NEUROLOGY, V65, P1376, DOI 10.1212/01.wnl.0000176914.70893.14; Kuijf ML, 2010, J IMMUNOL, V185, P748, DOI 10.4049/jimmunol.0903014; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; Meyrieux V, 1996, CLIN INFECT DIS, V22, P183, DOI 10.1093/clinids/22.1.183; Mortensen NP, 2009, MICROBES INFECT, V11, P988, DOI 10.1016/j.micinf.2009.07.004; Nachamkin I, 2008, CAMPYLOBACTER, 3RD EDITION, P1; Rathinam VAK, 2009, INFECT IMMUN, V77, P2499, DOI 10.1128/IAI.01562-08; Revilla C, 2009, VET RES, V40, DOI 10.1051/vetres:2008052; SKIRROW MB, 1993, EPIDEMIOL INFECT, V110, P567, DOI 10.1017/S0950268800050986; STANFIELD JT, 1987, MICROB PATHOGENESIS, V3, P155, DOI 10.1016/0882-4010(87)90092-1; Stubgen JP, 2009, J NEUROIMMUNOL, V207, P3, DOI 10.1016/j.jneuroim.2008.12.008; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101	33	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34416	10.1371/journal.pone.0034416	http://dx.doi.org/10.1371/journal.pone.0034416			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470569	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000304489000108
J	Breda, L; Casu, C; Gardenghi, S; Bianchi, N; Cartegni, L; Narla, M; Yazdanbakhsh, K; Musso, M; Manwani, D; Little, J; Gardner, LB; Kleinert, DA; Prus, E; Fibach, E; Grady, RW; Giardina, PJ; Gambari, R; Rivella, S				Breda, Laura; Casu, Carla; Gardenghi, Sara; Bianchi, Nicoletta; Cartegni, Luca; Narla, Mohandas; Yazdanbakhsh, Karina; Musso, Marco; Manwani, Deepa; Little, Jane; Gardner, Lawrence B.; Kleinert, Dorothy A.; Prus, Eugenia; Fibach, Eitan; Grady, Robert W.; Giardina, Patricia J.; Gambari, Roberto; Rivella, Stefano			Therapeutic Hemoglobin Levels after Gene Transfer in beta-Thalassemia Mice and in Hematopoietic Cells of beta-Thalassemia and Sickle Cells Disease Patients	PLOS ONE			English	Article							HUMAN ERYTHROID PROGENITORS; IN-VIVO SELECTION; GLOBIN GENE; STEM-CELLS; CLINICAL-TRIAL; MOUSE MODEL; INSULATOR; DIFFERENTIATION; INTEGRATION; EXPRESSION	Preclinical and clinical studies demonstrate the feasibility of treating beta-thalassemia and Sickle Cell Disease (SCD) by lentiviral-mediated transfer of the human beta-globin gene. However, previous studies have not addressed whether the ability of lentiviral vectors to increase hemoglobin synthesis might vary in different patients. We generated lentiviral vectors carrying the human beta-globin gene with and without an ankyrin insulator and compared their ability to induce hemoglobin synthesis in vitro and in thalassemic mice. We found that insertion of an ankyrin insulator leads to higher, potentially therapeutic levels of human beta-globin through a novel mechanism that links the rate of transcription of the transgenic beta-globin mRNA during erythroid differentiation with polysomal binding and efficient translation, as reported here for the first time. We also established a preclinical assay to test the ability of this novel vector to synthesize adult hemoglobin in erythroid precursors and in CD34(+) cells isolated from patients affected by beta-thalassemia and SCD. Among the thalassemic patients, we identified a subset of specimens in which hemoglobin production can be achieved using fewer copies of the vector integrated than in others. In SCD specimens the treatment with AnkT9W ameliorates erythropoiesis by increasing adult hemoglobin (Hb A) and concurrently reducing the sickling tetramer (Hb S). Our results suggest two major findings. First, we discovered that for the purpose of expressing the beta-globin gene the ankyrin element is particularly suitable. Second, our analysis of a large group of specimens from beta-thalassemic and SCD patients indicates that clinical trials could benefit from a simple test to predict the relationship between the number of vector copies integrated and the total amount of hemoglobin produced in the erythroid cells of prospective patients. This approach would provide vital information to select the best candidates for these clinical trials, before patients undergo myeloablation and bone marrow transplant.	[Breda, Laura; Casu, Carla; Gardenghi, Sara; Kleinert, Dorothy A.; Grady, Robert W.; Giardina, Patricia J.; Rivella, Stefano] Weill Cornell Med Coll, Dept Pediat, Div Hematol Oncol, Childrens Blood & Canc Fdn Labs, New York, NY USA; [Bianchi, Nicoletta; Gambari, Roberto] Univ Ferrara, Dipartmento Biochim & Biol Mol, I-44100 Ferrara, Italy; [Cartegni, Luca] Mem Sloan Kettering Canc Ctr, Dept Mol Pharmacol & Chem, New York, NY 10021 USA; [Narla, Mohandas; Yazdanbakhsh, Karina] New York Blood Ctr, Red Cell Physiol Lab, New York, NY 10021 USA; [Musso, Marco] Osped Galliera, Ctr Microcitemia & Anemie Congenite, Genoa, Italy; [Manwani, Deepa] Childrens Hosp Montefiore, Dept Pediat, Albert Einstein Coll Med, Bronx, NY USA; [Little, Jane] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA; [Gardner, Lawrence B.] NYU, Dept Pharmacol, Langone Med Ctr, New York, NY 10016 USA; [Prus, Eugenia; Fibach, Eitan] Hadassah Hebrew Univ, Dept Hematol, Med Ctr, Jerusalem, Israel; [Rivella, Stefano] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY USA	Cornell University; University of Ferrara; Memorial Sloan Kettering Cancer Center; New York Blood Center; Ente Ospedaliero Ospedali Galliera; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; New York University; NYU Langone Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Cornell University	Breda, L (corresponding author), Weill Cornell Med Coll, Dept Pediat, Div Hematol Oncol, Childrens Blood & Canc Fdn Labs, New York, NY USA.	str2010@med.cornell.edu	Gambari, Roberto/F-9555-2015; Bianchi, Nicoletta/H-1902-2015; Breda, Laura/T-3997-2017	Gambari, Roberto/0000-0001-9205-6033; Bianchi, Nicoletta/0000-0001-9280-6017; Breda, Laura/0000-0003-2133-4432; Rivella, Stefano/0000-0002-0938-6558; Gardner, Lawrence/0000-0003-0191-0172	Cooley's Anemia Foundation (CAF); Associazione Veneta Lotta alla Talassemia (AVLT; Veneta Association for the Fight Against Thalassemia - Italy); Carlo and Micol Schejola Foundation; Children's Cancer and Blood Foundation; United States National Institutes of Health [5K01DK063992, NHLBI-5R01HL102449]; Clinical and Translational Science Center (CTSC), NIH [UL1RR024992]; Telethon [GGP10124]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK063992] Funding Source: NIH RePORTER	Cooley's Anemia Foundation (CAF); Associazione Veneta Lotta alla Talassemia (AVLT; Veneta Association for the Fight Against Thalassemia - Italy); Carlo and Micol Schejola Foundation; Children's Cancer and Blood Foundation; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Center (CTSC), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon(Fondazione Telethon); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Cooley's Anemia Foundation (CAF), the Associazione Veneta Lotta alla Talassemia (AVLT; Veneta Association for the Fight Against Thalassemia - Italy) (to L. Breda). This work is supported by grants from the Carlo and Micol Schejola Foundation, the Children's Cancer and Blood Foundation and United States National Institutes of Health grants 5K01DK063992 and NHLBI-5R01HL102449 (to S. Rivella). Additional support was provided by the Clinical and Translational Science Center (CTSC; NIH grant UL1RR024992) and the Carlo and Micol Schejola Foundation (to S. Rivella). RG was funded by Telethon (contract #GGP10124). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam PI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006995; Bank A, 2005, ANN NY ACAD SCI, V1054, P308, DOI 10.1196/annals.1345.007; Bank A, 2008, PEDIATR HEMAT ONCOL, V25, P1, DOI 10.1080/08880010701773829; Bell AC, 1999, CURR OPIN GENET DEV, V9, P191, DOI 10.1016/S0959-437X(99)80029-X; Breda L, MEDITERRANEAN J HEMA, V1; Breda L, 2010, ANN NY ACAD SCI, V1202, P134, DOI 10.1111/j.1749-6632.2010.05594.x; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; CIAVATTA DJ, 1995, P NATL ACAD SCI USA, V92, P9259, DOI 10.1073/pnas.92.20.9259; FIBACH E, 1989, BLOOD, V73, P100; Gallagher PG, 2010, J CLIN INVEST, V120, P4453, DOI 10.1172/JCI42240; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Ikeda K, 2011, BLOOD, V117, P5860, DOI 10.1182/blood-2011-02-334425; Imren S, 2002, P NATL ACAD SCI USA, V99, P14380, DOI 10.1073/pnas.212507099; Leberbauer C, 2005, BLOOD, V105, P85, DOI 10.1182/blood-2004-03-1002; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; May C, 2002, BLOOD, V99, P1902, DOI 10.1182/blood.V99.6.1902; Miccio A, 2008, P NATL ACAD SCI USA, V105, P10547, DOI 10.1073/pnas.0711666105; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Persons DA, 2003, BLOOD, V102, P506, DOI 10.1182/blood-2003-03-0677; Puthenveetil G, 2004, BLOOD, V104, P3445, DOI 10.1182/blood-2004-04-1427; RIFKIND RA, 1978, BLOOD CELLS, V4, P189; Rivella S, 1998, SEMIN HEMATOL, V35, P112; Rivella S, 2000, J VIROL, V74, P4679, DOI 10.1128/JVI.74.10.4679-4687.2000; Rivella S, 2003, BLOOD, V101, P2932, DOI 10.1182/blood-2002-10-3305; Rivella S, 2009, EXPERT REV HEMATOL, V2, P685, DOI 10.1586/EHM.09.56; Sadelain M, 2007, HUM GENE THER, V18, P1, DOI 10.1089/hum.2006.151; Sadelain M, 2010, ANN NY ACAD SCI, V1202, P52, DOI 10.1111/j.1749-6632.2010.05597.x; STEINBERG MH, 2001, MOL MECH BETA THALAS; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; YANG BL, 1995, P NATL ACAD SCI USA, V92, P11608, DOI 10.1073/pnas.92.25.11608	34	64	67	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e32345	10.1371/journal.pone.0032345	http://dx.doi.org/10.1371/journal.pone.0032345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479321	Green Published, gold			2022-12-27	WOS:000303894900006
J	Duong, YT; Qiu, MF; De, AK; Jackson, K; Dobbs, T; Kim, AA; Nkengasong, JN; Parekh, BS				Duong, Yen T.; Qiu, Maofeng; De, Anindya K.; Jackson, Keisha; Dobbs, Trudy; Kim, Andrea A.; Nkengasong, John N.; Parekh, Bharat S.			Detection of Recent HIV-1 Infection Using a New Limiting-Antigen Avidity Assay: Potential for HIV-1 Incidence Estimates and Avidity Maturation Studies	PLOS ONE			English	Article							CAPTURE ENZYME-IMMUNOASSAY; SUBTYPE-E INFECTION; TYPE-1 INCIDENCE; PERFORMANCE-CHARACTERISTICS; INCIDENCE RATES; SEROCONVERSION; ANTIBODIES; ACCURACY; TRENDS; WOMEN	Background: Accurate and reliable laboratory methods are needed for estimation of HIV-1 incidence to identify the high-risk populations and target and monitor prevention efforts. We previously described a single-well limiting-antigen avidity enzyme immunoassay (LAg-Avidity EIA) to detect recent HIV-1 infection. Methods: We describe here further optimization and characterization of LAg-Avidity EIA, comparing it to the BED assay and a two-well avidity-index (AI) EIA. Specimen sets included longitudinal sera (n = 393), collected from 89 seroconverting individuals from 4 cohorts representing 4 HIV-1 subtypes, and sera from AIDS patients (n = 488) with or without TB co-infections from 3 different cohorts. Ninety seven HIV-1 positive specimens were purchased commercially. The BED assay, LAg-Avidity EIA, AI-EIA and HIV serology were performed, as needed. Results: Monitoring quality control specimens indicated high reproducibility of the LAg-Avidity EIA with coefficient of variation of <10% in the dynamic range. The LAg-Avidity EIA has an overall mean duration of recency (omega) of 141 days (95% CI 119-160) at normalized optical density (ODn) cutoff of 1.0, with similar omega in different HIV-1 subtypes and populations (132 to 143 days). Antibody avidity kinetics were similar among individuals and subtypes by both the LAg-Avidity EIA and AI-EIA compared to the HIV-IgG levels measured by the BED assay. The false recent rate among individuals with AIDS was 0.2% with the LAg-Avidity EIA, compared to 2.9% with the BED assay. Western blot profiles of specimens with increasing avidity confirm accurate detection of recent HIV-1 infections. Conclusions: These data demonstrate that the LAg-Avidity EIA is a promising assay with consistent omega in different populations and subtypes. The assay should be very useful for 1) estimating HIV-1 incidence in cross-sectional specimens as part of HIV surveillance, 2) identifying risk factors for recent infections, 3) measuring impact of prevention programs, and 4) studying avidity maturation during vaccine trials.	[Duong, Yen T.; Qiu, Maofeng; De, Anindya K.; Jackson, Keisha; Dobbs, Trudy; Kim, Andrea A.; Nkengasong, John N.; Parekh, Bharat S.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Duong, YT (corresponding author), Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30333 USA.	bparekh@cdc.gov		PAREKH, BHARAT/0000-0002-1088-4263	China-CDC, Beijing	China-CDC, Beijing	Maofeng Qiu was supported by China-CDC, Beijing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, Wkly Epidemiol Rec, V81, P40; Barin F, 2005, J CLIN MICROBIOL, V43, P4441, DOI 10.1128/JCM.43.9.4441-4447.2005; Barnighausen T, 2010, EPIDEMIOLOGY, V21, P685, DOI 10.1097/EDE.0b013e3181e9e978; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Chawla A, 2007, J CLIN MICROBIOL, V45, P415, DOI 10.1128/JCM.01879-06; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Dobbs T, 2011, J CLIN MICR IN PRESS; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hargrove JW, 2009, AIDS, V23, P2061, DOI 10.1097/QAD.0b013e32832f3d8b; Hladik W, 2011, AIDS RES HUM RETROVI; Hu DJ, 2003, AIDS RES HUM RETROV, V19, P727, DOI 10.1089/088922203769232511; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Janssen RS, 1999, JAMA-J AM MED ASSOC, V281, P1893; Karim QA, 2011, INT J EPIDEMIOL, V40, P922, DOI 10.1093/ije/dyq176; Kim AA, 2010, AIDS RES HUM RETROV, V26, P1051, DOI 10.1089/aid.2009.0218; Klein JS, 2010, PLOS PATHOG, V6, P1; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; McDougal JS, 2009, AIDS, V23, P2064, DOI 10.1097/QAD.0b013e32832eff6e; Nesheim S, 2005, AIDS RES HUM RETROV, V21, P537, DOI 10.1089/aid.2005.21.537; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V52, P265, DOI 10.1097/QAI.0b013e3181ab6ef0; Parekh B, 2007, DEV LIMITING ANTIGEN; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Parekh BS, 2001, AIDS RES HUM RETROV, V17, P137, DOI 10.1089/08892220150217229; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Rehle T, 2007, SAMJ S AFR MED J, V97, P194; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Saphonn V, 2005, JAIDS-J ACQ IMM DEF, V39, P587; Smith DK, 1997, AM J EPIDEMIOL, V146, P459, DOI 10.1093/oxfordjournals.aje.a009299; Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012; Suligoi B, 2002, J CLIN MICROBIOL, V40, P4015, DOI 10.1128/JCM.40.11.4015-4020.2002; Thomas HIJ, 1996, CLIN EXP IMMUNOL, V103, P185, DOI 10.1046/j.1365-2249.1996.951642.x; UNAIDS, 2010, UNAIDS REP GLOB AIDS; [UNAIDS WHO], 2011, WHEN US ASS REC INF; Vaine M, 2010, VACCINE, V28, P2999, DOI 10.1016/j.vaccine.2010.02.006; Wei XR, 2010, AIDS RES HUM RETROV, V26, P61, DOI 10.1089/aid.2009.0133; Wilson KM, 2004, AIDS, V18, P2253, DOI 10.1097/00002030-200411190-00005; Ying S, 2010, ANAL INTERVAL CENSOR; Young CL, 2003, AIDS RES HUM RETROV, V19, P481, DOI 10.1089/088922203766774522	45	152	172	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33328	10.1371/journal.pone.0033328	http://dx.doi.org/10.1371/journal.pone.0033328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479384	gold, Green Published			2022-12-27	WOS:000303894900023
J	Jia, BB; Madsen, L; Petersen, RK; Techer, N; Kopperud, R; Ma, T; Doskeland, SO; Ailhaud, G; Wang, JF; Amri, EZ; Kristiansen, K				Jia, Bingbing; Madsen, Lise; Petersen, Rasmus Koefoed; Techer, Nathalie; Kopperud, Reidun; Ma, Tao; Doskeland, Stein Ove; Ailhaud, Gerard; Wang, Jinfu; Amri, Ez-Zoubir; Kristiansen, Karsten			Activation of Protein Kinase A and Exchange Protein Directly Activated by cAMP Promotes Adipocyte Differentiation of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							RECEPTOR-GAMMA LIGAND; PEROXISOME-PROLIFERATOR; ADIPOSE-TISSUE; FATTY-ACIDS; ARACHIDONIC-ACID; GENE-EXPRESSION; EPAC; ADIPOGENESIS; ALPHA; EICOSANOIDS	Human mesenchymal stem cells are primary multipotent cells capable of differentiating into several cell types including adipocytes when cultured under defined in vitro conditions. In the present study we investigated the role of cAMP signaling and its downstream effectors, protein kinase A (PKA) and exchange protein directly activated by cAMP (Epac) in adipocyte conversion of human mesenchymal stem cells derived from adipose tissue (hMADS). We show that cAMP signaling involving the simultaneous activation of both PKA- and Epac-dependent signaling is critical for this process even in the presence of the strong adipogenic inducers insulin, dexamethasone, and rosiglitazone, thereby clearly distinguishing the hMADS cells from murine preadipocytes cell lines, where rosiglitazone together with dexamethasone and insulin strongly promotes adipocyte differentiation. We further show that prostaglandin I-2 (PGI(2)) may fully substitute for the cAMP-elevating agent isobutylmethylxanthine (IBMX). Moreover, selective activation of Epac-dependent signaling promoted adipocyte differentiation when the Rho-associated kinase (ROCK) was inhibited. Unlike the case for murine preadipocytes cell lines, long-chain fatty acids, like arachidonic acid, did not promote adipocyte differentiation of hMADS cells in the absence of a PPAR gamma agonist. However, prolonged treatment with the synthetic PPAR delta agonist L165041 promoted adipocyte differentiation of hMADS cells in the presence of IBMX. Taken together our results emphasize the need for cAMP signaling in concert with treatment with a PPAR gamma or PPAR delta agonist to secure efficient adipocyte differentiation of human hMADS mesenchymal stem cells.	[Jia, Bingbing; Wang, Jinfu] Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Hangzhou 310003, Zhejiang, Peoples R China; [Jia, Bingbing; Madsen, Lise; Petersen, Rasmus Koefoed; Ma, Tao; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Madsen, Lise] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Techer, Nathalie; Ailhaud, Gerard; Amri, Ez-Zoubir] Univ Nice Sophia Antipolis, CNRS, INSERM, Fac Med,IBV,UMR7277,UMR1091, Nice, France; [Kopperud, Reidun; Doskeland, Stein Ove] Univ Bergen, Dept Biomed, Bergen, Norway	Zhejiang University; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of Bergen	Jia, BB (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Cell Biol & Genet, Hangzhou 310003, Zhejiang, Peoples R China.	wjfu@zju.edu.cn; kk@bio.ku.dk	Madsen, Lise/C-6246-2012; Kristiansen, Karsten/J-5148-2014	Madsen, Lise/0000-0003-4468-1947; Kristiansen, Karsten/0000-0002-6024-0917; Doskeland, Stein Ove/0000-0002-4009-4756; amri, Ez-Zoubir/0000-0001-8426-5396	Danish Council for Strategic Research [2101-06-0005]; Danish Council for Independent Research \ Natural Sciences; Novo Nordisk Foundation; Carlsberg Foundation; Centre National de la Recherche Scientifique (CNRS); KOT-CEPRODI (Paris, France); National Science Foundation of China [30971460]; Ceprodi KOT	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); KOT-CEPRODI (Paris, France); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ceprodi KOT	This work was supported by the Danish Council for Strategic Research (Grant NO 2101-06-0005), http://en.fi.dk/councils-commissions/the-danish-council-for-strategic-research; the Danish Council for Independent Research vertical bar Natural Sciences, http://en.fi.dk; the Novo Nordisk Foundation, www.novonordiskfonden.dk and the Carlsberg Foundation, www.carlsbergfondet.dk. This work was in part supported by Centre National de la Recherche Scientifique (CNRS) and by a grant from KOT-CEPRODI (Paris, France) to G. A. (http://www.kot.fr/) and in part supported by a grant from the National Science Foundation of China (30971460) to J. F. W. (http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journals policy and declare the following conflict: the authors received funding from Ceprodi KOT, this does not alter the authors' adherence to the all the PLoS ONE policies on sharing data and materials.	AMRI EZ, 1995, J BIOL CHEM, V270, P2367, DOI 10.1074/jbc.270.5.2367; Aubert J, 2000, MOL CELL ENDOCRINOL, V160, P149, DOI 10.1016/S0303-7207(99)00210-5; Bastie C, 1999, J BIOL CHEM, V274, P21920, DOI 10.1074/jbc.274.31.21920; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; CHAWLA A, 1994, P NATL ACAD SCI USA, V91, P1786, DOI 10.1073/pnas.91.5.1786; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Cleary MP, 1999, P SOC EXP BIOL MED, V220, P153, DOI 10.1046/j.1525-1373.1999.d01-23.x; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Elabd C, 2007, BIOCHEM BIOPH RES CO, V361, P342, DOI 10.1016/j.bbrc.2007.06.180; Elabd C, 2009, STEM CELLS, V27, P2753, DOI 10.1002/stem.200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; GAILLARD D, 1989, BIOCHEM J, V257, P389, DOI 10.1042/bj2570389; Hallenborg P, 2010, MOL CELL BIOL, V30, P4077, DOI 10.1128/MCB.01806-08; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; Hansen JB, 2001, J BIOL CHEM, V276, P3175, DOI 10.1074/jbc.M005567200; Hao Q, 2010, BBA-MOL CELL BIOL L, V1801, P421, DOI 10.1016/j.bbalip.2009.11.008; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Kassel KM, 2008, AM J PHYSIOL-LUNG C, V294, pL131, DOI 10.1152/ajplung.00381.2007; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Keller H, 1997, BIOL CHEM, V378, P651, DOI 10.1515/bchm.1997.378.7.651; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Krey G, 1997, MOL ENDOCRINOL, V11, P779, DOI 10.1210/me.11.6.779; Lee JY, 2011, BIOCHEM BIOPH RES CO, V407, P818, DOI 10.1016/j.bbrc.2011.03.106; Ma T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021647; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Madsen L, 2010, ANN NY ACAD SCI, V1190, P1, DOI 10.1111/j.1749-6632.2009.05262.x; Massiera F, 2003, J LIPID RES, V44, P271, DOI 10.1194/jlr.M200346-JLR200; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nguyen VT, 1996, AM J CLIN NUTR, V63, P507, DOI 10.1093/ajcn/63.4.507; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; OSCAI LB, 1984, GROWTH, V48, P415; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Petersen RK, 2003, J LIPID RES, V44, P2320, DOI 10.1194/jlr.M300192-JLR200; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Rangarajan S, 2003, J CELL BIOL, V160, P487, DOI 10.1083/jcb.200209105; Reginato MJ, 1998, J BIOL CHEM, V273, P1855, DOI 10.1074/jbc.273.4.1855; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Rodriguez AM, 2004, BIOCHEM BIOPH RES CO, V315, P255, DOI 10.1016/j.bbrc.2004.01.053; Scheideler M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-340; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Troiano RP, 2000, AM J CLIN NUTR, V72, p1343S, DOI 10.1093/ajcn/72.5.1343s; Tzameli I, 2004, J BIOL CHEM, V279, P36093, DOI 10.1074/jbc.M405346200; Ukropec J, 2003, LIPIDS, V38, P1023, DOI 10.1007/s11745-006-1156-z; VANNIER C, 1985, INT J OBESITY, V9, P41; Walkey CJ, 2008, J BIOL CHEM, V283, P24290, DOI 10.1074/jbc.C800139200; Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g; Xiang Y, 2007, CELL BIOL INT, V31, P444, DOI 10.1016/j.cellbi.2006.11.012; YU K, 1995, J BIOL CHEM, V270, P23975, DOI 10.1074/jbc.270.41.23975; Zaragosi LE, 2007, STEM CELLS, V25, P790, DOI 10.1634/stemcells.2006-0235	60	37	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34114	10.1371/journal.pone.0034114	http://dx.doi.org/10.1371/journal.pone.0034114			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479536	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900062
J	Yasumura, EG; Stilhano, RS; Samoto, VY; Matsumoto, PK; de Carvalho, LP; Lapchik, VBV; Han, SW				Yasumura, Eduardo Gallatti; Stilhano, Roberta Sessa; Samoto, Vivian Yochiko; Matsumoto, Priscila Keiko; de Carvalho, Leonardo Pinto; Valero Lapchik, Valderez Bastos; Han, Sang Won			Treatment of Mouse Limb Ischemia with an Integrative Hypoxia-Responsive Vector Expressing the Vascular Endothelial Growth Factor Gene	PLOS ONE			English	Article							THERAPEUTIC ANGIOGENESIS; RABBIT MODEL; FACTOR VEGF; BINDING; OXYGEN; OVEREXPRESSION; MIGRATION; RECEPTOR; ELEMENT; PROTEIN	Constitutive vascular endothelial growth factor (VEGF) gene expression systems have been extensively used to treat peripheral arterial diseases, but most of the results have not been satisfactory. In this study, we designed a plasmid vector with a hypoxia-responsive element sequence incorporated into it with the phiC31 integrative system (pVHAVI) to allow long-term VEGF gene expression and to be activated under hypoxia. Repeated activations of VEGF gene expression under hypoxia were confirmed in HEK293 and C2C12 cells transfected with pVHAVI. In limb ischemic mice, the local administration of pVHAVI promoted gastrocnemius mass and force recovery and ameliorated limb necrosis much better than the group treated with hypoxia-insensitive vector, even this last group had produced more VEGF in muscle. Histological analyses carried out after four weeks of gene therapy showed increased capillary density and matured vessels, and reduced number of necrotic cells and fibrosis in pVHAVI treated group. By our study, we demonstrate that the presence of high concentration of VEGF in ischemic tissue is not beneficial or is less beneficial than maintaining a lower but sufficient and long-term concentration of VEGF locally.	[Yasumura, Eduardo Gallatti; Stilhano, Roberta Sessa; Samoto, Vivian Yochiko; Matsumoto, Priscila Keiko; de Carvalho, Leonardo Pinto; Valero Lapchik, Valderez Bastos; Han, Sang Won] Univ Fed Sao Paulo, Dept Biophys, Res Ctr Gene Therapy, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Yasumura, EG (corresponding author), Univ Fed Sao Paulo, Dept Biophys, Res Ctr Gene Therapy, Sao Paulo, Brazil.	sang.han@unifesp.br	STILHANO, roberta/F-6923-2015; Han, Sang W/D-4541-2012	STILHANO, roberta/0000-0002-0653-5968; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/59630-0, 2011/00859-6]; FAPESP [08/52381-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) 2006/59630-0 and 2011/00859-6. EGY was a recipient of FAPESP scholarship 08/52381-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; BAUTERS C, 1995, J VASC SURG, V21, P314, DOI 10.1016/S0741-5214(95)70272-5; Becit N, 2001, EUR J VASC ENDOVASC, V22, P310, DOI 10.1053/ejvs.2001.1468; Calos MP, 2006, CURR GENE THER, V6, P633, DOI 10.2174/156652306779010642; Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Goto Takako, 2006, Tokai J Exp Clin Med, V31, P128; Grosskreutz CL, 1999, MICROVASC RES, V58, P128, DOI 10.1006/mvre.1999.2171; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Hammond HK, 2001, CARDIOVASC RES, V49, P561, DOI 10.1016/S0008-6363(00)00257-1; Hourde C, 2006, J PHYSIOL SCI, V56, P361, DOI 10.2170/physiolsci.RP008106; Isner JM, 1996, LANCET, V348, P370, DOI 10.1016/S0140-6736(96)03361-2; Lee RJ, 2000, CIRCULATION, V102, P898; MACIAG T, 1984, SCIENCE, V225, P932, DOI 10.1126/science.6382607; Masaki I, 2002, CIRC RES, V90, P966, DOI 10.1161/01.RES.0000019540.41697.60; MCCAFFREY TA, 1992, J CELL PHYSIOL, V152, P430, DOI 10.1002/jcp.1041520226; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; Ozawa CR, 2004, J CLIN INVEST, V113, P516, DOI 10.1172/JCI200418420; Rissanen TT, 2007, MOL THER, V15, P1233, DOI 10.1038/sj.mt.6300175; Ruan HJ, 2001, NEOPLASIA, V3, P255, DOI 10.1038/sj.neo.7900157; Sacramento CB, 2010, BRAZ J MED BIOL RES, V43, P722, DOI 10.1590/S0100-879X2010000800005; Sacramento CB, 2010, J GENE MED, V12, P310, DOI 10.1002/jgm.1434; Sacramento CB, 2009, J GENE MED, V11, P345, DOI 10.1002/jgm.1298; Schwarz ER, 2000, J AM COLL CARDIOL, V35, P1323, DOI 10.1016/S0735-1097(00)00522-2; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Su H, 2002, P NATL ACAD SCI USA, V99, P9480, DOI 10.1073/pnas.132275299; Takeshita S, 1996, BIOCHEM BIOPH RES CO, V227, P628, DOI 10.1006/bbrc.1996.1556; TAKESHITA S, 1995, AM J PATHOL, V147, P1649; TAKESHITA S, 1994, J CLIN INVEST, V93, P662, DOI 10.1172/JCI117018; Tsurumi Y, 1996, CIRCULATION, V94, P3281, DOI 10.1161/01.CIR.94.12.3281; van Weel V, 2004, CIRC RES, V95, P58, DOI 10.1161/01.RES.0000133247.69803.c3; von Degenfeld G, 2006, FASEB J, V20, P2657, DOI 10.1096/fj.06-6568fje; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WITTENBERG BA, 1989, ANNU REV PHYSIOL, V51, P857, DOI 10.1146/annurev.physiol.51.1.857; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200	39	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33944	10.1371/journal.pone.0033944	http://dx.doi.org/10.1371/journal.pone.0033944			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470498	Green Submitted, gold, Green Published			2022-12-27	WOS:000303857100061
J	Brassac, J; Jakob, SS; Blattner, FR				Brassac, Jonathan; Jakob, Sabine S.; Blattner, Frank R.			Progenitor-Derivative Relationships of Hordeum Polyploids (Poaceae, Triticeae) Inferred from Sequences of TOPO6, a Nuclear Low-Copy Gene Region	PLOS ONE			English	Article							PCR-MEDIATED RECOMBINATION; DNA-SEQUENCES; PHYLOGENETIC ANALYSIS; MOLECULAR PHYLOGENY; RIBOSOMAL DNA; 18S-25S RDNA; AMERICAN; GENOME; EVOLUTION; HYBRIDIZATION	Polyploidization is a major mechanism of speciation in plants. Within the barley genus Hordeum, approximately half of the taxa are polyploids. While for diploid species a good hypothesis of phylogenetic relationships exists, there is little information available for the polyploids (4x, 6x) of Hordeum. Relationships among all 33 diploid and polyploid Hordeum species were analyzed with the low-copy nuclear marker region TOPO6 for 341 Hordeum individuals and eight outgroup species. PCR products were either directly sequenced or cloned and on average 12 clones per individual were included in phylogenetic analyses. In most diploid Hordeum species TOPO6 is probably a single-copy locus. Most sequences found in polyploid individuals phylogenetically cluster together with sequences derived from diploid species and thus allow the identification of parental taxa of polyploids. Four groups of sequences occurring only in polyploid taxa are interpreted as footprints of extinct diploid taxa, which contributed to allopolyploid evolution. Our analysis identifies three key species involved in the evolution of the American polyploids of the genus. (i) All but one of the American tetraploids have a TOPO6 copy originating from the Central Asian diploid H. roshevitzii, the second copy clustering with different American diploid species. (ii) All hexaploid species from the New World have a copy of an extinct close relative of H. californicum and (iii) possess the TOPO6 sequence pattern of tetraploid H. jubatum, each with an additional copy derived from different American diploids. Tetraploid H. bulbosum is an autopolyploid, while the assumed autopolyploid H. brevisubulatum (4x, 6x) was identified as allopolyploid throughout most of its distribution area. The use of a proof-reading DNA polymerase in PCR reduced the proportion of chimerical sequences in polyploids in comparison to Taq polymerase.	[Brassac, Jonathan; Jakob, Sabine S.; Blattner, Frank R.] Leibniz Inst Plant Genet & Crop Res IPK, Gatersleben, Germany	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Brassac, J (corresponding author), Leibniz Inst Plant Genet & Crop Res IPK, Gatersleben, Germany.	blattner@ipk-gatersleben.de	Brassac, Jonathan/J-3490-2019; Blattner, Frank/G-7402-2014	Brassac, Jonathan/0000-0001-6476-2619; Blattner, Frank/0000-0001-7731-7741	Deutsche Forschungsgemeinschaft;  [BL 462/9]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	The study was funded by the Deutsche Forschungsgemeinschaft (www.dfg.de) by a grant to FRB (grant no. BL 462/9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Ayres DR, 2004, WEED TECHNOL, V18, P1288, DOI 10.1614/0890-037X(2004)018[1288:EOACNS]2.0.CO;2; Baum BR, 2003, CAN J BOT, V81, P1, DOI [10.1139/b03-001, 10.1139/B03-001]; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Blattner FR, 1999, BIOTECHNIQUES, V27, P1180, DOI 10.2144/99276st04; Blattner FR, 2006, NEW PHYTOL, V169, P603, DOI 10.1111/j.1469-8137.2005.01610.x; Blattner FR, 2004, MOL PHYLOGENET EVOL, V33, P289, DOI 10.1016/j.ympev.2004.05.012; Blattner FR, 2009, BREEDING SCI, V59, P471, DOI 10.1270/jsbbs.59.471; Cronn R, 2002, THEOR APPL GENET, V104, P482, DOI 10.1007/s001220100741; Drummond A., 2011, GENEIOUS V5 5; Escobar JS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-181; Hartung F, 2002, NUCLEIC ACIDS RES, V30, P5175, DOI 10.1093/nar/gkf649; Hartung F, 2001, GENE, V271, P81, DOI 10.1016/S0378-1119(01)00496-6; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Hoot SB, 2004, AM J BOT, V91, P899, DOI 10.3732/ajb.91.6.899; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jakob SS, 2006, MOL BIOL EVOL, V23, P1602, DOI 10.1093/molbev/msl018; Jakob SS, 2010, MOL PHYLOGENET EVOL, V55, P650, DOI 10.1016/j.ympev.2009.10.021; Kakeda K, 2009, BREEDING SCI, V59, P595, DOI 10.1270/jsbbs.59.595; Komatsuda T, 2001, PLANT SYST EVOL, V227, P137, DOI 10.1007/s006060170044; Komatsuda T, 2009, BREEDING SCI, V59, P611, DOI 10.1270/jsbbs.59.611; Kotseruba V, 2010, MOL PHYLOGENET EVOL, V56, P146, DOI 10.1016/j.ympev.2010.01.003; Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lihova J, 2006, MOL PHYLOGENET EVOL, V39, P759, DOI 10.1016/j.ympev.2006.01.027; LINDELAURSEN I, 1990, PLANT SYST EVOL, V172, P141, DOI 10.1007/BF00937804; Mahelka V, 2010, MOL BIOL EVOL, V27, P1370, DOI 10.1093/molbev/msq021; Marcussen T, 2012, SYST BIOL, V61, P107, DOI 10.1093/sysbio/syr096; NYLANDER J.A.A., 2004, MRMODELTEST V2 3; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Petersen G, 2004, SYST BOT, V29, P862, DOI 10.1600/0363644042451080; Petersen G, 2011, CLADISTICS, V27, P428, DOI 10.1111/j.1096-0031.2011.00347.x; Pleines T, 2008, TAXON, V57, P875, DOI 10.1002/tax.573016; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Rambaut A., 2007, TRACER V1 5; Rodriguez DJ, 1996, AM NAT, V147, P33, DOI 10.1086/285838; Roelofs D, 1997, MOL ECOL, V6, P641, DOI 10.1046/j.1365-294X.1997.00225.x; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; STEBBINS GL, 1947, ADV GENET, V1, P403, DOI 10.1016/S0065-2660(08)60490-3; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taketa S, 2005, ANN BOT-LONDON, V96, P23, DOI 10.1093/aob/mci147; Taketa S, 1999, HEREDITAS, V130, P185, DOI 10.1111/j.1601-5223.1999.00185.x; Taketa S, 2009, BREEDING SCI, V59, P589, DOI 10.1270/jsbbs.59.589; Tang HB, 2010, P NATL ACAD SCI USA, V107, P472, DOI 10.1073/pnas.0908007107; Tanno K, 2010, HEREDITAS, V147, P34, DOI 10.1111/j.1601-5223.2009.02142.x; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; VONBOTHMER R, 1995, SYSTEMATIC ECOGEOGRA, V7; Wang H, 2011, BOTANY, V89, P405, DOI [10.1139/B11-030, 10.1139/b11-030]; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	57	41	45	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33808	10.1371/journal.pone.0033808	http://dx.doi.org/10.1371/journal.pone.0033808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479447	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100071
J	Garcia-Heredia, I; Martin-Cuadrado, AB; Mojica, FJM; Santos, F; Mira, A; Anton, J; Rodriguez-Valera, F				Garcia-Heredia, Inmaculada; Martin-Cuadrado, Ana-Belen; Mojica, Francisco J. M.; Santos, Fernando; Mira, Alex; Anton, Josefa; Rodriguez-Valera, Francisco			Reconstructing Viral Genomes from the Environment Using Fosmid Clones: The Case of Haloviruses	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; SALINITY GRADIENT; HALOQUADRATUM-WALSBYI; PHOTOSYNTHESIS GENES; NATRIALBA-MAGADII; MOLECULAR-BIOLOGY; CRISPR ELEMENTS; INNER-MONGOLIA; MARINE VIRUSES; IMMUNE-SYSTEM	Background: Metaviriomes, the viral genomes present in an environment, have been studied by direct sequencing of the viral DNA or by cloning in small insert libraries. The short reads generated by both approaches make it very difficult to assemble and annotate such flexible genomic entities. Many environmental viruses belong to unknown groups or prey on uncultured and little known cellular lineages, and hence might not be present in databases. Methodology and Principal Findings: Here we have used a different approach, the cloning of viral DNA into fosmids before sequencing, to obtain natural contigs that are close to the size of a viral genome. We have studied a relatively low diversity extreme environment: saturated NaCl brines, which simplifies the analysis and interpretation of the data. Forty-two different viral genomes were retrieved, and some of these were almost complete, and could be tentatively identified as head-tail phages (Caudovirales). Conclusions and Significance: We found a cluster of phage genomes that most likely infect Haloquadratum walsbyi, the square archaeon and major component of the community in these hypersaline habitats. The identity of the prey could be confirmed by the presence of CRISPR spacer sequences shared by the virus and one of the available strain genomes. Other viral clusters detected appeared to prey on the Nanohaloarchaea and on the bacterium Salinibacter ruber, covering most of the diversity of microbes found in this type of environment. This approach appears then as a viable alternative to describe metaviriomes in a much more detailed and reliable way than by the more common approaches based on direct sequencing. An example of transfer of a CRISPR cluster including repeats and spacers was accidentally found supporting the dynamic nature and frequent transfer of this peculiar prokaryotic mechanism of cell protection.	[Garcia-Heredia, Inmaculada; Martin-Cuadrado, Ana-Belen; Mira, Alex; Rodriguez-Valera, Francisco] Univ Miguel Hernandez, Div Microbiol, Evolutionary Genom Grp, Alicante, Spain; [Mojica, Francisco J. M.; Santos, Fernando; Anton, Josefa] Univ Alicante, Dept Fisiol Genet & Microbiol, E-03080 Alicante, Spain	Universidad Miguel Hernandez de Elche; Universitat d'Alacant	Garcia-Heredia, I (corresponding author), Univ Miguel Hernandez, Div Microbiol, Evolutionary Genom Grp, Alicante, Spain.	frvalera@umh.es	Mojica, Francisco J.M./K-2414-2014; Rodriguez-Valera, Francisco/M-2782-2013; Anton, Josefa/L-5283-2014; Mojica, Francisco/M-8478-2019	Mojica, Francisco J.M./0000-0002-6660-4996; Rodriguez-Valera, Francisco/0000-0002-9809-2059; Anton, Josefa/0000-0002-5823-493X; Mira, Alex/0000-0002-9127-3877; Mangan, Rachel/0000-0002-2984-3699	project MAGYK from the Spanish Ministerio de Ciencia e Innovacion [BIO2008-02444]; project MICROGEN from the Spanish Ministerio de Ciencia e Innovacion [CDS2009-00006]; Spanish Ministerio de Ciencia e Innovacion [CGL2'09-12651-C02-01]; DIMEGEN [PROMETEO/2010/089]; Generalitat Valenciana [ACOMP/2009/155]; FEDER; MAGYK from Ministerio de Ciencia e Innovacion; CONSOLIDER-INGENIO	project MAGYK from the Spanish Ministerio de Ciencia e Innovacion; project MICROGEN from the Spanish Ministerio de Ciencia e Innovacion; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); DIMEGEN; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); FEDER(European Commission); MAGYK from Ministerio de Ciencia e Innovacion; CONSOLIDER-INGENIO(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by projects MAGYK (BIO2008-02444), MICROGEN (Programa CONSOLIDERINGENIO 2010 CDS2009-00006), CGL2'09-12651-C02-01 from the Spanish Ministerio de Ciencia e Innovacion, DIMEGEN (PROMETEO/2010/089) and ACOMP/2009/155 from the Generalitat Valenciana. FEDER funds supported this project. IG-H was supported by MAGYK from Ministerio de Ciencia e Innovacion. A-BM-C was supported by CONSOLIDER-INGENIO 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson RE, 2011, FEMS MICROBIOL ECOL, V77, P120, DOI 10.1111/j.1574-6941.2011.01090.x; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Angly F, 2009, ENVIRON MICROBIOL, V11, P2863, DOI 10.1111/j.1462-2920.2009.02021.x; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Anton J, 1999, ENVIRON MICROBIOL, V1, P517, DOI 10.1046/j.1462-2920.1999.00065.x; Anton J, 2000, APPL ENVIRON MICROB, V66, P3052, DOI 10.1128/AEM.66.7.3052-3057.2000; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Avrani S, 2011, NATURE, V474, P604, DOI 10.1038/nature10172; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bath C, 2006, VIROLOGY, V350, P228, DOI 10.1016/j.virol.2006.02.005; Baxter BK, 2011, HALOPHILES HYPERSALY, V173, P190; Benlloch S, 2002, ENVIRON MICROBIOL, V4, P349, DOI 10.1046/j.1462-2920.2002.00306.x; Benlloch S, 1996, SYST APPL MICROBIOL, V18, P574; Bolhuis H, 2004, ENVIRON MICROBIOL, V6, P1287, DOI 10.1111/j.1462-2920.2004.00692.x; Bolhuis H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-169; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Cornelissen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018597; Cuadros-Orellana S, 2007, ISME J, V1, P235, DOI 10.1038/ismej.2007.35; Diez Beatriz, 2000, International Microbiology, V3, P159; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dyall-Smith M, 2003, RES MICROBIOL, V154, P309, DOI 10.1016/S0923-2508(03)00076-7; Dyall-Smith ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020968; Eddy SR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000069; Enav H, 2012, ISME J, V6, P619, DOI 10.1038/ismej.2011.146; Gao S, 2011, J BIOL CHEM, V286, P3944, DOI 10.1074/jbc.M110.196907; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Garrett RA, 2010, ENVIRON MICROBIOL, V12, P2918, DOI 10.1111/j.1462-2920.2010.02266.x; Ghai R, 2011, SCI REP-UK, V1, DOI 10.1038/srep00135; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; GuixaBoixareu N, 1996, AQUAT MICROB ECOL, V11, P215, DOI 10.3354/ame011215; Hatfull GF, 2008, RES MICROBIOL, V159, P332, DOI 10.1016/j.resmic.2008.04.008; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; HOWE MM, 1975, SCIENCE, V190, P624, DOI 10.1126/science.1103291; Huang S, 2011, ENV MICROBIOL; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kessel M, 1983, P 41 ANN M EL MICR S, P746; Klein R, 2000, VIROLOGY, V276, P376, DOI 10.1006/viro.2000.0565; Klein R, 2002, MOL MICROBIOL, V45, P851, DOI 10.1046/j.1365-2958.2002.03064.x; Krupovic M, 2010, MOL BIOL EVOL, V27, P2716, DOI 10.1093/molbev/msq161; Krupovic M, 2010, J MOL BIOL, V397, P144, DOI 10.1016/j.jmb.2010.01.037; Legault BA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-171; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Maniatis T., 1982, MOL CLONING; Maniloff J, 1998, ARCH VIROL, V143, P2051, DOI 10.1007/s007050050442; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Narasingarao P, 2011, ISME J; Noguchi H, 2008, DNA RES, V15, P387, DOI 10.1093/dnares/dsn027; Oren A, 1997, EXTREMOPHILES, V1, P143, DOI 10.1007/s007920050027; Ovreas L, 2003, MICROB ECOL, V46, P291, DOI 10.1007/s00248-003-3006-3; Pagaling E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-410; Park EJ, 2011, APPL ENVIRON MICROB, V77, P1284, DOI 10.1128/AEM.01859-10; Pasic L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-570; Pina M, 2011, FEMS MICROBIOL REV, V35, P1035, DOI 10.1111/j.1574-6976.2011.00280.x; Porter K, 2007, CURR OPIN MICROBIOL, V10, P418, DOI 10.1016/j.mib.2007.05.017; Portillo MC, 2009, J APPL GENET, V50, P421, DOI 10.1007/BF03195703; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pride DT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-420; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; RODRIGUEZVALERA F, 1985, MICROBIAL ECOL, V11, P107, DOI 10.1007/BF02010483; Sandaa RA, 2003, EXTREMOPHILES, V7, P347, DOI 10.1007/s00792-003-0328-5; Santos F, 2010, ENV MICROBIOL; Santos F, 2007, ENVIRON MICROBIOL, V9, P1711, DOI 10.1111/j.1462-2920.2007.01289.x; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shah SA, 2009, BIOCHEM SOC T, V37, P23, DOI 10.1042/BST0370023; Sime-Ngando T, 2010, ENV MICROBIOL; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Summer EJ, 2011, APPL ENVIRON MICROB, V77, P669, DOI 10.1128/AEM.01952-10; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tang SL, 2002, MOL MICROBIOL, V44, P283, DOI 10.1046/j.1365-2958.2002.02890.x; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Xu Y, 2001, INT J SYST EVOL MICR, V51, P1693, DOI 10.1099/00207713-51-5-1693	91	61	64	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33802	10.1371/journal.pone.0033802	http://dx.doi.org/10.1371/journal.pone.0033802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479446	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100070
J	Gupta, A; Wood, R; Kaplan, R; Bekker, LG; Lawn, SD				Gupta, Ankur; Wood, Robin; Kaplan, Richard; Bekker, Linda-Gail; Lawn, Stephen D.			Tuberculosis Incidence Rates during 8 Years of Follow-Up of an Antiretroviral Treatment Cohort in South Africa: Comparison with Rates in the Community	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ISONIAZID PREVENTIVE THERAPY; TREATMENT SERVICE; DRUG-RESISTANCE; RISK-FACTORS; SCALE-UP; OUTCOMES; HAART; PREVALENCE; PROGRAM	Background: Although antiretroviral therapy (ART) is known to be associated with time-dependent reductions in tuberculosis (TB) incidence, the long-term impact of ART on incidence remains imprecisely defined due to limited duration of follow-up and incomplete CD4 cell count recovery in existing studies. We determined TB incidence in a South African ART cohort with up to 8 years of follow-up and stratified rates according to CD4 cell count recovery. We compared these rates with those of HIV-uninfected individuals living in the same community. Methodology/Principal Findings: Prospectively collected clinical data on patients receiving ART in a community-based cohort in Cape Town were analysed. 1544 patients with a median follow-up of 5.0 years (IQR 2.4-5.8) were included in the analysis. 484 episodes of incident TB (73.6% culture-confirmed) were diagnosed in 424 patients during 6506 person-years (PYs) of follow-up. The TB incidence rate during the first year of ART was 12.4 (95% CI 10.8-14.4) cases/100PYs and decreased to 4.92 (95% CI 3.64-8.62) cases/100PYs between 5 and 8 years of ART. During person-time accrued within CD4 cell strata 0-100, 101-200, 201-300, 301-400, 401-500, 501-700 and >= 700 cells/mu L, TB incidence rates (95% CI) were 25.5 (21.6-30.3), 11.2 (9.4-13.5), 7.9 (6.4-9.7), 5.0 (3.9-6.6), 5.1 (3.8-6.8), 4.1 (3.1-5.4) and 2.7 (1.7-4.5) cases/100PYs, respectively. Overall, 75% (95% CI 70.9-78.8) of TB episodes were recurrent cases. Updated CD4 cell count and viral load measurements were independently associated with long-term TB risk. TB rates during person-time accrued in the highest CD4 cell count stratum (>700 cells/mL) were 4.4-fold higher that the rate in HIV-uninfected individuals living in the same community (2.7 versus 0.62 cases/100PYs; 95% CI 0.58-0.65). Conclusions/Significance: TB rates during long-term ART remained substantially greater than rates in the local HIV uninfected populations regardless of duration of ART or attainment of CD4 cell counts exceeding 700 cells/mu L.	[Gupta, Ankur; Lawn, Stephen D.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England; [Wood, Robin; Kaplan, Richard; Bekker, Linda-Gail; Lawn, Stephen D.] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Gupta, A (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England.	stevelawn@yahoo.co.uk	Bekker, Linda-Gail/AAZ-8929-2020	BEKKER, LINDA-GAIL/0000-0002-0755-4386; Gupta-Wright, Ankur/0000-0002-5150-2970; Kaplan, Richard/0000-0003-1565-4704	Wellcome Trust, London, UK [074641]; National Institute of Health [1U19AI53217-01]; O1 [A1058736-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI053217] Funding Source: NIH RePORTER	Wellcome Trust, London, UK(Wellcome Trust); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); O1; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	S.D.L. was funded by the Wellcome Trust, London, UK, with grant number 074641. R.W. was funded in part by the National Institute of Health through a CIPRA (COMPREHENSIVE INTERNATIONAL PROGRAM OF RESEARCH ON AIDS) grant 1U19AI53217-01 and also received support from O1 grant (A1058736-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actuarial Society of South Africa, 2008, AIDS DEM MOD; Ahoua L, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-81; [Anonymous], 2011, GUID INT TUB CAS FIN; Bekker LG, 2006, SAMJ S AFR MED J, V96, P315; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Charalambous S, 2008, INT J TUBERC LUNG D, V12, P942; Crampin AC, 2010, AIDS, V24, P417, DOI 10.1097/QAD.0b013e32832f51cf; Dawson R, 2010, INT J TUBERC LUNG D, V14, P52; Dembele M, 2010, INT J TUBERC LUNG D, V14, P318; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; El-Khatib Z, 2010, AIDS, V24, P1679, DOI 10.1097/QAD.0b013e32833a097b; Etard Jean-Francois, 2009, Open AIDS J, V3, P63, DOI 10.2174/1874613600903010063; Golub JE, 2007, AIDS, V21, P1441, DOI 10.1097/QAD.0b013e328216f441; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Hermans SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010527; Hosseinipour MC, 2010, HIV MED, V11, P510, DOI 10.1111/j.1468-1293.2010.00825.x; Houlihan CF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-23; Lawn SD, 2011, INT J TUBERC LUNG D, V15, P571, DOI 10.5588/ijtld.10.0483; Lawn SD, 2005, AIDS, V19, P2109, DOI 10.1097/01.aids.0000194808.20035.c1; Lawn SD, 2005, AIDS, V19, P1113, DOI 10.1097/01.aids.0000176211.08581.5a; Lawn SD, 2002, MICROBES INFECT, V4, P635, DOI 10.1016/S1286-4579(02)01582-4; Lawn SD, 2011, LANCET INFECT DIS, DOI [10.1016/S1473-3099(1011)70251-70251, DOI 10.1016/S1473-3099(1011)70251-70251]; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2011, SAMJ S AFR MED J, V101, P258, DOI 10.7196/SAMJ.4392; Lawn SD, 2010, LANCET INFECT DIS, V10, P489, DOI 10.1016/S1473-3099(10)70078-5; Lawn SD, 2010, AIDS, V24, P1323, DOI 10.1097/QAD.0b013e3283390dd1; Lawn SD, 2009, CLIN CHEST MED, V30, P685, DOI 10.1016/j.ccm.2009.08.010; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Middelkoop K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-156; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; National Department of Health, DEV DISTR HLTH INF S; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Nicholas S, 2011, JAIDS-J ACQ IMM DEF, V57, P311, DOI 10.1097/QAI.0b013e318218a713; Pujades-Rodriguez M, 2008, AIDS, V22, P1305, DOI 10.1097/QAD.0b013e3282fa75b9; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Sanne IM, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-38; Statistics South Africa, 2010, MID POP EST; The South African Tuberculosis Control Programme, PRACT GUID 2004; UN Joint Programme on HIV/AIDS, 2010, UNAIDS1011EJC1958E U; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; *WHO, 2003, WHOCDSTB2003319; WHO, 2007, IMPR DIAGN TREATM SM; Wood R, 2010, INT J TUBERC LUNG D, V14, P406; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098; Wood R, 2011, SAMJ S AFR MED J, V101, P111, DOI 10.7196/SAMJ.4587; World Health Organisation, 2011, WHOHTMTB201116; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2003, SCAL ANT THER RES LT	49	143	145	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34156	10.1371/journal.pone.0034156	http://dx.doi.org/10.1371/journal.pone.0034156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479548	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100127
J	Hernandez-Pinzon, I; Cifuentes, M; Henaff, E; Santiago, N; Espinas, L; Casacuberta, JM				Hernandez-Pinzon, Inmaculada; Cifuentes, Marta; Henaff, Elizabeth; Santiago, Nestor; Espinas, Lluisa; Casacuberta, Josep M.			The Tnt1 Retrotransposon Escapes Silencing in Tobacco, Its Natural Host	PLOS ONE			English	Article							PLANT RETROTRANSPOSONS; EPIGENETIC REGULATION; SEQUENCE VARIABILITY; DNA METHYLATION; HISTONE H2A.Z; ARABIDOPSIS; EXPRESSION; GENOME; RNA; PROMOTER	Retrotransposons' high capacity for mutagenesis is a threat that genomes need to control tightly. Transcriptional gene silencing is a general and highly effective control of retrotransposon expression. Yet, some retrotransposons manage to transpose and proliferate in plant genomes, suggesting that, as shown for plant viruses, retrotransposons can escape silencing. However no evidence of retrotransposon silencing escape has been reported. Here we analyze the silencing control of the tobacco Tnt1 retrotransposon and report that even though constructs driven by the Tnt1 promoter become silenced when stably integrated in tobacco, the endogenous Tnt1 elements remain active. Silencing of Tnt1-containing transgenes correlates with high DNA methylation and the inability to incorporate H2A.Z into their promoters, whereas the endogenous Tnt1 elements remain partially methylated at asymmetrical positions and incorporate H2A.Z upon induction. Our results show that the promoter of Tnt1 is a target of silencing in tobacco, but also that endogenous Tnt1 elements can escape this control and be expressed in their natural host.	[Hernandez-Pinzon, Inmaculada; Cifuentes, Marta; Henaff, Elizabeth; Santiago, Nestor; Casacuberta, Josep M.] CSIC IRTA UAB, CRAG, Dept Mol Genet, Barcelona, Spain; [Espinas, Lluisa] CSIC, IBMB, Dept Mol Genom, Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Hernandez-Pinzon, I (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich, Norfolk, England.	josep.casacuberta@cragenomica.es		Casacuberta, josep/0000-0002-5609-4152; Cifuentes, Marta/0000-0002-3347-0178; Espinas, M Lluisa/0000-0003-3914-2228	Spanish Ministerio de Ciencia e Innovacion [BFU2006-04005, BFU2009-11932, BFU2009-10983]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants BFU2006-04005 and BFU2009-11932 to JMC and BFU2009-10983 to MLE from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2011, NUCL ACIDS RES; Beguiristain T, 2001, PLANT PHYSIOL, V127, P212, DOI 10.1104/pp.127.1.212; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Canudas S, 2005, NUCLEIC ACIDS RES, V33, P4857, DOI 10.1093/nar/gki776; CASACUBERTA JM, 1995, EMBO J, V14, P2670, DOI 10.1002/j.1460-2075.1995.tb07265.x; Casacuberta JM, 1997, GENETICA, V100, P109, DOI 10.1023/A:1018309007841; Cheng C, 2006, MOL GENET GENOMICS, V276, P378, DOI 10.1007/s00438-006-0141-9; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Deal RB, 2007, PLANT CELL, V19, P74, DOI 10.1105/tpc.106.048447; Ding Y, 2009, PLANT SIGNAL BEHAV, V4, P1049, DOI 10.4161/psb.4.11.10103; Fukai E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000868; Furner IJ, 2011, CURR OPIN PLANT BIOL, V14, P137, DOI 10.1016/j.pbi.2010.11.004; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Giner A, 2010, RNA INTERFERENCE AND VIRUSES, P25; Grandbastien M, 2005, CYTOGENET GENOME RES, V110, P229, DOI 10.1159/000084957; Grandbastien MA, 1997, GENETICA, V100, P241, DOI 10.1023/A:1018302216927; Grandbastien MA, 1998, TRENDS PLANT SCI, V3, P181, DOI 10.1016/S1360-1385(98)01232-1; Gruntman E, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-371; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hernandez-Pinzon I, 2009, J MOL EVOL, V68, P269, DOI 10.1007/s00239-009-9204-y; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Ito H, 2011, NATURE, V472, P115, DOI 10.1038/nature09861; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Le QH, 2007, MOL GENET GENOMICS, V278, P639, DOI 10.1007/s00438-007-0281-6; Lisch D, 2009, ANN REV PLANT BIOL, V60; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Matzke MA, 1999, GENETICA, V107, P271, DOI 10.1023/A:1003921710672; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Mhiri C, 1997, PLANT MOL BIOL, V33, P257, DOI 10.1023/A:1005727132202; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; PAULS PK, 1994, PLANT MOL BIOL, V26, P393, DOI 10.1007/BF00039548; Pavet V, 2006, MOL PLANT MICROBE IN, V19, P577, DOI 10.1094/MPMI-19-0577; Perez-Hormaeche J, 2008, PLANT PHYSIOL, V147, P1264, DOI 10.1104/pp.108.117846; Picault N, 2009, PLANT J, V58, P754, DOI 10.1111/j.1365-313X.2009.03813.x; POUTEAU S, 1991, EMBO J, V10, P1911, DOI 10.1002/j.1460-2075.1991.tb07717.x; POUTEAU S, 1994, PLANT J, V5, P535, DOI 10.1046/j.1365-313X.1994.5040535.x; Roig-Villanova I, 2006, PLANT PHYSIOL, V141, P85, DOI 10.1104/pp.105.076331; Sabot F, 2011, PLANT J, V66, P241, DOI 10.1111/j.1365-313X.2011.04492.x; Saze H, 2011, CURR OPIN PLANT BIOL, V14, P81, DOI 10.1016/j.pbi.2010.08.017; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; Takeda S, 1999, PLANT J, V18, P383, DOI 10.1046/j.1365-313X.1999.00460.x; Tanurdzic M, 2008, PLOS BIOL, V6, P2880, DOI 10.1371/journal.pbio.0060302; Tittel-Elmer M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001175; Tsukahara S, 2009, NATURE, V461, P423, DOI 10.1038/nature08351; van Dijk K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-238; VAUCHERET H, 1993, CR ACAD SCI III-VIE, V316, P1471; Vaucheret H, 2001, J CELL SCI, V114, P3083; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Vernhettes S, 1997, PLANT MOL BIOL, V35, P673, DOI 10.1023/A:1005826605598; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wessler SR, 1996, CURR BIOL, V6, P959, DOI 10.1016/S0960-9822(02)00638-3; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	59	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33816	10.1371/journal.pone.0033816	http://dx.doi.org/10.1371/journal.pone.0033816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479451	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100074
J	Li, JZ; Brumme, CJ; Lederman, MM; Brumme, ZL; Wang, HY; Spritzler, J; Carrington, M; Medvik, K; Walker, BD; Schooley, RT; Kuritzkes, DR				Li, Jonathan Z.; Brumme, Chanson J.; Lederman, Michael M.; Brumme, Zabrina L.; Wang, Hongying; Spritzler, John; Carrington, Mary; Medvik, Kathleen; Walker, Bruce D.; Schooley, Robert T.; Kuritzkes, Daniel R.		AIDS Clin Trials Grp A5197 Study	Characteristics and Outcomes of Initial Virologic Suppressors during Analytic Treatment Interruption in a Therapeutic HIV-1 gag Vaccine Trial	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITOR; IMMUNODEFICIENCY-VIRUS TYPE-1; PLACEBO-CONTROLLED TRIAL; CD4(+) T-CELLS; ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; PROTEASE INHIBITOR; HIV-1-INFECTED PERSONS; VIRAL LOAD; INFECTION	Background: In the placebo-controlled trial ACTG A5197, a trend favoring viral suppression was seen in the HIV-1-infected subjects who received a recombinant Ad5 HIV-1 gag vaccine. Objective: To identify individuals with initial viral suppression (plasma HIV-1 RNA set point <3.0 log(10) copies/ml) during the analytic treatment interruption (ATI) and evaluate the durability and correlates of virologic control and characteristics of HIV sequence evolution. Methods: HIV-1 gag and pol RNA were amplified and sequenced from plasma obtained during the ATI. Immune responses were measured by flow cytometric analysis and intracellular cytokine expression assays. Characteristics of those with and without initial viral suppression were compared using the Wilcoxon rank sum and Fisher's exact tests. Results: Eleven out of 104 participants (10.6%) were classified as initial virologic suppressors, nine of whom had received the vaccine. Initial virologic suppressors had significantly less CD4+ cell decline by ATI week 16 as compared to non-suppressors (median 7 CD4+ cell gain vs. 247 CD4+ cell loss, P = 0.04). However, of the ten initial virologic suppressors with a pVL at ATI week 49, only three maintained pVL <3.0 log10 copies/ml. HIV-1 Gag-specific CD4+ interferon-c responses were not associated with initial virologic suppression and no evidence of vaccine-driven HIV sequence evolution was detected. Participants with initial virologic suppression were found to have a lower percentage of CD4+ CTLA-4+ cells prior to treatment interruption, but a greater proportion of HIV-1 Gag-reactive CD4+ TNF-alpha+ cells expressing either CTLA-4 or PD-1. Conclusions: Among individuals participating in a rAd5 therapeutic HIV-1 gag vaccine trial, initial viral suppression was found in a subset of patients, but this response was not sustained. The association between CTLA-4 and PD-1 expression on CD4+ T cells and virologic outcome warrants further study in trials of other therapeutic vaccines in development.	[Li, Jonathan Z.; Kuritzkes, Daniel R.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Li, Jonathan Z.; Walker, Bruce D.; Kuritzkes, Daniel R.] Harvard Univ, Sch Med, Boston, MA USA; [Brumme, Chanson J.; Brumme, Zabrina L.; Carrington, Mary; Walker, Bruce D.] MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA; [Brumme, Chanson J.; Brumme, Zabrina L.; Carrington, Mary; Walker, Bruce D.] Harvard Univ, Cambridge, MA 02138 USA; [Lederman, Michael M.; Medvik, Kathleen] Case Western Reserve Univ, Div Infect Dis, Cleveland, OH 44106 USA; [Brumme, Zabrina L.] Simon Fraser Univ, Burnaby, BC V5A 1S6, Canada; [Wang, Hongying; Spritzler, John] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Carrington, Mary] NCI Frederick, SAIC Frederick Inc, Canc & Inflammat Program, Expt Immunol Lab, Frederick, MD USA; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Schooley, Robert T.] Univ Calif San Diego, Div Infect Dis, La Jolla, CA 92093 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Case Western Reserve University; Simon Fraser University; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Howard Hughes Medical Institute; University of California System; University of California San Diego	Li, JZ (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.	Jli22@partners.org		Brumme, Chanson/0000-0003-2722-5288; Brumme, Zabrina/0000-0002-8157-1037	National Institutes of Health (NIH) [T32 AI07387, U01 AI068636, U01 AI068634, P30 AI60354, K24 RR016482]; Clinical Investigator Training Program Fellowship: Harvard/MIT Health Sciences and Technology - Beth Israel Deaconess Medical Center; Pfizer Inc.; Merck Co.; New Investigator Award from the Canadian Institutes of Health Research (CIHR); National Cancer Institute, National Institutes of Health [HHSN261200800001E]; Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; Merck; NATIONAL CANCER INSTITUTE [ZIABC010791] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR016482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068634, U01AI068636, P30AI060354, T32AI007387] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Investigator Training Program Fellowship: Harvard/MIT Health Sciences and Technology - Beth Israel Deaconess Medical Center; Pfizer Inc.(Pfizer); Merck Co.(Merck & Company); New Investigator Award from the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Merck(Merck & Company); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health (NIH) grants T32 AI07387 (to Dr. Li), U01 AI068636 (AIDS Clinical Trials Group), U01 AI068634 (ACTG Statistical and Data Management Center), P30 AI60354 (Harvard University Center for AIDS Research), K24 RR016482 (to Dr. Kuritzkes), and subcontracts from U01 AI068636 to the Harvard Virology Support Laboratory and the Case Immunology Support Laboratory. The Harvard Virologic Support Laboratory is affiliated with Harvard Medical School and the Case Immunology Support Laboratory is affiliated with Case Western Reserve University. Dr. Li is the recipient of a Clinical Investigator Training Program Fellowship: Harvard/MIT Health Sciences and Technology - Beth Israel Deaconess Medical Center, in collaboration with Pfizer Inc. and Merck & Co. Dr. Brumme is supported by a New Investigator Award from the Canadian Institutes of Health Research (CIHR). This project has been funded in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E, and by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following competing interests: Drs. Kuritzkes, Lederman, and Schooley are consultants to Merck; Dr. Kuritzkes has received research support from Merck. Mary Carrington is an employee of SAIC-Frederick, Inc. Dr. Li is the recipient of a Clinical Investigator Training Program Fellowship: Harvard/MIT Health Sciences and Technology - Beth Israel Deaconess Medical Center, in collaboration with Pfizer Inc. and Merck & Co. The authors appreciate Dr. Michael Robertson's (Merck Research Laboratories) input in the design of the study and review of the manuscript. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Autran B, 2008, AIDS, V22, P1313, DOI 10.1097/QAD.0b013e3282fdce94; Babiker A, 2011, LANCET INFECT DIS, V11, P273, DOI 10.1016/S1473-3099(10)70313-3; Boritz E, 2004, J VIROL, V78, P12638, DOI 10.1128/JVI.78.22.12638-12646.2004; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Fagard C, 2003, ARCH INTERN MED, V163, P1220, DOI 10.1001/archinte.163.10.1220; Fitzgerald DW, 2011, J INFECT DIS, V203, P765, DOI 10.1093/infdis/jiq114; Folkers GK, 2010, JAMA-J AM MED ASSOC, V304, P350, DOI 10.1001/jama.2010.957; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Ioannidis JPA, 2000, AIDS, V14, P1481, DOI 10.1097/00002030-200007280-00003; Johnston R, 2010, AIDS RES HUM RETROV, V26, P943, DOI 10.1089/aid.2010.0087; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kaufmann DE, 2009, J IMMUNOL, V182, P5891, DOI 10.4049/jimmunol.0803771; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Le Moing V, 2002, AIDS, V16, P21, DOI 10.1097/00002030-200201040-00004; Lederman MM, 2007, CURR OPIN HIV AIDS, V2, P56, DOI 10.1097/COH.0b013e3280119264; Li JZ, 2011, J INFECT DIS, V203, P976, DOI 10.1093/infdis/jiq143; Miller LG, 2004, J INFECT DIS, V189, P1487, DOI 10.1086/382895; Murphy RA, 2010, AIDS, V24, P1007, DOI 10.1097/QAD.0b013e3283333639; Papagno L, 2011, AIDS, V25, P27, DOI 10.1097/QAD.0b013e328340fe55; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Prendergast A, 2011, AIDS; Ramduth D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005013; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Riley JL, 2000, J EXP MED, V191, P1987, DOI 10.1084/jem.191.11.1987; Schooley RT, 2010, J INFECT DIS, V202, P705, DOI 10.1086/655468; Sungkanuparph S, 2005, CLIN INFECT DIS, V41, P1326, DOI 10.1086/496985; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Tobery TW, 2006, AIDS RES HUM RETROV, V22, P1081, DOI 10.1089/aid.2006.22.1081; Trigona WL, 2003, J INTERF CYTOK RES, V23, P369, DOI 10.1089/107999003322226023; van den Berg-Wolf M, 2008, HIV CLIN TRIALS, V9, P324, DOI 10.1310/hct0905-324	34	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34134	10.1371/journal.pone.0034134	http://dx.doi.org/10.1371/journal.pone.0034134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479542	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339100121
J	Morris, CR; Stanton, MJ; Manthey, KC; Oh, KB; Wagner, KU				Morris, Chantey R.; Stanton, Marissa J.; Manthey, Karoline C.; Oh, Keon Bong; Wagner, Kay-Uwe			A Knockout of the Tsg101 Gene Leads to Decreased Expression of ErbB Receptor Tyrosine Kinases and Induction of Autophagy Prior to Cell Death	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATION; ENDOSOMAL TRAFFICKING; FOCAL ADHESIONS; DOWN-REGULATION; QUALITY-CONTROL; CYCLE ARREST; MICE LACKING; PROTEIN; CANCER; PROLIFERATION	The Tumor Susceptibility Gene 101 (Tsg101) encodes a multi-domain protein that mediates a variety of molecular and biological processes including the trafficking and lysosomal degradation of cell surface receptors. Conventional and conditional knockout models have demonstrated an essential requirement of this gene for cell cycle progression and cell viability, but the consequences of a complete ablation of Tsg101 on intracellular processes have not been examined to date. In this study, we employed mouse embryonic fibroblasts that carry two Tsg101 conditional knockout alleles to investigate the expression of ErbB receptor tyrosine kinases as well as stress-induced intracellular processes that are known to be associated with a defect in growth and cell survival. The conditional deletion of the Tsg101 gene in this well-controlled experimental model resulted in a significant reduction in the steady-state levels of the EGFR and ErbB2 but a stress-induced elevation in the phosphorylation of mitogen activated protein ( MAP) kinases independent of growth factor stimulation. As part of an integrated stress response, Tsg101-deficient cells exhibited extensive remodeling of actin filaments and greatly enlarged lysosomes that were enriched with the autophagy-related protein LC3. The increase in the transcriptional activation and expression of LC3 and its association with Lamp1-positive lysosomes in a PI3K-dependent manner suggest that Tsg101 knockout cells utilize autophagy as a survival mechanism prior to their ultimate death. Collectively, this study shows that a knockout of the Tsg101 gene causes complex intracellular changes associated with stress response and cell death. These multifaceted alterations need to be recognized as they have an impact on defining particular functions for Tsg101 in processes such as signal transduction and lysosomal/endosomal trafficking.	[Morris, Chantey R.; Stanton, Marissa J.; Manthey, Karoline C.; Oh, Keon Bong; Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Wagner, Kay-Uwe] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Morris, CR (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	kuwagner@unmc.edu	Wagner, Kay-Uwe/B-6044-2009	Wagner, Kay-Uwe/0000-0002-5081-0226	Public Health Service from the National Cancer Institute [CA93797, CA093797-06A2S1]; Nebraska IDeA Networks of Biomedical Research Excellence [P20 RR16469]; NATIONAL CANCER INSTITUTE [R01CA093797] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016469] Funding Source: NIH RePORTER	Public Health Service from the National Cancer Institute; Nebraska IDeA Networks of Biomedical Research Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The main part of this work was supported by the Public Health Service grants CA93797 and CA093797-06A2S1 from the National Cancer Institute to K.U. W.M.J.S. received a graduate fellowship from the Nebraska IDeA Networks of Biomedical Research Excellence (grant number P20 RR16469). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Carstens MJ, 2004, J BIOL CHEM, V279, P35984, DOI 10.1074/jbc.M400408200; Doyotte A, 2005, J CELL SCI, V118, P3003, DOI 10.1242/jcs.02421; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Hittelman AB, 1999, EMBO J, V18, P5380, DOI 10.1093/emboj/18.19.5380; Ishidoh K, 1999, J BIOCHEM-TOKYO, V125, P770, DOI 10.1093/oxfordjournals.jbchem.a022348; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Koonin EV, 1997, NAT GENET, V16, P330, DOI 10.1038/ng0897-330; Krempler A, 2002, J BIOL CHEM, V277, P43216, DOI 10.1074/jbc.M207662200; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Li LM, 1996, CELL, V85, P319, DOI 10.1016/S0092-8674(00)81111-3; Li Y, 1999, MOL CELL BIOL, V19, P3588; Liu FL, 2010, MOL BIOL REP, V37, P2829, DOI 10.1007/s11033-009-9835-5; Liu RT, 2002, ONCOGENE, V21, P4830, DOI 10.1038/sj.onc.1205612; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Oh KB, 2007, ONCOGENE, V26, P5950, DOI 10.1038/sj.onc.1210401; Ponting CP, 1997, J MOL MED-JMM, V75, P467; Razi M, 2006, MOL BIOL CELL, V17, P3469, DOI 10.1091/mbc.E05-11-1054; Ru MX, 2008, TROP BIOMED, V25, P46; Ruland J, 2001, P NATL ACAD SCI USA, V98, P1859, DOI 10.1073/pnas.98.4.1859; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Tu C, 2010, P NATL ACAD SCI USA, V107, P16107, DOI 10.1073/pnas.1009471107; Wagner KU, 1999, CYTOGENET CELL GENET, V84, P87, DOI 10.1159/000015221; Wagner KU, 2003, MOL CELL BIOL, V23, P150, DOI 10.1128/MCB.23.1.150-162.2003; Wagner KU, 1998, ONCOGENE, V17, P2761, DOI 10.1038/sj.onc.1202529; Watanabe M, 1998, BIOCHEM BIOPH RES CO, V245, P900, DOI 10.1006/bbrc.1998.8547; Young TW, 2007, CLIN CANCER RES, V13, P3848, DOI 10.1158/1078-0432.CCR-07-0337; Zhang Y, 2011, HISTOL HISTOPATHOL, V26, P87, DOI 10.14670/HH-26.87; Zhu G, 2004, INT J CANCER, V109, P541, DOI 10.1002/ijc.20014	36	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34308	10.1371/journal.pone.0034308	http://dx.doi.org/10.1371/journal.pone.0034308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479596	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100148
J	Stiglic, G; Kocbek, S; Pernek, I; Kokol, P				Stiglic, Gregor; Kocbek, Simon; Pernek, Igor; Kokol, Peter			Comprehensive Decision Tree Models in Bioinformatics	PLOS ONE			English	Article							RULES	Purpose: Classification is an important and widely used machine learning technique in bioinformatics. Researchers and other end-users of machine learning software often prefer to work with comprehensible models where knowledge extraction and explanation of reasoning behind the classification model are possible. Methods: This paper presents an extension to an existing machine learning environment and a study on visual tuning of decision tree classifiers. The motivation for this research comes from the need to build effective and easily interpretable decision tree models by so called one-button data mining approach where no parameter tuning is needed. To avoid bias in classification, no classification performance measure is used during the tuning of the model that is constrained exclusively by the dimensions of the produced decision tree. Results: The proposed visual tuning of decision trees was evaluated on 40 datasets containing classical machine learning problems and 31 datasets from the field of bioinformatics. Although we did not expected significant differences in classification performance, the results demonstrate a significant increase of accuracy in less complex visually tuned decision trees. In contrast to classical machine learning benchmarking datasets, we observe higher accuracy gains in bioinformatics datasets. Additionally, a user study was carried out to confirm the assumption that the tree tuning times are significantly lower for the proposed method in comparison to manual tuning of the decision tree. Conclusions: The empirical results demonstrate that by building simple models constrained by predefined visual boundaries, one not only achieves good comprehensibility, but also very good classification performance that does not differ from usually more complex models built using default settings of the classical decision tree algorithm. In addition, our study demonstrates the suitability of visually tuned decision trees for datasets with binary class attributes and a high number of possibly redundant attributes that are very common in bioinformatics.	[Stiglic, Gregor; Kocbek, Simon; Pernek, Igor; Kokol, Peter] Univ Maribor, Fac Hlth Sci, SLO-2000 Maribor, Slovenia; [Stiglic, Gregor; Kokol, Peter] Univ Maribor, Fac Elect Engn & Comp Sci, SLO-2000 Maribor, Slovenia	University of Maribor; University of Maribor	Stiglic, G (corresponding author), Univ Maribor, Fac Hlth Sci, SLO-2000 Maribor, Slovenia.	gregor.stiglic@uni-mb.si	Stiglic, Gregor/E-5286-2011; Kocbek, Simon/O-1997-2019; Kokol, Peter/I-1542-2019	Stiglic, Gregor/0000-0002-0183-8679; Kokol, Peter/0000-0003-4073-6488				Andrews K, 1998, P IEEE S INF VIS INF, P9; Babic A., 1992, Artificial Intelligence in Medicine, V4, P373, DOI 10.1016/0933-3657(92)90021-G; Baneyx F, CURRENT OPINION BIOT; BOHANEC M, 1994, MACH LEARN, V15, P223, DOI 10.1007/BF00993345; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Brodley CE, 1999, J ARTIF INTELL RES, V11, P131, DOI 10.1613/jair.606; Buchheim C., 2002, Graph Drawing. 10th International Symposium, GD 2002. Revised Papers (Lecture Notes in Computer Science Vol.2528), P344; Cano JR, 2007, DATA KNOWL ENG, V60, P90, DOI 10.1016/j.datak.2006.01.008; Chow MK, 2006, PROTEIN EXPRESSION P; Darnell SJ, PROTEINS; Demsar J, 2006, J MACH LEARN RES, V7, P1; Freund Y, 1999, MACHINE LEARNING, PROCEEDINGS, P124; Hall M, WEKA DATA MINING SOF, V11; Huysmans J, 2010, DECISION SUPPORT SYS; John G. H., 1995, KDD-95 Proceedings. First International Conference on Knowledge Discovery and Data Mining, P174; JOHNSON B, 1991, VISUALIZATION 91, P284; Magnan CN, BIOINFORMATICS; Maree R., 2004, P 6 ASIAN C COMPUTER, P860; McGuffin MJ, 2010, INFORM VISUAL, V9, P115, DOI 10.1057/ivs.2009.4; Mingers J, MACH LEARN, V4, P227; Murphy PM, 1993, J ARTIF INTELL RES, V1, P257; Murthy SK, 1998, DATA MIN KNOWL DISC, V2, P345, DOI 10.1023/A:1009744630224; Newman D, UCI MACHINE LEARNING; Niwa T, 2009, P NATL ACAD SCI USA, V106, P4201, DOI 10.1073/pnas.0811922106; Oates T., 1997, P 14 INT C MACH LEAR, P254; Osei-Bryson KM, 2004, COMPUT OPER RES, V31, P1933, DOI 10.1016/S0305-0548(03)00156-4; Quinlan JR, C4 5 PROGRAMS MACHIN; REINGOLD EM, 1981, IEEE T SOFTWARE ENG, V7, P223, DOI 10.1109/TSE.1981.234519; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Serrano-Aguilar P, 2011, BR J OPHTHALMOL; Shafer J, 1996, PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON VERY LARGE DATA BASES, P544; SHNEIDERMAN B, 1992, ACM T GRAPHIC, V11, P92, DOI 10.1145/102377.115768; Smailowski P, 2007, BIOINFORMATICS; Stasko J, 2000, IEEE SYMPOSIUM ON INFORMATION VISUALIZATION 2000, P57, DOI 10.1109/INFVIS.2000.885091; Stiglic G, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/616358; Vapnik V, NATURE STAT LEARNING; Webb GI, 1996, J ARTIF INTELL RES, V4, P397, DOI 10.1613/jair.228; Wilkinson DL, BIOTECHNOLOGY; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Xiaojing Y, 2003, FLAIRS C, P92	41	45	45	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33812	10.1371/journal.pone.0033812	http://dx.doi.org/10.1371/journal.pone.0033812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479449	Green Published, gold			2022-12-27	WOS:000305339100073
J	Wei, DD; Shao, RF; Yuan, ML; Dou, W; Barker, SC; Wang, JJ				Wei, Dan-Dan; Shao, Renfu; Yuan, Ming-Long; Dou, Wei; Barker, Stephen C.; Wang, Jin-Jun			The Multipartite Mitochondrial Genome of Liposcelis bostrychophila: Insights into the Evolution of Mitochondrial Genomes in Bilateral Animals	PLOS ONE			English	Article							TRANSFER-RNA GENES; PHYLOGENETIC INFERENCE; MULTIPLE ORIGINS; DNA-MOLECULES; SISTER GROUP; LICE; REARRANGEMENTS; INSECTA; PHTHIRAPTERA; SEQUENCE	Booklice (order Psocoptera) in the genus Liposcelis are major pests to stored grains worldwide and are closely related to parasitic lice (order Phthiraptera). We sequenced the mitochondrial (mt) genome of Liposcelis bostrychophila and found that the typical single mt chromosome of bilateral animals has fragmented into and been replaced by two medium-sized chromosomes in this booklouse; each of these chromosomes has about half of the genes of the typical mt chromosome of bilateral animals. These mt chromosomes are 8,530 bp (mt chromosome I) and 7,933 bp (mt chromosome II) in size. Intriguingly, mt chromosome I is twice as abundant as chromosome II. It appears that the selection pressure for compact mt genomes in bilateral animals favors small mt chromosomes when small mt chromosomes co-exist with the typical large mt chromosomes. Thus, small mt chromosomes may have selective advantages over large mt chromosomes in bilateral animals. Phylogenetic analyses of mt genome sequences of Psocodea (i.e. Psocoptera plus Phthiraptera) indicate that: 1) the order Psocoptera (booklice and barklice) is paraphyletic; and 2) the order Phthiraptera (the parasitic lice) is monophyletic. Within parasitic lice, however, the suborder Ischnocera is paraphyletic; this differs from the traditional view that each suborder of parasitic lice is monophyletic.	[Wei, Dan-Dan; Yuan, Ming-Long; Dou, Wei; Wang, Jin-Jun] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China; [Shao, Renfu; Barker, Stephen C.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Shao, Renfu] Univ Sunshine Coast, Sch Sci Educ & Engn, Maroochydore, Qld, Australia	Southwest University - China; University of Queensland; University of the Sunshine Coast	Wei, DD (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.	rshao@usc.edu.au; jjwang7008@yahoo.com		Barker, Stephen/0000-0001-9431-8404; Shao, Renfu/0000-0002-1686-4968	National Natural Sciences Foundation [30871631, 31000860]; Program for Innovative Research Team in University [IRT0976]; Natural Science Foundation of Chongqing (CSTC) [2009BA1042]; Specialized Research Fund for the Doctoral Program of Higher Education of China [200806350009]	National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in University; Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was funded in part by the National Natural Sciences Foundation (30871631, 31000860), the Program for Innovative Research Team in University (IRT0976), the Natural Science Foundation of Chongqing (CSTC, 2009BA1042) and the Specialized Research Fund for the Doctoral Program of Higher Education (200806350009) of China, awarded to Jin-Jun Wang. The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Armstrong MR, 2000, GENETICS, V154, P181; Awata H, 2005, MOL GENET GENOMICS, V273, P441, DOI 10.1007/s00438-005-1157-2; Bogenhagen DF, 2011, BIOCHIM BIOPHYS ACTA, DOI [10.1016/j.bbagrm.2011.1011.1005, DOI 10.1016/J.BBAGRM.2011.1011.1005]; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Burger G, 2003, IUBMB LIFE, V55, P205, DOI 10.1080/1521654031000137380; Burger G, 2003, P NATL ACAD SCI USA, V100, P892, DOI 10.1073/pnas.0336115100; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Cameron SL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-394; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Covacin C, 2006, INSECT MOL BIOL, V15, P63, DOI 10.1111/j.1365-2583.2005.00608.x; Domes K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-532; Fan J, 2002, MOL BIOL EVOL, V19, P999, DOI 10.1093/oxfordjournals.molbev.a004180; FAURON C, 1995, TRENDS GENET, V11, P228, DOI 10.1016/S0168-9525(00)89056-3; Gibson T, 2007, J MOL EVOL, V65, P308, DOI 10.1007/s00239-007-9007-y; Grimaldi D, 2006, P ROY SOC B-BIOL SCI, V273, P625, DOI 10.1098/rspb.2005.3337; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAYASHI JI, 1991, P NATL ACAD SCI USA, V88, P10614, DOI 10.1073/pnas.88.23.10614; Helfenbein KG, 2004, P NATL ACAD SCI USA, V101, P10639, DOI 10.1073/pnas.0400941101; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Jiang HB, 2010, MOL BIOL REP, V37, P1019, DOI 10.1007/s11033-009-9803-0; Johnson KP, 2004, P ROY SOC B-BIOL SCI, V271, P1771, DOI 10.1098/rspb.2004.2798; Johnson KP, 2002, MOL PHYLOGENET EVOL, V22, P101, DOI 10.1006/mpev.2001.1028; Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821; Kim MJ, 2011, MOL PHYLOGENET EVOL, V61, P436, DOI 10.1016/j.ympev.2011.07.013; Klingbeil MM, 2001, PROTIST, V152, P255, DOI 10.1078/1434-4610-00066; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Lavrov DV, 2007, INTEGR COMP BIOL, V47, P734, DOI 10.1093/icb/icm045; Li FS, 2002, PSOCOPTERA CHINA, P77; Liu BY, 2005, TRENDS PARASITOL, V21, P363, DOI 10.1016/j.pt.2005.06.008; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LYAL CHC, 1985, SYST ENTOMOL, V10, P145; Marande W, 2005, EUKARYOT CELL, V4, P1137, DOI 10.1128/EC.4.6.1137-1146.2005; Marande W, 2007, SCIENCE, V318, P415, DOI 10.1126/science.1148033; Mathews DH, 2005, BIOINFORMATICS, V21, P2246, DOI 10.1093/bioinformatics/bti349; Melov S, 1997, NUCLEIC ACIDS RES, V25, P974, DOI 10.1093/nar/25.5.974; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419; Milligan B, 1998, MOL GENETIC ANAL POP, P29; Murrell A, 2005, PARASITOL RES, V97, P274, DOI 10.1007/s00436-005-1413-8; Nosek J, 1998, TRENDS GENET, V14, P184, DOI 10.1016/S0168-9525(98)01443-7; PALMER JD, 1984, NATURE, V307, P437, DOI 10.1038/307437a0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price Roger D., 2003, Illinois Natural History Survey Special Publication, V24, P1; Rand DM, 2009, GENOME RES, V19, P700, DOI 10.1101/gr.091132.109; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shao R, 2001, MOL BIOL EVOL, V18, P858, DOI 10.1093/oxfordjournals.molbev.a003867; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Shao RF, 2003, MOL BIOL EVOL, V20, P1612, DOI 10.1093/molbev/msg176; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith DR, 2011, GENOME BIOL EVOL, DOI [10.1093/gbe/evr1127, DOI 10.1093/GBE/EVR1127]; Suga K, 2008, MOL BIOL EVOL, V25, P1129, DOI 10.1093/molbev/msn058; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thao ML, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-25; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Voigt O, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-350; Watanabe KI, 1999, J MOL BIOL, V286, P645, DOI 10.1006/jmbi.1998.2523; Wei DD, 2011, J ECON ENTOMOL, V104, P1720, DOI 10.1603/EC11177; Wei SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-371; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yoshizawa K, 2003, MOL PHYLOGENET EVOL, V29, P102, DOI 10.1016/S1055-7903(03)00073-3; Yoshizawa K, 2010, MOL PHYLOGENET EVOL, V55, P939, DOI 10.1016/j.ympev.2010.02.026; Yuan ML, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-597	67	53	59	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33973	10.1371/journal.pone.0033973	http://dx.doi.org/10.1371/journal.pone.0033973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479490	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100091
J	Ying, HJ; Fu, HM; Rose, ML; McCormack, AM; Sarathchandra, P; Okkenhaug, K; Marelli-Berg, FM				Ying, Huijun; Fu, Hongmei; Rose, Marlene L.; McCormack, Ann M.; Sarathchandra, Padmini; Okkenhaug, Klaus; Marelli-Berg, Federica M.			Genetic or Pharmaceutical Blockade of Phosphoinositide 3-Kinase P110 delta Prevents Chronic Rejection of Heart Allografts	PLOS ONE			English	Article							CD4(+) T-CELLS; MURINE CARDIAC ALLOGRAFTS; MOUSE SKIN ALLOGRAFTS; TRANSENDOTHELIAL MIGRATION; ENDOTHELIAL-CELLS; IN-VIVO; INTERNATIONAL-SOCIETY; VASCULAR ENDOTHELIUM; LUNG-TRANSPLANTATION; INDIRECT RECOGNITION	Chronic rejection is the major cause of long-term heart allograft failure, characterized by tissue infiltration by recipient T cells with indirect allospecificity. Phosphoinositol-3-kinase p110 delta is a key mediator of T cell receptor signaling, regulating both T cell activation and migration of primed T cells to non-lymphoid antigen-rich tissue. We investigated the effect of genetic or pharmacologic inactivation of PI3K p110 delta on the development of chronic allograft rejection in a murine model in which HY-mismatched male hearts were transplanted into female recipients. We show that suppression of p110 delta activity significantly attenuates the development of chronic rejection of heart grafts in the absence of any additional immunosuppressive treatment by impairing the localization of antigen-specific T cells to the grafts, while not inducing specific T cell tolerance. p110 delta pharmacologic inactivation is effective when initiated after transplantation. Targeting p110 delta activity might be a viable strategy for the treatment of heart chronic rejection in humans.	[Ying, Huijun; Fu, Hongmei; Marelli-Berg, Federica M.] Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Div Med, London, England; [Rose, Marlene L.; McCormack, Ann M.; Sarathchandra, Padmini] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Div Med, Harefield Hosp, London, England; [Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England	Imperial College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Ying, HJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Immunol, Div Med, Hammersmith Campus, London, England.	f.marelli@imperial.ac.uk	Okkenhaug, Klaus/H-3154-2019; Okkenhaug, Klaus/D-5149-2012	Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051	British Heart Foundation [PG/07/090/23697, RG/09/002]; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C236, BB/C509890/1] Funding Source: researchfish; British Heart Foundation [RG/09/002/26425] Funding Source: researchfish; BBSRC [BBS/E/B/0000C236] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was entirely funded by the British Heart Foundation (Grants PG/07/090/23697 and RG/09/002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2004, NATURE, V431, P1007, DOI 10.1038/nature02991; Amano J, 1997, J THORAC CARDIOV SUR, V113, P19, DOI 10.1016/S0022-5223(97)70395-7; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; Capla JM, 2006, PLAST RECONSTR SURG, V117, P836, DOI 10.1097/01.prs.0000201459.91559.7f; Chen Y, 2003, J IMMUNOL, V171, P6510, DOI 10.4049/jimmunol.171.12.6510; Christen T, 2009, CIRCULATION, V119, P1925, DOI 10.1161/CIRCULATIONAHA.108.796888; DEWAAL RMW, 1986, TRANSPLANTATION, V42, P178, DOI 10.1097/00007890-198608000-00015; DEWAAL RMW, 1983, NATURE, V303, P426, DOI 10.1038/303426a0; Doukas J, 2006, P NATL ACAD SCI USA, V103, P19866, DOI 10.1073/pnas.0606956103; Hasegawa S, 1998, AM J PATHOL, V153, P69, DOI 10.1016/S0002-9440(10)65547-2; He CS, 2004, J IMMUNOL, V172, P240, DOI 10.4049/jimmunol.172.1.240; Huddleston SJ, 2006, AM J TRANSPLANT, V6, P1312, DOI 10.1111/j.1600-6143.2006.01309.x; Jarmin SJ, 2008, J CLIN INVEST, V118, P1154, DOI 10.1172/JCI33267; Kawai T, 1998, IMMUNOLOGY, V93, P11; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lee RS, 2001, P NATL ACAD SCI USA, V98, P3276, DOI 10.1073/pnas.051584498; Libby P, 2001, IMMUNITY, V14, P387, DOI 10.1016/S1074-7613(01)00119-4; Liu ZR, 1996, J CLIN INVEST, V98, P1150, DOI 10.1172/JCI118898; Manes TD, 2008, J IMMUNOL, V180, P8386, DOI 10.4049/jimmunol.180.12.8386; Marelli-Berg FM, 2008, J PATHOL, V214, P179, DOI 10.1002/path.2269; Marelli-Berg FM, 1999, J IMMUNOL, V162, P696; Marelli-Berg FM, 2004, BLOOD, V103, P3111, DOI 10.1182/blood-2003-08-2717; Millrain M, 2001, J IMMUNOL, V167, P3756, DOI 10.4049/jimmunol.167.7.3756; Mirenda V, 2007, BLOOD, V109, P2968, DOI 10.1182/blood-2006-10-050724; Murase N, 1999, J LEUKOCYTE BIOL, V66, P297, DOI 10.1002/jlb.66.2.297; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2002, SCIENCE, V297, P1031; Ozdemir BH, 2009, TRANSPL P, V41, P2890, DOI 10.1016/j.transproceed.2009.07.031; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Reif K, 2004, J IMMUNOL, V173, P2236, DOI 10.4049/jimmunol.173.4.2236; Savinov AY, 2003, J EXP MED, V197, P643, DOI 10.1084/jem.20021378; Schnickel GT, 2004, TRANSPLANTATION, V78, P1634, DOI 10.1097/01.TP.0000141362.33931.40; Schwoebel F, 2005, LAB ANIM-UK, V39, P209, DOI 10.1258/0023677053739792; Scott D, 2000, IMMUNITY, V12, P711, DOI 10.1016/S1074-7613(00)80221-6; Simpson E, 1997, ANNU REV IMMUNOL, V15, P39, DOI 10.1146/annurev.immunol.15.1.39; SOBEL RA, 1984, J IMMUNOL, V132, P2402; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Sun H, 2002, J HEART LUNG TRANSPL, V21, P738, DOI 10.1016/S1053-2498(02)00393-5; Szeto WY, 2002, TRANSPLANTATION, V73, P1116, DOI 10.1097/00007890-200204150-00019; Tanaka M, 2005, J HEART LUNG TRANSPL, V24, P316, DOI 10.1016/j.healun.2003.12.011; Taylor DO, 2009, J HEART LUNG TRANSPL, V28, P1007, DOI 10.1016/j.healun.2009.08.014; Taylor DO, 2003, J HEART LUNG TRANSPL, V22, P616, DOI 10.1016/S1053-2498(03)00186-4; Valujskikh A, 2006, J IMMUNOL, V176, P2190, DOI 10.4049/jimmunol.176.4.2190; Valujskikh A, 2002, NAT IMMUNOL, V3, P844, DOI 10.1038/ni831; van Loosdregt J, 2006, CIRCULATION, V114, P1599, DOI 10.1161/CIRCULATIONAHA.105.597526; Waaga AM, 2000, CURR OPIN IMMUNOL, V12, P517, DOI 10.1016/S0952-7915(00)00132-1; WANG J, 1995, J BIOL CHEM, V270, P12774, DOI 10.1074/jbc.270.21.12774; Xu Y, 2010, TRANSPLANTATION, V90, P1157, DOI 10.1097/TP.0b013e3181fa9480; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0	50	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32892	10.1371/journal.pone.0032892	http://dx.doi.org/10.1371/journal.pone.0032892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479345	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100022
J	Idda, ML; Kage, E; Lopez-Olmeda, JF; Mracek, P; Foulkes, NS; Vallone, D				Idda, Maria Laura; Kage, Elena; Lopez-Olmeda, Jose Fernando; Mracek, Philipp; Foulkes, Nicholas S.; Vallone, Daniela			Circadian Timing of Injury-Induced Cell Proliferation in Zebrafish	PLOS ONE			English	Article							TAIL FIN; REGENERATION; CLOCK; LIGHT; CYCLE; EXPRESSION; BLASTEMA; PHOSPHORYLATION; TRANSCRIPTION; MECHANISMS	In certain vertebrates such as the zebrafish, most tissues and organs including the heart and central nervous system possess the remarkable ability to regenerate following severe injury. Both spatial and temporal control of cell proliferation and differentiation is essential for the successful repair and re-growth of damaged tissues. Here, using the regenerating adult zebrafish caudal fin as a model, we have demonstrated an involvement of the circadian clock in timing cell proliferation following injury. Using a BrdU incorporation assay with a short labeling period, we reveal high amplitude daily rhythms in S-phase in the epidermal cell layer of the fin under normal conditions. Peak numbers of S-phase cells occur at the end of the light period while lowest levels are observed at the end of the dark period. Remarkably, immediately following amputation the basal level of epidermal cell proliferation increases significantly with kinetics, depending upon the time of day when the amputation is performed. In sharp contrast, we failed to detect circadian rhythms of S-phase in the highly proliferative mesenchymal cells of the blastema. Subsequently, during the entire period of outgrowth of the new fin, elevated, cycling levels of epidermal cell proliferation persist. Thus, our results point to a preferential role for the circadian clock in the timing of epidermal cell proliferation in response to injury.	[Idda, Maria Laura; Kage, Elena; Lopez-Olmeda, Jose Fernando; Mracek, Philipp; Foulkes, Nicholas S.; Vallone, Daniela] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Idda, ML (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein, Germany.	Nicholas.Foulkes@kit.edu; daniela.vallone@kit.edu	Foulkes, Nicholas S/K-7003-2013; Vallone, Daniela/S-2244-2019; Lopez-Olmeda, Jose Fernando/K-3848-2014	Foulkes, Nicholas S/0000-0002-1794-9891; Lopez-Olmeda, Jose Fernando/0000-0003-4920-5704	Max-Planck-Institute for Developmental Biology, Tubingen; Karlsruhe Institute of Technology (KIT, Germany); CNRS (France)	Max-Planck-Institute for Developmental Biology, Tubingen; Karlsruhe Institute of Technology (KIT, Germany); CNRS (France)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by funding from the Max-Planck-Institute for Developmental Biology, Tubingen, Karlsruhe Institute of Technology (KIT, Germany), the CNRS (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIMENKO MA, 1995, DEVELOPMENT, V121, P347; Bailes HJ, 2010, CELL MOL LIFE SCI, V67, P99, DOI 10.1007/s00018-009-0155-7; BECERRA J, 1983, CELL TISSUE RES, V230, P127; Becker CG, 2004, J NEUROSCI, V24, P7837, DOI 10.1523/JNEUROSCI.2420-04.2004; Bernhardt RR, 1996, J COMP NEUROL, V376, P253, DOI 10.1002/(SICI)1096-9861(19961209)376:2<253::AID-CNE7>3.0.CO;2-2; Bjarnason GA, 2000, PROG CELL CYC RES, V4, P193; Dekens MPS, 2003, CURR BIOL, V13, P2051, DOI 10.1016/j.cub.2003.10.022; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dickmeis T, 2007, PLOS BIOL, V5, P854, DOI 10.1371/journal.pbio.0050078; Fritsch-Decker S, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-23; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gaddameedhi S, 2011, P NATL ACAD SCI USA, V108, P18790, DOI 10.1073/pnas.1115249108; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Gu X, 2011, CELL DEATH DIFFER; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Jain I, 2007, DEV DYNAM, V236, P2668, DOI 10.1002/dvdy.21270; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Laforest L, 1998, DEVELOPMENT, V125, P4175; Lahiri K, 2005, PLOS BIOL, V3, P2005, DOI 10.1371/journal.pbio.0030351; Lopez-Schier H, 2006, P NATL ACAD SCI USA, V103, P18615, DOI 10.1073/pnas.0608536103; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; MONTES GS, 1982, HISTOCHEMISTRY, V75, P363, DOI 10.1007/BF00496739; Mori T, 2000, Prog Cell Cycle Res, V4, P185; Nakatani Y, 2008, DEV GROWTH DIFFER, V50, P71, DOI 10.1111/j.1440-169x.2007.00977.x; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Nikaido SS, 2000, PHOTOCHEM PHOTOBIOL, V71, P758, DOI 10.1562/0031-8655(2000)071<0758:DACVIS>2.0.CO;2; Nuesslein-Volhard CaD R, 2002, ZEBRAFISH PRACTICAL; Poleo G, 2001, DEV DYNAM, V221, P380, DOI 10.1002/dvdy.1152; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Sadler KC, 2007, P NATL ACAD SCI USA, V104, P1570, DOI 10.1073/pnas.0610774104; SANTAMARIA JA, 1991, J ANAT, V176, P9; Santos-Ruiz L, 2002, DEV DYNAM, V223, P262, DOI 10.1002/dvdy.10055; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Smaaland R, 2002, CHRONOBIOL INT, V19, P101, DOI 10.1081/CBI-120002594; Vallone D, 2004, P NATL ACAD SCI USA, V101, P4106, DOI 10.1073/pnas.0305436101; Vallone Daniela, 2007, Methods Mol Biol, V362, P429; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Vatine G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000223; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589	49	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34203	10.1371/journal.pone.0034203	http://dx.doi.org/10.1371/journal.pone.0034203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479565	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400060
J	Trautmann, M; Zepf, FD				Trautmann, Mireille; Zepf, Florian Daniel			Attentional Performance, Age and Scholastic Achievement in Healthy Children	PLOS ONE			English	Article							SELECTIVE ATTENTION; MEMORY; VALIDITY; ADHD	Background: Attentional processes in children play a critical role in daily school demands and accomplishments. Studies on the association of attentional processes with school achievement and age in healthy school children are scarce. The aim of the present study was to identify correlations between dimensions of attentional performance, scholastic achievement and age. Methodology/Principal Findings: An extensive testing battery was used to assess a wide range of attentional dimensions. A principal component analysis revealed three factors that are related to attentional performance (distractibility, lapses of attention, cognitive speed). Age was negatively associated with distractibility, lapses of attention and cognitive speed, indicating that distractibility and lapses of attention decreased with age in healthy children and resulted in lower cognitive speed. Conclusions/Significance: Attentional processes in healthy children should be measured in relation to distractibility, lapses of attention and cognitive speed.	[Trautmann, Mireille] Univ Freiburg, Dept Psychol, D-79106 Freiburg, Germany; [Trautmann, Mireille] Univ Leipzig, Dept Psychol, Leipzig, Germany; [Zepf, Florian Daniel] RWTH Univ, Univ Hosp, Dept Child & Adolescent Psychiat, Aachen, Germany; [Zepf, Florian Daniel] Julich Res Ctr, Inst Neurosci & Med, Julich, Germany; [Zepf, Florian Daniel] JARA Translat Brain Med, Julich, Germany	University of Freiburg; Leipzig University; RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; Research Center Julich	Trautmann, M (corresponding author), Univ Freiburg, Dept Psychol, Hugstetter Str 55, D-79106 Freiburg, Germany.	mireille.trautmann@uni-leipzig.de	Zepf, Florian D/J-5236-2013		American Psychiatric Association (APA); American Psychiatric Institute for Research and Education (APIRE); Astra Zeneca; Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi); German Society for Social Pediatrics and Adolescent Medicine (Deutsche Gesellschaft fur Sozialpadiatrie und Jugendmedizin, DGSPJ); Paul and Ursula Klein Foundation; Raine Foundation for Medical Research	American Psychiatric Association (APA); American Psychiatric Institute for Research and Education (APIRE); Astra Zeneca(AstraZeneca); Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi); German Society for Social Pediatrics and Adolescent Medicine (Deutsche Gesellschaft fur Sozialpadiatrie und Jugendmedizin, DGSPJ); Paul and Ursula Klein Foundation; Raine Foundation for Medical Research	The authors have read the journal's policy and report that in the past five years Dr. Zepf was the recipient of an unrestricted award donated by the American Psychiatric Association (APA), the American Psychiatric Institute for Research and Education (APIRE), and Astra Zeneca ("Young Minds in Psychiatry Award''). Dr. Zepf has also received research support from the Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, BMWi), the German Society for Social Pediatrics and Adolescent Medicine (Deutsche Gesellschaft fur Sozialpadiatrie und Jugendmedizin, DGSPJ), and from the Paul and Ursula Klein Foundation. Dr. Zepf was the recipient of a travel-stipend donated by the GlaxoSmithKline Foundation and an unrestricted educational grant, speaker honoraria and travel support donated by Shire pharmaceuticals. In addition, Dr. Zepf has received support from the Raine Foundation for Medical Research (Raine Visiting Professorship). All of the above are unrelated to this specific study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andersen S. K., 2011, COGNITIVE NEUROSCIEN; Ashkenazi S, 2009, NEUROPSYCHOLOGY, V23, P535, DOI 10.1037/a0015347; Breslau J, 2009, PEDIATRICS, V123, P1472, DOI 10.1542/peds.2008-1406; Breslau N, 2010, PSYCHOL MED, V40, P159, DOI 10.1017/S0033291709005960; Chang F, 2005, CHILD DEV, V76, P247, DOI 10.1111/j.1467-8624.2005.00842.x; Ciaramelli E, 2010, J NEUROSCI, V30, P4943, DOI 10.1523/JNEUROSCI.1209-09.2010; Davis CJ, 2002, TRENDS COGN SCI, V6, P359, DOI 10.1016/S1364-6613(02)01950-2; Drechsler R, 2009, KINDH ENTWICKL, V18, P153, DOI 10.1026/0942-5403.18.3.153; Duckworth AL, 2005, PSYCHOL SCI, V16, P939, DOI 10.1111/j.1467-9280.2005.01641.x; Facoetti A, 2000, CORTEX, V36, P109, DOI 10.1016/S0010-9452(08)70840-2; Facoetti A, 2000, EXP BRAIN RES, V132, P531, DOI 10.1007/s002219900330; Facoetti A, 2000, NEUROSCI LETT, V290, P216, DOI 10.1016/S0304-3940(00)01354-9; FOLDENYI M, 1999, Z NEUROPSYCHOL, V10, P87; Foldenyi M., 2000, Z NEUROPSYCHOL, V11, P1, DOI DOI 10.1024//1016-264X.11.1.1; Geier CF, 2009, J NEUROPHYSIOL, V101, P84, DOI 10.1152/jn.90562.2008; Hellwig-Brida S, 2011, J CHILD ADOL PSYCHOP, V21, P245, DOI 10.1089/cap.2010.0041; Kaller T, 2010, TRANSPLANTATION, V90, P1567, DOI 10.1097/TP.0b013e3181fe1398; Kaufmann L, 2010, DEV MED CHILD NEUROL, V52, P371, DOI 10.1111/j.1469-8749.2009.03560.x; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Michel E, 2011, CHILD NEUROPSYCHOL, V17, P151, DOI 10.1080/09297049.2010.525501; Muris P, 2006, PERCEPT MOTOR SKILL, V102, P78, DOI 10.2466/PMS.102.1.78-80; Nicolescu R, 2010, ENVIRON RES, V110, P476, DOI 10.1016/j.envres.2010.04.002; Oberauer K, 2006, J EXP PSYCHOL LEARN, V32, P197, DOI 10.1037/0278-7393.32.2.197; Oberauer K, 2003, EXP PSYCHOL, V50, P257, DOI 10.1026//1618-3169.50.4.257; Parasuraman, 1998, ATTENTIVE BRAIN; POSNER MI, 1987, NEUROPSYCHOLOGIA, V25, P135, DOI 10.1016/0028-3932(87)90049-2; Shallice T, 1993, ATTENTION SELECTION, P171; Sobeh J, 2011, CHILD NEUROPSYCHOL; STURM W, 2000, LEHRBUCH KLIN NEUROP, P345; TREISMAN A, 1969, NATURE, V222, P437, DOI 10.1038/222437a0; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; TREISMAN AM, 1969, J EXP PSYCHOL, V79, P27, DOI 10.1037/h0026890; Van Zomeren A.H., 1994, CLIN NEUROPSYCHOLOGY, V1st ed.; Zimmermann P., 2004, TESTBATTERIE AUFMERK	34	11	13	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32279					5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948SR	22479316	Green Published, gold			2022-12-27	WOS:000304523400003
J	Chiu, SC; Chen, SP; Huang, SY; Wang, MJ; Lin, SZ; Harn, HJ; Pang, CY				Chiu, Sheng-Chun; Chen, Shee-Ping; Huang, Sung-Ying; Wang, Mei-Jen; Lin, Shinn-Zong; Harn, Horng-Jyh; Pang, Cheng-Yoong			Induction of Apoptosis Coupled to Endoplasmic Reticulum Stress in Human Prostate Cancer Cells by n-butylidenephthalide	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CYCLIN D1; ANGELICA-SINENSIS; IN-VITRO; THERAPY; TRAIL; DEATH; CARCINOMA; PATHWAYS; TAXOL	Background: N-butylidenephthalide (BP) exhibits antitumor effect in a variety of cancer cell lines. The objective of this study was to obtain additional insights into the mechanisms involved in BP induced cell death in human prostate cancer cells. Methods/Principal Findings: Two human prostate cancer cell lines, PC-3 and LNCaP, were treated with BP, and subsequently evaluated for their viability and cell cycle profiles. BP caused cell cycle arrest and cell death in both cell lines. The G0/G1 phase arrest was correlated with increase levels of CDK inhibitors (p16, p21 and p27) and decrease of the checkpoint proteins. To determine the mechanisms of BP-induced growth arrest and cell death in prostate cancer cell lines, we performed a microarray study to identify alterations in gene expression induced by BP in the LNCaP cells. Several BP-induced genes, including the GADD153/CHOP, an endoplasmic reticulum stress (ER stress)-regulated gene, were identified. BP-induced ER stress was evidenced by increased expression of the downstream molecules GRP78/BiP, IRE1-alpha and GADD153/CHOP in both cell lines. Blockage of IRE1-alpha or GADD153/CHOP expression by siRNA significantly reduced BP-induced cell death in LNCaP cells. Furthermore, blockage of JNK1/2 signaling by JNK siRNA resulted in decreased expression of IRE1-alpha and GADD153/CHOP genes, implicating that BP-induced ER stress may be elicited via JNK1/2 signaling in prostate cancer cells. BP also suppressed LNCaP xenograft tumor growth in NOD-SCID mice. It caused 68% reduction in tumor volume after 18 days of treatment. Conclusions: Our results suggest that BP can cause G0/G1 phase arrest in prostate cancer cells and its cytotoxicity is mediated by ER stress induction. Thus, BP may serve as an anticancer agent by inducing ER stress in prostate cancer.	[Chiu, Sheng-Chun; Wang, Mei-Jen; Pang, Cheng-Yoong] Buddhist Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan; [Chen, Shee-Ping] Buddhist Tzu Chi Gen Hosp, Tzu Chi Stem Cells Ctr, Hualien, Taiwan; [Huang, Sung-Ying] Mackay Mem Hosp, Dept Ophthalmol, Hsinchu, Taiwan; [Lin, Shinn-Zong] China Med Univ Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Pang, Cheng-Yoong] Tzu Chi Univ, Sch Med, Inst Med Sci, Hualien, Taiwan; [Harn, Horng-Jyh] China Med Univ Hosp, Dept Pathol, Taichung, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Mackay Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Tzu Chi University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chiu, SC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan.	duke_harn@yahoo.com.tw; cypang@mail.tcu.edu.tw	Pang, Cheng-Yoong/AFO-1562-2022; Chiu, Sheng-Chun/F-9493-2015; Lin, Shinn-Zong/AAX-2379-2020; Pang, Cheng-Yoong/R-4990-2019	Pang, Cheng-Yoong/0000-0002-9063-2858; Chiu, Sheng-Chun/0000-0002-5927-8088	National Science Council, Taiwan [NSC-93-2320-B-303-004, NSC-94-2320-B-303-005, NSC-96-2113-M-303001]; Buddhist Tzu-Chi General Hospital, Hualien, Taiwan [TCSP-01-02, TCRD-I9801-03]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Buddhist Tzu-Chi General Hospital, Hualien, Taiwan	This work was supported by grants from the National Science Council, Taiwan (NSC-93-2320-B-303-004, NSC-94-2320-B-303-005, NSC-96-2113-M-303001), and Buddhist Tzu-Chi General Hospital, Hualien, Taiwan (TCSP-01-02, TCRD-I9801-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bellail AC, 2009, REV RECENT CLIN TRIA, V4, P34, DOI 10.2174/157488709787047530; Camidge DR, 2010, CLIN CANCER RES, V16, P1256, DOI 10.1158/1078-0432.CCR-09-1267; Caputi M, 1999, AM J RESP CELL MOL, V20, P746, DOI 10.1165/ajrcmb.20.4.3366; Chen YL, 2008, MOL PHARMACOL, V74, P1046, DOI 10.1124/mol.107.044800; Diehl JA, 2002, CANCER BIOL THER, V1, P226, DOI 10.4161/cbt.72; Dobashi Y, 2003, CURR MED CHEM, V10, P2549, DOI 10.2174/0929867033456495; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Griffith TS, 2009, CURR GENE THER, V9, P9, DOI 10.2174/156652309787354612; Gumbiner LM, 1999, PROSTATE, V38, P40, DOI 10.1002/(SICI)1097-0045(19990101)38:1<40::AID-PROS5>3.0.CO;2-I; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Herbst RS, 2010, J CLIN ONCOL, V28, P2839, DOI 10.1200/JCO.2009.25.1991; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Li BZ, 2007, VIRUS RES, V124, P44, DOI 10.1016/j.virusres.2006.09.011; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MARTIN SJ, 1995, CELL, V82, P349, DOI 10.1016/0092-8674(95)90422-0; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Nieto-Miguel T, 2007, CANCER RES, V67, P10368, DOI 10.1158/0008-5472.CAN-07-0278; Ong CS, 2010, CANCER LETT, V298, P167, DOI 10.1016/j.canlet.2010.07.001; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pei ZF, 2004, HEPATOLOGY, V39, P1371, DOI 10.1002/hep.20203; Ranganathan AC, 2008, CANCER RES, V68, P3260, DOI 10.1158/0008-5472.CAN-07-6215; REED SI, 1994, J CELL SCI, P69; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Shankar S, 2004, DRUG RESIST UPDATE, V7, P139, DOI 10.1016/j.drup.2004.03.002; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Tokunaga E, 2008, CURR CANCER DRUG TAR, V8, P27, DOI 10.2174/156800908783497140; Tsai NM, 2005, CLIN CANCER RES, V11, P3475, DOI 10.1158/1078-0432.CCR-04-1827; Tsai NM, 2006, J NEUROCHEM, V99, P1251, DOI 10.1111/j.1471-4159.2006.04151.x; Wang Haiyan, 1998, Zhongguo Zhongyao Zazhi, V23, P167; Wei CW, 2009, ACTA PHARMACOL SIN, V30, P1297, DOI 10.1038/aps.2009.124; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103	39	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33742	10.1371/journal.pone.0033742	http://dx.doi.org/10.1371/journal.pone.0033742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470469	Green Submitted, Green Published, gold			2022-12-27	WOS:000304489000031
J	Groom, HCT; Warren, AY; Neal, DE; Bishop, KN				Groom, Harriet C. T.; Warren, Anne Y.; Neal, David E.; Bishop, Kate N.			No Evidence for Infection of UK Prostate Cancer Patients with XMRV, BK Virus, Trichomonas vaginalis or Human Papilloma Viruses	PLOS ONE			English	Article							CHRONIC-FATIGUE-SYNDROME; BLOOD-CELLS; MOUSE DNA; SEQUENCES; CONTAMINATION; RETROVIRUS; GENOME; TISSUE; RISK; PCR	The prevalence of specific infections in UK prostate cancer patients was investigated. Serum from 84 patients and 62 controls was tested for neutralisation of xenotropic murine leukaemia virus-related virus (XMRV) Envelope. No reactivity was found in the patient samples. In addition, a further 100 prostate DNA samples were tested for XMRV, BK virus, Trichomonas vaginalis and human papilloma viruses by nucleic acid detection techniques. Despite demonstrating DNA integrity and assay sensitivity, we failed to detect the presence of any of these agents in DNA samples, bar one sample that was weakly positive for HPV16. Therefore we conclude that these infections are absent in this typical cohort of men with prostate cancer.	[Groom, Harriet C. T.; Bishop, Kate N.] MRC Natl Inst Med Res, Div Virol, London, England; [Warren, Anne Y.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Neal, David E.] Univ Cambridge, Dept Oncol, Cambridge, England	MRC National Institute for Medical Research; University of Cambridge; University of Cambridge	Groom, HCT (corresponding author), MRC Natl Inst Med Res, Div Virol, London, England.	kbishop@nimr.mrc.ac.uk		Neal, David/0000-0002-6033-5086	UK Medical Research Council [KNB U117592729]; Wellcome Trust [KNB 084955]; University of Cambridge; Cancer Research UK; National Institute for Health Research; NIHR Cambridge Biomedical Research Centre; National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT) [G0500966/75466]; MRC [G0900871, MC_U117592729] Funding Source: UKRI; Medical Research Council [G0900871, MC_U117592729] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of Cambridge(University of Cambridge); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council [KNB U117592729] and the Wellcome Trust [KNB 084955]. KNB is a Wellcome Trust Career Development Fellow. The authors would like to acknowledge the support of The University of Cambridge, Cancer Research UK, and the National Institute for Health Research, which funds the Cambridge Bio-medical Research Centre, Cambridge, UK. The Human Research Tissue Bank is supported by the NIHR Cambridge Biomedical Research Centre. The authors would also like to acknowledge the support of the National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT) collaborative (grant code G0500966/75466), which has funded tissue and urine collections in Cambridge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2011, SCIENCE, V334, P1636, DOI 10.1126/science.334.6063.1636-a; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Choo CK, 1999, PROSTATE, V40, P150, DOI 10.1002/(SICI)1097-0045(19990801)40:3<150::AID-PROS2>3.0.CO;2-7; Cingoz O, 2011, J VIROL; Das D, 2004, ONCOGENE, V23, P7031, DOI 10.1038/sj.onc.1207920; Das D, 2008, J VIROL, V82, P2705, DOI 10.1128/JVI.02461-07; Groom HCT, 2010, P NATL ACAD SCI USA, V107, P5166, DOI 10.1073/pnas.0913650107; Groom HCT, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-10; Hohn O, 2011, VIRUSES-BASEL, V3, P1312, DOI 10.3390/v3081312; Hohn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015632; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kenyon JC, 2011, BRIT MED BULL, V98, P61, DOI 10.1093/bmb/ldr010; Lo SC, 2012, P NATL ACAD SCI USA, V109, P346, DOI 10.1073/pnas.1119641109; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Martinez-Fierro ML, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-326; Oakes B, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-109; Paprotka T, 2011, SCIENCE; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Russo G, 2008, J MED VIROL, V80, P2100, DOI 10.1002/jmv.21312; Sato E, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-110; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; SEIF I, 1979, CELL, V18, P963, DOI 10.1016/0092-8674(79)90209-5; Sfanos KS, 2008, PROSTATE, V68, P306, DOI 10.1002/pros.20680; Sutcliffe S, 2010, FUTURE ONCOL, V6, P1289, DOI 10.2217/FON.10.95; Sutcliffe S, 2009, INT J CANCER, V124, P2082, DOI 10.1002/ijc.24144; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Voisset C, 2008, MICROBIOL MOL BIOL R, V72, P157, DOI 10.1128/MMBR.00033-07	30	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34221	10.1371/journal.pone.0034221	http://dx.doi.org/10.1371/journal.pone.0034221			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470540	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000079
J	O'Donoghue, L; Rudnicka, AR; McClelland, JF; Logan, NS; Saunders, KJ				O'Donoghue, Lisa; Rudnicka, Alicja R.; McClelland, Julie F.; Logan, Nicola S.; Saunders, Kathryn J.			Visual Acuity Measures Do Not Reliably Detect Childhood Refractive Error - an Epidemiological Study	PLOS ONE			English	Article							SCHOOL-CHILDREN; HYPEROPIA; POPULATION; AMBLYOPIA	Purpose: To investigate the utility of uncorrected visual acuity measures in screening for refractive error in white school children aged 6-7-years and 12-13-years. Methods: The Northern Ireland Childhood Errors of Refraction (NICER) study used a stratified random cluster design to recruit children from schools in Northern Ireland. Detailed eye examinations included assessment of logMAR visual acuity and cycloplegic autorefraction. Spherical equivalent refractive data from the right eye were used to classify significant refractive error as myopia of at least 1DS, hyperopia as greater than +3.50DS and astigmatism as greater than 1.50DC, whether it occurred in isolation or in association with myopia or hyperopia. Results: Results are presented from 661 white 12-13-year-old and 392 white 6-7-year-old school-children. Using a cut-off of uncorrected visual acuity poorer than 0.20 logMAR to detect significant refractive error gave a sensitivity of 50% and specificity of 92% in 6-7-year-olds and 73% and 93% respectively in 12-13-year-olds. In 12-13-year-old children a cut-off of poorer than 0.20 logMAR had a sensitivity of 92% and a specificity of 91% in detecting myopia and a sensitivity of 41% and a specificity of 84% in detecting hyperopia. Conclusions: Vision screening using logMAR acuity can reliably detect myopia, but not hyperopia or astigmatism in school-age children. Providers of vision screening programs should be cognisant that where detection of uncorrected hyperopic and/or astigmatic refractive error is an aspiration, current UK protocols will not effectively deliver.	[O'Donoghue, Lisa; McClelland, Julie F.; Saunders, Kathryn J.] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Rudnicka, Alicja R.] Univ London, Div Populat Hlth Sci & Educ, London, England; [Logan, Nicola S.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	Ulster University; University of London; Aston University	O'Donoghue, L (corresponding author), Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland.	l.odonoghue@ulster.ac.uk	Logan, Nicola/ABC-9102-2020; O'Donoghue, Lisa/C-7460-2013; Saunders, Kathryn/C-2328-2013	Saunders, Kathryn/0000-0002-9289-5731; Logan, Nicola S/0000-0002-0538-9516; Rudnicka, Alicja R/0000-0003-0369-8574	College of Optometrists	College of Optometrists	This study was funded by the College of Optometrists (www.college-optometrists.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, UK NSC POL VIS DEF S; Atkinson J, 2007, OPTOMETRY VISION SCI, V84, P84, DOI 10.1097/OPX.0b013e318031b69a; Bodack MI, 2010, OPTOMETRY, V81, P476, DOI 10.1016/j.optm.2010.05.006; Colburn JD, 2010, J AAPOS, V14, P211, DOI 10.1016/j.jaapos.2010.02.006; Cotter SA, 2011, OPHTHALMOLOGY, V118, P2251, DOI 10.1016/j.ophtha.2011.06.032; Donahue SP, 2007, OPTOMETRY VISION SCI, V84, P110, DOI 10.1097/OPX.0b013e318031b09b; Donahue SP, 2003, J AAPOS, V7, P314, DOI 10.1016/S1091-8531(03)00182-4; Farbrother JE, 2008, BRIT J OPHTHALMOL, V92, P392, DOI 10.1136/bjo.2007.123497; Hall DMB, 2003, HLTH ALL CHILDREN, P230; Harvey EM, 2007, OPHTHALMOLOGY, V114, P2293, DOI 10.1016/j.ophtha.2007.03.021; Hazel CA, 2002, OPTOMETRY VISION SCI, V79, P788, DOI 10.1097/00006324-200212000-00011; Leone JF, 2010, ARCH OPHTHALMOL-CHIC, V128, P894, DOI 10.1001/archophthalmol.2010.134; Mallen EAH, 2001, OPHTHAL PHYSL OPT, V21, P101, DOI 10.1016/S0275-5408(00)00049-1; National Screening Committee, 2005, CHILD HLTH SUBGR REP; NHS Centre for Reviews and Dissemination, 1998, EFF HLTH CAR B EFF H, P42; O'Donoghue L, 2010, BRIT J OPHTHALMOL, V94, P1150, DOI 10.1136/bjo.2009.167965; O'Donoghue L, 2010, BRIT J OPHTHALMOL, V94, P1155, DOI 10.1136/bjo.2009.176040; O'Donoghue L, 2011, INVEST OPHTH VIS SCI, V52, P4048, DOI 10.1167/iovs.10-6100; Ohlsson J, 2001, ACTA OPHTHALMOL SCAN, V79, P589, DOI 10.1034/j.1600-0420.2001.790609.x; Rosner J, 1997, J Am Optom Assoc, V68, P648; Rudnicka AR, 2008, AM J CLIN NUTR, V87, P1392, DOI 10.1093/ajcn/87.5.1392; Schmid KL, 2002, VISION RES, V42, P239, DOI 10.1016/S0042-6989(01)00277-2; Shankar S, 2007, OPTOMETRY VISION SCI, V84, P1031, DOI 10.1097/OPX.0b013e318157a67a; Snowden SK, 1997, 9 CRD; Tong L, 2002, OPTOMETRY VISION SCI, V79, P650, DOI 10.1097/00006324-200210000-00011; Williams C, 2008, BRIT J OPHTHALMOL, V92, P959, DOI 10.1136/bjo.2007.134700; Williams WR, 2005, ARCH DIS CHILD, V90, P150, DOI 10.1136/adc.2003.046755; Zadnik K, 2003, OPTOMETRY VISION SCI, V80, P226, DOI 10.1097/00006324-200303000-00012	28	46	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34441	10.1371/journal.pone.0034441	http://dx.doi.org/10.1371/journal.pone.0034441			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470571	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000304489000110
J	Rodondi, N; Locatelli, I; Aujesky, D; Butler, J; Vittinghoff, E; Simonsick, E; Satterfield, S; Newman, AB; Wilson, PWF; Pletcher, MJ; Bauer, DC				Rodondi, Nicolas; Locatelli, Isabella; Aujesky, Drahomir; Butler, Javed; Vittinghoff, Eric; Simonsick, Eleanor; Satterfield, Suzanne; Newman, Anne B.; Wilson, Peter W. F.; Pletcher, Mark J.; Bauer, Douglas C.		Hlth ABC Study	Framingham Risk Score and Alternatives for Prediction of Coronary Heart Disease in Older Adults	PLOS ONE			English	Article							ARTERY CALCIUM SCORE; CARDIOVASCULAR EVENTS; MORTALITY; ASSOCIATION; INFLAMMATION; VALIDATION; MARKERS; MODELS; HEALTH; IMPACT	Background: Guidelines for the prevention of coronary heart disease (CHD) recommend use of Framingham-based risk scores that were developed in white middle-aged populations. It remains unclear whether and how CHD risk prediction might be improved among older adults. We aimed to compare the prognostic performance of the Framingham risk score (FRS), directly and after recalibration, with refit functions derived from the present cohort, as well as to assess the utility of adding other routinely available risk parameters to FRS. Methods: Among 2193 black and white older adults (mean age, 73.5 years) without pre-existing cardiovascular disease from the Health ABC cohort, we examined adjudicated CHD events, defined as incident myocardial infarction, CHD death, and hospitalization for angina or coronary revascularization. Results: During 8-year follow-up, 351 participants experienced CHD events. The FRS poorly discriminated between persons who experienced CHD events vs. not (C-index: 0.577 in women; 0.583 in men) and underestimated absolute risk prediction by 51% in women and 8% in men. Recalibration of the FRS improved absolute risk prediction, particulary for women. For both genders, refitting these functions substantially improved absolute risk prediction, with similar discrimination to the FRS. Results did not differ between whites and blacks. The addition of lifestyle variables, waist circumference and creatinine did not improve risk prediction beyond risk factors of the FRS. Conclusions: The FRS underestimates CHD risk in older adults, particularly in women, although traditional risk factors remain the best predictors of CHD. Re-estimated risk functions using these factors improve accurate estimation of absolute risk.	[Rodondi, Nicolas; Aujesky, Drahomir] Univ Bern, Inselspital, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Locatelli, Isabella] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Locatelli, Isabella] Univ Lausanne, Univ Inst Social & Prevent Med, Lausanne, Switzerland; [Butler, Javed] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA; [Vittinghoff, Eric; Pletcher, Mark J.; Bauer, Douglas C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Simonsick, Eleanor] NIA, Intramural Res Program, Baltimore, MD 21224 USA; [Satterfield, Suzanne] Univ Tennessee, Coll Med, Dept Prevent Med, Memphis, TN USA; [Newman, Anne B.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Wilson, Peter W. F.] Emory Clin Cardiovasc Res Inst, Atlanta, GA USA; [Pletcher, Mark J.; Bauer, Douglas C.] Univ Calif San Francisco, Dept Med, Div Gen Internal Med, San Francisco, CA USA	University of Bern; University Hospital of Bern; University of Lausanne; University of Lausanne; Emory University; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Tennessee System; University of Tennessee Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco	Rodondi, N (corresponding author), Univ Bern, Inselspital, Dept Gen Internal Med, CH-3010 Bern, Switzerland.	Nicolas.Rodondi@insel.ch	Newman, Anne B./C-6408-2013; Wilson, Peter W.F./J-2455-2016; Simonsick, Eleanor/W-6864-2019	Newman, Anne B./0000-0002-0106-1150; Rodondi, Nicolas/0000-0001-9083-6896	NIAMS NIH HHS [K24 AR051895] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR051895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000015] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aktas MK, 2004, JAMA-J AM MED ASSOC, V292, P1462, DOI 10.1001/jama.292.12.1462; Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Butler J, 2006, J AM COLL CARDIOL, V47, P1595, DOI 10.1016/j.jacc.2005.12.046; Calonge N, 2009, ANN INTERN MED, V150, P396; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P101; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; de Ruijter W, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3083; Empana JP, 2003, EUR HEART J, V24, P1903, DOI 10.1016/j.ehj.2003.09.002; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; Ioannidis JPA, 2010, JAMA-J AM MED ASSOC, V303, P1646, DOI 10.1001/jama.2010.503; Lee CD, 2004, CIRCULATION, V109, P855, DOI 10.1161/01.CIR.0000116389.61864.DE; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Maraldi C, 2006, ARCH INTERN MED, V166, P1490, DOI 10.1001/archinte.166.14.1490; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; Parzen M, 1999, BIOMETRICS, V55, P580, DOI 10.1111/j.0006-341X.1999.00580.x; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Psaty BM, 2004, J AM GERIATR SOC, V52, P1639, DOI 10.1111/j.1532-5415.2004.52455.x; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; Rodondi N, 2010, AM J EPIDEMIOL, V171, P540, DOI 10.1093/aje/kwp428; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; 2003, MMWR MORB MORTAL WKL, V52, P106	34	62	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34287	10.1371/journal.pone.0034287	http://dx.doi.org/10.1371/journal.pone.0034287			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470551	gold, Green Published, Green Accepted			2022-12-27	WOS:000304489000090
J	Schut, ES; Brouwer, MC; Scarborough, M; Nguyen, THM; Thwaites, GE; Farrar, JJ; Reitsma, JB; van de Beek, D				Schut, Ewout S.; Brouwer, Matthijs C.; Scarborough, Matthew; Nguyen Thi Hoang Mai; Thwaites, Guy E.; Farrar, Jeremy J.; Reitsma, Johannes B.; van de Beek, Diederik			Validation of a Dutch Risk Score Predicting Poor Outcome in Adults with Bacterial Meningitis in Vietnam and Malawi	PLOS ONE			English	Article							PNEUMOCOCCAL MENINGITIS; STREPTOCOCCUS-SUIS; PROSPECTIVE COHORT; CLINICAL-FEATURES; DEXAMETHASONE; LEUKOCYTE; DIAGNOSIS	We have previously developed and validated a prognostic model to predict the risk for unfavorable outcome in Dutch adults with bacterial meningitis. The aim of the current study was to validate this model in adults with bacterial meningitis from two developing countries, Vietnam and Malawi. Demographic and clinical characteristics of Vietnamese (n = 426), Malawian patients (n = 465) differed substantially from those of Dutch patients (n = 696). The Dutch model underestimated the risk of poor outcome in both Malawi and Vietnam. The discrimination of the original model (c-statistic [c] 0.84; 95% confidence interval 0.81 to 0.86) fell considerably when re-estimated in the Vietnam cohort (c = 0.70) or in the Malawian cohort (c = 0.68). Our validation study shows that new prognostic models have to be developed for these countries in a sufficiently large series of unselected patients.	[Schut, Ewout S.; Brouwer, Matthijs C.; van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Scarborough, Matthew] John Radcliffe Hosp, Dept Med, Oxford OX3 9DU, England; [Nguyen Thi Hoang Mai; Farrar, Jeremy J.] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Thwaites, Guy E.] Kings Coll London, Dept Infect Dis, Ctr Clin Infect & Diagnost Res, London WC2R 2LS, England; [Reitsma, Johannes B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Oxford; University of Oxford; University of London; King's College London; University of Amsterdam; Academic Medical Center Amsterdam	Schut, ES (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	Farrar, Jeremy J./HGA-7610-2022; van de Beek, Diederik/Y-2713-2019; Thwaites, Guy E/R-4993-2019	van de Beek, Diederik/0000-0002-4571-044X; Thwaites, Guy E/0000-0002-2858-2087; Scarborough, Matthew/0000-0002-0455-0785; Reitsma, Johannes/0000-0003-4026-4345; Farrar, Jeremy/0000-0002-2700-623X				Brouwer MC, 2010, NEUROLOGY, V75, P1533, DOI 10.1212/WNL.0b013e3181f96297; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; de Gans J, 2002, NEW ENGL J MED, V347, P1549, DOI 10.1056/NEJMoa021334; Ganiem AR, 2009, AIDS, V23, P2309, DOI 10.1097/QAD.0b013e3283320de8; GIAMPAOLO C, 1981, ANN NEUROL, V9, P328, DOI 10.1002/ana.410090403; Heckenberg SGB, 2012, CLIN MICROBIOL INFEC, V18, P849, DOI 10.1111/j.1469-0691.2011.03668.x; Hoogman M, 2007, J NEUROL NEUROSUR PS, V78, P1092, DOI 10.1136/jnnp.2006.110023; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Mai NTH, 2007, NEW ENGL J MED, V357, P2431, DOI 10.1056/NEJMoa070852; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Scarborough M, 2008, LANCET NEUROL, V7, P637, DOI 10.1016/S1474-4422(08)70139-X; Scarborough M, 2007, NEW ENGL J MED, V357, P2441, DOI 10.1056/NEJMoa065711; Torok ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001772; van de Beek D, 2006, NEW ENGL J MED, V354, P44, DOI 10.1056/NEJMra052116; van de Beek D, 2004, NEW ENGL J MED, V351, P1849, DOI 10.1056/NEJMoa040845; van de Beek D, 2002, J INFECT DIS, V186, P1047, DOI 10.1086/344229; van de Beek D, 2010, LANCET NEUROL, V9, P254, DOI 10.1016/S1474-4422(10)70023-5; Weisfelt M, 2006, LANCET NEUROL, V5, P123, DOI 10.1016/S1474-4422(05)70288-X; Weisfelt M, 2008, ANN NEUROL, V63, P90, DOI 10.1002/ana.21216; Weisfelt M, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-149; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973	21	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34311	10.1371/journal.pone.0034311	http://dx.doi.org/10.1371/journal.pone.0034311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470555	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000094
J	Stark, JH; Sharma, R; Ostroff, S; Cummings, DAT; Ermentrout, B; Stebbins, S; Burke, DS; Wisniewski, SR				Stark, James H.; Sharma, Ravi; Ostroff, Stephen; Cummings, Derek A. T.; Ermentrout, Bard; Stebbins, Samuel; Burke, Donald S.; Wisniewski, Stephen R.			Local Spatial and Temporal Processes of Influenza in Pennsylvania, USA: 2003-2009	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; UNITED-STATES; VIRAL-INFECTIONS; CLIMATE FACTORS; RISK-FACTORS; VACCINATION; TRANSMISSION; MORTALITY; DYNAMICS; CHILDREN	Background: Influenza is a contagious respiratory disease responsible for annual seasonal epidemics in temperate climates. An understanding of how influenza spreads geographically and temporally within regions could result in improved public health prevention programs. The purpose of this study was to summarize the spatial and temporal spread of influenza using data obtained from the Pennsylvania Department of Health's influenza surveillance system. Methodology and Findings: We evaluated the spatial and temporal patterns of laboratory-confirmed influenza cases in Pennsylvania, United States from six influenza seasons (2003-2009). Using a test of spatial autocorrelation, local clusters of elevated risk were identified in the South Central region of the state. Multivariable logistic regression indicated that lower monthly precipitation levels during the influenza season (OR = 0.52, 95% CI: 0.28, 0.94), fewer residents over age 64 (OR = 0.27, 95% CI: 0.10, 0.73) and fewer residents with more than a high school education (OR = 0.76, 95% CI: 0.61, 0.95) were significantly associated with membership in this cluster. In addition, time series analysis revealed a temporal lag in the peak timing of the influenza B epidemic compared to the influenza A epidemic. Conclusions: These findings illustrate a distinct spatial cluster of cases in the South Central region of Pennsylvania. Further examination of the regional transmission dynamics within these clusters may be useful in planning public health influenza prevention programs.	[Stark, James H.] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA; [Sharma, Ravi] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Behav & Community Hlth Sci, Pittsburgh, PA USA; [Ostroff, Stephen] Penn Dept Hlth, Bur Epidemiol, Harrisburg, PA 17108 USA; [Cummings, Derek A. T.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Ermentrout, Bard] Univ Pittsburgh, Sch Arts & Sci, Dept Math, Pittsburgh, PA USA; [Stebbins, Samuel; Burke, Donald S.; Wisniewski, Stephen R.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	New York City Department of Health & Mental Hygiene; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Stark, JH (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.	jstark@health.nyc.gov	Stark, James/A-2895-2019	Stark, James/0000-0002-0728-876X; /0000-0002-5704-8094; Wisniewski, Stephen/0000-0002-3877-9860	National Institute of General Medical Sciences [U01 GM070708-05]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491, U01GM070708] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institute of General Medical Sciences (Grant Number: U01 GM070708-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; [Anonymous], 2008, AR RES FIL ARF; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Assuncao RM, 1999, STAT MED, V18, P2147, DOI 10.1002/(SICI)1097-0258(19990830)18:16<2147::AID-SIM179>3.0.CO;2-I; *CDC, 2009, FLU ACT SURV; Centers for Disease Control and Prevention, 1995, BEH RISK FACT SURV S; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P631; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Chew FT, 1998, EPIDEMIOL INFECT, V121, P121, DOI 10.1017/S0950268898008905; Crighton EJ, 2007, EPIDEMIOL INFECT, V135, P253, DOI 10.1017/S095026880600690X; DEARRUDA E, 1991, J INFECT DIS, V164, P252, DOI 10.1093/infdis/164.2.252; Epperson S., 2008, Morbidity and Mortality Weekly Report, V57, P692; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Greene SK, 2006, AM J EPIDEMIOL, V163, P316, DOI 10.1093/aje/kwj040; Jia HM, 2006, AM J PREV MED, V31, P275, DOI 10.1016/j.amepre.2006.06.005; Koch A, 2003, AM J EPIDEMIOL, V158, P374, DOI 10.1093/aje/kwg143; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Maune D.F., 2007, NAT EL DAT, VSecond edition, P99; Merrill RM, 2009, MED SCI MONITOR, V15, pPH92; Mugglin AS, 2002, STAT MED, V21, P2703, DOI 10.1002/sim.1217; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; Onozuka D, 2008, EPIDEMIOLOGY, V19, P824, DOI 10.1097/EDE.0b013e3181880eda; Paget J, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-141; Pennsylvania Department of Health, 2009, PA NAT EL DIS SURV S; Pennsylvania Department of Transportation, 2010, PENNS HIGHW STAT; Proff R, 2009, EMERG INFECT DIS, V15, P892, DOI 10.3201/eid1506.081645; Sakai T, 2004, EMERG INFECT DIS, V10, P1822, DOI 10.3201/eid1010.040147; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; SULLIVAN KM, 1993, AM J PUBLIC HEALTH, V83, P1712, DOI 10.2105/AJPH.83.12.1712; Tang JW, 2010, EPIDEMIOL INFECT, V138, P226, DOI 10.1017/S0950268809990410; Tang JW, 2010, J MED VIROL, V82, P1958, DOI 10.1002/jmv.21892; U.S. Census Bureau, 2000, CENS 2000; United States Geological Service, 2010, NAT EL DAT; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2004, EUR J EPIDEMIOL, V19, P1055, DOI 10.1007/s10654-004-2450-9; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Viboud C, 2004, EMERG INFECT DIS, V10, P32, DOI 10.3201/eid1001.020705; Waller L.A., 2004, APPL SPATIAL STAT PU; Wenger JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010187; Weycker D, 2005, VACCINE, V23, P1284, DOI 10.1016/j.vaccine.2004.08.044	47	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34245	10.1371/journal.pone.0034245	http://dx.doi.org/10.1371/journal.pone.0034245			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470544	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000304489000083
J	Brooks, SJ; O'Daly, O; Uher, R; Friederich, HC; Giampietro, V; Brammer, M; Williams, SCR; Schioth, HB; Treasure, J; Campbell, IC				Brooks, Samantha J.; O'Daly, Owen; Uher, Rudolf; Friederich, Hans-Christoph; Giampietro, Vincent; Brammer, Michael; Williams, Steven C. R.; Schioth, Helgi B.; Treasure, Janet; Campbell, Iain C.			Thinking about Eating Food Activates Visual Cortex with Reduced Bilateral Cerebellar Activation in Females with Anorexia Nervosa: An fMRI Study	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; PREFRONTAL CORTEX; BRAIN HYPOMETABOLISM; STATISTICAL-ANALYSIS; RESTRICTING-TYPE; ANTERIOR INSULA; DISORDERS; STIMULI; ANXIETY; GLUCOSE	Background: Women with anorexia nervosa (AN) have aberrant cognitions about food and altered activity in prefrontal cortical and somatosensory regions to food images. However, differential effects on the brain when thinking about eating food between healthy women and those with AN is unknown. Methods: Functional magnetic resonance imaging (fMRI) examined neural activation when 42 women thought about eating the food shown in images: 18 with AN (11 RAN, 7 BPAN) and 24 age-matched controls (HC). Results: Group contrasts between HC and AN revealed reduced activation in AN in the bilateral cerebellar vermis, and increased activation in the right visual cortex. Preliminary comparisons between AN subtypes and healthy controls suggest differences in cortical and limbic regions. Conclusions: These preliminary data suggest that thinking about eating food shown in images increases visual and prefrontal cortical neural responses in females with AN, which may underlie cognitive biases towards food stimuli and ruminations about controlling food intake. Future studies are needed to explicitly test how thinking about eating activates restraint cognitions, specifically in those with restricting vs. binge-purging AN subtypes.	[Brooks, Samantha J.; Schioth, Helgi B.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [O'Daly, Owen; Giampietro, Vincent; Brammer, Michael; Williams, Steven C. R.] Kings Coll London, Inst Psychiat, Ctr Neuroimaging Sci, Dept Neuroimaging, London WC2R 2LS, England; [Brooks, Samantha J.; Uher, Rudolf; Treasure, Janet; Campbell, Iain C.] Kings Coll London, Inst Psychiat, Sect Eating Disorders, Dept Psychol Med, London WC2R 2LS, England; [Friederich, Hans-Christoph] Ctr Psychosocial Med, Heidelberg, Germany	Uppsala University; University of London; King's College London; University of London; King's College London	Brooks, SJ (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	Samantha.brooks@neuro.uu.se	O'Daly, Owen G/A-2369-2013; Williams, Steve C/D-6979-2011; Brooks, Samantha/AAJ-2159-2020; Uher, Rudolf/A-5477-2008; Giampietro, Vincent P/D-1279-2011; Brammer, Michael J/B-7128-2012; Schioth, Helgi/AAQ-7239-2020	Williams, Steve C/0000-0003-4299-1941; Uher, Rudolf/0000-0002-2998-0546; Giampietro, Vincent P/0000-0002-9381-8201; Brammer, Michael J/0000-0001-9800-2052; Treasure, Janet/0000-0003-0871-4596; Brooks, Samantha/0000-0002-9146-6257; opoku, anita/0000-0001-7243-8157	Research Into Eating Disorders (RIED); Psychiatry Research Trust (PRT), Institute of Psychiatry, UK; Medical Research Council [G9817803B] Funding Source: researchfish	Research Into Eating Disorders (RIED); Psychiatry Research Trust (PRT), Institute of Psychiatry, UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Samantha Brooks was supported by the Nina Jackson Fellowship, Research Into Eating Disorders (RIED) and by the Psychiatry Research Trust (PRT), Institute of Psychiatry, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association A, 2002, DIAGN STAT MAN VERS; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beato-Fernandez L, 2009, PSYCHIAT RES-NEUROIM, V171, P129, DOI 10.1016/j.pscychresns.2008.01.001; Berridge KC, 2010, BRAIN RES, V1350, P43, DOI 10.1016/j.brainres.2010.04.003; Brammer M, 2003, STAT METHODS MED RES, V12, P373, DOI 10.1191/0962280203sm344ed; Brammer MJ, 1998, HUM BRAIN MAPP, V6, P378, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<378::AID-HBM9>3.0.CO;2-7; Brooks S, 2011, CLIN PSYCHOL REV, V31, P37, DOI 10.1016/j.cpr.2010.09.006; Brooks SJ, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-179; Brooks SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022259; BRUCH H, 1962, PSYCHOSOM MED, V24, P187, DOI 10.1097/00006842-196203000-00009; Bullmore ET, 2003, STAT METHODS MED RES, V12, P375, DOI 10.1191/0962280203sm339ra; Burger KS, 2011, NEUROIMAGE, V55, P233, DOI 10.1016/j.neuroimage.2010.12.009; Carnell S, 2011, OBES REV; Chowdhury U, 2003, INT J EAT DISORDER, V33, P388, DOI 10.1002/eat.10155; Cornier MA, 2010, PHYSIOL BEHAV, V99, P538, DOI 10.1016/j.physbeh.2010.01.008; Cowdrey FA, 2011, BIOL PSYCHIAT, V70, P736, DOI 10.1016/j.biopsych.2011.05.028; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; DELVENNE V, 1995, BIOL PSYCHIAT, V37, P161, DOI 10.1016/0006-3223(94)00189-A; Delvenne V, 1996, BIOL PSYCHIAT, V40, P761, DOI 10.1016/0006-3223(95)00522-6; Desmond JE, 2002, J NEUROSCI METH, V118, P115, DOI 10.1016/S0165-0270(02)00121-8; Ellinson Z, 1998, LANCET, V352, P1192, DOI 10.1016/S0140-6736(05)60529-6; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Fairburn CG, 2003, LANCET, V361, P407, DOI 10.1016/S0140-6736(03)12378-1; FAIRBURN CG, 1994, INT J EAT DISORDER, V16, P363; Fassino Secondo, 2006, Transcult Psychiatry, V43, P600, DOI 10.1177/1363461506070785; First M. B., 2001, USERS GUIDE STRUCTUR; Friederich HC, 2011, CURR TOP BEHAV NEURO, V6, P111, DOI 10.1007/7854_2010_83; Friederich HC, 2010, NEUROPSYCHOLOGIA, V48, P2878, DOI 10.1016/j.neuropsychologia.2010.04.036; Fusar-Poli P, 2010, J CLIN NEUROSCI, V17, P311, DOI 10.1016/j.jocn.2009.06.027; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Gizewski ER, 2010, NEUROPSYCHOBIOLOGY, V62, P182, DOI 10.1159/000319360; Goldstone AP, 2009, EUR J NEUROSCI, V30, P1625, DOI 10.1111/j.1460-9568.2009.06949.x; Gordon CM, 2001, J PEDIATR-US, V139, P51, DOI 10.1067/mpd.2001.114768; Gordon I, 1997, INT J EAT DISORDER, V22, P159; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Hambrook D, 2010, BR J CLIN PSYCHOL; HERHOLZ K, 1987, BIOL PSYCHIAT, V22, P43, DOI 10.1016/0006-3223(87)90128-4; Higgs S, 2008, PHYSIOL BEHAV, V94, P734, DOI 10.1016/j.physbeh.2008.04.012; Hildebrandt T, 2010, EUR EAT DISORD REV; Hollmann M., 2011, INT J OBES LOND; Jacobi C, 2004, PSYCHOL BULL, V130, P19, DOI 10.1037/0033-2909.130.1.19; Joos AAB, 2011, PSYCHIAT RES-NEUROIM, V191, P189, DOI 10.1016/j.pscychresns.2010.11.008; Kaye WH, 2011, CURR TOP BEHAV NEURO, V6, P37, DOI 10.1007/7854_2010_85; Kaye WH, 2009, NAT REV NEUROSCI, V10, P573, DOI 10.1038/nrn2682; Kent Justine M, 2003, Curr Psychiatry Rep, V5, P266, DOI 10.1007/s11920-003-0055-8; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Killgore WDS, 2005, NEUROREPORT, V16, P859, DOI 10.1097/00001756-200505310-00016; Kojima S, 2005, PSYCHIAT RES-NEUROIM, V140, P251, DOI 10.1016/j.pscychresns.2005.08.002; KRIEG JC, 1989, BIOL PSYCHIAT, V25, P1041, DOI 10.1016/0006-3223(89)90292-8; Kuruoglu AC, 1998, J NUCL MED, V39, P304; Lask B, 2005, INT J EAT DISORDER, V37, pS49, DOI 10.1002/eat.20117; Linden DEJ, 2006, MOL PSYCHIATR, V11, P528, DOI 10.1038/sj.mp.4001816; MAHLER P, 1993, PHYSIOL BEHAV, V54, P1063, DOI 10.1016/0031-9384(93)90325-A; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Naruo T, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-2; Nunn K, 2008, EUR EAT DISORD REV, V16, P355, DOI 10.1002/erv.890; Nunn K, 2011, MED HYPOTHESES, V76, P353, DOI 10.1016/j.mehy.2010.10.038; Oldershaw A, 2010, PSYCHOSOM MED, V72, P73, DOI 10.1097/PSY.0b013e3181c6c7ca; Pallister E, 2008, CLIN PSYCHOL REV, V28, P366, DOI 10.1016/j.cpr.2007.07.001; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Pietrini F, 2011, EUR PSYCHIAT, V26, P176, DOI 10.1016/j.eurpsy.2010.07.011; Santel S, 2006, BRAIN RES, V1114, P138, DOI 10.1016/j.brainres.2006.07.045; SCALERA G, 1991, J PHYSIOL-PARIS, V85, P214; Sehlmeyer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005865; Siep N, 2009, BEHAV BRAIN RES, V198, P149, DOI 10.1016/j.bbr.2008.10.035; Sinnett S, 2009, EXP BRAIN RES, V194, P191, DOI 10.1007/s00221-008-1687-z; Swinbourne JM, 2007, EUR EAT DISORD REV, V15, P253, DOI 10.1002/erv.784; Takano A, 2001, PSYCHIAT RES-NEUROIM, V107, P45, DOI 10.1016/S0925-4927(01)00093-2; Thirion B, 2007, IEEE T MED IMAGING, V26, P1256, DOI 10.1109/TMI.2007.903226; Tops M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00330; Uher R, 2004, AM J PSYCHIAT, V161, P1238, DOI 10.1176/appi.ajp.161.7.1238; Uher R, 2003, BIOL PSYCHIAT, V54, P934, DOI 10.1016/S0006-3223(03)00172-0; Van den Eynde F, 2010, BIOL PSYCHIAT, V67, P793, DOI 10.1016/j.biopsych.2009.11.023; Van Den Eynde F, 2009, CHILD ADOL PSYCH CL, V18, P95, DOI 10.1016/j.chc.2008.07.016; van Kuyck K, 2009, J PSYCHIATR RES, V43, P1133, DOI 10.1016/j.jpsychires.2009.04.005; Vanderhasselt MA, 2009, PSYCHON B REV, V16, P609, DOI 10.3758/PBR.16.3.609; Vocks S, 2011, PSYCHOL MED, V41, P1651, DOI 10.1017/S0033291710002382; Vocks S, 2010, PSYCHIAT RES-NEUROIM, V183, P114, DOI 10.1016/j.pscychresns.2010.05.011; Wagner A, 2003, NEUROREPORT, V14, P2193, DOI 10.1097/00001756-200312020-00012; Wagner A, 2008, NEUROPSYCHOPHARMACOL, V33, P513, DOI 10.1038/sj.npp.1301443; Wagner A, 2007, AM J PSYCHIAT, V164, P1842, DOI 10.1176/appi.ajp.2007.07040575; Wallis JD, 2011, ANN NY ACAD SCI, V1239, P33, DOI 10.1111/j.1749-6632.2011.06277.x; Yonezawa H, 2008, PSYCHIAT CLIN NEUROS, V62, P26, DOI 10.1111/j.1440-1819.2007.01769.x; Yonezawa LA, 2005, J VET MED A, V52, P292, DOI 10.1111/j.1439-0442.2005.00732.x; Zhu JN, 2008, CELL MOL NEUROBIOL, V28, P469, DOI 10.1007/s10571-007-9236-z; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	87	59	59	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34000	10.1371/journal.pone.0034000	http://dx.doi.org/10.1371/journal.pone.0034000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479499	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900057
J	Fehling, J; Davidson, K; Bolch, CJS; Brand, TD; Narayanaswamy, BE				Fehling, Johanna; Davidson, Keith; Bolch, Christopher J. S.; Brand, Tim D.; Narayanaswamy, Bhavani E.			The Relationship between Phytoplankton Distribution and Water Column Characteristics in North West European Shelf Sea Waters	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; DIATOM NITZSCHIA-PUNGENS; DOMOIC ACID PRODUCTION; NE ATLANTIC; SERIATA BACILLARIOPHYCEAE; MARINE DIATOMS; NUTRIENT; COASTAL; GROWTH; SHELLFISH	Phytoplankton underpin the marine food web in shelf seas, with some species having properties that are harmful to human health and coastal aquaculture. Pressures such as climate change and anthropogenic nutrient input are hypothesized to influence phytoplankton community composition and distribution. Yet the primary environmental drivers in shelf seas are poorly understood. To begin to address this in North Western European waters, the phytoplankton community composition was assessed in light of measured physical and chemical drivers during the "Ellett Line" cruise of autumn 2001 across the Scottish Continental shelf and into adjacent open Atlantic waters. Spatial variability existed in both phytoplankton and environmental conditions, with clear differences not only between on and off shelf stations but also between different on shelf locations. Temperature/salinity plots demonstrated different water masses existed in the region. In turn, principal component analysis (PCA), of the measured environmental conditions (temperature, salinity, water density and inorganic nutrient concentrations) clearly discriminated between shelf and oceanic stations on the basis of DIN:DSi ratio that was correlated with both salinity and temperature. Discrimination between shelf stations was also related to this ratio, but also the concentration of DIN and DSi. The phytoplankton community was diatom dominated, with multidimensional scaling (MDS) demonstrating spatial variability in its composition. Redundancy analysis (RDA) was used to investigate the link between environment and the phytoplankton community. This demonstrated a significant relationship between community composition and water mass as indexed by salinity (whole community), and both salinity and DIN: DSi (diatoms alone). Diatoms of the Pseudo-nitzschia seriata group occurred at densities potentially harmful to shellfish aquaculture, with the potential for toxicity being elevated by the likelihood of DSi limitation of growth at most stations and depths.	[Fehling, Johanna; Davidson, Keith; Brand, Tim D.; Narayanaswamy, Bhavani E.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Fehling, Johanna] Uppsala Univ, Dept Evolut Genom & Systemat, Evolutionary Biol Ctr, Uppsala, Sweden; [Bolch, Christopher J. S.] Univ Tasmania, Australian Maritime Coll, Natl Ctr Marine Conservat & Resource Sustainabil, Launceston, Tas 7250, Australia	UHI Millennium Institute; Uppsala University; University of Tasmania		Keith.Davidson@sams.ac.uk	Davidson, Keith/A-5474-2013; Bolch, Christopher J/J-7619-2014	Davidson, Keith/0000-0001-9269-3227; Bolch, Christopher J/0000-0001-9047-2391; Narayanaswamy, Bhavani/0000-0002-5810-9127	University of Highlands and Islands; Scottish Association for Marine Science/Natural Environmental Research Council; Natural Environment Research Council [dml011001] Funding Source: researchfish; NERC [dml011001] Funding Source: UKRI	University of Highlands and Islands; Scottish Association for Marine Science/Natural Environmental Research Council; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was funded by a University of the Highlands and Islands studentship (JF) and Scottish Association for Marine Science/Natural Environmental Research Council Oceans 2025 research funds (KD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT LJ, 1993, AQUACULTURE, V117, P215, DOI 10.1016/0044-8486(93)90321-O; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; BATES SS, 1991, CAN J FISH AQUAT SCI, V48, P1136, DOI 10.1139/f91-137; BATES SS, 1989, CAN J FISH AQUAT SCI, V46, P1203, DOI 10.1139/f89-156; Baxter JM, 2011, SCOTLANDS MARNE ATLA; Bresnan E, 2010, 201011 MCCIP; BRZEZINSKI MA, 1985, J PHYCOL, V21, P347; CADEE GC, 1986, NETH J SEA RES, V20, P29, DOI 10.1016/0077-7579(86)90058-X; Campbell DA, 2001, J SHELLFISH RES, V20, P75; Davidson K, 2006, AFR J MAR SCI, V28, P357, DOI 10.2989/18142320609504177; Davidson K, 1999, J PLANKTON RES, V21, P839, DOI 10.1093/plankt/21.5.839; Davidson K, 1996, LIMNOL OCEANOGR, V41, P779, DOI 10.4319/lo.1996.41.4.0779; Davidson K., 2010, 7 INT C MOLL SHELF S, P173; Davidson K, 2007, LIMNOL OCEANOGR, V52, P2147, DOI 10.4319/lo.2007.52.5.2147; Davidson K, 2011, ISS ENVIRON SCI TECH, V33, P95; Davidson K, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S12; Davidson K, 2009, HARMFUL ALGAE, V8, P349, DOI 10.1016/j.hal.2008.07.007; Dearman JR, 2003, MAR ECOL PROG SER, V250, P13, DOI 10.3354/meps250013; DODGE JD, 1994, REV PALAEOBOT PALYNO, V84, P169, DOI 10.1016/0034-6667(94)90049-3; DODGE JD, 1994, J PHYCOL, V30, P905, DOI 10.1111/j.0022-3646.1994.00905.x; Edwards M, 2006, LIMNOL OCEANOGR, V51, P820, DOI 10.4319/lo.2006.51.2.0820; Edwards M, 2001, ICES J MAR SCI, V58, P39, DOI 10.1006/jmsc.2000.0987; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; Ellett DJ, 1979, P ROYAL SOC EDIN B, V77B, P1; Fehling J, 2005, HARMFUL ALGAE, V4, P763, DOI 10.1016/j.hal.2004.11.002; Fehling J, 2004, J PHYCOL, V40, P622, DOI 10.1111/j.1529-8817.2004.03200.x; Fehling J, 2006, MAR ECOL PROG SER, V323, P91, DOI 10.3354/meps323091; Gilpin LC, 2004, J SEA RES, V51, P21, DOI 10.1016/j.seares.2003.05.005; Gowen RJ, 2005, J SEA RES, V54, P36, DOI 10.1016/j.seares.2005.02.003; Gowen RJ, 1998, ICES J MAR SCI, V55, P1095, DOI 10.1006/jmsc.1998.0418; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hasle G.R., 1965, SKR NOR VIDENSK AKAD, V18, P1; Hill AE, 1997, ESTUAR COAST SHELF S, V45, P473, DOI 10.1006/ecss.1996.0198; Hodgkiss IJ, 1997, HYDROBIOLOGIA, V352, P141, DOI 10.1023/A:1003046516964; HOLLIGAN PM, 1980, J MAR BIOL ASSOC UK, V60, P851, DOI 10.1017/S0025315400041941; Humborg C, 2008, J MARINE SYST, V73, P221, DOI 10.1016/j.jmarsys.2007.12.003; Jeffrey S. W., 1996, PHYTOPLANKTON PIGMEN; JONES KJ, 1990, ESTUAR COAST SHELF S, V30, P557, DOI 10.1016/0272-7714(90)90092-6; Lonborg C, 2009, ESTUAR COAST SHELF S, V82, P682, DOI 10.1016/j.ecss.2009.02.026; MCKAY WA, 1986, J ENVIRON RADIOACTIV, V4, P205, DOI 10.1016/0265-931X(86)90011-1; Narvarro JM, 2006, HARMFUL ALGAE, V5, P726; O'Boyle S, P ROYAL IRISH ACAD, V107, P95; OFFICER CB, 1980, MAR ECOL PROG SER, V3, P83, DOI 10.3354/meps003083; OTT J. A., 1996, MEERESKUNDE; Pete R, 2010, J EXP MAR BIOL ECOL, V391, P20, DOI 10.1016/j.jembe.2010.06.002; Proctor R, 2003, SCI TOTAL ENVIRON, V314, P787, DOI 10.1016/S0048-9697(03)00084-6; Raine R, 2002, J PLANKTON RES, V24, P1131, DOI 10.1093/plankt/24.11.1131; Raine R, 2010, J MARINE SYST, V83, P150, DOI 10.1016/j.jmarsys.2010.05.001; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; RIEGMAN R, 1992, MAR BIOL, V112, P479, DOI 10.1007/BF00356293; Rippeth TP, 2005, PHILOS T R SOC A, V363, P2837, DOI 10.1098/rsta.2005.1662; SAVIDGE G, 1987, CONT SHELF RES, V7, P45, DOI 10.1016/0278-4343(87)90063-X; Smayda TJ, 2003, J SEA RES, V49, P95, DOI 10.1016/S1385-1101(02)00219-8; SOMMER U, 1994, MAR ECOL PROG SER, V115, P309, DOI 10.3354/meps115309; Swan S. C., 2010, MONITORING PROGRAMME; TETT P, 1992, P ROY SOC EDINB B, V100, P27, DOI 10.1017/S0269727000011052; TETT P, 1978, J ECOL, V66, P227, DOI 10.2307/2259190; TETT P, 1981, PHILOS T R SOC A, V302, P605, DOI 10.1098/rsta.1981.0186; Tett P, 2007, MAR POLLUT BULL, V55, P282, DOI 10.1016/j.marpolbul.2006.08.028; Touzet N, 2010, PROTIST, V161, P370, DOI 10.1016/j.protis.2009.12.001; Utermohl H., 1931, Verhandlungen der Internationalen Vereinigung fuer Theoretische Limnologie Stuttgart, V5, P567; Wells ML, 2005, LIMNOL OCEANOGR, V50, P1908, DOI 10.4319/lo.2005.50.6.1908; Yallop ML, 2001, DEEP-SEA RES PT II, V48, P825, DOI 10.1016/S0967-0645(00)00099-0	63	43	46	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34098	10.1371/journal.pone.0034098	http://dx.doi.org/10.1371/journal.pone.0034098			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479533	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900061
J	Janssen, N; Barber, HA				Janssen, Niels; Barber, Horacio A.			Phrase Frequency Effects in Language Production	PLOS ONE			English	Article							RECOGNITION; PROGRAM; MODELS; WORDS; ACQUISITION; FAMILIARITY; ACCESS; AGE	A classic debate in the psychology of language concerns the question of the grain-size of the linguistic information that is stored in memory. One view is that only morphologically simple forms are stored (e. g., 'car', 'red'), and that more complex forms of language such as multi-word phrases (e. g., 'red car') are generated on-line from the simple forms. In two experiments we tested this view. In Experiment 1, participants produced noun+adjective and noun+noun phrases that were elicited by experimental displays consisting of colored line drawings and two superimposed line drawings. In Experiment 2, participants produced noun+adjective and determiner+noun+adjective utterances elicited by colored line drawings. In both experiments, naming latencies decreased with increasing frequency of the multi-word phrase, and were unaffected by the frequency of the object name in the utterance. These results suggest that the language system is sensitive to the distribution of linguistic information at grain-sizes beyond individual words.	[Janssen, Niels; Barber, Horacio A.] Univ La Laguna, Dept Psicol Cognit Social & Org, E-38207 San Cristobal la Laguna, Santa Cruz De T, Spain	Universidad de la Laguna	Janssen, N (corresponding author), Univ La Laguna, Dept Psicol Cognit Social & Org, E-38207 San Cristobal la Laguna, Santa Cruz De T, Spain.	njanssen@ull.es	Barber, Horacio A./G-7438-2011; Janssen, Niels/L-2626-2015	Barber, Horacio A./0000-0001-9425-1633; Janssen, Niels/0000-0001-9770-4458	Spanish Ministry of Economy and Competitiveness [RYC-2011-08433, PSI2010-19767]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	The Spanish Ministry of Economy and Competitiveness supported this research with grant RYC-2011-08433 to NJ, and grant PSI2010-19767 to HAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alario FX, 2004, BEHAV RES METH INS C, V36, P140, DOI 10.3758/BF03195559; Alario FX, 2002, LANG COGNITIVE PROC, V17, P673, DOI 10.1080/01690960143000461; Alario FX, 2002, LANG COGNITIVE PROC, V17, P299, DOI 10.1080/01690960143000236; Almeida J, 2007, PSYCHON B REV, V14, P1177, DOI 10.3758/BF03193109; Arnon I, 2010, J MEM LANG, V62, P67, DOI 10.1016/j.jml.2009.09.005; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Baayen RH, 2011, PSYCHOL REV, V118, P438, DOI 10.1037/a0023851; Baayen RH, 2007, STORAGE COMPUTATION, P81; Balota DA, 2004, J EXP PSYCHOL GEN, V133, P283, DOI 10.1037/0096-3445.133.2.283; Bannard C, 2008, PSYCHOL SCI, V19, P241, DOI 10.1111/j.1467-9280.2008.02075.x; Bates E, 2003, PSYCHON B REV, V10, P344, DOI 10.3758/BF03196494; Bod R, 1998, GRAMMAR EXPERIENCE B; Bonin P, 2006, MEM COGNITION, V34, P1172, DOI 10.3758/BF03193263; Bybee J, 1999, LINGUISTICS, V37, P575, DOI 10.1515/ling.37.4.575; Bybee J, 2006, LANGUAGE, V82, P711, DOI 10.1353/lan.2006.0186; Cuetos F, 2011, PSICOLOGICA, V32, P133; Davis CJ, 2005, BEHAV RES METHODS, V37, P665, DOI 10.3758/BF03192738; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; Elman J. L., 2009, COGNITIVE SCI, V33, P547, DOI [DOI 10.1111/j.1551-6709.2009.01023.x, DOI 10.1111/J.1551-6709.2009.01023.X]; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Gahl S, 2006, LINGUIST REV, V23, P213, DOI 10.1515/TLR.2006.007; Ghyselinck M, 2004, J EXP PSYCHOL LEARN, V30, P550, DOI 10.1037/0278-7393.30.2.550; Goldberg AdeleE., 1995, CONSTRUCTIONS CONSTR; Goldinger SD, 1996, J EXP PSYCHOL LEARN, V22, P1166, DOI 10.1037/0278-7393.22.5.1166; Janssen N, 2009, SELECTION DETE UNPUB; Janssen N, 2008, PSYCHOL SCI, V19, P216, DOI 10.1111/j.1467-9280.2008.02070.x; Janssen N, 2009, PSYCHOL SCI, V20, P1262, DOI 10.1111/j.1467-9280.2009.02429.x; Janssen N, 2008, LANG COGNITIVE PROC, V23, P1191, DOI 10.1080/01690960802250900; Jurafsky D, 1996, COGNITIVE SCI, V20, P137, DOI 10.1207/s15516709cog2002_1; Keller F, 2003, COMPUT LINGUIST, V29, P459, DOI 10.1162/089120103322711604; Langacker R.W., 1987, FDN COGNITIVE GRAMMA; Levelt W.J., 1993, SPEAKING INTENTION A; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; McDonald SA, 2003, PSYCHOL SCI, V14, P648, DOI 10.1046/j.0956-7976.2003.psci_1480.x; MITCHELL DC, 1995, J PSYCHOLINGUIST RES, V24, P469, DOI 10.1007/BF02143162; MORTON J, 1969, PSYCHOL REV, V76, P165, DOI 10.1037/h0027366; Naor-Raz G, 2003, PERCEPTION, V32, P667, DOI 10.1068/p5050; New B, 2004, BEHAV RES METH INS C, V36, P516, DOI 10.3758/BF03195598; OLDFIELD RC, 1965, Q J EXP PSYCHOL, V17, P273, DOI 10.1080/17470216508416445; Pinker S, 2002, TRENDS COGN SCI, V6, P456, DOI 10.1016/S1364-6613(02)01990-3; Pinker S, 1998, LINGUA, V106, P219, DOI 10.1016/S0024-3841(98)00035-7; Protopapas A, 2007, BEHAV RES METHODS, V39, P859, DOI 10.3758/BF03192979; Reali F, 2007, J MEM LANG, V57, P1, DOI 10.1016/j.jml.2006.08.014; Rumelhart D.E., 1986, PARALLEL DISTRIBUTED, DOI DOI 10.7551/MITPRESS/5237.001.0001; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Seidenberg MS, 2000, TRENDS COGN SCI, V4, P353, DOI 10.1016/S1364-6613(00)01515-1; Sereno JA, 1997, MEM COGNITION, V25, P425, DOI 10.3758/BF03201119; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Siyanova-Chanturia A, 2011, J EXP PSYCHOL LEARN, V37, P776, DOI 10.1037/a0022531; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Sosa AV, 2002, BRAIN LANG, V83, P227, DOI 10.1016/S0093-934X(02)00032-9; Stadthagen-Gonzalez H, 2009, Q J EXP PSYCHOL, V62, P1581, DOI 10.1080/17470210802511139; Tomasello M., 2005, CONSTRUCTING LANGUAG; Tremblay Antoine, 2010, PERSPECTIVES FORMULA, P151; Vitevitch MS, 2006, LANG COGNITIVE PROC, V21, P760, DOI 10.1080/01690960500287196	55	59	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33202	10.1371/journal.pone.0033202	http://dx.doi.org/10.1371/journal.pone.0033202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	940MY	22479370	Green Submitted, Green Published, gold			2022-12-27	WOS:000303894900019
J	Ranneberg-Nilsen, T; Rollag, H; Slettebakk, R; Backe, PH; Olsen, O; Luna, L; Bjoras, M				Ranneberg-Nilsen, Toril; Rollag, Halvor; Slettebakk, Ragnhild; Backe, Paul Hoff; Olsen, Oyvind; Luna, Luisa; Bjoras, Magnar			The Chromatin Remodeling Factor SMARCB1 Forms a Complex with Human Cytomegalovirus Proteins UL114 and UL44	PLOS ONE			English	Article							POLYMERASE PROCESSIVITY FACTOR; URACIL-DNA GLYCOSYLASE; VIRUS REPLICATION COMPARTMENTS; RENAL-ALLOGRAFT RECIPIENTS; NUCLEAR-MATRIX; LYTIC INFECTION; GENE-EXPRESSION; ACCESSORY PROTEIN; TRANSCRIPTIONAL ACTIVATION; HISTONE MODIFICATIONS	Background: Human cytomegalovirus (HCMV) uracil DNA glycosylase, UL114, is required for efficient viral DNA replication. Presumably, UL114 functions as a structural partner to other factors of the DNA-replication machinery and not as a DNA repair protein. UL114 binds UL44 (HCMV processivity factor) and UL54 (HCMV-DNA-polymerase). In the present study we have searched for cellular partners of UL114. Methodology/Principal Findings: In a yeast two-hybrid screen SMARCB1, a factor of the SWI/SNF chromatin remodeling complex, was found to be an interacting partner of UL114. This interaction was confirmed in vitro by co-immunoprecipitation and pull-down. Immunofluorescence microscopy revealed that SMARCB1 along with BRG-1, BAF170 and BAF155, which are the core SWI/SNF components required for efficient chromatin remodeling, were present in virus replication foci 24-48 hours post infection (hpi). Furthermore a direct interaction was also demonstrated for SMARCB1 and UL44. Conclusions/Significance: The core SWI/SNF factors required for efficient chromatin remodeling are present in the HCMV replication foci throughout infection. The proteins UL44 and UL114 interact with SMARCB1 and may participate in the recruitment of the SWI/SNF complex to the chromatinized virus DNA. Thus, the presence of the SWI/SNF chromatin remodeling complex in replication foci and its association with UL114 and with UL44 might imply its involvement in different DNA transactions.	[Ranneberg-Nilsen, Toril; Rollag, Halvor; Slettebakk, Ragnhild; Backe, Paul Hoff; Olsen, Oyvind; Luna, Luisa; Bjoras, Magnar] Univ Oslo, Dept Microbiol, Oslo, Norway; [Ranneberg-Nilsen, Toril; Rollag, Halvor; Slettebakk, Ragnhild; Backe, Paul Hoff; Olsen, Oyvind; Luna, Luisa; Bjoras, Magnar] Univ Oslo, Rikshosp, Oslo Univ Hosp HF, N-0027 Oslo, Norway; [Backe, Paul Hoff; Olsen, Oyvind; Bjoras, Magnar] Univ Oslo, Dept Med Biochem, Oslo, Norway; [Ranneberg-Nilsen, Toril; Backe, Paul Hoff; Olsen, Oyvind; Luna, Luisa; Bjoras, Magnar] Univ Oslo, Ctr Mol Biol & Neurosci, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Ranneberg-Nilsen, T (corresponding author), Univ Oslo, Dept Microbiol, Oslo, Norway.	magnar.bjoras@rr-research.no	Bjørås, Magnar/N-9286-2017		Norwegian Research Council and Health South-East, Norway	Norwegian Research Council and Health South-East, Norway	The work was supported by Norwegian Research Council and Health South-East, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler SP, 2007, SEMIN PERINATOL, V31, P10, DOI 10.1053/j.semperi.2007.01.002; Alvisi G, 2005, TRAFFIC, V6, P1002, DOI 10.1111/j.1600-0854.2005.00331.x; Alvisi G, 2009, J VIROL, V83, P9567, DOI 10.1128/JVI.00669-09; Anachkova B, 2005, J CELL BIOCHEM, V96, P951, DOI 10.1002/jcb.20610; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; BJELLAND S, 1995, BIOCHEMISTRY-US, V34, P14758, DOI 10.1021/bi00045a017; Bode J, 2003, CHROMOSOME RES, V11, P435, DOI 10.1023/A:1024918525818; Cha S, 2011, INTERVIROLOGY, V54, P66, DOI 10.1159/000318871; CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125; Chen RX, 2002, J GEN VIROL, V83, P2339, DOI 10.1099/0022-1317-83-10-2339; Cihlar T, 1997, PROTEIN EXPRES PURIF, V11, P209, DOI 10.1006/prep.1997.0781; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Courcelle CT, 2001, J VIROL, V75, P7592, DOI 10.1128/JVI.75.16.7592-7601.2001; Cuevas-Bennett C, 2008, J VIROL, V82, P9525, DOI 10.1128/JVI.00946-08; Davie JR, 1997, MOL BIOL REP, V24, P197, DOI 10.1023/A:1006811817247; Davison AJ, 2003, J GEN VIROL, V84, P17, DOI 10.1099/vir.0.18606-0; Emery VC, 2001, J CLIN PATHOL, V54, P84, DOI 10.1136/jcp.54.2.84; ERTL PF, 1992, J VIROL, V66, P4126, DOI 10.1128/JVI.66.7.4126-4133.1992; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Gao Y, 2008, J VIROL, V82, P96, DOI 10.1128/JVI.01559-07; Hargreaves DC, 2011, CELL RES, V21, P396, DOI 10.1038/cr.2011.32; Hassan-Walker AF, 1999, J MED VIROL, V58, P182, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;182::AID-JMV14&gt;3.0.CO;2-Q; HE DC, 1990, J CELL BIOL, V110, P569, DOI 10.1083/jcb.110.3.569; Heng HHQ, 2004, J CELL SCI, V117, P999, DOI 10.1242/jcs.00976; Herrera FJ, 2004, J VIROL, V78, P9689, DOI 10.1128/JVI.78.18.9689-9696.2004; Huang J, 2006, J VIROL, V80, P5740, DOI 10.1128/JVI.00169-06; Hwang S, 2003, J GEN VIROL, V84, P665, DOI 10.1099/vir.0.18699-0; Ioudinkova E, 2006, GENE, V384, P120, DOI 10.1016/j.gene.2006.07.021; Isomura H, 2007, J VIROL, V81, P6197, DOI 10.1128/JVI.00089-07; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Kent JR, 2004, J VIROL, V78, P10178, DOI 10.1128/JVI.78.18.10178-10186.2004; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Krosky PM, 2003, J VIROL, V77, P7720, DOI 10.1128/JVI.77.14.7720-7727.2003; Kudoh A, 2009, J VIROL, V83, P6641, DOI 10.1128/JVI.00049-09; Kumar RA, 2007, J VIROL, V81, P2213, DOI 10.1128/JVI.01746-06; Laemmli UK, 1992, CURR OPIN GENET DEV, V2, P275, DOI 10.1016/S0959-437X(05)80285-0; Lee D, 1999, NATURE, V399, P487, DOI 10.1038/20966; Lieberman PM, 2006, TRENDS MICROBIOL, V14, P132, DOI 10.1016/j.tim.2006.01.001; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Mattia E, 1999, VIROLOGY, V262, P9, DOI 10.1006/viro.1999.9854; Maxwell KL, 2007, MICROBIOL MOL BIOL R, V71, P398, DOI 10.1128/MMBR.00042-06; Mearini G, 2003, FEBS LETT, V547, P119, DOI 10.1016/S0014-5793(03)00690-2; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; Murphy JC, 2002, EMBO J, V21, P1112, DOI 10.1093/emboj/21.5.1112; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Nevels M, 2011, REV MED VIROL, V21, P154, DOI 10.1002/rmv.690; Nitzsche A, 2008, J VIROL, V82, P11167, DOI 10.1128/JVI.01218-08; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Oh J, 2008, J VIROL, V82, P3530, DOI 10.1128/JVI.00586-07; Pari GS, 2008, CURR TOP MICROBIOL, V325, P153; Paulus C, 2010, REV MED VIROL, V20, P34, DOI 10.1002/rmv.632; Penfold MET, 1997, VIROLOGY, V239, P46, DOI 10.1006/viro.1997.8848; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Prichard MN, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-55; Ranneberg-Nilsen T, 2008, J MOL BIOL, V381, P276, DOI 10.1016/j.jmb.2008.05.028; Ranneberg-Nilsen T, 2006, VIROLOGY, V348, P389, DOI 10.1016/j.virol.2006.01.001; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Sagedal S, 2000, TRANSPLANTATION, V70, P1166, DOI 10.1097/00007890-200010270-00007; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; Sinclair J, 2010, BBA-GENE REGUL MECH, V1799, P286, DOI 10.1016/j.bbagrm.2009.08.001; Strang BL, 2010, J VIROL, V84, P1771, DOI 10.1128/JVI.01510-09; Sudarsanam P, 2000, TRENDS GENET, V16, P345, DOI 10.1016/S0168-9525(00)02060-6; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; WEILAND KL, 1994, VIRUS RES, V34, P191, DOI 10.1016/0168-1702(94)90124-4; Wu DY, 1996, J VIROL, V70, P6020, DOI 10.1128/JVI.70.9.6020-6028.1996	69	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34119	10.1371/journal.pone.0034119	http://dx.doi.org/10.1371/journal.pone.0034119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479537	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900063
J	Donhauser, N; Pritschet, K; Helm, M; Harrer, T; Schuster, P; Ries, M; Bischof, G; Vollmer, J; Smola, S; Schmidt, B				Donhauser, Norbert; Pritschet, Kathrin; Helm, Martin; Harrer, Thomas; Schuster, Philipp; Ries, Moritz; Bischof, Georg; Vollmer, Joerg; Smola, Sigrun; Schmidt, Barbara		German Competence Network HIV AIDS	Chronic Immune Activation in HIV-1 Infection Contributes to Reduced Interferon Alpha Production via Enhanced CD40:CD40 Ligand Interaction	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; CD4(+) T-CELLS; APOPTOSIS-INDUCING LIGAND; ANTIRETROVIRAL THERAPY; CD40 LIGAND; HIV-1-INFECTED PATIENTS; LYMPHOID-TISSUE; IN-VITRO; EXPRESSION; TYPE-1	Although a signature of increased interferon (IFN-)alpha production is observed in HIV-1 infection, the response of circulating plasmacytoid dendritic cells (PDC) to Toll-like receptor ligand stimulation is substantially impaired. This functional PDC deficit, which we specifically observed in HIV-1 infected individuals with less than 500 CD4+ T cells/mu l, is not well understood. We provide evidence that the peripheral IFN-alpha production in HIV-1 infection is actively suppressed by the enhanced interaction of CD40 ligand (CD40L), a member of the tumor necrosis factor family, and its receptor CD40, which are both upregulated upon immune activation. Plasma levels of soluble CD40L were significantly higher in untreated HIV-1 infected individuals (n = 52) than in subjects on long-term antiretroviral therapy (n = 62, p<0.03) and in uninfected control donors (n = 16, p<0.001). Concomitantly, cell-associated CD40L and the expression of the receptor CD40 on the PDC were significantly upregulated in HIV-1 infection (p<0.05). Soluble and cell-associated CD40L inhibited the PDC-derived IFN-alpha production by CpG oligodeoxynucleotides dose-dependently. This suppressive effect was observed at much lower, physiological CD40L concentrations in peripheral blood mononuclear cells (PBMC) of HIV-1 infected individuals compared to controls (p<0.05). The CpG-induced IFN-alpha production in PBMC of HIV-1 infected donors was directly correlated with PDC and CD4+ T cell counts, and inversely correlated with the viral loads (p<0.001). In HIV-1 infected donors with less than 500 CD4+ T cells/mu l, the CpG-induced IFN-alpha production was significantly correlated with the percentage of CD40-expressing PDC and the level of CD40 expression on these cells (p<0.05), whereas CD40L plasma levels played a minor role. In addition, low-dose CD40L contributed to the enhanced production of interleukin 6 and 8 in PBMC of HIV-1 infected donors compared to controls. Our data support the conclusion that the chronic immune activation in HIV-1 infection impairs peripheral PDC innate immune responses at least in part via enhanced CD40:CD40L interactions.	[Donhauser, Norbert; Pritschet, Kathrin; Schuster, Philipp; Ries, Moritz; Bischof, Georg; Schmidt, Barbara] Univ Erlangen Nurnberg, German Natl Reference Ctr Retroviruses, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; [Harrer, Thomas] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Internal Med 3, D-91054 Erlangen, Germany; [Vollmer, Joerg] Coley Pharmaceut GmbH, Pfizer Oligonucleotide Therapeut Unit, Dusseldorf, Germany; [Smola, Sigrun] Univ Saarland, Inst Virol, D-6650 Homburg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Coley Pharmaceutical Group; Pfizer; Saarland University	Donhauser, N (corresponding author), Univ Erlangen Nurnberg, German Natl Reference Ctr Retroviruses, Inst Clin & Mol Virol, D-91054 Erlangen, Germany.	baschmid@viro.med.uni-erlangen.de			ELAN [VI-08-06.18.1]; German Research Foundation [SCHM1702/2-2, SCHM1702/3-1]; Interdisziplinares Zentrum fur Klinische Forschung, Erlangen [TP50]; German Competence Network HIV/AIDS; Akademie der Wissenschaften und Literatur zu Mainz;  [1071]	ELAN; German Research Foundation(German Research Foundation (DFG)); Interdisziplinares Zentrum fur Klinische Forschung, Erlangen; German Competence Network HIV/AIDS; Akademie der Wissenschaften und Literatur zu Mainz; 	This work was supported by the ELAN Fonds (VI-08-06.18.1), the German Research Foundation (SCHM1702/2-2, SCHM1702/3-1), the graduate college 1071 ("Viruses of the immune system''), the "Interdisziplinares Zentrum fur Klinische Forschung, Erlangen'' (TP50), the German Competence Network HIV/AIDS, and the "Akademie der Wissenschaften und Literatur zu Mainz''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/314849; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Cella M, 1999, NAT MED, V5, P919, DOI 10.1038/11360; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Chehimi J, 2010, J VIROL, V84, P2762, DOI 10.1128/JVI.01350-09; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Donhauser N, 2010, AIDS RES HUM RETROV, V26, P161, DOI 10.1089/aid.2008.0278; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; Finke JS, 2004, J CLIN IMMUNOL, V24, P647, DOI 10.1007/s10875-004-6250-5; Fong L, 2002, J VIROL, V76, P11033, DOI 10.1128/JVI.76.21.11033-11041.2002; Fox PA, 2010, AIDS, V24, P2331, DOI 10.1097/QAD.0b013e32833d466c; Graham SM, 2011, SEX TRANSM INFECT, V87, P114, DOI 10.1136/sti.2010.045369; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Herbeuval JP, 2006, P NATL ACAD SCI USA, V103, P7000, DOI 10.1073/pnas.0600363103; Herbeuval JP, 2005, BLOOD, V106, P3524, DOI 10.1182/blood-2005-03-1243; Herbeuval JP, 2005, P NATL ACAD SCI USA, V102, P13974, DOI 10.1073/pnas.0505251102; Hess S, 1996, J EXP MED, V183, P159, DOI 10.1084/jem.183.1.159; Hsu YM, 1997, J BIOL CHEM, V272, P911, DOI 10.1074/jbc.272.2.911; Killian MS, 2006, AIDS RES HUM RETROV, V22, P640, DOI 10.1089/aid.2006.22.640; Kirchhoff F, 2009, NAT REV MICROBIOL, V7, P467, DOI 10.1038/nrmicro2111; Lepelley A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001284; Lore K, 2002, AIDS, V16, P683, DOI 10.1097/00002030-200203290-00003; Martinson JA, 2007, IMMUNOLOGY, V120, P526, DOI 10.1111/j.1365-2567.2007.02530.x; Maurais E, 2009, VIROLOGY, V385, P227, DOI 10.1016/j.virol.2008.11.033; MAZZEI GJ, 1995, J BIOL CHEM, V270, P7025, DOI 10.1074/jbc.270.13.7025; MCDOUGAL JS, 1985, J IMMUNOL METHODS, V76, P171, DOI 10.1016/0022-1759(85)90489-2; Meyers JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000458; Nusslein HG, 1996, EUR J IMMUNOL, V26, P846, DOI 10.1002/eji.1830260418; O'Gorman MRG, 2001, CLIN DIAGN LAB IMMUN, V8, P1104, DOI 10.1128/CDLI.8.6.1104-1109.2001; Palefsky Joel, 2008, Curr HIV/AIDS Rep, V5, P78, DOI 10.1007/s11904-008-0013-5; Pham LV, 2005, BLOOD, V106, P3940, DOI 10.1182/blood-2005-03-1167; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; Ries M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/534929; Samulowitz U, 2010, OLIGONUCLEOTIDES, V20, P93, DOI 10.1089/oli.2009.0210; Schmidt B, 2006, J CLIN IMMUNOL, V26, P55, DOI 10.1007/s10875-006-8401-3; Schmidt B, 2004, VIROLOGY, V329, P280, DOI 10.1016/j.virol.2004.08.016; Schmidt B, 2005, VIROLOGY, V343, P256, DOI 10.1016/j.virol.2005.09.059; Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835; Siegal FP, 2001, AIDS, V15, P1603, DOI 10.1097/00002030-200109070-00002; Sipsas NV, 2002, CLIN DIAGN LAB IMMUN, V9, P558, DOI 10.1128/CDLI.9.3.558-561.2002; Sousa AE, 1999, CLIN EXP IMMUNOL, V116, P307; Subauste CS, 2007, J IMMUNOL, V178, P1645, DOI 10.4049/jimmunol.178.3.1645; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Tilton JC, 2008, J VIROL, V82, P3997, DOI 10.1128/JVI.01545-07; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vanham G, 1999, CLIN EXP IMMUNOL, V117, P335; von Hentig N, 2008, J ANTIMICROB CHEMOTH, V62, P1118, DOI 10.1093/jac/dkn333; Zhang R, 2006, BLOOD, V107, P1989, DOI 10.1182/blood-2005-07-2731	49	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33925	10.1371/journal.pone.0033925	http://dx.doi.org/10.1371/journal.pone.0033925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470494	gold, Green Published, Green Submitted			2022-12-27	WOS:000303857100058
J	Labed, SA; Omi, S; Gut, M; Ewbank, JJ; Pujol, N				Labed, Sid Ahmed; Omi, Shizue; Gut, Martha; Ewbank, Jonathan J.; Pujol, Nathalie			The Pseudokinase NIPI-4 Is a Novel Regulator of Antimicrobial Peptide Gene Expression	PLOS ONE			English	Article							ELEGANS INNATE IMMUNITY; PROTEIN-KINASE-C; CAENORHABDITIS-ELEGANS; SIGNALING PATHWAY; MICROBACTERIUM-NEMATOPHILUM; SERRATIA-MARCESCENS; BACTERIAL PATHOGEN; GENOME SEQUENCE; INFECTION; RESISTANCE	Hosts have developed diverse mechanisms to counter the pathogens they face in their natural environment. Throughout the plant and animal kingdoms, the up-regulation of antimicrobial peptides is a common response to infection. In C. elegans, infection with the natural pathogen Drechmeria coniospora leads to rapid induction of antimicrobial peptide gene expression in the epidermis. Through a large genetic screen we have isolated many new mutants that are incapable of upregulating the antimicrobial peptide nlp-29 in response to infection (i.e. with a Nipi or no induction of peptide after infection' phenotype). More than half of the newly isolated Nipi mutants do not correspond to genes previously associated with the regulation of antimicrobial peptides. One of these, nipi-4, encodes a member of a nematode-specific kinase family. NIPI-4 is predicted to be catalytically inactive, thus to be a pseudokinase. It acts in the epidermis downstream of the PKC partial derivative TPA-1, as a positive regulator of nlp antimicrobial peptide gene expression after infection. It also controls the constitutive expression of antimicrobial peptide genes of the cnc family that are targets of TGF beta regulation. Our results open the way for a more detailed understanding of how host defense pathways can be molded by environmental pathogens.	[Labed, Sid Ahmed; Omi, Shizue; Ewbank, Jonathan J.; Pujol, Nathalie] Aix Marseille Univ, CIML, UM2, Marseille, France; [Labed, Sid Ahmed; Omi, Shizue; Ewbank, Jonathan J.; Pujol, Nathalie] INSERM, U1104, F-13258 Marseille, France; [Labed, Sid Ahmed; Omi, Shizue; Ewbank, Jonathan J.; Pujol, Nathalie] CNRS, UMR7280, Marseille, France; [Gut, Martha] Ctr Nacl Anal Genom, Barcelona, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Labed, SA (corresponding author), Aix Marseille Univ, CIML, UM2, Marseille, France.	pujol@ciml.univ-mrs.fr	Ewbank, Jonathan J/G-4948-2010; Pujol, Nathalie/K-3880-2012	Ewbank, Jonathan J/0000-0002-1257-6862; Pujol, Nathalie/0000-0001-8889-3197; Omi, Shizue/0000-0002-2711-2016	INSERM; CNRS; Agence Nationale de la Recherche - French National Research Agency (ANR FUNGENOMICS); Fondation pour la Recherche Medicale - Medical Research Foundation (FRM) [ING20091217918]; French Ministry of Research; NIH National Center for Research Resources (NCRR)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche - French National Research Agency (ANR FUNGENOMICS)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale - Medical Research Foundation (FRM); French Ministry of Research(Ministry of Research, FranceEuropean Commission); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by institutional grants from INSERM and CNRS, program grants from the Agence Nationale de la Recherche - French National Research Agency (ANR FUNGENOMICS) and the Fondation pour la Recherche Medicale - Medical Research Foundation (FRM ING20091217918). S. L. is supported by a fellowship from the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank J. Belougne for worm sorting, G. Yuen, R. Duhecquet Derauville and C. Kergourlay for their help in the genetic screen, M. Dotsidou, Z. Jin Tu, F. Montanana-Sanchis and S. Jaeger for their help in installing Maqgene, L. Agueda and M. Bayes for whole genome sequencing, A. Chisholm, D. Dupuy and R. Korswagen for sharing constructs, G. Manning for insight on the structure of the NIPI-4 kinase and for proposing its possible heterodimerization, members of the lab for helpful discussion and A. Chisholm and P. Golstein for critical reading of the manuscript. Some nematode strains were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR), or by the National Bioresource Project coordinated by S. Mitani.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Bigelow H, 2009, NAT METHODS, V6, P549, DOI 10.1038/nmeth.f.260; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Coleman JJ, 2009, CELL HOST MICROBE, V5, P313, DOI 10.1016/j.chom.2009.04.002; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; COX GN, 1989, GENE, V76, P331, DOI 10.1016/0378-1119(89)90173-X; Dierking K, 2011, CELL HOST MICROBE, V9, P425, DOI 10.1016/j.chom.2011.04.011; DIJKSTERHUIS J, 1990, MYCOL RES, V94, P1, DOI 10.1016/S0953-7562(09)81257-4; Doitsidou M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015435; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Engelmann I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019055; Engelmann I, 2010, ADV EXP MED BIOL, V708, P105; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Giordano-Santini R, 2010, NAT METHODS, V7, P721, DOI 10.1038/nmeth.1494; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Hodgkin J, 2000, CURR BIOL, V10, P1615, DOI 10.1016/S0960-9822(00)00867-8; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; JANSSON HB, 1985, APPL ENVIRON MICROB, V49, P552, DOI 10.1128/AEM.49.3.552-555.1985; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Kurz CL, 2007, BIOCHEM BIOPH RES CO, V363, P438, DOI 10.1016/j.bbrc.2007.08.190; Liberati NT, 2004, P NATL ACAD SCI USA, V101, P6593, DOI 10.1073/pnas.0308625101; Manning G, 2005, GENOMIC OVERVIEW PRO, P1; Partridge FA, 2010, DEV DYNAM, V239, P1330, DOI 10.1002/dvdy.22232; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Pujol N, 2001, J BIOL CHEM, V276, P11913, DOI 10.1074/jbc.M009451200; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Ren M, 2009, IMMUNITY, V30, P521, DOI 10.1016/j.immuni.2009.03.007; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schulenburg H, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-49; Shivers RP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000892; Stiernagle Theresa, 2006, WormBook, P1; Stringham E, 2002, DEVELOPMENT, V129, P3367; TABUSE Y, 1989, SCIENCE, V243, P1713, DOI 10.1126/science.2538925; Tong A, 2009, P NATL ACAD SCI USA, V106, P1457, DOI 10.1073/pnas.0809339106; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Troemel ER, 2008, PLOS BIOL, V6, P2736, DOI 10.1371/journal.pbio.0060309; van der Linden AM, 2003, CURR BIOL, V13, P516, DOI 10.1016/S0960-9822(03)00164-7; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wood WB, NEMATODE CAENORHABDI; Xu S, 2011, CURR BIOL; Yook K, 2007, GENETICS, V175, P681, DOI 10.1534/genetics.106.060087; Ziegler K, 2009, CELL HOST MICROBE, V5, P341, DOI 10.1016/j.chom.2009.03.006; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	48	20	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33887	10.1371/journal.pone.0033887	http://dx.doi.org/10.1371/journal.pone.0033887			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470487	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100054
J	Sadasivan, S; Pond, BB; Pani, AK; Qu, CX; Jiao, Y; Smeyne, RJ				Sadasivan, Shankar; Pond, Brooks B.; Pani, Amar K.; Qu, Chunxu; Jiao, Yun; Smeyne, Richard J.			Methylphenidate Exposure Induces Dopamine Neuron Loss and Activation of Microglia in the Basal Ganglia of Mice	PLOS ONE			English	Article							NIGRA PARS COMPACTA; PARKINSONS-DISEASE; EXTRACELLULAR DOPAMINE; SUBSTANTIA-NIGRA; TYROSINE-HYDROXYLASE; OXIDATIVE STRESS; REACTIVE OXYGEN; ADHD; NEUROTOXICITY; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE	Background: Methylphenidate (MPH) is a psychostimulant that exerts its pharmacological effects via preferential blockade of the dopamine transporter (DAT) and the norepinephrine transporter (NET), resulting in increased monoamine levels in the synapse. Clinically, methylphenidate is prescribed for the symptomatic treatment of ADHD and narcolepsy; although lately, there has been an increased incidence of its use in individuals not meeting the criteria for these disorders. MPH has also been misused as a "cognitive enhancer'' and as an alternative to other psychostimulants. Here, we investigate whether chronic or acute administration of MPH in mice at either 1 mg/kg or 10 mg/kg, affects cell number and gene expression in the basal ganglia. Methodology/Principal Findings: Through the use of stereological counting methods, we observed a significant reduction (similar to 20%) in dopamine neuron numbers in the substantia nigra pars compacta (SNpc) following chronic administration of 10 mg/kg MPH. This dosage of MPH also induced a significant increase in the number of activated microglia in the SNpc. Additionally, exposure to either 1 mg/kg or 10 mg/kg MPH increased the sensitivity of SNpc dopaminergic neurons to the parkinsonian agent 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Unbiased gene screening employing Affymetrix GeneChip (R) HT MG-430 PM revealed changes in 115 and 54 genes in the substantia nigra (SN) of mice exposed to 1 mg/kg and 10 mg/kg MPH doses, respectively. Decreases in the mRNA levels of gdnf, dat1, vmat2, and th in the substantia nigra (SN) were observed with both acute and chronic dosing of 10 mg/kg MPH. We also found an increase in mRNA levels of the pro-inflammatory genes il-6 and tnf-alpha in the striatum, although these were seen only at an acute dose of 10 mg/kg and not following chronic dosing. Conclusion: Collectively, our results suggest that chronic MPH usage in mice at doses spanning the therapeutic range in humans, especially at prolonged higher doses, has long-term neurodegenerative consequences.	[Sadasivan, Shankar; Pond, Brooks B.; Pani, Amar K.; Jiao, Yun; Smeyne, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Pond, Brooks B.] E Tennessee State Univ, Dept Pharmaceut Sci, Bill Gatton Coll Pharm, Johnson City, TN 37614 USA; [Qu, Chunxu] St Jude Childrens Res Hosp, Dept Informat Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; East Tennessee State University; St Jude Children's Research Hospital	Sadasivan, S (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	Richard.smeyne@stjude.org		Smeyne, Richard/0000-0002-8459-5472	American Lebanese Syrian Associated Charities (ALSAC)	American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	The authors thank the American Lebanese Syrian Associated Charities (ALSAC) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agay N, 2010, PSYCHOPHARMACOLOGY, V210, P511, DOI 10.1007/s00213-010-1853-4; Andersen SL, 2002, BEHAV BRAIN RES, V130, P197, DOI 10.1016/S0166-4328(01)00417-X; Arnsten AFT, 2006, NEUROPSYCHOPHARMACOL, V31, P2376, DOI 10.1038/sj.npp.1301164; Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137; BALDWIN HA, 1993, BRIT J PHARMACOL, V108, P590, DOI 10.1111/j.1476-5381.1993.tb12847.x; Baquet ZC, 2009, NEUROSCIENCE, V161, P1082, DOI 10.1016/j.neuroscience.2009.04.031; Barlow BK, 2007, REPROD TOXICOL, V23, P457, DOI 10.1016/j.reprotox.2007.01.007; Boyd JD, 2007, BRAIN RES, V1175, P107, DOI 10.1016/j.brainres.2007.07.067; Callaghan RC, 2012, DRUG ALCOHOL DEPEN, V120, P35, DOI 10.1016/j.drugalcdep.2011.06.013; Callaghan RC, 2010, MOVEMENT DISORD, V25, P2333, DOI 10.1002/mds.23263; CAMPBRUNO JA, 1994, PSYCHOPHARMACOLOGY, V115, P46, DOI 10.1007/BF02244750; Capp Philip K, 2005, Expert Rev Neurother, V5, P325, DOI 10.1586/14737175.5.3.325; Carvey PM, 2006, CELL TRANSPLANT, V15, P239, DOI 10.3727/000000006783981990; Choi HJ, 2005, NEUROCHEM INT, V46, P329, DOI 10.1016/j.neuint.2004.10.009; Choi HJ, 2003, J NEUROCHEM, V86, P143, DOI 10.1046/j.1471-4159.2003.01808.x; Cory-Slechta DA, 2005, ENVIRON HEALTH PERSP, V113, P1263, DOI 10.1289/ehp.7570; Evans WN, 2010, J HEALTH ECON, V29, P657, DOI 10.1016/j.jhealeco.2010.07.005; FILLOUX F, 1993, EXP NEUROL, V119, P79, DOI 10.1006/exnr.1993.1008; Fumagalli F, 1999, J NEUROSCI, V19, P2424; Gatley SJ, 1999, PSYCHOPHARMACOLOGY, V146, P93, DOI 10.1007/s002130051093; Gerasimov MR, 2000, SYNAPSE, V38, P432, DOI 10.1002/1098-2396(20001215)38:4<432::AID-SYN8>3.0.CO;2-Q; Gomes KM, 2008, NEUROCHEM RES, V33, P1024, DOI 10.1007/s11064-007-9544-1; Gomes KM, 2009, NEUROSCI LETT, V465, P95, DOI 10.1016/j.neulet.2009.08.060; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; GRAHAM DG, 1978, MOL PHARMACOL, V14, P633; Greely H, 2008, NATURE, V456, P702, DOI 10.1038/456702a; Hamre K, 1999, BRAIN RES, V828, P91, DOI 10.1016/S0006-8993(99)01273-1; Hirai N, 2011, CURR TREAT OPTION NE, V13, P437, DOI 10.1007/s11940-011-0137-6; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson-Lewis V, 2005, NEUROTOX RES, V7, P193, DOI 10.1007/BF03036449; Jang H, 2012, J NEUROSCI IN PRESS; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Johnston L. D, 2011, MONITORING FUTURE NA, V1, P1; Johnston L. D, 2011, MONITORING FUTURE NA, VII; Kimko HC, 1999, CLIN PHARMACOKINET, V37, P457, DOI 10.2165/00003088-199937060-00002; Koda K, 2010, J NEUROCHEM, V114, P259, DOI 10.1111/j.1471-4159.2010.06750.x; Kuczenski R, 1997, J NEUROCHEM, V68, P2032; Kuhn DM, 1999, J NEUROSCI, V19, P10289; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Le WD, 2009, NEUROSCIENTIST, V15, P28, DOI 10.1177/1073858408319974; Leonard BE, 2004, HUM PSYCHOPHARM CLIN, V19, P151, DOI 10.1002/hup.579; Lloyd SA, 2006, NEUROSCIENCE, V137, P905, DOI 10.1016/j.neuroscience.2005.09.035; Martins MR, 2006, BRAIN RES, V1078, P189, DOI 10.1016/j.brainres.2006.01.004; Martins S, 2004, J CHILD ADOL PSYCHOP, V14, P195, DOI 10.1089/1044546041649066; MICHEL PP, 1990, J NEUROSCI RES, V26, P428, DOI 10.1002/jnr.490260405; Miyazaki I, 2008, ACTA MED OKAYAMA, V62, P141; Miyazaki I, 2007, FEBS LETT, V581, P5003, DOI 10.1016/j.febslet.2007.09.046; PAWLUK LK, 1995, J NERV MENT DIS, V183, P45, DOI 10.1097/00005053-199501000-00009; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Przedborski S, 2005, ANTIOXID REDOX SIGN, V7, P685, DOI 10.1089/ars.2005.7.685; Reinoso BS, 1996, J NEUROSCI RES, V43, P439, DOI 10.1002/(SICI)1097-4547(19960215)43:4<439::AID-JNR5>3.0.CO;2-G; Repantis D, 2010, PHARMACOL RES, V62, P187, DOI 10.1016/j.phrs.2010.04.002; ROCHE AF, 1979, PEDIATRICS, V63, P847; Schiffer WK, 2006, SYNAPSE, V59, P243, DOI 10.1002/syn.20235; Shen XM, 1997, CHEM RES TOXICOL, V10, P147, DOI 10.1021/tx960145c; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Swanson JM, 2002, BEHAV BRAIN RES, V130, P73, DOI 10.1016/S0166-4328(01)00433-8; TODD RD, 1992, BIOL PSYCHIAT, V31, P794, DOI 10.1016/0006-3223(92)90311-M; Uhl GR, 2000, FASEB J, V14, P2459, DOI 10.1096/fj.00-0205rev; Valvassori SS, 2007, BEHAV PHARMACOL, V18, P205, DOI 10.1097/FBP.0b013e328153daf5; Volkow ND, 1999, LIFE SCI, V65, pPL7, DOI 10.1016/S0024-3205(99)00225-8; Volkow ND, 2002, SYNAPSE, V43, P181, DOI 10.1002/syn.10038; Walitza S, 2007, J NEURAL TRANSM-SUPP, P311; WARGIN W, 1983, J PHARMACOL EXP THER, V226, P382; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Whitehead RE, 2001, J NEUROCHEM, V76, P1242, DOI 10.1046/j.1471-4159.2001.00125.x; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1; Xu YM, 1998, J NEUROSCI RES, V54, P691, DOI 10.1002/(SICI)1097-4547(19981201)54:5<691::AID-JNR14>3.0.CO;2-F; Yokoyama H, 2008, NEUROL SCI, V29, P293, DOI 10.1007/s10072-008-0986-2	70	77	79	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33693	10.1371/journal.pone.0033693	http://dx.doi.org/10.1371/journal.pone.0033693			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470460	Green Submitted, Green Published, gold			2022-12-27	WOS:000303857100038
J	Tou, WI; Chen, CYC				Tou, Weng Ieong; Chen, Calvin Yu-Chian			In Silico Investigation of Potential Src Kinase Ligands from Traditional Chinese Medicine	PLOS ONE			English	Article							PHASE-II TRIAL; GENETIC FUNCTION APPROXIMATION; METASTATIC BREAST-CANCER; SARACATINIB AZD0530; EXPERIMENTAL-DESIGN; OUABAIN; INHIBITORS; DASATINIB; HYPERTENSION; DISCOVERY	Src kinase is an attractive target for drug development based on its established relationship with cancer and possible link to hypertension. The suitability of traditional Chinese medicine (TCM) compounds as potential drug ligands for further biological evaluation was investigated using structure-based, ligand-based, and molecular dynamics (MD) analysis. Isopraeroside IV, 9alpha-hydroxyfraxinellone-9-O-beta-D-glucoside (9HFG) and aurantiamide were the top three TCM candidates identified from docking. Hydrogen bonds and hydrophobic interactions were the primary forces governing docking stability. Their stability with Src kinase under a dynamic state was further validated through MD and torsion angle analysis. Complexes formed by TCM candidates have lower total energy estimates than the control Sacaratinib. Four quantitative-structural activity relationship (QSAR) in silico verifications consistently suggested that the TCM candidates have bioactive properties. Docking conformations of 9HFG and aurantiamide in the Src kinase ATP binding site suggest potential inhibitor-like characteristics, including competitive binding at the ATP binding site (Lys295) and stabilization of the catalytic cleft integrity. The TCM candidates have significantly lower ligand internal energies and are estimated to form more stable complexes with Src kinase than Saracatinib. Structure-based and ligand-based analysis support the drug-like potential of 9HFG and aurantiamide and binding mechanisms reveal the tendency of these two candidates to compete for the ATP binding site.	[Tou, Weng Ieong] China Med Univ, Sch Med, Taichung, Taiwan; [Tou, Weng Ieong; Chen, Calvin Yu-Chian] China Med Univ, Lab Computat & Syst Biol, Taichung, Taiwan; [Chen, Calvin Yu-Chian] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Calvin Yu-Chian] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chen, Calvin Yu-Chian] Asia Univ, Dept Biomed Informat, Taichung, Taiwan; [Chen, Calvin Yu-Chian] China Med Univ Beigang Hosp, Yunlin, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan; Asia University Taiwan	Tou, WI (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.	ycc929@MIT.EDU	; Chen, Calvin Yu-Chian/E-9402-2010	Chen, Calvin Yu-Chian/0000-0001-9213-9832; Chen, Calvin Yu-Chian/0000-0003-3306-250X; Tou, Weng Ieong/0000-0003-4411-0546	National Science Council of Taiwan (NSC) [100-2325-B-039-001]; Committee on Chinese Medicine and Pharmacy [CCMP100-RD-030]; China Medical University; Asia University [DMR-101-094]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH101-TD-B-111-004]; Taiwan Department of Health Cancer Research Center of Excellence [DOH101-TD-C-111-005]	National Science Council of Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Committee on Chinese Medicine and Pharmacy; China Medical University(China Medical University); Asia University; Taiwan Department of Health Clinical Trial and Research Center of Excellence; Taiwan Department of Health Cancer Research Center of Excellence	This research was supported by grants from the National Science Council of Taiwan (NSC 100-2325-B-039-001), Committee on Chinese Medicine and Pharmacy (CCMP100-RD-030), China Medical University and Asia University (DMR-101-094). This study is also supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH101-TD-B-111-004) and Taiwan Department of Health Cancer Research Center of Excellence (DOH101-TD-C-111-005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; [Anonymous], SYBYL X; Bianchi G, 2005, AM J PHYSIOL-REG I, V289, pR1536, DOI 10.1152/ajpregu.00441.2005; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Brooks HD, 2011, CANCER-AM CANCER SOC, V117, P2112, DOI 10.1002/cncr.25769; Chang CL, 2011, GENOME RES, V21, P21, DOI 10.1101/gr.110593.110; Chang KW, 2011, J BIOMOL STRUCT DYN, V29, P243, DOI 10.1080/073911011010524988; Chang PC, 2011, J BIOMOL STRUCT DYN, V29, P471, DOI 10.1080/07391102.2011.10507399; Chang SS, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002315; Chang TT, 2011, J BIOMOL STRUCT DYN, V28, P773, DOI 10.1080/07391102.2011.10508605; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen CY, 2010, J MOL GRAPH MODEL, V29, P21, DOI 10.1016/j.jmgm.2010.04.002; Chen CY, 2009, ACTA PHARMACOL SIN, V30, P1186, DOI 10.1038/aps.2009.100; Chen KC, 2011, SOFT MATTER, V7, P4001, DOI 10.1039/c0sm01548b; Choi SY, 2005, PHYTOTHER RES, V19, P839, DOI 10.1002/ptr.1424; Cortes JE, 2011, BLOOD, V118, P4567, DOI 10.1182/blood-2011-05-355594; Ferrandi M, 2004, J BIOL CHEM, V279, P33306, DOI 10.1074/jbc.M402187200; Ferrandi M, 1999, AM J PHYSIOL-HEART C, V277, pH1338, DOI 10.1152/ajpheart.1999.277.4.H1338; Ferrandi M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001815; Ferrari P, 2010, BBA-MOL BASIS DIS, V1802, P1254, DOI 10.1016/j.bbadis.2010.01.009; Finn RS, 2011, CLIN CANCER RES, V17, P6905, DOI 10.1158/1078-0432.CCR-11-0288; Fury MG, 2011, ANTICANCER RES, V31, P249; Ganesan A, 2008, CURR OPIN CHEM BIOL, V12, P306, DOI 10.1016/j.cbpa.2008.03.016; Gianni D, 2010, MOL BIOL CELL, V21, P4287, DOI 10.1091/mbc.E10-08-0685; Gucalp A, 2011, CLIN BREAST CANCER, V11, P306, DOI 10.1016/j.clbc.2011.03.021; Hasegawa K, 2010, CURR COMPUT-AID DRUG, V6, P24, DOI 10.2174/157340910790980124; Hennequin LF, 2006, J MED CHEM, V49, P6465, DOI 10.1021/jm060434q; Herold CI, 2011, CLIN CANCER RES, V17, P6061, DOI 10.1158/1078-0432.CCR-11-1071; Irwin ME, 2011, CANCER BIOL THER, V12, P718, DOI 10.4161/cbt.12.8.16907; Jamois EA, 2004, ABSTR PAP AM CHEM S, V227, pU905; Johnson FM, 2010, J CLIN ONCOL, V28, P4609, DOI 10.1200/JCO.2010.30.5474; Johnson ML, 2011, J THORAC ONCOL, V6, P1128, DOI 10.1097/JTO.0b013e3182161508; Keller TH, 2006, CURR OPIN CHEM BIOL, V10, P357, DOI 10.1016/j.cbpa.2006.06.014; Khan MTH, 2010, CURR DRUG METAB, V11, P285; Kim HS, 2011, CLIN CANCER RES, V17, P1713, DOI 10.1158/1078-0432.CCR-10-2081; Kim JH, 2004, BIOINFORMATICS, V20, P3179, DOI 10.1093/bioinformatics/bth382; Kluger HM, 2011, CANCER-AM CANCER SOC, V117, P2202, DOI 10.1002/cncr.25766; Kowar TR, 1998, J CHEM INF COMP SCI, V38, P858, DOI 10.1021/ci980205f; Liu J, 2000, J BIOL CHEM, V275, P27838; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; Mackay HJ, 2012, INVEST NEW DRUG, V30, P1158, DOI 10.1007/s10637-011-9650-4; Manunta P, 2009, J HYPERTENS, V27, P9, DOI 10.1097/HJH.0b013e32831cf2c6; Mayer EL, 2011, CLIN CANCER RES, V17, P6897, DOI 10.1158/1078-0432.CCR-11-0070; Miyake T, 2012, ONCOGENE, V31, P1431, DOI 10.1038/onc.2011.332; Montes M, 2007, PROTEINS, V68, P712, DOI 10.1002/prot.21405; Noronha G, 2007, BIOORG MED CHEM LETT, V17, P602, DOI 10.1016/j.bmcl.2006.11.006; Oneyama C, 2012, ONCOGENE, V31, P1623, DOI 10.1038/onc.2011.367; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Scheiner-Bobis G, 2001, NAT MED, V7, P1288, DOI 10.1038/nm1201-1288; Sharma MR, 2012, INVEST NEW DRUG, V30, P1211, DOI 10.1007/s10637-011-9681-x; Slinker BK, 2008, CIRCULATION, V117, P1732, DOI 10.1161/CIRCULATIONAHA.106.654376; Sun MF, 2011, J BIOMOL STRUCT DYN, V28, P895, DOI 10.1080/07391102.2011.10508616; Thomas S, 2011, CANCER RES, V71, P832, DOI 10.1158/0008-5472.CAN-10-0730; Tsai TY, 2011, J COMPUT AID MOL DES, V25, P525, DOI 10.1007/s10822-011-9438-9; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wheeler DL, 2009, ONCOLOGIST, V14, P667, DOI 10.1634/theoncologist.2009-0009; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028793; Yang SC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002189; Yoon JS, 2008, J NAT PROD, V71, P208, DOI 10.1021/np070588o; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	61	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33728	10.1371/journal.pone.0033728	http://dx.doi.org/10.1371/journal.pone.0033728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470466	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100043
J	Zhang, XP; Degenstein, L; Cao, Y; Stein, J; Osei, K; Wang, J				Zhang, Xiaoping; Degenstein, Linda; Cao, Yun; Stein, Jeffrey; Osei, Kwame; Wang, Jie			beta-Cells with Relative Low HIMP1 Overexpression Levels in a Transgenic Mouse Line Enhance Basal Insulin Production and Hypoxia/Hypoglycemia Tolerance	PLOS ONE			English	Article							HUMAN PANCREATIC-ISLETS; GENE-EXPRESSION; CURRENT CHALLENGES; LOW GLUCOSE; APOPTOSIS; TRANSPLANTATION; DYSFUNCTION; PATHOGENESIS; PREVENTION; RESISTANCE	Rodent pancreatic beta-cells that naturally lack hypoglycemia/hypoxia inducible mitochondrial protein 1 (HIMP1) are susceptible to hypoglycemia and hypoxia influences. A linkage between the hypoglycemia/hypoxia susceptibility and the lack of HIMP1 is suggested in a recent study using transformed beta-cells lines. To further illuminate this linkage, we applied mouse insulin 1 gene promoter (MIP) to control HIMP1-a isoform cDNA and have generated three lines (L1 to L3) of heterozygous HIMP1 transgenic (Tg) mice by breeding of three founders with C57BL/6J mice. In HIMP1-Tg mice/islets, we performed quantitative polymerase chain reaction (PCR), immunoblot, histology, and physiology studies to investigate HIMP1 overexpression and its link to beta-cell function/survival and body glucose homeostasis. We found that the HIMP1 level increased steadily in beta-cells of L1 to L3 heterozygous HIMP1-Tg mice. HIMP1 overexpression at relatively lower levels in L1 heterozygotes results in a negligible decline in blood glucose concentrations and an insignificant elevation in blood insulin levels, while HIMP1 overexpression at higher levels are toxic, causing hyperglycemia in L2/3 heterozygotes. Follow-up studies in 5-30-week-old L1 heterozygous mice/islets found that HIMP1 overexpression at relatively lower levels in beta-cells has enhanced basal insulin biosynthesis, basal insulin secretion, and tolerances to low oxygen/glucose influences. The findings enforced the linkage between the hypoglycemia/hypoxia susceptibility and the lack of HIMP1 in beta-cells, and show a potential value of HIMP1 overexpression at relatively lower levels in modulating beta-cell function and survival.	[Zhang, Xiaoping; Osei, Kwame; Wang, Jie] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Cao, Yun; Stein, Jeffrey] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Degenstein, Linda] Univ Chicago, Transgen Core, Chicago, IL 60637 USA	University System of Ohio; Ohio State University; University of Chicago; University of Chicago	Zhang, XP (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.	jie.wang2@osumc.edu			Ohio State University	Ohio State University(Ohio State University)	This work was supported in part by the start-up fund, the Manuel Tzagournis Medical Research Award, and the William D. and Anna R. Cunningham Award from The Ohio State University (to JW). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An HJ, 2011, BBA-MOL CELL RES, V1813, P2088, DOI 10.1016/j.bbamcr.2011.07.017; BAGDADE JD, 1967, J CLIN INVEST, V46, P1549, DOI 10.1172/JCI105646; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; Cantley J, 2010, DIABETES OBES METAB, V12, P159, DOI 10.1111/j.1463-1326.2010.01276.x; Denko N, 2000, CLIN CANCER RES, V6, P480; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Eisenbarth GS, 2010, DIABETES, V59, P759, DOI 10.2337/db09-1855; Emamaullee JA, 2007, CELL TRANSPLANT, V16, P1, DOI 10.3727/000000007783464461; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Leitao CB, 2008, CURR DIABETES REP, V8, P324, DOI 10.1007/s11892-008-0057-3; Mineo D, 2009, DIABETES CARE, V32, P1563, DOI 10.2337/dc09-0490; Moritz W, 2002, FASEB J, V16, P745, DOI 10.1096/fj.01-0403fje; Mysore TB, 2005, DIABETES, V54, P2109, DOI 10.2337/diabetes.54.7.2109; Nielsen K, 1999, DIABETES, V48, P2324, DOI 10.2337/diabetes.48.12.2324; PALMITER RD, 1991, P NATL ACAD SCI USA, V88, P478, DOI 10.1073/pnas.88.2.478; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; PURANAM KL, 1999, CRC METH NEUROSCI S, P129; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Van de Casteele M, 2003, BIOCHEM BIOPH RES CO, V312, P937, DOI 10.1016/j.bbrc.2003.11.013; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang J, 2006, P NATL ACAD SCI USA, V103, P10636, DOI 10.1073/pnas.0604194103; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019446; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; WELSH N, 1995, MOL MED, V1, P806, DOI 10.1007/BF03401895; Xu B, 1999, FREE RADICAL BIO MED, V27, P830, DOI 10.1016/S0891-5849(99)00130-6; Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340, DOI 10.1152/ajpendo.2000.278.2.E340	35	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e34126	10.1371/journal.pone.0034126	http://dx.doi.org/10.1371/journal.pone.0034126			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470529	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100069
J	Goodenough, AE; Hart, AG; Stafford, R				Goodenough, Anne E.; Hart, Adam G.; Stafford, Richard			Regression with Empirical Variable Selection: Description of a New Method and Application to Ecological Datasets	PLOS ONE			English	Article							MODEL SELECTION; POSTFLEDGING SURVIVAL; PREDICTIVE MODEL; GREAT TITS; ALGORITHMS; INFERENCE; NOISE; BIRDS; SIZE	Despite recent papers on problems associated with full-model and stepwise regression, their use is still common throughout ecological and environmental disciplines. Alternative approaches, including generating multiple models and comparing them post-hoc using techniques such as Akaike's Information Criterion (AIC), are becoming more popular. However, these are problematic when there are numerous independent variables and interpretation is often difficult when competing models contain many different variables and combinations of variables. Here, we detail a new approach, REVS (Regression with Empirical Variable Selection), which uses all-subsets regression to quantify empirical support for every independent variable. A series of models is created; the first containing the variable with most empirical support, the second containing the first variable and the next most-supported, and so on. The comparatively small number of resultant models (n = the number of predictor variables) means that post-hoc comparison is comparatively quick and easy. When tested on a real dataset - habitat and offspring quality in the great tit (Parus major) - the optimal REVS model explained more variance (higher R-2), was more parsimonious (lower AIC), and had greater significance (lower P values), than full, stepwise or all-subsets models; it also had higher predictive accuracy based on split-sample validation. Testing REVS on ten further datasets suggested that this is typical, with R-2 values being higher than full or stepwise models (mean improvement = 31% and 7%, respectively). Results are ecologically intuitive as even when there are several competing models, they share a set of "core'' variables and differ only in presence/absence of one or two additional variables. We conclude that REVS is useful for analysing complex datasets, including those in ecology and environmental disciplines.	[Goodenough, Anne E.; Hart, Adam G.] Univ Gloucestershire, Dept Nat & Social Sci, Cheltenham, Glos, England; [Stafford, Richard] Univ Bedfordshire, Luton Inst Res Appl Nat Sci, Luton, Beds, England	University of Gloucestershire; University of Bedfordshire	Goodenough, AE (corresponding author), Univ Gloucestershire, Dept Nat & Social Sci, Cheltenham, Glos, England.	aegoodenough@glos.ac.uk	Stafford, Rick/B-1059-2013	Stafford, Rick/0000-0002-1964-5787; Goodenough, Anne/0000-0002-7662-6670				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALLISON T, 1976, SCIENCE, V194, P732, DOI 10.1126/science.982039; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; BERK KN, 1978, TECHNOMETRICS, V20, P1, DOI 10.2307/1268153; Bertolino S, 2007, ETHOL ECOL EVOL, V19, P51; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bolker B, 2008, ECOLOGICAL MODELS DA; Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; BREIMAN L, 1995, TECHNOMETRICS, V37, P373, DOI 10.2307/1269730; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calcagno V, 2010, J STAT SOFTW, V34, P1; Chatfield C., 1995, PROBLEM SOLVING STAT; Crawley MJ, 2005, STAT INTRO USING R; Datta S, 2007, BIOMETRICS, V63, P259, DOI 10.1111/j.1541-0420.2006.00660.x; DERKSEN S, 1992, BRIT J MATH STAT PSY, V45, P265, DOI 10.1111/j.2044-8317.1992.tb00992.x; EFRON B, 1986, J AM STAT ASSOC, V81, P461, DOI 10.2307/2289236; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Fan JQ, 2010, STAT SINICA, V20, P101; Faraway J.J., 2002, PRACTICAL REGRESSION; Foster DP, 2004, J AM STAT ASSOC, V99, P303, DOI 10.1198/016214504000000287; Gatu C, 2006, J COMPUT GRAPH STAT, V15, P139, DOI 10.1198/106186006X100290; George EI, 2000, J AM STAT ASSOC, V95, P1304, DOI 10.2307/2669776; Ginzburg LR, 2004, TRENDS ECOL EVOL, V19, P121, DOI 10.1016/j.tree.2003.11.004; Goodenough AE, 2008, ETHOL ECOL EVOL, V20, P375, DOI 10.1080/08927014.2008.9522518; Goodenough AE, 2010, 6 INT HOL NEST BIRD; Gosler AG, 1998, BIRD STUDY, V45, P92, DOI 10.1080/00063659809461082; Grieco F, 2003, CONDOR, V105, P599, DOI 10.1650/7177; HAYWOOD S, 1992, P ROY SOC B-BIOL SCI, V249, P195, DOI 10.1098/rspb.1992.0103; Hegyi G, 2011, BEHAV ECOL SOCIOBIOL, V65, P69, DOI 10.1007/s00265-010-1036-7; JAMES F C, 1970, Audubon Field Notes, V24, P727; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Klecka W. R., 1980, DISCRIMINANT ANAL; Liebminger A, 2007, SCAND S CHEM LAPP FI; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Lumley T, 2009, PACKAGE LEAPS REGRES; Manly BF, 1992, RESOURCE SELECTION A; McGarigal K., 2000, MULTIVARIATE STAT WI; McLeod A.I., 2010, BESTGLM BEST SUBSET; Miller AJ, 2002, SUBSET SELECTION REG, DOI DOI 10.1201/9781420035933; Monros JS, 2002, OIKOS, V99, P481, DOI 10.1034/j.1600-0706.2002.11909.x; Mundry R, 2009, AM NAT, V173, P119, DOI 10.1086/593303; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; Olden JD, 2000, ECOSCIENCE, V7, P501, DOI 10.1080/11956860.2000.11682622; RENCHER AC, 1980, TECHNOMETRICS, V22, P49, DOI 10.2307/1268382; Shaw P.J.A., 2003, MULTIVARIATE STAT EN; Shtatland ES, 2001, P 26 ANN SAS US GROU; Sokal R.R., 2012, BIOMETRY; Stephens PA, 2007, TRENDS ECOL EVOL, V22, P192, DOI 10.1016/j.tree.2006.12.003; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Toner M, 1997, ECOL APPL, V7, P236, DOI 10.1890/1051-0761(1997)007[0236:RHARWA]2.0.CO;2; VANSICKLE J, 1996, ECOL APPL, V6, P408; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Yuan M, 2006, J R STAT SOC B, V68, P49, DOI 10.1111/j.1467-9868.2005.00532.x; Garamszegi LZ, 2009, BEHAV ECOL, V20, P1363, DOI 10.1093/beheco/arp137	55	43	43	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34338	10.1371/journal.pone.0034338	http://dx.doi.org/10.1371/journal.pone.0034338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479605	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100150
J	Hirai, H; Katoku-Kikyo, N; Karian, P; Firpo, M; Kikyo, N				Hirai, Hiroyuki; Katoku-Kikyo, Nobuko; Karian, Peter; Firpo, Meri; Kikyo, Nobuaki			Efficient iPS Cell Production with the MyoD Transactivation Domain in Serum-Free Culture	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; MOUSE; EXPRESSION	A major difficulty of producing induced pluripotent stem cells (iPSCs) has been the low efficiency of reprogramming differentiated cells into pluripotent cells. We previously showed that 5% of mouse embryonic fibroblasts (MEFs) were reprogrammed into iPSCs when they were transduced with a fusion gene composed of Oct4 and the transactivation domain of MyoD (called M3O), along with Sox2, Klf4 and c-Myc (SKM). In addition, M3O facilitated chromatin remodeling of pluripotency genes in the majority of transduced MEFs, including cells that did not become iPSCs. These observations suggested the possibility that more than 5% of cells had acquired the ability to become iPSCs given more favorable culture conditions. Here, we raised the efficiency of making mouse iPSCs with M3O-SKM to 26% by culturing transduced cells at low density in serum-free culture medium. In contrast, the efficiency increased from 0.1% to only 2% with the combination of wild-type Oct4 and SKM (OSKM) under the same culture condition. For human iPSCs, M3O-SKM achieved 7% efficiency under a similar serum-free culture condition, in comparison to 1% efficiency with OSKM. This study highlights the power of combining the transactivation domain of MyoD with a favorable culture environment.	[Hirai, Hiroyuki; Katoku-Kikyo, Nobuko; Karian, Peter; Firpo, Meri; Kikyo, Nobuaki] Univ Minnesota, Dept Med, Stem Cell Inst, Minneapolis, MN 55455 USA; [Hirai, Hiroyuki; Karian, Peter; Kikyo, Nobuaki] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA; [Firpo, Meri] Univ Minnesota, Dept Med, Div Endocrinol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Hirai, H (corresponding author), Univ Minnesota, Dept Med, Stem Cell Inst, Box 736 UMHC, Minneapolis, MN 55455 USA.	kikyo001@umn.edu	Hirai, Hiroyuki/A-6866-2019	Hirai, Hiroyuki/0000-0001-7302-7587	comprehensive Masonic Cancer Center NIH [P30 CA077598-09]; Richard M. Schulze Family Foundation; National Institutes of Health [R01 DK082430]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082430] Funding Source: NIH RePORTER	comprehensive Masonic Cancer Center NIH; Richard M. Schulze Family Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Histological preparation was supported by the comprehensive Masonic Cancer Center NIH Grant (P30 CA077598-09). M. F. and N.K. were supported by Richard M. Schulze Family Foundation. N.K. was supported by a grant from the National Institutes of Health (R01 DK082430). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Gonzalez F, 2011, NAT REV GENET, V12, P231, DOI 10.1038/nrg2937; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hirai H, 2011, STEM CELLS, V29, P1349, DOI 10.1002/stem.684; Hirai H, 2010, INT J DEV BIOL, V54, P1589, DOI 10.1387/ijdb.103194hh; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Okada M, 2010, BBA-GEN SUBJECTS, V1800, P956, DOI 10.1016/j.bbagen.2010.04.004; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang Y, 2011, EMBO REP, V12, P373, DOI 10.1038/embor.2011.11; Watanabe S, 2011, STEM CELLS, V29, P505, DOI 10.1002/stem.598	16	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34149	10.1371/journal.pone.0034149	http://dx.doi.org/10.1371/journal.pone.0034149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479546	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100125
J	Iwanaga, S; Kato, T; Kaneko, I; Yuda, M				Iwanaga, Shiroh; Kato, Tomomi; Kaneko, Izumi; Yuda, Masao			Centromere Plasmid: A New Genetic Tool for the Study of Plasmodium falciparum	PLOS ONE			English	Article							RED-BLOOD-CELLS; MALARIA PARASITES; TRANSCRIPTION FACTOR; DNA; CHROMOSOME; SEQUENCE; IDENTIFICATION; TRANSFORMATION; TRANSFECTION; ERYTHROCYTES	The introduction of transgenes into Plasmodium falciparum, a highly virulent human malaria parasite, has been conducted either by single crossover recombination or by using episomal plasmids. However, these techniques remain insufficient because of the low transfection efficiency and the low frequency of recombination. To improve the genetic manipulation of P. falciparum, we developed the centromere plasmid as a new genetic tool. First, we attempted to clone all of the predicted centromeres from P. falciparum into E. coli cells but failed because of the high A/T contents of these sequences. To overcome this difficulty, we identified the common sequence features of the centromere of Plasmodium spp. and designed a small centromere that retained those features. The centromere plasmid constructed with the small centromere sequence, pFCEN, segregated into daughter parasites with approximately 99% efficiency, resulting in the stable maintenance of this plasmid in P. falciparum even in the absence of drug selection. This result demonstrated that the small centromere sequence harboured in pFCEN could function as an actual centromere in P. falciparum. In addition, transgenic parasites were more rapidly generated when using pFCEN than when using the control plasmid, which did not contain the centromere sequence. Furthermore, in contrast to the control plasmid, pFCEN did not form concatemers and, thus, was maintained as a single copy over multiple cell divisions. These unique properties of the pFCEN plasmid will solve the current technical limitations of the genetic manipulation of P. falciparum, and thus, this plasmid will become a standard genetic tool for the study of this parasite.	[Iwanaga, Shiroh; Kato, Tomomi; Kaneko, Izumi; Yuda, Masao] Mie Univ, Sch Med, Tsu, Mie 514, Japan	Mie University	Iwanaga, S (corresponding author), Mie Univ, Sch Med, Tsu, Mie 514, Japan.	iwanaga@doc.medic.mie-u.ac.jp; m-yuda@doc.medic.mie-u.ac.jp		Iwanaga, Shiroh/0000-0002-4394-7267	Ministry of Education, Science, Culture, and Sports of Japan (MEXT) [21022032, 21790406, 20249023, 21022019]; NEXT program; MEXT; Grants-in-Aid for Scientific Research [23659210] Funding Source: KAKEN	Ministry of Education, Science, Culture, and Sports of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEXT program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by the Ministry of Education, Science, Culture, and Sports of Japan (MEXT) (Grants 21022032 and 21790406 to S. I., and Grants 20249023 and 21022019 to M.Y.). In addition, this work is supported by NEXT program, which is funded by MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Enserink M, 2010, SCIENCE, V328, P844, DOI 10.1126/science.328.5980.844; Flueck C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000784; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Gerald N, 2011, EUKARYOT CELL, V10, P474, DOI 10.1128/EC.00314-10; Goldberg DE, 2010, NAT REV MICROBIOL, V8, P617, DOI 10.1038/nrmicro2420; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; Iwanaga S, 2010, CELL HOST MICROBE, V7, P245, DOI 10.1016/j.chom.2010.02.010; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Morris CA, 2007, CELL, V128, P647, DOI 10.1016/j.cell.2007.02.002; O'Donnell RA, 2001, NUCLEIC ACIDS RES, V29, P716, DOI 10.1093/nar/29.3.716; Perpelescu M, 2011, CHROMOSOMA, V120, P425, DOI 10.1007/s00412-011-0330-0; PLUTA AF, 1995, SCIENCE, V270, P1591, DOI 10.1126/science.270.5242.1591; vanDijk MR, 1997, MOL BIOCHEM PARASIT, V86, P155, DOI 10.1016/S0166-6851(97)02843-0; Waterkeyn JG, 1999, INT J PARASITOL, V29, P945, DOI 10.1016/S0020-7519(99)00047-8; Williamson DH, 2002, NUCLEIC ACIDS RES, V30, P726, DOI 10.1093/nar/30.3.726; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Wu YM, 1996, P NATL ACAD SCI USA, V93, P1130, DOI 10.1073/pnas.93.3.1130; Xiao H, 2011, MOL CELL, V43, P369, DOI 10.1016/j.molcel.2011.07.009; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	28	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33326	10.1371/journal.pone.0033326	http://dx.doi.org/10.1371/journal.pone.0033326			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479383	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100041
J	Klem, S; Klingler, M; Demmelmair, H; Koletzko, B				Klem, Sabrina; Klingler, Mario; Demmelmair, Hans; Koletzko, Berthold			Efficient and Specific Analysis of Red Blood Cell Glycerophospholipid Fatty Acid Composition	PLOS ONE			English	Article							LIPID-COMPOSITION; OMEGA-3 INDEX; PLASMA; STORAGE; SUPPLEMENTATION; HUMANS	Background: Red blood cell (RBC) n-3 fatty acid status is related to various health outcomes. Accepted biological markers for the fatty acid status determination are RBC phospholipids, phosphatidylcholine, and phosphatidyletholamine. The analysis of these lipid fractions is demanding and time consuming and total phospholipid n-3 fatty acid levels might be affected by changes of sphingomyelin contents in the RBC membrane during n-3 supplementation. Aim: We developed a method for the specific analysis of RBC glycerophospholipids. The application of the new method in a DHA supplementation trial and the comparison to established markers will determine the relevance of RBC GPL as a valid fatty acid status marker in humans. Methods: Methyl esters of glycerophospholipid fatty acids are selectively generated by a two step procedure involving methanolic protein precipitation and base-catalysed methyl ester synthesis. RBC GPL solubilisation is facilitated by ultrasound treatment. Fatty acid status in RBC glycerophospholipids and other established markers were evaluated in thirteen subjects participating in a 30 days supplementation trial (510 mg DHA/d). Outcome: The intra-assay CV for GPL fatty acids ranged from 1.0 to 10.5% and the inter-assay CV from 1.3 to 10.9%. Docosahexaenoic acid supplementation significantly increased the docosahexaenoic acid contents in all analysed lipid fractions. High correlations were observed for most of the mono-and polyunsaturated fatty acids, and for the omega-3 index (r = 0.924) between RBC phospholipids and glycerophospholipids. The analysis of RBC glycerophospholipid fatty acids yields faster, easier and less costly results equivalent to the conventional analysis of RBC total phospholipids.	[Klem, Sabrina; Klingler, Mario; Demmelmair, Hans; Koletzko, Berthold] Univ Munich, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp, Med Ctr, Munich, Germany	University of Munich	Klem, S (corresponding author), Univ Munich, Div Metab & Nutr Med, Dr von Hauner Childrens Hosp, Med Ctr, Munich, Germany.	office.koletzko@med.uni-muenchen.de			Federal Ministry of Education and Research [0315680B]; Freedom to Discover Award of the Bristol-Myers Squibb Foundation, New York, NY	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Freedom to Discover Award of the Bristol-Myers Squibb Foundation, New York, NY	This study was financially supported by the Federal Ministry of Education and Research (project number: 0315680B). B. Koletzko is the recipient of a Freedom to Discover Award of the Bristol-Myers Squibb Foundation, New York, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; Burdge GC, 2000, BRIT J NUTR, V84, P781; Carnielli VP, 1996, PEDIATR RES, V39, P671, DOI 10.1203/00006450-199604000-00019; Di Marino L, 2000, INT J CLIN LAB RES, V30, P197, DOI 10.1007/s005990070007; Fekete K, 2009, AM J CLIN NUTR, V89, p2070S, DOI 10.3945/ajcn.2009.27230I; FOLCH J, 1957, J BIOL CHEM, V226, P497; Geppert J, 2005, LIPIDS, V40, P807, DOI 10.1007/s11745-005-1442-9; Glaser C, 2009, HIGH THROUGHPUT METH; Glaser C, 2010, J LIPID RES, V51, P216, DOI 10.1194/jlr.D000547; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hermansson M, 2011, PROG LIPID RES, V50, P240, DOI 10.1016/j.plipres.2011.02.004; Hodson L, 2002, CLIN CHIM ACTA, V321, P63, DOI 10.1016/S0009-8981(02)00100-6; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Innis SM, 2003, AM J CLIN NUTR, V77, P473, DOI 10.1093/ajcn/77.2.473; Klingler M, 2012, BR J NUTR IN PRESS; Klingler M, 2011, LIPIDS; Koletzko B, 2008, J PERINAT MED, V36, P5, DOI 10.1515/JPM.2008.001; Otto SJ, 1997, EUR J CLIN CHEM CLIN, V35, P907; Plourde M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-5; POPPSNIJDERS C, 1984, SCAND J CLIN LAB INV, V44, P39, DOI 10.3109/00365518409083785; POPPSNIJDERS C, 1986, BIOCHIM BIOPHYS ACTA, V854, P31, DOI 10.1016/0005-2736(86)90061-1; ROSE HG, 1965, J LIPID RES, V6, P428; STANFORD JL, 1991, NUTR CANCER, V16, P183, DOI 10.1080/01635589109514156	23	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33874	10.1371/journal.pone.0033874	http://dx.doi.org/10.1371/journal.pone.0033874			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479463	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100077
J	Mazot, P; Cazes, A; Dingli, F; Degoutin, J; Irinopoulou, T; Boutterin, MC; Lombard, B; Loew, D; Hallberg, B; Palmer, RH; Delattre, O; Janoueix-Lerosey, I; Vigny, M				Mazot, Pierre; Cazes, Alex; Dingli, Florent; Degoutin, Joffrey; Irinopoulou, Theano; Boutterin, Marie-Claude; Lombard, Berangere; Loew, Damarys; Hallberg, Bengt; Palmer, Ruth Helen; Delattre, Olivier; Janoueix-Lerosey, Isabelle; Vigny, Marc			Internalization and Down-Regulation of the ALK Receptor in Neuroblastoma Cell Lines upon Monoclonal Antibodies Treatment	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; TYROSINE KINASE; EGF RECEPTOR; ACTIVATING MUTATIONS; INHIBITOR; GROWTH; IDENTIFICATION; ENDOCYTOSIS; MECHANISMS; CHIMERA	Recently, activating mutations of the full length ALK receptor, with two hot spots at positions F1174 and R1275, have been characterized in sporadic cases of neuroblastoma. Here, we report similar basal patterns of ALK phosphorylation between the neuroblastoma IMR-32 cell line, which expresses only the wild-type receptor (ALK(WT)), and the SH-SY5Y cell line, which exhibits a heterozygous ALK F1174L mutation and expresses both ALK(WT) and ALK(F1174L) receptors. We demonstrate that this lack of detectable increased phosphorylation in SH-SY5Y cells is a result of intracellular retention and proteasomal degradation of the mutated receptor. As a consequence, in SH-SY5Y cells, plasma membrane appears strongly enriched for ALK(WT) whereas both ALK(WT) and ALK(F1174L) were present in intracellular compartments. We further explored ALK receptor trafficking by investigating the effect of agonist and antagonist mAb (monoclonal antibodies) on ALK internalization and down-regulation, either in SH-SY5Y cells or in cells expressing only ALK(WT). We observe that treatment with agonist mAbs resulted in ALK internalization and lysosomal targeting for receptor degradation. In contrast, antagonist mAb induced ALK internalization and recycling to the plasma membrane. Importantly, we correlate this differential trafficking of ALK in response to mAb with the recruitment of the ubiquitin ligase Cbl and ALK ubiquitylation only after agonist stimulation. This study provides novel insights into the mechanisms regulating ALK trafficking and degradation, showing that various ALK receptor pools are regulated by proteasome or lysosome pathways according to their intracellular localization.	[Mazot, Pierre; Degoutin, Joffrey; Irinopoulou, Theano; Boutterin, Marie-Claude; Vigny, Marc] Univ Paris 06, Paris, France; [Mazot, Pierre; Degoutin, Joffrey; Irinopoulou, Theano; Boutterin, Marie-Claude; Vigny, Marc] INSERM, UMRS, Paris, France; [Mazot, Pierre; Degoutin, Joffrey; Irinopoulou, Theano; Boutterin, Marie-Claude; Vigny, Marc] Inst Fer Moulin, Paris, France; [Dingli, Florent; Lombard, Berangere; Loew, Damarys] Inst Curie, Ctr Rech, Lab Spectrometrie Masse Prote, Paris, France; [Cazes, Alex; Delattre, Olivier; Janoueix-Lerosey, Isabelle] Inst Curie, INSERM, Paris, France; [Hallberg, Bengt; Palmer, Ruth Helen] Umea Univ, Dept Mol Biol, Umea, Sweden	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Umea University	Mazot, P (corresponding author), Univ Paris 06, Paris, France.	isabelle.janoueix@curie.fr; marc.vigny@inserm.fr	Cazes, Alex/K-9899-2019; Janoueix-Lerosey, Isabelle/G-1758-2018	Janoueix-Lerosey, Isabelle/0000-0003-0434-3003; delattre, olivier/0000-0002-8730-2276; Damarys, Loew/0000-0002-9111-8842	Inserm; Universite Pierre et Marie Curie; Institut National du Cancer; Ligue Nationale contre le Cancer (Equipe labellisee); Association Hubert Gouin; Les Bagouz a Manon; les amis de Claire; Enfance et Sante	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Pierre et Marie Curie; Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Association Hubert Gouin; Les Bagouz a Manon; les amis de Claire; Enfance et Sante	Work at the Institut du Fer a Moulin UMR-S839 was supported by Inserm and Universite Pierre et Marie Curie. The U830 Inserm laboratory was supported by grants from the Institut National du Cancer, the Ligue Nationale contre le Cancer (Equipe labellisee), the Association Hubert Gouin, Les Bagouz a Manon, les amis de Claire and Enfance et Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertelsen V, 2011, TRAFFIC, V12, P507, DOI 10.1111/j.1600-0854.2011.01162.x; Buchwald M, 2010, LEUKEMIA, V24, P1412, DOI 10.1038/leu.2010.114; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Galkin AV, 2007, P NATL ACAD SCI USA, V104, P270, DOI 10.1073/pnas.0609412103; George P, 2005, BLOOD, V105, P1768, DOI 10.1182/blood-2004-09-3413; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Loren CE, 2003, EMBO REP, V4, P781, DOI 10.1038/sj.embor.embor897; Madshus IH, 2009, J CELL SCI, V122, P3433, DOI 10.1242/jcs.050260; Martinelli G, 2009, NAT CLIN PRACT ONCOL, V6, P68, DOI 10.1038/ncponc1276; Mathivet T, 2007, CELL SIGNAL, V19, P2434, DOI 10.1016/j.cellsig.2007.07.011; Mazot P, 2011, ONCOGENE, V30, P2017, DOI 10.1038/onc.2010.595; Milkiewicz KL, 2010, EXPERT OPIN THER PAT; Moog-Lutz C, 2005, J BIOL CHEM, V280, P26039, DOI 10.1074/jbc.M501972200; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Motegi A, 2004, J CELL SCI, V117, P3319, DOI 10.1242/jcs.01183; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Piccinini G, 2002, J BIOL CHEM, V277, P22231, DOI 10.1074/jbc.M111145200; Reiner DJ, 2008, CURR BIOL, V18, P1101, DOI 10.1016/j.cub.2008.06.060; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Serresi M, 2004, ONCOGENE, V23, P1098, DOI 10.1038/sj.onc.1207227; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19	31	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33581	10.1371/journal.pone.0033581	http://dx.doi.org/10.1371/journal.pone.0033581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479414	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100058
J	Ali, RA; Landsberg, MJ; Knauth, E; Morgan, GP; Marsh, BJ; Hankamer, B				Ali, Rubbiya A.; Landsberg, Michael J.; Knauth, Emily; Morgan, Garry P.; Marsh, Brad J.; Hankamer, Ben			A 3D Image Filter for Parameter-Free Segmentation of Macromolecular Structures from Electron Tomograms	PLOS ONE			English	Article							CRYO-EM MICROGRAPHS; EDGE-DETECTION; RESOLUTION; PARTICLES; RECONSTRUCTIONS; BSOFT	3D image reconstruction of large cellular volumes by electron tomography (ET) at high (<= 5 nm) resolution can now routinely resolve organellar and compartmental membrane structures, protein coats, cytoskeletal filaments, and macromolecules. However, current image analysis methods for identifying in situ macromolecular structures within the crowded 3D ultrastructural landscape of a cell remain labor-intensive, time-consuming, and prone to user-bias and/or error. This paper demonstrates the development and application of a parameter-free, 3D implementation of the bilateral edge-detection (BLE) algorithm for the rapid and accurate segmentation of cellular tomograms. The performance of the 3D BLE filter has been tested on a range of synthetic and real biological data sets and validated against current leading filters- the pseudo 3D recursive and Canny filters. The performance of the 3D BLE filter was found to be comparable to or better than that of both the 3D recursive and Canny filters while offering the significant advantage that it requires no parameter input or optimisation. Edge widths as little as 2 pixels are reproducibly detected with signal intensity and grey scale values as low as 0.72% above the mean of the background noise. The 3D BLE thus provides an efficient method for the automated segmentation of complex cellular structures across multiple scales for further downstream processing, such as cellular annotation and sub-tomogram averaging, and provides a valuable tool for the accurate and high-throughput identification and annotation of 3D structural complexity at the subcellular level, as well as for mapping the spatial and temporal rearrangement of macromolecular assemblies in situ within cellular tomograms.	[Ali, Rubbiya A.; Landsberg, Michael J.; Knauth, Emily; Morgan, Garry P.; Marsh, Brad J.; Hankamer, Ben] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland	Ali, RA (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia.	b.hankamer@imb.uq.edu.au	Landsberg, Michael/A-3363-2011; Hankamer, Ben D/C-9688-2015; Ali, Rubbiya/D-9044-2017	Landsberg, Michael/0000-0002-2464-990X; Hankamer, Ben D/0000-0001-9284-4929; Ali, Rubbiya/0000-0003-3241-5692	Australian Research Council [DP1093287]	Australian Research Council(Australian Research Council)	This work was supported by grant number DP1093287 from the Australian Research Council (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiga PSU, 2004, J STRUCT BIOL, V145, P142, DOI 10.1016/j.jsb.2003.10.025; Adiga U, 2005, J STRUCT BIOL, V152, P211, DOI 10.1016/j.jsb.2005.09.007; Baumeister W, 2002, CURR OPIN STRUC BIOL, V12, P679, DOI 10.1016/S0959-440X(02)00378-0; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; Deriche D, 1988, 9 INT C PATT REC, DOI [10.1109/ICPR.1988.28300, DOI 10.1109/ICPR.1988.28300]; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Heymann JB, 2008, J STRUCT BIOL, V161, P232, DOI 10.1016/j.jsb.2007.08.002; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hrabe T, 2011, STRUCTURE DETERMINAT; Jimenez N, 2009, J STRUCT BIOL, V166, P103, DOI 10.1016/j.jsb.2008.12.009; Jin Y., 2006, MULTIOBJECTIVE MACHI; JOHN C, 1986, IEEE T PATTERN ANAL, V8, P679; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Ludtke SJ, 2004, STRUCTURE, V12, P1129, DOI 10.1016/j.str.2004.05.006; Mallick SP, 2004, J STRUCT BIOL, V145, P52, DOI 10.1016/j.jsb.2003.11.005; Marsh BJ, 2004, P NATL ACAD SCI USA, V101, P5565, DOI 10.1073/pnas.0401242101; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; MONGA O, 1991, IMAGE VISION COMPUT, V9, P203, DOI 10.1016/0262-8856(91)90025-K; Mussgnug JH, 2007, PLANT BIOTECHNOL J, V5, P802, DOI 10.1111/j.1467-7652.2007.00285.x; Pantelic RS, 2007, J STRUCT BIOL, V160, P93, DOI 10.1016/j.jsb.2007.07.005; Sonka M., 2014, IMAGE PROCESSING ANA; van der Heide P, 2007, J STRUCT BIOL, V158, P196, DOI 10.1016/j.jsb.2006.10.030; Volkmann N, 2002, J STRUCT BIOL, V138, P123, DOI 10.1016/S1047-8477(02)00009-6; Volkmann N, 2010, METHOD ENZYMOL, V483, P31, DOI 10.1016/S0076-6879(10)83002-2; Woolford D, 2007, J STRUCT BIOL, V159, P122, DOI 10.1016/j.jsb.2007.03.003; Woolford D, 2007, J STRUCT BIOL, V157, P174, DOI 10.1016/j.jsb.2006.04.006; Yu ZY, 2004, J STRUCT BIOL, V145, P168, DOI 10.1016/j.jsb.2003.10.027; Zhu YX, 2003, IEEE T MED IMAGING, V22, P1053, DOI 10.1109/TMI.2003.816947	29	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33697	10.1371/journal.pone.0033697	http://dx.doi.org/10.1371/journal.pone.0033697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479430	Green Published, Green Submitted, gold			2022-12-27	WOS:000304523400029
J	Chen, WY; Lisowski, M; Khalil, G; Sweet, IR; Shen, AQ				Chen, Wanyu; Lisowski, Mark; Khalil, Gamal; Sweet, Ian R.; Shen, Amy Q.			Microencapsulated 3-Dimensional Sensor for the Measurement of Oxygen in Single Isolated Pancreatic Islets	PLOS ONE			English	Article							BETA-CELLS HIT; INSULIN-SECRETION; CALCIUM INFLUX; FREE CA2+; CONSUMPTION; ENCAPSULATION; OSCILLATIONS; MICROCAPSULES; FLUORESCENCE; LANGERHANS	Background: Oxygen consumption reflects multiple processes in pancreatic islets including mechanisms contributing to insulin secretion, oxidative stress and viability, providing an important readout in studies of islet function, islet viability and drug testing. Due to the scarcity, heterogeneity, and intrinsic kinetic properties of individual islets, it would be of great benefit to detect oxygen consumption by single islets. We present a novel method we have developed to image oxygen in single islets. Methodology/Principal Findings: Using a microfluidics system, individual islets and a fluorescent oxygen-sensitive dye were encased within a thin alginate polymer layer. Insulin secretion by the encapsulated islets was normal. Fluorescent signal from the encased dye, detected using a standard inverted fluorescence microscope and digital camera, was stable and proportional to the amount of oxygen in the media. When integrated into a perifusion system, the sensing system detected changes in response to metabolic substrates, mitochondrial poisons, and induced-oscillations. Glucose responses averaged 30.1 +/- 7.1% of the response to a metabolic inhibitor (cyanide), increases were observed in all cases (n = 6), and the system was able to resolve changes in oxygen consumption that had a period greater than 0.5 minutes. The sensing system operated similarly from 2-48 hours following encapsulation, and viability and function of the islets were not significantly affected by the encapsulation process. Conclusions/Significance: An oxygen-dependent dye situated around and within a pancreatic islet encapsulated by a thin layer of alginate was sensitive to changes in oxygen consumption, and was not harmful to the function or viability of islets over the course of two days. The microcapsule-based sensing method is particularly suited to assessing the effects of compounds (dose responses and time courses) and chronic changes occurring over the course of days. The approach should be applicable to other cell types and dyes sensitive to other biologically important molecules.	[Chen, Wanyu; Shen, Amy Q.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Lisowski, Mark; Sweet, Ian R.] Univ Washington, Dept Med, Seattle, WA USA; [Chen, Wanyu] Wuhan Univ Technol, Sch Mat Sci & Engn, Wuhan 430070, Peoples R China; [Khalil, Gamal] Univ Washington, Dept Aeronaut & Astronaut, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Wuhan University of Technology; University of Washington; University of Washington Seattle	Chen, WY (corresponding author), Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.	isweet@u.washington.edu	Shen, Amy/GVT-6125-2022; Shen, Amy Q/A-3598-2012	Shen, Amy Q/0000-0002-1222-6264	NIH (Cell Function Analysis Core) [DK 17047]; NSF (CBET-CAREER) [0852471]; University of Washington Royalty [65-5738]; Washington State Life Sciences Discovery Fund; National Science Foundation of China (NSFC) [51103113]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [0852471] Funding Source: National Science Foundation	NIH (Cell Function Analysis Core)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF (CBET-CAREER); University of Washington Royalty(University of Washington); Washington State Life Sciences Discovery Fund; National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding agencies include NIH (Cell Function Analysis Core, DK 17047), NSF (CBET-CAREER, 0852471), University of Washington Royalty Research Fund 65-5738, Washington State Life Sciences Discovery Fund, and National Science Foundation of China (NSFC 51103113).	Bae KH, 2006, BIOTECHNOL PROGR, V22, P297, DOI 10.1021/bp050312b; Carlsson PO, 1998, DIABETES, V47, P1027, DOI 10.2337/diabetes.47.7.1027; Chan LW, 2002, INT J PHARM, V242, P255, DOI 10.1016/S0378-5173(02)00169-2; Civelek VN, 1997, DIABETES, V46, P51, DOI 10.2337/diabetes.46.1.51; Dahgren GM, 2005, BBA-GEN SUBJECTS, V1724, P23, DOI 10.1016/j.bbagen.2005.04.007; Doliba NM, 2010, AM J PHYSIOL-ENDOC M, V299, pE475, DOI 10.1152/ajpendo.00072.2010; DUCHEN MR, 1993, BIOCHEM J, V294, P35, DOI 10.1042/bj2940035; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; Fraker C, 2006, CELL TRANSPLANT, V15, P745, DOI 10.3727/000000006783981440; Fraker CA, 2007, STEM CELLS, V25, P3155, DOI 10.1634/stemcells.2007-0445; Fraker CA, 2009, BIOL CELL, V101, P431, DOI 10.1042/BC20080178; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hall KK, 2011, ACTA BIOMATER, V7, P614, DOI 10.1016/j.actbio.2010.07.016; Hume PS, 2011, J BIOMED MATER RES A, V99A, P29, DOI 10.1002/jbm.a.33160; Johnson AS, 2011, TISSUE ENG PART C-ME, V17, P435, DOI [10.1089/ten.tec.2009.0510, 10.1089/ten.TEC.2009.0510]; Jung SR, 2009, AM J PHYSIOL-ENDOC M, V297, pE717, DOI 10.1152/ajpendo.00282.2009; Jung SK, 2000, J BIOL CHEM, V275, P6642, DOI 10.1074/jbc.275.9.6642; Jung SK, 1999, ANAL CHEM, V71, P3642, DOI 10.1021/ac990271w; Kim C, 2011, LAB CHIP, V11, P246, DOI [10.1039/c0lc00036a, 10.1039/c01c00036a]; Kulkarni RN, 2004, DIABETES, V53, P1517, DOI 10.2337/diabetes.53.6.1517; Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766; Morimoto Y, 2009, LAB CHIP, V9, P2217, DOI 10.1039/b900035f; Niswender CM, 2005, GENESIS, V43, P109, DOI 10.1002/gene.20159; O'Sullivan ES, 2010, DIABETOLOGIA, V53, P937, DOI 10.1007/s00125-009-1653-8; PANTEN U, 1973, DIABETOLOGIA, V9, P477, DOI 10.1007/BF00461692; Papkovsky DB, 2000, BIOCHEM SOC T, V28, P74, DOI 10.1042/bst0280074; Porterfield DM, 2000, DIABETES, V49, P1511, DOI 10.2337/diabetes.49.9.1511; Rabanel JM, 2009, BIOTECHNOL PROGR, V25, P946, DOI 10.1002/btpr.226; Robson-Doucette CA, 2011, DIABETES, V60, P2710, DOI 10.2337/db11-0132; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Sweet IR, 2008, AM J TRANSPLANT, V8, P183, DOI 10.1111/j.1600-6143.2007.02041.x; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P661, DOI 10.1089/152091502320798303; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Sweet IR, 2005, TRANSPLANTATION, V80, P1003, DOI 10.1097/01.tp.0000178381.35014.37; Sweet IR, 2004, DIABETES, V53, P401, DOI 10.2337/diabetes.53.2.401; TALJEDAL IB, 1978, J CELL BIOL, V76, P652, DOI 10.1083/jcb.76.3.652; Tan WH, 2007, ADV MATER, V19, P2696, DOI 10.1002/adma.200700433; Thakur A, 2010, J BIOMED MATER RES B, V94B, P296, DOI 10.1002/jbm.b.31648; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vetterli L, 2011, J BIOL CHEM, V286, P6049, DOI 10.1074/jbc.M110.176842; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wikstrom J, 2008, BIOMATERIALS, V29, P869, DOI 10.1016/j.biomaterials.2007.10.056; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Zimmermann H, 2007, APPL PHYS A-MATER, V89, P909, DOI 10.1007/s00339-007-4270-8	45	17	19	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33070	10.1371/journal.pone.0033070	http://dx.doi.org/10.1371/journal.pone.0033070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479359	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400011
J	Heikinheimo, T; Chimbayo, D; Kumwenda, JJ; Kampondeni, S; Allain, TJ				Heikinheimo, Terttu; Chimbayo, Daniel; Kumwenda, Johnstone J.; Kampondeni, Sam; Allain, Theresa J.			Stroke Outcomes in Malawi, a Country with High Prevalence of HIV: A Prospective Follow-Up Study	PLOS ONE			English	Article							YOUNG	Background: Stroke contributes significantly to disability and mortality in developing countries yet little is known about the determinants of stroke outcomes in such countries. 12% of Malawian adults have HIV/AIDS. It is not known whether having HIV-infection alters the outcome of stroke. The aim of this study was to document the functional outcome and mortality at 1 year of first-ever acute stroke in Malawi. Also to find out if the baseline variables, including HIV-infection, affect the outcome of stroke. Methods and Findings: 147 adult patients with first-ever acute stroke were prospectively followed up for 12 months. Conventional risk factors and HIV-infection were assessed at baseline. Stroke severity was evaluated with modified National Institute of Health Stroke Scale (mNIHSS) and functional outcome with modified Rankin scale (mRS). Fifty (34%) of patients were HIV-seropositive. 53.4% of patients had a poor outcome (severe disability or death, mRS 4-6) at 1 year. Poor outcome was related to stroke severity and female gender but not to presence of HIV-infection. HIV-seropositive patients were younger and had less often common risk factors for stroke. They suffer more often ischemic stroke than HIV-seronegative patients. Conclusions: Mild stroke and male gender were associated with favourable outcome. HIV-infection is common in stroke patients in Malawi but does not worsen the outcome of stroke. However, it may be a risk factor for ischemic stroke for young people, who do not have the common stroke risk factors. Our results are significant, because stroke outcome in HIV-seropositive patients has not been studied before in a setting such as ours, with very limited resources and a high prevalence of HIV.	[Heikinheimo, Terttu] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Heikinheimo, Terttu; Chimbayo, Daniel; Kumwenda, Johnstone J.; Allain, Theresa J.] Coll Med, Dept Med, Blantyre, Malawi; [Kampondeni, Sam] Coll Med, Dept Radiol, Blantyre, Malawi	University of Helsinki; Helsinki University Central Hospital; University of Malawi; University of Malawi	Heikinheimo, T (corresponding author), Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland.	tepuhei@gmail.com			Maire Taponen Foundation	Maire Taponen Foundation	Maire Taponen Foundation (www.mairetaposensaatio.fi). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2007, HIV CAS DEF SURV REV; [Anonymous], 2008, GUID US ANT THER MAL; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Connor MD, 2009, STROKE, V40, P355, DOI 10.1161/STROKEAHA.108.521609; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; Diouf F. Sene, 2006, Annales de Readaptation et de Medecine Physique, V49, P100; Garbusinski JM, 2005, STROKE, V36, P1388, DOI 10.1161/01.STR.0000170717.91591.7d; Hoffmann M, 2000, J NEUROVIROL, V6, P229, DOI 10.3109/13550280009015825; Kumwenda JJ, 2005, STROKE, V36, P960, DOI 10.1161/01.STR.0000162585.97216.ef; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; Malawi National Statistical Office ORC Macro, 2004, MAL DEM HLTH SURV; Mensah GA., 2004, ATLAS HEART DIS STRO; Modi Girish, 2008, Expert Rev Neurother, V8, P1247, DOI 10.1586/14737175.8.8.1247; Ovbiagele B, 2011, NEUROLOGY, V76, P444, DOI 10.1212/WNL.0b013e31820a0cfc; Patel VB, 2005, NEUROLOGY, V65, P759, DOI 10.1212/01.wnl.0000174434.00402.b5; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Subsai K, 2006, EUR J NEUROL, V13, P233, DOI 10.1111/j.1468-1331.2006.01178.x; Tipping B, 2007, J NEUROL NEUROSUR PS, V78, P1320, DOI 10.1136/jnnp.2007.116103; UNDP, 2011, HUM DEV IND; Voelker R, 2011, JAMA-J AM MED ASSOC, V305, P552, DOI 10.1001/jama.2011.101; WHO, 2008, COUNTR HLTH PROF; WHO and Ministry of Health in Malawi, 2010, MAL NAT STEPS SURV C; World Health Organization, 1978, CER DIS CLIN RES CLA; World Health Organization, 2006, DEF DIAGN DIAB INT H	26	40	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33765	10.1371/journal.pone.0033765	http://dx.doi.org/10.1371/journal.pone.0033765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479439	gold, Green Published, Green Submitted			2022-12-27	WOS:000304523400034
J	Szymanska, B; Wilczynska-Kalak, U; Kang, MH; Liem, NLM; Carol, H; Boehm, I; Groepper, D; Reynolds, CP; Stewart, CF; Lock, RB				Szymanska, Barbara; Wilczynska-Kalak, Urszula; Kang, Min H.; Liem, Natalia L. M.; Carol, Hernan; Boehm, Ingrid; Groepper, Daniel; Reynolds, C. Patrick; Stewart, Clinton F.; Lock, Richard B.			Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts	PLOS ONE			English	Article							B-CELL PRECURSOR; TERM-FOLLOW-UP; CHILDHOOD LEUKEMIA; MIMETIC ABT-737; SCID MICE; DEXAMETHASONE; ASPARAGINASE; CANCER; VINCRISTINE; RESISTANCE	Current regimens for induction therapy of pediatric acute lymphoblastic leukemia (ALL), or for re-induction post relapse, use a combination of vincristine (VCR), a glucocorticoid, and L-asparaginase (ASP) with or without an anthracycline. With cure rates now approximately 80%, robust pre-clinical models are necessary to prioritize active new drugs for clinical trials in relapsed/refractory patients, and the ability of these models to predict synergy/antagonism with established therapy is an essential attribute. In this study, we report optimization of an induction-type regimen by combining VCR, dexamethasone (DEX) and ASP (VXL) against ALL xenograft models established from patient biopsies in immune-deficient mice. We demonstrate that the VXL combination was synergistic in vitro against leukemia cell lines as well as in vivo against ALL xenografts. In vivo, VXL treatment caused delays in progression of individual xenografts ranging from 22 to > 146 days. The median progression delay of xenografts derived from long-term surviving patients was 2-fold greater than that of xenografts derived from patients who died of their disease. Pharmacokinetic analysis revealed that systemic DEX exposure in mice increased 2-fold when administered in combination with VCR and ASP, consistent with clinical findings, which may contribute to the observed synergy between the 3 drugs. Finally, as proof-of-principle we tested the in vivo efficacy of combining VXL with either the Bcl-2/Bcl-xL/Bcl-w inhibitor, ABT-737, or arsenic trioxide to provide evidence of a robust in vivo platform to prioritize new drugs for clinical trials in children with relapsed/refractory ALL.	[Szymanska, Barbara; Wilczynska-Kalak, Urszula; Liem, Natalia L. M.; Carol, Hernan; Boehm, Ingrid; Lock, Richard B.] Univ New S Wales, Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia; [Kang, Min H.; Reynolds, C. Patrick] Texas Tech Univ, Hlth Sci Ctr, Lubbock, TX 79430 USA; [Groepper, Daniel; Stewart, Clinton F.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN USA	Children's Cancer Institute; Children's Medical Research Institute - Australia; University of New South Wales Sydney; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Szymanska, B (corresponding author), Univ New S Wales, Childrens Canc Inst Australia Med Res, Sydney, NSW, Australia.	rlock@ccia.unsw.edu.au	Lock, Richard/G-4253-2013; Stewart, Clinton/N-3822-2018; Carol, Hernan/F-5750-2013	Stewart, Clinton/0000-0002-1546-9720; Carol, Hernan/0000-0002-9443-8032; Reynolds, C. Patrick/0000-0002-2827-8536; Kang, Min H/0000-0003-3603-7035; Stacey, Ingrid/0000-0002-3032-6031; Lock, Richard/0000-0002-3436-9071	University of Southern California-Children's Hospital Los Angeles Institute for Pediatric Clinical Research; Children's Cancer Institute Australia for Medical Research	University of Southern California-Children's Hospital Los Angeles Institute for Pediatric Clinical Research; Children's Cancer Institute Australia for Medical Research	This work was supported by the University of Southern California-Children's Hospital Los Angeles Institute for Pediatric Clinical Research and by the Children's Cancer Institute Australia for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen BK, 2001, BRIT J CLIN PHARMACO, V52, P433, DOI 10.1046/j.0306-5251.2001.01464.x; Arico M, 2010, J CLIN ONCOL, V28, P4755, DOI 10.1200/JCO.2010.30.1325; Avramis VI, 2005, CLIN PHARMACOKINET, V44, P367, DOI 10.2165/00003088-200544040-00003; Bachmann PS, 2007, CANCER RES, V67, P4482, DOI 10.1158/0008-5472.CAN-06-4244; Bachmann PS, 2010, BLOOD, V116, P3013, DOI 10.1182/blood-2010-05-284968; Baersch G, 1997, KLIN PADIATR, V209, P178, DOI 10.1055/s-2008-1043947; Beal SL, 2006, NONMEM USERS GUIDE I; Borgmann A, 2000, PEDIATR HEMAT ONCOL, V17, P635, DOI 10.1080/08880010050211349; Bornhauser BC, 2007, BLOOD, V110, P2084, DOI 10.1182/blood-2006-12-060970; Chessells JM, 2003, BRIT J HAEMATOL, V123, P396, DOI 10.1046/j.1365-2141.2003.04584.x; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Dumontet C, 1999, J CLIN ONCOL, V17, P1061, DOI 10.1200/JCO.1999.17.3.1061; Ek O, 1998, LEUKEMIA LYMPHOMA, V31, P143, DOI 10.3109/10428199809057594; Frost BM, 2003, ACTA PAEDIATR, V92, P551, DOI 10.1080/08035320310000000; Gaynon PS, 2005, BRIT J HAEMATOL, V131, P579, DOI 10.1111/j.1365-2141.2005.05773.x; High LM, 2010, MOL PHARMACOL, V77, P483, DOI 10.1124/mol.109.060780; Horton TM, 2010, PEDIATR BLOOD CANCER, V54, P872, DOI 10.1002/pbc.22414; INABA M, 1988, JPN J CANCER RES, V79, P509, DOI 10.1111/j.1349-7006.1988.tb01620.x; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kang MH, 2007, BLOOD, V110, P2057, DOI 10.1182/blood-2007-03-080325; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keshelava N, 2005, METH MOLEC MED, V110, P139; Ko RH, 2010, J CLIN ONCOL, V28, P648, DOI 10.1200/JCO.2009.22.2950; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Liem NLM, 2004, BLOOD, V103, P3905, DOI 10.1182/blood-2003-08-2911; Litzow MR, 2006, HAEMATOLOGICA, V91, P1105; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; Lock R, 2008, PEDIATR BLOOD CANCER, V50, P1181, DOI 10.1002/pbc.21433; Lonnerholm G, 2008, BRIT J HAEMATOL, V142, P616, DOI 10.1111/j.1365-2141.2008.07235.x; Moore VD, 2008, BLOOD, V111, P2300, DOI 10.1182/blood-2007-06-098012; Narta UK, 2006, CRIT REV ONCOL HEMAT; Nijmeijer BA, 2001, EXP HEMATOL, V29, P322, DOI 10.1016/S0301-472X(00)00669-X; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Peterson JK, 2004, EUR J CANCER, V40, P837, DOI 10.1016/j.ejca.2004.01.003; Pieters R, 2008, BLOOD, V112, P4832, DOI 10.1182/blood-2008-04-149443; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; Pui CH, 2010, J FORMOS MED ASSOC, V109, P777, DOI 10.1016/S0929-6646(10)60123-4; Puisset F, 2005, BRIT J CLIN PHARMACO, V60, P45, DOI 10.1111/j.1365-2125.2005.02384.x; Rose WC, 2004, CLIN CANCER RES, V10, P7413, DOI 10.1158/1078-0432.CCR-04-1045; Schwartz C L, 1999, Oncologist, V4, P45; Skinner R, 2006, LANCET ONCOL, V7, P489, DOI 10.1016/S1470-2045(06)70724-0; Steele JPC, 1997, BLOOD, V90, P2015, DOI 10.1182/blood.V90.5.2015; Su N, 2008, PEDIATR BLOOD CANCER, V50, P274, DOI 10.1002/pbc.21213; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Toth GG, 2002, INT J DERMATOL, V41, P525, DOI 10.1046/j.1365-4362.2002.15452.x; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Whiteford CC, 2007, CANCER RES, V67, P32, DOI 10.1158/0008-5472.CAN-06-0610; Yang J, 2008, ACTA OTO-LARYNGOL, V128, P496, DOI 10.1080/00016480701558906; Yang L, 2008, J CLIN ONCOL, V26, P1932, DOI 10.1200/JCO.2007.13.8404; Zamboni WC, 1998, J NATL CANCER I, V90, P505, DOI 10.1093/jnci/90.7.505	53	44	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33894	10.1371/journal.pone.0033894	http://dx.doi.org/10.1371/journal.pone.0033894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479469	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400043
J	Low, LA; Fitzgerald, M				Low, Lucie A.; Fitzgerald, Maria			Acute Pain and a Motivational Pathway in Adult Rats: Influence of Early Life Pain Experience	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NEONATAL INTENSIVE-CARE; LONG-TERM CONSEQUENCES; HYPOTHALAMIC OREXIN NEURONS; EXTREMELY PRETERM CHILDREN; RECEPTIVE-FIELD SIZE; SCHOOL-AGED CHILDREN; DORSAL-HORN; MATERNAL-CARE; NEUROPATHIC PAIN	Background: The importance of neonatal experience upon behaviour in later life is increasingly recognised. The overlap between pain and reward pathways led us to hypothesise that neonatal pain experience influences reward-related pathways and behaviours in adulthood. Methodology/Principal Findings: Rat pups received repeat plantar skin incisions (neonatal IN) or control procedures (neonatal anesthesia only, AN) at postnatal days (P)3, 10 and 17. When adult, rats with neonatal 'pain history' showed greater sensory sensitivity than control rats following acute plantar skin incision. Motivational behaviour in the two groups of rats was tested in a novelty-induced hypophagia (NIH) paradigm. The sensitivity of this paradigm to pain-induced changes in motivational behaviour was shown by significant increases in the time spent in the central zone of the arena (43.7 +/- 5.9% vs. 22.5 +/- 6.7%, p<0.05), close to centrally placed food treats, and decreased number of rears (9.5 +/- 1.4 vs. 19.2 +/- 2.3, p<0.001) in rats with acute plantar skin incision compared to naive, uninjured animals. Rats with a neonatal 'pain history' showed the same pain-induced behaviour in the novelty-induced hypophagia paradigm as controls. However, differences were observed in reward-related neural activity between the two groups. Two hours after behavioural testing, brains were harvested and neuronal activity mapped using c-Fos expression in lateral hypothalamic orexin neurons, part of a specific reward seeking pathway. Pain-induced activity in orexin neurons of control rats (18.4 +/- 2.8%) was the same as in uninjured naive animals (15.5 +/- 2.6%), but in those rats with a 'pain history', orexinergic activity was significantly increased (27.2 +/- 4.1%, p<0.01). Furthermore the extent of orexin neuron activation in individual rats with a 'pain history' was highly correlated with their motivational behaviour (r = 20.86, p = 0.01). Conclusions/Significance: These results show that acute pain alters motivational behaviour and that neonatal pain experience causes long-term changes in brain motivational orexinergic pathways, known to modulate mesolimbic dopaminergic reward circuitry.	[Low, Lucie A.; Fitzgerald, Maria] UCL, Div Neurosci Physiol & Pharmacol, London, England; [Low, Lucie A.] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada	University of London; University College London; McGill University	Low, LA (corresponding author), UCL, Div Neurosci Physiol & Pharmacol, London, England.	lucie.low@mcgill.ca		Low, Lucie/0000-0001-6082-8625	London Pain Consortium; Medical Research Council [G0901269] Funding Source: researchfish; MRC [G0901269] Funding Source: UKRI	London Pain Consortium; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a London Pain Consortium 4-year PhD Studentship (LAL), which covered stipend, university fees, research costs and travel funds (http://www.lpc.ac.uk/html/index.php?dataid=309&pageid=51). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand KJS, 1999, PHYSIOL BEHAV, V66, P627, DOI 10.1016/S0031-9384(98)00338-2; Anand KJS, 2005, CLIN THER, V27, P814, DOI 10.1016/j.clinthera.2005.06.021; Aston-Jones G, 2010, BRAIN RES, V1314, P74, DOI 10.1016/j.brainres.2009.09.106; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Beggs S, 2002, EUR J NEUROSCI, V16, P1249, DOI 10.1046/j.1460-9568.2002.02185.x; Beggs S, 2011, BRAIN IN PRESS; Bhutta AT, 2001, PHYSIOL BEHAV, V73, P51, DOI 10.1016/S0031-9384(01)00432-2; Bingham S, 2001, PAIN, V92, P81, DOI 10.1016/S0304-3959(00)00470-X; Borgland SL, 2008, EUR J NEUROSCI, V28, P1545, DOI 10.1111/j.1460-9568.2008.06397.x; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Borgland SL, 2010, BRAIN RES, V1314, P139, DOI 10.1016/j.brainres.2009.10.068; Borgland SL, 2009, J NEUROSCI, V29, P11215, DOI 10.1523/JNEUROSCI.6096-08.2009; Borsook D, 2007, EUR J PAIN, V11, P7, DOI 10.1016/j.ejpain.2005.12.005; Boucher T, 1998, NEUROSCI LETT, V257, P9, DOI 10.1016/S0304-3940(98)00779-4; Brennan TJ, 1996, PAIN, V64, P493, DOI 10.1016/0304-3959(95)01441-1; BRITTON DR, 1981, PHARMACOL BIOCHEM BE, V15, P577, DOI 10.1016/0091-3057(81)90212-4; Carbajal R, 2008, JAMA-J AM MED ASSOC, V300, P60, DOI 10.1001/jama.300.1.60; Chahoud I, 2009, ENVIRON RES, V109, P1021, DOI 10.1016/j.envres.2009.07.015; Champagne FA, 2003, PHYSIOL BEHAV, V79, P359, DOI 10.1016/S0031-9384(03)00149-5; Champagne FA, 2007, BEHAV NEUROSCI, V121, P1353, DOI 10.1037/0735-7044.121.6.1353; Champagne FA, 2006, BIOL PSYCHIAT, V59, P1227, DOI 10.1016/j.biopsych.2005.10.016; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cheng JK, 2003, J PHARMACOL EXP THER, V307, P1065, DOI 10.1124/jpet.103.056663; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; De Lima J, 1999, BRIT J ANAESTH, V83, P662, DOI 10.1093/bja/83.4.662; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Ennaceur A, 2006, BEHAV BRAIN RES, V171, P26, DOI 10.1016/j.bbr.2006.03.016; FERRE P, 1995, PHARMACOL BIOCHEM BE, V51, P199, DOI 10.1016/0091-3057(94)00419-J; Georgescu D, 2003, J NEUROSCI, V23, P3106; GRUNAU RVE, 1994, PAIN, V58, P341, DOI 10.1016/0304-3959(94)90128-7; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Harris GC, 2007, BEHAV BRAIN RES, V183, P43, DOI 10.1016/j.bbr.2007.05.025; Hathway GJ, 2009, J PHYSIOL-LONDON, V587, P2927, DOI 10.1113/jphysiol.2008.168013; Hathway GJ, 2012, PAIN IN PRESS; Hermann C, 2006, PAIN, V125, P278, DOI 10.1016/j.pain.2006.08.026; Hohmeister J, 2009, EUR J PAIN, V13, P94, DOI 10.1016/j.ejpain.2008.03.004; Hughes RN, 2007, NEUROSCI BIOBEHAV R, V31, P441, DOI 10.1016/j.neubiorev.2006.11.004; Hummel M, 2008, PAIN, V140, P436, DOI 10.1016/j.pain.2008.09.020; JEN KLC, 1978, DEV PSYCHOBIOL, V11, P279, DOI 10.1002/dev.420110312; Jennings E, 1998, J PHYSIOL-LONDON, V509, P859, DOI 10.1111/j.1469-7793.1998.859bm.x; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2010, J AM ACAD CHILD PSY, V49, P453, DOI 10.1016/j.jaac.2010.02.002; Johnson S, 2010, J PEDIATR-US, V156, P525, DOI 10.1016/j.jpeds.2009.10.041; Johnston CC, 1997, CLIN J PAIN, V13, P308, DOI 10.1097/00002508-199712000-00008; Kajiyama S, 2005, BRAIN RES, V1044, P76, DOI 10.1016/j.brainres.2005.03.007; Korotkova TM, 2003, J NEUROSCI, V23, P7; LaBuda CJ, 2000, EXP NEUROL, V163, P490, DOI 10.1006/exnr.2000.7395; LaPrairie JL, 2007, PAIN, V132, pS124, DOI 10.1016/j.pain.2007.08.010; LaPrairie JL, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.031.2009; Laprairie JL, 2008, PEDIATR RES, V64, P625, DOI 10.1203/PDR.0b013e31818702d4; Lawrence AJ, 2006, BRIT J PHARMACOL, V148, P752, DOI 10.1038/sj.bjp.0706789; Lidow MS, 2001, NEUROREPORT, V12, P399, DOI 10.1097/00001756-200102120-00042; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Loyd DR, 2008, J NEUROSCI, V28, P14007, DOI 10.1523/JNEUROSCI.4123-08.2008; Millecamps M, 2004, PAIN, V109, P214, DOI 10.1016/j.pain.2003.12.028; PAPP M, 1991, PSYCHOPHARMACOLOGY, V104, P255, DOI 10.1007/BF02244188; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Peters JWB, 2005, PAIN, V114, P444, DOI 10.1016/j.pain.2005.01.014; Plaza-Zabala A, 2010, J NEUROSCI, V30, P2300, DOI 10.1523/JNEUROSCI.5724-09.2010; Pryce CR, 2001, BEHAV NEUROSCI, V115, P71, DOI 10.1037//0735-7044.115.1.71; Ren K, 2004, PAIN, V110, P588, DOI 10.1016/j.pain.2004.04.006; Ren K, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-27; REYNOLDS ML, 1995, J COMP NEUROL, V358, P487, DOI 10.1002/cne.903580403; Ririe DG, 2008, ANESTHESIOLOGY, V109, P698, DOI 10.1097/ALN.0b013e3181870a32; Robbins TW, 2002, PSYCHOPHARMACOLOGY, V163, P362, DOI 10.1007/s00213-002-1154-7; Ruda MA, 2000, SCIENCE, V289, P628, DOI 10.1126/science.289.5479.628; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schmelzle-Lublecki BM, 2007, EUR J PAIN, V11, P799, DOI 10.1016/j.ejpain.2006.12.009; Scott DJ, 2008, ARCH GEN PSYCHIAT, V65, P220, DOI 10.1001/archgenpsychiatry.2007.34; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; SHEPHARD RA, 1982, NEUROPHARMACOLOGY, V21, P337, DOI 10.1016/0028-3908(82)90097-1; SHEPHARD RA, 1982, NEUROPHARMACOLOGY, V21, P771, DOI 10.1016/0028-3908(82)90063-6; SHIMADA C, 1990, BEHAV BRAIN RES, V36, P105, DOI 10.1016/0166-4328(90)90165-B; Simons SHP, 2003, ARCH PEDIAT ADOL MED, V157, P1058, DOI 10.1001/archpedi.157.11.1058; Slater R, 2010, LANCET, V376, P1225, DOI 10.1016/S0140-6736(10)61303-7; Taddio A, 1997, LANCET, V349, P599, DOI 10.1016/S0140-6736(96)10316-0; Taddio A, 2009, PAIN, V144, P43, DOI 10.1016/j.pain.2009.02.012; TALBOT JD, 1991, SCIENCE, V251, P1355, DOI 10.1126/science.2003220; Thompson JL, 2011, BEHAV BRAIN RES, V217, P446, DOI 10.1016/j.bbr.2010.09.028; Torsney C, 2003, J PHYSIOL-LONDON, V550, P255, DOI 10.1113/jphysiol.2003.043661; Torsney C, 2000, DEV BRAIN RES, V121, P55, DOI 10.1016/S0165-3806(00)00024-9; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; VANPRAAG H, 1991, DEV BRAIN RES, V64, P71, DOI 10.1016/0165-3806(91)90210-A; Vittoz NM, 2008, EUR J NEUROSCI, V28, P1629, DOI 10.1111/j.1460-9568.2008.06453.x; Vittoz NM, 2006, NEUROPSYCHOPHARMACOL, V31, P384, DOI 10.1038/sj.npp.1300807; Walker SM, 2003, PAIN, V105, P185, DOI 10.1016/S0304-3959(03)00201-X; Walker SM, 2009, PAIN, V147, P99, DOI 10.1016/j.pain.2009.08.017; Walker SM, 2009, PAIN, V141, P79, DOI 10.1016/j.pain.2008.10.012; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; WEHMER F, 1978, DEV PSYCHOBIOL, V11, P353, DOI 10.1002/dev.420110408; Winsky-Sommerer R, 2004, J NEUROSCI, V24, P11439, DOI 10.1523/JNEUROSCI.3459-04.2004; Yamamoto T, 2003, NEUROSCI LETT, V347, P183, DOI 10.1016/S0304-3940(03)00716-X; Zhou Y, 2008, NEUROSCIENCE, V153, P1225, DOI 10.1016/j.neuroscience.2008.03.023; Zubieta JK, 2005, J NEUROSCI, V25, P7754, DOI 10.1523/JNEUROSCI.0439-05.2005	99	37	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34316	10.1371/journal.pone.0034316	http://dx.doi.org/10.1371/journal.pone.0034316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470556	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000095
J	Weng, ZY; Zhang, BD; Asadi, S; Sismanopoulos, N; Butcher, A; Fu, XY; Katsarou-Katsari, A; Antoniou, C; Theoharides, TC				Weng, Zuyi; Zhang, Bodi; Asadi, Shahrzad; Sismanopoulos, Nikolaos; Butcher, Alan; Fu, Xueyan; Katsarou-Katsari, Alexandra; Antoniou, Christina; Theoharides, Theoharis C.			Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CALCIUM-ION LEVELS; FC-EPSILON-RI; SODIUM-CROMOGLYCATE; HISTAMINE-SECRETION; MEDIATOR RELEASE; SUBSTANCE-P; DISODIUM-CROMOGLYCATE; PLANT FLAVONOIDS; TNF-ALPHA	Mast cells are immune cells critical in the pathogenesis of allergic, but also inflammatory and autoimmune diseases through release of many pro-inflammatory cytokines such as IL-8 and TNF. Contact dermatitis and photosensitivity are skin conditions that involve non-immune triggers such as substance P (SP), and do not respond to conventional treatment. Inhibition of mast cell cytokine release could be effective therapy for such diseases. Unfortunately, disodium cromoglycate (cromolyn), the only compound marketed as a mast cell "stabilizer'', is not particularly effective in blocking human mast cells. Instead, flavonoids are potent anti-oxidant and anti-inflammatory compounds with mast cell inhibitory actions. Here, we first compared the flavonoid quercetin (Que) and cromolyn on cultured human mast cells. Que and cromolyn (100 mu M) can effectively inhibit secretion of histamine and PGD(2). Que and cromolyn also inhibit histamine, leukotrienes and PGD(2) from primary human cord blood-derived cultured mast cells (hCBMCs) stimulated by IgE/Anti-IgE. However, Que is more effective than cromolyn in inhibiting IL-8 and TNF release from LAD2 mast cells stimulated by SP. Moreover, Que reduces IL-6 release from hCBMCs in a dose-dependent manner. Que inhibits cytosolic calcium level increase and NF-kappa B activation. Interestingly, Que is effective prophylactically, while cromolyn must be added together with the trigger or it rapidly loses its effect. In two pilot, open-label, clinical trials, Que significantly decreased contact dermatitis and photosensitivity, skin conditions that do not respond to conventional treatment. In summary, Que is a promising candidate as an effective mast cell inhibitor for allergic and inflammatory diseases, especially in formulations that permit more sufficient oral absorption.	[Weng, Zuyi; Zhang, Bodi; Asadi, Shahrzad; Sismanopoulos, Nikolaos; Theoharides, Theoharis C.] Tufts Univ Sch Med, Dept Mol Physiol & Pharmacol, Mol Immunopharmacol & Drug Discovery Lab, Boston, MA USA; [Weng, Zuyi; Zhang, Bodi; Theoharides, Theoharis C.] Tufts Univ, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Zhang, Bodi; Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA; [Asadi, Shahrzad] Tufts Med Ctr, Dept Pharm, Boston, MA USA; [Butcher, Alan] Thorne Res Inc, Sandpoint, ID USA; [Fu, Xueyan] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Vitamin K Lab, Boston, MA 02111 USA; [Katsarou-Katsari, Alexandra; Antoniou, Christina] Univ Athens, Sch Med, A Sygros Hosp, Dept Dermatol 1, GR-11527 Athens, Greece; [Theoharides, Theoharis C.] Tufts Univ, Sch Med, Dept Internal Med, Boston, MA 02111 USA; [Theoharides, Theoharis C.] Tufts Med Ctr, Boston, MA USA	Tufts University; Tufts University; Tufts University; Tufts Medical Center; Tufts University; United States Department of Agriculture (USDA); Athens Medical School; National & Kapodistrian University of Athens; Tufts University; Tufts Medical Center	Weng, ZY (corresponding author), Tufts Univ Sch Med, Dept Mol Physiol & Pharmacol, Mol Immunopharmacol & Drug Discovery Lab, Boston, MA USA.	theoharis.theoharides@tufts.edu	weng, zuyi/J-4147-2015; Zhang, Bodi/ABI-6738-2020					ARCHER RK, 1980, J ROY SOC MED, V73, P318, DOI 10.1177/014107688007300502; Ashton GHS, 2004, J INVEST DERMATOL, V122, P78, DOI 10.1046/j.0022-202X.2003.22136.x; ASHTON MJ, 1973, TOXICOL APPL PHARM, V26, P319, DOI 10.1016/0041-008X(73)90268-8; ASKENASE PW, 1983, J IMMUNOL, V131, P2687; BARRETT KE, 1985, J IMMUNOL, V135, P2020; BISSONNETTE EY, 1995, CLIN EXP IMMUNOL, V102, P78; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; Camarasa JG, 1997, CONTACT DERMATITIS, V36, P160, DOI 10.1111/j.1600-0536.1997.tb00402.x; Castells M, 2006, IMMUNOL ALLERGY CLIN, V26, P465, DOI 10.1016/j.iac.2006.05.005; Castells M, 2011, AM J CLIN DERMATOL, V12, P259, DOI 10.2165/11588890-000000000-00000; Castells MC, 2004, ALLERGY ASTHMA PROC, V25, P33; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; CHRISTENSEN OB, 1986, CONTACT DERMATITIS, V15, P183, DOI 10.1111/j.1600-0536.1986.tb01322.x; Donelan J, 2006, P NATL ACAD SCI USA, V103, P7759, DOI 10.1073/pnas.0602210103; dos Santos RV, 2010, BRIT J DERMATOL, V162, P674, DOI 10.1111/j.1365-2133.2009.09516.x; Douglas WW., 1974, SECRETORY MECHANISMS, P116; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; El-Nour H, 2006, IMMUNOPHARM IMMUNOT, V28, P621, DOI 10.1080/08923970601067136; ENNIS M, 1981, NATURE, V289, P186, DOI 10.1038/289186a0; Ferry DR, 1996, CLIN CANCER RES, V2, P659; FEWTRELL CMS, 1977, BIOCHIM BIOPHYS ACTA, V469, P52, DOI 10.1016/0005-2736(77)90325-X; FOREMAN JC, 1984, J ALLERGY CLIN IMMUN, V73, P769, DOI 10.1016/0091-6749(84)90446-9; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; FOX CC, 1988, J ALLERGY CLIN IMMUN, V81, P89, DOI 10.1016/0091-6749(88)90225-4; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; GALLI SJ, 1993, NEW ENGL J MED, V328, P257; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; GRUCHALLA RS, 1995, AM J MED SCI, V309, P328, DOI 10.1097/00000441-199506000-00007; GUGLER R, 1975, EUR J CLIN PHARMACOL, V9, P229, DOI 10.1007/BF00614022; Hart PH, 2002, METHODS, V28, P79, DOI 10.1016/S1046-2023(02)00201-3; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; Hirano T, 2004, INT ARCH ALLERGY IMM, V134, P135, DOI 10.1159/000078498; Huxley RR, 2004, J EPIDEMIOL COMMUN H, V58, P288, DOI 10.1136/jech.2003.014274; Igarashi Y, 1996, CLIN EXP ALLERGY, V26, P597; Kakurai M, 2006, AM J PATHOL, V169, P1713, DOI 10.2353/ajpath.2006.060602; Kasteleijn-Nolst Trenite D G, 1989, Acta Neurol Scand Suppl, V125, P3; Katsarou A, 2000, CONTACT DERMATITIS, V42, P85, DOI 10.1034/j.1600-0536.2000.042002085.x; Kempuraj D, 2005, BRIT J PHARMACOL, V145, P934, DOI 10.1038/sj.bjp.0706246; Kempuraj D, 2004, ENDOCRINOLOGY, V145, P43, DOI 10.1210/en.2003-0805; Kempuraj D, 2003, INT ARCH ALLERGY IMM, V132, P231, DOI 10.1159/000074304; Kempuraj D, 2008, BRIT J PHARMACOL, V155, P1076, DOI 10.1038/bjp.2008.356; Kimata M, 2000, CLIN EXP ALLERGY, V30, P501, DOI 10.1046/j.1365-2222.2000.00768.x; Kimata M, 1999, BIOCHEM BIOPH RES CO, V257, P895, DOI 10.1006/bbrc.1999.0557; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kotani M, 2000, J ALLERGY CLIN IMMUN, V106, P159, DOI 10.1067/mai.2000.107194; Kovacs P, 2006, J NEUROIMMUNOL, V171, P1, DOI 10.1016/j.jneuroim.2005.07.026; Kraft S, 2004, INT ARCH ALLERGY IMM, V135, P62, DOI 10.1159/000080231; KUDO H, 1988, CONTACT DERMATITIS, V19, P312, DOI 10.1111/j.1600-0536.1988.tb02939.x; LAKO J, 2004, ASIA PAC J CLIN NUTR, V13, pS127; MATSUDA H, 1995, J IMMUNOL, V154, P5080; Mekori YA, 2000, IMMUNOL REV, V173, P131, DOI 10.1034/j.1600-065X.2000.917305.x; Metz M, 2009, CURR OPIN IMMUNOL, V21, P687, DOI 10.1016/j.coi.2009.09.009; Middleton E, 1998, ADV EXP MED BIOL, V439, P175; Middleton E, 2000, PHARMACOL REV, V52, P673; Millard Thomas P, 2002, Am J Clin Dermatol, V3, P239, DOI 10.2165/00128071-200203040-00002; Miller A L, 2001, Altern Med Rev, V6, P20; Moon H, 2008, ARCH PHARM RES, V31, P771, DOI 10.1007/s12272-001-1225-2; Moore C, 1998, ANN ALLERG ASTHMA IM, V81, P452, DOI 10.1016/S1081-1206(10)63145-6; OKAYAMA Y, 1992, CLIN EXP ALLERGY, V22, P401, DOI 10.1111/j.1365-2222.1992.tb03102.x; Park HH, 2008, ARCH PHARM RES, V31, P1303, DOI 10.1007/s12272-001-2110-5; Paus R, 2006, TRENDS IMMUNOL, V27, P32, DOI 10.1016/j.it.2005.10.002; PEARCE FL, 1984, J ALLERGY CLIN IMMUN, V73, P819, DOI 10.1016/0091-6749(84)90453-6; PEARCE FL, 1982, J IMMUNOL, V128, P2481; PIGATTO PD, 1990, CONTACT DERMATITIS, V22, P27, DOI 10.1111/j.1600-0536.1990.tb01501.x; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Saito H, 1996, J IMMUNOL, V157, P343; Scholzen TE, 2001, J IMMUNOL, V166, P1285, DOI 10.4049/jimmunol.166.2.1285; Schroeter H, 2003, NATURE, V426, P787, DOI 10.1038/426787b; Shelburne CP, 2009, CELL HOST MICROBE, V6, P331, DOI 10.1016/j.chom.2009.09.004; Siebenhaar F, 2008, J ALLERGY CLIN IMMUN, V121, P955, DOI 10.1016/j.jaci.2007.11.013; SIEGHART W, 1978, NATURE, V275, P329, DOI 10.1038/275329a0; Siraganian RP, 2003, CURR OPIN IMMUNOL, V15, P639, DOI 10.1016/j.coi.2003.09.010; Stainer R, 2005, BRIT J DERMATOL, V152, P334, DOI 10.1111/J.1365-2133.2004.06303.X; Stelekati E, 2009, IMMUNITY, V31, P665, DOI 10.1016/j.immuni.2009.08.022; Tachimoto H, 2000, J ALLERGY CLIN IMMUN, V106, P141, DOI 10.1067/mai.2000.107043; Theoharides TC, 2004, J NEUROIMMUNOL, V146, P1, DOI 10.1016/j.jneuroim.2003.10.041; THEOHARIDES TC, 1980, SCIENCE, V207, P80, DOI 10.1126/science.6153130; Theoharides TC, 2000, BRIT J PHARMACOL, V131, P1039, DOI 10.1038/sj.bjp.0703672; Theoharides TC, 2000, J PHARMACOL EXP THER, V294, P810; Theoharides TC, 2007, IMMUNOL REV, V217, P65, DOI 10.1111/j.1600-065X.2007.00519.x; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Theoharides TC, 2010, P NATL ACAD SCI USA, V107, P4448, DOI 10.1073/pnas.1000803107; Thyssen JP, 2007, CONTACT DERMATITIS, V57, P287, DOI 10.1111/j.1600-0536.2007.01220.x; Usatine RP, 2010, AM FAM PHYSICIAN, V82, P249; Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0; WELLS E, 1983, BIOCHEM PHARMACOL, V32, P837, DOI 10.1016/0006-2952(83)90585-3; Yamaguchi M, 1999, J IMMUNOL, V162, P5455; Zhang BD, 2011, J ALLERGY CLIN IMMUN, V127, P1522, DOI 10.1016/j.jaci.2011.02.005	89	107	109	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33805	10.1371/journal.pone.0033805	http://dx.doi.org/10.1371/journal.pone.0033805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470478	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000035
J	Cao, LQ; Kobayakawa, S; Yoshiki, A; Abe, K				Cao, Liqin; Kobayakawa, Satoru; Yoshiki, Atsushi; Abe, Kuniya			High Resolution Intravital Imaging of Subcellular Structures of Mouse Abdominal Organs Using a Microstage Device	PLOS ONE			English	Article							IN-VIVO; HIGH-SPEED; REAL-TIME; MICROSCOPY; ENDOMICROSCOPY; CELLS; MICE	Intravital imaging of brain and bone marrow cells in the skull with subcellular resolution has revolutionized neurobiology, immunology and hematology. However, the application of this powerful technology in studies of abdominal organs has long been impeded by organ motion caused by breathing and heartbeat. Here we describe for the first time a simple device designated 'microstage' that effectively reduces organ motions without causing tissue lesions. Combining this microstage device with an upright intravital laser scanning microscope equipped with a unique stick-type objective lens, the system enables subcellular-level imaging of abdominal organs in live mice. We demonstrate that this technique allows for the quantitative analysis of subcellular structures and gene expressions in cells, the tracking of intracellular processes in real-time as well as three-dimensional image construction in the pancreas and liver of the live mouse. As the aforementioned analyses based on subcellular imaging could be extended to other intraperitoneal organs, the technique should offer great potential for investigation of physiological and disease-specific events of abdominal organs. The microstage approach adds an exciting new technique to the in vivo imaging toolbox.	[Cao, Liqin; Kobayakawa, Satoru; Abe, Kuniya] RIKEN BioResource Ctr, Technol & Dev Team Mammalian Cellular Dynam, Tsukuba, Ibaraki, Japan; [Cao, Liqin] Japan Biol Informat Consortium, Koto Ku, Tokyo, Japan; [Yoshiki, Atsushi] RIKEN BioResource Ctr, Expt Anim Div, Tsukuba, Ibaraki, Japan	RIKEN; RIKEN	Cao, LQ (corresponding author), RIKEN BioResource Ctr, Technol & Dev Team Mammalian Cellular Dynam, Tsukuba, Ibaraki, Japan.	abe@rtc.riken.jp	Yoshiki, Atsushi/O-6162-2019	Yoshiki, Atsushi/0000-0002-9450-5151	Ministry of Education, Culture, Sports, Science and Technology of Japan [22570009]; RIKEN; New Energy and Industrial Technology Development Organization (NEDO)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 22570009 to Liqin Cao), a RIKEN Foreign Researcher grant to Liqin Cao, and and a grant from the New Energy and Industrial Technology Development Organization (NEDO) project "Development of Basic Technology to Control Biological Systems using Chemical Compounds" to Kuniya Abe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar H, 2005, NEOPLASIA, V7, P977, DOI 10.1593/neo.05376; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Coppieters K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015732; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Koehl GE, 2009, CLIN EXP METASTAS, V26, P329, DOI 10.1007/s10585-008-9234-7; Lee S, 2008, IEEE T ROBOT, V24, P45, DOI 10.1109/TRO.2007.914847; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Molitoris BA, 2005, AM J PHYSIOL-RENAL, V288, pF1084, DOI 10.1152/ajprenal.00473.2004; Moussata D, 2011, GUT, V60, P26, DOI 10.1136/gut.2010.213264; Murari K, 2011, OPT LETT, V36, P1299, DOI 10.1364/OL.36.001299; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nyman LR, 2008, J CLIN INVEST, V118, P3790, DOI 10.1172/JCI36209; Sandoval RM, 2004, AM J PHYSIOL-CELL PH, V287, pC517, DOI 10.1152/ajpcell.00006.2004; Serrels A, 2009, CANCER RES, V69, P2714, DOI 10.1158/0008-5472.CAN-08-4308; Toiyama Y, 2010, J GASTROENTEROL, V45, P544, DOI 10.1007/s00535-009-0187-7; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Watson AJM, 2005, GASTROENTEROLOGY, V129, P902, DOI 10.1053/j.gastro.2005.06.015; Weigert R, 2010, HISTOCHEM CELL BIOL, V133, P481, DOI 10.1007/s00418-010-0692-z; Witte S, 2011, P NATL ACAD SCI USA, V108, P5970, DOI 10.1073/pnas.1018743108	28	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33876	10.1371/journal.pone.0033876	http://dx.doi.org/10.1371/journal.pone.0033876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479464	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900045
J	Schrimpe-Rutledge, AC; Jones, MB; Chauhan, S; Purvine, SO; Sanford, JA; Monroe, ME; Brewer, HM; Payne, SH; Ansong, C; Frank, BC; Smith, RD; Peterson, SN; Motin, VL; Adkins, JN				Schrimpe-Rutledge, Alexandra C.; Jones, Marcus B.; Chauhan, Sadhana; Purvine, Samuel O.; Sanford, James A.; Monroe, Matthew E.; Brewer, Heather M.; Payne, Samuel H.; Ansong, Charles; Frank, Bryan C.; Smith, Richard D.; Peterson, Scott N.; Motin, Vladimir L.; Adkins, Joshua N.			Comparative Omics-Driven Genome Annotation Refinement: Application across Yersiniae	PLOS ONE			English	Article							LOW-CALCIUM RESPONSE; MASS-SPECTROMETRY; PROTEIN IDENTIFICATIONS; SALMONELLA-TYPHIMURIUM; PESTIS; SEQUENCE; PROTEOMICS; THROUGHPUT; DISCOVERY; DATABASE	Genome sequencing continues to be a rapidly evolving technology, yet most downstream aspects of genome annotation pipelines remain relatively stable or are even being abandoned. The annotation process is now performed almost exclusively in an automated fashion to balance the large number of sequences generated. One possible way of reducing errors inherent to automated computational annotations is to apply data from omics measurements (i.e. transcriptional and proteomic) to the un-annotated genome with a proteogenomic-based approach. Here, the concept of annotation refinement has been extended to include a comparative assessment of genomes across closely related species. Transcriptomic and proteomic data derived from highly similar pathogenic Yersiniae (Y. pestis CO92, Y. pestis Pestoides F, and Y. pseudotuberculosis PB1/+) was used to demonstrate a comprehensive comparative omic-based annotation methodology. Peptide and oligo measurements experimentally validated the expression of nearly 40% of each strain's predicted proteome and revealed the identification of 28 novel and 68 incorrect (i.e., observed frameshifts, extended start sites, and translated pseudogenes) protein-coding sequences within the three current genome annotations. Gene loss is presumed to play a major role in Y. pestis acquiring its niche as a virulent pathogen, thus the discovery of many translated pseudogenes, including the insertion-ablated argD, underscores a need for functional analyses to investigate hypotheses related to divergence. Refinements included the discovery of a seemingly essential ribosomal protein, several virulence-associated factors, a transcriptional regulator, and many hypothetical proteins that were missed during annotation.	[Schrimpe-Rutledge, Alexandra C.; Sanford, James A.; Monroe, Matthew E.; Payne, Samuel H.; Ansong, Charles; Smith, Richard D.; Adkins, Joshua N.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99354 USA; [Jones, Marcus B.; Frank, Bryan C.; Peterson, Scott N.] J Craig Venter Inst, Rockville, MD USA; [Chauhan, Sadhana; Motin, Vladimir L.] Univ Texas Med Branch, Galveston, TX USA; [Purvine, Samuel O.; Brewer, Heather M.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; J. Craig Venter Institute; University of Texas System; University of Texas Medical Branch Galveston; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Schrimpe-Rutledge, AC (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99354 USA.	Joshua.Adkins@pnl.gov	Motin, Vladimir L/O-1535-2013; Smith, Richard D/J-3664-2012; Adkins, Joshua/B-9881-2013; Monroe, Matthew/L-1157-2019; Payne, Samuel/AAC-6388-2021; Purvine, Samuel O/O-3358-2017	Smith, Richard D/0000-0002-2381-2349; Adkins, Joshua/0000-0003-0399-0700; Payne, Samuel/0000-0002-8351-1994; Purvine, Samuel O/0000-0002-2257-2400; Motin, Vladimir/0000-0002-4762-457X; Rutledge, Alexandra/0000-0001-7086-1170; Sanford, James/0000-0001-7901-5579	National Institute of Allergy and Infectious Diseases NIH/DHHS [Y1-AI-8401]; U.S. Department of Energy (DOE) Office of Biological and Environmental Research; NIH National Center for Research Resources [RR018522]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI008401, R22AI008401] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases NIH/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Energy (DOE) Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institute of Allergy and Infectious Diseases NIH/DHHS through Interagency agreement Y1-AI-8401. Proteomics capabilities were developed under support from the U.S. Department of Energy (DOE) Office of Biological and Environmental Research and the NIH National Center for Research Resources (RR018522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Adkins JN, 2006, MOL CELL PROTEOMICS, V5, P1450, DOI 10.1074/mcp.M600139-MCP200; Ahmed N, 2008, NAT REV MICROBIOL, V6, P387, DOI 10.1038/nrmicro1889; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ansong C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-433; Ansong C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004809; Armengaud J, 2009, CURR OPIN MICROBIOL, V12, P292, DOI 10.1016/j.mib.2009.03.005; Bakke P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006291; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Baudet M, 2010, MOL CELL PROTEOMICS, V9, P415, DOI 10.1074/mcp.M900359-MCP200; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brubaker RR, 2005, INFECT IMMUN, V73, P4743, DOI 10.1128/IAI.73.8.4743-4752.2005; BUTLER T, 1994, CLIN INFECT DIS, V19, P655, DOI 10.1093/clinids/19.4.655; Callister SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001542; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Castellana N, 2010, J PROTEOMICS, V73, P2124, DOI 10.1016/j.jprot.2010.06.007; Castellana NE, 2008, P NATL ACAD SCI USA, V105, P21034, DOI 10.1073/pnas.0811066106; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chandler M, 2002, MOBILE DNA, V2, P305; Cho BK, 2009, NAT BIOTECHNOL, V27, P1043, DOI 10.1038/nbt.1582; Cobucci-Ponzano B, 2010, J PROTEOME RES, V9, P2496, DOI 10.1021/pr901166q; Cottingham Katie, 2009, J Proteome Res, V8, P4172, DOI 10.1021/pr900703w; de Souza GA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-316; Duncan MW, 2010, NAT BIOTECHNOL, V28, P659, DOI 10.1038/nbt0710-659; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Farabaugh PJ, 1996, ANNU REV GENET, V30, P507, DOI 10.1146/annurev.genet.30.1.507; FOWLER JM, 1994, INFECT IMMUN, V62, P5234, DOI 10.1128/IAI.62.12.5234-5241.1994; Gallien S, 2009, GENOME RES, V19, P128, DOI 10.1101/gr.081901.108; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; Gupta N, 2008, GENOME RES, V18, P1133, DOI 10.1101/gr.074344.107; Gupta N, 2007, GENOME RES, V17, P1362, DOI 10.1101/gr.6427907; Gupta N, 2009, J PROTEOME RES, V8, P4173, DOI 10.1021/pr9004794; Higdon R, 2007, BIOINFORMATICS, V23, P277, DOI 10.1093/bioinformatics/btl595; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Kolker E, 2005, P NATL ACAD SCI USA, V102, P2099, DOI 10.1073/pnas.0409111102; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Kukkonen M, 2004, MOL MICROBIOL, V51, P215, DOI 10.1046/j.1365-2958.2003.03817.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lerat E, 2005, NUCLEIC ACIDS RES, V33, P3125, DOI 10.1093/nar/gki631; Li JW, 2012, NUCLEIC ACIDS RES, V40, pD1313, DOI 10.1093/nar/gkr1058; Livesay EA, 2008, ANAL CHEM, V80, P294, DOI 10.1021/ac701727r; Motin VL, 2002, J BACTERIOL, V184, P1019, DOI 10.1128/jb.184.4.1019-1027.2002; Mottaz-Brewer Heather M, 2008, J Biomol Tech, V19, P285; Nagarajan N, 2010, METHODS MOL BIOL, V673, P1, DOI 10.1007/978-1-60761-842-3_1; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Payne SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-460; Prasad TSK, 2012, J PROTEOME RES, V11, P247, DOI 10.1021/pr200827k; Price MN, 2011, J BACTERIOL, DOI [10.1128/JB.05563-05511, DOI 10.1128/JB.05563-05511]; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Qiu Y, 2010, GENOME RES, V20, P1304, DOI 10.1101/gr.107540.110; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Salzberg SL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-102; Sellam A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r71; Simonet M, 1996, INFECT IMMUN, V64, P375, DOI 10.1128/IAI.64.1.375-379.1996; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Stein L, 2001, NAT REV GENET, V2, P493, DOI 10.1038/35080529; Thomassen GOS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015356; Tong ZZ, 2005, J MED MICROBIOL, V54, P259, DOI 10.1099/jmm.0.45752-0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vivancos AP, 2010, GENOME RES, V20, P989, DOI 10.1101/gr.094318.109; Weiss M, 2010, PROTEOMICS, V10, P1297, DOI 10.1002/pmic.200900414; YATES JR, 1995, ANAL CHEM, V67, P3202, DOI 10.1021/ac00114a016; Yin YB, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-63; Zhou DS, 2004, J BACTERIOL, V186, P5147, DOI 10.1128/jb.186.15.5147-5152.2004; Zhu P, 2010, ANAL BIOCH	68	30	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33903	10.1371/journal.pone.0033903	http://dx.doi.org/10.1371/journal.pone.0033903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479471	gold, Green Submitted, Green Published			2022-12-27	WOS:000303894900049
J	Voigt, O; Wulfing, E; Worheide, G				Voigt, Oliver; Wuelfing, Eilika; Woerheide, Gert			Molecular Phylogenetic Evaluation of Classification and Scenarios of Character Evolution in Calcareous Sponges (Porifera, Class Calcarea)	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; RIBOSOMAL-RNA; MAXIMUM-LIKELIHOOD; COMPENSATORY MUTATIONS; TREE SELECTION; DNA-SEQUENCES; MODELS; CONSTRAINTS; TAXA	Calcareous sponges (Phylum Porifera, Class Calcarea) are known to be taxonomically difficult. Previous molecular studies have revealed many discrepancies between classically recognized taxa and the observed relationships at the order, family and genus levels; these inconsistencies question underlying hypotheses regarding the evolution of certain morphological characters. Therefore, we extended the available taxa and character set by sequencing the complete small subunit (SSU) rDNA and the almost complete large subunit (LSU) rDNA of additional key species and complemented this dataset by substantially increasing the length of available LSU sequences. Phylogenetic analyses provided new hypotheses about the relationships of Calcarea and about the evolution of certain morphological characters. We tested our phylogeny against competing phylogenetic hypotheses presented by previous classification systems. Our data reject the current order-level classification by again finding non-monophyletic Leucosolenida, Clathrinida and Murrayonida. In the subclass Calcinea, we recovered a clade that includes all species with a cortex, which is largely consistent with the previously proposed order Leucettida. Other orders that had been rejected in the current system were not found, but could not be rejected in our tests either. We found several additional families and genera polyphyletic: the families Leucascidae and Leucaltidae and the genus Leucetta in Calcinea, and in Calcaronea the family Amphoriscidae and the genus Ute. Our phylogeny also provided support for the vaguely suspected close relationship of several members of Grantiidae with giantortical diactines to members of Heteropiidae. Similarly, our analyses revealed several unexpected affinities, such as a sister group relationship between Leucettusa (Leucaltidae) and Leucettidae and between Leucascandra (Jenkinidae) and Sycon carteri (Sycettidae). According to our results, the taxonomy of Calcarea is in desperate need of a thorough revision, which cannot be achieved by considering morphology alone or relying on a taxon sampling based on the current classification below the subclass level.	[Voigt, Oliver; Wuelfing, Eilika; Woerheide, Gert] Univ Munich, Dept Earth & Environm Sci, Munich, Germany; [Woerheide, Gert] Univ Munich, GeoBio Ctr LMU, Munich, Germany; [Woerheide, Gert] Bayer Staatssammlung Palaontol & Geol, Munich, Germany	University of Munich; University of Munich	Voigt, O (corresponding author), Univ Munich, Dept Earth & Environm Sci, Marchioninistr 15, Munich, Germany.	woerheide@lmu.de	Wörheide, Gert/C-1080-2008; Voigt, Oliver/A-7449-2011; Voigt, Oliver/GXG-9889-2022	Wörheide, Gert/0000-0002-6380-7421; Voigt, Oliver/0000-0001-8708-0872; 	German Science Foundation (DFG) [Wo896/3, Wo896/6]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Science Foundation (DFG), through grants Wo896/3 and Wo896/6 (SPP 1174 "Deep Metazoan Phylogeny") to GW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, SYSTEMA PORIFERA GUI; Bidder GP, 1898, P ROY SOC LONDON, V64, P61, DOI DOI 10.1098/RSPL.1898.0070; BOROJEVIC R, 1990, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V12, P243; Borojevic R, 2002, SYSTEMA PORIFERA GUI, P1157, DOI DOI 10.1007/978-1-4615-0747-5_120; Borojevic R., 1965, ARCH ZOOL EXP GEN, V106, P665; Borojevic Radovan, 2000, Zoosystema, V22, P203; Borojevic Radovan, 2000, Zoosystema, V22, P187; Cavalcanti FF, 2011, ZOOMORPHOLOGY, V130, P255, DOI 10.1007/s00435-011-0139-7; Dendy A, 1892, P ROYAL SOC VICTORIA, V5, P69; DIXON MT, 1993, MOL BIOL EVOL, V10, P256; Dohrmann M, 2008, SYST BIOL, V57, P388, DOI 10.1080/10635150802161088; Dohrmann M, 2006, MOL PHYLOGENET EVOL, V40, P830, DOI 10.1016/j.ympev.2006.04.016; Erpenbeck D, 2007, J MOL EVOL, V64, P543, DOI 10.1007/s00239-006-0146-3; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gavaze E, 2011, HYDROBIOLOGIA, DOI [10.1007/s10750-011-0842-x, DOI 10.1007/S10750-011-0842-X]; Haeckel E, 1872, KALKSCHWAMME SYSTEM, V2; Haeckel E, 1872, KALKSCHWAMME ATLAS K, V3; Haeckel E, 1872, KALKSCHWAMME BIOL KA, V1; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393; HARTMAN WD, 1958, SYST ZOOL, V7, P97, DOI 10.2307/2411971; Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Hudelot C, 2003, MOL PHYLOGENET EVOL, V28, P241, DOI 10.1016/S1055-7903(03)00061-7; Jow H, 2002, MOL BIOL EVOL, V19, P1591, DOI 10.1093/oxfordjournals.molbev.a004221; Klautau M, 2003, ZOOL J LINN SOC-LOND, V139, P1, DOI 10.1046/j.0024-4082.2003.00063.x; MADDISON WP, 2002, MACCLADE; Manuel M, 2006, CAN J ZOOL, V84, P225, DOI 10.1139/Z06-005; Manuel M, 2003, SYST BIOL, V52, P311, DOI 10.1080/10635150390196966; Manuel M, 2002, SYSTEMA PORIFERA GUI, P1103; Manuel M, 2004, B MUS I BIOL U GEN, V68, P449; Minchin E. A., 1896, ANN MAG NAT HIST, V18, P349; MUSE SV, 1995, GENETICS, V139, P1429; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Rapp HT, 2011, DEEP-SEA RES PT II, V58, P58, DOI 10.1016/j.dsr2.2010.05.022; Rossi AL, 2006, CAH BIOL MAR, V47, P261; Rossi AL, 2011, ZOOL J LINN SOC-LOND, V163, P1026, DOI 10.1111/j.1096-3642.2011.00739.x; Savill NJ, 2001, GENETICS, V157, P399; Schnare MN, 1996, J MOL BIOL, V256, P701, DOI 10.1006/jmbi.1996.0119; SCHONIGER M, 1994, MOL PHYLOGENET EVOL, V3, P240, DOI 10.1006/mpev.1994.1026; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Telford MJ, 2005, MOL BIOL EVOL, V22, P1129, DOI 10.1093/molbev/msi099; Tillier ERM, 1998, GENETICS, V148, P1993; TILLIER ERM, 1995, MOL BIOL EVOL, V12, P7, DOI 10.1093/oxfordjournals.molbev.a040195; VACELET J, 1981, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V3, P313; VACELET J, 1961, SYST ZOOL, V10, P45, DOI 10.2307/2411699; van Soest RWM, WORLD PORIFERA DATAB; Voigt O, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-69; Voigt O, 2012, HYDROBIOLOGIA, V687, P101, DOI 10.1007/s10750-011-0800-7; WHEELER WC, 1988, MOL BIOL EVOL, V5, P90; Worheide Gert, 1999, Memoirs of the Queensland Museum, V43, P859	54	52	52	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33417	10.1371/journal.pone.0033417	http://dx.doi.org/10.1371/journal.pone.0033417			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479395	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900027
J	Barnes, A; Isohanni, M; Barnett, JH; Pietilanen, O; Veijola, J; Miettunen, J; Paunio, T; Tanskanen, P; Ridler, K; Suckling, J; Bullmore, ET; Murray, GK; Jones, PB				Barnes, Anna; Isohanni, Matti; Barnett, Jennifer H.; Pietilainen, Olli; Veijola, Juha; Miettunen, Jouko; Paunio, Tiina; Tanskanen, Paivikki; Ridler, Khanum; Suckling, John; Bullmore, Edward T.; Murray, Graham K.; Jones, Peter B.			No Association of COMT (Val158Met) Genotype with Brain Structure Differences between Men and Women	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; GRAY-MATTER VOLUME; COGNITIVE FUNCTION; CORTICAL STRUCTURE; PREFRONTAL CORTEX; GENETIC-VARIATION; MESSENGER-RNA; MR-IMAGES; POLYMORPHISM; SCHIZOPHRENIA	We examined the effect of the catechol-O-methyltransferase (COMT) Val158Met polymorphism (rs4680), on brain structure in a subset (N = 82) of general population members of the Northern Finland 1966 Birth Cohort, selected through a randomization procedure, aged 33-35. Optimised voxel-based morphometry was used to produce grey matter maps from each subject's high resolution T1 weighted brain magnetic resonance images, which were subsequently entered into a general linear model with COMT genotype as defined by Met allele loading, gender and genotype by gender interaction as independent variables. Additional analyses were carried out on grey matter volumes within the dorsal lateral pre-frontal cortex (DLPFC) to examine effects on overall DLPFC volume and also using the DLPFC as a mask for voxelwise analyses, as this is an area previously reported as associated with Met allele loading. We failed to find any statistically significant association with grey matter volume and Met allele loading in the COMT gene or interaction affects between COMT and gender in either the whole brain voxel-wise analysis or in the area of the DLPFC.	[Barnes, Anna; Barnett, Jennifer H.; Ridler, Khanum; Suckling, John; Bullmore, Edward T.; Murray, Graham K.; Jones, Peter B.] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England; [Barnes, Anna; Ridler, Khanum; Suckling, John; Bullmore, Edward T.; Murray, Graham K.] Univ Cambridge, Brain Mapping Unit, Cambridge, England; [Isohanni, Matti; Veijola, Juha; Miettunen, Jouko] Oulu Univ Hosp, Oulu, Finland; [Isohanni, Matti; Veijola, Juha; Miettunen, Jouko] Univ Oulu, Dept Psychiat, Inst Clin Med, Oulu, Finland; [Isohanni, Matti] Univ Oulu, Inst Hlth Sci, Dept Publ Hlth Sci & Gen Practice, Oulu, Finland; [Barnett, Jennifer H.] Cambridge Cognit, Cambridge, England; [Pietilainen, Olli] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Pietilainen, Olli] Natl Inst Hlth & Welf, Helsinki, Finland; [Paunio, Tiina] Univ Helsinki, Dept Psychiat, SF-00180 Helsinki, Finland; [Tanskanen, Paivikki] Univ Oulu, Dept Radiol, Inst Diagnost, Oulu, Finland; [Suckling, John; Bullmore, Edward T.; Murray, Graham K.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Oulu; University of Oulu; University of Oulu; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; University of Oulu; University of Cambridge	Barnes, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England.	annapbarnes@gmail.com	Bullmore, Ed/C-1706-2012; Miettunen, Jouko/AAC-4334-2019; Barnes, Anna/AAV-8780-2021; Suckling, John/ABD-7246-2021	Bullmore, Ed/0000-0002-8955-8283; Miettunen, Jouko/0000-0003-0575-2669; Barnes, Anna/0000-0002-6902-214X; Suckling, John/0000-0002-5098-1527; Murray, Graham/0000-0001-8296-1742; Jones, Peter Brian/0000-0002-0387-880X	Brain & Behavior Research Foundation: The Brain and Behavior Research Fund; Medical Research Council; Sigrid Juselius Foundation; Academy of Finland; Isaac Newton Trust; MRC [G0701911] Funding Source: UKRI; Medical Research Council [G0701911, G1000183B, G0001354, G0001354B] Funding Source: researchfish	Brain & Behavior Research Foundation: The Brain and Behavior Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland); Isaac Newton Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by awards from The Brain & Behavior Research Foundation: The Brain and Behavior Research Fund (to APB, MI, JM and GKM), the Medical Research Council (to GKM), the Sigrid Juselius Foundation (to APB, MI), Academy of Finland (to MI, JV and JM), and Isaac Newton Trust (to APB, KR and PBJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L., 2007, TR07JA1 FMRIB U OXF; Andersson J.L.R., 2007, TR07JA2 FMRIB AN GR; Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005; Barnett JH, 2007, AM J PSYCHIAT, V164, P142, DOI 10.1176/appi.ajp.164.1.142; Barnett JH, 2009, AM J PSYCHIAT, V166, P909, DOI 10.1176/appi.ajp.2009.08081251; Cerasa A, 2010, NEUROSCIENCE, V167, P809, DOI 10.1016/j.neuroscience.2010.02.040; Cerasa A, 2008, NEUROREPORT, V19, P405, DOI 10.1097/WNR.0b013e3282f5f784; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Chua SE, 2007, SCHIZOPHR RES, V89, P12, DOI 10.1016/j.schres.2006.09.009; Dorph-Petersen KA, 2005, NEUROPSYCHOPHARMACOL, V30, P1649, DOI 10.1038/sj.npp.1300710; Dutt A, 2009, PSYCHOL MED, V39, P1783, DOI 10.1017/S0033291709990316; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Girault JA, 2004, ARCH NEUROL-CHICAGO, V61, P641, DOI 10.1001/archneur.61.5.641; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Harrison PJ, 2008, NEUROPSYCHOPHARMACOL, V33, P3037, DOI 10.1038/sj.npp.1301543; Ho BC, 2005, MOL PSYCHIATR, V10, P287, DOI 10.1038/sj.mp.4001616; Honea R, 2009, NEUROIMAGE, V45, P44, DOI 10.1016/j.neuroimage.2008.10.064; Honea RA, 2009, J ALZHEIMERS DIS, V18, P553, DOI 10.3233/JAD-2009-1163; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kates WR, 2006, AM J MED GENET B, V141B, P274, DOI 10.1002/ajmg.b.30284; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; McClure RK, 2006, PSYCHIAT RES-NEUROIM, V148, P121, DOI 10.1016/j.pscychresns.2006.04.008; McIntosh AM, 2007, BIOL PSYCHIAT, V61, P1127, DOI 10.1016/j.biopsych.2006.05.020; Mier D, 2010, MOL PSYCHIATR, V15, P918, DOI 10.1038/mp.2009.36; Murray GK, 2006, J CHILD PSYCHOL PSYC, V47, P25, DOI 10.1111/j.1469-7610.2005.01450.x; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; Ohnishi T, 2006, BRAIN, V129, P399, DOI 10.1093/brain/awh702; Pooley EC, 2007, MOL PSYCHIATR, V12, P556, DOI 10.1038/sj.mp.4001951; Rantakallio P, 1969, ACTA PAEDIAT SC S193, V193, P191; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shaw P, 2009, MOL PSYCHIATR, V14, P348, DOI 10.1038/mp.2008.121; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Suckling J, 2012, HUM BRAIN MAPP, V33, P373, DOI 10.1002/hbm.21210; Suckling J, 2010, HUM BRAIN MAPP, V31, P1183, DOI 10.1002/hbm.20927; Tan HY, 2008, J CLIN INVEST, V118, P2200, DOI [10.1172/JCI3472S, 10.1172/JCI34725]; Tanskanen P, 2010, SCHIZOPHRENIA BULL, V36, P766, DOI 10.1093/schbul/sbn141; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; Toga AW, 2005, ANNU REV NEUROSCI, V28, P1, DOI 10.1146/annurev.neuro.28.061604.135655; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Worda C, 2003, HUM REPROD, V18, P262, DOI 10.1093/humrep/deg059; Wright IC, 2002, NEUROIMAGE, V17, P256, DOI 10.1006/nimg.2002.1163; Xie T, 1999, MOL PHARMACOL, V56, P31, DOI 10.1124/mol.56.1.31; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zinkstok J, 2006, NEUROSCI LETT, V405, P34, DOI 10.1016/j.neulet.2006.06.034	47	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33964	10.1371/journal.pone.0033964	http://dx.doi.org/10.1371/journal.pone.0033964			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479488	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100090
J	Fenner, L; Gagneux, S; Janssens, JP; Fehr, J; Cavassini, M; Hoffmann, M; Bernasconi, E; Schrenzel, J; Bodmer, T; Bottger, EC; Helbling, P; Egger, M				Fenner, Lukas; Gagneux, Sebastien; Janssens, Jean-Paul; Fehr, Jan; Cavassini, Matthias; Hoffmann, Matthias; Bernasconi, Enos; Schrenzel, Jacques; Bodmer, Thomas; Boettger, Erik C.; Helbling, Peter; Egger, Matthias		Swiss HIV Cohort Study Grp; Mol Epidemiology TB Study Grp	Tuberculosis in HIV-Negative and HIV-Infected Patients in a Low-Incidence Country: Clinical Characteristics and Treatment Outcomes	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; RISK-FACTORS; ANTIRETROVIRAL TREATMENT; DISEASE PROGRESSION; INCOME COUNTRIES; 1ST YEAR; SWITZERLAND; EUROPE; SURVEILLANCE; MORTALITY	Background: In Switzerland and other developed countries, the number of tuberculosis (TB) cases has been decreasing for decades, but HIV-infected patients and migrants remain risk groups. The aim of this study was to compare characteristics of TB in HIV-negative and HIV-infected patients diagnosed in Switzerland, and between coinfected patients enrolled and not enrolled in the national Swiss HIV Cohort Study (SHCS). Methods and Findings: All patients diagnosed with culture-confirmed TB in the SHCS and a random sample of culture-confirmed cases reported to the national TB registry 2000-2008 were included. Outcomes were assessed in HIV-infected patients and considered successful in case of cure or treatment completion. Ninety-three SHCS patients and 288 patients selected randomly from 4221 registered patients were analyzed. The registry sample included 10 (3.5%) coinfected patients not enrolled in the SHCS: the estimated number of HIV-infected patients not enrolled in the SHCS but reported to the registry 2000-2008 was 146 (95% CI 122-173). Coinfected patients were more likely to be from sub-Saharan Africa (51.5% versus 15.8%, P<0.0001) and to present disseminated disease (23.9% vs. 3.4%, P, 0.0001) than HIV-negative patients. Coinfected patients not enrolled in the SHCS were asylum seekers or migrant workers, with lower CD4 cell counts at TB diagnosis (median CD4 count 79 cells/mu L compared to 149 cells/mu L among SHCS patients, P = 0.07). There were 6 patients (60.0%) with successful outcomes compared to 82 (88.2%) patients in the SHCS (P = 0.023). Conclusions: The clinical presentation of coinfected patients differed from HIV-negative TB patients. The number of HIV-infected patients diagnosed with TB outside the SHCS is similar to the number diagnosed within the cohort but outcomes are poorer in patients not followed up in the national cohort. Special efforts are required to address the needs of this vulnerable population.	[Fenner, Lukas; Egger, Matthias] Univ Bern, Inst Social & Prevent Med ISPM, Bern, Switzerland; [Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Gagneux, Sebastien] Univ Basel, Basel, Switzerland; [Janssens, Jean-Paul] Univ Hosp Geneva, Div Pneumol, Geneva, Switzerland; [Fehr, Jan] Univ Zurich Hosp, Div Infect Dis, CH-8091 Zurich, Switzerland; [Cavassini, Matthias] Univ Lausanne Hosp, Div Infect Dis, Lausanne, Switzerland; [Hoffmann, Matthias] Kantonsspital St Gallen, Div Infect Dis, St Gallen, Switzerland; [Bernasconi, Enos] Osped Reg, Div Infect Dis, Lugano, Switzerland; [Schrenzel, Jacques] Univ Hosp Geneva, Bacteriol Lab, Geneva, Switzerland; [Bodmer, Thomas] Univ Bern, Inst Infect Dis, Mycobacteriol Unit, Bern, Switzerland; [Boettger, Erik C.] Univ Zurich, Inst Med Microbiol, Natl Ctr Mycobacteria, Zurich, Switzerland; [Helbling, Peter] Fed Off Publ Hlth, Div Communicable Dis, Bern, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Geneva; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Kantonsspital St. Gallen; University of Geneva; University of Bern; University of Zurich	Fenner, L (corresponding author), Univ Bern, Inst Social & Prevent Med ISPM, Bern, Switzerland.	lfenner@ispm.unibe.ch	Janssens, Jean-Paul/AAV-8083-2020; Schrenzel, Jacques/P-8525-2017; Schrenzel, Jacques/AAC-5685-2021; Fehr, Jan S/V-7499-2017; Böttger, Erik C./F-6175-2011; Gagneux, Sebastien/ABE-7909-2020; Pantaleo, Giuseppe/K-6163-2016; Jaton, Katia/A-2828-2016; cavassini, matthias/F-8987-2017	Schrenzel, Jacques/0000-0001-5464-7764; Schrenzel, Jacques/0000-0001-5464-7764; Fehr, Jan S/0000-0003-1113-9895; Fenner, Lukas/0000-0003-3309-4835; Egger, Matthias/0000-0001-7462-5132; Gagneux, Sebastien/0000-0001-7783-9048; cavassini, matthias/0000-0003-0933-7833; MAZZA-STALDER, JESICA/0000-0002-5693-7156; Jaton, Katia/0000-0001-8944-7295	Swiss National Science Foundation [324730-12544, PP00A-119205, 33CS30-134277]; Swiss HIV Cohort Study [588]; Federal Office of Public Health [09.007368]; National Center for Mycobacteria; National Institute of Allergy and Infectious Diseases [IeDEA Southern Africa] [5U01-AI069924-5]; National Institutes of Health [R01-AI090928-01]; University of Zurich; European Community [FP7-HEALTH-2009-241476]; Federal Office of Public Health (National Center for Mycobacteria); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, R01AI090928] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss HIV Cohort Study; Federal Office of Public Health; National Center for Mycobacteria; National Institute of Allergy and Infectious Diseases [IeDEA Southern Africa](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Zurich; European Community(European Commission); Federal Office of Public Health (National Center for Mycobacteria); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Swiss National Science Foundation [grant number 324730-12544], the Swiss HIV Cohort Study [grant number 588], and the Federal Office of Public Health [grant number 09.007368, the National Center for Mycobacteria]. Dr. Fenner and Dr. Egger are also supported by the National Institute of Allergy and Infectious Diseases [IeDEA Southern Africa, grant number 5U01-AI069924-5], and Dr. Gagneux by the National Institutes of Health [grant number R01-AI090928-01] and the Swiss National Science Foundation [grant number PP00A-119205]. Dr. Bottger was supported by the University of Zurich, the European Community (PAR, FP7-HEALTH-2009-241476) and the Federal Office of Public Health (National Center for Mycobacteria). The Swiss HIV Cohort Study is supported by the Swiss National Science Foundation [grant no. 33CS30-134277]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battegay M, 1998, J INTERN MED, V244, P479, DOI 10.1111/j.1365-2796.1998.00392.x; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Corbett EL, 2006, LANCET, V367, P926, DOI 10.1016/S0140-6736(06)68383-9; Elzi L, 2007, CLIN INFECT DIS, V44, P94, DOI 10.1086/510080; Faustini A, 2005, EUR RESPIR J, V26, P503, DOI 10.1183/09031936.05.00103504; Federal Office of Public Health, 2011, B BAG; Federal Office of Public Health, 2011, B BUNDESAMT GESUNDHE, P277; Federal Office of Public Health, 2011, B BAG, P205; Fenner L, 2011, INT J TUBERC LUNG D, V15, P620, DOI 10.5588/ijtld.10.0249; Fenner L, 2011, J CLIN MICR IN PRESS; Gebhardt M, 1998, AIDS, V12, P1195, DOI 10.1097/00002030-199810000-00012; Gras L, 2011, AIDS, V25, P813, DOI 10.1097/QAD.0b013e3283454cd7; Harries AD, 1998, CLIN TUBERCULOSIS, P315; Havlir DV, 1999, NEW ENGL J MED, V340, P367, DOI 10.1056/NEJM199902043400507; Helbling P, 2002, SWISS MED WKLY, V132, P517; Kherad O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-217; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Rieder HL, 1996, EUR RESPIR J, V9, P1097, DOI 10.1183/09031936.96.09051097; RIEDER HL, 1989, ARCH INTERN MED, V149, P1268, DOI 10.1001/archinte.149.6.1268; Schoeni-Affolter F, 2010, INT J EPIDEMIOL, V39, P1179, DOI 10.1093/ije/dyp321; SELWYN PA, 1992, NEW ENGL J MED, V327, P1697, DOI 10.1056/NEJM199212103272401; Sudre P, 1996, EUR RESPIR J, V9, P279, DOI 10.1183/09031936.96.09020279; Thiebaut R, 2000, AIDS, V14, P971, DOI 10.1097/00002030-200005260-00008; Thierfelder C, 2012, HIV MED, V13, P118, DOI 10.1111/j.1468-1293.2011.00949.x; Veen J, 1998, EUR RESPIR J, V12, P505, DOI 10.1183/09031936.98.12020505; Wolff H, 2010, J IMMIGR MINOR HEALT, V12, P18, DOI 10.1007/s10903-009-9271-6; Wood R, 2000, J ACQ IMMUN DEF SYND, V23, P75	27	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34186	10.1371/journal.pone.0034186	http://dx.doi.org/10.1371/journal.pone.0034186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479556	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000305339100133
J	Garcin, B; Volle, E; Dubois, B; Levy, R				Garcin, Beatrice; Volle, Emmanuelle; Dubois, Bruno; Levy, Richard			Similar or Different? The Role of the Ventrolateral Prefrontal Cortex in Similarity Detection	PLOS ONE			English	Article							FRONTAL-LOBE SUBGROUPS; SEMANTIC CATEGORY; COGNITIVE CONTROL; ABSTRACT RULES; FUNCTIONAL MRI; HUMAN BRAIN; RETRIEVAL; FMRI; PET; MEMORY	Patients with frontal lobe syndrome can exhibit two types of abnormal behaviour when asked to place a banana and an orange in a single category: some patients categorize them at a concrete level (e.g., "both have peel''), while others continue to look for differences between these objects (e.g., "one is yellow, the other is orange''). These observations raise the question of whether abstraction and similarity detection are distinct processes involved in abstract categorization, and that depend on separate areas of the prefrontal cortex (PFC). We designed an original experimental paradigm for a functional magnetic resonance imaging (fMRI) study involving healthy subjects, confirming the existence of two distinct processes relying on different prefrontal areas, and thus explaining the behavioural dissociation in frontal lesion patients. We showed that: 1) Similarity detection involves the anterior ventrolateral PFC bilaterally with a right-left asymmetry: the right anterior ventrolateral PFC is only engaged in detecting physical similarities; 2) Abstraction per se activates the left dorsolateral PFC.	[Garcin, Beatrice; Volle, Emmanuelle; Dubois, Bruno; Levy, Richard] INSERM, UMR S 975, CR ICM UPMC, Paris, France; [Garcin, Beatrice; Volle, Emmanuelle; Dubois, Bruno; Levy, Richard] Grp Hosp Pitie Salpetriere, CNRS, UMR 7225, F-75634 Paris, France; [Dubois, Bruno] Hop La Pitie Salpetriere, AP HP, Serv Neurol, Paris, France; [Garcin, Beatrice; Levy, Richard] Hop St Antoine, AP HP, Serv Neurol, F-75571 Paris, France; [Garcin, Beatrice] Grp Hosp Pitie Salpetriere, Ctr NeuroImagerie Rech CENIR, CR ICM UPMC UMR S975, INSERM,U975,CNRS,UMR7225, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Garcin, B (corresponding author), INSERM, UMR S 975, CR ICM UPMC, Paris, France.	beagarcin@msn.com	Volle, Emmanuelle/J-4164-2017	Volle, Emmanuelle/0000-0001-8420-4155	Journees de Neurologie de Langue Francaise; Agence Nationale de la Recherche [ANR-09-RPDOC-004-01]	Journees de Neurologie de Langue Francaise; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the "Journees de Neurologie de Langue Francaise'' scholarship to BG and by the "Agence Nationale de la Recherche'' (grant number ANR-09-RPDOC-004-01) to EV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2002, NEUROIMAGE, V16, P361, DOI 10.1006/nimg.2002.1088; Ashby FG, 2011, ANN NY ACAD SCI, V1224, P147, DOI 10.1111/j.1749-6632.2010.05874.x; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Boroojerdi B, 2001, NEUROLOGY, V56, P526, DOI 10.1212/WNL.56.4.526; Brett M, 2002, NEUROIMAGE, V16; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Bunge SA, 2005, CEREB CORTEX, V15, P239, DOI 10.1093/cercor/bhh126; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Bunge Silvia A., 2004, Cognitive Affective & Behavioral Neuroscience, V4, P564; Bunge SA, 2009, NEUROIMAGE, V46, P338, DOI 10.1016/j.neuroimage.2009.01.064; Cappa SF, 1998, NEUROIMAGE, V8, P350, DOI 10.1006/nimg.1998.0368; Christoff K, 2009, BRAIN RES, V1286, P94, DOI 10.1016/j.brainres.2009.05.096; Dalla Barba G, 1998, CORTEX, V34, P547; Delis DC, 2001, D KEFS; DEMB JB, 1995, J NEUROSCI, V15, P5870; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Devlin JT, 2002, NEUROPSYCHOLOGIA, V40, P54, DOI 10.1016/S0028-3932(01)00066-5; Dias R, 1997, J NEUROSCI, V17, P9285; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Fine EM, 2009, J CLIN EXP NEUROPSYC, V31, P624, DOI 10.1080/13803390802419017; Friederici AD, 2000, CEREB CORTEX, V10, P698, DOI 10.1093/cercor/10.7.698; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Geake JG, 2005, NEUROIMAGE, V26, P555, DOI 10.1016/j.neuroimage.2005.01.035; Gerlach C, 2000, NEUROPSYCHOLOGIA, V38, P1693, DOI 10.1016/S0028-3932(00)00082-8; GESCHWIN.N, 1970, SCIENCE, V170, P940, DOI 10.1126/science.170.3961.940; Goel V, 2004, COGNITION, V93, pB109, DOI 10.1016/j.cognition.2004.03.001; Goel V, 2000, J COGNITIVE NEUROSCI, V12, P110, DOI 10.1162/08989290051137639; Green AE, 2006, BRAIN RES, V1096, P125, DOI 10.1016/j.brainres.2006.04.024; Kostopoulos P, 2008, EUR J NEUROSCI, V27, P1037, DOI 10.1111/j.1460-9568.2008.06066.x; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; Milton F, 2009, NEUROIMAGE, V46, P319, DOI 10.1016/j.neuroimage.2009.01.043; Nakahara K, 2002, SCIENCE, V295, P1532, DOI 10.1126/science.1067653; Perani D, 1999, NEUROPSYCHOLOGIA, V37, P293, DOI 10.1016/S0028-3932(98)00073-6; PETRIDES M, 1995, P NATL ACAD SCI USA, V92, P5803, DOI 10.1073/pnas.92.13.5803; Pilgrim LK, 2002, NEUROIMAGE, V16, P713, DOI 10.1006/nimg.2002.1105; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Qiu J, 2008, NEUROPSYCHOLOGIA, V46, P3006, DOI 10.1016/j.neuropsychologia.2008.06.008; Reber PJ, 2002, COGNITIVE BRAIN RES, V14, P245, DOI 10.1016/S0926-6410(02)00122-2; Reverberi C, 2005, NEUROPSYCHOLOGIA, V43, P1924, DOI 10.1016/j.neuropsychologia.2005.03.004; Reverberi C, 2005, NEUROPSYCHOLOGIA, V43, P460, DOI 10.1016/j.neuropsychologia.2004.06.008; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; Smith EE, 2008, NEUROSCI BIOBEHAV R, V32, P249, DOI 10.1016/j.neubiorev.2007.07.009; SPITZER M, 1995, NEUROREPORT, V6, P2109, DOI 10.1097/00001756-199511000-00003; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tyler LK, 2001, BRAIN, V124, P1619, DOI 10.1093/brain/124.8.1619; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Vogels R, 2002, NEUROIMAGE, V16, P401, DOI 10.1006/nimg.2002.1109; Volle E, 2010, CEREB CORTEX, V20, P2647, DOI 10.1093/cercor/bhq012; Wendelken C, 2008, J COGNITIVE NEUROSCI, V20, P682, DOI 10.1162/jocn.2008.20055; Wood JN, 2003, J COGNITIVE NEUROSCI, V15, P236, DOI 10.1162/089892903321208178	53	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34164	10.1371/journal.pone.0034164	http://dx.doi.org/10.1371/journal.pone.0034164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479551	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100129
J	Gaskill, BN; Gordon, CJ; Pajor, EA; Lucas, JR; Davis, JK; Garner, JP				Gaskill, Brianna N.; Gordon, Christopher J.; Pajor, Edmond A.; Lucas, Jeffrey R.; Davis, Jerry K.; Garner, Joseph P.			Heat or Insulation: Behavioral Titration of Mouse Preference for Warmth or Access to a Nest	PLOS ONE			English	Article							MUS-MUSCULUS; ENVIRONMENTAL ENRICHMENT; TEMPERATURE REGULATION; LABORATORY MICE; AMBIENT-TEMPERATURE; SMALL MAMMALS; THERMOGENESIS; HYPOTHESIS; STRENGTH; GROWTH	In laboratories, mice are housed at 20-24 degrees C, which is below their lower critical temperature (approximate to 30 degrees C). This increased thermal stress has the potential to alter scientific outcomes. Nesting material should allow for improved behavioral thermoregulation and thus alleviate this thermal stress. Nesting behavior should change with temperature and material, and the choice between nesting or thermotaxis (movement in response to temperature) should also depend on the balance of these factors, such that mice titrate nesting material against temperature. Naive CD-1, BALB/c, and C57BL/6 mice (36 male and 36 female/strain in groups of 3) were housed in a set of 2 connected cages, each maintained at a different temperature using a water bath. One cage in each set was 20 degrees C (Nesting cage; NC) while the other was one of 6 temperatures (Temperature cage; TC: 20, 23, 26, 29, 32, or 35 degrees C). The NC contained one of 6 nesting provisions (0, 2, 4, 6, 8, or 10g), changed daily. Food intake and nest scores were measured in both cages. As the difference in temperature between paired cages increased, feed consumption in NC increased. Nesting provision altered differences in nest scores between the 2 paired temperatures. Nest scores in NC increased with increasing provision. In addition, temperature pairings altered the difference in nest scores with the smallest difference between locations at 26 degrees C and 29 degrees C. Mice transferred material from NC to TC but the likelihood of transfer decreased with increasing provision. Overall, mice of different strains and sexes prefer temperatures between 26-29 degrees C and the shift from thermotaxis to nest building is seen between 6 and 10 g of material. Our results suggest that under normal laboratory temperatures, mice should be provided with no less than 6 grams of nesting material, but up to 10 grams may be needed to alleviate thermal distress under typical temperatures.	[Gaskill, Brianna N.] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Gaskill, Brianna N.] Charles River Labs, Wilmington, MA USA; [Gordon, Christopher J.] US EPA, Res Triangle Pk, NC 27711 USA; [Pajor, Edmond A.] Univ Calgary, Dept Prod Anim Hlth, Calgary, AB, Canada; [Lucas, Jeffrey R.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Davis, Jerry K.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Garner, Joseph P.] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Garner, Joseph P.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Environmental Protection Agency; University of Calgary; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Stanford University; Stanford University	Gaskill, BN (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	brianna.gaskill@crl.com	Gaskill, Brianna/F-5950-2011; Garner, Joseph P/C-8422-2009	Gaskill, Brianna/0000-0002-1884-803X; 	Professor William Russell Fellowship from the Universities Federation for Animal Welfare	Professor William Russell Fellowship from the Universities Federation for Animal Welfare	This work was supported by the Professor William Russell Fellowship from the Universities Federation for Animal Welfare (http://www.ufaw.org.uk/williamrussellfellowship.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts JR, 2007, DEV PSYCHOBIOL, V49, P22, DOI 10.1002/dev.20190; [Anonymous], 2010, OFFICIAL J EUROPEAN, V276, P56; Batavia M, 2010, PHYSIOL BEHAV, V101, P376, DOI 10.1016/j.physbeh.2010.07.001; BROBECK JR, 1948, YALE J BIOL MED, V20, P545; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cannon B, 2009, P NUTR SOC, V68, P401, DOI 10.1017/S0029665109990255; COOPER JJ, 1991, ANIM BEHAV, V41, P971, DOI 10.1016/S0003-3472(05)80635-9; Crowcroft P., 1966, MICE ALL; DAWKINS MS, 1983, ANIM BEHAV, V31, P1195, DOI 10.1016/S0003-3472(83)80026-8; DAWKINS MS, 1990, BEHAV BRAIN SCI, V13, P1, DOI 10.1017/S0140525X00077104; DAWSON NJ, 1967, AUST J BIOL SCI, V20, P687, DOI 10.1071/BI9670687; DUNCAN LJH, 1992, POULTRY SCI, V71, P658, DOI 10.3382/ps.0710658; EEDY J W, 1970, Canadian Journal of Zoology, V48, P1303, DOI 10.1139/z70-221; Fraser D., 1997, Animal welfare., P159; FREEMAN ME, 1970, ENDOCRINOLOGY, V86, P717, DOI 10.1210/endo-86-4-717; Gaskill BN, 2011, J THERM BIOL, V36, P193, DOI 10.1016/j.jtherbio.2011.02.004; Gaskill BN, 2009, APPL ANIM BEHAV SCI, V116, P279, DOI 10.1016/j.applanim.2008.10.002; Gordon C. J., 1993, TEMPERATURE REGULATI, Vxii, P276; Gordon C.J., 2004, COMPARATIVE MED, V54, P51; Gordon CJ, 1998, PHYSIOL BEHAV, V65, P255, DOI 10.1016/S0031-9384(98)00148-6; Grafen A., 2002, MODERN STAT LIFE SCI, P155; GREENBERG G, 1972, BEHAVIOUR, V42, P119, DOI 10.1163/156853972X00130; Hess SE, 2008, J AM ASSOC LAB ANIM, V47, P25; Latham N, 2004, APPL ANIM BEHAV SCI, V86, P261, DOI 10.1016/j.applanim.2004.02.006; LEE CT, 1972, J GEN PSYCHOL, V87, P13; Leon LR, 2004, AM J PHYSIOL-REG I, V286, pR967, DOI 10.1152/ajpregu.00380.2003; LYNCH CB, 1973, BEHAV GENET, V3, P145, DOI 10.1007/BF01067654; LYNCH CB, 1972, BEHAV GENET, V2, P43, DOI 10.1007/BF01066733; LYNCH CB, 1984, GENET RES, V43, P299, DOI 10.1017/S0016672300026082; Mastika M., 1987, Recent advances in animal nutrition in Australia 1987, P260; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; MULDER JB, 1975, BEHAV RES METH INSTR, V7, P21, DOI 10.3758/BF03201283; National Research Counci, 2010, GUIDE CARE USE LAB A; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Newman JA, 1997, ECOLOGY, V78, P1312; OGILVIE DM, 1966, CAN J ZOOLOG, V44, P511, DOI 10.1139/z66-055; RIKKE BA, 1995, GENETICS, V139, P901; Sherwin CM, 1997, LAB ANIM, V31, P125, DOI 10.1258/002367797780600134; Silva JE, 1995, THYROID, V5, P481, DOI 10.1089/thy.1995.5.481; Townsend P, 1997, ANIM WELFARE, V6, P95; Van de Weerd HA, 1998, APPL ANIM BEHAV SCI, V55, P369, DOI 10.1016/S0168-1591(97)00043-9; VandeWeerd HA, 1997, LAB ANIM, V31, P133, DOI 10.1258/002367797780600152; Wansink B, 2004, ANNU REV NUTR, V24, P455, DOI 10.1146/annurev.nutr.24.012003.132140; WOLFE JL, 1977, BIOL J LINN SOC, V9, P73, DOI 10.1111/j.1095-8312.1977.tb00260.x; YAMAUCHI C, 1983, EXP ANIM TOKYO, V32, P1	45	131	131	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32799	10.1371/journal.pone.0032799	http://dx.doi.org/10.1371/journal.pone.0032799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479340	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100018
J	Ma, YC; Shi, C; Zhang, YN; Wang, LG; Liu, H; Jia, HT; Zhang, YX; Sarkar, FH; Wang, ZS				Ma, Yong-Chao; Shi, Chong; Zhang, Yao-Nan; Wang, Lan-Ge; Liu, Hao; Jia, Hong-Ti; Zhang, Yu-Xiang; Sarkar, Fazlul H.; Wang, Ze-Sheng			The Tyrosine Kinase c-Src Directly Mediates Growth Factor-Induced Notch-1 and Furin Interaction and Notch-1 Activation in Pancreatic Cancer Cells	PLOS ONE			English	Article							DOWN-REGULATION; RECEPTOR; APOPTOSIS; GOLGI	The proteolytic activity of Furin responsible for processing full length Notch-1 (p300) plays a critical role in Notch signaling. The amplitude and duration of Notch activity can be regulated at various points in the pathway, but there has been no report regarding regulation of the Notch-1-Furin interaction, despite its importance. In the present study, we found that the Notch-1-Furin interaction is regulated by the non-receptor tyrosine kinase, c-Src. c-Src and Notch-1 are physically associated, and this association is responsible for Notch-1 processing and activation. We also found that growth factor TGF-alpha, an EGFR ligand, and PDGF-BB, a PDGFR ligand, induce the Notch-1-Furin interaction mediated by c-Src. Our results support three new and provocative conclusions: (1) The association between Notch-1 and Furin is a well-regulated process; (2) Extracellular growth factor signals regulate this interaction, which is mediated by c-Src; (3) There is cross-talk between the plasma growth factor receptor-c-Src and Notch pathways. Co-localization of Notch-1 and c-Src was confirmed in xenograft tumor tissues and in the tissues of pancreatic cancer patients. Our findings have implications for the mechanism by which the Notch and growth factor receptor-c-Src signaling pathways regulate carcinogenesis and cancer cell growth.	[Ma, Yong-Chao; Shi, Chong; Zhang, Yao-Nan; Wang, Lan-Ge; Liu, Hao; Jia, Hong-Ti; Zhang, Yu-Xiang; Wang, Ze-Sheng] Capital Med Univ, Inst Canc, Dept Biochem & Mol Biol, Beijing, Peoples R China; [Sarkar, Fazlul H.] Wayne State Univ, Dept Pathol, Karmanos Canc Inst, Detroit, MI 48202 USA	Capital Medical University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Ma, YC (corresponding author), Capital Med Univ, Inst Canc, Dept Biochem & Mol Biol, Beijing, Peoples R China.	yxzhang@ccmu.edu.cn; zesheng@ccmu.edu.cn			National Natural Science Foundation of China [30873033]; Major State Basic Research Development Programs [2009CB521800, 2010CB529400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Programs(National Basic Research Program of China)	This work was supported by research grants from National Natural Science Foundation of China (30873033 to YXZ) and Major State Basic Research Development Programs (2009CB521800 and 2010CB529400 to YXZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; EBERT M, 1995, INT J CANCER, V62, P529, DOI 10.1002/ijc.2910620507; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; Heiser PW, 2004, CELL CYCLE, V3, P270; HUANG JS, 1984, CELL, V39, P79, DOI 10.1016/0092-8674(84)90193-4; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lake RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006728; Lee PL, 2009, GLYCOBIOLOGY, V19, P655, DOI 10.1093/glycob/cwp035; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Lutz MP, 1998, BIOCHEM BIOPH RES CO, V243, P503, DOI 10.1006/bbrc.1997.8043; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; STIFANI S, 1992, NAT GENET, V2, P119, DOI 10.1038/ng1092-119; Uegaki K, 1997, ANTICANCER RES, V17, P3841; Wang ZW, 2006, CANCER RES, V66, P2778, DOI 10.1158/0008-5472.CAN-05-4281; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324	26	45	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33414	10.1371/journal.pone.0033414	http://dx.doi.org/10.1371/journal.pone.0033414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479394	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339100047
J	Schulze-Topphoff, U; Shetty, A; Varrin-Doyer, M; Molnarfi, N; Sagan, SA; Sobel, RA; Nelson, PA; Zamvil, SS				Schulze-Topphoff, Ulf; Shetty, Aparna; Varrin-Doyer, Michel; Molnarfi, Nicolas; Sagan, Sharon A.; Sobel, Raymond A.; Nelson, Patricia A.; Zamvil, Scott S.			Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; SECONDARY PROGRESSIVE MS; CYTOKINE GM-CSF; NF-KAPPA-B; GLATIRAMER ACETATE; DOUBLE-BLIND; NEUROTROPHIC FACTOR; SUPPRESSOR-CELLS; COPOLYMER 1; T-CELLS	Laquinimod is a novel oral drug that is currently being evaluated for the treatment of relapsing-remitting (RR) multiple sclerosis (MS). Using the animal model for multiple sclerosis, experimental autoimmune encephalomyelitis (EAE), we examined how laquinimod promotes immune modulation. Oral laquinimod treatment reversed established RR-EAE and was associated with reduced central nervous system (CNS) inflammation, decreased Th1 and Th17 responses, and an increase in regulatory T cells (Treg). In vivo laquinimod treatment inhibited donor myelin-specific T cells from transferring EAE to naive recipient mice. In vivo laquinimod treatment altered subpopulations of myeloid antigen presenting cells (APC) that included a decrease in CD11c(+)CD11b(+)CD4(+) dendritic cells (DC) and an elevation of CD11b(hi)Gr1(hi) monocytes. CD11b(+) cells from these mice exhibited an anti-inflammatory type II phenotype characterized by reduced STAT1 phosphorylation, decreased production of IL-6, IL-12/23 and TNF, and increased IL-10. In adoptive transfer, donor type II monocytes from laquinimod-treated mice suppressed clinical and histologic disease in recipients with established EAE. As effects were observed in both APC and T cell compartments, we examined whether T cell immune modulation occurred as a direct effect of laquinimod on T cells, or as a consequence of altered APC function. Inhibition of Th1 and Th17 differentiation was observed only when type II monocytes or DC from laquinimod-treated mice were used as APC, regardless of whether myelin-specific T cells were obtained from laquinimod-treated or untreated mice. Thus, laquinimod modulates adaptive T cell immune responses via its effects on cells of the innate immune system, and may not influence T cells directly.	[Schulze-Topphoff, Ulf; Shetty, Aparna; Varrin-Doyer, Michel; Molnarfi, Nicolas; Sagan, Sharon A.; Nelson, Patricia A.; Zamvil, Scott S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Schulze-Topphoff, Ulf; Shetty, Aparna; Varrin-Doyer, Michel; Molnarfi, Nicolas; Sagan, Sharon A.; Nelson, Patricia A.; Zamvil, Scott S.] Univ Calif San Francisco, Program Immunol, San Francisco, CA USA; [Sobel, Raymond A.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Schulze-Topphoff, U (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	zamvil@ucsf.neuroimmunol.org	shetty, aparna/K-4050-2012	Sobel, Raymond/0000-0002-0477-9002	National Institutes of Health (NIH) [RO1 AI073737, RO1 NS063008]; National Multiple Sclerosis Society (NMSS) [RG 4124]; Teva Pharmaceuticals, Inc.; Maisin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063008] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); Teva Pharmaceuticals, Inc.(Teva Pharmaceutical Industries); Maisin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support for this work was provided to SSZ by the National Institutes of Health (NIH) (RO1 AI073737 and RO1 NS063008), the National Multiple Sclerosis Society (NMSS, RG 4124), Teva Pharmaceuticals, Inc. and the Maisin Foundation. US-T is a fellow of the Deutsche Forschungsgemeinschaft (DFG; SCHU 2587/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Majid KB, 2000, J NEUROIMMUNOL, V111, P23, DOI 10.1016/S0165-5728(00)00360-X; Aharoni R, 2000, P NATL ACAD SCI USA, V97, P11472, DOI 10.1073/pnas.97.21.11472; Aharoni R, 1997, P NATL ACAD SCI USA, V94, P10821, DOI 10.1073/pnas.94.20.10821; Apolloni E, 2000, J IMMUNOL, V165, P6723, DOI 10.4049/jimmunol.165.12.6723; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Bomback AS, 2010, J AM SOC NEPHROL, V21, P2028, DOI 10.1681/ASN.2010050472; Brueck W, 2011, J NEUROL SCI, V306, P173, DOI 10.1016/j.jns.2011.02.019; Brunmark C, 2002, J NEUROIMMUNOL, V130, P163, DOI 10.1016/S0165-5728(02)00225-4; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Comi G, 2008, LANCET, V371, P2085, DOI 10.1016/S0140-6736(08)60918-6; Comi G, 2010, MULT SCLER, V16, P1360, DOI 10.1177/1352458510378127; Comi G., 2011, ORAL LAQUINIMOD REDU; Dhib-Jalbut S, 2002, NEUROLOGY, V58, pS3, DOI 10.1212/WNL.58.8_suppl_4.S3; Duda PW, 2000, J CLIN INVEST, V105, P967, DOI 10.1172/JCI8970; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Guzzo C, 2010, J BIOL CHEM, V285, P24404, DOI 10.1074/jbc.M110.112599; Hennecke J, 2001, CELL, V104, P1, DOI 10.1016/S0092-8674(01)00185-4; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; Jonsson S, 2004, J MED CHEM, V47, P2075, DOI 10.1021/jm031044w; Kim HJ, 2004, J IMMUNOL, V172, P7144, DOI 10.4049/jimmunol.172.11.7144; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Linker RA, 2010, BRAIN, V133, P2248, DOI 10.1093/brain/awq179; Ma CJ, 2011, IMMUNOLOGY, V132, P421, DOI 10.1111/j.1365-2567.2010.03382.x; Neuhaus O, 2000, P NATL ACAD SCI USA, V97, P7452, DOI 10.1073/pnas.97.13.7452; Noseworthy JH, 2000, NEUROLOGY, V54, P1726, DOI 10.1212/WNL.54.9.1726; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Polman C, 2005, NEUROLOGY, V64, P987, DOI 10.1212/01.WNL.0000154520.48391.69; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Prod'homme T, 2008, NAT MED, V14, P614, DOI 10.1038/nm0608-614; Runstrom A, 2006, J NEUROIMMUNOL, V173, P69, DOI 10.1016/j.jneuroim.2005.11.023; Schulze-Topphoff U, 2009, NAT MED, V15, P788, DOI 10.1038/nm.1980; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Stuve O, 2006, J CLIN INVEST, V116, P1037, DOI 10.1172/JCI25805; Thone J, 2012, AM J PATHOL, V180, P267, DOI 10.1016/j.ajpath.2011.09.037; Thomas KE, 2006, J BIOL CHEM, V281, P31119, DOI 10.1074/jbc.M604958200; Vollmer T.L., 2011, PLACEBO CONTROLLED A; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Weber MS, 2004, BRAIN, V127, P1370, DOI 10.1093/brain/awh163; Wegner C, 2010, J NEUROIMMUNOL, V227, P133, DOI 10.1016/j.jneuroim.2010.07.009; Weiner HL, 2009, ANN NEUROL, V65, P239, DOI 10.1002/ana.21640; Wolinsky JS, 2000, NEUROLOGY, V54, P1734, DOI 10.1212/WNL.54.9.1734; Xiao ZY, 2007, IMMUNOL LETT, V114, P81, DOI 10.1016/j.imlet.2007.09.001; Yang HS, 2004, J NEUROIMMUNOL, V156, P3, DOI 10.1016/j.jneuroim.2004.02.016; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	47	77	81	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33797	10.1371/journal.pone.0033797	http://dx.doi.org/10.1371/journal.pone.0033797			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479444	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100069
J	Shanmugham, A; Bakayan, A; Voller, P; Grosveld, J; Lill, H; Bollen, YJM				Shanmugham, Anitha; Bakayan, Adil; Voller, Petra; Grosveld, Joost; Lill, Holger; Bollen, Yves J. M.			The Hydrophobic Core of Twin-Arginine Signal Sequences Orchestrates Specific Binding to Tat-Pathway Related Chaperones	PLOS ONE			English	Article							COFACTOR-CONTAINING PROTEINS; LEADER PEPTIDE BINDING; ESCHERICHIA-COLI; TRANSLOCATION PATHWAY; DIFFERENTIAL INTERACTIONS; PROOFREADING CHAPERONE; MOLYBDOENZYME TORA; QUALITY-CONTROL; EXPORT PATHWAY; REDUCTASE	Redox enzyme maturation proteins (REMPs) bind pre-proteins destined for translocation across the bacterial cytoplasmic membrane via the twin-arginine translocation system and enable the enzymatic incorporation of complex cofactors. Most REMPs recognize one specific pre-protein. The recognition site usually resides in the N-terminal signal sequence. REMP binding protects signal peptides against degradation by proteases. REMPs are also believed to prevent binding of immature pre-proteins to the translocon. The main aim of this work was to better understand the interaction between REMPs and substrate signal sequences. Two REMPs were investigated: DmsD (specific for dimethylsulfoxide reductase, DmsA) and TorD (specific for trimethylamine N-oxide reductase, TorA). Green fluorescent protein (GFP) was genetically fused behind the signal sequences of TorA and DmsA. This ensures native behavior of the respective signal sequence and excludes any effects mediated by the mature domain of the pre-protein. Surface plasmon resonance analysis revealed that these chimeric pre-proteins specifically bind to the cognate REMP. Furthermore, the region of the signal sequence that is responsible for specific binding to the corresponding REMP was identified by creating region-swapped chimeric signal sequences, containing parts of both the TorA and DmsA signal sequences. Surprisingly, specificity is not encoded in the highly variable positively charged N-terminal region of the signal sequence, but in the more similar hydrophobic C-terminal parts. Interestingly, binding of DmsD to its model substrate reduced membrane binding of the pre-protein. This property could link REMP-signal peptide binding to its reported proofreading function.	[Shanmugham, Anitha; Bakayan, Adil; Voller, Petra; Grosveld, Joost; Lill, Holger; Bollen, Yves J. M.] Vrije Univ Amsterdam, Dept Mol Cell Biol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Shanmugham, A (corresponding author), Vrije Univ Amsterdam, Dept Chem & Pharmaceut Sci, Amsterdam, Netherlands.	yves.bollen@vu.nl		Lill, H./0000-0001-9336-5428; Bollen, Yves/0000-0001-6251-3360				Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Barrett CML, 2003, BIOCHEM BIOPH RES CO, V304, P279, DOI 10.1016/S0006-291X(03)00583-7; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bogsch E, 1997, EMBO J, V16, P3851, DOI 10.1093/emboj/16.13.3851; Buchanan G, 2001, ARCH MICROBIOL, V177, P107, DOI 10.1007/s00203-001-0366-2; Buchanan G, 2008, FEBS LETT, V582, P3979, DOI 10.1016/j.febslet.2008.10.049; Chan CS, 2008, BIOCHEMISTRY-US, V47, P2749, DOI 10.1021/bi702138a; Chan CS, 2010, FEBS LETT, V584, P4553, DOI 10.1016/j.febslet.2010.10.043; Chan CS, 2009, J BACTERIOL, V191, P2091, DOI 10.1128/JB.00949-08; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; Fisher AC, 2004, J BACTERIOL, V186, P7467, DOI 10.1128/JB.186.22.7467-7473.2004; Genest O, 2006, BIOCHEM BIOPH RES CO, V339, P991, DOI 10.1016/j.bbrc.2005.11.107; Graubner W, 2007, J BIOL CHEM, V282, P7116, DOI 10.1074/jbc.M608235200; Guymer D, 2010, FEBS J, V277, P511, DOI 10.1111/j.1742-4658.2009.07507.x; Hatzixanthis K, 2005, P NATL ACAD SCI USA, V102, P8460, DOI 10.1073/pnas.0500737102; Ilbert M, 2003, J BIOL CHEM, V278, P28787, DOI 10.1074/jbc.M302730200; Ize B, 2002, J MOL BIOL, V317, P327, DOI 10.1006/jmbi.2002.5431; Lubitz SP, 2003, ARCH BIOCHEM BIOPHYS, V418, P205, DOI 10.1016/j.abb.2003.08.008; Oresnik IJ, 2001, MOL MICROBIOL, V40, P323, DOI 10.1046/j.1365-2958.2001.02391.x; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Papish AL, 2003, J BIOL CHEM, V278, P32501, DOI 10.1074/jbc.M301076200; Perez-Rodriguez R, 2007, J MOL BIOL, V367, P715, DOI 10.1016/j.jmb.2007.01.027; Pommier J, 1998, J BIOL CHEM, V273, P16615, DOI 10.1074/jbc.273.26.16615; Ray N, 2003, FEBS LETT, V534, P156, DOI 10.1016/S0014-5793(02)03839-5; Richter S, 2005, J BIOL CHEM, V280, P42723, DOI 10.1074/jbc.M509570200; San Miguel M, 2003, EUR J BIOCHEM, V270, P3345, DOI 10.1046/j.1432-1033.2003.03710.x; Sanders C, 2001, MOL MICROBIOL, V41, P241, DOI 10.1046/j.1365-2958.2001.02514.x; Sanders C, 2001, THESIS U OSNABRUCK G; Sargent F, 2007, BIOCHEM SOC T, V35, P835, DOI 10.1042/BST0350835; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Shanmugham A, 2006, BIOCHEMISTRY-US, V45, P2243, DOI 10.1021/bi052188a; Stevens CM, 2009, J MOL BIOL, V389, P124, DOI 10.1016/j.jmb.2009.03.069; Tranier S, 2002, PROTEIN SCI, V11, P2148, DOI 10.1110/ps.0202902; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Zakian S, 2010, FEBS J, V277, P1886, DOI 10.1111/j.1742-4658.2010.07611.x	38	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34159	10.1371/journal.pone.0034159	http://dx.doi.org/10.1371/journal.pone.0034159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479549	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100128
J	Surova, O; Akbar, NS; Zhivotovsky, B				Surova, Olga; Akbar, Nadeem Shahzad; Zhivotovsky, Boris			Knock-Down of Core Proteins Regulating MicroRNA Biogenesis Has No Effect on Sensitivity of Lung Cancer Cells to Ionizing Radiation	PLOS ONE			English	Article							NUCLEAR EXPORT; DICER; LINES; EXPRESSION; PROGNOSIS; ADENOCARCINOMA; ESTABLISHMENT; CARCINOMA; THERAPY; SCLC	Recent studies underline the important role of microRNAs (miRNA) in the development of lung cancer. The main regulators of miRNA biogenesis are the ribonucleases Drosha, Dicer and Ago2. Here the role of core proteins of miRNA biogenesis machinery in the response of human non-small and small cell lung carcinoma cell lines to treatment with ionizing radiation was assessed. We found that Drosha and Dicer were expressed at higher levels in radioresistant but not in sensitive cell lines. However, down-regulation of either Dicer or Drosha had no effect on the sensitivity of cells to irradiation. Elimination of components of the RNA-induced silencing complex Ago2 and Tudor staphylococcal nuclease also did not sensitize cells to the same treatment. Thus, modulation of miRNA biogenesis machinery is not sufficient to increase the radiosensitivity of lung tumors and other strategies are required to combat lung cancer.	[Surova, Olga; Akbar, Nadeem Shahzad; Zhivotovsky, Boris] Karolinska Inst, Inst Environm Med, Div Toxicol, S-10401 Stockholm, Sweden; [Zhivotovsky, Boris] Moscow MV Lomonosov State Univ, Fac Fundamental Med, Moscow, Russia	Karolinska Institutet; Lomonosov Moscow State University	Surova, O (corresponding author), Karolinska Inst, Inst Environm Med, Div Toxicol, S-10401 Stockholm, Sweden.	Boris.Zhivotovsky@ki.se	akbar, Noreen/G-2084-2015; Zhivotovsky, Boris/A-4346-2014	Zhivotovsky, Boris/0000-0002-2238-3482	Swedish Research Council; Stockholm Cancer Society; Swedish Childhood Cancer Foundation; Swedish Society for Medical Research; Russian Ministry of High Education and Science [11.G34.31.0006]; EC; Swedish Institute and Karolinska Institutet; NA by Higher Education Commission of Pakistan; Swedish Cancer Society	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm Cancer Society; Swedish Childhood Cancer Foundation(European Commission); Swedish Society for Medical Research; Russian Ministry of High Education and Science; EC(European CommissionEuropean Commission Joint Research Centre); Swedish Institute and Karolinska Institutet; NA by Higher Education Commission of Pakistan; Swedish Cancer Society(Swedish Cancer Society)	This study was supported by grants from the Swedish Research Council, the Swedish and the Stockholm Cancer Societies, the Swedish Childhood Cancer Foundation, Swedish Society for Medical Research, the Russian Ministry of High Education and Science (11.G34.31.0006), the EC FP-6 (Chemores) as well as the FP7 (APO-SYS) programs. OS was supported by a fellowship from the Swedish Institute and Karolinska Institutet and NA by Higher Education Commission of Pakistan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BERGH J, 1985, ACTA PATH MICRO IM A, V93, P133; BERGH J, 1982, ACTA PATH MICRO IM A, V90, P149; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Bu Y, 2009, ONCOL REP, V21, P13, DOI 10.3892/or_00000183; CARMICHAEL J, 1989, EUR J CANCER CLIN ON, V25, P527, DOI 10.1016/0277-5379(89)90266-6; CARNEY DN, 1983, CANCER RES, V43, P2806; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chen G, 2010, ONCOL REP, V23, P997, DOI 10.3892/or_00000725; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Du LQ, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-75; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Faggad A, 2010, J PATHOL, V220, P382, DOI 10.1002/path.2658; Han L, 2010, INT J ONCOL, V37, P299, DOI 10.3892/ijo_00000678; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Jiang P, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-100; Kaminskyy VO, 2011, CARCINOGENESIS, V32, P1450, DOI 10.1093/carcin/bgr135; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kraemer A, 2011, RADIAT RES, V176, P575, DOI 10.1667/RR2638.1; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Liu X, 2011, TRANSL RES, V157, P200, DOI 10.1016/j.trsl.2011.01.001; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Shin S, 2009, INT J ONCOL, V35, P81, DOI 10.3892/ijo_00000315; Spiro SG, 2005, AM J RESP CRIT CARE, V172, P523, DOI 10.1164/rccm.200504-531OE; Wang QZ, 2009, CURR CANCER DRUG TAR, V9, P572, DOI 10.2174/156800909788486731; Worden FP, 2000, EXPERT OPIN INV DRUG, V9, P565, DOI 10.1517/13543784.9.3.565; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zhang CZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-367; Zhang XN, 2011, MOL CELL, V41, P371, DOI 10.1016/j.molcel.2011.01.020	32	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33134	10.1371/journal.pone.0033134	http://dx.doi.org/10.1371/journal.pone.0033134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479364	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339100034
J	Svedruzic, ZM; Popovic, K; Smoljan, I; Sendula-Jengic, V				Svedruzic, Zeljko M.; Popovic, Katarina; Smoljan, Ivana; Sendula-Jengic, Vesna			Modulation of gamma-Secretase Activity by Multiple Enzyme-Substrate Interactions: Implications in Pathogenesis of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; APP LOCUS DUPLICATION; C-TERMINAL DOMAIN; A-BETA PEPTIDES; TRANSMEMBRANE DOMAIN; INTRAMEMBRANE CLEAVAGE; COUPLED RECEPTORS; MOUSE MODEL; PRESENILIN; INHIBITOR	Background: We describe molecular processes that can facilitate pathogenesis of Alzheimer's disease (AD) by analyzing the catalytic cycle of a membrane-imbedded protease gamma-secretase, from the initial interaction with its C99 substrate to the final release of toxic A beta peptides. Results: The C-terminal AICD fragment is cleaved first in a pre-steady-state burst. The lowest A beta 42/A beta 40 ratio is observed in pre-steady-state when A beta 40 is the dominant product. A beta 42 is produced after A beta 40, and therefore A beta 42 is not a precursor for A beta 40. The longer more hydrophobic A beta products gradually accumulate with multiple catalytic turnovers as a result of interrupted catalytic cycles. Saturation of gamma-secretase with its C99 substrate leads to 30% decrease in A beta 40 with concomitant increase in the longer A beta products and A beta 42/A beta 40 ratio. To different degree the same changes in A beta products can be observed with two mutations that lead to an early onset of AD, Delta E9 and G384A. Four different lines of evidence show that gamma-secretase can bind and cleave multiple substrate molecules in one catalytic turnover. Consequently depending on its concentration, Notch Delta E substrate can activate or inhibit gamma-secretase activity on C99 substrate. Multiple C99 molecules bound to gamma-secretase can affect processive cleavages of the nascent A beta catalytic intermediates and facilitate their premature release as the toxic membrane-imbedded A beta-bundles. Conclusions: Gradual saturation of gamma-secretase with its substrate can be the pathogenic process in different alleged causes of AD. Thus, competitive inhibitors of gamma-secretase offer the best chance for a successful therapy, while the noncompetitive inhibitors could even facilitate development of the disease by inducing enzyme saturation at otherwise sub-saturating substrate. Membrane-imbedded A beta-bundles generated by gamma-secretase could be neurotoxic and thus crucial for our understanding of the amyloid hypothesis and AD pathogenesis.	[Svedruzic, Zeljko M.; Popovic, Katarina; Smoljan, Ivana; Sendula-Jengic, Vesna] Univ Rijeka, Fac Med, Rab, Croatia	University of Rijeka	Svedruzic, ZM (corresponding author), Univ Rijeka, Fac Med, Rab, Croatia.	zsvedruz@biol.pmf.hr	Sendula Jengic, Vesna/U-2499-2018; Smoljan, Ivana/O-9740-2018; Svedruzic, Zeljko M/R-3281-2018	Sendula Jengic, Vesna/0000-0003-2126-3793; Smoljan, Ivana/0000-0002-9668-291X; Svedruzic, Zeljko M/0000-0002-0736-6182	Croatian Ministry of Health	Croatian Ministry of Health	Authors are funded by the Croatian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada-Utsugi M, 2011, J NEUROCHEM, V119, P354, DOI 10.1111/j.1471-4159.2011.07364.x; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Basi GS, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt60; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Benilova I, 2011, NAT NEUROSCI, V14, P949, DOI 10.1038/nn.2871; Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Burton CR, 2008, J BIOL CHEM, V283, P22992, DOI 10.1074/jbc.M804175200; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Chen AC, 2010, J BIOL CHEM, V285, P11378, DOI 10.1074/jbc.M109.088815; Citron M, 1996, P NATL ACAD SCI USA, V93, P13170, DOI 10.1073/pnas.93.23.13170; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Comery TA, 2005, J NEUROSCI, V25, P8898, DOI 10.1523/JNEUROSCI.2693-05.2005; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Dias BD, 2011, PRION, V5, P126, DOI 10.4161/pri.5.3.17025; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Fan JJ, 2009, BIOFACTORS, V35, P239, DOI 10.1002/biof.37; Fersht A., 1998, STRUCTURE MECH PROTE, V1st ed., P650; Fraering PC, 2007, CURR GENOMICS, V8, P531, DOI 10.2174/138920207783769521; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; German DC, 2004, REV NEUROSCIENCE, V15, P353, DOI 10.1515/REVNEURO.2004.15.5.353; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Guyant-Marechal L, 2007, NEUROLOGY, V68, P684, DOI 10.1212/01.wnl.0000255938.33739.46; Harris GC, 1997, PHOTOSYNTH RES, V54, P5, DOI 10.1023/A:1005895213775; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Henley DB, 2009, EXPERT OPIN PHARMACO, V10, P1657, DOI 10.1517/14656560903044982; Holsinger RMD, 2004, ANN NEUROL, V55, P898, DOI 10.1002/ana.20144; Hulko M, 2007, PROTEIN SCI, V16, P644, DOI 10.1110/ps.062478607; Imbimbo BP, 2011, EXPERT OPIN INV DRUG, V20, P325, DOI 10.1517/13543784.2011.550572; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kreft AF, 2009, J MED CHEM, V52, P6169, DOI 10.1021/jm900188z; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Kwok JBJ, 1997, NEUROREPORT, V8, P1537, DOI 10.1097/00001756-199704140-00043; Lanz TA, 2006, J PHARMACOL EXP THER, V319, P924, DOI 10.1124/jpet.106.110700; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lemberg MK, 2007, GENOME RES, V17, P1634, DOI 10.1101/gr.6425307; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Marlow L, 2003, BIOCHEM BIOPH RES CO, V305, P502, DOI 10.1016/S0006-291X(03)00797-6; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Miyashita N, 2009, J AM CHEM SOC, V131, P3438, DOI 10.1021/ja809227c; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Peralvarez-Marin A, 2009, BIOPHYS J, V97, P277, DOI 10.1016/j.bpj.2009.04.017; Perez-Revuelta BI, 2010, J NEUROCHEM, V112, P940, DOI 10.1111/j.1471-4159.2009.06510.x; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Refolo LM, 1999, J NEUROCHEM, V73, P2383, DOI 10.1046/j.1471-4159.1999.0732383.x; Rovelet-Lecrux A, 2007, J NEUROL NEUROSUR PS, V78, P1158, DOI 10.1136/jnnp.2006.113514; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Rushworth JV, 2011, INT J ALZHEIMERS DIS, V1-14, P1; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sambamurti K, 2011, J NEUROCHEM, V117, P359, DOI 10.1111/j.1471-4159.2011.07213.x; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shearman MS, 2000, BIOCHEMISTRY-US, V39, P8698, DOI 10.1021/bi0005456; SRIVASTAVA DK, 1987, ANNU REV BIOPHYS BIO, V16, P175; Sun AY, 2002, EXP NEUROL, V175, P10, DOI 10.1006/exnr.2002.7875; Svedruzic ZM, 2005, BIOCHEMISTRY-US, V44, P14977, DOI 10.1021/bi050988f; Szekeres PG, 2008, J BIOMOL SCREEN, V13, P101, DOI 10.1177/1087057107312778; Tabaton M, 2007, CELL MOL LIFE SCI, V64, P2211, DOI 10.1007/s00018-007-7219-3; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Thathiah A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.293re8; Tian GC, 2003, J BIOL CHEM, V278, P28968, DOI 10.1074/jbc.M300905200; Tian GC, 2002, J BIOL CHEM, V277, P31499, DOI 10.1074/jbc.M112328200; Tipton KF, 2002, ENZYME ASSAYS; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Tomita T, 2009, EXPERT REV NEUROTHER, V9, P661, DOI [10.1586/ern.09.24, 10.1586/ERN.09.24]; Uemura K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1129; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; VANNOORDEN CJF, 1995, HISTOCHEM J, V27, P101, DOI 10.1007/BF00243905; Wang H, 2011, J MOL BIOL, V408, P879, DOI 10.1016/j.jmb.2011.03.028; Wiltfang J, 2002, J NEUROCHEM, V81, P481, DOI 10.1046/j.1471-4159.2002.00818.x; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yagishita S, 2006, BIOCHEMISTRY-US, V45, P3952, DOI 10.1021/bi0521846; Yagishita S, 2008, J BIOL CHEM, V283, P733, DOI 10.1074/jbc.M707103200; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yin YI, 2007, J BIOL CHEM, V282, P23639, DOI 10.1074/jbc.M704601200; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	99	12	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32293	10.1371/journal.pone.0032293	http://dx.doi.org/10.1371/journal.pone.0032293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479317	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100007
J	Szpak, P; Longstaffe, FJ; Millaire, JF; White, CD				Szpak, Paul; Longstaffe, Fred J.; Millaire, Jean-Francois; White, Christine D.			Stable Isotope Biogeochemistry of Seabird Guano Fertilization: Results from Growth Chamber Studies with Maize (Zea Mays)	PLOS ONE			English	Article							N-15 NATURAL-ABUNDANCE; NITROGEN USE EFFICIENCY; WATER-USE EFFICIENCY; AMINO-ACIDS; DELTA-N-15 VALUES; ORNITHOGENIC PRODUCTS; NITRATE REDUCTASE; PENGUIN ROOKERIES; AMMONIUM TOXICITY; SEED-GERMINATION	Background: Stable isotope analysis is being utilized with increasing regularity to examine a wide range of issues (diet, habitat use, migration) in ecology, geology, archaeology, and related disciplines. A crucial component to these studies is a thorough understanding of the range and causes of baseline isotopic variation, which is relatively poorly understood for nitrogen (delta N-15). Animal excrement is known to impact plant delta N-15 values, but the effects of seabird guano have not been systematically studied from an agricultural or horticultural standpoint. Methodology/Principal Findings: This paper presents isotopic (delta C-13 and delta N-15) and vital data for maize (Zea mays) fertilized with Peruvian seabird guano under controlled conditions. The level of N-15 enrichment in fertilized plants is very large, with delta N-15 values ranging between 25.5 and 44.7 parts per thousand depending on the tissue and amount of fertilizer applied; comparatively, control plant delta N-15 values ranged between -0.3 and 5.7 parts per thousand. Intraplant and temporal variability in delta N-15 values were large, particularly for the guano-fertilized plants, which can be attributed to changes in the availability of guano-derived N over time, and the reliance of stored vs. absorbed N. Plant delta C-13 values were not significantly impacted by guano fertilization. High concentrations of seabird guano inhibited maize germination and maize growth. Moreover, high levels of seabird guano greatly impacted the N metabolism of the plants, resulting in significantly higher tissue N content, particularly in the stalk. Conclusions/Significance: The results presented in this study demonstrate the very large impact of seabird guano on maize delta N-15 values. The use of seabird guano as a fertilizer can thus be traced using stable isotope analysis in food chemistry applications (certification of organic inputs). Furthermore, the fertilization of maize with seabird guano creates an isotopic signature very similar to a high-trophic level marine resource, which must be considered when interpreting isotopic data from archaeological material.	[Szpak, Paul; Millaire, Jean-Francois; White, Christine D.] Univ Western Ontario, Dept Anthropol, London, ON, Canada; [Longstaffe, Fred J.] Univ Western Ontario, Dept Earth Sci, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Szpak, P (corresponding author), Univ Western Ontario, Dept Anthropol, London, ON, Canada.	pszpak@uwo.ca	Longstaffe, Fred J/A-6843-2008	Millaire, Jean-Francois/0000-0002-8074-5912	Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	The authors hank the Natural Sciences and Engineering Research Council of Canada, Canada Research Chairs Program and the Canada Foundation for Innovation for funding in support of this research. This is Laboratory for Stable Isotope Science Contribution #279. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson WB, 1999, OECOLOGIA, V118, P324, DOI 10.1007/s004420050733; ANDREWS M, 1986, PLANT CELL ENVIRON, V9, P511, DOI 10.1111/j.1365-3040.1986.tb01582.x; Ariz I, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-83; Barrett K, 2005, OIKOS, V109, P145, DOI 10.1111/j.0030-1299.2005.13728.x; Bateman AS, 2007, ISOT ENVIRON HEALT S, V43, P237, DOI 10.1080/10256010701550732; Bateman AS, 2007, J AGR FOOD CHEM, V55, P2664, DOI 10.1021/jf0627726; Bateman AS, 2005, J AGR FOOD CHEM, V53, P5760, DOI 10.1021/jf050374h; BEAUCHAMP EG, 1976, AGRON J, V68, P418, DOI 10.2134/agronj1976.00021962006800020055x; BELOW FE, 1981, PLANT PHYSIOL, V68, P1186, DOI 10.1104/pp.68.5.1186; BINFORD GD, 1990, AGRON J, V82, P124, DOI 10.2134/agronj1990.00021962008200010027x; Bird MI, 2008, RAPID COMMUN MASS SP, V22, P3393, DOI 10.1002/rcm.3739; Bogaard A, 2007, J ARCHAEOL SCI, V34, P335, DOI 10.1016/j.jas.2006.04.009; Bokhorst S, 2007, POLAR BIOL, V30, P1315, DOI 10.1007/s00300-007-0292-0; BREMNER JM, 1989, P NATL ACAD SCI USA, V86, P8185, DOI 10.1073/pnas.86.21.8185; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Burger A.E., 1978, South African Journal of Antarctic Research, V8, P59; Burger M, 2008, SOIL SCI SOC AM J, V72, P1570, DOI 10.2136/sssaj2007.0118; Cabrera-Bosquet L, 2007, ANN APPL BIOL, V151, P277, DOI 10.1111/j.1744-7348.2007.00195.x; Camin F, 2011, FOOD CHEM, V125, P1072, DOI 10.1016/j.foodchem.2010.09.081; Camin F, 2007, J SCI FOOD AGR, V87, P1330, DOI 10.1002/jsfa.2853; Chepstow-Lusty A, 2011, ANTIQUITY, V85, P570, DOI 10.1017/S0003598X0006796X; Choi WJ, 2005, COMMUN SOIL SCI PLAN, V36, P2719, DOI 10.1080/00103620500303913; Choi WJ, 2003, SOIL BIOL BIOCHEM, V35, P483, DOI 10.1016/S0038-0717(02)00299-7; Choi WJ, 2003, SOIL BIOL BIOCHEM, V35, P1493, DOI 10.1016/S0038-0717(03)00246-3; Choi WJ, 2002, PLANT SOIL, V245, P223, DOI 10.1023/A:1020475017254; Cieza de Leon Pedro de, 1964, TRAVELS PEDRO CIEZA; CLARKSON DT, 1982, J EXP BOT, V33, P865, DOI 10.1093/jxb/33.5.865; Clay DE, 2001, SOIL SCI SOC AM J, V65, P1823, DOI 10.2136/sssaj2001.1823; Cocks MP, 1998, POLAR BIOL, V20, P107, DOI 10.1007/s003000050283; Commisso RG, 2007, J ARCHAEOL SCI, V34, P440, DOI 10.1016/j.jas.2006.06.012; Cordle Celia, 2007, RURAL HIST, V18, P119; Cox G, 2001, WORLD ARCHAEOL, V33, P73, DOI 10.1080/00438240120047645; Cox G., 1997, INT J HIST ARCHAEOL, V1, P207, DOI [10.1023/A:1027349115474, DOI 10.1023/A:1027349115474]; Crawford NM, 1998, TRENDS PLANT SCI, V3, P389, DOI 10.1016/S1360-1385(98)01311-9; Cushman GT, THESIS U TEXAS AUSTI; DEIGNAN MT, 1988, NEW PHYTOL, V110, P1, DOI 10.1111/j.1469-8137.1988.tb00230.x; del Amor FM, 2008, J ENVIRON QUAL, V37, P182, DOI 10.2134/jeq2007.0329; DeNiro M.J., 1988, BAR International Series, P119; Dijkstra P, 2006, EUR J SOIL SCI, V57, P468, DOI 10.1111/j.1365-2389.2006.00793.x; Dijkstra P, 2003, ISOT ENVIRON HEALT S, V39, P29, DOI 10.1080/1025601031000102189; Donnison IS, 2007, NEW PHYTOL, V173, P481, DOI 10.1111/j.1469-8137.2006.01928.x; Duffy David C., 1994, Birdlife Conservation Series, V1, P68; Ellis JC, 2005, PLANT ECOL, V181, P227, DOI 10.1007/s11258-005-7147-y; ENGELSKJON T, 1986, Polar Research, V4, P205, DOI 10.1111/j.1751-8369.1986.tb00532.x; Erskine PD, 1998, OECOLOGIA, V117, P187, DOI 10.1007/s004420050647; Evans RD, 1996, PLANT CELL ENVIRON, V19, P1317, DOI 10.1111/j.1365-3040.1996.tb00010.x; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; FEIGIN A, 1974, SOIL SCI SOC AM J, V38, P465, DOI 10.2136/sssaj1974.03615995003800030026x; Flores P, 2007, J AGR FOOD CHEM, V55, P5740, DOI 10.1021/jf0701180; Flores P, 2011, J SCI FOOD AGR, V91, P2255, DOI 10.1002/jsfa.4447; Flores-Delgadillo L, 2011, SOIL TILL RES, V113, P112, DOI 10.1016/j.still.2011.03.001; Forero MG, 2004, J ANIM ECOL, V73, P789, DOI 10.1111/j.0021-8790.2004.00852.x; Fraser RA, 2011, J ARCHAEOL SCI, V38, P2790, DOI 10.1016/j.jas.2011.06.024; Gallais A, 2005, MAYDICA, V50, P531; Gallais A, 2006, NEW PHYTOL, V172, P696, DOI 10.1111/j.1469-8137.2006.01890.x; Garcia LV, 2002, OIKOS, V98, P75, DOI 10.1034/j.1600-0706.2002.980108.x; Garcilaso de la Vega I., 1966, ROYAL COMMENTARIES I; Garnica M, 2010, J SCI FOOD AGR, V90, P357, DOI 10.1002/jsfa.3811; GARTEN CT, 1993, ECOLOGY, V74, P2098, DOI 10.2307/1940855; Gaskell M, 2007, HORTTECHNOLOGY, V17, P431, DOI 10.21273/HORTTECH.17.4.431; GEBAUER G, 1994, PLANT SOIL, V164, P267, DOI 10.1007/BF00010079; Georgi M, 2005, PLANT SOIL, V275, P93, DOI 10.1007/s11104-005-0258-3; GILLHAM MARY E., 1960, AUSTRALIAN JOUR BOT, V8, P277, DOI 10.1071/BT9600277; GILLHAM ME, 1956, J ECOL, V44, P429, DOI 10.2307/2256831; Glass ADM, 2001, J PLANT NUTR SOIL SC, V164, P199, DOI 10.1002/1522-2624(200104)164:2<199::AID-JPLN199>3.0.CO;2-K; Guo SW, 2007, J PLANT NUTR SOIL SC, V170, P73, DOI 10.1002/jpln.200625073; HADAS A, 1992, FERT RES, V31, P209, DOI 10.1007/BF01063294; Harding JS, 2004, FRESHWATER BIOL, V49, P576, DOI 10.1111/j.1365-2427.2004.01210.x; Hartz TK, 2006, HORTTECHNOLOGY, V16, P39, DOI 10.21273/HORTTECH.16.1.0039; Hawke DJ, 2007, NEW ZEAL J BOT, V45, P309; Hawke DJ, 2005, J ZOOL, V266, P419, DOI 10.1017/S0952836905007065; Hobara S, 2005, PLANT SOIL, V268, P89, DOI 10.1007/s11104-004-0231-6; Hobbie EA, 2000, OECOLOGIA, V122, P273, DOI 10.1007/PL00008856; HOBSON KA, 1992, CONDOR, V94, P189, DOI 10.2307/1368808; HOBSON KA, 1995, CONDOR, V97, P752, DOI 10.2307/1369183; HOCH MP, 1992, LIMNOL OCEANOGR, V37, P1447, DOI 10.4319/lo.1992.37.7.1447; Hogberg P, 1999, NEW PHYTOL, V142, P569, DOI 10.1046/j.1469-8137.1999.00404.x; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; Hogberg P, 1996, OECOLOGIA, V108, P207, DOI 10.1007/BF00334643; HUTCHINSON GEORGE EVELYN, 1950, BULL AMER MUS NAT HIST, V96, P1; Iqbal MM, 2005, SOIL TILL RES, V80, P47, DOI 10.1016/j.still.2004.02.016; Ishida A, 1997, ECOL RES, V12, P249, DOI 10.1007/BF02529454; ISHIZUKA KAZUO, 1966, ECOL REV, V16, P229; JENKINSON DS, 1995, PLANT SOIL, V171, P365, DOI 10.1007/BF00010293; Julien C.J., 1985, ANDEAN ECOLOGY CIVIL, P185; Kameda K, 2006, HYDROBIOLOGIA, V567, P69, DOI 10.1007/s10750-006-0052-0; Katzenberg M. Anne, 1995, BODIES EVIDENCE RECO, P221; Katzenberg MA., 2000, BIOGEOCHEMICAL APPRO, P1; Kerley SJ, 1996, PLANT SOIL, V178, P287, DOI 10.1007/BF00011595; KIRCHMANN H, 1991, SWED J AGR RES, V21, P165; KIRSHENBAUM I, 1947, J CHEM PHYS, V15, P440, DOI 10.1063/1.1746562; Klippel WE, 2001, J ARCHAEOL SCI, V28, P1191, DOI 10.1006/jasc.2000.0636; Knudson KJ, 2007, J ARCHAEOL SCI, V34, P451, DOI 10.1016/j.jas.2006.07.003; Kolb GS, 2010, ECOSYSTEMS, V13, P353, DOI 10.1007/s10021-010-9323-8; Kolb KJ, 2002, NEW PHYTOL, V156, P57, DOI 10.1046/j.1469-8137.2002.00490.x; Kondo M, 2004, PLANT SOIL, V267, P165, DOI 10.1007/s11104-005-4884-6; Kubler G., 1948, MEMOIRS SOC AM ARCHA, V4, P29; LEDGARD SF, 1985, AUST J PLANT PHYSIOL, V12, P631, DOI 10.1071/PP9850631; LEENTVAAR P, 1967, Hydrobiologia, V29, P441, DOI 10.1007/BF00189906; LEWIS OAM, 1989, NEW PHYTOL, V111, P155, DOI 10.1111/j.1469-8137.1989.tb00676.x; Ligeza S, 2003, CHEMOSPHERE, V52, P595, DOI 10.1016/S0045-6535(03)00241-8; Lim SS, 2007, PLANT SOIL, V295, P67, DOI 10.1007/s11104-007-9262-0; LINDEBOOM HJ, 1984, ECOLOGY, V65, P269, DOI 10.2307/1939479; Loder TC, 1996, J EXP MAR BIOL ECOL, V196, P113, DOI 10.1016/0022-0981(95)00126-3; Ma BL, 1998, PLANT SOIL, V199, P283, DOI 10.1023/A:1004397219723; MARIOTTI A, 1980, PHYSIOL VEG, V18, P163; MARIOTTI A, 1982, PLANT PHYSIOL, V69, P880, DOI 10.1104/pp.69.4.880; Markwell TJ, 2002, ECOSCIENCE, V9, P293, DOI 10.1080/11956860.2002.11682715; MATHEW WM, 1970, ECON HIST REV, V23, P112; MCCOLL JG, 1976, AM MIDL NAT, V96, P270, DOI 10.2307/2424068; MCNABB FMA, 1980, CONDOR, V82, P219; Miller AJ, 2005, PLANT SOIL, V274, P1, DOI 10.1007/s11104-004-0965-1; Mizota C, 2009, APPL GEOCHEM, V24, P2027, DOI 10.1016/j.apgeochem.2009.07.013; Mizota C, 2009, APPL GEOCHEM, V24, P328, DOI 10.1016/j.apgeochem.2008.10.010; Mizota C, 2007, GEOCHEM J, V41, P297, DOI 10.2343/geochemj.41.297; MIZUTANI H, 1986, BIOGEOCHEMISTRY, V2, P221, DOI 10.1007/BF02180160; MIZUTANI H, 1985, J CHROMATOGR, V331, P371, DOI 10.1016/0021-9673(85)80043-1; MIZUTANI H, 1988, ECOLOGY, V69, P340, DOI 10.2307/1940432; MIZUTANI H, 1991, NATURWISSENSCHAFTEN, V78, P34, DOI 10.1007/BF01134042; MIZUTANI H, 1985, J CHROMATOGR, V331, P359, DOI 10.1016/0021-9673(85)80042-X; MIZUTANI H, 1991, AUK, V108, P960; MIZUTANI H, 1985, GEOCHEM J, V19, P323, DOI 10.2343/geochemj.19.323; Mulder CPH, 2001, OECOLOGIA, V127, P350, DOI 10.1007/s004420000600; MURPHY AT, 1987, NEW PHYTOL, V107, P327, DOI 10.1111/j.1469-8137.1987.tb00184.x; MURPHY RC, 1981, RESOURCE MANAGEMENT, P81; Nakano A, 2007, JARQ-JPN AGR RES Q, V41, P219, DOI 10.6090/jarq.41.219; NASHOLM T, 1990, TREE PHYSIOL, V6, P267, DOI 10.1093/treephys/6.3.267; NASHOLM T, 1994, OECOLOGIA, V99, P290, DOI 10.1007/BF00627741; Netherly P.J., 1977, PHD DISSERTATION; Nordt L, 2004, GEOARCHAEOLOGY, V19, P21, DOI 10.1002/gea.10102; Okano K, 1997, JPN J CROP SCI, V66, P279, DOI 10.1626/jcs.66.279; Potel F, 2009, FEBS J, V276, P4061, DOI 10.1111/j.1742-4658.2009.07114.x; POWELL GVN, 1991, ESTUAR COAST SHELF S, V32, P567, DOI 10.1016/0272-7714(91)90075-M; Pritchard ES, 2005, TREES-STRUCT FUNCT, V19, P89, DOI 10.1007/s00468-004-0367-2; Rajcan I, 1999, FIELD CROP RES, V60, P255, DOI 10.1016/S0378-4290(98)00143-9; Rapisarda P, 2005, J AGR FOOD CHEM, V53, P2664, DOI 10.1021/jf048733g; Rapisarda P, 2010, J AGR FOOD CHEM, V58, P3502, DOI 10.1021/jf903952v; RAVEN JA, 1992, NEW PHYTOL, V121, P19, DOI 10.1111/j.1469-8137.1992.tb01088.x; RAVEN JA, 1976, NEW PHYTOL, V76, P415, DOI 10.1111/j.1469-8137.1976.tb01477.x; Robinson D, 1998, PLANTA, V205, P397, DOI 10.1007/s004250050336; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; Rogers KM, 2008, J AGR FOOD CHEM, V56, P4078, DOI 10.1021/jf800797w; Romero S, 2008, NY TIMES        0530; Roosta HR, 2007, J PLANT NUTR, V30, P1933, DOI 10.1080/01904160701629211; Roy DM, 2005, AM J PHYS ANTHROPOL, V128, P444, DOI 10.1002/ajpa.20203; Ruan J, 2010, PLANT BIOLOGY, V12, P724, DOI 10.1111/j.1438-8677.2009.00288.x; Ruan JY, 2007, J SCI FOOD AGR, V87, P1505, DOI 10.1002/jsfa.2875; RYAN PG, 1989, POLAR BIOL, V10, P151; Schmidt HL, 2005, ISOT ENVIRON HEALT S, V41, P223, DOI 10.1080/10256010500230072; Schmidt S, 2004, FUNCT PLANT BIOL, V31, P517, DOI 10.1071/FP04024; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; Schortemeyer M, 1997, ANN BOT-LONDON, V79, P25, DOI 10.1006/anbo.1996.0298; Schroeder H, 2009, AM J PHYS ANTHROPOL, V139, P547, DOI 10.1002/ajpa.21019; SCHWARCZ HP, 1991, J ARCHAEOL SCI, V18, P261, DOI 10.1016/0305-4403(91)90065-W; SEALY J, 1995, ANTIQUITY, V69, P290, DOI 10.1017/S0003598X00064693; Serret MD, 2008, ANN APPL BIOL, V153, P243, DOI 10.1111/j.1744-7348.2008.00259.x; Shangguan ZP, 2000, ENVIRON EXP BOT, V44, P141, DOI 10.1016/S0098-8472(00)00064-2; SHEARER G, 1986, AUST J PLANT PHYSIOL, V13, P699, DOI 10.1071/PP9860699; Siegfried W.R., 1978, South African Journal of Antarctic Research, V8, P75; Simmons D, 2006, REPRESENTATIONS, P73; Slovak NM, 2011, INT J OSTEOARCHAEOL, V21, P253, DOI 10.1002/oa.1128; SMITH JS, 1995, MAR ECOL PROG SER, V124, P189, DOI 10.3354/meps124189; SMITH VR, 1978, OECOLOGIA, V32, P239, DOI 10.1007/BF00366075; Smolders AJP, 1996, AQUAT BOT, V53, P85, DOI 10.1016/0304-3770(95)01014-9; SPEIR TW, 1984, POLAR BIOL, V2, P199, DOI 10.1007/BF00263625; Stapp P, 1999, NATURE, V401, P467, DOI 10.1038/46769; Sturm M, 2011, ISOT ENVIRON HEALT S, V47, P214, DOI 10.1080/10256016.2011.570865; Sturm M, 2011, J SCI FOOD AGR, V91, P262, DOI 10.1002/jsfa.4179; Subedi KD, 2005, CROP SCI, V45, P740, DOI 10.2135/cropsci2005.0740; Szpak P, 2012, J ARCHAEOL SCI, V39, P1553, DOI 10.1016/j.jas.2011.12.006; Szpak P, 2009, J ARCHAEOL SCI, V36, P2734, DOI 10.1016/j.jas.2009.08.013; TA CT, 1991, PLANT PHYSIOL, V97, P1375, DOI 10.1104/pp.97.4.1375; Tcherkez G, 2006, FUNCT PLANT BIOL, V33, P531, DOI 10.1071/FP05284; Tcherkez G, 2011, FUNCT PLANT BIOL, V38, P1, DOI 10.1071/FP10091; Tomczak PD, 2003, J ANTHROPOL ARCHAEOL, V22, P262, DOI 10.1016/S0278-4165(03)00039-4; TSAI CY, 1980, PLANT PHYSIOL, V66, P330, DOI 10.1104/pp.66.2.330; Valentin F, 2006, J ARCHAEOL SCI, V33, P1396, DOI 10.1016/j.jas.2006.01.012; VAUGHNWE.D, 1971, AM MIDL NAT, V86, P57, DOI 10.2307/2423685; Vidal E, 2003, POLAR BIOL, V26, P432, DOI 10.1007/s00300-003-0500-5; Wainright SC, 1998, MAR BIOL, V131, P63, DOI 10.1007/s002270050297; Wait DA, 2005, J ARID ENVIRON, V60, P681, DOI 10.1016/j.jaridenv.2004.07.001; Warren CR, 2000, J EXP BOT, V51, P1147, DOI 10.1093/jexbot/51.347.1147; Williams A.J., 1978, South African Journal of Antarctic Research, V8, P53; Williams A.J., 1978, South African Journal of Antarctic Research, V8, P71; Winter CK, 2006, J FOOD SCI, V71, pR117, DOI 10.1111/j.1750-3841.2006.00196.x; WOOTTON JT, 1991, J EXP MAR BIOL ECOL, V151, P139, DOI 10.1016/0022-0981(91)90121-C; Yin ZH, 1998, PLANTA, V205, P574, DOI 10.1007/s004250050358; YONEYAMA T, 1993, PLANT CELL PHYSIOL, V34, P489; YONEYAMA T, 1991, PLANT CELL PHYSIOL, V32, P1211; YONEYAMA T, 1989, PLANT CELL PHYSIOL, V30, P957; Yoneyama T, 2001, PLANT CELL ENVIRON, V24, P133, DOI 10.1046/j.1365-3040.2001.00663.x; Yoneyama T., 1998, STABLE ISOTOPES INTE, P99; Yoneyama Tadakatsu, 2003, Phytochemistry Reviews, V2, P121, DOI 10.1023/B:PHYT.0000004198.95836.ad; Young HS, 2011, AM J BOT, V98, P207, DOI 10.3732/ajb.1000159; Young HS, 2010, P NATL ACAD SCI USA, V107, P2072, DOI 10.1073/pnas.0914169107; Yun SI, 2006, SOIL BIOL BIOCHEM, V38, P1682, DOI 10.1016/j.soilbio.2005.11.022; Zapata F., 2002, International Atomic Energy Agency Technical Documents (IAEA-TECDOCs), P83; Zhao LJ, 2007, J PLANT NUTR, V30, P947, DOI 10.1080/15226510701375572; Zhu RB, 2009, ANTARCT SCI, V21, P427, DOI 10.1017/S0954102009990204	199	52	53	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33741	10.1371/journal.pone.0033741	http://dx.doi.org/10.1371/journal.pone.0033741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479435	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100068
J	Chen, XD; Yang, YJ; Li, SY; Peng, QQ; Zheng, LJ; Jin, L; Wang, XF				Chen, Xing-dong; Yang, Ya-jun; Li, Shu-yuan; Peng, Qian-qian; Zheng, Li-juan; Jin, Li; Wang, Xiao-feng			Several Polymorphisms of KCNQ1 Gene Are Associated with Plasma Lipid Levels in General Chinese Populations	PLOS ONE			English	Article							POTASSIUM CHANNEL GENE; TARGETED DISRUPTION; FASTING GLUCOSE; COMMON VARIANTS; HAN POPULATION; DISEASE GENES; KVLQT1; MUTATION; JERVELL; SUSCEPTIBILITY	Background: Potassium voltage-gated channel, KQT-like subfamily, member 1 (KCNQ1) is thought to be an important candidate gene of diabetes. Several single nucleotide polymorphisms (SNPs) in a 40-kb linkage disequilibrium (LD) block in its intron 15 have been identified to be associated with diabetes in East Asian populations in recent genome-wide association studies. The aim of this study was to investigate whether KCNQ1 polymorphisms influence the levels of the metabolic phenotypes in general Chinese populations. Methodology/Principal Findings: We investigated the associations of two SNPs (rs2237892 and rs2237895) in the aforementioned 40-kb LD block, a missense variant rs12720449 (P448R) in exon 10, and a synonymous variant rs1057128 (S546S) in exon 13 with metabolic phenotypes in a Uyghur population (n = 478) and replicated these associations in a Han population (n = 2,485). We found that rs2237892-T allele was significantly associated with decreased triglyceride levels (p(combined) = 0.001). The minor G allele of the rs12720449, with sharp difference of the allelic frequency between European and East Asian populations (0.2% versus 14%, respectively), was associated with a lower triglyceride levels than G allele in Uyghur subjects (p = 0.004), in Han subjects (p = 0.052), and in subjects of meta-analysis (p(combined) = 0.001). Moreover, the minor A allele of the rs1057128 was also associated with decreased triglyceride levels in meta-analysis (p(combined) = 0.010). Conclusions: To the best of our knowledge, this is the first report associating a missense mutation of KCNQ1, rs12720449, with triglyceride levels. Rs2237892, representing the 40-kb LD block, is also associated with triglyceride levels in Han population. Further studies are required to replicate these findings in other East Asian populations.	[Chen, Xing-dong; Yang, Ya-jun; Li, Shu-yuan; Peng, Qian-qian; Zheng, Li-juan; Jin, Li; Wang, Xiao-feng] Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Chen, Xing-dong; Yang, Ya-jun; Li, Shu-yuan; Peng, Qian-qian; Zheng, Li-juan; Jin, Li; Wang, Xiao-feng] Fudan Univ, MOE Key Lab Contemporary Anthropol, Sch Life Sci, Shanghai 200433, Peoples R China; [Chen, Xing-dong; Yang, Ya-jun; Li, Shu-yuan; Peng, Qian-qian; Zheng, Li-juan; Jin, Li; Wang, Xiao-feng] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Chen, Xing-dong; Yang, Ya-jun; Li, Shu-yuan; Peng, Qian-qian; Zheng, Li-juan; Jin, Li; Wang, Xiao-feng] China Med City Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China	Fudan University; Fudan University; Fudan University	Chen, XD (corresponding author), Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	xiaofengautomatic@gmail.com	Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; Peng, Qianqian/0000-0002-2018-5706	National Natural Science Foundation [30625016, 30890034, 30971237, 31171216, 81100551]; Major National Science and Technology Program [2008ZX10002-016]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Major National Science and Technology Program	This work was supported by grants-in-aids from the National Natural Science Foundation (30625016, 30890034, 30971237, 31171216 and 81100551) and a grant from Major National Science and Technology Program (2008ZX10002-016). The authors thank the members of the survey teams and the participants for their contribution to this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Aydin A, 2005, J MOL MED, V83, P159, DOI 10.1007/s00109-004-0595-3; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Carlini DB, 2001, GENETICS, V159, P623; Casimiro MC, 2001, P NATL ACAD SCI USA, V98, P2526, DOI 10.1073/pnas.041398998; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Chen Z, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-35; Chen Z, 2010, MOL BIOL REP, V37, P207, DOI 10.1007/s11033-009-9597-0; Demolombe S, 2001, AM J PHYSIOL-CELL PH, V280, pC359, DOI 10.1152/ajpcell.2001.280.2.C359; Holmkvist J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005872; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Jonsson A, 2009, DIABETES, V58, P2409, DOI 10.2337/db09-0246; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Liang Lu, 2003, Zhonghua Er Ke Za Zhi, V41, P724; Liu Y, 2009, DIABETOLOGIA, V52, P1315, DOI 10.1007/s00125-009-1375-y; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Qi QB, 2009, HUM MOL GENET, V18, P3508, DOI 10.1093/hmg/ddp294; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Sharma D, 2004, J MOL CELL CARDIOL, V37, P79, DOI 10.1016/j.yjmcc.2004.03.015; Tan JT, 2009, DIABETES, V58, P1445, DOI 10.2337/db08-1138; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Ullrich S, 2005, PFLUG ARCH EUR J PHY, V451, P428, DOI 10.1007/s00424-005-1479-2; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Westenskow P, 2004, CIRCULATION, V109, P1834, DOI 10.1161/01.CIR.0000125524.34234.13; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zhang Y, 2008, ANN NONINVAS ELECTRO, V13, P180, DOI 10.1111/j.1542-474X.2008.00220.x	32	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34229	10.1371/journal.pone.0034229	http://dx.doi.org/10.1371/journal.pone.0034229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479571	gold, Green Published, Green Submitted			2022-12-27	WOS:000304523400062
J	Schwendt, M; Reichel, CM; See, RE				Schwendt, Marek; Reichel, Carmela M.; See, Ronald E.			Extinction-Dependent Alterations in Corticostriatal mGluR2/3 and mGluR7 Receptors following Chronic Methamphetamine Self-Administration in Rats	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; OBJECT RECOGNITION MEMORY; COCAINE-SEEKING BEHAVIOR; MEDIAL PREFRONTAL CORTEX; CELL-SURFACE EXPRESSION; NUCLEUS-ACCUMBENS; DRUG-SEEKING; GROUP-II; IMMUNOHISTOCHEMICAL LOCALIZATION; DOPAMINE TRANSPORTER	Methamphetamine (meth) is a highly addictive and widely abused psychostimulant. Repeated use of meth can quickly lead to dependence, and may be accompanied by a variety of persistent psychiatric symptoms and cognitive impairments. The neuroadaptations underlying motivational and cognitive deficits produced by chronic meth intake remain poorly understood. Altered glutamate neurotransmission within the prefrontal cortex (PFC) and striatum has been linked to both persistent drug-seeking and cognitive dysfunction. Therefore, the current study investigated changes in presynaptic mGluR receptors within corticostriatal circuitry after extended meth self-administration. Rats self-administered meth (or received yoked-saline) in 1 hr/day sessions for 7 days (short-access) followed by 14 days of 6 hrs/day (long-access). Rats displayed a progressive escalation of daily meth intake up to 6 mg/kg per day. After cessation of meth self-administration, rats underwent daily extinction or abstinence without extinction training for 14 days before being euthanized. Synaptosomes from the medial PFC, nucleus accumbens (NAc), and the dorsal striatum (dSTR) were isolated and labeled with membrane-impermeable biotin in order to measure surface mGluR2/3 and mGluR7 receptors. Extended access to meth self-administration followed by abstinence decreased surface and total levels of mGluR2/3 receptors in the NAc and dSTR, while in the PFC, only a loss of surface mGluR2/3 and mGluR7 receptors was detected. Daily extinction trials reversed the downregulation of mGluR2/3 receptors in the NAc and dSTR and mGluR7 in the PFC, but downregulation of surface mGluR2/3 receptors in the PFC was present regardless of post-meth experience. Thus, extinction learning can selectively restore some populations of downregulated mGluRs after prolonged exposure to meth. The present findings could have implications for our understanding of the persistence (or recovery) of meth-induced motivational and cognitive deficits.	[Schwendt, Marek; Reichel, Carmela M.; See, Ronald E.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA	Medical University of South Carolina	Schwendt, M (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	schwendt@musc.edu	REichel, Carmela M/E-8067-2016	REichel, Carmela M/0000-0003-3508-8754; Schwendt, Marek/0000-0002-2345-1555	National Institutes of Health [P20DA022658, C06 RR015455]; NARSAD; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033049, P20DA022658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health Grant P20DA022658 (RES), C06 RR015455, and NARSAD Young Investigator Award (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2001, NEUROPSYCHOPHARMACOL, V25, P173, DOI 10.1016/S0893-133X(00)00250-5; Barr AM, 2006, J PSYCHIATR NEUROSCI, V31, P301; Bongiovanni M, 2008, PHARMACOL BIOCHEM BE, V89, P227, DOI 10.1016/j.pbb.2007.12.019; Bulenger S, 2005, TRENDS PHARMACOL SCI, V26, P131, DOI 10.1016/j.tips.2005.01.004; Conklin CA, 2002, ADDICTION, V97, P155, DOI 10.1046/j.1360-0443.2002.00014.x; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Corti C, 2007, BIOL PSYCHIAT, V62, P747, DOI 10.1016/j.biopsych.2006.12.005; De la Garza R, 2010, DRUG ALCOHOL DEPEN, V106, P173, DOI 10.1016/j.drugalcdep.2009.08.013; Di Ciano P, 2008, NEUROPSYCHOPHARMACOL, V33, P1413, DOI 10.1038/sj.npp.1301522; Elkashef A, 2008, SUBST ABUS, V29, P31, DOI 10.1080/08897070802218554; Epstein DH, 2006, PSYCHOPHARMACOLOGY, V189, P1, DOI 10.1007/s00213-006-0529-6; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Fuchs RA, 2006, J NEUROSCI, V26, P3584, DOI 10.1523/JNEUROSCI.5146-05.2006; Gass JT, 2008, BIOCHEM PHARMACOL, V75, P218, DOI 10.1016/j.bcp.2007.06.039; Gass JT, 2009, NEUROPSYCHOPHARMACOL, V34, P820, DOI 10.1038/npp.2008.140; Ghahremani DG, 2011, NEUROPSYCHOPHARMACOL, V36, P950, DOI 10.1038/npp.2010.233; Ghasemzadeh MB, 2011, BRAIN RES, V1413, P60, DOI 10.1016/j.brainres.2011.06.041; Ghasemzadeh MB, 2009, NEUROSCI LETT, V452, P167, DOI 10.1016/j.neulet.2008.12.028; Glick SD, 2001, EUR J PHARMACOL, V422, P87, DOI 10.1016/S0014-2999(01)01066-4; Gonzalez-Maeso J, 2008, NATURE, V452, P93, DOI 10.1038/nature06612; Gravius A, 2010, CURR TOP MED CHEM, V10, P187, DOI 10.2174/156802610790411018; Gylys KH, 2000, J NEUROSCI RES, V61, P186, DOI 10.1002/1097-4547(20000715)61:2<186::AID-JNR9>3.0.CO;2-X; Hao Y, 2010, BIOL PSYCHIAT, V68, P240, DOI 10.1016/j.biopsych.2010.02.011; Hart CL, 2008, NEUROPSYCHOPHARMACOL, V33, P1847, DOI 10.1038/sj.npp.1301578; Havermans RC, 2003, ADDICT BEHAV, V28, P989, DOI 10.1016/S0306-4603(01)00289-1; Holtz NA, 2012, DRUG ALCOHOL DEPEN, V120, P233, DOI 10.1016/j.drugalcdep.2011.07.010; Hser YI, 2008, ADDICT BEHAV, V33, P1581, DOI 10.1016/j.addbeh.2008.07.024; Jun JH, 2000, PHARMACOL BIOCHEM BE, V67, P405, DOI 10.1016/S0091-3057(00)00317-8; Kelamangalath L, 2007, BEHAV BRAIN RES, V185, P119, DOI 10.1016/j.bbr.2007.08.001; Kinoshita A, 1998, J COMP NEUROL, V393, P332; Kitamura O, 2006, PSYCHOPHARMACOLOGY, V186, P48, DOI 10.1007/s00213-006-0353-z; Knackstedt LA, 2010, J NEUROSCI, V30, P7984, DOI 10.1523/JNEUROSCI.1244-10.2010; Krasnova IN, 2009, BRAIN RES REV, V60, P379, DOI 10.1016/j.brainresrev.2009.03.002; Lee NK, 2008, DRUG ALCOHOL REV, V27, P309, DOI 10.1080/09595230801919494; Li X, 2010, J NEUROCHEM, V114, P1368, DOI 10.1111/j.1471-4159.2010.06851.x; Liechti ME, 2007, EUR J PHARMACOL, V554, P164, DOI 10.1016/j.ejphar.2006.10.011; Lineberry TW, 2006, MAYO CLIN PROC, V81, P77, DOI 10.4065/81.1.77; Ling Walter, 2006, Curr Psychiatry Rep, V8, P345, DOI 10.1007/s11920-006-0035-x; Lominac KD, 2011, NEUROPSYCHOPHARMACOL; MACHIYAMA Y, 1992, SCHIZOPHRENIA BULL, V18, P107, DOI 10.1093/schbul/18.1.107; Meredith CW, 2005, HARVARD REV PSYCHIAT, V13, P141, DOI 10.1080/10673220591003605; Milligan G, 2007, ERNST SCHERING FOUND, V2, P145, DOI 10.1007/2789_2006_007; Moran MM, 2005, J NEUROSCI, V25, P6389, DOI 10.1523/JNEUROSCI.1007-05.2005; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Nakato Y, 2010, NEUROSCI LETT, V481, P183, DOI 10.1016/j.neulet.2010.07.002; Nordahl TE, 2003, J NEUROPSYCH CLIN N, V15, P317, DOI 10.1176/appi.neuropsych.15.3.317; Ohmori T, 1996, ANN NY ACAD SCI, V801, P315, DOI 10.1111/j.1749-6632.1996.tb17452.x; Okazaki Y, 2000, J BIOL CHEM, V275, P35751, DOI 10.1074/jbc.M007476200; Park WK, 2002, J NEUROSCI, V22, P2916, DOI 10.1523/JNEUROSCI.22-07-02916.2002; Paxinos G, 2007, RAT BRAIN STEROTAXIC, V6; Peters J, 2008, J NEUROSCI, V28, P6046, DOI 10.1523/JNEUROSCI.1045-08.2008; Peters J, 2006, PSYCHOPHARMACOLOGY, V186, P143, DOI 10.1007/s00213-006-0372-9; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; Reichel CM, 2012, NEUROPHARMACOLOGY, V62, P1119, DOI 10.1016/j.neuropharm.2011.11.003; Reichel CM, 2011, NEUROPSYCHOPHARMACOL, V36, P782, DOI 10.1038/npp.2010.212; Reichel CM, 2010, PSYCHOPHARMACOLOGY, V210, P337, DOI 10.1007/s00213-010-1828-5; Reichel Carmela M, 2009, Curr Drug Abuse Rev, V2, P184; Rocha A, 2010, EUR J NEUROSCI, V31, P903, DOI 10.1111/j.1460-9568.2010.07134.x; Rogers JL, 2008, PSYCHOPHARMACOLOGY, V199, P615, DOI 10.1007/s00213-008-1187-7; Salo R, 2007, BIOL PSYCHIAT, V61, P1272, DOI 10.1016/j.biopsych.2006.07.031; Samuvel DJ, 2008, J PHARMACOL EXP THER, V325, P293, DOI 10.1124/jpet.107.130534; Sargolini F, 2003, BEHAV BRAIN RES, V138, P153, DOI 10.1016/S0166-4328(02)00238-3; Schwendt M, 2009, J PHARMACOL EXP THER, V331, P555, DOI 10.1124/jpet.109.155770; See RE, 2007, PSYCHOPHARMACOLOGY, V194, P321, DOI 10.1007/s00213-007-0850-8; Self DW, 2004, LEARN MEMORY, V11, P648, DOI 10.1101/lm.81404; Shigemoto R, 2000, METABOTROPIC GLUTAMA; STEPHANS SE, 1994, SYNAPSE, V17, P203, DOI 10.1002/syn.890170310; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Sutton MA, 2003, NATURE, V421, P70, DOI 10.1038/nature01249; Tahsili-Fahadan P, 2010, NEUROPSYCHOPHARMACOL, V35, P2203, DOI 10.1038/npp.2010.94; Testa CM, 1998, J COMP NEUROL, V390, P5; Tsujimura J, 2002, B JAPANESE SOC NEURO, V41, P402; Vaidyanathan G, 2004, ONCOGENE, V23, P5858, DOI 10.1038/sj.onc.1207774; Xi ZX, 2002, J PHARMACOL EXP THER, V303, P608, DOI 10.1124/jpet.102.039735; Yao HH, 2005, J NEUROCHEM, V92, P948, DOI 10.1111/j.1471-4159.2004.02937.x; Zhu J, 2005, J NEUROCHEM, V93, P1434, DOI 10.1111/j.1471-4159.2005.03130.x	77	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34299	10.1371/journal.pone.0034299	http://dx.doi.org/10.1371/journal.pone.0034299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479593	gold, Green Submitted, Green Published			2022-12-27	WOS:000304523400070
J	Alminana, C; Heath, PR; Wilkinson, S; Sanchez-Osorio, J; Cuello, C; Parrilla, I; Gil, MA; Vazquez, JL; Vazquez, JM; Roca, J; Martinez, EA; Fazeli, A				Alminana, Carmen; Heath, Paul R.; Wilkinson, Stephen; Sanchez-Osorio, Jonatan; Cuello, Cristina; Parrilla, Inmaculada; Gil, Maria A.; Vazquez, Jose L.; Vazquez, Juan Maria; Roca, Jordi; Martinez, Emilio A.; Fazeli, Alireza			Early Developing Pig Embryos Mediate Their Own Environment in the Maternal Tract	PLOS ONE			English	Article							HUMAN ENDOMETRIAL RECEPTIVITY; INDUCED TRANSCRIPTOME CHANGES; GENE-EXPRESSION; EARLY-PREGNANCY; ESTROUS-CYCLE; BOVINE ENDOMETRIUM; MOLECULAR MARKERS; PROGESTERONE; ULTRASONOGRAPHY; IDENTIFICATION	The maternal tract plays a critical role in the success of early embryonic development providing an optimal environment for establishment and maintenance of pregnancy. Preparation of this environment requires an intimate dialogue between the embryo and her mother. However, many intriguing aspects remain unknown in this unique communication system. To advance our understanding of the process by which a blastocyst is accepted by the endometrium and better address the clinical challenges of infertility and pregnancy failure, it is imperative to decipher this complex molecular dialogue. The objective of the present work is to define the local response of the maternal tract towards the embryo during the earliest stages of pregnancy. We used a novel in vivo experimental model that eliminated genetic variability and individual differences, followed by Affymetrix microarray to identify the signals involved in this embryo-maternal dialogue. Using laparoscopic insemination one oviduct of a sow was inseminated with spermatozoa and the contralateral oviduct was injected with diluent. This model allowed us to obtain samples from the oviduct and the tip of the uterine horn containing either embryos or oocytes from the same sow. Microarray analysis showed that most of the transcripts differentially expressed were down-regulated in the uterine horn in response to blastocysts when compared to oocytes. Many of the transcripts altered in response to the embryo in the uterine horn were related to the immune system. We used an in silico mathematical model to demonstrate the role of the embryo as a modulator of the immune system. This model revealed that relatively modest changes induced by the presence of the embryo could modulate the maternal immune response. These findings suggested that the presence of the embryo might regulate the immune system in the maternal tract to allow the refractory uterus to tolerate the embryo and support its development.	[Alminana, Carmen; Fazeli, Alireza] Univ Sheffield, Dept Human Metab, Acad Unit Reprod & Dev Med, Sheffield, S Yorkshire, England; [Heath, Paul R.] SITraN, Sheffield, S Yorkshire, England; [Sanchez-Osorio, Jonatan; Cuello, Cristina; Parrilla, Inmaculada; Gil, Maria A.; Vazquez, Jose L.; Vazquez, Juan Maria; Roca, Jordi; Martinez, Emilio A.] Univ Murcia, Fac Vet, Dept Med & Anim Surg, Murcia, Spain	University of Sheffield; University of Murcia	Alminana, C (corresponding author), Univ Sheffield, Dept Human Metab, Acad Unit Reprod & Dev Med, Sheffield, S Yorkshire, England.	A.Fazeli@Sheffield.AC.UK	Fazeli, Alireza/G-3679-2010; Roca, Jordi/H-9365-2015; Cuello, Cristina/H-9986-2015; Heath, Paul/B-4778-2009; Martinez, Emilio A/I-1901-2015; GIL, MARIA A/H-6753-2015; Vazquez, Juan M/C-2053-2008; Parrilla, Inmaculada/I-1045-2015	Fazeli, Alireza/0000-0003-0870-9914; Roca, Jordi/0000-0002-4213-3093; Cuello, Cristina/0000-0002-6202-5946; Martinez, Emilio A/0000-0003-1260-9721; GIL, MARIA A/0000-0002-6955-7750; Parrilla, Inmaculada/0000-0002-5121-758X; Vazquez, Juan Maria/0000-0002-8674-6350	Marie Curie IEF [236708]; Minister of Science and Innovation (MICINN) [AGL2009-12091]; Seneca Foundation [GERM04543/07]; COST ACTION [FA0702]; Centre for the Development of Industrial Technology (CDTI) [2008/0268]; EPSRC [EP/E036252/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E036252/1] Funding Source: researchfish	Marie Curie IEF(European Commission); Minister of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)); Seneca Foundation(Fundacion Seneca); COST ACTION(European Cooperation in Science and Technology (COST)); Centre for the Development of Industrial Technology (CDTI); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Marie Curie IEF (236708), Minister of Science and Innovation (MICINN; AGL2009-12091), Seneca Foundation (GERM04543/07), COST ACTION FA0702 and Centre for the Development of Industrial Technology (CDTI; 2008/0268). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboussahoud W, 2010, HUM REPROD, V25, P2217, DOI 10.1093/humrep/deq185; An GC, 2009, MATH BIOSCI, V217, P53, DOI 10.1016/j.mbs.2008.08.013; Baker D, 1998, MOTHERS BABIES HLTH; Bauersachs S, 2006, REPRODUCTION, V132, P319, DOI 10.1530/rep.1.00996; Bolarin A, 2009, ANIM REPROD SCI, V113, P137, DOI 10.1016/j.anireprosci.2008.07.002; Chang HS, 2000, MOL REPROD DEV, V56, P331, DOI 10.1002/1098-2795(200007)56:3&lt;331::AID-MRD1&gt;3.0.CO;2-K; Denker HW, 2000, CELLS TISSUES ORGANS, V166, P180, DOI 10.1159/000016732; DEY SK, 1996, IMPLANTATION; Dumont J N, 1985, Dev Biol (N Y 1985), V1, P235; FAEDER JR, 2008, METHODS MOL BIOL SYS; Fazeli A, 2008, THERIOGENOLOGY, V70, P1182, DOI 10.1016/j.theriogenology.2008.06.010; Fleming TP, 2004, BIOL REPROD, V71, P1046, DOI 10.1095/biolreprod.104.030957; Fujiwara H, 2009, J REPROD IMMUNOL, V81, P1, DOI 10.1016/j.jri.2009.04.001; Geisert R D, 1990, J Reprod Fertil Suppl, V40, P293; Gluckman P, 2006, DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, P1, DOI 10.2277/ 0521847435; Haouzi D, 2009, HUM REPROD, V24, P1436, DOI 10.1093/humrep/dep039; Hendriks BS, 2008, BIOTECHNOL PROGR, V24, P96, DOI 10.1021/bp070084g; Hernandez M, 2007, J ANDROL, V28, P689, DOI 10.2164/jandrol.107.002725; Herrler A, 2000, CELLS TISSUES ORGANS, V166, P233, DOI 10.1159/000016736; Horcajadas JA, 2004, J REPROD IMMUNOL, V63, P41, DOI 10.1016/j.jri.2004.02.003; JOHNSON LA, 1975, J ANIM SCI, V40, P108, DOI 10.2527/jas1975.401108x; Ka H, 2009, MOL REPROD DEV, V76, P75, DOI 10.1002/mrd.20935; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kell DB, 2004, CURR OPIN MICROBIOL, V7, P296, DOI 10.1016/j.mib.2004.04.012; Klein C, 2006, BIOL REPROD, V74, P253, DOI 10.1095/biolreprod.105.046748; Klein C, 2011, BIOL REPROD, V84, P872, DOI 10.1095/biolreprod.110.088732; Klein C, 2010, BIOL REPROD, V83, P102, DOI 10.1095/biolreprod.109.081612; Koga K, 2010, AM J REPROD IMMUNOL, V63, P587, DOI 10.1111/j.1600-0897.2010.00848.x; Lee KF, 2000, BIOCHEM BIOPH RES CO, V277, P680, DOI 10.1006/bbrc.2000.3736; Lee KF, 2002, BIOCHEM BIOPH RES CO, V292, P564, DOI 10.1006/bbrc.2002.6676; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loubiere LS, 2010, PLACENTA, V31, P295, DOI 10.1016/j.placenta.2010.01.013; Martin JC, 2000, BIOL REPROD, V63, P1370, DOI 10.1095/biolreprod63.5.1370; Matsumoto H, 2004, BIOL REPROD, V70, P729, DOI 10.1095/biolreprod.103.022764; Michelmann HW, 2007, REPROD DOMEST ANIM, V42, P594, DOI 10.1111/j.1439-0531.2006.00829.x; Oda K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100057; Ostrup E, 2010, BIOL REPROD, V83, P277, DOI 10.1095/biolreprod.109.082321; Patel P, 2003, PLACENTA, V24, P39, DOI 10.1053/plac.2002.0879; Pope WF, 1994, EMBRYONIC MORTALITY, P53; Rath D, 2006, Soc Reprod Fertil Suppl, V62, P317; Reese J, 2001, J BIOL CHEM, V276, P44137, DOI 10.1074/jbc.M107563200; Riesewijk A, 2003, MOL HUM REPROD, V9, P253, DOI 10.1093/molehr/gag037; Roberts RM, 1999, PLACENTA, V20, P259, DOI 10.1053/plac.1998.0381; Ross JW, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-39; Simon C, 1998, HUM REPROD, V13, P219, DOI 10.1093/humrep/13.suppl_3.219; SOEDE NM, 1992, THERIOGENOLOGY, V38, P653, DOI 10.1016/0093-691X(92)90028-P; SPENCER TE, 1995, BIOL REPROD, V53, P1527, DOI 10.1095/biolreprod53.6.1527; Spencer TE, 2007, REPROD FERT DEVELOP, V19, P65, DOI 10.1071/RD06102; Spencer Thomas E, 2004, Reprod Biol Endocrinol, V2, P49, DOI 10.1186/1477-7827-2-49; TELFORD NA, 1990, MOL REPROD DEV, V26, P90, DOI 10.1002/mrd.1080260113; Tsai S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-328; Vickers MH, 2007, CURR DRUG TARGETS, V8, P923; Wakuda K, 1999, J REPROD FERTIL, V115, P315, DOI 10.1530/jrf.0.1150315; Walker CG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-474; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Wilkinson SJ, 2008, MOL BIOSYST, V4, P74, DOI 10.1039/b707506e; Wolf E, 2003, REPROD DOMEST ANIM, V38, P276, DOI 10.1046/j.1439-0531.2003.00435.x; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; YOSHINAG.K, 1966, J REPROD FERTIL, V12, P593, DOI 10.1530/jrf.0.0120593; Ziecik AJ, 2002, DOMEST ANIM ENDOCRIN, V23, P265, DOI 10.1016/S0739-7240(02)00162-5	60	63	64	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33625	10.1371/journal.pone.0033625	http://dx.doi.org/10.1371/journal.pone.0033625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470458	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000304489000028
J	Brancucci, A; Prete, G; Meraglia, E; di Domenico, A; Lugli, V; Penolazzi, B; Tommasi, L				Brancucci, Alfredo; Prete, Giulia; Meraglia, Elisa; di Domenico, Alberto; Lugli, Victor; Penolazzi, Barbara; Tommasi, Luca			Asymmetric Cortical Adaptation Effects during Alternating Auditory Stimulation	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; HIGH-RESOLUTION EEG; GO/NO-GO TASK; NEUROMAGNETIC EVIDENCE; STIMULUS ALTERNATION; EVOKED POTENTIALS; SPEECH SOUNDS; ALPHA RHYTHMS; HABITUATION; REPETITION	The present study investigates hemispheric asymmetries in the neural adaptation processes occurring during alternating auditory stimulation. Stimuli were two monaural pure tones having a frequency of 400 or 800 Hz and a duration of 500 ms. Electroencephalogram (EEG) was recorded from 14 volunteers during the presentation of the following stimulus sequences, lasting 12 s each: 1) evoked potentials (EP condition, control), 2) alternation of frequency and ear (FE condition), 3) alternation of frequency (F condition), and 4) alternation of ear (E condition). Main results showed that in the central area of the left hemisphere (around C3 site) the N100 response underwent adaptation in all patterns of alternation, whereas in the same area of the right hemisphere the tones presented at the right ear in the FE produced no adaptation. Moreover, the responses to right-ear stimuli showed a difference between hemispheres in the E condition, which produced less adaptation in the left hemisphere. These effects are discussed in terms of lateral symmetry as a product of hemispheric, pathway and ear asymmetries.	[Brancucci, Alfredo; Meraglia, Elisa; Lugli, Victor] G dAnnunzio Univ Chieti & Pescara, Dept Biomed Sci, Chieti, Italy; [Prete, Giulia; di Domenico, Alberto; Tommasi, Luca] G dAnnunzio Univ Chieti & Pescara, Dept Neurosci & Imaging, Chieti, Italy; [Penolazzi, Barbara] Alma Mater Studiorum Univ, Dept Psychol, Bologna, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Bologna	Brancucci, A (corresponding author), G dAnnunzio Univ Chieti & Pescara, Dept Biomed Sci, Chieti, Italy.	Alfredo.Brancucci@Unich.It	Prete, Giulia/H-6401-2019; Tommasi, Luca/F-3638-2012; Di Domenico, Alberto/AIB-7965-2022; Di Domenico, Alberto/O-2111-2015	Prete, Giulia/0000-0001-9969-6404; Di Domenico, Alberto/0000-0002-9962-2891; Di Domenico, Alberto/0000-0002-9962-2891; Tommasi, Luca/0000-0003-0664-714X; PENOLAZZI, Barbara/0000-0001-8717-6233	Commission of the European Communities	Commission of the European Communities(European Commission)	This research is part of the project EDCBNL (Evolution and Development of Cognitive, Behavioural and Neural Lateralization, 2006-2010), supported by the Commission of the European Communities within the framework of the specific research and technological development programme "Integrating and strengthening the European Research Area" (initiative "What it means to be human"), through a financial grant to LT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERBOOM S, 1983, J EXP PSYCHOL HUMAN, V9, P882, DOI 10.1037/0096-1523.9.6.882; Babiloni C, 2005, BEHAV NEUROSCI, V119, P503, DOI 10.1037/0735-7044.119.2.503; Babiloni C, 2004, NEUROPSYCHOLOGY, V18, P719, DOI 10.1037/0894-4105.18.4.719; Babiloni C, 2004, BEHAV NEUROSCI, V118, P925, DOI 10.1037/0735-7044.118.5.925; Barrick TR, 2007, CEREB CORTEX, V17, P591, DOI 10.1093/cercor/bhk004; BASHFORD JA, 1987, PERCEPT PSYCHOPHYS, V42, P431, DOI 10.3758/BF03209750; Baumann S, 2008, J COGNITIVE NEUROSCI, V20, P2238, DOI 10.1162/jocn.2008.20157; BOURBON WT, 1987, ELECTROEN CLIN NEURO, V66, P160, DOI 10.1016/0013-4694(87)90185-4; Brancucci A, 2005, NEUROPSYCHOLOGIA, V43, P1916, DOI 10.1016/j.neuropsychologia.2005.03.005; Brancucci A, 2003, NEUROPSYCHOLOGY, V17, P451, DOI 10.1037/0894-4105.17.3.451; Brancucci A, 2011, J ACOUST SOC AM, V130, P2179, DOI 10.1121/1.3631665; Brancucci A, 2011, BRAIN COGNITION, V76, P218, DOI 10.1016/j.bandc.2011.02.007; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; BUTLER RA, 1972, NEUROPSYCHOLOGIA, V10, P219, DOI 10.1016/0028-3932(72)90063-2; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; CSIBRA G, 1994, BIOL PSYCHOL, V37, P115, DOI 10.1016/0301-0511(94)90026-4; Del Percio C, 2006, NEUROIMAGE, V31, P1268, DOI 10.1016/j.neuroimage.2006.01.013; Della Penna S, 2007, CEREB CORTEX, V17, P2303, DOI 10.1093/cercor/bhl139; DEUTSCH D, 1974, NATURE, V251, P307, DOI 10.1038/251307a0; Edlinger G, 1997, BRAIN TOPOGR, V10, P103, DOI 10.1023/A:1022242126699; ELBERLING C, 1980, SCAND AUDIOL, V9, P185, DOI 10.3109/01050397909076320; GALINSKY TL, 1990, HUM FACTORS, V32, P717, DOI 10.1177/001872089003200608; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Haenschel C, 2000, P NATL ACAD SCI USA, V97, P7645, DOI 10.1073/pnas.120162397; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hidaka S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008188; King C, 1999, NEUROSCI LETT, V267, P89, DOI 10.1016/S0304-3940(99)00336-5; Le Pera D, 2007, EUR J NEUROSCI, V25, P1900, DOI 10.1111/j.1460-9568.2007.05389.x; Maurer U, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.018.2008; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nunez PL, 1996, EEG CL N SU, P37; Ott CGM, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00195; Pantev C, 2004, EUR J NEUROSCI, V19, P2337, DOI 10.1111/j.0953-816X.2004.03296.x; PANTEV C, 1989, SCIENCE, V246, P486, DOI 10.1126/science.2814476; PANTEV C, 1986, AUDIOLOGY, V25, P54; Peters M, 1998, Laterality, V3, P77, DOI 10.1080/713754291; Philibert B, 1998, NEUROSCI LETT, V253, P99, DOI 10.1016/S0304-3940(98)00615-6; REITE M, 1981, ELECTROEN CLIN NEURO, V51, P388, DOI 10.1016/0013-4694(81)90102-4; SAMS M, 1993, J COGNITIVE NEUROSCI, V5, P363, DOI 10.1162/jocn.1993.5.3.363; Schacter DL, 2004, NAT REV NEUROSCI, V5, P853, DOI 10.1038/nrn1534; SOKOLOV EN, 1977, ANNU REV PSYCHOL, V28, P85, DOI 10.1146/annurev.ps.28.020177.000505; SPRENG M, 1980, SCAND AUDIOL, P299; Tremblay KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010283; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Vonderschen K, 2009, J NEUROPHYSIOL, V101, P2348, DOI 10.1152/jn.91196.2008; WOODS DL, 1986, ELECTROEN CLIN NEURO, V65, P447, DOI 10.1016/0168-5597(86)90024-9; Yagcioglu S, 2008, NEUROREPORT, V19, P49, DOI 10.1097/WNR.0b013e3282f2dfe1; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	51	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34367	10.1371/journal.pone.0034367	http://dx.doi.org/10.1371/journal.pone.0034367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470563	Green Submitted, Green Published, gold			2022-12-27	WOS:000304489000102
J	Werning, S				Werning, Sarah			The Ontogenetic Osteohistology of Tenontosaurus tilletti	PLOS ONE			English	Article							LONG-BONE HISTOLOGY; NEUROCENTRAL SUTURES; GROWTH-PATTERNS; SEXUAL-MATURITY; AMPRINOS RULE; LIFE-HISTORY; DINOSAURS; ORNITHISCHIA; PHYSIOLOGY; PHYLOGENY	Tenontosaurus tilletti is an ornithopod dinosaur known from the Early Cretaceous (Aptian-Albian) Cloverly and Antlers formations of the Western United States. It is represented by a large number of specimens spanning a number of ontogenetic stages, and these specimens have been collected across a wide geographic range (from central Montana to southern Oklahoma). Here I describe the long bone histology of T. tilletti and discuss histological variation at the individual, ontogenetic and geographic levels. The ontogenetic pattern of bone histology in T. tilletti is similar to that of other dinosaurs, reflecting extremely rapid growth early in life, and sustained rapid growth through sub-adult ontogeny. But unlike other iguanodontians, this dinosaur shows an extended multi-year period of slow growth as skeletal maturity approached. Evidence of termination of growth (e.g., an external fundamental system) is observed in only the largest individuals, although other histological signals in only slightly smaller specimens suggest a substantial slowing of growth later in life. Histological differences in the amount of remodeling and the number of lines of arrested growth varied among elements within individuals, but bone histology was conservative across sampled individuals of the species, despite known paleoenvironmental differences between the Antlers and Cloverly formations. The bone histology of T. tilletti indicates a much slower growth trajectory than observed for other iguanodontians (e.g., hadrosaurids), suggesting that those taxa reached much larger sizes than Tenontosaurus in a shorter time.	[Werning, Sarah] Univ Oklahoma, Dept Zool, Norman, OK 73019 USA; [Werning, Sarah] Univ Oklahoma, Sam Noble Oklahoma Museum Nat Hist, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Werning, S (corresponding author), Univ Calif Berkeley, Museum Paleontol, Dept Integrat Biol, Berkeley, CA 94720 USA.	swerning@berkeley.edu	Werning, Sarah/E-8157-2016	Werning, Sarah/0000-0002-2405-595X	Paleontological Society; Geological Society of America; University of Oklahoma Department of Zoology and Graduate Student Senate; Samuel and Doris Welles Fund	Paleontological Society; Geological Society of America; University of Oklahoma Department of Zoology and Graduate Student Senate; Samuel and Doris Welles Fund	This project was supported in part by grants from the Paleontological Society, the Geological Society of America, the University of Oklahoma Department of Zoology and Graduate Student Senate, and the Samuel and Doris Welles Fund ( University of California Museum of Paleontology). Page charges were paid for by the Berkeley Research Impact Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcobendas M, 2000, HERPETOLOGICA, V56, P14; BARRETO C, 1993, SCIENCE, V262, P2020, DOI 10.1126/science.262.5142.2020; Barreto Claudia, 1997, P95; Benton MJ, 2010, PALAEOGEOGR PALAEOCL, V293, P438, DOI 10.1016/j.palaeo.2010.01.026; Botha J, 2004, ACTA PALAEONTOL POL, V49, P619; Brenner RL, 2003, CRETACEOUS RES, V24, P439, DOI 10.1016/S0195-6671(03)00054-5; Brinkman Daniel L., 1998, Oklahoma Geological Survey Bulletin, V146, P1; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Callison G., 1984, Journal of Vertebrate Paleontology, V3, P200; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Carrano Matthew T., 2006, P225; Castanet J, 2006, CR PALEVOL, V5, P629, DOI 10.1016/j.crpv.2005.10.006; Chinnery B, 2004, J VERTEBR PALEONTOL, V24, P572, DOI 10.1671/0272-4634(2004)024[0572:DOPPGE]2.0.CO;2; CHINSAMY A, 1995, J VERTEBR PALEONTOL, V15, P96, DOI 10.1080/02724634.1995.10011209; Chinsamy A, 2001, NATURE, V412, P402, DOI 10.1038/35086650; Chinsamy A, 1998, J VERTEBR PALEONTOL, V18, P385, DOI 10.1080/02724634.1998.10011066; Chinsamy A., 1992, Palaeontologia Africana, V29, P39; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; de Ricqles A, 2008, ANN PALEONTOL, V94, P57, DOI 10.1016/j.annpal.2008.03.002; de Ricqles Armand J., 2003, Annales de Paleontologie, V89, P67, DOI 10.1016/S0753-3969(03)00005-3; DORR J A JR, 1985, Contributions from the Museum of Paleontology University of Michigan, V27, P73; Enlow D. H., 1963, PRINCIPLES BONE REMO; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Erickson GM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007390; Forster C.A., 1984, Mosasaur, V2, P151; Forster C.A., 1990, Journal of Vertebrate Paleontology, V10, P273; FORSTER CA, 1990, J PALEONTOL, V64, P164, DOI 10.1017/S0022336000042402; Francillon-Vieillot H., 1990, P471; Galton PM, 1979, BRIGH YOUNG U GEOL, V25, P1; Guarino FM, 2008, ITAL J ZOOL, V75, P237, DOI 10.1080/11250000701883427; Horner JR, 2009, J VERTEBR PALEONTOL, V29, P734, DOI 10.1671/039.029.0312; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Hubner TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029958; Ikejiri T, 2003, J VERTEBR PALEONTOL, V23, p65A; Ikejiri T, 2012, ANAT REC, V295, P18, DOI 10.1002/ar.21495; Irmis RB, 2007, J VERTEBR PALEONTOL, V27, P350, DOI 10.1671/0272-4634(2007)27[350:ASOITP]2.0.CO;2; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2007, SP PALAEONT, P169; Lamm E. T., 2001, Journal of Vertebrate Paleontology, V21, p71A; Langston W. Jr., 1974, Geoscience Man, V8, P77; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; Lucas Spencer G., 2005, BULLETIN OF THE NEW MEXICO MUSEUM OF NATURAL HISTORY AND SCIENCE, P105; LUDVIGSON GA, 2004, GEOLOGICAL SOC AM AB, V36, P39; Mcdonald AT, 2010, ZOOTAXA, P1; MOBERLY R, 1960, GEOL SOC AM BULL, V71, P1137, DOI 10.1130/0016-7606(1960)71[1137:MCASMF]2.0.CO;2; Montes L, 2010, ANIM BIOL, V60, P25, DOI 10.1163/157075610X12610595764093; Nopcsa F., 1933, P ZOOL SOC LOND, V1933, P221, DOI [10.1111/j.1096-3642.1933.tb01588.x, DOI 10.1111/J.1096-3642.1933.TB01588.X]; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P413; Ostrom JH., 1970, PEABODY MUSEUM B, V35, P1; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Reid R.E.H., 1990, Modern Geology, V15, P19; REID REH, 1985, J PALEONTOL, V59, P140; REID REH, 1981, NATURE, V292, P49, DOI 10.1038/292049a0; REID REH, 1984, S ZOOLOGICAL SOC LON, V52, P629; RUBEN J, 1995, ANNU REV PHYSIOL, V57, P69, DOI 10.1146/annurev.ph.57.030195.000441; Ryan MJ, 2001, PALAIOS, V16, P482, DOI 10.2307/3515564; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Sanchez S, 2010, J EVOLUTION BIOL, V23, P2076, DOI 10.1111/j.1420-9101.2010.02081.x; Sander PM, 2005, SCIENCE, V310, P1800, DOI 10.1126/science.1120125; Starck J.M., 1993, Current Ornithology, V10, P275; Stein K., 2009, METHODS FOSSIL PREPA, P69; Sues H.-D., 1990, P498; Tumarkin-Deratzian AR, 2007, ZOOL J LINN SOC-LOND, V150, P1, DOI 10.1111/j.1096-3642.2007.00283.x; Tumarkin-Deratzian AR, 2006, ZOOL J LINN SOC-LOND, V148, P133, DOI 10.1111/j.1096-3642.2006.00232.x; Ufnar DF, 2004, GEOLOGY, V32, P1049, DOI 10.1130/G20828.1; Ufnar DF, 2002, PALAEOGEOGR PALAEOCL, V188, P51, DOI 10.1016/S0031-0182(02)00530-8; Weishampel D.B., 1983, Mosasaur, V1, P43; Weishampel David B., 2003, Journal of Systematic Palaeontology, V1, P65, DOI 10.1017/S1477201903001032; Whybrow PJ, 1985, CURATOR, P1; Wilson James W., 1994, P205; Winkler D. A., 1994, Journal of Vertebrate Paleontology, V14, p53A; Winkler DA, 1997, J VERTEBR PALEONTOL, V17, P330, DOI 10.1080/02724634.1997.10010978; Winkler DA, 2006, 2005 HEYUAN INT DIN, P169; Woodward HN, 2011, J HERPETOL, V45, P339; Woodward HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023339	83	59	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33539	10.1371/journal.pone.0033539	http://dx.doi.org/10.1371/journal.pone.0033539			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470454	gold, Green Published			2022-12-27	WOS:000304489000024
J	Xu, WW; Huang, JJH; Cheung, PCK				Xu, Wenwen; Huang, Jim Jun-hui; Cheung, Peter Chi Keung			Extract of Pleurotus pulmonarius Suppresses Liver Cancer Development and Progression through Inhibition of VEGF-Induced PI3K/AKT Signaling Pathway	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; POLYSACCHARIDE-PROTEIN COMPLEXES; HEPATOCELLULAR-CARCINOMA; TEA POLYPHENOLS; INDUCED APOPTOSIS; DRUG-RESISTANCE; GROWTH-FACTOR; CELLS; RESVERATROL; ANGIOGENESIS	Liver cancer or hepatocellular carcinoma is one of the leading causes of cancer-related deaths. Conventional chemotherapies are limited by the development of drug resistance and various side effects. Because of its non-toxicity and potent biopharmacological activity, metabolites derived from mushrooms have received more attention in cancer therapy. Our previous studies have demonstrated the anticancer effects of polysaccharide-protein complexes derived from the Pleurotus mushrooms. The aim of this study was to investigate the underlying molecular mechanism of the anticancer activity of a hot water extract containing a polysaccharide-protein complex isolated from Pleurotus pulmonarius (PP) in liver cancer cells. Our results indicated that exposure of liver cancer cells to PP not only significantly reduced the in vitro cancer cell proliferation and invasion but also enhanced the drug-sensitivity to the chemotherapeutic drug Cisplatin. Both oral administration and intraperitoneal injection of PP significantly inhibited the tumor growth in xenograft BALB/c nude mice. PP triggered a marked suppression of the PI3K/AKT signaling pathway in liver cancer cells in vitro and in vivo, and overexpression of the constitutively active form of AKT, Myr-AKT, abrogated this effect and the inhibited proliferation and invasion by PP. Both western blot and ELISA results showed that PP-treated liver cancer cells had reduced expression and secretion of vascular endothelial growth factor (VEGF). Addition of recombinant human VEGF attenuated the inhibitory effects of PP on PI3K/AKT pathway and the cancer phenotypes. Our results demonstrated that PP suppressed the proliferation, invasion, and drug-resistance of liver cancer cells in vitro and in vivo, mediated by the inhibition of autocrine VEGF-induced PI3K/AKT signaling pathway. This study suggests the potential therapeutic implication of PP in the treatment of human liver cancer.	[Xu, Wenwen; Huang, Jim Jun-hui; Cheung, Peter Chi Keung] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Huang, Jim Jun-hui] Shatou Univ, Inst Marine Biol, Shatou, Guangdong, Peoples R China	Chinese University of Hong Kong; Shantou University	Xu, WW (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China.	petercheung@cuhk.edu.hk	Cheung, Peter CK/N-1461-2014					Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Aharinejad Seyedhossein, 2009, V487, P243, DOI 10.1007/978-1-60327-547-7_12; Azam F, 2010, EUR J CANCER, V46, P1323, DOI 10.1016/j.ejca.2010.02.020; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Basnet P, 2011, MOLECULES, V16, P4567, DOI 10.3390/molecules16064567; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Chen JN, 2009, J AGR FOOD CHEM, V57, P6706, DOI 10.1021/jf901284s; Chen KF, 2011, J PHARMACOL EXP THER, V337, P155, DOI 10.1124/jpet.110.175786; Cheung PCK, 2011, ABSTRACT PERSONALIZE; El-Serag HB, 1999, NEW ENGL J MED, V340, P745, DOI 10.1056/NEJM199903113401001; Fulda S, 2004, ONCOGENE, V23, P6702, DOI 10.1038/sj.onc.1207630; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Gu YH, 2006, J MED FOOD, V9, P196, DOI 10.1089/jmf.2006.9.196; Gupta SC, 2011, ANN NY ACAD SCI, V1215, P150, DOI 10.1111/j.1749-6632.2010.05852.x; Halper J, 2010, VET PATHOL, V47, P77, DOI 10.1177/0300985809352981; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Hassan F. R. H., 2010, Australian Journal of Basic and Applied Sciences, V4, P99; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Jia GH, 2010, EXP MOL PATHOL, V89, P20, DOI 10.1016/j.yexmp.2010.04.002; Jin CY, 2008, J MICROBIOL BIOTECHN, V18, P1997, DOI 10.4014/jmb.0800.272; Khan HA, 2011, J APPL TOXI IN PRESS; Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011; Lavi I, 2010, APPL MICROBIOL BIOT, V85, P1977, DOI 10.1007/s00253-009-2296-x; Lee JS, 2011, INT J ONCOL, V38, P401, DOI 10.3892/ijo.2010.852; Li B, 2009, MOL CANCER THER, V8, P2635, DOI 10.1158/1535-7163.MCT-09-0162; Li HT, 2010, BRIT J PHARMACOL, V160, P1352, DOI 10.1111/j.1476-5381.2010.00785.x; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Llovet JM, 2003, J HEPATOL, V38, pS136, DOI 10.1016/S0168-8278(02)00432-4; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Mann CD, 2009, EUR J CANCER PREV, V18, P13, DOI 10.1097/CEJ.0b013e3282f0c090; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; McCubrey JA, 2011, J CELL PHYSIOL, V226, P2762, DOI 10.1002/jcp.22647; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Michl P, 2005, Z GASTROENTEROL, V43, P1133, DOI 10.1055/s-2005-858638; Mizuno M, 1999, BIOCHEM MOL BIOL INT, V47, P707; Nalla AK, 2011, EXP CELL RES, V317, P2512, DOI 10.1016/j.yexcr.2011.07.024; Ooi VEC, 2000, CURR MED CHEM, V7, P715; Pircher A, 2011, WORLD J HEPATOL, V3, P38, DOI 10.4254/wjh.v3.i2.38; Rexer BN, 2011, ONCOGENE, V30, P4163, DOI 10.1038/onc.2011.130; Russo M, 2010, TOXINS, V2, P517, DOI 10.3390/toxins2040517; Sanchez-Gonzalez PD, 2011, CRIT REV TO IN PRESS; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Schrenk D, 2009, MOL NUTR FOOD RES, V53, P1281, DOI 10.1002/mnfr.200800576; Shankar S, 2007, FRONT BIOSCI-LANDMRK, V12, P4881, DOI 10.2741/2435; She QB, 2003, CLIN CANCER RES, V9, P4340; Shimabukuro Y, 2011, J CELL PHYSIOL, V226, P809, DOI 10.1002/jcp.22406; Shukla Y, 2011, ANN NY ACAD SCI, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Siddiqui IA, 2004, J CELL BIOCHEM, V91, P232, DOI 10.1002/jcb.10737; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sliva D, 2008, BRIT J CANCER, V98, P1348, DOI 10.1038/sj.bjc.6604319; Song KS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-307; Steelman LS, 2011, CELL CYCLE, V10, P3003, DOI 10.4161/cc.10.17.17119; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsuji T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009885; Veeravagu A, 2007, RECENT PAT ANTI-CANC, V2, P59, DOI 10.2174/157489207779561426; Villanueva A, 2011, GASTROENTEROLOGY, V140, P1410, DOI 10.1053/j.gastro.2011.03.006; Wasser SP, 2011, APPL MICROBIOL BIOT, V89, P1323, DOI 10.1007/s00253-010-3067-4; Weng CJ, 2010, CLIN EXP METASTAS, V27, P361, DOI 10.1007/s10585-010-9334-z; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Zhang J, 2011, MINIREV MED IN PRESS; Zhang M, 2011, INT J BIOL MACROMOL, V48, P5, DOI 10.1016/j.ijbiomac.2010.09.003; Zhao JY, 2011, J AGR FOOD CHEM, V59, P5986, DOI 10.1021/jf200621y; Zhou Q, 2011, FUTURE ONCOL, V7, P1149, DOI [10.2217/FON.11.95, 10.2217/fon.11.95]; Zucman-Rossi J, 2010, DIGEST LIVER DIS, V42, pS235, DOI 10.1016/S1590-8658(10)60511-7	67	51	57	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34406	10.1371/journal.pone.0034406	http://dx.doi.org/10.1371/journal.pone.0034406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470568	Green Submitted, Green Published, gold			2022-12-27	WOS:000304489000107
J	Ahn, J; Hogan, N				Ahn, Jooeun; Hogan, Neville			Walking Is Not Like Reaching: Evidence from Periodic Mechanical Perturbations	PLOS ONE			English	Article							CENTRAL PATTERN GENERATORS; LAMPREY SPINAL-CORD; SUPERVISORY CONTROL; RHYTHMIC MOVEMENTS; FICTIVE LOCOMOTION; ARM MOVEMENTS; ENTRAINMENT; DISCRETE; GAIT; ADAPTATION	The control architecture underlying human reaching has been established, at least in broad outline. However, despite extensive research, the control architecture underlying human locomotion remains unclear. Some studies show evidence of high-level control focused on lower-limb trajectories; others suggest that nonlinear oscillators such as lower-level rhythmic central pattern generators (CPGs) play a significant role. To resolve this ambiguity, we reasoned that if a nonlinear oscillator contributes to locomotor control, human walking should exhibit dynamic entrainment to periodic mechanical perturbation; entrainment is a distinctive behavior of nonlinear oscillators. Here we present the first behavioral evidence that nonlinear neuro-mechanical oscillators contribute to the production of human walking, albeit weakly. As unimpaired human subjects walked at constant speed, we applied periodic torque pulses to the ankle at periods different from their preferred cadence. The gait period of 18 out of 19 subjects entrained to this mechanical perturbation, converging to match that of the perturbation. Significantly, entrainment occurred only if the perturbation period was close to subjects' preferred walking cadence: it exhibited a narrow basin of entrainment. Further, regardless of the phase within the walking cycle at which perturbation was initiated, subjects' gait synchronized or phase-locked with the mechanical perturbation at a phase of gait where it assisted propulsion. These results were affected neither by auditory feedback nor by a distractor task. However, the convergence to phase-locking was slow. These characteristics indicate that nonlinear neuro-mechanical oscillators make at most a modest contribution to human walking. Our results suggest that human locomotor control is not organized as in reaching to meet a predominantly kinematic specification, but is hierarchically organized with a semi-autonomous peripheral oscillator operating under episodic supervisory control.	[Ahn, Jooeun; Hogan, Neville] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Hogan, Neville] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ahn, J (corresponding author), MIT, Dept Mech Engn, Cambridge, MA 02139 USA.	aje@mit.edu		Ahn, Jooeun/0000-0002-7964-5148	New York State Center of Research Excellence [CO19772]; Eric P. and Evelyn E. Newman Fund; Samsung	New York State Center of Research Excellence; Eric P. and Evelyn E. Newman Fund; Samsung(Samsung)	This work was supported in part by the New York State Center of Research Excellence, contract CO19772; the Eric P. and Evelyn E. Newman Fund; and a Samsung Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKESON CG, 1985, J NEUROSCI, V5, P2318; Bennett M, 2002, P ROY SOC A-MATH PHY, V458, P563, DOI 10.1098/rspa.2001.0888; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Cazalets JR, 1996, J NEUROSCI, V16, P298; COLLINS JJ, 1994, BIOL CYBERN, V71, P375, DOI 10.1007/BF00198915; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Collins SH, 2001, INT J ROBOT RES, V20, P607, DOI 10.1177/02783640122067561; de Rugy A, 2003, BRAIN RES, V994, P160, DOI 10.1016/j.brainres.2003.09.031; Dietz V, 2004, J APPL PHYSIOL, V96, P1954, DOI 10.1152/japplphysiol.00942.2003; Dimitrijevic MR, 1998, ANN NY ACAD SCI, V860, P360, DOI 10.1111/j.1749-6632.1998.tb09062.x; FERRELL WR, 1967, IEEE SPECTRUM, V4, P81, DOI 10.1109/MSPEC.1967.5217126; FLANAGAN JR, 1995, J NEUROPHYSIOL, V74, P2174, DOI 10.1152/jn.1995.74.5.2174; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Gerasimenko Y, 2010, J NEUROSCI, V30, P3700, DOI 10.1523/JNEUROSCI.4751-09.2010; Grasso R, 2004, BRAIN, V127, P1019, DOI 10.1093/brain/awh115; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Grillner S, 1998, BRAIN RES REV, V26, P184, DOI 10.1016/S0165-0173(98)00002-2; GRILLNER S, 1981, BRAIN RES, V217, P380, DOI 10.1016/0006-8993(81)90015-9; Gurfinkel VS, 1998, EUR J NEUROSCI, V10, P1608, DOI 10.1046/j.1460-9568.1998.00179.x; Hansen AH, 2004, J BIOMECH, V37, P1467, DOI 10.1016/j.jbiomech.2004.01.017; Hogan N, 2007, EXP BRAIN RES, V181, P13, DOI 10.1007/s00221-007-0899-y; Ikegami T, 2010, J NEUROSCI, V30, P4515, DOI 10.1523/JNEUROSCI.3066-09.2010; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Ivanenko YP, 2005, J NEUROPHYSIOL, V94, P754, DOI 10.1152/jn.00088.2004; Khanna I, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-23; KRIELLAARS DJ, 1994, J NEUROPHYSIOL, V71, P2074, DOI 10.1152/jn.1994.71.6.2074; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; MATSUOKA K, 1987, BIOL CYBERN, V56, P345, DOI 10.1007/BF00319514; MCCLELLAN AD, 1993, J NEUROPHYSIOL, V70, P2442, DOI 10.1152/jn.1993.70.6.2442; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; MURRAY MP, 1964, J BONE JOINT SURG AM, V46, P335, DOI 10.2106/00004623-196446020-00009; NASA, 2008, ANTHR BIOM; Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4; PEARSON KG, 1992, EXP BRAIN RES, V90, P557; Perry J, GAIT ANAL, P52; Roy A, 2009, IEEE T ROBOT, V25, P569, DOI 10.1109/TRO.2009.2019783; Rybak IA, 2006, J PHYSIOL-LONDON, V577, P617, DOI 10.1113/jphysiol.2006.118703; Schaal S, 2004, NAT NEUROSCI, V7, P1137, DOI 10.1038/nn1322; Schulz BW, 2011, J BIOMECHANICS; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Sheridan TB, 1992, TELEROBOTICS AUTOMAT; Sim L, 2008, ACTA ASTRONAUT, V62, P648, DOI 10.1016/j.actaastro.2008.01.029; STEIN PSG, 1995, J NEUROSCI, V15, P4343; Sternad D, 2003, BRAIN RES, V989, P152, DOI 10.1016/S0006-8993(03)03292-X; Terrier P, 2003, EUR J APPL PHYSIOL, V90, P554, DOI 10.1007/s00421-003-0906-3; van der Pol B, 1926, PHILOS MAG, V2, P978; VanWezel BMH, 1997, J NEUROSCI, V17, P3804; von Holst E., 1939, J COMP PHYSIOL A, V26, P481, DOI [10.1007/BF00339408, DOI 10.1007/BF00339408]; WOLPERT DM, 1995, EXP BRAIN RES, V103, P460; Yang JF, 2006, NEUROSCIENTIST, V12, P379, DOI 10.1177/1073858406292151	51	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e31767	10.1371/journal.pone.0031767	http://dx.doi.org/10.1371/journal.pone.0031767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479311	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900004
J	Dong, J; Zhao, XJ; Shi, SS; Ma, ZN; Liu, M; Wu, QY; Ruan, CG; Dong, NZ				Dong, Jing; Zhao, Xiaojuan; Shi, Sensen; Ma, Zhenni; Liu, Meng; Wu, Qingyu; Ruan, Changgeng; Dong, Ningzheng			Identification and Functional Analysis of a Novel von Willebrand Factor Mutation in a Family with Type 2A von Willebrand Disease	PLOS ONE			English	Article							FACTOR A2 DOMAIN; FACTOR VWF; COMPOUND HETEROZYGOSITY; FACTOR GENE; D3 DOMAIN; SUBSTITUTION; DIAGNOSIS; CLASSIFICATION; PROPEPTIDE; SECRETION	von Willebrand factor (VWF) is essential for normal hemostasis. VWF gene mutations cause the hemorrhagic von Willebrand disease (VWD). In this study, a 9-year-old boy was diagnosed as type 2A VWD, based on a history of abnormal bleeding, low plasma VWF antigen and activity, low plasma factor VIII activity, and lack of plasma high-molecular-weight (HMW) VWF multimers. Sequencing analysis detected a 6-bp deletion in exon 28 of his VWF gene, which created a mutant lacking D1529V1530 residues in VWF A2 domain. This mutation also existed in his family members with abnormal bleedings but not in >60 normal controls. In transfected HEK293 cells, recombinant VWF Delta D1529V1530 protein had markedly reduced levels in the conditioned medium (42 +/- 4% of wild-type (WT) VWF, p<0.01). The mutant VWF in the medium had less HMW multimers. In contrast, the intracellular levels of the mutant VWF in the transfected cells were significantly higher than that of WT (174 +/- 29%, p<0.05), indicating intracellular retention of the mutant VWF. In co-transfection experiments, the mutant reduced WT VWF secretion from the cells. By immunofluorescence staining, the retention of the mutant VWF was identified within the endoplasmic reticulum (ER). Together, we identified a unique VWF mutation responsible for the bleeding phenotype in a patient family with type 2A VWD. The mutation impaired VWF trafficking through the ER, thereby preventing VWF secretion from the cells. Our results illustrate the diversity of VWF gene mutations, which contributes to the wide spectrum of VWD.	[Dong, Jing; Zhao, Xiaojuan; Ruan, Changgeng; Dong, Ningzheng] Soochow Univ, Jiangsu Inst Hematol, Affiliated Hosp 1, Minist Hlth,Key Lab Thrombosis & Hemostasis, Suzhou, Peoples R China; [Dong, Jing; Shi, Sensen; Liu, Meng; Wu, Qingyu; Dong, Ningzheng] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou, Peoples R China; [Wu, Qingyu] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA	Soochow University - China; Soochow University - China; Cleveland Clinic Foundation	Dong, J (corresponding author), Soochow Univ, Jiangsu Inst Hematol, Affiliated Hosp 1, Minist Hlth,Key Lab Thrombosis & Hemostasis, Suzhou, Peoples R China.	ningzheng_dong@yahoo.com.cn	Patience, Gregory/I-3434-2019	Patience, Gregory/0000-0001-6593-7986; Wu, Qingyu/0000-0003-0561-9315	National Natural Science Foundation of China [31070716, 81170247]; Natural Science Foundation of the Jiangsu Higher Education Institutions [10KJB320017]; Applied and Basic Research Project of Suzhou [SYS201021]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions; Applied and Basic Research Project of Suzhou; Priority Academic Program Development of Jiangsu Higher Education Institutions of China	This work was supported in part by grants from the National Natural Science Foundation of China (31070716, 81170247), the Natural Science Foundation of the Jiangsu Higher Education Institutions (10KJB320017), Applied and Basic Research Project of Suzhou (SYS201021), and the Priority Academic Program Development of Jiangsu Higher Education Institutions of China. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Baronciani L, 2007, J THROMB HAEMOST, V5, P282, DOI 10.1111/j.1538-7836.2007.02349.x; Baronciani L, 2009, J THROMB HAEMOST, V7, P1114, DOI 10.1111/j.1538-7836.2009.03457.x; Bernardi F, 1998, BRIT J HAEMATOL, V103, P885; Budde U, 2008, J THROMB HAEMOST, V6, P762, DOI 10.1111/j.1538-7836.2008.02945.x; Casari C, 2010, BLOOD, V116, P5371, DOI 10.1182/blood-2010-02-268920; Castaman G, 2010, J THROMB HAEMOST, V8, P2011, DOI 10.1111/j.1538-7836.2010.03971.x; Corrales I, 2009, THROMB HAEMOSTASIS, V101, P570, DOI 10.1160/TH08-08-0500; Daidone V, 2011, HAEMATOL-HEMATOL J, V96, P881, DOI 10.3324/haematol.2010.036848; Favaloro EJ, 2000, THROMB HAEMOSTASIS, V83, P127; GILL JC, 1987, BLOOD, V69, P1691; Gupta PK, 2008, BLOOD CELL MOL DIS, V41, P219, DOI 10.1016/j.bcmd.2008.03.004; Hassenpflug WA, 2006, BLOOD, V107, P2339, DOI 10.1182/blood-2005-04-1758; Holmberg L, 1998, THROMB HAEMOSTASIS, V79, P718; Hommais A, 2006, THROMB HAEMOSTASIS, V95, P776, DOI 10.1160/TH06-01-0026; Kashiwagi T, 2008, HAEMOPHILIA, V14, P556, DOI 10.1111/j.1365-2516.2008.01703.x; Knappe S, 2004, J BIOL CHEM, V279, P34464, DOI 10.1074/jbc.M405041200; Lethagen S, 2002, THROMB HAEMOSTASIS, V88, P421; Liao X, 2007, J BIOL CHEM, V282, P27728, DOI 10.1074/jbc.M703687200; LYONS SE, 1992, J BIOL CHEM, V267, P4424; Michiels JJ, 2006, CLIN APPL THROMB-HEM, V12, P397, DOI 10.1177/1076029606293422; O'Brien LA, 2004, J THROMB HAEMOST, V2, P1135, DOI 10.1111/j.1538-7836.2004.00732.x; PEERLINCK K, 1992, BRIT J HAEMATOL, V80, P358, DOI 10.1111/j.1365-2141.1992.tb08145.x; Penas N, 2004, AM J HEMATOL, V75, P73, DOI 10.1002/ajh.10455; Perez-Rodriguez A, 2009, HAEMATOL-HEMATOL J, V94, P679, DOI 10.3324/haematol.2008.003301; Ruggeri ZM, 2003, CURR OPIN HEMATOL, V10, P142, DOI 10.1097/00062752-200303000-00008; Sadler JE, 2006, J THROMB HAEMOST, V4, P2103, DOI 10.1111/j.1538-7836.2006.02146.x; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Schneppenheim R, 2010, BLOOD, V115, P4894, DOI 10.1182/blood-2009-07-226324; Sutherland JJ, 2004, J MOL MODEL, V10, P259, DOI 10.1007/s00894-004-0194-9; Tsai HM, 2004, J THROMB HAEMOST, V2, P2057, DOI 10.1111/j.1538-7836.2004.00985.x; Vanhoorelbeke K, 2000, THROMB HAEMOSTASIS, V83, P107; WAGNER DD, 1991, CELL, V64, P403, DOI 10.1016/0092-8674(91)90648-I; Wang JW, 2011, J BIOL CHEM, V286, P24180, DOI 10.1074/jbc.M110.215194; Wang YC, 2000, INT J HEMATOL, V72, P512	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33263	10.1371/journal.pone.0033263	http://dx.doi.org/10.1371/journal.pone.0033263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479377	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900021
J	Beneke, S; Meyer, K; Holtz, A; Huttner, K; Burkle, A				Beneke, Sascha; Meyer, Kirstin; Holtz, Anja; Huettner, Katharina; Buerkle, Alexander			Chromatin Composition Is Changed by Poly(ADP-ribosyl)ation during Chromatin Immunoprecipitation	PLOS ONE			English	Article							POLY(ADENOSINE DIPHOSPHATE RIBOSE); RNA-POLYMERASE-II; DNA-DAMAGE; BINDING-PROTEINS; PARP-1; TRANSCRIPTION; RECRUITMENT; ACTIVATION; TANKYRASE; DOMAINS	Chromatin-immunoprecipitation (ChIP) employs generally a mild formaldehyde cross-linking step, which is followed by isolation of specific protein-DNA complexes and subsequent PCR testing, to analyze DNA-protein interactions. Poly(ADP-ribosyl)ation, a posttranslational modification involved in diverse cellular functions like repair, replication, transcription, and cell death regulation, is most prominent after DNA damage. Poly(ADP-ribose)polymerase-1 is activated upon binding to DNA strand-breaks and coordinates repair by recruitment or displacement of proteins. Several proteins involved in different nuclear pathways are directly modified or contain poly(ADP-ribose)-interaction motifs. Thus, poly(ADP-ribose) regulates chromatin composition. In immunofluorescence experiments, we noticed artificial polymer-formation after formaldehyde-fixation of undamaged cells. Therefore, we analyzed if the formaldehyde applied during ChIP also induces poly(ADP-ribosyl)ation and its impact on chromatin composition. We observed massive polymer-formation in three different ChIP-protocols tested independent on the cell line. This was due to induction of DNA damage signaling as monitored by gamma H2AX formation. To abrogate poly(ADP-ribose) synthesis, we inhibited this enzymatic reaction either pharmacologically or by increased formaldehyde concentration. Both approaches changed ChIP-efficiency. Additionally, we detected specific differences in promoter-occupancy of tested transcription factors as well as the in the presence of histone H1 at the respective sites. In summary, we show here that standard ChIP is flawed by artificial formation of poly(ADP-ribose) and suppression of this enzymatic activity improves ChIP-efficiency in general. Also, we detected specific changes in promoter-occupancy dependent on poly(ADP-ribose). By preventing polymer synthesis with the proposed modifications in standard ChIP protocols it is now possible to analyze the natural chromatin-composition.	[Holtz, Anja] Univ Konstanz, BioImaging Ctr, Constance, Germany	University of Konstanz	Beneke, S (corresponding author), Univ Zurich Vetsuisse, Inst Pharmacol & Toxicol, Zurich, Switzerland.	sascha.beneke@vetpharm.uzh.ch	Beneke, Sascha/ABA-6014-2021	Beneke, Sascha/0000-0002-1998-7373; Deutzmann, Anja/0000-0002-3271-1427				Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; ALTHAUS FR, 1994, MOL CELL BIOCHEM, V138, P53, DOI 10.1007/BF00928443; Beneke S, 2008, NUCLEIC ACIDS RES, V36, P6309, DOI 10.1093/nar/gkn615; Boehler C, 2011, P NATL ACAD SCI USA, V108, P2783, DOI 10.1073/pnas.1016574108; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chang P, 2004, NATURE, V432, P645, DOI 10.1038/nature03061; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Collas P, 2010, MOL BIOTECHNOL, V45, P87, DOI 10.1007/s12033-009-9239-8; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Fahrer J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm944; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Haince JF, 2007, J BIOL CHEM, V282, P16441, DOI 10.1074/jbc.M608406200; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Heeres JT, 2007, CURR OPIN CHEM BIOL, V11, P644, DOI 10.1016/j.cbpa.2007.08.038; Iglehart JD, 2009, NEW ENGL J MED, V361, P189, DOI 10.1056/NEJMe0903044; Kanai M, 2003, MOL CELL BIOL, V23, P2451, DOI 10.1128/MCB.23.7.2451-2462.2003; KAWAMITSU H, 1984, BIOCHEMISTRY-US, V23, P3771, DOI 10.1021/bi00311a032; Kotova E, 2010, P NATL ACAD SCI USA, V107, P6406, DOI 10.1073/pnas.0914152107; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Lapucci A, 2011, MOL PHARMACOL, V79, P932, DOI 10.1124/mol.110.070110; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Mendoza-Alvarez H, 2001, J BIOL CHEM, V276, P36425, DOI 10.1074/jbc.M105215200; Meyer Ralph G., 2006, P1; Meyer-Ficca ML, 2005, INT J BIOCHEM CELL B, V37, P920, DOI 10.1016/j.biocel.2004.09.011; Nusinow DA, 2007, J BIOL CHEM, V282, P12851, DOI 10.1074/jbc.M610502200; Oei SL, 1998, J BIOL CHEM, V273, P31644, DOI 10.1074/jbc.273.48.31644; OEI SL, 1994, MOL CELL BIOCHEM, V138, P99, DOI 10.1007/BF00928449; PANZETER PL, 1992, BIOCHEMISTRY-US, V31, P1379, DOI 10.1021/bi00120a014; Pleschke JM, 2000, J BIOL CHEM, V275, P40974, DOI 10.1074/jbc.M006520200; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; Rouleau M, 2004, J CELL SCI, V117, P815, DOI 10.1242/jcs.01080; Rulten SL, 2008, MOL CELL BIOL, V28, P4620, DOI 10.1128/MCB.02243-07; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; SCHWEIGER M, 1995, BIOCHIMIE, V77, P480, DOI 10.1016/0300-9084(96)88164-8; Simbulan-Rosenthal CM, 1998, BIOCHEMISTRY-US, V37, P9363, DOI 10.1021/bi9731089; SLATTERY E, 1983, J BIOL CHEM, V258, P5955; Smith S, 1999, J CELL SCI, V112, P3649; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Soldatenkov VA, 2002, J BIOL CHEM, V277, P665, DOI 10.1074/jbc.M108551200; Till S, 2009, FRONT BIOSCI-LANDMRK, V14, P3246, DOI 10.2741/3448; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Trucco C, 1998, NUCLEIC ACIDS RES, V26, P2644, DOI 10.1093/nar/26.11.2644; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426; Zaremba T, 2007, ANTI-CANCER AGENT ME, V7, P515, DOI 10.2174/187152007781668715	53	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32914	10.1371/journal.pone.0032914	http://dx.doi.org/10.1371/journal.pone.0032914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479348	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000305339100024
J	Maher, BJ; LoTurco, JJ				Maher, Brady J.; LoTurco, Joseph J.			Disrupted-in-Schizophrenia (DISC1) Functions Presynaptically at Glutamatergic Synapses	PLOS ONE			English	Article							UTERO GENE-TRANSFER; CORTEX; TRANSLOCATION; MATURATION; KNOCKDOWN; RELEASE; NEURONS; MODEL	The pathophysiology of schizophrenia is believed to involve defects in synaptic transmission, and the function of many schizophrenia-associated genes, including DISC1, have been linked to synaptic function at glutamatergic synapses. Here we develop a rodent model via in utero electroporation to assay the presynaptic function of DISC1 at glutamatergic synapses. We used a combination of mosaic transgene expression, RNAi knockdown and optogenetics to restrict both genetic manipulation and synaptic stimulation of glutamatergic neurons presynaptic to other layer 2/3 neocortical pyramidal neurons that were then targeted for whole-cell patch-clamp recording. We show that expression of the DISC1 c-terminal truncation variant that is associated with Schizophrenia alters the frequency of mEPSCs and the kinetics of evoked glutamate release. In addition, we show that expression level of DISC1 is correlated with the probability of glutamate release such that increased DISC1 expression results in paired-pulse depression and RNAi knockdown of DISC1 produces paired-pulse facilitation. Overall, our results support a direct presynaptic function for the schizophrenia-associated gene, DISC1.	[Maher, Brady J.; LoTurco, Joseph J.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Maher, Brady J.] Lieber Inst Brain Dev, Baltimore, MD USA	University of Connecticut	Maher, BJ (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.	brady.maher@libd.org	Maher, Brady/GPC-8697-2022; Maher, Brady/L-8314-2016	Maher, Brady/0000-0001-5930-885X	NIMH (National Institute of Mental Health) [K01MH086050, R01MH056524]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055655, P01HD057853] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD020806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH086050, R01MH056524] Funding Source: NIH RePORTER	NIMH (National Institute of Mental Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by K01MH086050 to Brady Maher from NIMH (National Institute of Mental Health) and R01MH056524 to Joseph LoTurco from NIMH (www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin TA, 2011, MOL PSYCHIATR, V16, P122, DOI 10.1038/mp.2010.110; Ayhan Y, 2011, MOL PSYCHIAT; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Cai Q, 2011, NEUROSCI RES, V70, P9, DOI 10.1016/j.neures.2011.02.005; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Faulkner RL, 2008, P NATL ACAD SCI USA, V105, P14157, DOI 10.1073/pnas.0806658105; Flores R, 2011, NEUROSCI RES, V71, P71, DOI 10.1016/j.neures.2011.05.014; Hayashi-Takagi A, 2010, NAT NEUROSCI, V13, P327, DOI 10.1038/nn.2487; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Kirkpatrick B, 2006, J COMP NEUROL, V497, P436, DOI 10.1002/cne.21007; Kubo K, 2010, BIOCHEM BIOPH RES CO, V400, P631, DOI 10.1016/j.bbrc.2010.08.117; Kvajo M, 2011, P NATL ACAD SCI USA, V108, pE1349, DOI 10.1073/pnas.1114113108; Li L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011503; Ma H, 2009, J NEUROSCI, V29, P13019, DOI 10.1523/JNEUROSCI.2517-09.2009; Maher BJ, 2009, P NATL ACAD SCI USA, V106, P16865, DOI 10.1073/pnas.0808946106; Manent JB, 2009, NAT MED, V15, P84, DOI 10.1038/nm.1897; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Mizuno H, 2007, J NEUROSCI, V27, P6760, DOI 10.1523/JNEUROSCI.1215-07.2007; Nakata K, 2009, P NATL ACAD SCI USA, V106, P15873, DOI 10.1073/pnas.0903413106; Niwa M, 2010, NEURON, V65, P480, DOI 10.1016/j.neuron.2010.01.019; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Soares DC, 2011, ACS CHEM NEUROSCI, V2, P609, DOI 10.1021/cn200062k; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Wang Q, 2011, MOL PSYCHIATR, V16, P1006, DOI 10.1038/mp.2010.87	30	35	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34053	10.1371/journal.pone.0034053	http://dx.doi.org/10.1371/journal.pone.0034053			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479520	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339100109
J	Mao, WH; Li, ZY; Xia, XJ; Li, YD; Yu, JQ				Mao, Weihua; Li, Zeyun; Xia, Xiaojian; Li, Yadan; Yu, Jingquan			A Combined Approach of High-Throughput Sequencing and Degradome Analysis Reveals Tissue Specific Expression of MicroRNAs and Their Targets in Cucumber	PLOS ONE			English	Article							SMALL RNAS; MEDICAGO-TRUNCATULA; PLANT MICRORNAS; REGULATED MICRORNAS; PARALLEL ANALYSIS; INTERFERING RNA; MIRNA TARGETS; IDENTIFICATION; PREDICTION; GENOME	MicroRNAs (miRNAs) are endogenous small RNAs playing an important regulatory function in plant development and stress responses. Among them, some are evolutionally conserved in plant and others are only expressed in certain species, tissue or developmental stages. Cucumber is among the most important greenhouse species in the world, but only a limited number of miRNAs from cucumber have been identified and the experimental validation of the related miRNA targets is still lacking. In this study, two independent small RNA libraries from cucumber leaves and roots were constructed, respectively, and sequenced with the high-throughput Illumina Solexa system. Based on sequence similarity and hairpin structure prediction, a total of 29 known miRNA families and 2 novel miRNA families containing a total of 64 miRNA were identified. QRT-PCR analysis revealed that some of the cucumber miRNAs were preferentially expressed in certain tissues. With the recently developed 'high throughput degradome sequencing' approach, 21 target mRNAs of known miRNAs were identified for the first time in cucumber. These targets were associated with development, reactive oxygen species scavenging, signaling transduction and transcriptional regulation. Our study provides an overview of miRNA expression profile and interaction between miRNA and target, which will help further understanding of the important roles of miRNAs in cucumber plants.	[Mao, Weihua; Xia, Xiaojian; Yu, Jingquan] Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China; [Mao, Weihua; Li, Zeyun] Zhejiang Univ, Ctr Anal & Measurement, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Yadan] Hunan Agr Univ, Hunan Agr Bioengn Res Inst, Changsha, Hunan, Peoples R China	Zhejiang University; Zhejiang University; Hunan Agricultural University	Mao, WH (corresponding author), Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China.	jqyu@zju.edu.cn	Yu, J.Q./C-9509-2015	Yu, J.Q./0000-0002-7626-1165	National Basic Research Program of China [2009CB119000]; National Natural Science Foundation of China [30971701]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [200766]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China)	This work was supported by the National Basic Research Program of China (2009CB119000), National Natural Science Foundation of China (30971701), and Foundation for the Author of National Excellent Doctoral Dissertation of PR China (200766). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Ashburner M, 2005, GENOME RES, V15, P1661, DOI 10.1101/gr.3726705; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Chaudhuri K, 2007, DNA CELL BIOL, V26, P321, DOI 10.1089/dna.2006.0549; Chuck G, 2009, CURR OPIN PLANT BIOL, V12, P81, DOI 10.1016/j.pbi.2008.09.008; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; German MA, 2009, NAT PROTOC, V4, P356, DOI 10.1038/nprot.2009.8; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jagadeeswaran G, 2009, PLANTA, V229, P1009, DOI 10.1007/s00425-009-0889-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kantar M, 2010, FUNCT INTEGR GENOMIC, V10, P493, DOI 10.1007/s10142-010-0181-4; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Pilcher RLR, 2007, PLANTA, V226, P709, DOI 10.1007/s00425-007-0518-y; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Song QX, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-5; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Unver T, 2010, PLANT CELL REP, V29, P757, DOI 10.1007/s00299-010-0862-4; Unver T, 2009, PLANTA, V230, P659, DOI 10.1007/s00425-009-0974-7; Wang L, 2007, FEBS LETT, V581, P3848, DOI 10.1016/j.febslet.2007.07.010; Wang TZ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-367; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Xie FL, 2011, GENE, V473, P8, DOI 10.1016/j.gene.2010.09.007; Yang WZ, 2010, MOL BIOL REP, V37, P3081, DOI 10.1007/s11033-009-9881-z; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Yoon EK, 2010, NUCLEIC ACIDS RES, V38, P1382, DOI 10.1093/nar/gkp1128; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302	57	84	97	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33040	10.1371/journal.pone.0033040	http://dx.doi.org/10.1371/journal.pone.0033040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479356	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100030
J	Depla, M; d'Alteroche, L; Le Gouge, A; Moreau, A; Hourioux, C; Meunier, JC; Gaillard, J; de Muret, A; Bacq, Y; Kazemi, F; Avargues, A; Roch, E; Piver, E; Gaudy-Graffin, C; Giraudeau, B; Roingeard, P				Depla, Marion; d'Alteroche, Louis; Le Gouge, Amelie; Moreau, Alain; Hourioux, Christophe; Meunier, Jean-Christophe; Gaillard, Julien; de Muret, Anne; Bacq, Yannick; Kazemi, Farhad; Avargues, Aurelie; Roch, Emmanuelle; Piver, Eric; Gaudy-Graffin, Catherine; Giraudeau, Bruno; Roingeard, Philippe			Viral Sequence Variation in Chronic Carriers of Hepatitis C Virus Has a Low Impact on Liver Steatosis	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; CORE PROTEIN; LIPID DROPLETS; HCV GENOTYPE; ACCUMULATION; HEPATOCYTES; MECHANISMS; EXPRESSION; INFECTION; VARIANT	Most clinical studies suggest that the prevalence and severity of liver steatosis are higher in patients infected with hepatitis C virus (HCV) genotype 3 than in patients infected with other genotypes. This may reflect the diversity and specific intrinsic properties of genotype 3 virus proteins. We analyzed the possible association of particular residues of the HCV core and NS5A proteins known to dysregulate lipid metabolism with steatosis severity in the livers of patients chronically infected with HCV. We used transmission electron microscopy to quantify liver steatosis precisely in a group of 27 patients, 12 of whom were infected with a genotype 3 virus, the other 15 being infected with viruses of other genotypes. We determined the area covered by lipid droplets in liver tissues and analyzed the diversity of the core and NSSA regions encoded by the viral variants circulating in these patients. The area covered by lipid droplets did not differ significantly between patients infected with genotype 3 viruses and those infected with other genotypes. The core and NS5A protein sequences of the viral variants circulating in patients with mild or severe steatosis were evenly distributed throughout the phylogenic trees established from all the collected sequences. Thus, individual host factors seem to play a much greater role than viral factors in the development of severe steatosis in patients chronically infected with HCV, including those infected with genotype 3 viruses.	[Depla, Marion; d'Alteroche, Louis; Moreau, Alain; Hourioux, Christophe; Meunier, Jean-Christophe; Roch, Emmanuelle; Piver, Eric; Gaudy-Graffin, Catherine; Roingeard, Philippe] Univ Tours, INSERM, U966, Tours, France; [d'Alteroche, Louis; Bacq, Yannick] CHRU Tours, Serv Hepatogastroenterol, Hop Trousseau, Tours, France; [Le Gouge, Amelie; Avargues, Aurelie; Giraudeau, Bruno] Univ Tours, INSERM, CIC 0202, Tours, France; [Hourioux, Christophe; Roingeard, Philippe] CHRU Tours, Unite Biol Cellulaire, Hop Bretonneau, Tours, France; [Hourioux, Christophe; Gaillard, Julien; Roingeard, Philippe] Univ Tours, Plate Forme RIO Microscopies, PPF ASB, Tours, France; [de Muret, Anne] CHRU Tours, Serv Anat & Cytol Pathol, Hop Trousseau, Tours, France; [Kazemi, Farhad] Ctr Hosp Blois, Serv Hepatogastroenterol, Blois, France; [Piver, Eric] CHRU Tours, Serv Biochmie, Hop Trousseau, Tours, France; [Gaudy-Graffin, Catherine] CHRU Tours, Serv Bacteriol Virol, Hop Bretonneau, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Universite de Tours; CHU Tours; CHU Tours; CHU Tours	Depla, M (corresponding author), Univ Tours, INSERM, U966, Tours, France.	roingeard@med.univ-tours.fr	Piver, Eric/AAP-8453-2020; Giraudeau, Bruno/L-9003-2015	Giraudeau, Bruno/0000-0003-3031-8258	INSERM-DHOS; "Ligue Contre le Cancer'' (Loir et Cher and lle et Vilaine); INSERM-Region Centre; Fondation pour la Recherche Medicale	INSERM-DHOS(Institut National de la Sante et de la Recherche Medicale (Inserm)); "Ligue Contre le Cancer'' (Loir et Cher and lle et Vilaine); INSERM-Region Centre(Institut National de la Sante et de la Recherche Medicale (Inserm)Region Centre-Val de Loire); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants from INSERM-DHOS "Recherche Translationnelle: Virosteatose'' and by the "Ligue Contre le Cancer'' (Loir et Cher and lle et Vilaine). M.D. was supported by a fellowship from INSERM-Region Centre and the "Fondation pour la Recherche Medicale''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid K, 2005, J HEPATOL, V42, P744, DOI 10.1016/j.jhep.2004.12.034; Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Benga WJA, 2010, HEPATOLOGY, V51, P43, DOI 10.1002/hep.23278; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Cai T, 2011, J HEPATOL, V55, P529, DOI 10.1016/j.jhep.2010.12.020; Clement S, 2011, HEPATOLOGY, V54, P38, DOI 10.1002/hep.24340; Depla M, 2010, CELL MOL LIFE SCI, V67, P3151, DOI 10.1007/s00018-010-0373-z; Eslam M, 2011, J VIRAL HEPATITIS, V18, P675, DOI 10.1111/j.1365-2893.2011.01474.x; Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0; Grassi A, 2005, ALIMENT PHARM THER, V22, P79, DOI 10.1111/j.1365-2036.2005.02603.x; Hofer H, 2002, AM J GASTROENTEROL, V97, P2880, DOI 10.1111/j.1572-0241.2002.07056.x; Hourigan LF, 1999, HEPATOLOGY, V29, P1215, DOI 10.1002/hep.510290401; Hourioux C, 2007, GUT, V56, P1302, DOI 10.1136/gut.2006.108647; Jackel-Cram C, 2007, J HEPATOL, V46, P999, DOI 10.1016/j.jhep.2006.10.019; Jhaveri R, 2008, J INFECT DIS, V197, P283, DOI 10.1086/524846; Jhaveri R, 2009, J INFECT DIS, V200, P1781, DOI 10.1086/648094; Kim K, 2009, FEBS LETT, V583, P2720, DOI 10.1016/j.febslet.2009.07.034; Kumar D, 2002, HEPATOLOGY, V36, P1266, DOI 10.1053/jhep.2002.36370; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Mirandola S, 2009, LIVER INT, V29, P557, DOI 10.1111/j.1478-3231.2008.01892.x; PAWLOTSKY JM, 1995, J INFECT DIS, V171, P1607, DOI 10.1093/infdis/171.6.1607; Piodi A, 2008, HEPATOLOGY, V48, P16, DOI 10.1002/hep.22288; Piver E, 2010, INT J BIOCHEM CELL B, V42, P869, DOI 10.1016/j.biocel.2010.01.005; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Roingeard P, 2008, J VIRAL HEPATITIS, V15, P157, DOI 10.1111/j.1365-2893.2007.00953.x; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Ryan MC, 2011, J VIRAL HEPATITIS, V18, P53, DOI 10.1111/j.1365-2893.2010.01283.x; Siagris D, 2006, J VIRAL HEPATITIS, V13, P56, DOI 10.1111/j.1365-2893.2005.00655.x; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Sookoian S, 2009, J LIPID RES, V50, P2111, DOI 10.1194/jlr.P900013-JLR200; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang AG, 2009, J PATHOL, V219, P253, DOI 10.1002/path.2592; Waris G, 2007, J VIROL, V81, P8122, DOI 10.1128/JVI.00125-07; Zampino R, 2008, J VIRAL HEPATITIS, V15, P740, DOI 10.1111/j.1365-2893.2008.00994.x	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33749	10.1371/journal.pone.0033749	http://dx.doi.org/10.1371/journal.pone.0033749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479436	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400031
J	He, WY; Rao, ZC; Zhou, DH; Zheng, SC; Xu, WH; Feng, QL				He, Wen-yin; Rao, Zhong-chen; Zhou, Dao-hua; Zheng, Si-chun; Xu, Wei-hua; Feng, Qi-li			Analysis of Expressed Sequence Tags and Characterization of a Novel Gene, Slmg7, in the Midgut of the Common Cutworm, Spodoptera litura	PLOS ONE			English	Article							CHORISTONEURA-FUMIFERANA; CDNA CLONING; EST DATABASE; CELL-LINE; LEPIDOPTERA; IDENTIFICATION; TRANSCRIPTS; ANNOTATION; EXPOSURE; TISSUE	Background: Out total 3,081 assembled expressed sequence tags (ESTs) sequence representing 6,815 high-quality ESTs identified in three cDNA libraries constructed with RNA isolated from the midgut of Spodoptera litura, 1,039 ESTs showed significant hits and 1,107 ESTs did not show significant hits in BLAST searches. It is of interest to clarify whether or not these ESTs that did not show hits function in S. Litura. Results: Twenty "no-hit'' ESTs containing at least one putative open reading frame were selected for further expression analysis. The results from northern blot analysis showed that six of the selected ESTs are expressed in the larval midgut of this insect at different levels, suggesting that these ESTs represent true mRNA products, whereas the other 14 ESTs could not be detected. Homologues of the four larval midgut-predominant genes (Slmg2, Slmg7, Slmg9 and Slmg17) were detected in the genomes of other lepidopteran insects but not in Drosophila melanogaster. A novel gene, Slmg7, is expressed at a high level specifically in the midgut during each of the larval stages. Slmg7 is a single copy gene and encodes a 143-amino acids protein. The SLMG7 protein was localized to the cytoplasm of Spli-221 cells. Conclusions: Six ESTs from the no hit list are transcribed into mRNA and are mainly expressed in the midgut of S. litura. Slmg7 is a novel gene that is localized to the cytoplasm.	[He, Wen-yin; Rao, Zhong-chen; Zhou, Dao-hua; Zheng, Si-chun; Feng, Qi-li] S China Normal Univ, Sch Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China; [Xu, Wei-hua] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	South China Normal University; Sun Yat Sen University	He, WY (corresponding author), S China Normal Univ, Sch Life Sci, Guangdong Prov Key Lab Biotechnol Plant Dev, Guangzhou, Guangdong, Peoples R China.	qlfeng@scnu.edu.cn			National Basic Research Program of China [2010CB126100]; Ministry of Science and Technology of China [2008AA000238]; Chinese National Natural Science Foundation [31071688]	National Basic Research Program of China(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This research was supported partially by the National Basic Research Program of China (2010CB126100), the project of Programme Strategic Scientific Alliances between China and The Netherlands from the Ministry of Science and Technology of China (2008AA000238), and the Chinese National Natural Science Foundation (31071688). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvestad L, 2005, INSECT MOL BIOL, V14, P689, DOI 10.1111/j.1365-2583.2005.00600.x; Cirera S, 2000, MAMM GENOME, V11, P689, DOI 10.1007/s003350010127; Eum JH, 2007, DEV COMP IMMUNOL, V31, P1107, DOI 10.1016/j.dci.2007.02.002; Feng QL, 1999, INSECT BIOCHEM MOLEC, V29, P779, DOI 10.1016/S0965-1748(99)00048-X; Hegedus D, 2003, ARCH INSECT BIOCHEM, V53, P30, DOI 10.1002/arch.10084; Jia QD, 2010, J INSECT PHYSIOL, V56, P1763, DOI 10.1016/j.jinsphys.2010.07.007; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Liu JS, 2010, J PROTEOME RES, V9, P2117, DOI 10.1021/pr900826f; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOK S, 1984, NUCLEIC ACIDS RES, V12, P4517, DOI 10.1093/nar/12.11.4517; Maia RM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-249; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Meunier L, 2006, INSECT MOL BIOL, V15, P475, DOI 10.1111/j.1365-2583.2006.00659.x; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; MITSUHASHI J, 1995, APPL ENTOMOL ZOOL, V30, P75, DOI 10.1303/aez.30.75; Negre V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-322; Patil DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-386; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Simpson RM, 2007, INSECT MOL BIOL, V16, P675, DOI 10.1111/j.1365-2583.2007.00763.x; Takahashi T, 2009, MECH DEVELOP, V126, pS247, DOI 10.1016/j.mod.2009.06.647; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Zhou J, 2008, AQUACULTURE, V275, P356, DOI 10.1016/j.aquaculture.2007.12.005	22	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33621	10.1371/journal.pone.0033621	http://dx.doi.org/10.1371/journal.pone.0033621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470457	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000027
J	Abbruzzetti, S; Tilleman, L; Bruno, S; Viappiani, C; Desmet, F; Van Doorslaer, S; Coletta, M; Ciaccio, C; Ascenzi, P; Nardini, M; Bolognesi, M; Moens, L; Dewilde, S				Abbruzzetti, Stefania; Tilleman, Lesley; Bruno, Stefano; Viappiani, Cristiano; Desmet, Filip; Van Doorslaer, Sabine; Coletta, Massimo; Ciaccio, Chiara; Ascenzi, Paolo; Nardini, Marco; Bolognesi, Martino; Moens, Luc; Dewilde, Sylvia			Ligation Tunes Protein Reactivity in an Ancient Haemoglobin: Kinetic Evidence for an Allosteric Mechanism in Methanosarcina acetivorans Protoglobin	PLOS ONE			English	Article							GLOBIN-COUPLED SENSORS; LIGAND MIGRATION; STATE HEMOGLOBIN; HEME ENVIRONMENT; OXYGEN-AFFINITY; BINDING; NEUROGLOBIN; CONFORMATIONS; DYNAMICS; MODEL	Protoglobin from Methanosarcina acetivorans (MaPgb) is a dimeric globin with peculiar structural properties such as a completely buried haem and two orthogonal tunnels connecting the distal cavity to the solvent. CO binding to and dissociation from MaPgb occur through a biphasic kinetics. We show that the heterogenous kinetics arises from binding to (and dissociation from) two tertiary conformations in ligation-dependent equilibrium. Ligation favours the species with high binding rate (and low dissociation rate). The equilibrium is shifted towards the species with low binding (and high dissociation) rates for the unliganded molecules. A quantitative model is proposed to describe the observed carbonylation kinetics.	[Abbruzzetti, Stefania; Viappiani, Cristiano] Univ Parma, Dipartimento Fis, I-43100 Parma, Italy; [Abbruzzetti, Stefania; Viappiani, Cristiano] Ist Nanoscienze CNR, NEST, Pisa, Italy; [Tilleman, Lesley; Moens, Luc; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Bruno, Stefano] Univ Parma, Dipartimento Biochim & Biol Mol, I-43100 Parma, Italy; [Desmet, Filip; Van Doorslaer, Sabine] Univ Antwerp, Dept Phys, B-2020 Antwerp, Belgium; [Desmet, Filip; Coletta, Massimo; Ciaccio, Chiara] Univ Roma Tor Vergata, Dipartimento Sci Clin & Med Traslazionale, Rome, Italy; [Coletta, Massimo; Ciaccio, Chiara] Consorzio Interuniversitario Ric Chim Met Sistemi, Bari, Italy; [Ascenzi, Paolo] Univ Roma, Dipartimento Biol, Rome, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20122 Milan, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, CIMAINA, I-20122 Milan, Italy	University of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); University of Antwerp; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR); University of Parma; University of Antwerp; University of Rome Tor Vergata; Sapienza University Rome; University of Rome Tor Vergata; University of Milan; University of Milan	Abbruzzetti, S (corresponding author), Univ Parma, Dipartimento Fis, I-43100 Parma, Italy.	cristiano.viappiani@fis.unipr.it	abbruzzetti, stefania/AAE-5518-2020; Coletta, Massimiliano/GSN-5927-2022; Nardini, Marco/B-7842-2017; Viappiani, Cristiano/AAC-7579-2019; abbruzzetti, stefania/M-8640-2015; Van Doorslaer, Sabine/E-5050-2017; Bruno, Stefano/A-4582-2011; Bolognesi, Martino/B-7924-2017; Coletta, Massimo/N-9049-2015	abbruzzetti, stefania/0000-0001-7685-8554; Nardini, Marco/0000-0002-3718-2165; Viappiani, Cristiano/0000-0001-7470-4770; abbruzzetti, stefania/0000-0001-7685-8554; Van Doorslaer, Sabine/0000-0002-1685-9202; Bruno, Stefano/0000-0002-7890-2472; Bolognesi, Martino/0000-0002-9253-5170; COLETTA, Massimiliano/0000-0002-5489-9467	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca [2008BFJ34R, IT10L1M59M]; Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza; University of Antwerp; Fund for Scientific Research, Flanders, Belgium [G.0247.09]	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza; University of Antwerp; Fund for Scientific Research, Flanders, Belgium(FWO)	The authors acknowledge the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2008, 2008BFJ34R, and Azioni Integrate Italia Spagna 2009, IT10L1M59M), and Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina 2011-2013), the University of Antwerp (TOP/BOF UA project), and the Fund for Scientific Research, Flanders, Belgium (grant no. G.0247.09) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2001, J NANOSCI NANOTECHNO, V1, P407, DOI 10.1166/jnn.2001.058; Abbruzzetti S, 2007, J PHYS CHEM B, V111, P12582, DOI 10.1021/jp074954o; Abbruzzetti S, 2006, PHOTOCH PHOTOBIO SCI, V5, P1109, DOI 10.1039/b610236k; Abbruzzetti S, 2009, P NATL ACAD SCI USA, V106, P18984, DOI 10.1073/pnas.0905433106; ANSARI A, 1994, BIOCHEMISTRY-US, V33, P5128, DOI 10.1021/bi00183a017; ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Bapteste Eric, 2005, Archaea, V1, P353, DOI 10.1155/2005/859728; Battistuzzi FU, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-44; Bettati S, 1997, J BIOL CHEM, V272, P32050, DOI 10.1074/jbc.272.51.32050; Bikiel DE, 2010, J PHYS CHEM B, V114, P8536, DOI 10.1021/jp102135p; Bisht NK, 2011, BBA-PROTEINS PROTEOM, V1814, P1042, DOI 10.1016/j.bbapap.2010.09.016; BOLOGNESI M, 1982, J MOL BIOL, V158, P305, DOI 10.1016/0022-2836(82)90435-1; Bruno S, 2001, PROTEIN SCI, V10, P2401, DOI 10.1110/ps.20501; Bruno S, 2007, J AM CHEM SOC, V129, P2880, DOI 10.1021/ja066638d; Brunori M, 2001, EMBO REP, V2, P674, DOI 10.1093/embo-reports/kve159; Cerda J, 1999, BIOSPECTROSCOPY, V5, P289; Cerda-Colon JF, 1998, J AM CHEM SOC, V120, P9312, DOI 10.1021/ja972654m; Couture M, 2001, J BIOL CHEM, V276, P36377, DOI 10.1074/jbc.M103907200; Das TK, 2004, J BIOL CHEM, V279, P10433, DOI 10.1074/jbc.M309590200; Das TK, 1999, J BIOL CHEM, V274, P4207, DOI 10.1074/jbc.274.7.4207; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dewilde S, 2008, METHOD ENZYMOL, V436, P341, DOI 10.1016/S0076-6879(08)36019-4; Faggiano S, 2009, J PHYS CHEM B, V113, P16028, DOI 10.1021/jp9074477; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; Forti F, 2011, J PHYS CHEM B, V115, P13771, DOI 10.1021/jp208562b; Freitas TAK, 2005, J INORG BIOCHEM, V99, P23, DOI 10.1016/j.jinorgbio.2004.10.024; Freitas TAK, 2004, P NATL ACAD SCI USA, V101, P6675, DOI 10.1073/pnas.0308657101; Freitas TAK, 2003, FEBS LETT, V552, P99, DOI 10.1016/S0014-5793(03)00923-2; Gabba M, 2011, BIOPHYSICAL J UNPUB; Galagan JE, 2002, GENOME RES, V12, P532, DOI 10.1101/gr.223902; Hagen SJ, 1996, J CHEM PHYS, V104, P3395, DOI 10.1063/1.471044; Henry ER, 1997, BIOCHEMISTRY-US, V36, P6511, DOI 10.1021/bi9619177; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Henry ER, 2002, BIOPHYS CHEM, V98, P149, DOI 10.1016/S0301-4622(02)00091-1; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Krissinel E., 2005, DETECTION PROTEIN AS, P163; LIM MH, 1993, P NATL ACAD SCI USA, V90, P5801, DOI 10.1073/pnas.90.12.5801; Lou BS, 2000, BIOCHEMISTRY-US, V39, P12424, DOI 10.1021/bi001257c; Nardini M, 2008, EMBO REP, V9, P157, DOI 10.1038/sj.embor.7401153; RIVETTI C, 1993, BIOCHEMISTRY-US, V32, P2888, DOI 10.1021/bi00062a021; Rother M, 2004, P NATL ACAD SCI USA, V101, P16929, DOI 10.1073/pnas.0407486101; Sawai H, 2005, BIOCHEMISTRY-US, V44, P13257, DOI 10.1021/bi050997o; Sottini S, 2005, J AM CHEM SOC, V127, P17427, DOI 10.1021/ja056101k; Sottini S, 2005, J PHYS CHEM B, V109, P19523, DOI 10.1021/jp0540981; Steinbach PJ, 2002, J CHEM INF COMP SCI, V42, P1476, DOI 10.1021/ci025551i; Steinbach PJ, 2002, BIOPHYS J, V82, P2244, DOI 10.1016/S0006-3495(02)75570-7; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101; Vinogradov SN, 2007, GENE, V398, P132, DOI 10.1016/j.gene.2007.02.041; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	50	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33614	10.1371/journal.pone.0033614	http://dx.doi.org/10.1371/journal.pone.0033614			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479420	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900033
J	Baird, HP; Miller, KJ; Stark, JS				Baird, Helena Phoenix; Miller, Karen Joy; Stark, Jonathan Sean			Genetic Population Structure in the Antarctic Benthos: Insights from the Widespread Amphipod, Orchomenella franklini	PLOS ONE			English	Article							BROODING BRITTLE STAR; SOUTHERN-OCEAN; MITOCHONDRIAL LINEAGES; MCMURDO-STATION; CLIMATE-CHANGE; CASEY STATION; TELL US; DIFFERENTIATION; DIVERSITY; MARKERS	Currently there is very limited understanding of genetic population structure in the Antarctic benthos. We conducted one of the first studies of microsatellite variation in an Antarctic benthic invertebrate, using the ubiquitous amphipod Orchomenella franklini (Walker, 1903). Seven microsatellite loci were used to assess genetic structure on three spatial scales: sites (100 s of metres), locations (1-10 kilometres) and regions (1000 s of kilometres) sampled in East Antarctica at Casey and Davis stations. Considerable genetic diversity was revealed, which varied between the two regions and also between polluted and unpolluted sites. Genetic differentiation among all populations was highly significant (F-ST = 0.086, R-ST = 0.139, p < 0.001) consistent with the brooding mode of development in O. franklini. Hierarchical AMOVA revealed that the majority of the genetic subdivision occurred across the largest geographical scale, with N(e)m approximate to 1 suggesting insufficient gene flow to prevent independent evolution of the two regions, i.e., Casey and Davis are effectively isolated. Isolation by distance was detected at smaller scales and indicates that gene flow in O. franklini occurs primarily through stepping-stone dispersal. Three of the microsatellite loci showed signs of selection, providing evidence that localised adaptation may occur within the Antarctic benthos. These results provide insights into processes of speciation in Antarctic brooders, and will help inform the design of spatial management initiatives recently endorsed for the Antarctic benthos.	[Baird, Helena Phoenix; Miller, Karen Joy] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Miller, Karen Joy; Stark, Jonathan Sean] Australian Antarctic Div, Kingston, Tas, Australia	University of Tasmania; Australian Antarctic Division	Baird, HP (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	hpbaird@utas.edu.au	Miller, Karen/A-7902-2011; Miller, Karen/V-4098-2019; Stark, Jonathan/ABF-4025-2020	Stark, Jonathan/0000-0002-4268-8072; Baird, Helena/0000-0002-7560-8331	Australian Antarctic Division; Institute for Marine and Antarctic Studies; ANZ Trustees Foundation Holsworth Wildlife Research Endowment	Australian Antarctic Division; Institute for Marine and Antarctic Studies; ANZ Trustees Foundation Holsworth Wildlife Research Endowment	This work was supported by the Australian Antarctic Division (www.antarctica.gov.au/), the Institute for Marine and Antarctic Studies (http://www.imas.utas.edu.au/), and ANZ Trustees Foundation Holsworth Wildlife Research Endowment (http://www.anz.com/personal/private-bank-trustees/trustees/apply-grant/named-charitable-trusts/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARDY MT, 1994, TRENDS ECOL EVOL, V9, P267, DOI 10.1016/0169-5347(94)90297-6; Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Andre C, 2011, HEREDITY, V106, P270, DOI 10.1038/hdy.2010.71; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Arango CP, 2011, DEEP-SEA RES PT II, V58, P212, DOI 10.1016/j.dsr2.2010.05.019; ARNAUD PM, 1977, ADAPTATIONS ANTARCTI, P135; ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Bach L, 2009, THESIS ROSKILDE U RO; Baird HP, 2011, MOL ECOL, V20, P3439, DOI 10.1111/j.1365-294X.2011.05173.x; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bastidas C, 2002, CORAL REEFS, V21, P233, DOI 10.1007/s00338-002-0236-7; BATTAGLIA B, 1980, HELGOLANDER MEERESUN, V33, P587, DOI 10.1007/BF02414782; Bell JJ, 2005, P ROY SOC B-BIOL SCI, V272, P1067, DOI 10.1098/rspb.2005.3051; Bickham JW, 2000, MUTAT RES-REV MUTAT, V463, P33, DOI 10.1016/S1383-5742(00)00004-1; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Boissin E, 2008, MOL ECOL, V17, P1732, DOI 10.1111/j.1365-294X.2007.03652.x; Bowen BW, 1999, MOL ECOL, V8, pS5, DOI 10.1046/j.1365-294X.1999.00798.x; Brandt A, 2005, ANTARCT SCI, V17, P509, DOI 10.1017/S0954102005002932; Brandt A, 1999, SCI MAR, V63, P261, DOI 10.3989/scimar.1999.63s1261; CARVALHO GR, 1989, OLSEN INT S, P265; CHAKRABORTY R, 1982, THEOR POPUL BIOL, V21, P205, DOI 10.1016/0040-5809(82)90014-4; Chapman PM, 2005, ENVIRON SCI TECHNOL, V39, p200A, DOI 10.1021/es0532537; Clarke A, 2003, ENVIRON CONSERV, V30, P1, DOI 10.1017/S0376892903000018; CLARKE A, 1992, PHILOS T ROY SOC B, V338, P299, DOI 10.1098/rstb.1992.0150; Clement Olivier, 1998, P299; COHEN A S, 1987, Palaios, V2, P426, DOI 10.2307/3514614; Commission for the Conservation of Antarctic Marine Living Resources, 2005, MAR PROT AR WORKSH 2; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Dauby P, 2001, HYDROBIOLOGIA, V443, P69, DOI 10.1023/A:1017596120422; De Broyer C, 2003, ANTARCTIC BIOLOGY IN A GLOBAL CONTEXT, PROCEEDINGS, P201; De Broyer C, 1993, DOCUMENTS TRAVAIL I, V73, P1; De Broyer C, 2003, BELGIAN SCI RES PROG, V1, P1; De Wolf H, 2004, SCI TOTAL ENVIRON, V325, P59, DOI 10.1016/j.scitotenv.2003.11.004; DELL RK, 1972, ADV MAR BIOL, V10, P1, DOI 10.1016/S0065-2881(08)60416-2; Demarchi M, 2010, POLAR BIOL, P1; Deprez Patrick P., 1999, Polar Record, V35, P299; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; EVERITT DA, 1980, AUST J MAR FRESH RES, V31, P829; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feral JP, 2002, J EXP MAR BIOL ECOL, V268, P121, DOI 10.1016/S0022-0981(01)00382-3; Gautschi B, 2000, MOL ECOL, V9, P2193, DOI 10.1046/j.1365-294X.2000.105321.x; Gautschi B, 2000, MOL ECOL, V9, P2192; Goldstein D, 1999, MICROSATELLITES EVOL; Gooch J.L., 1975, Marine Ecol, V2, P349; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gray JS, 1997, BIODIVERS CONSERV, V6, P153, DOI 10.1023/A:1018335901847; Griffiths HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011683; Guidetti M, 2006, ANTARCT SCI, V18, P645, DOI 10.1017/S0954102006000678; Gutt J, 2007, ANTARCT SCI, V19, P165, DOI 10.1017/S0954102007000247; GUTTMAN SI, 1994, ENVIRON HEALTH PERSP, V102, P97, DOI 10.1289/ehp.94102s1297; Hamilton MB, 1999, BIOTECHNIQUES, V27, P500, DOI 10.2144/99273st03; Harris J, 2007, ANTARCT SCI, V19, P189, DOI 10.1017/S0954102007000260; HEDGECOCK D, 1986, B MAR SCI, V39, P550; Hedgpeth J. W., 1970, P97; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; Held C, 2007, POLAR BIOL, V30, P513, DOI 10.1007/s00300-006-0210-x; Hellberg ME, 2002, B MAR SCI, V70, P273; Hemond EM, 2011, MAR ECOL PROG SER, V423, P131, DOI 10.3354/meps08922; HESS H, 1988, J EXP MAR BIOL ECOL, V122, P187, DOI 10.1016/0022-0981(88)90184-0; Hilbish TJ, 1996, J EXP MAR BIOL ECOL, V200, P67, DOI 10.1016/S0022-0981(96)02645-7; HOFFMAN JI, 2010, J HEREDITY; HOWINGTON JP, 1992, MAR POLLUT BULL, V25, P324, DOI 10.1016/0025-326X(92)90690-8; Hunter RL, 2008, J HERED, V99, P137, DOI 10.1093/jhered/esm119; Janosik AM, 2010, INTEGR COMP BIOL, V50, P981, DOI 10.1093/icb/icq119; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; JAZDZEWSKI K, 1991, HYDROBIOLOGIA, V223, P105, DOI 10.1007/BF00047632; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; KIMURA M, 1964, GENETICS, V49, P561; Kimura M., 1953, ANNU REP NAT I GENET, V3, P62; Knox G. A., 2007, BIOL SO OCEAN; Krabbe K, 2010, POLAR BIOL, V33, P281, DOI 10.1007/s00300-009-0703-5; Lande R, 1996, EVOLUTION, V50, P434, DOI 10.2307/2410812; Larsson LC, 2007, MOL ECOL, V16, P1135, DOI 10.1111/j.1365-294X.2006.03217.x; Leese F, 2008, CONSERV GENET, V9, P1369, DOI 10.1007/s10592-007-9491-z; Leese F, 2010, NATURWISSENSCHAFTEN, V97, P583, DOI 10.1007/s00114-010-0674-y; LENIHAN HS, 1990, MAR POLLUT BULL, V21, P422, DOI 10.1016/0025-326X(90)90761-V; LEVINS R, 1964, EVOLUTION, V18, P635, DOI 10.2307/2406216; Linse K, 2007, POLAR BIOL, V30, P1059, DOI 10.1007/s00300-007-0265-3; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Lubchenco J, 2003, ECOL APPL, V13, pS3; Ma XL, 2000, MAR ENVIRON RES, V50, P559, DOI 10.1016/S0141-1136(00)00109-4; Mahon AR, 2008, MAR BIOL, V155, P315, DOI 10.1007/s00227-008-1029-5; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Morjan CL, 2004, MOL ECOL, V13, P1341, DOI 10.1111/j.1365-294X.2004.02164.x; NEVO E, 1986, BIOL J LINN SOC, V29, P139, DOI 10.1111/j.1095-8312.1986.tb01828.x; Nielsen EE, 2006, MOL ECOL, V15, P3219, DOI 10.1111/j.1365-294X.2006.03025.x; O'Brien PE, 2011, SEAFLOOR GE IN PRESS; Palumbi SR, 2003, ECOL APPL, V13, pS146; Palumbi Stephen R., 1995, P369; Parker PG, 1998, ECOLOGY, V79, P361, DOI 10.1890/0012-9658(1998)079[0361:WMCTUA]2.0.CO;2; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peck LS, 2005, ANTARCT SCI, V17, P497, DOI 10.1017/S0954102005002920; Picken G.B., 1985, P167; PICKEN GB, 1980, BIOL J LINN SOC, V14, P67, DOI 10.1111/j.1095-8312.1980.tb00098.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ragua-Gil JM, 2004, MAR BIOL, V144, P829, DOI 10.1007/s00227-003-1269-3; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reeves PA, 2011, SYST BIOL, V60, P45, DOI 10.1093/sysbio/syq056; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rieseberg LH, 2004, NEW PHYTOL, V161, P59, DOI 10.1046/j.1469-8137.2003.00933.x; Rogers AD, 2007, PHILOS T R SOC B, V362, P2191, DOI 10.1098/rstb.2006.1948; Sale PF, 2003, FISH RES, V65, P153, DOI 10.1016/j.fishres.2003.09.013; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Shanks AL, 2003, ECOL APPL, V13, pS159; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Slatkin Montgomery, 1994, P3; Sotka EE, 2005, ECOL LETT, V8, P448, DOI 10.1111/j.1461-0248.2004.00719.x; Stark JS, 2000, POLAR BIOL, V23, P840, DOI 10.1007/s003000000162; Stark JS, 2004, MAR ECOL PROG SER, V276, P53, DOI 10.3354/meps276053; Stark JS, 2003, AUSTRAL ECOL, V28, P287, DOI 10.1046/j.1442-9993.2003.01289.x; Stark JS, 2011, ENV IMPACT ASSESSMEN; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; TUCKER MJ, 1988, HYDROBIOLOGIA, V165, P129, DOI 10.1007/BF00025580; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; Watling L., 1989, Geological Society Special Publication, P297; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White M.C., 1984, P421; Wilson AB, 1997, MOL ECOL, V6, P917, DOI 10.1046/j.1365-294X.1997.00270.x; Wilson NG, 2007, MAR BIOL, V152, P895, DOI 10.1007/s00227-007-0742-9; Wilson NG, 2009, MOL ECOL, V18, P965, DOI 10.1111/j.1365-294X.2008.04071.x; WRIGHT JM, 1994, REV FISH BIOL FISHER, V4, P384, DOI 10.1007/BF00042912; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yang RC, 1998, EVOLUTION, V52, P950, DOI 10.1111/j.1558-5646.1998.tb01824.x	129	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34363	10.1371/journal.pone.0034363	http://dx.doi.org/10.1371/journal.pone.0034363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479613	Green Submitted, gold, Green Published			2022-12-27	WOS:000303894900085
J	Burton, C				Burton, Christopher			Heavy Tailed Distributions of Effect Sizes in Systematic Reviews of Complex Interventions	PLOS ONE			English	Review								Background: Systematic reviews of complex interventions commonly find heterogeneity of effect sizes among similar interventions which cannot be explained. Commentators have suggested that complex interventions should be viewed as interventions in complex systems. We hypothesised that if this is the case, the distribution of effect sizes from complex interventions should be heavy tailed, as in other complex systems. Thus, apparent heterogeneity may be a feature of the complex systems in which such interventions operate. Methodology/Principal Findings: We specified three levels of complexity and identified systematic reviews which reported effect sizes of healthcare interventions at two of these levels (interventions to change professional practice and personal interventions to help smoking cessation). These were compared with each other and with simulated data representing the lowest level of complexity. Effect size data were rescaled across reviews at each level using log-normal parameters and pooled. Distributions were plotted and fitted against the inverse power law (Pareto) and stretched exponential (Weibull) distributions, heavy tailed distributions which are commonly reported in the literature, using maximum likelihood fitting. The dataset included 155 studies of interventions to change practice and 98 studies of helping smoking cessation. Both distributions showed a heavy tailed distribution which fitted best to the inverse power law for practice interventions (exponent = 3.9, loglikelihood = -35.3) and to the stretched exponential for smoking cessation (loglikelihood = -75.2). Bootstrap sensitivity analysis to adjust for possible publication bias against weak results did not diminish the goodness of fit. Conclusions/Significance: The distribution of effect sizes from complex interventions includes heavy tails as typically seen in both theoretical and empirical complex systems. This is in keeping with the idea of complex interventions as interventions in complex systems.	Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Burton, C (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	chris.burton@ed.ac.uk		Burton, Christopher/0000-0003-0233-2431	Chief Scientist Office; Chief Scientist Office [CZP/4/11] Funding Source: researchfish	Chief Scientist Office; Chief Scientist Office	CB was supported by a Chief Scientist Office Primary Care Research Career Award (www.cso.scot.nhs.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L, 2011, NATURE, V474, P164, DOI 10.1038/474164a; Baek SK, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/043004; Bak P., 1996, NATURE WORKS SCI SEL; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Cochrane Effective Practice and Organisation of Care Group, 2011, TABL OTH INF PUBL OU; Coiera E, 2011, BMJ, V342; Crabtree BF, 2011, MED CARE, V49, pS28, DOI 10.1097/MLR.0b013e3181cad65c; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Egger M., 2008, SYSTEMATIC REV HLTH; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Hammond RA, 2009, PREV CHRONIC DIS, V6; Hawe P, 2009, AM J COMMUN PSYCHOL, V43, P267, DOI 10.1007/s10464-009-9229-9; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Lai DTC, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006936.pub2, 10.1002/14651858.CD006936.pub3]; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Lancaster T., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000165.pub2, DOI 10.1002/14651858.CD000165.PUB2, 10.1002/14651858.CD000165.pub2.AMBIGUOUS]; Miller WL, 1998, J FAM PRACTICE, V46, P369; Newman MEJ, 2011, AM J PHYS, V79, P800, DOI 10.1119/1.3590372; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; Paley J, 2010, J HEALTH SERV RES PO, V15, P59, DOI 10.1258/jhsrp.2009.009072; Plsek PE, 2001, BRIT MED J, V323, P625, DOI 10.1136/bmj.323.7313.625; Rickles D, 2007, J EPIDEMIOL COMMUN H, V61, P933, DOI 10.1136/jech.2006.054254; Rickles D, 2009, MED HEALTH CARE PHIL, V12, P77, DOI 10.1007/s11019-008-9140-4; Rwashana AS, 2009, HEALTH INFORM J, V15, P95, DOI 10.1177/1460458209102971; Shiell A, 2008, BMJ-BRIT MED J, V336, P1281, DOI 10.1136/bmj.39569.510521.AD; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; West Bruce J., 2006, WHERE MED WENT WRONG	32	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34222	10.1371/journal.pone.0034222	http://dx.doi.org/10.1371/journal.pone.0034222			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479569	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900072
J	Denis, C; Deiteren, K; Mortier, A; Tounsi, A; Fransen, E; Proost, P; Renauld, JC; Lambeir, AM				Denis, Catherine; Deiteren, Kathleen; Mortier, Anneleen; Tounsi, Amel; Fransen, Erik; Proost, Paul; Renauld, Jean-Christophe; Lambeir, Anne-Marie			C-Terminal Clipping of Chemokine CCL1/I-309 Enhances CCR8-Mediated Intracellular Calcium Release and Anti-Apoptotic Activity	PLOS ONE			English	Article							MEMBRANE-BOUND CARBOXYPEPTIDASE; DEXAMETHASONE-INDUCED APOPTOSIS; CELL-DERIVED FACTOR-1-ALPHA; RECEPTOR CCR8; NONPEPTIDE AGONIST; T-CELLS; I-309; IDENTIFICATION; ACTIVATION; EXPRESSION	Carboxypeptidase M (CPM) targets the basic amino acids arginine and lysine present at the C-terminus of peptides or proteins. CPM is thought to be involved in inflammatory processes. This is corroborated by CPM-mediated trimming and modulation of inflammatory factors, and expression of the protease in inflammatory environments. Since the function of CPM in and beyond inflammation remains mainly undefined, the identification of natural substrates can aid in discovering the (patho) physiological role of CPM. CCL1/I-309, with its three C-terminal basic amino acids, forms a potential natural substrate for CPM. CCL1 plays a role not only in inflammation but also in apoptosis, angiogenesis and tumor biology. Enzymatic processing differently impacts the biological activity of chemokines thereby contributing to the complex regulation of the chemokine system. The aim of the present study was to investigate whether (i) CCL1/I-309 is prone to trimming by CPM, and (ii) the biological activity of CCL1 is altered after C-terminal proteolytic processing. CCL1 was identified as a novel substrate for CPM in vitro using mass spectrometry. C-terminal clipping of CCL1 augmented intracellular calcium release mediated by CCR8 but reduced the binding of CCL1 to CCR8. In line with the higher intracellular calcium release, a pronounced increase of the anti-apoptotic activity of CCL1 was observed in the BW5147 cellular model. CCR8 signaling, CCR8 binding and anti-apoptotic activity were unaffected when CPM was exposed to the carboxypeptidase inhibitor DL-2-mercaptomethyl-3-guanidino-ethylthiopropanoic acid. The results of this study suggest that CPM is a likely candidate for the regulation of biological processes relying on the CCL1-CCR8 system.	[Denis, Catherine; Deiteren, Kathleen; Lambeir, Anne-Marie] Univ Antwerp, Dept Pharmaceut Sci, Med Biochem Lab, B-2020 Antwerp, Belgium; [Mortier, Anneleen; Proost, Paul] Katholieke Univ Leuven, Rega Inst, Dept Microbiol & Immunol, Lab Mol Immunol, Louvain, Belgium; [Tounsi, Amel; Renauld, Jean-Christophe] Catholic Univ Louvain, Ludwig Inst Canc Res, Brussels Branch, B-1200 Brussels, Belgium; [Tounsi, Amel; Renauld, Jean-Christophe] Catholic Univ Louvain, Expt Med Unit, de Duve Inst, B-1200 Brussels, Belgium; [Fransen, Erik] Univ Antwerp, StatUa Ctr Stat, Edegem, Belgium	University of Antwerp; KU Leuven; Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain; University of Antwerp	Denis, C (corresponding author), Univ Antwerp, Dept Pharmaceut Sci, Med Biochem Lab, B-2020 Antwerp, Belgium.	anne-marie.lambeir@ua.ac.be	Proost, Paul/V-3052-2017; Fransen, Erik/C-4102-2015; Lambeir, Anne-Marie/B-2477-2017; Renauld, Jean-Christophe/B-7268-2012	Proost, Paul/0000-0002-0133-5545; Fransen, Erik/0000-0001-7785-4790; Lambeir, Anne-Marie/0000-0001-9386-3777; Renauld, Jean-Christophe/0000-0003-1736-2131; Mortier, Anneleen/0000-0002-9662-674X	postdoctoral research fellowship of FWO-Vlaanderen (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen); fellowship of "Operation Televie"	postdoctoral research fellowship of FWO-Vlaanderen (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen); fellowship of "Operation Televie"	CD is a research assistant and AM holds a postdoctoral research fellowship of the FWO-Vlaanderen (Fonds voor Wetenschappelijk Onderzoek-Vlaanderen). AT was supported by a fellowship of the "Operation Televie". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardini G, 2000, BLOOD, V96, P4039, DOI 10.1182/blood.V96.13.4039.h8004039_4039_4045; Boffa MB, 2003, J BIOL CHEM, V278, P9250, DOI 10.1074/jbc.M209588200; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; CLARKLEWIS I, 1995, J LEUKOCYTE BIOL, V57, P703, DOI 10.1002/jlb.57.5.703; Davis DA, 2005, BLOOD, V105, P4561, DOI 10.1182/blood-2004-12-4618; De La Luz Sierra M, 2004, BLOOD, V103, P2452; Deiteren K, 2007, BBA-PROTEINS PROTEOM, V1774, P267, DOI 10.1016/j.bbapap.2006.11.017; Deiteren K, 2009, CLIN CHIM ACTA, V399, P24, DOI 10.1016/j.cca.2008.10.003; DESAINTVIS B, 1995, BLOOD, V86, P1098; Fox JM, 2006, J BIOL CHEM, V281, P36652, DOI 10.1074/jbc.M605584200; Goya I, 1998, J IMMUNOL, V160, P1975; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gutierrez J, 2004, J BIOL CHEM, V279, P14726, DOI 10.1074/jbc.M309689200; Haskell CA, 2006, MOL PHARMACOL, V69, P309, DOI 10.1124/mol.105.014779; Hoelzinger DB, 2010, J IMMUNOL, V184, P6833, DOI 10.4049/jimmunol.0904084; Horuk R, 1998, J BIOL CHEM, V273, P386, DOI 10.1074/jbc.273.1.386; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Inngjerdingen M, 2000, J IMMUNOL, V164, P4048, DOI 10.4049/jimmunol.164.8.4048; Jensen PC, 2007, MOL PHARMACOL, V72, P327, DOI 10.1124/mol.106.035543; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Keizer DW, 2000, BIOCHEMISTRY-US, V39, P6053, DOI 10.1021/bi000089l; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; Louahed J, 2003, EUR J IMMUNOL, V33, P494, DOI 10.1002/immu.200310025; Luz JG, 2005, J MOL BIOL, V352, P1019, DOI 10.1016/j.jmb.2005.08.011; Marquez-Curtis L, 2008, STEM CELLS, V26, P1211, DOI 10.1634/stemcells.2007-0725; Marro ML, 2006, BIOCHEM BIOPH RES CO, V349, P270, DOI 10.1016/j.bbrc.2006.08.029; MCGWIRE GB, 1995, J BIOL CHEM, V270, P17154, DOI 10.1074/jbc.270.29.17154; Michel B, 1996, CIRC RES, V78, P635; MILLER MD, 1992, P NATL ACAD SCI USA, V89, P2950, DOI 10.1073/pnas.89.7.2950; MILLER MD, 1989, J IMMUNOL, V143, P2907; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RENAULD JC, 1995, BLOOD, V85, P1300, DOI 10.1182/blood.V85.5.1300.bloodjournal8551300; Roos RS, 1997, J BIOL CHEM, V272, P17251, DOI 10.1074/jbc.272.28.17251; Ruckes T, 2001, BLOOD, V98, P1150, DOI 10.1182/blood.V98.4.1150; Sebastiani S, 2001, J IMMUNOL, V166, P996, DOI 10.4049/jimmunol.166.2.996; SKIDGEL RA, 1989, J BIOL CHEM, V264, P2236; SKIDGEL RA, 1984, ANAL BIOCHEM, V140, P520, DOI 10.1016/0003-2697(84)90203-3; SKIDGEL RA, 1988, ARCH BIOCHEM BIOPHYS, V267, P660, DOI 10.1016/0003-9861(88)90074-4; SKIDGEL RA, 1991, METHODS NEUROSCIENCE, P373; Spinetti G, 2003, J LEUKOCYTE BIOL, V73, P201, DOI 10.1189/jlb.0302105; Sun XO, 2008, BIOL CHEM, V389, P1477, DOI 10.1515/BC.2008.168; Tamguney G, 2004, ONCOGENE, V23, P8475, DOI 10.1038/sj.onc.1207903; Tan Y, 2006, EXP HEMATOL, V34, P1553, DOI 10.1016/j.exphem.2006.07.001; Tiffany HL, 1997, J EXP MED, V186, P165, DOI 10.1084/jem.186.1.165; VanSnick J, 1996, J IMMUNOL, V157, P2570; Zingoni A, 1998, J IMMUNOL, V161, P547	48	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34199	10.1371/journal.pone.0034199	http://dx.doi.org/10.1371/journal.pone.0034199			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479563	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900068
J	Du, SZ; Tu, CL; van Wyk, BJ; Ochola, EO; Chen, ZQ				Du, Shengzhi; Tu, Chunling; van Wyk, Barend J.; Ochola, Elisha Oketch; Chen, Zengqiang			Measuring Straight Line Segments Using HT Butterflies	PLOS ONE			English	Article							HOUGH-TRANSFORM; IMAGE; ACCURATE	This paper addresses the features of Hough Transform (HT) butterflies suitable for image-based segment detection and measurement. The full segment parameters such as the position, slope, width, length, continuity, and uniformity are related to the features of the HT butterflies. Mathematical analysis and experimental data are presented in order to demonstrate and build the relationship between the measurements of segments and the features of HT butterflies. An effective method is subsequently proposed to employ these relationships in order to discover the parameters of segments. Power line inspection is considered as an application of the proposed method. The application demonstrates that the proposed method is effective for power line inspection, especially for corner detection when they cross poles.	[Du, Shengzhi] Univ S Afr, Dept Elect & Min Engn, Florida, South Africa; [Tu, Chunling; van Wyk, Barend J.] Tshwane Univ Technol, FSATI, Pretoria, South Africa; [Ochola, Elisha Oketch] Univ S Afr, Sch Comp, Pretoria, South Africa; [Chen, Zengqiang] Nankai Univ, Dept Automat, Tianjin 300071, Peoples R China	University of South Africa; Tshwane University of Technology; University of South Africa; Nankai University	Du, SZ (corresponding author), Univ S Afr, Dept Elect & Min Engn, Florida, South Africa.	dushengzhi@gmail.com	Ochola, Elisha Oketch/P-9757-2019; Du, Shengzhi/A-9562-2010	Ochola, Elisha Oketch/0000-0001-8912-1578; Van Wyk, Barend/0000-0002-2222-4393	The National Research Foundation (NRF) South Africa [IFR2011032500005]	The National Research Foundation (NRF) South Africa(National Research Foundation - South Africa)	The work was supported by The National Research Foundation (NRF) South Africa (Ref. IFR2011032500005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal N, 2006, IEEE T IMAGE PROCESS, V15, P582, DOI 10.1109/TIP.2005.863021; Aghajan HK, 1993, IEEE T IMAGE PROCESS, V2, P454, DOI 10.1109/83.242355; AKHTAR MW, 1992, ELECTRON LETT, V28, P94, DOI 10.1049/el:19920058; Atiquzzaman M., 1995, Real-Time Imaging, V1, P419, DOI 10.1006/rtim.1995.1043; ATIQUZZAMAN M, 1994, IMAGE VISION COMPUT, V12, P267, DOI 10.1016/0262-8856(94)90032-9; BALLARD DH, 1981, PATTERN RECOGN, V13, P111, DOI 10.1016/0031-3203(81)90009-1; Cha J, 2006, PATTERN RECOGN, V39, P1034, DOI 10.1016/j.patcog.2005.05.014; Chandran S, 2003, IEEE T IMAGE PROCESS, V12, P678, DOI 10.1109/TIP.2002.806255; Ching YT, 2001, PATTERN RECOGN LETT, V22, P421, DOI 10.1016/S0167-8655(00)00130-6; Du S, 2012, ELECT LETT IN PRESS, P48; Du SZ, 2011, IEEE T IMAGE PROCESS, V20, P3612, DOI 10.1109/TIP.2011.2155076; Du SZ, 2010, IEEE T IMAGE PROCESS, V19, P573, DOI 10.1109/TIP.2009.2036714; Duan HB, 2007, IEEE C EVOL COMPUTAT, P149, DOI 10.1109/ICPCA.2007.4365429; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Fernandes LAF, 2008, PATTERN RECOGN, V41, P299, DOI 10.1016/j.patcog.2007.04.003; Furukawa Y, 2003, COMPUT VIS IMAGE UND, V92, P1, DOI 10.1016/j.cviu.2003.07.002; Gerig G., 1987, Proceedings of the First International Conference on Computer Vision (Cat. No.87CH2465-3), P112; Golightly I, 2002, THESIS U WALES BANGO; GUIL N, 1995, IEEE T IMAGE PROCESS, V4, P1541, DOI 10.1109/83.469935; Ho CT, 1996, IEEE T IMAGE PROCESS, V5, P547, DOI 10.1109/83.491329; Hough P.V.C., 1962, METHOD MEANS RECOGNI; Ji JH, 2011, PATTERN RECOGN LETT, V32, P1503, DOI 10.1016/j.patrec.2011.04.011; Kamat V, 1998, 1998 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING - PROCEEDINGS, VOL 1, P216, DOI 10.1109/ICIP.1998.723460; Kamat-Sadekar V, 1998, IMAGE VISION COMPUT, V16, P597, DOI 10.1016/S0262-8856(98)00076-6; LEAVERS VF, 1987, IMAGE VISION COMPUT, V5, P161, DOI 10.1016/0262-8856(87)90044-8; Li C, 2009, P 2009 2 INT C IMAGE, P1; Li HX, 2007, PROCEEDINGS OF THE FOURTH INTERNATIONAL CONFERENCE ON IMAGE AND GRAPHICS, P471, DOI 10.1109/ICIG.2007.114; Murakami K, 2000, INT C PATT RECOG, P467, DOI 10.1109/ICPR.2000.903585; Nagata N, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON FIELD-PROGRAMMABLE TECHNOLOGY, PROCEEDINGS, P89, DOI 10.1109/FPT.2004.1393255; Nguyen T. T., 2008, PROPOSED REAL VALUED, P1, DOI 10.1109/ICIT.2008.4608701; Niblack W, 1990, P IAPR INT WORKSH MA, P28; RICHARDS J, 1991, APPL OPTICS, V30, P2899, DOI 10.1364/AO.30.002899; Rocha J, 2004, P 35 INT S ROB; Sathyanarayana SS, 2009, IEEE T IMAGE PROCESS, V18, P2255, DOI 10.1109/TIP.2009.2026680; Shapiro V, 2006, COMPUT VIS IMAGE UND, V103, P1, DOI 10.1016/j.cviu.2006.02.001; Shi DM, 2010, IEEE T IMAGE PROCESS, V19, P1558, DOI 10.1109/TIP.2010.2042102; Song JQ, 2005, PATTERN RECOGN, V38, P539, DOI 10.1016/j.patcog.2004.09.003; Tu C, 2011, ELECTRON LETT, V47, P1360, DOI 10.1049/el.2011.3462; Walsh D, 2002, PATTERN RECOGN, V35, P1421, DOI 10.1016/S0031-3203(01)00114-5; Williams M, 2001, ROBOTICA, V19, P125, DOI 10.1017/S0263574700002952; Worz S, 2007, IEEE T IMAGE PROCESS, V16, P1994, DOI 10.1109/TIP.2007.901204; Yamato J., 1990, Systems and Computers in Japan, V21, P68, DOI 10.1002/scj.4690211010; YANG LX, 1993, 1993 IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS : PROCEEDINGS, VOLS 1-4 ( ISCAS 93 ), P543, DOI 10.1109/ISCAS.1993.393778; Zhang XF, 2000, INT C PATT RECOG, P672	44	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33790	10.1371/journal.pone.0033790	http://dx.doi.org/10.1371/journal.pone.0033790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479442	Green Published, gold			2022-12-27	WOS:000303894900037
J	Gupta, AB; Wee, LE; Zhou, YT; Hortsch, M; Low, BC				Gupta, Anjali Bansal; Wee, Liang En; Zhou, Yi Ting; Hortsch, Michael; Low, Boon Chuan			Cross-Species Analyses Identify the BNIP-2 and Cdc42GAP Homology (BCH) Domain as a Distinct Functional Subclass of the CRAL_TRIO/Sec14 Superfamily	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; GTPASE-ACTIVATING PROTEIN; VITAMIN-E-DEFICIENCY; I-TASSER; PHOSPHOLIPID-BINDING; AUTOMATED PREDICTION; CRYSTAL-STRUCTURE; CELL-DYNAMICS; CAYMAN ATAXIA; RHO-GTPASES	The CRAL_TRIO protein domain, which is unique to the Sec14 protein superfamily, binds to a diverse set of small lipophilic ligands. Similar domains are found in a range of different proteins including neurofibromatosis type-1, a Ras GTPase-activating Protein (RasGAP) and Rho guanine nucleotide exchange factors (RhoGEFs). Proteins containing this structural protein domain exhibit a low sequence similarity and ligand specificity while maintaining an overall characteristic three-dimensional structure. We have previously demonstrated that the BNIP-2 and Cdc42GAP Homology (BCH) protein domain, which shares a low sequence homology with the CRAL_TRIO domain, can serve as a regulatory scaffold that binds to Rho, RhoGEFs and RhoGAPs to control various cell signalling processes. In this work, we investigate 175 BCH domain-containing proteins from a wide range of different organisms. A phylogenetic analysis with similar to 100 CRAL_TRIO and similar domains from eight representative species indicates a clear distinction of BCH-containing proteins as a novel subclass within the CRAL_TRIO/Sec14 superfamily. BCH-containing proteins contain a hallmark sequence motif R(R/K) h(R/K)(R/K) NL(R/K) xhhhhHPs ('h' is large and hydrophobic residue and 's' is small and weekly polar residue) and can be further subdivided into three unique subtypes associated with BNIP-2-N, macro-and RhoGAP-type protein domains. A previously unknown group of genes encoding 'BCH-only' domains is also identified in plants and arthropod species. Based on an analysis of their gene-structure and their protein domain context we hypothesize that BCH domain-containing genes evolved through gene duplication, intron insertions and domain swapping events. Furthermore, we explore the point of divergence between BCH and CRAL-TRIO proteins in relation to their ability to bind small GTPases, GAPs and GEFs and lipid ligands. Our study suggests a need for a more extensive analysis of previously uncharacterized BCH, 'BCH-like' and CRAL_TRIO-containing proteins and their significance in regulating signaling events involving small GTPases.	[Gupta, Anjali Bansal; Wee, Liang En; Zhou, Yi Ting; Low, Boon Chuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Gupta, Anjali Bansal; Low, Boon Chuan] Natl Univ Singapore, Inst Mechanobiol, Singapore, Singapore; [Hortsch, Michael] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	National University of Singapore; National University of Singapore; University of Michigan System; University of Michigan	Gupta, AB (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbslowbc@nus.edu.sg	Gupta, Anjali/HCH-5986-2022; Low, Boon Chuan/H-8049-2012; Low, Boon Chuan/AAU-7685-2021	Low, Boon Chuan/0000-0003-0756-096X; Low, Boon Chuan/0000-0003-0756-096X; Hortsch, Michael/0000-0002-3750-737X; Zhou, Yi-Ting/0000-0003-4543-3099	Ministry of Education [T208A3121]; Mechanobiology Institute; National Research Foundation; Ministry of Education, Singapore	Ministry of Education; Mechanobiology Institute; National Research Foundation; Ministry of Education, Singapore(Ministry of Education, Singapore)	This project was funded in part by the Ministry of Education Tier 2 Grant (T208A3121) and the Mechanobiology Institute, co-funded by National Research Foundation and the Ministry of Education, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 1999, CURR BIOL, V9, pR195, DOI 10.1016/S0960-9822(99)80127-4; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Berken A, 2008, PLANT PHYSIOL BIOCH, V46, P380, DOI 10.1016/j.plaphy.2007.12.008; Bomar JM, 2003, NAT GENET, V35, P264, DOI 10.1038/ng1255; Buschdorf JP, 2006, J CELL SCI, V119, P3337, DOI 10.1242/jcs.03061; Buschdorf JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002686; Cavalier L, 1998, AM J HUM GENET, V62, P301, DOI 10.1086/301699; Chivian D, 2005, PROTEINS, V61, P157, DOI 10.1002/prot.20733; Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; D'Angelo I, 2006, EMBO REP, V7, P174, DOI 10.1038/sj.embor.7400602; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fedorov A, 2003, GENOME RES, V13, P1155, DOI 10.1101/gr.1008203; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; GU MX, 1991, P NATL ACAD SCI USA, V88, P5867, DOI 10.1073/pnas.88.13.5867; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; He XQ, 2009, P NATL ACAD SCI USA, V106, P18545, DOI 10.1073/pnas.0907454106; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hwang JU, 2008, CURR BIOL, V18, P1907, DOI 10.1016/j.cub.2008.11.057; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim DE, 2005, PROTEINS, V61, P193, DOI 10.1002/prot.20737; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2006, BIOINFORMATICS; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Low BC, 2000, J BIOL CHEM, V275, P14415, DOI 10.1074/jbc.275.19.14415; Low BC, 2000, J BIOL CHEM, V275, P37742, DOI 10.1074/jbc.M004897200; Lua BL, 2004, BIOCHEM SOC T, V32, P1110, DOI 10.1042/BST0321110; Lua BL, 2005, J CELL SCI, V118, P2707, DOI 10.1242/jcs.02383; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Min KC, 2003, P NATL ACAD SCI USA, V100, P14713, DOI 10.1073/pnas.2136684100; Mousley CJ, 2007, BBA-MOL CELL BIOL L, V1771, P727, DOI 10.1016/j.bbalip.2007.04.002; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Panagabko C, 2003, BIOCHEMISTRY-US, V42, P6467, DOI 10.1021/bi034086v; Phillips SE, 1999, MOL CELL, V4, P187, DOI 10.1016/S1097-2765(00)80366-4; Pirone DM, 2001, TRENDS GENET, V17, P370, DOI 10.1016/S0168-9525(01)02311-3; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qiu WG, 2004, MOL BIOL EVOL, V21, P1252, DOI 10.1093/molbev/msh120; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ryan MM, 2007, MOL BIOL CELL, V18, P1928, DOI 10.1091/mbc.E06-11-1024; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaaf G, 2008, MOL CELL, V29, P191, DOI 10.1016/j.molcel.2007.11.026; Schaefer A, 2011, BIOPOLYMERS, V95, P420, DOI 10.1002/bip.21601; Scott GB, 2010, BIOCHEM J, V431, P423, DOI 10.1042/BJ20091073; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; Shang X, 2003, J BIOL CHEM, V278, P45903, DOI 10.1074/jbc.M304514200; Soh UJK, 2008, J CELL SCI, V121, P1739, DOI 10.1242/jcs.021774; Stocker A, 2003, J MOL BIOL, V332, P759, DOI 10.1016/S0022-2836(03)00924-0; TASSABEHJI M, 1993, AM J HUM GENET, V53, P90; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Valencia CA, 2007, BIOCHEM BIOPH RES CO, V364, P495, DOI 10.1016/j.bbrc.2007.10.018; Wagner GP, 2003, P NATL ACAD SCI USA, V100, P14603, DOI 10.1073/pnas.2536656100; Welti S, 2011, HUM MUTAT, V32, P191, DOI 10.1002/humu.21405; Wu G, 2001, PLANT CELL, V13, P2841, DOI 10.1105/tpc.13.12.2841; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhou Yi Ting, 2005, Experimental Cell Research, V303, P263, DOI 10.1016/j.yexcr.2004.08.044; Zhou YT, 2010, MOL BIOL CELL, V21, P3232, DOI 10.1091/mbc.E09-05-0408; Zhou YT, 2006, ONCOGENE, V25, P2393, DOI 10.1038/sj.onc.1209274; Zhou YT, 2002, J BIOL CHEM, V277, P7483, DOI 10.1074/jbc.M109459200	64	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33863	10.1371/journal.pone.0033863	http://dx.doi.org/10.1371/journal.pone.0033863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479462	gold, Green Published, Green Submitted			2022-12-27	WOS:000303894900044
J	Nie, W; Li, B; Xiu, QY				Nie, Wei; Li, Bing; Xiu, Qing-yu			The-675 4G/5G Polymorphism in Plasminogen Activator Inhibitor-1 Gene Is Associated with Risk of Asthma: A Meta-Analysis	PLOS ONE			English	Article							PAI-1; EXPRESSION; MODEL; BIAS	Background: A number of studies assessed the association of -675 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor (PAI)-1 gene with asthma in different populations. However, most studies reported inconclusive results. A meta-analysis was conducted to investigate the association between polymorphism in the PAI-1 gene and asthma susceptibility. Methods: Databases including Pubmed, EMBASE, HuGE Literature Finder, Wanfang Database, China National Knowledge Infrastructure (CNKI) and Weipu Database were searched to find relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of association in the dominant model, recessive model, codominant model, and additive model. Results: Eight studies involving 1817 cases and 2327 controls were included. Overall, significant association between 4G/5G polymorphism and asthma susceptibility was observed for 4G4G + 4G5G vs. 5G5G (OR = 1.56, 95% CI 1.12-2.18, P = 0.008), 4G/4G vs. 4G/5G + 5G/5G (OR = 1.38, 95% CI 1.06-1.80, P = 0.02), 4G/4G vs. 5G/5G (OR = 1.80, 95% CI 1.17-2.76, P = 0.007), 4G/5G vs. 5G/5G (OR = 1.40, 95% CI 1.07-1.84, P = 0.02), and 4G vs. 5G (OR = 1.35, 95% CI 1.08-1.68, P = 0.008). Conclusions: This meta-analysis suggested that the -675 4G/5G polymorphism of PAI-1 gene was a risk factor of asthma.	[Nie, Wei; Li, Bing; Xiu, Qing-yu] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Resp Dis, Shanghai, Peoples R China	Naval Medical University	Nie, W (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Resp Dis, Shanghai, Peoples R China.	xiu_qingyu@126.com			National Natural Science Foundation of China [81170025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants NO. 81170025 from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Buckova D, 2002, ALLERGY, V57, P446; Cho SH, 2001, J ALLERGY CLIN IMMUN, V108, P212, DOI 10.1067/mai.2001.117260; Cosan D, 2009, GENET TEST MOL BIOMA, V13, P543, DOI 10.1089/gtmb.2009.0036; Dijkstra A, 2011, EUR RESPIR J, V38, P1036, DOI 10.1183/09031936.00182410; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ERIKSSON P, 1995, P NATL ACAD SCI USA, V92, P1851, DOI 10.1073/pnas.92.6.1851; Festa A, 2003, CIRCULATION, V107, P2422, DOI 10.1161/01.CIR.0000066908.82782.3A; Hizawa N, 2006, CLIN EXP ALLERGY, V36, P872, DOI 10.1111/j.1365-2222.2006.02413.x; Kelly MM, 2005, AM J RESP CELL MOL, V32, P99, DOI 10.1165/rcmb.2004-0190OC; Koppelman GH, 2006, CURR ALLERGY ASTHM R, V6, P103, DOI 10.1007/s11882-006-0047-y; Kowal K, 2008, J INVEST ALLERG CLIN, V18, P284; Kowal K, 2007, INT ARCH ALLERGY IMM, V144, P240, DOI 10.1159/000103998; Ma Z, 2009, CLIN EXP ALLERGY, V39, P1136, DOI 10.1111/j.1365-2222.2009.03272.x; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Mukherjee AB, 2011, J BIOL CHEM, V286, P32883, DOI 10.1074/jbc.R110.197046; Murphy DM, 2010, CHEST, V137, P1417, DOI 10.1378/chest.09-1895; Oh CK, 2002, BIOCHEM BIOPH RES CO, V294, P1155, DOI 10.1016/S0006-291X(02)00577-6; Ozbek OY, 2009, ALLERGY ASTHMA PROC, V30, P41, DOI 10.2500/aap.2009.30.3183; Pampuch A, 2006, ALLERGY, V61, P234, DOI 10.1111/j.1398-9995.2005.00948.x; Salanti G, 2005, GENET MED, V7, P13, DOI 10.1097/01.GIM.0000151839.12032.1A; Savov JD, 2003, AM J PHYSIOL-LUNG C, V285, pL940, DOI 10.1152/ajplung.00102.2003; Sejima T, 2005, J IMMUNOL, V174, P8135, DOI 10.4049/jimmunol.174.12.8135; Xu JF, 2000, AM J HUM GENET, V67, P1163, DOI 10.1086/321190; Zhang XP, 2009, INFLAMMATION, V32, P1, DOI 10.1007/s10753-008-9096-9	25	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34385	10.1371/journal.pone.0034385	http://dx.doi.org/10.1371/journal.pone.0034385			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479620	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900088
J	Friman, T; Gustafsson, R; Stuhr, LB; Chidiac, J; Heldin, NE; Reed, RK; Oldberg, A; Rubin, K				Friman, Tomas; Gustafsson, Renata; Stuhr, Linda B.; Chidiac, Jean; Heldin, Nils-Erik; Reed, Rolf K.; Oldberg, Ake; Rubin, Kristofer			Increased Fibrosis and Interstitial Fluid Pressure in Two Different Types of Syngeneic Murine Carcinoma Grown in Integrin beta 3-Subunit Deficient Mice	PLOS ONE			English	Article							COLLAGEN GEL CONTRACTION; TUMOR MICROENVIRONMENT; RAT DERMIS; FACTOR-BB; INHIBITION; NORMALIZATION; RECEPTORS; ANGIOGENESIS; CHEMOTHERAPY; VASCULATURE	Stroma properties affect carcinoma physiology and direct malignant cell development. Here we present data showing that alpha(V)beta(3) expressed by stromal cells is involved in the control of interstitial fluid pressure (IFP), extracellular volume (ECV) and collagen scaffold architecture in experimental murine carcinoma. IFP was elevated and ECV lowered in syngeneic CT26 colon and LM3 mammary carcinomas grown in integrin beta(3)-deficient compared to wild-type BALB/ c mice. Integrin beta(3)-deficiency had no effect on carcinoma growth rate or on vascular morphology and function. Analyses by electron microscopy of carcinomas from integrin beta(3)-deficient mice revealed a coarser and denser collagen network compared to carcinomas in wild-type littermates. Collagen fibers were built from heterogeneous and thicker collagen fibrils in carcinomas from integrin beta(3)-deficient mice. The fibrotic extracellular matrix (ECM) did not correlate with increased macrophage infiltration in integrin beta(3)-deficient mice bearing CT26 tumors, indicating that the fibrotic phenotype was not mediated by increased inflammation. In conclusion, we report that integrin beta(3)-deficiency in tumor stroma led to an elevated IFP and lowered ECV that correlated with a more fibrotic ECM, underlining the role of the collagen network for carcinoma physiology.	[Friman, Tomas; Gustafsson, Renata; Chidiac, Jean; Rubin, Kristofer] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Gustafsson, Renata; Oldberg, Ake] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Stuhr, Linda B.; Reed, Rolf K.] Univ Bergen, Dept Biomed, Bergen, Norway; [Heldin, Nils-Erik] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Uppsala University; Lund University; University of Bergen; Uppsala University	Friman, T (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	Kristofer.Rubin@imbim.uu.se	Reed, Rolf K./B-9422-2017; Rubin, Kristofer/AAC-1810-2020	Reed, Rolf K./0000-0002-2633-6595; Rubin, Kristofer/0000-0003-2789-6276	Swedish Cancer Society [10 0620]; Swedish Science Council [2009-66X-20030-04-03, K2011-X-7478-01-6]; Kocks Foundation; Alfred Osterlunds Foundation; Research Council of Norway [200878]	Swedish Cancer Society(Swedish Cancer Society); Swedish Science Council; Kocks Foundation; Alfred Osterlunds Foundation; Research Council of Norway(Research Council of Norway)	Funding was provided by the Swedish Cancer Society (to KR, project # 10 0620; http://www.cancerfonden.se/), the Swedish Science Council (to KR, project # 2009-66X-20030-04-03, and to AO, project # K2011-X-7478-01-6; http://www.vr.se/), the Kocks Foundation (to AO), the Alfred Osterlunds Foundation (to AO; http://www.med.lu.se/labmedmalmo/klinisk_bakteriologi/alfred_oesterlunds_stiftelse, http://www.kockskastiftelsen.se/), and the Research Council of Norway (to KRK, 200878; http://www.forskningsradet.no/en/Home_page/1177315753906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry-Hamilton V, 2010, NAT MED, V16, P1009, DOI 10.1038/nm.2208; BERG RA, 1982, METHOD ENZYMOL, V82, P372; BROWN LF, 1994, AM J PATHOL, V145, P610; Diop-Frimpong B, 2011, P NATL ACAD SCI USA, V108, P2909, DOI 10.1073/pnas.1018892108; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Emerich DF, 2001, J PHARMACOL EXP THER, V296, P623; Fukumoto Y, 2004, CIRCULATION, V110, P1953, DOI 10.1161/01.CIR.0000143174.41810.10; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Heuchel R, 1999, P NATL ACAD SCI USA, V96, P11410, DOI 10.1073/pnas.96.20.11410; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Hynes RO, 2002, COLD SPRING HARB SYM, V67, P143, DOI 10.1101/sqb.2002.67.143; Jain RK, 1996, SCIENCE, V271, P1079, DOI 10.1126/science.271.5252.1079; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jin HY, 2004, RESP MED, V98, P115, DOI 10.1016/j.rmed.2003.09.002; Klosowska-Wardega A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008149; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liden A, 2006, CIRC RES, V98, P635, DOI 10.1161/01.RES.0000207393.67851.d4; Liden A, 2006, BIOCHEM BIOPH RES CO, V340, P604, DOI 10.1016/j.bbrc.2005.12.043; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lunt SJ, 2009, CLIN EXP METASTAS, V26, P19, DOI 10.1007/s10585-008-9182-2; Nedrebo T, 2004, J PHYSIOL-LONDON, V559, P583, DOI 10.1113/jphysiol.2004.067751; OHTANI O, 1988, ARCH HISTOL CYTOL, V51, P249, DOI 10.1679/aohc.51.249; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Ozerdem Ugur, 2003, Angiogenesis, V6, P241, DOI 10.1023/B:AGEN.0000021401.58039.a9; Pietras K, 2002, CANCER RES, V62, P5476; Pietras K, 2001, CANCER RES, V61, P2929; Reed RK, 2010, J MOL CELL CARDIOL, V48, P518, DOI 10.1016/j.yjmcc.2009.06.023; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Rodt SA, 1996, J PHYSIOL-LONDON, V495, P193, DOI 10.1113/jphysiol.1996.sp021584; Rubin K, 2000, INT J CANCER, V86, P636, DOI 10.1002/(SICI)1097-0215(20000601)86:5<636::AID-IJC6>3.0.CO;2-R; Salnikov AV, 2006, INT J CANCER, V119, P2795, DOI 10.1002/ijc.22217; Salnikov AV, 2005, LAB INVEST, V85, P512, DOI 10.1038/labinvest.3700252; Salnikov AV, 2003, FASEB J, V17, P1756, DOI 10.1096/fj.02-1201fje; Starling E H, 1896, J Physiol, V19, P312; SUNDBERG C, 1993, AM J PATHOL, V143, P1377; Svendsen OS, 2008, AM J PHYSIOL-HEART C, V295, pH555, DOI 10.1152/ajpheart.00161.2008; Taverna D, 2005, CANCER RES, V65, P10324, DOI 10.1158/0008-5472.CAN-04-4098; Taverna D, 2004, P NATL ACAD SCI USA, V101, P763, DOI 10.1073/pnas.0307289101; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Tredan O, 2007, J NATL CANCER I, V99, P1441, DOI 10.1093/jnci/djm135; Urtreger AJ, 1997, INT J ONCOL, V11, P489; Varner Judith A., 1996, P69	47	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34082	10.1371/journal.pone.0034082	http://dx.doi.org/10.1371/journal.pone.0034082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479530	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100116
J	Irion, U				Irion, Uwe			Drosophila muscleblind Codes for Proteins with One and Two Tandem Zinc Finger Motifs	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY; GENE; RNA; MODEL; MBNL1; IDENTIFICATION; LOCALIZATION; EXPRESSION; TOXICITY	Muscleblind-like proteins, Muscleblind (Mbl) in Drosophila and MBNL1-3 in vertebrates, are regulators of alternative splicing. Human MBNL1 is a key factor in the etiology of myotonic dystrophy (DM), a muscle wasting disease caused by the occurrence of toxic RNA molecules containing CUG/CCUG repeats. MBNL1 binds to these RNAs and is sequestered in nuclear foci preventing it from exerting its normal function, which ultimately leads to mis-spliced mRNAs, a major cause of the disease. Muscleblind-proteins bind to RNAs via N-terminal zinc fingers of the Cys3-His type. These zinc fingers are arranged in one (invertebrates) or two (vertebrates) tandem zinc finger (TZF) motifs with both fingers targeting GC steps in the RNA molecule. Here I show that mbl genes in Drosophila and in other insects also encode proteins with two TZF motifs, highly similar to vertebrate MBNL proteins. In Drosophila the different protein isoforms have overlapping but possibly divergent functions in vivo, evident by their unequal capacities to rescue the splicing defects observed in mbl mutant embryos. In addition, using whole transcriptome analysis, I identified several new splicing targets for Mbl in Drosophila embryos. Two of these novel targets, kkv (krotzkopf-verkehrt, coding for Chitin Synthase 1) and cora (coracle, coding for the Drosophila homolog of Protein 4.1), are not muscle-specific but expressed mainly in epidermal cells, indicating a function for mbl not only in muscles and the nervous system.	Max Planck Inst Dev Biol, Tubingen, Germany	Max Planck Society	Irion, U (corresponding author), Max Planck Inst Dev Biol, Tubingen, Germany.	uwe.irion@tuebingen.mpg.de	Irion, Uwe/ABC-8635-2020	Irion, Uwe/0000-0003-2823-5840				Adereth Y, 2005, NAT CELL BIOL, V7, P1240, DOI 10.1038/ncb1335; Artero R, 1998, DEV BIOL, V195, P131, DOI 10.1006/dbio.1997.8833; BEALL CJ, 1991, J CELL BIOL, V114, P941, DOI 10.1083/jcb.114.5.941; Begemann G, 1997, DEVELOPMENT, V124, P4321; Benoist P, 1998, J BIOL CHEM, V273, P7538, DOI 10.1074/jbc.273.13.7538; Burnette JM, 2005, GENETICS, V170, P661, DOI 10.1534/genetics.104.039701; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Cho DH, 2007, BBA-MOL BASIS DIS, V1772, P195, DOI 10.1016/j.bbadis.2006.05.013; de Haro M, 2006, HUM MOL GENET, V15, P2138, DOI 10.1093/hmg/ddl137; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; FEHON RG, 1994, DEVELOPMENT, V120, P545; Fernandez-Costa JM, 2011, BIOL REV, V86, P947, DOI 10.1111/j.1469-185X.2011.00180.x; Fernandez-Costa JM, 2010, MOL CELLS, V30, P65, DOI 10.1007/s10059-010-0089-9; Garcia-Lopez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001595; Goers ES, 2008, BIOCHEMISTRY-US, V47, P7284, DOI 10.1021/bi702252d; Goers ES, 2010, NUCLEIC ACIDS RES, V38, P2467, DOI 10.1093/nar/gkp1209; Grammatikakis I, 2011, NUCLEIC ACIDS RES, V39, P2769, DOI 10.1093/nar/gkq1155; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Machuca-Tzili L, 2006, HUM GENET, V120, P487, DOI 10.1007/s00439-006-0228-8; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Monferrer L, 2006, J HERED, V97, P67, DOI 10.1093/jhered/esj003; Mooers BHM, 2005, P NATL ACAD SCI USA, V102, P16626, DOI 10.1073/pnas.0505873102; Osborne RJ, 2006, HUM MOL GENET, V15, pR162, DOI 10.1093/hmg/ddl181; Ostrowski S, 2002, GENETICS, V161, P171; Qiu F, 2005, J CELL SCI, V118, P1527, DOI 10.1242/jcs.02281; Sasagawa N, 2009, J NEUROSCI RES, V87, P1090, DOI 10.1002/jnr.21942; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Vicente-Crespo M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001613; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	34	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34248	10.1371/journal.pone.0034248	http://dx.doi.org/10.1371/journal.pone.0034248			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479576	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400064
J	Saied, MH; Marzec, J; Khalid, S; Smith, P; Down, TA; Rakyan, VK; Molloy, G; Raghavan, M; Debernardi, S; Young, BD				Saied, Marwa H.; Marzec, Jacek; Khalid, Sabah; Smith, Paul; Down, Thomas A.; Rakyan, Vardhman K.; Molloy, Gael; Raghavan, Manoj; Debernardi, Silvana; Young, Bryan D.			Genome Wide Analysis of Acute Myeloid Leukemia Reveal Leukemia Specific Methylome and Subtype Specific Hypomethylation of Repeats	PLOS ONE			English	Article							DNA METHYLATION ANALYSIS; CELL-LINE; ALTERNATIVE PROMOTERS; NORMALIZATION METHODS; PROFILING REVEALS; PROTEIN-KINASE; HUMAN-DISEASES; STEM-CELLS; CANCER; EXPRESSION	Methylated DNA immunoprecipitation followed by high-throughput sequencing (MeDIP-seq) has the potential to identify changes in DNA methylation important in cancer development. In order to understand the role of epigenetic modulation in the development of acute myeloid leukemia (AML) we have applied MeDIP-seq to the DNA of 12 AML patients and 4 normal bone marrows. This analysis revealed leukemia-associated differentially methylated regions that included gene promoters, gene bodies, CpG islands and CpG island shores. Two genes (SPHKAP and DPP6) with significantly methylated promoters were of interest and further analysis of their expression showed them to be repressed in AML. We also demonstrated considerable cytogenetic subtype specificity in the methylomes affecting different genomic features. Significantly distinct patterns of hypomethylation of certain interspersed repeat elements were associated with cytogenetic subtypes. The methylation patterns of members of the SINE family tightly clustered all leukemic patients with an enrichment of Alu repeats with a high CpG density (P<0.0001). We were able to demonstrate significant inverse correlation between intragenic interspersed repeat sequence methylation and gene expression with SINEs showing the strongest inverse correlation (R-2 = 0.7). We conclude that the alterations in DNA methylation that accompany the development of AML affect not only the promoters, but also the non-promoter genomic features, with significant demethylation of certain interspersed repeat DNA elements being associated with AML cytogenetic subtypes. MeDIP-seq data were validated using bisulfite pyrosequencing and the Infinium array.	[Saied, Marwa H.; Marzec, Jacek; Khalid, Sabah; Smith, Paul; Molloy, Gael; Raghavan, Manoj; Debernardi, Silvana; Young, Bryan D.] Queen Mary Univ, Barts & London Sch Med, Barts Canc Inst, Ctr Haematooncol, London, England; [Down, Thomas A.] Univ Cambridge, Dept Genet, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 3EH, England; [Rakyan, Vardhman K.] Queen Mary Univ London, Sch Med, Inst Cell & Mol Sci, London, England; [Saied, Marwa H.] Univ Alexandria, Fac Med, Dept Clin Pathol, Alexandria, Egypt	University of London; Queen Mary University London; University of Cambridge; University of London; Queen Mary University London; Egyptian Knowledge Bank (EKB); Alexandria University	Saied, MH (corresponding author), Queen Mary Univ, Barts & London Sch Med, Barts Canc Inst, Ctr Haematooncol, London, England.	b.d.young@qmul.ac.uk	Molloy, Gerard J/C-5721-2008	Molloy, Gerard J/0000-0002-7718-9898; Marzec, Jacek/0000-0001-6577-8866; Raghavan, Manoj/0000-0002-5464-2602	Cancer Research UK programme [C6277/A6789]	Cancer Research UK programme(Cancer Research UK)	This work was supported by Cancer Research UK programme grant number C6277/A6789. Cancer Research UK website: http://www.cancerresearchuk.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Nabi AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012464; Agrawal S, 2007, CANCER RES, V67, P1370, DOI 10.1158/0008-5472.CAN-06-1681; Barbacioru CC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-533; BARGOU RC, 1993, J EXP MED, V177, P1257, DOI 10.1084/jem.177.5.1257; Beck S, 2008, TRENDS GENET, V24, P231, DOI 10.1016/j.tig.2008.01.006; Bennett LB, 2009, GENE CHROMOSOME CANC, V48, P828, DOI 10.1002/gcc.20687; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chavez L, 2010, GENOME RES, V20, P1441, DOI 10.1101/gr.110114.110; Choi SH, 2009, INT J CANCER, V125, P723, DOI 10.1002/ijc.24384; Debernardi S, 2003, GENE CHROMOSOME CANC, V37, P149, DOI 10.1002/gcc.10198; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Feber A, 2011, GENOME RES; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Flanagan James M, 2007, Genome Biol, V8, P307, DOI 10.1186/gb-2007-8-6-307; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; HIROSE M, 1982, GANN, V73, P735; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Holt KE, 2009, BIOINFORMATICS, V25, P2074, DOI 10.1093/bioinformatics/btp344; Hsu MY, 2002, DIFFERENTIATION, V70, P522, DOI 10.1046/j.1432-0436.2002.700906.x; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jaeger J, 2007, CLIN CANCER RES, V13, P806, DOI 10.1158/1078-0432.CCR-06-1820; Kakuda H, 1996, BRIT J HAEMATOL, V95, P306, DOI 10.1046/j.1365-2141.1996.d01-1909.x; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Kilbey A, 2010, CANCER RES, V70, P5860, DOI 10.1158/0008-5472.CAN-10-0726; Kim JH, 2011, GENOME RES, V21, P1028, DOI 10.1101/gr.119347.110; Kirwan M, 2009, HUM MUTAT, V30, P1567, DOI 10.1002/humu.21115; Koga Y, 2009, GENOME RES, V19, P1462, DOI 10.1101/gr.091447.109; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; Lacana E, 2002, J BIOL CHEM, V277, P32947, DOI 10.1074/jbc.M202841200; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JY, 2008, NUCLEIC ACIDS RES, V36, P5581, DOI 10.1093/nar/gkn540; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Mansour A, 2007, J CELL MOL BIOL, V6, P99; Marcucci G, 2011, J CLIN ONCOL, V29, P475, DOI 10.1200/JCO.2010.30.2554; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Meyer C, 2009, LEUKEMIA, V23, P1490, DOI 10.1038/leu.2009.33; Pai AA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001316; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; QIAN JH, 1994, J IMMUNOL, V152, P4183; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; REHFELDT W, 1991, BIOCHEM J, V276, P631, DOI 10.1042/bj2760631; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Roman-Gomez J, 2005, ONCOGENE, V24, P7213, DOI 10.1038/sj.onc.1208866; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243; Tong Wei-Gang, 2010, Epigenetics, V5, P499; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Van der Auwera I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012616; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Virtaneva K, 2001, P NATL ACAD SCI USA, V98, P1124, DOI 10.1073/pnas.98.3.1124; Voelkerding KV, 2009, CLIN CHEM, V55, P641, DOI 10.1373/clinchem.2008.112789; von Bubnoff A, 2008, CELL, V132, P721, DOI 10.1016/j.cell.2008.02.028; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; WINTER JN, 1984, BLOOD, V63, P140; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521	71	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33213	10.1371/journal.pone.0033213	http://dx.doi.org/10.1371/journal.pone.0033213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479372	gold, Green Published, Green Submitted			2022-12-27	WOS:000304523400015
J	Fang, L; Lin, JF; Chai, CL; Yu, Z				Fang, Le; Lin, Junfen; Chai, Chengliang; Yu, Zhao			Risk Factors for Severe Cases of 2009 Influenza A (H1N1): A Case Control Study in Zhejiang Province, China	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ADULT PATIENTS; INFECTION; A(H1N1); MEXICO; FEATURES; VIRUS; WOMEN; 1ST	Few case control studies were conducted to explore risk factors for severe cases of 2009 influenza A (H1N1) with the mild cases as controls. Mild and severe cases of 2009 influenza A (H1N1), 230 cases each, were randomly selected from nine cities in Zhejiang Province, China, and unmatched case control study was conducted. This study found that it averagely took 5 days for the severe cases of 2009 influenza A (H1N1) to start antiviral therapy away from onset, 2 days later than mild cases. Having chronic underlying diseases and bad psychological health combined with chronic underlying diseases were two important risk factors for severe cases, and their OR values were 2.39 and 5.85 respectively. Timely anti-viral therapy was a protective factor for severe cases (OR = 0.35, 95% CI: [0.18-0.67]). In conclusion, psychological health education and intervention, as well as timely anti-viral therapy, could not be ignored in the prevention, control and treatment of 2009 influenza A (H1N1).	[Fang, Le; Lin, Junfen; Chai, Chengliang; Yu, Zhao] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Fang, L (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	lefangchina@yeah.net			Zhejiang Health Bureau [2010KYB030]	Zhejiang Health Bureau	This study was supported by grants from the Health Science Research Fund of Zhejiang Health Bureau (2010KYB030). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Enstone JE, 2011, EMERG INFECT DIS, V17, P592, DOI 10.3201/eid1704.101679; Erlewyn-Lajeunesse M, 2011, CLIN EXP ALLERGY, V41, P1367, DOI 10.1111/j.1365-2222.2011.03842.x; Falagas ME, 2011, EPIDEMIOL INFECT, V139, P27, DOI 10.1017/S0950268810002037; Gagne C, 2010, H1N1 SWINE FLU FOOD; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gautret P, 2010, LANCET, V375, P199, DOI 10.1016/S0140-6736(10)60093-1; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lenzi L, 2012, CAD SAUDE PUBLICA, V28, P395, DOI 10.1590/S0102-311X2012000200018; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Lucas S, 2010, HEALTH TECHNOL ASSES, V14, P83, DOI 10.3310/hta14550-02; McLean E, 2010, EPIDEMIOL INFECT, V138, P1531, DOI 10.1017/S0950268810001366; Ministry of Health of China, 2010, GLOBAL TRADITIONAL C, V3, P28; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Oh WS, 2011, J KOREAN MED SCI, V26, P499, DOI 10.3346/jkms.2011.26.4.499; World Health Organization, 2010, WHO IS MOR RISK SEV; World Health Organization, 2010, PAND H1N1 2009 UPD 1; Xi XM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-256	22	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34365	10.1371/journal.pone.0034365	http://dx.doi.org/10.1371/journal.pone.0034365			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470561	Green Submitted, gold, Green Published			2022-12-27	WOS:000304489000100
J	Attique, M; Gilanie, G; Hafeez-Ullah; Mehmood, MS; Naweed, MS; Ikram, M; Kamran, JA; Vitkin, A				Attique, Muhammad; Gilanie, Ghulam; Hafeez-Ullah; Mehmood, Malik S.; Naweed, Muhammad S.; Ikram, Masroor; Kamran, Javed A.; Vitkin, Alex			Colorization and Automated Segmentation of Human T2 MR Brain Images for Characterization of Soft Tissues	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY	Characterization of tissues like brain by using magnetic resonance (MR) images and colorization of the gray scale image has been reported in the literature, along with the advantages and drawbacks. Here, we present two independent methods; (i) a novel colorization method to underscore the variability in brain MR images, indicative of the underlying physical density of bio tissue, (ii) a segmentation method (both hard and soft segmentation) to characterize gray brain MR images. The segmented images are then transformed into color using the above-mentioned colorization method, yielding promising results for manual tracing. Our color transformation incorporates the voxel classification by matching the luminance of voxels of the source MR image and provided color image by measuring the distance between them. The segmentation method is based on single-phase clustering for 2D and 3D image segmentation with a new auto centroid selection method, which divides the image into three distinct regions (gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF) using prior anatomical knowledge). Results have been successfully validated on human T2-weighted (T2) brain MR images. The proposed method can be potentially applied to gray-scale images from other imaging modalities, in bringing out additional diagnostic tissue information contained in the colorized image processing approach as described.	[Attique, Muhammad; Gilanie, Ghulam; Naweed, Muhammad S.] Islamia Univ Bahawalpur, Dept Comp Sci & Informat Technol, Bahawalpur, Punjab, Pakistan; [Hafeez-Ullah; Mehmood, Malik S.; Ikram, Masroor] Pakistan Inst Engn & Appl Sci, Dept Phys & Appl Math, Islamabad, Pakistan; [Kamran, Javed A.] Bahawal Victoria Hosp, Dept Radiol & Diagnost Images, Bahawalpur, Pakistan; [Vitkin, Alex] Univ Toronto, Dept Med Biophys & Radiat Oncol, Toronto, ON, Canada; [Vitkin, Alex] Univ Hlth Network, Ontario Canc Inst, Div Biophys & Bioimaging, Toronto, ON, Canada	Islamia University of Bahawalpur; Pakistan Institute of Engineering & Applied Science; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Attique, M (corresponding author), Islamia Univ Bahawalpur, Dept Comp Sci & Informat Technol, Bahawalpur, Punjab, Pakistan.	hafeezullah79@gmail.com	Vitkin, Alex/C-8123-2016; Mehmood, Malik Sajjad/E-5729-2015; Attique, Muhammad/I-9429-2019; Ikram, Masroor/G-9117-2011; Vitkin, Alex/I-8166-2012	Mehmood, Malik Sajjad/0000-0002-5026-8203; Attique, Muhammad/0000-0002-6199-5238; Vitkin, Alex/0000-0001-5495-8888; Attique, Muhammad/0000-0001-8973-2993; Gilanie, Ghulam/0000-0001-6880-8506				Ahmed MM, 2008, INT J IMAGE PROCESS, V2, P27; Ajmal H, 2011, CANADIAN J MED, V2; Bauer CM, 2010, NEUROIMAGE, V52, P508, DOI 10.1016/j.neuroimage.2010.04.255; Bochko V, 2010, C COL GRAPH IM VIS, V5, P70; Celebi ME, 2010, IEEE IMAGE PROC, P1349, DOI 10.1109/ICIP.2010.5653124; Chaabane SB, 2009, EURASIP J ADV SIG PR, P1; dos Anjos A, 2008, BIOSIGNALS 2008: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON BIO-INSPIRED SYSTEMS AND SIGNAL PROCESSING, VOL II, P70; Hafeez-Ullah, 2011, OPT SPECTROSC+, V110, P313, DOI 10.1134/S0030400X11020093; Heckbert P., 1982, Computer Graphics, V16, P297, DOI 10.1145/965145.801294; HOLLAND GN, 1977, J PHYS E SCI INSTRUM, V10, P714, DOI 10.1088/0022-3735/10/7/014; Horiuchi T, 2006, IEICE T INF SYST, VE89D, P1231, DOI 10.1093/ietisy/e89-d.3.1231; Ilea D., 2006, P IRISH MACH VIS IMA, P146; Imperati D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023437; Jacob VG, 2009, IEEE IMAGE PROC, P1653, DOI 10.1109/ICIP.2009.5413392; Kanungo P., 2007, ELECT LETT COMPUTER, V6, P42; Krstinic D., 2009, IMAGE P IET, V5, P63; Lei M, 2009, AUTOMATED THICKNESS, P247; Murgasova M, 2007, ACAD RADIOL, V14, P1350, DOI 10.1016/j.acra.2007.07.020; Ongur D, 2010, MAGN RESON MED, V63, P1, DOI 10.1002/mrm.22148; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Panning A., 2009, P WORLD ACAD SCI ENG, V56, P779; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Pham DL, 2000, ANNU REV BIOMED ENG, V2, P315, DOI 10.1146/annurev.bioeng.2.1.315; Plataniotis K., 2000, DIGITAL SIGNAL PROC, DOI 10.0017/978-3-662-04186-4; Rai H, 2009, INTERJRI COMPUT SCI, V1, P1; Rathore Y., 2010, INT J ELECT COMMUN T, V1, P16; Rehman A., 2009, PROFESSIONAL MED J, V16, P579; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Ryan AG, 2004, BRIT J RADIOL, V77, P189, DOI 10.1259/bjr/97837637; Sauvaget C., 2010, Proceedings of the Sixth International Conference on Signal-Image Technology & Internet-Based Systems (SITIS 2010), P153, DOI 10.1109/SITIS.2010.35; Sharma N, 2010, J MED PHYS, V35, P3, DOI 10.4103/0971-6203.58777; Ullah H, 2011, LASER PHYS, V21, P1962, DOI 10.1134/S1054660X11190285; Ullah H, 2010, LASER PHYS LETT, V7, P889, DOI 10.1002/lapl.201010079; Hernandez MDV, 2010, EUR RADIOL, V20, P1684, DOI 10.1007/s00330-010-1718-6; Valdes Hernandez Mdel C, 2011, MAGNETIC RESONANCE I, V30, P222; Veksler B, 2008, LASER PHYS LETT, V5, P236, DOI 10.1002/lapl.200710116; Vlasova IM, 2006, LASER PHYS LETT, V3, P401, DOI 10.1002/lapl.200610015; Weiss Kenneth L, 2002, Radiographics, V22, pe3; WEISS KL, 1987, AM J ROENTGENOL, V149, P825, DOI 10.2214/ajr.149.4.825; Wu MN, 2007, 2007 THIRD INTERNATIONAL CONFERENCE ON INTELLIGENT INFORMATION HIDING AND MULTIMEDIA SIGNAL PROCESSING, VOL II, PROCEEDINGS, P245; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Barcelos CAZ, 2009, IEEE IMAGE PROC, P4049, DOI 10.1109/ICIP.2009.5413725	44	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33616	10.1371/journal.pone.0033616	http://dx.doi.org/10.1371/journal.pone.0033616			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479421	Green Published, gold			2022-12-27	WOS:000303894900034
J	Cho, SY; Jeong, HW; Sohn, JH; Seo, DB; Kim, WG; Lee, SJ				Cho, Si Young; Jeong, Hyun Woo; Sohn, Jong Hee; Seo, Dae-Bang; Kim, Wan Gi; Lee, Sang-Jun			An Ethanol Extract of Artemisia iwayomogi Activates PPAR delta Leading to Activation of Fatty Acid Oxidation in Skeletal Muscle	PLOS ONE			English	Article							GLUCOSE-METABOLISM; EXPRESSION; GW501516; AGONIST; OBESITY; BETA	Although Artemisia iwayomogi (AI) has been shown to improve the lipid metabolism, its mode of action is poorly understood. In this study, a 95% ethanol extract of AI (95EEAI) was identified as a potent ligand of peroxisome proliferator-activated receptor delta (PPAR delta) using ligand binding analysis and cell-based reporter assay. In cultured primary human skeletal muscle cells, treatment of 95EEAI increased expression of two important PPAR delta-regulated genes, carnitine palmitoyl-transferase-1 (CPT1) and pyruvate dehydrogenase kinase isozyme 4 (PDK4), and several genes acting in lipid efflux and energy expenditure. Furthermore, 95EEAI stimulated fatty acid oxidation in a PPAR delta-dependent manner. High-fat diet-induced obese mice model further indicated that administration of 95EEAI attenuated diet-induced obesity through the activation of fatty acid oxidation in skeletal muscle. These results suggest that a 95% ethanol extract of AI may have a role as a new functional food material for the prevention and/or treatment of hyperlipidermia and obesity.	[Cho, Si Young; Jeong, Hyun Woo; Sohn, Jong Hee; Seo, Dae-Bang; Kim, Wan Gi; Lee, Sang-Jun] AmorePacific Corp, Ctr Res & Dev, Hlth Sci Res Inst, Yongin, South Korea		Cho, SY (corresponding author), AmorePacific Corp, Ctr Res & Dev, Hlth Sci Res Inst, Yongin, South Korea.	leesjun@amorepacific.com						ALWAILI NSD, 1986, CLIN EXP PHARMACOL P, V13, P569, DOI 10.1111/j.1440-1681.1986.tb00940.x; Brunmair B, 2006, DIABETOLOGIA, V49, P2713, DOI 10.1007/s00125-006-0357-6; Cefalu WT, 2008, AM J CLIN NUTR, V87, p481S, DOI 10.1093/ajcn/87.2.481S; Coll Teresa, 2009, Curr Mol Pharmacol, V2, P46; de Lange P, 2007, FASEB J, V21, P3431, DOI 10.1096/fj.07-8527rev; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Ehrenborg E, 2009, PHARMACOL REV, V61, P373, DOI 10.1124/pr.109.001560; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Hamza N, 2010, J ETHNOPHARMACOL, V128, P513, DOI 10.1016/j.jep.2010.01.004; Jung UJ, 2009, J MED FOOD, V12, P1238, DOI 10.1089/jmf.2009.0039; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Kramer DK, 2005, DIABETES, V54, P1157, DOI 10.2337/diabetes.54.4.1157; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Lee J, 2011, ENDOCRINOLOGY, V152, P1742, DOI 10.1210/en.2011-0211; Lee J, 2008, J ETHNOPHARMACOL, V115, P263, DOI 10.1016/j.jep.2007.09.029; Nam SM, 1998, J KOR SOC FOOD SCI N, V27, P201; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; PALOU A, 1983, COMP BIOCHEM PHYS A, V75, P597, DOI 10.1016/0300-9629(83)90426-7; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Sprecher DL, 2007, ARTERIOSCL THROM VAS, V27, P359, DOI 10.1161/01.ATV.0000252790.70572.0c; Tan RX, 1998, PLANTA MED, V64, P295, DOI 10.1055/s-2006-957438; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Wagner KD, 2010, PHARMACOL THERAPEUT, V125, P423, DOI 10.1016/j.pharmthera.2009.12.001; Wang YX, 2005, PLOS BIOL, V3, P177, DOI 10.1371/journal.pbio.0030061; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Wang ZQ, 2008, METABOLISM, V57, pS58, DOI 10.1016/j.metabol.2008.04.003; Wang ZQ, 2011, J NUTR BIOCHEM, V22, P71, DOI 10.1016/j.jnutbio.2009.11.015; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yamamoto N, 2011, FOOD FUNCT, V2, P45, DOI 10.1039/c0fo00129e; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	30	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33815	10.1371/journal.pone.0033815	http://dx.doi.org/10.1371/journal.pone.0033815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479450	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900039
J	Du, JH; Teng, RJ; Lawrence, M; Guan, TJ; Xu, H; Ge, Y; Shi, Y				Du, Jianhai; Teng, Ru-Jeng; Lawrence, Matt; Guan, Tongju; Xu, Hao; Ge, Ying; Shi, Yang			The Protein Partners of GTP Cyclohydrolase I in Rat Organs	PLOS ONE			English	Article							FEEDBACK REGULATORY PROTEIN; TETRAHYDROBIOPTERIN BIOSYNTHESIS; MESSENGER-RNA; OVEREXPRESSION; DEGRADATION; DEFICIENCY; EXPRESSION; GROWTH; FORMS	Objective: GTP cyclohydrolase I (GCH1) is the rate-limiting enzyme for tetrahydrobiopterin biosynthesis and has been shown to be a promising therapeutic target in ischemic heart disease, hypertension, atherosclerosis and diabetes. The endogenous GCH1-interacting partners have not been identified. Here, we determined endogenous GCH1-interacting proteins in rat. Methods and Results: A pulldown and proteomics approach were used to identify GCH1 interacting proteins in rat liver, brain, heart and kidney. We demonstrated that GCH1 interacts with at least 17 proteins including GTP cyclohydrolase I feedback regulatory protein (GFRP) in rat liver by affinity purification followed by proteomics and validated six protein partners in liver, brain, heart and kidney by immunoblotting. GCH1 interacts with GFRP and very long-chain specific acyl-CoA dehydrogenase in the liver, tubulin beta-2A chain in the liver and brain, DnaJ homolog subfamily A member 1 and fatty aldehyde dehydrogenase in the liver, heart and kidney and eukaryotic translation initiation factor 3 subunit I (EIF3I) in all organs tested. Furthermore, GCH1 associates with mitochondrial proteins and GCH1 itself locates in mitochondria. Conclusion: GCH1 interacts with proteins in an organ dependant manner and EIF3I might be a general regulator of GCH1. Our finding indicates GCH1 might have broader functions beyond tetrahydrobiopterin biosynthesis.	[Du, Jianhai; Guan, Tongju; Xu, Hao; Shi, Yang] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA; [Du, Jianhai; Teng, Ru-Jeng; Guan, Tongju; Xu, Hao; Shi, Yang] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Teng, Ru-Jeng; Xu, Hao] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA; [Teng, Ru-Jeng] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Lawrence, Matt; Ge, Ying] Univ Wisconsin, Sch Med & Publ Hlth, Human Prote Program, Madison, WI USA; [Lawrence, Matt; Ge, Ying] Univ Wisconsin, Dept Physiol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Shi, Yang] Aurora Hlth Care, Patient Centered Res, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Du, JH (corresponding author), Med Coll Wisconsin, Dept Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.	dujianhai@gmail.com; scarlet.shi@aurora.org			National Institutes of Health [HL080468S]; American Heart Association [09POST2250335]; Wisconsin Partnership Funds for a Healthy Future; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Wisconsin Partnership Funds for a Healthy Future; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL080468S (to YS), American Heart Association Postdoctoral Fellowship Award 09POST2250335 (to JD), and Wisconsin Partnership Funds for a Healthy Future (to YG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P445, DOI 10.1161/01.ATV.0000115637.48689.77; An JZ, 2009, AM J PHYSIOL-HEART C, V297, pH1783, DOI 10.1152/ajpheart.00364.2009; Bowling KM, 2008, J BIOL CHEM, V283, P31449, DOI 10.1074/jbc.M802552200; Campbell CM, 2009, PAIN, V141, P114, DOI 10.1016/j.pain.2008.10.023; Ceylan-Isik AF, 2009, HYPERTENSION, V53, P1023, DOI 10.1161/HYPERTENSIONAHA.108.123422; CHEN RH, 1995, NATURE, V377, P548, DOI 10.1038/377548a0; Choy L, 1998, J BIOL CHEM, V273, P31455, DOI 10.1074/jbc.273.47.31455; Delgado-Esteban M, 2002, J NEUROCHEM, V82, P1148, DOI 10.1046/j.1471-4159.2002.01055.x; Du JH, 2009, ARTERIOSCL THROM VAS, V29, P2161, DOI 10.1161/ATVBAHA.109.194464; Du JH, 2009, BIOCHEM BIOPH RES CO, V385, P143, DOI 10.1016/j.bbrc.2009.05.026; Du YH, 2008, CIRCULATION, V117, P1045, DOI 10.1161/CIRCULATIONAHA.107.748236; Finocchietto PV, 2009, EXP BIOL MED, V234, P1020, DOI 10.3181/0902-MR-81; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Funderburk CD, 2006, J BIOL CHEM, V281, P33302, DOI 10.1074/jbc.M602196200; Ge ZD, 2011, CARDIOVASC RES; Ge ZD, 2011, CARDIOVASC RES, V91, P340, DOI 10.1093/cvr/cvr079; Golderer G, 2001, BIOCHEM J, V355, P499, DOI 10.1042/0264-6021:3550499; Gunasekera RS, 2009, MOL GENET METAB, V98, P264, DOI 10.1016/j.ymgme.2009.05.007; GUTLICH M, 1992, BIOCHIM BIOPHYS ACTA, V1171, P133, DOI 10.1016/0167-4781(92)90112-D; Higgins CE, 2010, J BIOL CHEM, V286, P11919; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; IMAZUMI K, 1994, BIOCHEM BIOPH RES CO, V205, P1409, DOI 10.1006/bbrc.1994.2822; Ionova IA, 2010, AM J PHYSIOL-HEART C, V299, pH88, DOI 10.1152/ajpheart.00203.2010; Kabuyama Y, 2010, AM J PHYSIOL-CELL PH, V298, pC107, DOI 10.1152/ajpcell.00231.2009; Li L, 2010, CIRC RES, V106, P328, DOI 10.1161/CIRCRESAHA.109.210658; Milstien S, 1996, J BIOL CHEM, V271, P19743, DOI 10.1074/jbc.271.33.19743; Moens AL, 2007, J CARDIOVASC PHARM, V50, P238, DOI 10.1097/FJC.0b013e318123f854; Muller U, 2002, J NEURAL TRANSM, V109, P321, DOI 10.1007/s007020200026; Perez RE, 2011, AM J PHYSIOL-LUNG C, V300, pL799, DOI 10.1152/ajplung.00350.2010; Peterson TE, 2009, HYPERTENSION, V53, P189, DOI 10.1161/HYPERTENSIONAHA.108.115709; Sha Z, 2009, MOL CELL, V36, P141, DOI 10.1016/j.molcel.2009.09.026; Swick L, 2006, J NEUROCHEM, V97, P1447, DOI 10.1111/j.1471-4159.2006.03836.x; Tatham AL, 2009, J BIOL CHEM, V284, P13660, DOI 10.1074/jbc.M807959200; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Tie L, 2009, AM J PHYSIOL-ENDOC M, V296, pE1423, DOI 10.1152/ajpendo.00150.2009; TOGARI A, 1992, BIOCHEM BIOPH RES CO, V187, P359, DOI 10.1016/S0006-291X(05)81501-3; Werner-Felmayer G, 2002, CURR DRUG METAB, V3, P159, DOI 10.2174/1389200024605073; Widder JD, 2007, CIRC RES, V101, P830, DOI 10.1161/CIRCRESAHA.107.153809; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795; Yoneyama T, 1998, J BIOL CHEM, V273, P20102, DOI 10.1074/jbc.273.32.20102	41	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33991	10.1371/journal.pone.0033991	http://dx.doi.org/10.1371/journal.pone.0033991			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479495	gold, Green Published, Green Submitted			2022-12-27	WOS:000303894900056
J	Hansen, CHF; Nielsen, DS; Kverka, M; Zakostelska, Z; Klimesova, K; Hudcovic, T; Tlaskalova-Hogenova, H; Hansen, AK				Hansen, Camilla Hartmann Friis; Nielsen, Dennis Sandris; Kverka, Miloslav; Zakostelska, Zuzana; Klimesova, Klara; Hudcovic, Tomas; Tlaskalova-Hogenova, Helena; Hansen, Axel Kornerup			Patterns of Early Gut Colonization Shape Future Immune Responses of the Host	PLOS ONE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; REGULATORY T-CELLS; MICROBIOTA; MICE; MICROFLORA; PROTECTION; EXPOSURE; HYGIENE; SYSTEM; FLORA	The most important trigger for immune system development is the exposure to microbial components immediately after birth. Moreover, targeted manipulation of the microbiota can be used to change host susceptibility to immune-mediated diseases. Our aim was to analyze how differences in early gut colonization patterns change the composition of the resident microbiota and future immune system reactivity. Germ-free (GF) mice were either inoculated by single oral gavage of caecal content or let colonized by co-housing with specific pathogen-free (SPF) mice at different time points in the postnatal period. The microbiota composition was analyzed by denaturing gradient gel electrophoresis for 16S rRNA gene followed by principal component analysis. Furthermore, immune functions and cytokine concentrations were analyzed using flow cytometry, ELISA or multiplex bead assay. We found that a single oral inoculation of GF mice at three weeks of age permanently changed the gut microbiota composition, which was not possible to achieve at one week of age. Interestingly, the ex-GF mice inoculated at three weeks of age were also the only mice with an increased pro-inflammatory immune response. In contrast, the composition of the gut microbiota of ex-GF mice that were co-housed with SPF mice at different time points was similar to the gut microbiota in the barrier maintained SPF mice. The existence of a short GF postnatal period permanently changed levels of systemic regulatory T cells, NK and NKT cells, and cytokine production. In conclusion, a time window exists that enables the artificial colonization of GF mice by a single oral dose of caecal content, which may modify the future immune phenotype of the host. Moreover, delayed microbial colonization of the gut causes permanent changes in the immune system.	[Hansen, Camilla Hartmann Friis; Hansen, Axel Kornerup] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Nielsen, Dennis Sandris] Univ Copenhagen, Fac Life Sci, Dept Food Sci, Frederiksberg C, Denmark; [Kverka, Miloslav; Zakostelska, Zuzana; Klimesova, Klara; Hudcovic, Tomas; Tlaskalova-Hogenova, Helena] Acad Sci Czech Republ, Inst Microbiol, Dept Immunol & Gnotobiol, Prague, Czech Republic; [Kverka, Miloslav; Zakostelska, Zuzana; Klimesova, Klara; Hudcovic, Tomas; Tlaskalova-Hogenova, Helena] Acad Sci Czech Republ, Inst Microbiol, Dept Immunol & Gnotobiol, Novy Hradek, Czech Republic	University of Copenhagen; University of Copenhagen; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Hansen, CHF (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.	camfriis@life.ku.dk	Tlaskalová-Hogenová, Helena/J-8008-2014; Hudcovic, Tomas/H-7917-2014; Kostovcikova, Klara/J-6851-2014; Zákostelská, Zuzana/ABB-9807-2021; Nielsen, Dennis/A-9769-2015; Kverka, Miloslav/H-2507-2014; Zakostelska, Zuzana/D-6518-2012	Hudcovic, Tomas/0000-0002-4761-5040; Kostovcikova, Klara/0000-0003-1821-398X; Nielsen, Dennis/0000-0001-8121-1114; Kverka, Miloslav/0000-0002-1335-5252; Zakostelska, Zuzana/0000-0002-6695-8188; Hansen, Camilla Hartmann Friis/0000-0002-1860-385X	Direktoer Jacob Madsens & Hustru Olga Madsens Fond; Center for Applied Laboratory Animal Research	Direktoer Jacob Madsens & Hustru Olga Madsens Fond; Center for Applied Laboratory Animal Research	This work was supported by grants from "Direktoer Jacob Madsens & Hustru Olga Madsens Fond" and the "Center for Applied Laboratory Animal Research." It was carried out as a part of the research program of the UNIK: Food, Fitness & Pharma for Health and Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Dimmitt RA, 2010, J PEDIATR GASTR NUTR, V51, P262, DOI 10.1097/MPG.0b013e3181e1a114; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaplan JL, 2011, PEDIATR RES, V69, P465, DOI 10.1203/PDR.0b013e318217638a; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; LEE A, 1972, INFECT IMMUN, V5, P1; Lodinova-Zadnikova R, 2003, INT ARCH ALLERGY IMM, V131, P209, DOI 10.1159/000071488; Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s; Marra F, 2006, CHEST, V129, P610, DOI 10.1378/chest.129.3.610; Mihatsch WA, 2012, CLIN NUTR, V31, P6, DOI 10.1016/j.clnu.2011.09.004; Min B, 2007, EUR J IMMUNOL, V37, P1916, DOI 10.1002/eji.200737236; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556; Newburg DS, 2007, PEDIATR RES, V61, P2, DOI 10.1203/01.pdr.0000250274.68571.18; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Reading NC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00148; Scott FW, 2002, DIABETES, V51, P73, DOI 10.2337/diabetes.51.1.73; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Sudo N, 1997, J IMMUNOL, V159, P1739; Tlaskalova-Hogenova H, 2004, IMMUNOL LETT, V93, P97, DOI 10.1016/j.imlet.2004.02.005; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721	29	199	206	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34043	10.1371/journal.pone.0034043	http://dx.doi.org/10.1371/journal.pone.0034043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479515	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900058
J	Zhang, LL; Dalal, K; Yin, MM; Yuan, DG; Andrews, JY; Wang, SM				Zhang, Ling-ling; Dalal, Koustuv; Yin, Ming-min; Yuan, De-guo; Andrews, Johanna Yvonne; Wang, Shu-mei			The KAP Evaluation of Intervention on Fall-Induced Injuries among Elders in a Safe Community in Shanghai, China	PLOS ONE			English	Article								Background: To evaluate the effect of an intervention on fall induced injuries of elderly people in a safe-community in Shanghai and to discuss an intervention model that is proper for the community to generalize. Methodology/Principal Findings: Five neighborhood areas in a Safe Community were purposively selected. All individuals aged 60 years or over in five neighborhoods were prospective participants. From randomly selected prospective households with elders, 2,889 (pre intervention) and 3,021 (post intervention) elderly people were included in the study. Knowledge, Attitude and Practice Model (KAP) questionnaires were used at the pre- and post-intervention phase for fall-induced injury prevention in the community. Descriptive statistics and chi-square tests were used. After the intervention, knowledge about the prevention of fall-induced injuries increased, as did attitudes, beliefs and good behaviors for fall prevention. Behavior modification was most notable with many behavior items changing significantly (p value<0.0001). Conclusions/Significance: The integrated program for reducing fall-related injuries in the community was effective in improving fall prevention among the elderly, but the intervention still needs further improvement.	[Zhang, Ling-ling; Yin, Ming-min; Yuan, De-guo; Wang, Shu-mei] Fudan Univ, Key Lab Publ Hlth Safety, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Dalal, Koustuv] Univ Orebro, Sch Hlth & Med Sci, Dept Publ Hlth Sci, Orebro, Sweden; [Andrews, Johanna Yvonne] Tufts Univ, Somerville, MA USA	Fudan University; Orebro University; Tufts University	Zhang, LL (corresponding author), Fudan Univ, Key Lab Publ Hlth Safety, Sch Publ Hlth, Shanghai 200433, Peoples R China.	smwang@fudan.edu.cn	Dalal, Koustuv/O-6737-2017; zhang, lingling/HDM-2189-2022	Dalal, Koustuv/0000-0001-7393-796X; 				[Anonymous], INTRO JINQIAO INT SA; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Han YF, 2007, MOD J INTEGR TRADIT, V16, P70; Laing SS, 2011, J AGING RES, V2011; Li H, 2007, JIANGSU J PREV MED, V18, P82; Li LM, 1997, CHINESE J EPIDEMIOLO, V18, P138; Lu J, 1999, CHIN J DIS CONTROL P, V3, P300; Stevens JA, 2005, J SAFETY RES, V36, P409, DOI 10.1016/j.jsr.2005.08.001; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; Vikman I, 2011, INT J CIRCUMPOL HEAL, V70, P195, DOI 10.3402/ijch.v70i2.17813; Walker W, 2001, NURS OLDER PEOPLE, V23, P21; Wang S.Y., 2003, INJURY EPIDEMIOLOGY; Wang SM, 2010, COMMUNITY INJURY PRE; Wang SY, 2001, CHIN J EPIDEMIOL, V22, P262; World Health Organization, 2007, WHO GLOB REP FALLP; Xia QingHua, 2010, Chinese Journal of Prevention and Control of Chronic Diseases, V18, P515; Xu WY, 2010, CHIN J EPIDEMIOL, V31, P15; Zhou Lei, 2008, Journal of Environmental & Occupational Medicine, V25, P519; Zhou LQ, 2009, J ENV OCCUP MED, V269, P285; Zhou SF, 2005, SH J PREV MED, V17, P113; Zhuo DH, 1998, DISABILITY PREVENTIO; 张玉, 2008, [中国老年学杂志, Chinese Journal of Gerontology], V28, P929	22	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e32848	10.1371/journal.pone.0032848	http://dx.doi.org/10.1371/journal.pone.0032848			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479343	Green Published, gold			2022-12-27	WOS:000303894900013
J	Simoes-Correia, J; Figueiredo, J; Lopes, R; Stricher, F; Oliveira, C; Serrano, L; Seruca, R				Simoes-Correia, Joana; Figueiredo, Joana; Lopes, Rui; Stricher, Francois; Oliveira, Carla; Serrano, Luis; Seruca, Raquel			E-Cadherin Destabilization Accounts for the Pathogenicity of Missense Mutations in Hereditary Diffuse Gastric Cancer	PLOS ONE			English	Article							CELL-CELL ADHESION; GERMLINE MUTATIONS; CLINICAL MANAGEMENT; ALIGNMENT METHODS; WEB SERVER; GENE CDH1; M-COFFEE; FAMILIES; STABILITY; INVASION	E-cadherin is critical for the maintenance of tissue architecture due to its role in cell-cell adhesion. E-cadherin mutations are the genetic cause of Hereditary Diffuse Gastric Cancer (HDGC) and missense mutations represent a clinical burden, due to the uncertainty of their pathogenic role. In vitro and in vivo, most mutations lead to loss-of-function, although the causal factor is unknown for the majority. We hypothesized that destabilization could account for the pathogenicity of E-cadherin missense mutations in HDGC, and tested our hypothesis using in silico and in vitro tools. FoldX algorithm was used to calculate the impact of each mutation in E-cadherin native-state stability, and the analysis was complemented with evolutionary conservation, by SIFT. Interestingly, HDGC patients harbouring germline E-cadherin destabilizing mutants present a younger age at diagnosis or death, suggesting that the loss of native-state stability of E-cadherin accounts for the disease phenotype. To elucidate the biological relevance of E-cadherin destabilization in HDGC, we investigated a group of newly identified HDGC-associated mutations (E185V, S232C and L583R), of which L583R is predicted to be destabilizing. We show that this mutation is not functional in vitro, exhibits shorter half-life and is unable to mature, due to premature proteasome-dependent degradation, a phenotype reverted by stabilization with the artificial mutation L583I (structurally tolerated). Herein we report E-cadherin structural models suitable to predict the impact of the majority of cancer-associated missense mutations and we show that E-cadherin destabilization leads to loss-of-function in vitro and increased pathogenicity in vivo.	[Simoes-Correia, Joana; Figueiredo, Joana; Lopes, Rui; Oliveira, Carla; Seruca, Raquel] Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal; [Simoes-Correia, Joana] Univ Coimbra, Fac Med, IBILI Inst Biomed Res Light & Image, Ctr Ophthalmol & Vis Sci, Coimbra, Portugal; [Figueiredo, Joana; Oliveira, Carla; Seruca, Raquel] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Simoes-Correia, Joana; Stricher, Francois; Serrano, Luis] UPF, Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain; [Serrano, Luis] Inst Catalana Recerca & Estudis Avancats, ICREA, Barcelona, Spain	Universidade do Porto; Universidade de Coimbra; Universidade do Porto; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA	Simoes-Correia, J (corresponding author), Univ Porto, IPATIMUP Inst Mol Pathol & Immunol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	jcorreia@ipatimup.pt	Figueiredo, Joana/J-7305-2013; seruca, raquel/F-8187-2011; Oliveira, Carla/F-8188-2011; Serrano, Luis/B-3355-2013; Stricher, François/L-2688-2015; Simões Correia, Joana/C-8755-2012	Figueiredo, Joana/0000-0002-1590-1974; Oliveira, Carla/0000-0001-8340-2264; Serrano, Luis/0000-0002-5276-1392; Stricher, François/0000-0003-0150-0878; Simões Correia, Joana/0000-0003-2623-5628; Seruca, Raquel/0000-0002-8851-4166	Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAU-OBD/64319/2006, PTDC/SAU-OBD/104017/2008, SFRH/BPD/48765/2008]; EMBO [ASTF 60-2009]; EU [HEALTH-F4-2008-201648]; ICREA Funding Source: Custom	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); EMBO(European Molecular Biology Organization (EMBO)); EU(European Commission); ICREA(ICREA)	This work was supported by Fundacao para a Ciencia e Tecnologia, Portugal (PTDC/SAU-OBD/64319/2006, PTDC/SAU-OBD/104017/2008, SFRH/BPD/48765/2008), EMBO (short-term fellowship ASTF 60-2009) and EU grant Prospects (HEALTH-F4-2008-201648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avizienyte E, 2001, J MED GENET, V38, P49, DOI 10.1136/jmg.38.1.49; Bajpai S, 2008, P NATL ACAD SCI USA, V105, P18331, DOI 10.1073/pnas.0806783105; Berx G, 1998, HUM MUTAT, V12, P226, DOI 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-D; Berx G, 1995, EMBO J, V14, P6107, DOI 10.1002/j.1460-2075.1995.tb00301.x; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Caldas C, 1999, J MED GENET, V36, P873; Carneiro F, 2008, J CLIN PATHOL, V61, P25, DOI 10.1136/jcp.2006.043679; Corso G, 2007, EJSO-EUR J SURG ONC, V33, P1061, DOI 10.1016/j.ejso.2007.03.001; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Fitzgerald RC, 2004, GUT, V53, P775, DOI 10.1136/gut.2003.022061; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hulpiau P, 2009, INT J BIOCHEM CELL B, V41, P349, DOI 10.1016/j.biocel.2008.09.027; Ishiyama N, 2010, CELL, V141, P117, DOI 10.1016/j.cell.2010.01.017; Kaurah P, 2007, JAMA-J AM MED ASSOC, V297, P2360, DOI 10.1001/jama.297.21.2360; Keller G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015594; Kim HC, 2000, GUT, V47, P262, DOI 10.1136/gut.47.2.262; Kluijt I, 2011, INT J CANC; Koch AW, 2004, STRUCTURE, V12, P793, DOI 10.1016/j.str.2004.02.034; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Mareel M, 2003, PHYSIOL REV, V83, P337, DOI 10.1152/physrev.00024.2002; More H, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9473; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Oliveira C, 2006, INT J SURG PATHOL, V14, P21, DOI 10.1177/106689690601400105; Oliveira C, 2005, VIRCHOWS ARCH, V446, P181, DOI 10.1007/s00428-004-1156-4; Oliveira C, 2003, EXPERT REV MOL DIAGN, V3, P201; Oliveira C, 2002, HUM MUTAT, V19, P510, DOI 10.1002/humu.10068; Oliveira C, 2009, GASTROENTEROLOGY, V136, P2137, DOI 10.1053/j.gastro.2009.02.065; Oliveira C, 2009, HUM MOL GENET, V18, P1545, DOI 10.1093/hmg/ddp046; OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645; Pey AL, 2007, AM J HUM GENET, V81, P1006, DOI 10.1086/521879; Pinheiro H, 2010, HUM MOL GENET, V19, P943, DOI 10.1093/hmg/ddp537; Rakoczy EP, 2011, J MOL BIOL, V405, P584, DOI 10.1016/j.jmb.2010.11.003; RISINGER JI, 1994, NAT GENET, V7, P98, DOI 10.1038/ng0594-98; Saito T, 2001, AM J PATHOL, V159, P2117, DOI 10.1016/S0002-9440(10)63063-5; Salahshor S, 2001, INT J MOL MED, V8, P439; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shapiro L, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003053; Shinmura K, 1999, CARCINOGENESIS, V20, P1127, DOI 10.1093/carcin/20.6.1127; Simoes-Correia J, 2008, HUM MOL GENET, V17, P3566, DOI 10.1093/hmg/ddn249; Suriano G, 2003, HUM MOL GENET, V12, P3007, DOI 10.1093/hmg/ddg316; Suriano G, 2005, CLIN CANCER RES, V11, P5401, DOI 10.1158/1078-0432.CCR-05-0247; Suriano G, 2003, ONCOGENE, V22, P5716, DOI 10.1038/sj.onc.1206672; Suriano G, 2003, HUM MOL GENET, V12, P575, DOI 10.1093/hmg/ddg048; Suriano Gianpaolo, 2006, Future Oncol, V2, P363, DOI 10.2217/14796694.2.3.363; Suriano G, 2006, J MOL MED-JMM, V84, P1023, DOI 10.1007/s00109-006-0091-z; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Wang J, 2000, BIOTECHNIQUES, V29, P976, DOI 10.2144/00295bm09; Wang Y, 2003, JPN J CLIN ONCOL, V33, P17, DOI 10.1093/jjco/hyg002; Yabuta T, 2002, INT J CANCER, V101, P434, DOI 10.1002/ijc.10633; Yoon KA, 1999, J HUM GENET, V44, P177, DOI 10.1007/s100380050137	53	46	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33783	10.1371/journal.pone.0033783	http://dx.doi.org/10.1371/journal.pone.0033783			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470475	Green Published, Green Submitted, gold			2022-12-27	WOS:000303857100050
J	Lama, A; Pane-Farre, J; Chon, T; Wiersma, AM; Sit, CS; Vederas, JC; Hecker, M; Nakano, MM				Lama, Amrita; Pane-Farre, Jan; Chon, Tai; Wiersma, Anna M.; Sit, Clarissa S.; Vederas, John C.; Hecker, Michael; Nakano, Michiko M.			Response of Methicillin-Resistant Staphylococcus aureus to Amicoumacin A	PLOS ONE			English	Article							MUREIN HYDROLASE ACTIVITY; ELONGATION-FACTOR-G; MICROBIAL PRODUCTS; BACILLUS-SUBTILIS; CHEMICAL NATURE; CELL-WALL; GENE; ACID; AUTOLYSIN; CLONING	Amicoumacin A exhibits strong antimicrobial activity against methicillin-resistant Staphylococcus aureus (MRSA), hence we sought to uncover its mechanism of action. Genome-wide transcriptome analysis of S. aureus COL in response to amicoumacin A showed alteration in transcription of genes specifying several cellular processes including cell envelope turnover, cross-membrane transport, virulence, metabolism, and general stress response. The most highly induced gene was lrgA, encoding an antiholin-like product, which is induced in cells undergoing a collapse of Delta psi. Consistent with the notion that LrgA modulates murein hydrolase activity, COL grown in the presence of amicoumacin A showed reduced autolysis, which was primarily caused by lower hydrolase activity. To gain further insight into the mechanism of action of amicoumacin A, a whole genome comparison of wild-type COL and amicoumacin A-resistant mutants isolated by a serial passage method was carried out. Single point mutations generating codon substitutions were uncovered in ksgA (encoding RNA dimethyltransferase), fusA (elongation factor G), dnaG (primase), lacD (tagatose 1,6-bisphosphate aldolase), and SACOL0611 (a putative glycosyl transferase). The codon substitutions in EF-G that cause amicoumacin A resistance and fusidic acid resistance reside in separate domains and do not bring about cross resistance. Taken together, these results suggest that amicoumacin A might cause perturbation of the cell membrane and lead to energy dissipation. Decreased rates of cellular metabolism including protein synthesis and DNA replication in resistant strains might allow cells to compensate for membrane dysfunction and thus increase cell survivability.	[Lama, Amrita; Chon, Tai; Nakano, Michiko M.] Oregon Hlth & Sci Univ, Inst Environm Hlth, Div Environm & Biomol Syst, Beaverton, OR USA; [Pane-Farre, Jan; Hecker, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany; [Wiersma, Anna M.; Sit, Clarissa S.; Vederas, John C.] Univ Alberta, Dept Chem, Edmonton, AB, Canada	Oregon Health & Science University; Ernst Moritz Arndt Universitat Greifswald; University of Alberta	Lama, A (corresponding author), Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Beaverton, OR 97006 USA.	mnakano@ebs.ogi.edu		Nakano, Michiko/0000-0002-0635-8535; Vederas, John/0000-0002-2996-0326	Public Health Service from the National Institutes of Health [AI081025]; Collins Medical Trust; Deutsche Forschungsgemeinschaft [SFB/TRR34]; Alberta Scholarship Programs; Natural Sciences and Engineering Research Council of Canada; Alberta Heritage Foundation for Medical Research; Canada Research Chair in Bioorganic and Medicinal Chemistry; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081025] Funding Source: NIH RePORTER	Public Health Service from the National Institutes of Health; Collins Medical Trust; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alberta Scholarship Programs; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canada Research Chair in Bioorganic and Medicinal Chemistry(Canada Research Chairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by Public Health Service grant AI081025 from the National Institutes of Health and a grant from the Collins Medical Trust to MMN, and by grants from the Deutsche Forschungsgemeinschaft (SFB/TRR34) to MH. This work was also supported by the Alberta Scholarship Programs (to CSS), the Natural Sciences and Engineering Research Council of Canada (to CSS and JCV), the Alberta Heritage Foundation for Medical Research (to CSS and JCV) and the Canada Research Chair in Bioorganic and Medicinal Chemistry (to JCV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Azumi M, 2008, TETRAHEDRON, V64, P6420, DOI 10.1016/j.tet.2008.04.076; Baba T, 1998, EMBO J, V17, P4639, DOI 10.1093/emboj/17.16.4639; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; Bischoff M, 2004, J BACTERIOL, V186, P4085, DOI 10.1128/JB.186.13.4085-4099.2004; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Brazas MD, 2005, DRUG DISCOV TODAY, V10, P1245, DOI 10.1016/S1359-6446(05)03566-X; Canedo LM, 1997, J ANTIBIOT, V50, P175, DOI 10.7164/antibiotics.50.175; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Charbonnier Y, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-95; Chen HJ, 2010, ANTIMICROB AGENTS CH, V54, P4985, DOI 10.1128/AAC.00523-10; Couto I, 1996, MICROB DRUG RESIST, V2, P377, DOI 10.1089/mdr.1996.2.377; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Gertz S, 1999, MOL GEN GENET, V261, P558, DOI 10.1007/s004380051001; Gioia J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000928; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Hashimoto M, 2007, J ANTIBIOT, V60, P752, DOI 10.1038/ja.2007.99; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Heilmann C, 2005, INFECT IMMUN, V73, P4793, DOI 10.1128/IAI.73.8.4793-4802.2005; HELSER TL, 1971, NATURE-NEW BIOL, V233, P12, DOI 10.1038/newbio233012a0; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Houston P, 2011, INFECT IMMUN, V79, P1153, DOI 10.1128/IAI.00364-10; Huang YF, 2006, J ANTIBIOT, V59, P355, DOI 10.1038/ja.2006.50; IGO MM, 1986, J MOL BIOL, V191, P615, DOI 10.1016/0022-2836(86)90449-3; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; ITOH J, 1981, J ANTIBIOT, V34, P611, DOI 10.7164/antibiotics.34.611; JOHANSON U, 1994, GENE, V143, P55, DOI 10.1016/0378-1119(94)90604-1; Kenny JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004344; KURODA M, 1995, BIOCHEM BIOPH RES CO, V207, P978, DOI 10.1006/bbrc.1995.1281; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Laurberg M, 2000, J MOL BIOL, V303, P593, DOI 10.1006/jmbi.2000.4168; MCINERNEY BV, 1991, J NAT PROD, V54, P785, DOI 10.1021/np50075a006; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; NAKANO MM, 1992, MOL GEN GENET, V232, P313, DOI 10.1007/BF00280011; Norstrom T, 2007, ANTIMICROB AGENTS CH, V51, P4438, DOI 10.1128/AAC.00328-07; OSHIDA T, 1995, P NATL ACAD SCI USA, V92, P285, DOI 10.1073/pnas.92.1.285; Pane-Farre J, 2006, INT J MED MICROBIOL, V296, P237, DOI 10.1016/j.ijmm.2005.11.011; Park D, 2009, MOL MICROBIOL, V73, P938, DOI 10.1111/j.1365-2958.2009.06817.x; Patton TG, 2006, MOL MICROBIOL, V59, P1395, DOI 10.1111/j.1365-2958.2006.05034.x; Pinchuk IV, 2001, ANTIMICROB AGENTS CH, V45, P3156, DOI 10.1128/AAC.45.11.3156-3161.2001; Ramadurai L, 1999, MICROBIOL-UK, V145, P801, DOI 10.1099/13500872-145-4-801; Renzoni A, 2006, ANTIMICROB AGENTS CH, V50, P3048, DOI 10.1128/AAC.00113-06; Rice KC, 2003, J BACTERIOL, V185, P2635, DOI 10.1128/JB.185.8.2635-2643.2003; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; SATO T, 1992, J ANTIBIOT, V45, P1949, DOI 10.7164/antibiotics.45.1949; Schlag M, 2010, MOL MICROBIOL, V75, P864, DOI 10.1111/j.1365-2958.2009.07007.x; SHIMOJIMA Y, 1982, TETRAHEDRON LETT, V23, P5435; SHIMOJIMA Y, 1982, AGR BIOL CHEM TOKYO, V46, P1823, DOI 10.1080/00021369.1982.10865335; SHIMOJIMA Y, 1984, TETRAHEDRON, V40, P2519, DOI 10.1016/S0040-4020(01)83504-3; Shinabarger DL, 1997, ANTIMICROB AGENTS CH, V41, P2132, DOI 10.1128/AAC.41.10.2132; Silverman JA, 2003, ANTIMICROB AGENTS CH, V47, P2538, DOI 10.1128/AAC.47.8.2538-2544.2003; Sonenshein AL., 2002, BACILLUS SUBTILIS IT, P369; Stapleton MR, 2007, J BACTERIOL, V189, P7316, DOI 10.1128/JB.00734-07; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; Sugai M, 1997, J BACTERIOL, V179, P2958, DOI 10.1128/jb.179.9.2958-2962.1997; Takahashi J, 2002, MICROBIOL IMMUNOL, V46, P601, DOI 10.1111/j.1348-0421.2002.tb02741.x; Wang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026833; WETZSTEIN M, 1992, J BACTERIOL, V174, P3300, DOI 10.1128/jb.174.10.3300-3310.1992	62	21	21	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34037	10.1371/journal.pone.0034037	http://dx.doi.org/10.1371/journal.pone.0034037			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479511	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100102
J	Stylianopoulou, E; Lykidis, D; Ypsilantis, P; Simopoulos, C; Skavdis, G; Grigoriou, M				Stylianopoulou, Electra; Lykidis, Dimitrios; Ypsilantis, Petros; Simopoulos, Constantinos; Skavdis, George; Grigoriou, Maria			A Rapid and Highly Sensitive Method of Non Radioactive Colorimetric In Situ Hybridization for the Detection of mRNA on Tissue Sections	PLOS ONE			English	Article							NONRADIOACTIVE INSITU HYBRIDIZATION; PARAFFIN-EMBEDDED TISSUE; SIGNAL AMPLIFICATION; FIXATION; EXPRESSION; DIGOXIGENIN; PRESERVATION; TRANSCRIPTS; EXTRACTION; MORPHOLOGY	Background: Non Radioactive colorimetric In Situ Hybridization (NoRISH) with hapten labeled probes has been widely used for the study of gene expression in development, homeostasis and disease. However, improvement in the sensitivity of the method is still needed to allow for the analysis of genes expressed at low levels. Methodology/Principal Findings: A stable, non-toxic, zinc-based fixative was tested in NoRISH experiments on sections of mouse embryos using four probes (Lhx6, Lhx7, ncapg and ret) that have different spatial patterns and expression levels. We showed that Z7 can successfully replace paraformaldehyde used so far for tissue fixation in NoRISH; the morphology of the cryosections of Z7-fixed tissues was excellent, and the fixation time required for tissues sized 1 cm was 1 hr instead of 24 hr for paraformaldehyde. The hybridization signal on the sections of the Z7-treated embryos always appeared earlier than that of the PFA-fixed embryos. In addition, a 50-60% shorter detection time was observed in specimen of Z7-treated embryos, reducing significantly the time required to complete the method. Finally and most importantly, the strength of the hybridization signal on the sections of the Z7-treated embryos always compared favorably to that of the sections of PFA-fixed embryos; these data demonstrate a significant improvement of the sensitivity the method that allows for the analysis of mRNAs that are barely or not detected by the standard colorimetric NoRISH method. Conclusions/Significance: Our NoRISH method provides excellent preservation of tissue morphology, is rapid, highly sensitive, and especially suitable to implement in the study of genes expressed at low levels and/or in sparse cells within a structure.	[Stylianopoulou, Electra; Lykidis, Dimitrios; Skavdis, George; Grigoriou, Maria] Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece; [Ypsilantis, Petros; Simopoulos, Constantinos] Democritus Univ Thrace, Sch Med, Alexandroupolis, Greece	Democritus University of Thrace; Democritus University of Thrace	Stylianopoulou, E (corresponding author), Democritus Univ Thrace, Dept Mol Biol & Genet, Alexandroupolis, Greece.	mgrigor@mbg.duth.gr	Ypsilantis, Petros/AAO-8216-2021; Grigoriou, Maria/AAM-8332-2021; Ypsilantis, Petros/ABH-2143-2021	Grigoriou, Maria/0000-0001-6336-5523; Skavdis, George/0000-0001-8929-6431; Simopoulos, Konstantinos/0000-0002-7994-3583	postdoctoral fellowship from the Greek State Scholarship Foundation (IKY)	postdoctoral fellowship from the Greek State Scholarship Foundation (IKY)	DL was supported by a postdoctoral fellowship from the Greek State Scholarship Foundation (IKY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2008, METHOD CELL BIOL, V87, P169, DOI 10.1016/S0091-679X(08)00209-4; ADAMS JC, 1992, J HISTOCHEM CYTOCHEM, V40, P1457, DOI 10.1177/40.10.1527370; AKAM ME, 1983, EMBO J, V2, P2075, DOI 10.1002/j.1460-2075.1983.tb01703.x; BECKSTEAD JH, 1994, J HISTOCHEM CYTOCHEM, V42, P1127, DOI 10.1177/42.8.8027531; BENEZRA J, 1991, J HISTOCHEM CYTOCHEM, V39, P351, DOI 10.1177/39.3.1704393; Carter BS, 2010, METHODS, V52, P322, DOI 10.1016/j.ymeth.2010.08.001; Chevalier J, 1997, J HISTOCHEM CYTOCHEM, V45, P481, DOI 10.1177/002215549704500401; Cinar O, 2006, ACTA HISTOCHEM, V108, P487, DOI 10.1016/j.acthis.2006.05.008; Coombs N, 1999, MICROS TODAY, V27, pe12; COX KH, 1984, DEV BIOL, V101, P485, DOI 10.1016/0012-1606(84)90162-3; Cox ML, 2006, EXP MOL PATHOL, V80, P183, DOI 10.1016/j.yexmp.2005.10.002; Darby IA, 2006, SITU HYBRIDIZATION P, p[131, 195]; Darby Ian A, 2006, Methods Mol Biol, V326, P17; Day HEW, 2008, BRAIN RES, V1218, P132, DOI 10.1016/j.brainres.2008.04.067; FOSS RD, 1994, DIAGN MOL PATHOL, V3, P148, DOI 10.1097/00019606-199409000-00003; GEE CE, 1983, NATURE, V306, P374, DOI 10.1038/306374a0; Gillespie JW, 2002, AM J PATHOL, V160, P449, DOI 10.1016/S0002-9440(10)64864-X; Goldsworthy SM, 1999, MOL CARCINOGEN, V25, P86, DOI 10.1002/(SICI)1098-2744(199906)25:2<86::AID-MC2>3.3.CO;2-W; Griffiths G., 1993, FINE STRUCTURE IMMUN, P26; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Guo DC, 2003, BIOTECHNIQUES, V34, P48, DOI 10.2144/03341bm06; Hadler-Olsen E, 2010, J HISTOCHEM CYTOCHEM, V58, P29, DOI 10.1369/jhc.2009.954354; Higo N, 1999, CEREB CORTEX, V9, P317, DOI 10.1093/cercor/9.4.317; Jensen UB, 2010, CYTOM PART A, V77A, P98, DOI 0.1002/cyto.a.20914; Jonker A, 1997, J HISTOCHEM CYTOCHEM, V45, P413, DOI 10.1177/002215549704500309; LARSSON LI, 1991, HISTOCHEMISTRY, V95, P209; Lykidis D, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm433; Paavilainen L, 2010, J HISTOCHEM CYTOCHEM, V58, P237, DOI 10.1369/jhc.2009.954321; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Polak J, 1998, SITU HYBRIDIZATION P, P21; PUCHTLER H, 1985, HISTOCHEMISTRY, V82, P201, DOI 10.1007/BF00501395; ROBBINS E, 1991, ANAT RECORD, V231, P559, DOI 10.1002/ar.1092310417; Roth KA, 1999, J HISTOCHEM CYTOCHEM, V47, P1644; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schwarzacher T., 2000, PRACTICAL SITU HYBRI; SINGER RH, 1982, P NATL ACAD SCI-BIOL, V79, P7331, DOI 10.1073/pnas.79.23.7331; Sirinarumitr T, 1997, MOL CELL PROBE, V11, P273, DOI 10.1006/mcpr.1997.0114; Speel EJM, 1998, HISTOCHEM CELL BIOL, V110, P571, DOI 10.1007/s004180050319; van der Ploeg M, 2000, EUR J HISTOCHEM, V44, P7; Wester K, 2003, LAB INVEST, V83, P889, DOI 10.1097/01.LAB.0000074892.53211.A5; WILCOX JN, 1993, J HISTOCHEM CYTOCHEM, V41, P1725, DOI 10.1177/41.12.8245419; Wilkinson D, 1998, SITU HYBRIDIZATION P, p[2, 69, 87]	42	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33898	10.1371/journal.pone.0033898	http://dx.doi.org/10.1371/journal.pone.0033898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479470	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100078
J	van Holst, RJ; van Holstein, M; van den Brink, W; Veltman, DJ; Goudriaan, AE				van Holst, Ruth J.; van Holstein, Mieke; van den Brink, Wim; Veltman, Dick J.; Goudriaan, Anna E.			Response Inhibition during Cue Reactivity in Problem Gamblers: An fMRI Study	PLOS ONE			English	Article							BRAIN ACTIVATION PATTERNS; PATHOLOGICAL GAMBLERS; ADDICTIVE BEHAVIORS; PREFRONTAL CORTEX; ABSTINENT ALCOHOLICS; ANTERIOR CINGULATE; COCAINE ADDICTION; TASK-PERFORMANCE; ATTENTIONAL BIAS; VENTRAL STRIATUM	Disinhibition over drug use, enhanced salience of drug use and decreased salience of natural reinforcers are thought to play an important role substance dependence. Whether this is also true for pathological gambling is unclear. To understand the effects of affective stimuli on response inhibition in problem gamblers (PRGs), we designed an affective Go/Nogo to examine the interaction between response inhibition and salience attribution in 16 PRGs and 15 healthy controls (HCs). Four affective blocks were presented with Go trials containing neutral, gamble, positive or negative affective pictures. The No-Go trials in these blocks contained neutral pictures. Outcomes of interest included percentage of impulsive errors and mean reaction times in the different blocks. Brain activity related to No-Go trials was assessed to measure response inhibition in the various affective conditions and brain activity related to Go trials was assessed to measure salience attribution. PRGs made fewer errors during gamble and positive trials than HCs, but were slower during all trials types. Compared to HCs, PRGs activated the dorsolateral prefrontal cortex, anterior cingulate and ventral striatum to a greater extent while viewing gamble pictures. The dorsal lateral and inferior frontal cortex were more activated in PRGs than in HCs while viewing positive and negative pictures. During neutral inhibition, PRGs were slower but similar in accuracy to HCs, and showed more dorsolateral prefrontal and anterior cingulate cortex activity. In contrast, during gamble and positive pictures PRGs performed better than HCs, and showed lower activation of the dorsolateral and anterior cingulate cortex. This study shows that gambling-related stimuli are more salient for PRGs than for HCs. PRGs seem to rely on compensatory brain activity to achieve similar performance during neutral response inhibition. A gambling-related or positive context appears to facilitate response inhibition as indicated by lower brain activity and fewer behavioural errors in PRGs.	[van Holst, Ruth J.; van den Brink, Wim; Veltman, Dick J.; Goudriaan, Anna E.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [van Holst, Ruth J.; van den Brink, Wim; Veltman, Dick J.; Goudriaan, Anna E.] Amsterdam Inst Addict Res, Amsterdam, Netherlands; [Veltman, Dick J.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [van Holstein, Mieke] Radboud Univ Nijmegen, Donders Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Radboud University Nijmegen	van Holst, RJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	ruthvan.holst@gmail.com	van Holst, Ruth Janke/J-1655-2012	van Holst, Ruth Janke/0000-0002-1184-9355; van Holstein, Mieke/0000-0002-1784-6147	Dutch Scientific Organization (NWO ZonMw) [91676084]; Amsterdam Brain Imaging Platform	Dutch Scientific Organization (NWO ZonMw)(Netherlands Organization for Scientific Research (NWO)); Amsterdam Brain Imaging Platform	This study was funded by a New Investigator grant to AEG from the Dutch Scientific Organization (NWO ZonMw, #91676084, 2007-10). Scanning costs were partly funded by a grant of the Amsterdam Brain Imaging Platform to RJvH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Asensio S, 2010, ADDICT BIOL, V15, P504, DOI 10.1111/j.1369-1600.2010.00230.x; Beck A, 2009, BIOL PSYCHIAT, V66, P734, DOI 10.1016/j.biopsych.2009.04.035; Boyd WH, 1982, EXCITEMENT GAMBLERS; Boyer M, 2003, ADDICTION, V98, P61, DOI 10.1046/j.1360-0443.2003.00219.x; Braus DF, 2001, J NEURAL TRANSM, V108, P887, DOI 10.1007/s007020170038; Brevers D, 2011, J BEHAV THER EXP PSY, V42, P265, DOI 10.1016/j.jbtep.2011.01.005; Brown JW, 2007, COGN AFFECT BEHAV NE, V7, P266, DOI 10.3758/CABN.7.4.266; CACIOPPO JT, 1993, J PERS SOC PSYCHOL, V65, P5; Casey BJ, 1997, DEV PSYCHOBIOL, V30, P61, DOI 10.1002/(SICI)1098-2302(199701)30:1<61::AID-DEV6>3.3.CO;2-B; Colibazzi T, 2010, EMOTION, V10, P377, DOI 10.1037/a0018484; Comings DE, 1997, MOL PSYCHIATR, V2, P44, DOI 10.1038/sj.mp.4000207; Comings DE, 1999, AM J MED GENET, V88, P358, DOI 10.1002/(SICI)1096-8628(19990820)88:4<358::AID-AJMG13>3.0.CO;2-G; Crockford DN, 2005, BIOL PSYCHIAT, V58, P787, DOI 10.1016/j.biopsych.2005.04.037; David SP, 2005, BIOL PSYCHIAT, V58, P488, DOI 10.1016/j.biopsych.2005.04.028; de Greck M, 2010, HUM BRAIN MAPP, V31, P1802, DOI 10.1002/hbm.20981; de Ruiter MB, 2012, DRUG ALCOHOL DEPEN, V121, P81, DOI 10.1016/j.drugalcdep.2011.08.010; de Ruiter MB, 2009, NEUROPSYCHOPHARMACOL, V34, P1027, DOI 10.1038/npp.2008.175; Field Matt, 2008, Curr Drug Abuse Rev, V1, P263; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; Garavan H, 2000, AM J PSYCHIAT, V157, P1789, DOI 10.1176/appi.ajp.157.11.1789; Gerdes ABM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00175; Goudriaan AE, 2008, PSYCHOL MED, V38, P41, DOI 10.1017/S0033291707000694; Goudriaan AE, 2010, ADDICT BIOL, V15, P491, DOI 10.1111/j.1369-1600.2010.00242.x; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Hayes DJ, 2011, NEUROSCI BIOBEHAV R, V35, P1419, DOI 10.1016/j.neubiorev.2011.03.005; Heinz A, 2007, ALCOHOL CLIN EXP RES, V31, P1138, DOI 10.1111/j.1530-0277.2007.00406.x; Hester R, 2004, J NEUROSCI, V24, P11017, DOI 10.1523/JNEUROSCI.3321-04.2004; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ibanez Angela, 2003, J Gambl Stud, V19, P11, DOI 10.1023/A:1021271029163; Ihssen N, 2010, DIFFERENTIATING HEAV; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Kertzman S, 2008, PSYCHIAT RES, V161, P1, DOI 10.1016/j.psychres.2007.06.026; Kertzman S, 2006, PSYCHIAT RES, V142, P1, DOI 10.1016/j.psychres.2005.07.027; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Krieglmeyer R, 2010, PSYCHOL SCI, V21, P607, DOI 10.1177/0956797610365131; Lang P.J., 1997, MOTIVATED ATTENTION; Lang PJ, 2008, INT AFFECTIVE PICTUR; Lawrence AJ, 2009, PSYCHOPHARMACOLOGY, V207, P163, DOI 10.1007/s00213-009-1645-x; LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184; Linnet J, 2011, SCAND J PSYCHOL, V52, P28, DOI 10.1111/j.1467-9450.2010.00837.x; Linnet J, 2011, ADDICTION, V106, P383, DOI 10.1111/j.1360-0443.2010.03126.x; Lobo DSS, 2010, BIOL PSYCHOL, V85, P33, DOI 10.1016/j.biopsycho.2010.04.008; MacKillop J, 2006, PSYCHOL ADDICT BEHAV, V20, P75, DOI 10.1037/0893-164X.20.1.75; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McCusker CG, 1997, BRIT J CLIN PSYCHOL, V36, P543, DOI 10.1111/j.2044-8260.1997.tb01259.x; Nielen MMA, 2009, BRAIN COGNITION, V71, P387, DOI 10.1016/j.bandc.2009.05.007; Park SQ, 2010, J NEUROSCI, V30, P7749, DOI 10.1523/JNEUROSCI.5587-09.2010; Peira N, 2010, EXP PSYCHOL, V57, P470, DOI 10.1027/1618-3169/a000058; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Petry NM, 2006, ADDICTION, V101, P152, DOI 10.1111/j.1360-0443.2006.01593.x; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Potenza MN, 2006, ADDICTION, V101, P142, DOI 10.1111/j.1360-0443.2006.01591.x; Potenza MN, 2003, AM J PSYCHIAT, V160, P1990, DOI 10.1176/appi.ajp.160.11.1990; Potenza MN, GAMBLING URGE QUESTI; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Robbins TW, 2009, ANNU REV NEUROSCI, V32, P267, DOI 10.1146/annurev.neuro.051508.135535; Roberts GMP, 2010, NEUROIMAGE, V52, P429, DOI 10.1016/j.neuroimage.2010.04.192; Robins L. N., 1998, DIAGNOSTIC INTERVIEW; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rodriguez-Jimenez R, 2006, J GAMBL STUD, V22, P451, DOI 10.1007/s10899-006-9028-2; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SPSS Inc, STAT PACK SOC SCI SP; Tomasi D, 2007, BRAIN RES, V1171, P83, DOI 10.1016/j.brainres.2007.06.102; Townshend JM, 2001, PSYCHOPHARMACOLOGY, V157, P67, DOI 10.1007/s002130100764; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Dantzig S, 2008, Q J EXP PSYCHOL, V61, P1298, DOI 10.1080/17470210802027987; van Holst RJ, 2010, NEUROSCI BIOBEHAV R, V34, P87, DOI 10.1016/j.neubiorev.2009.07.007; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Vollstadt-Klein S, 2010, ADDICTION, V105, P1741, DOI 10.1111/j.1360-0443.2010.03022.x; Watanabe J, 2002, NEUROIMAGE, V17, P1207, DOI 10.1006/nimg.2002.1198; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wiens S, 2011, NEUROSCI LETT, pS0304; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Wrase J, 2002, EUR PSYCHIAT, V17, P287, DOI 10.1016/S0924-9338(02)00676-4; Wrase J, 2007, NEUROIMAGE, V35, P787, DOI 10.1016/j.neuroimage.2006.11.043; Wulfert E, 2005, PSYCHOL ADDICT BEHAV, V19, P311, DOI 10.1037/0893-164X.19.3.311	81	86	86	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e30909	10.1371/journal.pone.0030909	http://dx.doi.org/10.1371/journal.pone.0030909			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479305	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100002
J	Veyrat-Durebex, C; Deblon, N; Caillon, A; Andrew, R; Altirriba, J; Odermatt, A; Rohner-Jeanrenaud, F				Veyrat-Durebex, Christelle; Deblon, Nicolas; Caillon, Aurelie; Andrew, Ruth; Altirriba, Jordi; Odermatt, Alex; Rohner-Jeanrenaud, Francoise			Central Glucocorticoid Administration Promotes Weight Gain and Increased 11 beta-Hydroxysteroid Dehydrogenase Type 1 Expression in White Adipose Tissue	PLOS ONE			English	Article							DIET-INDUCED OBESITY; CCAAT/ENHANCER-BINDING PROTEINS; INSULIN-RESISTANCE; METABOLIC SYNDROME; ZUCKER RATS; HEXOSE-6-PHOSPHATE DEHYDROGENASE; VISCERAL OBESITY; IMPAIRS INSULIN; STROMAL CELLS; WISTAR RATS	Glucocorticoids (GCs) are involved in multiple metabolic processes, including the regulation of insulin sensitivity and adipogenesis. Their action partly depends on their intracellular activation by 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1). We previously demonstrated that central GC administration promotes hyperphagia, body weight gain, hyperinsulinemia and marked insulin resistance at the level of skeletal muscles. Similar dysfunctions have been reported to occur upon specific overexpression of 11 beta-HSD1 in adipose tissue. The aim of the present study was therefore to determine whether the effects of central GC infusion may enhance local GC activation in white adipose tissue. Male Wistar and Sprague Dawley (SD) rats were intracerebroventricularly infused with GCs for 2 to 3 days. Body weight, food intake and metabolic parameters were measured, and expression of enzymes regulating 11 beta-HSD1, as well as that of genes regulated by GCs, were quantified. Central GC administration induced a significant increase in body weight gain and in 11 beta-HSD1 and resistin expression in adipose tissue. A decrease 11 beta-HSD1 expression was noticed in the liver of SD rats, as a partial compensatory mechanism. Such effects of GCs are centrally elicited. This model of icv dexamethasone infusion thus appears to be a valuable acute model, that helps delineating the initial metabolic defects occurring in obesity. An impaired downregulation of intracellular GC activation in adipose tissue may be important for the development of insulin resistance.	[Veyrat-Durebex, Christelle; Deblon, Nicolas; Caillon, Aurelie; Altirriba, Jordi; Rohner-Jeanrenaud, Francoise] Univ Geneva, Lab Metab, Dept Internal Med, Fac Med, Geneva, Switzerland; [Andrew, Ruth] Queens Med Res Inst, Mass Spectrometry Core Lab, Edinburgh, Midlothian, Scotland; [Odermatt, Alex] Univ Basel, Dept Pharmaceut Sci, Div Mol & Syst Toxicol, Basel, Switzerland	University of Geneva; University of Edinburgh; University of Basel	Veyrat-Durebex, C (corresponding author), Univ Geneva, Lab Metab, Dept Internal Med, Fac Med, Geneva, Switzerland.	christelle.veyrat-durebex@unige.ch	Andrew, Ruth/C-2727-2008	Andrew, Ruth/0000-0002-6916-2994; Veyrat-Durebex, Christelle/0000-0001-5301-6493; Altirriba, Jordi/0000-0002-8922-2333; Odermatt, Alex/0000-0002-6820-2712	Swiss National Science Foundation [3100AO-105889, 310000-112279]; EUFP6 [LSHM-CT-2003-503041]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EUFP6(European Commission)	This work was supported by the Swiss National Science Foundation grants No3100AO-105889 to FR-J, and No310000-112279 to AO, as well as by the EUFP6 grant LSHM-CT-2003-503041 to FR-J. The funders had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript.	AGARWAL AK, 1989, J BIOL CHEM, V264, P18939; ALBISTON AL, 1994, MOL CELL ENDOCRINOL, V105, pR11, DOI 10.1016/0303-7207(94)90176-7; Apostolova G, 2005, AM J PHYSIOL-ENDOC M, V288, pE957, DOI 10.1152/ajpendo.00442.2004; Asensio C, 2004, ENDOCRINOLOGY, V145, P2206, DOI 10.1210/en.2003-1679; ASHBY P, 1980, BIOCHEM J, V188, P185, DOI 10.1042/bj1880185; Atanasov AG, 2004, FEBS LETT, V571, P129, DOI 10.1016/j.febslet.2004.06.065; Balachandran A, 2008, ENDOCRINOLOGY, V149, P4069, DOI 10.1210/en.2008-0088; Balazs Z, 2008, J AM SOC NEPHROL, V19, P92, DOI 10.1681/ASN.2007030263; Banhegyi G, 2004, J BIOL CHEM, V279, P27017, DOI 10.1074/jbc.M404159200; Best R, 1997, J ENDOCRINOL, V153, P41, DOI 10.1677/joe.0.1530041; Bujalska IJ, 1999, ENDOCRINOLOGY, V140, P3188, DOI 10.1210/en.140.7.3188; Bujalska IJ, 2002, J CLIN ENDOCR METAB, V87, P1205, DOI 10.1210/jc.87.3.1205; Chapman KE, 2008, NEUROCHEM RES, V33, P624, DOI 10.1007/s11064-007-9504-9; Cusin I, 2001, OBES RES, V9, P401, DOI 10.1038/oby.2001.52; Dallman MF, 2007, J PHYSIOL-LONDON, V583, P431, DOI 10.1113/jphysiol.2007.136051; Drake AJ, 2005, ENDOCRINOLOGY, V146, P913, DOI 10.1210/en.2004-1063; Friedman TC, 1996, ENDOCR J, V43, P645, DOI 10.1507/endocrj.43.645; Gout J, 2006, BIOCHIMIE, V88, P1115, DOI 10.1016/j.biochi.2006.05.020; Hautanen A, 1997, J INTERN MED, V241, P451; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Iovino A, 2010, Rev Med Liege, V65, P140; IYNEDJIAN PB, 1980, EUR J BIOCHEM, V111, P89; Jamieson PM, 1999, J ENDOCRINOL, V160, P103, DOI 10.1677/joe.0.1600103; JAMIESON PM, 1995, ENDOCRINOLOGY, V136, P4754, DOI 10.1210/en.136.11.4754; Jorgensen SB, 2009, AM J PHYSIOL-ENDOC M, V297, pE57, DOI 10.1152/ajpendo.90744.2008; Junkin KA, 2009, AM J PHYSIOL-REG I, V296, pR944, DOI 10.1152/ajpregu.90971.2008; Kershaw EE, 2005, DIABETES, V54, P1023, DOI 10.2337/diabetes.54.4.1023; Kotelevtsev Y, 1997, P NATL ACAD SCI USA, V94, P14924, DOI 10.1073/pnas.94.26.14924; Lee MJ, 2008, OBESITY, V16, P1178, DOI 10.1038/oby.2008.207; Levin BE, 2002, AM J PHYSIOL-REG I, V283, pR941, DOI 10.1152/ajpregu.00245.2002; LEVIN BE, 1983, AM J PHYSIOL, V245, pR364, DOI 10.1152/ajpregu.1983.245.3.R364; Li G, J LIPID RES, V52, P971; Liu YJ, 2003, DIABETES, V52, P1409, DOI 10.2337/diabetes.52.6.1409; Liu YJ, 1996, LIFE SCI, V59, P227, DOI 10.1016/0024-3205(96)00288-3; Livingstone DEW, 2003, J PHARMACOL EXP THER, V305, P167, DOI 10.1124/jpet.102.044842; Livingstone DEW, 2000, ENDOCRINOLOGY, V141, P560, DOI 10.1210/en.141.2.560; LOW SC, 1994, J MOL ENDOCRINOL, V13, P167, DOI 10.1677/jme.0.0130167; Marcolongo P, 2007, ENDOCRINOLOGY, V148, P2487, DOI 10.1210/en.2006-1472; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Masuzaki Hiroaki, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P255; Milagro FI, 2007, J STEROID BIOCHEM, V104, P81, DOI 10.1016/j.jsbmb.2006.10.006; Morton NM, 2004, DIABETES, V53, P931, DOI 10.2337/diabetes.53.4.931; Napolitano A, 1998, J STEROID BIOCHEM, V64, P251, DOI 10.1016/S0960-0760(97)00200-8; NEWBY FD, 1990, AM J PHYSIOL, V259, pR1117, DOI 10.1152/ajpregu.1990.259.6.R1117; Paterson JM, 2004, P NATL ACAD SCI USA, V101, P7088, DOI 10.1073/pnas.0305524101; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-132; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; REBUFFESCRIVE M, 1988, J CLIN ENDOCR METAB, V67, P1122, DOI 10.1210/jcem-67-6-1122; ROLLAND V, 1995, BIOCHEM BIOPH RES CO, V207, P761, DOI 10.1006/bbrc.1995.1252; Sai S, 2008, MOL ENDOCRINOL, V22, P2049, DOI 10.1210/me.2007-0489; Sato N, 2005, ENDOCRINOLOGY, V146, P273, DOI 10.1210/en.2004-0985; Satoh H, 2004, J CLIN INVEST, V114, P224, DOI 10.1172/JCI200420785; Shimojo M, 1996, J MOL ENDOCRINOL, V17, P121, DOI 10.1677/jme.0.0170121; Shojima N, 2002, DIABETES, V51, P1737, DOI 10.2337/diabetes.51.6.1737; Song HY, 2002, BIOCHEM BIOPH RES CO, V299, P291, DOI 10.1016/S0006-291X(02)02551-2; Steppan CM, 2004, J INTERN MED, V255, P439, DOI 10.1111/j.1365-2796.2004.01306.x; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; Tomlinson JW, 2008, DIABETES, V57, P2652, DOI 10.2337/db08-0495; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; VETTOR R, 1994, DIABETOLOGIA, V37, P1202, DOI 10.1007/s001250050236; Williams LJS, 2000, J BIOL CHEM, V275, P30232, DOI 10.1074/jbc.M001286200; Zakrzewska KE, 1999, DIABETES, V48, P365, DOI 10.2337/diabetes.48.2.365; Zakrzewska KE, 1999, ENDOCRINOLOGY, V140, P3183, DOI 10.1210/en.140.7.3183	64	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34002	10.1371/journal.pone.0034002	http://dx.doi.org/10.1371/journal.pone.0034002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479501	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100093
J	von Wettberg, EJB; Stinchcombe, JR; Schmitt, J				von Wettberg, Eric J. B.; Stinchcombe, John R.; Schmitt, Johanna			Early Developmental Responses to Seedling Environment Modulate Later Plasticity to Light Spectral Quality	PLOS ONE			English	Article							SHADE-AVOIDANCE RESPONSES; IMPATIENS-CAPENSIS; PHENOTYPIC PLASTICITY; POPULATION DIFFERENTIATION; GENETIC ARCHITECTURE; DEPENDENT SELECTION; ADAPTIVE DIVERGENCE; NATURAL-POPULATION; TRAITS; EVOLUTION	Correlations between developmentally plastic traits may constrain the joint evolution of traits. In plants, both seedling de-etiolation and shade avoidance elongation responses to crowding and foliage shade are mediated by partially overlapping developmental pathways, suggesting the possibility of pleiotropic constraints. To test for such constraints, we exposed inbred lines of Impatiens capensis to factorial combinations of leaf litter (which affects de-etiolation) and simulated foliage shade (which affects phytochrome-mediated shade avoidance). Increased elongation of hypocotyls caused by leaf litter phenotypically enhanced subsequent elongation of the first internode in response to low red: far red (R:FR). Trait expression was correlated across litter and shade conditions, suggesting that phenotypic effects of early plasticity on later plasticity may affect variation in elongation traits available to selection in different light environments.	[von Wettberg, Eric J. B.] Florida Int Univ, Miami, FL 33199 USA; [von Wettberg, Eric J. B.] Fairchild Trop Bot Garden, Ctr Trop Plant Conservat, Coral Gables, FL USA; [Stinchcombe, John R.] Univ Toronto, Toronto, ON, Canada; [Schmitt, Johanna] Brown Univ, Providence, RI 02912 USA	State University System of Florida; Florida International University; University of Toronto; Brown University	von Wettberg, EJB (corresponding author), Florida Int Univ, Miami, FL 33199 USA.	eric.vonwettberg@fiu.edu	Stinchcombe, John/A-2941-2008; von Wettberg, Eric/C-1115-2016	Stinchcombe, John/0000-0003-3349-2964; von Wettberg, Eric/0000-0002-2724-0317	National Science Foundation [DDIG 0408015, DEB 0129018]; Environmental Protection Agency STAR graduate fellowship; Ecole Nacional Superieure Agronomique de Toulouse	National Science Foundation(National Science Foundation (NSF)); Environmental Protection Agency STAR graduate fellowship(United States Environmental Protection Agency); Ecole Nacional Superieure Agronomique de Toulouse	This work was supported by National Science Foundation grants DDIG 0408015 and DEB 0129018, an Environmental Protection Agency STAR graduate fellowship (EvW), and a visiting fellowship from Ecole Nacional Superieure Agronomique de Toulouse (EvW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Agrawal AA, 2002, AM NAT, V159, P553, DOI 10.1086/339463; Alabadi D, 2009, PLANT MOL BIOL, V69, P409, DOI 10.1007/s11103-008-9400-y; [Anonymous], 2017, ANIM COGN, DOI DOI 10.1007/s10071-016-1007-0; Anten NPR, 2009, AM NAT, V173, P241, DOI 10.1086/595761; Baythavong BS, 2010, EVOLUTION, V64, P2904, DOI 10.1111/j.1558-5646.2010.01057.x; BLISS D, 1985, PLANT CELL ENVIRON, V8, P475, DOI 10.1111/j.1365-3040.1985.tb01683.x; Botto JF, 2002, PLANT CELL ENVIRON, V25, P53, DOI 10.1046/j.0016-8025.2001.00812.x; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Casal JJ, 2004, TRENDS PLANT SCI, V9, P309, DOI 10.1016/j.tplants.2004.04.007; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Chen M, 2011, TRENDS CELL BIOL; Donohue K, 2000, EVOLUTION, V54, P1969, DOI 10.1111/j.0014-3820.2000.tb01241.x; Donohue K, 2001, EVOLUTION, V55, P692, DOI 10.1554/0014-3820(2001)055[0692:ADIPIN]2.0.CO;2; Donohue K, 1999, EVOLUTION, V53, P1377, DOI [10.2307/2640884, 10.1111/j.1558-5646.1999.tb05402.x]; Donohue K, 2000, EVOLUTION, V54, P1956, DOI 10.1111/j.0014-3820.2000.tb01240.x; DUDLEY SA, 1995, FUNCT ECOL, V9, P655, DOI 10.2307/2390158; Dudley SA, 1996, AM NAT, V147, P445, DOI 10.1086/285860; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; Franklin KA, 2010, J EXP BOT, V61, P11, DOI 10.1093/jxb/erp304; GILBERT IR, 1995, PLANT CELL ENVIRON, V18, P475, DOI 10.1111/j.1365-3040.1995.tb00549.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Griffith TM, 2005, NEW PHYTOL, V166, P141, DOI 10.1111/j.1469-8137.2004.01277.x; HOULE D, 1992, GENETICS, V130, P195; Huber H, 2004, AM NAT, V163, P548, DOI 10.1086/382549; Kolbe JJ, 2011, EVOLUTIONEARLY ONLIN; LEVINS RICHARD, 1968; McGoey BV, 2009, NEW PHYTOL, V183, P880, DOI 10.1111/j.1469-8137.2009.02934.x; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; MORGAN DC, 1979, PLANTA, V145, P253, DOI 10.1007/BF00454449; Murren Courtney J., 2002, Plant Species Biology, V17, P89, DOI 10.1046/j.1442-1984.2002.00079.x; Nicotra AB, 2007, NEW PHYTOL, V176, P136, DOI 10.1111/j.1469-8137.2007.02157.x; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pigliucci M., 2004, PHENOTYPIC INTEGRATI; Price TD, 2003, P ROY SOC B-BIOL SCI, V270, P1433, DOI 10.1098/rspb.2003.2372; Sardans J, 2006, ECOSCIENCE, V13, P258, DOI 10.2980/i1195-6860-13-2-258.1; SCHLICHTING CD, 1989, OECOLOGIA, V78, P496, DOI 10.1007/BF00378740; SCHLICHTING CD, 1989, BIOSCIENCE, V39, P460, DOI 10.2307/1311138; Schlichting CD, 1998, PHENOTYPIC EVOLUTION; SCHMITT J, 1987, J ECOL, V75, P651, DOI 10.2307/2260197; Schmitt J, 2003, INTEGR COMP BIOL, V43, P459, DOI 10.1093/icb/43.3.459; SCHMITT J, 1993, EVOLUTION, V47, P1654, DOI 10.1111/j.1558-5646.1993.tb01258.x; Schwinning S, 1998, OECOLOGIA, V113, P447, DOI 10.1007/s004420050397; Smith H, 1997, PLANT CELL ENVIRON, V20, P840, DOI 10.1046/j.1365-3040.1997.d01-104.x; SMITH H, 1982, ANNU REV PLANT PHYS, V33, P481, DOI 10.1146/annurev.pp.33.060182.002405; Steinger T, 2003, J EVOLUTION BIOL, V16, P313, DOI 10.1046/j.1420-9101.2003.00518.x; Stinchcombe JR, 2010, EVOLUTION, V64, P2887, DOI 10.1111/j.1558-5646.2010.01060.x; Stinchcombe JR, 2006, ECOL LETT, V9, P255, DOI 10.1111/j.1461-0248.2005.00872.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sultan SE, 2010, CURR OPIN PLANT BIOL, V13, P96, DOI 10.1016/j.pbi.2009.09.021; Tabak NM, 2008, NORTHEAST NAT, V15, P159, DOI 10.1656/1092-6194(2008)15[159:NAIJOT]2.0.CO;2; VANHINSBERG A, 1997, J EVOLUTION BIOL, V10, P87; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; von Wettberg EJ, 2005, EVOL ECOL RES, V7, P531; von Wettberg EJ, 2005, AM J BOT, V92, P868, DOI 10.3732/ajb.92.5.868; von Wettberg EJ, 2008, EVOLUTION, V62, P654, DOI 10.1111/j.1558-5646.2007.00309.x; WALLER DM, 1979, AM J BOT, V66, P313, DOI 10.2307/2442608; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; Weinig C, 2000, EVOLUTION, V54, P124, DOI 10.1111/j.0014-3820.2000.tb00013.x; Weinig C, 2000, EVOLUTION, V54, P441, DOI 10.1111/j.0014-3820.2000.tb00047.x; Weinig C, 2001, EVOLUTION, V55, P930, DOI 10.1554/0014-3820(2001)055[0930:PPEILC]2.0.CO;2; Whitman D, 2010, PHENOTYPIC PLASTICIT, P2; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826	65	6	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34121	10.1371/journal.pone.0034121	http://dx.doi.org/10.1371/journal.pone.0034121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479538	Green Published, gold			2022-12-27	WOS:000305339100118
J	Choudhary, SP; Kanwar, M; Bhardwaj, R; Yu, JQ; Tran, LSP				Choudhary, Sikander Pal; Kanwar, Mukesh; Bhardwaj, Renu; Yu, Jing-Quan; Lam-Son Phan Tran			Chromium Stress Mitigation by Polyamine-Brassinosteroid Application Involves Phytohormonal and Physiological Strategies in Raphanus sativus L.	PLOS ONE			English	Article							RESPONSIVE 2-COMPONENT SYSTEM; ABSCISIC-ACID; OXIDATIVE STRESS; CELL-DEATH; TOLERANCE; LIGHT; WATER; SPERMIDINE; TOXICITY; DROUGHT	Brassinosteroids (BRs) and polyamines (PAs) are well-established growth regulators playing key roles in stress management among plants. In the present study, we evaluated the effects of epibrassinolide (EBL, an active BR) and spermidine (Spd, an active PA) on the tolerance of radish to oxidative stress induced by Cr (VI) metal. Our investigation aimed to study the impacts of EBL (10(-9) M) and/or Spd (1 mM) on the biochemical and physiological responses of radish (Raphanus sativus L.) under Cr-stress. Applications of EBL and/or Spd were found to improve growth of Cr-stressed seedlings in terms of root length, shoot length and fresh weight. Our data also indicated that applications of EBL and Spd have significant impacts, particularly when applied together, on the endogenous titers of PAs, free and bound forms of IAA and ABA in seedlings treated with Cr-stress. Additionally, co-applications of EBL and Spd modulated more remarkably the titers of antioxidants (glutathione, ascorbic acid, proline, glycine betaine and total phenol) and activities of antioxidant enzymes (guaicol peroxidase, catalase, superoxide dismutase and glutathione reductase) in Cr-stressed plants than their individual applications. Attenuation of Cr-stress by EBL and/or Spd (more efficient with EBL and Spd combination) was also supported by enhanced values of stress indices, such as phytochelatins, photosynthetic pigments and total soluble sugars, and reduction in malondialdehyde and H2O2 levels in Cr-treated seedlings. Diminution of ROS production and enhanced ROS scavenging capacities were also noted for EBL and/or Spd under Cr-stress. However, no significant reduction in Cr uptake was observed for co-application of EBL and Spd when compared to their individual treatments in Cr-stressed seedlings. Taken together, our results demonstrate that co-applications of EBL and Spd are more effective than their independent treatments in lowering the Cr-induced oxidative stress in radish, leading to improved growth of radish seedlings under Cr-stress.	[Choudhary, Sikander Pal; Yu, Jing-Quan] Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China; [Choudhary, Sikander Pal] Univ Jammu, Dept Bot, Jammu 180004, India; [Kanwar, Mukesh; Bhardwaj, Renu] Guru Nanak Dev Univ, Dept Bot & Environm Sci, Amritsar, Punjab, India; [Lam-Son Phan Tran] RIKEN Plant Sci Ctr, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan	Zhejiang University; University of Jammu; Guru Nanak Dev University; RIKEN	Choudhary, SP (corresponding author), Zhejiang Univ, Dept Hort, Hangzhou 310003, Zhejiang, Peoples R China.	sikanderchowdhary@gmail.com; tran@psc.riken.jp	Bhardwaj, Renu/AAA-6359-2020; Tran, Lam-Son P/A-1346-2009; Yu, J.Q./C-9509-2015	Tran, Lam-Son P/0000-0001-9883-9768; Yu, J.Q./0000-0002-7626-1165; PAL, SIKANDER/0000-0002-3827-466X; Bhardwaj, Renu/0000-0001-7523-5654	Council of Scientific and Industrial Research (India); Department of Science and Technology (India) [SR/SO/PS-23/07]	Council of Scientific and Industrial Research (India)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (India)(Department of Science & Technology (India))	This research work was supported by the Council of Scientific and Industrial Research (India, www.csir.res.in) in the form of Junior Research Fellowship. This research work was supported by the Department of Science and Technology (India, www.dst.gov.in) (No. SR/SO/PS-23/07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi HE, 1983, CATALASE; Ali S, 2011, ENVIRON EXP BOT, V70, P185, DOI 10.1016/j.envexpbot.2010.09.002; Andre CM, 2010, CURR NUTR FOOD SCI, V6, P2, DOI 10.2174/157340110790909563; Aruoma OI, 1996, J AM OIL CHEM SOC, V73, P1617, DOI 10.1007/BF02517962; Baek SH, 2008, BIOSCI BIOTECH BIOCH, V72, P1176, DOI 10.1271/bbb.70545; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Chary NS, 2008, ECOTOX ENVIRON SAFE, V69, P513, DOI 10.1016/j.ecoenv.2007.04.013; Choudhary SP, 2010, PHYSIOL PLANTARUM, V140, P280, DOI 10.1111/j.1399-3054.2010.01403.x; Chow B, 2004, J EXP BOT, V55, P247, DOI 10.1093/jxb/erh032; CHOW PYT, 1995, ANALYST, V120, P1221, DOI 10.1039/an9952001221; Clouse SD, 2011, PLANT CELL, V23, P1219, DOI 10.1105/tpc.111.084475; Deeb F, 2010, PLANT CELL, V22, P3678, DOI 10.1105/tpc.109.073254; Dimkpa CO, 2009, SOIL BIOL BIOCHEM, V41, P154, DOI 10.1016/j.soilbio.2008.10.010; Divi UK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-151; Diwan H, 2010, PLANT GROWTH REGUL, V61, P97, DOI 10.1007/s10725-010-9454-0; Doring S, 2000, FRESEN J ANAL CHEM, V366, P316, DOI 10.1007/s002160050062; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; GRIEVE CM, 1983, PLANT SOIL, V70, P303, DOI 10.1007/BF02374789; Gudesblat GE, 2011, CURR OPIN PLANT BIOL, V14, P530, DOI 10.1016/j.pbi.2011.05.004; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; HALLIWELL B, 1976, BIOCHEM J, V155, P697, DOI 10.1042/bj1550697; HALLIWELL B, 1987, ANAL BIOCHEM, V165, P215, DOI 10.1016/0003-2697(87)90222-3; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hussain SS, 2011, BIOTECHNOL ADV, V29, P300, DOI 10.1016/j.biotechadv.2011.01.003; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Jogaiah S, 2012, CRIT REV BIOTECHNOL, DOI [10.3109/07388551.2012.659174, DOI 10.3109/07388551.2012.659174]; Kagale S, 2007, PLANTA, V225, P353, DOI 10.1007/s00425-006-0361-6; KONO Y, 1978, ARCH BIOCHEM BIOPHYS, V186, P189, DOI 10.1016/0003-9861(78)90479-4; Tran LSP, 2010, PLANT SIGNAL BEHAV, V5, P148, DOI 10.4161/psb.5.2.10411; LARSSON C, 1987, METHOD ENZYMOL, V148, P558; Le DT, 2011, DNA RES, V18, P17, DOI 10.1093/dnares/dsq032; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Linos A, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-50; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mochida K, 2010, DNA RES, V17, P303, DOI 10.1093/dnares/dsq021; Thao NP, 2012, CRIT REV BIOTECHNOL, V32, P349, DOI 10.3109/07388551.2011.643463; Nishiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032124; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; OYAIZU M, 1986, Japanese Journal of Nutrition, V44, P307; Pieroni A, 2002, PHYTOTHER RES, V16, P467, DOI 10.1002/ptr.1243; Putter J, 1974, PEROXIDASE; RAGAZZI E, 1973, J CHROMATOGR, V77, P369, DOI 10.1016/S0021-9673(00)92204-0; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Shanker AK, 2005, ENVIRON INT, V31, P739, DOI 10.1016/j.envint.2005.02.003; Sharma I, 2011, ECOTOXICOLOGY, V20, P862, DOI 10.1007/s10646-011-0650-0; Sun Y, 2005, PLANT CELL PHYSIOL, V46, P1384, DOI 10.1093/pcp/pci150; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Toumi I, 2010, J PLANT PHYSIOL, V167, P519, DOI 10.1016/j.jplph.2009.10.022; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Villacorta NF, 2008, J PLANT GROWTH REGUL, V27, P93, DOI 10.1007/s00344-007-9028-1; Wang HQ, 2009, J PLANT GROWTH REGUL, V28, P21, DOI 10.1007/s00344-008-9069-0; Wen XP, 2011, ENVIRON EXP BOT, V72, P157, DOI 10.1016/j.envexpbot.2011.03.001; White AJ, 1999, PHOTOSYNTH RES, V59, P63, DOI 10.1023/A:1006188004189; Xia XJ, 2009, PLANT PHYSIOL, V150, P801, DOI 10.1104/pp.109.138230; Zhang H, 2010, BIOL PLANTARUM, V54, P743, DOI 10.1007/s10535-010-0133-9	62	131	138	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33210	10.1371/journal.pone.0033210	http://dx.doi.org/10.1371/journal.pone.0033210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479371	gold, Green Published, Green Submitted			2022-12-27	WOS:000304523400014
J	Nguyen, TN; Power, UF; Robert, A; Haeuw, JF; Helffer, K; Perez, A; Asin, MA; Corvaia, N; Libon, C				Nguyen, Thien N.; Power, Ultan F.; Robert, Alain; Haeuw, Jean-Francois; Helffer, Katia; Perez, Amadeo; Asin, Miguel-Angel; Corvaia, Nathalie; Libon, Christine			The Respiratory Syncytial Virus G Protein Conserved Domain Induces a Persistent and Protective Antibody Response in Rodents	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; G-GLYCOPROTEIN; BALB/C MICE; RSV CHALLENGE; VACCINE CANDIDATE; FUSION PROTEIN; UNITED-STATES; BBG2NA; IMMUNOGENICITY; INFECTION	Respiratory syncytial virus (RSV) is an important cause of severe upper and lower respiratory disease in infants and in the elderly. There are 2 main RSV subtypes A and B. A recombinant vaccine was designed based on the central domain of the RSV-A attachment G protein which we had previously named G2Na (aa130-230). Here we evaluated immunogenicity, persistence of antibody (Ab) response and protective efficacy induced in rodents by: (i) G2Na fused to DT (Diphtheria toxin) fragments in cotton rats. DT fusion did not potentiate neutralizing Ab responses against RSV-A or cross-reactivity to RSV-B. (ii) G2Nb (aa130-230 of the RSV-B G protein) either fused to, or admixed with G2Na. G2Nb did not induce RSV-B-reactive Ab responses. (iii) G2Na at low doses. Two injections of 3 mu g G2Na in Alum were sufficient to induce protective immune responses in mouse lungs, preventing RSV-A and greatly reducing RSV-B infections. In cotton rats, G2Na-induced RSV-reactive Ab and protective immunity against RSV-A challenge that persisted for at least 24 weeks. (iv) injecting RSV primed mice with a single dose of G2Na/Alum or G2Na/PLGA [poly(D, L-lactide-co-glycolide]. Despite the presence of pre-existing RSV-specific Abs, these formulations effectively boosted anti-RSV Ab titres and increased Ab titres persisted for at least 21 weeks. Affinity maturation of these Abs increased from day 28 to day 148. These data indicate that G2Na has potential as a component of an RSV vaccine formulation.	[Nguyen, Thien N.; Helffer, Katia; Libon, Christine] Ctr Rech & Dev Pierre Fabre, Toulouse, France; [Power, Ultan F.] Queens Univ Belfast, Ctr Med Biol, Ctr Infect & Immun, Sch Med Dent & Biomed Sci, Belfast BT9 7BL, Antrim, North Ireland; [Robert, Alain; Haeuw, Jean-Francois; Corvaia, Nathalie] Ctr Immunol Pierre Fabre, St Julien En Genevois, France; [Perez, Amadeo; Asin, Miguel-Angel] Ctr Rech Galen Pierre Fabre, Barcelona, Spain	Queens University Belfast; Centre d'Immunologie Pierre Fabre	Nguyen, TN (corresponding author), Ctr Rech & Dev Pierre Fabre, Toulouse, France.	thien.nguyen@pierre-fabre.com		Power, Ultan/0000-0003-3246-3774; Nguyen, Thien/0000-0003-4575-0422	Institute de Recherche Pierre Fabre	Institute de Recherche Pierre Fabre	The work was entirely supported by Institute de Recherche Pierre Fabre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A, 2000, Dev Biol (Basel), V103, P231; Chaiwatpongsakorn S, 2011, J VIROL, V85, P3968, DOI 10.1128/JVI.01813-10; Chang J, 2011, BMB REP, V44, P232, DOI 10.5483/BMBRep.2011.44.4.232; Chevalet L, 2000, BIOTECHNOL BIOENG, V69, P351, DOI 10.1002/1097-0290(20000820)69:4<351::AID-BIT1>3.0.CO;2-G; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Collins PL, 2007, FIELDS VIROLOGY RESP, P1606; Corvaia N, 1997, J INFECT DIS, V176, P560, DOI 10.1086/514075; Crowe JE, 2001, J IMMUNOL, V167, P3910, DOI 10.4049/jimmunol.167.7.3910; de Waal L, 2004, VACCINE, V22, P915, DOI 10.1016/j.vaccine.2003.10.008; Falsey AR, 2008, J INFECT DIS, V198, P1317, DOI 10.1086/592168; Falsey AR, 2007, SEMIN RESP CRIT CARE, V28, P171, DOI 10.1055/s-2007-976489; FALSEY AR, 1995, J INFECT DIS, V172, P389, DOI 10.1093/infdis/172.2.389; Feldman SA, 1999, J VIROL, V73, P6610, DOI 10.1128/JVI.73.8.6610-6617.1999; GIANNINI G, 1984, NUCLEIC ACIDS RES, V12, P4063, DOI 10.1093/nar/12.10.4063; Graham BS, 2011, IMMUNOL REV, V239, P149, DOI 10.1111/j.1600-065X.2010.00972.x; Haynes LM, 2009, J INFECT DIS, V200, P439, DOI 10.1086/600108; Jiang WL, 2005, ADV DRUG DELIVER REV, V57, P391, DOI 10.1016/j.addr.2004.09.003; Libon C, 1999, VACCINE, V17, P406, DOI 10.1016/S0264-410X(98)00198-4; Libon C DF, 2007, 6 INT RESP SYNC VIR; Marchant A, 2006, J INFECT DIS, V193, P1598, DOI 10.1086/503775; Melendi GA, 2011, VIRUS GENES, V42, P46, DOI 10.1007/s11262-010-0545-9; Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013; Munoz FM, 2003, VACCINE, V21, P3465, DOI 10.1016/S0264-410X(03)00352-9; Murata Y, 2010, VACCINE, V28, P6242, DOI 10.1016/j.vaccine.2010.07.011; Mutuc Jeffry D., 2011, Morbidity and Mortality Weekly Report, V60, P1203; Nguyen TN, 1994, ADV BIOMAGNETIC SEPA, P73; Piedra PA, 2003, PEDIATR INFECT DIS J, V22, pS94, DOI 10.1097/00006454-200302001-00014; Plotnicky H, 2003, VACCINE, V21, P2651, DOI 10.1016/S0264-410X(03)00055-0; Plotnicky-Gilquin H, 2002, VIROLOGY, V303, P130, DOI 10.1006/viro.2002.1563; Plotnicky-Gilquin H, 1999, VIROLOGY, V258, P128, DOI 10.1006/viro.1999.9702; Plotnicky-Gilquin H, 1999, J VIROL, V73, P5637, DOI 10.1128/JVI.73.7.5637-5645.1999; Power UF, 2003, VACCINE, V22, P168, DOI 10.1016/S0264-410X(03)00570-X; Power UF, 1997, VIROLOGY, V230, P155, DOI 10.1006/viro.1997.8465; Power UF, 2001, VACCINE, V19, P2345, DOI 10.1016/S0264-410X(00)00525-9; Power UF, 2001, J VIROL, V75, P12421, DOI 10.1128/JVI.75.24.12421-12430.2001; Power UF, 2001, J INFECT DIS, V184, P1456, DOI 10.1086/324426; Power UF, 2008, J CLIN VIROL, V41, P38, DOI 10.1016/j.jcv.2007.10.024; Radu GU, 2010, J VIROL, V84, P9632, DOI 10.1128/JVI.00451-10; Roder C, 2000, J CHROMATOGR B, V737, P97, DOI 10.1016/S0378-4347(99)00442-9; Schallert N, 2002, EUR J IMMUNOL, V32, P752, DOI 10.1002/1521-4141(200203)32:3<752::AID-IMMU752>3.0.CO;2-5; Shadman KA, 2011, EXPERT OPIN BIOL TH, V11, P1455, DOI 10.1517/14712598.2011.608062; Simard C, 1997, VACCINE, V15, P423, DOI 10.1016/S0264-410X(97)00189-8; Tebbey PW, 1998, J EXP MED, V188, P1967, DOI 10.1084/jem.188.10.1967; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Tripp RA, 2003, J VIROL, V77, P6580, DOI 10.1128/JVI.77.11.6580-6584.2003; TRUDEL M, 1991, VIROLOGY, V185, P749, DOI 10.1016/0042-6822(91)90546-N; van Bleek Grada M, 2011, Vaccine, V29, P7285, DOI 10.1016/j.vaccine.2011.07.114; Zhang WL, 2010, J VIROL, V84, P1148, DOI 10.1128/JVI.01755-09; Zheng YP, 2012, PROTEIN EXPRES PURIF, V81, P115, DOI 10.1016/j.pep.2011.09.011	49	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34331	10.1371/journal.pone.0034331	http://dx.doi.org/10.1371/journal.pone.0034331			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479601	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400073
J	Burkewitz, K; Choe, KP; Lee, ECH; Deonarine, A; Strange, K				Burkewitz, Kristopher; Choe, Keith P.; Lee, Elaine Choung-Hee; Deonarine, Andrew; Strange, Kevin			Characterization of the Proteostasis Roles of Glycerol Accumulation, Protein Degradation and Protein Synthesis during Osmotic Stress in C. elegans	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; MAMMALIAN-CELL SIZE; CAENORHABDITIS-ELEGANS; THERMAL INACTIVATION; ORGANIC OSMOLYTES; AGGREGATION; HOMEOSTASIS; PROLINE; ACCLIMATION; CHAPERONES	Exposure of C. elegans to hypertonic stress-induced water loss causes rapid and widespread cellular protein damage. Survival in hypertonic environments depends critically on the ability of worm cells to detect and degrade misfolded and aggregated proteins. Acclimation of C. elegans to mild hypertonic stress suppresses protein damage and increases survival under more extreme hypertonic conditions. Suppression of protein damage in acclimated worms could be due to 1) accumulation of the chemical chaperone glycerol, 2) upregulation of protein degradation activity, and/or 3) increases in molecular chaperoning capacity of the cell. Glycerol and other chemical chaperones are widely thought to protect proteins from hypertonicity-induced damage. However, protein damage is unaffected by gene mutations that inhibit glycerol accumulation or that cause dramatic constitutive elevation of glycerol levels. Pharmacological or RNAi inhibition of proteasome and lyosome function and measurements of cellular protein degradation activity demonstrated that upregulation of protein degradation mechanisms plays no role in acclimation. Thus, changes in molecular chaperone capacity must be responsible for suppressing protein damage in acclimated worms. Transcriptional changes in chaperone expression have not been detected in C. elegans exposed to hypertonic stress. However, acclimation to mild hypertonicity inhibits protein synthesis 50-70%, which is expected to increase chaperone availability for coping with damage to existing proteins. Consistent with this idea, we found that RNAi silencing of essential translational components or acute exposure to cycloheximide results in a 50-80% suppression of hypertonicity-induced aggregation of polyglutamine-YFP (Q35::YFP). Dietary changes that increase protein production also increase Q35::YFP aggregation 70-180%. Our results demonstrate directly for the first time that inhibition of protein translation protects extant proteins from damage brought about by an environmental stressor, demonstrate important differences in aging-versus stress-induced protein damage, and challenge the widely held view that chemical chaperones are accumulated during hypertonic stress to protect protein structure/function.	[Burkewitz, Kristopher; Lee, Elaine Choung-Hee; Strange, Kevin] Mt Desert Isl Biol Lab, Boylan Ctr Cellular & Mol Physiol, Salsbury Cove, ME 04672 USA; [Choe, Keith P.; Deonarine, Andrew] Univ Florida, Dept Biol, Gainesville, FL USA	Mount Desert Island Biological Laboratory; State University System of Florida; University of Florida	Burkewitz, K (corresponding author), Mt Desert Isl Biol Lab, Boylan Ctr Cellular & Mol Physiol, Salsbury Cove, ME 04672 USA.	kstrange@mdibl.org		, Kristopher/0000-0001-8531-0566	NIH [R01 DK61168]; NIH National Research Service Award (NRSA) [F32 GM077904]; National Science Foundation (NSF) [IOS1120130]; Division Of Integrative Organismal Systems [1120130] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077904] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by NIH grant R01 DK61168 to KS and NIH National Research Service Award (NRSA) F32 GM077904 and National Science Foundation (NSF) IOS1120130 to KPC.	Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Burkewitz K, 2011, AM J PHYSIOL-CELL PH, V301, pC566, DOI 10.1152/ajpcell.00030.2011; Caldas T, 1999, MICROBIOL-SGM, V145, P2543, DOI 10.1099/00221287-145-9-2543; Cauchi RJ, 2006, NEURODEGENER DIS, V3, P338, DOI 10.1159/000097303; Chattopadhyay MK, 2004, J BACTERIOL, V186, P8149, DOI 10.1128/JB.186.23.8149-8152.2004; Choe KP, 2008, AM J PHYSIOL-CELL PH, V295, pC1488, DOI 10.1152/ajpcell.00450.2008; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Do Lee S, 2011, AM J PHYSIOL-RENAL, V300, pF707, DOI 10.1152/ajprenal.00227.2010; Eronina TB, 2009, BIOPHYS CHEM, V141, P66, DOI 10.1016/j.bpc.2008.12.007; Faber-Barata J, 2005, MOL CELL BIOCHEM, V269, P203, DOI 10.1007/s11010-005-3090-4; Faridi J, 2003, AM J PHYSIOL-ENDOC M, V285, pE964, DOI 10.1152/ajpendo.00239.2003; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; GANDHI S, 1980, MECH AGEING DEV, V12, P137, DOI 10.1016/0047-6374(80)90090-1; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Hamer G, 2010, NAT METHODS, V7, P473, DOI [10.1038/nmeth.1460, 10.1038/NMETH.1460]; Hannan RD, 2003, CLIN EXP PHARMACOL P, V30, P517, DOI 10.1046/j.1440-1681.2003.03873.x; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hu Char Y, 2009, F1000 Biol Rep, V1, P41; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Khan SH, 2010, IUBMB LIFE, V62, P891, DOI 10.1002/iub.406; King MA, 2008, MOL PHARMACOL, V73, P1052, DOI 10.1124/mol.107.043398; Komatsu H, 2008, PLOS BIOL, V6, P1730, DOI 10.1371/journal.pbio.0060196; Kourtis N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004547; Lamitina ST, 2004, AM J PHYSIOL-CELL PH, V286, pC785, DOI 10.1152/ajpcell.00381.2003; Lamitina T, 2006, P NATL ACAD SCI USA, V103, P12173, DOI 10.1073/pnas.0602987103; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Mehta R, 2010, ADV EXP MED BIOL, V694, P14; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Moulder KL, 1999, J NEUROSCI, V19, P705; Muyssen BTA, 2004, ENVIRON POLLUT, V130, P309, DOI 10.1016/j.envpol.2004.01.003; Natalello A, 2009, PROTEINS, V75, P509, DOI 10.1002/prot.22266; Neuhofer W, 2005, CONTRIB NEPHROL, V148, P21, DOI 10.1159/000086041; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Orsborn AM, 2007, DEVELOPMENT, V134, P3383, DOI 10.1242/dev.005181; Rohlfing AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009010; Samuel D, 2000, PROTEIN SCI, V9, P344; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Schultz T, 2007, BIOCHEM BIOPH RES CO, V355, P234, DOI 10.1016/j.bbrc.2007.01.149; Singh K, 2011, CURR BIOL, V21, P825, DOI 10.1016/j.cub.2011.04.010; So SH, 2011, GENES CELLS, V16, P639, DOI 10.1111/j.1365-2443.2011.01514.x; Solomon A, 2004, GENETICS, V167, P161, DOI 10.1534/genetics.167.1.161; SOMERO GN, 1986, AM J PHYSIOL, V251, pR197, DOI 10.1152/ajpregu.1986.251.2.R197; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Warringer J, 2010, MOL BIOL CELL, V21, P3080, DOI 10.1091/mbc.E10-01-0006; Wheeler JM, 2006, GENETICS, V174, P1327, DOI 10.1534/genetics.106.059089; Wu P, 2006, PROTEINS, V63, P290, DOI 10.1002/prot.20868; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Yoshida H, 2002, NEUROBIOL DIS, V10, P88, DOI 10.1006/nbdi.2002.0502; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817	59	27	29	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34153	10.1371/journal.pone.0034153	http://dx.doi.org/10.1371/journal.pone.0034153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470531	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000070
J	Dukers-Muijrers, NHTM; Morre, SA; Speksnijder, A; van der Sande, MAB; Hoebe, CJPA				Dukers-Muijrers, Nicole H. T. M.; Morre, Servaas A.; Speksnijder, Arjen; van der Sande, Marianne A. B.; Hoebe, Christian J. P. A.			Chlamydia trachomatis Test-of-Cure Cannot Be Based on a Single Highly Sensitive Laboratory Test Taken at Least 3 Weeks after Treatment	PLOS ONE			English	Article							AMPLIFICATION; INFECTION; WOMEN	Current test-of-cure practice in patients with Chlamydia trachomatis (Ct) infection is to confirm cure with a single test taken at least 3 weeks after treatment. Effectiveness of single-time-point testing however lacks a scientific evidence basis and the high sensitivity of laboratory assays nowadays in use for this purpose may compromise the clinical significance of their results. Prospectively following 59 treated Ct infections, administering care as usual, the presence of Ct plasmid DNA and rRNA was systematically assessed by multiple time-sequential measurements, i.e. on 18 samples taken per patient during 8 weeks following treatment with a single dose of 1000 mg Azythromycin. A high proportion (42%) of Ct infections tested positive on at least one of the samples taken after 3 weeks. Patients' test results showed substantial inter-individual and intra-individual variation over time and by type of NAAT used. We demonstrated frequent intermittent positive patterns in Ct test results over time, and strongly argue against current test-of-cure practice.	[Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.] S Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, South Limburg, Netherlands; [Dukers-Muijrers, Nicole H. T. M.; Hoebe, Christian J. P. A.] MUMC, Sch Publ Hlth & Primary Care CAPHRI, Dept Med Microbiol, Maastricht, Netherlands; [Morre, Servaas A.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Morre, Servaas A.] Univ Maastricht, Fac Hlth Med & Life Sci, Res Inst CAPHRI, Inst Publ Hlth Genom,Dept Genet & Cell Biol, Maastricht, Netherlands; [Morre, Servaas A.] Univ Maastricht, Fac Hlth Med & Life Sci, Res Inst GROW, Inst Publ Hlth Genom,Dept Genet & Cell Biol, Maastricht, Netherlands; [Speksnijder, Arjen] Hlth Serv Amsterdam, Publ Hlth Lab, Amsterdam, Netherlands; [van der Sande, Marianne A. B.] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands; [van der Sande, Marianne A. B.] Univ Med Ctr Utrecht, Julius Ctr, Utrecht, Netherlands	Maastricht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Maastricht University; Maastricht University; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Dukers-Muijrers, NHTM (corresponding author), S Limburg Publ Hlth Serv, Dept Sexual Hlth Infect Dis & Environm Hlth, Geleen, South Limburg, Netherlands.	nicole.dukers@ggdzl.nl	Speksnijder, Arjen/M-3406-2017; Dukers-Muijrers, Nicole/M-7178-2014	Speksnijder, Arjen/0000-0002-1966-7265; Hoebe, Christian/0000-0003-1815-0974; Dukers-Muijrers, Nicole/0000-0003-4896-758X; van der Sande, Marianne AB/0000-0002-4778-6739	Dutch National Institute for Environment and Health, Centre for Infectious Diseases Control [3900051587]	Dutch National Institute for Environment and Health, Centre for Infectious Diseases Control	This work was supported by an unrestricted grant from the Dutch National Institute for Environment and Health, Centre for Infectious Diseases Control [3900051587]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	British Association for Sexual Health and HIV (BASHH), 2010, CHLAM TRACH; Catsburg A, 2006, 11 INT S HUM CHLAM I, P521; Centers for Disease Control and Prevention, 2010, MMWR RECOMM REP, V59, P1484; Drummond F, 2011, INT J STD AIDS, V22, P478, DOI 10.1258/ijsa.2011.010490; Geisler WM, 2011, SEX TRANSM INFECT, V87, pA76, DOI 10.1136/sextrans-2011-050109.123; Hadgu A, 2009, EUR J CLIN MICROBIOL, V28, P9, DOI 10.1007/s10096-008-0586-3; Handsfield HH, 2011, SEX TRANSM DIS, V38, P1028, DOI 10.1097/OLQ.0b013e318227a366; Heijne J, 2011, SEX TRANSM INFECT, V87, pA22, DOI 10.1136/sextrans-2011-050109.5; Hoover K, 2011, SEX TRANSM INFECT, V87, pA22, DOI 10.1136/sextrans-2011-050109.4; Horner P, 2006, SEX TRANSM INFECT, V82, P340, DOI 10.1136/sti.2005.019158; Morre SA, 1998, J CLIN PATHOL-MOL PA, V51, P149; Suchland RJ, 2009, IN VITRO ANTIMIC NOV, P4604	12	38	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34108	10.1371/journal.pone.0034108	http://dx.doi.org/10.1371/journal.pone.0034108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470526	Green Published, gold			2022-12-27	WOS:000304489000066
J	Nercessian, O; Parot, S; Delia, ML; Bergel, A; Achouak, W				Nercessian, Olivier; Parot, Sandrine; Delia, Marie-Line; Bergel, Alain; Achouak, Wafa			Harvesting Electricity with Geobacter bremensis Isolated from Compost	PLOS ONE			English	Article							ELECTROCHEMICALLY ACTIVE BIOFILMS; EXTRACELLULAR ELECTRON-TRANSFER; POLYMERASE-CHAIN-REACTION; RIBOSOMAL-RNA; FE(III)-REDUCING BACTERIUM; SHEWANELLA-PUTREFACIENS; GARDEN COMPOST; FUEL-CELL; GENERATION; REDUCTION	Electrochemically active (EA) biofilms were formed on metallic dimensionally stable anode-type electrode (DSA), embedded in garden compost and polarized at +0.50 V/SCE. Analysis of 16S rRNA gene libraries revealed that biofilms were heavily enriched in Deltaproteobacteria in comparison to control biofilms formed on non-polarized electrodes, which were preferentially composed of Gammaproteobacteria and Firmicutes. Among Deltaproteobacteria, sequences affiliated with Pelobacter and Geobacter genera were identified. A bacterial consortium was cultivated, in which 25 isolates were identified as Geobacter bremensis. Pure cultures of 4 different G. bremensis isolates gave higher current densities (1400 mA/m(2) on DSA, 2490 mA/m(2) on graphite) than the original multi-species biofilms (in average 300 mA/m(2) on DSA) and the G. bremensis DSM type strain (100-300 A/m(2) on DSA; 2485 mA/m(2) on graphite). FISH analysis confirmed that G. bremensis represented a minor fraction in the original EA biofilm, in which species related to Pelobacter genus were predominant. The Pelobacter type strain did not show EA capacity, which can explain the lower performance of the multi-species biofilms. These results stressed the great interest of extracting and culturing pure EA strains from wild EA biofilms to improve the current density provided by microbial anodes.	[Nercessian, Olivier; Achouak, Wafa] CEA, SBVME, IBEB, DSV,Lab Ecol Microb Rhizosphere & Environ Extrem, St Paul Les Durance, France; [Nercessian, Olivier; Achouak, Wafa] CNRS UMR 7265, St Paul Les Durance, France; [Nercessian, Olivier; Achouak, Wafa] FR CNRS 3098 ECCOREV, St Paul Les Durance, France; [Nercessian, Olivier; Achouak, Wafa] Aix Marseille Univ, St Paul Les Durance, France; [Parot, Sandrine; Delia, Marie-Line; Bergel, Alain] Univ Toulouse INPT, CNRS, Lab Genie Chim, Toulouse, France	CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Nercessian, O (corresponding author), CEA, SBVME, IBEB, DSV,Lab Ecol Microb Rhizosphere & Environ Extrem, St Paul Les Durance, France.	wafa.achouak@cea.fr	Achouak, Wafa W/J-3160-2016; Bergel, Alain/GVS-8027-2022; Achouak, Wafa/AAX-8916-2021	Achouak, Wafa W/0000-0003-4297-6661; Achouak, Wafa/0000-0003-4297-6661; BERGEL, Alain/0000-0002-0637-1828	European Community [NEST 508866]	European Community(European Commission)	This work was supported by the 6th FP of the European Community under the "Electrochemically Active Biofilms'' project (NEST 508866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achouak W, 2000, FEMS MICROBIOL ECOL, V31, P11, DOI 10.1111/j.1574-6941.2000.tb00666.x; Achouak W, 1999, INT J SYST BACTERIOL, V49, P787, DOI 10.1099/00207713-49-2-787; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Dulon S, 2007, J APPL ELECTROCHEM, V37, P173, DOI 10.1007/s10800-006-9250-8; Dumas C, 2008, ELECTROCHIM ACTA, V53, P3200, DOI 10.1016/j.electacta.2007.10.066; Erable B, 2009, ENVIRON SCI TECHNOL, V43, P3194, DOI 10.1021/es803549v; Freguia S, 2010, BIORESOURCE TECHNOL, V101, P1233, DOI 10.1016/j.biortech.2009.09.054; Haichar FEZ, 2007, ENVIRON MICROBIOL, V9, P625, DOI 10.1111/j.1462-2920.2006.01182.x; Holmes DE, 2004, MICROB ECOL, V48, P178, DOI 10.1007/s00248-003-0004-4; Kim BH, 1999, BIOTECHNOL TECH, V13, P475, DOI 10.1023/A:1008993029309; Kim BH, 1999, J MICROBIOL BIOTECHN, V9, P127; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Mussmann M, 2005, ENVIRON MICROBIOL, V7, P405, DOI 10.1111/j.1462-2920.2005.00708.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Parameswaran P, 2010, BIOTECHNOL BIOENG, V105, P69, DOI 10.1002/bit.22508; Parot S, 2009, J APPL MICROBIOL, V106, P1350, DOI 10.1111/j.1365-2672.2008.04103.x; Parot S, 2008, BIORESOURCE TECHNOL, V99, P4809, DOI 10.1016/j.biortech.2007.09.047; Parot S, 2008, ELECTROCHIM ACTA, V53, P2737, DOI 10.1016/j.electacta.2007.10.059; Pernthaler J, 2001, METHOD MICROBIOL, V30, P207, DOI 10.1016/S0580-9517(01)30046-6; Pham TH, 2008, APPL MICROBIOL BIOT, V77, P1119, DOI 10.1007/s00253-007-1248-6; Richter H, 2007, APPL ENVIRON MICROB, V73, P5347, DOI 10.1128/AEM.00804-07; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Straub KL, 2004, ARCH MICROBIOL, V182, P175, DOI 10.1007/s00203-004-0686-0; Straub KL, 2001, INT J SYST EVOL MICR, V51, P1805, DOI 10.1099/00207713-51-5-1805; Tender LM, 2002, NAT BIOTECHNOL, V20, P821, DOI 10.1038/nbt716; Torres CI, 2009, ENVIRON SCI TECHNOL, V43, P9519, DOI 10.1021/es902165y; Torres CI, 2010, FEMS MICROBIOL REV, V34, P3, DOI 10.1111/j.1574-6976.2009.00191.x; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Xing DF, 2008, ENVIRON SCI TECHNOL, V42, P4146, DOI 10.1021/es800312v; Zuo Y, 2008, APPL ENVIRON MICROB, V74, P3130, DOI 10.1128/AEM.02732-07	33	25	27	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34216	10.1371/journal.pone.0034216	http://dx.doi.org/10.1371/journal.pone.0034216			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470538	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000077
J	Sumbayev, VV; Yasinska, I; Oniku, AE; Streatfield, CL; Gibbs, BF				Sumbayev, Vadim V.; Yasinska, Inna; Oniku, Abraham E.; Streatfield, Claire L.; Gibbs, Bernhard F.			Involvement of Hypoxia-Inducible Factor-1 in the Inflammatory Responses of Human LAD2 Mast Cells and Basophils	PLOS ONE			English	Article							FC-EPSILON-RI; HIF-1-ALPHA PROTEIN; ACTIVATION; IL-6; INHIBITION; SECRETION; APOPTOSIS; DEPLETION; ASK1; ATP	We recently showed that hypoxia-inducible factor 1 (HIF-1) plays a crucial role in the pro-allergic functions of human basophils by transcriptional control of energy metabolism via glycolysis as well as directly triggering expression of the angiogenic cytokine vascular endothelium growth factor (VEGF). Here, we investigated HIF-1 involvement in controlling the synthesis of angiogenic and inflammatory cytokines from various human effector cells stimulated by IgE-dependent or innate immune triggers. Purified primary human basophils, LAD2 human mast cells and THP-1 human myeloid cells were used for investigations of FceRI and Toll-like receptor (TLR) ligand-induced responses. In contrast to basophils, LAD2 mast cells expressed background levels of HIF-1 alpha, which was largely independent of the effects of stem cell factor (SCF). Both mast cells and basophils expressed TLR2 and 4, albeit weakly compared to THP-1 cells. Cytokine production in mast cells following TLR ligand stimulation was markedly reduced by HIF-1 alpha knockdown in LAD2 mast cells. In contrast, although HIF-1 is involved in IgE-mediated IL-4 secretion from basophils, it is not clearly induced by peptidoglycan (PGN). HIF-1 alpha accumulation is critical for sustaining human allergic effector cell survival and function. This transcription complex facilitates generation of both pro-angiogenic and inflammatory cytokines in mast cells but has a differential role in basophil stimulation comparing IgE-dependent triggering with innate immune stimuli.	[Sumbayev, Vadim V.; Yasinska, Inna; Oniku, Abraham E.; Streatfield, Claire L.; Gibbs, Bernhard F.] Univ Kent, Medway Sch Pharm, Chatham, Kent, England	University of Greenwich; University of Kent	Sumbayev, VV (corresponding author), Univ Kent, Medway Sch Pharm, Chatham, Kent, England.	V.Sumbayev@kent.ac.uk; B.F.Gibbs@kent.ac.uk	Sumbayev, Vadim/HCH-7696-2022	Yasinska, Inna/0000-0002-0775-1689	Asthma UK [10/065]	Asthma UK	Work was supported by the Asthma UK Grant (grant number 10/065 - to BFG and VS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bieneman AP, 2005, J ALLERGY CLIN IMMUN, V115, P295, DOI 10.1016/j.jaci.2004.10.018; Crivellato E, 2010, INT ARCH ALLERGY IMM, V151, P89, DOI 10.1159/000235998; Falcone FH, 2000, BLOOD, V96, P4028; Gibbs BF, 2008, CLIN EXP ALLERGY, V38, P480, DOI 10.1111/j.1365-2222.2007.02919.x; Gibbs BF, 2006, J ALLERGY CLIN IMMUN, V118, P1060, DOI 10.1016/j.jaci.2006.07.022; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kitahata Y, 2010, INT ARCH ALLERGY IMM, V152, P22, DOI 10.1159/000312122; Lall H, 2008, MOL IMMUNOL, V45, P3045, DOI 10.1016/j.molimm.2008.03.014; Lee SA, 2011, BIOCHEM BIOPH RES CO, V408, P132, DOI 10.1016/j.bbrc.2011.03.136; McCurdy JD, 2003, J IMMUNOL, V170, P1625, DOI 10.4049/jimmunol.170.4.1625; Nicholas SA, 2011, INT J BIOCHEM CELL B, V43, P674, DOI 10.1016/j.biocel.2011.01.012; Nicholas SA, 2011, CELL MOL LIFE SCI, V68, P151, DOI 10.1007/s00018-010-0450-3; Nicholas SA, 2009, CELL RES, V19, P973, DOI 10.1038/cr.2009.44; Oldford SA, 2010, J IMMUNOL, V185, P7067, DOI 10.4049/jimmunol.1001137; Pchejetski D, 2011, IMMUNOL CELL BIOL, V89, P268, DOI 10.1038/icb.2010.91; Pedersen M, 2008, BIOCHEM BIOPH RES CO, V377, P98, DOI 10.1016/j.bbrc.2008.09.102; Pendleton A, 2003, J BIOL CHEM, V278, P14394, DOI 10.1074/jbc.M206393200; Sumbayev VV, 2008, FEBS LETT, V582, P319, DOI 10.1016/j.febslet.2007.12.024; Sumbayev VV, 2010, ARCH IMMUNOL THER EX, V58, P287, DOI 10.1007/s00005-010-0083-0; Sumbayev VV, 2009, EUR J IMMUNOL, V39, P3511, DOI 10.1002/eji.200939370; Tancowny BP, 2010, IMMUNOLOGY, V131, P220, DOI 10.1111/j.1365-2567.2010.03296.x; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Tu Y, 2005, GASTROENTEROLOGY, V129, P928, DOI 10.1053/j.gastro.2005.06.014; Varadaradjalou S, 2003, EUR J IMMUNOL, V33, P899, DOI 10.1002/eji.200323830; Walczak-Drzewiecka A, 2008, J IMMUNOL, V181, P1665, DOI 10.4049/jimmunol.181.3.1665; Zarember KA, 2005, J CLIN INVEST, V115, P1702, DOI 10.1172/JCI25740	27	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34259	10.1371/journal.pone.0034259	http://dx.doi.org/10.1371/journal.pone.0034259			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470546	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000304489000085
J	Zapassky, E; Gadot, Y; Finkelstein, I; Benenson, I				Zapassky, Elena; Gadot, Yuval; Finkelstein, Israel; Benenson, Itzhak			An Ancient Relation between Units of Length and Volume Based on a Sphere	PLOS ONE			English	Article								The modern metric system defines units of volume based on the cube. We propose that the ancient Egyptian system of measuring capacity employed a similar concept, but used the sphere instead. When considered in ancient Egyptian units, the volume of a sphere, whose circumference is one royal cubit, equals half a hekat. Using the measurements of large sets of ancient containers as a database, the article demonstrates that this formula was characteristic of Egyptian and Egyptian-related pottery vessels but not of the ceramics of Mesopotamia, which had a different system of measuring length and volume units.	[Zapassky, Elena; Gadot, Yuval; Finkelstein, Israel] Tel Aviv Univ, Inst Archaeol, Tel Aviv, Israel; [Benenson, Itzhak] Tel Aviv Univ, Dept Geog & Human Environm, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Zapassky, E (corresponding author), Tel Aviv Univ, Inst Archaeol, Tel Aviv, Israel.	bennya@post.tau.ac.il	Benenson, Itzhak/R-3666-2016	Benenson, Itzhak/0000-0003-0704-0673	European Research Council [229418]	European Research Council(European Research Council (ERC)European Commission)	This study was supported by the European Research Council Advanced Grant no 229418, titled Reconstructing Ancient Israel: The Exact and Life Sciences Perspective (RAIELSP), see http://erc.europa.eu/index.cfm?fuseaction = page. display&topicID = 517. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, B AM SCH ORIENTAL RE, V316, P1; ARIE E., 2006, MEGIDDO, V24, P191; Aston D. A., 1998, KERAMIK GRABUNGSPLAT, V1; Aston David, 1999, POTTERY LATE NEW KIN; Balensi J, 1980, THESIS U SCI HUMAINE, VII; Barta M., 1996, CAHIERS CERAMIQUE EG, V4, P127; Bell L, 2011, ASHKELON, P397; Ben-Tor A, QEDEM REPORTS; Bienkowski P, 2011, TOOLEY GIFTS NILE AN; Bikai P.M., 1987, PHOENICIAN POTTERY C; Bikai P.M., 1978, THE POTTERY OF TYRE; Briend J, 1980, TELL KEISAN 1971 197, P197; Castel G, 1980, D ELMEDINEH 1970 FOU; de Miroschedji P, 2002, EGYPT LEVANT INTERRE, P39; Duistermaat K., 2008, POTS POTTERS ASSYRIA; Finkelstein I, 2012, AGYPTEN LEV IN PRESS; Guy PLO, 1938, MEG TOMBS; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; HARTIGAN PM, 1985, J R STAT SOC C-APPL, V34, P320; Hayes WC, 1959, SCEPTER EGYPT BACK 1; Helck W., 1980, LEXIKON AGYPTOLOGIE LEXIKON AGYPTOLOGIE, P1199; Holthoer R, 1977, NEW KINGDOM PHARAONI; Imhausen Annette, 2007, MATH EGYPT MESOPOTAM, P7; Karageorghis V, 1983, PALAEPAPHOS SKALES; KEEL O., 1998, GODS GODDESSES IMAGE; Loud G., 1948, ORIENTAL I PUBLICATI, V62; Mazar A, 1985, EXCAVATIONS TELL Q 2; Peet T. E., 1923, RHIND MATH PAPYRUS B; Pommerening Tanja, 2005, ALTAGYPTISCHEN HOHLM; Redford D.B, 1992, EGYPT CANAAN ISRAEL; Robins G., 1987, RHIND MATH PAPYRUS A; Rose P., 2007, 18 DYNASTY POTTERY C; Roux V, 2012, EGYPTIAN TYPE POTTER; Sowada K. N., 2009, EGYPT E MEDITERRANEA; Stager L.E., 1992, CHRONOLOGIES OLD WOR, P22; Stager LE, 2001, ORIENTAL I U CHICAGO, V59, P625; Winter IJ, 1976, IRAQ, V38, P1, DOI DOI 10.2307/4200021; ZAPASSKY E., 2006, MONOGRAPH SERIES I A, V24, P601; Zarzecki-Peleg A., 2005, THESIS HEBREW U JERU; Zupko Ronald Edward, 1990, REVOLUTION MEASUREME	40	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33895	10.1371/journal.pone.0033895	http://dx.doi.org/10.1371/journal.pone.0033895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470489	Green Submitted, Green Published, gold			2022-12-27	WOS:000304489000042
J	Secora, KR; Peterson, JR; Urbano, CM; Chung, B; Okanoya, K; Cooper, BG				Secora, Kristen R.; Peterson, Jennifer R.; Urbano, Catherine M.; Chung, Boah; Okanoya, Kazuo; Cooper, Brenton G.			Syringeal Specialization of Frequency Control during Song Production in the Bengalese Finch (Lonchura striata domestica)	PLOS ONE			English	Article							AUDITORY-FEEDBACK; VOCAL PRODUCTION; MOTOR DYNAMICS; HUMAN SPEECH; LATERALIZATION; BIRD; MAINTENANCE; MECHANISMS; DOMINANCE; LANGUAGE	Background: Singing in songbirds is a complex, learned behavior which shares many parallels with human speech. The avian vocal organ (syrinx) has two potential sound sources, and each sound generator is under unilateral, ipsilateral neural control. Different songbird species vary in their use of bilateral or unilateral phonation (lateralized sound production) and rapid switching between left and right sound generation (interhemispheric switching of motor control). Bengalese finches (Lonchura striata domestica) have received considerable attention, because they rapidly modify their song in response to manipulations of auditory feedback. However, how the left and right sides of the syrinx contribute to acoustic control of song has not been studied. Methodology: Three manipulations of lateralized syringeal control of sound production were conducted. First, unilateral syringeal muscular control was eliminated by resection of the left or right tracheosyringeal portion of the hypoglossal nerve, which provides neuromuscular innervation of the syrinx. Spectral and temporal features of song were compared before and after lateralized nerve injury. In a second experiment, either the left or right sound source was devoiced to confirm the role of each sound generator in the control of acoustic phonology. Third, air pressure was recorded before and after unilateral denervation to enable quantification of acoustic change within individual syllables following lateralized nerve resection. Significance: These experiments demonstrate that the left sound source produces louder, higher frequency, lower entropy sounds, and the right sound generator produces lower amplitude, lower frequency, higher entropy sounds. The bilateral division of labor is complex and the frequency specialization is the opposite pattern observed in most songbirds. Further, there is evidence for rapid interhemispheric switching during song production. Lateralized control of song production in Bengalese finches may enhance acoustic complexity of song and facilitate the rapid modification of sound production following manipulations of auditory feedback.	[Secora, Kristen R.; Peterson, Jennifer R.; Urbano, Catherine M.; Chung, Boah; Cooper, Brenton G.] Texas Christian Univ, Dept Psychol, Ft Worth, TX 76129 USA; [Okanoya, Kazuo] Univ Tokyo, Dept Cognit & Behav Sci, Tokyo, Japan	Texas Christian University; University of Tokyo	Secora, KR (corresponding author), Texas Christian Univ, Dept Psychol, Ft Worth, TX 76129 USA.	Brenton.cooper@tcu.edu			Texas Christian University [6052]	Texas Christian University	This work was supported by the Texas Christian University Research and Creative Activities Award, #6052. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN SE, 1994, J NEUROBIOL, V25, P1154, DOI 10.1002/neu.480250910; Amador A, 2008, J NEUROPHYSIOL, V99, P2383, DOI 10.1152/jn.01002.2007; Baynes K, 2005, LINGUIST REV, V22, P303, DOI 10.1515/tlir.2005.22.2-4.303; Cooper BG, 2004, J NEUROBIOL, V61, P317, DOI 10.1002/neu.20062; Cooper BG, 2006, J NEUROPHYSIOL, V95, P3798, DOI 10.1152/jn.01123.2005; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Franz M, 2002, J NEUROBIOL, V51, P129, DOI 10.1002/neu.10043; Ghosh SS, 2008, J SPEECH LANG HEAR R, V51, P1183, DOI 10.1044/1092-4388(2008/07-0119); Goller F, 2004, ANN NY ACAD SCI, V1016, P130, DOI 10.1196/annals.1298.009; Goller F, 1996, J NEUROPHYSIOL, V75, P867, DOI 10.1152/jn.1996.75.2.867; Goller F, 1996, J NEUROPHYSIOL, V76, P287, DOI 10.1152/jn.1996.76.1.287; Goller F, 1999, J NEUROBIOL, V41, P513, DOI 10.1002/(SICI)1097-4695(199912)41:4<513::AID-NEU7>3.0.CO;2-P; GOLLER F, 1995, NATURE, V373, P63, DOI 10.1038/373063a0; HARRIS LJ, 1989, CAN J PSYCHOL, V43, P369, DOI 10.1037/h0084228; Honda E, 1999, ZOOL SCI, V16, P319, DOI 10.2108/zsj.16.319; Hopkins WD, 2007, PSYCHOL SCI, V18, P971, DOI 10.1111/j.1467-9280.2007.02011.x; Jensen KK, 2007, P R SOC B, V274, P2703, DOI 10.1098/rspb.2007.0781; Leybaert J, 2003, INT J AUDIOL, V42, pS34; Magat M, 2009, P ROY SOC B-BIOL SCI, V276, P4155, DOI 10.1098/rspb.2009.1397; Nealen PM, 2002, J COMP PHYSIOL A, V188, P929, DOI 10.1007/s00359-002-0357-z; NOTTEBOHM F, 1976, J COMP PHYSIOL, V108, P171, DOI 10.1007/BF02169047; NOTTEBOHM F, 1971, J EXP ZOOL, V177, P229, DOI 10.1002/jez.1401770210; Okanoya K, 2004, ADV STUD BEHAV, V34, P297, DOI 10.1016/S0065-3454(04)34008-8; Okanoya K, 1997, J NEUROBIOL, V33, P343; Okanoya K, 1995, ZOOL SCI, V12, P801, DOI 10.2108/zsj.12.801; Okanoya K, 1994, NERVOUS SYSTEMS BEHA; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Riede T, 2010, BRAIN LANG, V115, P69, DOI 10.1016/j.bandl.2009.11.003; Rutledge R, 2004, ANIM BEHAV, V67, P327, DOI 10.1016/j.anbehav.2003.07.002; Sakata JT, 2006, J NEUROSCI, V26, P9619, DOI 10.1523/JNEUROSCI.2027-06.2006; Schmidt MF, 2008, PLOS BIOL, V6, P2089, DOI 10.1371/journal.pbio.0060269; Schmidt MF, 2004, ANN NY ACAD SCI, V1016, P171, DOI 10.1196/annals.1298.014; Schmidt MF, 2003, J NEUROPHYSIOL, V90, P3931, DOI 10.1152/jn.00003.2003; Sober SJ, 2008, J NEUROSCI, V28, P10370, DOI 10.1523/JNEUROSCI.2448-08.2008; Sober SJ, 2009, NAT NEUROSCI, V12, P927, DOI 10.1038/nn.2336; Suthers RA, 2004, ANN NY ACAD SCI, V1016, P109, DOI 10.1196/annals.1298.041; Suthers RA, 1997, J NEUROBIOL, V33, P632, DOI 10.1002/(SICI)1097-4695(19971105)33:5<632::AID-NEU10>3.0.CO;2-B; SUTHERS RA, 1994, J NEUROBIOL, V25, P917, DOI 10.1002/neu.480250803; Suthers RA, 2002, P NATL ACAD SCI USA, V99, P5680, DOI 10.1073/pnas.042103199; Suthers RA, 2004, J NEUROBIOL, V60, P381, DOI 10.1002/neu.20040; Suthers RA, 2011, J COMP PHYSIOL A, V197, P45, DOI 10.1007/s00359-010-0585-6; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Wang CZH, 2008, PLOS BIOL, V6, P2154, DOI 10.1371/journal.pbio.0060250; Watanabe A, 1998, ZOOL SCI, V15, P837, DOI 10.2108/zsj.15.837; Wetzel W, 1998, NEUROSCI LETT, V252, P115, DOI 10.1016/S0304-3940(98)00561-8; WILLIAMS H, 1992, J NEUROBIOL, V23, P1006, DOI 10.1002/neu.480230807; Woolley SMN, 1997, J NEUROSCI, V17, P6380	48	19	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34135	10.1371/journal.pone.0034135	http://dx.doi.org/10.1371/journal.pone.0034135			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479543	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900064
J	Tramper, JJ; van den Broek, B; Wiegerinck, W; Kappen, HJ; Gielen, S				Tramper, Julian J.; van den Broek, Bart; Wiegerinck, Wim; Kappen, Hilbert J.; Gielen, Stan			Time-Integrated Position Error Accounts for Sensorimotor Behavior in Time-Constrained Tasks	PLOS ONE			English	Article							OPTIMAL FEEDBACK-CONTROL; ADAPTIVE-CONTROL; ADAPTATION; STRATEGIES; MOVEMENTS	Several studies have shown that human motor behavior can be successfully described using optimal control theory, which describes behavior by optimizing the trade-off between the subject's effort and performance. This approach predicts that subjects reach the goal exactly at the final time. However, another strategy might be that subjects try to reach the target position well before the final time to avoid the risk of missing the target. To test this, we have investigated whether minimizing the control effort and maximizing the performance is sufficient to describe human motor behavior in time-constrained motor tasks. In addition to the standard model, we postulate a new model which includes an additional cost criterion which penalizes deviations between the position of the effector and the target throughout the trial, forcing arrival on target before the final time. To investigate which model gives the best fit to the data and to see whether that model is generic, we tested both models in two different tasks where subjects used a joystick to steer a ball on a screen to hit a target (first task) or one of two targets (second task) before a final time. Noise of different amplitudes was superimposed on the ball position to investigate the ability of the models to predict motor behavior for different levels of uncertainty. The results show that a cost function representing only a trade-off between effort and accuracy at the end time is insufficient to describe the observed behavior. The new model correctly predicts that subjects steer the ball to the target position well before the final time is reached, which is in agreement with the observed behavior. This result is consistent for all noise amplitudes and for both tasks.	[Tramper, Julian J.; van den Broek, Bart; Wiegerinck, Wim; Kappen, Hilbert J.; Gielen, Stan] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Biophys, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Tramper, JJ (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Biophys, NL-6525 ED Nijmegen, Netherlands.	j.tramper@donders.ru.nl	Kappen, H.J./L-4425-2015; Wiegerinck, Wim/J-2510-2012; Gielen, Stan CAM/D-3380-2009					Bellman R., 1957, DYNAMIC PROGRAMMING; Braun DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000468; Braun DA, 2009, J NEUROSCI, V29, P6472, DOI 10.1523/JNEUROSCI.3075-08.2009; Chen-Harris H, 2008, J NEUROSCI, V28, P2804, DOI 10.1523/JNEUROSCI.5300-07.2008; Chhabra M, 2006, J NEUROSCI, V26, P10883, DOI 10.1523/JNEUROSCI.2238-06.2006; Day BL, 2000, EXP BRAIN RES, V130, P159, DOI 10.1007/s002219900218; Diedrichsen J, 2007, CURR BIOL, V17, P1675, DOI 10.1016/j.cub.2007.08.051; Franklin DW, 2008, J NEUROSCI, V28, P14165, DOI 10.1523/JNEUROSCI.4406-08.2008; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Kappen HJ, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/11/P11011; Kappen HJ, 2005, PHYS REV LETT, V95, DOI [10.1103/PhysRevLett.95.200201, 10.1103/PhysRevLett.200201]; Kording KP, 2004, P NATL ACAD SCI USA, V101, P9839, DOI 10.1073/pnas.0308394101; Liu D, 2007, J NEUROSCI, V27, P9354, DOI 10.1523/JNEUROSCI.1110-06.2007; Nagengast AJ, 2011, J NEUROPHYSIOL, V105, P2668, DOI 10.1152/jn.00804.2010; Nagengast AJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000857; Nagengast AJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000419; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Sims CR, 2011, J NEUROSCI, V31, P928, DOI 10.1523/JNEUROSCI.4240-10.2011; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Vinter R., 2010, OPTIMAL CONTROL	23	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33724	10.1371/journal.pone.0033724	http://dx.doi.org/10.1371/journal.pone.0033724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470464	Green Published, Green Submitted, gold			2022-12-27	WOS:000303857100041
J	Carilli, J; Donner, SD; Hartmann, AC				Carilli, Jessica; Donner, Simon D.; Hartmann, Aaron C.			Historical Temperature Variability Affects Coral Response to Heat Stress	PLOS ONE			English	Article							THERMAL TOLERANCE; OXIDATIVE STRESS; REEF; GROWTH; PORITES; SUSCEPTIBILITY; ADAPTATION; ANNULARIS; MORTALITY; PATTERNS	Coral bleaching is the breakdown of symbiosis between coral animal hosts and their dinoflagellate algae symbionts in response to environmental stress. On large spatial scales, heat stress is the most common factor causing bleaching, which is predicted to increase in frequency and severity as the climate warms. There is evidence that the temperature threshold at which bleaching occurs varies with local environmental conditions and background climate conditions. We investigated the influence of past temperature variability on coral susceptibility to bleaching, using the natural gradient in peak temperature variability in the Gilbert Islands, Republic of Kiribati. The spatial pattern in skeletal growth rates and partial mortality scars found in massive Porites sp. across the central and northern islands suggests that corals subject to larger year-to-year fluctuations in maximum ocean temperature were more resistant to a 2004 warm-water event. In addition, a subsequent 2009 warm event had a disproportionately larger impact on those corals from the island with lower historical heat stress, as indicated by lower concentrations of triacylglycerol, a lipid utilized for energy, as well as thinner tissue in those corals. This study indicates that coral reefs in locations with more frequent warm events may be more resilient to future warming, and protection measures may be more effective in these regions.	[Carilli, Jessica] Australian Nucl Sci & Technol Org, Inst Environm Res, Lucas Heights, NSW, Australia; [Donner, Simon D.] Univ British Columbia, Dept Geog, Vancouver, BC, Canada; [Hartmann, Aaron C.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Australian Nuclear Science & Technology Organisation; University of British Columbia; University of California System; University of California San Diego; Scripps Institution of Oceanography	Carilli, J (corresponding author), Australian Nucl Sci & Technol Org, Inst Environm Res, Lucas Heights, NSW, Australia.	jcarilli@gmail.com			Natural Sciences and Engineering Research Council of Canada; Australian Nuclear Science and Technology Organization; United States National Science Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Nuclear Science and Technology Organization; United States National Science Foundation(National Science Foundation (NSF))	This work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant (SDD; www.nserc-crsng.gc.ca), an Australian Nuclear Science and Technology Organization Postdoctoral Fellowship (JC; ansto.gov.au), and a United States National Science Foundation Graduate Research Fellowship (ACH; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2007, LIMNOL OCEANOGR, V52, P716, DOI 10.4319/lo.2007.52.2.0716; Anthony KRN, 2006, MAR ECOL PROG SER, V319, P111, DOI 10.3354/meps319111; BARNES DJ, 1992, J EXP MAR BIOL ECOL, V159, P113, DOI 10.1016/0022-0981(92)90261-8; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; Benson AA, 1972, P BIOCH SOC, V128, P1; Berkelmans R, 1999, CORAL REEFS, V18, P219, DOI 10.1007/s003380050186; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Brown BE, 2002, CORAL REEFS, V21, P119, DOI 10.1007/s00338-002-0215-z; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carilli JE, 2010, B MAR SCI, V86, P709; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Castillo KD, 2005, MAR BIOL, V148, P261, DOI 10.1007/s00227-005-0046-x; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2010, ATOLL RES B, P587; Donner SD, 2011, ECOL APPL, V21, P1718, DOI 10.1890/10-0107.1; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; GOREAU TJ, 1994, AMBIO, V23, P176; Halley R, 2007, GEOLOGICAL APPROACHE; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; LEDER JJ, 1991, CORAL REEFS, V10, P19, DOI 10.1007/BF00301902; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Lough JM, 2000, GEOPHYS RES LETT, V27, P3901, DOI 10.1029/2000GL011715; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Maynard JA, 2008, MAR BIOL, V155, P173, DOI 10.1007/s00227-008-1015-y; McWilliams JP, 2005, ECOLOGY, V86, P2055, DOI 10.1890/04-1657; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; Rodrigues L, 2005, THESIS U PENNSYLVANI; Rodrigues LJ, 2008, J EXP MAR BIOL ECOL, V358, P136, DOI 10.1016/j.jembe.2008.02.004; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Strong A.E., 1997, P 8 INT COR REEF S, V2, P1495; Strong AE, 2004, B MAR SCI, V75, P259; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Williams GJ, 2010, MAR POLLUT BULL, V60, P1467, DOI 10.1016/j.marpolbul.2010.05.009; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013; Yee SH, 2008, ECOL MODEL, V218, P162, DOI 10.1016/j.ecolmodel.2008.06.037	52	100	103	0	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34418	10.1371/journal.pone.0034418	http://dx.doi.org/10.1371/journal.pone.0034418			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479626	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339100156
J	Dong, HY; Shi, L; Zhao, XQ; Sang, B; Lv, B; Liu, ZG; Wan, KL				Dong, Haiyan; Shi, Li; Zhao, Xiuqin; Sang, Ba; Lv, Bing; Liu, Zhiguang; Wan, Kanglin			Genetic Diversity of Mycobacterium tuberculosis Isolates from Tibetans in Tibet, China	PLOS ONE			English	Article							BEIJING FAMILY; MOLECULAR EPIDEMIOLOGY; DISCRIMINATORY ABILITY; VARIABLE NUMBERS; TANDEM REPEATS; STRAINS; GENOTYPE; LOCI; POLYMORPHISM; DATABASE	Background: Tuberculosis (TB) is a serious health problem in Tibet where Tibetans are the major ethnic group. Although genotyping of Mycobacterium tuberculosis (M. tuberculosis) isolates is a valuable tool for TB control, our knowledge of population structure of M. tuberculosis circulating in Tibet is limited. Methodology/Principal Findings: In our study, a total of 576 M. tuberculosis isolates from Tibetans in Tibet, China, were analyzed via spoligotyping and 24-locus MIRU-VNTR. The Beijing genotype was the most prevalent family (90.63%, n = 522). Shared-type (ST) 1 was the most dominant genotype (88.89%, n = 512). We found that there was no association between the Beijing genotype and sex, age and treatment status. In this sample collection, 7 of the 24 MIRU-VNTR loci were highly or moderately discriminative according to their Hunter-Gaston discriminatory index. An informative set of 12 loci had similar discriminatory power with 24 loci set. Conclusions/Significance: The population structure of M. tuberculosis isolates in Tibetans is homogeneous and dominated by Beijing genotype. The analysis of 24-locus MIRU-VNTR data might be useful to select appropriate VNTR loci for the genotyping of M. tuberculosis.	[Dong, Haiyan; Zhao, Xiuqin; Lv, Bing; Liu, Zhiguang; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China; [Shi, Li; Sang, Ba] Tibet Autonomous Reg Peoples Hosp, Lhasa, Tibet Autonomou, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Dong, HY (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Inst Communicable Dis Control & Prevent, Beijing, Peoples R China.	wankanglin@icdc.cn			project "Transmission Mode of Tuberculosis" of National Key Program of Mega Infectious Disease [2008ZX100/03-010-02]; project of National Nature Science Funding in China [30860243]; project of State Key Laboratory for Infectious Disease Prevention and Control [2011SKLID2008]	project "Transmission Mode of Tuberculosis" of National Key Program of Mega Infectious Disease; project of National Nature Science Funding in China; project of State Key Laboratory for Infectious Disease Prevention and Control	This work was funded by the project "Transmission Mode of Tuberculosis" (2008ZX100/03-010-02) of National Key Program of Mega Infectious Disease and by the project of National Nature Science Funding in China (30860243). It was also funded by the project of State Key Laboratory for Infectious Disease Prevention and Control (2011SKLID2008).	Affolabi D, 2009, INT J TUBERC LUNG D, V13, P317; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chai Li-Quan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P785; Dong HY, 2010, J CLIN MICROBIOL, V48, P4102, DOI 10.1128/JCM.00549-10; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Han H, 2007, J MED MICROBIOL, V56, P1219, DOI 10.1099/jmm.0.47005-0; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2007, FEMS MICROBIOL LETT, V270, P67, DOI 10.1111/j.1574-6968.2007.00658.x; Jiao WW, 2008, J CLIN MICROBIOL, V46, P1045, DOI 10.1128/JCM.01869-07; Kam KM, 2006, FEMS MICROBIOL LETT, V256, P258, DOI 10.1111/j.1574-6968.2006.00126.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kremer K, 2005, J CLIN MICROBIOL, V43, P314, DOI 10.1128/JCM.43.1.314-320.2005; Kremer K, 2004, J CLIN MICROBIOL, V42, P4040, DOI 10.1128/JCM.42.9.4040-4049.2004; Li Wei-min, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P381; Maes M, 2008, TUBERCULOSIS, V88, P490, DOI 10.1016/j.tube.2008.04.003; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mokrousov I, 2004, J CLIN MICROBIOL, V42, P2438, DOI 10.1128/JCM.42.6.2438-2444.2004; Mokrousov I, 2008, J CLIN MICROBIOL, V46, P3576, DOI 10.1128/JCM.00414-08; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; National Technic Steering Group Of The Epidemiological Sampling Survey For Tuberculosis, 2002, Zhonghua Jie He He Hu Xi Za Zhi, V25, P3; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Oota H, 2002, AM J PHYS ANTHROPOL, V118, P146, DOI 10.1002/ajpa.10056; Shamputa IC, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-99; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tian R, 2011, TIBETS SCI TECHOLOGY, V214, P2; Valcheva V, 2008, J CLIN MICROBIOL, V46, P3005, DOI 10.1128/JCM.00437-08; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Wang JA, 2011, J CLIN MICROBIOL, V49, P1354, DOI 10.1128/JCM.02274-10; Zhang L, 2008, FEMS MICROBIOL LETT, V282, P22, DOI 10.1111/j.1574-6968.2008.01081.x	36	27	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33904	10.1371/journal.pone.0033904	http://dx.doi.org/10.1371/journal.pone.0033904			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479472	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100079
J	Evans, AL; Faial, T; Gilchrist, MJ; Down, T; Vallier, L; Pedersen, RA; Wardle, FC; Smith, JC				Evans, Amanda L.; Faial, Tiago; Gilchrist, Michael J.; Down, Thomas; Vallier, Ludovic; Pedersen, Roger A.; Wardle, Fiona C.; Smith, James C.			Genomic Targets of Brachyury (T) in Differentiating Mouse Embryonic Stem Cells	PLOS ONE			English	Article							PRIMORDIAL GERM-CELLS; LEFT-RIGHT SPECIFICATION; MESODERM FORMATION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ZEBRAFISH HOMOLOG; BOX GENES; IN-VITRO; PROTEIN; GASTRULATION	Background: The T-box transcription factor Brachyury (T) is essential for formation of the posterior mesoderm and the notochord in vertebrate embryos. Work in the frog and the zebrafish has identified some direct genomic targets of Brachyury, but little is known about Brachyury targets in the mouse. Methodology/Principal Findings: Here we use chromatin immunoprecipitation and mouse promoter microarrays to identify targets of Brachyury in embryoid bodies formed from differentiating mouse ES cells. The targets we identify are enriched for sequence-specific DNA binding proteins and include components of signal transduction pathways that direct cell fate in the primitive streak and tailbud of the early embryo. Expression of some of these targets, such as Axin2, Fgf8 and Wnt3a, is down regulated in Brachyury mutant embryos and we demonstrate that they are also Brachyury targets in the human. Surprisingly, we do not observe enrichment of the canonical T-domain DNA binding sequence 5'-TCACACCT-3' in the vicinity of most Brachyury target genes. Rather, we have identified an (AC)(n) repeat sequence, which is conserved in the rat but not in human, zebrafish or Xenopus. We do not understand the significance of this sequence, but speculate that it enhances transcription factor binding in the regulatory regions of Brachyury target genes in rodents. Conclusions/Significance: Our work identifies the genomic targets of a key regulator of mesoderm formation in the early mouse embryo, thereby providing insights into the Brachyury-driven genetic regulatory network and allowing us to compare the function of Brachyury in different species.	[Evans, Amanda L.; Gilchrist, Michael J.; Down, Thomas; Smith, James C.] Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge, England; [Faial, Tiago; Vallier, Ludovic; Pedersen, Roger A.] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England; [Faial, Tiago; Smith, James C.] Univ Cambridge, Dept Zool, Cambridge, England; [Evans, Amanda L.; Faial, Tiago; Gilchrist, Michael J.; Smith, James C.] Natl Inst Med Res, Med Res Council, London NW7 1AA, England; [Wardle, Fiona C.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	Cancer Research UK; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London	Evans, AL (corresponding author), Univ Cambridge, Wellcome Trust, Canc Res UK Gurdon Inst, Cambridge, England.	jim.smith@nimr.mrc.ac.uk	vallier, ludovic/C-6368-2011; Wardle, Fiona C/G-4013-2012; Pillay, Nischalan/F-9536-2012	Wardle, Fiona C/0000-0001-5444-1889; Vallier, Ludovic/0000-0002-3848-2602; Smith, Jim/0000-0003-2413-9392; Faial, Tiago/0000-0003-0864-1200	Wellcome Trust; MRC; Fundacao para a Ciencia e a Tecnologia; MRC Career Development Award; MRC Programme grant; EU/PluriSys; Diabetes/UK-MRC Career Development Fellowship; Cambridge NIHR Biomedical Research Centre; European Commission; PluriSys; MRC [G0701448, MC_U117597140, MC_U117597137, G0800784, G0700213, G0600275] Funding Source: UKRI; Medical Research Council [G0800784, G0701448, MC_U117597137, G0800784B, G0600275, MC_U117597140, G0700213] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); MRC Career Development Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU/PluriSys; Diabetes/UK-MRC Career Development Fellowship(Diabetes UK); Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); PluriSys; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust Programme Grant to JCS (www.wellcome.ac.uk); MRC core support to JCS (www.nimr.mrc.ac.uk); a Fundacao para a Ciencia e a Tecnologia fellowship (www.fct.pt) to TF; an MRC Career Development Award (www.mrc.ac.uk) and a Lister Institute Research Prize (www.lister-institute.org.uk) to FCW; an MRC Programme grant (www.mrc.ac.uk) and an EU/PluriSys (plurisys.biotalentum.eu/) grant to RAP; a Diabetes/UK-MRC Career Development Fellowship to LV (diabetes.org.uk); and by the Cambridge NIHR Biomedical Research Centre (RAP and LV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; A proportion of the consumables funding for the RAP laboratory during the period in which the work was accomplished was provided by PluriSys. PluriSys is a non-commercial, FP7 consortium grant funded by the European Commission. BioTalentum, a Hungarian limited company, coordinates the PluriSys consortium but does not take any commercial interest in the materials or results generated by the consortium. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anderson R, 2000, MECH DEVELOP, V91, P61, DOI 10.1016/S0925-4773(99)00271-3; ARMSTRONG JF, 1993, MECH DEVELOP, V40, P85, DOI 10.1016/0925-4773(93)90090-K; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bernemann C, 2011, STEM CELLS, V29, P1496, DOI 10.1002/stem.709; Brown S, 2011, STEM CELLS, V29, P1176, DOI 10.1002/stem.666; Casey ES, 1998, DEVELOPMENT, V125, P3887; Casey ES, 1999, DEVELOPMENT, V126, P4193; Clements D, 1996, MECH DEVELOP, V56, P139, DOI 10.1016/0925-4773(96)00520-5; Conlon FL, 2001, DEVELOPMENT, V128, P3749; Conlon FL, 1996, DEVELOPMENT, V122, P2427; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; CUNLIFFE V, 1992, NATURE, V358, P427, DOI 10.1038/358427a0; Dobrovolskaia-Zavadskaia N, 1927, CR SOC BIOL, V97, P114; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Elms P, 2004, GENE EXPRESSION PATT; Essner JJ, 1996, DEV BIOL, V177, P449, DOI 10.1006/dbio.1996.0177; Evans Amanda Lisabeth, 2007, Angiogenesis, V10, P217, DOI 10.1007/s10456-007-9076-y; Faisst AM, 2002, MECH DEVELOP, V113, P15, DOI 10.1016/S0925-4773(02)00003-5; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Galceran J, 2001, P NATL ACAD SCI; Garnett AT, 2009, DEVELOPMENT, V136, P749, DOI 10.1242/dev.024703; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Griffin KJP, 2003, DEV BIOL, V264, P456, DOI 10.1016/j.ydbio.2003.09.008; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; Istrail S, 2005, P NATL ACAD SCI USA, V102, P4954, DOI 10.1073/pnas.0409624102; Jacobs-Cohen RJ, 1984, DIFFERENTIATION, V25, P48; King T, 1998, MECH DEVELOP, V79, P29, DOI 10.1016/S0925-4773(98)00166-X; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; Kispert Andreas, 1995, Seminars in Developmental Biology, V6, P395, DOI 10.1016/S1044-5781(06)80003-4; Kurisaki T, 1998, MECH DEVELOP, V73, P211, DOI 10.1016/S0925-4773(98)00043-4; Kusch T, 2002, GENE DEV, V16, P518, DOI 10.1101/gad.213002; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Lin D, 2008, CANCER RES, V68, P4352, DOI 10.1158/0008-5472.CAN-07-5237; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Morley RH, 2009, P NATL ACAD SCI USA, V106, P3829, DOI 10.1073/pnas.0808382106; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; Nentwich O, 2009, DEV BIOL, V336, P313, DOI 10.1016/j.ydbio.2009.09.039; Niimi M, 2005, BIOTECHNIQUES, V38, P349, DOI 10.2144/05383BM01; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Passamaneck YJ, 2009, DEVELOPMENT, V136, P3679, DOI 10.1242/dev.038141; Pearce JJH, 1999, MECH DEVELOP, V87, P189, DOI 10.1016/S0925-4773(99)00135-5; Popsueva AE, 2001, DEV BIOL, V234, P483, DOI 10.1006/dbio.2001.0261; Rana AA, 2004, DEVELOPMENT, V131, P4999, DOI 10.1242/dev.01389; RASHBASS P, 1994, INT J DEV BIOL, V38, P35; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; SCHULTEMERKER S, 1995, CURR BIOL, V5, P62, DOI 10.1016/S0960-9822(95)00017-0; SCHULTEMERKER S, 1992, DEVELOPMENT, V116, P1021; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; SHUR BD, 1982, DEV BIOL, V91, P149, DOI 10.1016/0012-1606(82)90018-5; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Sousa-Nunes R, 2003, GENOME RES, V13, P2609, DOI 10.1101/gr.1362303; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tada M, 2000, DEVELOPMENT, V127, P2227; Tada M, 1998, DEVELOPMENT, V125, P3997; Tamplin OJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-511; Thomas-Chollier M, 2008, RSAT REGULATORY SEQU; Thomson M, 2011, CELL, V145, P875, DOI 10.1016/j.cell.2011.05.017; Tsang TE, 1999, CELL MOL BIOL, V45, P493; Valamehr B, 2008, P NATL ACAD SCI USA, V105, P14459, DOI 10.1073/pnas.0807235105; Van Eynde A, 2004, MOL CELL BIOL, V24, P5863, DOI 10.1128/MCB.24.13.5863-5874.2004; Wartenberg M, 1998, LAB INVEST, V78, P1301; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; White SM, 2005, AM J PHYSIOL-HEART C, V288, pH670, DOI 10.1152/ajpheart.00841.2004; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wilkinson DG., 1992, SITU HYBRIDIZATION P, P75; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wilson MD, 2009, CURR OPIN GENET DEV, V19, P579, DOI 10.1016/j.gde.2009.10.003; WILSON V, 1995, DEVELOPMENT, V121, P877; Wittler L, 2007, EMBO REP, V8, P784, DOI 10.1038/sj.embor.7401030; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; YANAGISAWA KO, 1981, DEV BIOL, V87, P242, DOI 10.1016/0012-1606(81)90147-0; Zariwala M, 2004, AM J RESP CELL MOL, V30, P428, DOI 10.1165/rcmb.2003-0338RC	87	53	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33346	10.1371/journal.pone.0033346	http://dx.doi.org/10.1371/journal.pone.0033346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479388	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100043
J	Halsall, J; Gupta, V; O'Neill, LP; Turner, BM; Nightingale, KP				Halsall, John; Gupta, Vibhor; O'Neill, Laura P.; Turner, Bryan M.; Nightingale, Karl P.			Genes Are Often Sheltered from the Global Histone Hyperacetylation Induced by HDAC Inhibitors	PLOS ONE			English	Article							DEACETYLASE INHIBITORS; MICROARRAY DATA; ACETYLATION; CHROMATIN; SITES; CELLS; ANTIBODIES	Histone deacetylase inhibitors (HDACi) are increasingly used as therapeutic agents, but the mechanisms by which they alter cell behaviour remain unclear. Here we use microarray expression analysis to show that only a small proportion of genes (similar to 9%) have altered transcript levels after treating HL60 cells with different HDACi (valproic acid, Trichostatin A, suberoylanilide hydroxamic acid). Different gene populations respond to each inhibitor, with as many genes down-as up-regulated. Surprisingly, HDACi rarely induced increased histone acetylation at gene promoters, with most genes examined showing minimal change, irrespective of whether genes were up-or down-regulated. Many genes seem to be sheltered from the global histone hyperacetyation induced by HDACi.	[Halsall, John; Gupta, Vibhor; O'Neill, Laura P.; Turner, Bryan M.; Nightingale, Karl P.] Univ Birmingham, Chromatin & Gene Express Grp, Inst Biomed Res, Coll Med & Dent Sci, Birmingham, W Midlands, England	University of Birmingham	Halsall, J (corresponding author), Univ Birmingham, Chromatin & Gene Express Grp, Inst Biomed Res, Coll Med & Dent Sci, Birmingham, W Midlands, England.	k.p.nightingale@bham.ac.uk		Halsall, John/0000-0003-4671-9013	Cancer Research UK [C1015/A9077]; Cancer Research UK [14487] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK, Programme grant C1015/A9077 (Turner BM, Nightingale KP, ONeill LP). http://aboutus.cancerresearchuk.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Batty N, 2009, CANCER LETT, V280, P192, DOI 10.1016/j.canlet.2009.03.013; BIRNIE GD, 1988, BRIT J CANCER, V58, P41; Bradbury C, THESIS U BIRMINGHAM; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Marmorstein R., 2008, BIOCHIM BIOPHYS ACTA, V1789, P58; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montaner D, 2006, NUCLEIC ACIDS RES, V34, pW486, DOI 10.1093/nar/gkl197; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Rada-Iglesias A, 2007, GENOME RES, V17, P708, DOI 10.1101/gr.5540007; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Smith CL, 2008, BIOESSAYS, V30, P15, DOI 10.1002/bies.20687; THORNE AW, 1990, EUR J BIOCHEM, V193, P701, DOI 10.1111/j.1432-1033.1990.tb19390.x; TURNER BM, 1989, EUR J BIOCHEM, V179, P131, DOI 10.1111/j.1432-1033.1989.tb14530.x; TURNER BM, 1989, FEBS LETT, V253, P141, DOI 10.1016/0014-5793(89)80947-0; Turner BM, 2011, FEBS LETT, V585, P2032, DOI 10.1016/j.febslet.2010.11.041; VanLint C, 1996, GENE EXPRESSION, V5, P245; VerMilyea MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006086; Waldecker M, 2008, J NUTR BIOCHEM, V19, P587, DOI 10.1016/j.jnutbio.2007.08.002; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wilson MA, 2002, J BIOL CHEM, V277, P15171, DOI 10.1074/jbc.M200349200; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	27	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33453	10.1371/journal.pone.0033453	http://dx.doi.org/10.1371/journal.pone.0033453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479401	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100050
J	He, YH; Isono, S; Shibuya, M; Tsuji, M; Purushothama, CRA; Tanaka, K; Sano, T				He, Ying-Hong; Isono, Sayaka; Shibuya, Makoto; Tsuji, Masaharu; Purushothama, Charith-Raj Adkar; Tanaka, Kazuaki; Sano, Teruo			Oligo-DNA Custom Macroarray for Monitoring Major Pathogenic and Non-Pathogenic Fungi and Bacteria in the Phyllosphere of Apple Trees	PLOS ONE			English	Article							MICROBIAL-POPULATION DYNAMICS; PESTICIDE PROGRAM; PLANT; DIVERSITY	Background: To monitor the richness in microbial inhabitants in the phyllosphere of apple trees cultivated under various cultural and environmental conditions, we developed an oligo-DNA macroarray for major pathogenic and non-pathogenic fungi and bacteria inhabiting the phyllosphere of apple trees. Methods and Findings: First, we isolated culturable fungi and bacteria from apple orchards by an agar-plate culture method, and detected 32 fungal and 34 bacterial species. Alternaria, Aureobasidium, Cladosporium, Rhodotorula, Cystofilobasidium, and Epicoccum genera were predominant among the fungi, and Bacillus, Pseudomonas, Sphingomonas, Methylobacterium, and Pantoea genera were predominant among the bacteria. Based on the data, we selected 29 major non-pathogenic and 12 phytopathogenic fungi and bacteria as the targets of macroarray. Forty-one species-specific 40-base pair long oligo-DNA sequences were selected from the nucleotide sequences of rDNA-internal transcribed spacer region for fungi and 16S rDNA for bacteria. The oligo-DNAs were fixed on nylon membrane and hybridized with digoxigenin-labeled cRNA probes prepared for each species. All arrays except those for Alternaria, Bacillus, and their related species, were specifically hybridized. The array was sensitive enough to detect 10(3) CFU for Aureobasidium pullulans and Bacillus cereus. Nucleotide sequencing of 100 each of independent fungal rDNA-ITS and bacterial 16S-rDNA sequences from apple tree was in agreement with the macroarray data obtained using the same sample. Finally, we analyzed the richness in the microbial inhabitants in the samples collected from apple trees in four orchards. Major apple pathogens that cause scab, Alternaria blotch, and Marssonina blotch were detected along with several non-phytopathogenic fungal and bacterial inhabitants. Conclusions: The macroarray technique presented here is a strong tool to monitor the major microbial species and the community structures in the phyllosphere of apple trees and identify key species antagonistic, supportive or co-operative to specific pathogens in the orchard managed under different environmental conditions.	[He, Ying-Hong; Isono, Sayaka; Shibuya, Makoto; Tsuji, Masaharu; Purushothama, Charith-Raj Adkar; Tanaka, Kazuaki; Sano, Teruo] Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan	Hirosaki University	He, YH (corresponding author), Hirosaki Univ, Fac Agr & Life Sci, Hirosaki, Aomori, Japan.	sano@cc.hirosaki-u.ac.jp	Tanaka, Kazuaki/F-1924-2013; Tsuji, Masaharu/M-6609-2019	Tsuji, Masaharu/0000-0002-9375-7998	Ministry of Education, Science, Sports, and Culture of Japan [1865801, 22658012]; Ministry of Agriculture, Forestry; Fisheries of Japan (Development of mitigation and adaptation techniques to global warming in the sectors of agriculture, forestry and fisheries); Grants-in-Aid for Scientific Research [22658012] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Agriculture, Forestry; Fisheries of Japan (Development of mitigation and adaptation techniques to global warming in the sectors of agriculture, forestry and fisheries); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research 1865801 and 22658012 from the Ministry of Education, Science, Sports, and Culture of Japan, and a grant from the Ministry of Agriculture, Forestry, and a Fisheries of Japan (Development of mitigation and adaptation techniques to global warming in the sectors of agriculture, forestry and fisheries). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS JH, 1978, CAN J MICROBIOL, V24, P1058, DOI 10.1139/m78-175; ANDREWS JH, 1979, CAN J MICROBIOL, V25, P1331, DOI 10.1139/m79-211; Baker CM, 2010, BRAZ J MED BIOL RES, V43, P698, DOI 10.1590/S0100-879X2010000800001; Balint-Kurti P, 2010, MOL PLANT MICROBE IN, V23, P473, DOI 10.1094/MPMI-23-4-0473; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Falacy JS, 2007, PHYTOPATHOLOGY, V97, P1290, DOI 10.1094/PHYTO-97-10-1290; Fessehaie A, 2003, PHYTOPATHOLOGY, V93, P262, DOI 10.1094/PHYTO.2003.93.3.262; Granado J, 2008, MICROB ECOL, V56, P720, DOI 10.1007/s00248-008-9391-x; Ikeda S, 2009, MICROB ECOL, V58, P703, DOI 10.1007/s00248-009-9566-0; Izzo AD, 2009, MYCOL RES, V113, P802, DOI 10.1016/j.mycres.2008.11.020; Kinkel LL, 1997, ANNU REV PHYTOPATHOL, V35, P327, DOI 10.1146/annurev.phyto.35.1.327; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Langenheder S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010834; Lenz O, 2010, J MICROBIOL METH, V82, P90, DOI 10.1016/j.mimet.2010.05.004; Lievens B, 2005, ENVIRON MICROBIOL, V7, P1698, DOI 10.1111/j.1462-2920.2005.00816.x; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Pelludat C, 2009, EUR J PLANT PATHOL, V125, P413, DOI 10.1007/s10658-009-9490-7; PENNYCOOK SR, 1981, NEW ZEAL J BOT, V19, P273, DOI 10.1080/0028825X.1981.10426380; Sholberg P, 2005, PLANT DIS, V89, P1143, DOI 10.1094/PD-89-1143; Teixido N, 1999, ANN APPL BIOL, V134, P109, DOI 10.1111/j.1744-7348.1999.tb05241.x; Walter M, 2007, CAN J MICROBIOL, V53, P45, DOI 10.1139/W06-093; Whipps JM, 2008, J APPL MICROBIOL, V105, P1744, DOI 10.1111/j.1365-2672.2008.03906.x; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Zhang N, 2008, PLANT DIS, V92, P953, DOI 10.1094/PDIS-92-6-0953; Zhang N, 2007, PLANT DIS, V91, P1612, DOI 10.1094/PDIS-91-12-1612	25	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34249	10.1371/journal.pone.0034249	http://dx.doi.org/10.1371/journal.pone.0034249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479577	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100140
J	Hu, W; Wang, XJ; Ding, XR; Li, Y; Zhang, XJ; Xie, PW; Yang, J; Wang, SQ				Hu, Wei; Wang, Xuejun; Ding, Xiaoran; Li, Ying; Zhang, Xiujuan; Xie, Peiwen; Yang, Jing; Wang, Shengqi			MicroRNA-141 Represses HBV Replication by Targeting PPARA	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; TRANSCRIPTION; EXPRESSION; RECEPTORS; ELEMENTS; BIOLOGY; ROLES; RNAS	MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression primarily at the post-transcriptional level and play critical roles in a variety of physiological and pathological processes. In this report, miR-141 was identified to repress HBV expression by screening a small miRNA expressing library and synthetic miR-141 mimics could also significantly suppress HBV expression and replication in HepG2 cells. Bioinformatic analysis and experiment assays indicate that peroxisome proliferator-activated receptor alpha (PPARA) was the target of hsa-miR-141 during this process. Furthermore, knockdown of PPARA by small interfering RNA (siRNA) inhibited HBV replication similar to levels observed for miR-141. Promoter functional analysis indicated that repression of HBV replication by miR-141 mimics or siRNA was mediated by interfering with the HBV promoter functions, consistent with previous studies demonstrating that PPARA regulated HBV gene expression through interactions with HBV promoter regulatory elements. Our results suggest that miR-141 suppressed HBV replication by reducing HBV promoter activities by down-regulating PPARA. This study provides new insights into the molecular mechanisms associated with HBV-host interactions. Furthermore, this information may facilitate the development of novel anti-HBV therapeutic strategies.	[Hu, Wei; Wang, Xuejun; Ding, Xiaoran; Li, Ying; Zhang, Xiujuan; Xie, Peiwen; Yang, Jing; Wang, Shengqi] Beijing Inst Radiat Med, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Hu, W (corresponding author), Beijing Inst Radiat Med, Beijing, Peoples R China.	jingyang0511@yahoo.com.cn; sqwang@nic.bmi.ac.cn		Wang, Xue-jun/0000-0001-5895-936X	National High-tech Research and Development Program (863 Program) of China [2007AA02Z108]; Chinese Science and Technology Key [2012ZX10004503-011, 2012ZX09103301-044]	National High-tech Research and Development Program (863 Program) of China; Chinese Science and Technology Key	This work was financially supported by the National High-tech Research and Development Program (863 Program) of China (No. 2007AA02Z108) http://www.863.gov.cn/, and the Chinese Science and Technology Key Projects (2012ZX10004503-011 and 2012ZX09103301-044) http://www.nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; GANEM D, 1987, ANNU REV BIOCHEM, V56, P651, DOI 10.1146/annurev.biochem.56.1.651; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guidotti LG, 1999, J VIROL, V73, P10377, DOI 10.1128/JVI.73.12.10377-10386.1999; HE YY, 2001, CHIN J HEPATOL, V9, P376; HUAN BF, 1995, J VIROL, V69, P547, DOI 10.1128/JVI.69.1.547-551.1995; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Jun C, 2007, PROG BIOCHEM BIOPHYS, V34, P389; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewellyn EB, 2007, J VIROL, V81, P6207, DOI 10.1128/JVI.00210-07; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Qin J, 2009, J GEN VIROL, V90, P1246, DOI 10.1099/vir.0.006007-0; Qiu LP, 2010, BIOCHEM BIOPH RES CO, V398, P771, DOI 10.1016/j.bbrc.2010.07.021; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Raney AK, 1997, J VIROL, V71, P1058, DOI 10.1128/JVI.71.2.1058-1071.1997; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Tang H, 2001, P NATL ACAD SCI USA, V98, P1841, DOI 10.1073/pnas.041479698; Tang H, 2001, DRUG NEWS PERSPECT, V14, P325; Tseng YP, 2008, ANTIVIR RES, V77, P206, DOI 10.1016/j.antiviral.2007.12.011; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Yu XM, 2001, J VIROL, V75, P11354, DOI 10.1128/JVI.75.23.11354-11364.2001; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195; Zheng SQ, 2011, ANTIVIR RES, V89, P219, DOI 10.1016/j.antiviral.2011.01.008	35	84	94	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34165	10.1371/journal.pone.0034165	http://dx.doi.org/10.1371/journal.pone.0034165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479552	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100130
J	Konrat, C; Boutron, I; Trinquart, L; Auleley, GR; Ricordeau, P; Ravaud, P				Konrat, Cecile; Boutron, Isabelle; Trinquart, Ludovic; Auleley, Guy-Robert; Ricordeau, Philippe; Ravaud, Philippe			Underrepresentation of Elderly People in Randomised Controlled Trials. The Example of Trials of 4 Widely Prescribed Drugs	PLOS ONE			English	Article							CLINICAL-TRIALS; OLDER PATIENTS; AGE; QUALITY; CARE; ENROLLMENT; WOMEN; PARTICIPATION; EXCLUSION; CRITERIA	Background: We aimed to determine the representation of elderly people in published reports of randomized controlled trials (RCTs). We focused on trials of 4 medications-pioglitazone, rosuvastatin, risedronate, and valsartan-frequently used by elderly patients with chronic medical conditions. Methods and Findings: We selected all reports of RCTs indexed in PubMed from 1966 to April 2008 evaluating one of the 4 medications of interest. Estimates of the community-based "on-treatment" population were from a national health insurance database (SNIIR-AM) covering approximately 86% of the population in France. From this database, we evaluated data claims from January 2006 to December 2007 for 1,958,716 patients who received one of the medications of interest for more than 6 months. Of the 155 RCT reports selected, only 3 studies were exclusively of elderly patients (2 assessing valsartan; 1 risedronate). In only 4 of 37 reports (10.8%) for pioglitazone, 4 of 22 (18.2%) for risedronate, 3 of 29 (10.3%) for rosuvastatine and 9 of 67 (13.4%) for valsartan, the proportion of patients aged 65 or older was within or above that treated in clinical practice. In 62.2% of the reports for pioglitazone, 40.9% for risedronate, 37.9% for rosuvastatine, and 70.2% for valsartan, the proportion of patients aged 65 or older was lower than half that in the treated population. The representation of elderly people did not differ by publication date or sample size. Conclusions: Elderly patients are poorly represented in RCTs of drugs they are likely to receive.	[Konrat, Cecile; Boutron, Isabelle; Trinquart, Ludovic; Ravaud, Philippe] INSERM, U738, Paris, France; [Boutron, Isabelle; Trinquart, Ludovic; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75181 Paris, France; [Boutron, Isabelle; Ravaud, Philippe] Univ Paris 05, Fac Med, Paris, France; [Boutron, Isabelle; Trinquart, Ludovic; Ravaud, Philippe] French Cochrane Ctr, Paris, France; [Auleley, Guy-Robert] Natl Canc Inst, Dept Rech Clin, Paris, France; [Ricordeau, Philippe] CNAMTS, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National du Cancer (INCA) France	Konrat, C (corresponding author), INSERM, U738, Paris, France.	isabelle.boutron@htd.aphp.fr	ravaud, philippe/C-1694-2009; Trinquart, Ludovic/H-4961-2019	Trinquart, Ludovic/0000-0002-3028-4900; Ravaud, Philippe/0000-0001-8264-9206; Boutron, Isabelle/0000-0002-5263-6241	Assistance Publique des Hopitaux de Paris Clinical Research Department [RSR-08-008]	Assistance Publique des Hopitaux de Paris Clinical Research Department	This project was supported by a public funding grant No. RSR-08-008 from the Assistance Publique des Hopitaux de Paris Clinical Research Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aapro MS, 2005, ONCOLOGIST, V10, P198, DOI 10.1634/theoncologist.10-3-198; [Anonymous], 2000, MED EXP PAN SURV 200; Auleley GR, 2005, PRESSE MED, V34, P703, DOI 10.1016/S0755-4982(05)84023-0; Bandyopadhyay S, 2001, QJM-INT J MED, V94, P127, DOI 10.1093/qjmed/94.3.127; Bowling A, 2001, HEART, V85, P680, DOI 10.1136/heart.85.6.680; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Cherubini A, 2011, ARCH INTERN MED, V171, P550, DOI 10.1001/archinternmed.2011.31; COHEN AC, 1950, ANN MATH STAT, V21, P557, DOI 10.1214/aoms/1177729751; Commitee on Comparative Research Prioritization, 2009, I MED IN NAT PRIOR C; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; European Commission, 2009, 2009 AG REP; Fahy N, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3815; Goode PS, 2008, J AM COLL SURGEONS, V207, P303, DOI 10.1016/j.jamcollsurg.2008.03.012; GURWITZ JH, 1992, JAMA-J AM MED ASSOC, V268, P1417, DOI 10.1001/jama.1992.03490110055029; Gurwitz JH, 2002, ARCH INTERN MED, V162, P1670, DOI 10.1001/archinte.162.15.1670; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; Higashi T, 2004, ANN INTERN MED, V140, P714, DOI 10.7326/0003-4819-140-9-200405040-00011; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; JYLHA M, 1994, J CLIN EPIDEMIOL, V47, P69, DOI 10.1016/0895-4356(94)90035-3; Le Quintrec JL, 2005, J GERONTOL A-BIOL, V60, P340, DOI 10.1093/gerona/60.3.340; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Lernfelt B, 2003, EUR J CLIN PHARMACOL, V59, P637, DOI 10.1007/s00228-003-0647-6; Lewis JH, 2003, J CLIN ONCOL, V21, P1383, DOI 10.1200/JCO.2003.08.010; Liberopoulos G, 2009, J CLIN EPIDEMIOL, V62, P1218, DOI 10.1016/j.jclinepi.2008.12.009; Mannesse CK, 2000, AGE AGEING, V29, P35, DOI 10.1093/ageing/29.1.35; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; McMurdo MET, 2005, BMJ-BRIT MED J, V331, P1036, DOI 10.1136/bmj.331.7524.1036; O'Connor PJ, 2003, ARCH INTERN MED, V163, P2677, DOI 10.1001/archinte.163.22.2677; O'Leary TJ, 2010, J AM GERIATR SOC, V58, P1187, DOI 10.1111/j.1532-5415.2010.02939.x; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Roberts R, 2003, JAMA-J AM MED ASSOC, V290, P905, DOI 10.1001/jama.290.7.905; ROCHON PA, 1993, ARCH INTERN MED, V153, P243, DOI 10.1001/archinte.153.2.243; Scott Ian A, 2010, Arch Intern Med, V170, P587, DOI 10.1001/archinternmed.2010.18; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Steinbrook R, 2002, NEW ENGL J MED, V347, P1462, DOI 10.1056/NEJMhpr021646; Stuart Bruce, 2003, Am J Geriatr Pharmacother, V1, P61, DOI 10.1016/S1543-5946(03)90002-X; Talarico L, 2004, J CLIN ONCOL, V22, P4626, DOI 10.1200/JCO.2004.02.175; Tuppin P, 2010, REV EPIDEMIOL SANTE, V58, P286, DOI 10.1016/j.respe.2010.04.005; United Nations, 2004, WORLD POP 2300; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233	42	90	95	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33559	10.1371/journal.pone.0033559	http://dx.doi.org/10.1371/journal.pone.0033559			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479411	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100056
J	Liu, ML; Amodu, AS; Pitts, S; Patrickson, J; Hibbert, JM; Battle, M; Ofori-Acquah, SF; Stiles, JK				Liu, Mingli; Amodu, Audu S.; Pitts, Sidney; Patrickson, John; Hibbert, Jacqueline M.; Battle, Monica; Ofori-Acquah, Solomon F.; Stiles, Jonathan K.			Heme Mediated STAT3 Activation in Severe Malaria	PLOS ONE			English	Article							MURINE CEREBRAL MALARIA; MESSENGER-RNA EXPRESSION; CHEMOKINE RECEPTOR CXCR3; HEMATOPOIETIC STEM-CELLS; PLASMODIUM-BERGHEI ANKA; NF-KAPPA-B; GENE-EXPRESSION; SUSCEPTIBLE MICE; IFN-GAMMA; OXYGENASE-1	Background: The mortality of severe malaria [cerebral malaria (CM), severe malaria anemia (SMA), acute lung injury (ALI) and acute respiratory distress syndrome (ARDS)] remains high despite the availability associated with adequate treatments. Recent studies in our laboratory and others have revealed a hitherto unknown correlation between chemokine CXCL10/CXCR3, Heme/HO-1 and STAT3 and cerebral malaria severity and mortality. Although Heme/HO-1 and CXCL10/CXCR3 interactions are directly involved in the pathogenesis of CM and fatal disease, the mechanism dictating how Heme/HO-1 and CXCL10/CXCR3 are expressed and regulated under these conditions is still unknown. We therefore tested the hypothesis that these factors share common signaling pathways and may be mutually regulated. Methods: We first clarified the roles of Heme/HO-1, CXCL10/CXCR3 and STAT3 in CM pathogenesis utilizing a well established experimental cerebral malaria mouse (ECM, P. berghei ANKA) model. Then, we further determined the mechanisms how STAT3 regulates HO-1 and CXCL10 as well as mutual regulation among them in CRL-2581,a murine endothelial cell line. Results: The results demonstrate that (1) STAT3 is activated by P. berghei ANKA (PBA) infection in vivo and Heme in vitro. (2) Heme up-regulates HO-1 and CXCL10 production through STAT3 pathway, and regulates CXCL10 at the transcriptional level in vitro. (3) HO-1 transcription is positively regulated by CXCL10. (4) HO-1 regulates STAT3 signaling. Conclusion: Our data indicate that Heme/HO-1, CXCL10/CXCR3 and STAT3 molecules as well as related signaling pathways play very important roles in the pathogenesis of severe malaria. We conclude that these factors are mutually regulated and provide new opportunities to develop potential novel therapeutic targets that could be used to supplement traditional prophylactics and treatments for malaria and improve clinical outcomes while reducing malaria mortality. Our ultimate goal is to develop novel therapies targeting Heme or CXCL10-related biological signaling molecules associated with development of fatal malaria.	[Liu, Mingli; Amodu, Audu S.; Hibbert, Jacqueline M.; Battle, Monica; Stiles, Jonathan K.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Pitts, Sidney; Patrickson, John] Morehouse Sch Med, Dept Pathol, Atlanta, GA 30310 USA; [Ofori-Acquah, Solomon F.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA	Morehouse School of Medicine; Morehouse School of Medicine; Emory University	Liu, ML (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	jstiles@msm.edu	Hibbert, Jacqueline/W-2282-2019; Stiles, Jonathan K./AFM-1940-2022	Stiles, Jonathan Kwamina/0000-0003-0829-1482; Hibbert, Jacqueline/0000-0001-5232-9404; Ofori-Acquah, Solomon/0000-0001-5000-3048	National Institutes of Health [NIH/FIC T90-HG004151, NIH/FIC/NINDS R21TW006804, NIH/MBRS/SCORE S06GM08248, NIH/RCMI RR033062, NIH/K02HL088026]; FOGARTY INTERNATIONAL CENTER [R21TW006804] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106192, K02HL088026] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R90HG004151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grant numbers NIH/FIC T90-HG004151 for postdoctoral training in Genomics and Hemoglobinopathies, NIH/FIC/NINDS R21TW006804, NIH/MBRS/SCORE S06GM08248 and NIH/RCMI RR033062 awarded to JKS and NIH/K02HL088026 awarded to SFOA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; ASAMI M, 1992, INT J PARASITOL, V22, P43, DOI 10.1016/0020-7519(92)90078-Y; Balachandar S, 2010, EUR J CLIN MICROBIOL; Baptista FG, 2010, INFECT IMMUN, V78, P4033, DOI 10.1128/IAI.00079-10; Belcher JD, 2006, J CLIN INVEST, V116, P808, DOI 10.1172/JCI26857; Belcher JD, 2010, J MOL MED, V88, P665, DOI 10.1007/s00109-010-0613-6; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Bussolati B, 2006, ANTIOXID REDOX SIGN, V8, P1153, DOI 10.1089/ars.2006.8.1153; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Chen L, 2001, PARASITOL INT, V50, P139, DOI 10.1016/S1383-5769(01)00063-0; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; Datta D, 2010, J BIOL CHEM; Datta D, 2007, AM J PHYSIOL-RENAL, V293, pF1222, DOI 10.1152/ajprenal.00164.2007; Delahaye NF, 2006, J INFECT DIS, V193, P312, DOI 10.1086/498579; Delahaye NF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-452; Ehrich JHH, 2007, PEDIATR NEPHROL, V22, P626, DOI 10.1007/s00467-006-0332-y; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Epiphanio S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000916; Fu N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000216; Geuken E, 2005, AM J TRANSPLANT, V5, P1875, DOI 10.1111/j.1600-6143.2005.00960.x; Gillrie MR, 2007, BLOOD, V110, P3426, DOI 10.1182/blood-2007-04-084582; Hansen DS, 2007, J IMMUNOL, V178, P5779, DOI 10.4049/jimmunol.178.9.5779; Hansen DS, 2003, IMMUNITY, V18, P391, DOI 10.1016/S1074-7613(03)00052-9; Hanum S, 2003, INT IMMUNOL, V15, P633, DOI 10.1093/intimm/dxg065; Hunt NH, 2007, NAT MED, V13, P667, DOI 10.1038/nm0607-667; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Ke BB, 2010, MOL THER, V18, P1019, DOI 10.1038/mt.2009.285; Kim HP, 2004, FASEB J, V18, P1080, DOI 10.1096/fj.03-1391com; Kotsch K, 2007, ANTIOXID REDOX SIGN, V9, P2049, DOI 10.1089/ars.2007.1801; Labbe K, 2010, J IMMUNOL, V185, P5495, DOI 10.4049/jimmunol.1002517; Lamikanra AA, 2007, BLOOD, V110, P18, DOI 10.1182/blood-2006-09-018069; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Loetscher M, 1998, EUR J IMMUNOL, V28, P3696, DOI 10.1002/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W; MAGGIOPRICE L, 1985, BLOOD, V66, P1080; Milner DA, 2010, CURR OPIN INFECT DIS, V23, P456, DOI 10.1097/QCO.0b013e32833c3dbe; Miu J, 2008, J IMMUNOL, V180, P1217, DOI 10.4049/jimmunol.180.2.1217; Mohan Alladi, 2008, Journal of Vector Borne Diseases, V45, P179; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Nguansangiam S, 2007, TROP MED INT HEALTH, V12, P1037, DOI 10.1111/j.1365-3156.2007.01881.x; Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369; Pae HO, 2005, ENDOCRINOLOGY, V146, P2229, DOI 10.1210/en.2004-1431; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Pamplona A, 2009, INT J BIOCHEM CELL B, V41, P711, DOI 10.1016/j.biocel.2008.09.020; Ryter SW, 2009, AM J RESP CELL MOL, V41, P251, DOI 10.1165/rcmb.2009-0170TR; Sarfo BY, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-69; Shi XB, 2008, CELL MOL IMMUNOL, V5, P341, DOI 10.1038/cmi.2008.42; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Takeda M, 2005, JPN J INFECT DIS, V58, P268; Taoufiq Z, 2008, J INFECT DIS, V197, P1062, DOI 10.1086/528988; Tripathi AK, 2009, BLOOD, V114, P4243, DOI 10.1182/blood-2009-06-226415; Tsuchihashi S, 2005, TRANSPL P, V37, P1677, DOI 10.1016/j.transproceed.2005.03.080; Tsuchihashi S, 2007, TRANSPLANTATION, V83, P1628, DOI 10.1097/01.tp.0000266917.39958.47; Van den Steen PE, 2008, EUR J IMMUNOL, V38, P1082, DOI 10.1002/eji.200737906; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Wilson NO, 2008, MOL BIOCHEM PARASIT, V162, P172, DOI 10.1016/j.molbiopara.2008.09.003; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yipp BG, 2003, BLOOD, V101, P2850, DOI 10.1182/blood-2002-09-2841; Yoshimura Akihiko, 2009, Keio Journal of Medicine, V58, P73; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang ZX, 1997, BIOCHEM BIOPH RES CO, V237, P90, DOI 10.1006/bbrc.1997.7082; Zhu JZ, 2009, J BIOL CHEM, V284, P15750, DOI 10.1074/jbc.M901111200	62	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34280	10.1371/journal.pone.0034280	http://dx.doi.org/10.1371/journal.pone.0034280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479586	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339100143
J	Moore, JWJ; Beattie, L; Dalton, JE; Owens, BMJ; Maroof, A; Coles, MC; Kaye, PM				Moore, John W. J.; Beattie, Lynette; Dalton, Jane E.; Owens, Benjamin M. J.; Maroof, Asher; Coles, Mark C.; Kaye, Paul M.			B Cell: T Cell Interactions Occur within Hepatic Granulomas during Experimental Visceral Leishmaniasis	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; ANTIGEN PRESENTATION; DEFICIENT MICE; EXPRESSION; SUSCEPTIBILITY; LYMPHOCYTES; ACTIVATION; MACROPHAGE; RESISTANCE; INFECTION	Hepatic resistance to Leishmania donovani infection in mice is associated with the development of granulomas, in which a variety of lymphoid and non-lymphoid populations accumulate. Although previous studies have identified B cells in hepatic granulomas and functional studies in B cell-deficient mice have suggested a role for B cells in the control of experimental visceral leishmaniasis, little is known about the behaviour of B cells in the granuloma microenvironment. Here, we first compared the hepatic B cell population in infected mice, where approximate to 60% of B cells are located within granulomas, with that of naive mice. In infected mice, there was a small increase in mIgM(lo)mIgD(+) mature B2 cells, but no enrichment of B cells with regulatory phenotype or function compared to the naive hepatic B cell population, as assessed by CD1d and CD5 expression and by IL-10 production. Using 2-photon microscopy to quantify the entire intra-granuloma B cell population, in conjunction with the adoptive transfer of polyclonal and HEL-specific BCR-transgenic B cells isolated from L. donovani-infected mice, we demonstrated that B cells accumulate in granulomas over time in an antigen-independent manner. Intravital dynamic imaging was used to demonstrate that within the polyclonal B cell population obtained from L. donovani-infected mice, the frequency of B cells that made multiple long contacts with endogenous T cells was greater than that observed using HEL-specific B cells obtained from the same inflammatory environment. These data indicate, therefore, that a subset of this polyclonal B cell population is capable of making cognate interactions with T cells within this unique environment, and provide the first insights into the dynamics of B cells within an inflammatory site.	[Moore, John W. J.] Univ York, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	University of Hull; University of York - UK; University of York - UK	Moore, JWJ (corresponding author), Univ York, Ctr Immunol & Infect, Hull York Med Sch, York YO10 5DD, N Yorkshire, England.	paul.kaye@york.ac.uk		Owens, Benjamin/0000-0003-4710-6841; Dalton, Jane/0000-0001-9115-8855; Kaye, Paul/0000-0002-8796-4755; Beattie, Lynette/0000-0002-5794-7233	UK Medical Research Council; Wellcome Trust; MRC [G0400786, G0601156, G1000230] Funding Source: UKRI; Medical Research Council [G0601156, G1000230, G0400786] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants to PMK from the UK Medical Research Council and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Beattie L, 2008, PARASITE IMMUNOL, V30, P255, DOI 10.1111/j.1365-3024.2008.01020.x; Beattie L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000805; Brown DR, 1999, INFECT IMMUN, V67, P266, DOI 10.1128/IAI.67.1.266-270.1999; Buendia AJ, 2002, INFECT IMMUN, V70, P6911, DOI 10.1128/IAI.70.12.6911-6918.2002; Cannons JL, 2010, IMMUNITY, V32, P253, DOI 10.1016/j.immuni.2010.01.010; Carragher DM, 2008, SEMIN IMMUNOL, V20, P26, DOI 10.1016/j.smim.2007.12.004; Crawford A, 2006, J IMMUNOL, V176, P3498, DOI 10.4049/jimmunol.176.6.3498; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Deak E, 2010, EUR J IMMUNOL, V40, P1355, DOI 10.1002/eji.200939455; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; GESSNER A, 1995, IMMUNOLOGY, V84, P416; GeurtsvanKessel CH, 2009, J EXP MED, V206, P2339, DOI 10.1084/jem.20090410; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Greter M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000109; Halle S, 2009, J EXP MED, V206, P2593, DOI 10.1084/jem.20091472; Hoerauf A, 1996, INT IMMUNOL, V8, P1569, DOI 10.1093/intimm/8.10.1569; Kumar V, 2010, BLOOD, V115, P4725, DOI 10.1182/blood-2009-10-250118; Maglione PJ, 2007, J IMMUNOL, V178, P7222, DOI 10.4049/jimmunol.178.11.7222; Malissen B, 2009, NAT IMMUNOL, V10, P371, DOI 10.1038/ni0409-371; Maroof A, 2008, IMMUNITY, V29, P295, DOI 10.1016/j.immuni.2008.06.012; MCELRATH MJ, 1988, J EXP MED, V167, P1927, DOI 10.1084/jem.167.6.1927; Moritoki Y, 2009, GASTROENTEROLOGY, V136, P1037, DOI 10.1053/j.gastro.2008.11.035; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mueller A, 2008, RHEUMATOLOGY, V47, P1111, DOI 10.1093/rheumatology/ken202; Nurieva RI, 2010, CELL MOL IMMUNOL, V7, P190, DOI 10.1038/cmi.2010.24; Pereira JP, 2010, INT IMMUNOL, V22, P413, DOI 10.1093/intimm/dxq047; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Quah BJC, 2008, P NATL ACAD SCI USA, V105, P4259, DOI 10.1073/pnas.0800259105; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Rodriguez-Pinto D, 2005, CELL IMMUNOL, V238, P67, DOI 10.1016/j.cellimm.2006.02.005; Ronet C, 2008, J IMMUNOL, V180, P4825, DOI 10.4049/jimmunol.180.7.4825; Ronet C, 2010, J IMMUNOL, V184, P886, DOI 10.4049/jimmunol.0901114; Sacks D L, 1988, Mem Inst Oswaldo Cruz, V83 Suppl 1, P506, DOI 10.1590/S0074-02761988000500060; SACKS DL, 1984, J IMMUNOL, V132, P2072; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; SCOTT P, 1986, J IMMUNOL, V137, P1017; Smelt SC, 2000, J IMMUNOL, V164, P3681, DOI 10.4049/jimmunol.164.7.3681; Stager S, 2003, INFECT IMMUN, V71, P4804, DOI 10.1128/IAI.71.8.4804-4807.2003; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Wanasen N, 2008, INT J PARASITOL, V38, P417, DOI 10.1016/j.ijpara.2007.08.010; Wilson MS, 2010, EUR J IMMUNOL, V40, P1682, DOI 10.1002/eji.200939721; Wilson ME, 1996, J IMMUNOL, V156, P2231; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	48	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34143	10.1371/journal.pone.0034143	http://dx.doi.org/10.1371/journal.pone.0034143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479545	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100123
J	Pink, DBS; Schulte, W; Parseghian, MH; Zijlstra, A; Lewis, JD				Pink, Desmond B. S.; Schulte, Wendy; Parseghian, Missag H.; Zijlstra, Andries; Lewis, John D.			Real-Time Visualization and Quantitation of Vascular Permeability In Vivo: Implications for Drug Delivery	PLOS ONE			English	Article							CHICK CHORIOALLANTOIC MEMBRANE; TRANSCAPILLARY PRESSURE-GRADIENT; ENDOTHELIAL BARRIER FUNCTION; MICROVASCULAR PERMEABILITY; INTERSTITIAL HYPERTENSION; PHYSIOLOGICAL BARRIERS; TUMOR MICROENVIRONMENT; MICROVESSEL LEAKINESS; SOLID TUMORS; ANGIOGENESIS	The leaky, heterogeneous vasculature of human tumors prevents the even distribution of systemic drugs within cancer tissues. However, techniques for studying vascular delivery systems in vivo often require complex mammalian models and time-consuming, surgical protocols. The developing chicken embryo is a well-established model for human cancer that is easily accessible for tumor imaging. To assess this model for the in vivo analysis of tumor permeability, human tumors were grown on the chorioallantoic membrane (CAM), a thin vascular membrane which overlays the growing chick embryo. The real-time movement of small fluorescent dextrans through the tumor vasculature and surrounding tissues were used to measure vascular leak within tumor xenografts. Dextran extravasation within tumor sites was selectively enhanced an interleukin-2 (IL-2) peptide fragment or vascular endothelial growth factor (VEGF). VEGF treatment increased vascular leak in the tumor core relative to surrounding normal tissue and increased doxorubicin uptake in human tumor xenografts. This new system easily visualizes vascular permeability changes in vivo and suggests that vascular permeability may be manipulated to improve chemotherapeutic targeting to tumors.	[Pink, Desmond B. S.; Schulte, Wendy; Zijlstra, Andries; Lewis, John D.] Innovascreen Inc, Halifax, NS, Canada; [Parseghian, Missag H.] Stonsa Biopharm Inc, Carlsbad, CA USA; [Zijlstra, Andries] Vanderbilt Univ, Dept Pathol, Nashville, TN USA; [Lewis, John D.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	Vanderbilt University; University of Alberta	Pink, DBS (corresponding author), Innovascreen Inc, Halifax, NS, Canada.	jdlewis@ualberta.ca	zijlstra, andries/G-4564-2013	zijlstra, andries/0000-0001-8460-8803; Parseghian, Missag/0000-0001-6712-6925	Canadian Cancer Society Research Institute [700537]; National Institutes of Health/National Cancer Institute [CA120711-01A1]; National Research Council [636054]; NATIONAL CANCER INSTITUTE [K01CA120711] Funding Source: NIH RePORTER	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Canadian Cancer Society Research Institute grant # 700537 to Dr. Lewis and National Institutes of Health/National Cancer Institute grant # CA120711-01A1 to Dr. Zijlstra. Dr. Pink was supported by National Research Council-Industrial Research Assistance Program # 636054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSPRUNK DH, 1974, DEV BIOL, V38, P237, DOI 10.1016/0012-1606(74)90004-9; Brkovic A, 2007, J CELL BIOCHEM, V100, P727, DOI 10.1002/jcb.21124; Cairns R, 2006, MOL CANCER RES, V4, P61, DOI 10.1158/1541-7786.MCR-06-0002; Campbell Robert B., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P503, DOI 10.2174/187152006778699077; CHAMBERS A F, 1990, In Vivo (Attiki), V4, P215; Cho CF, 2011, JOVE-J VIS EXP, DOI 10.3791/2808; Cruz A, 2000, MICROVASC RES, V59, P195, DOI 10.1006/mvre.1999.2226; Cruz A, 1997, TISSUE CELL, V29, P277, DOI 10.1016/S0040-8166(97)80003-1; Czabanka M, 2011, EUR J CANCER, V47, P1276, DOI 10.1016/j.ejca.2011.02.001; Czabanka M, 2009, INT J CANCER, V124, P1293, DOI 10.1002/ijc.24019; DeFouw LM, 2000, MICROVASC RES, V60, P212, DOI 10.1006/mvre.2000.2276; DeFouw LM, 2000, TISSUE CELL, V32, P238, DOI 10.1054/tice.2000.0111; Delmonte A, 2009, EXPERT OPIN INV DRUG, V18, P1541, DOI 10.1517/13543780903213697; Dickson PV, 2007, MOL CANCER RES, V5, P531, DOI 10.1158/1541-7786.MCR-06-0259; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; Dvorak HF, 2011, J SURG ONCOL, V103, P468, DOI 10.1002/jso.21709; Eikenes L, 2005, BRIT J CANCER, V93, P81, DOI 10.1038/sj.bjc.6602626; Eikenes L, 2004, CANCER RES, V64, P4768, DOI 10.1158/0008-5472.CAN-03-1472; Epstein AL, 2003, J NATL CANCER I, V95, P741, DOI 10.1093/jnci/95.10.741; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Fukumura D, 2010, MICROCIRCULATION, V17, P206, DOI 10.1111/j.1549-8719.2010.00029.x; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; JAIN RK, 1989, JNCI-J NATL CANCER I, V81, P570, DOI 10.1093/jnci/81.8.570; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; Khawli L, 2005, CLIN CANCER RES, V11, P3084, DOI 10.1158/1078-0432.CCR-04-2310; Kim TJ, 2007, CANCER RES, V67, P9337, DOI 10.1158/0008-5472.CAN-06-4018; LEESON TS, 1963, J ANAT, V97, P585; Leong HS, 2010, NAT PROTOC, V5, P1406, DOI 10.1038/nprot.2010.103; Lewis JD, 2006, NAT MED, V12, P354, DOI 10.1038/nm1368; Machado MJC, 2011, J PHYSIOL-LONDON, V589, P4681, DOI 10.1113/jphysiol.2011.208355; Maeda H, 2003, INT IMMUNOPHARMACOL, V3, P319, DOI 10.1016/S1567-5769(02)00271-0; Mikhail AS, 2009, J CONTROL RELEASE, V138, P214, DOI 10.1016/j.jconrel.2009.04.010; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Murohara T, 1998, CIRCULATION, V97, P99, DOI 10.1161/01.CIR.97.1.99; Palmer TD, 2011, JOVE-J VIS EXP, DOI 10.3791/2815; Pietras K, 2004, SEMIN ONCOL, V31, P18, DOI 10.1053/j.seminoncol.2004.03.036; Pietras K, 2001, CANCER RES, V61, P2929; Presta LG, 1997, CANCER RES, V57, P4593; Qayum N, 2011, CLIN CANC RES; Qayum N, 2009, CANCER RES, V69, P6347, DOI 10.1158/0008-5472.CAN-09-0657; Reyes-Aldasoro CC, 2008, MICROCIRCULATION, V15, P65, DOI 10.1080/10739680701436350; Ribatti D, 2008, INT REV CEL MOL BIO, V270, P181, DOI 10.1016/S1937-6448(08)01405-6; RIZZO V, 1993, MICROVASC RES, V46, P320, DOI 10.1006/mvre.1993.1056; RIZZO V, 1995, MICROVASC RES, V49, P49, DOI 10.1006/mvre.1995.1005; Rizzo V, 1997, INT J MICROCIRC, V17, P75, DOI 10.1159/000179210; Saw CLL, 2008, DRUG DEV IND PHARM, V34, P1168, DOI [10.1080/03639040801974295, 10.1080/03639040801974295 ]; Seandel M, 2001, BLOOD, V97, P2323, DOI 10.1182/blood.V97.8.2323; Stacker SA, 1999, J BIOL CHEM, V274, P34884, DOI 10.1074/jbc.274.49.34884; Staton CA, 2009, INT J EXP PATHOL, V90, P195, DOI 10.1111/j.1365-2613.2008.00633.x; Stohrer M, 2000, CANCER RES, V60, P4251; Strieth S, 2008, CLIN CANCER RES, V14, P4603, DOI 10.1158/1078-0432.CCR-07-4738; Strojnik T, 2010, ANTICANCER RES, V30, P4851; Tailor TD, 2010, MOL CANCER THER, V9, P1798, DOI 10.1158/1535-7163.MCT-09-0856; Tartis MS, 2006, ULTRASOUND MED BIOL, V32, P1771, DOI 10.1016/j.ultrasmedbio.2006.03.017; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Valdes TI, 2003, J BIOMED MATER RES A, V67A, P215, DOI 10.1002/jbm.a.10055; Valdes TI, 2002, J BIOMED MATER RES, V62, P273, DOI 10.1002/jbm.10152; Vargas A, 2007, ADV DRUG DELIVER REV, V59, P1162, DOI 10.1016/j.addr.2007.04.019; WU NZ, 1993, CANCER RES, V53, P3765; YUAN F, 1995, CANCER RES, V55, P3752; Zijlstra A, 2002, CANCER RES, V62, P7083; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	64	37	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33760	10.1371/journal.pone.0033760	http://dx.doi.org/10.1371/journal.pone.0033760			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479438	Green Published, gold			2022-12-27	WOS:000304523400033
J	Schnee, C; Schulsse, S; Hotzel, H; Ayling, RD; Nicholas, RAJ; Schubert, E; Heller, M; Ehricht, R; Sachse, K				Schnee, Christiane; Schulsse, Samuel; Hotzel, Helmut; Ayling, Roger D.; Nicholas, Robin A. J.; Schubert, Evelyn; Heller, Martin; Ehricht, Ralf; Sachse, Konrad			A Novel Rapid DNA Microarray Assay Enables Identification of 37 Mycoplasma Species and Highlights Multiple Mycoplasma Infections	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; RESPIRATORY-DISEASE; CELL-CULTURES; PCR; DIAGNOSIS; KERATOCONJUNCTIVITIS; PLEUROPNEUMONIA; CHLAMYDOPHILA; SAMPLES; CATTLE	Mycoplasmas comprise a conglomerate of pathogens and commensals occurring in humans and animals. The genus Mycoplasma alone contains more than 120 species at present, and new members are continuously being discovered. Therefore, it seems promising to use a single highly parallel detection assay rather than develop separate tests for each individual species. In this study, we have designed a DNA microarray carrying 70 oligonucleotide probes derived from the 23S rRNA gene and 86 probes from the tuf gene target regions. Following a PCR amplification and biotinylation step, hybridization on the array was shown to specifically identify 31 Mycoplasma spp., as well as 3 Acholeplasma spp. and 3 Ureaplasma spp. Members of the Mycoplasma mycoides cluster can be recognized at subgroup level. This procedure enables parallel detection of Mollicutes spp. occurring in humans, animals or cell culture, from mono- and multiple infections, in a single run. The main advantages of the microarray assay include ease of operation, rapidity, high information content, and affordability. The new test's analytical sensitivity is equivalent to that of real-time PCR and allows examination of field samples without the need for culture. When 60 field samples from ruminants and birds previously analyzed by denaturing-gradient gel electrophoresis (DGGE) were tested by the microarray assay both tests identified the same agent in 98.3% of the cases. Notably, microarray testing revealed an unexpectedly high proportion (35%) of multiple mycoplasma infections, i. e., substantially more than DGGE (15%). Two of the samples were found to contain four different Mycoplasma spp. This phenomenon deserves more attention, particularly its implications for epidemiology and treatment.	[Schnee, Christiane; Schulsse, Samuel; Schubert, Evelyn; Heller, Martin; Sachse, Konrad] Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Friedrich Loeffler Inst, Jena, Germany; [Hotzel, Helmut] Fed Res Inst Anim Hlth, Inst Bacterial Infect & Zoonoses, Friedrich Loeffler Inst, Jena, Germany; [Ayling, Roger D.; Nicholas, Robin A. J.] Mycoplasma Grp, Anim Hlth & Vet Labs Agcy, Dept Bacteriol, Addlestone, Surrey, England; [Ehricht, Ralf] Alere Technol GmbH, Jena, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute; Friedrich Loeffler Institute; Veterinary Laboratories Agency; Alere	Schnee, C (corresponding author), Fed Res Inst Anim Hlth, Inst Mol Pathogenesis, Friedrich Loeffler Inst, Jena, Germany.	konrad.sachse@fli.bund.de	Nicholas, Robin A. J./F-6660-2010; Sachse, Konrad/GWC-4999-2022; Ayling, Roger D/C-7567-2011	Sachse, Konrad/0000-0003-1230-1786; Schnee, Christiane/0000-0001-7643-9114	European Initiative EMIDA ERA-Net [0315859]	European Initiative EMIDA ERA-Net	This study was supported by grant no. 0315859 "Improvements in the diagnosis and control of bovine mycoplasmosis'' of the European Initiative EMIDA ERA-Net. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battaglia A, 2011, J FORENSIC SCI, V56, P760, DOI 10.1111/j.1556-4029.2011.01708.x; Bergonier D, 1997, REV SCI TECH OIE, V16, P848, DOI 10.20506/rst.16.3.1062; Borel N, 2008, MOL CELL PROBE, V22, P55, DOI 10.1016/j.mcp.2007.06.003; Brown D.R., 2011, BERGEYS MANUAL SYSTE, P575; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; Freund EA, 1983, METHODS MYCOPLASMOLO, P127, DOI DOI 10.1016/B978-0-12-583801-6.50029-9; Garner CM, 2000, BRIT J BIOMED SCI, V57, P295; Geue L, 2010, APPL ENVIRON MICROB, V76, P5510, DOI 10.1128/AEM.00743-10; Giacometti M, 1999, J VET MED B, V46, P173, DOI 10.1046/j.1439-0450.1999.00218.x; JONES GE, 1976, VET REC, V99, P137, DOI 10.1136/vr.99.8.137; Kamla V, 1996, GENE, V171, P83, DOI 10.1016/0378-1119(95)00884-5; Katoh Kazutaka, 2005, Genome Inform, V16, P22; Kleven SH, 1998, POULTRY SCI, V77, P1146, DOI 10.1093/ps/77.8.1146; Kobayashi H, 1998, J VET MED SCI, V60, P1299, DOI 10.1292/jvms.60.1299; Levisohn S, 2004, J VET DIAGN INVEST, V16, P579, DOI 10.1177/104063870401600615; Manso-Silvan L, 2009, INT J SYST EVOL MICR, V59, P1353, DOI 10.1099/ijs.0.005546-0; Marois C, 2007, VET MICROBIOL, V120, P96, DOI 10.1016/j.vetmic.2006.10.015; Marques LM, 2007, J VET DIAGN INVEST, V19, P103, DOI 10.1177/104063870701900118; McAuliffe L, 2005, J MED MICROBIOL, V54, P731, DOI 10.1099/jmm.0.46058-0; McAuliffe L, 2003, VET REC, V153, P687, DOI 10.1136/vr.153.22.687; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nicholas R, 1998, METH MOL B, V104, P37; NICHOLAS RAJ, 1995, J COMP PATHOL, V113, P1, DOI 10.1016/S0021-9975(05)80065-9; Pfutzner H, 1996, REV SCI TECH OIE, V15, P1477, DOI 10.20506/rst.15.4.987; Pitcher DG, 2005, VET J, V170, P300, DOI 10.1016/j.tvjl.2004.08.011; Razin S, 1997, INDIAN J BIOCHEM BIO, V34, P124; Rebelo AR, 2011, J VET DIAGN INVEST, V23, P932, DOI 10.1177/1040638711416846; RHOADES KR, 1981, AVIAN DIS, V25, P131, DOI 10.2307/1589834; Righter DJ, 2011, VET MICROBIOL, V153, P246, DOI 10.1016/j.vetmic.2011.06.010; Ross DF, 1992, DIS SWINE, P537; Ruettger A, 2011, MOL CELL PROBE, V25, P19, DOI 10.1016/j.mcp.2010.09.004; Sachse K, 2005, MOL CELL PROBE, V19, P41, DOI 10.1016/j.mcp.2004.09.005; Sachse K, 2010, VET J, V186, P299, DOI 10.1016/j.tvjl.2009.10.008; Sachse K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-63; Sachse K, 2009, VET MICROBIOL, V135, P22, DOI 10.1016/j.vetmic.2008.09.041; Stormer M, 2009, INT J MED MICROBIOL, V299, P291, DOI 10.1016/j.ijmm.2008.08.002; Thiaucourt F, 1996, REV SCI TECH OIE, V15, P1415, DOI 10.20506/rst.15.4.989; Timenetsky J, 2006, BRAZ J MED BIOL RES, V39, P907, DOI 10.1590/S0100-879X2006000700009; Volokhov DV, 2006, APPL MICROBIOL BIOT, V71, P680, DOI 10.1007/s00253-005-0280-7; Volokhov DV, 2011, MOL CELL PROBE, V25, P69, DOI 10.1016/j.mcp.2011.01.002; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104	41	26	29	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33237	10.1371/journal.pone.0033237	http://dx.doi.org/10.1371/journal.pone.0033237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479374				2022-12-27	WOS:000304523400016
J	Batista, TM; Alonso-Magdalena, P; Vieira, E; Amaral, MEC; Cederroth, CR; Nef, S; Quesada, I; Carneiro, EM; Nadal, A				Batista, Thiago M.; Alonso-Magdalena, Paloma; Vieira, Elaine; Amaral, Maria Esmeria C.; Cederroth, Christopher R.; Nef, Serge; Quesada, Ivan; Carneiro, Everardo M.; Nadal, Angel			Short-Term Treatment with Bisphenol-A Leads to Metabolic Abnormalities in Adult Male Mice	PLOS ONE			English	Article							ENDOCRINE DISRUPTORS; ESTROGEN-RECEPTOR; SKELETAL-MUSCLE; INSULIN-SECRETION; EXPOSURE; LEPTIN; CELLS; SENSITIVITY; MECHANISMS; EXPRESSION	Bisphenol-A (BPA) is one of the most widespread endocrine disrupting chemicals (EDC) used as the base compound in the manufacture of polycarbonate plastics. Although evidence points to consider exposure to BPA as a risk factor for insulin resistance, its actions on whole body metabolism and on insulin-sensitive tissues are still unclear. The aim of the present work was to study the effects of low doses of BPA in insulin-sensitive peripheral tissues and whole body metabolism in adult mice. Adult mice were treated with subcutaneous injection of 100 mu g/kg BPA or vehicle for 8 days. Whole body energy homeostasis was assessed with in vivo indirect calorimetry. Insulin signaling assays were conducted by western blot analysis. Mice treated with BPA were insulin resistant and had increased glucose-stimulated insulin release. BPA-treated mice had decreased food intake, lower body temperature and locomotor activity compared to control. In skeletal muscle, insulin-stimulated tyrosine phosphorylation of the insulin receptor beta subunit was impaired in BPA-treated mice. This impairment was associated with a reduced insulin-stimulated Akt phosphorylation in the Thr(308) residue. Both skeletal muscle and liver displayed an upregulation of IRS-1 protein by BPA. The mitogen-activated protein kinase (MAPK) signaling pathway was also impaired in the skeletal muscle from BPA-treated mice. In the liver, BPA effects were of lesser intensity with decreased insulin-stimulated tyrosine phosphorylation of the insulin receptor b subunit. In conclusion, short-term treatment with low doses of BPA slows down whole body energy metabolism and disrupts insulin signaling in peripheral tissues. Thus, our findings support the notion that BPA can be considered a risk factor for the development of type 2 diabetes.	[Batista, Thiago M.; Carneiro, Everardo M.] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Anat Biol Celular Fisiol & Biofis, Campinas, SP, Brazil; [Batista, Thiago M.; Carneiro, Everardo M.] Inst Nacl Ciencia & Tecnol Obesidade & Diabet, Sao Paulo, Brazil; [Alonso-Magdalena, Paloma; Vieira, Elaine; Quesada, Ivan; Nadal, Angel] Univ Miguel Hernandez Elche, Inst Bioingn, Elche, Spain; [Alonso-Magdalena, Paloma; Vieira, Elaine; Quesada, Ivan; Nadal, Angel] CIBERDEM, Ctr Invest Biomed Red Diabet & Enfermedades Metab, Elche, Spain; [Cederroth, Christopher R.; Nef, Serge] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Amaral, Maria Esmeria C.] UNIARARAS, Ctr Univ Herminio Ometto, Programa Pos Grad Ciencias Biomed, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Geneva; Centro Universitario Herminio Ometto	Batista, TM (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Anat Biol Celular Fisiol & Biofis, Campinas, SP, Brazil.	emc@unicamp.br; nadal@umh.es	Batista, Thiago M/C-9816-2014; Amaral, Maria Esmeria/E-6263-2012; Cederroth, Christopher R./AAO-9501-2020; Nef, Serge/AAV-6445-2020; Vieira, Elaine/AAG-1127-2020; Carneiro, Everardo/D-4758-2012; Alonso-Magdalena, Paloma/AAH-2076-2021; Vieira, Elaine/F-7273-2019; Ivan, Quesada/P-6541-2014; Nadal, Angel/G-6721-2014; Batista, Thiago/F-1851-2012	Batista, Thiago M/0000-0001-6971-1191; Amaral, Maria Esmeria/0000-0001-5128-2202; Nef, Serge/0000-0001-5462-0676; Vieira, Elaine/0000-0002-0621-9367; Vieira, Elaine/0000-0002-0621-9367; Ivan, Quesada/0000-0002-9808-514X; Nadal, Angel/0000-0003-4178-2152; ALONSO MAGDALENA, PALOMA/0000-0003-1065-5388; Cederroth, Christopher/0000-0001-7267-5136	Ministerio de Ciencia e Innovacion [BFU2008-01492, BFU2011-28358, BFU2010-21773]; Generalitat Valenciana [Prometeo/2011/080, ACOMP/2010/113]; European Commission; Swiss National Science Foundation; Sir Jules Thorn Charitable Overseas Trust	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Sir Jules Thorn Charitable Overseas Trust	This research was supported by grants from Ministerio de Ciencia e Innovacion grants BFU2008-01492, BFU2011-28358 and BFU2010-21773, Generalitat Valenciana grants Prometeo/2011/080 and ACOMP/2010/113, the European Commission (Program PEOPLE). The "Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas'' is an initiative of the Instituto de Salud Carlos III. SN and CRC were supported by the Swiss National Science Foundation and the Sir Jules Thorn Charitable Overseas Trust Registry Schaan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2005, FOOD CHEM TOXICOL, V43, P713, DOI 10.1016/j.fct.2005.01.009; Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Alonso-Magdalena P, 2011, NAT REV ENDOCRINOL, V7, P346, DOI 10.1038/nrendo.2011.56; Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993; Barros RPA, 2006, TRENDS MOL MED, V12, P425, DOI 10.1016/j.molmed.2006.07.004; BEARD JC, 1987, J CLIN ENDOCR METAB, V65, P59, DOI 10.1210/jcem-65-1-59; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Cederroth CR, 2007, ENVIRON HEALTH PERSP, V115, P1467, DOI 10.1289/ehp.10413; Clegg DJ, 2006, DIABETES, V55, P978, DOI 10.2337/diabetes.55.04.06.db05-1339; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; DeFronzo RA, 1997, DIABETES REV, V5, P177; DELPRATO S, 1994, DIABETOLOGIA, V37, P1025, DOI 10.1007/BF00400466; Devedjian JC, 2000, J CLIN INVEST, V105, P731, DOI 10.1172/JCI5656; Faulds MH, 2012, J ENDOCRINOL, V212, P3, DOI 10.1530/JOE-11-0044; Gao Q, 2007, NAT MED, V13, P89, DOI 10.1038/nm1525; Glass DJ, 2010, CURR TOP MICROBIOL, V346, P267, DOI 10.1007/82_2010_78; Hamdi MM, 2011, J PHYSIOL-LONDON, V589, P3623, DOI 10.1113/jphysiol.2011.207175; Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Leng Y, 2004, REV ENDOCR METAB DIS, V5, P111, DOI 10.1023/B:REMD.0000021432.84588.f6; Maroni P, 2009, MOL CELL ENDOCRINOL, V309, P26, DOI 10.1016/j.mce.2009.05.021; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Meyer MR, 2011, ACTA PHYSIOL, V203, P259, DOI 10.1111/j.1748-1716.2010.02237.x; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; Oliveira AG, 2011, DIABETES, V60, P784, DOI 10.2337/db09-1907; Park CJ, 2011, J CLIN INVEST, V121, P604, DOI 10.1172/JCI41702; Phrakonkham P, 2008, J STEROID BIOCHEM, V110, P95, DOI 10.1016/j.jsbmb.2008.02.006; Prins GS, 2011, REPROD TOXICOL, V31, P1, DOI 10.1016/j.reprotox.2010.09.009; Ropero AB, 2008, STEROIDS, V73, P874, DOI 10.1016/j.steroids.2007.12.018; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Sakurai K, 2004, BRIT J PHARMACOL, V141, P209, DOI 10.1038/sj.bjp.0705520; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Soriano S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031109; Soriano S, 2009, MOL ENDOCRINOL, V23, P1973, DOI 10.1210/me.2009-0287; Stahlhut RW, 2009, ENVIRON HEALTH PERSP, V117, P784, DOI 10.1289/ehp.0800376; Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281; Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Wada K, 2007, J PHARMACOL SCI, V105, P133, DOI 10.1254/jphs.FM0070034; Wang TG, 2012, J CLIN ENDOCR METAB, V97, pE223, DOI 10.1210/jc.2011-1989; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010; Wong WPS, 2010, P NATL ACAD SCI USA, V107, P13057, DOI 10.1073/pnas.0914501107; Zalko D, 2011, CHEMOSPHERE, V82, P424, DOI 10.1016/j.chemosphere.2010.09.058	51	123	128	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33814	10.1371/journal.pone.0033814	http://dx.doi.org/10.1371/journal.pone.0033814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470480	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000037
J	Qi, DL; Chao, Y; Guo, SC; Zhao, LY; Li, TP; Wei, FL; Zhao, XQ				Qi, Delin; Chao, Yan; Guo, Songchang; Zhao, Lanying; Li, Taiping; Wei, Fulei; Zhao, Xinquan			Convergent, Parallel and Correlated Evolution of Trophic Morphologies in the Subfamily Schizothoracinae from the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							ANCESTRAL CHARACTER STATES; MOLECULAR PHYLOGENY; MITOCHONDRIAL-DNA; DISCRETE CHARACTERS; MAXIMUM-LIKELIHOOD; FISHES TELEOSTEI; CYPRINIDAE; BIOGEOGRAPHY; CYPRINIFORMES; OSTARIOPHYSI	Schizothoracine fishes distributed in the water system of the Qinghai-Tibetan plateau (QTP) and adjacent areas are characterized by being highly adaptive to the cold and hypoxic environment of the plateau, as well as by a high degree of diversity in trophic morphology due to resource polymorphisms. Although convergent and parallel evolution are prevalent in the organisms of the QTP, it remains unknown whether similar evolutionary patterns have occurred in the schizothoracine fishes. Here, we constructed for the first time a tentative molecular phylogeny of the schizothoracine fishes based on the complete sequences of the cytochrome b gene. We employed this molecular phylogenetic framework to examine the evolution of trophic morphologies. We used Pagel's maximum likelihood method to estimate the evolutionary associations of trophic morphologies and food resource use. Our results showed that the molecular and published morphological phylogenies of Schizothoracinae are partially incongruent with respect to some intergeneric relationships. The phylogenetic results revealed that four character states of five trophic morphologies and of food resource use evolved at least twice during the diversification of the subfamily. State transitions are the result of evolutionary patterns including either convergence or parallelism or both. Furthermore, our analyses indicate that some characters of trophic morphologies in the Schizothoracinae have undergone correlated evolution, which are somewhat correlated with different food resource uses. Collectively, our results reveal new examples of convergent and parallel evolution in the organisms of the QTP. The adaptation to different trophic niches through the modification of trophic morphologies and feeding behaviour as found in the schizothoracine fishes may account for the formation and maintenance of the high degree of diversity and radiations in fish communities endemic to QTP.	[Qi, Delin; Chao, Yan; Zhao, Lanying; Li, Taiping; Wei, Fulei] Qinghai Univ, Agr & Anim Husb Coll, Dept Anim Sci, Xining, Qinghai, Peoples R China; [Guo, Songchang; Zhao, Xinquan] Chinese Acad Sci, NW Plateau Inst Biol, Key Lab Qinghai Tibetan Plateau Biol Evolut & Ada, Xining, Qinghai, Peoples R China	Qinghai University; Chinese Academy of Sciences; Northwest Institute of Plateau Biology, CAS	Qi, DL (corresponding author), Qinghai Univ, Agr & Anim Husb Coll, Dept Anim Sci, Xining, Qinghai, Peoples R China.	delinqi@126.com; xqzhao@nwipb.ac.cn			National Natural Science Foundation of China [30860048, 31160226]; Program for New Century Excellent Talents in University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was sponsored in part by the National Natural Science Foundation of China (30860048, 31160226) and the Program for New Century Excellent Talents in University (NCET-09-0861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandrino A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-164; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; AVISE JC, 1986, PHILOS T ROY SOC B, V312, P325, DOI 10.1098/rstb.1986.0011; BILLINGTON N, 1988, CAN J FISH AQUAT SCI, V45, P643, DOI 10.1139/f88-078; Britz R, 2009, J MORPHOL, V270, P389, DOI 10.1002/jmor.10698; Burridge CP, 1999, MOL PHYLOGENET EVOL, V13, P93, DOI 10.1006/mpev.1999.0622; Chen Y., 2000, FAUNA SINICA OSTEICH, P273; Chu Y.T., 1935, BIOL BULL+, V2, P1, DOI DOI 10.2307/1436747; Day JJ, 2002, BIOL J LINN SOC, V76, P269, DOI 10.1046/j.1095-8312.2002.00066.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gleiser G, 2005, NEW PHYTOL, V165, P633, DOI 10.1111/j.1469-8137.2004.01242.x; He DK, 2006, J BIOGEOGR, V33, P1448, DOI 10.1111/j.1365-2699.2006.01510.x; He DK, 2004, CHINESE SCI BULL, V49, P39, DOI 10.1360/03wc0212; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Maddison WP, 2009, MESQUITE 2 6 MODULAR; MIRZA M R, 1991, Pakistan Journal of Zoology, V23, P339; Mooers AO, 1999, SYST BIOL, V48, P623, DOI 10.1080/106351599260193; Muschick M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-116; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pasco-Viel E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011293; Patterson C., 1987, MOL MORPHOLOGY EVOLU, P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qi DL, 2006, BIOCHEM GENET, V44, P270, DOI 10.1007/s10528-006-9022-5; Revell LJ, 2007, EVOLUTION, V61, P2898, DOI 10.1111/j.1558-5646.2007.00225.x; ROBINSON BW, 1994, AM NAT, V144, P596, DOI 10.1086/285696; Ruber L, 2001, J EVOLUTION BIOL, V14, P325, DOI 10.1046/j.1420-9101.2001.00269.x; Ruber L, 1999, P NATL ACAD SCI USA, V96, P10230, DOI 10.1073/pnas.96.18.10230; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang Y, 2004, BIOCHEM SYST ECOL, V32, P1009, DOI 10.1016/j.bse.2004.04.005; Wang YJ, 2004, ACTA PHYTOTAXON SIN, V42, P481; WILSON E O, 1992; Wu Y, 1992, FISHES QINGHAI XIZAN; Wu Y.-F., 1984, ACTA BIOL PLATEAU SI, V3, P119; Xiao H, 2005, MOL PHYLOGENET EVOL, V36, P67, DOI 10.1016/j.ympev.2004.12.007; Xiao WH, 2001, MOL PHYLOGENET EVOL, V18, P163, DOI 10.1006/mpev.2000.0879; YAMAOKA K, 1986, Physiology and Ecology Japan, V23, P17; Zeng Y, 2011, HYDROBIOLOGIA, V664, P183, DOI 10.1007/s10750-010-0598-8; Zhao K, 2005, CHINESE SCI BULL, V50, P1325, DOI 10.1360/982005-223; Zheng D, 1996, SCI CHINA SER D, V39, P410; Zhu S.-Q., 1981, STUDIES PERIOD AMPLI, P118	51	49	53	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34070	10.1371/journal.pone.0034070	http://dx.doi.org/10.1371/journal.pone.0034070			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470515	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000059
J	Rong, GX; Reinhard, BM				Rong, Guoxin; Reinhard, Bjoern M.			Monitoring the Size and Lateral Dynamics of ErbB1 Enriched Membrane Domains through Live Cell Plasmon Coupling Microscopy	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SCATTERING SUBMICROSCOPIC PARTICLES; HIGHLY FLUORESCENT ANALOGS; SINGLE-MOLECULE TECHNIQUES; HIGHER-ORDER OLIGOMERS; FACTOR RECEPTOR; EGF-RECEPTOR; GOLD NANOPARTICLES; LIVING CELLS; BIOLOGICAL APPLICATIONS	To illuminate the role of the spatial organization of the epidermal growth factor receptor (ErbB1) in signal transduction quantitative information about the receptor topography on the cell surface, ideally on living cells and in real time, are required. We demonstrate that plasmon coupling microscopy (PCM) enables to detect, size, and track individual membrane domains enriched in ErbB1 with high temporal resolution. We used a dendrimer enhanced labeling strategy to label ErbB1 receptors on epidermoid carcinoma cells (A431) with 60 nm Au nanoparticle (NP) immunolabels under physiological conditions at 37 degrees C. The statistical analysis of the spatial NP distribution on the cell surface in the scanning electron microscope (SEM) confirmed a clustering of the NP labels consistent with a heterogeneous distribution of ErbB1 in the plasma membrane. Spectral shifts in the scattering response of clustered NPs facilitated the detection and sizing of individual NP clusters on living cells in solution in an optical microscope. We tracked the lateral diffusion of individual clusters at a frame rate of 200 frames/s while simultaneously monitoring the configurational dynamics of the clusters. Structural information about the NP clusters in their membrane confinements were obtained through analysis of the electromagnetic coupling of the co-confined NP labels through polarization resolved PCM. Our studies show that the ErbB1 receptor is enriched in membrane domains with typical diameters in the range between 60-250 nm. These membrane domains exhibit a slow lateral diffusion with a diffusion coefficient of D = vertical bar 0.0054 +/- 0.0064 vertical bar mu m(2)/s, which is almost an order of magnitude slower than the mean diffusion coefficient of individual NP tagged ErbB1 receptors under identical conditions.	[Rong, Guoxin] Boston Univ, Dept Chem, Boston, MA 02215 USA; Boston Univ, Photon Ctr, Boston, MA 02215 USA	Boston University; Boston University	Rong, GX (corresponding author), Boston Univ, Dept Chem, 590 Commonwealth Ave, Boston, MA 02215 USA.	bmr@bu.edu	Rong, Guoxin/A-6288-2010	Rong, Guoxin/0000-0001-8894-4986	National Institutes of Health [5 R01 CA138509-04]; NATIONAL CANCER INSTITUTE [R01CA138509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health through grant 5 R01 CA138509-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron J, 2009, NANO LETT, V9, P3612, DOI 10.1021/nl9018275; Abulrob A, 2010, J BIOL CHEM, V285, P3145, DOI 10.1074/jbc.M109.073338; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Ariotti N, 2010, MOL CELL BIOL, V30, P3795, DOI 10.1128/MCB.01615-09; Bader AN, 2009, BIOPHYS J, V97, P2613, DOI 10.1016/j.bpj.2009.07.059; Balzani V, 2000, CHEM COMMUN, P853, DOI 10.1039/b002116o; Brinkers S, 2010, I S BIOMED IMAGING, P1269, DOI 10.1109/ISBI.2010.5490227; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; Chen Y, 2004, LIPIDS, V39, P1115, DOI 10.1007/s11745-004-1337-9; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Clayton AHA, 2007, BIOCHEMISTRY-US, V46, P4589, DOI 10.1021/bi700002b; Clayton AHA, 2008, GROWTH FACTORS, V26, P316, DOI 10.1080/08977190802442187; Crow MJ, 2011, ACS NANO, V5, P8532, DOI 10.1021/nn201451c; Crow MJ, 2009, AM J ROENTGENOL, V192, P1021, DOI 10.2214/AJR.07.3535; de Lange F, 2001, J CELL SCI, V114, P4153; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hsieh MY, 2008, IET SYST BIOL, V2, P256, DOI 10.1049/iet-syb:20070073; Jain AK., 1988, TECHNOMETRICS; Jain PK, 2007, NANO LETT, V7, P2854, DOI 10.1021/nl071496m; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Mayawala K, 2005, FEBS LETT, V579, P3043, DOI 10.1016/j.febslet.2005.04.059; Michalet X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041914; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Murase K, 2004, BIOPHYS J, V86, P4075, DOI 10.1529/biophysj.103.035717; Nagy P, 1999, J CELL SCI, V112, P1733; Nagy P, 2002, J CELL SCI, V115, P4251, DOI 10.1242/jcs.00118; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; Prescher JA, 2004, NATURE, V430, P873, DOI 10.1038/nature02791; Reinhard BM, 2005, NANO LETT, V5, P2246, DOI 10.1021/nl051592s; Roepstorff K, 2002, J BIOL CHEM, V277, P18954, DOI 10.1074/jbc.M201422200; Rong GX, 2008, NANO LETT, V8, P3386, DOI 10.1021/nl802058q; Rong GX, 2010, NANO LETT, V10, P230, DOI 10.1021/nl903350f; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; SAXTON MJ, 1989, BIOPHYS J, V55, P21, DOI 10.1016/S0006-3495(89)82776-6; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schultz S, 2000, P NATL ACAD SCI USA, V97, P996, DOI 10.1073/pnas.97.3.996; Sheets ED, 1997, BIOCHEMISTRY-US, V36, P12449, DOI 10.1021/bi9710939; SHEETZ MP, 1983, SEMIN HEMATOL, V20, P175; Sonnichsen C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.077402; Sowa Y, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3495960; Su KH, 2003, NANO LETT, V3, P1087, DOI 10.1021/nl034197f; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Suzuki K, 2005, BIOPHYS J, V88, P3659, DOI 10.1529/biophysj.104.048538; Szabo A, 2008, BIOPHYS J, V95, P2086, DOI 10.1529/biophysj.108.133371; Takeuchi M, 1998, BIOPHYS J, V74, P2171, DOI 10.1016/S0006-3495(98)77926-3; Tang Q, 2003, BIOPHYS J, V84, P400, DOI 10.1016/S0006-3495(03)74860-7; TSUJI A, 1986, BIOCHEMISTRY-US, V25, P6133, DOI 10.1021/bi00368a045; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; Wang HY, 2011, NANO LETT, V11, P498, DOI 10.1021/nl103315t; Wang HY, 2009, J PHYS CHEM C, V113, P11215, DOI 10.1021/jp900874n; Wang J, 2011, ACS NANO, V5, P6619, DOI 10.1021/nn202055b; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Wei CYJ, 2007, J FLUORESC, V17, P797, DOI 10.1007/s10895-007-0234-9; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Xiao ZY, 2008, BIOCHEM BIOPH RES CO, V369, P730, DOI 10.1016/j.bbrc.2008.02.084; Yan B, 2011, J PHYS CHEM C, V115, P24437, DOI 10.1021/jp207821t; Yan B, 2011, J PHYS CHEM C, V115, P4578, DOI 10.1021/jp112146d; Yang LL, 2010, J PHYS CHEM C, V114, P4901, DOI 10.1021/jp911858v; Yang S, 2007, J CELL SCI, V120, P2763, DOI 10.1242/jcs.007658; Yang YH, 2009, ANAL CHEM, V81, P2564, DOI 10.1021/ac802477h; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yguerabide J, 1998, ANAL BIOCHEM, V262, P137, DOI 10.1006/abio.1998.2759; Yguerabide J, 1998, ANAL BIOCHEM, V262, P157, DOI 10.1006/abio.1998.2760	75	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34175	10.1371/journal.pone.0034175	http://dx.doi.org/10.1371/journal.pone.0034175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470534	Green Submitted, gold, Green Published			2022-12-27	WOS:000304489000073
J	Andres, C; Hasenauer, J; Allgower, F; Hucho, T				Andres, Christine; Hasenauer, Jan; Allgower, Frank; Hucho, Tim			Threshold-Free Population Analysis Identifies Larger DRG Neurons to Respond Stronger to NGF Stimulation	PLOS ONE			English	Article							PRIMARY AFFERENT NEURONS; RECEPTOR POTENTIAL VANILLOID-1; MAP KINASE-ACTIVITY; MOLECULAR-MECHANISMS; MESSENGER-RNA; CELL; TRANSIENT; SIGNAL; BINDING; PROTEIN	Sensory neurons in dorsal root ganglia (DRG) are highly heterogeneous in terms of cell size, protein expression, and signaling activity. To analyze their heterogeneity, threshold-based methods are commonly used, which often yield highly variable results due to the subjectivity of the individual investigator. In this work, we introduce a threshold-free analysis approach for sparse and highly heterogeneous datasets obtained from cultures of sensory neurons. This approach is based on population estimates and completely free of investigator-set parameters. With a quantitative automated microscope we measured the signaling state of single DRG neurons by immunofluorescently labeling phosphorylated, i.e., activated Erk1/2. The population density of sensory neurons with and without pain-sensitizing nerve growth factor (NGF) treatment was estimated using a kernel density estimator (KDE). By subtraction of both densities and integration of the positive part, a robust estimate for the size of the responsive subpopulations was obtained. To assure sufficiently large datasets, we determined the number of cells required for reliable estimates using a bootstrapping approach. The proposed methods were employed to analyze response kinetics and response amplitude of DRG neurons after NGF stimulation. We thereby determined the portion of NGF responsive cells on a true population basis. The analysis of the dose dependent NGF response unraveled a biphasic behavior, while the study of its time dependence showed a rapid response, which approached a steady state after less than five minutes. Analyzing two parameter correlations, we found that not only the number of responsive small-sized neurons exceeds the number of responsive large-sized neurons-which is commonly reported and could be explained by the excess of small-sized cells-but also the probability that small-sized cells respond to NGF is higher. In contrast, medium-sized and large-sized neurons showed a larger response amplitude in their mean Erk1/2 activity.	[Andres, Christine; Hucho, Tim] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Andres, Christine] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Hasenauer, Jan; Allgower, Frank] Univ Stuttgart, Inst Syst Theory & Automat Control, Stuttgart, Germany	Max Planck Society; Free University of Berlin; University of Stuttgart	Andres, C (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	hucho@molgen.mpg.de	Allgöwer, Frank/F-3909-2011; Kotov, Nicholas/AAZ-4204-2021; Hasenauer, Jan/B-8853-2013; Hucho, Tim/Q-5218-2018	Allgöwer, Frank/0000-0002-3702-3658; Kotov, Nicholas/0000-0002-6864-5804; Hasenauer, Jan/0000-0002-4935-3312; Hucho, Tim/0000-0002-4147-9308	German Federal Ministry of Education and Research (BMBF) within FORSYS [0315-280A, 0315449D]; German Research Foundation (DFG) within Cluster of Excellence in Simulation Technology (EXC) at University of Stuttgart [310/1]; Center Systems Biology (CSB) at University of Stuttgart; Max Planck Institute for Molecular Genetics, Berlin	German Federal Ministry of Education and Research (BMBF) within FORSYS(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG) within Cluster of Excellence in Simulation Technology (EXC) at University of Stuttgart(German Research Foundation (DFG)); Center Systems Biology (CSB) at University of Stuttgart; Max Planck Institute for Molecular Genetics, Berlin	This project has been funded by: 1) The German Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/) within the FORSYS-Partner program (grant nr. 0315-280A) and within the project Modelling of Pain Switches (MoPS, grant nr. 0315449D). 2) The German Research Foundation (DFG, http://www.dfg.de/) within the Cluster of Excellence in Simulation Technology (EXC 310/1) at the University of Stuttgart. 3) The Center Systems Biology (CSB, http://www.centersysbio.uni-stuttgart.de/) at the University of Stuttgart. 4) Dr. H. H. Ropers from the Max Planck Institute for Molecular Genetics, Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres C, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-98; Apgar JF, 2010, MOL BIOSYST, V6, P1890, DOI 10.1039/b918098b; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Bagwell B, 1996, CLIN IMMUNOL NEWSL, V16, P33; Balsa-Canto E, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-11; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Belmonte C, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-14; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Fang X, 2005, J NEUROSCI, V25, P4868, DOI 10.1523/JNEUROSCI.0249-05.2005; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Hasenauer J, 2011, J PROCESS CONTR, V21, P1417, DOI 10.1016/j.jprocont.2011.06.020; Hasenauer J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-125; Hoffman EM, 2010, J HISTOCHEM CYTOCHEM, V58, P329, DOI 10.1369/jhc.2009.954008; Huang SG, 2010, J COMPUT BIOL, V17, P879, DOI 10.1089/cmb.2009.0071; Hucho TB, 2005, J NEUROSCI, V25, P6119, DOI 10.1523/JNEUROSCI.0285-05.2005; Hucho T, 2007, NEURON, V55, P365, DOI 10.1016/j.neuron.2007.07.008; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kashiba H, 2001, MOL BRAIN RES, V95, P18, DOI 10.1016/S0169-328X(01)00224-8; Kreutz C, 2009, FEBS J, V276, P923, DOI 10.1111/j.1742-4658.2008.06843.x; Lampariello F, 1998, CYTOMETRY, V32, P241, DOI 10.1002/(SICI)1097-0320(19980701)32:3<241::AID-CYTO11>3.0.CO;2-N; Lampariello F, 2009, CYTOM PART A, V75A, P665, DOI 10.1002/cyto.a.20755; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Malik-Hall M, 2005, EUR J NEUROSCI, V21, P3387, DOI 10.1111/j.1460-9568.2005.04173.x; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MOLLIVER DC, 1995, J COMP NEUROL, V361, P404, DOI 10.1002/cne.903610305; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; Orozco OE, 2001, EUR J NEUROSCI, V13, P2177, DOI 10.1046/j.0953-816x.2001.01596.x; OVERTON WR, 1988, CYTOMETRY, V9, P619, DOI 10.1002/cyto.990090617; Paszek P, 2010, PNAS, V107, P1; Price TJ, 2007, J PAIN, V8, P263, DOI 10.1016/j.jpain.2006.09.005; Raue A, 2011, IET SYST BIOL, V5, P120, DOI 10.1049/iet-syb.2010.0061; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Schilling M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.91; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Silverman BW., 1986, DENSITY ESTIMATION S, V26, DOI 10.1201/9781315140919; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Song C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000699; Stamboulian S, 2010, J NEUROSCI, V30, P1637, DOI 10.1523/JNEUROSCI.4872-09.2010; Vial E, 2003, J CELL SCI, V116, P4957, DOI 10.1242/jcs.00812; Xu XJ, 2009, J NEUROSCI RES, V87, P482, DOI 10.1002/jnr.21844	48	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34257	10.1371/journal.pone.0034257	http://dx.doi.org/10.1371/journal.pone.0034257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479579	Green Submitted, Green Published, gold			2022-12-27	WOS:000303894900074
J	Karlsson-Lindahl, L; Schmidt, L; Haage, D; Hansson, C; Taube, M; Egeciouglu, E; Tan, YX; Admyre, T; Jansson, JO; Vlodavsky, I; Li, JP; Lindahl, U; Dickson, SL				Karlsson-Lindahl, Linda; Schmidt, Linnea; Haage, David; Hansson, Caroline; Taube, Magdalena; Egeciouglu, Emil; Tan, Ying-xia; Admyre, Therese; Jansson, John-Olov; Vlodavsky, Israel; Li, Jin-Ping; Lindahl, Ulf; Dickson, Suzanne L.			Heparanase Affects Food Intake and Regulates Energy Balance in Mice	PLOS ONE			English	Article							AGOUTI-RELATED PEPTIDE; MELANOCORTIN-4 RECEPTOR; TRANSGENIC EXPRESSION; BODY-WEIGHT; IN-VIVO; OBESITY; SYNDECAN-3; SULFATE; SYSTEM; MC4R	Mutation of the melanocortin-receptor 4 (MC4R) is the most frequent cause of severe obesity in humans. Binding of agouti-related peptide (AgRP) to MC4R involves the co-receptor syndecan-3, a heparan sulfate proteoglycan. The proteoglycan can be structurally modified by the enzyme heparanase. Here we tested the hypothesis that heparanase plays a role in food intake behaviour and energy balance regulation by analysing body weight, body composition and food intake in genetically modified mice that either lack or overexpress heparanase. We also assessed food intake and body weight following acute central intracerebroventricular administration of heparanase; such treatment reduced food intake in wildtype mice, an effect that was abolished in mice lacking MC4R. By contrast, heparanase knockout mice on a high-fat diet showed increased food intake and maturity-onset obesity, with up to a 40% increase in body fat. Mice overexpressing heparanase displayed essentially the opposite phenotypes, with a reduced fat mass. These results implicate heparanase in energy balance control via the central melanocortin system. Our data indicate that heparanase acts as a negative modulator of AgRP signaling at MC4R, through cleavage of heparan sulfate chains presumably linked to syndecan-3.	[Karlsson-Lindahl, Linda; Schmidt, Linnea; Hansson, Caroline; Taube, Magdalena; Egeciouglu, Emil; Jansson, John-Olov; Dickson, Suzanne L.] Univ Gothenburg, Inst Neurosci & Physiol Endocrinol, Sahlgrenska Acad, Gothenburg, Sweden; [Haage, David] Umea Univ, Dept Integrat Med Biol, Physiol Sect, Umea, Sweden; [Vlodavsky, Israel] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Canc & Vasc Biol Res Ctr, IL-31096 Haifa, Israel; [Tan, Ying-xia; Li, Jin-Ping; Lindahl, Ulf] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	University of Gothenburg; Umea University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Uppsala University	Karlsson-Lindahl, L (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol Endocrinol, Sahlgrenska Acad, Gothenburg, Sweden.	Linda.Lindahl@gu.se	Dickson, Suzanne L/U-4628-2019	Taube, Magdalena/0000-0002-7944-9673; Dickson, Suzanne/0000-0002-3822-5294	Swedish Medical Research Council [K2007-54X-20328-013, K2009-67X-21128-01-3, K2010-55X-20328-04-3, K2010-54X-09894-19-3]; European Union [LSHM-CT-2003-503041, FP7- HEALTH-2009- 241592, FP7-KBBE-2009-3-245009]; Novo Nordisk Fonden (GeA/AIR); ALF Goteborg [SU7601]; Cancerfonden [090717]; Polysackaridforskning AB (Uppsala); Swedish Foundation for Strategic Research [A305-188]; Polysackaridforskning AB; Novo Nordisk Fonden [NNF12OC1016479] Funding Source: researchfish	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); European Union(European Commission); Novo Nordisk Fonden (GeA/AIR)(Novo Nordisk Foundation); ALF Goteborg; Cancerfonden(Swedish Cancer Society); Polysackaridforskning AB (Uppsala); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Polysackaridforskning AB(HOGANAS ABStatisticon AB); Novo Nordisk Fonden(Novo Nordisk Foundation)	This research is supported by the Swedish Medical Research Council (K2007-54X-20328-013; K2009-67X-21128-01-3; K2010-55X-20328-04-3; K2010-54X-09894-19-3), European Union 6th and 7th Framework (LSHM-CT-2003-503041, FP7- HEALTH-2009- 241592, FP7-KBBE-2009-3-245009); Novo Nordisk Fonden (GeA/AIR); ALF Goteborg (SU7601); Cancerfonden (090717); Polysackaridforskning AB (Uppsala); and the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research (A305-188). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The financial support from the commercial funder (Polysackaridforskning AB) involves a patent on heparanase-knockout mice. Author TA is employed by AstraZeneca. Also, funders received from Novo Nordisk Fonden (GeA/AIR). These conditions do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ailenberg M, 2000, BIOTECHNIQUES, V29, P1018, DOI 10.2144/00295st03; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bluher S, 2004, J NUTR, V134, p2469S, DOI 10.1093/jn/134.9.2469S; Bode L, 2008, J CLIN INVEST, V118, P229, DOI 10.1172/JCI32335; Butler AA, 2001, NAT NEUROSCI, V4, P605, DOI 10.1038/88423; Butler AA, 2006, PEPTIDES, V27, P281, DOI 10.1016/j.peptides.2005.02.029; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Coll AP, 2007, CLIN SCI, V113, P171, DOI 10.1042/CS20070105; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Garza JC, 2008, J ENDOCRINOL, V197, P471, DOI 10.1677/JOE-08-0009; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Ha E, 2006, J CLIN ENDOCR METAB, V91, P5095, DOI 10.1210/jc.2005-2086; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Lindahl U, 2009, INT REV CEL MOL BIO, V276, P105, DOI 10.1016/S1937-6448(09)76003-4; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Mul JD, 2011, MELANOCORTIN RECEPTO; Nadir Y, 2006, J THROMB HAEMOST, V4, P2443, DOI 10.1111/j.1538-7836.2006.02212.x; Nardella C, 2004, BIOCHEMISTRY-US, V43, P1862, DOI 10.1021/bi030203a; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; OGREN S, 1975, J BIOL CHEM, V250, P2690; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Pierroz DD, 2002, DIABETES, V51, P1337, DOI 10.2337/diabetes.51.5.1337; Reizes O, 2006, PEPTIDES, V27, P274, DOI 10.1016/j.peptides.2005.02.030; Reizes O, 2003, ANN NY ACAD SCI, V994, P66, DOI 10.1111/j.1749-6632.2003.tb03163.x; Reizes O, 2001, CELL, V106, P105, DOI 10.1016/S0092-8674(01)00415-9; Schwartz MW, 2002, NATURE, V418, P595, DOI 10.1038/418595a; Strader AD, 2004, J CLIN INVEST, V114, P1354, DOI 10.1172/JCI200420631; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tolle V, 2008, DIABETES, V57, P86, DOI 10.2337/db07-0733; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wikberg JES, 2008, NAT REV DRUG DISCOV, V7, P307, DOI 10.1038/nrd2331; Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630; Wortley KE, 2005, CELL METAB, V2, P421, DOI 10.1016/j.cmet.2005.11.004; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Zcharia E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005181	41	25	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34313	10.1371/journal.pone.0034313	http://dx.doi.org/10.1371/journal.pone.0034313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479599	Green Submitted, Green Published, gold			2022-12-27	WOS:000303894900080
J	Perez, E; Edmonds, BA				Perez, Elvira; Edmonds, Barrie A.			A Systematic Review of Studies Measuring and Reporting Hearing Aid Usage in Older Adults since 1999: A Descriptive Summary of Measurement Tools	PLOS ONE			English	Review							QUALITY-OF-LIFE; INTERNATIONAL OUTCOME INVENTORY; AUDITORY REHABILITATION; FOLLOW-UP; POPULATION; PEOPLE; SATISFACTION; OWNERSHIP; LISTENERS; COMMUNITY	Objective: A systematic review was conducted to identify and quality assess how studies published since 1999 have measured and reported the usage of hearing aids in older adults. The relationship between usage and other dimensions of hearing aid outcome, age and hearing loss are summarised. Data sources: Articles were identified through systematic searches in PubMed/MEDLINE, The University of Nottingham Online Catalogue, Web of Science and through reference checking. Study eligibility criteria: (1) participants aged fifty years or over with sensori-neural hearing loss, (2) provision of an air conduction hearing aid, (3) inclusion of hearing aid usage measure(s) and (4) published between 1999 and 2011. Results: Of the initial 1933 papers obtained from the searches, a total of 64 were found eligible for review and were quality assessed on six dimensions: study design, choice of outcome instruments, level of reporting (usage, age, and audiometry) and cross validation of usage measures. Five papers were rated as being of high quality (scoring 10-12), 35 papers were rated as being of moderate quality (scoring 7-9), 22 as low quality (scoring 4-6) and two as very low quality (scoring 0-2). Fifteen different methods were identified for assessing the usage of hearing aids. Conclusions: Generally, the usage data reviewed was not well specified. There was a lack of consistency and robustness in the way that usage of hearing aids was assessed and categorised. There is a need for more standardised level of reporting of hearing aid usage data to further understand the relationship between usage and hearing aid outcomes.	[Perez, Elvira; Edmonds, Barrie A.] Natl Inst Hlth Res NIHR, Natl Biomed Res Unit Hearing, Nottingham, England; [Perez, Elvira; Edmonds, Barrie A.] Univ Nottingham, Sch Clin Sci, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Perez, E (corresponding author), Natl Inst Hlth Res NIHR, Natl Biomed Res Unit Hearing, Nottingham, England.	elvira.perez@nottingham.ac.uk		Perez Vallejos, Elvira/0000-0002-0258-9440	National Institute for Health Research; EPSRC [EP/G065802/1] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The National Biomedical Research Unit in Hearing is funded by the National Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Action for Hearing Loss, 2011, FACTS FIG DEAFN TINN; Arlinger S, 1999, BRIT J AUDIOL, V33, P223, DOI 10.3109/03005369909090103; Beck D, 2009, AUDIOLOGY TODAY, V12; Bentler RA, 2000, EAR HEARING, V21, p37S, DOI 10.1097/00003446-200008001-00006; Bertoli S, 2009, INT J AUDIOL, V48, P183, DOI 10.1080/14992020802572627; Boothroyd A, HEARINGS STATUS QUES; Brannstrom KJ, 2010, J AM ACAD AUDIOL, V21, P512, DOI 10.3766/jaaa.21.8.3; Brattt GW, 2007, J AM ACAD AUDIOL, V18, P274, DOI 10.3766/jaaa.18.4.2; BROOKS D N, 1985, British Journal of Audiology, V19, P211, DOI 10.3109/03005368509078975; Brooks DN, 1996, BRIT J AUDIOL, V30, P55, DOI 10.3109/03005369609077930; Cacciatore F, 1999, GERONTOLOGY, V45, P323, DOI 10.1159/000022113; Cox R, 2000, EAR HEARING, V21, p106S, DOI 10.1097/00003446-200008001-00014; Cox R, 2009, ANN M AM AUD SOC; Cox R M, 1992, J Am Acad Audiol, V3, P242; COX RM, 1987, EAR HEARING, V8, pS119, DOI 10.1097/00003446-198710001-00010; COX RM, 1988, EAR HEARING, V9, P198, DOI 10.1097/00003446-198808000-00005; COX RM, 1995, EAR HEARING, V16, P176, DOI 10.1097/00003446-199504000-00005; Cox RM, 1999, EAR HEARING, V20, P306, DOI 10.1097/00003446-199908000-00004; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; Davis A, 2007, HEALTH TECHNOL ASSES, V11, P1, DOI 10.3310/hta11420; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Dillon H., 1999, J AM ACAD AUDIOL, V10, P67; Forster S, 1988, AUD SOC AUSTR C; Gatehouse S., 1999, J AM ACAD AUDIOL, V10, P80; Gnewikow D, 2009, J REHABIL RES DEV, V46, P603, DOI 10.1682/JRRD.2007.03.0052; Goggins S, 2009, INT J AUDIOL, V48, P204, DOI 10.1080/14992020802575687; Gopinath B, 2011, ANN EPIDEMIOL, V21, P497, DOI 10.1016/j.annepidem.2011.03.005; Gussekloo J, 2003, BRIT J GEN PRACT, V53, P536; Hartley D, 2010, J AM ACAD AUDIOL, V21, P642, DOI 10.3766/jaaa.21.10.4; Hickson L, 1999, AUST J AUDIOLOGY, V21, P11; Humes Larry E, 2004, Am J Audiol, V13, P39, DOI 10.1044/1059-0889(2004/007); Humes Larry E., 2009, Seminars in Hearing, V30, P112, DOI 10.1055/s-0029-1215439; Humes LE, 2001, J SPEECH LANG HEAR R, V44, P469, DOI 10.1044/1092-4388(2001/037); Hutton CL, 1980, J ACADEMY REHABILITA, V13, P133; Ivory Peter J, 2009, Trends Amplif, V13, P260, DOI 10.1177/1084713809354902; Jerram JC., 2001, J AM ACAD AUDIOL, V12, P64, DOI [DOI 10.1055/S-0042-1745582, 10.1055/s-0042-1745582]; Keidser G, 2008, AM J AUDIOL, V17, P136, DOI 10.1044/1059-0889(2008/07-0012); Killion MC, 2004, J ACOUST SOC AM, V116, P2395, DOI 10.1121/1.1784440; Kochkin S., 2000, HEAR J, V53, P38, DOI 10.1097/00025572-200001000-00005; Kochkin S, 2005, HEAR J, V58; Kramer SE, 2002, INT J AUDIOL, V41, P36, DOI 10.3109/14992020209101310; Levitt H, 1978, SCAND AUDIOL S, V6, P107; Hidalgo JLT, 2009, ARCH GERONTOL GERIAT, V49, P88, DOI 10.1016/j.archger.2008.05.006; Lupsakko TA, 2005, EUR ARCH OTO-RHINO-L, V262, P165, DOI 10.1007/s00405-004-0789-x; Maki-Torkko EM, 2001, SCAND AUDIOL, V30, P81, DOI 10.1080/010503901300007146; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; NHS Centre for Research and Dissemination, 2009, NHS CTR RES DISS SYS; Parving A, 2001, AUDIOLOGY, V40, P43; Roup CM, 2009, AM J AUDIOL, V18, P45, DOI 10.1044/1059-0889(2009/08-0028); Schneider J, 2010, AGE AGEING, V39, P458, DOI 10.1093/ageing/afq051; Smeeth L, 2002, LANCET, V359, P1466, DOI 10.1016/S0140-6736(02)08433-7; Stephens D, 2001, AUDIOLOGY, V40, P104; Taubman LB, 1999, EAR HEARING, V20, P299, DOI 10.1097/00003446-199908000-00003; Uriarte Margaret, 2005, J Am Acad Audiol, V16, P383, DOI 10.3766/jaaa.16.6.6; VENTRY IM, 1982, EAR HEARING, V3, P128, DOI 10.1097/00003446-198205000-00006; Vuorialho A, 2006, INT J AUDIOL, V45, P400, DOI 10.1080/14992020600625007; Vuorialho A, 2006, EUR ARCH OTO-RHINO-L, V263, P355, DOI 10.1007/s00405-005-1007-1; WALDEN BE, 1984, J SPEECH HEAR RES, V27, P49, DOI 10.1044/jshr.2701.49; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Weinstein B E, 1986, ASHA, V28, P41; Williams VA, 2009, J AM ACAD AUDIOL, V20, P422, DOI 10.3766/jaaa.20.7.4; Yueh B, 2005, ARCH OTOLARYNGOL, V131, P851, DOI 10.1001/archotol.131.10.851	63	51	52	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e31831	10.1371/journal.pone.0031831	http://dx.doi.org/10.1371/journal.pone.0031831			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479312	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900005
J	Romiguier, J; Figuet, E; Galtier, N; Douzery, EJP; Boussau, B; Dutheil, JY; Ranwez, V				Romiguier, Jonathan; Figuet, Emeric; Galtier, Nicolas; Douzery, Emmanuel J. P.; Boussau, Bastien; Dutheil, Julien Y.; Ranwez, Vincent			Fast and Robust Characterization of Time-Heterogeneous Sequence Evolutionary Processes Using Substitution Mapping	PLOS ONE			English	Article							AMINO-ACID SITES; DELETERIOUS MUTATIONS; COEVOLVING POSITIONS; DNA-SEQUENCES; SELECTION; DATABASE; MODELS; ACCUMULATION; LINEAGES; GENES	Genes and genomes do not evolve similarly in all branches of the tree of life. Detecting and characterizing the heterogeneity in time, and between lineages, of the nucleotide (or amino acid) substitution process is an important goal of current molecular evolutionary research. This task is typically achieved through the use of non-homogeneous models of sequence evolution, which being highly parametrized and computationally-demanding are not appropriate for large-scale analyses. Here we investigate an alternative methodological option based on probabilistic substitution mapping. The idea is to first reconstruct the substitutional history of each site of an alignment under a homogeneous model of sequence evolution, then to characterize variations in the substitution process across lineages based on substitution counts. Using simulated and published datasets, we demonstrate that probabilistic substitution mapping is robust in that it typically provides accurate reconstruction of sequence ancestry even when the true process is heterogeneous, but a homogeneous model is adopted. Consequently, we show that the new approach is essentially as efficient as and extremely faster than (up to 25 000 times) existing methods, thus paving the way for a systematic survey of substitution process heterogeneity across genes and lineages.	[Romiguier, Jonathan; Figuet, Emeric; Galtier, Nicolas; Douzery, Emmanuel J. P.; Dutheil, Julien Y.; Ranwez, Vincent] Univ Montpellier 2, CNRS, Inst Sci Evolut Montpellier, Montpellier, France; [Boussau, Bastien] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, F-69622 Villeurbanne, France; [Ranwez, Vincent] Montpellier SupAgro, Unite Mixte Rech Ameliorat Genet & Adaptat Plante, Montpellier, France; [Boussau, Bastien] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; Institut Agro; Montpellier SupAgro; University of California System; University of California Berkeley	Romiguier, J (corresponding author), Univ Montpellier 2, CNRS, Inst Sci Evolut Montpellier, Montpellier, France.	jonathan.romiguier@univ-montp2.fr	DOUZERY, Emmanuel J. P./ABC-4050-2020; ranwez, vincent/I-5490-2017; Dutheil, Julien Yann/K-5479-2016	DOUZERY, Emmanuel J. P./0000-0001-5286-647X; ranwez, vincent/0000-0002-9308-7541; Dutheil, Julien Yann/0000-0001-7753-4121; Boussau, Bastien/0000-0003-0776-4460; Romiguier, Jonathan/0000-0002-2527-4740	Agence Nationale de la Recherche [ANR-08-GENM-036-01 CoGeBi]; European Research Council [ERC 232971 PopPhyl]	Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by an Agence Nationale de la Recherche grant (ANR-08-GENM-036-01 CoGeBi) and a European Research Council Advanced Grant (ERC 232971 PopPhyl) to NG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barraclough TG, 2007, MOL BIOL EVOL, V24, P1952, DOI 10.1093/molbev/msm123; Boussau B, 2008, NATURE, V456, P942, DOI 10.1038/nature07393; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Dimmic MW, 2005, BIOINFORMATICS, V21, pI126, DOI 10.1093/bioinformatics/bti1032; Duret L, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000071; Dutheil J, 2005, MOL BIOL EVOL, V22, P1919, DOI 10.1093/molbev/msi183; Dutheil J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-242; Dutheil J, 2008, J MOL EVOL, V67, P257, DOI 10.1007/s00239-008-9139-8; Dutheil J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-188; Dutheil J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-255; Escobar JS, 2011, MOL BIOL; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J., 2004, INFERRING PHYLOGENIE; Galtier N, 1998, MOL BIOL EVOL, V15, P871, DOI 10.1093/oxfordjournals.molbev.a025991; Galtier N, 2000, J MOL EVOL, V50, P224, DOI 10.1007/s002399910025; Haussler D, 2009, J HERED, V100, P659, DOI 10.1093/jhered/esp086; Hobolth A, 2005, J COMPUT BIOL, V12, P186, DOI 10.1089/cmb.2005.12.186; Hobolth A, 2009, ANN APPL STAT; Jobson RW, 2010, MOL BIOL EVOL, V27, P840, DOI 10.1093/molbev/msp293; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Lartillot N, 2006, J COMPUT BIOL, V13, P1701, DOI 10.1089/cmb.2006.13.1701; Lartillot N, 2011, MOL BIOL EVOL, V28, P729, DOI 10.1093/molbev/msq244; Liberles D, 2001, GENOME BIOL, V2; Mayrose I, 2011, MOL BIOL EVOL, V28, P759, DOI 10.1093/molbev/msq263; Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176; Neiman M, 2010, MOL BIOL EVOL, V27, P954, DOI 10.1093/molbev/msp300; Nickel GC, 2008, NUCLEIC ACIDS RES, V36, pD800, DOI 10.1093/nar/gkm764; Nielsen R, 1998, GENETICS, V148, P929; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Paland S, 2006, SCIENCE, V311, P990, DOI 10.1126/science.1118152; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Popadin K, 2007, P NATL ACAD SCI USA, V104, P13390, DOI 10.1073/pnas.0701256104; Proux E, 2009, NUCLEIC ACIDS RES, V37, pD404, DOI 10.1093/nar/gkn768; Pupko T, 2003, GENE, V319, P127, DOI 10.1016/S0378-1119(03)00802-3; Ranwez V, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-241; Robinson DM, 2003, MOL BIOL EVOL, V20, P1692, DOI 10.1093/molbev/msg184; Rodrigue N, 2008, BIOINFORMATICS, V24, P56, DOI 10.1093/bioinformatics/btm532; Romiguier J, 2010, GENOME RES, V20, P1001, DOI 10.1101/gr.104372.109; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tataru P, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-465; Team RDC, 2008, R FDN STAT COMP, V1; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zhai WW, 2007, J MOL EVOL, V65, P340, DOI 10.1007/s00239-007-9019-7	48	35	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33852	10.1371/journal.pone.0033852	http://dx.doi.org/10.1371/journal.pone.0033852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479459	Green Published, gold			2022-12-27	WOS:000303894900042
J	Wurzburger, N; Bellenger, JP; Kraepiel, AML; Hedin, LO				Wurzburger, Nina; Bellenger, Jean Philippe; Kraepiel, Anne M. L.; Hedin, Lars O.			Molybdenum and Phosphorus Interact to Constrain Asymbiotic Nitrogen Fixation in Tropical Forests	PLOS ONE			English	Article							SOIL ORGANIC PHOSPHORUS; RAIN-FOREST; LEAF-LITTER; LIMITATION; FRACTIONS; DYNAMICS; CYCLES	Biological di-nitrogen fixation (N-2) is the dominant natural source of new nitrogen to land ecosystems. Phosphorus (P) is thought to limit N-2 fixation in many tropical soils, yet both molybdenum (Mo) and P are crucial for the nitrogenase reaction (which catalyzes N-2 conversion to ammonia) and cell growth. We have limited understanding of how and when fixation is constrained by these nutrients in nature. Here we show in tropical forests of lowland Panama that the limiting element on asymbiotic N-2 fixation shifts along a broad landscape gradient in soil P, where Mo limits fixation in P-rich soils while Mo and P co-limit in P-poor soils. In no circumstance did P alone limit fixation. We provide and experimentally test a mechanism that explains how Mo and P can interact to constrain asymbiotic N-2 fixation. Fixation is uniformly favored in surface organic soil horizons - a niche characterized by exceedingly low levels of available Mo relative to P. We show that soil organic matter acts to reduce molybdate over phosphate bioavailability, which, in turn, promotes Mo limitation in sites where P is sufficient. Our findings show that asymbiotic N-2 fixation is constrained by the relative availability and dynamics of Mo and P in soils. This conceptual framework can explain shifts in limitation status across broad landscape gradients in soil fertility and implies that fixation depends on Mo and P in ways that are more complex than previously thought.	[Wurzburger, Nina; Hedin, Lars O.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Wurzburger, Nina] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Bellenger, Jean Philippe] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Kraepiel, Anne M. L.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Smithsonian Institution; Smithsonian Tropical Research Institute; Princeton University; Princeton University	Wurzburger, N (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	lhedin@princeton.edu			National Science Foundation [DEB-0614116]; Andrew W. Mellon Foundation	National Science Foundation(National Science Foundation (NSF)); Andrew W. Mellon Foundation	This work was supported by the National Science Foundation grant #DEB-0614116 to LOH and the Andrew W. Mellon Foundation grant to LOH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberty RA, 2005, BIOPHYS CHEM, V114, P115, DOI 10.1016/j.bpc.2004.11.009; Baillie I., 2007, SEMIDETAILED SOIL SU; Barron AR, 2011, OECOLOGIA, V165, P511, DOI 10.1007/s00442-010-1838-3; Barron AR, 2009, NAT GEOSCI, V2, P42, DOI 10.1038/NGEO366; Bellenger JP, 2011, ENVIRON MICROBIOL, V13, P1395, DOI 10.1111/j.1462-2920.2011.02440.x; Bellenger JP, 2009, NATURE GEOSCIENCE, V1, P243; Brookshire ENJ, 2012, NAT GEOSCI, V5, P123, DOI 10.1038/NGEO1372; Chacon N, 2004, BIOL FERT SOILS, V40, P14, DOI 10.1007/s00374-004-0733-7; Crews TE, 2000, ECOSYSTEMS, V3, P386, DOI 10.1007/s100210000034; Cusack DF, 2009, ECOSYSTEMS, V12, P1299, DOI 10.1007/s10021-009-9290-0; Dieter D, 2010, CATENA, V82, P118, DOI 10.1016/j.catena.2010.05.010; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gerber S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2008GB003336; GUPTA UC, 1981, ADV AGRON, V34, P73, DOI 10.1016/S0065-2113(08)60885-8; Gupta UC, 1997, MOLYBDENUM AGR; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Kaiser BN, 2005, ANN BOT-LONDON, V96, P745, DOI 10.1093/aob/mci226; Kirby MX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002791; Lang F, 1999, J PLANT NUTR SOIL SC, V162, P309, DOI 10.1002/(SICI)1522-2624(199906)162:3&lt;309::AID-JPLN309&gt;3.0.CO;2-6; Newbery DM, 1997, ECOL MONOGR, V67, P367, DOI 10.1890/0012-9615(1997)067[0367:PDIALA]2.0.CO;2; Olander LP, 2004, ECOSYSTEMS, V7, P404, DOI 10.1007/s10021-004-0264-y; Pearson HL, 2002, ECOSYSTEMS, V5, P587, DOI 10.1007/s10021-002-0172-y; Quesada CA, 2010, BIOGEOSCIENCES, V7, P1515, DOI 10.5194/bg-7-1515-2010; Reed SC, 2007, BIOTROPICA, V39, P585, DOI 10.1111/j.1744-7429.2007.00310.x; Reed SC, 2011, ANNU REV ECOL EVOL S, V42, P489, DOI 10.1146/annurev-ecolsys-102710-145034; ROSKOSKI JP, 1980, PLANT SOIL, V54, P33, DOI 10.1007/BF02181997; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; SILVESTER WB, 1989, SOIL BIOL BIOCHEM, V21, P283, DOI 10.1016/0038-0717(89)90106-5; THIEN SJ, 1991, SOIL SCI SOC AM J, V55, P890, DOI 10.2136/sssaj1991.03615995005500030045x; TIESSEN H, 1994, OECOLOGIA, V99, P145, DOI 10.1007/BF00317095; Turner BL, 2008, J ECOL, V96, P698, DOI 10.1111/j.1365-2745.2008.01384.x; Turner BL, 2011, BIOGEOCHEMISTRY, V103, P297, DOI 10.1007/s10533-010-9466-x; Vincent AG, 2010, EUR J SOIL SCI, V61, P48, DOI 10.1111/j.1365-2389.2009.01200.x; Vitousek PM, 2000, ECOLOGY, V81, P2366, DOI 10.1890/0012-9658(2000)081[2366:HNFIDL]2.0.CO;2; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Vitousek PM, 1999, ECOSYSTEMS, V2, P505, DOI 10.1007/s100219900098; Wang YP, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002797; Wang YP, 2010, BIOGEOSCIENCES, V7, P2261, DOI 10.5194/bg-7-2261-2010; Wichard T, 2009, NAT GEOSCI, V2, P625, DOI 10.1038/NGEO589; Williams JH, 1956, PLANT SOIL, V4, P327	40	109	111	4	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33710	10.1371/journal.pone.0033710	http://dx.doi.org/10.1371/journal.pone.0033710			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470462	Green Submitted, gold, Green Published			2022-12-27	WOS:000303857100040
J	Becker, K; Jahrling, N; Saghafi, S; Weiler, R; Dodt, HU				Becker, Klaus; Jaehrling, Nina; Saghafi, Saiedeh; Weiler, Reto; Dodt, Hans-Ulrich			Chemical Clearing and Dehydration of GFP Expressing Mouse Brains	PLOS ONE			English	Article							TETRAHYDROFURAN; ULTRAMICROSCOPY; RECONSTRUCTION	Generally, chemical tissue clearing is performed by a solution consisting of two parts benzyl benzoate and one part benzyl alcohol. However, prolonged exposure to this mixture markedly reduces the fluorescence of GFP expressing specimens, so that one has to compromise between clearing quality and fluorescence preservation. This can be a severe drawback when working with specimens exhibiting low GFP expression rates. Thus, we screened for a substitute and found that dibenzyl ether (phenylmethoxymethylbenzene, CAS 103-50-4) can be applied as a more GFP-friendly clearing medium. Clearing with dibenzyl ether provides improved tissue transparency and strikingly improved fluorescence intensity in GFP expressing mouse brains and other samples as mouse spinal cords, or embryos. Chemical clearing, staining, and embedding of biological samples mostly requires careful foregoing tissue dehydration. The commonly applied tissue dehydration medium is ethanol, which also can markedly impair GFP fluorescence. Screening for a substitute also for ethanol we found that tetrahydrofuran (CAS 109-99-9) is a more GFP-friendly dehydration medium than ethanol, providing better tissue transparency obtained by successive clearing. Combined, tetrahydrofuran and dibenzyl ether allow dehydration and chemical clearing of even delicate samples for UM, confocal microscopy, and other microscopy techniques.	[Becker, Klaus; Jaehrling, Nina; Saghafi, Saiedeh; Dodt, Hans-Ulrich] Vienna Univ Technol, FKE, Dept Bioelect, A-1040 Vienna, Austria; [Becker, Klaus; Jaehrling, Nina; Saghafi, Saiedeh; Dodt, Hans-Ulrich] Med Univ Vienna, Ctr Brain Res, Vienna, Austria; [Jaehrling, Nina; Weiler, Reto] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-2900 Oldenburg, Germany	Technische Universitat Wien; Medical University of Vienna; Carl von Ossietzky Universitat Oldenburg	Becker, K (corresponding author), Vienna Univ Technol, FKE, Dept Bioelect, A-1040 Vienna, Austria.	klaus.becker@meduniwien.ac.at		Becker, Klaus/0000-0002-2406-0476; saghafi, saiedeh/0000-0002-7598-541X	German Hertie Foundation; Theodor Korner Funds, Austria; Austrian Science Fund (FWF) [P 23102] Funding Source: researchfish	German Hertie Foundation; Theodor Korner Funds, Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the German Hertie Foundation. N. Jahrling is supported by the Theodor Korner Funds, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnuami AA, 2008, INT J BIOL MACROMOL, V43, P182, DOI 10.1016/j.ijbiomac.2008.05.002; Becker K, 2008, J BIOPHOTONICS, V1, P36, DOI 10.1002/jbio.200710011; BURDOCK GA, 1992, FOOD CHEM TOXICOL, V30, P559, DOI 10.1016/0278-6915(92)90189-R; DASLER W, 1946, IND ENG CHEM, V18, P52, DOI 10.1021/i560149a017; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; EGGER MD, 1967, SCIENCE, V157, P305, DOI 10.1126/science.157.3786.305; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; HAUST MD, 1958, LAB INVEST, V7, P58; MALKINSON FD, 1960, ARCH DERMATOL, V82, P798, DOI 10.1001/archderm.1960.01580050140021; Nultsch W, 1954, Z M LUTHER U HALLEWI, V4, P161; ONeil M.J., 2006, MERCK INDEX ENCY CHE, V14th; Spalteholz W., 1914, DURCHSICHTIGMACHEN M; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Viswanath DS, 2007, VISCOSITY LIQUIDS TH; Ward WW, 2006, METHOD BIOCHEM ANAL, V47, P39; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	18	211	221	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33916	10.1371/journal.pone.0033916	http://dx.doi.org/10.1371/journal.pone.0033916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479475	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339100081
J	Boyd, SE; Nair, B; Ng, SW; Keith, JM; Orian, JM				Boyd, Sarah E.; Nair, Betina; Ng, Sze Woei; Keith, Jonathan M.; Orian, Jacqueline M.			Computational Characterization of 3 ' Splice Variants in the GFAP Isoform Family	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; IN-VITRO; ASTROCYTES; BINDING; ROLES; IDENTIFICATION; EXPRESSION; FILAMENTS; CELLS; ORGANIZATION	Glial fibrillary acidic protein (GFAP) is an intermediate filament (IF) protein specific to central nervous system (CNS) astrocytes. It has been the subject of intense interest due to its association with neurodegenerative diseases, and because of growing evidence that IF proteins not only modulate cellular structure, but also cellular function. Moreover, GFAP has a family of splicing isoforms apparently more complex than that of other CNS IF proteins, consistent with it possessing a range of functional and structural roles. The gene consists of 9 exons, and to date all isoforms associated with 39 end splicing have been identified from modifications within intron 7, resulting in the generation of exon 7a (GFAP delta/epsilon) and 7b (GFAP kappa). To better understand the nature and functional significance of variation in this region, we used a Bayesian multiple change-point approach to identify conserved regions. This is the first successful application of this method to a single gene - it has previously only been used in whole-genome analyses. We identified several highly or moderately conserved regions throughout the intron 7/7a/7b regions, including untranslated regions and regulatory features, consistent with the biology of GFAP. Several putative unconfirmed features were also identified, including a possible new isoform. We then integrated multiple computational analyses on both the DNA and protein sequences from the mouse, rat and human, showing that the major isoform, GFAP alpha, has highly conserved structure and features across the three species, whereas the minor isoforms GFAP delta/epsilon and GFAP kappa have low conservation of structure and features at the distal 3' end, both relative to each other and relative to GFAP alpha. The overall picture suggests distinct and tightly regulated functions for the 3' end isoforms, consistent with complex astrocyte biology. The results illustrate a computational approach for characterising splicing isoform families, using both DNA and protein sequences.	[Boyd, Sarah E.; Keith, Jonathan M.] Monash Univ, Sch Math Sci, Clayton, Vic, Australia; [Nair, Betina; Ng, Sze Woei; Orian, Jacqueline M.] La Trobe Univ, Dept Biochem, Bundoora, Vic 3083, Australia	Monash University; La Trobe University	Boyd, SE (corresponding author), Monash Univ, Sch Math Sci, Clayton, Vic, Australia.	J.Orian@latrobe.edu.au	Boyd, Sarah E/I-9047-2012	Keith, Jonathan/0000-0002-9675-3976; Boyd, Sarah/0000-0002-7264-8602	National Multiple Sclerosis Society [RG 3642-B-5, RG 4132-A-5]; Australian Research Council Discovery Grants [DP0879308, DP1095849]	National Multiple Sclerosis Society(National Multiple Sclerosis Society); Australian Research Council Discovery Grants(Australian Research Council)	National Multiple Sclerosis Society RG 3642-B-5, RG 4132-A-5 (www.nationalmssociety.org/), Australian Research Council Discovery Grants DP0879308, DP1095849 (www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2003, TRENDS NEUROSCI, V26, P340, DOI 10.1016/S0166-2236(03)00141-3; Barash Y, 2010, BIOINFORMATICS, V26, pi325, DOI 10.1093/bioinformatics/btq200; Bennett MVL, 2003, TRENDS NEUROSCI, V26, P610, DOI 10.1016/j.tins.2003.09.008; Blechingberg J, 2007, NUCLEIC ACIDS RES, V35, P7636, DOI 10.1093/nar/gkm931; Blechingberg J, 2007, GLIA, V55, P497, DOI 10.1002/glia.20475; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chotard C, 2004, TRENDS NEUROSCI, V27, P655, DOI 10.1016/j.tins.2004.09.001; Condorelli DF, 1999, J NEUROSCI RES, V56, P219, DOI 10.1002/(SICI)1097-4547(19990501)56:3<219::AID-JNR1>3.0.CO;2-2; Eng LF, 1998, J NEUROSCI RES, V53, P353, DOI 10.1002/(SICI)1097-4547(19980801)53:3<353::AID-JNR9>3.0.CO;2-9; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; ENG LF, 1994, BRAIN PATHOL, V4, P229, DOI 10.1111/j.1750-3639.1994.tb00838.x; FEINSTEIN DL, 1992, J NEUROSCI RES, V32, P1, DOI 10.1002/jnr.490320102; Finch CE, 2003, NEUROBIOL AGING, V24, pS123, DOI 10.1016/S0197-4580(03)00051-4; FOISNER R, 1988, J CELL BIOL, V106, P723, DOI 10.1083/jcb.106.3.723; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GALEA E, 1995, J NEUROSCI RES, V41, P452, DOI 10.1002/jnr.490410404; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hertz L, 2004, TRENDS NEUROSCI, V27, P735, DOI 10.1016/j.tins.2004.10.008; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Horner PJ, 2003, TRENDS NEUROSCI, V26, P597, DOI 10.1016/j.tins.2003.09.010; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Keith JM, 2008, J COMPUT BIOL, V15, P407, DOI 10.1089/cmb.2007.0173; Keith JM, 2006, J COMPUT BIOL, V13, P1369, DOI 10.1089/cmb.2006.13.1369; Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107; Kimelberg HK, 2010, NEUROSCIENTIST, V16, P79, DOI 10.1177/1073858409342593; Korn T, 2007, NEUROMOL MED, V9, P1, DOI 10.1385/NMM:9:1:1; Ku NO, 1998, EMBO J, V17, P1892, DOI 10.1093/emboj/17.7.1892; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JA, 2007, PLOS BIOL, V5, P281, DOI 10.1371/journal.pbio.0050040; LEUBA G, 1989, EXP BRAIN RES, V77, P31; Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Matyash V, 2010, BRAIN RES REV, V63, P2, DOI 10.1016/j.brainresrev.2009.12.001; MCLENDON RE, 1986, J NEUROPATH EXP NEUR, V45, P692, DOI 10.1097/00005072-198611000-00007; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Nielsen AL, 2004, J BIOL CHEM, V279, P41537, DOI 10.1074/jbc.M406601200; Nielsen AL, 2002, J BIOL CHEM, V277, P29983, DOI 10.1074/jbc.M112121200; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oldmeadow C, 2011, BIOINFORMATICS, V27, P604, DOI 10.1093/bioinformatics/btq716; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Pegram CN, 1983, MOL CHEM NEUROPATH, V3, P119; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pellerin L, 2005, MOL NEUROBIOL, V32, P59, DOI 10.1385/MN:32:1:059; Perez I, 1997, BIOCHEMISTRY-US, V36, P11881, DOI 10.1021/bi9711745; Perng MD, 1999, J CELL SCI, V112, P2099; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Quinlan RA, 2007, EXP CELL RES, V313, P2077, DOI 10.1016/j.yexcr.2007.04.004; RALTON JE, 1994, J CELL SCI, V107, P1935; Ransom B, 2003, TRENDS NEUROSCI, V26, P520, DOI 10.1016/j.tins.2003.08.006; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Satoh J, 2004, AM J PATHOL, V165, P577, DOI 10.1016/S0002-9440(10)63322-6; Savidge TC, 2007, LAB INVEST, V87, P731, DOI 10.1038/labinvest.3700600; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; SWEET RM, 1983, J MOL BIOL, V171, P479, DOI 10.1016/0022-2836(83)90041-4; Tian RJ, 2006, AM J PATHOL, V168, P888, DOI 10.2353/ajpath.2006.051028; Valcarcel J, 1997, CURR BIOL, V7, pR705, DOI 10.1016/S0960-9822(06)00361-7; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; Wagner EJ, 2001, MOL CELL BIOL, V21, P3281, DOI 10.1128/MCB.21.10.3281-3288.2001; Wang DW, 2005, GLIA, V51, P235, DOI 10.1002/glia.20199; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wiche Gerhard, 2011, Bioarchitecture, V1, P14; Winau F, 2008, CURR OPIN IMMUNOL, V20, P68, DOI 10.1016/j.coi.2007.10.006; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; Wolburg H, 2005, NEUROGLIA, V2, P19, DOI [10.1093/acprof:oso/9780195152227.001.0001/acprof-9780195152227-chapter-2, DOI 10.1093/ACPROF:OSO/9780195152227.003]; ZELENIKA D, 1995, MOL BRAIN RES, V30, P251, DOI 10.1016/0169-328X(95)00010-P	74	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33565	10.1371/journal.pone.0033565	http://dx.doi.org/10.1371/journal.pone.0033565			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479412	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100057
J	Radonic, T; de Witte, P; Groenink, M; de Waard, V; Lutter, R; van Eijk, M; Jansen, M; Timmermans, J; Kempers, M; Scholte, AJ; Hilhorst-Hofstee, Y; van den Berg, MP; van Tintelen, JP; Pals, G; Baars, MJH; Mulder, BJM; Zwinderman, AH				Radonic, Teodora; de Witte, Piet; Groenink, Maarten; de Waard, Vivian; Lutter, Rene; van Eijk, Marco; Jansen, Marnix; Timmermans, Janneke; Kempers, Marlies; Scholte, Arthur J.; Hilhorst-Hofstee, Yvonne; van den Berg, Maarten P.; van Tintelen, J. Peter; Pals, Gerard; Baars, Marieke J. H.; Mulder, Barbara J. M.; Zwinderman, Aeilko H.			Inflammation Aggravates Disease Severity in Marfan Syndrome Patients	PLOS ONE			English	Article							AORTIC-ANEURYSM PROGRESSION; MOUSE MODEL; LOSARTAN; MUTATION; THERAPY; GENE; MICE; PATHOGENESIS; CONTRIBUTES; CHEMOTAXIS	Background: Marfan syndrome (MFS) is a pleiotropic genetic disorder with major features in cardiovascular, ocular and skeletal systems, associated with large clinical variability. Numerous studies reveal an involvement of TGF-beta signaling. However, the contribution of tissue inflammation is not addressed so far. Methodology/Principal Findings: Here we showed that both TGF-beta and inflammation are up-regulated in patients with MFS. We analyzed transcriptome-wide gene expression in 55 MFS patients using Affymetrix Human Exon 1.0 ST Array and levels of TGF-beta and various cytokines in their plasma. Within our MFS population, increased plasma levels of TGF-beta were found especially in MFS patients with aortic root dilatation (124 pg/ml), when compared to MFS patients with normal aorta (10 pg/ml; p = 8 x 10(-6), 95% CI: 70-159 pg/ml). Interestingly, our microarray data show that increased expression of inflammatory genes was associated with major clinical features within the MFS patients group; namely severity of the aortic root dilatation (HLA-DRB1 and HLA-DRB5 genes; r = 0.56 for both; False Discovery Rate(FDR) = 0%), ocular lens dislocation (RAET1L, CCL19 and HLA-DQB2; Fold Change (FC) = 1.8; 1.4; 1.5, FDR = 0%) and specific skeletal features (HLA-DRB1, HLA-DRB5, GZMK; FC = 8.8, 7.1, 1.3; FDR = 0%). Patients with progressive aortic disease had higher levels of Macrophage Colony Stimulating Factor (M-CSF) in blood. When comparing MFS aortic root vessel wall with non-MFS aortic root, increased numbers of CD4+ T-cells were found in the media (p = 0.02) and increased number of CD8+ T-cells (p = 0.003) in the adventitia of the MFS patients. Conclusion/Significance: In conclusion, our results imply a modifying role of inflammation in MFS. Inflammation might be a novel therapeutic target in these patients.	[Radonic, Teodora; Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Radonic, Teodora; de Witte, Piet; Groenink, Maarten; Mulder, Barbara J. M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Radonic, Teodora; de Witte, Piet; Groenink, Maarten; Mulder, Barbara J. M.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Groenink, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [de Waard, Vivian; van Eijk, Marco] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Pulmonol & Expt Immunol, NL-1105 AZ Amsterdam, Netherlands; [Jansen, Marnix] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Timmermans, Janneke] St Radboud Univ, Med Ctr, Dept Cardiol, Nijmegen, Netherlands; [Kempers, Marlies] St Radboud Univ, Med Ctr, Dept Clin Genet, Nijmegen, Netherlands; [Scholte, Arthur J.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Hilhorst-Hofstee, Yvonne] Leiden Univ, Med Ctr, Dept Clin & Human Genet, Leiden, Netherlands; [van den Berg, Maarten P.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9713 AV Groningen, Netherlands; [van Tintelen, J. Peter] Univ Med Ctr Groningen, Dept Clin Genet, NL-9713 AV Groningen, Netherlands; [van Tintelen, J. Peter; Zwinderman, Aeilko H.] Durrer Cardiogenet Res Ctr, Utrecht, Netherlands; [Pals, Gerard] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet & DNA Diagnost, Amsterdam, Netherlands; [Baars, Marieke J. H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Groningen; University of Groningen; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Radonic, T (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.h.zwinderman@amc.nl	Radonic, Teodora/HGU-0171-2022; Hilhorst-Hofstee, Yvonne/AAC-5120-2022; van Tintelen, J. Peter/J-8926-2012; Timmermans, J./L-4693-2015; van Tintelen, J. Peter/AAJ-9962-2021	Radonic, Teodora/0000-0002-6015-5202; Hilhorst-Hofstee, Yvonne/0000-0003-0951-6524; van den Berg, Maarten/0000-0002-1493-2998; van Eijk, Marco/0000-0001-7751-4112; Jansen, Marnix/0000-0003-0645-564X; Pals, Gerard/0000-0003-4091-7115	Netherlands Heart Foundation [2008B115]; Fighting Aneurysmal Disease (FAD) project	Netherlands Heart Foundation(Netherlands Heart Foundation); Fighting Aneurysmal Disease (FAD) project	This study is funded by the The Netherlands Heart Foundation (grant 2008B115) and Fighting Aneurysmal Disease (FAD) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badger SA, 2007, J VASC SURG, V45, P475, DOI 10.1016/j.jvs.2006.09.067; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; De BJ, 2007, CLIN GENET, V72, P188, DOI 10.1111/j.1399-0004.2007.00845.x; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; ESTERLY NB, 1984, ARCH DERMATOL, V120, P1308, DOI 10.1001/archderm.120.10.1308; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; GABLER WL, 1991, RES COMMUN CHEM PATH, V74, P131; Groenink M, 1998, AM J CARDIOL, V82, P203, DOI 10.1016/S0002-9149(98)00315-4; Guo G, 2006, CIRCULATION, V114, P1855, DOI 10.1161/CIRCULATIONAHA.105.601674; Guo G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020138; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; He RM, 2008, J THORAC CARDIOV SUR, V136, P922, DOI 10.1016/j.jtcvs.2007.12.063; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Kappert K, 2009, HYPERTENSION, V54, P738, DOI 10.1161/HYPERTENSIONAHA.109.132886; Kramer C, 2002, CIRC RES, V90, P770, DOI 10.1161/01.RES.0000014434.48463.35; La Cava A, 2009, FRONT BIOSCI-LANDMRK, V14, P333, DOI 10.2741/3247; Lindeman JHN, 2010, P NATL ACAD SCI USA, V107, P862, DOI 10.1073/pnas.0910312107; Martorana D, 2006, ARTHRIT RHEUM-ARTHR, V55, P126, DOI 10.1002/art.21698; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Radonic T, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-3; Ramirez F, 2007, J CELL PHYSIOL, V213, P326, DOI 10.1002/jcp.21189; Rasmussen TE, 1997, J VASC SURG, V25, P356, DOI 10.1016/S0741-5214(97)70358-6; THONG YH, 1979, CLIN EXP IMMUNOL, V35, P443; Tilson MD, 1996, ANN NY ACAD SCI, V800, P208, DOI 10.1111/j.1749-6632.1996.tb33311.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Y, 2010, J CLIN INVEST, V120, P422, DOI 10.1172/JCI38136; Zhang Z, 2009, P NATL ACAD SCI USA, V106, P3219, DOI 10.1073/pnas.0813400106	32	49	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32963	10.1371/journal.pone.0032963	http://dx.doi.org/10.1371/journal.pone.0032963			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479353	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100027
J	Uteshev, VV				Uteshev, Victor V.			Somatic Integration of Single Ion Channel Responses of alpha 7 Nicotinic Acetylcholine Receptors Enhanced by PNU-120596	PLOS ONE			English	Article							POSITIVE ALLOSTERIC MODULATOR; ACTIVATION; AGONISTS; NEURONS	Positive allosteric modulators of highly Ca2+-permeable alpha 7 nicotinic acetylcholine receptors, such as PNU-120596, may become useful therapeutic tools supporting neuronal survival and function. However, despite promising results, the initial optimism has been tempered by the concerns for cytotoxicity. The same concentration of a given nicotinic agent can be neuroprotective, ineffective or neurotoxic due to differences in the expression of alpha 7 receptors and susceptibility to Ca2+ influx among various subtypes of neurons. Resolution of these concerns may require an ability to reliably detect, evaluate and optimize the extent of alpha 7 somatic ionic influx, a key determinant of the likelihood of neuronal survival and function. In the presence of PNU-120596 and physiological choline (similar to 10 mu M), the activity of individual alpha 7 channels can be detected in whole-cell recordings as step-like current/voltage deviations. However, the extent of alpha 7 somatic influx remains elusive because the activity of individual alpha 7 channels may not be integrated across the entire soma, instead affecting only specific subdomains located in the channel vicinity. Such a compartmentalization may obstruct detection and integration of alpha 7 currents, causing an underestimation of alpha 7 activity. By contrast, if step-like alpha 7 currents are integrated across the soma, then a reliable quantification of alpha 7 influx in whole-cell recordings is possible and could provide a rational basis for optimization of conditions that support survival of alpha 7-expressing neurons. This approach can be used to directly correlate alpha 7 single-channel activity to neuronal function. In this study, somatic dual-patch recordings were conducted using large hypothalamic and hippocampal neurons in acute coronal rat brain slices. The results demonstrate that the membrane electrotonic properties do not impede somatic signaling, allowing reliable estimates of somatic ionic and Ca2+ influx through alpha 7 channels, while the somatic space-clamp error is minimal (similar to 0.01 mV/mu m). These research efforts could benefit optimization of potential alpha 7-PAM-based therapies.	[Uteshev, Victor V.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University	Uteshev, VV (corresponding author), Univ N Texas Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA.	Victor.Uteshev@unthsc.edu			National Institutes of Health [DK082625]; Department of Pharmacology and Neuroscience of the University of North Texas Health Science Center at Fort Worth, Texas; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pharmacology and Neuroscience of the University of North Texas Health Science Center at Fort Worth, Texas; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the National Institutes of Health grant DK082625 and the start-up funds provided by the Department of Pharmacology and Neuroscience of the University of North Texas Health Science Center at Fort Worth, Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	del Barrio L, 2011, TOXICOL SCI, V123, P193, DOI 10.1093/toxsci/kfr163; Dinklo T, 2011, J PHARMACOL EXP THER, V336, P560, DOI 10.1124/jpet.110.173245; Faghih R, 2009, J MED CHEM, V52, P3377, DOI 10.1021/jm9003818; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Gusev AG, 2010, J PHARMACOL EXP THER, V332, P588, DOI 10.1124/jpet.109.162099; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Kalappa BI, 2011, AM J PHYSIOL-CELL PH, V301, pC347, DOI 10.1152/ajpcell.00473.2010; Kalappa BI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013964; Li YX, 1999, BRAIN RES, V830, P218, DOI 10.1016/S0006-8993(99)01372-4; Meyer EM, 1997, BRAIN RES, V768, P49, DOI 10.1016/S0006-8993(97)00536-2; Papke RL, 2000, EUR J PHARMACOL, V393, P179, DOI 10.1016/S0014-2999(00)00009-1; UTESHEV V, 1995, NEUROSCIENCE, V66, P143, DOI 10.1016/0306-4522(94)00593-T; Uteshev VV, 1996, PFLUG ARCH EUR J PHY, V432, P607, DOI 10.1007/s004240050176; Uteshev VV, 2012, ADV EXPT ME IN PRESS, V740	14	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32951	10.1371/journal.pone.0032951	http://dx.doi.org/10.1371/journal.pone.0032951			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479351	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100025
J	Zhou, F; Gao, L; Li, SM; Li, DL; Zhang, LF; Fan, WS; Yang, XY; Yu, MR; Xiao, D; Yan, L; Zhang, Z; Shi, W; Luo, FJ; Ruan, YH; Jin, Q				Zhou, Feng; Gao, Lei; Li, Shuming; Li, Dongliang; Zhang, Lifen; Fan, Wensheng; Yang, Xueying; Yu, Mingrun; Xiao, Dong; Yan, Li; Zhang, Zheng; Shi, Wei; Luo, Fengji; Ruan, Yuhua; Jin, Qi			Willingness to Accept HIV Pre-Exposure Prophylaxis among Chinese Men Who Have Sex with Men	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; HIGH-RISK; LIMITED KNOWLEDGE; PREVENTION; PREVALENCE; ACCEPTABILITY; POSTEXPOSURE; SYPHILIS; CHALLENGES; ATTITUDES	Objective: We investigated the awareness and acceptability of pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) and potential predicting factors. Methods: This study was conducted among MSM in Beijing, China. Study participants, randomly selected from an MSM cohort, completed a structured questionnaire, and provided their blood samples to test for HIV infection and syphilis. Univariate logistic regression analyses were performed to evaluate the factors associated with willingness to accept (WTA) PrEP. Factors independently associated with willingness to accept were identified by entering variables into stepwise logistic regression analysis. Results: A total of 152 MSM completed the survey; 11.2% had ever heard of PrEP and 67.8% were willing to accept it. Univariate analysis showed that age, years of education, consistent condom use in the past 6 months, heterosexual behavior in the past 6 months, having ever heard of PrEP and the side effects of antiretroviral drugs, and worry about antiretroviral drugs cost were significantly associated with willingness to accept PrEP. In the multivariate logistic regression model, only consistent condom use in the past 6 months (odds ratio [OR]: 0.31; 95% confidence interval [CI]: 0.13-0.70) and having ever heard of the side effects of antiretroviral drugs (OR: 0.30; 95% CI: 0.14-0.67) were independently associated with willingness to accept PrEP. Conclusions: The awareness of PrEP in the MSM population was low. Sexual behavioral characteristics and knowledge about ART drugs may have effects on willingness to accept PrEP. Comprehensive prevention strategies should be recommended in the MSM community.	[Zhou, Feng; Gao, Lei; Jin, Qi] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Zhang, Lifen] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Li, Shuming; Li, Dongliang; Yang, Xueying; Zhang, Zheng; Luo, Fengji] Beijing Chaoyang Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhang, Lifen] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Stat, Beijing 100730, Peoples R China; [Fan, Wensheng] Western Kentucky Univ, Dept Publ Hlth, Coll Hlth & Human Serv, Bowling Green, KY 42101 USA; [Yu, Mingrun; Ruan, Yuhua] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Yu, Mingrun; Ruan, Yuhua] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent NCAIDS, Beijing, Peoples R China; [Xiao, Dong] Chaoyang Chinese AIDS Volunteer Grp, Beijing, Peoples R China; [Yan, Li] Beijing Jingcheng Skin Dis Hosp, Beijing, Peoples R China; [Shi, Wei] Beijing Chaoyang Hlth Bur, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Western Kentucky University; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Zhou, F (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Beijing 100730, Peoples R China.	luofengji@yahoo.com.cn; ruanyuhua92@gmail.com			Ministry of Science and Technology of China	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the grants from the Ministry of Science and Technology of China. The funders had no role in study design, data collection and analysis, desicion to publish, or preparation of the manuscript.	Anglemyer A, 2011, COCHRANE DATABASE SY; Choi KH, 2003, LANCET, V361, P2125, DOI 10.1016/S0140-6736(03)13690-2; Choi KH, 2007, JAIDS-J ACQ IMM DEF, V45, P77, DOI 10.1097/QAI.0b013e3180415dd7; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guest G, 2010, J WOMENS HEALTH, V19, P791, DOI 10.1089/jwh.2009.1576; Guo HX, 2009, SEX TRANSM DIS, V36, P120, DOI 10.1097/OLQ.0b013e31818d3fa0; He Q, 2006, AIDS BEHAV, V10, pS17, DOI 10.1007/s10461-006-9125-3; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2005, MON DECL COMM HIV AI; Kim SC, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-24; Li QC, 2010, VACCINE, V28, P4638, DOI 10.1016/j.vaccine.2010.04.073; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Lu F, 2006, SEX TRANSM INFECT, V82, pIII87, DOI 10.1136/sti.2006.020404; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Michael NL, 2010, NEW ENGL J MED, V363, P2663, DOI 10.1056/NEJMe1012929; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2010, 2009 EST HIV AIDS EP; Nodin N, 2008, AIDS CARE, V20, P106, DOI 10.1080/09540120701449096; Nyandiko WM, 2010, JAIDS-J ACQ IMM DEF, V54, P42, DOI 10.1097/QAI.0b013e3181d8ad51; Paintsil E, 2009, CURR OPIN PEDIATR, V21, P94, DOI 10.1097/MOP.0b013e32831ec353; Poynten IM, 2010, HIV MED, V11, P282, DOI 10.1111/j.1468-1293.2009.00777.x; Ruan SM, 2009, AIDS BEHAV, V13, P671, DOI 10.1007/s10461-009-9567-5; Ruan YH, 2009, AIDS BEHAV, V13, P663, DOI 10.1007/s10461-008-9503-0; Schechter M, 2004, JAIDS-J ACQ IMM DEF, V35, P519, DOI 10.1097/00126334-200404150-00010; Schneider JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011922; Smith Dawn K., 2005, Morbidity and Mortality Weekly Report, V54, P1; Zhang B, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P337; Zhang B, 2002, CHIN J AIDS STD, V8, P197; Zhang DP, 2007, J INFECTION, V55, P456, DOI 10.1016/j.jinf.2007.06.015	30	69	77	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32329	10.1371/journal.pone.0032329	http://dx.doi.org/10.1371/journal.pone.0032329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UC	22479320	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100009
J	Hariri, S; Steinau, M; Rinas, A; Gargano, JW; Ludema, C; Unger, ER; Carter, AL; Grant, KL; Bamberg, M; McDermott, JE; Markowitz, LE; Brewer, NT; Smith, JS				Hariri, Susan; Steinau, Martin; Rinas, Allen; Gargano, Julia W.; Ludema, Christina; Unger, Elizabeth R.; Carter, Alicia L.; Grant, Kathy L.; Bamberg, Melanie; McDermott, James E.; Markowitz, Lauri E.; Brewer, Noel T.; Smith, Jennifer S.			HPV Genotypes in High Grade Cervical Lesions and Invasive Cervical Carcinoma as Detected by Two Commercial DNA Assays, North Carolina, 2001-2006	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE DISTRIBUTION; UNITED-STATES; INNO-LIPA; CANCER; INFECTION; METAANALYSIS; VACCINATION; SPECIMENS; TISSUES	Background: HPV typing using formalin fixed paraffin embedded (FFPE) cervical tissue is used to evaluate HPV vaccine impact, but DNA yield and quality in FFPE specimens can negatively affect test results. This study aimed to evaluate 2 commercial assays for HPV detection and typing using FFPE cervical specimens. Methods: Four large North Carolina pathology laboratories provided FFPE specimens from 299 women ages18 and older diagnosed with cervical disease from 2001 to 2006. For each woman, one diagnostic block was selected and unstained serial sections were prepared for DNA typing. Extracts from samples with residual lesion were used to detect and type HPV using parallel and serial testing algorithms with the Linear Array and LiPA HPV genotyping assays. Findings: LA and LiPA concordance was 0.61 for detecting any high-risk (HR) and 0.20 for detecting any low-risk (LR) types, with significant differences in marginal proportions for HPV16, 51, 52, and any HR types. Discordant results were most often LiPA-positive, LA-negative. The parallel algorithm yielded the highest prevalence of any HPV type (95.7%). HR type prevalence was similar using parallel (93.1%) and serial (92.1%) approaches. HPV16, 33, and 52 prevalence was slightly lower using the serial algorithm, but the median number of HR types per woman (1) did not differ by algorithm. Using the serial algorithm, HPV DNA was detected in >85% of invasive and >95% of pre-invasive lesions. The most common type was HPV16, followed by 52, 18, 31, 33, and 35; HPV16/18 was detected in 56.5% of specimens. Multiple HPV types were more common in lower grade lesions. Conclusions: We developed an efficient algorithm for testing and reporting results of two commercial assays for HPV detection and typing in FFPE specimens, and describe HPV type distribution in pre-invasive and invasive cervical lesions in a state-based sample prior to HPV vaccine introduction.	[Hariri, Susan; Markowitz, Lauri E.] Ctr Dis Control & Prevent, Div STD Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA; [Steinau, Martin; Gargano, Julia W.; Unger, Elizabeth R.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Rinas, Allen; Ludema, Christina; Brewer, Noel T.; Smith, Jennifer S.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Rinas, Allen; Ludema, Christina; Brewer, Noel T.; Smith, Jennifer S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Gargano, Julia W.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Carter, Alicia L.] Lab Corp Amer Holdings, Burlington, NC USA; [Grant, Kathy L.] Duke Univ Hlth Syst, Durham, NC USA; [Bamberg, Melanie; McDermott, James E.] Carolinas Med Ctr, Charlotte, NC 28203 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Centers for Disease Control & Prevention - USA; Duke University; Carolinas Medical Center	Hariri, S (corresponding author), Ctr Dis Control & Prevent, Div STD Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	shariri@cdc.gov	Brewer, Noel T/C-4375-2008	Brewer, Noel T/0000-0003-2241-7002; Unger, Elizabeth/0000-0002-2925-5635; Ludema, Christina/0000-0003-0779-810X	Centers for Disease Control and Prevention [S3715-25/2]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding was provided by the Centers for Disease Control and Prevention, grant # S3715-25/2. The funders collaborated on study design, analysis, decision to publish, and preparation of the manuscript.	Castle PE, 2006, CANCER RES, V66, P1218, DOI 10.1158/0008-5472.CAN-05-3066; Chang YL, 2009, VACCINE, V27, P4355, DOI 10.1016/j.vaccine.2009.03.008; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Galan-Sanchez F, 2011, ACTA CYTOL, V55, P341, DOI 10.1159/000327526; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Markowitz LE, 2010, VACCINE, V28, P4731, DOI 10.1016/j.vaccine.2010.02.019; Onyekwuluje JM, 2012, CLIN LAB, V58, P61; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Steinau M, 2011, J MOL DIAGN, V13, P377, DOI 10.1016/j.jmoldx.2011.03.007; Tan SE, 2010, J CLIN MICROBIOL, V48, P1458, DOI 10.1128/JCM.02311-09; Trottier H, 2008, J INFECT DIS, V197, P1436, DOI 10.1086/587698; van Doorn LJ, 2002, J CLIN MICROBIOL, V40, P979, DOI 10.1128/JCM.40.3.979-983.2002; van Hamont D, 2006, J CLIN MICROBIOL, V44, P3122, DOI 10.1128/JCM.00517-06; Watson M, 2008, CANCER-AM CANCER SOC, V113, P2841, DOI 10.1002/cncr.23758; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510	18	22	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34044	10.1371/journal.pone.0034044	http://dx.doi.org/10.1371/journal.pone.0034044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479516	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400052
J	van Schalkwyk, C; Cule, M; Welte, A; van Helden, P; van der Spuy, G; Uys, P				van Schalkwyk, Cari; Cule, Madeleine; Welte, Alex; van Helden, Paul; van der Spuy, Gian; Uys, Pieter			Towards Eliminating Bias in Cluster Analysis of TB Genotyped Data	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MOLECULAR EPIDEMIOLOGY; RECENT TRANSMISSION; POPULATION	The relative contributions of transmission and reactivation of latent infection to TB cases observed clinically has been reported in many situations, but always with some uncertainty. Genotyped data from TB organisms obtained from patients have been used as the basis for heuristic distinctions between circulating (clustered strains) and reactivated infections (unclustered strains). Naive methods previously applied to the analysis of such data are known to provide biased estimates of the proportion of unclustered cases. The hypergeometric distribution, which generates probabilities of observing clusters of a given size as realized clusters of all possible sizes, is analyzed in this paper to yield a formal estimator for genotype cluster sizes. Subtle aspects of numerical stability, bias, and variance are explored. This formal estimator is seen to be stable with respect to the epidemiologically interesting properties of the cluster size distribution (the number of clusters and the number of singletons) though it does not yield satisfactory estimates of the number of clusters of larger sizes. The problem that even complete coverage of genotyping, in a practical sampling frame, will only provide a partial view of the actual transmission network remains to be explored.	[van Schalkwyk, Cari; Welte, Alex; Uys, Pieter] Univ Stellenbosch, Fac Sci, Ctr Excellence Epidemiol Modelling & Anal, S African Dept Sci & Technol Natl Res Fdn DST NRF, ZA-7600 Stellenbosch, South Africa; [Cule, Madeleine] African Inst Math Sci, Muizenberg, South Africa; [Cule, Madeleine] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [van Helden, Paul; van der Spuy, Gian] Univ Stellenbosch, Fac Hlth Sci, Div Mol Biol & Human Genet, DST NRF Ctr Excellence Biomed TB Res MRC Ctr Mol, ZA-7600 Stellenbosch, South Africa	Stellenbosch University; University of Oxford; National Research Foundation - South Africa; Stellenbosch University	van Schalkwyk, C (corresponding author), Univ Stellenbosch, Fac Sci, Ctr Excellence Epidemiol Modelling & Anal, S African Dept Sci & Technol Natl Res Fdn DST NRF, ZA-7600 Stellenbosch, South Africa.	carivs@sun.ac.za	van der Spuy, Gian/AAY-7701-2020	van der Spuy, Gian/0000-0002-9067-5903; van Schalkwyk, Cari/0000-0001-5154-1390				Benedetti A, 2010, AM J EPIDEMIOL, V172, P318, DOI 10.1093/aje/kwq124; Borgdorff MW, 2011, AM J EPIDEMIOL, V174, P243, DOI 10.1093/aje/kwr061; Glynn JR, 1999, AM J EPIDEMIOL, V149, P366, DOI 10.1093/oxfordjournals.aje.a009822; Haddad MB, 2007, AM J PREV MED, V32, P239, DOI 10.1016/j.amepre.2006.10.013; Kempf MC, 2005, J CLIN MICROBIOL, V43, P870, DOI 10.1128/JCM.43.2.870-878.2005; Lopez-Calleja AI, 2007, INT J TUBERC LUNG D, V11, P1080; Murray M, 2002, EMERG INFECT DIS, V8, P363, DOI 10.3201/eid0804.000444; Pretorius C, 2011, J THEOR BIOL, V270, P154, DOI 10.1016/j.jtbi.2010.10.012; Scott AN, 2008, STAT MED, V27, P140, DOI 10.1002/sim.2899; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; van der Spuy GD, 2009, TUBERCULOSIS, V89, P238, DOI 10.1016/j.tube.2009.01.006	11	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34109	10.1371/journal.pone.0034109	http://dx.doi.org/10.1371/journal.pone.0034109			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479534	Green Published, gold			2022-12-27	WOS:000304523400055
J	Meng, FX; Hackenberg, M; Li, ZG; Yan, J; Chen, T				Meng, Fanxue; Hackenberg, Michael; Li, Zhiguang; Yan, Jian; Chen, Tao			Discovery of Novel MicroRNAs in Rat Kidney Using Next Generation Sequencing and Microarray Validation	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNAS; IDENTIFICATION; TOOL; TECHNOLOGIES; MIRANALYZER; ARABIDOPSIS; BIOGENESIS; PROFILES; DATABASE	MicroRNAs (miRNAs) are small non-coding RNAs that regulate a variety of biological processes. The latest version of the miRBase database (Release 18) includes 1,157 mouse and 680 rat mature miRNAs. Only one new rat mature miRNA was added to the rat miRNA database from version 16 to version 18 of miRBase, suggesting that many rat miRNAs remain to be discovered. Given the importance of rat as a model organism, discovery of the completed set of rat miRNAs is necessary for understanding rat miRNA regulation. In this study, next generation sequencing (NGS), microarray analysis and bioinformatics technologies were applied to discover novel miRNAs in rat kidneys. MiRanalyzer was utilized to analyze the sequences of the small RNAs generated from NGS analysis of rat kidney samples. Hundreds of novel miRNA candidates were examined according to the mappings of their reads to the rat genome, presence of sequences that can form a miRNA hairpin structure around the mapped locations, Dicer cleavage patterns, and the levels of their expression determined by both NGS and microarray analyses. Nine novel rat hairpin precursor miRNAs (pre-miRNA) were discovered with high confidence. Five of the novel pre-miRNAs are also reported in other species while four of them are rat specific. In summary, 9 novel pre-miRNAs (14 novel mature miRNAs) were identified via combination of NGS, microarray and bioinformatics high-throughput technologies.	[Meng, Fanxue; Li, Zhiguang; Yan, Jian; Chen, Tao] US FDA, Div Genet & Mol Toxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Hackenberg, Michael] Univ Granada, Fac Ciencias, Dpto Genet, Granada, Spain	US Food & Drug Administration (FDA); University of Granada	Meng, FX (corresponding author), US FDA, Div Genet & Mol Toxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	tao.chen@fda.hhs.gov	Hackenberg, Michael/X-9662-2018; Hackenberg, Michael/A-2503-2009	Hackenberg, Michael/0000-0003-2248-3114; Hackenberg, Michael/0000-0003-2248-3114; Chen, Tao/0000-0001-9240-9484; li, zhiguang/0000-0003-2474-3485				Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-414; Chen L, 2006, TOXICOL LETT, V165, P250, DOI 10.1016/j.toxlet.2006.04.008; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander M, 2011, NUCL ACIDS RES; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gomase Virendra S, 2009, Int J Bioinform Res Appl, V5, P479, DOI 10.1504/IJBRA.2009.028678; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guan DG, 2011, RNA BIOL, V8, P1, DOI [10.4161/rna.8.5, 10.4161/rna.8.5.16026]; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Hendrix D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r39; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li ZG, 2011, ENVIRON MOL MUTAGEN, V52, P469, DOI 10.1002/em.20645; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mathelier A, 2010, BIOINFORMATICS, V26, P2226, DOI 10.1093/bioinformatics/btq329; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Oulas A, 2011, METHODS MOL BIOL, V676, P243, DOI 10.1007/978-1-60761-863-8_17; Oulas A, 2009, NUCLEIC ACIDS RES, V37, P3276, DOI 10.1093/nar/gkp120; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Pruitt KD, 2011, NUCL ACIDS RES; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; Sharbati S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-275; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shivdasani Ramesh A, 2006, Blood, V108, P3646; Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292; Su ZQ, 2011, CHEM RES TOXICOL, V24, P1486, DOI 10.1021/tx200103b; Tandon M, 2011, ORAL DIS; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Virts EL, 2010, MECH AGEING DEV, V131, P743, DOI 10.1016/j.mad.2010.09.008; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang WC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-328; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei ZL, 2011, INT J BIOL SCI, V7, P180, DOI 10.7150/ijbs.7.180; Willenbrock H, 2009, RNA, V15, P2028, DOI 10.1261/rna.1699809; Yang JH, 2010, NUCLEIC ACIDS RES, V38, pD123, DOI 10.1093/nar/gkp943; Yang XZ, 2011, BIOINFORMATICS, V27, P2614, DOI 10.1093/bioinformatics/btr430; Yang XZ, 2011, GENOMICS, V98, P40, DOI 10.1016/j.ygeno.2011.03.011; Zhu EL, 2010, NUCLEIC ACIDS RES, V38, pW392, DOI 10.1093/nar/gkq393; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19	68	15	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34394	10.1371/journal.pone.0034394	http://dx.doi.org/10.1371/journal.pone.0034394			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470567	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000106
J	Mones, E; Vicsek, L; Vicsek, T				Mones, Enys; Vicsek, Lilla; Vicsek, Tamas			Hierarchy Measure for Complex Networks	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATORY NETWORK; COMMUNITY STRUCTURE; SELF-ORGANIZATION; ANIMAL SOCIETIES; SMALL-WORLD; DYNAMICS; CENTRALITY; EMERGENCE	Nature, technology and society are full of complexity arising from the intricate web of the interactions among the units of the related systems (e. g., proteins, computers, people). Consequently, one of the most successful recent approaches to capturing the fundamental features of the structure and dynamics of complex systems has been the investigation of the networks associated with the above units (nodes) together with their relations (edges). Most complex systems have an inherently hierarchical organization and, correspondingly, the networks behind them also exhibit hierarchical features. Indeed, several papers have been devoted to describing this essential aspect of networks, however, without resulting in a widely accepted, converging concept concerning the quantitative characterization of the level of their hierarchy. Here we develop an approach and propose a quantity (measure) which is simple enough to be widely applicable, reveals a number of universal features of the organization of real-world networks and, as we demonstrate, is capable of capturing the essential features of the structure and the degree of hierarchy in a complex network. The measure we introduce is based on a generalization of the m-reach centrality, which we first extend to directed/partially directed graphs. Then, we define the global reaching centrality (GRC), which is the difference between the maximum and the average value of the generalized reach centralities over the network. We investigate the behavior of the GRC considering both a synthetic model with an adjustable level of hierarchy and real networks. Results for real networks show that our hierarchy measure is related to the controllability of the given system. We also propose a visualization procedure for large complex networks that can be used to obtain an overall qualitative picture about the nature of their hierarchical structure.	[Mones, Enys; Vicsek, Tamas] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Vicsek, Lilla] Corvinus Univ Budapest, Inst Sociol & Social Policy, Budapest, Hungary; [Vicsek, Tamas] Hungarian Acad Sci, Biol Phys Res Grp, Budapest, Hungary	Eotvos Lorand University; Corvinus University Budapest; Hungarian Academy of Sciences	Mones, E (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary.	vicsek@hal.elte.hu		Mones, Enys/0000-0001-7724-0094; Vicsek, Lilla/0000-0002-6034-7503	EU [227878]	EU(European Commission)	This work was supported by the EU FP7 COLLMOT Grant No: 227878. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], 1992, AYS NEUROANATOMY C E; [Anonymous], [No title captured]; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bhardwaj N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001014; Bollobas B., 2001, RANDOM GRAPHS; Bonabeau E, 1999, B MATH BIOL, V61, P727, DOI 10.1006/bulm.1999.0108; Borgatti SP, 2003, KEY PLAYER PROBLEM, P241; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Carmel L., 2002, DRAWING DIRECTED GRA, P193; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; CECCATTO HA, 1988, PHYS SCRIPTA, V37, P145, DOI 10.1088/0031-8949/37/1/021; Christian RR, 1999, ECOL MODEL, V117, P99, DOI 10.1016/S0304-3800(99)00022-8; Chung F., 2002, ANN COMB, V6, P125, DOI [10.1007/PL00012580, 10.1007/PL00012580.pdf, DOI 10.1007/PL00012580.PDF]; Cross R., 2004, HIDDEN POWER SOCIAL; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dubreuil Benoit, 2010, HUMAN EVOLUTION ORIG; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; ERDOS P, 1960, B INT STATIST INST, V38, P343; Freeman S. C., 1979, SOCIAL SCI RES REPOR, V46; Fushing H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017817; Garey M.R., 1979, COMPUTERS INTRACTABI; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goessmann C, 2000, BEHAV ECOL SOCIOBIOL, V48, P418, DOI 10.1007/s002650000222; Goh KI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.278701; Grinstead C. M., 1997, INTRO PROBABILITY; Healy P, 2004, HIERARCHICAL DRAWIND; HUBERMAN BA, 1986, PHYSICA D, V22, P376, DOI 10.1016/0167-2789(86)90308-1; HUMMON NP, 1995, SOC NETWORKS, V17, P1, DOI 10.1016/0378-8733(94)00245-6; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; JOHNSEN EC, 1985, SOC NETWORKS, V7, P203, DOI 10.1016/0378-8733(85)90015-2; Klimt B, 2004, INTRODUCING ENRON CO; Lane D, 2006, METHODS SER, V3, P81; LEBLEBICI H, 1984, SOC NETWORKS, V6, P31, DOI 10.1016/0378-8733(84)90003-0; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Leskovec J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1361; Leskovec J, 2009, INTERNET MATH, V6, P29, DOI 10.1080/15427951.2009.10129177; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Ma HW, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-199; Mak V, 2008, EMERGENCE OPINION LE; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Memon N, 2008, LECT NOTES COMPUT SC, V5075, P477, DOI 10.1007/978-3-540-69304-8_50; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Negyessy L, 2006, EUR J NEUROSCI, V23, P1919, DOI 10.1111/j.1460-9568.2006.04678.x; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pastor-Satorras R, 2004, EVOLUTION STRCUTURE; Pumain D, 2006, METHODS SER, V3, P1; Ripeanu M, 2002, IEEE INTERNET COMPUT, V6, P50, DOI 10.1109/4236.978369; Rowe R, 2007, P 9 WEBKDD 1 SNA KDD, P109; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Smaje C., 2000, NATURAL HIERARCHIES; Song X., 2007, P 16 ACM C C INF KNO, P971, DOI DOI 10.1145/1321440.1321588; SUGIYAMA K, 1981, IEEE T SYST MAN CYB, V11, P109, DOI 10.1109/TSMC.1981.4308636; THERAULAZ G, 1995, J THEOR BIOL, V174, P313, DOI 10.1006/jtbi.1995.0101; Trusina A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.178702; Tutte W.T., 2001, GRAPH THEORY; van Duijn MAJ, 2003, J MATH SOCIOL, V27, P153, DOI 10.1080/00222500305889; Vicsek T, 2010, ARXIV10105017; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wimberley E. T., 2009, NESTED ECOLOGY PLACE	66	112	114	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33799	10.1371/journal.pone.0033799	http://dx.doi.org/10.1371/journal.pone.0033799			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470477	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000034
J	Tasic, B; Miyamichi, K; Hippenmeyer, S; Dani, VS; Zeng, H; Joo, W; Zong, H; Chen-Tsai, Y; Luo, LQ				Tasic, Bosiljka; Miyamichi, Kazunari; Hippenmeyer, Simon; Dani, Vardhan S.; Zeng, Hong; Joo, William; Zong, Hui; Chen-Tsai, Yanru; Luo, Liqun			Extensions of MADM (Mosaic Analysis with Double Markers) in Mice	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SITE-SPECIFIC RECOMBINATION; GREEN FLUORESCENT PROTEIN; TETRACYCLINE-CONTROLLED GENES; CRE-LOXP; CHROMOSOMAL TRANSLOCATION; MEDIATED RECOMBINATION; TRANSGENE EXPRESSION; FLP-RECOMBINASE; REPORTER MOUSE	Mosaic Analysis with Double Markers (MADM) is a method for generating genetically mosaic mice, in which sibling mutant and wild-type cells are labeled with different fluorescent markers. It is a powerful tool that enables analysis of gene function at the single cell level in vivo. It requires transgenic cassettes to be located between the centromere and the mutation in the gene of interest on the same chromosome. Here we compare procedures for introduction of MADM cassettes into new loci in the mouse genome, and describe new approaches for expanding the utility of MADM. We show that: 1) Targeted homologous recombination outperforms random transgenesis in generation of reliably expressed MADM cassettes, 2) MADM cassettes in new genomic loci need to be validated for biallelic and ubiquitous expression, 3) Recombination between MADM cassettes on different chromosomes can be used to study reciprocal chromosomal deletions/duplications, and 4) MADM can be modified to permit transgene expression by combining it with a binary expression system. The advances described in this study expand current, and enable new and more versatile applications of MADM.	[Tasic, Bosiljka; Miyamichi, Kazunari; Hippenmeyer, Simon; Dani, Vardhan S.; Joo, William; Luo, Liqun] Stanford Univ, Dept Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Zeng, Hong; Chen-Tsai, Yanru] Stanford Univ, Sch Med, Transgen Facil, Stanford Canc Ctr, Stanford, CA 94305 USA; [Zong, Hui] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Joo, William] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford Cancer Institute; Stanford University; University of Oregon; Stanford University	Tasic, B (corresponding author), Allen Inst Brain Sci, Seattle, WA USA.	llou@stanford.edu	Miyamichi, Kazunari/AAO-3705-2021	Hippenmeyer, Simon/0000-0003-2279-1061; Luo, Liqun/0000-0001-5467-9264	National Institutes of Health [R01-NS050835]; Damon Runyon Cancer Research Foundation [DRG-1819-04]; Japan Society for the Promotion of Science; Human Frontier Science Program Organization [LT00300/2007-L, LT00805/2006-L]; European Molecular Biology Organization [ALTF 851-2005]; Swiss National Science Foundation [PA00P3_124160, PA00P3_136482]; Pew Charitable Trusts; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Human Frontier Science Program Organization(Human Frontier Science Program); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Pew Charitable Trusts; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a National Institutes of Health grant to LL (R01-NS050835). BT was a Damon Runyon Fellow and was supported by the Damon Runyon Cancer Research Foundation Grant DRG-1819-04. KM was supported by the Japan Society for the Promotion of Science program for Research Abroad and Human Frontier Science Program Organization (LT00300/2007-L). SH was supported by postdoctoral fellowships from the European Molecular Biology Organization (ALTF 851-2005), Human Frontier Science Program Organization (LT00805/2006-L), and Swiss National Science Foundation (PA00P3_124160 and PA00P3_136482). HZ is a Pew Scholar in Biomedical Sciences, supported by The Pew Charitable Trusts. LL is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; BROACH JR, 1982, CELL, V29, P227, DOI 10.1016/0092-8674(82)90107-6; Buchholz F, 2000, EMBO REP, V1, P133, DOI 10.1093/embo-reports/kvd027; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Collins EC, 2000, EMBO REP, V1, P127, DOI 10.1093/embo-reports/kvd021; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Drynan LF, 2005, EMBO J, V24, P3136, DOI 10.1038/sj.emboj.7600760; Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008; Espinosa JS, 2009, NEURON, V62, P205, DOI 10.1016/j.neuron.2009.03.006; Forster A, 2003, CANCER CELL, V3, P449, DOI 10.1016/S1535-6108(03)00106-5; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Griffin R, 2009, NAT METHODS, V6, P600, DOI 10.1038/nmeth.1349; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hippenmeyer S, 2010, NEURON, V68, P695, DOI 10.1016/j.neuron.2010.09.027; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Joyner AL, 2000, GENE TARGETING PRACT; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011503; Liu C, 2011, CELL; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Luo L, 2007, BRAIN RES REV, V55, P220, DOI 10.1016/j.brainresrev.2007.01.012; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Muzumdar MD, 2007, P NATL ACAD SCI USA, V104, P4495, DOI 10.1073/pnas.0606491104; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Okada A, 1999, EXP NEUROL, V156, P394, DOI 10.1006/exnr.1999.7033; Pankiewicz R, 2005, J GENE MED, V7, P117, DOI 10.1002/jgm.644; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; Seibler J, 1997, BIOCHEMISTRY-US, V36, P1740, DOI 10.1021/bi962443e; Seibler J, 1998, BIOCHEMISTRY-US, V37, P6229, DOI 10.1021/bi980288t; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Siemering KR, 1996, CURR BIOL, V6, P1653, DOI 10.1016/S0960-9822(02)70789-6; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TOWNES TM, 1985, EMBO J, V4, P1715, DOI 10.1002/j.1460-2075.1985.tb03841.x; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; VANDEURSEN J, 1995, P NATL ACAD SCI USA, V92, P7376, DOI 10.1073/pnas.92.16.7376; XU T, 1993, DEVELOPMENT, V117, P1223; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zeng HK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000069; Zhu PX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000533; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	53	41	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33332	10.1371/journal.pone.0033332	http://dx.doi.org/10.1371/journal.pone.0033332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479386	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900024
J	Hu, BL; Shen, LD; Du, P; Zheng, P; Xu, XY; Zeng, JN				Hu, Baolan; Shen, Lidong; Du, Ping; Zheng, Ping; Xu, Xiangyang; Zeng, Jiangning			The Influence of Intense Chemical Pollution on the Community Composition, Diversity and Abundance of Anammox Bacteria in the Jiaojiang Estuary (China)	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; IN-SITU DETECTION; OXIDIZING BACTERIA; FRESH-WATER; MARINE-SEDIMENTS; MOLECULAR EVIDENCE; NITROGEN-CYCLE; REACTOR; SLUDGE; PLANCTOMYCETE	Continuous chemical pollution is one of the most serious environmental problems in the Jiaojiang Estuary of the East Sea (China). This chemical pollution has significantly changed the estuarine environmental conditions and may have profoundly influenced the distribution of anammox bacterial communities in this estuary. Here, we investigated the influence of chemical pollution on the community composition, diversity and abundance of anammox bacteria in Jiaojiang estuarine sediments. Phylogenetic analysis of 16S rRNA genes showed that the majority of anammox bacterial sequences retrieved from the estuarine intertidal sediments were associated with Kuenenia. In contrast, different anammox communities composed of Brocadia, Kuenenia, Scalindua and Jettenia were found in the estuarine subtidal sediments. Redundancy analysis (RDA) indicated that the sediment nitrobenzene and organic content had significant impacts on the distribution of anammox communities in the intertidal sediments. Pearson correlation analysis showed that the diversity of anammox bacteria in the intertidal sediments was positively correlated with the organic content. In contrast, RDA results showed that the nitrobenzene content, NO3- concentration and salinity significantly influenced the distribution of anammox communities in the subtidal sediments. The diversity and relative abundance of anammox bacteria in the subtidal sediments were positively correlated with NO3- concentration.	[Hu, Baolan; Shen, Lidong; Zheng, Ping; Xu, Xiangyang] Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China; [Du, Ping; Zeng, Jiangning] State Ocean Adm, Inst Oceanog 2, Dept Ecol & Environm, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; State Oceanic Administration	Hu, BL (corresponding author), Zhejiang Univ, Dept Environm Engn, Hangzhou 310003, Zhejiang, Peoples R China.	xuxy@zju.edu.cn; jiangningz@126.com	Hu, baolan/K-8163-2012; 郑, 平/B-1890-2014; 徐, 向阳/I-6211-2015	徐, 向阳/0000-0001-9734-4616; Shen, Lidong/0000-0003-0524-4728	Laboratory of Marine Ecosystem and Biogeochemistry [LMEB201007]; Science Foundation of Zhejiang province [Y5100401]; Science and Technology Specific Project of Zhejiang Province [2008C13007]; Fundamental Research Funds for the Central Universities [2010QNA6017]	Laboratory of Marine Ecosystem and Biogeochemistry; Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Science and Technology Specific Project of Zhejiang Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors wish to thank the fund of Laboratory of Marine Ecosystem and Biogeochemistry (LMEB201007), the Science Foundation of Zhejiang province (Y5100401), the Science and Technology Specific Project of Zhejiang Province (2008C13007) and the Fundamental Research Funds for the Central Universities (2010QNA6017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2007, MICROBES ENVIRON, V22, P232, DOI 10.1264/jsme2.22.232; Boyes S, 2006, MAR POLLUT BULL, V53, P136, DOI 10.1016/j.marpolbul.2005.09.011; BRODA E, 1977, Z ALLG MIKROBIOL, V17, P491, DOI 10.1002/jobm.3630170611; DALE NG, 1974, LIMNOL OCEANOGR, V19, P509, DOI 10.4319/lo.1974.19.3.0509; Dale OR, 2009, ENVIRON MICROBIOL, V11, P1194, DOI 10.1111/j.1462-2920.2008.01850.x; Dang HY, 2010, APPL ENVIRON MICROB, V76, P7036, DOI 10.1128/AEM.01264-10; Dong LF, 2009, APPL ENVIRON MICROB, V75, P3171, DOI 10.1128/AEM.02511-08; Du Ping, 2011, Chinese Journal of Applied and Environmental Biology, V17, P486, DOI 10.3724/SP.J.1145.2011.00486; Engstrom P, 2005, GEOCHIM COSMOCHIM AC, V69, P2057, DOI 10.1016/j.gca.2004.09.032; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Hu BL, 2010, WATER RES, V44, P5014, DOI 10.1016/j.watres.2010.07.021; Humbert S, 2010, ISME J, V4, P450, DOI 10.1038/ismej.2009.125; Jetten MSM, 2009, CRIT REV BIOCHEM MOL, V44, P65, DOI 10.1080/10409230902722783; Jetten MSM, 2003, APPL MICROBIOL BIOT, V63, P107, DOI 10.1007/s00253-003-1422-4; Juretschko S, 1998, APPL ENVIRON MICROB, V64, P3042; Kartal B, 2008, FEMS MICROBIOL ECOL, V63, P46, DOI 10.1111/j.1574-6941.2007.00408.x; Kartal B, 2007, SYST APPL MICROBIOL, V30, P39, DOI 10.1016/j.syapm.2006.03.004; Kartal B, 2006, J BIOTECHNOL, V126, P546, DOI 10.1016/j.jbiotec.2006.05.012; Kuenen JG, 2008, NAT REV MICROBIOL, V6, P320, DOI 10.1038/nrmicro1857; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Li D, 2008, FEMS MICROBIOL ECOL, V65, P494, DOI 10.1111/j.1574-6941.2008.00540.x; Li M, 2011, MICROBES ENVIRON, V26, P15, DOI 10.1264/jsme2.ME10131; Liu L, 2005, J MAR SCI, V23, P51; MULDER A, 1995, FEMS MICROBIOL ECOL, V16, P177, DOI 10.1016/0168-6496(94)00081-7; Neef A, 1998, MICROBIOL-UK, V144, P3257, DOI 10.1099/00221287-144-12-3257; Ni BJ, 2010, APPL ENVIRON MICROB, V76, P2652, DOI 10.1128/AEM.02271-09; Padda RS, 2003, ENVIRON TOXICOL CHEM, V22, P2293, DOI 10.1897/02-220; Penton CR, 2006, APPL ENVIRON MICROB, V72, P6829, DOI 10.1128/AEM.01254-06; Quan ZX, 2008, ENVIRON MICROBIOL, V10, P3130, DOI 10.1111/j.1462-2920.2008.01642.x; Rich JJ, 2008, MICROB ECOL, V55, P311, DOI 10.1007/s00248-007-9277-3; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93, DOI 10.1016/S0723-2020(00)80050-8; Schmid M, 2003, SYST APPL MICROBIOL, V26, P529, DOI 10.1078/072320203770865837; Schmid MC, 2007, ENVIRON MICROBIOL, V9, P1476, DOI 10.1111/j.1462-2920.2007.01266.x; Schmid MC, 2005, APPL ENVIRON MICROB, V71, P1677, DOI 10.1128/AEM.71.4.1677-1684.2005; Schubert CJ, 2006, ENVIRON MICROBIOL, V8, P1857, DOI 10.1111/j.1462-2920.2006.01074.x; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Ter Braak C.J.F, CANOCO REFERENCE MAN; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Wang Y. M., 2005, J ZHEJIANG OCEAN U N, V24, P221; Woebken D, 2008, ENVIRON MICROBIOL, V10, P3106, DOI 10.1111/j.1462-2920.2008.01640.x; Zhao S, 2009, FEMS MICROBIOL ECOL, V70, P315, DOI 10.1111/j.1574-6941.2009.00773.x; [赵永强 ZHAO Yong-Qiang], 2009, [生态学报, Acta Ecologica Sinica], V29, P1578	47	26	32	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33826	10.1371/journal.pone.0033826	http://dx.doi.org/10.1371/journal.pone.0033826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470481	Green Published, Green Submitted, gold			2022-12-27	WOS:000303857100052
J	Mange, A; Goux, A; Badiou, S; Patrier, L; Canaud, B; Maudelonde, T; Cristol, JP; Solassol, J				Mange, Alain; Goux, Aurelie; Badiou, Stephanie; Patrier, Laure; Canaud, Bernard; Maudelonde, Thierry; Cristol, Jean-Paul; Solassol, Jerome			HDL Proteome in Hemodialysis Patients: A Quantitative Nanoflow Liquid Chromatography-Tandem Mass Spectrometry Approach	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; CHRONIC KIDNEY-DISEASE; APOLIPOPROTEIN C-III; RENAL-FAILURE; PLASMA-LIPOPROTEINS; OXIDATIVE STRESS; IN-VIVO; INFLAMMATION; INHIBITION	Aside from a decrease in the high-density lipoprotein (HDL) cholesterol levels, qualitative abnormalities of HDL can contribute to an increase in cardiovascular (CV) risk in end-stage renal disease (ESRD) patients undergoing chronic hemodialysis (HD). Dysfunctional HDL leads to an alteration of reverse cholesterol transport and the antioxidant and anti-inflammatory properties of HDL. In this study, a quantitative proteomics approach, based on iTRAQ labeling and nanoflow liquid chromatography mass spectrometry analysis, was used to generate detailed data on HDL-associated proteins. The HDL composition was compared between seven chronic HD patients and a pool of seven healthy controls. To confirm the proteomics results, specific biochemical assays were then performed in triplicate in the 14 samples as well as 46 sex-matched independent chronic HD patients and healthy volunteers. Of the 122 proteins identified in the HDL fraction, 40 were differentially expressed between the healthy volunteers and the HD patients. These proteins are involved in many HDL functions, including lipid metabolism, the acute inflammatory response, complement activation, the regulation of lipoprotein oxidation, and metal cation homeostasis. Among the identified proteins, apolipoprotein C-II and apolipoprotein C-III were significantly increased in the HDL fraction of HD patients whereas serotransferrin was decreased. In this study, we identified new markers of potential relevance to the pathways linked to HDL dysfunction in HD. Proteomic analysis of the HDL fraction provides an efficient method to identify new and uncharacterized candidate biomarkers of CV risk in HD patients.	[Mange, Alain; Maudelonde, Thierry; Solassol, Jerome] CHU Arnaud de Villeneuve, Dept Cellular Biol, Montpellier, France; [Mange, Alain; Goux, Aurelie; Badiou, Stephanie; Patrier, Laure; Canaud, Bernard; Maudelonde, Thierry; Cristol, Jean-Paul; Solassol, Jerome] Univ Montpellier I, Montpellier, France; [Mange, Alain; Maudelonde, Thierry; Solassol, Jerome] Val dAurelle Canc Inst, Dept Clin Oncoprote, Montpellier, France; [Badiou, Stephanie; Patrier, Laure; Cristol, Jean-Paul] CHU Lapeyronie, Dept Biochem, Montpellier, France; [Goux, Aurelie; Badiou, Stephanie; Patrier, Laure; Canaud, Bernard; Cristol, Jean-Paul] Univ Montpellier I II, UMR NUTRIPASS 204, Montpellier, France; [Canaud, Bernard] CHU Lapeyronie, Dept Nephrol, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Solassol, J (corresponding author), CHU Arnaud de Villeneuve, Dept Cellular Biol, Montpellier, France.	jerome.solassol@univ-montp1.fr	Mange, Alain/U-1157-2017; Solassol, Jerome/G-2320-2018	Mange, Alain/0000-0002-1566-9407; Solassol, Jerome/0000-0002-0293-6158				Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; ATTMAN PO, 1991, NEPHRON, V57, P401, DOI 10.1159/000186303; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; BUKBERG PR, 1985, J LIPID RES, V26, P1047; Chua ACG, 2007, CRIT REV CL LAB SCI, V44, P413, DOI 10.1080/10408360701428257; Davidson WS, 2009, ARTERIOSCL THROM VAS, V29, P870, DOI 10.1161/ATVBAHA.109.186031; Davidsson P, 2010, ARTERIOSCL THROM VAS, V30, P156, DOI 10.1161/ATVBAHA.108.179317; Deighan CJ, 2000, AM J KIDNEY DIS, V35, P852, DOI 10.1016/S0272-6386(00)70255-1; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Feig JE, 2008, CURR DRUG TARGETS, V9, P196; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gordon SM, 2010, J PROTEOME RES, V9, P5239, DOI 10.1021/pr100520x; HB G, 2011, CHOLESTEROL; Holzer M, 2011, J AM SOC NEPHROL, V22, P1631, DOI 10.1681/ASN.2010111144; Hoofnagle AN, 2009, J LIPID RES, V50, P1967, DOI 10.1194/jlr.R900015-JLR200; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Jurek A, 2008, CLIN BIOCHEM, V41, P1015, DOI 10.1016/j.clinbiochem.2008.04.019; Karlsson H, 2005, PROTEOMICS, V5, P1431, DOI 10.1002/pmic.200401010; Katoh N, 1999, J VET MED SCI, V61, P119, DOI 10.1292/jvms.61.119; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; KUNITAKE ST, 1992, P NATL ACAD SCI USA, V89, P6993, DOI 10.1073/pnas.89.15.6993; McGillicuddy FC, 2009, CIRCULATION, V119, P1135, DOI 10.1161/CIRCULATIONAHA.108.810721; Montazerifar F, 2010, J MED FOOD, V13, P1490, DOI 10.1089/jmf.2010.1074; Moradi H, 2009, TRANSL RES, V153, P77, DOI 10.1016/j.trsl.2008.11.007; Morena M, 2000, NEPHROL DIAL TRANSPL, V15, P389, DOI 10.1093/ndt/15.3.389; Morena Marion, 2005, Hemodial Int, V9, P37, DOI 10.1111/j.1492-7535.2005.01116.x; Muntner P, 2005, J AM SOC NEPHROL, V16, P529, DOI 10.1681/ASN.2004080656; NGUYEN AT, 1985, KIDNEY INT, V28, P158, DOI 10.1038/ki.1985.136; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; PEUCHANT E, 1994, FREE RADICAL BIO MED, V16, P339, DOI 10.1016/0891-5849(94)90035-3; Rezaee F, 2006, PROTEOMICS, V6, P721, DOI 10.1002/pmic.200500191; Shao BH, 2006, CURR OPIN CARDIOL, V21, P322, DOI 10.1097/01.hco.0000231402.87232.aa; Stenvinkel P, 2002, SEMIN DIALYSIS, V15, P329, DOI 10.1046/j.1525-139X.2002.00083.x; SUTHERLAND WHF, 1995, NEPHROL DIAL TRANSPL, V10, P358; Tang WH, 2008, J PROTEOME RES, V7, P3661, DOI 10.1021/pr070492f; Tian L, 2009, METABOLISM, V58, P668, DOI 10.1016/j.metabol.2009.01.007; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vaziri ND, 2006, AM J PHYSIOL-RENAL, V290, pF262, DOI 10.1152/ajprenal.00099.2005; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Weinstein T, 2000, NEPHROL DIAL TRANSPL, V15, P883, DOI 10.1093/ndt/15.6.883; Yu R, 2008, CURR ATHEROSCLER REP, V10, P171, DOI 10.1007/s11883-008-0025-z	42	58	60	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e34107	10.1371/journal.pone.0034107	http://dx.doi.org/10.1371/journal.pone.0034107			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470525	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100068
J	Richard-Fiardo, P; Franken, PR; Lamit, A; Marsault, R; Guglielmi, J; Cambien, B; Graslin, F; Lindenthal, S; Darcourt, J; Pourcher, T; Vassaux, G				Richard-Fiardo, Peggy; Franken, Philippe R.; Lamit, Audrey; Marsault, Robert; Guglielmi, Julien; Cambien, Beatrice; Graslin, Fanny; Lindenthal, Sabine; Darcourt, Jacques; Pourcher, Thierry; Vassaux, Georges			Normalisation to Blood Activity Is Required for the Accurate Quantification of Na/I Symporter Ectopic Expression by SPECT/CT in Individual Subjects	PLOS ONE			English	Article							SODIUM-IODIDE SYMPORTER; POSITRON-EMISSION-TOMOGRAPHY; REPORTER GENE-EXPRESSION; IN-VIVO; RADIOIODINE THERAPY; TRANSGENE EXPRESSION; SODIUM/IODIDE SYMPORTER; PROSTATE-CANCER; THYROID-CANCER; MAMMARY-GLAND	The utilisation of the Na/I symporter (NIS) and associated radiotracers as a reporter system for imaging gene expression is now reaching the clinical setting in cancer gene therapy applications. However, a formal assessment of the methodology in terms of normalisation of the data still remains to be performed, particularly in the context of the assessment of activities in individual subjects in longitudinal studies. In this context, we administered to mice a recombinant, replication-incompetent adenovirus encoding rat NIS, or a human colorectal carcinoma cell line (HT29) encoding mouse NIS. We used Tc-99m pertechnetate as a radiotracer for SPECT/CT imaging to determine the pattern of ectopic NIS expression in longitudinal kinetic studies. Some animals of the cohort were culled and NIS expression was measured by quantitative RTPCR and immunohistochemistry. The radioactive content of some liver biopsies was also measured ex vivo. Our results show that in longitudinal studies involving datasets taken from individual mice, the presentation of non-normalised data (activity expressed as %ID/g or %ID/cc) leads to 'noisy', and sometimes incoherent, results. This variability is due to the fact that the blood pertechnetate concentration can vary up to three-fold from day to day. Normalisation of these data with blood activities corrects for these inconsistencies. We advocate that, blood pertechnetate activity should be determined and used to normalise the activity measured in the organ/region of interest that expresses NIS ectopically. Considering that NIS imaging has already reached the clinical setting in the context of cancer gene therapy, this normalisation may be essential in order to obtain accurate and predictive information in future longitudinal clinical studies in biotherapy.	[Richard-Fiardo, Peggy; Vassaux, Georges] CHU Nantes, Hotel Dieu, INSERM, U948, F-44035 Nantes 01, France; [Richard-Fiardo, Peggy; Vassaux, Georges] CHU Nantes, Inst Malad Appareil Digestif, F-44035 Nantes 01, France; [Franken, Philippe R.; Lamit, Audrey; Marsault, Robert; Guglielmi, Julien; Cambien, Beatrice; Graslin, Fanny; Lindenthal, Sabine; Darcourt, Jacques; Pourcher, Thierry] Ctr Antoine Lacassagne, F-06054 Nice, France; [Franken, Philippe R.; Lamit, Audrey; Marsault, Robert; Guglielmi, Julien; Cambien, Beatrice; Graslin, Fanny; Lindenthal, Sabine; Darcourt, Jacques; Pourcher, Thierry] Univ Nice Sophia Antipolis, Fac Med, Nice, France; [Franken, Philippe R.; Lamit, Audrey; Marsault, Robert; Guglielmi, Julien; Cambien, Beatrice; Graslin, Fanny; Lindenthal, Sabine; Darcourt, Jacques; Pourcher, Thierry] Commissariat Energie Atom, Lab TIRO, UMRE 4320, iBEB,DSV, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; UNICANCER; Centre Antoine Lacassagne; UDICE-French Research Universities; Universite Cote d'Azur; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Cote d'Azur	Richard-Fiardo, P (corresponding author), CHU Nantes, Hotel Dieu, INSERM, U948, F-44035 Nantes 01, France.	georges.vassaux@inserm.fr	Vassaux, Georges/N-9724-2016; Cambien, Béatrice/AAD-8973-2021	Vassaux, Georges/0000-0002-1149-7716; Cambien, Béatrice/0000-0002-6914-0525; Pourcher, Thierry/0000-0003-2839-4622	INSERM; la Ligue Nationale Contre le Cancer; INCa; Canceropole "Grand Ouest''; Vaincre la Mucoviscidose; Region Pays de la Loire	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); la Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); INCa(Institut National du Cancer (INCA) France); Canceropole "Grand Ouest''; Vaincre la Mucoviscidose; Region Pays de la Loire(Region Pays de la Loire)	This work is supported by grants from INSERM, la Ligue Nationale Contre le Cancer, INCa, Canceropole "Grand Ouest'', Vaincre la Mucoviscidose and by a grant from the "Paris scientifiques regionaux'' scheme from the Region Pays de la Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baril P, 2010, BRIT J PHARMACOL, V159, P761, DOI 10.1111/j.1476-5381.2009.00412.x; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; Barton KN, 2011, MOL THER, V19, P1353, DOI 10.1038/mt.2011.89; Barton KN, 2003, MOL THER, V8, P508, DOI 10.1016/S1525-0016(03)00153-9; Carlson SK, 2006, MOL IMAGING BIOL, V8, P324, DOI 10.1007/s11307-006-0058-z; Carlson SK, 2009, AM J ROENTGENOL, V192, P279, DOI 10.2214/AJR.08.1205; Chen LB, 2006, NUCL MED BIOL, V33, P575, DOI 10.1016/j.nucmedbio.2006.01.011; Chisholm EJ, 2009, CANCER RES, V69, P2655, DOI 10.1158/0008-5472.CAN-08-2657; Dayem M, 2008, J ENDOCRINOL, V197, P95, DOI 10.1677/JOE-07-0455; Dingli D, 2006, MOL IMAGING BIOL, V8, P16, DOI 10.1007/s11307-005-0025-0; Faivre J, 2004, CANCER RES, V64, P8045, DOI 10.1158/0008-5472.CAN-04-0893; Goel A, 2007, BLOOD, V110, P2342, DOI 10.1182/blood-2007-01-065573; Groot-Wassink T, 2004, CANCER RES, V64, P4906, DOI 10.1158/0008-5472.CAN-04-0426; Groot-Wassink T, 2004, MOL THER, V9, P436, DOI 10.1016/j.ymthe.2003.12.001; Groot-Wassink T, 2002, HUM GENE THER, V13, P1723, DOI 10.1089/104303402760293565; Hanscheid H, 2011, EUR J NUCL MED MOL I, V38, P1296, DOI 10.1007/s00259-011-1788-y; Hanscheid H, 2006, J NUCL MED, V47, P648; Higuchi T, 2009, J NUCL MED, V50, P1088, DOI 10.2967/jnumed.108.060665; Higuchi T, 2009, J NUCL MED, V50, P1881, DOI 10.2967/jnumed.109.067801; Hingorani M, 2010, CURR CANCER DRUG TAR, V10, P242, DOI 10.2174/156800910791054194; Huang R, 2011, CANCER GENE THER, V18, P144, DOI 10.1038/cgt.2010.66; Jung KH, 2009, NUCL MED BIOL, V36, P967, DOI 10.1016/j.nucmedbio.2009.06.010; Klutz K, 2009, CLIN CANCER RES, V15, P6079, DOI 10.1158/1078-0432.CCR-09-0851; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Lorenz JN, 2002, AM J PHYSIOL-REG I, V282, pR1565, DOI 10.1152/ajpregu.00759.2001; Meneton P, 2000, AM J PHYSIOL-RENAL, V278, pF339, DOI 10.1152/ajprenal.2000.278.3.F339; Merron A, 2007, GENE THER, V14, P1731, DOI 10.1038/sj.gt.3303043; Merron A, 2010, EUR J NUCL MED MOL I, V37, P1377, DOI 10.1007/s00259-009-1379-3; Peerlinck I, 2009, CLIN CANCER RES, V15, P6595, DOI 10.1158/1078-0432.CCR-09-0262; Penheiter A.R., 2011, GENE THER; Perron B, 2001, J ENDOCRINOL, V170, P185, DOI 10.1677/joe.0.1700185; Rajecki M, 2011, MOL THER, V19, P629, DOI 10.1038/mt.2011.31; Ricci D, 2008, EUR J CARDIO-THORAC, V33, P32, DOI 10.1016/j.ejcts.2007.09.033; Richard JC, 2004, J NUCL MED, V45, P644; Siddiqui F, 2007, HUM GENE THER, V18, P312, DOI 10.1089/hum.2006.131; Sieger S, 2003, EUR J NUCL MED MOL I, V30, P748, DOI 10.1007/s00259-002-1099-4; Spitzweg C, 1998, J CLIN ENDOCR METAB, V83, P1746, DOI 10.1210/jc.83.5.1746; Terrovitis J, 2008, J AM COLL CARDIOL, V52, P1652, DOI 10.1016/j.jacc.2008.06.051; Verburg FA, 2011, EUR J NUCL MED MOL I, V38, P673, DOI 10.1007/s00259-010-1689-5; Watanabe Y, 2010, J NUCL MED, V51, P951, DOI 10.2967/jnumed.109.074443; Wu JC, 2001, MOL THER, V4, P297, DOI 10.1006/mthe.2001.0460; Zuckier LS, 2004, J NUCL MED, V45, P500	42	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e34086	10.1371/journal.pone.0034086	http://dx.doi.org/10.1371/journal.pone.0034086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470517	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100065
J	Ferreira, JCB; Boer, BN; Grinberg, M; Brum, PC; Mochly-Rosen, D				Ferreira, Julio C. B.; Boer, Berta Napchan; Grinberg, Max; Brum, Patricia Chakur; Mochly-Rosen, Daria			Protein Quality Control Disruption by PKC beta II in Heart Failure; Rescue by the Selective PKC beta II Inhibitor, beta IIV5-3	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; KINASE-C-BETA; DILATED CARDIOMYOPATHY; CARDIAC DYSFUNCTION; HYPERTENSIVE-RATS; IN-VIVO; HYPERTROPHY; EPSILON; DEATH; BORTEZOMIB	Myocardial remodeling and heart failure (HF) are common sequelae of many forms of cardiovascular disease and a leading cause of mortality worldwide. Accumulation of damaged cardiac proteins in heart failure has been described. However, how protein quality control (PQC) is regulated and its contribution to HF development are not known. Here, we describe a novel role for activated protein kinase C isoform beta II (PKC beta II) in disrupting PQC. We show that active PKC beta II directly phosphorylated the proteasome and inhibited proteasomal activity in vitro and in cultured neonatal cardiomyocytes. Importantly, inhibition of PKC beta II, using a selective PKC beta II peptide inhibitor (beta IIV5-3), improved proteasomal activity and conferred protection in cultured neonatal cardiomyocytes. We also show that sustained inhibition of PKC beta II increased proteasomal activity, decreased accumulation of damaged and misfolded proteins and increased animal survival in two rat models of HF. Interestingly, beta IIV5-3-mediated protection was blunted by sustained proteasomal inhibition in HF. Finally, increased cardiac PKC beta II activity and accumulation of misfolded proteins associated with decreased proteasomal function were found also in remodeled and failing human hearts, indicating a potential clinical relevance of our findings. Together, our data highlights PKC beta II as a novel inhibitor of proteasomal function. PQC disruption by increased PKC beta II activity in vivo appears to contribute to the pathophysiology of heart failure, suggesting that PKC beta II inhibition may benefit patients with heart failure. (218 words)	[Ferreira, Julio C. B.; Mochly-Rosen, Daria] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Ferreira, Julio C. B.; Brum, Patricia Chakur] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Boer, Berta Napchan; Grinberg, Max] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil	Stanford University; Universidade de Sao Paulo; Universidade de Sao Paulo	Ferreira, JCB (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	mochly@stanford.edu	Brum, Patricia C/E-6605-2011; Ferreira, Julio/L-4687-2019; Ferreira, Julio Cesar Batista/AEU-0494-2022; Ferreira, Julio Cesar Batista/I-3177-2012	Brum, Patricia C/0000-0002-4750-6506; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Mochly-Rosen, Daria/0000-0002-6691-8733	National Institute of Health [HL076675]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2009/03143-1]; Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior - Programa de Doutorado no Pais com Estagio no Exterior (CAPES-PDEE) - Brasil [2177-07-2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076675, R01HL052141] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior - Programa de Doutorado no Pais com Estagio no Exterior (CAPES-PDEE) - Brasil; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by National Institute of Health Grant HL076675 to DMR. JCBF held a post-doctoral fellowship from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2009/03143-1) and and Coordenacao de Aperfeicoamento de Pessoal de Ensino Superior - Programa de Doutorado no Pais com Estagio no Exterior (CAPES-PDEE, 2177-07-2) - Brasil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; Asai M, 2009, J MOL CELL CARDIOL, V46, P452, DOI 10.1016/j.yjmcc.2008.11.001; Ferreira JCB, 2011, J MOL CELL CARDIOL, V51, P479, DOI 10.1016/j.yjmcc.2010.10.020; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Bowman JC, 1997, J CLIN INVEST, V100, P2189, DOI 10.1172/JCI119755; Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663; Chen QH, 2005, CIRC RES, V97, P1018, DOI 10.1161/01.RES.0000189262.92896.0b; Churchill EN, 2010, CARDIOVASC RES, V85, P385, DOI 10.1093/cvr/cvp334; Disatnik MH, 2002, J CELL SCI, V115, P2151; Farout L, 2006, ARCH BIOCHEM BIOPHYS, V453, P135, DOI 10.1016/j.abb.2006.02.003; Ferreira JCB, 2011, J MOL CELL CARDIOL, V51, P980, DOI 10.1016/j.yjmcc.2011.08.025; Ferreira JCB, 2011, LIFE SCI, V88, P578, DOI 10.1016/j.lfs.2011.01.009; Fu HY, 2008, CARDIOVASC RES, V79, P600, DOI 10.1093/cvr/cvn128; Gomes AV, 2009, MOL CELL PROTEOMICS, V8, P302, DOI 10.1074/mcp.M800058-MCP200; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Hedhli N, 2008, AM J PHYSIOL-HEART C, V295, pH1385, DOI 10.1152/ajpheart.00532.2008; Hemeryck A, 2007, CANCER CHEMOTH PHARM, V60, P777, DOI 10.1007/s00280-007-0424-9; Inagaki K, 2003, CIRCULATION, V108, P2304, DOI 10.1161/01.CIR.0000101682.24138.36; Inagaki K, 2002, J MOL CELL CARDIOL, V34, P1377, DOI 10.1006/jmcc.2002.2089; Iwanaga Y, 1998, CIRCULATION, V98, P2065, DOI 10.1161/01.CIR.98.19.2065; JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006; JOHNSON JA, 1995, CIRC RES, V76, P654, DOI 10.1161/01.RES.76.4.654; Kim JW, 2008, CANCER RES, V68, P6831, DOI 10.1158/0008-5472.CAN-07-6195; Liu JB, 2006, FASEB J, V20, P362, DOI 10.1096/fj.05-4869fje; Lu HJ, 2008, MOL CELL PROTEOMICS, V7, P2073, DOI 10.1074/mcp.M800064-MCP200; Mearini G, 2008, BBA-MOL BASIS DIS, V1782, P749, DOI 10.1016/j.bbadis.2008.06.009; Meiners S, 2008, HYPERTENSION, V51, P302, DOI 10.1161/HYPERTENSIONAHA.107.097816; Nowis D, 2010, AM J PATHOL, V176, P2658, DOI 10.2353/ajpath.2010.090690; Orciuolo E, 2007, BRIT J HAEMATOL, V138, P396, DOI 10.1111/j.1365-2141.2007.06659.x; Palaniyandi SS, 2011, J CELL MOL MED, V15, P1769, DOI 10.1111/j.1582-4934.2010.01174.x; Palaniyandi SS, 2009, CARDIOVASC RES, V82, P229, DOI 10.1093/cvr/cvp001; Patterson C, 2007, CIRCULATION, V115, P1456, DOI 10.1161/CIRCULATIONAHA.106.649863; Paulus WJ, 2010, J AM COLL CARDIOL, V55, P526, DOI 10.1016/j.jacc.2009.06.067; Simonis G, 2007, MOL CELL BIOCHEM, V305, P103, DOI 10.1007/s11010-007-9533-3; Sohn D, 2006, CELL CYCLE, V5, P841, DOI 10.4161/cc.5.8.2740; Souroujon MC, 1998, NAT BIOTECHNOL, V16, P919, DOI 10.1038/nbt1098-919; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Su HB, 2010, CARDIOVASC RES, V85, P253, DOI 10.1093/cvr/cvp287; Vallentin A, 2007, J BIOL CHEM, V282, P1650, DOI 10.1074/jbc.M601710200; Wakasaki H, 1997, P NATL ACAD SCI USA, V94, P9320, DOI 10.1073/pnas.94.17.9320; Wang XJ, 2006, CIRC RES, V99, P1315, DOI 10.1161/01.RES.0000252342.61447.a2; Weekes J, 1999, ELECTROPHORESIS, V20, P898, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<898::AID-ELPS898>3.0.CO;2-B; Weekes J, 2003, PROTEOMICS, V3, P208, DOI 10.1002/pmic.200390029; Willis MS, 2009, CARDIOVASC RES, V81, P439, DOI 10.1093/cvr/cvn289; Zong C, 2006, CIRC RES, V99, P372, DOI 10.1161/01.RES.0000237389.40000.02	46	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33175	10.1371/journal.pone.0033175	http://dx.doi.org/10.1371/journal.pone.0033175			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479367	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100036
J	Herrera-Molina, R; Frischknecht, R; Maldonado, H; Seidenbecher, CI; Gundelfinger, ED; Hetz, C; Aylwin, MD; Schneider, P; Quest, AFG; Leyton, L				Herrera-Molina, Rodrigo; Frischknecht, Renato; Maldonado, Horacio; Seidenbecher, Constanze I.; Gundelfinger, Eckart D.; Hetz, Claudio; de la Luz Aylwin, Maria; Schneider, Pascal; Quest, Andrew F. G.; Leyton, Lisette			Astrocytic alpha(V)beta(3) Integrin Inhibits Neurite Outgrowth and Promotes Retraction of Neuronal Processes by Clustering Thy-1	PLOS ONE			English	Article							MATRIX INTERACTIONS; NEGATIVE REGULATOR; AXON REGENERATION; PLASMA-MEMBRANE; MOLECULE THY-1; MICE LACKING; P190 RHOGAP; SPINAL-CORD; CELL; EXPRESSION	Thy-1 is a membrane glycoprotein suggested to stabilize or inhibit growth of neuronal processes. However, its precise function has remained obscure, because its endogenous ligand is unknown. We previously showed that Thy-1 binds directly to alpha(V)beta(3) integrin in trans eliciting responses in astrocytes. Nonetheless, whether alpha(V)beta(3) integrin might also serve as a Thy-1-ligand triggering a neuronal response has not been explored. Thus, utilizing primary neurons and a neuron-derived cell line CAD, Thy-1-mediated effects of alpha(V)beta(3) integrin on growth and retraction of neuronal processes were tested. In astrocyte-neuron co-cultures, endogenous alpha(V)beta(3) integrin restricted neurite outgrowth. Likewise, alpha(V)beta(3)-Fc was sufficient to suppress neurite extension in Thy-1(+), but not in Thy-1(2) CAD cells. In differentiating primary neurons exposed to alpha(V)beta 3-Fc, fewer and shorter dendrites were detected. This effect was abolished by cleavage of Thy-1 from the neuronal surface using phosphoinositide-specific phospholipase C (PI-PLC). Moreover, alpha(V)beta(3)-Fc also induced retraction of already extended Thy1(+)-axon-like neurites in differentiated CAD cells as well as of axonal terminals in differentiated primary neurons. Axonal retraction occurred when redistribution and clustering of Thy-1 molecules in the plasma membrane was induced by alpha(V)beta(3) integrin. Binding of alpha(V)beta(3)-Fc was detected in Thy-1 clusters during axon retraction of primary neurons. Moreover, alpha(V)beta(3)-Fc-induced Thy-1 clustering correlated in time and space with redistribution and inactivation of Src kinase. Thus, our data indicates that alpha(V)beta(3) integrin is a ligand for Thy-1 that upon binding not only restricts the growth of neurites, but also induces retraction of already existing processes by inducing Thy-1 clustering. We propose that these events participate in bidirectional astrocyte-neuron communication relevant to axonal repair after neuronal damage.	[Herrera-Molina, Rodrigo; Maldonado, Horacio; Hetz, Claudio; Quest, Andrew F. G.; Leyton, Lisette] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Biol Celular & Mol, Santiago 7, Chile; [Herrera-Molina, Rodrigo; Maldonado, Horacio; Hetz, Claudio; Quest, Andrew F. G.; Leyton, Lisette] Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Estudios Mol Celula, Santiago 7, Chile; [de la Luz Aylwin, Maria] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Fisiol & Biofis, Santiago 7, Chile; [de la Luz Aylwin, Maria] Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Neurociencias Integradas, Santiago 7, Chile; [Maldonado, Horacio; Hetz, Claudio; Leyton, Lisette] Univ Chile, Fac Med, Inst Ciencias Biomed, Biomed Neurosci Inst, Santiago 7, Chile; [Herrera-Molina, Rodrigo; Frischknecht, Renato; Seidenbecher, Constanze I.; Gundelfinger, Eckart D.] Leibniz Inst Neurobiol, Dept Neurochem & Mol Biol, Magdeburg, Germany; [Schneider, Pascal] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Leibniz Institut fur Neurobiologie (LIN); University of Lausanne	Herrera-Molina, R (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Biol Celular & Mol, Santiago 7, Chile.	lleyton@med.uchile.cl	Hetz, Claudio/I-1900-2013; Hetz, Claudio/ABD-7514-2021; Herrera-Molina, Rodrigo/GLU-3904-2022; , CIAE/R-5423-2017	Hetz, Claudio/0000-0001-7724-1767; Seidenbecher, Constanze/0000-0002-7433-2716; Schneider, Pascal/0000-0003-0677-9409; Maldonado, Horacio/0000-0002-7017-5215	FONDECYT [1070699, 1110490, 1090071, 1100176]; Fogarty International Center, National Institutes of Health [R03TW007810]; Iniciativas Cientificas Milenio: Biomedical Neuroscience Institute [P09-015-F]; Millennium Nucleus [P07-048-F, P04-068-F]; Fondecyt-FONDAP [15010006]; CONICYT; VAA-U Chile; DAAD-Germany; International Society for Neurochemistry; Swiss National Science Foundation; Deutsche Forschungsgemeinschaft [GU230/5-3]; FOGARTY INTERNATIONAL CENTER [R03TW007810] Funding Source: NIH RePORTER	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Iniciativas Cientificas Milenio: Biomedical Neuroscience Institute; Millennium Nucleus; Fondecyt-FONDAP(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); VAA-U Chile; DAAD-Germany(Deutscher Akademischer Austausch Dienst (DAAD)); International Society for Neurochemistry; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by FONDECYT 1070699, 1110490 (to LL), 1090071 (to AFGQ), 1100176 (to CH); Award Number R03TW007810 from the Fogarty International Center, National Institutes of Health (to LL); from Iniciativas Cientificas Milenio: Biomedical Neuroscience Institute P09-015-F (To LL and CH), Millennium Nucleus P07-048-F (to CH) and P04-068-F (to MA); Fondecyt-FONDAP 15010006 (to AQ, LL and CH); Ph.D. fellowships from CONICYT (to RH-M), awards from VAA-U Chile and DAAD-Germany (to RH-M); Travel award from the Journal of Cell Science and the International Society for Neurochemistry (to RH-M); Swiss National Science Foundation Grants (to PS); Deutsche Forschungsgemeinschaft (GU230/5-3) (to RF, CIS and EDG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avalos AM, 2004, J BIOL CHEM, V279, P39139, DOI 10.1074/jbc.M403439200; Avalos AM, 2002, BIOL RES, V35, P231, DOI 10.4067/S0716-97602002000200015; Barker TH, 2004, EXP CELL RES, V295, P488, DOI 10.1016/j.yexcr.2004.01.026; Barker TH, 2009, BBA-MOL CELL RES, V1793, P921, DOI 10.1016/j.bbamcr.2008.10.004; Barlow JZ, 2002, NEUROSCIENCE, V111, P837, DOI 10.1016/S0306-4522(02)00023-4; Baudouin SJ, 2008, MOL BIOL CELL, V19, P2444, DOI 10.1091/mbc.E07-09-0947; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Cao QL, 2005, J NEUROSCI, V25, P6947, DOI 10.1523/JNEUROSCI.1065-05.2005; Chen CH, 2005, J CELL BIOCHEM, V94, P684, DOI 10.1002/jcb.20341; Chen Y, 2006, J CELL BIOL, V175, P169, DOI 10.1083/jcb.200512116; Chen Y, 2009, J CELL SCI, V122, P3966, DOI 10.1242/jcs.049346; del Zoppo GJ, 2006, ARTERIOSCL THROM VAS, V26, P1966, DOI 10.1161/01.ATV.0000232525.65682.a2; DOHERTY P, 1993, J CELL BIOL, V122, P181, DOI 10.1083/jcb.122.1.181; DOTTI CG, 1991, NATURE, V349, P158, DOI 10.1038/349158a0; DREYER EB, 1995, P NATL ACAD SCI USA, V92, P11195, DOI 10.1073/pnas.92.24.11195; Ellison JA, 1998, STROKE, V29, P1698, DOI 10.1161/01.STR.29.8.1698; Ellison JA, 1999, ANN NY ACAD SCI, V890, P204, DOI 10.1111/j.1749-6632.1999.tb07996.x; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fouad K, 2005, J NEUROSCI, V25, P1169, DOI 10.1523/JNEUROSCI.3562-04.2005; Frischknecht R, 2009, NAT NEUROSCI, V12, P897, DOI 10.1038/nn.2338; GLADSON CL, 1991, J CLIN INVEST, V88, P1924, DOI 10.1172/JCI115516; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Henriquez M, 2011, J CELL SCI, V124, P1581, DOI 10.1242/jcs.073171; Hermosilla T, 2008, BBA-MOL CELL RES, V1783, P1111, DOI 10.1016/j.bbamcr.2008.01.034; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; HIRSCH E, 1994, DEV DYNAM, V201, P108, DOI 10.1002/aja.1002010203; ISHIHARA A, 1987, P NATL ACAD SCI USA, V84, P1290, DOI 10.1073/pnas.84.5.1290; Kusumi A, 2004, TRAFFIC, V5, P213, DOI 10.1111/j.1600-0854.2004.0178.x; Kusumi A, 2010, FEBS LETT, V584, P1814, DOI 10.1016/j.febslet.2010.02.047; Leyton L, 2001, CURR BIOL, V11, P1028, DOI 10.1016/S0960-9822(01)00262-7; Lisbona F, 2009, MOL CELL, V33, P679, DOI 10.1016/j.molcel.2009.02.017; MACDONALD HR, 1985, EUR J IMMUNOL, V15, P495, DOI 10.1002/eji.1830150514; MAHANTHAPPA NK, 1992, DEV BIOL, V150, P47, DOI 10.1016/0012-1606(92)90006-3; MAHANTHAPPA NK, 1992, DEV BIOL, V150, P60, DOI 10.1016/0012-1606(92)90007-4; Avalos AM, 2009, J CELL SCI, V122, P3462, DOI 10.1242/jcs.034827; Mayeux-Portas V, 2000, CURR BIOL, V10, P68, DOI 10.1016/S0960-9822(99)00278-X; Milner R, 2006, MOL CELL NEUROSCI, V33, P429, DOI 10.1016/j.mcn.2006.09.004; Minerbi A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000136; Mokin M, 2006, J NEUROPHYSIOL, V95, P215, DOI 10.1152/jn.00737.2005; MORRIS RJ, 1992, BIOCHEM SOC T, V20, P401, DOI 10.1042/bst0200401; Morris RJ, 1985, DEV NEUROSC, V7, P1133; NostenBertrand M, 1996, NATURE, V379, P826, DOI 10.1038/379826a0; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; Qi YP, 1997, J NEUROSCI, V17, P1217; Rege TA, 2006, BBA-MOL CELL RES, V1763, P991, DOI 10.1016/j.bbamcr.2006.08.008; Rege TA, 2006, FASEB J, V20, P1045, DOI 10.1096/fj.05-5460rev; Shimamura N, 2006, J NEUROSCI RES, V84, P1837, DOI 10.1002/jnr.21073; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; TIVERON MC, 1992, NATURE, V355, P745, DOI 10.1038/355745a0; XUE GP, 1991, DEVELOPMENT, V112, P161; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	51	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34295	10.1371/journal.pone.0034295	http://dx.doi.org/10.1371/journal.pone.0034295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479590	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100145
J	Hu, XS; Simila, J; Platz, SS; Moore, SS; Plastow, G; Meghen, CN				Hu, Xin-Sheng; Simila, Janika; Platz, Sindey Schueler; Moore, Stephen S.; Plastow, Graham; Meghen, Ciaran N.			Estimating Animal Abundance in Ground Beef Batches Assayed with Molecular Markers	PLOS ONE			English	Article							NONPARAMETRIC-ESTIMATION; SPECIES-ABUNDANCE; CLOSED POPULATION; RECAPTURE MODELS; NUMBER; SIZE; RICHNESS; SAMPLE; IDENTIFICATION; INDIVIDUALS	Estimating animal abundance in industrial scale batches of ground meat is important for mapping meat products through the manufacturing process and for effectively tracing the finished product during a food safety recall. The processing of ground beef involves a potentially large number of animals from diverse sources in a single product batch, which produces a high heterogeneity in capture probability. In order to estimate animal abundance through DNA profiling of ground beef constituents, two parameter-based statistical models were developed for incidence data. Simulations were applied to evaluate the maximum likelihood estimate (MLE) of a joint likelihood function from multiple surveys, showing superiority in the presence of high capture heterogeneity with small sample sizes, or comparable estimation in the presence of low capture heterogeneity with a large sample size when compared to other existing models. Our model employs the full information on the pattern of the capture-recapture frequencies from multiple samples. We applied the proposed models to estimate animal abundance in six manufacturing beef batches, genotyped using 30 single nucleotide polymorphism (SNP) markers, from a large scale beef grinding facility. Results show that between 411 similar to 1367 animals were present in six manufacturing beef batches. These estimates are informative as a reference for improving recall processes and tracing finished meat products back to source.	[Hu, Xin-Sheng; Moore, Stephen S.; Plastow, Graham] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Simila, Janika; Platz, Sindey Schueler; Meghen, Ciaran N.] IdentiGEN N Amer, Lawrence, KS USA; [Moore, Stephen S.] Univ Queensland, Queensland Alliance Agr & Food Innovat, Ctr Anim Sci, St Lucia, Qld, Australia	University of Alberta; University of Queensland	Hu, XS (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	xin-sheng.hu@ualberta.ca	Moore, Stephen S/F-5285-2013	Plastow, Graham/0000-0002-3774-3110; Moore, Stephen/0000-0002-9758-166X	Genome Alberta; Alberta Livestock and Meat Agency Ltd.	Genome Alberta; Alberta Livestock and Meat Agency Ltd.	This project is funded by the Genome Alberta and Alberta Livestock and Meat Agency (ALMA) Applied Livestock Genomics Program(http://www.genomealberta.ca/livestock/genetic-identification-techniques-to-improve-food-safety-recall-of-ground-meat-products.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Simila, Dr. Platz and Dr. Meghen are employed by IdentiGEN North America Inc. This study was funded by the Alberta Livestock and Meat Agency Ltd. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abramowitz M., 1972, HDB MATH FUNCTIONS, P258; [Anonymous], 1982, ESTIMATION ANIMAL AB; BULMER MG, 1974, BIOMETRICS, V30, P101, DOI 10.2307/2529621; Bunge J, 2008, BIOMETRICAL J, V50, P971, DOI 10.1002/bimj.200810452; BURNHAM KP, 1978, BIOMETRIKA, V65, P625, DOI 10.2307/2335915; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Chao A, 2000, STAT SINICA, V10, P227; Chao A, 2001, J AGR BIOL ENVIR ST, V6, P158, DOI 10.1198/108571101750524670; Chao A, 2003, USERS GUIDE PROGRAM; Chao A., 2005, ENCY STAT SCI, V12, P7907, DOI DOI 10.1890/13-0133.1; Cunningham EP, 2001, REV SCI TECH OIE, V20, P491, DOI 10.20506/rst.20.2.1284; Davis C. G, 2005, FACTORS AFFECTING US; Dorazio RM, 2003, BIOMETRICS, V59, P351, DOI 10.1111/1541-0420.00042; EDWARDS WR, 1967, J WILDLIFE MANAGE, V31, P87, DOI 10.2307/3798362; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; He FL, 2005, ECOL LETT, V8, P386, DOI 10.1111/j.1461-0248.2005.00729.x; Heaton MP, 2002, MAMM GENOME, V13, P272, DOI 10.1007/s00335-001-2146-3; HELTSHE JF, 1983, BIOMETRICS, V39, P1, DOI 10.2307/2530802; Hu XS, 2007, AM NAT, V170, P844, DOI 10.1086/522935; Hubbell Stephen P., 2001, V32, pi; Jolly G.M., 1981, Studies in Avian Biology, P137; JOLLY GM, 1982, BIOMETRICS, V38, P301, DOI 10.2307/2530445; KIMURA M, 1964, GENETICS, V49, P725; Kimura M., 1983, NEUTRAL THEORY MOL E; Leigh EG, 1999, TROPICAL FOREST ECOL; Loftus RT, 2011, MICROBIAL FORENSICS, 2ND EDITION, P59, DOI 10.1016/B978-0-12-382006-8.00005-0; Lukacs P.M., 2007, Wildlife Biology in Practice, V3, P83; Meghen C. N., 1998, Animal Genetics, V29, P48; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Mousavi A., 2002, British Food Journal, V104, P7, DOI 10.1108/00070700210418703; ORD JK, 1986, COMMUN STAT THEORY, V15, P853, DOI 10.1080/03610928608829156; OTIS DL, 1978, WILDLIFE MONOGR, P1; PRESS WH, 1991, NUMERICAL RECIPES C; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; SANATHANAN L, 1977, J AM STAT ASSOC, V72, P669, DOI 10.2307/2286238; Sanathanan L, 1972, ANN MATH STAT, V42, P58; Schumacher F. X., 1943, JOUR TENNESSEE ACAD SCI, V18, P228; Seber G. A. F., 1985, LECTURE NOTES STATIS, P363; SEBER GAF, 1986, BIOMETRICS, V42, P267, DOI 10.2307/2531049; Shackell GH, 2008, MEAT BIOTECHNOL, P61; Shen TJ, 2008, ECOLOGY, V89, P2052, DOI 10.1890/07-1526.1; SICHEL HS, 1986, COMMUN STAT THEORY, V15, P935, DOI 10.1080/03610928608829161; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Stollenwerk N., 2011, POPULATION BIOL CRIT, DOI DOI 10.1142/P645; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wilberg MJ, 2004, MOL ECOL NOTES, V4, P783, DOI 10.1111/j.1471-8286.2004.00797.x; Wright S, 1938, P NATL ACAD SCI USA, V24, P253, DOI 10.1073/pnas.24.7.253; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Xu CJ, 2006, IEEE T SIGNAL PROCES, V54, P3759, DOI 10.1109/TSP.2006.880211	53	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34191	10.1371/journal.pone.0034191	http://dx.doi.org/10.1371/journal.pone.0034191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479559	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100135
J	Kolbus, D; Ljungcrantz, I; Soderberg, I; Alm, R; Bjorkbacka, H; Nilsson, J; Fredrikson, GN				Kolbus, Daniel; Ljungcrantz, Irena; Soderberg, Ingrid; Alm, Ragnar; Bjorkbacka, Harry; Nilsson, Jan; Fredrikson, Gunilla Nordin			TAP1-Deficiency Does Not Alter Atherosclerosis Development in Apoe(-/-) Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; REGULATORY T-CELLS; E-KNOCKOUT MICE; MUTANT MICE; LYMPHOCYTES; DEFICIENT; MOUSE; SPECIFICITY; ACTIVATION; INDUCTION	Antigen presenting cells (APC) have the ability to present both extra-cellular and intra-cellular antigens via MHC class I molecules to CD8(+) T cells. The cross presentation of extra-cellular antigens is reduced in mice with deficient Antigen Peptide Transporter 1 (TAP1)-dependent MHC class I antigen presentation, and these mice are characterized by a diminished CD8(+) T cell population. We have recently reported an increased activation of CD8(+) T cells in hypercholesterolemic Apoe(-/-) mice. Therefore, this study included TAP1-deficient Apoe(-/-) mice (Apoe(-/-) Tap1(-/-)) to test the atherogenicity of CD8(+) T cells and TAP1-dependent cross presentation in a hypercholesterolemic environment. As expected the CD8(+) T cell numbers were low in Apoe(-/-) Tap1(-/-) mice in comparison to Apoe(-/-) mice, constituting similar to 1% of the lymphocyte population. In spite of this there were no differences in the extent of atherosclerosis as assessed by en face Oil Red O staining of the aorta and cross-sections of the aortic root between Apoe(-/-) Tap1(-/-) and Apoe(-/-) mice. Moreover, no differences were detected in lesion infiltration of macrophages or CD3(+) T cells in Apoe(-/-) Tap1(-/-) compared to Apoe(-/-) mice. The CD3(+) CD4(+) T cell fraction was increased in Apoe(-/-) Tap1(-/-) mice, suggesting a compensation for the decreased CD8(+) T cell population. Interestingly, the fraction of CD8(+) effector memory T cells was increased but this appeared to have little impact on the atherosclerosis development. In conclusion, Apoe(-/-) Tap1(-/-) mice develop atherosclerosis equal to Apoe(-/-) mice, indicating a minor role for CD8(+) T cells and TAP1-dependent antigen presentation in the disease process.	[Kolbus, Daniel; Ljungcrantz, Irena; Soderberg, Ingrid; Alm, Ragnar; Bjorkbacka, Harry; Nilsson, Jan; Fredrikson, Gunilla Nordin] Lund Univ, Dept Clin Sci, Skane Univ Hosp Malmo, Malmo, Sweden; [Fredrikson, Gunilla Nordin] Malmo Univ, Fac Hlth & Soc, Malmo, Sweden	Lund University; Skane University Hospital; Malmo University	Kolbus, D (corresponding author), Lund Univ, Dept Clin Sci, Skane Univ Hosp Malmo, Malmo, Sweden.	Gunilla.Nordin_Fredrikson@med.lu.se	Björkbacka, Harry/I-7157-2019	Björkbacka, Harry/0000-0003-3918-0857	Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Foundation for Strategic Research; VINNOVA; Crafoord Foundation; Knut and Alice Wallenberg Foundation; Soderberg Foundation; Albert Pahlsson Foundation; Malmo University Hospital Foundation; Lundstrom Foundation; European Community's Sixth Framework Programme contract ("IMMUNATH") [LSHM-CT-2006-037400]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); VINNOVA(Vinnova); Crafoord Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Soderberg Foundation; Albert Pahlsson Foundation; Malmo University Hospital Foundation; Lundstrom Foundation; European Community's Sixth Framework Programme contract ("IMMUNATH")	This study was supported by grants from the Swedish Research Council, the Swedish Heart-Lung Foundation, Swedish Foundation for Strategic Research, VINNOVA, the Crafoord Foundation, the Knut and Alice Wallenberg Foundation, the Soderberg Foundation, the Albert Pahlsson Foundation, the Malmo University Hospital Foundation, the Lundstrom Foundation and the European Community's Sixth Framework Programme contract ("IMMUNATH") LSHM-CT-2006-037400. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; ALDRICH CJ, 1994, P NATL ACAD SCI USA, V91, P6525, DOI 10.1073/pnas.91.14.6525; Branen L, 2001, HISTOCHEM J, V33, P227, DOI 10.1023/A:1017902509083; Dansky HM, 1997, P NATL ACAD SCI USA, V94, P4642, DOI 10.1073/pnas.94.9.4642; DELASALLE H, 1994, SCIENCE, V265, P237, DOI 10.1126/science.7517574; Elhage R, 2004, AM J PATHOL, V165, P2013, DOI 10.1016/S0002-9440(10)63252-X; Epstein SE, 1999, AM HEART J, V138, pS476, DOI 10.1016/S0002-8703(99)70279-6; FROSTEGARD J, 1992, ARTERIOSCLER THROMB, V12, P461, DOI 10.1161/01.ATV.12.4.461; Gewaltig J, 2008, HUM PATHOL, V39, P1756, DOI 10.1016/j.humpath.2008.04.018; JONES M, 1993, J IMMUNOL, V150, P5429; Kolbus D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-58; Ljunggren HG, 1996, IMMUNOL REV, V151, P123, DOI 10.1111/j.1600-065X.1996.tb00706.x; Ludewig B, 2000, P NATL ACAD SCI USA, V97, P12752, DOI 10.1073/pnas.220427097; Mallat Z, 2003, CIRCULATION, V108, P1232, DOI 10.1161/01.CIR.0000089083.61317.A1; Medina F, 2009, J IMMUNOL, V183, P4639, DOI 10.4049/jimmunol.0901356; Nilsson J, 2008, J INTERN MED, V263, P464, DOI 10.1111/j.1365-2796.2008.01945.x; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Sandberg JK, 1996, EUR J IMMUNOL, V26, P288, DOI 10.1002/eji.1830260203; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Suzuki H, 2008, HUM IMMUNOL, V69, P751, DOI 10.1016/j.humimm.2008.08.285; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Xiang J, 2005, J IMMUNOL, V174, P7497, DOI 10.4049/jimmunol.174.12.7497; Zhou XH, 2000, CIRCULATION, V102, P2919; Zhou XH, 2005, CIRC RES, V96, P427, DOI 10.1161/01.RES.0000156889.22364.f1	25	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33932	10.1371/journal.pone.0033932	http://dx.doi.org/10.1371/journal.pone.0033932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479479	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100084
J	Sun, CY; Chang, SC; Wu, MS				Sun, Chiao-Yin; Chang, Shih-Chung; Wu, Mai-Szu			Uremic Toxins Induce Kidney Fibrosis by Activating Intrarenal Renin-Angiotensin-Aldosterone System Associated Epithelial-to-Mesenchymal Transition	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; P-CRESYLSULPHATE; SULFATE; PROGRESSION; EXPRESSION; MOTILITY	Background: Uremic toxins are considered to have a determinant pathological role in the progression of chronic kidney disease. The aim of this study was to define the putative pathological roles of the renal renin-angiotensin-aldosterone system (RAAS) and renal tubular epithelial-to-mesenchymal transition (EMT) in kidney fibrosis induced by (indoxyl sulfate) IS and (p-cresol sulfate) PCS. Methods: Mouse proximal renal tubular cells (PKSV-PRs) treated with IS or PCS were used. Half-nephrectomized B-6 mice were treated with IS or PCS for 4 weeks. In the losartan treatment study, the study animal was administrated with IS+losartan or PCS+losartan for 4 weeks. Results: IS and PCS significantly activated the intrarenal RAAS by increasing renin, angiotensinogen, and angiotensin 1 (AT1) receptor expression, and decreasing AT2 receptor expression in vitro and in vivo. IS and PCS significantly increased transforming growth factor-beta 1 (TGF-beta 1) expression and activated the TGF-beta pathway by increasing Smad2/Smad2-P, Smad3/Smad3-P, and Smad4 expression. The expression of the EMT-associated transcription factor Snail was increased by IS and PCS treatment. IS and PCS induced the phenotype of EMT-like transition in renal tubules by increasing the expression of fibronectin and alpha-smooth muscle actin and decreasing the expression of E-cadherin. Losartan significantly attenuated the expression of TGF-beta 1 and Snail, and decreased kidney fibrosis induced by IS and PCS in vivo. Conclusion: Activating the renal RAAS/TGF-beta pathway has an important pathological role in chronic kidney injury caused by IS and PCS. IS and PCS may increase Snail expression and induce EMT-like transition.	[Sun, Chiao-Yin; Wu, Mai-Szu] Chang Gung Univ, Sch Med, Tao Yuan, Taiwan; [Sun, Chiao-Yin; Wu, Mai-Szu] Chang Gung Mem Hosp, Div Nephrol, Keelung, Taiwan; [Chang, Shih-Chung] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; National Taiwan University	Sun, CY (corresponding author), Chang Gung Univ, Sch Med, Tao Yuan, Taiwan.	maxwu1@adm.cgmh.org.tw	Hsiao, Wei-Hung/B-9931-2013	CHANG, SHIH-CHUNG/0000-0002-5015-8178	Chang Gung Memorial Hospital [CMRPG290021]; National Science Council [NMRPD190361]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council(Ministry of Science and Technology, Taiwan)	This study was supported by research grant from Chang Gung Memorial Hospital (CMRPG290021) and National Science Council (NMRPD190361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adijiang A, 2011, J RENAL NUTR, V21, P105, DOI 10.1053/j.jrn.2010.10.020; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Burns WC, 2011, CELLS TISSUES ORGANS, V193, P74, DOI 10.1159/000320359; Burns WC, 2010, AM J PHYSIOL-RENAL, V299, pF585, DOI 10.1152/ajprenal.00538.2009; Campbell RC, 2002, J AM SOC NEPHROL, V13, pS190, DOI 10.1097/01.ASN.0000032522.29672.0A; Dhasarathy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026514; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Ise M., 1997, KIDNEY INT S, V62, P15; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Kang YS, 2010, KIDNEY INT, V78, P363, DOI 10.1038/ki.2010.137; Langham RG, 2006, DIABETES CARE, V29, P2670, DOI 10.2337/dc06-0911; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P1183, DOI 10.1093/ndt/gfp592; Lin HL, 2011, AM J PHYSIOL-RENAL, V300, pF1017, DOI 10.1152/ajprenal.00426.2010; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Meijers BKI, 2009, CLIN J AM SOC NEPHRO, V4, P1932, DOI 10.2215/CJN.02940509; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Miyazaki T, 1997, KIDNEY INT S, V63, P211; Muller DN, 2008, HYPERTENSION, V51, P676, DOI 10.1161/HYPERTENSIONAHA.107.101493; Natsuizaka M, 2010, CARCINOGENESIS, V31, P1344, DOI 10.1093/carcin/bgq108; Ouar Z, 1998, KIDNEY INT, V53, P59, DOI 10.1046/j.1523-1755.1998.00721.x; Palm F, 2010, AM J PHYSIOL-RENAL, V299, pF380, DOI 10.1152/ajprenal.00175.2010; Peng HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014750; Raff AC, 2008, CURR OPIN NEPHROL HY, V17, P560, DOI 10.1097/MNH.0b013e32830f45b6; Remuzzi G, 2005, KIDNEY INT, V68, P57; Rodrigues-Diez R, 2008, PHARM RES-DORDR, V25, P2447, DOI 10.1007/s11095-008-9636-x; Roelen BAJ, 2003, AM J PHYSIOL-CELL PH, V285, pC823, DOI 10.1152/ajpcell.00053.2003; Ruster C, 2006, J AM SOC NEPHROL, V17, P2985, DOI 10.1681/ASN.2006040356; Schepers E, 2007, NEPHROL DIAL TRANSPL, V22, P592, DOI 10.1093/ndt/gfl584; Shimamura M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001170; Thiery JP, 2010, B CANCER, V97, P1285, DOI 10.1684/bdc.2010.1206; Tumur Z, 2010, AM J NEPHROL, V31, P435, DOI 10.1159/000299798; Vanholder R, 2001, KIDNEY INT, V59, pS266, DOI 10.1046/j.1523-1755.2001.59780266.x; Wang WS, 2005, NEPHROLOGY, V10, P48, DOI 10.1111/j.1440-1797.2005.00334.x; Wells A, 2011, FRONT BIOSCI-LANDMRK, V16, P815, DOI 10.2741/3722; Wolf G, 2008, FRONT BIOSCI-LANDMRK, V13, P4993, DOI 10.2741/3058; Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580; Wu WP, 2010, AM J PHYSIOL-RENAL, V299, pF929, DOI 10.1152/ajprenal.00192.2010; Xu ZH, 2010, BIOCHEM BIOPH RES CO, V401, P376, DOI 10.1016/j.bbrc.2010.09.059; Yang FY, 2010, J PATHOL, V221, P390, DOI 10.1002/path.2721; Yeh YC, 2010, AM J PATHOL, V177, P1743, DOI 10.2353/ajpath.2010.091183; Yu M, 2011, CLIN J AM SOC NEPHRO, V6, P30, DOI 10.2215/CJN.05340610	42	165	180	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34026	10.1371/journal.pone.0034026	http://dx.doi.org/10.1371/journal.pone.0034026			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479508	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100099
J	Jiang, JH; Thyagarajan-Sahu, A; Krchnak, V; Jedinak, A; Sandusky, GE; Sliva, D				Jiang, Jiahua; Thyagarajan-Sahu, Anita; Krchnak, Viktor; Jedinak, Andrej; Sandusky, George E.; Sliva, Daniel			NAHA, a Novel Hydroxamic Acid-Derivative, Inhibits Growth and Angiogenesis of Breast Cancer In Vitro and In Vivo	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; INVASIVE BEHAVIOR; SUPPRESSES GROWTH; DOWN-REGULATION; CELLS; EXPRESSION; UPA; METASTASIS; SECRETION; COMPLEX	Background: We have recently synthesized novel N-alkylated amino acid-derived hydroxamate, 2-[Benzyl-(2-nitrobenzenesulfonyl)- amino]-N-hydroxy-3-methyl-N-propyl-butyramide (NAHA). Here, we evaluate the anticancer activity of NAHA against highly invasive human breast cancer cells MDA-MB-231 in vitro and in vivo. Methodology/Principal Findings: Cell growth was evaluated by MTT and soft agar assays. Protein expression was determined by DNA microarray and Western blot analysis. Metastatic potential was evaluated by cell adhesion, migration, invasion, capillary morphogenesis, and ELISA assays. The anticancer activity in vivo was evaluated in mouse xenograft model. NAHA inhibited proliferation and colony formation of MDA-MB-231 cells together with the down-regulation of expression of Cdk2 and CDC20 proteins. NAHA inhibited cell adhesion, migration, and invasion through the suppression of secretion of uPA. NAHA suppressed secretion of VEGF from MDA-MB-231 cells and inhibited capillary morphogenesis of human aortic endothelial cells (HAECs). Finally, NAHA at 50 mg/kg was not toxic and decreased tumor volume and tumor weight in vivo. This suppression of tumor growth was associated with the inhibition of mitotic figures and induction of apoptosis, and the reduction of CD31 and VEGF positive cells in tumors. Conclusion: NAHA could be a novel promising compound for the development of new drugs for the therapy of invasive breast cancers.	[Jiang, Jiahua; Thyagarajan-Sahu, Anita; Jedinak, Andrej; Sliva, Daniel] Indiana Univ Hlth, Methodist Res Inst, Canc Res Lab, Indianapolis, IN USA; [Krchnak, Viktor] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Sandusky, George E.] Indiana Univ, Sch Med, Dept Pathol, Indianapolis, IN 46202 USA; [Sliva, Daniel] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA; [Sliva, Daniel] Indiana Univ, Sch Med, IU Simon Canc Ctr, Indianapolis, IN USA	Indiana University System; University of Notre Dame; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Jiang, JH (corresponding author), Indiana Univ Hlth, Methodist Res Inst, Canc Res Lab, Indianapolis, IN USA.	dsliva@iuhealth.org	Jedinak, Andrej/AAB-7354-2020; Krchnak, Viktor/AAG-2841-2020	Krchnak, Viktor/0000-0001-5688-4069	Methodist Health Foundation; Department of Chemistry and Biochemistry, University of Notre Dame	Methodist Health Foundation; Department of Chemistry and Biochemistry, University of Notre Dame	This work was supported by the Methodist Health Foundation and by the Department of Chemistry and Biochemistry, University of Notre Dame. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almstead NG, 1999, J MED CHEM, V42, P4547, DOI 10.1021/jm990330y; Amir S, 2005, CANCER BIOL THER, V4, P400; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Barta TE, 2001, BIOORG MED CHEM LETT, V11, P2481, DOI 10.1016/S0960-894X(01)00487-5; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Fukumoto S, 2005, CLIN EXP METASTAS, V22, P31, DOI 10.1007/s10585-005-3973-5; Jang YJ, 2007, J BIOCHEM MOL BIOL, V40, P439; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang JH, 2004, NUTR CANCER, V49, P209, DOI 10.1207/s15327914nc4902_13; Jiang JH, 2011, BIOCHEM BIOPH RES CO, V415, P325, DOI 10.1016/j.bbrc.2011.10.055; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Kong DJ, 2007, CANCER RES, V67, P3310, DOI 10.1158/0008-5472.CAN-06-4277; Levin JI, 2004, CURR TOP MED CHEM, V4, P1289, DOI 10.2174/1568026043387935; LLoyd FP, 2003, INT J ONCOL, V23, P1277; MacPherson LJ, 1997, J MED CHEM, V40, P2525, DOI 10.1021/jm960871c; Pakneshan P, 2005, CARCINOGENESIS, V26, P557, DOI 10.1093/carcin/bgi009; Parvathy S, 1998, BIOCHEM SOC T, V26, pS242, DOI 10.1042/bst026s242; Pasqualini JR, 2004, BBA-REV CANCER, V1654, P123, DOI 10.1016/j.bbcan.2004.03.001; Peterson JT, 2006, CARDIOVASC RES, V69, P677, DOI 10.1016/j.cardiores.2005.11.032; Price John T, 2002, Expert Opin Ther Targets, V6, P217; Price JT, 1997, CRIT REV BIOCHEM MOL, V32, P175, DOI 10.3109/10409239709082573; Santos MA, 2003, J ENZYM INHIB MED CH, V18, P233, DOI 10.1080/1475636031000081134; Sliva D, 2008, BRIT J CANCER, V98, P1348, DOI 10.1038/sj.bjc.6604319; Sliva D, 2002, BIOCHEM BIOPH RES CO, V298, P603, DOI 10.1016/S0006-291X(02)02496-8; Slivova V, 2005, NUTR CANCER, V52, P66, DOI 10.1207/s15327914nc5201_9; Slivova V, 2004, J CANC INTEGR MED, V2, P25; Stanger KJ, 2006, COMB CHEM HIGH T SCR, V9, P651, DOI 10.2174/138620706778700161; Stanley G, 2005, BIOCHEM BIOPH RES CO, V330, P46, DOI 10.1016/j.bbrc.2005.02.116; Wang LH, 2004, MT SINAI J MED, V71, P361; Wasch R, 2005, ONCOGENE, V24, P1, DOI 10.1038/sj.onc.1208017; Wong NC, 1998, CLIN EXP METASTAS, V16, P50; Yu AE, 1997, DRUG AGING, V11, P229, DOI 10.2165/00002512-199711030-00006; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903	36	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34283	10.1371/journal.pone.0034283	http://dx.doi.org/10.1371/journal.pone.0034283			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479587	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400067
J	Poehlein, A; Schmidt, S; Kaster, AK; Goenrich, M; Vollmers, J; Thurmer, A; Bertsch, J; Schuchmann, K; Voigt, B; Hecker, M; Daniel, R; Thauer, RK; Gottschalk, G; Muller, V				Poehlein, Anja; Schmidt, Silke; Kaster, Anne-Kristin; Goenrich, Meike; Vollmers, John; Thuermer, Andrea; Bertsch, Johannes; Schuchmann, Kai; Voigt, Birgit; Hecker, Michael; Daniel, Rolf; Thauer, Rudolf K.; Gottschalk, Gerhard; Mueller, Volker			An Ancient Pathway Combining Carbon Dioxide Fixation with the Generation and Utilization of a Sodium Ion Gradient for ATP Synthesis	PLOS ONE			English	Article							ENERGY-CONSERVATION; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; THERMOTOGA-MARITIMA; IRON-HYDROGENASE; FERREDOXIN; COMPLEX; NADH; ACETOGEN; BACTERIA; DEHYDROGENASE	Synthesis of acetate from carbon dioxide and molecular hydrogen is considered to be the first carbon assimilation pathway on earth. It combines carbon dioxide fixation into acetyl-CoA with the production of ATP via an energized cell membrane. How the pathway is coupled with the net synthesis of ATP has been an enigma. The anaerobic, acetogenic bacterium Acetobacterium woodii uses an ancient version of this pathway without cytochromes and quinones. It generates a sodium ion potential across the cell membrane by the sodium-motive ferredoxin:NAD oxidoreductase (Rnf). The genome sequence of A. woodii solves the enigma: it uncovers Rnf as the only ion-motive enzyme coupled to the pathway and unravels a metabolism designed to produce reduced ferredoxin and overcome energetic barriers by virtue of electron-bifurcating, soluble enzymes.	[Poehlein, Anja; Vollmers, John; Thuermer, Andrea; Daniel, Rolf; Gottschalk, Gerhard] Univ Gottingen, Inst Microbiol & Genet, Gottingen Genom Lab, Gottingen, Germany; [Schmidt, Silke; Bertsch, Johannes; Schuchmann, Kai; Mueller, Volker] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany; [Kaster, Anne-Kristin; Goenrich, Meike; Thauer, Rudolf K.] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Voigt, Birgit; Hecker, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, Greifswald, Germany	University of Gottingen; Goethe University Frankfurt; Max Planck Society; Ernst Moritz Arndt Universitat Greifswald	Poehlein, A (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Gottingen Genom Lab, Gottingen, Germany.	vmueller@bio.uni-frankfurt.de	Kaster, Anne-Kristin/W-7752-2019; Vollmers, John/H-1075-2019; Daniel, Rolf/AAQ-5933-2021; Mueller, Volker/ABE-4305-2021	Vollmers, John/0000-0001-5980-5178; Daniel, Rolf/0000-0002-8646-7925; Mueller, Volker/0000-0001-7955-5508; Poehlein, Anja/0000-0002-2473-6202	Deutsche Forschungsgemeinschaft; Niedersachsisches Ministerium fur Wissenschaft und Kultur; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Niedersachsisches Ministerium fur Wissenschaft und Kultur; Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to V.M.), from the Niedersachsisches Ministerium fur Wissenschaft und Kultur (to R.D. and G.G.) and by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Biegel E, 2010, P NATL ACAD SCI USA, V107, P18138, DOI 10.1073/pnas.1010318107; Biegel E, 2009, ENVIRON MICROBIOL, V11, P1438, DOI 10.1111/j.1462-2920.2009.01871.x; Buttner K, 2001, ELECTROPHORESIS, V22, P2908, DOI 10.1002/1522-2683(200108)22:14<2908::AID-ELPS2908>3.0.CO;2-M; CLARK JE, 1984, J BIOL CHEM, V259, P845; CORDRUWISCH R, 1988, ARCH MICROBIOL, V149, P350, DOI 10.1007/BF00411655; DANGEL W, 1987, ARCH MICROBIOL, V148, P52, DOI 10.1007/BF00429647; Fritz M, 2007, FEBS J, V274, P3421, DOI 10.1111/j.1742-4658.2007.05874.x; FUCHS G, 1986, FEMS MICROBIOL LETT, V39, P181, DOI 10.1111/j.1574-6968.1986.tb01859.x; Gottschalk G, 2001, BBA-BIOENERGETICS, V1505, P28, DOI 10.1016/S0005-2728(00)00274-7; Graentzdoerffer A, 2003, ARCH MICROBIOL, V179, P116, DOI 10.1007/s00203-002-0508-1; Hedderich R, 2005, J MOL MICROB BIOTECH, V10, P92, DOI 10.1159/000091557; HEISE R, 1989, J BACTERIOL, V171, P5473, DOI 10.1128/jb.171.10.5473-5478.1989; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Hess V, 2011, J BACTERIOL, V193, P971, DOI 10.1128/JB.01126-10; HUGENHOLTZ J, 1990, FEMS MICROBIOL LETT, V87, P383; HUGENHOLTZ J, 1987, J BACTERIOL, V169, P5845, DOI 10.1128/jb.169.12.5845-5847.1987; Imkamp F, 2007, J BACTERIOL, V189, P8145, DOI 10.1128/JB.01017-07; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; LJUNGDAHL LG, 1986, ANNU REV MICROBIOL, V40, P415, DOI 10.1146/annurev.mi.40.100186.002215; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Martin W, 2011, FEBS LETT IN PRESS; Martin W, 2007, PHILOS T R SOC B, V362, P1887, DOI 10.1098/rstb.2006.1881; Matson EG, 2010, ENVIRON MICROBIOL, V12, P2245, DOI 10.1111/j.1462-2920.2010.02188.x; Mulkidjanian AY, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-13; Mulkidjanian AY, 2008, BBA-BIOENERGETICS, V1777, P985, DOI 10.1016/j.bbabio.2008.04.028; Muller V, 2003, APPL ENVIRON MICROB, V69, P6345, DOI 10.1128/AEM.69.11.6345-6353.2003; Pedersen A, 2008, J BIOENERG BIOMEMBR, V40, P463, DOI 10.1007/s10863-008-9170-x; Pierce E, 2008, ENVIRON MICROBIOL, V10, P2550, DOI 10.1111/j.1462-2920.2008.01679.x; Ragsdale SW, 2008, ANN NY ACAD SCI, V1125, P129, DOI 10.1196/annals.1419.015; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; SCHULER S, 1990, FEMS MICROBIOL ECOL, V73, P77, DOI 10.1111/j.1574-6968.1990.tb03927.x; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Takami H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030559; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; vandeVossenberg JLCM, 1995, MOL MICROBIOL, V18, P925, DOI 10.1111/j.1365-2958.1995.18050925.x; Verhagen MFJM, 1999, BBA-BIOENERGETICS, V1412, P212, DOI 10.1016/S0005-2728(99)00062-6; Voigt B, 2006, PROTEOMICS, P6; Wang SN, 2010, J BACTERIOL, V192, P5115, DOI 10.1128/JB.00612-10; WOHLFARTH G, 1991, ARCH MICROBIOL, V155, P378; WOHLFARTH G, 1990, EUR J BIOCHEM, V192, P411, DOI 10.1111/j.1432-1033.1990.tb19242.x; WOOD HG, 1986, FEMS MICROBIOL LETT, V39, P345, DOI 10.1016/0378-1097(86)90022-4	44	178	187	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33439	10.1371/journal.pone.0033439	http://dx.doi.org/10.1371/journal.pone.0033439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479398	gold, Green Submitted, Green Published			2022-12-27	WOS:000304523400022
J	Tani, A; Takai, Y; Suzukawa, I; Akita, M; Murase, H; Kimbara, K				Tani, Akio; Takai, Yuichiro; Suzukawa, Ikko; Akita, Motomu; Murase, Haruhiko; Kimbara, Kazuhide			Practical Application of Methanol-Mediated Mutualistic Symbiosis between Methylobacterium Species and a Roof Greening Moss, Racomitrium	PLOS ONE			English	Article							GROWTH PROMOTION; PYRROLOQUINOLINE QUINONE; ACC DEAMINASE; BACTERIA; EMISSION; PHYTOSYMBIONTS; PHYLLOSPHERE; PURIFICATION; EXTORQUENS; PHOSPHATE	Bryophytes, or mosses, are considered the most maintenance-free materials for roof greening. Racomitrium species are most often used due to their high tolerance to desiccation. Because they grow slowly, a technology for forcing their growth is desired. We succeeded in the efficient production of R. japonicum in liquid culture. The structure of the microbial community is crucial to stabilize the culture. A culture-independent technique revealed that the cultures contain methylotrophic bacteria. Using yeast cells that fluoresce in the presence of methanol, methanol emission from the moss was confirmed, suggesting that it is an important carbon and energy source for the bacteria. We isolated Methylobacterium species from the liquid culture and studied their characteristics. The isolates were able to strongly promote the growth of some mosses including R. japonicum and seed plants, but the plant-microbe combination was important, since growth promotion was not uniform across species. One of the isolates, strain 22A, was cultivated with R. japonicum in liquid culture and in a field experiment, resulting in strong growth promotion. Mutualistic symbiosis can thus be utilized for industrial moss production.	[Tani, Akio; Kimbara, Kazuhide] Okayama Univ, Inst Plant Sci & Resources, Okayama 7008530, Japan; [Takai, Yuichiro] Osaka Prefectural Govt, Res Inst Environm Agr & Fisheries, Osaka, Japan; [Suzukawa, Ikko] Meiho Construct Inc, Shiga, Japan; [Akita, Motomu] Kinki Univ, Fac Biol Engn, Wakayama, Japan; [Murase, Haruhiko] Osaka Prefecture Univ, Grad Sch Agr & Biol Sci, Osaka, Japan; [Kimbara, Kazuhide] Shizuoka Univ, Fac Engn, Shizuoka, Japan	Okayama University; Kindai University (Kinki University); Osaka Metropolitan University; Shizuoka University	Tani, A (corresponding author), Okayama Univ, Inst Plant Sci & Resources, Okayama 7008530, Japan.	atani@rib.okayama-u.ac.jp	TANI, Akio/B-2516-2011	Tani, Akio/0000-0001-7685-9063	Kansai Bureau of Economy, Trade and Industry [18S5021]; Bio-Oriented Technology Research Advancement Institution	Kansai Bureau of Economy, Trade and Industry; Bio-Oriented Technology Research Advancement Institution	This work is supported by the Regional New Consortium Projects of the Kansai Bureau of Economy, Trade and Industry (grant number 18S5021) (http://www.kansai.meti.go.jp/) and by the Bio-Oriented Technology Research Advancement Institution (2008) (http:// brain. naro.affrc.go.jp/tokyo/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanda-Nkpwatt D, 2006, J EXP BOT, V57, P4025, DOI 10.1093/jxb/erl173; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Ali B, 2009, LETT APPL MICROBIOL, V48, P542, DOI 10.1111/j.1472-765X.2009.02565.x; Anandham R, 2008, J BASIC MICROB, V48, P439, DOI 10.1002/jobm.200700380; Anesti V, 2005, ENVIRON MICROBIOL, V7, P1227, DOI 10.1111/j.1462-2920.2005.00805.x; Ano Y, 2005, MOL BIOL CELL, V16, P446, DOI 10.1091/mbc.E04-09-0842; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Boden R, 2008, ENVIRON MICROBIOL, V10, P3225, DOI 10.1111/j.1462-2920.2008.01711.x; CHERNIN L, 1995, APPL ENVIRON MICROB, V61, P1720, DOI 10.1128/AEM.61.5.1720-1726.1995; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Dey R, 2004, MICROBIOL RES, V159, P371, DOI 10.1016/j.micres.2004.08.004; Fall R, 1996, TRENDS PLANT SCI, V1, P296, DOI 10.1016/S1360-1385(96)88175-0; Fedorov DN, 2010, BIOCHEMISTRY-MOSCOW+, V75, P1435, DOI 10.1134/S0006297910120035; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Hornschuh M, 2006, NATURWISSENSCHAFTEN, V93, P480, DOI 10.1007/s00114-006-0137-7; Hornschuh M, 2002, PLANT BIOLOGY, V4, P682, DOI 10.1055/s-2002-37403; Hung WL, 2011, ARCH MICROBIOL, V193, P407, DOI 10.1007/s00203-011-0689-6; Ikeda S, 2010, ISME J, V4, P315, DOI 10.1038/ismej.2009.119; Iwatsuki Z, 2001, MOSSES LIVERWORTS JA; Jayashree S, 2011, ARCH MICROBIOL, V193, P543, DOI 10.1007/s00203-011-0691-z; Kawaguchi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025257; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Kutschera U, 2005, NATURWISSENSCHAFTEN, V92, P347, DOI 10.1007/s00114-005-0640-2; Kutschera U, 2007, PLANT SIGNAL BEHAV, V2, P74, DOI 10.4161/psb.2.2.4073; Liu QF, 2006, PROTEIN EXPRES PURIF, V46, P316, DOI 10.1016/j.pep.2005.07.014; Madhaiyan M, 2007, PLANTA, V226, P867, DOI 10.1007/s00425-007-0532-0; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Nadalig T, 2011, FEMS MICROBIOL ECOL, V77, P438, DOI 10.1111/j.1574-6941.2011.01125.x; Nautiyal CS, 1999, FEMS MICROBIOL LETT, V170, P265, DOI 10.1111/j.1574-6968.1999.tb13383.x; NEMECEKMARSHALL M, 1995, PLANT PHYSIOL, V108, P1359, DOI 10.1104/pp.108.4.1359; Nisbet RER, 2009, P ROY SOC B-BIOL SCI, V276, P1347, DOI 10.1098/rspb.2008.1731; Opelt K, 2004, APPL ENVIRON MICROB, V70, P6569, DOI 10.1128/AEM.70.11.6569-6579.2004; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Ramette A, 2003, MOL PLANT MICROBE IN, V16, P525, DOI 10.1094/MPMI.2003.16.6.525; Saiz S, 2006, ENVIRON SCI TECHNOL, V40, P4312, DOI 10.1021/es0517522; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; SHAW JF, 1995, BOT BULL ACAD SINICA, V36, P195; Tani A, 2012, INT J SYST EVOL MICR, V62, P1647, DOI 10.1099/ijs.0.033019-0; Tani A, 2011, J BIOSCI BIOENG, V112, P32, DOI 10.1016/j.jbiosc.2011.03.012; URAKAMI T, 1992, APPL ENVIRON MICROB, V58, P3970, DOI 10.1128/AEM.58.12.3970-3976.1992	43	29	32	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33800	10.1371/journal.pone.0033800	http://dx.doi.org/10.1371/journal.pone.0033800			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479445	gold, Green Published, Green Submitted			2022-12-27	WOS:000304523400037
J	Schmitz, JPJ; Jeneson, JAL; van Oorschot, JWM; Prompers, JJ; Nicolay, K; Hilbers, PAJ; van Riel, NAW				Schmitz, Joep P. J.; Jeneson, Jeroen A. L.; van Oorschot, Joep W. M.; Prompers, Jeanine J.; Nicolay, Klaas; Hilbers, Peter A. J.; van Riel, Natal A. W.			Prediction of Muscle Energy States at Low Metabolic Rates Requires Feedback Control of Mitochondrial Respiratory Chain Activity by Inorganic Phosphate	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; OXIDATIVE-PHOSPHORYLATION; IN-VIVO; ATP HYDROLYSIS; SYSTEMS BIOLOGY; P-31 MRS; RECOVERY; ACTIVATION; ENERGETICS; EXERCISE	The regulation of the 100-fold dynamic range of mitochondrial ATP synthesis flux in skeletal muscle was investigated. Hypotheses of key control mechanisms were included in a biophysical model of oxidative phosphorylation and tested against metabolite dynamics recorded by 31 P nuclear magnetic resonance spectroscopy (P-31 MRS). Simulations of the initial model featuring only ADP and Pi feedback control of flux failed in reproducing the experimentally sampled relation between myoplasmic free energy of ATP hydrolysis (Delta G(p) = Delta Gp o'+RT In ([ADP][Pi]/[ATP]) and the rate of mitochondrial ATP synthesis at low fluxes (<0.2 mM/s). Model analyses including Monte Carlo simulation approaches and metabolic control analysis (MCA) showed that this problem could not be amended by model re-parameterization, but instead required reformulation of ADP and Pi feedback control or introduction of additional control mechanisms (feed forward activation), specifically at respiratory Complex III. Both hypotheses were implemented and tested against time course data of phosphocreatine (PCr), Pi and ATP dynamics during post-exercise recovery and validation data obtained by 31 P MRS of sedentary subjects and track athletes. The results rejected the hypothesis of regulation by feed forward activation. Instead, it was concluded that feedback control of respiratory chain complexes by inorganic phosphate is essential to explain the regulation of mitochondrial ATP synthesis flux in skeletal muscle throughout its full dynamic range.	[Schmitz, Joep P. J.; Jeneson, Jeroen A. L.; van Oorschot, Joep W. M.; Prompers, Jeanine J.; Nicolay, Klaas] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, NL-5600 MB Eindhoven, Netherlands; [Prompers, Jeanine J.; Nicolay, Klaas; Hilbers, Peter A. J.; van Riel, Natal A. W.] Eindhoven Univ Technol, Dept Biomed Engn, Netherlands Consortium Syst Biol, NL-5600 MB Eindhoven, Netherlands; [Jeneson, Jeroen A. L.] Univ Med Ctr Utrecht, Wilhelmina Kinderziekenhuis, Child Dev & Exercise Ctr, Utrecht, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Schmitz, JPJ (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, POB 513, NL-5600 MB Eindhoven, Netherlands.	J.P.J.Schmitz@tue.nl	Hilbers, Peter A.J./D-2468-2013; van Riel, Natal/J-5319-2013	Hilbers, Peter A.J./0000-0002-8805-5633; van Riel, Natal/0000-0001-9375-4730; Nicolay, Klaas/0000-0002-4179-616X; Prompers, Jeanine/0000-0002-4756-4474	Center for Translational Molecular Medicine [01C-104]; Netherlands Heart Foundation; Dutch Diabetes Research Foundation; Dutch Kidney Foundation; National Institutes of Health [HL-072011]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072011] Funding Source: NIH RePORTER	Center for Translational Molecular Medicine; Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes Research Foundation; Dutch Kidney Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine www.ctmm.nl, project PREDICCt grant 01C-104, supported by the Netherlands Heart Foundation, Dutch Diabetes Research Foundation and Dutch Kidney Foundation, and funded in part by the National Institutes of Health through a subcontract to grant HL-072011. This work was carried out within the research programme of the Netherlands Consortium for Systems Biology (NCSB), which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzu V, 2008, BIOCHEM J, V413, P323, DOI 10.1042/BJ20080321; Azzu V, 2010, TRENDS BIOCHEM SCI, V35, P298, DOI 10.1016/j.tibs.2009.11.001; Balaban RS, 2006, AM J PHYSIOL-CELL PH, V291, pC1107, DOI 10.1152/ajpcell.00223.2006; Balaban RS, 2010, ENVIRON MOL MUTAGEN, V51, P352, DOI 10.1002/em.20574; Balaban RS, 2009, J MOL CELL CARDIOL, V46, P832, DOI 10.1016/j.yjmcc.2009.02.018; Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082; BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Beard DA, 2005, PHYSIOL GENOMICS, V23, P1, DOI 10.1152/physiolgenomics.00117.2005; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; BLEI ML, 1993, J PHYSIOL-LONDON, V465, P203, DOI 10.1113/jphysiol.1993.sp019673; Bose S, 2003, J BIOL CHEM, V278, P39155, DOI 10.1074/jbc.M306409200; BOSKA M, 1994, MAGN RESON MED, V32, P1, DOI 10.1002/mrm.1910320102; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Chance B, 1965, J GEN PHYSL S95, V49; Conley KE, 1997, AM J PHYSIOL-CELL PH, V273, pC306, DOI 10.1152/ajpcell.1997.273.1.C306; Crowther GJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE74, DOI 10.1152/ajpendo.2002.282.1.E74; De Feyter HM, 2008, EUR J ENDOCRINOL, V158, P643, DOI 10.1530/EJE-07-0756; FELL DA, 1992, BIOCHEM J, V286, P313, DOI 10.1042/bj2860313; Feneson JAL, 2010, MAGN RESON MED, V63, P257, DOI 10.1002/mrm.22179; JENESON JAL, 1995, AM J PHYSIOL-CELL PH, V268, pC1474, DOI 10.1152/ajpcell.1995.268.6.C1474; Jeneson JAL, 2011, AM J PHYSIOL-REG I, V300, pR1316, DOI 10.1152/ajpregu.00204.2010; Jeneson JAL, 2009, AM J PHYSIOL-ENDOC M, V297, pE774, DOI 10.1152/ajpendo.00370.2009; Kemp GJ, 1997, EUR J APPL PHYSIOL O, V76, P462, DOI 10.1007/s004210050276; KEMP GJ, 1993, NMR BIOMED, V6, P73, DOI 10.1002/nbm.1940060112; Kemp GJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE640, DOI 10.1152/ajpendo.00797.2007; Kemp GJ, 2007, NMR BIOMED, V20, P555, DOI 10.1002/nbm.1192; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; Korzeniewski B, 2003, BIOCHEM J, V375, P799, DOI 10.1042/BJ20030882; Korzeniewski B, 2000, BIOPHYS CHEM, V83, P19, DOI 10.1016/S0301-4622(99)00120-9; Korzeniewski B, 2007, BIOPHYS CHEM, V129, P93, DOI 10.1016/j.bpc.2007.05.013; LAWSON JWR, 1979, J BIOL CHEM, V254, P6528; Mayevsky A, 2007, MITOCHONDRION, V7, P330, DOI 10.1016/j.mito.2007.05.001; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; Praet SFE, 2006, MAGN RESON MATER PHY, V19, P321, DOI 10.1007/s10334-006-0060-0; Prompers JJ, 2006, NMR BIOMED, V19, P927, DOI 10.1002/nbm.1095; QUISTORFF B, 1993, BIOCHEM J, V291, P681, DOI 10.1042/bj2910681; Taylor D J, 1983, Mol Biol Med, V1, P77; TAYLOR DJ, 1986, MAGNET RESON MED, V3, P44, DOI 10.1002/mrm.1910030107; Vicini P, 2000, AM J PHYSIOL-CELL PH, V279, pC213, DOI 10.1152/ajpcell.2000.279.1.C213; WESTERHOFF HV, 1995, BIOPHYS CHEM, V54, P137, DOI 10.1016/0301-4622(94)00129-8; Wu F, 2008, J PHYSIOL-LONDON, V586, P4193, DOI 10.1113/jphysiol.2008.154732; Wu F, 2007, AM J PHYSIOL-CELL PH, V292, pC115, DOI 10.1152/ajpcell.00237.2006; Wu F, 2009, P NATL ACAD SCI USA, V106, P7143, DOI 10.1073/pnas.0812768106; Wust RCI, 2011, J PHYSIOL-LONDON, V589, P3995, DOI 10.1113/jphysiol.2010.203422	47	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34118	10.1371/journal.pone.0034118	http://dx.doi.org/10.1371/journal.pone.0034118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470528	gold, Green Submitted, Green Published			2022-12-27	WOS:000304489000068
J	Givvimani, S; Munjal, C; Tyagi, N; Sen, U; Metreveli, N; Tyagi, SC				Givvimani, Srikanth; Munjal, Charu; Tyagi, Neetu; Sen, Utpal; Metreveli, Naira; Tyagi, Suresh C.			Mitochondrial division/mitophagy inhibitor (Mdivi) Ameliorates Pressure Overload Induced Heart Failure	PLOS ONE			English	Article							OXIDATIVE STRESS; MATRIX-METALLOPROTEINASE; ISCHEMIC CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; MAMMALIAN-CELLS; AUTOPHAGY; FISSION; ANGIOGENESIS; APOPTOSIS; DEATH	Background: We have previously reported the role of anti-angiogenic factors in inducing the transition from compensatory cardiac hypertrophy to heart failure and the significance of MMP-9 and TIMP-3 in promoting this process during pressure overload hemodynamic stress. Several studies reported the evidence of cardiac autophagy, involving removal of cellular organelles like mitochondria (mitophagy), peroxisomes etc., in the pathogenesis of heart failure. However, little is known regarding the therapeutic role of mitochondrial division inhibitor (Mdivi) in the pressure overload induced heart failure. We hypothesize that treatment with mitochondrial division inhibitor (Mdivi) inhibits abnormal mitophagy in a pressure overload heart and thus ameliorates heart failure condition. Materials and Methods: To verify this, ascending aortic banding was done in wild type mice to create pressure overload induced heart failure and then treated with Mdivi and compared with vehicle treated controls. Results: Expression of MMP-2, vascular endothelial growth factor, CD31, was increased, while expression of anti angiogenic factors like endostatin and angiostatin along with MMP-9, TIMP-3 was reduced in Mdivi treated AB 8 weeks mice compared to vehicle treated controls. Expression of mitophagy markers like LC3 and p62 was decreased in Mdivi treated mice compared to controls. Cardiac functional status assessed by echocardiography showed improvement and there is also a decrease in the deposition of fibrosis in Mdivi treated mice compared to controls. Conclusion: Above results suggest that Mdivi inhibits the abnormal cardiac mitophagy response during sustained pressure overload stress and propose the novel therapeutic role of Mdivi in ameliorating heart failure.	[Givvimani, Srikanth; Munjal, Charu; Tyagi, Neetu; Sen, Utpal; Metreveli, Naira; Tyagi, Suresh C.] Univ Louisville, Sch Med, Dept Physiol & Biophys, Louisville, KY 40292 USA	University of Louisville	Givvimani, S (corresponding author), Univ Louisville, Sch Med, Dept Physiol & Biophys, Louisville, KY 40292 USA.	s0tyag01@louisville.edu	Tyagi, Neetu/AFZ-1370-2022	Tyagi, Neetu/0000-0002-1789-0754	National Institutes of Health [HL-71010, HL-74185, HL-88012]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074185, R01HL071010, R01HL088012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants HL-71010, HL-74185, and HL-88012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker AH, 1998, J CLIN INVEST, V101, P1478, DOI 10.1172/JCI1584; Beer M, 2002, J AM COLL CARDIOL, V40, P1267, DOI 10.1016/S0735-1097(02)02160-5; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Fliss H, 1996, CIRC RES, V79, P949, DOI 10.1161/01.RES.79.5.949; Friehs I, 2006, BASIC RES CARDIOL, V101, P204, DOI 10.1007/s00395-005-0581-0; Friehs I, 2004, ANN THORAC SURG, V77, P2004, DOI 10.1016/j.athoracsur.2003.11.003; GERDES AM, 1992, CIRCULATION, V86, P426, DOI 10.1161/01.CIR.86.2.426; Givvimani S, 2011, J APPL PHYSL; Givvimani Srikanth, 2010, Archives of Physiology and Biochemistry, V116, P63, DOI 10.3109/13813451003652997; Gottlieb RA, 2010, BIOCH BIOPHYS ACTA; Hamanaka RB, 2010, TRENDS BIOCHEM SCI, V35, P505, DOI 10.1016/j.tibs.2010.04.002; Ide T, 2001, CIRC RES, V88, P529, DOI 10.1161/01.RES.88.5.529; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Lemieux H, 2009, J BIOENERG BIOMEMBR, V41, P99, DOI 10.1007/s10863-009-9211-0; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Martinet W, 2007, TRENDS MOL MED, V13, P482, DOI 10.1016/j.molmed.2007.08.004; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Nguyen TMB, 2009, J CELL MOL MED, V13, P3687, DOI 10.1111/j.1582-4934.2009.00722.x; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; PAPAIOANNOU VE, 1993, LAB ANIM SCI, V43, P189; Roberts JT, 1941, AM HEART J, V21, P617, DOI 10.1016/S0002-8703(41)90726-3; Rosca MG, 2009, J BIOENERG BIOMEMBR, V41, P107, DOI 10.1007/s10863-009-9215-9; Rothermel BA, 2007, AUTOPHAGY, V3, P632, DOI 10.4161/auto.4913; Rottman JN, 2007, ECHOCARDIOGR-J CARD, V24, P83, DOI 10.1111/j.1540-8175.2006.00356.x; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Sodha NR, 2009, AM J PHYSIOL-HEART C, V296, pH428, DOI 10.1152/ajpheart.00283.2008; Sorescu Dan, 2002, Congest Heart Fail, V8, P132, DOI 10.1111/j.1527-5299.2002.00717.x; TAKIGAWA M, 1990, BIOCHEM BIOPH RES CO, V171, P1264, DOI 10.1016/0006-291X(90)90822-5; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Tyagi SC, 1996, J MOL CELL CARDIOL, V28, P1415, DOI 10.1006/jmcc.1996.0132; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	45	140	148	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e32388	10.1371/journal.pone.0032388	http://dx.doi.org/10.1371/journal.pone.0032388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479323	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900008
J	Owusu-Ofori, AK; Bates, I				Owusu-Ofori, Alex K.; Bates, Imelda			Impact of Inconsistent Policies for Transfusion-Transmitted Malaria on Clinical Practice in Ghana	PLOS ONE			English	Article							BLOOD-DONORS; PARASITEMIA; PREVALENCE; CHILDREN; BACTEREMIA; IBADAN	Background: Policies concerning the prevention of transfusion transmitted malaria (TTM) are the responsibility of blood transfusion services and malaria control programmes. To prevent spreading drug resistance due to over-use of malaria drugs, recent malaria treatment guidelines recommend prompt parasitological confirmation before treatment is started. In contrast, blood safety policies from the World Health Organisation (WHO) recommend presumptive malaria treatment for recipients of blood in endemic countries but evidence supporting this approach is lacking. Our study documented how these conflicting policies relating to malaria transmission through blood transfusion impact on clinical practice in a teaching hospital in West Africa. Methods/Principal Findings: We randomly selected and reviewed case notes of 151 patients within 24 hours of their receiving a blood transfusion. Transfusion practices including the confirmation of diagnosis and anti-malarial treatment given were compared across three departments; Obstetrics and Gynaecology (O&G), Paediatrics and Medicine. Overall, 66 (44%) of patients received malaria treatment within 24 hrs of their blood transfusion; of which only 2 (3%) received anti-malarials based on a laboratory confirmation of malaria. Paediatric patients (87%) received the most anti-malarials and only 7% and 24% of recipients in medicine and O&G respectively received anti malarials. In 51 patients (78%), the anti-malarials were prescribed at the same time as the blood transfusion and anti-malarials prescriptions exceeded the number of patients with a presumptive diagnosis of malaria. Conclusions: It is common practice in paediatrics to prescribe anti-malarials routinely with blood transfusions. This contravenes the malaria treatment guidelines of laboratory confirmation before treatment but is in accordance with the less-well evidenced blood safety guidelines. There is an urgent need for more evidence about the clinical impact of transfusion transmitted malaria to enable malaria and blood transfusion programmes to harmonize their policies and give clear guidance to clinicians who prescribe blood transfusions in malaria-endemic areas	[Owusu-Ofori, Alex K.] Komfo Anokye Teaching Hosp, Dept Clin Microbiol, Kumasi, Ghana; [Owusu-Ofori, Alex K.; Bates, Imelda] Univ Liverpool, Liverpool Sch Trop Med, Dis Control Strategy Grp, Liverpool L3 5QA, Merseyside, England	Kwame Nkrumah University Science & Technology; Liverpool School of Tropical Medicine; University of Liverpool	Owusu-Ofori, AK (corresponding author), Komfo Anokye Teaching Hosp, Dept Clin Microbiol, Kumasi, Ghana.	owusu_ofori@hotmail.com	Owusu-Ofori, Alex/AAU-9071-2020	Owusu-Ofori, Alex Kwame/0000-0002-2172-8645; bates, imelda/0000-0002-0862-8199	Commonwealth Scholarship Commission, UK	Commonwealth Scholarship Commission, UK	This work forms part of the PhD of AOO. AOO acknowledges the Commonwealth Scholarship Commission, UK, for sponsorship of his PhD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achidi EA, 1995, ANN TROP MED PARASIT, V89, P601, DOI 10.1080/00034983.1995.11812994; AKINBOYE DO, 1987, T ROY SOC TROP MED H, V81, P398, DOI 10.1016/0035-9203(87)90147-7; Ali M. S. M., 2004, Ethiopian Journal of Health Development, V18, P70; Allain JP, 2010, CLIN INFECT DIS, V51, P1199, DOI 10.1086/656807; Bassat Q, 2009, TROP MED INT HEALTH, V14, P1011, DOI 10.1111/j.1365-3156.2009.02326.x; CARME B, 1993, ANN SOC BELG MED TR, V73, P179; Crawley J, 2010, LANCET, V375, P1468, DOI 10.1016/S0140-6736(10)60447-3; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Emmanuel JC., 2001, CLIN US BLOOD HDB; English M, 2000, T ROY SOC TROP MED H, V94, P585, DOI 10.1016/S0035-9203(00)90197-4; Erhabor O, 2007, TROP DOCT, V37, P32, DOI 10.1258/004947507779951998; Hassall O, 2009, TRANSFUSION, V49, P2594, DOI 10.1111/j.1537-2995.2009.02344.x; Ibhanesebhor SE, 1996, ANN TROP PAEDIATR, V16, P93, DOI 10.1080/02724936.1996.11747810; Juma E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-1; Kinde-Gazard, 2000, Sante, V10, P389; Kitchen AD, 2006, VOX SANG, V90, P77, DOI 10.1111/j.1423-0410.2006.00733.x; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; [Ministry of Health Ghana National Drugs Programme (GNDP)], 2010, STAND TREATM GUID GH; National Blood Service, 2006, NAT BLOOD POL HLTH S; National Toxicology Program, 2002, Natl Toxicol Program Tech Rep Ser, P1; Noedl H, 2009, TRENDS PARASITOL, V25, P540, DOI 10.1016/j.pt.2009.09.001; Okocha E. C., 2005, Journal of Vector Borne Diseases, V42, P21; Owusu-Ofori AK, 2010, CLIN INFECT DIS, V51, P1192, DOI 10.1086/656806; Planche T, 2005, TRENDS PARASITOL, V21, P562, DOI 10.1016/j.pt.2005.09.010; Pongtavornpinyo W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-229; Rajab J A, 2005, East Afr Med J, V82, P565; Rivers EP, 2008, CRIT CARE CLIN, V24, pS1, DOI 10.1016/j.ccc.2008.04.002; Sserwanga A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016316; Tagny CT, 2009, TRANSFUS CLIN BIOL, V16, P431, DOI 10.1016/j.tracli.2009.07.005; Tapko JB, 2009, STATUS BLOOD SAFETY; Walsh AL, 2002, T ROY SOC TROP MED H, V96, P276, DOI 10.1016/S0035-9203(02)90098-2; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2011, BLOOD TRANSF SAF TES; WHO, 2010, GUID TREATM MAL, V2nd; Winstanley P, 2004, CLIN MICROBIOL REV, V17, P612, DOI 10.1128/CMR.17.3.612-637.2004	35	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34201	10.1371/journal.pone.0034201	http://dx.doi.org/10.1371/journal.pone.0034201			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479564	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000303894900069
J	Wei, DD; Yuan, ML; Wang, BJ; Zhou, AW; Dou, W; Wang, JJ				Wei, Dan-Dan; Yuan, Ming-Long; Wang, Bao-Jun; Zhou, An-Wei; Dou, Wei; Wang, Jin-Jun			Population Genetics of Two Asexually and Sexually Reproducing Psocids Species Inferred by the Analysis of Mitochondrial and Nuclear DNA Sequences	PLOS ONE			English	Article							LIPOSCELIS-BOSTRYCHOPHILA PSOCOPTERA; PHYLOGENETIC INFERENCE; STATISTICAL TESTS; DECOLOR PEARMAN; MATING SYSTEM; INSECT PEST; DIVERSITY; WOLBACHIA; INFECTION; POLYMORPHISM	Background: The psocids Liposcelis bostrychophila and L. entomophila (Psocoptera: Liposcelididae) are found throughout the world and are often associated with humans, food stores and habitations. These insects have developed high levels of resistance to various insecticides in grain storage systems. However, the population genetic structure and gene flow of psocids has not been well categorized, which is helpful to plan appropriate strategies for the control of these pests. Methodology/Principal Findings: The two species were sampled from 15 localities in China and analyzed for polymorphisms at the mitochondrial DNA (Cytb) and ITS (ITS1-5.8S-ITS2) regions. In total, 177 individual L. bostrychophila and 272 individual L. entomophila were analysed. Both Cytb and ITS sequences showed high genetic diversity for the two species with haplotype diversities ranged from 0.154 +/- 0.126 to 1.000 +/- 0.045, and significant population differentiation (mean F-ST = 0.358 for L. bostrychophila; mean F-ST = 0.336 for L. entomophila) was also detected among populations investigated. A Mantel test indicated that for both species there was no evidence for isolation-by-distance (IBD). The neutrality test and mismatch distribution statistics revealed that the two species might have undergone population expansions in the past. Conclusion: Both L. bostrychophila and L. entomophila displayed high genetic diversity and widespread population genetic differentiation within and between populations. The significant population differentiation detected for both psocids may be mainly due to other factors, such as genetic drift, inbreeding or control practices, and less by geographic distance since an IBD effect was not found.	[Wei, Dan-Dan; Yuan, Ming-Long; Wang, Bao-Jun; Zhou, An-Wei; Dou, Wei; Wang, Jin-Jun] SW Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China	Southwest University - China	Wei, DD (corresponding author), SW Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.	jjwang7008@yahoo.com			National Natural Sciences Foundation [30871631, 31000860]; Program for Innovative Research Team in University [IRT0976]; Natural Science Foundation of Chongqing (CSTC) [2009BA1042]; Specialized Research Fund for the Doctoral Program of Higher Education of China [200806350009]	National Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Program for Innovative Research Team in University; Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was funded in part by the National Natural Sciences Foundation (30871631, 31000860), the Program for Innovative Research Team in University (IRT0976), the Natural Science Foundation of Chongqing (CSTC, 2009BA1042), and the Specialized Research Fund for the Doctoral Program of Higher Education (200806350009) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmedani MS, 2010, APPL ENTOMOL ZOOL, V45, P89, DOI 10.1303/aez.2010.89; Ali N, 2001, J STORED PROD RES, V37, P111, DOI 10.1016/S0022-474X(00)00013-8; Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Behar A, 2010, APPL ENVIRON MICROB, V76, P2280, DOI 10.1128/AEM.00026-10; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Bengtsson BO, 2003, J EVOLUTION BIOL, V16, P189, DOI 10.1046/j.1420-9101.2003.00523.x; Cheng WX, 2007, PESTIC BIOCHEM PHYS, V89, P151, DOI 10.1016/j.pestbp.2007.05.004; Collins FH, 1996, INSECT MOL BIOL, V5, P1, DOI 10.1111/j.1365-2583.1996.tb00034.x; David JP, 2003, MOL ECOL, V12, P1951, DOI 10.1046/j.1365-294X.2003.01870.x; de la Rua N, 2011, INFECT GENET EVOL, V11, P671, DOI 10.1016/j.meegid.2011.02.009; Dsouli-Aymes N, 2011, INFECT GENET EVOL, V11, P334, DOI 10.1016/j.meegid.2010.11.001; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Graustein A, 2002, GENETICS, V161, P99; Guedes RNC, 2008, J ECON ENTOMOL, V101, P1974, DOI 10.1603/0022-0493-101.6.1974; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harpke D, 2008, BOTANY, V86, P300, DOI 10.1139/B07-134; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jia FX, 2009, ENVIRON ENTOMOL, V38, P1365, DOI 10.1603/022.038.0503; Jiang HB, 2010, MOL BIOL REP, V37, P1019, DOI 10.1007/s11033-009-9803-0; Li FS, 2002, PSOCOPTERA CHINA, P77; Li Jianhua, 2004, Harvard Papers in Botany, V9, P69; Li ZH, 2011, J STORED PROD RES, V47, P168, DOI 10.1016/j.jspr.2010.10.005; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin YC, 2004, CLIN EXP DERMATOL, V29, P620, DOI 10.1111/j.1365-2230.2004.01609.x; Loxdale HD, 2010, ECOL ENTOMOL, V35, P155, DOI 10.1111/j.1365-2311.2009.01141.x; Markert JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-205; Mikac KM, 2006, B ENTOMOL RES, V96, P523, DOI 10.1079/BER2006453; Mikac KM, 2010, B ENTOMOL RES, V100, P521, DOI 10.1017/S0007485309990538; Mikac KM, 2007, J STORED PROD RES, V43, P594, DOI 10.1016/j.jspr.2007.01.005; Mikac KM, 2006, MOL ECOL NOTES, V6, P1102, DOI 10.1111/j.1471-8286.2006.01448.x; Mockford EL, 2008, ZOOTAXA, P53, DOI 10.11646/zootaxa.1766.1.3; Narita S, 2006, MOL ECOL, V15, P1095, DOI 10.1111/j.1365-294X.2006.02857.x; Nayak MK, 2006, PEST MANAG SCI, V62, P646, DOI 10.1002/ps.1220; Nei M., 1987, MOL EVOLUTIONARY GEN; Oh HK, 2009, GENES GENOM, V31, P293, DOI 10.1007/BF03191202; Opit GP, 2009, J ECON ENTOMOL, V102, P1369, DOI 10.1603/029.102.0365; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Shreve SM, 2011, MOL ECOL, V20, P4433, DOI 10.1111/j.1365-294X.2011.05298.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SUOMALAINEN E, 1980, THEOR APPL GENET, V57, P129, DOI 10.1007/BF00253887; Sweigart AL, 2003, EVOLUTION, V57, P2490, DOI 10.1111/j.0014-3820.2003.tb01494.x; Szalanski AL, 2008, J MED ENTOMOL, V45, P229, DOI 10.1603/0022-2585(2008)45[229:MARITS]2.0.CO;2; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TURNER BD, 1994, INT J PEST MANAGE, V40, P179, DOI 10.1080/09670879409371879; Wang JJ, 2008, J ECON ENTOMOL, V101, P1711, DOI 10.1603/0022-0493(2008)101[1711:EOROCI]2.0.CO;2; Weeks AR, 2001, SCIENCE, V292, P2479, DOI 10.1126/science.1060411; Wei DD, 2011, J ECON ENTOMOL, V104, P1720, DOI 10.1603/EC11177; [魏丹丹 WEI Dandan], 2011, [生态学报, Acta Ecologica Sinica], V31, P4182; Wuyts J, 2001, NUCLEIC ACIDS RES, V29, P175, DOI 10.1093/nar/29.1.175; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Yu MZ, 2011, INSECT MOL BIOL, V20, P311, DOI 10.1111/j.1365-2583.2010.01066.x; Yuan ML, 2011, ANN ENTOMOL SOC AM, V104, P800, DOI 10.1603/AN10159; Yusuf M, 2000, J STORED PROD RES, V36, P169, DOI 10.1016/S0022-474X(99)00037-5; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	68	10	12	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33883	10.1371/journal.pone.0033883	http://dx.doi.org/10.1371/journal.pone.0033883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479465	gold, Green Published, Green Submitted			2022-12-27	WOS:000303894900046
J	Tutarel, O; Denecke, A; Bode-Boger, SM; Martens-Lobenhoffer, J; Lovric, S; Bauersachs, J; Schieffer, B; Westhoff-Bleck, M; Kielstein, JT				Tutarel, Oktay; Denecke, Agnieszka; Bode-Boeger, Stefanie M.; Martens-Lobenhoffer, Jens; Lovric, Svjetlana; Bauersachs, Johann; Schieffer, Bernhard; Westhoff-Bleck, Mechthild; Kielstein, Jan T.			Asymmetrical Dimethylarginine - More Sensitive than NT-proBNP to Diagnose Heart Failure in Adults with Congenital Heart Disease	PLOS ONE			English	Article							OXIDE SYNTHASE INHIBITOR; NITRIC-OXIDE; SYMMETRIC DIMETHYLARGININE; EXERCISE; ARGININE; DYSFUNCTION; SEVERITY; LINK	Background: Chronic heart failure is an important cause for morbidity and mortality in adults with congenital heart disease (ACHD). While NT-proBNP is an established biomarker for heart failure of non-congenital origin, its value in ACHD has limitations. Asymmetrical dimethylarginine (ADMA) correlates with disease severity and independently predicts adverse clinical events in heart failure of non-congenital origin. Its role in ACHD has not been investigated. Methods: In 102 patients ADMA and NT-proBNP were measured and related to NYHA class, systemic ventricular function and parameters of cardiopulmonary exercise testing. Results: In contrast to NT-proBNP ADMA differentiated between NYHA classes I-III. Both, ADMA and NT-proBNP showed a good correlation with parameters of cardiopulmonary exercise testing with comparable receiver-operating characteristic curves for identifying patients with severely limited cardiopulmonary exercise capacity. Conclusion: ADMA seems to be a better biomarker than NT-proBNP for the assessment of NYHA class and as a good as NT-proBNP for the estimation of maximum exercise capacity in adults with congenital heart disease. Its use in clinical routine should be evaluated.	[Tutarel, Oktay; Denecke, Agnieszka; Bauersachs, Johann; Schieffer, Bernhard; Westhoff-Bleck, Mechthild] Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany; [Denecke, Agnieszka; Lovric, Svjetlana; Kielstein, Jan T.] Hannover Med Sch, Dept Hypertens & Nephrol, D-3000 Hannover, Germany; [Bode-Boeger, Stefanie M.; Martens-Lobenhoffer, Jens] Otto von Guericke Univ, Inst Clin Pharmacol, Magdeburg, Germany	Hannover Medical School; Hannover Medical School; Otto von Guericke University	Tutarel, O (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, D-3000 Hannover, Germany.	otutarel@hotmail.com	Kielstein, Jan T./I-2956-2019	Kielstein, Jan T./0000-0001-8110-9064; Bode-Boger, Stefanie/0000-0002-5132-6591; Tutarel, Oktay/0000-0002-5201-5509				Bolger AP, 2003, EUR HEART J, V24, P970, DOI 10.1016/S0195-668X(03)00005-8; Bolger AP, 2002, CIRCULATION, V106, P92, DOI 10.1161/01.CIR.0000020009.30736.3F; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Diller GP, 2005, CIRCULATION, V112, P828, DOI 10.1161/CIRCULATIONAHA.104.529800; Dimopoulos K, 2006, CIRCULATION, V113, P2796, DOI 10.1161/CIRCULATIONAHA.105.594218; Feng QP, 1998, CARDIOVASC RES, V37, P667, DOI 10.1016/S0008-6363(97)00242-3; Garg R, 2008, PEDIATR CARDIOL, V29, P641, DOI 10.1007/s00246-007-9187-7; Gewillig M, 2010, INTERACT CARDIOV TH, V10, P428, DOI 10.1510/icvts.2009.218594; Giannakoulas G, 2010, AM J CARDIOL, V105, P869, DOI 10.1016/j.amjcard.2009.11.041; Kielstein JT, 2009, SEMIN DIALYSIS, V22, P346, DOI 10.1111/j.1525-139X.2009.00578.x; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; Kielstein JT, 2003, EUR J CLIN INVEST, V33, P370, DOI 10.1046/j.1365-2362.2003.01149.x; Kim HN, 2011, CIRCULATION, V123, P2015, DOI 10.1161/CIRCULATIONAHA.110.979500; Larsson DA, 2007, INT J CARDIOL, V114, P345, DOI 10.1016/j.ijcard.2006.01.023; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Martens-Lobenhoffer J, 2006, CLIN CHEM, V52, P488, DOI 10.1373/clinchem.2005.060152; Massion PB, 2003, CIRC RES, V93, P388, DOI 10.1161/01.RES.0000088351.58510.21; Norozi K, 2007, CLIN RES CARDIOL, V96, P542, DOI 10.1007/s00392-007-0530-z; Oechslin E, 2005, CIRCULATION, V112, P1106, DOI 10.1161/CIRCULATIONAHA.105.534073; Shaddy Robert E, 2008, Expert Rev Cardiovasc Ther, V6, P165, DOI 10.1586/14779072.6.2.165; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; Tang WHW, 2008, EUR HEART J, V29, P2506, DOI 10.1093/eurheartj/ehn360; Thum T, 2005, J AM COLL CARDIOL, V46, P1693, DOI 10.1016/j.jacc.2005.04.066; Usui M, 1998, LIFE SCI, V62, P2425, DOI 10.1016/S0024-3205(98)00225-2; Visser M, 2010, EUR J HEART FAIL, V12, P1274, DOI 10.1093/eurjhf/hfq158; von Haehling S, 2010, CLIN PHARMACOL THER, V88, P506, DOI 10.1038/clpt.2010.116; Warnes CA, 2001, J AM COLL CARDIOL, V37, P1170, DOI 10.1016/S0735-1097(01)01272-4; Zoccali C, 2003, EUR J CLIN INVEST, V33, P361, DOI 10.1046/j.1365-2362.2003.01150.x; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	29	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33795	10.1371/journal.pone.0033795	http://dx.doi.org/10.1371/journal.pone.0033795			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470476	Green Submitted, Green Published, gold			2022-12-27	WOS:000303857100051
J	Wan, GH; Huang, CG; Huang, YC; Huang, JP; Yang, SL; Lin, TY; Tsao, KC				Wan, Gwo-Hwa; Huang, Chung-Guei; Huang, Yhu-Chering; Huang, Ju-Ping; Yang, Su-Li; Lin, Tzou-Yien; Tsao, Kuo-Chien			Surveillance of Airborne Adenovirus and Mycoplasma pneumoniae in a Hospital Pediatric Department	PLOS ONE			English	Article						adenovirus; Mycoplasma pneumoniae; filter sampling; real-time polymerase chain reaction; hospital; pediatric public areas	ACUTE RESPIRATORY SYNDROME; INDOOR AIR-POLLUTION; INFLUENZA-VIRUS; PCR ASSAY; CORONAVIRUS; RHINOVIRUS	This investigation evaluated the distributions of airborne adenovirus and Mycoplasma pneumoniae in public areas in the pediatric department of Children's Hospital in northern Taiwan. The airborne viral and bacterial concentrations were evaluated twice a week for a year using filter sampling with an airflow rate of 12 liters per minute for eight hours in the pediatric outpatient department and 24 hours in the pediatric emergency room. Real-time polymerase chain reaction assays were conducted for analysis. Approximately 18% of the air samples from the pediatric emergency room were found to contain adenovirus. Approximately forty-six percent of the air samples from the pediatric outpatient department contained Mycoplasma pneumoniae DNA products. High detection rates of airborne adenovirus DNA were obtained in July and August in the pediatric public areas. Airborne Mycoplasma pneumoniae was detected only in July in the pediatric emergency room and the peak levels were found from August to January in the pediatric outpatient department. Airborne particles that contained adenovirus and Mycoplasma pneumoniae were the most prevalent in the pediatric public areas. The potential relationship between these airborne viral/bacterial particles and human infection should be examined further.	[Wan, Gwo-Hwa; Huang, Ju-Ping] Chang Gung Univ, Coll Med, Dept Resp Therapy, Tao Yuan, Taiwan; [Huang, Chung-Guei; Yang, Su-Li; Tsao, Kuo-Chien] Chang Gung Mem Hosp, Dept Lab Med, Tao Yuan, Taiwan; [Huang, Chung-Guei; Tsao, Kuo-Chien] Chang Gung Univ, Res Ctr Emerging Viral Infect, Dept Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Huang, Yhu-Chering; Lin, Tzou-Yien] Chang Gung Mem Hosp, Div Pediat Infect Dis, Tao Yuan, Taiwan; [Huang, Yhu-Chering; Lin, Tzou-Yien] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Wan, GH (corresponding author), Chang Gung Univ, Coll Med, Dept Resp Therapy, Tao Yuan, Taiwan.	ghwan@mail.cgu.edu.tw			Chang Gung Memorial Hospital, Taiwan [CMRPD170831]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	The authors would like to thank the Chang Gung Memorial Hospital, Taiwan, for financially supporting this research under grant CMRPD170831. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aintablian N, 1998, INFECT CONT HOSP EP, V19, P918; Aller JY, 2005, J AEROSOL SCI, V36, P801, DOI 10.1016/j.jaerosci.2004.10.012; Blachere FM, 2009, CLIN INFECT DIS, V48, P438, DOI 10.1086/596478; Booth TF, 2005, J INFECT DIS, V191, P1472, DOI 10.1086/429634; Centers for Disease Control and Prevention Department of Health R.O.C. (Taiwan), 2010, STAT COMM DIS SURV R, P60; Chang Ya-Ting, 2006, Journal of Microbiology Immunology and Infection, V39, P28; Dharan S, 2002, J HOSP INFECT, V51, P79, DOI 10.1053/jhin.2002.1217; Hermann JR, 2006, APPL ENVIRON MICROB, V72, P4811, DOI 10.1128/AEM.00472-06; Hogan CJ, 2005, J APPL MICROBIOL, V99, P1422, DOI 10.1111/j.1365-2672.2005.02720.x; Lindsley WG, 2010, CLIN INFECT DIS, V50, P693, DOI 10.1086/650457; Myatt TA, 2004, AM J RESP CRIT CARE, V169, P1187, DOI 10.1164/rccm.200306-760OC; Myatt TA, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-5; Pyankov OV, 2007, ENVIRON MICROBIOL, V9, P992, DOI 10.1111/j.1462-2920.2006.01226.x; SAMET JM, 1987, AM REV RESPIR DIS, V136, P1486, DOI 10.1164/ajrccm/136.6.1486; SPENGLER JD, 1983, SCIENCE, V221, P9, DOI 10.1126/science.6857273; Tsai YH, 2006, INFECT CONT HOSP EP, V27, P523, DOI 10.1086/504357; Tseng CC, 2010, J ENVIRON HEALTH, V73, P22; Wan GH, 2004, INFECT CONT HOSP EP, V25, P1113, DOI 10.1086/502353; Welti M, 2003, DIAGN MICR INFEC DIS, V45, P85, DOI 10.1016/S0732-8893(02)00484-4; Yang SH, 2007, J AEROSOL MED, V20, P484, DOI 10.1089/jam.2007.0610; Yen MY, 2005, J FORMOS MED ASSOC, V104, P724	21	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33974	10.1371/journal.pone.0033974	http://dx.doi.org/10.1371/journal.pone.0033974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470502	Green Published, Green Submitted, gold			2022-12-27	WOS:000303857100063
J	Boivin, WA; Shackleford, M; Vanden Hoek, A; Zhao, HY; Hackett, TL; Knight, DA; Granville, DJ				Boivin, Wendy A.; Shackleford, Marlo; Vanden Hoek, Amanda; Zhao, Hongyan; Hackett, Tillie L.; Knight, Darryl A.; Granville, David J.			Granzyme B Cleaves Decorin, Biglycan and Soluble Betaglycan, Releasing Active Transforming Growth Factor-beta 1	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; EXTRACELLULAR-MATRIX; RHEUMATOID-ARTHRITIS; SYNOVIAL-FLUID; TARGET-CELLS; HUMAN SKIN; PROTEOGLYCAN; LYMPHOCYTES; PROTEIN	Objective: Granzyme B (GrB) is a pro-apoptotic serine protease that contributes to immune-mediated target cell apoptosis. However, during inflammation, GrB accumulates in the extracellular space, retains its activity, and is capable of cleaving extracellular matrix (ECM) proteins. Recent studies have implicated a pathogenic extracellular role for GrB in cardiovascular disease, yet the pathophysiological consequences of extracellular GrB activity remain largely unknown. The objective of this study was to identify proteoglycan (PG) substrates of GrB and examine the ability of GrB to release PG-sequestered TGF-beta 1 into the extracellular milieu. Methods/Results: Three extracellular GrB PG substrates were identified; decorin, biglycan and betaglycan. As all of these PGs sequester active TGF-beta 1, cytokine release assays were conducted to establish if GrB-mediated PG cleavage induced TGF-beta 1 release. Our data confirmed that GrB liberated TGF-beta 1 from all three substrates as well as from endogenous ECM and this process was inhibited by the GrB inhibitor 3,4-dichloroisocoumarin. The released TGF-beta 1 retained its activity as indicated by the induction of SMAD-3 phosphorylation in human coronary artery smooth muscle cells. Conclusion: In addition to contributing to ECM degradation and the loss of tissue structural integrity in vivo, increased extracellular GrB activity is also capable of inducing the release of active TGF-beta 1 from PGs.	[Boivin, Wendy A.; Shackleford, Marlo; Zhao, Hongyan; Hackett, Tillie L.; Knight, Darryl A.; Granville, David J.] St Pauls Hosp, UBC James Hogg Res Ctr, Inst Heart Lung Hlth, Vancouver, BC V6Z 1Y6, Canada; [Boivin, Wendy A.; Vanden Hoek, Amanda; Zhao, Hongyan; Hackett, Tillie L.; Granville, David J.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Knight, Darryl A.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; University of British Columbia	Boivin, WA (corresponding author), St Pauls Hosp, UBC James Hogg Res Ctr, Inst Heart Lung Hlth, Vancouver, BC V6Z 1Y6, Canada.	david.granville@hli.ubc.ca			Canadian Institutes for Health Research (CIHR) [MOP-26 84205]; Heart and Stroke Foundation of British Columbia and Yukon (HSFBCY) [20R20069]; Natural Sciences and Engineering Research Council of Canada; CIHR; Canadian Lung Association; Integrated and Mentored Pulmonary and Cardiovascular Training (IMPACT); Michael Smith Foundation for Health Research (MSFHR)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of British Columbia and Yukon (HSFBCY); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Lung Association; Integrated and Mentored Pulmonary and Cardiovascular Training (IMPACT); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This research was funded by grants from the Canadian Institutes for Health Research (MOP-26 84205; CIHR; DJG) and the Heart and Stroke Foundation of British Columbia and Yukon (20R20069; HSFBCY; DJG). DJG is a founder and scientific officer to viDA Therapeutics, Inc., however no funding from viDA Therapeutics, Inc. was used to support this study. WAB was supported by an Alexander Graham Bell Canadian Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada. TLH is supported by a CIHR, Canadian Lung Association, Integrated and Mentored Pulmonary and Cardiovascular Training (IMPACT), and Michael Smith Foundation for Health Research (MSFHR) post-doctoral fellowships. DAK is the Canada Research Chair in Airway Disease and a MSFHR Career Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2011, MOL CELL, V44, P265, DOI 10.1016/j.molcel.2011.07.037; Amalinei Cornelia, 2007, Rom J Morphol Embryol, V48, P323; Ang LS, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.102; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Bae YA, 2011, PARASITOLOGY, V138, P1143, DOI 10.1017/S0031182011000813; Bird CH, 2005, MOL CELL BIOL, V25, P7854, DOI 10.1128/MCB.25.17.7854-7867.2005; Boivin WA, 2009, LAB INVEST, V89, P1195, DOI 10.1038/labinvest.2009.91; Bratke K, 2004, CLIN EXP IMMUNOL, V136, P542, DOI 10.1111/j.1365-2249.2004.02468.x; Buzza MS, 2008, J BIOL CHEM, V283, P22498, DOI 10.1074/jbc.M709080200; Buzza MS, 2005, J BIOL CHEM, V280, P23549, DOI 10.1074/jbc.M412001200; Carrino DA, 2012, BIOCH J; Casciola-Rosen L, 2007, J BIOL CHEM, V282, P4545, DOI 10.1074/jbc.M606564200; Chamberlain CM, 2010, AM J PATHOL, V176, P1038, DOI 10.2353/ajpath.2010.090700; Chang C, 2001, TRENDS CELL BIOL, V11, pS37, DOI 10.1016/S0962-8924(01)82222-4; Chau Y, 2004, BIOCONJUGATE CHEM, V15, P931, DOI 10.1021/bc0499174; Choy JC, 2004, ARTERIOSCL THROM VAS, V24, P2245, DOI 10.1161/01.ATV.0000147162.51930.b7; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; FLEISCHMAJER R, 1991, J STRUCT BIOL, V106, P82, DOI 10.1016/1047-8477(91)90065-5; FROELICH CJ, 1993, J IMMUNOL, V151, P7161; Gahring LC, 2001, J IMMUNOL, V166, P1433, DOI 10.4049/jimmunol.166.3.1433; Gambichler T, 2007, J DERMATOL SCI, V45, P203, DOI 10.1016/j.jdermsci.2006.10.012; Granville DJ, 2010, CELL DEATH DIFFER, V17, P565, DOI 10.1038/cdd.2009.218; Harris JL, 1998, J BIOL CHEM, V273, P27364, DOI 10.1074/jbc.273.42.27364; Hendel A, 2010, CELL DEATH DIFFER, V17, P596, DOI 10.1038/cdd.2010.5; Hiebert PR, 2011, EXP GERONTOL, V46, P489, DOI 10.1016/j.exger.2011.02.004; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Imai K, 1997, BIOCHEM J, V322, P809, DOI 10.1042/bj3220809; ISAAZ S, 1995, EUR J IMMUNOL, V25, P1071, DOI 10.1002/eji.1830250432; Ito S, 2008, APPL MICROBIOL BIOT, V79, P433, DOI 10.1007/s00253-008-1449-7; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Kondo H, 2009, CIRC J, V73, P503, DOI 10.1253/circj.CJ-08-0668; Kratzer R, 2011, BIOTECHNOL BIOENG, V108, P797, DOI 10.1002/bit.23002; Ling HB, 2008, J MICROBIOL BIOTECHN, V18, P397; LOPEZCASILLAS F, 1994, J CELL BIOL, V124, P557, DOI 10.1083/jcb.124.4.557; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Medema JP, 1997, EUR J IMMUNOL, V27, P3492, DOI 10.1002/eji.1830271250; Mohamed SA, 2009, BIOMARK INSIGHTS, V4, P81; Mukhopadhyay A, 2010, J TRAUMA, V68, P999, DOI 10.1097/TA.0b013e3181c4070d; Mulligan-Kehoe MJ, 2007, ARTHRITIS RHEUM-US, V56, P3448, DOI 10.1002/art.22861; Mythreye K, 2009, CELL SIGNAL, V21, P1548, DOI 10.1016/j.cellsig.2009.05.001; Prakash MD, 2009, IMMUNOL CELL BIOL, V87, P249, DOI 10.1038/icb.2008.98; Raja SM, 2005, J BIOL CHEM, V280, P20752, DOI 10.1074/jbc.M501181200; Raja SM, 2002, J BIOL CHEM, V277, P49523, DOI 10.1074/jbc.M209607200; Ronday HK, 2001, RHEUMATOLOGY, V40, P55, DOI 10.1093/rheumatology/40.1.55; Schiller M, 2004, J DERMATOL SCI, V35, P83, DOI 10.1016/j.jdermsci.2003.12.006; SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776; Spaeny-Dekking EHA, 1998, J IMMUNOL, V160, P3610; Tak PP, 1999, CLIN EXP IMMUNOL, V116, P366; Tamarina NA, 1998, J SURG RES, V74, P76, DOI 10.1006/jsre.1997.5201; Taylor AW, 2009, J LEUKOCYTE BIOL, V85, P29, DOI 10.1189/jlb.0708415; Thomas DA, 2005, CANCER CELL, V8, P369, DOI 10.1016/j.ccr.2005.10.012; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; Velasco-Loyden G, 2004, J BIOL CHEM, V279, P7721, DOI 10.1074/jbc.M306499200; Veugelers K, 2006, MOL BIOL CELL, V17, P623, DOI 10.1091/mbc.E05-07-0631; Wu JH, 2001, J DERMATOL SCI, V27, P95, DOI 10.1016/S0923-1811(01)00102-5; YOUNG LHY, 1992, AM J PATHOL, V140, P1261	57	73	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33163	10.1371/journal.pone.0033163	http://dx.doi.org/10.1371/journal.pone.0033163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479366	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100035
J	Karimi, R; Tornling, G; Grunewald, J; Eklund, A; Skold, CM				Karimi, Reza; Tornling, Goran; Grunewald, Johan; Eklund, Anders; Skold, C. Magnus			Cell Recovery in Bronchoalveolar Lavage Fluid in Smokers Is Dependent on Cumulative Smoking History	PLOS ONE			English	Article							INTERSTITIAL LUNG-DISEASES; NORMAL VOLUNTEER SUBJECT; CIGARETTE-SMOKING; TOBACCO-SMOKE; ALVEOLAR MACROPHAGES; AIRWAY INFLAMMATION; LYMPHOCYTE SUBSETS; INDUCED SPUTUM; EX-SMOKERS; CESSATION	Background: Smoking is a risk factor for various lung diseases in which BAL may be used as a part of a clinical investigation. Interpretation of BAL fluid cellularity is however difficult due to high variability, in particular among smokers. In this study we aimed to evaluate the effect of smoking on BAL cellular components in asymptomatic smokers. The effects of smoking cessation, age and gender were also investigated in groups of smokers and exsmokers. Methods: We performed a retrospective review of BAL findings, to our knowledge the largest single center investigation, in our department from 1999 to 2009. One hundred thirty two current smokers (48 males and 84 females) and 44 ex-smokers (16 males and 28 females) were included. A group of 295 (132 males and 163 females) never-smokers served as reference. Result: The median [5-95 pctl] total number of cells and cell concentration in current smokers were 63.4 [28.6-132.1] x 10(6) and 382.1 [189.7-864.3] x 10(6)/L respectively and correlated positively to the cumulative smoking history. Macrophages were the predominant cell type (96.7% [90.4-99.0]) followed by lymphocytes (2% [0.8-7.7]) and neutrophils (0.6% [0-2.9]). The concentration of all inflammatory cells was increased in smokers compared to never smokers and ex-smokers. BAL fluid recovery was negatively correlated with age (p < 0.001). Smoking men had a lower BAL fluid recovery than smoking women. Conclusion: Smoking has a profound effect on BAL fluid cellularity, which is dependent on smoking history. Our results performed on a large group of current smokers and ex-smokers in a well standardized way, can contribute to better interpretation of BAL fluid cellularity in clinical context.	[Karimi, Reza; Tornling, Goran; Grunewald, Johan; Eklund, Anders; Skold, C. Magnus] Karolinska Inst, Div Resp Med, Dept Med, Karolinska Univ Hosp Solna, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Karimi, R (corresponding author), Karolinska Inst, Div Resp Med, Dept Med, Karolinska Univ Hosp Solna, Stockholm, Sweden.	reza.karimi@ki.se	Grunewald, Johan/GQZ-8122-2022	Grunewald, Johan/0000-0003-0473-3984	Swedish Research Council; Swedish Heart-Lung Foundation; Astra Zeneca; King Oscar II Jubilee Foundation; Torsten and Ragnar Soderbergs Foundation; Mats Kleeberg Foundation; King Gustaf V and Queen Victoria's Freemasons Foundation; Hesselmans Foundation; Karolinska Institutet; Stockholm County Council	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Astra Zeneca(AstraZeneca); King Oscar II Jubilee Foundation; Torsten and Ragnar Soderbergs Foundation; Mats Kleeberg Foundation; King Gustaf V and Queen Victoria's Freemasons Foundation; Hesselmans Foundation; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council)	This work was supported by the Swedish Research Council, the Swedish Heart-Lung Foundation, Astra Zeneca, the King Oscar II Jubilee Foundation, the Torsten and Ragnar Soderbergs Foundation, Mats Kleeberg Foundation, King Gustaf V and Queen Victoria's Freemasons Foundation, Hesselmans Foundation, Karolinska Institutet and through the Regional Agreement on Medical Training and Clinical Research (ALF) between Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, Eur Respir J, V2, P561; [Anonymous], 1990, Eur Respir J, V3, P937; [Anonymous], 1990, AM REV RESPIR DIS, V141, pS169; Arnson Y, 2010, J AUTOIMMUN, V34, pJ258, DOI 10.1016/j.jaut.2009.12.003; Babusyte A, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-81; Balbi B, 2007, EUR RESPIR J, V30, P769, DOI 10.1183/09031936.00112306; Birrell MA, 2008, J CELL PHYSIOL, V214, P27, DOI 10.1002/jcp.21158; BURKE WMJ, 1992, EUR RESPIR J, V5, P780; COSTABEL U, 1992, EUR RESPIR J, V5, P776; Domagala-Kulawik J, 2008, J PHYSIOL PHARMACOL, V59, P19; Domagala-Kulawik J, 2008, DIAGN CYTOPATHOL, V36, P909, DOI 10.1002/dc.20944; Dransfield MT, 2007, CHEST, V132, P464, DOI 10.1378/chest.07-0863; Elston WJ, 2004, EUR RESPIR J, V24, P375, DOI 10.1183/09031936.04.00063003; ETTENSOHN DB, 1988, CHEST, V94, P275, DOI 10.1378/chest.94.2.275; ETTENSOHN DB, 1988, CHEST, V94, P281, DOI 10.1378/chest.94.2.281; Flaherty KR, 2004, MED CLIN N AM, V88, P1643, DOI 10.1016/j.mcna.2004.08.001; Fraig M, 2002, AM J SURG PATHOL, V26, P647, DOI 10.1097/00000478-200205000-00011; GOLDSTEIN RA, 1990, AM REV RESPIR DIS, V142, P481; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Kollert F, 2009, INFLAMMATION, V32, P163, DOI 10.1007/s10753-009-9115-5; Kunz LIZ, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-34; Kuschner WG, 1996, EUR RESPIR J, V9, P1989, DOI 10.1183/09031936.96.09101989; LAM S, 1985, CHEST, V88, P856, DOI 10.1378/chest.88.6.856; Lapperre TS, 2006, THORAX, V61, P115, DOI 10.1136/thx.2005.040519; Lensmar C, 1998, EUR RESPIR J, V12, P595, DOI 10.1183/09031936.98.12030595; Lofdahl JM, 2006, CLIN EXP IMMUNOL, V145, P428, DOI 10.1111/j.1365-2249.2006.03154.x; Lofdahl JM, 2005, EUR RESPIR J, V25, P275, DOI 10.1183/09031936.05.00033504; Lommatzsch M, 2010, EUR RESPIR J, V35, P1130, DOI 10.1183/09031936.00090109; LUSUARDI M, 1994, THORAX, V49, P1211, DOI 10.1136/thx.49.12.1211; MacNee W, 2009, BIOCHEM SOC T, V37, P819, DOI 10.1042/BST0370819; MERCHANT RK, 1992, AM REV RESPIR DIS, V146, P448, DOI 10.1164/ajrccm/146.2.448; Meyer KC, 2007, SEMIN RESP CRIT CARE, V28, P546, DOI 10.1055/s-2007-991527; Mund E, 2001, THORAX, V56, P450, DOI 10.1136/thorax.56.6.450; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; RENNARD SI, 1990, EUR RESPIR J, V3, P752; Reynolds HY, 2000, LUNG, V178, P271, DOI 10.1007/s004080000032; REYNOLDS HY, 1974, J LAB CLIN MED, V84, P559; Roos-Engstrand E, 2009, COPD, V6, P112, DOI 10.1080/15412550902755358; Ryu JH, 2001, EUR RESPIR J, V17, P122, DOI 10.1183/09031936.01.17101220; SCHWARTZ DA, 1991, J APPL PHYSIOL, V71, P1688, DOI 10.1152/jappl.1991.71.5.1688; SCHWARTZ DA, 1992, AM REV RESPIR DIS, V145, P400, DOI 10.1164/ajrccm/145.2_Pt_1.400; SKOLD CM, 1990, EUR RESPIR J, V3, P842; SKOLD CM, 1989, EXP LUNG RES, V15, P823, DOI 10.3109/01902148909069629; Skold CM, 1996, CLIN EXP IMMUNOL, V106, P108, DOI 10.1046/j.1365-2249.1996.d01-805.x; SKOLD CM, 1992, CHEST, V101, P989, DOI 10.1378/chest.101.4.989; SUTINEN S, 1995, RESP MED, V89, P85, DOI 10.1016/0954-6111(95)90189-2; Takeuchi M, 2001, RESPIRATION, V68, P262, DOI 10.1159/000050508; TASKINEN EI, 1994, PATHOL ANNU, V29, P121; Tazi A, 2006, EUR RESPIR J, V27, P1272, DOI 10.1183/09031936.06.00024004; Torre O, 2010, RESP MED, V104, pS81, DOI 10.1016/j.rmed.2010.03.021; TURATO G, 1995, AM J RESP CRIT CARE, V152, P1262, DOI 10.1164/ajrccm.152.4.7551380; Wen Yudong, 2010, Int J Chron Obstruct Pulmon Dis, V5, P327, DOI 10.2147/COPD.S11343; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704	53	45	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34232	10.1371/journal.pone.0034232	http://dx.doi.org/10.1371/journal.pone.0034232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479573	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400063
J	Pereira, FD; Matte, U; Habekost, CT; de Castilhos, RM; El Husny, AS; Lourenco, CM; Vianna-Morgante, AM; Giuliani, L; Galera, MF; Honjo, R; Kim, CA; Politei, J; Vargas, CR; Jardim, LB				Pereira, Fernanda dos Santos; Matte, Ursula; Habekost, Clarissa Troller; de Castilhos, Raphael Machado; El Husny, Antonette Souto; Lourenco, Charles Marques; Vianna-Morgante, Angela M.; Giuliani, Liane; Galera, Marcial Francis; Honjo, Rachel; Kim, Chong Ae; Politei, Juan; Vargas, Carmen Regla; Jardim, Laura Bannach			Mutations, Clinical Findings and Survival Estimates in South American Patients with X-Linked Adrenoleukodystrophy	PLOS ONE			English	Article							GENE; FAMILIES; DNA	In this study, we analyzed the ABCD1 gene in X-linked adrenoleukodystrophy (X-ALD) patients and relatives from 38 unrelated families from South America, as well as phenotypic proportions, survival estimates, and the potential effect of geographical origin in clinical characteristics. Methods: X-ALD patients from Brazil, Argentina and Uruguay were invited to participate in molecular studies to determine their genetic status, characterize the mutations and improve the genetic counseling of their families. All samples were screened by SSCP analysis of PCR fragments, followed by automated DNA sequencing to establish the specific mutation in each family. Age at onset and at death, male phenotypes, genetic status of women, and the effect of family and of latitude of origin were also studied. Results: We identified thirty-six different mutations (twelve novel). This population had an important allelic heterogeneity, as only p. Arg518Gln was repeatedly found (three families). Four cases carried de novo mutations. Intra-familiar phenotype variability was observed in all families. Out of 87 affected males identified, 65% had the cerebral phenotype (CALD). The mean (95% CI) ages at onset and at death of the CALD were 10.9 (9.1-12.7) and 24.7 (19.8-29.6) years. No association was found between phenotypic manifestations and latitude of origin. One index-case was a girl with CALD who carried an ABCD1 mutation, and had completely skewed X inactivation. Conclusions: This study extends the spectrum of mutations in X-ALD, confirms the high rates of de novo mutations and the absence of common mutations, and suggests a possible high frequency of cerebral forms in our population.	[Pereira, Fernanda dos Santos; Matte, Ursula] Hosp Clin Porto Alegre, Gene Therapy Ctr, Porto Alegre, RS, Brazil; [Habekost, Clarissa Troller; de Castilhos, Raphael Machado; El Husny, Antonette Souto; Vargas, Carmen Regla; Jardim, Laura Bannach] Hosp Clin Porto Alegre, Med Genet Serv, Porto Alegre, RS, Brazil; [Pereira, Fernanda dos Santos; de Castilhos, Raphael Machado; Jardim, Laura Bannach] Univ Fed Rio Grande do Sul, Postgrad Program Med Sci, Porto Alegre, RS, Brazil; [Matte, Ursula; Habekost, Clarissa Troller; Jardim, Laura Bannach] Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol, Porto Alegre, RS, Brazil; [Vargas, Carmen Regla] Univ Fed Rio Grande do Sul, Dept Anal, Porto Alegre, RS, Brazil; [Jardim, Laura Bannach] Univ Fed Rio Grande do Sul, Dept Internal Med, Porto Alegre, RS, Brazil; [Lourenco, Charles Marques] Univ Sao Paulo, Hosp Clin Ribeirao Preto, Sao Paulo, Brazil; [Vianna-Morgante, Angela M.] Univ Sao Paulo, Inst Biosci, Dept Genet & Evolutionary Biol, Sao Paulo, Brazil; [Honjo, Rachel; Kim, Chong Ae] Univ Sao Paulo, Children Inst, Dept Genet, Sao Paulo, Brazil; [Giuliani, Liane] Univ Fed Mato Grosso do Sul, Dept Pediat, Campo Grande, Brazil; [Galera, Marcial Francis] Univ Cuiaba, Sch Med, Cuiaba, Brazil; [Politei, Juan] Hosp Juan A Fernandez, Dept Neurol, Neuromuscular Disorders & Neuropath Pain Sect, Buenos Aires, DF, Argentina	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Mato Grosso do Sul; Universidade de Cuiaba; University of Buenos Aires	Pereira, FD (corresponding author), Hosp Clin Porto Alegre, Gene Therapy Ctr, Porto Alegre, RS, Brazil.	ljardim@hcpa.ufrgs.br	Matte, Ursula/J-4589-2012; Cetgen, Inct/I-2412-2013; Da Silveira Matte umatte, Ursula/U-3912-2019; Jardim, Laura B/B-6149-2013; Vargas, Carmen/W-9939-2019	Da Silveira Matte umatte, Ursula/0000-0003-4977-6662; Kim, Chong/0000-0002-1754-1300	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao do Amparo a Pesquisa do Rio Grande do Sul (FAPERGS); Instituto Nacional de Genetica Medica Populacional (INAGEMP); Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE-HCPA)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao do Amparo a Pesquisa do Rio Grande do Sul (FAPERGS); Instituto Nacional de Genetica Medica Populacional (INAGEMP); Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE-HCPA)	This study was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao do Amparo a Pesquisa do Rio Grande do Sul (FAPERGS), Instituto Nacional de Genetica Medica Populacional (INAGEMP), and Fundo de Incentivo a Pesquisa do Hospital de Clinicas de Porto Alegre (FIPE-HCPA). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezman L, 2001, ANN NEUROL, V49, P512, DOI 10.1002/ana.101; Boehm CD, 1999, MOL GENET METAB, V66, P128, DOI 10.1006/mgme.1998.2779; Dubey P, 2005, NEUROLOGY, V64, P304, DOI 10.1212/01.WNL.0000149514.13580.84; Ferrer I, 2010, BRAIN PATHOL, V20, P817, DOI 10.1111/j.1750-3639.2010.00390.x; Guimaraes CP, 2002, MOL GENET METAB, V76, P62, DOI 10.1016/S1096-7192(02)00023-9; Heinzer AK, 2003, ADV EXP MED BIOL, V544, P75; Hershkovitz E, 2002, ANN NEUROL, V52, P234, DOI 10.1002/ana.10248; Imamura A, 1997, CLIN GENET, V51, P322; Ito R, 2001, NEUROLOGY, V56, P544, DOI 10.1212/WNL.56.4.544; Jardim LB, 2010, BRAIN DEV-JPN, V32, P180, DOI 10.1016/j.braindev.2009.02.002; Kemp S, 2001, HUM MUTAT, V18, P499, DOI 10.1002/humu.1227; Kemp S, 2010, BRAIN PATHOL, V20, P831, DOI 10.1111/j.1750-3639.2010.00391.x; Kumar N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025094; Maier EM, 2002, ANN NEUROL, V52, P683, DOI 10.1002/ana.10376; Matsumoto T, 2003, J HUM GENET, V48, P125, DOI 10.1007/s100380300019; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moser H., 2001, METABOLIC MOL BASES, VII, P3257; Raymond GV, 2010, J NEUROL SCI, V290, P70, DOI 10.1016/j.jns.2009.11.005; Simpson S, 2011, J NEUROL NEUROSUR PS, V82, P1132, DOI 10.1136/jnnp.2011.240432; Singh I, 2010, BRAIN PATHOL, V20, P838, DOI 10.1111/j.1750-3639.2010.00392.x; Takano H, 1999, ARCH NEUROL-CHICAGO, V56, P295, DOI 10.1001/archneur.56.3.295	21	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34195	10.1371/journal.pone.0034195	http://dx.doi.org/10.1371/journal.pone.0034195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479560	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400058
J	You, JHS; Chan, ESK; Leung, MYK; Ip, M; Lee, NLS				You, Joyce H. S.; Chan, Eva S. K.; Leung, Maggie Y. K.; Ip, Margaret; Lee, Nelson L. S.			A Cost-Effectiveness Analysis of "Test'' versus "Treat'' Patients Hospitalized with Suspected Influenza in Hong Kong	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUSES; REVERSE TRANSCRIPTION-PCR; A H1N1; VIRAL CULTURE; RAPID DIAGNOSIS; UNITED-STATES; B VIRUSES; FLU-A; INFECTION; ADULTS	Background: Seasonal and 2009 H1N1 influenza viruses may cause severe diseases and result in excess hospitalization and mortality in the older and younger adults, respectively. Early antiviral treatment may improve clinical outcomes. We examined potential outcomes and costs of test-guided versus empirical treatment in patients hospitalized for suspected influenza in Hong Kong. Methods: We designed a decision tree to simulate potential outcomes of four management strategies in adults hospitalized for severe respiratory infection suspected of influenza: "immunofluorescence-assay'' (IFA) or "polymerase-chain-reaction'' (PCR)-guided oseltamivir treatment, " empirical treatment plus PCR'' and "empirical treatment alone''. Model inputs were derived from literature. The average prevalence (11%) of influenza in 2010-2011 (58% being 2009 H1N1) among cases of respiratory infections was used in the base-case analysis. Primary outcome simulated was cost per quality-adjusted life-year (QALY) expected (ICER) from the Hong Kong healthcare providers' perspective. Results: In base-case analysis, "empirical treatment alone'' was shown to be the most cost-effective strategy and dominated the other three options. Sensitivity analyses showed that "PCR-guided treatment'' would dominate "empirical treatment alone'' when the daily cost of oseltamivir exceeded USD18, or when influenza prevalence was <2.5% and the predominant circulating viruses were not 2009 H1N1. Using USD50,000 as the threshold of willingness-to-pay, "empirical treatment alone'' and "PCR-guided treatment'' were cost-effective 97% and 3% of time, respectively, in 10,000 Monte-Carlo simulations. Conclusions: During influenza epidemics, empirical antiviral treatment appears to be a cost-effective strategy in managing patients hospitalized with severe respiratory infection suspected of influenza, from the perspective of healthcare providers in Hong Kong.	[You, Joyce H. S.; Chan, Eva S. K.; Leung, Maggie Y. K.] Chinese Univ Hong Kong, Fac Med, Sch Pharm, Ctr Pharmacoecon Res, Shatin, Hong Kong, Peoples R China; [Ip, Margaret] Chinese Univ Hong Kong, Dept Microbiol, Fac Med, Shatin, Hong Kong, Peoples R China; [Lee, Nelson L. S.] Chinese Univ Hong Kong, Dept Med & Therapeut, Fac Med, Div Infect Dis, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	You, JHS (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Pharm, Ctr Pharmacoecon Res, Shatin, Hong Kong, Peoples R China.	leelsn@cuhk.edu.hk	You, Joyce H. S./C-2984-2008; Lee, Nelson/B-6418-2008; Ip, Margaret/K-1096-2013	You, Joyce H. S./0000-0002-5763-7403; Lee, Nelson/0000-0002-0783-6607; Ip, Margaret/0000-0003-1291-6537	F. Hoffmann-La Roche Ltd.	F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche)	Dr. Lee has previously received grant support from F. Hoffmann-La Roche Ltd. on principal-investigator initiated clinical influenza research, paid to the Chinese University of Hong Kong, unrelated to the study of cost-effectiveness of oseltamivir treatment. F. Hoffmann- La Roche Ltd. has no role in the initiation, original conception, design and execution of this study, nor has any influence on the results. All other authors: no conflict of interest declared. This does not affect the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Boivin G, 2004, J CLIN MICROBIOL, V42, P45, DOI 10.1128/JCM.42.1.45-51.2004; Campbell CN, 2010, EPIDEMIOL INFECT, V26, P1, DOI DOI 10.1017/S0950268810002657; Cheng PKC, 2010, J CLIN VIROL, V47, P182, DOI 10.1016/j.jcv.2009.11.022; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Falsey AR, 2007, ARCH INTERN MED, V167, P354, DOI 10.1001/archinte.167.4.ioi60207; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Hui DS, 2010, CHEST, V137, P916, DOI 10.1378/chest.09-2344; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kaufman MA, 2009, MED J AUSTRALIA, V191, P154, DOI 10.5694/j.1326-5377.2009.tb02726.x; Lavelle TA, 2012, J PEDIATR-US, V160, P67, DOI 10.1016/j.jpeds.2011.07.001; Lee BY, 2011, AM J MANAG CARE, V17, P693; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Lee N, 2010, THORAX, V65, P510, DOI 10.1136/thx.2009.130799; Lee N, ANTIVIRAL T IN PRESS; Lee N, 2007, ANTIVIR THER, V12, P501; Lee N, 2011, J INFECT DIS, V203, P1739, DOI 10.1093/infdis/jir187; LeGoff J, 2008, J CLIN MICROBIOL, V46, P789, DOI 10.1128/JCM.00959-07; Louie JK, 2011, CLIN INFECT DIS, V52, P301, DOI 10.1093/cid/ciq152; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; McGeer AJ, 2009, CLIN INFECT DIS, V48, pS14, DOI 10.1086/591852; Mehlmann M, 2007, J CLIN MICROBIOL, V45, P1234, DOI 10.1128/JCM.02202-06; Okomo-Adhiambo M, 2010, VIRUSES-BASEL, V2, P2269, DOI 10.3390/v2102269; Rahman M, 2008, DIAGN MICR INFEC DIS, V62, P162, DOI 10.1016/j.diagmicrobio.2007.10.012; Shiley KT, 2010, INFECT CONT HOSP EP, V31, P676, DOI 10.1086/653204; Smit M, 2007, DIAGN MICR INFEC DIS, V57, P67, DOI 10.1016/j.diagmicrobio.2006.11.003; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; van den Hoeven AM, 2007, INFECTION, V35, P65, DOI 10.1007/s15010-007-6112-1; Venkata C, 2010, MAYO CLIN PROC, V85, P798, DOI 10.4065/mcp.2010.0166; Viasus D, 2011, CLIN MICROBIOL INFEC, V17, P738, DOI 10.1111/j.1469-0691.2010.03362.x; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; You JHS, 2009, J EPIDEMIOL COMMUN H, V63, P906, DOI 10.1136/jech.2008.081885; [No title captured]	35	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33123	10.1371/journal.pone.0033123	http://dx.doi.org/10.1371/journal.pone.0033123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479363	Green Published, Green Submitted, gold			2022-12-27	WOS:000304523400012
J	Ziemert, N; Podell, S; Penn, K; Badger, JH; Allen, E; Jensen, PR				Ziemert, Nadine; Podell, Sheila; Penn, Kevin; Badger, Jonathan H.; Allen, Eric; Jensen, Paul R.			The Natural Product Domain Seeker NaPDoS: A Phylogeny Based Bioinformatic Tool to Classify Secondary Metabolite Gene Diversity	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASES; MULTIPLE SEQUENCE ALIGNMENT; COMPLETE GENOME SEQUENCE; I POLYKETIDE SYNTHASES; CONDENSATION DOMAINS; SILICO PREDICTION; DRUG DISCOVERY; BIOSYNTHESIS; BACTERIAL; EVOLUTION	New bioinformatic tools are needed to analyze the growing volume of DNA sequence data. This is especially true in the case of secondary metabolite biosynthesis, where the highly repetitive nature of the associated genes creates major challenges for accurate sequence assembly and analysis. Here we introduce the web tool Natural Product Domain Seeker (NaPDoS), which provides an automated method to assess the secondary metabolite biosynthetic gene diversity and novelty of strains or environments. NaPDoS analyses are based on the phylogenetic relationships of sequence tags derived from polyketide synthase (PKS) and non-ribosomal peptide synthetase (NRPS) genes, respectively. The sequence tags correspond to PKS-derived ketosynthase domains and NRPS-derived condensation domains and are compared to an internal database of experimentally characterized biosynthetic genes. NaPDoS provides a rapid mechanism to extract and classify ketosynthase and condensation domains from PCR products, genomes, and metagenomic datasets. Close database matches provide a mechanism to infer the generalized structures of secondary metabolites while new phylogenetic lineages provide targets for the discovery of new enzyme architectures or mechanisms of secondary metabolite assembly. Here we outline the main features of NaPDoS and test it on four draft genome sequences and two metagenomic datasets. The results provide a rapid method to assess secondary metabolite biosynthetic gene diversity and richness in organisms or environments and a mechanism to identify genes that may be associated with uncharacterized biochemistry.	[Ziemert, Nadine; Penn, Kevin; Jensen, Paul R.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Badger, Jonathan H.] J Craig Venter Inst, San Diego, CA USA; [Podell, Sheila; Allen, Eric] Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; J. Craig Venter Institute; University of California System; University of California San Diego; Scripps Institution of Oceanography	Ziemert, N (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA.	pjensen@ucsd.edu	Ziemert, Nadine/H-1935-2015	Ziemert, Nadine/0000-0002-7264-1857; jensen, paul/0000-0003-2349-1888	National Institutes of Health [RO1GM086261, UO1TW0007401, RO1GM085770]; German Research Foundation (DFG) [1325/1-1]; FOGARTY INTERNATIONAL CENTER [U01TW007401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085770, R01GM086261] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grant numbers RO1GM086261 to PRJ, UO1TW0007401 to PRJ, and RO1GM085770 to PRJ, and a grant from the German Research Foundation (DFG 1325/1-1) to NZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Baker DD, 2007, NAT PROD REP, V24, P1225, DOI 10.1039/b602241n; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Blodgett JAV, 2010, P NATL ACAD SCI USA, V107, P11692, DOI 10.1073/pnas.1001513107; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Chang ZX, 2004, J NAT PROD, V67, P1356, DOI 10.1021/np0499261; Cundliffe E, 2001, ANTON LEEUW INT J G, V79, P229, DOI 10.1023/A:1012065300116; Davies J, 2011, CURR OPIN CHEM BIOL, V15, P5, DOI 10.1016/j.cbpa.2010.11.001; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Du LC, 2000, CHEM BIOL, V7, P623, DOI 10.1016/S1074-5521(00)00011-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards DJ, 2004, CHEM BIOL, V11, P817, DOI 10.1016/j.chembiol.2004.03.030; Eisen JA, 2003, SCIENCE, V300, P1706, DOI 10.1126/science.1086292; Eisen JA, 1998, NUCLEIC ACIDS RES, V26, P4291, DOI 10.1093/nar/26.18.4291; Eustaquio AS, 2011, CHEMBIOCHEM, V12, P61, DOI 10.1002/cbic.201000564; Eustaquio AS, 2009, P NATL ACAD SCI USA, V106, P12295, DOI 10.1073/pnas.0901237106; Finking R, 2004, ANNU REV MICROBIOL, V58, P453, DOI 10.1146/annurev.micro.58.030603.123615; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fischbach MA, 2006, CHEM REV, V106, P3468, DOI 10.1021/cr0503097; Foerstner KU, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003515; Freel KC, 2011, APPL ENVIRON MICROB, V77, P7261, DOI 10.1128/AEM.05943-11; Ginolhac A, 2005, J MOL EVOL, V60, P716, DOI 10.1007/s00239-004-0161-1; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Gontang EA, 2007, APPL ENVIRON MICROB, V73, P3272, DOI 10.1128/AEM.02811-06; Gontang EA, 2010, APPL ENVIRON MICROB, V76, P2487, DOI 10.1128/AEM.02852-09; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Hornung A, 2007, CHEMBIOCHEM, V8, P757, DOI 10.1002/cbic.200600375; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Jenke-Kodama H, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100033; Jenke-Kodama H, 2009, PHYTOCHEMISTRY, V70, P1858, DOI 10.1016/j.phytochem.2009.05.021; Jenke-Kodama H, 2009, NAT PROD REP, V26, P874, DOI 10.1039/b810283j; Jensen PR, 2007, APPL ENVIRON MICROB, V73, P1146, DOI 10.1128/AEM.01891-06; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Lautru S, 2005, NAT CHEM BIOL, V1, P265, DOI 10.1038/nchembio731; Lautru S, 2004, MICROBIOL-SGM, V150, P1629, DOI 10.1099/mic.0.26837-0; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Maddison WP, 2019, MESQUITE MODULAR SYS; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McAlpine JB, 2005, J NAT PROD, V68, P493, DOI 10.1021/np0401664; McPherson JD, 2009, NAT METHODS, V6, pS2, DOI [10.1038/NMETH.F.268, 10.1038/nmeth.f.268]; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Metsa-Ketela M, 1999, FEMS MICROBIOL LETT, V180, P1; Moffitt MC, 2003, J MOL EVOL, V56, P446, DOI 10.1007/s00239-002-2415-0; Moore BS, 2001, CHEMBIOCHEM, V2, P35, DOI 10.1002/1439-7633(20010105)2:1<35::AID-CBIC35>3.3.CO;2-T; Moss SJ, 2004, NAT PROD REP, V21, P575, DOI 10.1039/b315020h; Nett M, 2009, J MED CHEM, V52, P6163, DOI 10.1021/jm901098m; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nguyen T, 2008, NAT BIOTECHNOL, V26, P225, DOI 10.1038/nbt1379; Penn K, 2009, ISME J, V3, P1193, DOI 10.1038/ismej.2009.58; Piel J, 2010, NAT PROD REP, V27, P996, DOI 10.1039/b816430b; Rausch C, 2005, NUCLEIC ACIDS RES, V33, P5799, DOI 10.1093/nar/gki885; Rausch C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-78; Ridley CP, 2008, P NATL ACAD SCI USA, V105, P4595, DOI 10.1073/pnas.0710107105; Roongsawang N, 2005, FEMS MICROBIOL LETT, V252, P143, DOI 10.1016/j.femsle.2005.08.041; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Shulse CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020146; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Starcevic A, 2008, NUCLEIC ACIDS RES, V36, P6882, DOI 10.1093/nar/gkn685; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Udwary DW, 2007, P NATL ACAD SCI USA, V104, P10376, DOI 10.1073/pnas.0700962104; Weissman KJ, 2004, PHILOS T R SOC A, V362, P2671, DOI 10.1098/rsta.2004.1470; Wenzel SC, 2005, CURR OPIN CHEM BIOL, V9, P447, DOI 10.1016/j.cbpa.2005.08.001; Winter JM, 2011, CURR OPIN CHEM BIOL, V15, P22, DOI 10.1016/j.cbpa.2010.10.020; Yadav G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000351	70	287	297	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34064	10.1371/journal.pone.0034064	http://dx.doi.org/10.1371/journal.pone.0034064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479523	Green Published, gold			2022-12-27	WOS:000304523400053
J	Payne, KM; Hatfull, GF				Payne, Kimberly M.; Hatfull, Graham F.			Mycobacteriophage Endolysins: Diverse and Modular Enzymes with Multiple Catalytic Activities	PLOS ONE			English	Article							CELL-WALL; PSEUDOMONAS-AERUGINOSA; N-GLYCOLYLATION; OUTER-MEMBRANE; MS6 ENCODES; PEPTIDOGLYCAN; IDENTIFICATION; GENOMES; TUBERCULOSIS; PHAGE	The mycobacterial cell wall presents significant challenges to mycobacteriophages - viruses that infect mycobacterial hosts - because of its unusual structure containing a mycolic acid-rich mycobacterial outer membrane attached to an arabinogalactan layer that is in turn linked to the peptidoglycan. Although little is known about how mycobacteriophages circumvent these barriers during the process of infection, destroying it for lysis at the end of their lytic cycles requires an unusual set of functions. These include Lysin B proteins that cleave the linkage of mycolic acids to the arabinogalactan layer, chaperones required for endolysin delivery to peptidoglycan, holins that regulate lysis timing, and the endolysins (Lysin As) that hydrolyze peptidoglycan. Because mycobacterial peptidoglycan contains atypical features including 3 -> 3 interpeptide linkages, it is not surprising that the mycobacteriophage endolysins also have non-canonical features. We present here a bioinformatic dissection of these lysins and show that they are highly diverse and extensively modular, with an impressive number of domain organizations. Most contain three domains with a novel N- terminal predicted peptidase, a centrally located amidase, muramidase, or transglycosylase, and a C-terminal putative cell wall binding domain.	[Payne, Kimberly M.; Hatfull, Graham F.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Payne, KM (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	gfh@pitt.edu			National Institutes of Health [GM093901]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM093901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM093901 to GFH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM A, 1969, FEBS LETT, V4, P87, DOI 10.1016/0014-5793(69)80203-6; Adindla S, 2004, COMP FUNCT GENOM, V5, P2, DOI 10.1002/cfg.358; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bernhardt TG, 2002, RES MICROBIOL, V153, P493, DOI 10.1016/S0923-2508(02)01330-X; BIENKOWSKASZEWCZYK K, 1981, MOL GEN GENET, V184, P111, DOI 10.1007/BF00271205; Both D, 2011, J MOL BIOL; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Briers Y, 2011, J APPL MICROBIOL, V110, P778, DOI 10.1111/j.1365-2672.2010.04931.x; Briers Y, 2007, MOL MICROBIOL, V65, P1334, DOI 10.1111/j.1365-2958.2007.05870.x; Catalao MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020515; Catalao MJ, 2010, MOL MICROBIOL, V77, P672, DOI 10.1111/j.1365-2958.2010.07239.x; Catalao MJ, 2011, J BACTERIOL; Cresawn SG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-395; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P5108, DOI 10.1128/AEM.03065-05; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Garcia M, 2002, J BACTERIOL, V184, P3034, DOI 10.1128/JB.184.11.3034-3043.2002; Gil F, 2008, MICROBIOL-SGM, V154, P1364, DOI 10.1099/mic.0.2007/014621-0; Gil F, 2010, MICROBIOL-SGM, V156, P1497, DOI 10.1099/mic.0.032821-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Hatfull GF, 2012, J VIROLOGY IN PRESS; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; HENRISSAT B, 1995, P NATL ACAD SCI USA, V92, P7090, DOI 10.1073/pnas.92.15.7090; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Korndorfer IP, 2008, ACTA CRYSTALLOGR D, V64, P644, DOI 10.1107/S0907444908007890; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Lopez R, 1997, MICROB DRUG RESIST, V3, P199, DOI 10.1089/mdr.1997.3.199; Mahapatra S, 2005, J BACTERIOL, V187, P2341, DOI 10.1128/JB.187.7.2341-2347.2005; Manoharadas S, 2009, J BIOTECHNOL, V139, P118, DOI 10.1016/j.jbiotec.2008.09.003; Marinelli LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003957; Mikoulinskaia GV, 2009, FEBS J, V276, P7329, DOI 10.1111/j.1742-4658.2009.07443.x; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Pavelka MS, 1996, J BACTERIOL, V178, P6496, DOI 10.1128/jb.178.22.6496-6507.1996; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; PETIT JF, 1969, BIOCHEM BIOPH RES CO, V35, P478, DOI 10.1016/0006-291X(69)90371-4; Petrovski S, 2011, APPL ENVIRON MICROB, V77, P1389, DOI 10.1128/AEM.01938-10; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026750; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Raymond JB, 2005, J BIOL CHEM, V280, P326, DOI 10.1074/jbc.M411006200; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sudiarta IP, 2010, J BIOL CHEM, V285, P41232, DOI 10.1074/jbc.M110.156273; Summer EJ, 2011, APPL ENVIRON MICROB, V77, P669, DOI 10.1128/AEM.01952-10; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; WIETZERBIN J, 1974, BIOCHEMISTRY-US, V13, P3471, DOI 10.1021/bi00714a008; Xu M, 2005, SCIENCE, V307, P113, DOI 10.1126/science.1105143	59	79	88	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34052	10.1371/journal.pone.0034052	http://dx.doi.org/10.1371/journal.pone.0034052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470512	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000304489000056
J	Rezlescu, C; Duchaine, B; Olivola, CY; Chater, N				Rezlescu, Constantin; Duchaine, Brad; Olivola, Christopher Y.; Chater, Nick			Unfakeable Facial Configurations Affect Strategic Choices in Trust Games with or without Information about Past Behavior	PLOS ONE			English	Article							1ST IMPRESSIONS; FACE; TRUSTWORTHINESS; INFERENCES; ACCURACY	Background: Many human interactions are built on trust, so widespread confidence in first impressions generally favors individuals with trustworthy-looking appearances. However, few studies have explicitly examined: 1) the contribution of unfakeable facial features to trust-based decisions, and 2) how these cues are integrated with information about past behavior. Methodology/Principal Findings: Using highly controlled stimuli and an improved experimental procedure, we show that unfakeable facial features associated with the appearance of trustworthiness attract higher investments in trust games. The facial trustworthiness premium is large for decisions based solely on faces, with trustworthy identities attracting 42% more money (Study 1), and remains significant though reduced to 6% when reputational information is also available (Study 2). The face trustworthiness premium persists with real (rather than virtual) currency and when higher payoffs are at stake (Study 3). Conclusions/Significance: Our results demonstrate that cooperation may be affected not only by controllable appearance cues (e. g., clothing, facial expressions) as shown previously, but also by features that are impossible to mimic (e. g., individual facial structure). This unfakeable face trustworthiness effect is not limited to the rare situations where people lack any information about their partners, but survives in richer environments where relevant details about partner past behavior are available.	[Rezlescu, Constantin] UCL, London, England; [Duchaine, Brad] Dartmouth Coll, Dept Psychol & Brain Sci, Hanover, NH 03755 USA; [Olivola, Christopher Y.; Chater, Nick] Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England	University of London; University College London; Dartmouth College; University of Warwick	Rezlescu, C (corresponding author), UCL, London, England.	c.rezlescu@ucl.ac.uk	Chater, Nick/GRX-6742-2022; Olivola, Christopher/A-5630-2010; Rezlescu, Constantin/C-3314-2012	Olivola, Christopher/0000-0002-3359-3055; Rezlescu, Constantin/0000-0001-8960-6305	ELSE (ESRC Centre for Economic Learning and Social Evolution); AXA; Royal Society; British Academy; Royal Academy of Engineering	ELSE (ESRC Centre for Economic Learning and Social Evolution); AXA; Royal Society(Royal Society of London); British Academy; Royal Academy of Engineering(Royal Academy of Engineering - UK)	This research was supported by ELSE (ESRC Centre for Economic Learning and Social Evolution), by a Ph.D. fellowship from the AXA Research Fund (www.axa-research.org, to C.R.), and by a Newton postdoctoral fellowship from the Royal Society, The British Academy, and The Royal Academy of Engineering (to C.Y.O.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrow K, 1973, LIMITS ORG; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; BERRY DS, 1991, J PERS SOC PSYCHOL, V61, P298, DOI 10.1037/0022-3514.61.2.298; Bond CF, 2008, PSYCHOL BULL, V134, P477, DOI 10.1037/0033-2909.134.4.477; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Chang LJ, 2010, COGNITIVE PSYCHOL, V61, P87, DOI 10.1016/j.cogpsych.2010.03.001; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; Fukuyama F., 1995, TRUST SOCIAL VIRTUES; Gorn GJ, 2008, J CONSUM RES, V35, P36, DOI 10.1086/529533; Hassin R, 2000, J PERS SOC PSYCHOL, V78, P837, DOI 10.1037/0022-3514.78.5.837; Mueller U, 1996, SOC FORCES, V74, P823, DOI 10.2307/2580383; Olivola CY, 2010, J NONVERBAL BEHAV, V34, P83, DOI 10.1007/s10919-009-0082-1; Olivola CY, 2010, J EXP SOC PSYCHOL, V46, P315, DOI 10.1016/j.jesp.2009.12.002; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Scharlemann JPW, 2001, J ECON PSYCHOL, V22, P617, DOI 10.1016/S0167-4870(01)00059-9; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P195, DOI 10.1093/scan/nsn013; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; van't Wout M, 2008, COGNITION, V108, P796, DOI 10.1016/j.cognition.2008.07.002; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Xiao E, 2005, P NATL ACAD SCI USA, V102, P7398, DOI 10.1073/pnas.0502399102; ZEBROWITZ LA, 1991, LAW HUMAN BEHAV, V15, P603, DOI 10.1007/BF01065855	22	115	119	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34293	10.1371/journal.pone.0034293	http://dx.doi.org/10.1371/journal.pone.0034293			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948FM	22470553	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000092
J	Santos, CSA; Monteiro, MS; Soares, AMVM; Loureiro, S				Santos, Catia S. A.; Monteiro, Marta S.; Soares, Amadeu M. V. M.; Loureiro, Susana			Characterization of Cholinesterases in Plasma of Three Portuguese Native Bird Species: Application to Biomonitoring	PLOS ONE			English	Article							ACETYLCHOLINESTERASE ACTIVITY; PESTICIDE EXPOSURE; CARBAMATE PESTICIDES; INHIBITION; BIOMARKER; ORGANOPHOSPHATE; SEABIRDS	Over the last decades the inhibition of plasma cholinesterase (ChE) activity has been widely used as a biomarker to diagnose organophosphate and carbamate exposure. Plasma ChE activity is a useful and non-invasive method to monitor bird exposure to anticholinesterase compounds; nonetheless several studies had shown that the ChE form(s) present in avian plasma may vary greatly among species. In order to support further biomonitoring studies and provide reference data for wildlife risk-assessment, plasma cholinesterase of the northern gannet (Morus bassanus), the white stork (Ciconia ciconia) and the grey heron (Ardea cinerea) were characterized using three substrates (acetylthiocholine iodide, propionylthiocholine iodide, and S-butyrylthiocholine iodide) and three ChE inhibitors (eserine sulphate, BW284C51, and iso-OMPA). Additionally, the range of ChE activity that may be considered as basal levels for non-exposed individuals was determined. The results suggest that in the plasma of the three species studied the main cholinesterase form present is butyrylcholinesterase (BChE). Plasma BChE activity in non-exposed individuals was 0.48 +/- 0.11 SD U/ml, 0.39 +/- 0.12 SD U/ml, 0.15 +/- 0.04 SD U/ml in the northern gannet, white stork and grey heron, respectively. These results are crucial for the further use of plasma BChE activity in these bird species as a contamination bioindicator of anti-cholinesterase agents in both wetland and marine environments. Our findings also underscore the importance of plasma ChE characterization before its use as a biomarker in biomonitoring studies with birds.	[Santos, Catia S. A.] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; Univ Aveiro, CESAM, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro	Santos, CSA (corresponding author), Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.	catiasantos@ua.pt	Santos, Cátia/F-9296-2012; Monteiro, Marta/B-2830-2009; Soares, Amadeu/A-8304-2008; Loureiro, Susana/B-4462-2008; Santos, Cátia/AAA-3530-2019	Santos, Cátia/0000-0002-8350-7573; Monteiro, Marta/0000-0002-1891-7365; Soares, Amadeu/0000-0003-0879-9470; Loureiro, Susana/0000-0002-5393-9623; Santos, Cátia/0000-0002-8350-7573	Portuguese Foundation for Science and Technology [FCT/SFRH/BPD/45911/2008]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	The Portuguese Foundation for Science and Technology supported the postdoctoral fellowship of M. S. Monteiro (FCT/SFRH/BPD/45911/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat JA, 2010, CONSERVATION MONITORING IN FRESHWATER HABITATS: A PRACTICAL GUIDE AND CASE STUDIES, P45, DOI 10.1007/978-1-4020-9278-7_5; [Anonymous], 1974, ORGANOPHOSPHORUS PES; AUSTIN L, 1953, BIOCHEM J, V53, pR9; Blakley BR, 2002, VET HUM TOXICOL, V44, P129; Cordi B, 1997, ENVIRON TOXICOL CHEM, V16, P2118, DOI [10.1002/etc.5620161019, 10.1897/1551-5028(1997)016&lt;2118:TBRIWP&gt;2.3.CO;2]; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fildes K, 2009, EMU, V109, P41, DOI 10.1071/MU08027; Fossi MC, 1994, ECOTOXICOLOGY, P11; Franson JC, 1999, SEMIN AVIAN EXOT PET, V8, P3, DOI 10.1016/S1055-937X(99)80030-9; Frasco MF, 2005, BIOMARKERS, V10, P360, DOI 10.1080/13547500500264660; Garcia LM, 2000, BIOMARKERS, V5, P274, DOI 10.1080/135475000413827; Goldstein MI, 1999, ECOTOXICOLOGY, V8, P215, DOI 10.1023/A:1026448415467; Grue CE, 1997, AM ZOOL, V37, P369; Guilhermino L, 1996, CHEMOSPHERE, V32, P727, DOI 10.1016/0045-6535(95)00360-6; Guilhermino L, 1998, BIOMARKERS, V3, P157, DOI 10.1080/135475098231318; Hill E. F, 2003, HDB ECOTOXICOLOGY, P281; McInnes PF, 1996, ENVIRON TOXICOL CHEM, V15, P544, DOI [10.1897/1551-5028(1996)015&lt;0544:MEONST&gt;2.3.CO;2, 10.1002/etc.5620150420]; Monteiro M, 2005, ECOTOX ENVIRON SAFE, V62, P341, DOI 10.1016/j.ecoenv.2004.12.007; Moralev S.N., 2007, COMP ENZYMOLOGY CHOL, P15; Oropesa AL, 2007, SCI TOTAL ENVIRON, V372, P532, DOI 10.1016/j.scitotenv.2006.09.006; Parsons KC, 2000, ENV TOXICOLOGY CHEM, V19; Radic Z, 2006, TOXICOLOGY ORGANOPHO, P161; Roy C, 2005, J WILDLIFE DIS, V41, P184, DOI 10.7589/0090-3558-41.1.184; Sanchez-Hernandez J.C., 2007, ENVIRON SCI POLICY, P1; Sanchez-Hernandez JC, 2002, ENVIRON TOXICOL CHEM, V21, P2319, DOI [10.1897/1551-5028(2002)021<2319:LCABOP>2.0.CO;2, 10.1897/1551-5028(2002)021&lt;2319:LCABOP&gt;2.0.CO;2]; Strum KM, 2008, ORNITOL NEOTROP, V19, P641	27	19	19	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33975	10.1371/journal.pone.0033975	http://dx.doi.org/10.1371/journal.pone.0033975			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470503	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000048
J	Arca, M; Hinsinger, DD; Cruaud, C; Tillier, A; Bousquet, J; Frascaria-Lacoste, N				Arca, Mariangela; Hinsinger, Damien Daniel; Cruaud, Corinne; Tillier, Annie; Bousquet, Jean; Frascaria-Lacoste, Nathalie			Deciduous Trees and the Application of Universal DNA Barcodes: A Case Study on the Circumpolar Fraxinus	PLOS ONE			English	Article							NUCLEAR RIBOSOMAL DNA; TRANSCRIBED SPACER; LAND PLANTS; BIOLOGICAL IDENTIFICATIONS; PHYLOGENETIC-RELATIONSHIPS; SPECIES IDENTIFICATION; EVOLUTIONARY RATES; GENETIC DIVERSITY; CHLOROPLAST DNA; PICEA PINACEAE	The utility of DNA barcoding for identifying representative specimens of the circumpolar tree genus Fraxinus (56 species) was investigated. We examined the genetic variability of several loci suggested in chloroplast DNA barcode protocols such as matK, rpoB, rpoC1 and trnH-psbA in a large worldwide sample of Fraxinus species. The chloroplast intergenic spacer rpl32-trnL was further assessed in search for a potentially variable and useful locus. The results of the study suggest that the proposed cpDNA loci, alone or in combination, cannot fully discriminate among species because of the generally low rates of substitution in the chloroplast genome of Fraxinus. The intergenic spacer trnH-psbA was the best performing locus, but genetic distance-based discrimination was moderately successful and only resulted in the separation of the samples at the subgenus level. Use of the BLAST approach was better than the neighbor-joining tree reconstruction method with pairwise Kimura's two-parameter rates of substitution, but allowed for the correct identification of only less than half of the species sampled. Such rates are substantially lower than the success rate required for a standardised barcoding approach. Consequently, the current cpDNA barcodes are inadequate to fully discriminate Fraxinus species. Given that a low rate of substitution is common among the plastid genomes of trees, the use of the plant cpDNA "universal" barcode may not be suitable for the safe identification of tree species below a generic or sectional level. Supplementary barcoding loci of the nuclear genome and alternative solutions are proposed and discussed.	[Arca, Mariangela; Hinsinger, Damien Daniel; Frascaria-Lacoste, Nathalie] Univ Paris 11, UMR 8079, Orsay, France; [Arca, Mariangela; Hinsinger, Damien Daniel; Frascaria-Lacoste, Nathalie] CNRS, UMR 8079, F-91405 Orsay, France; [Arca, Mariangela; Hinsinger, Damien Daniel; Frascaria-Lacoste, Nathalie] AgroParisTech, UMR 8079, Orsay, France; [Hinsinger, Damien Daniel; Bousquet, Jean] Univ Laval, Ctr Etude Foret, Chaire Rech Canada Genom Forestiere & Environm, Quebec City, PQ, Canada; [Cruaud, Corinne] Ctr Natl Sequencage, Evry, France; [Tillier, Annie] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France; [Tillier, Annie] Museum Natl Hist Nat, Serv Systemat Mol, F-75231 Paris, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Laval University; UDICE-French Research Universities; Universite Paris Saclay; Museum National d'Histoire Naturelle (MNHN); Museum National d'Histoire Naturelle (MNHN)	Arca, M (corresponding author), Univ Paris 11, UMR 8079, Orsay, France.	damien.hinsinger@u-psud.fr; nathalie.frascaria@u-psud.fr	Hinsinger, Damien/V-5892-2019	Hinsinger, Damien/0000-0001-7459-7610; Cruaud, Corinne/0000-0002-4752-7278; Frascaria-Lacoste, Nathalie/0000-0002-3425-7838	Ministere des Affaires Etrangeres; French Ministry of Education; Universite Paris-Sud [11]; "Consortium National de Recherche en Genomique" of the Museum National d'Histoire Naturelle [IFR 101]; "Service de Systematique Moleculaire" of Museum National d'Histoire Naturelle [IFR 101]; European research contract [RAP-QLK-52001-00631]	Ministere des Affaires Etrangeres; French Ministry of Education; Universite Paris-Sud; "Consortium National de Recherche en Genomique" of the Museum National d'Histoire Naturelle; "Service de Systematique Moleculaire" of Museum National d'Histoire Naturelle; European research contract	D.D. Hinsinger is the recipient of a fellowship from the Ministere des Affaires Etrangeres (Bourse Lavoisier) and received financial support from the French Ministry of Education and the Universite Paris-Sud 11 (Orsay). This work was supported by the "Consortium National de Recherche en Genomique", and the "Service de Systematique Moleculaire'' of the Museum National d'Histoire Naturelle (IFR 101). It is part of agreement no. 2005/67 between Genoscope and the Museum National d'Histoire Naturelle on the project "Macrophylogeny of Life", directed by Guillaume Lecointre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the staff at all arboreta, botanical gardens and nurseries listed in Table S1 who kindly provided samples, as well as Kazuya Iizuka (Utsunomiya University) and Naoko Miyamoto (Forestry and Forest Products Research Institute) who provided samples from wild Japanese species, Jean Dufour (INRA Orleans) for his help in population sampling under the framework of the European research contract RAP-QLK-52001-00631, and Paola Bertolino for her very useful help in the laboratory and with field collections.	Ashton P. S., 1969, Biological Journal of the Linnean Society, V1, P155, DOI 10.1111/j.1095-8312.1969.tb01818.x; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Ball SL, 2005, J N AM BENTHOL SOC, V24, P508, DOI 10.1899/04-142.1; Besnard G, 2009, ANN BOT-LONDON, V104, P143, DOI 10.1093/aob/mcp105; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Borek K, 2009, PIERCE CEDAR CREEK I; Bouille M, 2005, AM J BOT, V92, P63, DOI 10.3732/ajb.92.1.63; Bouille M, 2011, TREE GENET GENOMES, V7, P469, DOI 10.1007/s11295-010-0349-z; BOUSQUET J, 1992, P NATL ACAD SCI USA, V89, P7844, DOI 10.1073/pnas.89.16.7844; Campbell CS, 2005, MOL PHYLOGENET EVOL, V35, P165, DOI 10.1016/j.ympev.2004.11.010; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Clare EL, 2007, MOL ECOL NOTES, V7, P184, DOI 10.1111/j.1471-8286.2006.01657.x; Cunningham CW, 1997, SYST BIOL, V46, P464, DOI 10.2307/2413692; Dexter KG, 2010, ECOL MONOGR, V80, P267, DOI 10.1890/09-0267.1; DJURDJEVIC L, 1998, ARCH BIOL SCI BELGRA, V50, P21; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Fernandez-Manjarres JF, 2006, MOL ECOL, V15, P3245, DOI 10.1111/j.1365-294X.2006.02975.x; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Franc A, 1996, AUTECOLOGIE FEUILLUS, P15; FRASCARIA N, 1993, GENOME, V36, P668, DOI 10.1139/g93-089; Friesen N, 2001, MOL BIOL EVOL, V18, P1176, DOI 10.1093/oxfordjournals.molbev.a003905; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Gerard PR, 2006, MOL ECOL, V15, P3655, DOI 10.1111/j.1365-294X.2006.03032.x; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; Gigot G., 2007, LANKESTERIANA INT J, V7, P200, DOI [DOI 10.15517/LANK.V7I1-2.19502, 10.15517/lank.v7i1-2.19502]; Gu J, 2011, J SYST EVOL, V49, P213, DOI 10.1111/j.1759-6831.2011.00136.x; Guillet-Claude C, 2004, MOL BIOL EVOL, V21, P2232, DOI 10.1093/molbev/msh235; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamzeh M, 2004, AM J BOT, V91, P1398, DOI 10.3732/ajb.91.9.1398; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heuertz M, 2006, MOL ECOL, V15, P2131, DOI 10.1111/j.1365-294X.2006.02897.x; Hoggard GD, 2004, AM J BOT, V91, P139, DOI 10.3732/ajb.91.1.139; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Jeandroz S, 1997, MOL PHYLOGENET EVOL, V7, P241, DOI 10.1006/mpev.1996.0393; JOHNSON LA, 1995, ANN MO BOT GARD, V82, P149, DOI 10.2307/2399875; JOHNSON LA, 1994, SYST BOT, V19, P143, DOI 10.2307/2419718; Kelly LJ, 2010, TAXON, V59, P251, DOI 10.1002/tax.591023; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kinlaw CS, 1997, TRENDS PLANT SCI, V2, P356, DOI 10.1016/S1360-1385(97)84624-9; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Laroche J, 1997, P NATL ACAD SCI USA, V94, P5722, DOI 10.1073/pnas.94.11.5722; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Le Clerc-Blain J, 2010, MOL ECOL RESOUR, V10, P69, DOI 10.1111/j.1755-0998.2009.02725.x; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Li JH, 2002, SYST BOT, V27, P592; Linder CR, 2000, MOL PHYLOGENET EVOL, V14, P285, DOI 10.1006/mpev.1999.0706; Lingelsheim A, 1920, DAS PFLANZENREICH, P1; Liu J, 2011, MOL ECOL RESOUR, V11, P89, DOI 10.1111/j.1755-0998.2010.02907.x; Logacheva MD, 2010, MOL PHYLOGENET EVOL, V57, P471, DOI 10.1016/j.ympev.2010.06.001; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Luo K, 2010, SCI CHINA LIFE SCI, V53, P701, DOI 10.1007/s11427-010-4009-1; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Mayol M, 2001, MOL PHYLOGENET EVOL, V19, P167, DOI 10.1006/mpev.2001.0934; Miller GN, 1955, N AM N MEXICO; Morand-Prieur ME, 2002, MOL ECOL, V11, P613, DOI 10.1046/j.1365-294X.2002.01453.x; Mort ME, 2010, TAXON, V59, P581, DOI 10.1002/tax.592022; Muellner AN, 2011, MOL ECOL RESOUR, V11, P450, DOI 10.1111/j.1755-0998.2011.02984.x; Muellner AN, 2005, AM J BOT, V92, P534, DOI 10.3732/ajb.92.3.534; Muellner AN, 2003, AM J BOT, V90, P471, DOI 10.3732/ajb.90.3.471; Muellner AN, 2009, MOL PHYLOGENETICS EV, V52; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nitta JH, 2008, TAXON, V57, P725, DOI 10.1002/tax.573006; Okuyama Y, 2005, MOL BIOL EVOL, V22, P285, DOI 10.1093/molbev/msi016; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Pavy N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-21; Pelgas B, 2006, THEOR APPL GENET, V113, P1371, DOI 10.1007/s00122-006-0354-7; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Plunkett GM, 1997, AM J BOT, V84, P565, DOI 10.2307/2446032; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Ragupathy S, 2009, MOL ECOL RESOUR, V9, P164, DOI 10.1111/j.1755-0998.2009.02641.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reichheld JP, 2002, PLANT PHYSIOL BIOCH, V40, P685, DOI 10.1016/S0981-9428(02)01406-7; RIESEBERG LH, 1994, TAXON, V43, P21, DOI 10.2307/1223457; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Rubinoff D, 2006, TRENDS ECOL EVOL, V21, P1, DOI 10.1016/j.tree.2005.10.019; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santamour FSJ, 1962, ANN BOT, V104, P143; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; SAVARD L, 1993, MOL PHYLOGENET EVOL, V2, P112, DOI 10.1006/mpev.1993.1011; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Stanford AM, 2000, AM J BOT, V87, P872, DOI 10.2307/2656895; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Thomasset M, 2011, CLIMATE CHANGE ECOLO, P320, DOI DOI 10.1017/CBO9780511974540.016; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Van De Wiel CCM, 2009, MOL ECOL RESOUR, V9, P1086, DOI 10.1111/j.1755-0998.2009.02547.x; Vandepoele K, 2002, GENOME RES, V12, P1792, DOI 10.1101/gr.400202; Wallander E, 2000, AM J BOT, V87, P1827, DOI 10.2307/2656836; Wallander E, 2008, PLANT SYST EVOL, V273, P25, DOI 10.1007/s00606-008-0005-3; Wang Q, 2011, J SYST EVOL, V49, P182, DOI 10.1111/j.1759-6831.2011.00135.x; Wang YiHong, 2009, Acta Horticulturae Sinica, V36, P1651; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Wei Z, 1996, FLORA CHINA, P273; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Willyard A, 2009, MOL PHYLOGENET EVOL, V52, P498, DOI 10.1016/j.ympev.2009.02.011; Xiang QY, 1998, AM J BOT, V85, P285, DOI 10.2307/2446317; Xiang XG, 2011, J SYST EVOL, V49, P252, DOI 10.1111/j.1759-6831.2011.00116.x; Yamashiro T, 2004, MOL PHYLOGENET EVOL, V31, P689, DOI 10.1016/j.ympev.2003.08.016; Yao H, 2009, PLANTA MED, V75, P667, DOI 10.1055/s-0029-1185385; Yoo KO, 2007, PLANT SYST EVOL, V267, P25, DOI 10.1007/s00606-007-0533-2; Yuan WJ, 2010, J SYST EVOL, V48, P482, DOI 10.1111/j.1759-6831.2010.00099.x; Zhou L, 2008, J PHARMACEUT BIOMED, V47, P39, DOI 10.1016/j.jpba.2007.12.009	125	32	36	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34089	10.1371/journal.pone.0034089	http://dx.doi.org/10.1371/journal.pone.0034089			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479532	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900060
J	Bushel, PR; McGovern, R; Liu, LW; Hofmann, O; Huda, A; Lu, J; Hide, W; Lin, XH				Bushel, Pierre R.; McGovern, Ray; Liu, Liwen; Hofmann, Oliver; Huda, Ahsan; Lu, Jun; Hide, Winston; Lin, Xihong			Population Differences in Transcript-Regulator Expression Quantitative Trait Loci	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; FALSE DISCOVERY; IDENTIFICATION; GENOTYPE; SNP; ASSOCIATIONS; REPRESSOR; SEQUENCES	Gene expression quantitative trait loci (eQTL) are useful for identifying single nucleotide polymorphisms (SNPs) associated with diseases. At times, a genetic variant may be associated with a master regulator involved in the manifestation of a disease. The downstream target genes of the master regulator are typically co-expressed and share biological function. Therefore, it is practical to screen for eQTLs by identifying SNPs associated with the targets of a transcript-regulator (TR). We used a multivariate regression with the gene expression of known targets of TRs and SNPs to identify TReQTLs in European (CEU) and African (YRI) HapMap populations. A nominal p-value of <1 x 10(-6) revealed 234 SNPs in CEU and 154 in YRI as TReQTLs. These represent 36 independent (tag) SNPs in CEU and 39 in YRI affecting the downstream targets of 25 and 36 TRs respectively. At a false discovery rate (FDR) = 45%, one cis-acting tag SNP (within 1 kb of a gene) in each population was identified as a TReQTL. In CEU, the SNP (rs16858621) in Pcnxl2 was found to be associated with the genes regulated by CREM whereas in YRI, the SNP (rs16909324) was linked to the targets of miRNA hsa-miR-125a. To infer the pathways that regulate expression, we ranked TReQTLs by connectivity within the structure of biological process subtrees. One TReQTL SNP (rs3790904) in CEU maps to Lphn2 and is associated (nominal p-value = 8.1 x 10(-7)) with the targets of the X-linked breast cancer suppressor Foxp3. The structure of the biological process subtree and a gene interaction network of the TReQTL revealed that tumor necrosis factor, NF-kappaB and variants in G-protein coupled receptors signaling may play a central role as communicators in Foxp3 functional regulation. The potential pleiotropic effect of the Foxp3 TReQTLs was gleaned from integrating mRNA-Seq data and SNP-set enrichment into the analysis.	[Bushel, Pierre R.] Natl Inst Environm Hlth Sci, Biostat Branch, Res Triangle Pk, NC 27709 USA; [Liu, Liwen] Natl Inst Environm Hlth Sci, Microarray Core, Res Triangle Pk, NC USA; [McGovern, Ray; Hofmann, Oliver; Hide, Winston] Harvard Univ, Sch Publ Hlth, Bioinformat Core, Boston, MA 02115 USA; [Hofmann, Oliver; Hide, Winston; Lin, Xihong] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Huda, Ahsan; Lu, Jun] SRA Int Inc, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; SRA International	Bushel, PR (corresponding author), Natl Inst Environm Hlth Sci, Biostat Branch, Res Triangle Pk, NC 27709 USA.	bushel@niehs.nih.gov	Hofmann, Oliver/F-1800-2013; Hide, Winston/C-7217-2009	Hofmann, Oliver/0000-0002-7738-1513; Hide, Winston/0000-0002-8621-3271	National Institutes of Health (NIH); National Institute of Environmental Health Sciences (NIEHS) [Z01 ES102345-04]; National Cancer Institute [R37CA76404, P01CA134294]; NATIONAL CANCER INSTITUTE [R37CA076404, P01CA134294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102345, Z01ES102345] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH) and National Institute of Environmental Health Sciences (NIEHS) [Z01 ES102345-04] and in part by the National Cancer Institute Grants R37CA76404 and P01CA134294. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2007, NAT GENET, V39, P807, DOI 10.1038/ng0707-807; Barrett T, NUCL ACIDS RES, V39, P1005; Bates GJ, 2006, BREAST CANCER RES, V8, pS15, DOI 10.1186/bcr1586; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett PC, 1998, FEBS LETT, V431, P386, DOI 10.1016/S0014-5793(98)00795-9; Bhasin JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001435; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Breslin T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-163; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Coulombe-Huntington J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000766; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Grundberg E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001279; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Heap GA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-1; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holden M, 2008, BIOINFORMATICS, V24, P2784, DOI 10.1093/bioinformatics/btn516; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang Q, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-194; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kennedy DO, 2005, JNCI-J NATL CANCER I, V97, P127, DOI 10.1093/jnci/dji013; Kim S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000587; Kliebenstein DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-308; Krull M, 2003, NUCLEIC ACIDS RES, V31, P97, DOI 10.1093/nar/gkg089; Kwan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000608; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li SY, 2010, J BIOPHARM STAT, V20, P373, DOI 10.1080/10543400903572803; Liu L, 2010, J COMPUT BIOL, V17, P21, DOI 10.1089/cmb.2007.0228; Liu Lan, 2007, Comput Syst Bioinformatics Conf, V6, P67, DOI 10.1142/9781860948732_0011; Lv D, 2011, IUBMB LIFE, V63, P62, DOI 10.1002/iub.416; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McCauley JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-266; Min JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022070; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naylor MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010395; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Parts L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001276; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000294; Raskin L, 2009, CANCER GENET CYTOGEN, V190, P40, DOI 10.1016/j.cancergencyto.2008.12.005; Ruden DM, 2009, NEUROTOXICOLOGY, V30, P898, DOI 10.1016/j.neuro.2009.08.011; Sarkar SK, 2006, ANN STAT, V34, P394, DOI 10.1214/009053605000000778; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schisler JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008183; Schwartzman A, 2011, BIOMETRIKA, V98, P199, DOI 10.1093/biomet/asq075; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tiedemann RE, 2008, J CLIN INVEST, V118, P1750, DOI 10.1172/JCI34149; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vinuela A, 2010, GENOME RES, V20, P929, DOI 10.1101/gr.102160.109; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Xu Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-451; Ye C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000311; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zapala MA, 2006, P NATL ACAD SCI USA, V103, P19430, DOI 10.1073/pnas.0609333103; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015; Zou W, 2009, GENETICA, V137, P125, DOI 10.1007/s10709-009-9365-z; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	73	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34286	10.1371/journal.pone.0034286	http://dx.doi.org/10.1371/journal.pone.0034286			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479588	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900078
J	Hostetler, JA; Kneip, E; Van Vuren, DH; Oli, MK				Hostetler, Jeffrey A.; Kneip, Eva; Van Vuren, Dirk H.; Oli, Madan K.			Stochastic Population Dynamics of a Montane Ground-Dwelling Squirrel	PLOS ONE			English	Article							DENSITY-DEPENDENCE; CLIMATE-CHANGE; ENVIRONMENTAL STOCHASTICITY; GROWTH-RATE; DEMOGRAPHY; RATES; ELASTICITIES; IMMIGRATION; VARIABILITY; DISPERSAL	Understanding the causes and consequences of population fluctuations is a central goal of ecology. We used demographic data from a long-term (1990-2008) study and matrix population models to investigate factors and processes influencing the dynamics and persistence of a golden-mantled ground squirrel (Callospermophilus lateralis) population, inhabiting a dynamic subalpine habitat in Colorado, USA. The overall deterministic population growth rate lambda was 0.946 +/- SE 0.05 but it varied widely over time, ranging from 0.45 +/- 0.09 in 2006 to 1.50 +/- 0.12 in 2003, and was below replacement (lambda < 1) for 9 out of 18 years. The stochastic population growth rate lambda(s) was 0.92, suggesting a declining population; however, the 95% CI on lambda(s) included 1.0 (0.52-1.60). Stochastic elasticity analysis showed that survival of adult females, followed by survival of juvenile females and litter size, were potentially the most influential vital rates; analysis of life table response experiments revealed that the same three life history variables made the largest contributions to year-to year changes in lambda. Population viability analysis revealed that, when the influences of density dependence and immigration were not considered, the population had a high (close to 1.0 in 50 years) probability of extinction. However, probability of extinction declined to as low as zero when density dependence and immigration were considered. Destabilizing effects of stochastic forces were counteracted by regulating effects of density dependence and rescue effects of immigration, which allowed our study population to bounce back from low densities and prevented extinction. These results suggest that dynamics and persistence of our study population are determined synergistically by density-dependence, stochastic forces, and immigration.	[Hostetler, Jeffrey A.; Kneip, Eva; Oli, Madan K.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32610 USA; [Hostetler, Jeffrey A.] Smithsonian Inst, Natl Zool Pk, Migratory Bird Ctr, Smithsonian Conservat Biol Inst, Washington, DC 20008 USA; [Van Vuren, Dirk H.] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA	State University System of Florida; University of Florida; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of California System; University of California Davis	Hostetler, JA (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32610 USA.	olim@ufl.edu	Hostetler, Jeffrey A./A-3345-2011	Hostetler, Jeffrey A./0000-0003-3669-1758	California Agricultural Experiment Station, University of California Davis; School of Natural Resources and the Environment, University of Florida; Department of Wildlife Ecology and Conservation, University of Florida	California Agricultural Experiment Station, University of California Davis; School of Natural Resources and the Environment, University of Florida(University of Florida); Department of Wildlife Ecology and Conservation, University of Florida(University of Florida)	This work was supported by California Agricultural Experiment Station, University of California Davis; School of Natural Resources and the Environment, University of Florida; and the Department of Wildlife Ecology and Conservation, University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; Armitage K., 2003, OECOL MONTANA, V12, P15, DOI [10.1073/pnas.97.4.1630, DOI 10.1073/PNAS.97.4.1630]; Armitage Kenneth B., 2010, P134; Armitage KB, 2011, ECOLOGY, V92, P218, DOI 10.1890/10-0109.1; Bartels Molly A., 1993, Mammalian Species, V440, P1; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; BRONSON MT, 1979, ECOLOGY, V60, P272, DOI 10.2307/1937655; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Caswell, 2000, MATRIX POPULATION MO; Caswell H, 2005, AUST NZ J STAT, V47, P75, DOI 10.1111/j.1467-842X.2005.00373.x; Clinchy M, 2001, J ANIM ECOL, V70, P515, DOI 10.1046/j.1365-2656.2001.00510.x; Clobert J, DISPERSAL; Coulson T, 2000, P ROY SOC B-BIOL SCI, V267, P1771, DOI 10.1098/rspb.2000.1209; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; FERRON J, 1985, CAN J ZOOL, V63, P2529, DOI 10.1139/z85-375; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Getz LL, 2005, ACTA THERIOL, V50, P323, DOI 10.1007/BF03192629; Goswami VR, 2011, ECOLOGY, V92, P1680, DOI 10.1890/10-2317.1; Gould WR, 1998, ECOLOGY, V79, P2531, DOI 10.2307/176841; Grotan V, 2009, J ANIM ECOL, V78, P447, DOI 10.1111/j.1365-2656.2008.01488.x; Hanski I., 1999, METAPOPULATION ECOLO; Haridas CV, 2005, AM NAT, V166, P481, DOI 10.1086/444444; Helgen KM, 2009, J MAMMAL, V90, P270, DOI 10.1644/07-MAMM-A-309.1; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Jesmer BR, 2011, AM MIDL NAT, V165, P162, DOI 10.1674/0003-0031-165.1.162; Jonzen N, 2010, J ANIM ECOL, V79, P109, DOI 10.1111/j.1365-2656.2009.01601.x; Kendall BE, 1998, ECOL APPL, V8, P184, DOI 10.2307/2641320; Kendall BE, 2010, AM NAT, V175, P461, DOI 10.1086/650724; Kneip E, 2011, J MAMMAL, V92, P367, DOI 10.1644/10-MAMM-A-156.1; Kolpas A, 2010, B MATH BIOL, V72, P1254, DOI 10.1007/s11538-009-9489-4; Krebs CJ, 2006, CLIM RES, V32, P143, DOI 10.3354/cr032143; Kruger O, 2007, OECOLOGIA, V152, P459, DOI 10.1007/s00442-007-0677-3; Lee AM, 2011, AM NAT, V177, P301, DOI 10.1086/658344; Leirs H, 1997, NATURE, V389, P176, DOI 10.1038/38271; Mathworks Inc, 2006, MATLAB; McEachern MB, 2011, CONSERV GENET, V12, P285, DOI 10.1007/s10592-010-0139-z; Morris W. F., 2002, QUANTITATIVE CONSERV; Morris WF, 2004, AM NAT, V163, P579, DOI 10.1086/382550; Morris WF, 2008, ECOLOGY, V89, P19, DOI 10.1890/07-0774.1; Murray BG, 2000, AUSTRAL ECOL, V25, P308; Oli MK, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2969; Oli MK, 2004, ECOLOGY, V85, P2446, DOI 10.1890/03-0513; Oli MK, 2001, ECOLOGY, V82, P1921, DOI 10.1890/0012-9658(2001)082[1921:EODROU]2.0.CO;2; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Ozgul A, 2009, AM NAT, V173, P517, DOI 10.1086/597225; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Phillips JA, 1984, BIOL GROUND DWELLING; Regehr EV, 2010, J ANIM ECOL, V79, P117, DOI 10.1111/j.1365-2656.2009.01603.x; Reif J, 2008, ANIM CONSERV, V11, P412, DOI 10.1111/j.1469-1795.2008.00200.x; Rolland V, 2011, WILDLIFE RES, V38, P396, DOI 10.1071/WR10239; Royama T., 1992, ANAL POPULATION ECOL; Sherman PW, 2002, ECOLOGY, V83, P2816, DOI 10.1890/0012-9658(2002)083[2816:DOAPCT]2.0.CO;2; Shick KR, 2006, NORTHWEST SCI, V80, P133; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Tuljapurkar S, 2003, AM NAT, V162, P489, DOI 10.1086/378648; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; WATKINSON AR, 1995, J ANIM ECOL, V64, P126, DOI 10.2307/5833; White GG, 2000, RES TECHNIQUES ANIMA	62	13	13	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34379	10.1371/journal.pone.0034379	http://dx.doi.org/10.1371/journal.pone.0034379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479616	Green Published, gold			2022-12-27	WOS:000303894900086
J	Thakur, M; Rahman, W; Hobbs, C; Dickenson, AH; Bennett, DLH				Thakur, Matthew; Rahman, Wahida; Hobbs, Carl; Dickenson, Anthony H.; Bennett, David L. H.			Characterisation of a Peripheral Neuropathic Component of the Rat Monoiodoacetate Model of Osteoarthritis	PLOS ONE			English	Article							IODOACETATE-INDUCED OSTEOARTHRITIS; ACTIVATING TRANSCRIPTION FACTOR-3; PAIN-RELATED BEHAVIOR; TUMOR-NECROSIS-FACTOR; MOVEMENT-EVOKED PAIN; NERVE INJURY; CENTRAL SENSITIZATION; SPINAL MICROGLIA; PHARMACOLOGICAL CHARACTERIZATION; KNEE-JOINT	Joint degeneration observed in the rat monoiodoacetate (MIA) model of osteoarthritis shares many histological features with the clinical condition. The accompanying pain phenotype has seen the model widely used to investigate the pathophysiology of osteoarthritis pain, and for preclinical screening of analgesic compounds. We have investigated the pathophysiological sequellae of MIA used at low (1 mg) or high (2 mg) dose. Intra-articular 2 mg MIA induced expression of ATF-3, a sensitive marker for peripheral neuron stress/injury, in small and large diameter DRG cell profiles principally at levels L4 and 5 (levels predominated by neurones innervating the hindpaw) rather than L3. At the 7 day timepoint, ATF-3 signal was significantly smaller in 1 mg MIA treated animals than in the 2 mg treated group. 2 mg, but not 1 mg, intra-articular MIA was also associated with a significant reduction in intra-epidermal nerve fibre density in plantar hindpaw skin, and produced spinal cord dorsal and ventral horn microgliosis. The 2 mg treatment evoked mechanical pain-related hypersensitivity of the hindpaw that was significantly greater than the 1 mg treatment. MIA treatment produced weight bearing asymmetry and cold hypersensitivity which was similar at both doses. Additionally, while pregabalin significantly reduced deep dorsal horn evoked neuronal responses in animals treated with 2 mg MIA, this effect was much reduced or absent in the 1 mg or sham treated groups. These data demonstrate that intra-articular 2 mg MIA not only produces joint degeneration, but also evokes significant axonal injury to DRG cells including those innervating targets outside of the knee joint such as hindpaw skin. This significant neuropathic component needs to be taken into account when interpreting studies using this model, particularly at doses greater than 1 mg MIA.	[Thakur, Matthew; Rahman, Wahida; Dickenson, Anthony H.] UCL, Dept Neurosci Physiol & Pharmacol, Neuropharmacol Pain Grp, London, England; [Hobbs, Carl; Bennett, David L. H.] Kings Coll London, Wolfson CARD, Neurorestorat Grp, London WC2R 2LS, England	University of London; University College London; University of London; King's College London	Thakur, M (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Neuropharmacol Pain Grp, London, England.	ucklmth@ucl.ac.uk	bennett, david/ABG-1184-2020	Thakur, Matthew/0000-0002-1325-1795; Bennett, David/0000-0002-7996-2696	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Arendt-Nielsen L, 2010, PAIN, V149, P573, DOI 10.1016/j.pain.2010.04.003; Bee LA, 2007, NEUROSCIENCE, V147, P786, DOI 10.1016/j.neuroscience.2007.05.004; Bee LA, 2008, PAIN, V140, P209, DOI 10.1016/j.pain.2008.08.008; Bee LA, 2011, PAIN, V152, P131, DOI 10.1016/j.pain.2010.10.004; Beiswenger KK, 2008, NEUROSCI LETT, V442, P267, DOI 10.1016/j.neulet.2008.06.079; Bohatschek M, 2001, J NEUROSCI RES, V64, P508, DOI 10.1002/jnr.1103; Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)00163-8; Braz JM, 2010, PAIN, V150, P290, DOI 10.1016/j.pain.2010.05.005; Calvo M, 2011, EXP NEUROL; Calvo M, 2010, J NEUROSCI, V30, P5437, DOI 10.1523/JNEUROSCI.5169-09.2010; Chandran P, 2009, EUR J PHARMACOL, V613, P39, DOI 10.1016/j.ejphar.2009.04.009; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Clements KM, 2009, OSTEOARTHR CARTILAGE, V17, P805, DOI 10.1016/j.joca.2008.11.002; Combe R, 2004, NEUROSCI LETT, V370, P236, DOI 10.1016/j.neulet.2004.08.023; Coyle DE, 1998, GLIA, V23, P75; Echeverry S, 2008, PAIN, V135, P37, DOI 10.1016/j.pain.2007.05.002; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Ferreira-Gomes J, 2008, J PAIN, V9, P945, DOI 10.1016/j.jpain.2008.05.012; Ferreira-Gomes J, 2010, ARTHRITIS RHEUM-US, V62, P3677, DOI 10.1002/art.27713; Fischer HG, 2001, J IMMUNOL, V166, P2717, DOI 10.4049/jimmunol.166.4.2717; Fricker FR, 2009, J NEUROSCI, V29, P7667, DOI 10.1523/JNEUROSCI.6053-08.2009; Guingamp C, 1997, ARTHRITIS RHEUM, V40, P1670, DOI 10.1002/art.1780400917; Guzman RE, 2003, TOXICOL PATHOL, V31, P619, DOI 10.1080/01926230390241800; Gwilym SE, 2009, ARTHRIT RHEUM-ARTHR, V61, P1226, DOI 10.1002/art.24837; Harvey VL, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-18; Harvey WF, 2008, RHEUM DIS CLIN N AM, V34, P777, DOI 10.1016/j.rdc.2008.05.006; Hendiani JA, 2003, J PAIN, V4, P203, DOI 10.1016/S1526-5900(03)00557-1; Heuts PHTG, 2004, PAIN, V110, P228, DOI 10.1016/j.pain.2004.03.035; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Hsieh GC, 2010, PHARMACOL BIOCHEM BE, V95, P41, DOI 10.1016/j.pbb.2009.12.004; Iannetti GD, 2005, P NATL ACAD SCI USA, V102, P18195, DOI 10.1073/pnas.0506624102; Inglis JJ, 2005, ARTHRITIS RES THER, V7, pR807, DOI 10.1186/ar1743; Ivanavicius SP, 2007, PAIN, V128, P272, DOI 10.1016/j.pain.2006.12.022; Janusz MJ, 2002, OSTEOARTHR CARTILAGE, V10, P785, DOI 10.1053/joca.2002.0823; Janusz MJ, 2001, OSTEOARTHR CARTILAGE, V9, P751, DOI 10.1053/joca.2001.0472; Kataoka K, 2007, SCAND J PLAST RECONS, V41, P158, DOI 10.1080/02844310701318288; Lauria G, 2005, J PERIPHER NERV SYST, V10, P202, DOI 10.1111/j.1085-9489.2005.0010210.x; Lauria G, 2009, HISTOPATHOLOGY, V54, P273, DOI 10.1111/j.1365-2559.2008.03096.x; Liu CC, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-76; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Molander C, 1997, BRAIN RES, V747, P122, DOI 10.1016/S0006-8993(96)01230-9; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Peters CM, 2007, EXP NEUROL, V203, P42, DOI 10.1016/j.expneurol.2006.07.022; Petrescu N, 2007, MUSCLE NERVE, V35, P451, DOI 10.1002/mus.20731; Pittenger GL, 2004, DIABETES CARE, V27, P1974, DOI 10.2337/diacare.27.8.1974; Pomonis JD, 2005, PAIN, V114, P339, DOI 10.1016/j.pain.2004.11.008; Rahman W, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-45; Sagar DR, 2010, ARTHRITIS RHEUM-US, V62, P3666, DOI 10.1002/art.27698; Salo PT, 1997, J ANAT, V190, P515, DOI 10.1046/j.1469-7580.1997.19040515.x; Schmidt Maike M, 2009, Front Neuroenergetics, V1, P1, DOI 10.3389/neuro.14.001.2009; Schuelert N, 2009, NEUROSCI LETT, V465, P184, DOI 10.1016/j.neulet.2009.08.063; Shakoor N, 2011, ARTHRITIS RHEUM; Shan S, 2007, NEUROBIOL DIS, V26, P558, DOI 10.1016/j.nbd.2007.02.007; Siau C, 2006, EXP NEUROL, V201, P507, DOI 10.1016/j.expneurol.2006.05.007; Silva A, 2008, PAIN, V140, P446, DOI 10.1016/j.pain.2008.09.025; Straube S, 2008, BRIT J CLIN PHARMACO, V66, P266, DOI 10.1111/j.1365-2125.2008.03200.x; Suzuki R, 2005, NEUROSIGNALS, V14, P175, DOI 10.1159/000087656; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Urch CE, 2003, BRAIN RES PROTOC, V12, P26, DOI 10.1016/S1385-299X(03)00068-0; von Banchet GS, 2009, PAIN, V145, P151, DOI 10.1016/j.pain.2009.06.002; Vonsy JL, 2009, EUR J PAIN, V13, P786, DOI 10.1016/j.ejpain.2008.09.008; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Wylde V, 2011, PAIN, V152, P566, DOI 10.1016/j.pain.2010.11.023; YAO J, 1990, J NEUROSCI RES, V27, P36, DOI 10.1002/jnr.490270106; Zheng FY, 2011, NEUROSCIENCE, V176, P447, DOI 10.1016/j.neuroscience.2010.12.052; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	69	101	103	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33730	10.1371/journal.pone.0033730	http://dx.doi.org/10.1371/journal.pone.0033730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470467	Green Published, Green Submitted, gold			2022-12-27	WOS:000303857100044
J	Wang, XY; Chen, WJ; Lv, XL; Tian, YL; Men, JT; Zhang, XF; Lei, HL; Zhou, CH; Lu, FL; Liang, C; Hu, XC; Xu, J; Wu, ZD; Li, XR; Yu, XB				Wang, Xiaoyun; Chen, Wenjun; Lv, Xiaoli; Tian, Yanli; Men, Jingtao; Zhang, Xifeng; Lei, Huali; Zhou, Chenhui; Lu, Fangli; Liang, Chi; Hu, Xuchu; Xu, Jin; Wu, Zhongdao; Li, Xuerong; Yu, Xinbing			Identification and Characterization of Paramyosin from Cyst Wall of Metacercariae Implicated Protective Efficacy against Clonorchis sinensis Infection	PLOS ONE			English	Article							SCHISTOSOMA-JAPONICUM; VACCINE CANDIDATE; OPISTHORCHIS-VIVERRINI; IMMUNE-RESPONSE; ADULT STAGE; TEGUMENT; SURFACE; UPDATE; IMMUNOGENICITY; PROTEINS	Human clonorchiasis has been increasingly prevalent in recent years and results in a threat to the public health in epidemic regions, motivating current strategies of vaccines to combat Clonorchis sinensis (C. sinensis). In this study, we identified C. sinensis paramyosin (CsPmy) from the cyst wall proteins of metacercariae by proteomic approaches and characterized the expressed recombinant pET-26b-CsPmy protein (101 kDa). Bioinformatics analysis indicated that full-length sequences of paramyosin are conserved in helminthes and numerous B-cell/T-cell epitopes were predicted in amino acid sequence of CsPmy. Western blot analysis showed that CsPmy was expressed at four life stages of C. sinensis, both cyst wall proteins and soluble tegumental components could be probed by anti-CsPmy serum. Moreover, immunolocalization results revealed that CsPmy was specifically localized at cyst wall and excretory bladder of metacercaria, as well as the tegument, oral sucker and vitellarium of adult worm. Both immunoblot and immunolocalization results demonstrated that CsPmy was highly expressed at the stage of adult worm, metacercariae and cercaria, which could be supported by real-time PCR analysis. Both recombinant protein and nucleic acid of CsPmy showed strong immunogenicity in rats and induced combined Th1/Th2 immune responses, which were reflected by continuous high level of antibody titers and increased level of IgG1/IgG2a subtypes in serum. In vaccine trials, comparing with control groups, both CsPmy protein and DNA vaccine exhibited protective effect with significant worm reduction rate of 54.3% (p<0.05) and 36.1% (p<0.05), respectively. In consistence with immune responses in sera, elevated level of cytokines IFN-gamma and IL-4 in splenocytes suggested that CsPmy could induce combined cellular immunity and humoral immunity in host. Taken together, CsPmy could be a promising vaccine candidate in the prevention of C. sinensis regarding its high immunogenicity and surface localization.	[Wang, Xiaoyun; Chen, Wenjun; Lv, Xiaoli; Tian, Yanli; Men, Jingtao; Lei, Huali; Zhou, Chenhui; Lu, Fangli; Liang, Chi; Hu, Xuchu; Xu, Jin; Wu, Zhongdao; Li, Xuerong; Yu, Xinbing] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Xiaoyun; Chen, Wenjun; Lv, Xiaoli; Tian, Yanli; Men, Jingtao; Lei, Huali; Zhou, Chenhui; Lu, Fangli; Liang, Chi; Hu, Xuchu; Xu, Jin; Wu, Zhongdao; Li, Xuerong; Yu, Xinbing] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xifeng] Wuhan Polytech Univ, Dept Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Wuhan Polytechnic University	Wang, XY (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Parasitol, Guangzhou 510275, Guangdong, Peoples R China.	xuerong2@mail.sysu.edu.cn; yuxb@mail.sysu.edu.cn	Wang, Xiaoyun/F-1212-2015		Major State Basic Research Development Program of China (973 program) [2010CB530000]; Sun Yat-sen University [50000-3181310]	Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); Sun Yat-sen University	This work was supported by the Major State Basic Research Development Program of China (973 program; no. 2010CB530000), the Sun Yat-sen University grant (no. 50000-3181310) and the Sun Yat-sen University innovative talents cultivation program for excellent tutors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cancela M, 2004, PARASITOL RES, V92, P441, DOI 10.1007/s00436-003-1059-3; Castro-Borges W, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000993; de Jesus AR, 2000, INFECT IMMUN, V68, P2797, DOI 10.1128/IAI.68.5.2797-2803.2000; Deng JS, 2003, INFECT IMMUN, V71, P6402, DOI 10.1128/IAI.71.11.6402-6410.2003; Erban T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022860; Faghiri Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010451; Fan PC, 1998, INT J PARASITOL, V28, P603, DOI 10.1016/S0020-7519(97)00215-4; Farias LP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000597; Ge F, 2010, J PROTEOMICS, V73, P1381, DOI 10.1016/j.jprot.2010.03.004; Gobert GN, 2005, PARASITOL INT, V54, P101, DOI 10.1016/j.parint.2005.02.004; Gobert GN, 1998, PARASITOL TODAY, V14, P115, DOI 10.1016/S0169-4758(97)01205-2; Jiz M, 2008, INFECT IMMUN, V76, P3164, DOI 10.1128/IAI.00409-08; Keiser J, 2007, TRENDS PARASITOL, V23, P555, DOI 10.1016/j.pt.2007.07.012; Lai DH, 2008, ACTA TROP, V107, P213, DOI 10.1016/j.actatropica.2008.05.003; Lee JS, 2006, VACCINE, V24, P2358, DOI 10.1016/j.vaccine.2005.11.062; Liang Chi, 2009, Chinese Journal of Parasitology and Parasitic Diseases, V27, P148; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loukas A, 2007, INT J PARASITOL, V37, P257, DOI 10.1016/j.ijpara.2006.12.001; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Mazumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014644; McManus DR, 2001, VACCINE, V20, P870, DOI 10.1016/S0264-410X(01)00405-4; Mulvenna J, 2010, INT J PARASITOL, V40, P543, DOI 10.1016/j.ijpara.2009.10.002; Mulvenna J, 2010, PROTEOMICS, V10, P1063, DOI 10.1002/pmic.200900393; Park TJ, 2009, KOREAN J PARASITOL, V47, P359, DOI 10.3347/kjp.2009.47.4.359; Perez-Sanchez R, 2006, PROTEOMICS, V6, pS226, DOI 10.1002/pmic.200500420; Petavy AF, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000125; Rassy D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011287; Rim HJ, 2005, J HELMINTHOL, V79, P269, DOI 10.1079/JOH2005300; Sachdeva R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007880; Schirmbeck R, 2001, BIOL CHEM, V382, P543, DOI 10.1515/BC.2001.068; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Strube C, 2009, PARASITOL INT, V58, P334, DOI 10.1016/j.parint.2009.07.003; Toledo R, 2011, J PROTEOMICS, V74, P1485, DOI 10.1016/j.jprot.2011.03.029; Vazquez-Talavera J, 2001, INFECT IMMUN, V69, P5412, DOI 10.1128/IAI.69.9.5412-5416.2001; Wang XY, 2011, MOL BIOCHEM PARASIT, V177, P135, DOI 10.1016/j.molbiopara.2011.02.011; Wang XY, 2009, PARASITOL RES, V106, P15, DOI 10.1007/s00436-009-1622-7; Wei JF, 2011, VACCINE, V29, P3162, DOI 10.1016/j.vaccine.2011.02.072; Young ND, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000719; Zhao QP, 2007, EXP PARASITOL, V115, P9, DOI 10.1016/j.exppara.2006.05.004; Zhou ZW, 2008, VACCINE, V26, P1817, DOI 10.1016/j.vaccine.2008.02.015	41	20	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33703	10.1371/journal.pone.0033703	http://dx.doi.org/10.1371/journal.pone.0033703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470461	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100039
J	Hannoun, S; Bagory, M; Durand-Dubief, F; Ibarrola, D; Comte, JC; Confavreux, C; Cotton, F; Sappey-Marinier, D				Hannoun, Salem; Bagory, Matthieu; Durand-Dubief, Francoise; Ibarrola, Danielle; Comte, Jean-Christophe; Confavreux, Christian; Cotton, Francois; Sappey-Marinier, Dominique			Correlation of Diffusion and Metabolic Alterations in Different Clinical Forms of Multiple Sclerosis	PLOS ONE			English	Article							APPEARING WHITE-MATTER; CORPUS-CALLOSUM; WATER DIFFUSION; LESIONS; TENSOR; SPECTROSCOPY; MECHANISMS; DAMAGE; DEMYELINATION; DEGENERATION	Diffusion tensor imaging (DTI) and MR spectroscopic imaging (MRSI) provide greater sensitivity than conventional MRI to detect diffuse alterations in normal appearing white matter (NAWM) of Multiple Sclerosis (MS) patients with different clinical forms. Therefore, the goal of this study is to combine DTI and MRSI measurements to analyze the relation between diffusion and metabolic markers, T2-weighted lesion load (T2-LL) and the patients clinical status. The sensitivity and specificity of both methods were then compared in terms of MS clinical forms differentiation. MR examination was performed on 71 MS patients (27 relapsing remitting (RR), 26 secondary progressive (SP) and 18 primary progressive (PP)) and 24 control subjects. DTI and MRSI measurements were obtained from two identical regions of interest selected in left and right centrum semioval (CSO) WM. DTI metrics and metabolic contents were significantly altered in MS patients with the exception of N-acetyl-aspartate (NAA) and NAA/Choline (Cho) ratio in RR patients. Significant correlations were observed between diffusion and metabolic measures to various degrees in every MS patients group. Most DTI metrics were significantly correlated with the T2-LL while only NAA/Cr ratio was correlated in RR patients. A comparison analysis of MR methods efficiency demonstrated a better sensitivity/specificity of DTI over MRSI. Nevertheless, NAA/Cr ratio could distinguish all MS and SP patients groups from controls, while NAA/Cho ratio differentiated PP patients from controls. This study demonstrated that diffusivity changes related to microstructural alterations were correlated with metabolic changes and provided a better sensitivity to detect early changes, particularly in RR patients who are more subject to inflammatory processes. In contrast, the better specificity of metabolic ratios to detect axonal damage and demyelination may provide a better index for identification of PP patients.	[Hannoun, Salem; Bagory, Matthieu; Durand-Dubief, Francoise; Cotton, Francois; Sappey-Marinier, Dominique] Univ Lyon 1, CREATIS, CNRS, UMR 5220, F-69365 Lyon, France; [Hannoun, Salem; Bagory, Matthieu; Durand-Dubief, Francoise; Cotton, Francois; Sappey-Marinier, Dominique] Univ Lyon 1, INSERM, U1044, F-69365 Lyon, France; [Durand-Dubief, Francoise; Confavreux, Christian] Hop Neurol & Neurochirurg P Wertheimer, Serv Neurol A, Bron, France; [Ibarrola, Danielle; Comte, Jean-Christophe; Sappey-Marinier, Dominique] CERMEP Imagerie Vivant, Dept IRM, Bron, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Hannoun, S (corresponding author), Univ Lyon 1, CREATIS, CNRS, UMR 5220, F-69365 Lyon, France.	sappey-marinier@univ-lyon1.fr	cotton, francois/F-4762-2013; Hannoun, Salem/I-2761-2016; DURAND-DUBIEF, Françoise/M-2187-2014; Sappey-Marinier, Dominique/L-2925-2014; IBARROLA, Danielle/GRR-7305-2022	cotton, francois/0000-0003-0046-2478; Hannoun, Salem/0000-0002-5982-3242; Sappey-Marinier, Dominique/0000-0003-4104-1514; IBARROLA, Danielle/0000-0001-8999-8740	French government grant "PHRC"	French government grant "PHRC"	This research was sponsored by the French government grant "PHRC 2004". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagory M, 2011, IEEE T BIOM IN PRESS; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Baslow MH, 2003, NEUROCHEM RES, V28, P941, DOI 10.1023/A:1023250721185; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; Caramanos Z, 2005, BRAIN, V128, P2483, DOI 10.1093/brain/awh640; Ciccarelli O, 2003, J NEUROL, V250, P287, DOI 10.1007/s00415-003-0992-5; Compston A, 2006, MCALPINES MULTIPLE S, V4th; De Stefano N, 2005, J NEUROL SCI, V233, P203, DOI 10.1016/j.jns.2005.03.018; De Stefano N, 2002, J NEUROL, V249, P1072, DOI 10.1007/s00415-002-0790-5; De Stefano N, 2001, ARCH NEUROL-CHICAGO, V58, P65, DOI 10.1001/archneur.58.1.65; DESTEFANO N, 1995, NEUROLOGY, V45, P1193, DOI 10.1212/WNL.45.6.1193; Filippi M, 2000, ARCH NEUROL-CHICAGO, V57, P1017, DOI 10.1001/archneur.57.7.1017; Goldberg-Zimring D, 2005, J NEUROIMAGING, V15, p68S, DOI 10.1177/1051228405283363; GRAVERONDEMILLY D, 1993, J MAGN RESON SER A, V101, P233, DOI 10.1006/jmra.1993.1038; Hannoun S, 2009, IRBM, V30, P179, DOI 10.1016/j.irbm.2009.05.001; Hohlfeld R, 1997, BRAIN, V120, P865, DOI 10.1093/brain/120.5.865; Lowe MJ, 2006, NEUROIMAGE, V32, P1127, DOI 10.1016/j.neuroimage.2006.04.208; Mader I, 2000, AM J NEURORADIOL, V21, P1220; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Miller DH, 2007, LANCET NEUROL, V6, P903, DOI 10.1016/S1474-4422(07)70243-0; Narayanan S, 2006, NEUROIMAGE, V29, P637, DOI 10.1016/j.neuroimage.2005.07.017; Neema M, 2007, NEUROTHERAPEUTICS, V4, P602, DOI 10.1016/j.nurt.2007.08.001; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; Oh J, 2004, J NEUROL NEUROSUR PS, V75, P1281, DOI 10.1136/jnnp.2004.039032; Pan JW, 2002, MULT SCLER J, V8, P200, DOI 10.1191/1352458502ms802oa; Phillips JT, 2001, ARCH NEUROL-CHICAGO, V58, P30, DOI 10.1001/archneur.58.1.30; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895; Rovaris M, 2005, NEUROLOGY, V65, P1526, DOI 10.1212/01.wnl.0000184471.83948.e0; Schubert F, 2002, MAGN RESON MATER PHY, V14, P213, DOI 10.1007/BF02668215; Sijens PE, 2005, EUR RADIOL, V15, P1686, DOI 10.1007/s00330-005-2775-0; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Souplet J.C., 2009, THESIS U NICE SOPHIA; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626	35	27	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32525	10.1371/journal.pone.0032525	http://dx.doi.org/10.1371/journal.pone.0032525			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479330	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100013
J	Luo, W; Meng, Y; Ji, HL; Pan, CQ; Huang, S; Yu, CH; Xiao, LM; Cui, K; Ni, SY; Zhang, ZS; Li, X				Luo, Wei; Meng, Ying; Ji, Hong-Li; Pan, Chun-Qiu; Huang, Shan; Yu, Chang-Hui; Xiao, Li-Ming; Cui, Kai; Ni, Shu-Yuan; Zhang, Zhen-Shu; Li, Xu			Spironolactone Lowers Portal Hypertension by Inhibiting Liver Fibrosis, ROCK-2 Activity and Activating NO/PKG Pathway in the Bile-Duct-Ligated Rat	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; KINASE SIGNALING CONTRIBUTES; SECONDARY BILIARY-CIRRHOSIS; NITRIC-OXIDE SYNTHASE; RHOA/RHO-KINASE; UP-REGULATION; ALDOSTERONE; PRESSURE; FIBROGENESIS; PHOSPHORYLATION	Objective: Aldosterone, one of the main peptides in renin angiotensin aldosterone system (RAAS), has been suggested to mediate liver fibrosis and portal hypertension. Spironolactone, an aldosterone antagonist, has beneficial effect on hyperdynamic circulation in clinical practice. However, the mechanisms remain unclear. The present study aimed to investigate the role of spionolactone on liver cirrhosis and portal hypertension. Methods: Liver cirrhosis was induced by bile duct ligation (BDL). Spironolactone was administered orally (20 mg/kg/d) after bile duct ligation was performed. Liver fibrosis was assessed by histology, Masson's trichrome staining, and the measurement of hydroxyproline and type I collagen content. The activation of HSC was determined by analysis of alpha smooth muscle actin (alpha-SMA) expression. Protein expressions and protein phosphorylation were determined by immunohistochemical staining and Western blot analysis, Messenger RNA levels by quantitative real time polymerase chain reaction (Q-PCR). Portal pressure and intrahepatic resistance were examined in vivo. Results: Treatment with spironolactone significantly lowered portal pressure. This was associated with attenuation of liver fibrosis, intrahepatic resistance and inhibition of HSC activation. In BDL rat liver, spironolactone suppressed up-regulation of proinflammatory cytokines (TNF alpha and IL-6). Additionally, spironolactone significantly decreased ROCK-2 activity without affecting expression of RhoA and Ras. Moreover, spironolactone markedly increased the levels of endothelial nitric oxide synthase (eNOS), phosphorylated eNOS and the activity of NO effector-protein kinase G (PKG) in the liver. Conclusion: Spironolactone lowers portal hypertension by improvement of liver fibrosis and inhibition of intrahepatic vasoconstriction via down-regulating ROCK-2 activity and activating	[Luo, Wei; Zhang, Zhen-Shu] So Med Univ, Dept Gastroenterol, Nanfang Hosp, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Meng, Ying; Yu, Chang-Hui] So Med Univ, Dept Resp Dis, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Ji, Hong-Li] 153rd Hosp Peoples Liberat Army, Dept Oncol, Zhengzhou, Peoples R China; [Pan, Chun-Qiu; Huang, Shan; Xiao, Li-Ming; Ni, Shu-Yuan; Li, Xu] So Med Univ, Dept Emergency, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China; [Cui, Kai] So Med Univ, Dept Cardiovasc, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Zhang, ZS (corresponding author), So Med Univ, Dept Gastroenterol, Nanfang Hosp, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China.	zzs6689@163.com; mylx99@163.com	JI, HONGLONG/N-7822-2014	JI, HONGLONG/0000-0002-3228-7144	National Natural Scientific Foundation of China [30871155]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Scientific Foundation of China (#30871155) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch J, 2000, J HEPATOL, V32, P141, DOI 10.1016/S0168-8278(00)80422-5; Caligiuri A, 2003, GASTROENTEROLOGY, V124, P504, DOI 10.1053/gast.2003.50058; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Fujisawa G, 2004, KIDNEY INT, V66, P1493, DOI 10.1111/j.1523-1755.2004.00913.x; Fujisawa G, 2006, TRANSL RES, V148, P149, DOI 10.1016/j.trsl.2006.03.007; Groszmann RJ, 2005, J CLIN GASTROENTEROL, V39, pS125, DOI 10.1097/01.mcg.0000155552.14396.3d; Hennenberg M, 2006, GASTROENTEROLOGY, V130, P838, DOI 10.1053/j.gastro.2005.11.029; Hennenberg M, 2011, LAB INVEST, V91, P241, DOI 10.1038/labinvest.2010.148; Ji HL, 2011, REGUL PEPTIDES, V169, P13, DOI 10.1016/j.regpep.2011.04.010; KOUNTOURAS J, 1984, BRIT J EXP PATHOL, V65, P305; Lavina B, 2009, GUT, V58, P118, DOI 10.1136/gut.2008.149880; Lee JS, 2007, HEPATOLOGY, V45, P817, DOI 10.1002/hep.21564; Leopold JA, 2007, NAT MED, V13, P189, DOI 10.1038/nm1545; Li X, 2001, CHINESE MED J-PEKING, V114, P64; Li X, 2007, REGUL PEPTIDES, V138, P15, DOI 10.1016/j.regpep.2006.07.011; Matei V, 2008, J HEPATOL, V49, P192, DOI 10.1016/j.jhep.2008.04.014; Ming XF, 2002, MOL CELL BIOL, V22, P8467, DOI 10.1128/MCB.22.24.8467-8477.2002; Miyata K, 2005, J AM SOC NEPHROL, V16, P2906, DOI 10.1681/ASN.2005040390; Miyoshi H, 1999, GASTROENTEROLOGY, V117, P669, DOI 10.1016/S0016-5085(99)70461-0; Murthy KS, 2003, AM J PHYSIOL-GASTR L, V284, pG1006, DOI 10.1152/ajpgi.00465.2002; Nevens F, 1996, HEPATOLOGY, V23, P1047; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; OKUMURA H, 1991, AM J GASTROENTEROL, V86, P46; Paizis G, 2002, GASTROENTEROLOGY, V123, P1667, DOI 10.1053/gast.2002.36561; Rajagopalan S, 2002, CIRCULATION, V105, P2212, DOI 10.1161/01.CIR.0000015854.60710.10; Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Rodriguez-Vilarrupla A, 2007, ANN HEPATOL, V6, P28, DOI 10.1016/S1665-2681(19)31950-7; Rombouts K, 2001, J HEPATOL, V34, P230, DOI 10.1016/S0168-8278(00)00087-8; Sowers JR, 2009, ANN INTERN MED, V150, P776, DOI 10.7326/0003-4819-150-11-200906020-00005; Sun Y, 2002, AM J PATHOL, V161, P1773, DOI 10.1016/S0002-9440(10)64454-9; Tandon P, 2010, J HEPATOL, V53, P273, DOI 10.1016/j.jhep.2010.03.013; Trebicka J, 2008, HEPATOLOGY, V47, P1264, DOI 10.1002/hep.22170; Trebicka J, 2007, HEPATOLOGY, V46, P242, DOI 10.1002/hep.21673; Wack KE, 2001, HEPATOLOGY, V33, P363, DOI 10.1053/jhep.2001.21998; Wada T, 2010, ENDOCRINOLOGY, V151, P2040, DOI 10.1210/en.2009-0869; Wang Y, 2010, J HEPATOL, V53, P132, DOI 10.1016/j.jhep.2010.02.027; Wiest R, 2002, HEPATOLOGY, V35, P478, DOI 10.1053/jhep.2002.31432; Yang XS, 2000, HORM RES, V53, P288, DOI 10.1159/000053185; Yang YY, 2006, AM J PHYSIOL-GASTR L, V290, pG328, DOI 10.1152/ajpgi.00367.2005; Yu J, 2008, BIOCHEM BIOPH RES CO, V372, P571, DOI 10.1016/j.bbrc.2008.05.069; Zhang XL, 2006, WORLD J GASTROENTERO, V12, P6376, DOI 10.3748/wjg.v12.i39.6376; Zhou Q, 2006, GUT, V55, P1296, DOI 10.1136/gut.2005.081059	43	21	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34230	10.1371/journal.pone.0034230	http://dx.doi.org/10.1371/journal.pone.0034230			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479572	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100138
J	Rajesh, A; Yenugu, S				Rajesh, Angireddy; Yenugu, Suresh			Genomic Organization, Tissue Distribution and Functional Characterization of the Rat Pate Gene Cluster	PLOS ONE			English	Article							SEMINAL-VESICLE; SPERM MOTILITY; ANTIBACTERIAL ACTIVITY; PLASMINOGEN-ACTIVATOR; MOLECULAR-CLONING; TESTIS FLUID; EPIDIDYMIS; PROTEINS; FAMILY; PURIFICATION	The cysteine rich prostate and testis expressed (Pate) proteins identified till date are thought to resemble the three fingered protein/urokinase-type plasminogen activator receptor proteins. In this study, for the first time, we report the identification, cloning and characterization of rat Pate gene cluster and also determine the expression pattern. The rat Pate genes are clustered on chromosome 8 and their predicted proteins retained the ten cysteine signature characteristic to TFP/Ly-6 protein family. PATE and PATE-F three dimensional protein structure was found to be similar to that of the toxin bucandin. Though Pate gene expression is thought to be prostate and testis specific, we observed that rat Pate genes are also expressed in seminal vesicle and epididymis and in tissues beyond the male reproductive tract. In the developing rats (2060 day old), expression of Pate genes seem to be androgen dependent in the epididymis and testis. In the adult rat, androgen ablation resulted in down regulation of the majority of Pate genes in the epididymides. PATE and PATE-F proteins were found to be expressed abundantly in the male reproductive tract of rats and on the sperm. Recombinant PATE protein exhibited potent antibacterial activity, whereas PATE-F did not exhibit any antibacterial activity. Pate expression was induced in the epididymides when challenged with LPS. Based on our results, we conclude that rat PATE proteins may contribute to the reproductive and defense functions.	[Rajesh, Angireddy; Yenugu, Suresh] Univ Hyderabad, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Rajesh, A (corresponding author), Univ Hyderabad, Dept Anim Sci, Hyderabad 500134, Andhra Pradesh, India.	ysnaidu@yahoo.com	Angireddy, Rajesh/GMX-3147-2022; Yenugu, Suresh/Y-7661-2019	Angireddy, Rajesh/0000-0002-9215-2209; Yenugu, Suresh/0000-0002-5431-2267				Bera TK, 2002, P NATL ACAD SCI USA, V99, P3058, DOI 10.1073/pnas.052713699; Biswas B, 2011, AM J REPROD IMMUNOL, V65, P557, DOI 10.1111/j.1600-0897.2010.00937.x; Blankenvoorde MFJ, 1998, BIOL CHEM, V379, P1371; CHAREST NJ, 1989, ENDOCRINOLOGY, V125, P942, DOI 10.1210/endo-125-2-942; COLLARD MW, 1987, BIOCHEMISTRY-US, V26, P3297, DOI 10.1021/bi00386a008; CORNWALL GA, 1995, J ANDROL, V16, P379; CORONEL CE, 1992, J BIOL CHEM, V267, P20909; Dacheux JL, 2003, MICROSC RES TECHNIQ, V61, P7, DOI 10.1002/jemt.10312; Fry BG, 2003, J MOL EVOL, V57, P110, DOI 10.1007/s00239-003-2461-2; GRISWOLD MD, 1986, BIOCHEMISTRY-US, V25, P7265, DOI 10.1021/bi00371a003; Hall SH, 2002, J ANDROL, V23, P585; Hamil Katherine G, 2003, Reprod Biol Endocrinol, V1, P112, DOI 10.1186/1477-7827-1-112; Hamil KG, 2000, ENDOCRINOLOGY, V141, P1245, DOI 10.1210/en.141.3.1245; Hamil KG, 2002, ENDOCRINOLOGY, V143, P2787, DOI 10.1210/en.143.7.2787; HARRIS ME, 1974, ENDOCRINOLOGY, V95, P701, DOI 10.1210/endo-95-3-701; HARRIS ME, 1981, EXPERIENTIA, V37, P426, DOI 10.1007/BF01959901; Hiemstra PS, 1996, INFECT IMMUN, V64, P4520, DOI 10.1128/IAI.64.11.4520-4524.1996; Hinton BT, 1998, J REPROD FERTIL, P47; Jalkanen J, 2005, BIOL REPROD, V72, P1268, DOI 10.1095/biolreprod.104.035758; Kaplan N, 2007, J MOL BIOL, V369, P553, DOI 10.1016/j.jmb.2007.02.106; Levitin F, 2008, J BIOL CHEM, V283, P16928, DOI 10.1074/jbc.M801454200; Liu Q, 2001, ENDOCRINOLOGY, V142, P4529, DOI 10.1210/en.142.10.4529; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; Metayer S, 2002, BIOL REPROD, V66, P1219, DOI 10.1095/biolreprod66.5.1219; NAYFEH SN, 1966, ENDOCRINOLOGY, V78, P1041, DOI 10.1210/endo-78-5-1041; PEITZ B, 1988, J REPROD FERTIL, V83, P169, DOI 10.1530/jrf.0.0830169; PEITZ B, 1986, BIOL REPROD, V35, P608, DOI 10.1095/biolreprod35.3.608; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Ploug M, 2003, CURR PHARM DESIGN, V9, P1499, DOI 10.2174/1381612033454630; Rajesh A, 2011, MOL REPROD DEV; Robert M, 1996, BIOL REPROD, V55, P813, DOI 10.1095/biolreprod55.4.813; Rodrigues A, 2008, BIOL REPROD, V79, P1135, DOI 10.1095/biolreprod.108.069930; Rodriguez CM, 2001, REPRODUCTION, V122, P41, DOI 10.1530/reprod/122.1.41; Soler-Garcia AA, 2005, REPRODUCTION, V129, P515, DOI 10.1530/rep.1.00576; Torres AM, 2001, BIOCHEM J, V360, P539, DOI 10.1042/0264-6021:3600539; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Turunen HT, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-128; Yenugu S, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-7; Yenugu S, 2004, BIOL REPROD, V71, P1484, DOI 10.1095/biolreprod.104.031567; Yenugu S, 2004, ENDOCRINOLOGY, V145, P3165, DOI 10.1210/en.2003-1698; Yenugu S, 2003, BIOCHEM J, V372, P473, DOI 10.1042/BJ20020225; Zhang KX, 2005, BIOL REPROD, V73, P1064, DOI 10.1095/biolreprod.105.041889; Zhou CX, 2004, NAT CELL BIOL, V6, P458, DOI 10.1038/ncb1127	43	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32633	10.1371/journal.pone.0032633	http://dx.doi.org/10.1371/journal.pone.0032633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479333	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100016
J	Sahara, M; Sata, M; Morita, T; Hirata, Y; Nagai, R				Sahara, Makoto; Sata, Masataka; Morita, Toshihiro; Hirata, Yasunobu; Nagai, Ryozo			Nicorandil Attenuates Monocrotaline-Induced Vascular Endothelial Damage and Pulmonary Arterial Hypertension	PLOS ONE			English	Article							K-ATP CHANNELS; CELL-PROLIFERATION; POTASSIUM CHANNELS; CARDIAC PROTECTION; ACTIVATION; INHIBITION; SURVIVAL; INJURY; RATS	Background: An antianginal K-ATP channel opener nicorandil has various beneficial effects on cardiovascular systems; however, its effects on pulmonary vasculature under pulmonary arterial hypertension (PAH) have not yet been elucidated. Therefore, we attempted to determine whether nicorandil can attenuate monocrotaline (MCT)-induced PAH in rats. Materials and Methods: Sprague-Dawley rats injected intraperitoneally with 60 mg/kg MCT were randomized to receive either vehicle; nicorandil (5.0 mg.kg(-1).day(-1)) alone; or nicorandil as well as either a K-ATP channel blocker glibenclamide or a nitric oxide synthase (NOS) inhibitor N-infinity-nitro-L-arginine methyl ester (L-NAME), from immediately or 21 days after MCT injection. Four or five weeks later, right ventricular systolic pressure (RVSP) was measured, and lung tissue was harvested. Also, we evaluated the nicorandil-induced anti-apoptotic effects and activation status of several molecules in cell survival signaling pathway in vitro using human umbilical vein endothelial cells (HUVECs). Results: Four weeks after MCT injection, RVSP was significantly increased in the vehicle-treated group (51.0 +/- 4.7 mm Hg), whereas it was attenuated by nicorandil treatment (33.2 +/- 3.9 mm Hg; P<0.01). Nicorandil protected pulmonary endothelium from the MCT-induced thromboemboli formation and induction of apoptosis, accompanied with both upregulation of endothelial NOS (eNOS) expression and downregulation of cleaved caspase-3 expression. Late treatment with nicorandil for the established PAH was also effective in suppressing the additional progression of PAH. These beneficial effects of nicorandil were blocked similarly by glibenclamide and L-NAME. Next, HUVECs were incubated in serum-free medium and then exhibited apoptotic morphology, while these changes were significantly attenuated by nicorandil administration. Nicorandil activated the phosphatidylinositol 3-kinase (PI3K)/Akt and extracellular signal-regulated kinase (ERK) pathways in HUVECs, accompanied with the upregulation of both eNOS and Bcl-2 expression. Conclusions: Nicorandil attenuated MCT-induced vascular endothelial damage and PAH through production of eNOS and anti-apoptotic factors, suggesting that nicorandil might have a promising therapeutic potential for PAH.	[Sahara, Makoto; Morita, Toshihiro; Hirata, Yasunobu; Nagai, Ryozo] Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan; [Sata, Masataka] Univ Tokushima, Grad Sch, Dept Cardiovasc Med, Inst Hlth Biosci, Tokushima 770, Japan; [Sahara, Makoto] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Cardiol,Cardiovasc Res Ctr, Boston, MA USA	University of Tokyo; Tokushima University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Sahara, M (corresponding author), Univ Tokyo, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan.	saharam-tky@umin.ac.jp		Sahara, Makoto/0000-0002-6281-5454	Ministry of Education, Culture, Sports, Science and Technology of Japan [17390227]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22390159] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan to M. Sata (#17390227; http://kaken.nii.ac.jp/) and by a research fellowship from the Japan Society for the Promotion of Science to M. Sahara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2006, AM J PHYSIOL-HEART C, V290, pH2402, DOI 10.1152/ajpheart.00737.2005; Akao M, 2002, J AM COLL CARDIOL, V40, P803, DOI 10.1016/S0735-1097(02)02007-7; Archer S, 2000, CIRCULATION, V102, P2781, DOI 10.1161/01.CIR.102.22.2781; Dargie HJ, 2002, LANCET, V359, P1269, DOI 10.1016/s0140-6736(02)08265-x; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Farkas L, 2009, J CLIN INVEST, V119, P1298, DOI 10.1172/JCI36136; FUJIWARA R, 1993, CARDIOVASC DRUG THER, V7, P365, DOI 10.1007/BF00880160; Guyton KZ, 1996, J BIOL CHEM, V271, P4138, DOI 10.1074/jbc.271.7.3604; Hongo M, 2005, J CARDIOVASC PHARM, V46, P452, DOI 10.1097/01.fjc.0000176728.74690.09; Horinaka S, 2001, J CARDIOVASC PHARM, V38, P200, DOI 10.1097/00005344-200108000-00005; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Kasuno K, 2004, J BIOL CHEM, V279, P2550, DOI 10.1074/jbc.M308197200; Lame MW, 2000, J BIOL CHEM, V275, P29091, DOI 10.1074/jbc.M001372200; Malhotra Rajeev, 2011, Pulm Circ, V1, P250; Pain T, 2000, CIRC RES, V87, P460; Rabinovitch M, 1997, CARDIOVASC RES, V34, P268; Sahara M, 2007, CIRCULATION, V115, P509, DOI 10.1161/CIRCULATIONAHA.106.655837; Sahara M, 2006, CARDIOVASC DRUG THER, V20, P377, DOI 10.1007/s10557-006-0498-3; Sato T, 2000, J AM COLL CARDIOL, V35, P514, DOI 10.1016/S0735-1097(99)00552-5; SEGAR R, 1995, FASEB J, V9, P726; TAIRA N, 1989, AM J CARDIOL, V63, P18; Tamosiuniene R, 2011, CIRC RES, V109, P867, DOI 10.1161/CIRCRESAHA.110.236927; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Voelkel NF, 2004, CARDIOL CLIN, V22, P343, DOI 10.1016/j.ccl.2004.04.010; Wang YG, 2007, AM J PHYSIOL-HEART C, V292, pH2300, DOI 10.1152/ajpheart.01163.2006; Xu ZL, 2004, AM J PHYSIOL-HEART C, V286, pH1433, DOI 10.1152/ajpheart.00882.2003; Zhao YD, 2003, CIRC RES, V92, P984, DOI 10.1161/01.RES.0000070587.79937.F0	27	37	38	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33367	10.1371/journal.pone.0033367	http://dx.doi.org/10.1371/journal.pone.0033367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479390	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100045
J	Fesel, C				Fesel, Constantin			Coreferentiality: A New Method for the Hypothesis-Based Analysis of Phenotypes Characterized by Multivariate Data	PLOS ONE			English	Article							ANTIBODY REPERTOIRES; AUTOREACTIVE REPERTOIRES; GLOBAL ANALYSIS; SERUM; ASSOCIATION; IMMUNIZATION; SUSCEPTIBILITY; SPECIFICITY; INFECTION; ANTIGENS	Many multifactorial biologic effects, particularly in the context of complex human diseases, are still poorly understood. At the same time, the systematic acquisition of multivariate data has become increasingly easy. The use of such data to analyze and model complex phenotypes, however, remains a challenge. Here, a new analytic approach is described, termed coreferentiality, together with an appropriate statistical test. Coreferentiality is the indirect relation of two variables of functional interest in respect to whether they parallel each other in their respective relatedness to multivariate reference data, which can be informative for a complex effect or phenotype. It is shown that the power of coreferentiality testing is comparable to multiple regression analysis, sufficient even when reference data are informative only to a relatively small extent of 2.5%, and clearly exceeding the power of simple bivariate correlation testing. Thus, coreferentiality testing uses the increased power of multivariate analysis, however, in order to address a more straightforward interpretable bivariate relatedness. Systematic application of this approach could substantially improve the analysis and modeling of complex phenotypes, particularly in the context of human study where addressing functional hypotheses by direct experimentation is often difficult.	Gulbenkian Inst Sci, Oeiras, Portugal		Fesel, C (corresponding author), Gulbenkian Inst Sci, Oeiras, Portugal.	cfesel@igc.gulbenkian.pt		Fesel, Constantin/0000-0003-3537-5243	Fundaco para a Ciencia e a Tecnologia (FCT), Portugal [POCTI/SAU-MMO/59913/2004]	Fundaco para a Ciencia e a Tecnologia (FCT), Portugal	The author received a postdoctoral fellowship from Fundaco para a Ciencia e a Tecnologia (FCT), Portugal. The research work that motivated the development of the described method was funded by the research grant POCTI/SAU-MMO/59913/2004 by the same institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Fesel C, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-5; Fesel C, 1999, SCAND J IMMUNOL, V49, P251; Fesel C, 2000, J AUTOIMMUN, V14, P319, DOI 10.1006/jaut.2000.0373; Fesel C, 1998, EUR J IMMUNOL, V28, P3616, DOI 10.1002/(SICI)1521-4141(199811)28:11&lt;3616::AID-IMMU3616&gt;3.0.CO;2-B; Fesel C, 2011, PLOS ONE IN PRESS; HAURY M, 1994, SCAND J IMMUNOL, V39, P79, DOI 10.1111/j.1365-3083.1994.tb03343.x; KEMPTHORNE O, 1955, J AM STAT ASSOC, V50, P946, DOI 10.2307/2281178; LUDBROOK J, 1994, CLIN EXP PHARMACOL P, V21, P673, DOI 10.1111/j.1440-1681.1994.tb02570.x; Medland S, 2010, EUR J HUM GENET, V18, P233, DOI 10.1038/ejhg.2009.133; MOUTHON L, 1995, P NATL ACAD SCI USA, V92, P3839, DOI 10.1073/pnas.92.9.3839; NOBREGA A, 1993, EUR J IMMUNOL, V23, P2851, DOI 10.1002/eji.1830231119; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; RASMUSSEN JL, 1989, BRIT J MATH STAT PSY, V42, P103, DOI 10.1111/j.2044-8317.1989.tb01118.x; Rencher A.C., 1995, METHODS MULTIVARIATE; Santos-Lima EC, 2001, EUR J IMMUNOL, V31, P634, DOI 10.1002/1521-4141(200102)31:2&lt;634::AID-IMMU634&gt;3.0.CO;2-H; Sharshar T, 1998, EUR J IMMUNOL, V28, P2344, DOI 10.1002/(SICI)1521-4141(199808)28:08<2344::AID-IMMU2344>3.0.CO;2-T; Silva SC, 2004, J NEUROIMMUNOL, V152, P176, DOI 10.1016/j.jneuroim.2004.03.015; Sundblad A, 1997, J AUTOIMMUN, V10, P193, DOI 10.1006/jaut.1996.0116; Yang QO, 2010, GENET EPIDEMIOL, V34, P444, DOI 10.1002/gepi.20497	21	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33990	10.1371/journal.pone.0033990	http://dx.doi.org/10.1371/journal.pone.0033990			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479494	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400047
J	Weisinger, RM; Wrenn, SJ; Harbury, PB				Weisinger, Rebecca M.; Wrenn, S. Jarrett; Harbury, Pehr B.			Highly Parallel Translation of DNA Sequences into Small Molecules	PLOS ONE			English	Article							IN-VITRO SELECTION; DRUG DISCOVERY; RNA; LIGANDS; LIBRARY; INHIBITORS; EVOLUTION; DISPLAY; APTAMER; BIND	A large body of in vitro evolution work establishes the utility of biopolymer libraries comprising 10(10) to 10(15) distinct molecules for the discovery of nanomolar-affinity ligands to proteins.[1,2,3,4,5] Small-molecule libraries of comparable complexity will likely provide nanomolar-affinity small-molecule ligands.[6,7] Unlike biopolymers, small molecules can offer the advantages of cell permeability, low immunogenicity, metabolic stability, rapid diffusion and inexpensive mass production. It is thought that such desirable in vivo behavior is correlated with the physical properties of small molecules, specifically a limited number of hydrogen bond donors and acceptors, a defined range of hydrophobicity, and most importantly, molecular weights less than 500 Daltons.[8] Creating a collection of 10(10) to 10(15) small molecules that meet these criteria requires the use of hundreds to thousands of diversity elements per step in a combinatorial synthesis of three to five steps. With this goal in mind, we have reported a set of mesofluidic devices that enable DNA-programmed combinatorial chemistry in a highly parallel 384-well plate format. Here, we demonstrate that these devices can translate DNA genes encoding 384 diversity elements per coding position into corresponding small-molecule gene products. This robust and efficient procedure yields small molecule-DNA conjugates suitable for in vitro evolution experiments.	[Weisinger, Rebecca M.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Weisinger, Rebecca M.; Wrenn, S. Jarrett; Harbury, Pehr B.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University; Stanford University	Weisinger, RM (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	harbury@cmgm.stanford.edu			NIH [DP OD000429]; Gabilan Stanford Graduate Fellowship; Stanford University; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000429] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabilan Stanford Graduate Fellowship; Stanford University(Stanford University); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by an NIH Pioneer Award (DP OD000429 to P.B.H.). R.M.W. was partially supported by the Gabilan Stanford Graduate Fellowship. S.J.W. was partially supported by the Stanford University Medical Scientist Training Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOCK LC, 1992, NATURE, V355, P564, DOI 10.1038/355564a0; BRENNER S, 1992, P NATL ACAD SCI USA, V89, P5381, DOI 10.1073/pnas.89.12.5381; Burmeister PE, 2005, CHEM BIOL, V12, P25, DOI 10.1016/j.chembiol.2004.10.017; Carothers JM, 2004, J AM CHEM SOC, V126, P5130, DOI 10.1021/ja031504a; Clark MA, 2010, CURR OPIN CHEM BIOL, V14, P396, DOI 10.1016/j.cbpa.2010.02.017; Clark MA, 2009, NAT CHEM BIOL, V5, P647, DOI 10.1038/nchembio.211; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Halpin DR, 2004, PLOS BIOL, V2, P1015, DOI 10.1371/journal.pbio.0020173; JOYCE GF, 1989, GENE, V82, P83, DOI 10.1016/0378-1119(89)90033-4; Kleiner RE, 2010, J AM CHEM SOC, V132, P11779, DOI 10.1021/ja104903x; LANCET D, 1993, P NATL ACAD SCI USA, V90, P3715, DOI 10.1073/pnas.90.8.3715; Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Mannocci L, 2010, BIOCONJUGATE CHEM, V21, P1836, DOI 10.1021/bc100198x; MILLS DR, 1967, P NATL ACAD SCI USA, V58, P217, DOI 10.1073/pnas.58.1.217; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; TIAN Y, 1995, RNA, V1, P317; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Valler MJ, 2000, DRUG DISCOV TODAY, V5, P286, DOI 10.1016/S1359-6446(00)01517-8; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Weisinger RM, 2012, MESOFLUIDIC DEVICES; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Wrenn SJ, 2007, J AM CHEM SOC, V129, P13137, DOI 10.1021/ja073993a; Wrenn SJ, 2007, ANNU REV BIOCHEM, V76, P331, DOI 10.1146/annurev.biochem.76.062205.122741	24	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e28056	10.1371/journal.pone.0028056	http://dx.doi.org/10.1371/journal.pone.0028056			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479303	gold, Green Published, Green Submitted			2022-12-27	WOS:000304523400001
J	Fridh, V; Rittinger, K				Fridh, Veronica; Rittinger, Katrin			The Tandem CARDs of NOD2: Intramolecular Interactions and Recognition of RIP2	PLOS ONE			English	Article							DEATH DOMAIN SUPERFAMILY; NF-KAPPA-B; INNATE IMMUNITY; CROHNS-DISEASE; TOLL RECEPTOR; HOST RESPONSE; CELL-DEATH; PROTEINS; COMPLEX; SUSCEPTIBILITY	Caspase recruitment domains (CARDs) are homotypic protein interaction modules that link the stimulus-dependent assembly of large signaling platforms such as inflammasomes to the activation of downstream effectors that often include caspases and kinases and thereby play an important role in the regulation of inflammatory and apoptotic signaling pathways. NOD2 belongs to the NOD-like (NLR) family of intracellular pattern recognition receptors (PRR) and induces activation of the NF-kappa B pathway in response to the recognition of bacterial components. This process requires the specific recognition of the CARD of the protein kinase RIP2 by the tandem CARDs of NOD2. Here we demonstrate that the tandem CARDs of NOD2 are engaged in an intramolecular interaction that is important for the structural stability of this region. Using a combination of ITC and pull-down experiments we identify distinct surface areas that are involved in the intramolecular tandem CARD interaction and the interaction with the downstream effector RIP2. Our findings indicate that while CARDa of NOD2 might be the primary binding partner of RIP2 the two CARDs of NOD2 do not act independently of one another but may cooperate to from a binding surface that is distinct from that of single CARDs.	[Fridh, Veronica; Rittinger, Katrin] MRC Natl Inst Med Res, Div Mol Struct, London, England	MRC National Institute for Medical Research	Fridh, V (corresponding author), MRC Technol, London, England.	katrin.rittinger@nimr.mrc.ac.uk	Rittinger, Katrin/N-3344-2019; Rittinger, Katrin/D-2586-2014	Rittinger, Katrin/0000-0002-7698-4435; Rittinger, Katrin/0000-0002-7698-4435	Medical Research Council, UK [U117565398]; MRC [MC_U117533887, MC_U117565398] Funding Source: UKRI; Medical Research Council [MC_U117533887] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council, UK, grant U117565398. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Chen YR, 2004, PROTEIN SCI, V13, P2196, DOI 10.1110/ps.03521504; Doyle ML, 1999, TITRATION MICROCALOR; Fedoroff OY, 2004, J BIOL CHEM, V279, P34991, DOI 10.1074/jbc.M404987200; Feng W, 2003, NAT STRUCT BIOL, V10, P972, DOI 10.1038/nsb992; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2002, CURR OPIN MICROBIOL, V5, P76, DOI 10.1016/S1369-5274(02)00289-8; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Rosenstiel P, 2006, P NATL ACAD SCI USA, V103, P3280, DOI 10.1073/pnas.0505423103; Schiffmann DA, 1999, BIOCHEMISTRY-US, V38, P11722, DOI 10.1021/bi9904252; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Srimathi T, 2008, J BIOL CHEM, V283, P15390, DOI 10.1074/jbc.M801589200; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Wagner RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004931; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Weber CH, 2001, TRENDS BIOCHEM SCI, V26, P475, DOI 10.1016/S0968-0004(01)01905-3; Wilmanski JM, 2008, J LEUKOCYTE BIOL, V83, P13, DOI 10.1189/jlb.0607402; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1	34	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34375	10.1371/journal.pone.0034375	http://dx.doi.org/10.1371/journal.pone.0034375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470564	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000103
J	Gladyshev, MI; Sushchik, NN; Kalachova, GS; Makhutova, ON				Gladyshev, Michail I.; Sushchik, Nadezhda N.; Kalachova, Galina S.; Makhutova, Olesia N.			Stable Isotope Composition of Fatty Acids in Organisms of Different Trophic Levels in the Yenisei River	PLOS ONE			English	Article							FOOD-WEB; BENTHIC INVERTEBRATES; GAMMARUS-LACUSTRIS; SEASONAL DYNAMICS; ALGAL COMMUNITY; CARBON; SEA; FRACTIONATION; BIOMARKER; DIETARY	We studied four-link food chain, periphytic microalgae and water moss (producers), trichopteran larvae (consumers I), gammarids (omnivorous - consumers II) and Siberian grayling (consumers III) at a littoral site of the Yenisei River on the basis of three years monthly sampling. Analysis of bulk carbon stable isotopes and compound specific isotope analysis of fatty acids (FA) were done. As found, there was a gradual depletion in C-13 contents of fatty acids, including essential FA upward the food chain. In all the trophic levels a parabolic dependence of delta C-13 values of fatty acids on their degree of unsaturation/chain length occurred, with 18:2n-6 and 18:3n-3 in its lowest point. The pattern in the delta C-13 differences between individual fatty acids was quite similar to that reported in literature for marine pelagic food webs. Hypotheses on isotope fractionation were suggested to explain the findings.	[Gladyshev, Michail I.; Sushchik, Nadezhda N.; Kalachova, Galina S.; Makhutova, Olesia N.] Russian Acad Sci, Siberian Branch, Inst Biophys, Krasnoyarsk, Russia; [Gladyshev, Michail I.; Sushchik, Nadezhda N.; Kalachova, Galina S.; Makhutova, Olesia N.] Siberian Fed Univ, Krasnoyarsk, Russia	Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Biophysics Institute, Siberian Branch, Russian Academy of Sciences; Siberian Federal University	Gladyshev, MI (corresponding author), Russian Acad Sci, Siberian Branch, Inst Biophys, Krasnoyarsk, Russia.	glad@ibp.ru	Makhutova, Olesia N/I-9855-2016; Sushchik, Nadezhda/P-9395-2015; Kalacheva, Galina/I-8975-2014; Gladyshev, Michail/F-6975-2013	Gladyshev, Michail/0000-0003-2276-3095	Institute of Biophysics of Siberian Branch of Russian Academy of Sciences from Russian Foundation for Basic Research (RFBR) [11-04-00168]; Ministry of Education and Sciences of Russian Federation (Theme B-4 of Siberian Federal University); Government of Russian Federation [11.G34.31.0014]	Institute of Biophysics of Siberian Branch of Russian Academy of Sciences from Russian Foundation for Basic Research (RFBR); Ministry of Education and Sciences of Russian Federation (Theme B-4 of Siberian Federal University)(Ministry of Education and Science, Russian Federation); Government of Russian Federation	Funding was provided by the Institute of Biophysics of Siberian Branch of Russian Academy of Sciences, award no. 11-04-00168 from the Russian Foundation for Basic Research (RFBR), the "Thematic Plans Program'' from the Ministry of Education and Sciences of Russian Federation (Theme B-4 of Siberian Federal University), and from grant no. 11.G34.31.0014 of the Government of Russian Federation for support of scientific research activities implemented under the supervision of leading scientists at Russian institutions of higher education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAJANO TA, 1994, ORG GEOCHEM, V21, P611, DOI 10.1016/0146-6380(94)90007-8; Anishchenko OV, 2010, CENT EUR J BIOL, V5, P125, DOI 10.2478/s11535-009-0060-y; Bec A, 2011, METHODS ECOL EVOL, V2, P651, DOI 10.1111/j.2041-210X.2011.00111.x; BECKER G, 1994, HYDROBIOLOGIA, V273, P171, DOI 10.1007/BF00005640; Bell JG, 2007, J AGR FOOD CHEM, V55, P5934, DOI 10.1021/jf0704561; Boschker HTS, 2005, LIMNOL OCEANOGR, V50, P70, DOI 10.4319/lo.2005.50.1.0070; Budge SM, 2008, OECOLOGIA, V157, P117, DOI 10.1007/s00442-008-1053-7; Budge SM, 2011, J EXP BIOL, V214, P3790, DOI 10.1242/jeb.057596; Campbell RC, 1967, STAT BIOL; Chamberlain PM, 2006, SOIL BIOL BIOCHEM, V38, P1146, DOI 10.1016/j.soilbio.2005.09.015; Chamberlain PM, 2004, OECOLOGIA, V139, P325, DOI 10.1007/s00442-003-1422-1; DENIRO MJ, 1977, SCIENCE, V197, P261, DOI 10.1126/science.327543; Dijkman NA, 2009, LIMNOL OCEANOGR-METH, V7, P612, DOI 10.4319/lom.2009.7.612; FRY B, 1988, LIMNOL OCEANOGR, V33, P1182, DOI 10.4319/lo.1988.33.5.1182; Gladyshev MI, 2000, HYDROBIOLOGIA, V431, P155, DOI 10.1023/A:1004036111433; Jim S, 2003, LIPIDS, V38, P179, DOI 10.1007/s11745-003-1049-1; JOHNSTON M, 1995, P ROY SOC B-BIOL SCI, V260, P293, DOI 10.1098/rspb.1995.0094; Kalachova GS, 2011, CENT EUR J BIOL, V6, P236, DOI 10.2478/s11535-010-0115-0; Kolmakov VI, 2008, J APPL PHYCOL, V20, P289, DOI 10.1007/s10811-007-9246-8; Koussoroplis AM, 2010, MAR ECOL PROG SER, V404, P207, DOI 10.3354/meps08485; Lau DCP, 2009, OECOLOGIA, V159, P767, DOI 10.1007/s00442-008-1262-0; Lau DCP, 2009, FRESHWATER BIOL, V54, P127, DOI 10.1111/j.1365-2427.2008.02099.x; MacNeil C, 1997, BIOL REV, V72, P349, DOI 10.1017/S0006323196005038; Makhutova ON, 2003, AQUAT ECOL, V37, P159, DOI 10.1023/A:1023975101075; Morino H, 2000, ADV ECOL RES, V31, P355, DOI 10.1016/S0065-2504(00)31019-4; Morrison DJ, 2007, LIPIDS, V42, P537, DOI 10.1007/s11745-007-3055-3; Parrish CC, 2007, LIMNOL OCEANOGR, V52, P476, DOI 10.4319/lo.2007.52.1.0476; Pel R, 2003, LIMNOL OCEANOGR, V48, P2200, DOI 10.4319/lo.2003.48.6.2200; Pond DW, 2008, DEEP-SEA RES PT I, V55, P1718, DOI 10.1016/j.dsr.2008.07.006; Pond DW, 2006, J PLANKTON RES, V28, P419, DOI 10.1093/plankt/fbi130; Rhee SK, 1997, LIPIDS, V32, P1257, DOI 10.1007/s11745-006-0161-6; Schouten S, 1998, GEOCHIM COSMOCHIM AC, V62, P1397, DOI 10.1016/S0016-7037(98)00076-3; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Sushchik NN, 2006, COMP BIOCHEM PHYS B, V145, P278, DOI 10.1016/j.cbpb.2006.05.014; Sushchik NN, 2007, AQUAT ECOL, V41, P349, DOI 10.1007/s10452-006-9065-z; Sushchik NN, 2010, J APPL PHYCOL, V22, P11, DOI 10.1007/s10811-009-9418-9; Sushchik NN, 2003, COMP BIOCHEM PHYS B, V134, P111, DOI 10.1016/S1096-4959(02)00191-4; Telang S.A., 1991, BIOGEOCHEMISTRY MAJO, P75; Tolosa I, 2004, MAR CHEM, V88, P103, DOI 10.1016/j.marchem.2004.03.005; Uhle ME, 1997, ORG GEOCHEM, V27, P103, DOI 10.1016/S0146-6380(97)00075-2; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Veefkind R., 2003, THESIS U VICTORIA VI	42	33	34	3	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34059	10.1371/journal.pone.0034059	http://dx.doi.org/10.1371/journal.pone.0034059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470513	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000057
J	Lenochova, P; Vohnoutova, P; Roberts, SC; Oberzaucher, E; Grammer, K; Havlicek, J				Lenochova, Pavlina; Vohnoutova, Pavla; Roberts, S. Craig; Oberzaucher, Elisabeth; Grammer, Karl; Havlicek, Jan			Psychology of Fragrance Use: Perception of Individual Odor and Perfume Blends Reveals a Mechanism for Idiosyncratic Effects on Fragrance Choice	PLOS ONE			English	Article							MENSTRUAL-CYCLE; BODY ODOR; MATE CHOICE; ATTRACTIVENESS; SCENT; PREFERENCES; HUMANS; SEX; BEHAVIOR; SMELLS	Cross-culturally, fragrances are used to modulate body odor, but the psychology of fragrance choice has been largely overlooked. The prevalent view is that fragrances mask an individual's body odor and improve its pleasantness. In two experiments, we found positive effects of perfume on body odor perception. Importantly, however, this was modulated by significant interactions with individual odor donors. Fragrances thus appear to interact with body odor, creating an individually-specific odor mixture. In a third experiment, the odor mixture of an individual's body odor and their preferred perfume was perceived as more pleasant than a blend of the same body odor with a randomly-allocated perfume, even when there was no difference in pleasantness between the perfumes. This indicates that fragrance use extends beyond simple masking effects and that people choose perfumes that interact well with their own odor. Our results provide an explanation for the highly individual nature of perfume choice.	[Lenochova, Pavlina; Vohnoutova, Pavla; Havlicek, Jan] Charles Univ Prague, Dept Anthropol, Prague, Czech Republic; [Roberts, S. Craig] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Oberzaucher, Elisabeth; Grammer, Karl] Univ Vienna, Dept Anthropol, Vienna, Austria	Charles University Prague; University of Stirling; University of Vienna	Lenochova, P (corresponding author), Charles Univ Prague, Dept Anthropol, Prague, Czech Republic.	jan.havlicek@fhs.cuni.cz	Roberts, Craig/E-6919-2011; Havlíček, Jan/F-8985-2011; Grammer, Karl U/A-5012-2011; oberzaucher, elisabeth/A-5702-2011	Roberts, Craig/0000-0002-9641-6101; Havlíček, Jan/0000-0003-2374-7337; Grammer, Karl U/0000-0001-7801-6131; oberzaucher, elisabeth/0000-0003-0083-3160	Grant Agency of Charles University (GAUK) [55108/2008]; Czech Science Foundation (GACR) [P407/10/1303]; Czech Ministry of Education [0021620843]	Grant Agency of Charles University (GAUK); Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic)	The study was supported by Grant Agency of Charles University (GAUK 55108/2008), Czech Science Foundation (GACR P407/10/1303) and Czech Ministry of Education grant 0021620843. The authors are also very grateful for a material donation provided by the Yves Rocher, Optimum Distribution CZ & SK and Fann Parfumery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerl K, 2002, NEUROENDOCRINOL LETT, V23, P79; [Anonymous], 2012, FLAVOR FRAGRANCE IND; Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; BARON RA, 1981, PERS SOC PSYCHOL B, V7, P611, DOI 10.1177/014616728174016; Behan JM, 2006, INT J COSMETIC SCI, V18, P237; Berglund H, 2006, P NATL ACAD SCI USA, V103, P8269, DOI 10.1073/pnas.0600331103; Classen C., 1994, AROMA CULTURAL HIST; Cornwell RE, 2004, P ROY SOC B-BIOL SCI, V271, P635, DOI 10.1098/rspb.2003.2649; DOTY RL, 1978, BEHAV BIOL, V23, P373, DOI 10.1016/S0091-6773(78)91393-7; Ferdenzi C, 2011, EMOTION, V11, P1168, DOI 10.1037/a0022853; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Graham CA, 2000, PSYCHOPHYSIOLOGY, V37, P76, DOI 10.1017/S0048577200981964; GRAHAM JA, 1980, INT J COSMETIC SCI, V2, P77, DOI 10.1111/j.1467-2494.1980.tb00237.x; Havlicek J, 2006, ETHOLOGY, V112, P81, DOI 10.1111/j.1439-0310.2006.01125.x; Havlicek J, 2005, BIOL LETTERS, V1, P256, DOI 10.1098/rsbl.2005.0332; Havlicek J, 2008, PERS INDIV DIFFER, V45, P565, DOI 10.1016/j.paid.2008.06.019; Havlicek J, 2011, CHEMOSENS PERCEPT, V4, P186, DOI 10.1007/s12078-011-9104-6; Havlicek J, 2010, VITAM HORM, V83, P47, DOI 10.1016/S0083-6729(10)83003-1; Havlicek J, 2009, PSYCHONEUROENDOCRINO, V34, P497, DOI 10.1016/j.psyneuen.2008.10.007; Henrich J., 2007, OXFORD HDB EVOLUTION, P555, DOI DOI 10.1093/OXFORDHB/9780198568308.013.0038; Herz RS, 1997, HUM NATURE-INT BIOS, V8, P275, DOI 10.1007/BF02912495; Herz RS, 2002, EVOL HUM BEHAV, V23, P359, DOI 10.1016/S1090-5138(02)00095-8; Higuchi T, 2005, INT J PSYCHOL, V40, P90, DOI 10.1080/00207590444000050; Holland RW, 2005, PSYCHOL SCI, V16, P689, DOI 10.1111/j.1467-9280.2005.01597.x; Kuukasjarvi S, 2004, BEHAV ECOL, V15, P579, DOI 10.1093/beheco/arh050; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; LARGEY GP, 1972, AM J SOCIOL, V77, P1021, DOI 10.1086/225257; Lenochova P, 2009, CHEM SENSES, V34, P127, DOI 10.1093/chemse/bjn067; Li W, 2007, PSYCHOL SCI, V18, P1044, DOI 10.1111/j.1467-9280.2007.02023.x; Livermore A, 1998, PERCEPT PSYCHOPHYS, V60, P650, DOI 10.3758/BF03206052; Milinski M, 2001, BEHAV ECOL, V12, P140, DOI 10.1093/beheco/12.2.140; Miller SL, 2010, PSYCHOL SCI, V21, P276, DOI 10.1177/0956797609357733; Mujica-Parodi LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006415; Navarrete-Palacios E, 2003, BIOL PSYCHOL, V63, P269, DOI 10.1016/S0301-0511(03)00076-0; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Prescott J, 2007, PSYCHOL SCI, V18, P308, DOI 10.1111/j.1467-9280.2007.01894.x; Richerson PeterJ., 2006, NOT GENES ALONE CULT; Rikowski A, 1999, P ROY SOC B-BIOL SCI, V266, P869, DOI 10.1098/rspb.1999.0717; Roberts S. Craig, 2009, International Journal of Cosmetic Science, V31, P47, DOI 10.1111/j.1468-2494.2008.00477.x; Saxton TK, 2008, HORM BEHAV, V54, P597, DOI 10.1016/j.yhbeh.2008.06.001; SCHLEIDT M, 1980, ETHOL SOCIOBIOL, V1, P225, DOI 10.1016/0162-3095(80)90009-6; SCHLEIDT M, 1981, J CHEM ECOL, V7, P19, DOI 10.1007/BF00988632; Stoddart D. M., 1990, SCENTED APE BIOL CUL; Thornhill R, 1999, EVOL HUM BEHAV, V20, P175, DOI 10.1016/S1090-5138(99)00005-7; VARENDI H, 1994, LANCET, V344, P989, DOI 10.1016/S0140-6736(94)91645-4; Wysocki CJ, 1991, SMELL TASTE HLTH DIS, P287	47	44	44	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33810	10.1371/journal.pone.0033810	http://dx.doi.org/10.1371/journal.pone.0033810			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948FM	22470479	Green Published, gold			2022-12-27	WOS:000304489000036
J	Nieder, C; Pawinski, A; Dalhaug, A				Nieder, Carsten; Pawinski, Adam; Dalhaug, Astrid			Contribution of Case Reports to Brain Metastases Research: Systematic Review and Analysis of Pattern of Citation	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; SCIENTOMETRIC INDICATORS; IMPACT FACTOR; CANCER; REGRESSION; SUNITINIB; THERAPY	Research activity related to different aspects of prevention, prediction, diagnosis and treatment of brain metastases has increased during recent years. One of the major databases (Scopus) contains 942 scientific articles that were published during the 5-year time period 2006-2010. Of these, 195 (21%) reported on single patient cases and 12 (1%) were reports of 2 cases. Little is known about their influence on advancement of the field or scientific merits. Do brain metastases case reports attract attention and provide stimuli for further research or do they go largely unrecognized? Different measures of impact, visibility and quality of published research are available, each with its own pros and cons. For the present evaluation, article citation rate was chosen. The median number of citations overall and stratified by year of publication was 0, except for the year 2006 when it was 2. As compared to other articles, case reports remained more often without citation (p<0.05 except for 2006 data). All case reports with 10 or more citations (n = 6) reported on newly introduced anticancer drugs, which commonly are prescribed to treat extracranial metastases, and the responses observed in single patients with brain metastases. Average annual numbers of citations were also calculated. The articles with most citations per year were the same six case reports mentioned above (the only ones that obtained more than 2.0 citations per year). Citations appeared to gradually increase during the first two years after publication but remained on a generally low or modest level. It cannot be excluded that case reports without citation provide interesting information to some clinicians or researchers. Apparently, case reports describing unexpected therapeutic success gain more attention, at least in terms of citation, than others.	[Nieder, Carsten; Pawinski, Adam; Dalhaug, Astrid] Nordland Hosp, Dept Oncol & Palliat Med, Bodo, Norway; [Nieder, Carsten; Dalhaug, Astrid] Univ Tromso, Fac Hlth Sci, Inst Clin Med, Tromso, Norway	UiT The Arctic University of Tromso	Nieder, C (corresponding author), Nordland Hosp, Dept Oncol & Palliat Med, Bodo, Norway.	carsten.nieder@nlsh.no						Aoyama H, 2006, JAMA-J AM MED ASSOC, V295, P2483, DOI 10.1001/jama.295.21.2483; Durieux V, 2010, RADIOLOGY, V255, P342, DOI 10.1148/radiol.09090626; Fabi A, 2006, CANCER INVEST, V24, P466, DOI 10.1080/07357900600705805; Gounant V, 2007, LUNG CANCER, V58, P425, DOI 10.1016/j.lungcan.2007.07.010; Hodi FS, 2008, NAT CLIN PRACT ONCOL, V5, P557, DOI 10.1038/ncponc1183; Kanaan Z, 2011, ANN SURG, V253, P619, DOI 10.1097/SLA.0b013e31820d9b04; Koutras AK, 2007, ANTICANCER RES, V27, P4255; Kulkarni AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020885; Kumar V, 2009, SINGAP MED J, V50, P752; Leydesdorff L, 2010, J INFORMETR, V4, P644, DOI 10.1016/j.joi.2010.05.003; Medioni J, 2007, ANN ONCOL, V18, P1282, DOI 10.1093/annonc/mdm275; Nieder C, 2011, CANCER-AM CANCER SOC, V117, P2505, DOI 10.1002/cncr.25707; Owlia P, 2011, J BIOMED INFORM, V44, P216, DOI 10.1016/j.jbi.2010.11.002; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Schubert A, 1996, SCIENTOMETRICS, V36, P311, DOI 10.1007/BF02129597; Stringer MJ, 2010, J AM SOC INF SCI TEC, V61, P1377, DOI 10.1002/asi.21335; Stringer MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001683; Thibault F, 2008, J NEURO-ONCOL, V86, P243, DOI 10.1007/s11060-007-9449-5; Vinkler P, 2003, SCIENTOMETRICS, V58, P687, DOI 10.1023/B:SCIE.0000006888.69146.24; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	21	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34300	10.1371/journal.pone.0034300	http://dx.doi.org/10.1371/journal.pone.0034300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470554	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000093
J	Pouliot, M; Talbot, S; Senecal, J; Dotigny, F; Vaucher, E; Couture, R				Pouliot, Mylene; Talbot, Sebastien; Senecal, Jacques; Dotigny, Florence; Vaucher, Elvire; Couture, Rejean			Ocular Application of the Kinin B-1 Receptor Antagonist LF22-0542 Inhibits Retinal Inflammation and Oxidative Stress in Streptozotocin-Diabetic Rats	PLOS ONE			English	Article							VASCULAR-PERMEABILITY; ADHESION MOLECULE-1; MITOCHONDRIAL SUPEROXIDE; PLASMA EXTRAVASATION; INDUCIBLE EXPRESSION; BARRIER BREAKDOWN; UP-REGULATION; RETINOPATHY; BRADYKININ; KALLIKREIN	Purpose: Kinin B-1 receptor (B1R) is upregulated in retina of Streptozotocin (STZ)-diabetic rats and contributes to vasodilation of retinal microvessels and breakdown of the blood-retinal barrier. Systemic treatment with B1R antagonists reversed the increased retinal plasma extravasation in STZ rats. The present study aims at determining whether ocular application of a water soluble B1R antagonist could reverse diabetes-induced retinal inflammation and oxidative stress. Methods: Wistar rats were made diabetic with STZ (65 mg/kg, i.p.) and 7 days later, they received one eye drop application of LF22-0542 (1% in saline) twice a day for a 7 day-period. The impact was determined on retinal vascular permeability (Evans blue exudation), leukostasis (leukocyte infiltration using Fluorescein-isothiocyanate (FITC)-coupled Concanavalin A lectin), retinal mRNA levels (by qRT-PCR) of inflammatory (B1R, iNOS, COX-2, ICAM-1, VEGF-A, VEGF receptor type 2, IL-1 beta and HIF-1 alpha) and anti-inflammatory (B2R, eNOS) markers and retinal level of superoxide anion (dihydroethidium staining). Results: Retinal plasma extravasation, leukostasis and mRNA levels of B1R, iNOS, COX-2, VEGF receptor type 2, IL-1 beta and HIF-1 alpha were significantly increased in diabetic retinae compared to control rats. All these abnormalities were reversed to control values in diabetic rats treated with LF22-0542. B1R antagonist also significantly inhibited the increased production of superoxide anion in diabetic retinae. Conclusion: B1R displays a pathological role in the early stage of diabetes by increasing oxidative stress and pro-inflammatory mediators involved in retinal vascular alterations. Hence, topical application of kinin B1R antagonist appears a highly promising novel approach for the treatment of diabetic retinopathy.	[Pouliot, Mylene; Dotigny, Florence; Vaucher, Elvire] Univ Montreal, Ecole Optometrie, Montreal, PQ H3C 3J7, Canada; [Pouliot, Mylene; Talbot, Sebastien; Senecal, Jacques; Couture, Rejean] Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Pouliot, M (corresponding author), Univ Montreal, Ecole Optometrie, Montreal, PQ H3C 3J7, Canada.	rejean.couture@umontreal.ca		Vaucher, Elvire/0000-0001-7075-5263	Vision Research Network of the Fonds de la Recherche en Sante du Quebec (FRSQ); Canadian Diabetes Association [OG-3-07-2428]; Foundation Fighting Blindness; Canadian Institutes of Health Research; Fovea Pharmaceuticals [LF22-0542]	Vision Research Network of the Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Diabetes Association; Foundation Fighting Blindness(European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fovea Pharmaceuticals	This work was funded by Grants-in-Aid from the Vision Research Network of the Fonds de la Recherche en Sante du Quebec (FRSQ) and the Canadian Diabetes Association (OG-3-07-2428). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PhD Studentship Awards were obtained from the Foundation Fighting Blindness (MP), the FRSQ (MP, ST) and the Canadian Institutes of Health Research (ST). Authors are thankful to Denis Latendresse for the artwork.; RC has received research funds from Fovea Pharmaceuticals, the manufacturer or the compound LF22-0542. Fovea Pharmaceuticals provided the compound LF22-0542 employed in this study. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Abdouh M, 2008, BRIT J PHARMACOL, V154, P136, DOI 10.1038/bjp.2008.48; Abdouh M, 2003, BRIT J PHARMACOL, V140, P33, DOI 10.1038/sj.bjp.0705210; Ahluwalia A, 1999, TRENDS PHARMACOL SCI, V20, P100, DOI 10.1016/S0165-6147(99)01321-8; Amrite AC, 2006, INVEST OPHTH VIS SCI, V47, P1149, DOI 10.1167/iovs.05-0531; Araujo RC, 2001, BIOL CHEM, V382, P91, DOI 10.1515/BC.2001.014; Ayalasomayajula SP, 2003, EUR J PHARMACOL, V458, P283, DOI 10.1016/S0014-2999(02)02793-0; Clermont A, 2011, DIABETES, V60, P1590, DOI 10.2337/db10-1260; Couture R, 2001, EUR J PHARMACOL, V429, P161, DOI 10.1016/S0014-2999(01)01318-8; Couture R, 2004, EUR J PHARMACOL, V500, P467, DOI 10.1016/j.ejphar.2004.07.045; Cui Y, 2006, EXP EYE RES, V83, P807, DOI 10.1016/j.exer.2006.03.024; Dias JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012622; Du YP, 2004, AM J PHYSIOL-REG I, V287, pR735, DOI 10.1152/ajpregu.00080.2003; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; El-Asrar AM, 2001, AM J OPHTHALMOL, V132, P551, DOI 10.1016/S0002-9394(01)01127-8; Feener EP, 2010, CURR DIABETES REP, V10, P270, DOI 10.1007/s11892-010-0127-1; Frank RN, 2004, NEW ENGL J MED, V350, P48, DOI 10.1056/NEJMra021678; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Joussen Antonia M, 2007, Dev Ophthalmol, V39, P1, DOI 10.1159/000098495; Kanwar M, 2007, INVEST OPHTH VIS SCI, V48, P3805, DOI 10.1167/iovs.06-1280; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kowluru RA, 2006, INVEST OPHTH VIS SCI, V47, P1594, DOI 10.1167/iovs.05-1276; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Kowluru RA, 2001, DIABETES, V50, P1938, DOI 10.2337/diabetes.50.8.1938; Kowluru RA, 2007, EXP DIABETES RES, DOI 10.1155/2007/43603; Kuhr F, 2010, NEUROPEPTIDES, V44, P145, DOI 10.1016/j.npep.2009.12.004; KUZNETSOVA TP, 1991, VOP MED KHIM, V37, P79; Lawson SR, 2005, EUR J PHARMACOL, V514, P69, DOI 10.1016/j.ejphar.2005.03.023; Lawson SR, 2005, REGUL PEPTIDES, V124, P221, DOI 10.1016/j.regpep.2004.09.002; Leal EC, 2007, INVEST OPHTH VIS SCI, V48, P5257, DOI 10.1167/iovs.07-0112; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Lim SK, 2008, LIFE SCI, V83, P761, DOI 10.1016/j.lfs.2008.09.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lungu C, 2007, NEUROPEPTIDES, V41, P375, DOI 10.1016/j.npep.2007.09.005; Ma JX, 1996, EXP EYE RES, V63, P19, DOI 10.1006/exer.1996.0087; Marceau F, 1997, CAN J PHYSIOL PHARM, V75, P725, DOI 10.1139/cjpp-75-6-725; MARCEAU F, 1995, IMMUNOPHARMACOLOGY, V30, P1, DOI 10.1016/0162-3109(95)00011-H; McLean PG, 2000, J EXP MED, V192, P367, DOI 10.1084/jem.192.3.367; McLean PG, 1999, BRIT J PHARMACOL, V128, P275, DOI 10.1038/sj.bjp.0702743; MCLEOD DS, 1995, AM J PATHOL, V147, P642; Miller FJ, 1998, CIRC RES, V82, P1298, DOI 10.1161/01.RES.82.12.1298; Miyahara S, 2004, AM J PATHOL, V164, P1697, DOI 10.1016/S0002-9440(10)63728-5; Miyamoto K, 1999, P NATL ACAD SCI USA, V96, P10836, DOI 10.1073/pnas.96.19.10836; Miyamoto K, 1998, INVEST OPHTH VIS SCI, V39, P2190; Miyamoto K, 2000, AM J PATHOL, V156, P1733, DOI 10.1016/S0002-9440(10)65044-4; Moss SE, 1998, OPHTHALMOLOGY, V105, P998, DOI 10.1016/S0161-6420(98)96025-0; Ni AG, 1998, J BIOL CHEM, V273, P2784, DOI 10.1074/jbc.273.5.2784; Noda K, 2009, EXP EYE RES, V89, P774, DOI 10.1016/j.exer.2009.07.010; Pesquero JB, 2000, P NATL ACAD SCI USA, V97, P8140, DOI 10.1073/pnas.120035997; Petcu M, 2008, INT IMMUNOPHARMACOL, V8, P188, DOI 10.1016/j.intimp.2007.09.009; Phipps JA, 2008, KIDNEY INT, V73, P1114, DOI 10.1038/ki.2008.9; Porreca F, 2006, J PHARMACOL EXP THER, V318, P195, DOI 10.1124/jpet.105.098368; Poulaki V, 2004, AM J PATHOL, V165, P457, DOI 10.1016/S0002-9440(10)63311-1; Pouliot M, 2011, EXP EYE RES, V92, P482, DOI 10.1016/j.exer.2011.03.007; Qaum T, 2001, INVEST OPHTH VIS SCI, V42, P2408; Regoli D, 1998, EUR J PHARMACOL, V348, P1, DOI 10.1016/S0014-2999(98)00165-4; REGOLI D, 1980, PHARMACOL REV, V32, P1; Sasaki M, 2010, DIABETOLOGIA, V53, P971, DOI 10.1007/s00125-009-1655-6; Simard B, 2002, CAN J PHYSIOL PHARM, V80, P1203, DOI 10.1139/Y02-153; Takeda H, 1999, IMMUNOPHARMACOLOGY, V45, P51, DOI 10.1016/S0162-3109(99)00057-0; Vianna RMJ, 1998, BRIT J PHARMACOL, V123, P281, DOI 10.1038/sj.bjp.0701590; Vianna RMJ, 2003, BRIT J PHARMACOL, V138, P13, DOI 10.1038/sj.bjp.0704999; Westermann D, 2009, DIABETES, V58, P1373, DOI 10.2337/db08-0329; Wilkinson-Berka JL, 2004, CURR PHARM DESIGN, V10, P3313, DOI 10.2174/1381612043383179	64	48	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33864	10.1371/journal.pone.0033864	http://dx.doi.org/10.1371/journal.pone.0033864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470485	gold, Green Published			2022-12-27	WOS:000304489000041
J	Schaier, M; Seissler, N; Schmitt, E; Meuer, S; Hug, F; Zeier, M; Steinborn, A				Schaier, Matthias; Seissler, Nicole; Schmitt, Edgar; Meuer, Stefan; Hug, Friederike; Zeier, Martin; Steinborn, Andrea			DR(high+)CD45RA(-)-Tregs Potentially Affect the Suppressive Activity of the Total Treg Pool in Renal Transplant Patients	PLOS ONE			English	Article							REGULATORY T-CELLS; ALLOGRAFT-REJECTION; MULTIPLE-SCLEROSIS; TOLERANCE; SURVIVAL; HOMEOSTASIS; RECIPIENTS; DISEASE; REG	Recent studies show that regulatory T cells (Tregs) play an essential role in tolerance induction after organ transplantation. In order to examine whether there are differences in the composition of the total CD4(+)CD127(low+/-)FoxP3(+)-Treg cell pool between stable transplant patients and patients with biopsy proven rejection (BPR), we compared the percentages and the functional activity of the different Treg cell subsets (DR(high+)CD45RA(-)-Tregs, DR(low+)CD45RA(-)-Tregs, DR(-)CD45RA(-)-Tregs, DR(-)CD45RA(+)-Tregs). All parameters were determined during the three different periods of time after transplantation (0-30 days, 31-1,000 days, >1,000 days). Among 156 transplant patients, 37 patients suffered from BPR. The most prominent differences between rejecting and non-rejecting patients were observed regarding the DR(high+)CD45RA(-)-Treg cell subset. Our data demonstrate that the suppressive activity of the total Treg pool strongly depends on the presence of these Treg cells. Their percentage within the total Treg pool strongly decreased after transplantation and remained relatively low during the first year after transplantation in all patients. Subsequently, the proportion of this Treg subset increased again in patients who accepted the transplant and reached a value of healthy non-transplanted subjects. By contrast, in patients with acute kidney rejection, the DR(high+)CD45RA(-)-Treg subset disappeared excessively, causing a reduction in the suppressive activity of the total Treg pool. Therefore, both the monitoring of its percentage within the total Treg pool and the monitoring of the HLA-DR MFI of the DR(+)CD45RA(-)-Treg subset may be useful tools for the prediction of graft rejection.	[Schaier, Matthias; Seissler, Nicole; Hug, Friederike; Zeier, Martin] Univ Heidelberg, Dept Nephrol, Heidelberg, Germany; [Schmitt, Edgar] Johannes Gutenberg Univ Mainz, Inst Immunol, D-6500 Mainz, Germany; [Meuer, Stefan] Univ Heidelberg, Inst Immunol, D-6900 Heidelberg, Germany; [Steinborn, Andrea] Univ Heidelberg, Dept Obstet & Gynecol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Schaier, M (corresponding author), Univ Heidelberg, Dept Nephrol, Heidelberg, Germany.	matthias_schaier@med.uni-heidelberg.de		Schaier, Matthias/0000-0003-1040-1150	Deutsche Forschungsgemeinschaft [STE 885/3-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft grant STE 885/3-2 (to A. Steinborn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Ashley CW, 2009, J IMMUNOL, V183, P4843, DOI 10.4049/jimmunol.0900845; Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; Baecher-Allan CM, 2011, J IMMUNOL, V186, P3317, DOI 10.4049/jimmunol.1002502; Banham AH, 2006, EUR J IMMUNOL, V36, P2832, DOI 10.1002/eji.200636459; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Boros P, 2009, AM J TRANSPLANT, V9, P1719, DOI 10.1111/j.1600-6143.2009.02704.x; Braudeau C, 2007, TRANSPL INT, V20, P845, DOI 10.1111/j.1432-2277.2007.00537.x; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Dijke IE, 2009, TRANSPLANTATION, V87, P1191, DOI 10.1097/TP.0b013e31819ec2fb; Ekberg H, 2009, AM J TRANSPLANT, V9, P1876, DOI 10.1111/j.1600-6143.2009.02726.x; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Joffre O, 2008, NAT MED, V14, P88, DOI 10.1038/nm1688; Kisielewicz A, 2010, CLIN IMMUNOL, V137, P209, DOI 10.1016/j.clim.2010.07.008; Kreijveld E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002711; Li XC, 2010, NAT REV NEPHROL, V6, P577, DOI 10.1038/nrneph.2010.101; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lopez-Hoyos M, 2009, TRANSPLANTATION, V88, pS31, DOI 10.1097/TP.0b013e3181af7b99; Louis S, 2006, TRANSPLANTATION, V81, P398, DOI 10.1097/01.tp.0000203166.44968.86; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Noris M, 2007, J AM SOC NEPHROL, V18, P1007, DOI 10.1681/ASN.2006101143; Pirsch JD, 1996, TRANSPLANTATION, V61, P1581, DOI 10.1097/00007890-199606150-00006; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rouse BT, 2006, IMMUNOL REV, V212, P272, DOI 10.1111/j.0105-2896.2006.00412.x; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Steinborn A, 2008, CLIN IMMUNOL, V129, P401, DOI 10.1016/j.clim.2008.07.032; Stenard F, 2009, PEDIATR TRANSPLANT, V13, P70, DOI 10.1111/j.1399-3046.2008.00917.x; TESI RJ, 1993, TRANSPLANT P, V25, P901; Venken K, 2008, J IMMUNOL, V180, P6411, DOI 10.4049/jimmunol.180.9.6411; Yolcu ES, 2008, IMMUNOL CELL BIOL, V86, P650, DOI 10.1038/icb.2008.62	33	43	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34208	10.1371/journal.pone.0034208	http://dx.doi.org/10.1371/journal.pone.0034208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470536	Green Submitted, Green Published, gold			2022-12-27	WOS:000304489000075
J	Zhu, HZ; Lee, HY; Tong, YF; Hong, BS; Kim, KP; Shen, Y; Lim, KJ; Mackenzie, F; Tempel, W; Park, HW				Zhu, Haizhong; Lee, Han Youl; Tong, Yufeng; Hong, Bum-Soo; Kim, Kyung-Phil; Shen, Yang; Lim, Kyung Jik; Mackenzie, Farrell; Tempel, Wolfram; Park, Hee-Won			Crystal Structures of the Tetratricopeptide Repeat Domains of Kinesin Light Chains: Insight into Cargo Recognition Mechanisms	PLOS ONE			English	Article							PROTEIN-STRUCTURE; TPR DOMAIN; TRANSPORT; COMPLEX; INTERACTS; SCAFFOLD; SYSTEM; ARF6; JIP4	Kinesin-1 transports various cargos along the axon by interacting with the cargos through its light chain subunit. Kinesin light chains (KLC) utilize its tetratricopeptide repeat (TPR) domain to interact with over 10 different cargos. Despite a high sequence identity between their TPR domains (87%), KLC1 and KLC2 isoforms exhibit differential binding properties towards some cargos. We determined the structures of human KLC1 and KLC2 tetratricopeptide repeat (TPR) domains using X-ray crystallography and investigated the different mechanisms by which KLCs interact with their cargos. Using isothermal titration calorimetry, we attributed the specific interaction between KLC1 and JNK-interacting protein 1 (JIP1) cargo to residue N343 in the fourth TRP repeat. Structurally, the N343 residue is adjacent to other asparagines and lysines, creating a positively charged polar patch within the groove of the TPR domain. Whereas, KLC2 with the corresponding residue S328 did not interact with JIP1. Based on these finding, we propose that N343 of KLC1 can form "a carboxylate clamp'' with its neighboring asparagine to interact with JIP1, similar to that of HSP70/HSP90 organizing protein-1's (HOP1) interaction with heat shock proteins. For the binding of cargos shared by KLC1 and KLC2, we propose a different site located within the groove but not involving N343. We further propose a third binding site on KLC1 which involves a stretch of polar residues along the inter-TPR loops that may form a network of hydrogen bonds to JIP3 and JIP4. Together, these results provide structural insights into possible mechanisms of interaction between KLC TPR domains and various cargo proteins.	[Zhu, Haizhong; Tong, Yufeng; Hong, Bum-Soo; Shen, Yang; Mackenzie, Farrell; Tempel, Wolfram; Park, Hee-Won] Struct Genom Consortium, Toronto, ON, Canada; [Lee, Han Youl; Kim, Kyung-Phil; Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada; [Lim, Kyung Jik] Philip Pocock Catholic Secondary Sch, Mississauga, ON, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto	Zhu, HZ (corresponding author), Struct Genom Consortium, Toronto, ON, Canada.	heewon.park@utoronto.ca	Tong, Yufeng/D-2785-2011	Tong, Yufeng/0000-0001-7740-1812	Natural Sciences and Engineering Research Council of Canada (NSERC) [371633-09]; Canadian Institutes for Health Research; Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck and Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Karolinska Institutet	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute(Genome CanadaCanada Foundation for Innovation); GlaxoSmithKline(GlaxoSmithKline); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck and Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Karolinska Institutet(Karolinska Institutet)	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant 371633-09 (H.-W.P). The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck and Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BLOOM GS, 1988, BIOCHEMISTRY-US, V27, P3409, DOI 10.1021/bi00409a043; Bracale A, 2007, MOL BIOL CELL, V18, P142, DOI 10.1091/mbc.E06-05-0453; Bricogne G, 2009, BUSTER VERSION 2 8 0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Dutta S, 2008, BIOCHEMISTRY-US, V47, P10123, DOI 10.1021/bi800758a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gatto GJ, 2000, NAT STRUCT BIOL, V7, P1091; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hammond JW, 2008, TRAFFIC, V9, P725, DOI 10.1111/j.1600-0854.2008.00722.x; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Isabet T, 2009, EMBO J, V28, P2835, DOI 10.1038/emboj.2009.209; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamal A, 2002, CURR OPIN CELL BIOL, V14, P63, DOI 10.1016/S0955-0674(01)00295-2; Kamm C, 2004, J BIOL CHEM, V279, P19882, DOI 10.1074/jbc.M401332200; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; Lalioti VS, 2009, J CELL PHYSIOL, V218, P416, DOI 10.1002/jcp.21614; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Mandelkow E, 2002, TRENDS CELL BIOL, V12, P585, DOI 10.1016/S0962-8924(02)02400-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonald A, 2009, ISLETS, V1, P198, DOI 10.4161/isl.1.3.9608; McGuire JR, 2006, J BIOL CHEM, V281, P3552, DOI 10.1074/jbc.M509806200; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen Q, 2005, J BIOL CHEM, V280, P30185, DOI 10.1074/jbc.M505499200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Vagnoni A, 2011, J CELL SCI, V124, P1032, DOI 10.1242/jcs.075168; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; YANG JT, 1990, SCIENCE, V249, P42, DOI 10.1126/science.2142332	44	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33943	10.1371/journal.pone.0033943	http://dx.doi.org/10.1371/journal.pone.0033943			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470497	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000045
J	Cardador, L; Carrete, M; Manosa, S				Cardador, Laura; Carrete, Martina; Manosa, Santi			Inter-Individual Variability and Conspecific Densities: Consequences for Population Regulation and Range Expansion	PLOS ONE			English	Article							HARRIERS CIRCUS-AERUGINOSUS; BEHAVIORAL FLEXIBILITY; COLONY SIZE; PHENOTYPIC PLASTICITY; BREEDING PERFORMANCE; DEPENDENT REGULATION; INVASION SUCCESS; MARSH HARRIER; DISPERSAL; SELECTION	The presence of conspecifics can strongly modulate the quality of a breeding site. Both positive and negative effects of conspecifics can act on the same individuals, with the final balance between its costs and benefits depending on individual characteristics. A particular case of inter-individual variation found in many avian species is chromatic variability. Among birds, plumage coloration can co-vary with morphology, physiology and behavior as well as with age. These relationships suggest that cost-benefit balances of conspecific presence may be different for individuals with different colorations. We investigated whether inter-individual variability affects population regulation and expansion processes by analyzing potential differences in density-dependent productivity and settlement patterns in relation to plumage coloration in a population of a long-lived avian species recently undergoing a notable increase in numbers and distribution range. Our results show strong variation in the effect of density on productivity of breeding pairs depending on plumage coloration of their members. Productivity of dark birds decreased along the breeding density gradient while that of lighter breeders remained unchanged with conspecific density. In a similar way, our results showed an uneven occupation of localities by individuals with different plumage coloration in relation to local densities, with the breeding of lighter harriers more aggregated than that of dark-brown ones. At a population scale, darker birds had higher probability of colonization of the most isolated, empty sites. Explanations for species range expansion and population regulation usually make the inferred assumption that species traits are similar among individuals. However, in most species, there could be individual variation in niche requirements or dispersal propensities among individuals with different traits. Our results contribute to the growing appreciation that the individual traits, but not the average trait at the level of species, are important during population regulation and expansion processes.	[Cardador, Laura; Manosa, Santi] Univ Barcelona, Dept Biol Anim, Barcelona, Spain; [Carrete, Martina] Univ Pablo de Olavide, Dept Phys Chem & Nat Syst, Seville, Spain	University of Barcelona; Universidad Pablo de Olavide	Cardador, L (corresponding author), Univ Barcelona, Dept Biol Anim, Barcelona, Spain.	lcardador@ub.edu	Mañosa, Santiago/R-6693-2018; Carrete, Martina/A-6376-2009; Carrete, Martina/D-2618-2017; Cardador, Laura/K-4412-2014	Carrete, Martina/0000-0002-0491-2950; Cardador, Laura/0000-0003-2548-8578; Chiaradia, Andre/0000-0002-6178-4211; Manosa, Santi/0000-0003-0681-1552	Ministerio de Educacion from Spain [AP20054104]	Ministerio de Educacion from Spain	L. Cardador was partially supported by a postgraduate grant (FPU 2006-2009: AP20054104) from the Ministerio de Educacion (www.educacion.gob.es) from Spain. The research, which is part of the PhD of L. Cardador, has been carried out without any other kind of external financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTENBURG W, 1982, BEHAVIOUR, V79, P272, DOI 10.1163/156853982X00300; Arroyo B, 2001, BEHAV ECOL SOCIOBIOL, V50, P109, DOI 10.1007/s002650100342; Arroyo BE, 1999, CONDOR, V101, P340, DOI 10.2307/1369997; Balkiz O, 2010, J ANIM ECOL, V79, P1045, DOI 10.1111/j.1365-2656.2010.01721.x; BAVOUX C, 1991, Alauda, V59, P248; Bavoux C, 2006, J RAPTOR RES, V40, P57, DOI 10.3356/0892-1016(2006)40[57:GDITWM]2.0.CO;2; BirdLife International, 2004, BIRDS EUR POP EST TR; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; BROWN CR, 1990, TRENDS ECOL EVOL, V5, P398, DOI 10.1016/0169-5347(90)90023-7; Cardador L, 2011, ANIM CONSERV, V14, P382, DOI 10.1111/j.1469-1795.2011.00449.x; Cardador L, 2012, BIRD STUDY, V59, P228, DOI 10.1080/00063657.2011.648165; Cardador L, 2011, J RAPTOR RES, V45, P168, DOI 10.3356/JRR-10-64.1; Cardador L, 2009, IBIS, V151, P766, DOI 10.1111/j.1474-919X.2009.00963.x; Carrete M, 2006, OIKOS, V112, P680, DOI 10.1111/j.0030-1299.2006.14528.x; Carrete M, 2008, OIKOS, V117, P1115, DOI 10.1111/j.0030-1299.2008.16968.x; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Carrete M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018859; Carrete M, 2010, BIOL LETTERS, V6, P167, DOI 10.1098/rsbl.2009.0739; Clobert J, 2009, ECOL LETT, V12, P197, DOI 10.1111/j.1461-0248.2008.01267.x; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Cramp S., 1994, BIRDS W PALEARCTIC; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Edelaar P, 2008, EVOLUTION, V62, P2462, DOI 10.1111/j.1558-5646.2008.00459.x; Fernandez C, 1998, IBIS, V140, P64, DOI 10.1111/j.1474-919X.1998.tb04542.x; Fogarty S, 2011, AM NAT, V177, P273, DOI 10.1086/658174; FORSLUND P, 1995, TRENDS ECOL EVOL, V10, P374, DOI 10.1016/S0169-5347(00)89141-7; Forsman D, 1999, RAPTORS EUROPE MIDDL; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Hill G. E., 2002, RED BIRD BROWN BAG F; Jacquin L, 2011, J AVIAN BIOL, V42, P11, DOI 10.1111/j.1600-048X.2010.05120.x; Kim SY, 2009, ECOLOGY, V90, P230, DOI 10.1890/08-0133.1; Kokko H, 2004, J ANIM ECOL, V73, P367, DOI 10.1111/j.0021-8790.2004.00813.x; KORPIMAKI E, 1988, J ANIM ECOL, V57, P97, DOI 10.2307/4766; Margalida A, 2008, ARDEA, V96, P173, DOI 10.5253/078.096.0203; Marti R., 2003, ATLAS AVES REPRODUCT; McGraw K. J., 2006, BIRD COLORATION, VI; Molina B., 2008, AGUILUCHO LAGUNERO E; Morgan C, 2004, CHEM SENSES, V29, P111, DOI 10.1093/chemse/bjh011; Mougeot F, 2001, BEHAV ECOL, V12, P1, DOI 10.1093/beheco/12.1.1; Newton I., 1998, POPULATION LIMITATIO; Newton I., 1979, POPULATION ECOLOGY R; Oro D, 2008, ECOLOGY, V89, P838, DOI 10.1890/06-1936.1; Part T, 2001, P ROY SOC B-BIOL SCI, V268, P2267, DOI 10.1098/rspb.2001.1803; Rodenhouse NL, 1997, ECOLOGY, V78, P2025, DOI 10.2307/2265942; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; Sergio F, 2009, OECOLOGIA, V160, P507, DOI 10.1007/s00442-009-1314-0; Serrano D, 2005, AM NAT, V166, pE22, DOI 10.1086/431255; Serrano D, 2004, ECOLOGY, V85, P3438, DOI 10.1890/04-0463; SIIKAMAKI P, 1995, ECOLOGY, V76, P308, DOI 10.2307/1940652; Sol D, 2000, OIKOS, V90, P599, DOI 10.1034/j.1600-0706.2000.900317.x; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Sol D, 1998, CONDOR, V100, P298, DOI 10.2307/1370270; Soutullo A, 2006, OECOLOGIA, V149, P543, DOI 10.1007/s00442-006-0465-5; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Sternalski A, 2012, BIOL LETTERS, V8, P167, DOI 10.1098/rsbl.2011.0914; Sternalski A, 2010, BEHAV ECOL SOCIOBIOL, V64, P1351, DOI 10.1007/s00265-010-0950-z; THOMPSON JD, 1991, TRENDS ECOL EVOL, V6, P246, DOI 10.1016/0169-5347(91)90070-E; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Viera VM, 2008, ETHOLOGY, V114, P146, DOI 10.1111/j.1439-0310.2007.01454.x; WIKLUND CG, 1994, J ANIM ECOL, V63, P765, DOI 10.2307/5254; Wright TF, 2010, ETHOL ECOL EVOL, V22, P393, DOI 10.1080/03949370.2010.505580	66	10	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33375	10.1371/journal.pone.0033375	http://dx.doi.org/10.1371/journal.pone.0033375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479391	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900025
J	Lin, MH; Shu, JC; Huang, HY; Cheng, YC				Lin, Mei-Hui; Shu, Jwu-Ching; Huang, Hsiu-Yun; Cheng, Yi-Ching			Involvement of Iron in Biofilm Formation by Staphylococcus aureus	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; PSEUDOMONAS-AERUGINOSA; CELLS; EPIDERMIDIS; ICA; AGGREGATION; ACQUISITION; LACTOFERRIN; MECHANISMS; EXPRESSION	Staphylococcus aureus is a human pathogen that forms biofilm on catheters and medical implants. The authors' earlier study established that 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose (PGG) inhibits biofilm formation by S. aureus by preventing the initial attachment of the cells to a solid surface and reducing the production of polysaccharide intercellular adhesin (PIA). Our cDNA microarray and MALDI-TOF mass spectrometric studies demonstrate that PGG treatment causes the expression of genes and proteins that are normally expressed under iron-limiting conditions. A chemical assay using ferrozine verifies that PGG is a strong iron chelator that depletes iron from the culture medium. This study finds that adding FeSO4 to a medium that contains PGG restores the biofilm formation and the production of PIA by S. aureus SA113. The requirement of iron for biofilm formation by S. aureus SA113 can also be verified using a semi-defined medium, BM, that contains an iron chelating agent, 2,2'-dipyridyl (2-DP). Similar to the effect of PGG, the addition of 2-DP to BM medium inhibits biofilm formation and adding FeSO4 to BM medium that contains 2-DP restores biofilm formation. This study reveals an important mechanism of biofilm formation by S. aureus SA113.	[Lin, Mei-Hui; Shu, Jwu-Ching; Huang, Hsiu-Yun; Cheng, Yi-Ching] Chang Gung Univ, Dept Med Biotechnol, Tao Yuan, Taiwan; [Lin, Mei-Hui; Shu, Jwu-Ching; Huang, Hsiu-Yun; Cheng, Yi-Ching] Chang Gung Univ, Lab Sci, Tao Yuan, Taiwan; [Lin, Mei-Hui; Shu, Jwu-Ching] Chang Gung Univ, Res Ctr Pathogen Bacteria, Tao Yuan, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University	Lin, MH (corresponding author), Chang Gung Univ, Dept Med Biotechnol, Tao Yuan, Taiwan.	thea@mail.cgu.edu.tw		Shu, Jwu-Ching/0000-0003-4862-6056; Lin, Mei-Hui/0000-0002-3498-9377	Chang Gung Memorial Hospital [CMRPD1B0101]; National Science Council of the Republic of China, Taiwan [NSC-99-2320-B-182-013-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Chang Gung Memorial Hospital (grant number CMRPD1B0101) and from the National Science Council of the Republic of China, Taiwan (grant number NSC-99-2320-B-182-013-MY3). (The funders' websites: http://web1.nsc.gov.tw/mp.aspx?mp = 7, http://www.cgmh.org.tw/eng2002/index.asp.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agladze K, 2005, J BACTERIOL, V187, P8237, DOI 10.1128/JB.187.24.8237-8246.2005; Ardehali R, 2002, ARTIF ORGANS, V26, P512, DOI 10.1046/j.1525-1594.2002.06923.x; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Banin E, 2006, APPL ENVIRON MICROB, V72, P2064, DOI 10.1128/AEM.72.3.2064-2069.2006; Barasch J, 2004, NATURE, V432, P811, DOI 10.1038/432811a; Berlutti F, 2005, INT J IMMUNOPATH PH, V18, P661, DOI 10.1177/039463200501800407; Berlutti F, 2004, BIOMETALS, V17, P271; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Fitzpatrick F, 2005, J CLIN MICROBIOL, V43, P1973, DOI 10.1128/JCM.43.4.1973-1976.2005; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Hall-Stoodley L, 2002, CURR OPIN BIOTECH, V13, P228, DOI 10.1016/S0958-1669(02)00318-X; Hindre T, 2008, MICROBIOL-SGM, V154, P30, DOI 10.1099/mic.0.2007/008698-0; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Johnson M, 2005, J BACTERIOL, V187, P8211, DOI 10.1128/JB.187.23.8211-8215.2005; Johnson M, 2008, INFECT IMMUN, V76, P1756, DOI 10.1128/IAI.01635-07; Lin MH, 2011, ANTIMICROB AGENTS CH, V55, P1021, DOI 10.1128/AAC.00843-10; Lyte M, 2003, LANCET, V361, P130, DOI 10.1016/S0140-6736(03)12231-3; Maresso AW, 2006, BIOMETALS, V19, P193, DOI 10.1007/s10534-005-4863-7; Martin-Lopez JV, 2002, J CLIN MICROBIOL, V40, P1569, DOI 10.1128/JCM.40.4.1569-1570.2002; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mey AR, 2005, INFECT IMMUN, V73, P5706, DOI 10.1128/IAI.73.9.5706-5719.2005; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Mladenka P, 2011, J INORG BIOCHEM, V105, P693, DOI 10.1016/j.jinorgbio.2011.02.003; Moreau-Marquis S, 2009, AM J RESP CELL MOL, V41, P305, DOI 10.1165/rcmb.2008-0299OC; O'Neill E, 2009, J MED MICROBIOL, V58, P399, DOI 10.1099/jmm.0.005504-0; Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Resch A, 2006, PROTEOMICS, V6, P1867, DOI 10.1002/pmic.200500531; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Singh PK, 2004, BIOMETALS, V17, P267, DOI 10.1023/B:BIOM.0000027703.77456.27; Thompson KM, 2010, FEMS MICROBIOL LETT, V305, P143, DOI 10.1111/j.1574-6968.2010.01918.x; Wu Y, 2009, J BACTERIOL, V191, P1248, DOI 10.1128/JB.01086-08; Yang L, 2007, MICROBIOL-SGM, V153, P1318, DOI 10.1099/mic.0.2006/004911-0; Ymele-Leki P, 2007, APPL ENVIRON MICROB, V73, P1834, DOI 10.1128/AEM.01319-06	38	65	70	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34388	10.1371/journal.pone.0034388	http://dx.doi.org/10.1371/journal.pone.0034388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479621	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900089
J	Tato, CM; Joyce-Shaikh, B; Banerjee, A; Chen, Y; Sathe, M; Ewald, SE; Liu, MR; Gorman, D; McClanahan, TK; Phillips, JH; Heyworth, PG; Cua, DJ				Tato, Cristina M.; Joyce-Shaikh, Barbara; Banerjee, Antara; Chen, Yi; Sathe, Manjiri; Ewald, Sarah E.; Liu, Man-Ru; Gorman, Daniel; McClanahan, Terrill K.; Phillips, Joseph H.; Heyworth, Paul G.; Cua, Daniel J.			The Myeloid Receptor PILR beta Mediates the Balance of Inflammatory Responses through Regulation of IL-27 Production	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TOXOPLASMA-GONDII; T-CELLS; TYPE-2 RECEPTOR; SMALL-INTESTINE; IN-VIVO; TYROSINE PHOSPHORYLATION; INHIBITORY RECEPTOR; PERORAL INFECTION	Paired immunoglobulin-like receptors beta, PILR beta, and alpha, PILR alpha, are related to the Siglec family of receptors and are expressed primarily on cells of the myeloid lineage. PILR beta is a DAP12 binding partner expressed on both human and mouse myeloid cells. The potential ligand, CD99, is found on many cell types, such as epithelial cells where it plays a role in migration of immune cells to sites of inflammation. Pilrb deficient mice were challenged with the parasite Toxoplasma gondii in two different models of infection induced inflammation; one involving the establishment of chronic encephalitis and a second mimicking inflammatory bowel disease in order to understand the potential role of this receptor in persistent inflammatory responses. It was found that in the absence of activating signals from PILR beta, antigen-presenting cells (APCs) produced increased amounts of IL-27, p28 and promoted IL-10 production in effector T cells. The sustained production of IL-27 led ultimately to enhanced survival after challenge due to dampened immune pathology in the gut. Similar protection was also observed in the CNS during chronic T. gondii infection after i.p. challenge again providing evidence that PILR beta is important for regulating aberrant inflammatory responses.	[Tato, Cristina M.; Joyce-Shaikh, Barbara; Banerjee, Antara; Chen, Yi; Sathe, Manjiri; Liu, Man-Ru; Gorman, Daniel; McClanahan, Terrill K.; Phillips, Joseph H.; Heyworth, Paul G.; Cua, Daniel J.] Merck Res Labs, Palo Alto, CA USA; [Ewald, Sarah E.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Tato, Cristina M.] Stanford Univ, Inst Immun Transplantat & Infect, Sch Med, Stanford, CA 94305 USA	Merck & Company; Stanford University; Stanford University	Tato, CM (corresponding author), Merck Res Labs, Palo Alto, CA USA.	daniel.cua@spcorp.com	Ewald, Sarah/AAM-8918-2020	Ewald, Sarah/0000-0002-5327-7578; Tato, Cristina M./0000-0002-0614-756X	Merck and CO; National Institutes of Health (NIH) [AI73756]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073756] Funding Source: NIH RePORTER	Merck and CO(Merck & Company); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study is funded by Schering Plough, now part of Merck and CO. This funder reviewed the progress of the project annually and as the authors are employed by Schering Plough, the funders played a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Phillips is supported by National Institutes of Health (NIH) grant AI73756. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2004, J IMMUNOL, V173, P5626, DOI 10.4049/jimmunol.173.9.5626; Banerjee A, 2010, INFECT IMMUN, V78, P1353, DOI 10.1128/IAI.00969-09; Bixel MG, 2007, BLOOD, V109, P5327, DOI 10.1182/blood-2006-08-043109; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Diveu C, 2009, J IMMUNOL, V182, P5748, DOI 10.4049/jimmunol.0801162; Dufour EM, 2008, CELL COMMUN ADHES, V15, P351, DOI 10.1080/15419060802442191; Fehniger TA, 1999, J IMMUNOL, V162, P4511; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fitzgerald DC, 2007, J IMMUNOL, V179, P3268, DOI 10.4049/jimmunol.179.5.3268; Fournier N, 2000, J IMMUNOL, V165, P1197, DOI 10.4049/jimmunol.165.3.1197; Furuzawa-Carballeda J, 2007, AUTOIMMUN REV, V6, P169, DOI 10.1016/j.autrev.2006.10.002; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; HUNTER CA, 1993, INFECT IMMUN, V61, P4038, DOI 10.1128/IAI.61.10.4038-4044.1993; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Kasper L, 2004, INT J PARASITOL, V34, P401, DOI 10.1016/j.ijpara.2003.11.023; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li JF, 2005, J NEUROL SCI, V232, P3, DOI 10.1016/j.jns.2004.12.013; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1999, PARASITE IMMUNOL, V21, P365, DOI 10.1046/j.1365-3024.1999.00237.x; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Lou O, 2007, J IMMUNOL, V178, P1136, DOI 10.4049/jimmunol.178.2.1136; Mousseau DD, 2000, J BIOL CHEM, V275, P4467, DOI 10.1074/jbc.275.6.4467; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Niedbala W, 2008, ANN RHEUM DIS, V67, P1474, DOI 10.1136/ard.2007.083360; Oh KI, 2007, EXP MOL MED, V39, P176, DOI 10.1038/emm.2007.20; Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043; Satoh Takeshi, 2008, Virus (Nagoya), V58, P27; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Sonobe Y, 2005, BRAIN RES, V1040, P202, DOI 10.1016/j.brainres.2005.01.100; Stumhofer JS, 2008, IMMUNOL LETT, V117, P123, DOI 10.1016/j.imlet.2008.01.011; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Tabata S, 2008, J BIOL CHEM, V283, P8893, DOI 10.1074/jbc.M709793200; Tait ED, 2009, MEM I OSWALDO CRUZ, V104, P201, DOI 10.1590/S0074-02762009000200013; Troy AE, 2009, J IMMUNOL, V183, P2037, DOI 10.4049/jimmunol.0802918; Turnbull IR, 2007, NAT REV IMMUNOL, V7, P155, DOI 10.1038/nri2014; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2006, J IMMUNOL, V176, P237, DOI 10.4049/jimmunol.176.1.237; Wang J, 2008, J IMMUNOL, V180, P1686, DOI 10.4049/jimmunol.180.3.1686; Wilson EH, 2005, J NEUROIMMUNOL, V165, P63, DOI 10.1016/j.jneuroim.2005.04.018; Wilson EH, 2004, INT J PARASITOL, V34, P543, DOI 10.1016/j.ijpara.2003.12.010; Yap GS, 1999, IMMUNOBIOLOGY, V201, P240, DOI 10.1016/S0171-2985(99)80064-3	48	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e31680	10.1371/journal.pone.0031680	http://dx.doi.org/10.1371/journal.pone.0031680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479310	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900003
J	Brown, MG; McAlpine, SM; Huang, YY; Haidl, ID; Al-Afif, A; Marshall, JS; Anderson, R				Brown, Michael G.; McAlpine, Sarah M.; Huang, Yan Y.; Haidl, Ian D.; Al-Afif, Ayham; Marshall, Jean S.; Anderson, Robert			RNA Sensors Enable Human Mast Cell Anti-Viral Chemokine Production and IFN-Mediated Protection in Response to Antibody-Enhanced Dengue Virus Infection	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; INNATE IMMUNITY; DENDRITIC CELLS; RIG-I; HEMORRHAGIC-FEVER; VIRAL REPLICATION; INTERFERON; EXPRESSION; ACTIVATION	Dengue hemorrhagic fever and/or dengue shock syndrome represent the most serious pathophysiological manifestations of human dengue virus infection. Despite intensive research, the mechanisms and important cellular players that contribute to dengue disease are unclear. Mast cells are tissue-resident innate immune cells that play a sentinel cell role in host protection against infectious agents via pathogen-recognition receptors by producing potent mediators that modulate inflammation, cell recruitment and normal vascular homeostasis. Most importantly, mast cells are susceptible to antibody-enhanced dengue virus infection and respond with selective cytokine and chemokine responses. In order to obtain a global view of dengue virus-induced gene regulation in mast cells, primary human cord blood-derived mast cells (CBMCs) and the KU812 and HMC-1 mast cell lines were infected with dengue virus in the presence of dengue-immune sera and their responses were evaluated at the mRNA and protein levels. Mast cells responded to antibody-enhanced dengue virus infection or polyinosinic. polycytidylic acid treatment with the production of type I interferons and the rapid and potent production of chemokines including CCL4, CCL5 and CXCL10. Multiple interferon-stimulated genes were also upregulated as well as mRNA and protein for the RNA sensors PKR, RIG-I and MDA5. Dengue virus-induced chemokine production by KU812 cells was significantly modulated by siRNA knockdown of RIG-I and PKR, in a negative and positive manner, respectively. Pretreatment of fresh KU812 cells with supernatants from dengue virus-infected mast cells provided protection from subsequent infection with dengue virus in a type I interferon-dependent manner. These findings support a role for tissue-resident mast cells in the early detection of antibody-enhanced dengue virus infection via RNA sensors, the protection of neighbouring cells through interferon production and the potential recruitment of leukocytes via chemokine production.	[Brown, Michael G.; McAlpine, Sarah M.; Huang, Yan Y.; Haidl, Ian D.; Al-Afif, Ayham; Marshall, Jean S.; Anderson, Robert] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Marshall, Jean S.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Anderson, Robert] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Brown, Michael G.; Huang, Yan Y.; Al-Afif, Ayham; Anderson, Robert] IWK Hlth Ctr, Canadian Ctr Vaccinol, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Brown, MG (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	robert.anderson@dal.ca		Marshall, Jean S./0000-0002-5642-1379; McAlpine, Sarah M/0000-0002-9298-9682	Canadian Institutes of Health Research [MOP79419, MOP10966]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants MOP79419 and MOP10966 from the Canadian Institutes of Health Research (www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIFFL WL, 1995, J TRAUMA, V39, P98, DOI 10.1097/00005373-199507000-00013; Bonini S, 2005, OPHTHALMOLOGY, V112, P1528, DOI 10.1016/j.ophtha.2005.04.009; Boo KH, 2010, YONSEI MED J, V51, P9, DOI 10.3349/ymj.2010.51.1.9; Bozza FA, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-86; Brown MG, 2011, J VIROL, V85, P1145, DOI 10.1128/JVI.01630-10; Burke SM, 2008, BLOOD, V111, P5467, DOI 10.1182/blood-2007-10-118547; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014; Chen JP, 2006, J IMMUNOL, V177, P3185, DOI 10.4049/jimmunol.177.5.3185; Dawicki W, 2007, CURR OPIN IMMUNOL, V19, P31, DOI 10.1016/j.coi.2006.11.006; Dejnirattisai W, 2008, J IMMUNOL, V181, P5865, DOI 10.4049/jimmunol.181.9.5865; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; FARRELL PJ, 1977, CELL, V11, P187, DOI 10.1016/0092-8674(77)90330-0; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Galli SJ, 1999, CURR OPIN IMMUNOL, V11, P53, DOI 10.1016/S0952-7915(99)80010-7; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P276; HE RT, 1995, J MED VIROL, V45, P451, DOI 10.1002/jmv.1890450417; HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162; Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855; KADEREIT S, 1994, J INTERFERON RES, V14, P251, DOI 10.1089/jir.1994.14.251; Kadowaki N, 2001, J IMMUNOL, V166, P2291, DOI 10.4049/jimmunol.166.4.2291; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; King CA, 2000, J VIROL, V74, P7146, DOI 10.1128/JVI.74.15.7146-7150.2000; King CA, 2002, J VIROL, V76, P8408, DOI 10.1128/JVI.76.16.8408-8419.2002; KISHI K, 1985, LEUKEMIA RES, V9, P381, DOI 10.1016/0145-2126(85)90060-8; Kulka A, 2006, MOL IMMUNOL, V43, P1579, DOI 10.1016/j.molimm.2005.09.019; Kulka M, 2004, J ALLERGY CLIN IMMUN, V114, P174, DOI 10.1016/j.jaci.2004.03.049; Lin TJ, 2000, J IMMUNOL, V165, P211, DOI 10.4049/jimmunol.165.1.211; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lundberg AM, 2007, BLOOD, V110, P3245, DOI 10.1182/blood-2007-02-072934; Marshall JS, 2004, J ALLERGY CLIN IMMUN, V114, P21, DOI 10.1016/j.jaci.2004.04.045; Marshall JS, 2003, CURR PHARM DESIGN, V9, P11, DOI 10.2174/1381612033392413; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; Matsushima H, 2004, J IMMUNOL, V173, P531, DOI 10.4049/jimmunol.173.1.531; McCurdy JD, 2003, J IMMUNOL, V170, P1625, DOI 10.4049/jimmunol.170.4.1625; Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005; Metz M, 2008, IMMUNOBIOLOGY, V213, P251, DOI 10.1016/j.imbio.2007.10.017; Metz M, 2007, TRENDS IMMUNOL, V28, P234, DOI 10.1016/j.it.2007.03.003; Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676; Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926; Nightingale ZD, 2008, J LEUKOCYTE BIOL, V84, P1028, DOI 10.1189/jlb.0208105; Orinska Z, 2005, BLOOD, V106, P978, DOI 10.1182/blood-2004-07-2656; Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qin CF, 2011, MOL BIOL REP, V38, P3867, DOI 10.1007/s11033-010-0502-7; Raghupathy R, 1998, J MED VIROL, V56, P280, DOI 10.1002/(SICI)1096-9071(199811)56:3&lt;280::AID-JMV18&gt;3.0.CO;2-I; Siren J, 2006, MICROBES INFECT, V8, P2013, DOI 10.1016/j.micinf.2006.02.028; St John AL, 2011, P NATL ACAD SCI USA, V108, P9190, DOI 10.1073/pnas.1105079108; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x; Varadaradjalou S, 2003, EUR J IMMUNOL, V33, P899, DOI 10.1002/eji.200323830; Wagoner J, 2007, J VIROL, V81, P309, DOI 10.1128/JVI.01411-06; Yoshida H, 2007, NEUROSCI RES, V58, P199, DOI 10.1016/j.neures.2007.02.017; Yount JS, 2007, J VIROL, V81, P7316, DOI 10.1128/JVI.00545-07	55	72	72	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34055	10.1371/journal.pone.0034055	http://dx.doi.org/10.1371/journal.pone.0034055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479521	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100110
J	Houppert, AS; Kwiatkowski, E; Glass, EM; DeBord, KL; Merritt, PM; Schneewind, O; Marketon, MM				Houppert, Andrew S.; Kwiatkowski, Elizabeth; Glass, Elizabeth M.; DeBord, Kristin L.; Merritt, Peter M.; Schneewind, Olaf; Marketon, Melanie M.			Identification of Chromosomal Genes in Yersinia pestis that Influence Type III Secretion and Delivery of Yops into Target Cells	PLOS ONE			English	Article							LOW-CALCIUM RESPONSE; SIGNATURE-TAGGED MUTAGENESIS; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; PLASMINOGEN-ACTIVATOR; PASTEURELLA-PESTIS; VIRULENCE PLASMID; GENOME SEQUENCE; V ANTIGEN; ENTEROCOLITICA	Pathogenic Yersinia species possess a type III secretion system, which is required for the delivery of effector Yop proteins into target cells during infection. Genes encoding the type III secretion machinery, its substrates, and several regulatory proteins all reside on a 70-Kb virulence plasmid. Genes encoded in the chromosome of yersiniae are thought to play important roles in bacterial perception of host environments and in the coordinated activation of the type III secretion pathway. Here, we investigate the contribution of chromosomal genes to the complex regulatory process controlling type III secretion in Yersinia pestis. Using transposon mutagenesis, we identified five chromosomal genes required for expression or secretion of Yops in laboratory media. Four out of the five chromosomal mutants were defective to various extents at injecting Yops into tissue culture cells. Interestingly, we found one mutant that was not able to secrete in vitro but was fully competent for injecting Yops into host cells, suggesting independent mechanisms for activation of the secretion apparatus. When tested in a mouse model of plague disease, three mutants were avirulent, whereas two strains were severely attenuated. Together these results demonstrate the importance of Y. pestis chromosomal genes in the proper function of type III secretion and in the pathogenesis of plague.	[Houppert, Andrew S.; Merritt, Peter M.; Marketon, Melanie M.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Kwiatkowski, Elizabeth; DeBord, Kristin L.; Schneewind, Olaf; Marketon, Melanie M.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Glass, Elizabeth M.] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA	Indiana University System; Indiana University Bloomington; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory	Houppert, AS (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	mmarketo@indiana.edu			Region V "Great Lakes'' Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases Award) [1-U54-AI-057153]; Career Development Program at the Great Lakes RCE [CDP6]; Office of the Vide Provost of Research at Indiana University-Bloomington through the Faculty Research Support Program; National Institute of Allergy and Infectious Diseases, Infectious Diseases Branch [AI055545, AI42797]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI055545, R01AI042797, U54AI057153] Funding Source: NIH RePORTER	Region V "Great Lakes'' Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases Award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Career Development Program at the Great Lakes RCE; Office of the Vide Provost of Research at Indiana University-Bloomington through the Faculty Research Support Program; National Institute of Allergy and Infectious Diseases, Infectious Diseases Branch(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors acknowledge membership within and support from the Region V "Great Lakes'' Regional Center of Excellence in Biodefense and Emerging Infectious Diseases Consortium (GLRCE, National Institute of Allergy and Infectious Diseases Award 1-U54-AI-057153). MM acknowledges funding for this work through the Career Development Program at the Great Lakes RCE (CDP6). In addition, this work was partially funded by the Office of the Vide Provost of Research at Indiana University-Bloomington through the Faculty Research Support Program (MM). This work was also partially funded by grant awards to OS, AI055545 and AI42797, from the National Institute of Allergy and Infectious Diseases, Infectious Diseases Branch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAOUI A, 1995, J BACTERIOL, V177, P4230, DOI 10.1128/jb.177.15.4230-4237.1995; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Bartra SS, 2008, INFECT IMMUN, V76, P612, DOI 10.1128/IAI.01125-07; Bartra SS, 2006, INFECT IMMUN, V74, P1381, DOI 10.1128/IAI.74.2.1381-1386.2006; Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x; Brubaker RR, 2005, INFECT IMMUN, V73, P4743, DOI 10.1128/IAI.73.8.4743-4752.2005; BRUBAKER RR, 1969, J BACTERIOL, V98, P1404, DOI 10.1128/JB.98.3.1404-1406.1969; BRUBAKER RR, 1964, J INFECT DIS, V114, P13, DOI 10.1093/infdis/114.1.13; Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004; CARTER PB, 1980, INFECT IMMUN, V28, P638; Cheng LW, 2000, J BACTERIOL, V182, P3183, DOI 10.1128/JB.182.11.3183-3190.2000; Cheng LW, 2001, J BACTERIOL, V183, P5293, DOI 10.1128/JB.183.18.5293-5301.2001; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dacheux D, 2002, INFECT IMMUN, V70, P3973, DOI 10.1128/IAI.70.7.3973-3977.2002; Darwin AJ, 1999, MOL MICROBIOL, V51-62, P32; Dasgupta N, 2006, INFECT IMMUN, V74, P3334, DOI 10.1128/IAI.00090-06; DAVIES DAL, 1956, BIOCHEM J, V63, P105, DOI 10.1042/bj0630105; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; DeBord KL, 2001, J BACTERIOL, V183, P4588, DOI 10.1128/JB.183.15.4588-4598.2001; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; DEV IK, 1978, J BIOL CHEM, V253, P4245; Dewoody R, 2011, MOL MICROBIOL, V79, P1445, DOI 10.1111/j.1365-2958.2011.07534.x; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; DREYFUS LA, 1978, J BACTERIOL, V136, P757, DOI 10.1128/JB.136.2.757-764.1978; Ferracci F, 2005, MOL MICROBIOL, V57, P970, DOI 10.1111/j.1365-2958.2005.04738.x; Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999; Flashner Y, 2004, INFECT IMMUN, V72, P908, DOI 10.1128/IAI.72.2.908-915.2004; GOGUEN JD, 1984, J BACTERIOL, V160, P842, DOI 10.1128/JB.160.3.842-848.1984; Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002; Ha UH, 2004, MOL MICROBIOL, V54, P307, DOI 10.1111/j.1365-2958.2004.04282.x; Ha UW, 1999, INFECT IMMUN, V67, P5324, DOI 10.1128/IAI.67.10.5324-5331.1999; HEESEMANN J, 1984, INFECT IMMUN, V46, P105, DOI 10.1128/IAI.46.1.105-110.1984; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; HIGUCHI K, 1959, J BACTERIOL, V77, P317, DOI 10.1128/JB.77.3.317-321.1959; Hitchen PG, 2002, MOL MICROBIOL, V44, P1637, DOI 10.1046/j.1365-2958.2002.02990.x; HOE NP, 1993, J BACTERIOL, V175, P7901, DOI 10.1128/JB.175.24.7901-7909.1993; HOE NP, 1992, J BACTERIOL, V174, P4275, DOI 10.1128/JB.174.13.4275-4286.1992; Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798; Hu P, 1998, J BACTERIOL, V180, P5192, DOI 10.1128/JB.180.19.5192-5202.1998; Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x; Jackson MW, 1998, J BACTERIOL, V180, P4912, DOI 10.1128/JB.180.18.4912-4921.1998; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlyshev AV, 2001, INFECT IMMUN, V69, P7810, DOI 10.1128/IAI.69.12.7810-7819.2001; KLENA JD, 1993, MOL MICROBIOL, V9, P393, DOI 10.1111/j.1365-2958.1993.tb01700.x; Kolodziejek AM, 2007, MICROBIOL-SGM, V153, P2941, DOI 10.1099/mic.0.2006/005694-0; Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x; Lathem WW, 2007, SCIENCE, V315, P509, DOI 10.1126/science.1137195; Lee VT, 2001, J BACTERIOL, V183, P4970, DOI 10.1128/JB.183.17.4970-4978.2001; Maden BEH, 2000, BIOCHEM J, V350, P609, DOI 10.1042/0264-6021:3500609; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; Mecsas J, 2001, INFECT IMMUN, V69, P2779, DOI 10.1128/IAI.67.5.2779-2787.2001; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990; MORTLOCK RP, 1962, J BACTERIOL, V84, P1122, DOI 10.1128/JB.84.5.1122-1123.1962; Nilles ML, 1997, J BACTERIOL, V179, P1307, DOI 10.1128/jb.179.4.1307-1316.1997; Nilles ML, 1998, J BACTERIOL, V180, P3410, DOI 10.1128/JB.180.13.3410-3420.1998; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; PORTNOY DA, 1981, INFECT IMMUN, V31, P775, DOI 10.1128/IAI.31.2.775-782.1981; Ramamurthi KS, 2002, J BACTERIOL, V184, P3321, DOI 10.1128/JB.184.12.3321-3328.2002; Rietsch A, 2004, INFECT IMMUN, V72, P1383, DOI 10.1128/IAI.72.3.1383-1390.2004; RONCERO C, 1990, J BACTERIOL, V172, P1899, DOI 10.1128/jb.172.4.1899-1904.1990; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Sebbane F, 2006, P NATL ACAD SCI USA, V103, P5526, DOI 10.1073/pnas.0509544103; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; SKRZYPEK E, 1993, J BACTERIOL, V175, P3520, DOI 10.1128/jb.175.11.3520-3528.1993; SODEINDE OA, 1988, INFECT IMMUN, V56, P2749, DOI 10.1128/IAI.56.10.2749-2752.1988; SODEINDE OA, 1988, INFECT IMMUN, V56, P2743, DOI 10.1128/IAI.56.10.2743-2748.1988; STRALEY SC, 1993, MOL MICROBIOL, V8, P1005, DOI 10.1111/j.1365-2958.1993.tb01644.x; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Thompkins K, 2008, J BACTERIOL, V190, P4489, DOI 10.1128/JB.00414-08; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Tzeng YL, 2005, J BACTERIOL, V187, P5387, DOI 10.1128/JB.187.15.5387-5396.2005; Wang JY, 1996, P NATL ACAD SCI USA, V93, P10434, DOI 10.1073/pnas.93.19.10434; WATTIAU P, 1994, J BACTERIOL, V176, P3878, DOI 10.1128/JB.176.13.3878-3884.1994; YOTHER J, 1986, J BACTERIOL, V165, P443, DOI 10.1128/jb.165.2.443-447.1986; Young GM, 1997, MOL MICROBIOL, V25, P319, DOI 10.1046/j.1365-2958.1997.4661829.x; Zolfaghar I, 2005, MICROBES INFECT	82	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34039	10.1371/journal.pone.0034039	http://dx.doi.org/10.1371/journal.pone.0034039			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479512	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100103
J	Koo, Y; Jung, DK; Bae, E				Koo, Yoon; Jung, Du-kyo; Bae, Euiyoung			Crystal Structure of Streptococcus pyogenes Csn2 Reveals Calcium-Dependent Conformational Changes in Its Tertiary and Quaternary Structure	PLOS ONE			English	Article							IMMUNE-SYSTEM; RNA; CRISPR/CAS; INTERFACE; BACTERIA	Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins constitute a microbial immune system against invading genetic elements, such as plasmids and phages. Csn2 is an Nmeni subtype-specific Cas protein, and was suggested to function in the adaptation process, during which parts of foreign nucleic acids are integrated into the host microbial genome to enable immunity against future invasion. Here, we report a 2.2 angstrom crystal structure of Streptococcus pyogenes Csn2. The structure revealed previously unseen calcium-dependent conformational changes in its tertiary and quaternary structure. This supports the proposed double-stranded DNA-binding function of S. pyogenes Csn2.	[Koo, Yoon; Jung, Du-kyo; Bae, Euiyoung] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Bae, Euiyoung] Seoul Natl Univ, Ctr Agr Biomat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Koo, Y (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.	bae@snu.ac.kr			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0004451]; Bio-industry Technology Development Program; Ministry for Food, Agriculture, Forestry and Fisheries; National Junior Research Fellowship Program; Pohang Accelerator Laboratory	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Bio-industry Technology Development Program; Ministry for Food, Agriculture, Forestry and Fisheries; National Junior Research Fellowship Program; Pohang Accelerator Laboratory	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0004451), and the Bio-industry Technology Development Program funded by the Ministry for Food, Agriculture, Forestry and Fisheries. D.J. was also supported by the National Junior Research Fellowship Program. Travel to the Photon factory was partially supported by the Pohang Accelerator Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Busso D, 2005, ANAL BIOCHEM, V343, P313, DOI 10.1016/j.ab.2005.05.015; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Nam KH, 2011, J BIOL CHEM, V286, P30759, DOI 10.1074/jbc.M111.256263; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Zheng H, 2008, J INORG BIOCHEM, V102, P1765, DOI 10.1016/j.jinorgbio.2008.05.006	27	20	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33401	10.1371/journal.pone.0033401	http://dx.doi.org/10.1371/journal.pone.0033401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479393	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100046
J	Laemmle, A; Lechleiter, A; Roh, V; Schwarz, C; Portmann, S; Furer, C; Keogh, A; Tschan, MP; Candinas, D; Vorburger, SA; Stroka, D				Laemmle, Alexander; Lechleiter, Antje; Roh, Vincent; Schwarz, Christa; Portmann, Simone; Furer, Cynthia; Keogh, Adrian; Tschan, Mario P.; Candinas, Daniel; Vorburger, Stephan A.; Stroka, Deborah			Inhibition of SIRT1 Impairs the Accumulation and Transcriptional Activity of HIF-1 alpha Protein under Hypoxic Conditions	PLOS ONE			English	Article							INDUCIBLE FACTOR 1-ALPHA; PYRUVATE-KINASE M2; NF-KAPPA-B; TUMOR-SUPPRESSOR; CALORIE RESTRICTION; CELL-SURVIVAL; HEPATOCELLULAR-CARCINOMA; SACCHAROMYCES-CEREVISIAE; FACTOR (HIF)-1-ALPHA; HISTONE DEACETYLASE	Sirtuins and hypoxia-inducible transcription factors (HIF) have well-established roles in regulating cellular responses to metabolic and oxidative stress. Recent reports have linked these two protein families by demonstrating that sirtuins can regulate the activity of HIF-1 and HIF-2. Here we investigated the role of SIRT1, a NAD+-dependent deacetylase, in the regulation of HIF-1 activity in hypoxic conditions. Our results show that in hepatocellular carcinoma (HCC) cell lines, hypoxia did not alter SIRT1 mRNA or protein expression, whereas it predictably led to the accumulation of HIF-1 alpha and the up-regulation of its target genes. In hypoxic models in vitro and in in vivo models of systemic hypoxia and xenograft tumor growth, knockdown of SIRT1 protein with shRNA or inhibition of its activity with small molecule inhibitors impaired the accumulation of HIF-1 alpha protein and the transcriptional increase of its target genes. In addition, endogenous SIRT1 and HIF-1 alpha proteins co-immunoprecipitated and loss of SIRT1 activity led to a hyperacetylation of HIF-1 alpha. Taken together, our data suggest that HIF-1 alpha and SIRT1 proteins interact in HCC cells and that HIF-1 alpha is a target of SIRT1 deacetylase activity. Moreover, SIRT1 is necessary for HIF-1 alpha protein accumulation and activation of HIF-1 target genes under hypoxic conditions.	[Laemmle, Alexander; Lechleiter, Antje; Roh, Vincent; Schwarz, Christa; Portmann, Simone; Furer, Cynthia; Keogh, Adrian; Candinas, Daniel; Vorburger, Stephan A.; Stroka, Deborah] Univ Hosp Bern, Clin Visceral Surg & Med Visceral & Transplantat, CH-3010 Bern, Switzerland; [Laemmle, Alexander; Lechleiter, Antje; Roh, Vincent; Schwarz, Christa; Portmann, Simone; Furer, Cynthia; Keogh, Adrian; Tschan, Mario P.; Candinas, Daniel; Vorburger, Stephan A.; Stroka, Deborah] Univ Bern, Bern, Switzerland; [Tschan, Mario P.] Univ Hosp Bern, Inselspital, Dept Clin Res, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University Hospital of Bern	Laemmle, A (corresponding author), Univ Hosp Bern, Clin Visceral Surg & Med Visceral & Transplantat, CH-3010 Bern, Switzerland.	deborah.stroka@dkf.unibe.ch	Laemmle, Alexander/ADK-5108-2022; Stroka, Deborah M/F-1806-2013	Laemmle, Alexander/0000-0001-9191-1886; Tschan, Mario P./0000-0001-5897-3647; Stroka, Deborah/0000-0002-3517-3871	Werner and Hedy Berger-Janser Foundation of Cancer Research; Swiss National Science Foundation [3100A0- 104023]; Swiss Cancer League [OCS 01431-08-2003, KFS-02486-08-2009]	Werner and Hedy Berger-Janser Foundation of Cancer Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League	This work was supported by Werner and Hedy Berger-Janser Foundation of Cancer Research (www.krebskrankheiten.ch) to DS, the Swiss National Science Foundation (award: 3100A0- 104023; www.snf.ch) and Swiss Cancer League (award: OCS 01431-08-2003; www.swisscancer.ch/research) to SAV and the Swiss Cancer League (award: KFS-02486-08-2009; www.swisscancer.ch/research) to MPT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen T, 2005, FEBS LETT, V579, P6428, DOI 10.1016/j.febslet.2005.10.036; Bangoura G, 2007, WORLD J GASTROENTERO, V13, P3176, DOI 10.3748/wjg.v13.i23.3176; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bilton R, 2005, J BIOL CHEM, V280, P31132, DOI 10.1074/jbc.M504482200; Bilton R, 2006, TRENDS CELL BIOL, V16, P616, DOI 10.1016/j.tcb.2006.10.002; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Camenisch G, 1999, FASEB J, V13, P81, DOI 10.1096/fasebj.13.1.81; Camenisch G, 2001, PFLUG ARCH EUR J PHY, V443, P240, DOI 10.1007/s004240100679; Chen J, 2011, CANCER RES, V71, P4138, DOI 10.1158/0008-5472.CAN-10-4274; Chen R, 2011, J BIOL CHEM, V286, P13869, DOI 10.1074/jbc.M110.175414; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jeong J, 2007, EXP MOL MED, V39, P8, DOI 10.1038/emm.2007.2; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Krieg M, 2000, ONCOGENE, V19, P5435, DOI 10.1038/sj.onc.1203938; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; RINE J, 1987, GENETICS, V116, P9; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Schlicker C, 2011, AGING-US, V3, P852, DOI 10.18632/aging.100388; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Sowter HM, 2003, CANCER RES, V63, P6130; Spoden GA, 2009, J CELL BIOCHEM, V107, P293, DOI 10.1002/jcb.22125; Stein S, 2010, AGING-US, V2, P353, DOI 10.18632/aging.100162; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tschan MP, 2003, J BIOL CHEM, V278, P42750, DOI 10.1074/jbc.M307067200; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wei W, 2007, CANCER LETT, V257, P145, DOI 10.1016/j.canlet.2007.08.009; Wykoff CC, 2000, ONCOGENE, V19, P6297, DOI 10.1038/sj.onc.1204012; Xie HH, 2008, DIGEST DIS SCI, V53, P3225, DOI 10.1007/s10620-008-0296-9; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	71	102	107	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33433	10.1371/journal.pone.0033433	http://dx.doi.org/10.1371/journal.pone.0033433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479397	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339100048
J	Moreira-Tabaka, H; Peluso, J; Vonesch, JL; Hentsch, D; Kessler, P; Reimund, JM; Dumont, S; Muller, CD				Moreira-Tabaka, Helena; Peluso, Jean; Vonesch, Jean-Luc; Hentsch, Didier; Kessler, Pascal; Reimund, Jean-Marie; Dumont, Serge; Muller, Christian D.			Unlike for Human Monocytes after LPS Activation, Release of TNF-alpha by THP-1 Cells Is Produced by a TACE Catalytically Different from Constitutive TACE	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CONVERTING-ENZYME; METALLOPROTEINASE; IDENTIFICATION; MACROPHAGES; DISINTEGRIN; CELASTROL; LOCALIZATION; SPECIFICITY; NEUTROPHILS	Background: Tumor necrosis factor-alpha (TNF-alpha) is a pro-inflammatory cytokine today identified as a key mediator of several chronic inflammatory diseases. TNF-alpha, initially synthesized as a membrane-anchored precursor (pro-TNF-alpha), is processed by proteolytic cleavage to generate the secreted mature form. TNF-alpha converting enzyme (TACE) is currently the first and single protease described as responsible for the inducible release of soluble TNF-alpha. Methodology/Principal Findings: Here, we demonstrated the presence on THP-1 cells as on human monocytes of a constitutive proteolytical activity able to cleave pro-TNF-alpha. Revelation of the cell surface TACE protein expression confirmed that the observed catalytic activity is due to TACE. However, further studies using effective and innovative TNF-alpha inhibitors, as well as a highly selective TACE inhibitor, support the presence of a catalytically different sheddase activity on LPS activated THP-1 cells. It appears that this catalytically different TACE protease activity might have a significant contribution to TNF-alpha release in LPS activated THP-1 cells, by contrast to human monocytes where the TACE activity remains catalytically unchanged even after LPS activation. Conclusions/Significance: On the surface of LPS activated THP-1 cells we identified a releasing TNF-alpha activity, catalytically different from the sheddase activity observed on human monocytes from healthy donors. This catalytically-modified TACE activity is different from the constitutive shedding activity and appears only upon stimulation by LPS.	[Moreira-Tabaka, Helena; Peluso, Jean; Dumont, Serge; Muller, Christian D.] Univ Strasbourg, Fac Pharm, Lab Innovat Therapeut, UMR 7200, Illkirch Graffenstaden, France; [Vonesch, Jean-Luc; Hentsch, Didier; Kessler, Pascal] Univ Strasbourg, INSERM, Inst Genet & Biol Mol & Cellulaire,U596, Ctr Imagerie,CNRS,UMR 7104, Illkirch Graffenstaden, France; [Reimund, Jean-Marie] CHU Caen, Serv Hepatogastroenterol & Nutr, F-14000 Caen, France; [Reimund, Jean-Marie] Univ Caen Basse Normandie, CHU Caen, Lab Microenvironm Cellulaire & Pathol, UFR Med, Caen, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Moreira-Tabaka, H (corresponding author), Univ Strasbourg, Fac Pharm, Lab Innovat Therapeut, UMR 7200, Illkirch Graffenstaden, France.	heltab@basmed.am.wroc.pl; cdmuller@unistra.fr	MULLER, Christian D./F-8399-2010	MULLER, Christian D./0000-0002-3463-1025; Moreira, Helena/0000-0002-8084-3686				Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93; Allison AC, 2001, PROG NEURO-PSYCHOPH, V25, P1341, DOI 10.1016/S0278-5846(01)00192-0; Beck G, 2002, J PHARMACOL EXP THER, V302, P390, DOI 10.1124/jpet.302.1.390; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 2003, BIOCHEM SOC SYMP, V70, P39, DOI 10.1042/bss0700039; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P31; Cavaillon JM, 1996, LES CYTOKINES, V21, P301; Chesneau V, 2003, J BIOL CHEM, V278, P22331, DOI 10.1074/jbc.M302781200; Coeshott C, 1999, P NATL ACAD SCI USA, V96, P6261, DOI 10.1073/pnas.96.11.6261; DECOSTER E, 1995, J BIOL CHEM, V270, P18473, DOI 10.1074/jbc.270.31.18473; Doedens JR, 2000, J BIOL CHEM, V275, P14598, DOI 10.1074/jbc.275.19.14598; El Gazzar MA, 2007, BBA-GEN SUBJECTS, V1770, P556, DOI 10.1016/j.bbagen.2007.01.002; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Ghosheh OA, 1999, J PHARMACEUT BIOMED, V19, P757, DOI 10.1016/S0731-7085(98)00300-8; Glaser KB, 1999, BIOCHEM PHARMACOL, V57, P291, DOI 10.1016/S0006-2952(98)00300-1; Haro H, 2000, J CLIN INVEST, V105, P143, DOI 10.1172/JCI7091; Hikita A, 2009, BIOCHEM CELL BIOL, V87, P581, DOI [10.1139/O09-015, 10.1139/o09-015]; Jin GX, 2002, ANAL BIOCHEM, V302, P269, DOI 10.1006/abio.2001.5549; Jin HZ, 2002, J NAT PROD, V65, P89, DOI 10.1021/np010428r; KENNEY JS, 1987, J IMMUNOL, V138, P4236; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Li L, 2002, J HUAZHONG U SCI TEC, V22, P2002; Mezyk-Kopec R, 2009, CYTOKINE, V46, P309, DOI 10.1016/j.cyto.2009.03.002; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Neumann U, 2004, ANAL BIOCHEM, V328, P166, DOI 10.1016/j.ab.2003.12.035; Pinna GF, 2004, BIOCHEM BIOPH RES CO, V322, P778, DOI 10.1016/j.bbrc.2004.07.186; ROBACHEGALLEA S, 1995, J BIOL CHEM, V270, P23688, DOI 10.1074/jbc.270.40.23688; Rosendahl MS, 1997, J BIOL CHEM, V272, P24588, DOI 10.1074/jbc.272.39.24588; SASSA H, 1990, BIOCHEM BIOPH RES CO, V172, P890, DOI 10.1016/0006-291X(90)90759-G; Schlondorff J, 2000, BIOCHEM J, V347, P131, DOI 10.1042/0264-6021:3470131; Shurety W, 2001, LAB INVEST, V81, P107, DOI 10.1038/labinvest.3780216; Shurety W, 2000, J INTERF CYTOK RES, V20, P427, DOI 10.1089/107999000312379; Sibilia J, 2002, ENCY MED CHIR; Skotnicki JS, 2003, CURR OPIN DRUG DISC, V6, P742; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Wagner G, 2006, MED RES REV, V26, P1, DOI 10.1002/med.20042; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Zhang YJ, 2008, CLIN CANCER RES, V14, P7981, DOI 10.1158/1078-0432.CCR-08-0324; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200	40	12	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34184	10.1371/journal.pone.0034184	http://dx.doi.org/10.1371/journal.pone.0034184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479555	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100132
J	Murawski, C; Harris, PG; Bode, S; Dominguez, JF; Egan, GF				Murawski, Carsten; Harris, Philip G.; Bode, Stefan; Dominguez D, Juan F.; Egan, Gary F.			Led into Temptation? Rewarding Brand Logos Bias the Neural Encoding of Incidental Economic Decisions	PLOS ONE			English	Article							ATTITUDE STRENGTH; BRAIN; CONSUMER; TIME; REPRESENTATIONS; ANTICIPATION; PREFERENCE; MAGNITUDE; IMMEDIATE; RESPONSES	Human decision-making is driven by subjective values assigned to alternative choice options. These valuations are based on reward cues. It is unknown, however, whether complex reward cues, such as brand logos, may bias the neural encoding of subjective value in unrelated decisions. In this functional magnetic resonance imaging (fMRI) study, we subliminally presented brand logos preceding intertemporal choices. We demonstrated that priming biased participants' preferences towards more immediate rewards in the subsequent temporal discounting task. This was associated with modulations of the neural encoding of subjective values of choice options in a network of brain regions, including but not restricted to medial prefrontal cortex. Our findings demonstrate the general susceptibility of the human decision making system to apparently incidental contextual information. We conclude that the brain incorporates seemingly unrelated value information that modifies decision making outside the decision-maker's awareness.	[Murawski, Carsten] Univ Melbourne, Dept Finance, Parkville, Vic 3052, Australia; [Harris, Philip G.] Univ Melbourne, Dept Management & Mkt, Parkville, Vic 3052, Australia; [Bode, Stefan; Dominguez D, Juan F.; Egan, Gary F.] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3052, Australia; [Egan, Gary F.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Egan, Gary F.] Monash Univ, Sch Psychol & Psychiat, Clayton, Vic, Australia; [Egan, Gary F.] Monash Biomed Imaging, Clayton, Vic, Australia	University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Monash University	Murawski, C (corresponding author), Univ Melbourne, Dept Finance, Parkville, Vic 3052, Australia.	carstenm@unimelb.edu.au	Egan, Gary F./A-1381-2013	Bode, Stefan/0000-0002-0258-7795; Murawski, Carsten/0000-0002-1237-9535; Dominguez Duque, Juan Fernando/0000-0002-6715-1060; Dominguez, Juan/0000-0001-9643-1849; Egan, Gary/0000-0002-3186-4026	University of Melbourne Early Career Researcher; University of Melbourne Interdisciplinary Seed Funding Scheme	University of Melbourne Early Career Researcher(University of Melbourne); University of Melbourne Interdisciplinary Seed Funding Scheme	This study was partly funded by a University of Melbourne Early Career Researcher grant to Philip G. Harris and a grant in the University of Melbourne Interdisciplinary Seed Funding Scheme 2010. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2000, J PERS SOC PSYCHOL, V78, P53, DOI 10.1037/0022-3514.78.1.53; Allen CT, 2008, HDB CONSUMER PSYCHOL; Ballard K, 2009, NEUROIMAGE, V45, P143, DOI 10.1016/j.neuroimage.2008.11.004; Balleine BW, 2005, PHYSIOL BEHAV, V86, P717, DOI 10.1016/j.physbeh.2005.08.061; Berridge KC, 2008, SOC COGNITION, V26, P621, DOI 10.1521/soco.2008.26.5.621; Berridge KC, 2009, CURR OPIN PHARMACOL, V9, P65, DOI 10.1016/j.coph.2008.12.014; Bode S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021612; Bode S, 2009, NEUROIMAGE, V45, P606, DOI 10.1016/j.neuroimage.2008.11.031; Bogler C, 2011, CURR BIOL, V21, P1667, DOI 10.1016/j.cub.2011.08.039; Carter R.M.K., 2010, J NEUROSCI PSYCHOL E, V3, P27, DOI [10.1037/a0018046, DOI 10.1037/A0018046]; Chabris CF, 2009, J EUR ECON ASSOC, V7, P628, DOI 10.1162/JEEA.2009.7.2-3.628; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chartrand TL, 2008, J CONSUM RES, V35, P189, DOI 10.1086/588685; Chartrand TL, 2011, J CONSUM PSYCHOL, V21, P1, DOI 10.1016/j.jcps.2010.12.001; Clithero JA, 2009, NEUROIMAGE, V45, P1329, DOI 10.1016/j.neuroimage.2008.12.074; Custers R, 2010, SCIENCE, V329, P47, DOI 10.1126/science.1188595; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Dayan P, 2008, BETTER CONSCIOUS DEC, P51; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; Deppe M, 2005, J NEUROIMAGING, V15, P171, DOI 10.1177/1051228405275074; Dijksterhuis A, 2005, J CONSUM PSYCHOL, V15, P193, DOI 10.1207/s15327663jcp1503_3; Erk S, 2002, NEUROREPORT, V13, P2499, DOI 10.1097/00001756-200212200-00024; Fournier S, 1998, J CONSUM RES, V24, P343, DOI 10.1086/209515; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Glimcher P. W., 2011, FDN NEUROECONOMIC AN; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P503, DOI 10.1016/B978-0-12-374176-9.00032-4; Glimcher PW, 2003, BRADFORD BOOKS, P1; Guitart-Masip M, 2010, NEUROIMAGE, V53, P206, DOI 10.1016/j.neuroimage.2010.06.021; Guitart-Masip M, 2010, J NEUROSCI, V30, P1721, DOI 10.1523/JNEUROSCI.5331-09.2010; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hariri AR, 2006, J NEUROSCI, V26, P13213, DOI 10.1523/JNEUROSCI.3446-06.2006; Harris PG, 2010, ADV CONSUMER RES, V38; Hassin RR, 2007, P NATL ACAD SCI USA, V104, P19757, DOI 10.1073/pnas.0704679104; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kahnt T, 2010, P NATL ACAD SCI USA, V107, P6010, DOI 10.1073/pnas.0912838107; Karremans JC, 2006, J EXP SOC PSYCHOL, V42, P792, DOI 10.1016/j.jesp.2005.12.002; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2008, PHILOS T R SOC B, V363, P3771, DOI 10.1098/rstb.2008.0155; Knutson B, 2008, NEUROREPORT, V19, P509, DOI 10.1097/WNR.0b013e3282f85c01; Knutson B, 2007, J NEUROSCI, V27, P8174, DOI 10.1523/JNEUROSCI.1564-07.2007; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2007, NEUROIMAGE, V38, P666, DOI 10.1016/j.neuroimage.2007.06.030; Mazur J.E., 1987, QUANTITATIVE ANAL BE, P55; McClure SM, 2007, J NEUROSCI, V27, P5796, DOI 10.1523/JNEUROSCI.4246-06.2007; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Park CW, 2010, J MARKETING, V74, P1, DOI 10.1509/jmkg.74.6.1; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Peters J, 2010, NEURON, V66, P138, DOI 10.1016/j.neuron.2010.03.026; Plassmann H., 2008, J CONSUM BEHAV, V7, P360, DOI [10.1002/cb.257, DOI 10.1002/CB.257]; Priester JR, 2004, J CONSUM RES, V30, P574, DOI 10.1086/380290; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; Samuelson PA, 1936, REV ECON STUD, V4, P155; Schaefer M, 2007, BRAIN RES, V1165, P98, DOI 10.1016/j.brainres.2007.06.038; Schaefer M, 2007, NEUROREPORT, V18, P141, DOI 10.1097/WNR.0b013e328010ac84; Schaefer M, 2006, NEUROIMAGE, V31, P861, DOI 10.1016/j.neuroimage.2005.12.047; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; STROTZ RH, 1956, REV ECON STUD, V23, P165; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Tusche A, 2010, J NEUROSCI, V30, P8024, DOI 10.1523/JNEUROSCI.0064-10.2010; Van den Bergh B, 2008, J CONSUM RES, V35, P85, DOI 10.1086/525505; Wilson M, 2004, P ROY SOC B-BIOL SCI, V271, pS177, DOI 10.1098/rsbl.2003.0134; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309; Wittmann M, 2008, TRENDS COGN SCI, V12, P7, DOI 10.1016/j.tics.2007.10.004	74	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34155	10.1371/journal.pone.0034155	http://dx.doi.org/10.1371/journal.pone.0034155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UC	22479547	gold, Green Published			2022-12-27	WOS:000305339100126
J	Piepoli, A; Tavano, F; Copetti, M; Mazza, T; Palumbo, O; Panza, A; di Mola, FF; Pazienza, V; Mazzoccoli, G; Biscaglia, G; Gentile, A; Mastrodonato, N; Carella, M; Pellegrini, F; di Sebastiano, P; Andriulli, A				Piepoli, Ada; Tavano, Francesca; Copetti, Massimiliano; Mazza, Tommaso; Palumbo, Orazio; Panza, Anna; di Mola, Francesco Fabio; Pazienza, Valerio; Mazzoccoli, Gianluigi; Biscaglia, Giuseppe; Gentile, Annamaria; Mastrodonato, Nicola; Carella, Massimo; Pellegrini, Fabio; di Sebastiano, Pierluigi; Andriulli, Angelo			Mirna Expression Profiles Identify Drivers in Colorectal and Pancreatic Cancers	PLOS ONE			English	Article							VARIABLE IMPORTANCE; MICRORNAS	Background and Aim: Altered expression of microRNAs (miRNAs) hallmarks many cancer types. The study of the associations of miRNA expression profile and cancer phenotype could help identify the links between deregulation of miRNA expression and oncogenic pathways. Methods: Expression profiling of 866 human miRNAs in 19 colorectal and 17 pancreatic cancers and in matched adjacent normal tissues was investigated. Classical paired t-test and random forest analyses were applied to identify miRNAs associated with tissue-specific tumors. Network analysis based on a computational approach to mine associations between cancer types and miRNAs was performed. Results: The merge between the two statistical methods used to intersect the miRNAs differentially expressed in colon and pancreatic cancers allowed the identification of cancer-specific miRNA alterations. By miRNA-network analysis, tissue-specific patterns of miRNA deregulation were traced: the driving miRNAs were miR-195, miR-1280, miR-140-3p and miR-1246 in colorectal tumors, and miR-103, miR-23a and miR-15b in pancreatic cancers. Conclusion: MiRNA expression profiles may identify cancer-specific signatures and potentially useful biomarkers for the diagnosis of tissue specific cancers. miRNA-network analysis help identify altered miRNA regulatory networks that could play a role in tumor pathogenesis.	[Piepoli, Ada; Panza, Anna; Pazienza, Valerio; Biscaglia, Giuseppe; Gentile, Annamaria; Andriulli, Angelo] Res Hosp, IRCCS Casa Sollievo Sofferenza, Dept & Lab Gastroenterol, San Giovanni Rotondo, Italy; [Tavano, Francesca; di Mola, Francesco Fabio; Mastrodonato, Nicola; di Sebastiano, Pierluigi] Res Hosp, IRCCS Casa Sollievo Sofferenza, Dept Surg, San Giovanni Rotondo, Italy; [Copetti, Massimiliano; Pellegrini, Fabio] Res Hosp, IRCCS Casa Sollievo Sofferenza, Biostat Unit, San Giovanni Rotondo, Italy; [Mazza, Tommaso; Pellegrini, Fabio] Res Hosp, IRCCS Casa Sollievo Sofferenza, Unit Bioinformat, San Giovanni Rotondo, Italy; [Palumbo, Orazio; Carella, Massimo; Pellegrini, Fabio] Res Hosp, IRCCS Casa Sollievo Sofferenza, Med Genet Unit, San Giovanni Rotondo, Italy; [Mazzoccoli, Gianluigi; Pellegrini, Fabio] Res Hosp, IRCCS Casa Sollievo Sofferenza, Dept Internal Med, San Giovanni Rotondo, Italy; [Mazzoccoli, Gianluigi; Pellegrini, Fabio] Res Hosp, IRCCS Casa Sollievo Sofferenza, Chronobiol Unit, San Giovanni Rotondo, Italy; [Pellegrini, Fabio] DCPE Consorzio Mario Negri Sud, Biostat Unit, Santa Maria Imbaro, Italy	IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza	Piepoli, A (corresponding author), Res Hosp, IRCCS Casa Sollievo Sofferenza, Dept & Lab Gastroenterol, San Giovanni Rotondo, Italy.	a.piepoli@operapadrepio.it	Mazzoccoli, Gianluigi/H-2447-2016; Andriulli, Angelo/B-5027-2017; Mazza, Tommaso/I-4531-2019; COPETTI, MASSIMILIANO/AAG-1473-2021; PALUMBO, ORAZIO/C-1133-2014; Piepoli, Ada/K-9299-2016; di Mola, Fabio Francesco/J-3082-2018; Tavano, Francesca/K-2203-2016; Pazienza, Valerio/K-5073-2012; Mazza, Tommaso/H-6414-2016; di sebastiano, pierluigi/I-9851-2018; Copetti, Massimiliano/K-3186-2016; Carella, Massimo/A-2804-2014; Panza, Anna/K-1989-2016; Biscaglia, Giuseppe/K-2153-2016	Mazzoccoli, Gianluigi/0000-0003-3535-7635; Andriulli, Angelo/0000-0001-8862-7083; Mazza, Tommaso/0000-0003-0434-8533; COPETTI, MASSIMILIANO/0000-0002-7960-5947; PALUMBO, ORAZIO/0000-0001-6583-3482; Piepoli, Ada/0000-0001-7487-8754; di Mola, Fabio Francesco/0000-0001-9877-2946; Tavano, Francesca/0000-0002-8831-7349; Pazienza, Valerio/0000-0002-3492-1153; Mazza, Tommaso/0000-0003-0434-8533; Copetti, Massimiliano/0000-0002-7960-5947; Carella, Massimo/0000-0002-6830-6829; Panza, Anna/0000-0001-5840-0849; Biscaglia, Giuseppe/0000-0002-3799-2547; di sebastiano, pierluigi/0000-0002-9386-8241	Ministry of Italian Health through Research Unit of Gastroenterology [RC0903GA51, RC1003GA52, RC1103GA47, RC0903CH47, RC1003CH50, RC1103CH46, RC1003BS14, RC1102BS45]; Ministry of Italian Health through Research Unit of Surgery [RC0903GA51, RC1003GA52, RC1103GA47, RC0903CH47, RC1003CH50, RC1103CH46, RC1003BS14, RC1102BS45]; Ministry of Italian Health through Unit of Biostatistics [RC0903GA51, RC1003GA52, RC1103GA47, RC0903CH47, RC1003CH50, RC1103CH46, RC1003BS14, RC1102BS45]; Casa Sollievo della Sofferenza (IRCCS), San Giovanni Rotondo (FG), Italy	Ministry of Italian Health through Research Unit of Gastroenterology; Ministry of Italian Health through Research Unit of Surgery; Ministry of Italian Health through Unit of Biostatistics; Casa Sollievo della Sofferenza (IRCCS), San Giovanni Rotondo (FG), Italy	This work was supported by the Ministry of Italian Health grants RC0903GA51, RC1003GA52, RC1103GA47, RC0903CH47, RC1003CH50, RC1103CH46, RC1003BS14 and RC1102BS45 through Research Unit of Gastroenterology, Research Unit of Surgery, and Unit of Biostatistics; and Casa Sollievo della Sofferenza (IRCCS), San Giovanni Rotondo (FG), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay Sanghamitra, 2010, Silence, V1, P6, DOI 10.1186/1758-907X-1-6; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Esquela-Kerscher A, 2004, NAT METHODS, V1, P106, DOI 10.1038/nmeth1104-106; Hruban RH, 2009, HUM PATHOL, V40, P612, DOI 10.1016/j.humpath.2009.01.008; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Liu AH, 2009, INT J CLIN EXP PATHO, V2, P519; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Negrini M, 2009, CURR OPIN CELL BIOL, V21, P470, DOI 10.1016/j.ceb.2009.03.002; Newman MEJ., 2008, NEW PALGRAVE ENCY EC, V2, P1, DOI DOI 10.1057/9780230226203.1064; Perera RF, 2007, BIODRUGS, V21, P97, DOI 10.2165/00063030-200721020-00004; SABIDUSSI G, 1966, PSYCHOMETRIKA, V31, P581, DOI 10.1007/BF02289527; Schank T., 2005, J GRAPH ALGORITHMS A, V9, P265, DOI DOI 10.7155/JGAA.00108; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Smith M., 2010, NODEXL FREE OPEN NET; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Szafranska AE, 2008, CLIN CHEM, V54, P1716, DOI 10.1373/clinchem.2008.109603; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang Y, 2011, EMBO REP, V12, P811, DOI 10.1038/embor.2011.98	27	124	134	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33663	10.1371/journal.pone.0033663	http://dx.doi.org/10.1371/journal.pone.0033663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479426	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100065
J	Saha, SK; Al Emran, HM; Hossain, B; Darmstadt, GL; Saha, S; Islam, M; Chowdhury, AI; Foster, D; Naheed, A; El Arifeen, S; Baqui, AH; Qazi, SA; Luby, SP; Breiman, RF; Santosham, M; Black, RE; Crook, DW				Saha, Samir K.; Al Emran, Hassan M.; Hossain, Belal; Darmstadt, Gary L.; Saha, Senjuti; Islam, Maksuda; Chowdhury, Atique I.; Foster, Dona; Naheed, Aliya; El Arifeen, Shams; Baqui, Abdullah H.; Qazi, Shamim A.; Luby, Stephen P.; Breiman, Robert F.; Santosham, Mathuram; Black, Robert E.; Crook, Derrick W.		Pneumococcal Study Grp	Streptococcus pneumoniae Serotype-2 Childhood Meningitis in Bangladesh: A Newly Recognized Pneumococcal Infection Threat	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; NEISSERIA-MENINGITIDIS; INVASIVE-DISEASE; SOUTH-AFRICA; CHILDREN; BURDEN; SURVEILLANCE; IDENTIFICATION; BACTEREMIA; RESISTANCE	Background: Streptococcus pneumoniae is a leading cause of meningitis in countries where pneumococcal conjugate vaccines (PCV) targeting commonly occurring serotypes are not routinely used. However, effectiveness of PCV would be jeopardized by emergence of invasive pneumococcal diseases (IPD) caused by serotypes which are not included in PCV. Systematic hospital based surveillance in Bangladesh was established and progressively improved to determine the pathogens causing childhood sepsis and meningitis. This also provided the foundation for determining the spectrum of serotypes causing IPD. This article reports an unprecedented upsurge of serotype 2, an uncommon pneumococcal serotype, without any known intervention. Methods and Findings: Cases with suspected IPD had blood or cerebrospinal fluid (CSF) collected from the beginning of 2001 till 2009. Pneumococcal serotypes were determined by capsular swelling of isolates or PCR of culture-negative CSF specimens. Multicenter national surveillance, expanded from 2004, identified 45,437 patients with suspected bacteremia who were blood cultured and 10,618 suspected meningitis cases who had a lumber puncture. Pneumococcus accounted for 230 culture positive cases of meningitis in children <5 years. Serotype-2 was the leading cause of pneumococcal meningitis, accounting for 20.4% (45/221; 95% CI 15%-26%) of cases. Ninety eight percent (45/46) of these serotype-2 strains were isolated from meningitis cases, yielding the highest serotype-specific odds ratio for meningitis (29.6; 95% CI 3.4-256.3). The serotype-2 strains had three closely related pulsed field gel electrophoresis types. Conclusions: S. pneumoniae serotype-2 was found to possess an unusually high potential for causing meningitis and was the leading serotype-specific cause of childhood meningitis in Bangladesh over the past decade. Persisting disease occurrence or progressive spread would represent a major potential infection threat since serotype-2 is not included in PCVs currently licensed or under development.	[Saha, Samir K.; Al Emran, Hassan M.; Hossain, Belal; Islam, Maksuda] Dhaka Shishu Children Hosp, Child Hlth Res Fdn, Dept Microbiol, Dhaka, Bangladesh; [Darmstadt, Gary L.; Baqui, Abdullah H.; Santosham, Mathuram; Black, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Saha, Senjuti] Univ Toronto, Davidson Lab, Dept Mol Genet, Toronto, ON, Canada; [Chowdhury, Atique I.; Naheed, Aliya; El Arifeen, Shams; Luby, Stephen P.] Int Ctr Diarrhoeal Dis & Res, Dhaka, Bangladesh; [Foster, Dona; Crook, Derrick W.] Univ Oxford, Oxford, England; [Qazi, Shamim A.] WHO, Child & Adolescent Hlth Dept, CH-1211 Geneva, Switzerland; [Luby, Stephen P.; Breiman, Robert F.] Ctr Dis Control & Prevent, Atlanta, GA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto; International Centre for Diarrhoeal Disease Research (ICDDR); University of Oxford; World Health Organization; Centers for Disease Control & Prevention - USA	Saha, SK (corresponding author), Dhaka Shishu Children Hosp, Child Hlth Res Fdn, Dept Microbiol, Dhaka, Bangladesh.	samirk.sks@gmail.com	A, Naheed/AHB-2940-2022; A, Naheed/AHB-2941-2022; Darmstadt, Gary/AAU-7488-2020; Chowdhury, Atique Iqbal/A-6046-2016	A, Naheed/0000-0002-6016-5603; A, Naheed/0000-0002-6016-5603; Chowdhury, Atique Iqbal/0000-0001-9140-5983; Darmstadt, Gary/0000-0002-7522-5824; Black, Robert/0000-0001-9926-7984; Saha, Senjuti/0000-0001-6087-6766; Arifeen, Shams/0000-0002-5372-5932	World Health Organization [C6-181-452, 98011]; Gavi's PneumoADIP, based at Johns Hopkins Bloomberg School of Public Health; Oxford Biomedical Research Center, National Institutes of Health (NIHR), England, United Kingdom; Pfizer Inc.; Novartis	World Health Organization(World Health Organization); Gavi's PneumoADIP, based at Johns Hopkins Bloomberg School of Public Health; Oxford Biomedical Research Center, National Institutes of Health (NIHR), England, United Kingdom; Pfizer Inc.(Pfizer); Novartis(Novartis)	The study was partially supported by World Health Organization (Reg file C6-181-452; ID. 98011) and Gavi's PneumoADIP, based at Johns Hopkins Bloomberg School of Public Health. Dr. Crook is funded by the Oxford Biomedical Research Center, National Institutes of Health (NIHR), England, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Crook and Dr. Saha received a research grant from Pfizer Inc. and Novartis respectively. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Antonio M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-198; Brooks WA, 2007, AM J TROP MED HYG, V77, P795, DOI 10.4269/ajtmh.2007.77.795; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Cecil RL, 1932, J AMER MED ASSOC, V98, P779, DOI 10.1001/jama.1932.02730360001001; Cherian Thomas, 2007, Vaccine, V25, P6557, DOI 10.1016/j.vaccine.2007.06.044; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Feikin DR, 2002, CLIN INFECT DIS, V35, P547, DOI 10.1086/341896; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Harboe ZB, 2010, CLIN INFECT DIS, V50, P329, DOI 10.1086/649872; Hefferon R, 1939, PNEUMONIA; Karstaedt AS, 2001, CLIN INFECT DIS, V33, P610, DOI 10.1086/322589; Karstaedt AS, 2000, PEDIATR INFECT DIS J, V19, P454, DOI 10.1097/00006454-200005000-00012; LEFEVRE JC, 1993, J CLIN MICROBIOL, V31, P2724, DOI 10.1128/JCM.31.10.2724-2728.1993; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Luby SP, 2010, VACCINE, V28, P4903, DOI 10.1016/j.vaccine.2010.05.040; McEllistrem MC, 2000, J CLIN MICROBIOL, V38, P351; Naheed A, 2009, CLIN INFECT DIS, V48, pS82, DOI 10.1086/596485; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Saha SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003576; Saha SK, 2009, CLIN INFECT DIS, V48, pS75, DOI 10.1086/596544; Saha SK, 1999, J CLIN MICROBIOL, V37, P798, DOI 10.1128/JCM.37.3.798-800.1999; Saha SK, 2003, J CLIN MICROBIOL, V41, P5582, DOI 10.1128/JCM.41.12.5582-5587.2003; Shah AS, 2009, CLIN INFECT DIS, V48, pS123, DOI 10.1086/596490; SMIT P, 1977, JAMA-J AM MED ASSOC, V238, P2613, DOI 10.1001/jama.238.24.2613; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tzanakaki G, 2005, CLIN MICROBIOL INFEC, V11, P386, DOI 10.1111/j.1469-0691.2005.01109.x; World Health Organization, 2011, EST HIB PNEUM DEATHS; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	28	27	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32134	10.1371/journal.pone.0032134	http://dx.doi.org/10.1371/journal.pone.0032134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479314	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100005
J	Wu, J; Lu, CY; Deng, XQ; Wang, H; Hong, LY				Wu Jie; Lu Ciyong; Deng Xueqing; Wang Hui; Hong Lingyao			A Syndemic of Psychosocial Problems Places the MSM (Men Who Have Sex with Men) Population at Greater Risk of HIV Infection	PLOS ONE			English	Article							HEALTH-PROBLEMS; STRESS; DEPRESSION; TRAUMA; GAY; ASSOCIATION; SEVERITY; ABUSE	Background: The MSM (Men who have sex with men) population suffers from very high rates of concurrent psychosocial problems. Together, these problems comprise a syndemic that increases the risk of HIV infection for this community. The precise mechanisms through which this syndemic can raise the likelihood of HIV infection warrant further exploration. Methodology/Principal Findings: A total of 522 MSM were enrolled via a multiframe sampling approach and were asked to report psychosocial problems, risky sexual behaviors and HIV test results. A count of psychosocial health problems was calculated to test the additive relationship of these factors on HIV risk. Adjusting analysis and restriction analysis were used to determine a proposed intermediate pathway. Psychosocial health problems are highly concurrent and intercorrelated among urban MSM. Greater numbers of health problems are significantly and positively associated with HIV infection, which is mediated, at least partially, by risky sexual behaviors. Conclusions/Significance: MSM experience concurrent psychosocial health problems that correlate with HIV infection in this community. We recommend the development of coping strategies for this population to deal with these psychosocial problems, both in prevention research and health policy.	[Wu Jie; Lu Ciyong; Deng Xueqing; Wang Hui; Hong Lingyao] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Wu, J (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	luciyong@yahoo.cn			Sun Yat-sen University Faculty Research Grant	Sun Yat-sen University Faculty Research Grant	This study was supported by the Sun Yat-sen University Faculty Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SYND PREV NETW SPOTL; Burchell AN, 2010, AIDS, V24, P1757, DOI 10.1097/QAD.0b013e32833af7c9; Cole SR, 2002, INT J EPIDEMIOL, V31, P163, DOI 10.1093/ije/31.1.163; Glover DA, 2010, J TRAUMA DISSOCIATIO, V11, P152, DOI 10.1080/15299730903502920; HALLORAN ME, 1995, EPIDEMIOLOGY, V6, P142, DOI 10.1097/00001648-199503000-00010; Kaufman Jay S, 2004, Epidemiol Perspect Innov, V1, P4, DOI 10.1186/1742-5573-1-4; Leserman J, 2008, PSYCHOSOM MED, V70, P539, DOI 10.1097/PSY.0b013e3181777a5f; Li SW, 2008, CHINESE MED J-PEKING, V121, P1105, DOI 10.1097/00029330-200806020-00013; Liu H, 2006, SEX TRANSM DIS, V33, P68, DOI 10.1097/01.olq.0000187266.29927.11; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; MEYER IH, 1995, J HEALTH SOC BEHAV, V36, P38, DOI 10.2307/2137286; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Mustanski B, 2007, ANN BEHAV MED, V34, P37, DOI 10.1007/BF02879919; Roberts AL, 2010, AM J PUBLIC HEALTH, V100, P2433, DOI 10.2105/AJPH.2009.168971; Schoedl AF, 2010, J CHILD SEX ABUS, V19, P156, DOI 10.1080/10538711003615038; SINGER M, 1994, SOC SCI MED, V39, P931, DOI 10.1016/0277-9536(94)90205-4; Singer M., 1996, FREE INQ CREAT SOCIO, V24, P99, DOI [10.1093/jn/nxaa361, DOI 10.1093/jn/nxaa361]; Sivasubramanian M, 2011, PSYCHOL HEALTH MED, V16, P450, DOI 10.1080/13548506.2011.554645; Stall R, 2003, AM J PUBLIC HEALTH, V93, P939, DOI 10.2105/AJPH.93.6.939; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; SZKLO M., 2014, EPIDEMIOLOGY BASICS, V3; Zhang D, 2007, J INFECTION, V25, P185	22	60	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32312	10.1371/journal.pone.0032312	http://dx.doi.org/10.1371/journal.pone.0032312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UC	22479319	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339100008
J	Rasmussen, TA; Jensen, D; Tolstrup, M; Nielsen, US; Erlandsen, EJ; Birn, H; Ostergaard, L; Langdahl, BL; Laursen, AL				Rasmussen, Thomas A.; Jensen, Danny; Tolstrup, Martin; Nielsen, Ulla S.; Erlandsen, Erland J.; Birn, Henrik; Ostergaard, Lars; Langdahl, Bente L.; Laursen, Alex L.			Comparison of Bone and Renal Effects In HIV-infected Adults Switching to Abacavir or Tenofovir Based Therapy in a Randomized Trial	PLOS ONE			English	Article							SOCIETY-USA PANEL; MINERAL DENSITY; ANTIRETROVIRAL THERAPY; DISOPROXIL FUMARATE; KIDNEY-FUNCTION; NAIVE PATIENTS; CYSTATIN C; VITAMIN-D; TENOFOVIR/EMTRICITABINE; ABACAVIR/LAMIVUDINE	Introduction: Our objective was to compare the bone and renal effects among HIV-infected patients randomized to abacavir or tenofovir-based combination anti-retroviral therapy. Methods: In an open-label randomized trial, HIV-infected patients were randomized to switch from zidovudine/lamivudine (AZT/3TC) to abacavir/lamivudine (ABC/3TC) or tenofovir/emtricitabine (TDF/FTC). We measured bone mass density (BMD) and bone turnover biomarkers (osteocalcin, osteocalcin, procollagen type 1 N-terminal propeptide (P1NP), alkaline phosphatase, type I collagen cross-linked C-telopeptide (CTx), and osteoprotegerin). We assessed renal function by estimated creatinine clearance, plasma cystatin C, and urinary levels of creatinine, albumin, cystatin C, and neutrophil gelatinase-associated lipocalin (NGAL). The changes from baseline in BMD and renal and bone biomarkers were compared across study arms. Results: Of 40 included patients, 35 completed 48 weeks of randomized therapy and follow up. BMD was measured in 33, 26, and 27 patients at baseline, week 24, and week 48, respectively. In TDF/FTC-treated patients we observed significant reductions from baseline in hip and lumbar spine BMD at week 24 (-1.8% and -2.5%) and week 48 (-2.1% and -2.1%), whereas BMD was stable in patients in the ABC/3TC arm. The changes from baseline in BMD were significantly different between study arms. All bone turnover biomarkers except osteoprotegerin increased in the TDF/FTC arm compared with the ABC/3TC arm, but early changes did not predict subsequent loss of BMD. Renal function parameters were similar between study arms although a small increase in NGAL was detected among TDF-treated patients. Conclusion: Switching to TDF/FTC-based therapy led to decreases in BMD and increases in bone turnover markers compared with ABC/3TC-based treatment. No major difference in renal function was observed.	[Rasmussen, Thomas A.; Tolstrup, Martin; Nielsen, Ulla S.; Ostergaard, Lars; Laursen, Alex L.] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark; [Jensen, Danny; Birn, Henrik] Aarhus Univ Hosp, Dept Nephrol, DK-8000 Aarhus, Denmark; [Jensen, Danny; Birn, Henrik] Aarhus Univ, Aarhus, Denmark; [Erlandsen, Erland J.] Viborg Reg Hosp, Dept Clin Biochem, Viborg, Denmark; [Langdahl, Bente L.] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, DK-8000 Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Rasmussen, TA (corresponding author), Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark.	thomrasm@rm.dk	Birn, Henrik/C-3931-2009; Ostergaard, Lars/AAA-3020-2020	Birn, Henrik/0000-0003-3715-7266; Ostergaard, Lars/0000-0003-2459-0511; Erlandsen, Erland J/0000-0002-6686-3971; Tolstrup, Martin/0000-0001-7020-5173; Laursen, Alex Lund/0000-0002-1206-156X; Nielsen, Ulla Schierup/0000-0001-5849-9586; Rasmussen, Thomas Aagaard/0000-0001-5354-2442; Ostergaard, Lars/0000-0002-7619-605X	GlaxoSmithKline; Abbott; MSD; Pfizer; Bristol-Meyer Squibb; ViiV Healthcare; Gilead; Tibotec	GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); MSD; Pfizer(Pfizer); Bristol-Meyer Squibb; ViiV Healthcare; Gilead(Gilead Sciences); Tibotec	The study was supported by a grant of US$ 9,100 from GlaxoSmithKline (www.gsk.com). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by a grant of US$ 9,100 from GlaxoSmithKline (www.gsk.com). Lars Ostergaard has received consultancy and speaker's fee from: Abbott, MSD, Pfizer, Bristol-Meyer Squibb, GlaxoSmithKline, ViiV Healthcare, Gilead, and Tibotec. Alex L Laursen has served on the advisory board for GlaxoSmithKline, Gilead, and Janssen. Lamivudine/zidovudine and abacavir/lamivudine are manufactured by GSK; tenofovir/emtricitabine is manufactured by Gilead. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Barraclough K, 2009, NEPHRON CLIN PRACT, V111, pC39, DOI 10.1159/000178978; Bolland MJ, 2007, J CLIN ENDOCR METAB, V92, P1283, DOI 10.1210/jc.2006-2216; Bonjoch A, 2010, ANTIVIR RES, V88, P347, DOI 10.1016/j.antiviral.2010.09.015; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Brown TT, 2009, JAIDS-J ACQ IMM DEF, V51, P554, DOI 10.1097/QAI.0b013e3181adce44; Carr A, 2010, CLIN INFECT DIS, V51, P973, DOI 10.1086/656418; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Duvivier C, 2009, AIDS, V23, P817, DOI 10.1097/QAD.0b013e328328f789; Erlandsen EJ, 1999, SCAND J CLIN LAB INV, V59, P1, DOI 10.1080/00365519950185940; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Grigsby IF, 2010, BIOCHEM BIOPH RES CO, V394, P48, DOI 10.1016/j.bbrc.2010.02.080; Grigsby IF, 2010, BIOCHEM BIOPH RES CO, V391, P1324, DOI 10.1016/j.bbrc.2009.12.039; Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792; Guaraldi G, 2004, HIV CLIN TRIALS, V5, P269, DOI 10.1310/MD8V-5DLG-EN3T-BRHX; Gutierrez F, 2011, AIDS REV, V13, P109; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hansen AB, 2011, HIV MED, V12, P157, DOI 10.1111/j.1468-1293.2010.00864.x; Haskelberg HJJ, 2011, C HIV PATH TREATM PR; Hoy J, 2011, 13 INT WORKSH ADV DR; Karras A, 2003, CLIN INFECT DIS, V36, P1070, DOI 10.1086/368314; Leeming DJ, 2006, EUR J CLIN PHARMACOL, V62, P781, DOI 10.1007/s00228-006-0174-3; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Mallon PWG, 2010, CURR OPIN INFECT DIS, V23, P1, DOI 10.1097/QCO.0b013e328334fe9a; Martin A, 2009, CLIN INFECT DIS, V49, P1591, DOI 10.1086/644769; Martinez E, 2009, JAIDS-J ACQ IMM DEF, V51, P290, DOI 10.1097/QAI.0b013e3181aa12d5; McComsey GA, 2007, AIDS, V21, P2473, DOI 10.1097/QAD.0b013e3282ef961d; McComsey GA, 2011, J INFECT DIS, V203, P1791, DOI 10.1093/infdis/jir188; Mondy K, 2005, JAIDS-J ACQ IMM DEF, V38, P426, DOI 10.1097/01.qai.0000145352.04440.1e; Moyle GJ, 2006, AIDS, V20, P2043, DOI 10.1097/01.aids.0000247574.33998.03; Peyriere H, 2004, JAIDS-J ACQ IMM DEF, V35, P269, DOI 10.1097/00126334-200403010-00007; Post FA, 2010, JAIDS-J ACQ IMM DEF, V55, P49, DOI 10.1097/QAI.0b013e3181dd911e; Randers E, 2000, CLIN NEPHROL, V54, P203; Rasmussen TA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-267; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Society EAC, 2009, GUID CLIN MAN TREATM; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; Szulc P, 2008, OSTEOPOROSIS INT, V19, P1683, DOI 10.1007/s00198-008-0660-9; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Trouvin AP, 2010, CLIN INTERV AGING, V5, P345, DOI 10.2147/CIA.S10153; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P777, DOI 10.1007/s001980200108; van Vonderen MGA, 2009, AIDS, V23, P1367, DOI 10.1097/QAD.0b013e32832c4947; Wagner D, 2010, WIEN MED WOCHENSCHR, V160, P452, DOI 10.1007/s10354-010-0818-x; Warming L, 2002, OSTEOPOROSIS INT, V13, P105, DOI 10.1007/s001980200001; Young B, 2011, CLIN INFECT DIS, V52, P1061, DOI 10.1093/cid/ciq242	45	62	63	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32445	10.1371/journal.pone.0032445	http://dx.doi.org/10.1371/journal.pone.0032445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479327				2022-12-27	WOS:000304523400006
J	Svarverud, E; Gilson, S; Glennerster, A				Svarverud, Ellen; Gilson, Stuart; Glennerster, Andrew			A Demonstration of 'Broken' Visual Space	PLOS ONE			English	Article							VIRTUAL ENVIRONMENTS; PARIETAL CORTEX; DISTANCE; NAVIGATION; MOTION; DEPTH; VIEW; INTEGRATION; PERCEPTION; ILLUSIONS	It has long been assumed that there is a distorted mapping between real and ' perceived' space, based on demonstrations of systematic errors in judgements of slant, curvature, direction and separation. Here, we have applied a direct test to the notion of a coherent visual space. In an immersive virtual environment, participants judged the relative distance of two squares displayed in separate intervals. On some trials, the virtual scene expanded by a factor of four between intervals although, in line with recent results, participants did not report any noticeable change in the scene. We found that there was no consistent depth ordering of objects that can explain the distance matches participants made in this environment (e.g. A > B > D yet also A < C < D) and hence no single one-to-one mapping between participants' perceived space and any real 3D environment. Instead, factors that affect pairwise comparisons of distances dictate participants' performance. These data contradict, more directly than previous experiments, the idea that the visual system builds and uses a coherent internal 3D representation of a scene.	[Svarverud, Ellen; Gilson, Stuart] Buskerud Univ Coll, Dept Optometry & Visual Sci, Kongsberg, Norway; [Gilson, Stuart] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Glennerster, Andrew] Univ Reading, Sch Psychol & Clin Language Sci, Reading, Berks, England	University College of Southeast Norway; University of Oxford; University of Reading	Svarverud, E (corresponding author), Buskerud Univ Coll, Dept Optometry & Visual Sci, Kongsberg, Norway.	a.glennerster@reading.ac.uk			Wellcome Trust [086526/A/08/Z]; Buskerud University College; University of Reading	Wellcome Trust(Wellcome TrustEuropean Commission); Buskerud University College; University of Reading	This work was funded by The Wellcome Trust (086526/A/08/Z, http://www. wellcome.ac.uk/); Buskerud University College (http://www. hibu.no/english/) and The University of Reading (http://www.reading.ac.uk/pcls/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; [Anonymous], 1947, MATH ANAL BINOCULAR; Bingham GP, 2001, J EXP PSYCHOL HUMAN, V27, P1314, DOI 10.1037//0096-1523.27.6.1314; BULTHOFF HH, 1992, P NATL ACAD SCI USA, V89, P60, DOI 10.1073/pnas.89.1.60; Burgess N, 1999, HIPPOCAMPAL PARIETAL, P3; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Cuijpers RH, 2003, J MATH PSYCHOL, V47, P278, DOI 10.1016/S0022-2496(03)00004-X; Cummins M, 2008, INT J ROBOT RES, V27, P647, DOI 10.1177/0278364908090961; DIXON WJ, 1946, J AM STAT ASSOC, V41, P557, DOI 10.2307/2280577; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; ERKELENS CJ, 1985, VISION RES, V25, P583, DOI 10.1016/0042-6989(85)90164-6; Escher MC, 1961, GRAPHIC WORK MC ESCH; Finney D.J., 1971, PROBIT ANAL; FOLEY JM, 1980, PSYCHOL REV, V87, P411, DOI 10.1037/0033-295X.87.5.411; Franz MO, 1998, AUTON ROBOT, V5, P111, DOI 10.1023/A:1008821210922; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gillner S, 1998, J COGNITIVE NEUROSCI, V10, P445, DOI 10.1162/089892998562861; Gilson SJ, 2008, J NEUROSCI METH, V173, P140, DOI 10.1016/j.jneumeth.2008.05.015; Glennerster A, 2006, CURR BIOL, V16, P428, DOI 10.1016/j.cub.2006.01.019; Glennerster A, 2001, VISION RES, V41, P815, DOI 10.1016/S0042-6989(00)00300-X; GOGEL WC, 1990, PERCEPT PSYCHOPHYS, V48, P105, DOI 10.3758/BF03207077; He ZJJ, 2004, PERCEPTION, V33, P789, DOI 10.1068/p5256a; Henriques DYP, 1998, J NEUROSCI, V18, P1583; Howard IP, 2008, SPATIAL VISION, V21, P581, DOI 10.1163/156856808786451417; INDOW T, 1991, PSYCHOL REV, V98, P430, DOI 10.1037/0033-295X.98.3.430; JOHNSTON EB, 1993, VISION RES, V33, P813, DOI 10.1016/0042-6989(93)90200-G; Knapp JM, 2004, PRESENCE-TELEOP VIRT, V13, P572, DOI 10.1162/1054746042545238; Koenderink JJ, 2000, PERCEPTION, V29, P69, DOI 10.1068/p2921; Koenderink JJ, 2002, PERCEPTION, V31, P1467, DOI 10.1068/p3295; Ni K, 2009, IEEE T PATTERN ANAL, V31, P2158, DOI 10.1109/TPAMI.2009.165; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; Ogle K. N., 1950, RES BINOCULAR VISION; Rauschecker AM, 2006, J VISION, V6, P1471, DOI 10.1167/6.12.12; Sibley G, 2010, INT J ROBOT RES, V29, P958, DOI 10.1177/0278364910369268; Smeets JBJ, 2002, EXP BRAIN RES, V147, P135, DOI 10.1007/s00221-002-1185-7; Smeets JBJ, 2009, PERCEPTION, V38, P1467, DOI 10.1068/p6439; Svarverud E, 2010, J VISION, V10, DOI 10.1167/10.1.5; Wu J, 2008, PERCEPT PSYCHOPHYS, V70, P707, DOI 10.3758/PP.70.4.707; Zhang H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001023	40	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33782	10.1371/journal.pone.0033782	http://dx.doi.org/10.1371/journal.pone.0033782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479441	Green Published, Green Accepted, gold			2022-12-27	WOS:000304523400036
J	Bocquillon, P; Bourriez, JL; Palmero-Soler, E; Destee, A; Defebvre, L; Derambure, P; Dujardin, K				Bocquillon, Perrine; Bourriez, Jean-Louis; Palmero-Soler, Ernesto; Destee, Alain; Defebvre, Luc; Derambure, Philippe; Dujardin, Kathy			Role of Basal Ganglia Circuits in Resisting Interference by Distracters: A swLORETA Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; NONDEMENTED PARKINSONS-DISEASE; AUDITORY SELECTIVE ATTENTION; ANTERIOR CINGULATE CORTEX; NOVELTY ODDBALL; HUMAN BRAIN; PARIETAL OVERACTIVITY; DIAGNOSTIC-CRITERIA; BIMANUAL MOVEMENTS; PREFRONTAL CORTEX	Background: The selection of task-relevant information requires both the focalization of attention on the task and resistance to interference from irrelevant stimuli. Both mechanisms rely on a dorsal frontoparietal network, while focalization additionally involves a ventral frontoparietal network. The role of subcortical structures in attention is less clear, despite the fact that the striatum interacts significantly with the frontal cortex via frontostriatal loops. One means of investigating the basal ganglia's contributions to attention is to examine the features of P300 components (i.e. amplitude, latency, and generators) in patients with basal ganglia damage (such as in Parkinson's disease (PD), in which attention is often impaired). Three-stimulus oddball paradigms can be used to study distracter-elicited and target-elicited P300 subcomponents. Methodology/Principal Findings: In order to compare distracter-and target-elicited P300 components, high-density (128-channel) electroencephalograms were recorded during a three-stimulus visual oddball paradigm in 15 patients with early PD and 15 matched healthy controls. For each subject, the P300 sources were localized using standardized weighted low-resolution electromagnetic tomography (swLORETA). Comparative analyses (one-sample and two-sample t-tests) were performed using SPM5 (R) software. The swLORETA analyses showed that PD patients displayed fewer dorsolateral prefrontal (DLPF) distracter-P300 generators but no significant differences in target-elicited P300 sources; this suggests dysfunction of the DLPF cortex when the executive frontostriatal loop is disrupted by basal ganglia damage. Conclusions/Significance: Our results suggest that the cortical attention frontoparietal networks (mainly the dorsal one) are modulated by the basal ganglia. Disruption of this network in PD impairs resistance to distracters, which results in attention disorders.	[Bocquillon, Perrine; Destee, Alain; Defebvre, Luc; Derambure, Philippe; Dujardin, Kathy] Univ Lille Nord France, Lille, France; [Bocquillon, Perrine; Bourriez, Jean-Louis; Defebvre, Luc; Derambure, Philippe; Dujardin, Kathy] Lab Neurosci Fonct & Pathol, Lille, France; [Bocquillon, Perrine; Bourriez, Jean-Louis; Derambure, Philippe] Univ Lille, Med Ctr, Dept Clin Neurophysiol, Lille, France; [Palmero-Soler, Ernesto] Eemagine Med Imaging Solut GmbH, Berlin, Germany; [Destee, Alain; Defebvre, Luc; Dujardin, Kathy] Univ Lille, Med Ctr, Neurol & Movement Disorders Dept, Lille, France	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Bocquillon, P (corresponding author), Univ Lille Nord France, Lille, France.	pebocq@hotmail.fr	Dujardin, Kathy/H-5037-2011; Derambure, Philippe/AAK-8546-2020	Dujardin, Kathy/0000-0002-0110-574X; 	France Parkinson Association	France Parkinson Association	This study was supported by a grant from France Parkinson Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, DOI [10.1176/appi.books.9780890423349., DOI 10.1176/APPI.BOOKS.9780890423349]; Antal A, 1996, J NEURAL TRANSM, V103, P1053, DOI 10.1007/BF01291790; Barch DM, 2001, CEREB CORTEX, V11, P837, DOI 10.1093/cercor/11.9.837; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Bledowski C, 2004, NEUROIMAGE, V22, P530, DOI 10.1016/j.neuroimage.2003.12.034; Bocquillon P, 2011, CLIN NEUROPHYSIOL, V122, P1991, DOI 10.1016/j.clinph.2011.03.014; BRANDEIS D, 1986, NEUROPSYCHOLOGIA, V24, P151, DOI 10.1016/0028-3932(86)90049-7; BROWN RG, 1988, BRAIN, V111, P323, DOI 10.1093/brain/111.2.323; Clark VP, 2000, J NEUROPHYSIOL, V83, P3133, DOI 10.1152/jn.2000.83.5.3133; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Cools R, 2002, BRAIN, V125, P584, DOI 10.1093/brain/awf052; Cools R, 2010, J COGNITIVE NEUROSCI, V22, P848, DOI 10.1162/jocn.2009.21227; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Cunnington R, 2001, MOVEMENT DISORD, V16, P849, DOI 10.1002/mds.1181; Cycowicz YM, 1998, BRAIN COGNITION, V36, P30, DOI 10.1006/brcg.1997.0955; Daffner KR, 2011, NEUROIMAGE, V54, P427, DOI 10.1016/j.neuroimage.2010.08.006; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; de Lau LML, 2004, NEUROLOGY, V63, P1240, DOI 10.1212/01.WNL.0000140706.52798.BE; Debener S, 2005, COGNITIVE BRAIN RES, V22, P309, DOI 10.1016/j.cogbrainres.2004.09.006; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dien J, 2003, COGNITIVE BRAIN RES, V17, P637, DOI 10.1016/S0926-6410(03)00188-5; DONCHIN E, 1981, PSYCHOPHYSIOLOGY, V18, P493, DOI 10.1111/j.1469-8986.1981.tb01815.x; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Dubois B, 1997, J NEUROL, V244, P2, DOI 10.1007/pl00007725; Dujardin K, 1999, J NEUROL, V246, P783, DOI 10.1007/s004150050455; EBMEIER KP, 1992, BIOL PSYCHOL, V33, P73, DOI 10.1016/0301-0511(92)90007-H; EBMEIER KP, 1992, ELECTROEN CLIN NEURO, V84, P440, DOI 10.1016/0168-5597(92)90031-6; Elwan OH, 1996, J NEUROL SCI, V143, P64, DOI 10.1016/S0022-510X(96)00161-X; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; EVANS AC, 1993, NUCLEAR SCIENCE SYMPOSIUM & MEDICAL IMAGING CONFERENCE, VOLS 1-3, P1813, DOI 10.1109/NSSMIC.1993.373602; Fabiani M, 1998, PSYCHOPHYSIOLOGY, V35, P698, DOI 10.1017/S0048577298970780; FABIANI M, 1995, PSYCHOPHYSIOLOGY, V32, P579, DOI 10.1111/j.1469-8986.1995.tb01234.x; Fjell AM, 2004, PSYCHOPHYSIOLOGY, V41, P575, DOI 10.1111/j.1469-8986.2004.00177.x; FLOWERS KA, 1995, PERCEPTION, V24, P1201, DOI 10.1068/p241201; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; FOX PT, 1988, J CEREBR BLOOD F MET, V8, P642, DOI 10.1038/jcbfm.1988.111; FRIEDMAN D, 1978, ELECTROEN CLIN NEURO, V45, P319, DOI 10.1016/0013-4694(78)90184-0; FRISTON KJ, 1990, J CEREBR BLOOD F MET, V10, P458, DOI 10.1038/jcbfm.1990.88; FUKATSU R, 1990, TOHOKU J EXP MED, V161, P329, DOI 10.1620/tjem.161.329; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; GESELOWI.DB, 1967, BIOPHYS J, V7, P1, DOI 10.1016/S0006-3495(67)86571-8; Goldstein A, 2002, PSYCHOPHYSIOLOGY, V39, P781, DOI 10.1017/S004857720201048X; GOODIN DS, 1987, ANN NEUROL, V21, P90, DOI 10.1002/ana.410210116; Graham J S, 1990, Clin Exp Neurol, V27, P89; Green J, 1996, MOVEMENT DISORD, V11, P32, DOI 10.1002/mds.870110108; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hansenne M, 2000, NEUROPHYSIOL CLIN, V30, P211, DOI 10.1016/S0987-7053(00)00224-0; HILLYARD SA, 1984, PERCEPT PSYCHOPHYS, V36, P185, DOI 10.3758/BF03202679; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Iijima M, 2000, BEHAV NEUROL, V12, P143, DOI 10.1155/2000/764795; Jiang CH, 2000, PHYSIOL BEHAV, V68, P741, DOI 10.1016/S0031-9384(99)00244-9; JOHNSON R, 1978, ELECTROEN CLIN NEURO, V44, P424, DOI 10.1016/0013-4694(78)90027-5; KARAYANIDIS F, 1995, PSYCHOPHYSIOLOGY, V32, P335, DOI 10.1111/j.1469-8986.1995.tb01216.x; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Katsarou Z, 2004, PERCEPT MOTOR SKILL, V98, P1441, DOI 10.2466/PMS.98.4.1441-1448; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kikuchi A, 2001, J NEUROL SCI, V193, P29, DOI 10.1016/S0022-510X(01)00641-4; Lawrence AD, 1998, TRENDS COGN SCI, V2, P379, DOI 10.1016/S1364-6613(98)01231-5; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Loring DW, 2002, EPILEPSY BEHAV, V3, P539, DOI 10.1016/S1525-5050(02)00558-9; Luck SJ, 2008, BIOL PSYCHIAT, V64, P34, DOI 10.1016/j.biopsych.2008.02.014; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Owen AM, 1998, BRAIN, V121, P949, DOI 10.1093/brain/121.5.949; Owen AM, 2004, NEUROSCIENTIST, V10, P525, DOI 10.1177/1073858404266776; Palmero-Soler E, 2007, PHYS MED BIOL, V52, P1783, DOI 10.1088/0031-9155/52/7/002; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PLAYFORD ED, 1992, ANN NEUROL, V32, P151, DOI 10.1002/ana.410320206; Praamstra P, 1998, BRAIN, V121, P769, DOI 10.1093/brain/121.4.769; PRASHER D, 1991, J NEUROL NEUROSUR PS, V54, P603, DOI 10.1136/jnnp.54.7.603; Raudino F, 1997, Electromyogr Clin Neurophysiol, V37, P409; Rinne JO, 2000, ARCH NEUROL-CHICAGO, V57, P470, DOI 10.1001/archneur.57.4.470; Samuel M, 1997, BRAIN, V120, P963, DOI 10.1093/brain/120.6.963; Sawaki R, 2008, CLIN NEUROPHYSIOL, V119, P1300, DOI 10.1016/j.clinph.2008.01.107; Sawaki R, 2009, J COGNITIVE NEUROSCI, V21, P359, DOI 10.1162/jocn.2008.21022; Seger CA, 2008, NEUROSCI BIOBEHAV R, V32, P265, DOI 10.1016/j.neubiorev.2007.07.010; Sohn YH, 1998, J NEUROL SCI, V158, P83, DOI 10.1016/S0022-510X(98)00102-6; Solis-Vivanco R, 2011, NEUROSCI LETT, V495, P144, DOI 10.1016/j.neulet.2011.03.058; Spencer KM, 2001, PSYCHOPHYSIOLOGY, V38, P343, DOI 10.1111/1469-8986.3820343; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; STAM CJ, 1993, BRAIN, V116, P1139, DOI 10.1093/brain/116.5.1139; STANZIONE P, 1991, ELECTROEN CLIN NEURO, V80, P446, DOI 10.1016/0168-5597(91)90093-D; Stanzione P, 1998, EVOKED POTENTIAL, V108, P80, DOI 10.1016/S0168-5597(97)00070-1; Strobel A, 2008, NEUROIMAGE, V40, P869, DOI 10.1016/j.neuroimage.2007.10.065; Tachibana H, 1997, J NEUROL SCI, V149, P47, DOI 10.1016/S0022-510X(97)05372-0; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Van Den Eeden SK, 2003, AM J EPIDEMIOL, V157, P1015, DOI 10.1093/aje/kwg068; Verleger R, 2005, PSYCHOPHYSIOLOGY, V42, P677, DOI 10.1111/j.1469-8986.2005.354.x; VERLEGER R, 1988, BEHAV BRAIN SCI, V11, P343, DOI 10.1017/S0140525X00058015; Verleger R, 2010, NEUROPSYCHOLOGIA, V48, P467, DOI 10.1016/j.neuropsychologia.2009.10.004; VIEREGGE P, 1994, COGNITIVE BRAIN RES, V2, P117, DOI 10.1016/0926-6410(94)90008-6; Volpe U, 2007, BRAIN RES BULL, V73, P220, DOI 10.1016/j.brainresbull.2007.03.003; Wagner M, 2004, BRAIN TOPOGR, V16, P277; Wang L, 1999, J NEUROL SCI, V164, P139, DOI 10.1016/S0022-510X(99)00060-X; Wang LH, 1999, J NEUROL NEUROSUR PS, V67, P497, DOI 10.1136/jnnp.67.4.497; Wang LH, 2000, NEUROSCI LETT, V282, P133, DOI 10.1016/S0304-3940(00)00886-7; Witt K, 2006, BRAIN RES, V1114, P173, DOI 10.1016/j.brainres.2006.07.055; Wylie SA, 2009, NEUROPSYCHOLOGIA, V47, P1844, DOI 10.1016/j.neuropsychologia.2009.02.025; Wylie SA, 2009, NEUROPSYCHOLOGIA, V47, P145, DOI 10.1016/j.neuropsychologia.2008.08.001; Young DE, 2010, VISION RES, V50, P2495, DOI 10.1016/j.visres.2010.08.029	109	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34239	10.1371/journal.pone.0034239	http://dx.doi.org/10.1371/journal.pone.0034239			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470542	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000081
J	Davis, RE; Rossier, CE; Enfield, KB				Davis, Robert E.; Rossier, Colleen E.; Enfield, Kyle B.			The Impact of Weather on Influenza and Pneumonia Mortality in New York City, 1975-2002: A Retrospective Study	PLOS ONE			English	Article							SYNOPTIC CLIMATOLOGICAL APPROACH; RELATIVE-HUMIDITY; UNITED-STATES; SEASONALITY; VIRUS; TRANSMISSION; TEMPERATURE; SURVIVAL; HOSPITALIZATIONS; POLLUTION	The substantial winter influenza peak in temperate climates has lead to the hypothesis that cold and/or dry air is a causal factor in influenza variability. We examined the relationship between cold and/or dry air and daily influenza and pneumonia mortality in the cold season in the New York metropolitan area from 1975-2002. We conducted a retrospective study relating daily pneumonia and influenza mortality for New York City and surroundings from 1975-2002 to daily air temperature, dew point temperature (a measure of atmospheric humidity), and daily air mass type. We identified high mortality days and periods and employed temporal smoothers and lags to account for the latency period and the time between infection and death. Unpaired t-tests were used to compare high mortality events to non-events and nonparametric bootstrapped regression analysis was used to examine the characteristics of longer mortality episodes. We found a statistically significant (p = 0.003) association between periods of low dew point temperature and above normal pneumonia and influenza mortality 17 days later. The duration (r = 20.61) and severity (r = 20.56) of high mortality episodes was inversely correlated with morning dew point temperature prior to and during the episodes. Weeks in which moist polar air masses were common (air masses characterized by low dew point temperatures) were likewise followed by above normal mortality 17 days later (p = 0.019). This research supports the contention that cold, dry air may be related to influenza mortality and suggests that warning systems could provide enough lead time to be effective in mitigating the effects.	[Davis, Robert E.; Rossier, Colleen E.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Enfield, Kyle B.] Univ Virginia Hlth Syst, Dept Med, Div Pulm & Crit Care, Charlottesville, VA USA	University of Virginia; University of Virginia	Davis, RE (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	red3u@virginia.edu	Davis, Robert/A-9078-2008; Enfield, Kyle/J-1840-2019	Enfield, Kyle/0000-0003-4624-0176				Anderson R N, 1998, Natl Vital Stat Rep, V47, P1; ANESTAD G, 1987, EPIDEMIOL INFECT, V99, P523, DOI 10.1017/S0950268800068023; ASSAAD FA, 1971, B WORLD HEALTH ORGAN, V45, P113; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Crighton EJ, 2004, EPIDEMIOL INFECT, V132, P1167, DOI 10.1017/S0950268804002924; Davis RE, 2004, CLIM RES, V26, P61, DOI 10.3354/cr026061; Denoeud L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000464; Dolney TJ, 2006, ENVIRON RES, V101, P94, DOI 10.1016/j.envres.2005.08.008; Dowell SF, 2004, LANCET INFECT DIS, V4, P704, DOI 10.1016/S1473-3099(04)01177-6; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Eccles R, 2002, ACTA OTO-LARYNGOL, V122, P183, DOI 10.1080/00016480252814207; Fuhrmann C, 2010, GEOGR COMPASS, V4, DOI 10.1111/j.1749-8198.2010.00343.x; Grabowska K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-58; Hall CB, 2007, CLIN INFECT DIS, V45, P353, DOI 10.1086/519433; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; Hondula DM, 2011, THEOR APPL CLIMATOL, V103, P27, DOI 10.1007/s00704-010-0278-7; Kalkstein LS, 2008, B AM METEOROL SOC, V89, P75, DOI 10.1175/BAMS-89-1-75; Knight DB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033697; LeMerre C, 1996, RESP PHYSIOL, V105, P235; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Loosli CG, 1943, P SOC EXP BIOL MED, V53, P205, DOI 10.3181/00379727-53-14251P; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Ma JL, 2011, J THEOR BIOL, V288, P29, DOI 10.1016/j.jtbi.2011.08.003; Michelozzi P, 2006, J EPIDEMIOL COMMUN H, V60, P417, DOI 10.1136/jech.2005.040857; Morabito M, 2006, ENVIRON RES, V102, P52, DOI 10.1016/j.envres.2005.12.007; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; Rainham DGC, 2005, INT J ENVIRON HEAL R, V15, P347, DOI 10.1080/09603120500289119; SCHAFFER FL, 1976, ARCH VIROL, V51, P263, DOI 10.1007/BF01317930; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Sheridan S, 2004, EPIDEMIOLOGY, V15, pS40, DOI 10.1097/00001648-200407000-00090; Sheridan SC, 2003, CLIM RES, V24, P255, DOI 10.3354/cr024255; Sheridan SC, 2002, INT J CLIMATOL, V22, P51, DOI 10.1002/joc.709; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; SPRENGER MJW, 1991, INT J EPIDEMIOL, V20, P1118, DOI 10.1093/ije/20.4.1118; Tamerius J, 2011, ENVIRON HEALTH PERSP, V119, P439, DOI 10.1289/ehp.1002383; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Wilks DS., 2006, STAT METHODS ATMOSPH, V3, P133; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315	45	61	65	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34091	10.1371/journal.pone.0034091	http://dx.doi.org/10.1371/journal.pone.0034091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470518	gold, Green Published			2022-12-27	WOS:000304489000061
J	De Marco, F; Bucaj, E; Foppoli, C; Fiorini, A; Blarzino, C; Filipi, K; Giorgi, A; Schinina, ME; Di Domenico, F; Coccia, R; Butterfield, DA; Perluigi, M				De Marco, Federico; Bucaj, Elona; Foppoli, Cesira; Fiorini, Ada; Blarzino, Carla; Filipi, Kozeta; Giorgi, Alessandra; Schinina, Maria Eugenia; Di Domenico, Fabio; Coccia, Raffaella; Butterfield, D. Allan; Perluigi, Marzia			Oxidative Stress in HPV-Driven Viral Carcinogenesis: Redox Proteomics Analysis of HPV-16 Dysplastic and Neoplastic Tissues	PLOS ONE			English	Article							ROLLING-CIRCLE AMPLIFICATION; HUMAN-PAPILLOMAVIRUS DNA; CERVICAL-CANCER; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MALIGNANT PROGRESSION; PROTEIN OXIDATION; THIOREDOXIN REDUCTASE; UVB IRRADIATION; RETINOIC ACID; CELL-LINES	Genital infection by high risk Human Papillomavirus (HR-HPV), although recognized as the main etio-pathogenetic factor of cervical cancer, is not per se sufficient to induce tumour development. Oxidative stress (OS) represents an interesting and under-explored candidate as a promoting factor in HPV-initiated carcinogenesis. To gain insight into the role of OS in cervical cancer, HPV-16 positive tissues were collected from patients with invasive squamous cervical carcinoma, from patients with High Grade dysplastic HPV lesions and from patients with no clinical evidence of HPV lesions. After virological characterization, modulation of proteins involved in the redox status regulation was investigated. ERp57 and GST were sharply elevated in dysplastic and neoplastic tissues. TrxR2 peaked in dysplastic samples while iNOS was progressively reduced in dysplastic and neoplastic samples. By redox proteomic approach, five proteins were found to have increased levels of carbonyls in dysplastic samples respect to controls namely: cytokeratin 6, actin, cornulin, retinal dehydrogenase and GAPDH. In carcinoma samples the peptidyl-prolyl cis-trans isomerase A, ERp57, serpin B3, Annexin 2 and GAPDH were found less oxidized than in dysplastic tissues. HPV16 neoplastic progression seems associated with increased oxidant environment. In dysplastic tissues the oxidative modification of DNA and proteins involved in cell morphogenesis and terminal differentiation may provide the conditions for the neoplastic progression. Conversely cancer tissues seem to attain an improved control on oxidative damage as shown by the selective reduction of carbonyl adducts on key detoxifying/prosurvival proteins.	[De Marco, Federico; Bucaj, Elona; Blarzino, Carla] Regina Elena Inst Canc Res, Virol Lab, Rome, Italy; [Bucaj, Elona; Fiorini, Ada; Giorgi, Alessandra; Schinina, Maria Eugenia; Di Domenico, Fabio; Coccia, Raffaella; Perluigi, Marzia] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Foppoli, Cesira] CNR Inst Mol Biol & Pathol, Rome, Italy; [Filipi, Kozeta] Inst Publ Hlth, Canc Unit, Dept Epidemiol, Tirana, Albania; [Butterfield, D. Allan] Univ Kentucky, Dept Chem, Ctr Membrane Sci, Lexington, KY 40506 USA; [Butterfield, D. Allan] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); University of Kentucky; University of Kentucky	De Marco, F (corresponding author), Regina Elena Inst Canc Res, Virol Lab, Rome, Italy.	marzia.perluigi@uniroma1.it	Di Domenico, Fabio/AAA-9241-2022; perluigi, marzia/D-3260-2009; De Marco, Federico/H-5160-2018; Foppoli, Cesira/AAL-4119-2021; Di Domenico, Fabio/J-4767-2018	Di Domenico, Fabio/0000-0002-2013-209X; De Marco, Federico/0000-0002-1173-2843; Di Domenico, Fabio/0000-0002-2013-209X; BLARZINO, Carla/0000-0003-4518-0028; FOPPOLI, CESIRA/0000-0001-9170-1336; COCCIA, Raffaella/0000-0001-5161-4094	Italian Ministry of Foreign Affairs DGPCC - Ufficio V; Italian Ministry of Health	Italian Ministry of Foreign Affairs DGPCC - Ufficio V; Italian Ministry of Health(Ministry of Health, Italy)	This work has been partially supported by the Italian Ministry of Foreign Affairs DGPCC - Ufficio V and by The Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arnouk H, 2009, PROTEOM CLIN APPL, V3, P516, DOI 10.1002/prca.200800068; Baak JPA, 2006, J CLIN PATHOL, V59, P1017, DOI 10.1136/jcp.2005.027839; Borutinskaite VV, 2006, ANN NY ACAD SCI, V1091, P346, DOI 10.1196/annals.1378.079; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; Butterfield DA, 2010, FREE RADICAL BIO MED, V48, P136, DOI 10.1016/j.freeradbiomed.2009.10.035; BUTTERFIELD DA, 1997, ADV CELL AGING GERON, V2, P161; Carcopino X, 2012, J MED VIROL, V84, P306, DOI 10.1002/jmv.23190; Catanzaro JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019096; CHAI XY, 1995, J BIOL CHEM, V270, P3900, DOI 10.1074/jbc.270.8.3900; Choi JH, 2002, ANTICANCER RES, V22, P3331; Cicchillitti L, 2009, J PROTEOME RES, V8, P1902, DOI 10.1021/pr800856b; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Contzler R, 2005, J INVEST DERMATOL, V124, P990, DOI 10.1111/j.0022-202X.2005.23694.x; DARR D, 1994, J INVEST DERMATOL, V102, P671, DOI 10.1111/1523-1747.ep12374036; De Marco F, 2007, VIRUS RES, V130, P249, DOI 10.1016/j.virusres.2007.06.018; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Faluhelyi Z, 2004, ANTICANCER RES, V24, P807; Guo GG, 2002, J INTERF CYTOK RES, V22, P555, DOI 10.1089/10799900252982034; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Hensley K, 2000, FREE RADICAL BIO MED, V28, P1456, DOI 10.1016/S0891-5849(00)00252-5; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Lee KA, 2005, GYNECOL ONCOL, V99, P142, DOI 10.1016/j.ygyno.2005.05.039; Lizardi PM, 1998, NAT GENET, V19, P225, DOI 10.1038/898; Lunardi F, 2011, LAB INVEST, V91, P945, DOI 10.1038/labinvest.2011.1; Mai JX, 2000, BBA-PROTEIN STRUCT M, V1477, P215, DOI 10.1016/S0167-4838(99)00274-5; MANOS MM, 1989, CANCER CEL, V7, P209; Maurer HH, 2005, THER DRUG MONIT, V27, P686, DOI 10.1097/01.ftd.0000180224.19384.f0; Mazibrada J, 2008, GYNECOL ONCOL, V108, P112, DOI 10.1016/j.ygyno.2007.08.095; Meissner JD, 1999, J GEN VIROL, V80, P1725, DOI 10.1099/0022-1317-80-7-1725; MINCHEVA A, 1987, MED MICROBIOL IMMUN, V176, P245, DOI 10.1007/bf00190531; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nagao S, 2002, J CLIN MICROBIOL, V40, P863, DOI 10.1128/JCM.40.3.863-867.2002; Nguyen P, 2006, CANCER LETT, V236, P164, DOI 10.1016/j.canlet.2005.04.028; Pappin Darryl J C, 2003, Methods Mol Biol, V211, P211; Perluigi M, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-13; Perluigi M, 2009, J CELL MOL MED, V13, P1809, DOI 10.1111/j.1582-4934.2008.00465.x; Roberts I, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-57; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Schaaij-Visser TBM, 2010, ORAL ONCOL, V46, P123, DOI 10.1016/j.oraloncology.2009.11.012; SCHWARZ E, 1985, NATURE, V314, P111, DOI 10.1038/314111a0; Sharma MC, 2007, CURR PHARM DESIGN, V13, P3568, DOI 10.2174/138161207782794167; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sjo A, 2005, J MEMBRANE BIOL, V203, P21, DOI 10.1007/s00232-004-0728-1; Southern SA, 2001, HUM PATHOL, V32, P1351, DOI 10.1053/hupa.2001.29656; World Medical Association General Assembly, 2004, J Int Bioethique, V15, P124; Xu GYG, 2009, DRUG NEWS PERSPECT, V22, P399, DOI [10.1358/dnp.2009.22.7.1414594, 10.1358/dnp.2009.22.7.1381751]; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	53	50	50	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34366	10.1371/journal.pone.0034366	http://dx.doi.org/10.1371/journal.pone.0034366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470562	Green Published, gold			2022-12-27	WOS:000304489000101
J	Hanoun, M; Eisele, L; Suzuki, M; Greally, JM; Huttmann, A; Aydin, S; Scholtysik, R; Klein-Hitpass, L; Duhrsen, U; Durig, J				Hanoun, Maher; Eisele, Lewin; Suzuki, Masako; Greally, John M.; Huettmann, Andreas; Aydin, Semra; Scholtysik, Rene; Klein-Hitpass, Ludger; Duehrsen, Ulrich; Duerig, Jan			Epigenetic Silencing of the Circadian Clock Gene CRY1 is Associated with an Indolent Clinical Course in Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							CD38 EXPRESSION; PROGNOSTIC MARKER; TUMOR SUPPRESSION; CANCER; CRYPTOCHROME; METHYLATION; RISK; SUBGROUPS; ZAP-70	Disruption of circadian rhythm is believed to play a critical role in cancer development. Cryptochrome 1 (CRY1) is a core component of the mammalian circadian clock and we have previously shown its deregulated expression in a subgroup of patients with chronic lymphocytic leukemia (CLL). Using real-time RT-PCR in a cohort of 76 CLL patients and 35 normal blood donors we now demonstrate that differential CRY1 mRNA expression in high-risk (HR) CD38+/immunoglobulin variable heavy chain gene (IgVH) unmutated patients as compared to low-risk (LR) CD38-/IgVH mutated patients can be attributed to down-modulation of CRY1 in LR CLL cases. Analysis of the DNA methylation profile of the CRY1 promoter in a subgroup of 57 patients revealed that CRY1 expression in LR CLL cells is silenced by aberrant promoter CpG island hypermethylation. The methylation pattern of the CRY1 promoter proved to have high prognostic impact in CLL where aberrant promoter methylation predicted a favourable outcome. CRY1 mRNA transcript levels did not change over time in the majority of patients where sequential samples were available for analysis. We also compared the CRY1 expression in CLL with other lymphoid malignancies and observed epigenetic silencing of CRY1 in a patient with B cell acute lymphoblastic leukemia (B-ALL).	[Hanoun, Maher; Eisele, Lewin; Huettmann, Andreas; Aydin, Semra; Duehrsen, Ulrich; Duerig, Jan] Univ Hosp, Dept Hematol, Essen, Germany; [Scholtysik, Rene; Klein-Hitpass, Ludger] Univ Essen Gesamthsch, Inst Cell Biol, Duisburg, Germany; [Suzuki, Masako; Greally, John M.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA	University of Duisburg Essen; University of Duisburg Essen; Yeshiva University; Albert Einstein College of Medicine	Hanoun, M (corresponding author), Univ Hosp, Dept Hematol, Essen, Germany.	jan.duerig@uk-essen.de	Hüttmann, Andreas/W-6106-2019; Scholtysik, Rene/G-6300-2012; Huettmann, Andreas/AAH-6483-2019; Greally, John/AAF-9540-2019; Suzuki, Masako/ABF-6497-2020; Aydin, Semra/AAT-3053-2021	Hüttmann, Andreas/0000-0003-2230-3873; Greally, John/0000-0001-6069-7960; Suzuki, Masako/0000-0003-0605-9225; 				Boivin DB, 2003, BLOOD, V102, P4143, DOI 10.1182/blood-2003-03-0779; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Davis S, 2001, JNCI-J NATL CANCER I, V93, P1557, DOI 10.1093/jnci/93.20.1557; Durig J, 2002, LEUKEMIA, V16, P30, DOI 10.1038/sj.leu.2402339; Eisele L, 2009, EUR J HAEMATOL, V83, P320, DOI 10.1111/j.1600-0609.2009.01287.x; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gauger MA, 2005, CANCER RES, V65, P6828, DOI 10.1158/0008-5472.CAN-05-1119; Gery S, 2010, CELL CYCLE, V9, P1097, DOI 10.4161/cc.9.6.11046; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Hoffman AE, 2010, CANCER RES, V70, P1459, DOI 10.1158/0008-5472.CAN-09-3798; Hoffman AE, 2009, CANCER RES, V69, P3605, DOI 10.1158/0008-5472.CAN-08-4572; Huttmann A, 2006, LEUKEMIA, V20, P1774, DOI 10.1038/sj.leu.2404363; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Irving L, 2011, EPIGENETICS-US, V6, P300, DOI 10.4161/epi.6.3.14038; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Lewintre EJ, 2009, HAEMATOL-HEMATOL J, V94, P280, DOI 10.3324/haematol.13052; Kay NE, 2007, LEUKEMIA, V21, P1885, DOI 10.1038/sj.leu.2404802; Kuo SJ, 2009, VIRCHOWS ARCH, V454, P467, DOI 10.1007/s00428-009-0761-7; Lee CC, 2006, CANCER CAUSE CONTROL, V17, P525, DOI 10.1007/s10552-005-9003-8; Lee S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010995; Lewintre EJ, 2009, LEUKEMIA LYMPHOMA, V50, P68, DOI 10.1080/10428190802541807; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Olk-Batz C, 2011, BLOOD, V117, P4871, DOI 10.1182/blood-2010-08-298968; Ozturk N, 2009, P NATL ACAD SCI USA, V106, P2841, DOI 10.1073/pnas.0813028106; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sahar S, 2007, CELL CYCLE, V6, P1329, DOI 10.4161/cc.6.11.4295; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sancar A, 2004, J BIOL CHEM, V279, P34079, DOI 10.1074/jbc.R400016200; Schroers R, 2005, LEUKEMIA, V19, P750, DOI 10.1038/sj.leu.2403707; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Sellmann L, 2010, CANCER GENET CYTOGEN, V203, P149, DOI 10.1016/j.cancergencyto.2010.09.002; Shih MC, 2006, MOL CARCINOGEN, V45, P732, DOI 10.1002/mc.20198; Thompson RF, 2009, BIOINFORMATICS, V25, P2164, DOI 10.1093/bioinformatics/btp382; Yang XM, 2009, CHRONOBIOL INT, V26, P1323, DOI 10.3109/07420520903431301; Yang XM, 2009, INTEGR CANCER THER, V8, P309, DOI 10.1177/1534735409352083; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Zhu Y, 2009, CANCER RES, V69, P9315, DOI 10.1158/0008-5472.CAN-09-0648	39	37	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34347	10.1371/journal.pone.0034347	http://dx.doi.org/10.1371/journal.pone.0034347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470559	Green Submitted, Green Published, gold			2022-12-27	WOS:000304489000098
J	Moreira, X; Zas, R; Sampedro, L				Moreira, Xoaquin; Zas, Rafael; Sampedro, Luis			Differential Allocation of Constitutive and Induced Chemical Defenses in Pine Tree Juveniles: A Test of the Optimal Defense Theory	PLOS ONE			English	Article							METHYL JASMONATE; EXTRAFLORAL NECTAR; VOLATILE TERPENE; THEORY PREDICTS; PLANT; HERBIVORY; PATTERNS; INDUCTION; CHEMISTRY; BIOSYNTHESIS	Optimal defense theory (ODT) predicts that the within-plant quantitative allocation of defenses is not random, but driven by the potential relative contribution of particular plant tissues to overall fitness. These predictions have been poorly tested on long-lived woody plants. We explored the allocation of constitutive and methyl-jasmonate (MJ) inducible chemical defenses in six half-sib families of Pinus radiata juveniles. Specifically, we studied the quantitative allocation of resin and polyphenolics (the two major secondary chemicals in pine trees) to tissues with contrasting fitness value (stem phloem, stem xylem and needles) across three parts of the plants (basal, middle and apical upper part), using nitrogen concentration as a proxy of tissue value. Concentration of nitrogen in the phloem, xylem and needles was found to be greater higher up the plant. As predicted by the ODT, the same pattern was found for the concentration of non-volatile resin in the stem. However, in leaf tissues the concentrations of both resin and total phenolics were greater towards the base of the plant. Two weeks after MJ application, the concentrations of nitrogen in the phloem, resin in the stem and total phenolics in the needles increased by roughly 25% compared with the control plants, inducibility was similar across all plant parts, and families differed in the inducibility of resin compounds in the stem. In contrast, no significant changes were observed either for phenolics in the stems, or for resin in the needles after MJ application. Concentration of resin in the phloem was double that in the xylem and MJ-inducible, with inducibility being greater towards the base of the stem. In contrast, resin in the xylem was not MJ-inducible and increased in concentration higher up the plant. The pattern of inducibility by MJ-signaling in juvenile P. radiata is tissue, chemical-defense and plant-part specific, and is genetically variable.	[Moreira, Xoaquin; Zas, Rafael] CSIC, Mision Biol Galicia, Pontevedra, Galicia, Spain; [Sampedro, Luis] Ctr Invest Forestal Lourizan Unidad Asociada Misi, Pontevedra, Galicia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Mision Biologica de Galicia (MBG)	Moreira, X (corresponding author), CSIC, Mision Biol Galicia, Pontevedra, Galicia, Spain.	lsampe@uvigo.es	Moreira, Xoaquín/J-9427-2018; Zas, Rafael/I-5729-2014; Sampedro, Luis/B-7187-2011	Moreira, Xoaquín/0000-0003-0166-838X; Zas, Rafael/0000-0001-6563-2461; Sampedro, Luis/0000-0002-3921-2575	Spanish Ministry of Science and Innovation [PSE310000, AGL2010-18724]; Spanish National Institute for Agricultural and Food Research and Technology (INIA)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish National Institute for Agricultural and Food Research and Technology (INIA)(Instituto de Investigacion Agropecuaria (INIA))	This research was supported by PSE310000 and AGL2010-18724 grants from the Spanish Ministry of Science and Innovation. LS and XM received financial support from the Spanish National Institute for Agricultural and Food Research and Technology (INIA) grant program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, EVOLUTION, V53, P1093, DOI [10.2307/2640814, 10.1111/j.1558-5646.1999.tb04524.x]; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Asplund J, 2010, ECOLOGY, V91, P3100, DOI 10.1890/09-1829.1; Barto EK, 2005, OECOLOGIA, V146, P169, DOI 10.1007/s00442-005-0207-0; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; Bega RV, 1978, AGR HDB USDA; Boege K, 2005, OECOLOGIA, V143, P117, DOI 10.1007/s00442-004-1779-9; CHAPIN FS, 1980, ANNU REV ECOL SYST, V11, P233, DOI 10.1146/annurev.es.11.110180.001313; Euler M, 1996, OECOLOGIA, V107, P102, DOI 10.1007/BF00582240; Eyles A, 2009, TREE PHYSIOL, V29, P753, DOI 10.1093/treephys/tpp014; Fritz RS, 2001, OECOLOGIA, V129, P87, DOI 10.1007/s004420100703; Furniss R.L., 1977, MISCELLANEOUS PUBLIC, V1339; Gomez S, 2010, NEW PHYTOL, V188, P835, DOI 10.1111/j.1469-8137.2010.03414.x; Gutbrodt B, 2011, PLANTA, V233, P1199, DOI 10.1007/s00425-011-1371-6; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Holland JN, 2009, J ECOL, V97, P89, DOI 10.1111/j.1365-2745.2008.01446.x; Honkanen T, 1999, FUNCT ECOL, V13, P126, DOI 10.1046/j.1365-2435.1999.00296.x; Huber DPW, 2005, TREE PHYSIOL, V25, P1075, DOI 10.1093/treephys/25.8.1075; Kaitaniemi P, 1996, ECOL MODEL, V88, P227, DOI 10.1016/0304-3800(95)00109-3; Kaplan I, 2008, ECOLOGY, V89, P392, DOI 10.1890/07-0471.1; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; Kessler A, 2009, FUNCT ECOL, V23, P901, DOI 10.1111/j.1365-2435.2009.01639.x; Littell R. C., 2006, SAS SYSTEM MIXED MOD; Martin D, 2002, PLANT PHYSIOL, V129, P1003, DOI 10.1104/pp.011001; Martin DM, 2003, PLANT PHYSIOL, V132, P1586, DOI 10.1104/pp.103.021196; McCall AC, 2010, J ECOL, V98, P985, DOI 10.1111/j.1365-2745.2010.01693.x; MCKEY D, 1974, AM NAT, V108, P305, DOI 10.1086/282909; Miller B, 2005, PLANT PHYSIOL, V137, P369, DOI 10.1104/pp.104.050187; Moreira X, 2011, J ECOL IN PRESS; Moreira X, 2012, TREES-STRUCT FUNCT, V26, P677, DOI 10.1007/s00468-011-0602-6; Moreira X, 2009, ENVIRON EXP BOT, V67, P94, DOI 10.1016/j.envexpbot.2009.05.015; Morris WF, 2006, OIKOS, V112, P102, DOI 10.1111/j.0030-1299.2006.14253.x; Mumm R, 2006, TRENDS PLANT SCI, V11, P351, DOI 10.1016/j.tplants.2006.05.007; Nordlander G, 2011, FOREST ECOL MANAG, V262, P2354, DOI 10.1016/j.foreco.2011.08.033; Nystrand O, 2000, J APPL ECOL, V37, P449, DOI 10.1046/j.1365-2664.2000.00505.x; Ohnmeiss TE, 2000, ECOLOGY, V81, P1765, DOI 10.1890/0012-9658(2000)081[1765:ODTPTO]2.0.CO;2; Pavia H, 2002, ECOLOGY, V83, P891; Radhika V, 2008, PLANTA, V228, P449, DOI 10.1007/s00425-008-0749-6; Rhoades DF, 1979, HERBIVORES THEIR INT, P4; Sampedro L, 2011, J ECOL, V99, P818, DOI 10.1111/j.1365-2745.2011.01814.x; Sampedro L, 2011, PLANT ECOL, V212, P397, DOI 10.1007/s11258-010-9830-x; Sampedro L, 2010, J EXP BOT, V61, P4437, DOI 10.1093/jxb/erq246; Strauss SY, 2004, J ECOL, V92, P132, DOI 10.1111/j.1365-2745.2004.00843.x; Takahashi D, 2010, AM NAT, V175, P538, DOI 10.1086/651594; Taylor RB, 2002, OECOLOGIA, V132, P68, DOI 10.1007/s00442-002-0944-2; Terashima I, 2005, ANN BOT-LONDON, V95, P507, DOI 10.1093/aob/mci049; Tomlin ES, 2000, TREE PHYSIOL, V20, P1087; Toth GB, 2005, ECOLOGY, V86, P612, DOI 10.1890/04-0484; Traw MB, 2008, ECOLOGY, V89, P763, DOI 10.1890/07-0729.1; VanDam NM, 1996, FUNCT ECOL, V10, P128, DOI 10.2307/2390271; Zangerl A. R., 1992, Plant resistance to herbivores and pathogens: ecology, evolution, and genetics., P363; Zangerl AR, 1996, AM NAT, V147, P599, DOI 10.1086/285868	52	49	49	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34006	10.1371/journal.pone.0034006	http://dx.doi.org/10.1371/journal.pone.0034006			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470508	Green Published, gold			2022-12-27	WOS:000304489000052
J	Syphard, AD; Keeley, JE; Bar Massada, A; Brennan, TJ; Radeloff, VC				Syphard, Alexandra D.; Keeley, Jon E.; Bar Massada, Avi; Brennan, Teresa J.; Radeloff, Volker C.			Housing Arrangement and Location Determine the Likelihood of Housing Loss Due to Wildfire	PLOS ONE			English	Article							WILDLAND-URBAN INTERFACE; FIRE; HAZARD	Surging wildfires across the globe are contributing to escalating residential losses and have major social, economic, and ecological consequences. The highest losses in the U. S. occur in southern California, where nearly 1000 homes per year have been destroyed by wildfires since 2000. Wildfire risk reduction efforts focus primarily on fuel reduction and, to a lesser degree, on house characteristics and homeowner responsibility. However, the extent to which land use planning could alleviate wildfire risk has been largely missing from the debate despite large numbers of homes being placed in the most hazardous parts of the landscape. Our goal was to examine how housing location and arrangement affects the likelihood that a home will be lost when a wildfire occurs. We developed an extensive geographic dataset of structure locations, including more than 5500 structures that were destroyed or damaged by wildfire since 2001, and identified the main contributors to property loss in two extensive, fire-prone regions in southern California. The arrangement and location of structures strongly affected their susceptibility to wildfire, with property loss most likely at low to intermediate structure densities and in areas with a history of frequent fire. Rates of structure loss were higher when structures were surrounded by wildland vegetation, but were generally higher in herbaceous fuel types than in higher fuel-volume woody types. Empirically based maps developed using housing pattern and location performed better in distinguishing hazardous from non-hazardous areas than maps based on fuel distribution. The strong importance of housing arrangement and location indicate that land use planning may be a critical tool for reducing fire risk, but it will require reliable delineations of the most hazardous locations.	[Syphard, Alexandra D.] Conservat Biol Inst, La Mesa, CA USA; [Keeley, Jon E.; Brennan, Teresa J.] US Geol Survey, Western Ecol Res Ctr, Three Rivers, CA USA; [Keeley, Jon E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Bar Massada, Avi; Radeloff, Volker C.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA	United States Department of the Interior; United States Geological Survey; University of California System; University of California Los Angeles; University of Wisconsin System; University of Wisconsin Madison	Syphard, AD (corresponding author), Conservat Biol Inst, La Mesa, CA USA.	asyphard@consbio.org	Radeloff, Volker C/B-6124-2016	Radeloff, Volker C/0000-0001-9004-221X; Syphard, Alexandra/0000-0003-3070-0596	United States Geological Survey Multi-Hazards Demonstration Project; United States Forest Service Northern Research Station	United States Geological Survey Multi-Hazards Demonstration Project; United States Forest Service Northern Research Station	Funding was provided by the United States Geological Survey Multi-Hazards Demonstration Project and the United States Forest Service Northern Research Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABT SR, 1989, WATER RESOUR BULL, V25, P881; BARRO S. C., 1987, PSW102 USDA FOR SERV; Beverly JL, 2010, INT J WILDLAND FIRE, V19, P299, DOI 10.1071/WF09071; Blanchi R, 2010, INT J WILDLAND FIRE, V19, P914, DOI 10.1071/WF08175; Boschetti L, 2008, INT J REMOTE SENS, V29, P2433, DOI 10.1080/01431160701874561; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Brooks ML, 2004, BIOSCIENCE, V54, P677, DOI 10.1641/0006-3568(2004)054[0677:EOIAPO]2.0.CO;2; Buckley D, 2005, GEOWORLD, V18, P34; Calfire, 2000, FIN REP FEMA; Cohen JD, 2000, J FOREST, V98, P15; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Franklin J, 2009, MAPPING SPECIES DIST; Gude P, 2008, J FOREST, V106, P198; Haight RG, 2004, J FOREST, V102, P41; Keane RE, 2010, ECOL MODEL, V221, P2, DOI 10.1016/j.ecolmodel.2008.10.022; Keeley JE, 1999, SCIENCE, V284, P1829, DOI 10.1126/science.284.5421.1829; Keeley JE, 2009, J FOREST, V107, P287; Lampin-Maillet C, 2010, J ENVIRON MANAGE, V91, P732, DOI 10.1016/j.jenvman.2009.10.001; Mell WE, 2010, INT J WILDLAND FIRE, V19, P238, DOI 10.1071/WF07131; Military Fire Department of the Federal District (CBMDF) Fire Fighting Techniques, 2009, FIR INSTR MAN, P234; Moritz MA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041735; Murphy K, 2007, R5TP025 USDA PAC SW; National Association of State Foresters, 2003, FIELD GUID ID PRIOR; Parisien MA, 2009, ECOL MONOGR, V79, P127, DOI 10.1890/07-1289.1; Pausas JG, 2009, BIOSCIENCE, V59, P593, DOI 10.1525/bio.2009.59.7.10; Peng R, 2001, ESTIMATION WILDFIRE; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pincetl S, 2008, REAL ESTATE REV, V37, P25; Pyne S, 1996, INTRO WILDLAND FIRE; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Radtke, 1983, GTRPSW067 US DEP AGR, P67; Schoennagel T, 2009, P NATL ACAD SCI USA, V106, P10706, DOI 10.1073/pnas.0900991106; Schwab J, 2005, PLANNING WILDFIRES; Scott J., 2005, RMRSGTR153 USDA FOR; Spyratos V, 2007, P NATL ACAD SCI USA, V104, P14272, DOI 10.1073/pnas.0704488104; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Syphard AD, 2009, CONSERV BIOL, V23, P758, DOI 10.1111/j.1523-1739.2009.01223.x; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Winter G, 2009, FOREST POLICY ECON, V11, P570, DOI 10.1016/j.forpol.2009.07.004; YEE TW, 1991, J VEG SCI, V2, P587, DOI 10.2307/3236170	42	96	97	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33954	10.1371/journal.pone.0033954	http://dx.doi.org/10.1371/journal.pone.0033954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470499	gold, Green Published			2022-12-27	WOS:000304489000046
J	Cote, M; Zheng, YM; Liu, SL				Cote, Marceline; Zheng, Yi-Min; Liu, Shan-Lu			Membrane Fusion and Cell Entry of XMRV Are pH-Independent and Modulated by the Envelope Glycoprotein's Cytoplasmic Tail	PLOS ONE			English	Article							MURINE-LEUKEMIA-VIRUS; CATHEPSIN-L; INFECTIOUS RETROVIRUS; DEPENDENT FUSION; SURFACE RECEPTOR; MEDIATED ENTRY; PROTEIN; ENDOCYTOSIS; MECHANISMS; DOMAIN	Xenotropic murine leukemia virus-related virus (XMRV) is a gammaretrovirus that was originally identified from human prostate cancer patients and subsequently linked to chronic fatigue syndrome. Recent studies showed that XMRV is a recombinant mouse retrovirus; hence, its association with human diseases has become questionable. Here, we demonstrated that XMRV envelope (Env)-mediated pseudoviral infection is not blocked by lysosomotropic agents and cellular protease inhibitors, suggesting that XMRV entry is not pH-dependent. The full length XMRV Env was unable to induce syncytia formation and cell-cell fusion, even in cells overexpressing the viral receptor, XPR1. However, truncation of the C-terminal 21 or 33 amino acid residues in the cytoplasmic tail (CT) of XMRV Env induced substantial membrane fusion, not only in the permissive 293 cells but also in the nonpermissive CHO cells that lack a functional XPR1 receptor. The increased fusion activities of these truncations correlated with their enhanced SU shedding into culture media, suggesting conformational changes in the ectodomain of XMRV Env. Noticeably, further truncation of the CT of XMRV Env proximal to the membrane-spanning domain severely impaired the Env fusogenicity, as well as dramatically decreased the Env incorporations into MoMLV oncoretroviral and HIV-1 lentiviral vectors resulting in greatly reduced viral transductions. Collectively, our studies reveal that XMRV entry does not require a low pH or low pH-dependent host proteases, and that the cytoplasmic tail of XMRV Env critically modulates membrane fusion and cell entry. Our data also imply that additional cellular factors besides XPR1 are likely to be involved in XMRV entry.	[Cote, Marceline; Liu, Shan-Lu] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Zheng, Yi-Min; Liu, Shan-Lu] Univ Missouri, Christopher Bond Life Sci Ctr, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA	McGill University; University of Missouri System; University of Missouri Columbia	Cote, M (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	liushan@missouri.edu	Cote, Marceline/AAA-6386-2021; Liu, Shan-Lu/L-5923-2016	Liu, Shan-Lu/0000-0003-1620-3817	Canadian Institutes of Health Research (CIHR); University of Missouri at Columbia; Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds de la Recherche en Sante du Quebec (FRSQ)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of Missouri at Columbia; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This work was supported by the Canadian Institutes of Health Research (CIHR) and a fund from the University of Missouri at Columbia to S-LL. MC was supported by scholarships from the Natural Sciences and Engineering Research Council of Canada (NSERC) and Fonds de la Recherche en Sante du Quebec (FRSQ). S-LL was a Canada Research Chair in Virology and Gene Therapy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar HC, 2003, J VIROL, V77, P1281, DOI 10.1128/JVI.77.2.1281-1291.2003; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; Bertrand P, 2008, J VIROL, V82, P2555, DOI 10.1128/JVI.01853-07; Bhosle S, 2010, J VIROL, V84, P6288, DOI 10.1128/JVI.00274-10; Brindley MA, 2005, J VIROL, V79, P14482, DOI 10.1128/JVI.79.23.14482-14488.2005; BRODY BA, 1992, J VIROL, V66, P3466, DOI 10.1128/JVI.66.6.3466-3475.1992; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Cingoz O, 2011, J VIROL; Coffin J, 1997, RETROVIRUSES; Cote M, 2011, VIROLOGY; Cote M, 2008, J VIROL, V82, P9023, DOI 10.1128/JVI.00648-08; Cote M, 2008, J VIROL, V82, P2543, DOI 10.1128/JVI.01852-07; Cote M, 2009, J VIROL, V83, P11447, DOI 10.1128/JVI.00748-09; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Dorairaj S, 2007, P NATL ACAD SCI USA, V104, P4943, DOI 10.1073/pnas.0610470104; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Grange MP, 2000, J VIROL, V74, P11734, DOI 10.1128/JVI.74.24.11734-11743.2000; GREEN N, 1981, P NATL ACAD SCI-BIOL, V78, P6023, DOI 10.1073/pnas.78.10.6023; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Januszeski MM, 1997, J VIROL, V71, P3613, DOI 10.1128/JVI.71.5.3613-3619.1997; Jin S, 2005, J VIROL, V79, P14489, DOI 10.1128/JVI.79.23.14489-14497.2005; Kamiyama H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026180; Katen LJ, 2001, J VIROL, V75, P5018, DOI 10.1128/JVI.75.11.5018-5026.2001; Knoper RC, 2009, VIROLOGY, V391, P232, DOI 10.1016/j.virol.2009.06.015; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Kozak CA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-101; Kumar P, 2007, J VIROL, V81, P10506, DOI 10.1128/JVI.02853-06; LABRANCHE CC, 1995, J VIROL, V69, P5217, DOI 10.1128/JVI.69.9.5217-5227.1995; Liu SL, 2003, J VIROL, V77, P2850, DOI 10.1128/JVI.77.5.2850-2858.2003; Lodge R, 1997, EMBO J, V16, P695, DOI 10.1093/emboj/16.4.695; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; MCCLURE MO, 1990, J GEN VIROL, V71, P767, DOI 10.1099/0022-1317-71-4-767; Melikyan GB, 2000, J VIROL, V74, P447, DOI 10.1128/JVI.74.1.447-455.2000; Melikyan GB, 1997, J CELL BIOL, V136, P995, DOI 10.1083/jcb.136.5.995; Miller AD, 1996, J VIROL, V70, P5564, DOI 10.1128/JVI.70.8.5564-5571.1996; MILLER DG, 1993, J VIROL, V67, P5346, DOI 10.1128/JVI.67.9.5346-5352.1993; MILLER DG, 1992, J VIROL, V66, P78, DOI 10.1128/JVI.66.1.78-84.1992; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Mothes W, 2000, CELL, V103, P679, DOI 10.1016/S0092-8674(00)00170-7; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ochsenbauer C, 2000, MOL CELL BIOL, V20, P249, DOI 10.1128/MCB.20.1.249-260.2000; Pager CT, 2005, J VIROL, V79, P12714, DOI 10.1128/JVI.79.20.12714-12720.2005; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Picard-Maureau M, 2003, J VIROL, V77, P4722, DOI 10.1128/JVI.77.8.4722-4730.2003; Quinones-Kochs MI, 2002, J VIROL, V76, P4199, DOI 10.1128/JVI.76.9.4199-4211.2002; REIN A, 1994, J VIROL, V68, P1773, DOI 10.1128/JVI.68.3.1773-1781.1994; RICE NR, 1990, J VIROL, V64, P3770, DOI 10.1128/JVI.64.8.3770-3778.1990; Ross SR, 2002, P NATL ACAD SCI USA, V99, P12386, DOI 10.1073/pnas.192360099; Sakuma T, 2010, HUM GENE THER, V21, P1665, DOI 10.1089/hum.2010.063; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Setty MKHG, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-423; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2011, SCIENCE, V334, P814, DOI 10.1126/science.1213841; Steckbeck JD, 2011, J BIOL CHEM, V286, P27156, DOI 10.1074/jbc.M111.258855; Stieler K, 2010, VIROLOGY, V399, P23, DOI 10.1016/j.virol.2009.12.028; Tailor CS, 1999, P NATL ACAD SCI USA, V96, P927, DOI 10.1073/pnas.96.3.927; Taylor GM, 2003, VIROLOGY, V312, P295, DOI 10.1016/S0042-6822(03)00297-6; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; Xu WQ, 2011, J VIROL, V85, P3498, DOI 10.1128/JVI.02586-10; Yan YH, 2010, J VIROL, V84, P11970, DOI 10.1128/JVI.01549-10; Yang YL, 1999, NAT GENET, V21, P216, DOI 10.1038/6005	66	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33734	10.1371/journal.pone.0033734	http://dx.doi.org/10.1371/journal.pone.0033734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479434	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900036
J	Elloumi, HZ; Maharshak, N; Rao, KN; Kobayashi, T; Ryu, HS; Muhlbauer, M; Li, FL; Jobin, C; Plevy, SE				Elloumi, Houda Z.; Maharshak, Nitsan; Rao, Kavitha N.; Kobayashi, Taku; Ryu, Hyungjin S.; Muehlbauer, Marcus; Li, Fengling; Jobin, Christian; Plevy, Scott E.			A Cell Permeable Peptide Inhibitor of NFAT Inhibits Macrophage Cytokine Expression and Ameliorates Experimental Colitis	PLOS ONE			English	Article							ACTIVATED T-CELLS; FACTOR-ALPHA GENE; INTERLEUKIN-12 P40 PROMOTER; CHRONIC MURINE COLITIS; NITRIC-OXIDE SYNTHASE; CYCLOSPORINE-A; NUCLEAR FACTOR; KAPPA-B; CALCINEURIN INHIBITORS; IFN-GAMMA	Nuclear factor of activated T cells (NFAT) plays a critical role in the development and function of immune and non-immune cells. Although NFAT is a central transcriptional regulator of T cell cytokines, its role in macrophage specific gene expression is less defined. Previous work from our group demonstrated that NFAT regulates Il12b gene expression in macrophages. Here, we further investigate NFAT function in murine macrophages and determined the effects of a cell permeable NFAT inhibitor peptide 11R-VIVIT on experimental colitis in mice. Treatment of bone marrow derived macrophages (BMDMs) with tacrolimus or 11R-VIVIT significantly inhibited LPS and LPS plus IFN-gamma induced IL-12 p40 mRNA and protein expression. IL-12 p70 and IL-23 secretion were also decreased. NFAT nuclear translocation and binding to the IL-12 p40 promoter was reduced by NFAT inhibition. Experiments in BMDMs from IL-10 deficient (Il10(-/-)) mice demonstrate that inhibition of IL-12 expression by 11R-VIVIT was independent of IL-10 expression. To test its therapeutic potential, 11R-VIVIT was administered systemically to Il10(-/-) mice with piroxicam-induced colitis. 11R-VIVIT treated mice demonstrated significant improvement in colitis compared to mice treated with an inactive peptide. Moreover, decreased spontaneous secretion of IL-12 p40 and TNF in supernatants from colon explant cultures was demonstrated. In summary, NFAT, widely recognized for its role in T cell biology, also regulates important innate inflammatory pathways in macrophages. Selective blocking of NFAT via a cell permeable inhibitory peptide is a promising therapeutic strategy for the treatment of inflammatory bowel diseases.	[Elloumi, Houda Z.; Maharshak, Nitsan; Kobayashi, Taku; Ryu, Hyungjin S.; Muehlbauer, Marcus; Li, Fengling; Jobin, Christian; Plevy, Scott E.] Univ N Carolina, Sch Med, Dept Med, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA; [Elloumi, Houda Z.; Maharshak, Nitsan; Kobayashi, Taku; Ryu, Hyungjin S.; Muehlbauer, Marcus; Li, Fengling; Jobin, Christian; Plevy, Scott E.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Rao, Kavitha N.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Elloumi, HZ (corresponding author), Univ N Carolina, Sch Med, Dept Med, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27515 USA.	scott_plevy@med.unc.edu	Kobayashi, Taku/AAO-6437-2020; Maharshak, Nitsan/AAK-5288-2020	Kobayashi, Taku/0000-0002-2073-4234; 	National Institutes of Health [RO1 DK54452]; American Physicians Fellowship for Medicine in Israel; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Physicians Fellowship for Medicine in Israel; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1 DK54452 (to S. E. P.). N. M. is a recipient of a fellowship grant from The American Physicians Fellowship for Medicine in Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAMBURU J, 1995, J EXP MED, V182, P801, DOI 10.1084/jem.182.3.801; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Aste-Amezaga M, 1998, J IMMUNOL, V160, P5936; Bechstein WO, 2000, TRANSPL INT, V13, P313, DOI 10.1111/j.1432-2277.2000.tb01004.x; Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527; Brombacher F, 2003, TRENDS IMMUNOL, V24, P207, DOI 10.1016/S1471-4906(03)00067-X; Choi JM, 2010, P NATL ACAD SCI USA, V107, P18575, DOI 10.1073/pnas.1000400107; Conboy IM, 1999, P NATL ACAD SCI USA, V96, P6324, DOI 10.1073/pnas.96.11.6324; Costa GL, 2001, J IMMUNOL, V167, P2379, DOI 10.4049/jimmunol.167.4.2379; Dave SH, 2007, J IMMUNOL, V179, P7852, DOI 10.4049/jimmunol.179.11.7852; Du SQ, 2009, J IMMUNOL, V182, P7201, DOI 10.4049/jimmunol.0801772; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; Granucci F, 2009, CELL CYCLE, V8, P3816, DOI 10.4161/cc.8.23.9998; Hamalainen M, 2002, EUR J PHARMACOL, V448, P239, DOI 10.1016/S0014-2999(02)01947-7; Hamalainen M, 2009, INT IMMUNOPHARMACOL, V9, P159, DOI 10.1016/j.intimp.2008.07.012; Han JH, 2005, NAT IMMUNOL, V6, P1198, DOI 10.1038/ni1274; Hegazi RAF, 2005, J EXP MED, V202, P1703, DOI 10.1084/jem.20051047; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; Honda K, 2005, INFLAMM BOWEL DIS, V11, P1044, DOI 10.1097/01.MIB.0000191611.05466.1f; Hong K, 1999, J IMMUNOL, V162, P7480; Jeffrey KL, 2006, NAT IMMUNOL, V7, P274, DOI 10.1038/ni1310; Jennings C, 2009, INNATE IMMUN-LONDON, V15, P109, DOI 10.1177/1753425908100928; KAHAN BD, 1989, NEW ENGL J MED, V321, P1725; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; Kim Y, 2004, BIOCHEM BIOPH RES CO, V314, P695, DOI 10.1016/j.bbrc.2003.12.153; Kitahara K, 2007, CURR OPIN RHEUMATOL, V19, P238, DOI 10.1097/BOR.0b013e328099af80; Kuriyama M, 2006, CHEM BIOL DRUG DES, V67, P238, DOI 10.1111/j.1747-0285.2006.00360.x; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Ma W, 2007, J BIOL CHEM, V282, P13351, DOI 10.1074/jbc.M611522200; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Minematsu H, 2007, ANN NY ACAD SCI, V1117, P143, DOI 10.1196/annals.1402.026; Miskin JE, 2000, J VIROL, V74, P9412, DOI 10.1128/JVI.74.20.9412-9420.2000; Monticelli S, 2004, J BIOL CHEM, V279, P36210, DOI 10.1074/jbc.M406354200; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Nagamoto-Combs K, 2010, J NEUROSCI, V30, P9641, DOI 10.1523/JNEUROSCI.0828-10.2010; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Olyaei A J, 2001, Curr Opin Crit Care, V7, P384, DOI 10.1097/00075198-200112000-00003; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; Porter CM, 2002, J IMMUNOL, V168, P4936, DOI 10.4049/jimmunol.168.10.4936; Rogers Arlin B., 2009, V511, P267, DOI 10.1007/978-1-59745-447-6_11; Schroeder JT, 2002, J ALLERGY CLIN IMMUN, V109, P507, DOI 10.1067/mai.2002.122460; Seminario MC, 2001, J ALLERGY CLIN IMMUN, V107, P143, DOI 10.1067/mai.2001.111931; Shapiro R, 1995, CLIN TRANSPL, P199; Shen Z, 2009, MED RES REV, V29, P742, DOI 10.1002/med.20152; Sitara D, 2010, IMMUNOL REV, V233, P286, DOI 10.1111/j.0105-2896.2009.00849.x; Testa G, 1997, Clin Liver Dis, V1, P417, DOI 10.1016/S1089-3261(05)70278-6; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tozawa K, 2003, J GASTROEN HEPATOL, V18, P578, DOI 10.1046/j.1440-1746.2003.03024.x; Trinchieri G, 1997, CURR OPIN IMMUNOL, V9, P17, DOI 10.1016/S0952-7915(97)80154-9; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weigmann B, 2008, J EXP MED, V205, P2099, DOI 10.1084/jem.20072484; Winslow MM, 2006, IMMUNITY, V24, P141, DOI 10.1016/j.immuni.2005.12.013; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; XIE QW, 1993, J EXP MED, V177, P1779, DOI 10.1084/jem.177.6.1779; Xiong HB, 2003, J BIOL CHEM, V278, P2271, DOI 10.1074/jbc.M209583200; Xiong HB, 2004, J BIOL CHEM, V279, P10776, DOI 10.1074/jbc.M313416200; Yarilina A, 2011, P NATL ACAD SCI USA, V108, P1573, DOI 10.1073/pnas.1010030108; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhu C, 2003, J BIOL CHEM, V278, P39372, DOI 10.1074/jbc.M306441200; Zhu C, 2001, J BIOL CHEM, V276, P18519, DOI 10.1074/jbc.M100440200	67	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34172	10.1371/journal.pone.0034172	http://dx.doi.org/10.1371/journal.pone.0034172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479554	Green Published, gold, Green Accepted			2022-12-27	WOS:000303894900066
J	Strimbu, CE; Fredrickson-Hemsing, L; Bozovic, D				Strimbu, Clark Elliott; Fredrickson-Hemsing, Lea; Bozovic, Dolores			Coupling and Elastic Loading Affect the Active Response by the Inner Ear Hair Cell Bundles	PLOS ONE			English	Article							OTOLITHIC-MEMBRANE; BULLFROG SACCULUS; MECHANICAL AMPLIFICATION; SPONTANEOUS OSCILLATIONS; COCHLEAR AMPLIFIER; TRANSDUCTION; SENSITIVITY; MOVEMENTS; MOTILITY; MOTION	Active hair bundle motility has been proposed to underlie the amplification mechanism in the auditory endorgans of nonmammals and in the vestibular systems of all vertebrates, and to constitute a crucial component of cochlear amplification in mammals. We used semi-intact in vitro preparations of the bullfrog sacculus to study the effects of elastic mechanical loading on both natively coupled and freely oscillating hair bundles. For the latter, we attached glass fibers of different stiffness to the stereocilia and observed the induced changes in the spontaneous bundle movement. When driven with sinusoidal deflections, hair bundles displayed phase-locked response indicative of an Arnold Tongue, with the frequency selectivity highest at low amplitudes and decreasing under stronger stimulation. A striking broadening of the mode-locked response was seen with increasing stiffness of the load, until approximate impedance matching, where the phase-locked response remained flat over the physiological range of frequencies. When the otolithic membrane was left intact atop the preparation, the natural loading of the bundles likewise decreased their frequency selectivity with respect to that observed in freely oscillating bundles. To probe for signatures of the active process under natural loading and coupling conditions, we applied transient mechanical stimuli to the otolithic membrane. Following the pulses, the underlying bundles displayed active movement in the opposite direction, analogous to the twitches observed in individual cells. Tracking features in the otolithic membrane indicated that it moved in phase with the bundles. Hence, synchronous active motility evoked in the system of coupled hair bundles by external input is sufficient to displace large overlying structures.	[Strimbu, Clark Elliott; Fredrickson-Hemsing, Lea; Bozovic, Dolores] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90024 USA; [Bozovic, Dolores] Univ Calif Los Angeles, Calif NanoSystems Inst, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Strimbu, CE (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90024 USA.	bozovic@physics.ucla.edu			NSF [0920694]; NIH [1R01DC011380]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011380] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NSF under Grant 0920694 and NIH under 1R01DC011380. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold V.I., 1988, GRUNDLEHREN MATH WIS; Ashmore J, 2010, HEARING RES, V266, P1, DOI 10.1016/j.heares.2010.05.001; Barral J, 2010, P NATL ACAD SCI USA, V107, P8079, DOI 10.1073/pnas.0913657107; Benser ME, 1996, J NEUROSCI, V16, P5629; BENSER ME, 1993, HEARING RES, V68, P243, DOI 10.1016/0378-5955(93)90128-N; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; Camalet S, 2000, P NATL ACAD SCI USA, V97, P3183, DOI 10.1073/pnas.97.7.3183; Cheung ELM, 2006, BIOPHYS J, V90, P124, DOI 10.1529/biophysj.105.061226; Choe Y, 1998, P NATL ACAD SCI USA, V95, P15321, DOI 10.1073/pnas.95.26.15321; CRAWFORD AC, 1985, J PHYSIOL-LONDON, V364, P359, DOI 10.1113/jphysiol.1985.sp015750; Dierkes K, 2008, P NATL ACAD SCI USA, V105, P18669, DOI 10.1073/pnas.0805752105; Eatock RA, 2000, ANNU REV NEUROSCI, V23, P285, DOI 10.1146/annurev.neuro.23.1.285; Eguiluz VM, 2000, PHYS REV LETT, V84, P5232, DOI 10.1103/PhysRevLett.84.5232; Freeman DM, 2003, HEARING RES, V180, P11, DOI 10.1016/S0378-5955(03)00072-8; Glass L., 1988, CLOCKS CHAOS RHYTHMS; HILLMAN DE, 1971, SCIENCE, V174, P416, DOI 10.1126/science.174.4007.416; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; Hudspeth AJ, 2010, J NEUROPHYSIOL, V104, P1219, DOI 10.1152/jn.00437.2010; KACHAR B, 1990, HEARING RES, V45, P179, DOI 10.1016/0378-5955(90)90119-A; Kandel E. R., 2000, PRINCIPLES NEURAL SC, V4, P590; Kennedy HJ, 2006, J NEUROSCI, V26, P2757, DOI 10.1523/JNEUROSCI.3808-05.2006; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; LEWIS ER, 1988, BIOPHYS J, V53, P441, DOI 10.1016/S0006-3495(88)83120-5; LEWIS ER, 1982, SCIENCE, V215, P1641, DOI 10.1126/science.6978525; Manley GA, 2001, J NEUROPHYSIOL, V86, P541, DOI 10.1152/jn.2001.86.2.541; Martin P, 1999, P NATL ACAD SCI USA, V96, P14306, DOI 10.1073/pnas.96.25.14306; Martin P, 2003, J NEUROSCI, V23, P4533; Martin P, 2001, P NATL ACAD SCI USA, V98, P14386, DOI 10.1073/pnas.251530498; MIROLLO RE, 1990, J STAT PHYS, V60, P245, DOI 10.1007/BF01013676; Nadrowski B, 2004, P NATL ACAD SCI USA, V101, P12195, DOI 10.1073/pnas.0403020101; NARINS PM, 1984, J ACOUST SOC AM, V76, P1384, DOI 10.1121/1.391455; Rabbitt RD, 2010, P NATL ACAD SCI USA, V107, P3864, DOI 10.1073/pnas.0906765107; Ramunno-Johnson D, 2009, BIOPHYS J, V96, P1159, DOI 10.1016/j.bpj.2008.09.060; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Roongthumskul Y, 2011, BIOPHYS J, V101, P603, DOI 10.1016/j.bpj.2011.06.027; Strimbu C, 2011, PROGR AUDITORY BIOME, P133; Strimbu CE, 2010, HEARING RES, V265, P38, DOI 10.1016/j.heares.2010.03.001; Strimbu CE, 2009, HEARING RES, V256, P58, DOI 10.1016/j.heares.2009.06.015; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tinevez JY, 2007, BIOPHYS J, V93, P4053, DOI 10.1529/biophysj.107.108498; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917	42	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33862	10.1371/journal.pone.0033862	http://dx.doi.org/10.1371/journal.pone.0033862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479461	gold, Green Published, Green Submitted			2022-12-27	WOS:000303894900043
J	Ahmad, J; Niazi, U; Mansoor, S; Siddique, U; Bibby, J				Ahmad, Jamil; Niazi, Umar; Mansoor, Sajid; Siddique, Umair; Bibby, Jaclyn			Formal Modeling and Analysis of the MAL-Associated Biological Regulatory Network: Insight into Cerebral Malaria	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; LOGICAL ANALYSIS; SIGNAL-TRANSDUCTION; DYNAMICAL BEHAVIOR; TYROSINE KINASE; FEEDBACK LOOPS; PARASITEMIA; CHILDREN; IMMUNITY; DISEASE	The discrete modeling formalism of Rene Thomas is a well known approach for the modeling and analysis of Biological Regulatory Networks (BRNs). This formalism uses a set of parameters which reflect the dynamics of the BRN under study. These parameters are initially unknown but may be deduced from the appropriately chosen observed dynamics of a BRN. The discrete model can be further enriched by using the model checking tool HyTech along with delay parameters. This paves the way to accurately analyse a BRN and to make predictions about critical trajectories which lead to a normal or diseased response. In this paper, we apply the formal discrete and hybrid (discrete and continuous) modeling approaches to characterize behavior of the BRN associated with MyD88-adapter-like (MAL) - a key protein involved with innate immune response to infections. In order to demonstrate the practical effectiveness of our current work, different trajectories and corresponding conditions that may lead to the development of cerebral malaria (CM) are identified. Our results suggest that the system converges towards hyperinflammation if Bruton's tyrosine kinase (BTK) remains constitutively active along with pre-existing high cytokine levels which may play an important role in CM pathogenesis.	[Ahmad, Jamil; Niazi, Umar; Siddique, Umair] Natl Univ Sci & Technol, RCMS, Islamabad, Pakistan; [Mansoor, Sajid] Natl Univ Sci & Technol, NUST Ctr Virol & Immunol, Islamabad, Pakistan; [Bibby, Jaclyn] Univ Liverpool, Dept Struct & Chem Biol, Liverpool L69 3BX, Merseyside, England	National University of Sciences & Technology - Pakistan; National University of Sciences & Technology - Pakistan; University of Liverpool	Ahmad, J (corresponding author), Natl Univ Sci & Technol, RCMS, Islamabad, Pakistan.	dr.ahmad.jamil@gmail.com	Ahmad, Jamil/AAF-5499-2021	Ahmad, Jamil/0000-0001-6618-6811; Niazi, Umar/0000-0001-7176-8883; Siddique, Umair/0000-0001-6871-5289	research grants from Higher Education Commission of Pakistan [20-1464/RD/09/5252]; COMSTECH-TWAS [09-047RG/ITC/AS_C]	research grants from Higher Education Commission of Pakistan; COMSTECH-TWAS	This work was supported by research grants from Higher Education Commission of Pakistan (Grant No. 20-1464/R&D/09/5252) and COMSTECH-TWAS (Grant No. 09-047RG/ITC/AS_C) (Standing Committee on Scientific and Technological Cooperation (COMSTECH) and The Academy of Sciences for the Developing World (TWAS)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeliade M, 2004, ELECT NOTES THEOR CO; Ahmad J, 2009, THESIS ECOLE CENTRAL; Ahmad J, 2009, BIOSYSTEMS, V98, P149, DOI 10.1016/j.biosystems.2009.05.002; Ahmad Jamil, 2008, Int J Bioinform Res Appl, V4, P240, DOI 10.1504/IJBRA.2008.019573; Ahmad Jamil, 2006, ComPlexUs, V3, P231, DOI 10.1159/000110010; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; ALUR R, 1994, THEOR COMPUT SCI, V126, P183, DOI 10.1016/0304-3975(94)90010-8; Amante FH, 2010, J IMMUNOL, V185, P3632, DOI 10.4049/jimmunol.1000944; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bernot G, 2007, ELECTRON NOTES THEOR, V180, P3, DOI 10.1016/j.entcs.2004.01.038; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; Bottius E, 1996, T ROY SOC TROP MED H, V90, P15, DOI 10.1016/S0035-9203(96)90463-0; Calder M., 2005, P COMP METH SYST BIO, P179; Clark IA, 1999, PARASITOL TODAY, V15, P458, DOI 10.1016/S0169-4758(99)01535-5; Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002; Crookston BT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-39; Demongeot L, 2000, CR ACAD SCI III-VIE, V323, P69, DOI 10.1016/S0764-4469(00)00112-8; Ellson J, 2002, LECT NOTES COMPUT SC, V2265, P483; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Franklin BS, 2011, P NATL ACAD SCI USA, V108, P3689, DOI 10.1073/pnas.1015406108; Gonzalez AG, 2006, BIOSYSTEMS, V84, P91, DOI 10.1016/j.biosystems.2005.10.003; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hamann L, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-65; Heemels W.P.M.H., 2009, HDB HYBRID SYSTEMS C, P3; Henzinger T., 1997, SOFTW TOOLS TECHNOL, V1, P110, DOI [DOI 10.1007/S100090050008, 10.1007/s100090050008]; Henzinger TA, 1996, IEEE S LOG, P278, DOI 10.1109/LICS.1996.561342; Hirayama Kenji, 2002, Korean Journal of Parasitology, V40, P165, DOI 10.3347/kjp.2002.40.4.165; Honigberg LA, 2010, P NATL ACAD SCI USA, V107, P13075, DOI 10.1073/pnas.1004594107; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Klucinski Piotr, 2005, Przegl Epidemiol, V59, P695; Koutsofios E, 1993, DRAWING GRAPHS DOT; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Loiarro M, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/674363; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Nebl T, 2005, PARASITOLOGY, V130, pS45, DOI 10.1017/S0031182005008152; Niazi UHK, 2011, J RECEPT SIG TRANSD, V31, P53, DOI 10.3109/10799893.2010.512014; Njama-Meya D, 2004, TROP MED INT HEALTH, V9, P862, DOI 10.1111/j.1365-3156.2004.01277.x; O'Neill LAJ, 2000, IMMUNOL TODAY, V21, P206, DOI 10.1016/S0167-5699(00)01611-X; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Praetorius F, 1999, DEUT MED WOCHENSCHR, V124, P998, DOI 10.1055/s-2007-1024464; Priami C, 2009, COMMUN ACM, V52, P80, DOI 10.1145/1506409.1506427; Ramasawmy R, 2009, J INFECT DIS, V199, P1838, DOI 10.1086/599212; Serhan CN, 2010, FUNDAMENTALS INAMMAT; Siebert H, 2006, LECT NOTES COMPUT SC, V4210, P169; SMITH T, 1993, ACTA TROP, V54, P55, DOI 10.1016/0001-706X(93)90068-M; SNOUSSI E, 1993, B MATH BIOL, V55, P973, DOI 10.1016/S0092-8240(05)80199-5; THIEFFRY D, 1995, B MATH BIOL, V57, P277, DOI 10.1016/0092-8240(94)00037-D; Thomas R, 1998, INT J DEV BIOL, V42, P479; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; THOMAS R, 1978, J THEOR BIOL, V73, P631, DOI 10.1016/0022-5193(78)90127-3; THOMAS R, 1973, J THEOR BIOL, V42, P563, DOI 10.1016/0022-5193(73)90247-6; THOMAS R, 1991, J THEOR BIOL, V153, P1, DOI 10.1016/S0022-5193(05)80350-9; Thomas R, 2001, CHAOS, V11, P180, DOI 10.1063/1.1349893; THOMAS R, 1976, EUR J BIOCHEM, V71, P211, DOI 10.1111/j.1432-1033.1976.tb11108.x; Thomas R., 1990, BIOL FEEDBACK; Thomas R, 1981, SPRINGER SERIES SYNE, V9, P180; Thomas R, 1979, LECT NOTES BIOMATH, V29, P507, DOI DOI 10.1007/978-3-642-49321-8; Thomas R, 2001, CHAOS, V11, P65; Tsujimoto H, 2008, SHOCK, V29, P315, DOI [10.1097/shk.0b013e318157ee55, 10.1097/SHK.0b013e318157ee55]; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zhu JK, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/781235	65	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33532	10.1371/journal.pone.0033532	http://dx.doi.org/10.1371/journal.pone.0033532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479409	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100054
J	Higginson, DM; Henn, KRH				Higginson, Dawn M.; Henn, Kali R. H.			Effects of Sperm Conjugation and Dissociation on Sperm Viability In Vitro	PLOS ONE			English	Article							COOPERATION; COMPETITION; SPERMATOZOA	Sperm conjugation is an unusual variation in sperm behavior where two or more spermatozoa physically unite for motility or transport through the female reproductive tract. Conjugation has frequently been interpreted as sperm cooperation, including reproductive altruism, with some sperm advancing their siblings toward the site of fertilization while ostensibly forfeiting their own ability to fertilize through damage incurred during conjugate break-up. Conversely, conjugation has been proposed to protect sensitive regions of spermatozoa from spermicidal conditions within the female reproductive tract. We investigated the possibility of dissociation-induced sperm mortality and tested for a protective function of conjugation using the paired sperm of the diving beetle, Graphoderus liberus. Sperm conjugates were mechanically dissociated and exposed to potentially damaging tissue extracts of the female reproductive tract and somatic tissue. We found no significant difference in viability between paired sperm and dissociated, single sperm. The results further indicate that the reproductive tract of female G. liberus might not be spermicidal and conjugation is not protective of sperm viability when damaging conditions do exist. Our results support the interpretation that, at least in some taxa, sperm conjugation is neither protective nor damaging to sperm viability.	[Higginson, Dawn M.; Henn, Kali R. H.] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Higginson, DM (corresponding author), Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA.	dmhigginson@email.arizona.edu			National Science Foundation [DDIG-0910049]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Science Foundation (DDIG-0910049 to D.M.H). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEDFORD JM, 1984, PROC R SOC SER B-BIO, V221, P221, DOI 10.1098/rspb.1984.0031; BIRKHEAD TR, 1993, J THEOR BIOL, V161, P51, DOI 10.1006/jtbi.1993.1039; Breed WG, 2004, J MORPHOL, V261, P52, DOI 10.1002/jmor.10228; DALLAI R, 1985, TISSUE CELL, V17, P561, DOI 10.1016/0040-8166(85)90032-1; DALLAI R, 1987, B ZOOL, V54, P301; FAWCETT DW, 1975, DEV BIOL, V44, P394, DOI 10.1016/0012-1606(75)90411-X; Firman RC, 2011, J EVOLUTION BIOL, V24, P856, DOI 10.1111/j.1420-9101.2010.02219.x; Firman RC, 2009, J EVOLUTION BIOL, V22, P2505, DOI 10.1111/j.1420-9101.2009.01867.x; Fisher HS, 2010, NATURE, V463, P801, DOI 10.1038/nature08736; FRIEND DS, 1974, J CELL BIOL, V63, P641, DOI 10.1083/jcb.63.2.641; Higginson DM, 2011, BIOL REV, V86, P249, DOI 10.1111/j.1469-185X.2010.00147.x; Higginson DM, 2012, EVOLUTION IN PRESS; Higginson DM, 2012, P NATL ACAD IN PRESS; Holman L, 2006, J EVOLUTION BIOL, V19, P1660, DOI 10.1111/j.1420-9101.2006.01112.x; Holman L, 2008, CURR BIOL, V18, P292, DOI 10.1016/j.cub.2008.01.048; Immler S, 2008, REPRODUCTION, V135, P275, DOI 10.1530/REP-07-0482; Immler S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000170; Keller L, 2002, TRENDS ECOL EVOL, V17, P113, DOI 10.1016/S0169-5347(01)02420-X; Miller KB, 2001, INSECT SYST EVOL, V32, P45, DOI 10.1163/187631201X00029; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; Moore T, 2002, TRENDS ECOL EVOL, V17, P112, DOI 10.1016/S0169-5347(01)02425-9; PHILLIPS DM, 1970, J CELL BIOL, V44, P243, DOI 10.1083/jcb.44.2.243; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P247, DOI 10.1016/B978-0-12-372568-4.00007-0; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; Pizzari T, 2008, PLOS BIOL, V6, P925, DOI 10.1371/journal.pbio.0060130; RODGER JC, 1982, J REPROD FERTIL, V64, P171; Sivinsky J., 1984, SPERM COMPETITION EV, P86; Yang YP, 2008, PHYS REV A, V78, DOI [10.1103/PhysRevE.82.031904, 10.1103/PhysRevA.78.059902, 10.1103/PhysRevE.78.061903]	28	2	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34190	10.1371/journal.pone.0034190	http://dx.doi.org/10.1371/journal.pone.0034190			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479558	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100134
J	Khairallah, RJ; Kim, J; O'Shea, KM; O'Connell, KA; Brown, BH; Galvao, T; Daneault, C; Des Rosiers, C; Polster, BM; Hoppel, CL; Stanley, WC				Khairallah, Ramzi J.; Kim, Junhwan; O'Shea, Karen M.; O'Connell, Kelly A.; Brown, Bethany H.; Galvao, Tatiana; Daneault, Caroline; Des Rosiers, Christine; Polster, Brian M.; Hoppel, Charles L.; Stanley, William C.			Improved Mitochondrial Function with Diet-Induced Increase in Either Docosahexaenoic Acid or Arachidonic Acid in Membrane Phospholipids	PLOS ONE			English	Article							EICOSAPENTAENOIC ACID; FISH-OIL; PERMEABILITY TRANSITION; FATTY-ACIDS; CARDIOLIPIN; CHROMATOGRAPHY; ACTIVATION; LIPIDS; N-3	Mitochondria can depolarize and trigger cell death through the opening of the mitochondrial permeability transition pore (MPTP). We recently showed that an increase in the long chain n3 polyunsaturated fatty acids (PUFA) docosahexaenoic acid (DHA; 22:6n3) and depletion of the n6 PUFA arachidonic acid (ARA; 20:4n6) in mitochondrial membranes is associated with a greater Ca2+ load required to induce MPTP opening. Here we manipulated mitochondrial phospholipid composition by supplementing the diet with DHA, ARA or combined DHA+ARA in rats for 10 weeks. There were no effects on cardiac function, or respiration of isolated mitochondria. Analysis of mitochondrial phospholipids showed DHA supplementation increased DHA and displaced ARA in mitochondrial membranes, while supplementation with ARA or DHA+ARA increased ARA and depleted linoleic acid (18:2n6). Phospholipid analysis revealed a similar pattern, particularly in cardiolipin. Tetralinoleoyl cardiolipin was depleted by 80% with ARA or DHA+ARA supplementation, with linoleic acid side chains replaced by ARA. Both the DHA and ARA groups had delayed Ca2+-induced MPTP opening, but the DHA+ARA group was similar to the control diet. In conclusion, alterations in mitochondria membrane phospholipid fatty acid composition caused by dietary DHA or ARA was associated with a greater cumulative Ca2+ load required to induced MPTP opening. Further, high levels of tetralinoleoyl cardiolipin were not essential for normal mitochondrial function if replaced with very-long chain n3 or n6 PUFAs.	[Khairallah, Ramzi J.; O'Shea, Karen M.; O'Connell, Kelly A.; Brown, Bethany H.; Galvao, Tatiana; Stanley, William C.] Univ Maryland, Dept Med, Div Cardiol, Baltimore, MD 21201 USA; [Kim, Junhwan; Hoppel, Charles L.] Case Western Reserve Univ, Dept Med & Pharmacol, Cleveland, OH 44106 USA; [Daneault, Caroline; Des Rosiers, Christine] Univ Montreal, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Daneault, Caroline; Des Rosiers, Christine] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Polster, Brian M.] Univ Maryland, Dept Anesthesiol, Baltimore, MD 21201 USA; [Polster, Brian M.] Univ Maryland, Shock Trauma & Anesthesiol Res STAR Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Case Western Reserve University; Universite de Montreal; Universite de Montreal; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Khairallah, RJ (corresponding author), Univ Maryland, Dept Med, Div Cardiol, Baltimore, MD 21201 USA.	wstanley@medicine.umaryland.edu	Rosiers, Christine Des/O-6285-2014	Polster, Brian/0000-0003-2571-7510; Kim, Junhwan/0000-0002-1162-8616	National Institutes of Health [HL074237, HL091307, HL101434]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL091307, P01HL074237, P20HL101434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants HL074237, HL091307 and HL101434. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEYWARDENA MY, 1991, AM J CLIN NUTR, V53, pS1039, DOI 10.1093/ajcn/53.4.1039S; ABEYWARDENA MY, 1991, AM J PHYSIOL, V260, pH379, DOI 10.1152/ajpheart.1991.260.2.H379; CHRISTIANSEN K, 1975, ANAL BIOCHEM, V66, P93, DOI 10.1016/0003-2697(75)90728-9; Duda MK, 2009, CARDIOVASC RES, V81, P319, DOI 10.1093/cvr/cvn310; Farina EK, 2011, J NUTR, V141, P1146, DOI 10.3945/jn.110.133728; Gelinas R, 2011, AM J PHYSIOL-HEART C, V301, pH813, DOI 10.1152/ajpheart.01275.2010; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; INGALLS ST, 1993, J CHROMATOGR-BIOMED, V619, P9, DOI 10.1016/0378-4347(93)80441-6; Kawabata T, 2011, PROSTAG LEUKOTR ESS, V84, P131, DOI 10.1016/j.plefa.2011.01.001; Khairallah RJ, 2010, J PHARMACOL EXP THER, V335, P155, DOI 10.1124/jpet.110.170605; Khairallah RJ, 2010, BBA-BIOENERGETICS, V1797, P1555, DOI 10.1016/j.bbabio.2010.05.007; Kinsey GR, 2007, J PHARMACOL EXP THER, V321, P707, DOI 10.1124/jpet.107.119545; MCMILLIN JB, 1992, AM J PHYSIOL, V263, pH1479, DOI 10.1152/ajpheart.1992.263.5.H1479; Minkler PE, 2010, J LIPID RES, V51, P856, DOI 10.1194/jlr.D002857; Nodari S, 2011, J AM COLL CARDIOL, V57, P870, DOI 10.1016/j.jacc.2010.11.017; O'Shea KM, 2009, J MOL CELL CARDIOL, V47, P819, DOI 10.1016/j.yjmcc.2009.08.014; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Pepe S, 1999, AM J PHYSIOL-HEART C, V276, pH149, DOI 10.1152/ajpheart.1999.276.1.H149; Pompeia C, 2003, CELL BIOCHEM FUNCT, V21, P97, DOI 10.1002/cbf.1012; Ricchelli F, 2011, BBA-BIOENERGETICS, V1807, P482, DOI 10.1016/j.bbabio.2011.02.012; Rosca M, 2011, BBA-BIOENERGETICS, V1807, P1373, DOI 10.1016/j.bbabio.2011.02.003; Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schlame M, 2002, ANN NEUROL, V51, P634, DOI 10.1002/ana.10176; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Scorrano L, 2001, J BIOL CHEM, V276, P12035, DOI 10.1074/jbc.M010603200; SEYBERTH HW, 1975, CLIN PHARMACOL THER, V18, P521; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Williams SD, 2002, BIOCHEM J, V362, P23, DOI 10.1042/bj3620023	31	66	68	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34402	10.1371/journal.pone.0034402	http://dx.doi.org/10.1371/journal.pone.0034402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479624	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100155
J	Mogto, CAK; De Serres, G; Fradet, MD; Lebel, G; Toutant, S; Gilca, R; Ouakki, M; Janjua, NZ; Skowronski, DM				Mogto, Christelle Aicha Kom; De Serres, Gaston; Fradet, Monique Douville; Lebel, Germain; Toutant, Steve; Gilca, Rodica; Ouakki, Manale; Janjua, Naveed Zafar; Skowronski, Danuta M.			School Absenteeism As an Adjunct Surveillance Indicator: Experience during the Second Wave of the 2009 H1N1 Pandemic in Quebec, Canada	PLOS ONE			English	Article							INFLUENZA; CLOSURE; OUTBREAK; CHILDREN	Background: A school absenteeism surveillance system was implemented in the province of Quebec, Canada during the second wave of the 2009 H1N1pandemic. This paper compares this surveillance approach with other available indicators. Method: All (3432) elementary and high schools from Quebec were included. Each school was required to report through a web-based system any day where the proportion of students absent for influenza-like illness (ILI) exceeded 10% of current school enrolment. Results: Between October 18 and December 12 2009, 35.6% of all schools met the 10% absenteeism threshold. This proportion was greater in elementary compared to high schools (40% vs 19%) and in smaller compared to larger schools (44% vs 22%). The maximum absenteeism rate was reached the first day of reporting or within the next two days in 55% and 31% of schools respectively. The first reports and subsequent peak in school absenteeism provincially preceded the peak in paediatric hospitalization by two and one weeks, respectively. Trends in school surveillance otherwise mirrored other indicators. Conclusion: During a pandemic, school outbreak surveillance based on a 10% threshold appears insufficient to trigger timely intervention within a given affected school. However, school surveillance appears well-correlated and slightly anticipatory compared to other population indicators. As such, school absenteeism warrants further evaluation as an adjunct surveillance indicator whose overall utility will depend upon specified objectives, and other existing capacity for monitoring and response.	[Mogto, Christelle Aicha Kom; De Serres, Gaston] Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada; [De Serres, Gaston; Fradet, Monique Douville; Lebel, Germain; Toutant, Steve; Gilca, Rodica; Ouakki, Manale] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Janjua, Naveed Zafar; Skowronski, Danuta M.] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Janjua, Naveed Zafar; Skowronski, Danuta M.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada	Laval University; Institut national de sante publique du Quebec (INSPQ); University of British Columbia	Mogto, CAK (corresponding author), Univ Laval, Dept Social & Prevent Med, Quebec City, PQ, Canada.	gaston.deserres@ssss.gouv.qc.ca	Zafar, Naveed/A-2712-2008	Zafar, Naveed/0000-0001-5681-719X				Besculides M, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-105; Cauchemez S, 2010, LANCET INFECT DIS, V10, P294; Centers for Disease Control and Prevention, 2010 2011 INFL SEAS; Douville-Fradet M, 2010, BILAN EPIDEMIOLOGIQU; Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005; Faucher B, 2009, GUIDE PLANIFICATION; Halder N, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-221; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; Johnson AJ, 2008, EMERG INFECT DIS, V14, P1024, DOI 10.3201/eid1407.080096; Lee BY, 2010, J PUBLIC HEALTH MAN, V16, P252, DOI 10.1097/PHH.0b013e3181ce594e; LENAWAY DD, 1995, PUBLIC HEALTH REP, V110, P333; Mikolajczyk RT, 2008, EPIDEMIOL INFECT, V136, P813, DOI 10.1017/S0950268807009181; Mook P, 2007, EUROSURVEILLANCE, V12, P346; PETERSON D, 1979, PUBLIC HEALTH REP, V94, P88; Public Health Agency of Canada, 2009, FLUWATCH DEF 2009 20; Rodriguez CV, 2009, EPIDEMIOLOGY, V20, P787, DOI 10.1097/EDE.0b013e3181b5f3ec; Sadique MZ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-135; Sasaki A, 2009, EMERG INFECT DIS, V15, P1841, DOI 10.3201/eid1511.090798; Schmidt WP, 2010, EUROSURVEILLANCE, V15, P4; Wainer H, 2007, AM SCI, V95, P249, DOI 10.1511/2007.65.249	20	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34084	10.1371/journal.pone.0034084	http://dx.doi.org/10.1371/journal.pone.0034084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479531	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100117
J	Choi, SY; Kim, YS; Seo, YJ; Yang, J; Choi, KS				Choi, Se-Young; Kim, Young-Sun; Seo, Yeong-Ju; Yang, Jehoon; Choi, Kyu-Sil			Gas-Filled Phospholipid Nanoparticles Conjugated with Gadolinium Play a Role as a Potential Theragnostics for MR-Guided HIFU Ablation	PLOS ONE			English	Article							INTENSITY FOCUSED ULTRASOUND; CONTRAST-AGENT; THERMAL ABLATION; MICROBUBBLE; WATER; EFFICIENCY; KIDNEY; TUMORS	To develop a long-circulating theragnostics, meaning therapeutics and diagnostics for MR-guided HIFU ablation, we designed and prepared Gd-C5F12-phospholipid nanobubbles (PLNs) 30-100 nm in diameter. The biochemical and physical characterization of Gd-C5F12-PLNs were performed. Since Gd-C5F12-PLN-50 (Phi = 50 nm) and Gd-C5F12-PLN-100 (Phi = 100 nm) enhanced the hyperthermal effect of HIFU size-and concentration-dependently in a tissue-mimicking phantom, its circulation, distribution, tumor accumulation and tumor ablation were examined in tumor-bearing mice. The plasma-half life of Gd-C5F12-PLNs was longer than 1.5 hrs. Gd-C5F12-PLNs mainly accumulated in the liver and the spleen, suggesting that they are slowly secreted through the hepatobiliary pathway. Monitored by the T1 signal intensity of MR, Gd-C5F12-PLNs accumulated in tumor tissues for 8 hours in mice. HIFU with Gd-C5F12-PLN-100 showed the increased tumor ablation area as compared with HIFU alone. The results suggest that Gd-C5F12-PLNs exhibit a potential theragnostics for MR-guided HIFU ablation.	[Choi, Se-Young; Seo, Yeong-Ju; Yang, Jehoon; Choi, Kyu-Sil] Sungkyunkwan Univ, Sch Med, Mol & Cellular Imaging Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Kim, Young-Sun] Sungkyunkwan Univ, Sch Med, Ctr Imaging Sci, Seoul, South Korea; [Kim, Young-Sun] Sungkyunkwan Univ, Sch Med, Dept Radiol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Choi, SY (corresponding author), Sungkyunkwan Univ, Sch Med, Mol & Cellular Imaging Ctr, Samsung Biomed Res Inst, Seoul, South Korea.	qsil@skku.edu			Ministry for Health, Welfare and Family affairs, Republic of Korea [0920160]	Ministry for Health, Welfare and Family affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family affairs, Republic of Korea (# 0920160) to K-S Choi (http://ncc.re.kr/english/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2011, CHEMOSPHERE, V84, P1175, DOI 10.1016/j.chemosphere.2011.05.054; Anderson JK, 2007, J ENDOUROL, V21, P223, DOI 10.1089/end.2005.1128; BOXENBAUM H, 1984, DRUG METAB REV, V15, P1071, DOI 10.3109/03602538409033558; Bui T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013082; Farny CH, 2010, IEEE T BIO-MED ENG, V57, P175, DOI 10.1109/TBME.2009.2028133; Hanajiri K, 2006, HEPATOL RES, V36, P308, DOI 10.1016/j.hepres.2006.08.013; He W, 2010, CARDIOVASC INTERVENT; Kennedy JE, 2005, NAT REV CANCER, V5, P321, DOI 10.1038/nrc1591; Kennedy JE, 2003, BRIT J RADIOL, V76, P590, DOI 10.1259/bjr/17150274; Leighton TG, 2011, J ACOUST SOC AM, V130, P3333, DOI 10.1121/1.3638132; Ljunggren S, 1997, J COLLOID INTERF SCI, V191, P424, DOI 10.1006/jcis.1997.4961; Luo W, 2007, J ULTRAS MED, V26, P469, DOI 10.7863/jum.2007.26.4.469; Luo W, 2006, ADV THER, V23, P861, DOI 10.1007/BF02850207; Martin DR, 2008, EUR J RADIOL, V66, P220, DOI 10.1016/j.ejrad.2008.01.029; Tachibana Katsuro, 2004, Hum Cell, V17, P7; Takegami K, 2005, ULTRASOUND MED BIOL, V31, P385, DOI 10.1016/j.ultrasmedbio.2004.11.007; Takegami K, 2004, ULTRASOUND MED BIOL, V30, P1419, DOI 10.1016/j.ultrasmedbio.2004.07.016; Tung YS, 2006, ULTRASOUND MED BIOL, V32, P1103, DOI 10.1016/j.ultrasmedbio.2006.04.005; Yang JW, 2003, J PHYS CHEM B, V107, P6139, DOI 10.1021/jp0224113; Yu TH, 2004, UROL RES, V32, P14, DOI 10.1007/s00240-003-0362-x; Yu TH, 2008, WORLD J UROL, V26, P631, DOI 10.1007/s00345-008-0290-z; Zhang P, 2010, ULTRASOUND MED BIOL, V36, P1856, DOI 10.1016/j.ultrasmedbio.2010.07.001; Zhang XH, 2006, LANGMUIR, V22, P5025, DOI 10.1021/la0601814; Zhao Z, 2010, EJSO-EUR J SURG ONC, V36, P1149, DOI 10.1016/j.ejso.2010.09.012	24	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34333	10.1371/journal.pone.0034333	http://dx.doi.org/10.1371/journal.pone.0034333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479602	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400074
J	Millares, P; LaCourse, EJ; Perally, S; Ward, DA; Prescott, MC; Hodgkinson, JE; Brophy, PM; Rees, HH				Millares, Paul; LaCourse, E. James; Perally, Samirah; Ward, Deborah A.; Prescott, Mark C.; Hodgkinson, Jane E.; Brophy, Peter M.; Rees, Huw H.			Proteomic Profiling and Protein Identification by MALDI-TOF Mass Spectrometry in Unsequenced Parasitic Nematodes	PLOS ONE			English	Article							GLUTATHIONE TRANSFERASE; DRUG-RESISTANCE; GENOMES; STATE	Lack of genomic sequence data and the relatively high cost of tandem mass spectrometry have hampered proteomic investigations into helminths, such as resolving the mechanism underpinning globally reported anthelmintic resistance. Whilst detailed mechanisms of resistance remain unknown for the majority of drug-parasite interactions, gene mutations and changes in gene and protein expression are proposed key aspects of resistance. Comparative proteomic analysis of drug-resistant and -susceptible nematodes may reveal protein profiles reflecting drug-related phenotypes. Using the gastrointestinal nematode, Haemonchus contortus as case study, we report the application of freely available expressed sequence tag (EST) datasets to support proteomic studies in unsequenced nematodes. EST datasets were translated to theoretical protein sequences to generate a searchable database. In conjunction with matrix-assisted laser desorption ionisation timeof-flight mass spectrometry (MALDI-TOF-MS), Peptide Mass Fingerprint (PMF) searching of databases enabled a cost-effective protein identification strategy. The effectiveness of this approach was verified in comparison with MS/MS de novo sequencing with searching of the same EST protein database and subsequent searches of the NCBInr protein database using the Basic Local Alignment Search Tool (BLAST) to provide protein annotation. Of 100 proteins from 2-DE gel spots, 62 were identified by MALDI-TOF-MS and PMF searching of the EST database. Twenty randomly selected spots were analysed by electrospray MS/MS and MASCOT Ion Searches of the same database. The resulting sequences were subjected to BLAST searches of the NCBI protein database to provide annotation of the proteins and confirm concordance in protein identity from both approaches. Further confirmation of protein identifications from the MS/MS data were obtained by de novo sequencing of peptides, followed by FASTS algorithm searches of the EST putative protein database. This study demonstrates the cost-effective use of available EST databases and inexpensive, accessible MALDI-TOF MS in conjunction with PMF for reliable protein identification in unsequenced organisms.	[Millares, Paul; Ward, Deborah A.; Prescott, Mark C.; Rees, Huw H.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [LaCourse, E. James] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Perally, Samirah; Hodgkinson, Jane E.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Brophy, Peter M.] Aberystwyth Univ, IBERS, Aberystwyth, Dyfed, Wales	University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Millares, P (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	reeshh@liverpool.ac.uk		LaCourse, James/0000-0001-9261-7136	English Beef and Lamb Executive (EBLEX); Hybu Cig Cymru (HCC); Quality Meat Scotland (QMS); BBSRC	English Beef and Lamb Executive (EBLEX); Hybu Cig Cymru (HCC); Quality Meat Scotland (QMS); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding for this research was provided by a PhD scholarship to PM from the English Beef and Lamb Executive (EBLEX; http://www.eblex.org.uk/),Hybu Cig Cymru (HCC; http://www.hccmpw.org.uk/) and Quality Meat Scotland (QMS; http://www.qmscotland.co.uk/). The authors also thank the BBSRC for funding of equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barrett J, 2000, PARASITOL TODAY, V16, P400, DOI 10.1016/S0169-4758(00)01739-7; Beech R, 2010, MOL BIOCHEM PARASIT, V171, P74, DOI 10.1016/j.molbiopara.2010.02.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chemale G, 2006, PROTEOMICS, V6, P6263, DOI 10.1002/pmic.200600499; Chemale G, 2010, J PROTEOME RES, V9, P4940, DOI 10.1021/pr1000785; Falkner JA, 2007, BIOINFORMATICS, V23, P262, DOI 10.1093/bioinformatics/btl573; Gorg A, 2000, ELECTROPHORESIS, V21, P1037, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1037::AID-ELPS1037>3.0.CO;2-V; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; HUNT DF, 1986, P NATL ACAD SCI USA, V83, P6233, DOI 10.1073/pnas.83.17.6233; Jabbar A, 2006, LIFE SCI, V79, P2413, DOI 10.1016/j.lfs.2006.08.010; James CE, 2009, INT J PARASITOL, V39, P213, DOI 10.1016/j.ijpara.2008.06.009; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; KARAS M, 1988, ANAL CHEM, V60, P2299, DOI 10.1021/ac00171a028; Lottaz C, 2003, BIOINFORMATICS, V19, pII103, DOI 10.1093/bioinformatics/btg1067; Mackey AJ, 2002, MOL CELL PROTEOMICS, V1, P139, DOI 10.1074/mcp.M100004-MCP200; McKellar QA, 2004, TRENDS PARASITOL, V20, P456, DOI 10.1016/j.pt.2004.08.002; Mitreva M, 2007, VET PARASITOL, V148, P31, DOI 10.1016/j.vetpar.2007.05.008; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Parkinson J, 2004, NUCLEIC ACIDS RES, V32, pD427, DOI 10.1093/nar/gkh018; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perry BD, 1999, VET PARASITOL, V84, P145, DOI 10.1016/S0304-4017(99)00040-0; Robinson MW, 2007, INT J PARASITOL, V37, P139, DOI 10.1016/j.ijpara.2006.08.007; Sackett D, 2006, ASSESSING EC COST EN, P1; Schuller DJ, 2005, PROTEINS, V61, P1024, DOI 10.1002/prot.20649; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skuce PJ, 1999, PARASITOLOGY, V118, P297, DOI 10.1017/S0031182098003850; Smith SK, 2009, PARASITE IMMUNOL, V31, P10, DOI 10.1111/j.1365-3024.2008.01067.x; Van Rossum AJ, 2004, INFECT IMMUN, V72, P2780, DOI 10.1128/IAI.72.5.2780-2790.2004; Vizcaino JA, 2009, PROTEOMICS, V9, P4276, DOI 10.1002/pmic.200900402; VORM O, 1994, ANAL CHEM, V66, P3281, DOI 10.1021/ac00091a044; Wasmuth JD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-187; Williamson SM, 2011, J HELMINTHOL, V1, P1; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Yan F, 2009, VET J, P1; Yates JR, 1998, J MASS SPECTROM, V33, P1; Yatsuda AP, 2003, J BIOL CHEM, V278, P16941, DOI 10.1074/jbc.M212453200	38	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33590	10.1371/journal.pone.0033590	http://dx.doi.org/10.1371/journal.pone.0033590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479418	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000304523400026
J	Radicchi, F; Castellano, C				Radicchi, Filippo; Castellano, Claudio			A Reverse Engineering Approach to the Suppression of Citation Biases Reveals Universal Properties of Citation Distributions	PLOS ONE			English	Article							SCIENTOMETRIC INDICATORS; FIELD-NORMALIZATION; SCIENTIFIC IMPACT; CROSS-FIELD; VALIDATION; APPLICANTS; EXCELLENCE; SELECTION; SCIENCE; COUNTS	The large amount of information contained in bibliographic databases has recently boosted the use of citations, and other indicators based on citation numbers, as tools for the quantitative assessment of scientific research. Citations counts are often interpreted as proxies for the scientific influence of papers, journals, scholars, and institutions. However, a rigorous and scientifically grounded methodology for a correct use of citation counts is still missing. In particular, cross-disciplinary comparisons in terms of raw citation counts systematically favors scientific disciplines with higher citation and publication rates. Here we perform an exhaustive study of the citation patterns of millions of papers, and derive a simple transformation of citation counts able to suppress the disproportionate citation counts among scientific domains. We find that the transformation is well described by a power-law function, and that the parameter values of the transformation are typical features of each scientific discipline. Universal properties of citation patterns descend therefore from the fact that citation distributions for papers in a specific field are all part of the same family of univariate distributions.	[Radicchi, Filippo] Univ Rovira & Virgili, Dept Engn Quim, Catalunya, Spain; [Radicchi, Filippo] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL USA; [Radicchi, Filippo] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Castellano, Claudio] Ist Sistemi Complessi ISC CNR, Rome, Italy; [Castellano, Claudio] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy	Universitat Rovira i Virgili; Howard Hughes Medical Institute; Northwestern University; Northwestern University; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome	Radicchi, F (corresponding author), Univ Rovira & Virgili, Dept Engn Quim, Catalunya, Spain.	f.radicchi@gmail.com	Castellano, Claudio/B-6946-2008; Radicchi, Filippo/B-4407-2009	Castellano, Claudio/0000-0002-3773-3801; Radicchi, Filippo/0000-0002-8352-1287				Adler R, 2009, STAT SCI, V24, P1, DOI 10.1214/09-STS285; Albarran P, 2011, SCIENTOMETRICS, V88, P385, DOI 10.1007/s11192-011-0407-9; [Anonymous], HIRSCH INDEX RANKS T; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Bornmann L, 2006, SCIENTOMETRICS, V68, P427, DOI 10.1007/s11192-006-0121-1; Bornmann L, 2011, J INFORMETR, V5, P228, DOI 10.1016/j.joi.2010.10.009; Bornmann L, 2009, J AM SOC INF SCI TEC, V60, P1664, DOI 10.1002/asi.21076; Bornmann L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003480; DAVIS P, 1984, AM ECON REV, V74, P225; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; HAMILTON DP, 1991, SCIENCE, V251, P25, DOI 10.1126/science.1986409; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Kinney AL, 2007, P NATL ACAD SCI USA, V104, P17943, DOI 10.1073/pnas.0704416104; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; Lawless J.F, 1982, STAT MODELS METHODS; Leydesdorff L, 2011, J AM SOC INF SCI TEC, V62, P1370, DOI 10.1002/asi.21534; Leydesdorff L, 2010, J INFORMETR, V4, P644, DOI 10.1016/j.joi.2010.05.003; Lundberg J, 2007, J INFORMETR, V1, P145, DOI 10.1016/j.joi.2006.09.007; MacRoberts MH, 1996, SCIENTOMETRICS, V36, P435, DOI 10.1007/BF02129604; MACROBERTS MH, 1989, J AM SOC INFORM SCI, V40, P342, DOI 10.1002/(SICI)1097-4571(198909)40:5<342::AID-ASI7>3.0.CO;2-U; Mahmoud H., 2008, POLYA URN MODELS; Mukhopadhyay N., 2000, PROBABILITY STAT INF; Palsberg J, H INDEX COMPUTER SCI; PRICE DJD, 1965, SCIENCE, V149, P510; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Radicchi F, 2012, J INFORMETR, V6, P121, DOI 10.1016/j.joi.2011.09.002; Radicchi F, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046116; Redner S, 1998, EUR PHYS J B, V4, P131, DOI 10.1007/s100510050359; Schubert A, 1996, SCIENTOMETRICS, V36, P311, DOI 10.1007/BF02129597; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; Stringer MJ, 2010, J AM SOC INF SCI TEC, V61, P1377, DOI 10.1002/asi.21335; Stringer MJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001683; Thomson Reuters, 2009, SCI CIT IND EXP SUBJ; Thomson Reuters, 2011, WEB SCI DAT; van Raan AFJ, 2001, PHYSICA A, V298, P530, DOI 10.1016/S0378-4371(01)00254-0; Vinkler P, 2003, SCIENTOMETRICS, V58, P687, DOI 10.1023/B:SCIE.0000006888.69146.24; Vinkler P, 1996, SCIENTOMETRICS, V36, P223, DOI 10.1007/BF02017315; Wallace ML, 2009, J INFORMETR, V3, P296, DOI 10.1016/j.joi.2009.03.010; Waltman L, 2012, J AM SOC INF SCI TEC, V63, P72, DOI 10.1002/asi.21671; Wilk MB, 1968, BIOMETRIKA, V68, P1; Zitt M, 2005, SCIENTOMETRICS, V63, P373, DOI 10.1007/s11192-005-0218-y	43	66	66	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33833	10.1371/journal.pone.0033833	http://dx.doi.org/10.1371/journal.pone.0033833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948SR	22479454	gold, Green Published, Green Submitted			2022-12-27	WOS:000304523400039
J	Usha, V; Hobrath, JV; Gurcha, SS; Reynolds, RC; Besra, GS				Usha, Veeraraghavan; Hobrath, Judith V.; Gurcha, Sudagar S.; Reynolds, Robert C.; Besra, Gurdyal S.			Identification of Novel Mt-Guab2 Inhibitor Series Active against M. tuberculosis	PLOS ONE			English	Article							INOSINE MONOPHOSPHATE DEHYDROGENASE; IMP DEHYDROGENASE; 5'-MONOPHOSPHATE DEHYDROGENASE; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; CELL-WALL; MECHANISM; DISCOVERY; COMPLEX; PURIFICATION	Tuberculosis (TB) remains a leading cause of mortality worldwide. With the emergence of multidrug resistant TB, extensively drug resistant TB and HIV-associated TB it is imperative that new drug targets be identified. The potential of Mycobacterium tuberculosis inosine monophosphate dehydrogenase (IMPDH) as a novel drug target was explored in the present study. IMPDH exclusively catalyzes the conversion of inosine monophosphate (IMP) to xanthosine monophosphate (XMP) in the presence of the cofactor nicotinamide adenine dinucleotide (NAD(+)). Although the enzyme is a dehydrogenase, the enzyme does not catalyze the reverse reaction i.e. the conversion of XMP to IMP. Unlike other bacteria, M. tuberculosis harbors three IMPDH-like genes, designated as Mt-guaB1, Mt-guaB2 and Mt-guaB3 respectively. Of the three putative IMPDH's, we previously confirmed that Mt-GuaB2 was the only functional ortholog by characterizing the enzyme kinetically. Using an in silico approach based on designed scaffolds, a series of novel classes of inhibitors was identified. The inhibitors possess good activity against M. tuberculosis with MIC values in the range of 0.4 to 11.4 mu g mL(-1). Among the identified ligands, two inhibitors have nanomolar K(i)s against the Mt-GuaB2 enzyme.	[Usha, Veeraraghavan; Gurcha, Sudagar S.; Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Hobrath, Judith V.; Reynolds, Robert C.] So Res Inst, Drug Discovery Div, Birmingham, AL 35255 USA	University of Birmingham	Usha, V (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	g.besra@bham.ac.uk		Besra, Gurdyal/0000-0002-5605-0395	American Reinvestment and Recovery Act [1RC1AI086677-01]; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); Tuberculosis Antimicrobial Acquisition and Coordinating Facility through research and development [NO1 AI-95385]; Colorado State University; DHHS; NIH; NIAID-United States of America IDIQ [HHSN266200600011C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI095385, RC1AI086677] Funding Source: NIH RePORTER	American Reinvestment and Recovery Act; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Tuberculosis Antimicrobial Acquisition and Coordinating Facility through research and development; Colorado State University; DHHS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID-United States of America IDIQ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	GSB acknowledges support in the form of a Personal Research Chair from Mr. James Bardrick, Royal Society Wolfson Research Merit Award, as a former Lister Institute-Jenner Fellow. RCR acknowledges American Reinvestment and Recovery Act Grant 1RC1AI086677-01 (National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID)) "Targeting MDR-TB''; the Tuberculosis Antimicrobial Acquisition and Coordinating Facility through research and development contracts NO1 AI-95385 by Dr. Anne Lenaerts at Colorado State University (Program Officer: Dr. Robert Goldman); DHHS, NIH, NIAID-United States of America IDIQ contract number HHSN266200600011C by Dr. Anne Lenaerts at Colorado State University (Program Officer: Dr. Tina Parker). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; Arai M, 2008, BIOORGAN MED CHEM, V16, P6732, DOI 10.1016/j.bmc.2008.05.061; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; CARR SF, 1993, J BIOL CHEM, V268, P27286; Chaturvedi V, 2007, J GEN APPL MICROBIOL, V53, P333, DOI 10.2323/jgam.53.333; Chen LQ, 2010, J MED CHEM, V53, P4768, DOI 10.1021/jm100424m; Chen P, 2003, BIOORG MED CHEM LETT, V13, P1345, DOI 10.1016/S0960-894X(03)00107-0; Chiang CY, 2010, RESPIROLOGY, V15, P413, DOI 10.1111/j.1440-1843.2010.01738.x; Colby TD, 1999, P NATL ACAD SCI USA, V96, P3531, DOI 10.1073/pnas.96.7.3531; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COONEY DA, 1982, BIOCHEM PHARMACOL, V31, P2133, DOI 10.1016/0006-2952(82)90436-1; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Dhar TGM, 2002, J MED CHEM, V45, P2127, DOI 10.1021/jm0105777; Digits JA, 1999, BIOCHEMISTRY-US, V38, P15388, DOI 10.1021/bi991558q; Digits JA, 1999, BIOCHEMISTRY-US, V38, P2295, DOI 10.1021/bi982305k; Dobie F, 2007, MOL BIOCHEM PARASIT, V152, P11, DOI 10.1016/j.molbiopara.2006.11.007; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Engelhardt H, 2002, J BIOL CHEM, V277, P37567, DOI 10.1074/jbc.M206983200; FRANKLIN TJ, 1969, BIOCHEM J, V113, P515, DOI 10.1042/bj1130515; Gan L, 2002, BIOCHEMISTRY-US, V41, P13309, DOI 10.1021/bi0203785; GILBERT HJ, 1979, BIOCHEM J, V183, P481, DOI 10.1042/bj1830481; Goldstein BM, 1999, CURR MED CHEM, V6, P519; Harries AD, 2006, ANN TROP MED PARASIT, V100, P415, DOI 10.1179/136485906X91477; HEDSTROM L, 1990, BIOCHEMISTRY-US, V29, P849, DOI 10.1021/bi00456a001; Hedstrom L, 2010, PCT Int Appl, Patent No. [WO201010 8187 A2 20100923, 2010108187]; Hedstrom L. K., 2007, Patent No. [WO 2007143557, 2007143557]; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; JARLIER V, 1994, FEMS MICROBIOL LETT, V123, P11, DOI 10.1111/j.1574-6968.1994.tb07194.x; Lenaerts AJM, 2003, ANTIMICROB AGENTS CH, V47, P783, DOI 10.1128/AAC.47.2.783-785.2003; Lenaerts AJ, 2008, ANTIMICROB AGENTS CH, V52, P1513, DOI 10.1128/AAC.00897-07; Li XZ, 2004, ANTIMICROB AGENTS CH, V48, P2415, DOI 10.1128/AAC.48.7.2415-2423.2004; MacPherson IS, 2010, J AM CHEM SOC, V132, P1230, DOI 10.1021/ja909947a; Maddry JA, 2009, TUBERCULOSIS, V89, P354, DOI 10.1016/j.tube.2009.07.006; Martinson Neil A, 2011, Proc Am Thorac Soc, V8, P288, DOI 10.1513/pats.201010-064WR; Maurya SK, 2009, J MED CHEM, V52, P4623, DOI 10.1021/jm900410u; McMillan FM, 2000, BIOCHEMISTRY-US, V39, P4533, DOI 10.1021/bi992645l; OGara MJ, 1997, ANTIMICROB AGENTS CH, V41, P40, DOI 10.1128/AAC.41.1.40; Orme I, 2001, ANTIMICROB AGENTS CH, V45, P1943, DOI 10.1128/AAC.45.7.1943-1946.2001; Park SJ, 2004, PROTEOMICS, V4, P3632, DOI 10.1002/pmic.200400921; Pimkin M, 2009, J BIOL CHEM, V284, P7960, DOI 10.1074/jbc.M808541200; Prosise GL, 2002, J BIOL CHEM, V277, P50654, DOI 10.1074/jbc.M208330200; Reynolds RC, 2012, TUBERCULOSIS, V92, P72, DOI 10.1016/j.tube.2011.05.005; Riera TV, 2008, BIOCHEMISTRY-US, V47, P8689, DOI 10.1021/bi800674a; Rullas J, 2010, ANTIMICROB AGENTS CH, V54, P2262, DOI 10.1128/AAC.01423-09; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498; Sharling L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000794; Shu QN, 2008, MED RES REV, V28, P219, DOI 10.1002/med.20104; Sintchak MD, 1996, CELL, V85, P921, DOI 10.1016/S0092-8674(00)81275-1; Umejiego NN, 2004, J BIOL CHEM, V279, P40320, DOI 10.1074/jbc.M407121200; Usha V, 2010, MICROBIOLOGY, V715, P290; Wang W, 1998, BIOCHEMISTRY-US, V37, P11949, DOI 10.1021/bi981132w; Watterson SH, 2007, J MED CHEM, V50, P3730, DOI 10.1021/jm070299x; Whitby FG, 1997, BIOCHEMISTRY-US, V36, P10666, DOI 10.1021/bi9708850; Yew WW, 2011, AM J RESP CRIT CARE, V184, P180, DOI 10.1164/rccm.201102-0325UP; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v; Zhang XH, 2009, MICROB PATHOGENESIS, V47, P267, DOI 10.1016/j.micpath.2009.09.001; Zhou X, 1997, J BIOL CHEM, V272, P21977, DOI 10.1074/jbc.272.35.21977	58	25	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33886	10.1371/journal.pone.0033886	http://dx.doi.org/10.1371/journal.pone.0033886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479467	gold, Green Submitted, Green Published			2022-12-27	WOS:000304523400042
J	Bieghs, V; Verheyen, F; van Gorp, PJ; Hendrikx, T; Wouters, K; Lutjohann, D; Gijbels, MJJ; Febbraio, M; Binder, CJ; Hofker, MH; Shiri-Sverdlov, R				Bieghs, Veerle; Verheyen, Fons; van Gorp, Patrick J.; Hendrikx, Tim; Wouters, Kristiaan; Luetjohann, Dieter; Gijbels, Marion J. J.; Febbraio, Maria; Binder, Christoph J.; Hofker, Marten H.; Shiri-Sverdlov, Ronit			Internalization of Modified Lipids by CD36 and SR-A Leads to Hepatic Inflammation and Lysosomal Cholesterol Storage in Kupffer Cells	PLOS ONE			English	Article							SCAVENGER RECEPTOR CD36; ATHEROSCLEROSIS; DISEASE; ACCUMULATION; PROTECTS; LDL	Background & Aims: Non-alcoholic steatohepatitis (NASH) is characterized by steatosis and inflammation, which can further progress into fibrosis and cirrhosis. Recently, we demonstrated that combined deletion of the two main scavenger receptors, CD36 and macrophage scavenger receptor 1 (MSR1), which are important for modified cholesterol-rich lipoprotein uptake, reduced NASH. The individual contributions of these receptors to NASH and the intracellular mechanisms by which they contribute to inflammation have not been established. We hypothesize that CD36 and MSR1 contribute independently to the onset of inflammation in NASH, by affecting intracellular cholesterol distribution inside Kupffer cells (KCs). Methods & Results: Ldlr(-/-) mice were transplanted with wild-type (Wt), Cd36(-/-) or Msr1(-/-) bone marrow and fed a Western diet for 3months. Cd36(-/-)- and Msr1(-/-)- transplanted (tp) mice showed a similar reduction in hepatic inflammation compared to Wt-tp mice. While the total amount of cholesterol inside KCs was similar in all groups, KCs of Cd36(-/-)- and Msr1(-/-) -tp mice showed increased cytoplasmic cholesterol accumulation, while Wt-tp mice showed increased lysosomal cholesterol accumulation. Conclusion: CD36 and MSR1 contribute similarly and independently to the progression of inflammation in NASH. One possible explanation for the inflammatory response related to expression of these receptors could be abnormal cholesterol trafficking in KCs. These data provide a new basis for prevention and treatment of NASH.	[Bieghs, Veerle; Verheyen, Fons; van Gorp, Patrick J.; Hendrikx, Tim; Gijbels, Marion J. J.; Shiri-Sverdlov, Ronit] Univ Maastricht, Dept Mol Genet, Electron Microscopy Unit Mol Cell Biol & Pathol N, Maastricht, Netherlands; [Bieghs, Veerle; Verheyen, Fons; van Gorp, Patrick J.; Hendrikx, Tim; Gijbels, Marion J. J.; Shiri-Sverdlov, Ronit] Univ Maastricht, Cardiovasc Res CARIM Inst Maastricht, Maastricht, Netherlands; [Wouters, Kristiaan] Univ Lille Nord France, Inserm U1011, UDSL, Inst Pasteur Lille, Lille, France; [Luetjohann, Dieter] Univ Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Febbraio, Maria] Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH USA; [Binder, Christoph J.] Med Univ Vienna, Ctr Mol Med, Austrian Acad Sci, Vienna, Austria; [Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, Vienna, Austria; [Hofker, Marten H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, Groningen, Netherlands	Maastricht University; Maastricht University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; University of Bonn; Cleveland Clinic Foundation; Austrian Academy of Sciences; Medical University of Vienna; Medical University of Vienna; University of Groningen	Bieghs, V (corresponding author), Univ Maastricht, Dept Mol Genet, Electron Microscopy Unit Mol Cell Biol & Pathol N, Maastricht, Netherlands.	r.sverdlov@maastrichtuniversity.nl	Shiri-Sverdlov, Ronit/E-5571-2017; Shiri-Sverdlov, Ronit/X-2642-2019; van Gorp, Patrick/S-3892-2019; Hendrikx, Tim/AAE-2329-2020; Wouters, Kristiaan/A-8536-2013; Hendrikx, Tim/AAI-8252-2021; van Gorp, Patrick/L-9580-2018	Shiri-Sverdlov, Ronit/0000-0002-6736-7814; Shiri-Sverdlov, Ronit/0000-0002-6736-7814; van Gorp, Patrick/0000-0002-0355-5349; Wouters, Kristiaan/0000-0001-7127-6950; Hendrikx, Tim/0000-0002-3381-2107; van Gorp, Patrick/0000-0002-0355-5349; Binder, Christoph J./0000-0001-8313-7050	Veni grant [916.76.070 (2006/00496/MW)]; Maag Lever Darm Stichting (MLDS) [WO 08-16]	Veni grant; Maag Lever Darm Stichting (MLDS)	This work was supported by Veni grant: 916.76.070 (2006/00496/MW) www.nwo.nl and Maag Lever Darm Stichting (MLDS) (WO 08-16) www.mlds.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Cox BE, 2007, J LIPID RES, V48, P1012, DOI 10.1194/jlr.M600390-JLR200; Duewell P, NATURE, V466, P652; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Griffin EE, 2005, J LIPID RES, V46, P2052, DOI 10.1194/jlr.M500059-JLR200; IGNARRO LJ, 1974, AGENTS ACTIONS, V4, P241, DOI 10.1007/BF01965227; Jerome WG, 2003, MICROSC MICROANAL, V9, P54, DOI 10.1017/S1431927603030010; KELLY DA, 1993, J PEDIATR-US, V123, P242, DOI 10.1016/S0022-3476(05)81695-6; Kuchibhotla S, 2008, CARDIOVASC RES, V78, P185, DOI 10.1093/cvr/cvm093; Liao GH, 2009, BRAIN RES, V1270, P140, DOI 10.1016/j.brainres.2009.03.027; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Pennings M, 2006, FEBS LETT, V580, P5588, DOI 10.1016/j.febslet.2006.08.022; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tessitore Alessandra, 2009, Pathogenetics, V2, P4, DOI 10.1186/1755-8417-2-4; Vanier MT, 2003, CLIN GENET, V64, P269, DOI 10.1034/j.1399-0004.2003.00147.x; WEISSMANN G, 1967, ANNU REV MED, V18, P97, DOI 10.1146/annurev.me.18.020167.000525; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Yamada Y, 1998, CELL MOL LIFE SCI, V54, P628, DOI 10.1007/s000180050191; Yan C, 2006, AM J PATHOL, V169, P916, DOI 10.2353/ajpath.2006.051327	23	84	88	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34378	10.1371/journal.pone.0034378	http://dx.doi.org/10.1371/journal.pone.0034378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470565	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000104
J	Yuan, ML; Chen, M; Zhang, W; Lu, W; Wang, J; Yang, MK; Zhao, P; Tang, R; Li, XN; Hao, YH; Zhou, ZF; Zhan, YH; Yu, HY; Teng, C; Yan, YL; Ping, SZ; Wang, YD; Lin, M				Yuan, Menglong; Chen, Ming; Zhang, Wei; Lu, Wei; Wang, Jin; Yang, Mingkun; Zhao, Peng; Tang, Ran; Li, Xinna; Hao, Yanhua; Zhou, Zhengfu; Zhan, Yuhua; Yu, Haiying; Teng, Chao; Yan, Yongliang; Ping, Shuzhen; Wang, Yingdian; Lin, Min			Genome Sequence and Transcriptome Analysis of the Radioresistant Bacterium Deinococcus gobiensis. Insights into the Extreme Environmental Adaptations	PLOS ONE			English	Article							ESCHERICHIA-COLI; RADIODURANS; RADIATION; UV; PROTEIN; RESISTANCE; EXPOSURE; ENZYME; REPAIR; PERSPECTIVE	The desert is an excellent model for studying evolution under extreme environments. We present here the complete genome and ultraviolet (UV) radiation-induced transcriptome of Deinococcus gobiensis I-0, which was isolated from the cold Gobi desert and shows higher tolerance to gamma radiation and UV light than all other known microorganisms. Nearly half of the genes in the genome encode proteins of unknown function, suggesting that the extreme resistance phenotype may be attributed to unknown genes and pathways. D. gobiensis also contains a surprisingly large number of horizontally acquired genes and predicted mobile elements of different classes, which is indicative of adaptation to extreme environments through genomic plasticity. High-resolution RNA-Seq transcriptome analyses indicated that 30 regulatory proteins, including several well-known regulators and uncharacterized protein kinases, and 13 noncoding RNAs were induced immediately after UV irradiation. Particularly interesting is the UV irradiation induction of the phrB and recB genes involved in photoreactivation and recombinational repair, respectively. These proteins likely include key players in the immediate global transcriptional response to UV irradiation. Our results help to explain the exceptional ability of D. gobiensis to withstand environmental extremes of the Gobi desert, and highlight the metabolic features of this organism that have biotechnological potential.	[Yuan, Menglong; Chen, Ming; Zhang, Wei; Lu, Wei; Wang, Jin; Yang, Mingkun; Zhao, Peng; Tang, Ran; Li, Xinna; Hao, Yanhua; Zhou, Zhengfu; Zhan, Yuhua; Yu, Haiying; Teng, Chao; Yan, Yongliang; Ping, Shuzhen; Lin, Min] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Yuan, Menglong; Wang, Yingdian] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Beijing Normal University	Yuan, ML (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	linmin57@vip.163.com	min, lin/AAJ-7325-2020; teng, chao/GVU-5372-2022; hao, yan/HGB-0465-2022	yan, yongliang/0000-0002-4297-6648	National Basic Research (973) Program of China [2010CB126504, 2007CB109203]; National Natural Science Foundation of China [30925002, 30970069]; National Research and Development Project of Transgenic Crops of China [2011ZX08009-003, 2009ZX08009-075B]	National Basic Research (973) Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research and Development Project of Transgenic Crops of China	This work was supported by grants from the National Basic Research (973) Program of China (No. 2010CB126504 and 2007CB109203), the National Natural Science Foundation of China (No. 30925002 and 30970069) and the National Research and Development Project of Transgenic Crops of China (2011ZX08009-003 and 2009ZX08009-075B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MA, 2009, ISME J, V3, P1012, DOI 10.1038/ismej.2009.45; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON AW, 1956, FOOD TECHNOL-CHICAGO, V10, P575; Bagwell CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003878; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; Buis JM, 2006, J BIOL CHEM, V281, P25994, DOI 10.1074/jbc.M603931200; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Castiglioni P, 2008, PLANT PHYSIOL, V147, P446, DOI 10.1104/pp.108.118828; Courcelle J, 2001, GENETICS, V158, P41; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; de Groot A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000434; Dillingham MS, 2008, MICROBIOL MOL BIOL R, V72, P642, DOI 10.1128/MMBR.00020-08; Ferenci T, 2009, J BACTERIOL, V191, P4025, DOI 10.1128/JB.00118-09; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Filiatrault MJ, 2010, J BACTERIOLOGY; Fredrickson JK, 2008, ISME J, V2, P393, DOI 10.1038/ismej.2007.116; Goldberg SMD, 2006, P NATL ACAD SCI USA, V103, P11240, DOI 10.1073/pnas.0604351103; Gupta R, 2009, J BACTERIOL, V191, P5785, DOI 10.1128/JB.00335-09; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Ivanova N, 2011, STAND GENOMIC SCI, V4, P91, DOI 10.4056/sigs.1563919; Jiang QF, 2009, NATURE, V460, P359, DOI 10.1038/nature08178; Khairnar NP, 2008, DNA REPAIR, V7, P40, DOI 10.1016/j.dnarep.2007.07.007; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Mackiewicz P, 2001, GENOME BIOL, V2; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; MAKINO K, 1989, J MOL BIOL, V210, P551, DOI 10.1016/0022-2836(89)90131-9; Marshall OJ, 2004, BIOINFORMATICS, V20, P2471, DOI 10.1093/bioinformatics/bth254; Norais CA, 2009, J BIOL CHEM, V284, P21402, DOI 10.1074/jbc.M109.010454; Osburne MS, 2010, ENVIRON MICROBIOL, V12, P1978, DOI 10.1111/j.1462-2920.2010.02203.x; Pan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004422; Patel BA, 2009, P NATL ACAD SCI USA, V106, P18183, DOI 10.1073/pnas.0907262106; Pukall R, 2011, STAND GENOMIC SCI, V4, P163, DOI 10.4056/sigs.1633949; Qiu XY, 2005, J BACTERIOL, V187, P3556, DOI 10.1128/JB.187.10.3556-3564.2005; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Stallings CL, 2009, CELL, V138, P146, DOI 10.1016/j.cell.2009.04.041; Sugiman-Marangos S, 2010, NUCLEIC ACIDS RES, V38, P3432, DOI 10.1093/nar/gkq036; Sun ZT, 2009, MICROBIOL-SGM, V155, P2775, DOI 10.1099/mic.0.027623-0; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Warren-Rhodes KA, 2007, FEMS MICROBIOL ECOL, V61, P470, DOI 10.1111/j.1574-6941.2007.00351.x; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yuan ML, 2009, INT J SYST EVOL MICR, V59, P1513, DOI 10.1099/ijs.0.004523-0; Zhaxybayeva O, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-4; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	58	33	37	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34458	10.1371/journal.pone.0034458	http://dx.doi.org/10.1371/journal.pone.0034458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470573	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000112
J	Sattar, S; Ahmed, T; Rasul, CH; Saha, D; Salam, MA; Hossain, MI				Sattar, Samima; Ahmed, Tahmeed; Rasul, Choudhury Habibur; Saha, Debasish; Salam, Mohammed Abdus; Hossain, Md Iqbal			Efficacy of a High-Dose in Addition to Daily Low-Dose Vitamin A in Children Suffering from Severe Acute Malnutrition with Other Illnesses	PLOS ONE			English	Article							CONTROLLED CLINICAL-TRIAL; RESPIRATORY-TRACT INFECTIONS; RETINOL-BINDING-PROTEIN; DAR-ES-SALAAM; DOUBLE-BLIND; MALNOURISHED CHILDREN; BANGLADESHI CHILDREN; ACUTE-INFLAMMATION; YOUNG-CHILDREN; SERUM RETINOL	Background: Efficacy of high-dose vitamin A (VA) in children suffering from severe acute malnutrition (SAM) has recently been questioned. This study compared the efficacy of a single high-dose (200,000 IU) in addition to daily low-dose (5000 IU) VA in the management of children suffering from SAM with diarrhea and/or acute lower respiratory tract infection (ALRI). Methods: In a randomized, double-blind, controlled clinical trial in icddr,b, Bangladesh during 2005-07, children aged 6-59 months with weight-for-height <-3 Z-score and/or bipedal edema (SAM) received either a high-dose VA or placebo on admission day. Both the groups received 5,000 IU/day VA in a multivitamins drop for 15 days and other standard treatment which is similar to WHO guidelines. Results: A total 260 children (130 in each group) were enrolled. All had diarrhea, 54% had concomitant ALRI, 50% had edema, 48.5% were girl with a mean +/- SD age of 16 +/- 10 months. None had clinical signs of VA deficiency. Mean +/- SD baseline serum retinol was 13.15 +/- 9.28 mu g/dl, retinol binding protein was 1.27 +/- 0.95 mg/dl, and pre-albumin was 7.97 +/- 3.96 mg/dl. Median (inter quartile range) of C-reactive protein was 7.8 (2.1, 22.2) mg/L. Children of the two groups did not differ in any baseline characteristic. Over the 15 days treatment period resolution of diarrhea, ALRI, edema, anthropometric changes, and biochemical indicators of VA were similar between the groups. The high-dose VA supplementation in children with SAM did not show any adverse event. Conclusions: Efficacy of daily low-dose VA compared to an additional single high-dose was not observed to be better in the management of children suffering from SAM with other acute illnesses. A single high-dose VA may be given especially where the children with SAM may leave the hospital/treatment center early.	[Sattar, Samima; Ahmed, Tahmeed; Salam, Mohammed Abdus; Hossain, Md Iqbal] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Div Clin Sci, Dhaka, Bangladesh; [Sattar, Samima; Ahmed, Tahmeed; Salam, Mohammed Abdus; Hossain, Md Iqbal] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Ctr Nutr & Food Secur, Dhaka, Bangladesh; [Rasul, Choudhury Habibur] Khulna Med Coll & Hosp, Dept Paediat, Khulna, Bangladesh; [Saha, Debasish] Univ Otago, Dept Social & Prevent Med, Ctr Int Hlth, Dunedin, New Zealand	International Centre for Diarrhoeal Disease Research (ICDDR); International Centre for Diarrhoeal Disease Research (ICDDR); University of Otago	Sattar, S (corresponding author), Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Div Clin Sci, Dhaka, Bangladesh.	ihossain@icddrb.org			Improved Health for the Poor, Government of the People's Republic of Bangladesh; ICDDR,B; Australian Agency for International Development (AusAID); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Department for International Development (DFID), UK; Drug International Ltd., Bangladesh	Improved Health for the Poor, Government of the People's Republic of Bangladesh; ICDDR,B; Australian Agency for International Development (AusAID)(Australian Aid (AusAID)); Government of the People's Republic of Bangladesh; Canadian International Development Agency (CIDA); Embassy of the Kingdom of the Netherlands (EKN); Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Department for International Development (DFID), UK; Drug International Ltd., Bangladesh	The study was funded by Improved Health for the Poor, Government of the People's Republic of Bangladesh, and supported by ICDDR,B and its donors which provide unrestricted support to the Centre for its operations and research. Current donors providing unrestricted support include: Australian Agency for International Development (AusAID), Government of the People's Republic of Bangladesh, Canadian International Development Agency (CIDA), Embassy of the Kingdom of the Netherlands (EKN), Swedish International Development Cooperation Agency (Sida), Swiss Agency for Development and Cooperation (SDC), and Department for International Development (DFID), UK. The authors gratefully acknowledge these donors for their support and commitment to the Centre's research efforts. The study was also supported by Drug International Ltd., Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Ahmed T., 2004, GLIMPSE, P26; Beaton GH, 1993, UN ADM COMMITTEE COO; BLOEM MW, 1990, AM J EPIDEMIOL, V131, P332, DOI 10.1093/oxfordjournals.aje.a115502; Bresee JS, 1996, PEDIATR INFECT DIS J, V15, P777, DOI 10.1097/00006454-199609000-00008; COUTSOUDIS A, 1991, AM J CLIN NUTR, V54, P890, DOI 10.1093/ajcn/54.5.890; Dewan V, 1995, Indian Pediatr, V32, P21; Dibley MJ, 1996, J NUTR, V126, P434, DOI 10.1093/jn/126.2.434; Donnen P, 2007, EUR J CLIN NUTR, V61, P1393, DOI 10.1038/sj.ejcn.1602671; Donnen P, 1998, AM J CLIN NUTR, V68, P1254, DOI 10.1093/ajcn/68.6.1254; DRISKELL WJ, 1982, J CHROMATOGR, V231, P439, DOI 10.1016/S0378-4347(00)81869-1; Faruque ASG, 1999, ACTA PAEDIATR, V88, P154, DOI 10.1080/08035259950170312; Fawzi WW, 2000, J PEDIATR-US, V137, P660, DOI 10.1067/mpd.2000.110136; Fawzi WW, 1998, AM J CLIN NUTR, V68, P187, DOI 10.1093/ajcn/68.1.187; FELDING P, 1985, ACTA PHYSIOL SCAND, V123, P477, DOI 10.1111/j.1748-1716.1985.tb07613.x; Ghana VAST study Team, 1993, LANCET, V342, P7; Grubesic RB, 2003, J NURS SCHOLARSHIP, V35, P15, DOI 10.1111/j.1547-5069.2003.00015.x; HENNING B, 1992, EUR J CLIN NUTR, V46, P437; Hossain S, 1998, BRIT MED J, V316, P422, DOI 10.1136/bmj.316.7129.422; HUSSEY GD, 1990, NEW ENGL J MED, V323, P160, DOI 10.1056/NEJM199007193230304; INGENBLEEK Y, 1975, METABOLISM, V24, P633, DOI 10.1016/0026-0495(75)90143-2; Julien MR, 1999, TROP MED INT HEALTH, V4, P794, DOI 10.1046/j.1365-3156.1999.00493.x; KJOLHEDE CL, 1995, J PEDIATR-US, V126, P807, DOI 10.1016/S0022-3476(95)70416-7; Mahalanabis D, 2004, AM J CLIN NUTR, V79, P430; McNally Lisa, 2001, Food and Nutrition Bulletin, V22, P295; Mitra AK, 1998, AM J CLIN NUTR, V68, P1088, DOI 10.1093/ajcn/68.5.1088; More T, 1960, VITAM HORM, V18, P431; Nacul LC, 1997, BMJ-BRIT MED J, V315, P505, DOI 10.1136/bmj.315.7107.505; RAHMATHULLAH L, 1991, AM J CLIN NUTR, V54, P568, DOI 10.1093/ajcn/54.3.568; Rosales FJ, 1996, J LIPID RES, V37, P962; Ross DA, 2002, J NUTR, V132, p2902S, DOI 10.1093/jn/132.9.2902S; Si NV, 1997, ACTA PAEDIATR, V86, P1052, DOI 10.1111/j.1651-2227.1997.tb14805.x; SOMMER A, 1986, LANCET, V1, P1169; Sommer A., 1996, VITAMIN A DEFICIENCY, P19; STANSFIELD SK, 1993, LANCET, V342, P578, DOI 10.1016/0140-6736(93)91410-N; Stephensen CB, 2000, AM J CLIN NUTR, V72, P1170; Stephensen CB, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.5.e3; Villamor E, 2000, J INFECT DIS, V182, pS122, DOI 10.1086/315921; *WHO, 1995, VIT A DEF ITS CONS F; World Health Organization, 2003, SEARO TECHN PUBL; World Health Organization, 1999, MAN SEV MALN MAN PHY; World Health Organization, 2005, SEV MALN REP CONS RE	42	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33112	10.1371/journal.pone.0033112	http://dx.doi.org/10.1371/journal.pone.0033112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479361	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900017
J	da Silva, MFL; Zampieri, RA; Muxel, SM; Beverley, SM; Floeter-Winter, LM				Laranjeira da Silva, Maria Fernanda; Zampieri, Ricardo Andrade; Muxel, Sandra M.; Beverley, Stephen M.; Floeter-Winter, Lucile M.			Leishmania amazonensis Arginase Compartmentalization in the Glycosome Is Important for Parasite Infectivity	PLOS ONE			English	Article							L-ARGININE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MURINE MACROPHAGES; TRYPANOSOMA-BRUCEI; METABOLISM; BIOSYNTHESIS; ENZYMES; GROWTH	In Leishmania, de novo polyamine synthesis is initiated by the cleavage of L-arginine to urea and L-ornithine by the action of arginase (ARG, E.C. 3.5.3.1). Previous studies in L. major and L. mexicana showed that ARG is essential for in vitro growth in the absence of polyamines and needed for full infectivity in animal infections. The ARG protein is normally found within the parasite glycosome, and here we examined whether this localization is required for survival and infectivity. First, the localization of L. amazonensis ARG in the glycosome was confirmed in both the promastigote and amastigote stages. As in other species, arg(-) L. amazonensis required putrescine for growth and presented an attenuated infectivity. Restoration of a wild type ARG to the arg(-) mutant restored ARG expression, growth and infectivity. In contrast, restoration of a cytosol-targeted ARG lacking the glycosomal SKL targeting sequence (arg Delta SKL) restored growth but failed to restore infectivity. Further study showed that the ARG Delta SKL protein was found in the cytosol as expected, but at very low levels. Our results indicate that the proper compartmentalization of L. amazonensis arginase in the glycosome is important for enzyme activity and optimal infectivity. Our conjecture is that parasite arginase participates in a complex equilibrium that defines the fate of L-arginine and that its proper subcellular location may be essential for this physiological orchestration.	[Laranjeira da Silva, Maria Fernanda; Zampieri, Ricardo Andrade; Muxel, Sandra M.; Floeter-Winter, Lucile M.] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil; [Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Universidade de Sao Paulo; Washington University (WUSTL)	da Silva, MFL (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, Brazil.	lucile@ib.usp.br	Laranjeira-Silva, Maria Fernanda/H-9056-2012; Muxel, Sandra/F-7464-2012; Floeter-Winter, Lucile Maria/AAE-7629-2019; Zampieri, Ricardo/D-3706-2018; Floeter-Winter, Lucile Maria/K-2618-2012	Laranjeira-Silva, Maria Fernanda/0000-0002-7128-6208; Muxel, Sandra/0000-0003-0118-5361; Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Floeter-Winter, Lucile Maria/0000-0002-8954-8704; Beverley, Stephen/0000-0001-5319-0811	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (CNPq); National Institute of Health [AI 21903, AI 29646]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI021903, R01AI029646, R01AI021903] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Conselho Nacional para o Desenvolvimento Cientifico e Tecnologico (CNPq) and National Institute of Health (AI 21903; AI 29646). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopyants NS, 2009, SCIENCE, V324, P265, DOI 10.1126/science.1169464; Al-Ani GK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027802; Archer S, 2008, METHOD ENZYMOL, V448, P359, DOI 10.1016/S0076-6879(08)02618-9; Blattner J, 1998, P NATL ACAD SCI USA, V95, P11596, DOI 10.1073/pnas.95.20.11596; Bogdan C, 1999, PARASITOL TODAY, V15, P22, DOI 10.1016/S0169-4758(98)01362-3; Boucher JL, 1999, CELL MOL LIFE SCI, V55, P1015, DOI 10.1007/s000180050352; Castilho-Martins EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027818; CORRALIZA IM, 1995, BIOCHEM BIOPH RES CO, V206, P667, DOI 10.1006/bbrc.1995.1094; CRUZ A, 1990, NATURE, V348, P171, DOI 10.1038/348171a0; Cunningham AC, 2002, EXP MOL PATHOL, V72, P132, DOI 10.1006/exmp.2002.2418; da Silva ER, 2008, MOL BIOCHEM PARASIT, V159, P104, DOI 10.1016/j.molbiopara.2008.02.011; da Silva ER, 2002, INT J PARASITOL, V32, P727, DOI 10.1016/S0020-7519(02)00002-4; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; Darlyuk I, 2009, J BIOL CHEM, V284, P19800, DOI 10.1074/jbc.M901066200; Godoy PDD, 2009, EUKARYOT CELL, V8, P1592, DOI 10.1128/EC.00161-09; Field MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008468; Gaur U, 2007, J IMMUNOL, V179, P8446, DOI 10.4049/jimmunol.179.12.8446; Genestra M, 2006, ARCH MED RES, V37, P328, DOI 10.1016/j.arcmed.2005.07.011; Guerra-Giraidez C, 2002, J CELL SCI, V115, P2651; Haanstra JR, 2008, P NATL ACAD SCI USA, V105, P17718, DOI 10.1073/pnas.0806664105; Iniesta V, 2001, J EXP MED, V193, P777, DOI 10.1084/jem.193.6.777; Kropf P, 2005, FASEB J, V19, P1000, DOI 10.1096/fj.04-3416fje; Kubota H, 2009, J BIOCHEM, V146, P609, DOI 10.1093/jb/mvp139; LAMBEIR AM, 1991, EUR J BIOCHEM, V198, P429, DOI 10.1111/j.1432-1033.1991.tb16032.x; MICHELS PAM, 1991, EUR J BIOCHEM, V198, P421, DOI 10.1111/j.1432-1033.1991.tb16031.x; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Mieulet V, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000934; Muleme HM, 2009, J IMMUNOL, V183, P8068, DOI 10.4049/jimmunol.0803979; Munder M, 1999, J IMMUNOL, V163, P3771; Munder M, 1998, J IMMUNOL, V160, P5347; Munder M, 2009, EUR J IMMUNOL, V39, P2161, DOI 10.1002/eji.200839041; OPPERDOES FR, 1987, ANNU REV MICROBIOL, V41, P127, DOI 10.1146/annurev.mi.41.100187.001015; Opperdoes FR, 2006, MOL BIOCHEM PARASIT, V147, P193, DOI 10.1016/j.molbiopara.2006.02.010; Reguera RM, 2009, MOL BIOCHEM PARASIT, V165, P48, DOI 10.1016/j.molbiopara.2009.01.001; Riley E, 2011, INT J PARASITOL, V41, P545, DOI 10.1016/j.ijpara.2010.12.006; Roberts SC, 2004, J BIOL CHEM, V279, P23668, DOI 10.1074/jbc.M402042200; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Su W, 2011, P NATL ACAD SCI USA, V108, P870, DOI 10.1073/pnas.1013251108; Wanasen N, 2008, IMMUNOL RES, V41, P15, DOI 10.1007/s12026-007-8012-y; Wanasen N, 2007, INFECT IMMUN, V75, P2802, DOI 10.1128/IAI.00026-07	41	73	73	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34022	10.1371/journal.pone.0034022	http://dx.doi.org/10.1371/journal.pone.0034022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479507	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100098
J	Liu, D; Lin, YM; Kang, T; Huang, B; Xu, W; Garcia-Barrio, M; Olatinwo, M; Matthews, R; Chen, YE; Thompson, WE				Liu, Dong; Lin, Yiming; Kang, Ting; Huang, Bo; Xu, Wei; Garcia-Barrio, Minerva; Olatinwo, Moshood; Matthews, Roland; Chen, Y. Eugene; Thompson, Winston E.			Mitochondrial Dysfunction and Adipogenic Reduction by Prohibitin Silencing in 3T3-L1 Cells	PLOS ONE			English	Article							ADIPOCYTE DIFFERENTIATION; CRISTAE MORPHOGENESIS; GENE-EXPRESSION; ADIPOSE-TISSUE; DNA NUCLEOIDS; CANCER CELLS; C-MYC; ACTIVATION; MEMBRANE; PROTEINS	Increase in mitochondrial biogenesis has been shown to accompany brown and white adipose cell differentiation. Prohibitins (PHBs), comprised of two evolutionarily conserved proteins, prohibitin-1 (PHB1) and prohibitin-2 (PHB2), are present in a high molecular-weight complex in the inner membrane of mitochondria. However, little is known about the effect of mitochondrial PHBs in adipogenesis. In the present study, we demonstrate that the levels of both PHB1 and PHB2 are significantly increased during adipogenesis of 3T3-L1 preadipocytes, especially in mitochondria. Knockdown of PHB1 or PHB2 by oligonucleotide siRNA significantly reduced the expression of adipogenic markers, the accumulation of lipids and the phosphorylation of extracellular signal-regulated kinases. In addition, fragmentation of mitochondrial reticulum, loss of mitochondrial cristae, reduction of mitochondrial content, impairment of mitochondrial complex I activity and excessive production of ROS were observed upon PHB-silencing in 3T3-L1 cells. Our results suggest that PHBs are critical mediators in promoting 3T3-L1 adipocyte differentiation and may be the potential targets for obesity therapies.	[Liu, Dong; Kang, Ting; Huang, Bo; Garcia-Barrio, Minerva] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA; [Liu, Dong] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA; [Lin, Yiming] Emory Univ, Sch Med, Dept Endocrinol, Atlanta, GA USA; [Kang, Ting] Nanchang Univ, Affiliated Hosp 1, Div Cardiol, Nanchang, Peoples R China; [Huang, Bo] Nanchang Univ, Affiliated Hosp 2, Dept Clin Lab Sci, Nanchang, Peoples R China; [Xu, Wei; Olatinwo, Moshood; Matthews, Roland; Thompson, Winston E.] Morehouse Sch Med, Dept Obstet & Gynecol, Atlanta, GA 30310 USA; [Chen, Y. Eugene] Univ Michigan, Ctr Cardiovasc, Ann Arbor, MI 48109 USA	Morehouse School of Medicine; Morehouse School of Medicine; Emory University; Nanchang University; Nanchang University; Morehouse School of Medicine; University of Michigan System; University of Michigan	Liu, D (corresponding author), Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA.	dliu@msm.edu; wthompson@msm.edu			National Institutes of Health [G12RR003034, U54HD41749]; Department of Defense [BC020050]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD041749] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by the National Institutes of Health grants G12RR003034 and G12RR003034-supplement to DL, U54HD41749 to WET (http://grants.nih.gov/grants/oer.htm); and by the Department of Defense grant BC020050 to WET (http://cdmrp.army.mil/bcrp/default.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the munuscript.	Ande SR, 2011, INT J OBES LOND; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Artal-Sanz M, 2009, NATURE, V461, P793, DOI 10.1038/nature08466; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Berger KH, 1998, MOL CELL BIOL, V18, P4043, DOI 10.1128/MCB.18.7.4043; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; Burton GR, 2004, GENE, V329, P167, DOI 10.1016/j.gene.2003.12.012; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Carriere A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200; Chowdhury I, 2007, ENDOCRINOLOGY, V148, P206, DOI 10.1210/en.2006-0187; Chowdhury Indrajit, 2012, Front Biosci (Elite Ed), V4, P690; CLEARY MP, 1979, AM J PHYSIOL, V236, pE508, DOI 10.1152/ajpendo.1979.236.5.E508; Coates PJ, 2001, EXP CELL RES, V265, P262, DOI 10.1006/excr.2001.5166; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; De Pauw A, 2009, AM J PATHOL, V175, P927, DOI 10.2353/ajpath.2009.081155; Gregory-Bass RC, 2008, INT J CANCER, V122, P1923, DOI 10.1002/ijc.23351; HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; Heron-Milhavet L, 2008, J CELL PHYSIOL, V214, P158, DOI 10.1002/jcp.21177; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; JOHNSON PR, 1972, J LIPID RES, V13, P2; Kajimoto K, 2005, MOL GENET METAB, V85, P46, DOI 10.1016/j.ymgme.2005.01.006; Kasashima K, 2008, EXP CELL RES, V314, P988, DOI 10.1016/j.yexcr.2008.01.005; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Liu D, 2006, CIRC RES, V98, P480, DOI 10.1161/01.RES.0000205764.85931.4b; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mawson A, 2005, MOL CELL ENDOCRINOL, V229, P161, DOI 10.1016/j.mce.2004.08.002; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Osman C, 2009, J CELL SCI, V122, P3823, DOI 10.1242/jcs.037655; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rajalingam K, 2005, CELL CYCLE, V4, P1503, DOI 10.4161/cc.4.11.2142; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200; Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Sripathi SR, 2011, BIOCHEMISTRY-US, V50, P8342, DOI 10.1021/bi2008933; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Vankoningsloo S, 2005, J LIPID RES, V46, P1133, DOI 10.1194/jlr.M400464-JLR200; Vessal M, 2006, FEBS J, V273, P568, DOI 10.1111/j.1742-4658.2005.05090.x; Wang P, 2004, CELL MOL LIFE SCI, V61, P2405, DOI 10.1007/s00018-004-4256-z; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Wu JJ, 2006, CELL METAB, V4, P61, DOI 10.1016/j.cmet.2006.05.010	54	50	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34315	10.1371/journal.pone.0034315	http://dx.doi.org/10.1371/journal.pone.0034315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479600	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100149
J	Meiler, E; Nieto-Pelegrin, E; Martinez-Quiles, N				Meiler, Eugenia; Nieto-Pelegrin, Elvira; Martinez-Quiles, Narcisa			Cortactin Tyrosine Phosphorylation Promotes Its Deacetylation and Inhibits Cell Spreading	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ACTIN POLYMERIZATION; LYSINE ACETYLATION; FAMILY KINASES; PROTEIN; ACTIVATION; DYNAMICS; CYTOSKELETON; SWITCH; NETWORK	Background: Cortactin is a classical Src kinase substrate that participates in actin cytoskeletal dynamics by activating the Arp2/3 complex and interacting with other regulatory proteins, including FAK. Cortactin has various domains that may contribute to the assembly of different protein platforms to achieve process specificity. Though the protein is known to be regulated by post-translational modifications such as phosphorylation and acetylation, how tyrosine phosphorylation regulates cortactin activity is poorly understood. Since the basal level of tyrosine phosphorylation is low, this question must be studied using stimulated cell cultures, which are physiologically relevant but unreliable and difficult to work with. In fact, their unreliability may be the cause of some contradictory findings about the dynamics of tyrosine phosphorylation of cortactin in different processes. Methodology/Principal Findings: In the present study, we try to overcome these problems by using a Functional Interaction Trap (FIT) system, which involves cotransfecting cells with a kinase (Src) and a target protein (cortactin), both of which are fused to complementary leucine-zipper domains. The FIT system allowed us to control precisely the tyrosine phosphorylation of cortactin and explore its relationship with cortactin acetylation. Conclusions/Significance: Using this system, we provide definitive evidence that a competition exists between acetylation and tyrosine phosphorylation of cortactin and that phosphorylation inhibits cell spreading. We confirmed the results from the FIT system by examining endogenous cortactin in different cell types. Furthermore, we demonstrate that cell spreading promotes the association of cortactin and FAK and that tyrosine phosphorylation of cortactin disrupts this interaction, which may explain how it inhibits cell spreading.	[Meiler, Eugenia; Nieto-Pelegrin, Elvira; Martinez-Quiles, Narcisa] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain	Complutense University of Madrid	Meiler, E (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Madrid, Spain.	narcisaquiles@farm.ucm.es	Nieto-Pelegrin, Elvira/A-8696-2019; Martinez-Quiles, Narcisa/G-8514-2013	Martinez Quiles, Narcisa/0000-0002-0366-6591; Nieto Pelegrin, Elvira/0000-0003-2755-2641	Instituto de Salud Carlos III [PS09/0080]; Fundacion Medica Mutua Madrilena [01754/2008]; I3 program [Ministerio de Ciencia e Innovacion (MICINN)]; Formacion Personal Universitario (FPU) program of MICINN; Universidad Complutense de Madrid (UCM)	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Medica Mutua Madrilena(Instituto de Salud Carlos III); I3 program [Ministerio de Ciencia e Innovacion (MICINN)]; Formacion Personal Universitario (FPU) program of MICINN; Universidad Complutense de Madrid (UCM)	This work was funded by an Instituto de Salud Carlos III grant (PS09/0080) and a Fundacion Medica Mutua Madrilena Personnel grant (01754/2008) to NMQ. NMQ is also funded by the I3 program [Ministerio de Ciencia e Innovacion (MICINN)]. EMR and ENP are predoctoral fellows supported, respectively, by the Formacion Personal Universitario (FPU) program of MICINN and by the Universidad Complutense de Madrid (UCM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammer AG, 2008, CELL MOTIL CYTOSKEL, V65, P687, DOI 10.1002/cm.20296; Arndt KM, 2000, J MOL BIOL, V295, P627, DOI 10.1006/jmbi.1999.3352; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Campbell DH, 1999, CANCER RES, V59, P5376; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cowieson NP, 2008, J BIOL CHEM, V283, P16187, DOI 10.1074/jbc.M708917200; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Grassart A, 2010, TRAFFIC, V11, P1079, DOI 10.1111/j.1600-0854.2010.01075.x; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Huang C, 1997, J BIOL CHEM, V272, P13911, DOI 10.1074/jbc.272.21.13911; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kelley LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013847; Kelley LC, 2010, J CELL SCI, V123, P3923, DOI 10.1242/jcs.075200; Kinley AW, 2003, CURR BIOL, V13, P384, DOI 10.1016/S0960-9822(03)00107-6; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; Kruchten AE, 2008, AM J PHYSIOL-CELL PH, V295, pC1113, DOI 10.1152/ajpcell.00238.2008; Li YS, 2001, CANCER RES, V61, P6906; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Martin KH, 2006, J CELL SCI, V119, P2851, DOI 10.1242/jcs03034; Martinez-Quiles N, 2004, MOL CELL BIOL, V24, P5269, DOI 10.1128/MCB.24.12.5269-5280.2004; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; Mizutani K, 2002, CANCER RES, V62, P669; Nieto-Pelegrin E, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-11; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Ren G, 2009, CELL MOTIL CYTOSKEL, V66, P865, DOI 10.1002/cm.20380; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; SCHUURING E, 1993, MOL CELL BIOL, V13, P2891, DOI 10.1128/MCB.13.5.2891; Sharma A, 2003, MOL CELL PROTEOMICS, V2, P1217, DOI 10.1074/mcp.M300078-MCP200; Sharma A, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-50; Tegtmeyer N, 2011, CELL HOST MICROBE, V9, P520, DOI 10.1016/j.chom.2011.05.007; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Wang WQ, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-49; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Weed SA, 2001, ONCOGENE, V20, P6418, DOI 10.1038/sj.onc.1204783; WENG ZG, 1993, J BIOL CHEM, V268, P14956; WU H, 1991, MOL CELL BIOL, V11, P5113, DOI 10.1128/MCB.11.10.5113; Yadav SS, 2009, BIOCHEMISTRY-US, V48, P10956, DOI 10.1021/bi900978f; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yang XJ, 2007, EMBO REP, V8, P556, DOI 10.1038/sj.embor.7400977; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	48	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33662	10.1371/journal.pone.0033662	http://dx.doi.org/10.1371/journal.pone.0033662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479425	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100064
J	Nadiminty, N; Tummala, R; Lou, W; Zhu, YZ; Shi, XB; Zou, JX; Chen, HW; Zhang, J; Chen, XB; Luo, J; White, RWD; Kung, HJ; Evans, CP; Gao, AC				Nadiminty, Nagalakshmi; Tummala, Ramakumar; Lou, Wei; Zhu, Yezi; Shi, Xu-Bao; Zou, June X.; Chen, Hongwu; Zhang, Jin; Chen, Xinbin; Luo, Jun; White, Ralph W. deVere; Kung, Hsing-Jien; Evans, Christopher P.; Gao, Allen C.			MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth	PLOS ONE			English	Article							ANDROGEN-INDEPENDENT GROWTH; CELL-DEATH; EXPRESSION; LIN28; DIFFERENTIATION; TRANSFORMATION; ACTIVATION; NF-KAPPA-B2/P52; INHIBITOR; RECEPTOR	Purpose: Prostate cancer (PCa) is characterized by deregulated expression of several tumor suppressor or oncogenic miRNAs. The objective of this study was the identification and characterization of miR-let-7c as a potential tumor suppressor in PCa. Experimental Design: Levels of expression of miR-let-7c were examined in human PCa cell lines and tissues using qRT-PCR and in situ hybridization. Let-7c was overexpressed or suppressed to assess the effects on the growth of human PCa cell lines. Lentiviral-mediated re-expression of let-7c was utilized to assess the effects on human PCa xenografts. Results: We identified miR-let-7c as a potential tumor suppressor in PCa. Expression of let-7c is downregulated in castration-resistant prostate cancer (CRPC) cells. Overexpression of let-7c decreased while downregulation of let-7c increased cell proliferation, clonogenicity and anchorage-independent growth of PCa cells in vitro. Suppression of let-7c expression enhanced the ability of androgen-sensitive PCa cells to grow in androgen-deprived conditions in vitro. Reconstitution of Let-7c by lentiviral-mediated intratumoral delivery significantly reduced tumor burden in xenografts of human PCa cells. Furthermore, let-7c expression is downregulated in clinical PCa specimens compared to their matched benign tissues, while the expression of Lin28, a master regulator of let-7 miRNA processing, is upregulated in clinical PCa specimens. Conclusions: These results demonstrate that microRNA let-7c is downregulated in PCa and functions as a tumor suppressor, and is a potential therapeutic target for PCa.	[Nadiminty, Nagalakshmi; Tummala, Ramakumar; Lou, Wei; Zhu, Yezi; Shi, Xu-Bao; White, Ralph W. deVere; Evans, Christopher P.; Gao, Allen C.] Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA; [Zou, June X.; Chen, Hongwu; Kung, Hsing-Jien] Univ Calif Davis, Dept Biochem & Mol Med, Sacramento, CA 95817 USA; [Zou, June X.; Chen, Hongwu; Chen, Xinbin; White, Ralph W. deVere; Kung, Hsing-Jien; Evans, Christopher P.; Gao, Allen C.] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA; [Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Sch Vet Med, Comparat Oncol Lab, Sacramento, CA 95817 USA; [Luo, Jun] Johns Hopkins Univ, Dept Urol, Baltimore, MD USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Johns Hopkins University	Nadiminty, N (corresponding author), Univ Calif Davis, Dept Urol, Sacramento, CA 95817 USA.	nnadiminty@ucdavis.edu; acgao@ucdavis.edu	Kung, Hsing-Jien/C-7651-2013; Zhu, Yezi/F-2373-2014; Jackson, Benjamin L/C-4297-2012		NIH [CA140468, CA118887, CA109441, DOD PC080538, DOD PC100502]; American Cancer Society-IRG; NATIONAL CANCER INSTITUTE [R01CA081237, R01CA109441, R01CA123227, R01CA118887, R01CA140468, P30CA093373, R01CA168601] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society-IRG(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH CA140468, CA118887, CA109441, DOD PC080538 (AG) and DOD PC100502, American Cancer Society-IRG (NN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RJ, 2010, CANCER CELL, V17, P535, DOI 10.1016/j.ccr.2010.04.027; Barh D, 2010, CURR ONCOL, V17, P70; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; COPPOLA V, 2009, ENDOCR RELAT CANC; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Dong QC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010147; Dunn TA, 2006, AM J PATHOL, V169, P1843, DOI 10.2353/ajpath.2006.060316; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Gandellini P, 2009, TRENDS MOL MED, V15, P381, DOI 10.1016/j.molmed.2009.07.004; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lawrie CH, 2009, J CELL MOL MED, V13, P1248, DOI 10.1111/j.1582-4934.2008.00628.x; Lee SO, 2003, CLIN CANCER RES, V9, P370; Lee SO, 2007, PROSTATE, V67, P764, DOI 10.1002/pros.20553; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nadiminty N, 2011, J BIOL CHEM; Nadiminty N, 2006, P NATL ACAD SCI USA, V103, P7264, DOI 10.1073/pnas.0509808103; Nadiminty N, 2010, CANCER RES, V70, P3309, DOI 10.1158/0008-5472.CAN-09-3703; Nadiminty N, 2010, PROSTATE, V70, P276, DOI 10.1002/pros.21062; Nadiminty N, 2008, PROSTATE, V68, P1725, DOI 10.1002/pros.20839; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Shi XB, 2008, CELL CYCLE, V7, P1529, DOI 10.4161/cc.7.11.5977; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	37	126	129	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32832	10.1371/journal.pone.0032832	http://dx.doi.org/10.1371/journal.pone.0032832			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479342	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100020
J	Ridzuan, MAM; Moon, RW; Knuepfer, E; Black, S; Holder, AA; Green, JL				Ridzuan, Mohd A. Mohd; Moon, Robert W.; Knuepfer, Ellen; Black, Sally; Holder, Anthony A.; Green, Judith L.			Subcellular Location, Phosphorylation and Assembly into the Motor Complex of GAP45 during Plasmodium falciparum Schizont Development	PLOS ONE			English	Article							ERYTHROCYTE INVASION; CYTOKINESIS; KINASES	An actomyosin motor complex assembled below the parasite's plasma membrane drives erythrocyte invasion by Plasmodium falciparum merozoites. The complex is comprised of several proteins including myosin (MyoA), myosin tail domain interacting protein (MTIP) and glideosome associated proteins (GAP) 45 and 50, and is anchored on the inner membrane complex (IMC), which underlies the plasmalemma. A ternary complex of MyoA, MTIP and GAP45 is formed that then associates with GAP50. We show that full length GAP45 labelled internally with GFP is assembled into the motor complex and transported to the developing IMC in early schizogony, where it accumulates during intracellular development until merozoite release. We show that GAP45 is phosphorylated by calcium dependent protein kinase 1 (CDPK1), and identify the modified serine residues. Replacing these serine residues with alanine or aspartate has no apparent effect on GAP45 assembly into the motor protein complex or its subcellular location in the parasite. The early assembly of the motor complex suggests that it has functions in addition to its role in erythrocyte invasion.	[Ridzuan, Mohd A. Mohd; Moon, Robert W.; Knuepfer, Ellen; Black, Sally; Holder, Anthony A.; Green, Judith L.] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England; [Ridzuan, Mohd A. Mohd] Inst Med Res, Herbal Med Res Ctr, Kuala Lumpur 50588, Malaysia	MRC National Institute for Medical Research; Kementerian Kesihatan Malaysia	Ridzuan, MAM (corresponding author), Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England.	judith.green@nimr.mrc.ac.uk	Mohd Abd Razak, Mohd Ridzuan/GXZ-7049-2022; Moon, Robert/AAF-9808-2019; Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; Mohd Abd Razak, Mohd Ridzuan/0000-0002-9589-5892; Green, Judith/0000-0001-6825-9404; Knuepfer, Ellen/0000-0002-6090-1877; Moon, Robert/0000-0002-9070-4292	Ministry of Science, Technology and Innovation (MOSTI); Director of Institute for Medical Research, Ministry of Health, Malaysia; Medical Research Council [U117532067]; European Community's Seventh Framework Programme [242095]; MRC [MC_U117532067] Funding Source: UKRI; Medical Research Council [MC_U117532067] Funding Source: researchfish	Ministry of Science, Technology and Innovation (MOSTI)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Director of Institute for Medical Research, Ministry of Health, Malaysia; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community's Seventh Framework Programme(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MAMR was in receipt of a studentship and granted a full time study leave from the Ministry of Science, Technology and Innovation (MOSTI) and the Director of Institute for Medical Research, Ministry of Health, Malaysia, respectively. This work was funded by the Medical Research Council (U117532067) and the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 242095. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agop-Nersesian C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000270; Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Bullen HE, 2009, J BIOL CHEM, V284, P25353, DOI 10.1074/jbc.M109.036772; Burgess DR, 2005, CURR BIOL, V15, pR310, DOI 10.1016/j.cub.2005.04.008; Delbac F, 2001, J CELL BIOL, V155, P613, DOI 10.1083/jcb.200012116; Farrow RE, 2011, SEMIN CELL DEV BIOL, V22, P953, DOI 10.1016/j.semcdb.2011.09.022; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Field C, 1999, CURR OPIN CELL BIOL, V11, P68, DOI 10.1016/S0955-0674(99)80009-X; Frenal K, 2010, CELL HOST MICROBE, V8, P343, DOI 10.1016/j.chom.2010.09.002; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gilk SD, 2009, EUKARYOT CELL, V8, P190, DOI 10.1128/EC.00201-08; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; Jones ML, 2006, MOL BIOCHEM PARASIT, V147, P74, DOI 10.1016/j.molbiopara.2006.01.009; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Papakrivos J, 2005, MOL MICROBIOL, V55, P1272, DOI 10.1111/j.1365-2958.2004.04468.x; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; Striepen B, 2007, PLOS PATHOG, V3, P691, DOI 10.1371/journal.ppat.0030078; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; Yeoman JA, 2011, EUKARYOT CELL, V10, P556, DOI 10.1128/EC.00244-10	29	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33845	10.1371/journal.pone.0033845	http://dx.doi.org/10.1371/journal.pone.0033845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479457	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305339100075
J	Shao, J; Diamond, MI				Shao, Jieya; Diamond, Marc I.			Protein Phosphatase 1 Dephosphorylates Profilin-1 at Ser-137	PLOS ONE			English	Article							BREAST-CANCER CELLS; FASUDIL; ACTIN; REGULATOR; KINASE; PHOSPHORYLATION; OVEREXPRESSION; SPECIFICITY; INHIBITORS; VASOSPASM	Profilin-1 (PFN1) plays an important role in the control of actin dynamics, and could represent an important therapeutic target in several diseases. We previously identified PFN1 as a huntingtin aggregation inhibitor, and others have implicated it as a tumor-suppressor. Rho-associated kinase (ROCK) directly phosphorylates PFN1 at Ser-137 to prevent its binding to polyproline sequences. This negatively regulates its anti-aggregation activity. However, the phosphatase that dephosphorylates PFN1 at Ser-137, and thus activates it, is unknown. Using a phospho-specific antibody against Ser-137 of PFN1, we characterized PFN1 dephosphorylation in cultured cells based on immunocytochemistry and a quantitative plate reader-based assay. Both okadaic acid and endothall increased pS137-PFN1 levels at concentrations more consistent with their known IC(50)s for protein phosphatase 1 (PP1) than protein phosphatase 2A (PP2A). Knockdown of the catalytic subunit of PP1 (PP1C alpha), but not PP2A (PP2AC alpha), increased pS137-PFN1 levels. PP1C alpha binds PFN1 in cultured cells, and this interaction was increased by a phosphomimetic mutation of PFN1 at Ser-137 (S137D). Together, these data define PP1 as the principal phosphatase for Ser-137 of PFN1, and provide mechanistic insights into PFN1 regulation by phosphorylation.	[Shao, Jieya; Diamond, Marc I.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA	Washington University (WUSTL)	Shao, J (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	shaoj@neuro.wustl.edu			American Cancer Society Institutional Research Grant; Muscular Dystrophy Association; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R01 NS50284]; Neuroscience Blueprint Core grant from NIH [P30 NS057105]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050284, P30NS057105] Funding Source: NIH RePORTER	American Cancer Society Institutional Research Grant(American Cancer Society); Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Neuroscience Blueprint Core grant from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the American Cancer Society Institutional Research Grant (Dr. Shao, www.cancer.org), the Muscular Dystrophy Association (Dr. Shao and Dr. Diamond, www.mdausa.org), National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) R01 NS50284 (Dr. Diamond). The Hope Center Viral Vectors Core is supported by a Neuroscience Blueprint Core grant (P30 NS057105) from NIH to Washington University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Behnen M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-34; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Birbach A, 2008, BIOESSAYS, V30, P994, DOI 10.1002/bies.20822; Bottcher RT, 2009, EMBO J, V28, P1157, DOI 10.1038/emboj.2009.58; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Burthem J, 2007, LEUKEMIA, V21, P1708, DOI 10.1038/sj.leu.2404762; Cohen PTW, 2002, J CELL SCI, V115, P241; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Feng Yunfeng, 2010, Genomics Proteomics & Bioinformatics, V8, P238, DOI 10.1016/S1672-0229(10)60025-3; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Janke J, 2000, J EXP MED, V191, P1675, DOI 10.1084/jem.191.10.1675; Li M, 2009, NEUROBIOL DIS, V36, P413, DOI 10.1016/j.nbd.2009.06.011; LI YM, 1992, P NATL ACAD SCI USA, V89, P11867, DOI 10.1073/pnas.89.24.11867; Mitsuhashi S, 2003, J BIOL CHEM, V278, P82, DOI 10.1074/jbc.M208888200; Roy P, 2004, CELL MOTIL CYTOSKEL, V57, P84, DOI 10.1002/cm.10160; Sahai E, 1999, CURR BIOL, V9, P136, DOI 10.1016/S0960-9822(99)80067-0; Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001; Schluter K, 1997, BBA-MOL CELL RES, V1359, P97, DOI 10.1016/S0167-4889(97)00100-6; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Swingle Mark, 2007, V365, P23; Tachibana E, 1999, ACTA NEUROCHIR, V141, P13, DOI 10.1007/s007010050260; Takanashi Y, 2001, NEUROSURGERY, V48, P894, DOI 10.1097/00006123-200104000-00041; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Wittenmayer N, 2004, MOL BIOL CELL, V15, P1600, DOI 10.1091/mbc.E03-12-0873; Yi KD, 2008, ENDOCRINOLOGY, V149, P5235, DOI 10.1210/en.2008-0610; Ying H, 2006, MOL CANCER THER, V5, P2158, DOI 10.1158/1535-7163.MCT-05-0440; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038; Zou L, 2010, J CELL PHYSIOL, V223, P623, DOI 10.1002/jcp.22058	30	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32802	10.1371/journal.pone.0032802	http://dx.doi.org/10.1371/journal.pone.0032802			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479341	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100019
J	Chapman, R; Shephard, E; Stutz, H; Douglass, N; Sambandamurthy, V; Garcia, I; Ryffel, B; Jacobs, W; Williamson, AL				Chapman, Rosamund; Shephard, Enid; Stutz, Helen; Douglass, Nicola; Sambandamurthy, Vasan; Garcia, Irene; Ryffel, Bernhard; Jacobs, William; Williamson, Anna-Lise			Priming with a Recombinant Pantothenate Auxotroph of Mycobacterium bovis BCG and Boosting with MVA Elicits HIV-1 Gag Specific CD8(+) T Cells	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BACILLUS-CALMETTE-GUERIN; SURFACE PROTEIN-A; VACCINE; TUBERCULOSIS; INFECTION; PROTECTION; RESPONSES; REPLICATION; EXPRESSION	A safe and effective HIV vaccine is required to significantly reduce the number of people becoming infected with HIV each year. In this study wild type Mycobacterium bovis BCG Pasteur and an attenuated pantothenate auxotroph strain (BCG Delta panCD) that is safe in SCID mice, have been compared as vaccine vectors for HIV-1 subtype C Gag. Genetically stable vaccines BCG[pHS400] (BCG-Gag) and BCGDpanCD[pHS400] (BCGpan-Gag) were generated using the Pasteur strain of BCG, and a panothenate auxotroph of Pasteur respectively. Stability was achieved by the use of a codon optimised gag gene and deletion of the hsp60-lysA promoter-gene cassette from the episomal vector pCB119. In this vector expression of gag is driven by the mtrA promoter and the Gag protein is fused to the Mycobacterium tuberculosis 19 kDa signal sequence. Both BCG-Gag and BCGpan-Gag primed the immune system of BALB/c mice for a boost with a recombinant modified vaccinia virus Ankara expressing Gag (MVA-Gag). After the boost high frequencies of predominantly Gag-specific CD8(+) T cells were detected when BCGpan-Gag was the prime in contrast to induction of predominantly Gag-specific CD4(+) T cells when priming with BCG-Gag. The differing Gag-specific T-cell phenotype elicited by the prime-boost regimens may be related to the reduced inflammation observed with the pantothenate auxotroph strain compared to the parent strain. These features make BCGpan-Gag a more desirable HIV vaccine candidate than BCG-Gag. Although no Gag-specific cells could be detected after vaccination of BALB/c mice with either recombinant BCG vaccine alone, BCGpan-Gag protected mice against a surrogate vaccinia virus challenge.	[Chapman, Rosamund; Shephard, Enid; Stutz, Helen; Douglass, Nicola; Williamson, Anna-Lise] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Chapman, Rosamund; Stutz, Helen; Douglass, Nicola; Williamson, Anna-Lise] Univ Cape Town, Div Med Virol, Dept Clin Lab Sci, ZA-7925 Cape Town, South Africa; [Shephard, Enid] Univ Cape Town, Dept Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Shephard, Enid] MRC, Cape Town, South Africa; [Sambandamurthy, Vasan] AstraZeneca Res & Dev, Infect iMED, Bangalore, Karnataka, India; [Garcia, Irene] Univ Geneva, Dept Pathol & Immunol, Ctr Med Univ, Hop Univ Geneve, Geneva, Switzerland; [Ryffel, Bernhard] Univ Orleans, Orleans, France; [Ryffel, Bernhard] CNRS, Unite Mixte Rech Mol Immunol & Embryol, F-45071 Orleans, France; [Jacobs, William] Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10467 USA; [Williamson, Anna-Lise] Natl Hlth Lab Serv, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; AstraZeneca; University of Geneva; Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	Chapman, R (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	Anna-Lise.Williamson@uct.ac.za	Chapman, Rosamund/AAJ-6490-2020	Williamson, Anna-Lise/0000-0002-5467-1200; Douglass, Nicola/0000-0002-8929-6279; Jacobs, William/0000-0003-3321-3080; Chapman, Rosamund/0000-0001-9162-2099	South African AIDS Vaccine Initiative (SAAVI); National Institutes of Health (NIH USA); Phased Innovation Awards in AIDS Vaccine Research [PIA R21, PIA R33, 5R33AI73182-4]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI073182, P01AI063537] Funding Source: NIH RePORTER	South African AIDS Vaccine Initiative (SAAVI); National Institutes of Health (NIH USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Phased Innovation Awards in AIDS Vaccine Research; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the South African AIDS Vaccine Initiative (SAAVI) and National Institutes of Health (NIH USA) for funding from the Phased Innovation Awards (PIA R21/R33) in AIDS Vaccine Research; grant number 5R33AI73182-4. This work is also based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zarouni M, 2002, TUBERCULOSIS, V82, P283, DOI 10.1054/tube.2002.0374; Aldovini A, 1990, Int Rev Immunol, V7, P79, DOI 10.3109/08830189009061766; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Ami Y, 2006, J VIROL, V80, P10288, DOI 10.1128/JVI.01681-06; BINDER D, 1991, J IMMUNOL, V146, P4301; Cayabyab MJ, 2009, J VIROL, V83, P5505, DOI 10.1128/JVI.02544-08; Cayabyab MJ, 2006, J VIROL, V80, P1645, DOI 10.1128/JVI.80.4.1645-1652.2006; Chapman R, 2010, CURR HIV RES, V8, P282, DOI 10.2174/157016210791208686; Chege GK, 2009, VACCINE, V27, P4857, DOI 10.1016/j.vaccine.2009.05.064; CIRILLO JD, 1995, CLIN INFECT DIS, V20, P1001, DOI 10.1093/clinids/20.4.1001; Dennehy M, 2007, VACCINE, V25, P3646, DOI 10.1016/j.vaccine.2007.01.087; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; Dudani R, 2002, J IMMUNOL, V168, P5737, DOI 10.4049/jimmunol.168.11.5737; FENNELLY GJ, 1995, J INFECT DIS, V172, P698, DOI 10.1093/infdis/172.3.698; Govan VA, 2007, VIRUS RES, V127, P43, DOI 10.1016/j.virusres.2007.03.016; Grode L, 2005, J CLIN INVEST, V115, P2472, DOI 10.1172/JCI24617; HAESELEER F, 1994, RES MICROBIOL, V145, P683, DOI 10.1016/0923-2508(94)90040-X; HANSON MS, 1995, DEV BIOL STAND, V84, P229; Hesseling AC, 2007, VACCINE, V25, P6565, DOI 10.1016/j.vaccine.2007.06.045; Hesseling AC, 2003, CLIN INFECT DIS, V37, P1226, DOI 10.1086/378298; Hinchey J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015857; Hondalus MK, 2000, INFECT IMMUN, V68, P2888, DOI 10.1128/IAI.68.5.2888-2898.2000; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Hopkins R, 2011, EUR J IMMUNOL, V41, P3542, DOI 10.1002/eji.201141962; Hopkins R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020067; Im EJ, 2007, J VIROL, V81, P9408, DOI 10.1128/JVI.00707-07; Joseph J, 2006, EXPERT REV VACCINES, V5, P827, DOI 10.1586/14760584.5.6.827; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kumar D, 1998, VACCINE, V16, P1212, DOI 10.1016/S0264-410X(98)80121-7; LANGERMANN S, 1994, NATURE, V372, P552, DOI 10.1038/372552a0; Letvin NL, 2002, J CLIN INVEST, V110, P15, DOI 10.1172/JCI200215985; Masemola AM, 2004, J IMMUNOL, V173, P4607, DOI 10.4049/jimmunol.173.7.4607; Mata M, 1998, J IMMUNOL, V161, P2985; Mata M, 1999, J IMMUNOL, V163, P1449; Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129; Ranganathan UDK, 2009, VACCINE, V28, P152, DOI 10.1016/j.vaccine.2009.09.087; Richmond M, 2011, J VIROL, V85, P1275, DOI 10.1128/JVI.01707-10; Rosario M, 2010, J VIROL, V84, P7815, DOI 10.1128/JVI.00726-10; Rosario M, 2010, J VIROL, V84, P5898, DOI 10.1128/JVI.02607-09; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; Sampson SL, 2004, INFECT IMMUN, V72, P3031, DOI 10.1128/IAI.72.5.3031-3037.2004; Saubi N, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/516219; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Someya K, 2006, J IMMUNOL, V176, P1784, DOI 10.4049/jimmunol.176.3.1784; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; STOVER CK, 1993, J EXP MED, V178, P197, DOI 10.1084/jem.178.1.197; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun R, 2009, VACCINE, V27, P4412, DOI 10.1016/j.vaccine.2009.05.048; Tullius MV, 2008, INFECT IMMUN, V76, P5200, DOI 10.1128/IAI.00434-08; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; van Faassen H, 2005, J IMMUNOL, V174, P5341, DOI 10.4049/jimmunol.174.9.5341; van Harmelen JH, 2003, VACCINE, V21, P4380, DOI 10.1016/S0264-410X(03)00406-7; Velaparthi S, 2008, J MED CHEM, V51, P1999, DOI 10.1021/jm701372r; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2; Yu JS, 2007, CLIN VACCINE IMMUNOL, V14, P886, DOI 10.1128/CVI.00407-06	59	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32769	10.1371/journal.pone.0032769	http://dx.doi.org/10.1371/journal.pone.0032769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479338	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400008
J	Haro, M; Serra, J; Herrera, P; Corral, A				Haro, Martin; Serra, Joan; Herrera, Perfecto; Corral, Alvaro			Zipf's Law in Short-Time Timbral Codings of Speech, Music, and Environmental Sound Signals	PLOS ONE			English	Article							POWER-LAW; 1/F NOISE; DISTRIBUTIONS; SCALE; TAILS; RECOGNITION; LOUDNESS	Timbre is a key perceptual feature that allows discrimination between different sounds. Timbral sensations are highly dependent on the temporal evolution of the power spectrum of an audio signal. In order to quantitatively characterize such sensations, the shape of the power spectrum has to be encoded in a way that preserves certain physical and perceptual properties. Therefore, it is common practice to encode short-time power spectra using psychoacoustical frequency scales. In this paper, we study and characterize the statistical properties of such encodings, here called timbral code-words. In particular, we report on rank-frequency distributions of timbral code-words extracted from 740 hours of audio coming from disparate sources such as speech, music, and environmental sounds. Analogously to text corpora, we find a heavy-tailed Zipfian distribution with exponent close to one. Importantly, this distribution is found independently of different encoding decisions and regardless of the audio source. Further analysis on the intrinsic characteristics of most and least frequent code-words reveals that the most frequent code-words tend to have a more homogeneous structure. We also find that speech and music databases have specific, distinctive code-words while, in the case of the environmental sounds, this database-specific code-words are not present. Finally, we find that a Yule-Simon process with memory provides a reasonable quantitative approximation for our data, suggesting the existence of a common simple generative mechanism for all considered sound sources.	[Haro, Martin; Serra, Joan; Herrera, Perfecto] Univ Pompeu Fabra, Mus Technol Grp, Barcelona, Spain; [Serra, Joan] CSIC, Artificial Intelligence Res Inst IIIA CSIC, Barcelona, Spain; [Corral, Alvaro] Ctr Recerca Matemat, Complex Syst Grp, Barcelona, Spain	Pompeu Fabra University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Inteligencia Artificial (IIIA); Centre de Recerca Matematica (CRM)	Haro, M (corresponding author), Univ Pompeu Fabra, Mus Technol Grp, Barcelona, Spain.	martin.haro@upf.edu	Corral, Alvaro/I-5590-2015; Herrera, Perfecto/C-4658-2012	Corral, Alvaro/0000-0002-5280-2692; Herrera, Perfecto/0000-0003-2799-7675	Classical Planet [TSI-070100-2009-407]; DRIMS [TIN2009-14247-C02-01, FIS2009-09508, 2009SGR-164]; Consejo Superior de Investigaciones Cientificas [JAEDOC069/2010]; Generalitat de Catalunya [2009-SGR-1434]	Classical Planet; DRIMS; Consejo Superior de Investigaciones Cientificas; Generalitat de Catalunya(Generalitat de Catalunya)	Funding was received from Classical Planet: TSI-070100-2009-407 (MITYC), www.mityc.es; DRIMS: TIN2009-14247-C02-01 (MICINN), www. micinn. es; FIS2009-09508, www.micinn.es; and 2009SGR-164, www.gencat.cat.JS acknowledges funding from Consejo Superior de Investigaciones Cientificas (JAEDOC069/2010), www.csic.es; and Generalitat de Catalunya (2009-SGR-1434), www.gencat.cat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic L.A., 2002, GLOTTOMETRICS, V3, P143; American National Standards Institute, 1973, PSYCH TERM S3 20; Aucouturier JJ, 2007, J ACOUST SOC AM, V122, P881, DOI 10.1121/1.2750160; Baeza-Yates RA, 1999, MODERN INFORM RETRIE; Bak P., 1996, NATURE WORKS SCI SEL; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Berg R.E., 1995, PHYS SOUND; Bethge M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088104; Bigand E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027024; Bregman A.S., 1990, AUDITORY SCENE ANAL; Cancho RFI, 2003, P NATL ACAD SCI USA, V100, P788, DOI 10.1073/pnas.0335980100; Casey MA, 2008, P IEEE, V96, P668, DOI 10.1109/JPROC.2008.916370; Cattuto C, 2007, P NATL ACAD SCI USA, V104, P1461, DOI 10.1073/pnas.0610487104; Chater N, 1999, COGNITION, V69, pB17, DOI 10.1016/S0010-0277(98)00066-3; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Corominas-Murtra B, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011102; Corral A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066103; del Rio MB, 2008, PHYSICA A, V387, P5552, DOI 10.1016/j.physa.2008.05.031; Eliazar I, 2009, P NATL ACAD SCI USA, V106, P12251, DOI 10.1073/pnas.0900299106; Ferrer-i-Cancho R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009411; Fletcher H, 1933, J ACOUST SOC AM, V5, P82, DOI 10.1121/1.1915637; Assaneo MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028317; Haitsma J., 2002, ISMIR 2002, P107; Harding S, 2008, LECT NOTES ARTIFICIA; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; HSU KJ, 1990, P NATL ACAD SCI USA, V87, P938, DOI 10.1073/pnas.87.3.938; HSU KJ, 1991, P NATL ACAD SCI USA, V88, P3507, DOI 10.1073/pnas.88.8.3507; Klapuri A., 2006, SIGNAL PROCESSING ME; Kramer EM, 1996, PHYS REV E, V53, P1465, DOI 10.1103/PhysRevE.53.1465; Liu B, 2011, DATA CENTRIC SYST AP, P1, DOI 10.1007/978-3-642-19460-3; Madisetti V., 1997, DIGITAL SIGNAL PROCE; Malamud BD, 2004, PHYS WORLD, V17, P31; Manaris B, 2005, COMPUT MUSIC J, V29, P55, DOI 10.1162/comj.2005.29.1.55; Manning C.D., 1999, FDN STAT NATURAL LAN; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; MONTROLL EW, 1982, P NATL ACAD SCI USA, V79, P3380, DOI 10.1073/pnas.79.10.3380; Moore BCJ, 1996, ACUSTICA, V82, P335; Moore BCJ, 2005, BLACKWELL HDB SENSAT; Muller M, 2011, IEEE J-STSP, V5, P1088, DOI 10.1109/JSTSP.2011.2112333; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Oceak A, 2008, NEUROSCI LETT, V436, P85, DOI 10.1016/j.neulet.2008.02.066; Peterson GJ, 2010, P NATL ACAD SCI USA, V107, P16023, DOI 10.1073/pnas.1010757107; Plazak J, 2011, MUSIC SCI, V15, P29, DOI 10.1177/1029864910391455; Quatieri T.F., 2001, DISCRETE TIME SPEECH, V1st; Saichev A., 2009, LECT NOTES EC MATH S, VVolume 632; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; SIMON HA, 1955, BIOMETRIKA, V42, P425; SORNETTE D, 2004, SPRINGER SERIES SYNE, P1; Stevens SS, 1937, J ACOUST SOC AM, V8, P185, DOI 10.1121/1.1915893; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; Zanette D, 2008, NATURE, V453, P988, DOI 10.1038/453988a; Zanette DH, 2006, MUSIC SCI, V10, P3, DOI 10.1177/102986490601000101; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL; ZWICKER E, 1980, J ACOUST SOC AM, V68, P1523, DOI 10.1121/1.385079; ZWICKER E, 1961, J ACOUST SOC AM, V33, P248, DOI 10.1121/1.1908630	56	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33993	10.1371/journal.pone.0033993	http://dx.doi.org/10.1371/journal.pone.0033993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479497	Green Published, Green Submitted, gold			2022-12-27	WOS:000304523400049
J	Leise, TL; Wang, CW; Gitis, PJ; Welsh, DK				Leise, Tanya L.; Wang, Connie W.; Gitis, Paula J.; Welsh, David K.			Persistent Cell-Autonomous Circadian Oscillations in Fibroblasts Revealed by Six-Week Single-Cell Imaging of PER2::LUC Bioluminescence	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; INDIVIDUAL FIBROBLASTS; COHERENCE RESONANCE; NOISE-PROPAGATION; TIME; CLOCK; ROBUSTNESS; SIMULATION; STABILITY; FEEDBACK	Biological oscillators naturally exhibit stochastic fluctuations in period and amplitude due to the random nature of molecular reactions. Accurately measuring the precision of noisy oscillators and the heterogeneity in period and strength of rhythmicity across a population of cells requires single-cell recordings of sufficient length to fully represent the variability of oscillations. We found persistent, independent circadian oscillations of clock gene expression in 6-week-long bioluminescence recordings of 80 primary fibroblast cells dissociated from PER2::LUC mice and kept in vitro for 6 months. Due to the stochastic nature of rhythmicity, the proportion of cells appearing rhythmic increases with the length of interval examined, with 100% of cells found to be rhythmic when using 3-week windows. Mean period and amplitude are remarkably stable throughout the 6-week recordings, with precision improving over time. For individual cells, precision of period and amplitude are correlated with cell size and rhythm amplitude, but not with period, and period exhibits much less cycle-to-cycle variability (CV 7.3%) than does amplitude (CV 37%). The time series are long enough to distinguish stochastic fluctuations within each cell from differences among cells, and we conclude that the cells do exhibit significant heterogeneity in period and strength of rhythmicity, which we measure using a novel statistical metric. Furthermore, stochastic modeling suggests that these single-cell clocks operate near a Hopf bifurcation, such that intrinsic noise enhances the oscillations by minimizing period variability and sustaining amplitude.	[Leise, Tanya L.] Amherst Coll, Dept Math, Amherst, MA 01002 USA; [Wang, Connie W.; Gitis, Paula J.; Welsh, David K.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Wang, Connie W.; Gitis, Paula J.; Welsh, David K.] Univ Calif San Diego, Ctr Chronobiol, La Jolla, CA 92093 USA; [Welsh, David K.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	Amherst College; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Leise, TL (corresponding author), Amherst Coll, Dept Math, Amherst, MA 01002 USA.	tleise@amherst.edu		Leise, Tanya/0000-0002-7458-7604	National Institutes of Health [R01 MH082945]; Veterans Affairs Career Development Award; Faculty at Amherst College; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Career Development Award; Faculty at Amherst College; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institutes of Health (R01 MH082945 to DKW) and a Veterans Affairs Career Development Award (DKW). TLL gratefully acknowledges support from the Dean of Faculty at Amherst College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Beek PJ, 2002, BRAIN COGNITION, V48, P149, DOI 10.1006/brcg.2001.1310; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BLISS RD, 1982, J THEOR BIOL, V97, P177, DOI 10.1016/0022-5193(82)90098-4; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dowse HB, 2009, METHOD ENZYMOL, V454, P141, DOI 10.1016/S0076-6879(08)03806-8; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Forger DB, 2005, P NATL ACAD SCI USA, V102, P321, DOI 10.1073/pnas.0408465102; GANG H, 1993, PHYS REV LETT, V71, P807, DOI 10.1103/PhysRevLett.71.807; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Geva-Zatorsky N, 2010, P NATL ACAD SCI USA, V107, P13550, DOI 10.1073/pnas.1001107107; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Hogenesch JB, 2011, FEBS LETT, V585, P1427, DOI 10.1016/j.febslet.2011.04.048; Hooshangi S, 2006, CHAOS, V16, DOI 10.1063/1.2208927; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Kuske R, 2007, J THEOR BIOL, V245, P459, DOI 10.1016/j.jtbi.2006.10.029; Lang M, 2011, B MATH BIOL, V73, P2678, DOI 10.1007/s11538-011-9642-8; Leise TL, 2011, J BIOL RHYTHM, V26, P454, DOI 10.1177/0748730411416330; Li H, 2008, BIOTECHNOL PROGR, V24, P56, DOI 10.1021/bp070255h; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Locke JCW, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-22; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Morelli LG, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.228101; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Petronis A, 2010, NATURE, V465, P721, DOI 10.1038/nature09230; Pikovsky AS, 1997, PHYS REV LETT, V78, P775, DOI 10.1103/PhysRevLett.78.775; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rawlings JO, 1998, APPL REGRESSION ANAL, DOI 10.1007/b98890; Rougemont J, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011104; Rougemont J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100130; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Steuer R, 2003, BIOSYSTEMS, V72, P241, DOI 10.1016/j.biosystems.2003.07.001; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tyson J.J., 2002, INTERD APPL, P230, DOI 10.1007/978-0-387-22459-6_9; Vasalou C, 2009, J BIOL RHYTHM, V24, P243, DOI 10.1177/0748730409333220; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Welsh DK, 2005, METHOD ENZYMOL, V393, P269, DOI 10.1016/S0076-6879(05)93011-5; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Westermark PO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000580; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	58	64	64	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33334	10.1371/journal.pone.0033334	http://dx.doi.org/10.1371/journal.pone.0033334			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479387	Green Published, gold			2022-12-27	WOS:000304523400021
J	Rainio, MJ; Kanerva, M; Wahlberg, N; Nikinmaa, M; Eeva, T				Rainio, Miia J.; Kanerva, Mirella; Wahlberg, Niklas; Nikinmaa, Mikko; Eeva, Tapio			Variation of Basal EROD Activities in Ten Passerine Bird Species - Relationships with Diet and Migration Status	PLOS ONE			English	Article							FUNCTION OXIDASE ACTIVITY; METABOLIC-RATE; FOOD-HABITS; CYTOCHROME-P450; ETHOXYRESORUFIN; ENVIRONMENT; VARIABILITY; PHYLOGENY; DEFENSE; FOREST	Inter-specific differences in animal defence mechanisms against toxic substances are currently poorly understood. The ethoxyresorufin-O-deethylase (EROD) enzyme plays an important role in defence against toxic chemicals in a wide variety of animals, and it is an important biomarker for environmental contamination. We compared basal hepatic EROD activity levels among ten passerine species to see if there is inter-specific variation in enzyme activity, especially in relation to their diet and migration status. Migratory insectivores showed higher EROD activity compared to granivores. We hypothesize that the variable invertebrate diet of migratory insectivores contains a wider range of natural toxins than the narrower diet of granivores. This may have affected the evolution of mixed function oxidases (MFO) system and enzyme activities. We further tested whether metabolic rates or relative liver size were associated with the variation in detoxification capacity. We found no association between EROD activity and relative (per mass unit) basal metabolic rate (BMR). Instead, EROD activity and relative liver mass (% of body mass) correlated positively, suggesting that a proportionally large liver also functions efficiently. Our results suggest that granivores and non- migratory birds may be more vulnerable to environmental contaminants than insectivores and migratory birds. The diet and migration status, however, are phylogenetically strongly connected to each other, and their roles cannot be fully separated in our analysis with only ten passerine species.	[Rainio, Miia J.; Eeva, Tapio] Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland; [Kanerva, Mirella; Wahlberg, Niklas; Nikinmaa, Mikko] Univ Turku, Dept Biol, Div Genet & Physiol, SF-20500 Turku, Finland	University of Turku; University of Turku	Rainio, MJ (corresponding author), Univ Turku, Dept Biol, Sect Ecol, SF-20500 Turku, Finland.	miikoi@utu.fi	Wahlberg, Niklas/B-7765-2008; Rainio, Miia Johanna/H-9450-2019; Eeva, Tapio/V-8922-2018; Nikinmaa, Mikko/AAZ-2803-2021	Wahlberg, Niklas/0000-0002-1259-3363; Rainio, Miia Johanna/0000-0003-0420-9314; Eeva, Tapio/0000-0002-0395-1536; Nikinmaa, Mikko/0000-0003-0593-1018	Academy of Finland [8119367]	Academy of Finland(Academy of Finland)	The study was financed by Academy of Finland (T.E. project 8119367). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON T, 1992, AQUAT TOXICOL, V24, P1, DOI 10.1016/0166-445X(92)90014-E; [Anonymous], IBM SPSS STAT 19 0; Benson W.W, 1991, EVOLUTIONARY ECOLOGY, P25; Bernhardt R, 1996, REV PHYSIOL BIOCH P, V127, P137, DOI 10.1007/BFb0048267; Bozinovic F, 2007, PHYSIOL BIOCHEM ZOOL, V80, P452, DOI 10.1086/518376; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brody S., 1945, BIOENERGETICS GROWTH; BROWER LP, 1969, SCI AM, V220, P22, DOI 10.1038/scientificamerican0269-22; BROWN KS, 1995, ALKALOIDS, V47, P227; BURKE MD, 1974, DRUG METAB DISPOS, V2, P583; Cork S.J., 1991, P133; Costantini D, 2008, ECOL LETT, V11, P1238, DOI 10.1111/j.1461-0248.2008.01246.x; Cramp C.M., 1994, BIRDS W PALEARCTIC, VIX; Cramp S., 1992, BIRDS W PALEARCTIC, VVI; Cramp S., 1993, BIRDS W PALEARCTIC, V7; Cramp S.E., 1994, HDB BIRDS EUROPE MID; Cruz-Neto AP, 2001, ZOOL-ANAL COMPLEX SY, V104, P49, DOI 10.1078/0944-2006-00006; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; Davis JA, 1997, ENVIRON TOXICOL CHEM, V16, P1441, DOI 10.1002/etc.5620160717; Discher S, 2009, CHEMBIOCHEM, V10, P2223, DOI 10.1002/cbic.200900226; Eeva T, 2000, FUNCT ECOL, V14, P235, DOI 10.1046/j.1365-2435.2000.00406.x; FOLEY WJ, 1994, DIGESTIVE SYSTEM IN MAMMALS: FOOD, FORM, AND FUNCTION, P370, DOI 10.1017/CBO9780511661716.023; FOSSI MC, 1995, SCI TOTAL ENVIRON, V171, P221, DOI 10.1016/0048-9697(95)04679-1; FOSSI MC, 1991, ENVIRON TOXICOL CHEM, V10, P1179, DOI 10.1002/etc.5620100910; FOSSI MC, 1995, ENVIRON POLLUT, V90, P15, DOI 10.1016/0269-7491(94)00098-X; Gorbi S, 2005, ARCH ENVIRON CON TOX, V49, P62, DOI 10.1007/s00244-004-0150-9; GT Prance, 1985, AMAZONIA, P207; GUENGERICH FP, 1985, CRC CR REV TOXICOL, V14, P259, DOI 10.3109/10408448509037460; HAILS CJ, 1983, CONDOR, V85, P61, DOI 10.2307/1367889; HOLMES RT, 1979, SCIENCE, V206, P462, DOI 10.1126/science.206.4417.462; HOLMES RT, 1986, ECOL MONOGR, V56, P201, DOI 10.2307/2937074; Janzen D.H., 1973, Systematics Ass Spec Vol, VNo. 5,1973, P201; Jetz W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003261; Kennedy SW, 1996, TOXICOL APPL PHARM, V141, P214; KLOEPPERSAMS PJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P525, DOI 10.1016/0003-9861(89)90319-6; Koivula MJ, 2010, ENVIRON POLLUT, V158, P2359, DOI 10.1016/j.envpol.2010.03.013; Liukkonen-Anttila T, 2003, COMP BIOCHEM PHYS C, V134, P69, DOI 10.1016/S1532-0456(02)00211-9; Maddison W., 2018, MESQUITE MODULAR SYS; Marshall MR, 2002, ECOL APPL, V12, P261, DOI 10.1890/1051-0761(2002)012[0261:EOERPA]2.0.CO;2; McKechnie AE, 2006, P ROY SOC B-BIOL SCI, V273, P931, DOI 10.1098/rspb.2005.3415; McKechnie AE, 2008, J COMP PHYSIOL B, V178, P235, DOI 10.1007/s00360-007-0218-8; McNab B.K, 2002, PHYSL ECOLOGY VERTEB, DOI DOI 10.1643/0045-8511(2002)002[1170:]2.0.CO;2; MCNAB BK, 1986, ECOL MONOGR, V56, P1, DOI 10.2307/2937268; Mcnab BK, 2008, COMP BIOCHEM PHYS A, V151, P5, DOI 10.1016/j.cbpa.2008.05.008; Mcnab BK, 2009, COMP BIOCHEM PHYS A, V152, P22, DOI 10.1016/j.cbpa.2008.08.021; MOREL GJ, 1992, IBIS, V134, P83; Muller MS, 2006, OIKOS, V114, P507, DOI 10.1111/j.2006.0030-1299.14668.x; NEBERT DW, 1989, XENOBIOTICA, V19, P1149, DOI 10.3109/00498258909043167; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Newman M.C., 2010, FUNDAMENTALS ECOTOXI; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Opitz SEW, 2009, CHEMOECOLOGY, V19, P117, DOI 10.1007/s00049-009-0018-6; Orlowski G, 2007, AGR ECOSYST ENVIRON, V118, P244, DOI 10.1016/j.agee.2006.05.026; PASTEELS JM, 1991, ENTOMOL GEN, V15, P227; Pasteels JM, 1988, PLANT DERIVED DEFENS, P235; PETTIT TN, 1985, AUK, V102, P172, DOI 10.2307/4086838; Rensch I, 1956, ZOOL ANZ, V56, P106; ROBINSON SK, 1982, ECOLOGY, V63, P1918, DOI 10.2307/1940130; Ronis M.J.J., 1989, Reviews in Biochemical Toxicology, V10, P301; Sabat P, 2010, COMP BIOCHEM PHYS A, V157, P35, DOI 10.1016/j.cbpa.2010.05.007; Sabat P, 2009, COMP BIOCHEM PHYS A, V154, P502, DOI 10.1016/j.cbpa.2009.08.009; SANDERSON JT, 1994, J TOXICOL ENV HEALTH, V41, P435, DOI 10.1080/15287399409531855; SCHLUTER D, 1991, ECOLOGY, V72, P1763, DOI 10.2307/1940975; SCHOLANDER PF, 1950, BIOL BULL, V99, P259, DOI 10.2307/1538742; Schoonhoven L.M., 2006, INSECT PLANT BIOL; Silva SI, 2004, COMP BIOCHEM PHYS A, V137, P33, DOI 10.1016/j.cbpb.2003.09.022; Sinclair JF, 1993, HDB EXPT PHARM, P259; Swofford DL., 2001, PAUP PHYLOGENETIC AN; Tanhuanpaa S, 1999, COMP BIOCHEM PHYS C, V124, P197, DOI 10.1016/S0742-8413(99)00066-3; Treplin S, 2008, CLADISTICS, V24, P328, DOI 10.1111/j.1096-0031.2007.00178.x; Van den Steen E, 2010, SCI TOTAL ENVIRON, V408, P1451, DOI 10.1016/j.scitotenv.2009.12.028; Van den Steen E, 2009, ENVIRON INT, V35, P310, DOI 10.1016/j.envint.2008.08.002; VLECK CM, 1979, CONDOR, V81, P89, DOI 10.2307/1367864; WEATHERS WW, 1979, OECOLOGIA, V42, P81, DOI 10.1007/BF00347620; Whyte JJ, 2000, CRIT REV TOXICOL, V30, P347, DOI 10.1080/10408440091159239; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P9340, DOI 10.1073/pnas.0702212104; Williams JB, 2010, INTEGR COMP BIOL, V50, P855, DOI 10.1093/icb/icq024; Zhang QY, 1997, DRUG METAB DISPOS, V25, P21	79	24	24	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33926	10.1371/journal.pone.0033926	http://dx.doi.org/10.1371/journal.pone.0033926			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479477	gold, Green Published, Green Submitted			2022-12-27	WOS:000304523400044
J	Chen, GC; Chen, HH; Wang, C; Peng, YM; Sun, L; Liu, H; Liu, FY				Chen, Guochun; Chen, Huihui; Wang, Chang; Peng, Youming; Sun, Lin; Liu, Hong; Liu, Fuyou			Rapamycin Ameliorates Kidney Fibrosis by Inhibiting the Activation of mTOR Signaling in Interstitial Macrophages and Myofibroblasts	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CELL-CYCLE ARREST; MAMMALIAN TARGET; TUMOR ANGIOGENESIS; INJURY; PROGRESSION; PATHWAY; DISEASE; INFLAMMATION; NEPHROPATHY	Interstitial fibrosis is an inevitable outcome of all kinds of progressive chronic kidney disease (CKD). Emerging data indicate that rapamycin can ameliorate kidney fibrosis by reducing the interstitial infiltrates and accumulation of extra cellular matrix (ECM). However, the cellular mechanism that regulates those changes has not been well understood yet. In this study, we revealed the persistent activation of mammalian target of rapamycin (mTOR) signaling in the interstitial macrophages and myofibroblasts, but rarely in injured proximal epithelial cells, CD4+ T cells, neutrophils, or endothelial cells, during the development of kidney fibrosis. Administration of rapamycin to unilateral ureteral obstruction (UUO) mice significantly suppressed the immunoreactivity of mTOR signaling, which decreased the inflammatory responses and ECM accumulation in the obstructed kidneys. Isolated macrophages from rapamycin-treated obstructed kidneys presented less inflammatory activity than vehicle groups. In vitro study confirmed that rapamycin significantly inhibited the fibrogenic activation of cultured fibroblasts (NIH3T3 cells), which was induced by the stimulation of TGF-beta(1). Further experiment revealed that rapamycin did not directly inhibit the fibrogenesis of HK2 cells with aristolochic acid treatment. Our findings clarified that rapamycin can ameliorate kidney fibrosis by blocking the mTOR signaling in interstitial macrophages and myofibroblasts.	[Chen, Guochun; Wang, Chang; Peng, Youming; Sun, Lin; Liu, Hong; Liu, Fuyou] Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha, Hunan, Peoples R China; [Chen, Guochun; Wang, Chang; Peng, Youming; Sun, Lin; Liu, Hong; Liu, Fuyou] Cent S Univ, Kidney Res Inst, Changsha, Hunan, Peoples R China; [Chen, Huihui] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Chen, GC (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Nephrol, Changsha, Hunan, Peoples R China.	chenguochun@hotmail.com; lfy410@yahoo.com.cn			Foundation of the Ministry of Education of China for Outstanding Young Teachers in University [200805331032]; Fund for Young Teachers in Central South University [2011QNZT165]; National Natural Science Foundation of China [30871169]	Foundation of the Ministry of Education of China for Outstanding Young Teachers in University; Fund for Young Teachers in Central South University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by the Foundation of the Ministry of Education of China for Outstanding Young Teachers in University (200805331032) to Dr. Guochun Chen, the Research Award Fund for Young Teachers in Central South University (2011QNZT165) to Dr. Guochun Chen and National Natural Science Foundation of China (30871169) to Dr. Fuyou Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2011, KIDNEY INT; Bonegio RGB, 2005, J AM SOC NEPHROL, V16, P2063, DOI 10.1681/ASN.2004030180; Chen JK, 2009, AM J PHYSIOL-RENAL, V297, pF585, DOI 10.1152/ajprenal.00186.2009; Diekmann F, 2007, J AM SOC NEPHROL, V18, P2653, DOI 10.1681/ASN.2007010087; Ferrer IR, 2011, AM J TRANSPLANT, V11, P654, DOI 10.1111/j.1600-6143.2011.03473.x; Fogo AB, 2011, J CLIN INVEST, V121, P2142, DOI 10.1172/JCI57935; Guo GJ, 1999, AM J PHYSIOL-RENAL, V277, pF766, DOI 10.1152/ajprenal.1999.277.5.F766; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huber TB, 2011, KIDNEY INT, V79, P502, DOI 10.1038/ki.2010.457; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Kramer S, 2008, AM J PHYSIOL-RENAL, V294, pF440, DOI 10.1152/ajprenal.00379.2007; Lee DF, 2007, CELL CYCLE, V6, P3011, DOI 10.4161/cc.6.24.5085; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lieberthal W, 2001, AM J PHYSIOL-RENAL, V281, pF693, DOI 10.1152/ajprenal.2001.281.4.F693; Lieberthal W, 2006, TRANSPLANTATION, V82, P17, DOI 10.1097/01.tp.0000225772.22757.5e; Lieberthal W, 2009, J AM SOC NEPHROL, V20, P2493, DOI 10.1681/ASN.2008111186; Liu FY, 2008, KIDNEY INT, V73, P588, DOI 10.1038/sj.ki.5002713; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Lloberas N, 2006, J AM SOC NEPHROL, V17, P1395, DOI 10.1681/ASN.2005050549; Lock HR, 2007, AM J PHYSIOL-RENAL, V292, pF76, DOI 10.1152/ajprenal.00128.2006; McMahon G, 2011, J AM SOC NEPHROL, V22, P408, DOI 10.1681/ASN.2010040351; Pozdzik AA, 2008, KIDNEY INT, V73, P595, DOI 10.1038/sj.ki.5002714; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Shegogue D, 2004, J BIOL CHEM, V279, P23166, DOI 10.1074/jbc.M401238200; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; Vinuesa E, 2008, J PATHOL, V214, P104, DOI 10.1002/path.2259; Wang SN, 2010, AM J PHYSIOL-RENAL, V298, pF142, DOI 10.1152/ajprenal.00320.2009; Winbanks CE, 2007, INT J BIOCHEM CELL B, V39, P206, DOI 10.1016/j.biocel.2006.08.004; Wu MJ, 2006, KIDNEY INT, V69, P2029, DOI 10.1038/sj.ki.5000161; Yang L, 2007, NEPHROL DIAL TRANSPL, V22, P445, DOI 10.1093/ndt/gfl556; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009	38	86	95	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33626	10.1371/journal.pone.0033626	http://dx.doi.org/10.1371/journal.pone.0033626			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470459	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000029
J	Skalski, JR; Millspaugh, JJ; Clawson, MV				Skalski, John R.; Millspaugh, Joshua J.; Clawson, Michael V.			Comparison of Statistical Population Reconstruction Using Full and Pooled Adult Age-Class Data	PLOS ONE			English	Article							BLACK BEARS; TAILED DEER; HARVEST; MODELS; WEAR; SEX	Background: Age-at-harvest data are among the most commonly collected, yet neglected, demographic data gathered by wildlife agencies. Statistical population construction techniques can use this information to estimate the abundance of wild populations over wide geographic areas and concurrently estimate recruitment, harvest, and natural survival rates. Although current reconstruction techniques use full age-class data (0.5, 1.5, 2.5, 3.5, ... years), it is not always possible to determine an animal's age due to inaccuracy of the methods, expense, and logistics of sample collection. The ability to inventory wild populations would be greatly expanded if pooled adult age-class data (e.g., 0.5, 1.5, 2.5+ years) could be successfully used in statistical population reconstruction. Methodology/Principal Findings: We investigated the performance of statistical population reconstruction models developed to analyze full age-class and pooled adult age-class data. We performed Monte Carlo simulations using a stochastic version of a Leslie matrix model, which generated data over a wide range of abundance levels, harvest rates, and natural survival probabilities, representing medium-to-big game species. Results of full age-class and pooled adult age-class population reconstructions were compared for accuracy and precision. No discernible difference in accuracy was detected, but precision was slightly reduced when using the pooled adult age-class reconstruction. On average, the coefficient of variation (i.e., SE((theta) over cap)/theta) increased by 0.059 when the adult age-class data were pooled prior to analyses. The analyses and maximum likelihood model for pooled adult age-class reconstruction are illustrated for a black-tailed deer (Odocoileus hemionus) population in Washington State. Conclusions/Significance: Inventorying wild populations is one of the greatest challenges of wildlife agencies. These new statistical population reconstruction models should expand the demographic capabilities of wildlife agencies that have already collected pooled adult age-class data or are seeking a cost-effective method for monitoring the status and trends of our wild resources.	[Skalski, John R.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Millspaugh, Joshua J.] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO USA; [Clawson, Michael V.] Univ Washington, Sch Forest Resources, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Missouri System; University of Missouri Columbia; University of Washington; University of Washington Seattle	Skalski, JR (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	skalski@uw.edu		Clawson, Michael/0000-0002-8413-7009; Skalski, John/0000-0002-7070-2505	School of Aquatic & Fishery Sciences at University of Washington; Missouri Department of Conservation; University of Missouri	School of Aquatic & Fishery Sciences at University of Washington; Missouri Department of Conservation; University of Missouri	No external funding was used in this research. Support for this research and publishing costs were provided by the School of Aquatic & Fishery Sciences at University of Washington, the Missouri Department of Conservation, and the University of Missouri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anscombe F. J., 1953, J ROYAL STAT SOC B, V15, P165; Biederbeck HH, 2001, WILDLIFE SOC B, V29, P1271; Broms K, 2010, J WILDLIFE MANAGE, V74, P310, DOI 10.2193/2008-469; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Costello CM, 2004, WILDLIFE SOC B, V32, P169, DOI 10.2193/0091-7648(2004)32[169:ROTCAT]2.0.CO;2; Diefenbach DR, 2004, J WILDLIFE MANAGE, V68, P947, DOI 10.2193/0022-541X(2004)068[0947:SADVIT]2.0.CO;2; Dimmick Ralph W., 1994, P169; Gee KL, 2002, WILDLIFE SOC B, V30, P387; Gilbert BA, 2007, J WILDLIFE MANAGE, V71, P144, DOI 10.2193/2005-567; Gove NE, 2002, J WILDLIFE MANAGE, V66, P310, DOI 10.2307/3803163; Hamlin KL, 2000, J WILDLIFE MANAGE, V64, P441, DOI 10.2307/3803242; Harshyne WA, 1998, J WILDLIFE MANAGE, V62, P1281, DOI 10.2307/3801992; Hewison AJM, 1999, CAN J ZOOL, V77, P58, DOI 10.1139/cjz-77-1-58; JENKS JA, 1984, J WILDLIFE MANAGE, V48, P626, DOI 10.2307/3801204; Kelly G., 1975, Proceedings of the National Wild Turkey Symposium, V3, P205; Kuehn D.W., 1983, Wildlife Society Bulletin, V11, P68; Millspaugh JJ, 2009, J WILDLIFE MANAGE, V73, P442, DOI 10.2193/2008-099; QUIMBY DON C., 1957, JOUR WILDLIFE MANAGEMENT, V21, P435, DOI 10.2307/3796676; Rupp SP, 2000, WILDLIFE SOC B, V28, P570; SEVERINGHAUS CW, 1949, J WILDLIFE MANAGE, V13, P195, DOI 10.2307/3796089; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; Skalski JR, 2007, J WILDLIFE MANAGE, V71, P1309, DOI 10.2193/2005-707; WILLEY CH, 1974, J WILDLIFE MANAGE, V38, P97, DOI 10.2307/3800203	23	8	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33910	10.1371/journal.pone.0033910	http://dx.doi.org/10.1371/journal.pone.0033910			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470491	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000043
J	Wieding, J; Souffrant, R; Fritsche, A; Mittelmeier, W; Bader, R				Wieding, Jan; Souffrant, Robert; Fritsche, Andreas; Mittelmeier, Wolfram; Bader, Rainer			Finite Element Analysis of Osteosynthesis Screw Fixation in the Bone Stock: An Appropriate Method for Automatic Screw Modelling	PLOS ONE			English	Article							DOUBLE-PLATING FIXATION; DISTAL FEMUR FRACTURES; INTERNAL-FIXATION; RADIUS FRACTURE; LOCKING PLATE; VALIDATION; SYSTEM; ANGLE; OSTEOTOMY; BEHAVIOR	The use of finite element analysis (FEA) has grown to a more and more important method in the field of biomedical engineering and biomechanics. Although increased computational performance allows new ways to generate more complex biomechanical models, in the area of orthopaedic surgery, solid modelling of screws and drill holes represent a limitation of their use for individual cases and an increase of computational costs. To cope with these requirements, different methods for numerical screw modelling have therefore been investigated to improve its application diversity. Exemplarily, fixation was performed for stabilization of a large segmental femoral bone defect by an osteosynthesis plate. Three different numerical modelling techniques for implant fixation were used in this study, i.e. without screw modelling, screws as solid elements as well as screws as structural elements. The latter one offers the possibility to implement automatically generated screws with variable geometry on arbitrary FE models. Structural screws were parametrically generated by a Python script for the automatic generation in the FE-software Abaqus/CAE on both a tetrahedral and a hexahedral meshed femur. Accuracy of the FE models was confirmed by experimental testing using a composite femur with a segmental defect and an identical osteosynthesis plate for primary stabilisation with titanium screws. Both deflection of the femoral head and the gap alteration were measured with an optical measuring system with an accuracy of approximately 3 mm. For both screw modelling techniques a sufficient correlation of approximately 95% between numerical and experimental analysis was found. Furthermore, using structural elements for screw modelling the computational time could be reduced by 85% using hexahedral elements instead of tetrahedral elements for femur meshing. The automatically generated screw modelling offers a realistic simulation of the osteosynthesis fixation with screws in the adjacent bone stock and can be used for further investigations.	[Wieding, Jan; Souffrant, Robert; Fritsche, Andreas; Mittelmeier, Wolfram; Bader, Rainer] Univ Rostock, Dept Orthopaed, Rostock, Germany	University of Rostock	Wieding, J (corresponding author), Univ Rostock, Dept Orthopaed, Rostock, Germany.	jan.wieding@med.uni-rostock.de			European Union; Ministry of Economic Affairs, Employment and Tourism of Mecklenburg-Vorpommern [ESF/IV-WM-B34-0015/08]	European Union(European Commission); Ministry of Economic Affairs, Employment and Tourism of Mecklenburg-Vorpommern	This work has been financially supported by the European Union and the Ministry of Economic Affairs, Employment and Tourism of Mecklenburg-Vorpommern within the project "Tissue Regeneration'', sub-project "BONET'' ESF/IV-WM-B34-0015/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atac MS, 2008, INT J ORAL MAX SURG, V37, P1117, DOI 10.1016/j.ijom.2008.10.004; Beltran-Fernandez JA, 2008, APPL MECH MATER, V13-14, P49, DOI 10.4028/www.scientific.net/AMM.13-14.49; Blecha L. D., 2005, Computer Methods in Biomechanics and Biomedical Engineering, V8, P307, DOI 10.1080/10255840500322433; Cegonino J., 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P245, DOI 10.1080/10255840412331307182; Cheng HYK, 2007, CLIN BIOMECH, V22, P510, DOI 10.1016/j.clinbiomech.2006.12.010; Cristofolini L, 1996, J BIOMECH, V29, P525, DOI 10.1016/0021-9290(95)00084-4; Cronier P, 2010, ORTHOP TRAUMATOL-SUR, P17; Cross AR, 1999, AM J VET RES, V60, P615; Heiner AD, 2008, J BIOMECH, V41, P3282, DOI 10.1016/j.jbiomech.2008.08.013; Higgins TF, 2007, J ORTHOP TRAUMA, V21, P43, DOI 10.1097/BOT.0b013e31802bb372; Hussain M, 2009, SPINE J, V9, P1016, DOI 10.1016/j.spinee.2009.08.461; Keaveny TM, 2001, ANNU REV BIOMED ENG, V3, P307, DOI 10.1146/annurev.bioeng.3.1.307; Kim SH, 2010, COMPOS STRUCT, V92, P2109, DOI 10.1016/j.compstruct.2009.09.051; Kluess D, 2009, COMPUT METH PROG BIO, V95, P23, DOI 10.1016/j.cmpb.2009.01.004; Lin CL, 2006, MED BIOL ENG COMPUT, V44, P665, DOI 10.1007/s11517-006-0082-9; Lovald ST, 2006, J BIOMECH ENG-T ASME, V128, P654, DOI 10.1115/1.2244575; Ohman C, 2011, BONE, V49, P769, DOI 10.1016/j.bone.2011.06.035; Otto RJ, 2009, J ORTHOP TRAUMA, V23, P645, DOI 10.1097/BOT.0b013e3181a567c8; Perren SM, 2002, J BONE JOINT SURG BR, V84B, P1093, DOI 10.1302/0301-620X.84B8.13752; Polgar K, 2001, P I MECH ENG H, V215, P85, DOI 10.1243/0954411011533562; Prendergast P. J., 1994, Proceedings of the Institution of Mechanical Engineers, Part H (Journal of Engineering in Medicine), V208, P103, DOI 10.1243/PIME_PROC_1994_208_272_02; Schuller-Gotzburg P, 2009, INT J ORAL MAX SURG, V38, P1298, DOI 10.1016/j.ijom.2009.07.060; Seral B, 2004, INJURY, V35, P130, DOI 10.1016/S0020-1383(03)00076-7; Tai CL, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-112; Taylor W. R., 2004, Computer Methods in Biomechanics and Biomedical Engineering, V7, P131, DOI 10.1080/10255840410001712108; Viceconti M, 1998, MED ENG PHYS, V20, P1, DOI 10.1016/S1350-4533(97)00049-0; Wilke HJ, 2009, SPINE, V34, P255, DOI 10.1097/BRS.0b013e3181920e9c; Wilkens KJ, 2008, J ORTHOP TRAUMA, V22, P624, DOI 10.1097/BOT.0b013e31818896b3; ZWEYMULLER K, 1982, ARCH ORTHOP TRAUM SU, V100, P229, DOI 10.1007/BF00381662	29	59	60	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33776	10.1371/journal.pone.0033776	http://dx.doi.org/10.1371/journal.pone.0033776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470474	Green Submitted, Green Published, gold			2022-12-27	WOS:000304489000033
J	Bajer, K; Molnar, O; Torok, J; Herczeg, G				Bajer, Katalin; Molnar, Orsolya; Toeroek, Janos; Herczeg, Gabor			Temperature, but Not Available Energy, Affects the Expression of a Sexually Selected Ultraviolet (UV) Colour Trait in Male European Green Lizards	PLOS ONE			English	Article							PLUMAGE COLORATION; STRUCTURAL COLORATION; NUTRITIONAL CONDITION; CONDITION-DEPENDENCE; CONVERGENT EVOLUTION; NUPTIAL COLORATION; NATURAL-SELECTION; BODY-TEMPERATURE; MATE PREFERENCES; HONEST SIGNAL	Background: Colour signals are widely used in intraspecific communication and often linked to individual fitness. The development of some pigment-based (e.g. carotenoids) colours is often environment-dependent and costly for the signaller, however, for structural colours (e.g. ultraviolet [UV]) this topic is poorly understood, especially in terrestrial ectothermic vertebrates. Methodology/Principal Findings: In a factorial experiment, we studied how available energy and time at elevated body temperature affects the annual expression of the nuptial throat colour patch in male European green lizards (Lacerta viridis) after hibernation and before mating season. In this species, there is a female preference for males with high throat UV reflectance, and males with high UV reflectance are more likely to win fights. We found that (i) while food shortage decreased lizards' body condition, it did not affect colour development, and (ii) the available time for maintaining high body temperature affected the development of UV colour without affecting body condition or other colour traits. Conclusions/Significance: Our results demonstrate that the expression of a sexually selected structural colour signal depends on the time at elevated body temperature affecting physiological performance but not on available energy gained from food per se in an ectothermic vertebrate. We suggest that the effect of high ambient temperature on UV colour in male L. viridis makes it an honest signal, because success in acquiring thermally favourable territories and/or effective behavioural thermoregulation can both be linked to individual quality.	[Bajer, Katalin; Molnar, Orsolya; Toeroek, Janos; Herczeg, Gabor] Eotvos Lorand Univ, Behav Ecol Grp, Dept Systemat Zool & Ecol, Budapest, Hungary; [Herczeg, Gabor] Univ Helsinki, Dept Biosci, Ecol Genet Res Unit, Helsinki, Finland	Eotvos Lorand University; University of Helsinki	Bajer, K (corresponding author), Eotvos Lorand Univ, Behav Ecol Grp, Dept Systemat Zool & Ecol, Budapest, Hungary.	cascadis@gmail.com	Bajer-Molnar, Orsolya/E-9684-2014; Herczeg, Gábor/AAF-9978-2020; Herczeg, Gabor/AAZ-1661-2021; Bajer, Katalin/E-8935-2013; Torok, Janos/C-6144-2008	Bajer-Molnar, Orsolya/0000-0002-2458-4659; Herczeg, Gabor/0000-0003-0441-342X; Bajer, Katalin/0000-0003-3960-965X; Torok, Janos/0000-0002-4799-5522	Hungarian Scientific Research Fund [OTKA-F68403]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by a Hungarian Scientific Research Fund [OTKA-F68403 to Gabor Herczeg]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADOLPH SC, 1990, ECOLOGY, V71, P315, DOI 10.2307/1940271; Alonso-Alvarez C, 2004, BEHAV ECOL, V15, P805, DOI 10.1093/beheco/arh083; ANDERSSON M, 1982, BIOL J LINN SOC, V17, P375, DOI 10.1111/j.1095-8312.1982.tb02028.x; Andersson Malte, 1994; Andersson S, 1999, J AVIAN BIOL, V30, P193, DOI 10.2307/3677129; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Bajer K, 2011, BIOL LETTERS, V7, P866, DOI 10.1098/rsbl.2011.0520; Bajer K, 2010, BEHAV ECOL SOCIOBIOL, V64, P2007, DOI 10.1007/s00265-010-1012-2; Bauwens D, 1996, ECOLOGY, V77, P1818, DOI 10.2307/2265786; Bokony V, 2008, BEHAV ECOL SOCIOBIOL, V62, P1229, DOI 10.1007/s00265-008-0551-2; Cuthill Innes C., 2000, P61; de Lanuza GPI, 2007, AMPHIBIA-REPTILIA, V28, P438, DOI 10.1163/156853807781374764; del Cerro S, 2010, OECOLOGIA, V162, P825, DOI 10.1007/s00442-009-1510-y; Doucet SM, 2003, BEHAV ECOL, V14, P503, DOI 10.1093/beheco/arg035; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Evans MR, 1996, BEHAV ECOL, V7, P1, DOI 10.1093/beheco/7.1.1; Fitzpatrick S, 1998, ANN ZOOL FENN, V35, P67; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Font E, 2009, BIOL J LINN SOC, V97, P766, DOI 10.1111/j.1095-8312.2009.01251.x; Gasc J. P., 1997, ATLAS AMPHIBIANS REP; GHIRADELLA H, 1972, SCIENCE, V178, P1214, DOI 10.1126/science.178.4066.1214; Goda M, 1995, ZOOL SCI, V12, P811, DOI 10.2108/zsj.12.811; Gonzalez G, 1999, J ANIM ECOL, V68, P1225, DOI 10.1046/j.1365-2656.1999.00364.x; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Grether GF, 2004, BIOL REV, V79, P583, DOI 10.1017/S1464793103006390; Griggio M, 2007, BEHAV ECOL SOCIOBIOL, V61, P423, DOI 10.1007/s00265-006-0270-5; Griggio M, 2010, ECOL RES, V25, P77, DOI 10.1007/s11284-009-0632-3; Hill G. E., 2006, BIRD COLORATION, V1; Hill GE, 2000, J AVIAN BIOL, V31, P559, DOI 10.1034/j.1600-048X.2000.310415.x; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; HILL GE, 1994, P ROY SOC B-BIOL SCI, V258, P47, DOI 10.1098/rspb.1994.0140; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; HUEY RB, 1989, TRENDS ECOL EVOL, V4, P131, DOI 10.1016/0169-5347(89)90211-5; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Hunt S, 1999, ANIM BEHAV, V58, P809, DOI 10.1006/anbe.1999.1214; Imasheva AG, 1997, BIOL J LINN SOC, V61, P117, DOI 10.1006/bijl.1996.0125; Iwasa Y, 1991, EVOLUTION, V48, P853; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Kemp DJ, 2008, EVOLUTION, V62, P2346, DOI 10.1111/j.1558-5646.2008.00461.x; Kemp DJ, 2007, EVOLUTION, V61, P168, DOI 10.1111/j.1558-5646.2007.00014.x; Keyser AJ, 2000, BEHAV ECOL, V11, P202, DOI 10.1093/beheco/11.2.202; Keyser AJ, 1999, P ROY SOC B-BIOL SCI, V266, P771, DOI 10.1098/rspb.1999.0704; Lannoo M, 2008, MALFORMED FROGS: THE COLLAPSE OF AQUATIC ECOSYSTEMS, P1; LeBas NR, 2000, P ROY SOC B-BIOL SCI, V267, P445, DOI 10.1098/rspb.2000.1020; Lim MLM, 2007, P ROY SOC B-BIOL SCI, V274, P569, DOI 10.1098/rspb.2006.0020; Loew ER, 2002, J EXP BIOL, V205, P927; Lopez P, 2005, Z NATURFORSCH C, V60, P632; Lopez P, 2002, BEHAV ECOL SOCIOBIOL, V52, P342, DOI 10.1007/s00265-002-0514-y; LUDWIG D, 1990, AM NAT, V135, P686, DOI 10.1086/285069; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Martin J, 1999, BEHAV ECOL, V10, P396, DOI 10.1093/beheco/10.4.396; Martin J, 2010, BEHAVIOUR, V147, P275, DOI 10.1163/000579509X12529330682239; Martin J, 2009, BEHAV ECOL SOCIOBIOL, V63, P1743, DOI 10.1007/s00265-009-0794-6; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; McGraw KJ, 2002, J EXP BIOL, V205, P3747; Metcalfe NB, 2010, FUNCT ECOL, V24, P984, DOI 10.1111/j.1365-2435.2010.01750.x; Needham AE., 1974, SIGNIFICANCE ZOOCHRO; Olsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019360; Parker AR, 1998, J EXP BIOL, V201, P1307; Parker AR, 1998, J EXP BIOL, V201, P2343; Pearn SM, 2001, P ROY SOC B-BIOL SCI, V268, P2273, DOI 10.1098/rspb.2001.1813; Penteriani V, 2006, J AVIAN BIOL, V37, P110, DOI 10.1111/j.0908-8857.2006.03569.x; Peters A, 2011, J EVOLUTION BIOL, V24, P976, DOI 10.1111/j.1420-9101.2011.02229.x; POMIANKOWSKI A, 1991, EVOLUTION, V45, P1422, DOI 10.1111/j.1558-5646.1991.tb02645.x; Pough H, 1998, HERPETOLOGY; PRICE T, 1993, BIOL J LINN SOC, V48, P187, DOI 10.1111/j.1095-8312.1993.tb00887.x; Prum RO, 2004, J EXP BIOL, V207, P3999, DOI 10.1242/jeb.01240; Prum RO, 2004, J EXP BIOL, V207, P2157, DOI 10.1242/jeb.00989; Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431; PRUM RO, 2006, BIRD COLORATION, V1; Quinn VS, 2003, COPEIA, P858, DOI 10.1643/h202-116.1; RISMILLER PD, 1988, OECOLOGIA, V75, P125, DOI 10.1007/BF00378825; Roulin A, 2000, P ROY SOC B-BIOL SCI, V267, P937, DOI 10.1098/rspb.2000.1093; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Savalli Udo M., 1995, Current Ornithology, V12, P141; Senar JC, 2003, NATURWISSENSCHAFTEN, V90, P234, DOI 10.1007/s00114-003-0414-7; Senar JC., 1999, P INT ORNITHOLOGICAL, V22, P1669; Soler JJ, 2007, ANIM BEHAV, V74, P1139, DOI 10.1016/j.anbehav.2006.09.026; Stapley J, 2006, BIOL LETTERS, V2, P169, DOI 10.1098/rsbl.2005.0419; STEVENSON RD, 1985, AM NAT, V126, P362, DOI 10.1086/284423; Thomas F., 2009, ECOLOGY EVOLUTION PA; Whiting MJ, 2006, ANIM BEHAV, V72, P353, DOI 10.1016/j.anbehav.2005.10.018; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	85	34	34	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34359	10.1371/journal.pone.0034359	http://dx.doi.org/10.1371/journal.pone.0034359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479611	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900083
J	Cai, RK; Liu, ZX; Ren, J; Ma, C; Gao, TS; Zhou, YH; Yang, Q; Xue, Y				Cai, Ruikun; Liu, Zexian; Ren, Jian; Ma, Chuang; Gao, Tianshun; Zhou, Yanhong; Yang, Qing; Xue, Yu			GPS-MBA: Computational Analysis of MHC Class II Epitopes in Type 1 Diabetes	PLOS ONE			English	Article							BINDING PEPTIDES; PREDICTION; SEQUENCE; MOLECULES; PROTEIN; I-A(G7); ALIGNMENT; MOUSE; MOTIF	As a severe chronic metabolic disease and autoimmune disorder, type 1 diabetes (T1D) affects millions of people worldwide. Recent advances in antigen-based immunotherapy have provided a great opportunity for further treating T1D with a high degree of selectivity. It is reported that MHC class II I-A(g7) in the non-obese diabetic (NOD) mouse and human HLA-DQ8 are strongly linked to susceptibility to T1D. Thus, the identification of new I-A(g7) and HLA-DQ8 epitopes would be of great help to further experimental and biomedical manipulation efforts. In this study, a novel GPS-MBA (MHC Binding Analyzer) software package was developed for the prediction of I-A(g7) and HLA-DQ8 epitopes. Using experimentally identified epitopes as the training data sets, a previously developed GPS (Group-based Prediction System) algorithm was adopted and improved. By extensive evaluation and comparison, the GPS-MBA performance was found to be much better than other tools of this type. With this powerful tool, we predicted a number of potentially new I-A(g7) and HLA-DQ8 epitopes. Furthermore, we designed a T1D epitope database (TEDB) for all of the experimentally identified and predicted T1D-associated epitopes. Taken together, this computational prediction result and analysis provides a starting point for further experimental considerations, and GPS-MBA is demonstrated to be a useful tool for generating starting information for experimentalists. The GPS-MBA is freely accessible for academic researchers at: http://mba.biocuckoo.org.	[Cai, Ruikun; Gao, Tianshun; Zhou, Yanhong; Yang, Qing; Xue, Yu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Syst Biol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Peoples R China; [Liu, Zexian] Univ Sci & Technol China, Microscale & Sch Life Sci, Hefei Natl Lab Phys Sci, Hefei 230026, Peoples R China; [Ren, Jian] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Ma, Chuang] Univ So Calif, Dept Pediat, Saban Res Inst Childrens Hosp Los Angeles, Los Angeles, CA 90089 USA	Huazhong University of Science & Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sun Yat Sen University; Children's Hospital Los Angeles; University of Southern California	Cai, RK (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Dept Syst Biol, Hubei Bioinformat & Mol Imaging Key Lab, Wuhan 430074, Peoples R China.	yangqinghust@mail.hust.edu.cn; xueyu@mail.hust.edu.cn	Xue, Yu/G-5929-2011; Ren, Jian/D-3270-2011; Ma, Chuang/H-7948-2012; Liu, Zexian/D-1153-2011	Xue, Yu/0000-0002-9403-6869; Ren, Jian/0000-0002-4161-1292; Ma, Chuang/0000-0001-9612-7898; Liu, Zexian/0000-0001-9698-0610	National Basic Research Program (973 project) [2010CB945400, 2012CB911200, 2012CB910101]; Natural Science Foundation of China [90919001, 31071154, 30900835, 30830036, 91019020, 31171263]; Fundamental Research Funds for the Central Universities [HUST: 2010JC049, 2010ZD018, 2011TS085, SYSU: 11lgzd11]	National Basic Research Program (973 project)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported, in whole or in part, by the National Basic Research Program (973 project) (2010CB945400, 2012CB911200,2012CB910101), the Natural Science Foundation of China (90919001, 31071154, 30900835, 30830036, 91019020, 31171263) and by the Fundamental Research Funds for the Central Universities (HUST: 2010JC049, 2010ZD018, 2011TS085; SYSU: 11lgzd11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhasin M, 2004, BIOINFORMATICS, V20, P421, DOI 10.1093/bioinformatics/btg424; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Burn P, 2010, NAT REV DRUG DISCOV, V9, P187, DOI 10.1038/nrd3097; Chang KY, 2007, PROTEOMICS, V7, P367, DOI 10.1002/pmic.200600584; Chang KY, 2009, INT IMMUNOL, V21, P705, DOI 10.1093/intimm/dxp039; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Culina S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/286248; Fierabracci A, 2011, CURR MED CHEM, V18, P577, DOI 10.2174/092986711794480230; Harrison LC, 1997, J EXP MED, V185, P1013, DOI 10.1084/jem.185.6.1013; Lata Sneh, 2007, V409, P201, DOI 10.1007/978-1-60327-118-9_14; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lehuen A, 2010, NAT REV IMMUNOL, V10, P501, DOI 10.1038/nri2787; Liu Z, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027887, 10.1371/journal.pone.0019001]; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Luo XR, 2010, IMMUNITY, V32, P488, DOI 10.1016/j.immuni.2010.04.002; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Panagiotopoulos Constadina, 2004, Curr Diab Rep, V4, P87, DOI 10.1007/s11892-004-0062-0; PARKER KC, 1994, J IMMUNOL, V152, P163; Rajapakse M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-459; Rajapakse M, 2006, AUTOIMMUNITY, V39, P645, DOI 10.1080/08916930601062494; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reche Pedro A., 2007, V409, P185, DOI 10.1007/978-1-60327-118-9_13; Reizis B, 1997, INT IMMUNOL, V9, P43, DOI 10.1093/intimm/9.1.43; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SETTE A, 1989, P NATL ACAD SCI USA, V86, P3296, DOI 10.1073/pnas.86.9.3296; Sherr J, 2008, NAT CLIN PRACT ENDOC, V4, P334, DOI 10.1038/ncpendmet0832; Suri A, 2002, J IMMUNOL, V168, P1235, DOI 10.4049/jimmunol.168.3.1235; Suri A, 2005, J CLIN INVEST, V115, P2268, DOI 10.1172/JCI25350; Tong JC, 2007, BRIEF BIOINFORM, V8, P96, DOI 10.1093/bib/bbl038; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Waldron-Lynch F, 2011, NAT REV DRUG DISCOV, V10, P439, DOI 10.1038/nrd3402; Xue Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011290	33	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33884	10.1371/journal.pone.0033884	http://dx.doi.org/10.1371/journal.pone.0033884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479466	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900047
J	Hung, CC; Haines, L; Altier, C				Hung, Chien-Che; Haines, Leanne; Altier, Craig			The Flagellar Regulator fliT Represses Salmonella Pathogenicity Island 1 through flhDC and fliZ	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INVASION GENE-EXPRESSION; III SECRETION SYSTEM; FAMILY-MEMBERS; LON PROTEASE; IN-VITRO; HILA; PROTEINS; VIRULENCE; BINDING	Salmonella pathogenicity island 1 (SPI1), comprising a type III section system that translocates effector proteins into host cells, is essential for the enteric pathogen Salmonella to penetrate the intestinal epithelium and subsequently to cause disease. Using random transposon mutagenesis, we found that a Tn10 disruption in the flagellar fliDST operon induced SPI1 expression when the strain was grown under conditions designed to repress SPI1, by mimicking the environment of the large intestine through the use of the intestinal fatty acid butyrate. Our genetic studies showed that only fliT within this operon was required for this effect, and that exogenous over-expression of fliT alone significantly reduced the expression of SPI1 genes, including the invasion regulator hilA and the sipBCDA operon, encoding type III section system effector proteins, and Salmonella invasion of cultured epithelial cells. fliT has been known to inhibit the flagellar machinery through repression of the flagellar master regulator flhDC. We found that the repressive effect of fliT on invasion genes was completely abolished in the absence of flhDC or fliZ, the latter previously shown to induce SPI1, indicating that this regulatory pathway is required for invasion control by fliT. Although this flhDC-fliZ pathway was necessary for fliT to negatively control invasion genes, fliZ was not essential for the repressive effect of fliT on motility, placing fliT high in the regulatory cascade for both invasion and motility.	[Hung, Chien-Che; Haines, Leanne; Altier, Craig] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14850 USA	Cornell University	Hung, CC (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY 14850 USA.	altier@cornell.edu			National Research Initiative of USDA Cooperative State Research, Education and Extension Service [2005-35201-16270]	National Research Initiative of USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This project was supported by the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, award number 2005-35201-16270. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar S, 2003, MOL MICROBIOL, V47, P715, DOI 10.1046/j.1365-2958.2003.03322.x; Aldridge C, 2010, MOL MICROBIOL, V78, P1416, DOI 10.1111/j.1365-2958.2010.07415.x; Altier C, 2000, MOL MICROBIOL, V35, P635, DOI 10.1046/j.1365-2958.2000.01734.x; Altier C, 2005, J MICROBIOL, V43, P85; Altier C, 2000, INFECT IMMUN, V68, P6790, DOI 10.1128/IAI.68.12.6790-6797.2000; Bajaj V, 1996, MOL MICROBIOL, V22, P703, DOI 10.1046/j.1365-2958.1996.d01-1718.x; Baxter MA, 2003, INFECT IMMUN, V71, P1295, DOI 10.1128/IAI.71.3.1295-1305.2003; BEHLAU I, 1993, J BACTERIOL, V175, P4475, DOI 10.1128/JB.175.14.4475-4484.1993; Bennett JCQ, 2001, MOL MICROBIOL, V39, P781, DOI 10.1046/j.1365-2958.2001.02268.x; Boddicker JD, 2004, INFECT IMMUN, V72, P2002, DOI 10.1128/IAI.72.4.2002-2013.2004; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Chubiz JEC, 2010, J BACTERIOL, V192, P6261, DOI 10.1128/JB.00635-10; Clements MO, 2002, P NATL ACAD SCI USA, V99, P8784, DOI 10.1073/pnas.132047099; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; Darwin KH, 1999, J BACTERIOL, V181, P4949; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eichelberg K, 1999, INFECT IMMUN, V67, P4099, DOI 10.1128/IAI.67.8.4099-4105.1999; Ekhnovich IN, 2007, J BACTERIOL, V189, P6882, DOI 10.1128/JB.00905-07; Ellermeier CD, 2005, MOL MICROBIOL, V57, P691, DOI 10.1111/j.1365-2958.2005.04737.x; Ellermeier CD, 2003, J BACTERIOL, V185, P5096, DOI 10.1128/JB.185.17.5096-5108.2003; Ellermeier JR, 2007, CURR OPIN MICROBIOL, V10, P24, DOI 10.1016/j.mib.2006.12.002; ERNST RK, 1990, INFECT IMMUN, V58, P2014, DOI 10.1128/IAI.58.6.2014-2016.1990; Fahlen TF, 2000, FEMS IMMUNOL MED MIC, V28, P25, DOI 10.1016/S0928-8244(99)00199-6; Fahlen TF, 2001, J BACTERIOL, V183, P6620, DOI 10.1128/JB.183.22.6620-6629.2001; Fraser GM, 1999, MOL MICROBIOL, V32, P569, DOI 10.1046/j.1365-2958.1999.01372.x; Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998; GALAN JE, 1989, P NATL ACAD SCI USA, V86, P6383, DOI 10.1073/pnas.86.16.6383; Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006; Garner CD, 2009, INFECT IMMUN, V77, P2691, DOI 10.1128/IAI.01570-08; GRANA D, 1988, GENETICS, V120, P319; GROISMAN EA, 1993, EMBO J, V12, P3779, DOI 10.1002/j.1460-2075.1993.tb06056.x; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003; HUECK CJ, 1995, MOL MICROBIOL, V18, P479, DOI 10.1111/j.1365-2958.1995.mmi_18030479.x; Ikebe T, 1999, GENES GENET SYST, V74, P179, DOI 10.1266/ggs.74.179; Imada K, 2010, P NATL ACAD SCI USA, V107, P8812, DOI 10.1073/pnas.1001866107; Kage H, 2008, J BACTERIOL, V190, P2470, DOI 10.1128/JB.01385-07; KLECKNER N, 1991, METHOD ENZYMOL, V204, P139; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kutsukake K, 1999, GENES GENET SYST, V74, P287, DOI 10.1266/ggs.74.287; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; LEE CA, 1992, P NATL ACAD SCI USA, V89, P1847, DOI 10.1073/pnas.89.5.1847; Lee C, 2007, METHOD ENZYMOL, V421, P159, DOI 10.1016/S0076-6879(06)21014-0; LIUT XY, 1995, J BACTERIOL, V177, P5186, DOI 10.1128/JB.177.17.5186-5188.1995; Lucas RL, 2000, J BACTERIOL, V182, P1872, DOI 10.1128/JB.182.7.1872-1882.2000; Miller J.H., 1992, SHORT COURSE BACTERI, P150; MILLS DM, 1995, MOL MICROBIOL, V15, P749, DOI 10.1111/j.1365-2958.1995.tb02382.x; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Olekhnovich IN, 2002, J BACTERIOL, V184, P4148, DOI 10.1128/JB.184.15.4148-4160.2002; Saini S, 2008, J BACTERIOL, V190, P4979, DOI 10.1128/JB.01996-07; Saini S, 2010, J BACTERIOL, V192, P5767, DOI 10.1128/JB.00624-10; Schechter LM, 1999, MOL MICROBIOL, V32, P629, DOI 10.1046/j.1365-2958.1999.01381.x; SCHIEMANN DA, 1991, INFECT IMMUN, V59, P437, DOI 10.1128/IAI.59.1.437-440.1991; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Takaya A, 2002, J BACTERIOL, V184, P224, DOI 10.1128/JB.184.1.224-232.2002; Tomoyasu T, 2003, MOL MICROBIOL, V48, P443, DOI 10.1046/j.1365-2958.2003.03437.x; Winter SE, 2009, MOL MICROBIOL, V74, P175, DOI 10.1111/j.1365-2958.2009.06859.x; Yamamoto S, 2006, J BACTERIOL, V188, P6703, DOI 10.1128/JB.00799-06; Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092	61	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34220	10.1371/journal.pone.0034220	http://dx.doi.org/10.1371/journal.pone.0034220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479568	Green Submitted, Green Published, gold			2022-12-27	WOS:000303894900071
J	Lewis, JC; Powell, RA; Zielinski, WJ				Lewis, Jeffrey C.; Powell, Roger A.; Zielinski, William J.			Carnivore Translocations and Conservation: Insights from Population Models and Field Data for Fishers (Martes pennanti)	PLOS ONE			English	Article							REINTRODUCTION	Translocations are frequently used to restore extirpated carnivore populations. Understanding the factors that influence translocation success is important because carnivore translocations can be time consuming, expensive, and controversial. Using population viability software, we modeled reintroductions of the fisher, a candidate for endangered or threatened status in the Pacific states of the US. Our model predicts that the most important factor influencing successful reestablishment of a fisher population is the number of adult females reintroduced (provided some males are also released). Data from 38 translocations of fishers in North America, including 30 reintroductions, 5 augmentations and 3 introductions, show that the number of females released was, indeed, a good predictor of success but that the number of males released, geographic region and proximity of the source population to the release site were also important predictors. The contradiction between model and data regarding males may relate to the assumption in the model that all males are equally good breeders. We hypothesize that many males may need to be released to insure a sufficient number of good breeders are included, probably large males. Seventy-seven percent of reintroductions with known outcomes (success or failure) succeeded; all 5 augmentations succeeded; but none of the 3 introductions succeeded. Reintroductions were instrumental in reestablishing fisher populations within their historical range and expanding the range from its most-contracted state (43% of the historical range) to its current state (68% of the historical range). To increase the likelihood of translocation success, we recommend that managers: 1) release as many fishers as possible, 2) release more females than males (55-60% females) when possible, 3) release as many adults as possible, especially large males, 4) release fishers from a nearby source population, 5) conduct a formal feasibility assessment, and 6) develop a comprehensive implementation plan that includes an active monitoring program.	[Lewis, Jeffrey C.] Washington Dept Fish & Wildlife, Olympia, WA USA; [Powell, Roger A.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Zielinski, William J.] ARS, USDA, Pacific SW Res Stn, Arcata, CA USA	Washington Department of Fish & Wildlife (WDFW); University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA)	Lewis, JC (corresponding author), Washington Dept Fish & Wildlife, Olympia, WA USA.	Jeffrey.Lewis@dfw.wa.gov			U.S. Fish and Wildlife Service (Yreka, CA office); U.S. Fish and Wildlife Service (Lacey, WA office)	U.S. Fish and Wildlife Service (Yreka, CA office); U.S. Fish and Wildlife Service (Lacey, WA office)	The authors have received funding from two different offices of the U.S. Fish and Wildlife Service (Yreka, CA office, and Lacey, WA office) to support this research. The funders had no role in study design, data collection and analyis, decision to publich or preparation of the manuscript.	Anderson B., 2002, REINTRODUCTION FISHE; Anderson Benedict, 2005, COMMUNICATION, V12, P00; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Apker J, 2006, COMMUNICATION; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Aubry KB, 2003, BIOL CONSERV, V114, P79, DOI 10.1016/S0006-3207(03)00003-X; Aubry KB, 2007, J WILDLIFE MANAGE, V71, P2147, DOI 10.2193/2006-548; BAILEY VERNON, 1936, NORTH AMERICAN FAUNA, V55, P1, DOI 10.3996/nafa.55.0001; Baird R., 2000, RIDING MOUNTAIN NATL; Baird R, 2005, COMMUNICATION; Baker J, 2005, COMMUNICATION; Benson D. A., 1959, Journal of Mammalogy, V40, P451, DOI 10.2307/1376588; Berg W, 2004, COMMUNICATION; Berg WE, 1982, MIDWEST FURBEARER MA, P159; Boitani Luigi, 2003, P317; Boudreau M, 2006, COMMUNICATION; Bradle B.J, 1957, WISCONSIN CONSERV B, V22, P9; BRANDER RB, 1973, NAT HIST, V82, P52; Breitenmoser U, 2001, CONSERV BIOL SER, V5, P241; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Buskirk Steven W., 1994, P283; Callas R.L., 2008, TRANSLOCATION PLAN R; COOK DAVID B., 1957, JOUR FOREST, V55, P719; Coulter M. W., 1966, THESIS STATE U NEW Y; Dalquest W.W., 1948, MAMMALS WASHINGTON; Davie JW, 1984, FISHER INTRO PROJECT; deVos A, 1952, TECHNICAL B WILDLIFE; Dilworth T, 2006, COMMUNICATION; DILWORTH T G, 1974, Canadian Field-Naturalist, V88, P495; DODDS D G, 1971, Canadian Field-Naturalist, V85, P62; Dodge W.E., 1977, STATUS FISHER UNPUB; Douglas C.W., 1987, WILD FURBEARER MANAG, P511; Drew RE, 2003, MOL ECOL, V12, P51, DOI 10.1046/j.1365-294X.2003.01715.x; Earle R, 2005, COMMUNICATION; EARLE RD, 1982, AM MIDL NAT, V107, P244, DOI 10.2307/2425375; Earle RD, 1978, THESIS MICHIGAN TECH; ERLINGE S, 1986, OIKOS, V47, P57, DOI 10.2307/3565919; Fontana AJ, 1999, E KOOTENAY FISHER RE; Gibilisco Charles J., 1994, P59; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Grinnell J., 1937, FUR BEARING MAMMALS, VI; HAGMEIER EDWIN M., 1956, CANADIAN FIELD NAT, V70, P149; HALL E. RAYMOND, 1942, CALIFORNIA FISH AND GAME, V28, P143; Hayes G.E., 2006, WASHINGTON STATE REC; Heinemeyer K.S., 1993, THESIS U MONTANA MIS; Henry R, 2005, COMMUNICATION; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Ingram R, 1973, 732 CENTR REG ADM OR; International Union for Conservation of Nature (IUCN), 1987, IUCN POS STAT TRANSL; IPCC (Intergovernmental Panel on Climate Change), 2007, SYNTH REP 4 ASS INT; IRVINE GEORGE W., 1964, TRANS N AMER WILDLIFE NATUR RESOURCES CONF, V29, P307; Irvine GW, 1960, PROGR REPORT P UNPUB; IUCN, 1995, 41 M IUCN COUNC GLAN; Jakubas W, 2005, COMMUNICATION; Jorgenson J, 2005, COMMUNICATION; Jung Thomas S., 2011, Northwestern Naturalist, V92, P57; Kebbe C.E., 1961, OREGON STATE GAME CO, V16, P3; Kebbe C.E., 1961, W ASS STATE GAME FIS, V41, P165; Kohn B. E., 1993, WISCONSIN DEP NATURA, V183; Kovach AI, 2003, CAN J ZOOL, V81, P1257, DOI 10.1139/Z03-111; KROHN WB, 1995, FOREST CHRON, V71, P97, DOI 10.5558/tfc71097-1; Krohn WB, BIOL CONSER IN PRESS; Kyle CJ, 2001, MOL ECOL, V10, P2341, DOI 10.1046/j.1365-294X.2001.01351.x; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lewis J, 2011, UNPUB; Lewis J.C., 2006, IMPLEMENTATION PLAN; Lewis JC, 1996, NORTHWEST SCI, V70, P291; Lewis JC, 2004, FEASIBILITY ASSESSME; Lofroth E, 2005, COMMUNICATION; Lofroth E.C., 2010, CONSERVATION FISHERS, VI; Luque M, 1984, IDAHO WILDLIFE, V4, P12; McLachlan JS, 2007, CONSERV BIOL, V21, P297, DOI 10.1111/j.1523-1739.2007.00676.x; Miller B., 1996, PRAIRIE NIGHT BLACK; Miller B, 1999, ANIM CONSERV, V2, P59, DOI 10.1111/j.1469-1795.1999.tb00049.x; Mills J, 2006, COMMUNICATION; Naney R. H., 2012, CONSERVATION FISHERS, VIII; Newsom W. M., 1937, Journal of Mammalogy, V18, P435, DOI 10.2307/1374333; Nielsen L., 1988, P12; Novak M, COMMUNICATION; Pack J.C., 1981, Proceedings of the Worldwide Furbearer Conference, V1, P1431; Petersen L.R., 1977, WISCONSIN DEP NATURA, V92, P1; Potter D, 2002, THESIS ACADIA U WOLF; Potter D, 2006, COMMUNICATION; Powell R, 2012, UNPUB; Powell R.A., 1993, FISHER LIFE HIST ECO, V2nd ed.; Proulx G, 2004, MARTENS AND FISHERS (MARTES) IN HUMAN-ALTERED ENVIRONMENTS: AN INTERNATIONAL PERSPECTIVE, P21; Proulx GA, 2005, EDMONTON NATURE NEWS, V2, P21; Proulx Gilbert, 1994, P197; Raine R. M., 1981, THESIS U MANITOBA WI; Reading Richard P., 1996, P296; Rego P, 2005, COMMUNICATION; Rego PW, 1991, 1019093091 CONN DEP; Rego PW, 1990, 1018993090 CONN DEP; Rego PW, 1989, 1018893089 CONN DEP; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Roy K.D., 1991, THESIS U MONTANA MIS; Royar K, COMMUNICATION; Schorger AW, 1942, T WISC ACAD SCI, V34, P24; Schwartz MW, 2006, ECOLOGY, V87, P1611, DOI 10.1890/0012-9658(2006)87[1611:PEAARO]2.0.CO;2; Schwartz MK, 2007, J MAMMAL, V88, P921, DOI 10.1644/06-MAMM-A-217R1.1; Serfass T.L., 2001, FISHER REINTRODUCTIO; Seton E.T., 1926, LIVES GAME ANIMALS, V2; Strickland M.A., 1982, P586; Strickland MA, 1981, P WORLDW FURB C FROS, P1443; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; United States Fish and Wildlife Service, 2004, FED REGISTER, V69, P18770; Vinkey RS, 2006, J MAMMAL, V87, P265, DOI 10.1644/05-MAMM-A-151R1.1; Vinkey RS, 2003, THESIS U MONTANA MIS; Wallace K., 1985, CONSERVATIONIST, V40, P17; WECKWERTH RP, 1968, J WILDLIFE MANAGE, V32, P977, DOI 10.2307/3799580; Weir R, 2006, COMMUNICATION; Weir R.D., 1995, THESIS S FRASER U BU; Weir RD, 2003, E KOOTENAY FISHER AS; Williams RM, 1963, FINAL SEGMENT REPORT; Williams RM, 1962, TRAPPING TRANSPLANT; Wood J, 1977, NATURAL WILDLIFE, V15, P18; YALDEN DW, 1993, SYM ZOOL S, P289; Zielinski WJ, 2005, J BIOGEOGR, V32, P1385, DOI 10.1111/j.1365-2699.2005.01234.x	120	57	58	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e32726	10.1371/journal.pone.0032726	http://dx.doi.org/10.1371/journal.pone.0032726			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479336	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900011
J	Miyamoto, N; Wakahara, T; Kawakami, Y				Miyamoto, Naokazu; Wakahara, Taku; Kawakami, Yasuo			Task-Dependent Inhomogeneous Muscle Activities within the Bi-Articular Human Rectus Femoris Muscle	PLOS ONE			English	Article							FUNCTIONALLY COMPLEX MUSCLES; SURFACE ELECTROMYOGRAPHY; DIFFERENTIAL ACTIVATION; NEURAL ACTIVATION; STRAIN INJURIES; CAT HINDLIMB; FATIGUE; REFLEX	The motor nerve of the bi-articular rectus femoris muscle is generally split from the femoral nerve trunk into two sub-branches just before it reaches the distal and proximal regions of the muscle. In this study, we examined whether the regional difference in muscle activities exists within the human rectus femoris muscle during maximal voluntary isometric contractions of knee extension and hip flexion. Surface electromyographic signals were recorded from the distal, middle, and proximal regions. In addition, twitch responses were evoked by stimulating the femoral nerve with supramaximal intensity. The root mean square value of electromyographic amplitude during each voluntary task was normalized to the maximal compound muscle action potential amplitude (M-wave) for each region. The electromyographic amplitudes were significantly smaller during hip flexion than during knee extension task for all regions. There was no significant difference in the normalized electromyographic amplitude during knee extension among regions within the rectus femoris muscle, whereas those were significantly smaller in the distal than in the middle and proximal regions during hip flexion task. These results indicate that the bi-articular rectus femoris muscle is differentially controlled along the longitudinal direction and that in particular the distal region of the muscle cannot be fully activated during hip flexion.	[Miyamoto, Naokazu; Wakahara, Taku; Kawakami, Yasuo] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan	Waseda University	Miyamoto, N (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	miyamoto@aoni.waseda.jp	Kawakami, Yasuo/AFM-0651-2022; Kawakami, Yasuo/AAH-3075-2022	Kawakami, Yasuo/0000-0003-0588-4039; Kawakami, Yasuo/0000-0003-0588-4039; Wakahara, Taku/0000-0001-6864-7706	Waseda University Global COE	Waseda University Global COE	This study was partly supported by the Waseda University Global COE Program, "Sport Sciences for the Promotion of Active Life''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amarantini D, 2010, J BIOMECH, V43, P1827, DOI 10.1016/j.jbiomech.2010.02.025; Barr KM, 2010, GAIT POSTURE, V32, P363, DOI 10.1016/j.gaitpost.2010.06.010; Battermann N, 2011, INT J SPORTS MED, V32, P211, DOI 10.1055/s-0030-1268011; Blazevich AJ, 2007, J APPL PHYSIOL, V103, P1565, DOI 10.1152/japplphysiol.00578.2007; BUCHTHAL F, 1959, ACTA PHYSIOL SCAND, V45, P72, DOI 10.1111/j.1748-1716.1959.tb01678.x; Byrne CA, 2005, J ELECTROMYOGR KINES, V15, P564, DOI 10.1016/j.jelekin.2005.03.002; CHANAUD CM, 1991, EXP BRAIN RES, V85, P271, DOI 10.1007/BF00229406; De Luca CJ, 1997, J APPL BIOMECH, V13, P135, DOI 10.1123/jab.13.2.135; Disselhorst-Klug C, 2009, CLIN BIOMECH, V24, P225, DOI 10.1016/j.clinbiomech.2008.08.003; ENGLISH AW, 1993, PHYS THER, V73, P857, DOI 10.1093/ptj/73.12.857; Farina D, 2002, BIOL CYBERN, V86, P445, DOI 10.1007/s00422-002-0309-2; Garrett WE, 1996, AM J SPORT MED, V24, pS2, DOI 10.1177/036354659602406S02; Hagio S, 2012, J BIOMECH, V45, P179, DOI 10.1016/j.jbiomech.2011.10.012; HASSELMAN CT, 1995, AM J SPORT MED, V23, P493, DOI 10.1177/036354659502300421; Holtermann A, 2008, ACTA PHYSIOL, V192, P559, DOI 10.1111/j.1748-1716.2007.01775.x; Holtermann A, 2009, J ELECTROMYOGR KINES, V19, P896, DOI 10.1016/j.jelekin.2008.04.016; HUGHES C, 1995, AM J SPORT MED, V23, P500, DOI 10.1177/036354659502300422; Keen DA, 2004, J NEUROPHYSIOL, V91, P57, DOI 10.1152/jn.00650.2003; Kilbreath SL, 2002, J PHYSIOL-LONDON, V543, P289, DOI 10.1113/jphysiol.2002.023861; MERLETTI, 2001, EXERCISE SPORT SCI R, V29, P20; Millet GY, 2004, SPORTS MED, V34, P105, DOI 10.2165/00007256-200434020-00004; Miyamoto N, 2012, MUSCLE NERVE, V45, P110, DOI 10.1002/mus.22259; Miyamoto N, 2011, MUSCLE NERVE, V43, P360, DOI 10.1002/mus.21871; Naito Akira, 2004, Anatomical Science International, V79, P11, DOI 10.1111/j.1447-073x.2004.00064.x; Narici MV, 1996, ACTA PHYSIOL SCAND, V157, P175, DOI 10.1046/j.1365-201X.1996.483230000.x; Nishihara K., 2010, Journal of Medical Engineering & Technology, V34, P141, DOI 10.3109/03091900903480754; Pasquet B, 2000, MUSCLE NERVE, V23, P1727; PRATT CA, 1991, EXP BRAIN RES, V85, P281, DOI 10.1007/BF00229407; ROMENY BMT, 1982, EXP NEUROL, V78, P360, DOI 10.1016/0014-4886(82)90054-1; Sacco P, 1997, MUSCLE NERVE, V20, P710; Staudenmann D, 2009, J ELECTROMYOGR KINES, V19, P882, DOI 10.1016/j.jelekin.2008.04.013; Stegeman DF, 2000, J ELECTROMYOGR KINES, V10, P313, DOI 10.1016/S1050-6411(00)00023-7; Sung DH, 2003, ARCH PHYS MED REHAB, V84, P1028, DOI 10.1016/S0003-9993(03)00029-7; TERHAAR RBM, 1984, EXP NEUROL, V85, P631; Tucker KJ, 2005, HUM MOVEMENT SCI, V24, P667, DOI 10.1016/j.humov.2005.09.010; Watanabe K, 2012, J ELECTROMYOGR KINES, V22, P251, DOI 10.1016/j.jelekin.2011.11.004; WINDHORST U, 1989, BEHAV BRAIN SCI, V12, P629, DOI 10.1017/S0140525X00024985; Yang DP, 1999, PLAST RECONSTR SURG, V104, P102, DOI 10.1097/00006534-199907000-00015	38	23	23	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34269	10.1371/journal.pone.0034269	http://dx.doi.org/10.1371/journal.pone.0034269			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479583	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900076
J	Sucheston, LE; Bensen, JT; Xu, ZL; Singh, PK; Preus, L; Mohler, JL; Su, LJ; Fontham, ETH; Ruiz, B; Smith, GJ; Taylor, JA				Sucheston, Lara E.; Bensen, Jeannette T.; Xu, Zongli; Singh, Prashant K.; Preus, Leah; Mohler, James L.; Su, L. Joseph; Fontham, Elizabeth T. H.; Ruiz, Bernardo; Smith, Gary J.; Taylor, Jack A.			Genetic Ancestry, Self-Reported Race and Ethnicity in African Americans and European Americans in the PCaP Cohort	PLOS ONE			English	Article							HUMAN-POPULATION STRUCTURE; PROSTATE-CANCER; ASSOCIATION; STRATIFICATION; TWINS; RISK; MUTATIONS; ADMIXTURE	Background: Family history and African-American race are important risk factors for both prostate cancer (CaP) incidence and aggressiveness. When studying complex diseases such as CaP that have a heritable component, chances of finding true disease susceptibility alleles can be increased by accounting for genetic ancestry within the population investigated. Race, ethnicity and ancestry were studied in a geographically diverse cohort of men with newly diagnosed CaP. Methods: Individual ancestry (IA) was estimated in the population-based North Carolina and Louisiana Prostate Cancer Project (PCaP), a cohort of 2,106 incident CaP cases (2063 with complete ethnicity information) comprising roughly equal numbers of research subjects reporting as Black/African American (AA) or European American/Caucasian/Caucasian American/White (EA) from North Carolina or Louisiana. Mean genome wide individual ancestry estimates of percent African, European and Asian were obtained and tested for differences by state and ethnicity (Cajun and/or Creole and Hispanic/Latino) using multivariate analysis of variance models. Principal components (PC) were compared to assess differences in genetic composition by self-reported race and ethnicity between and within states. Results: Mean individual ancestries differed by state for self-reporting AA (p = 0.03) and EA (p = 0.001). This geographic difference attenuated for AAs who answered "no" to all ethnicity membership questions (non-ethnic research subjects; p = 0.78) but not EA research subjects, p = 0.002. Mean ancestry estimates of self-identified AA Louisiana research subjects for each ethnic group; Cajun only, Creole only and both Cajun and Creole differed significantly from self-identified non-ethnic AA Louisiana research subjects. These ethnicity differences were not seen in those who self-identified as EA. Conclusions: Mean IA differed by race between states, elucidating a potential contributing factor to these differences in AA research participants: self-reported ethnicity. Accurately accounting for genetic admixture in this cohort is essential for future analyses of the genetic and environmental contributions to CaP.	[Sucheston, Lara E.; Preus, Leah] Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA; [Bensen, Jeannette T.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Bensen, Jeannette T.; Mohler, James L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Xu, Zongli; Taylor, Jack A.] Natl Inst Environm Hlth Sci, Epidemiol Branch, Res Triangle Pk, NC USA; [Xu, Zongli; Taylor, Jack A.] Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, Res Triangle Pk, NC USA; [Singh, Prashant K.] Roswell Pk Canc Inst, Dept Genet & Pharmacol, Buffalo, NY 14263 USA; [Mohler, James L.; Smith, Gary J.] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA; [Mohler, James L.; Smith, Gary J.] SUNY Buffalo, Dept Urol, Buffalo, NY 14260 USA; [Su, L. Joseph] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Fontham, Elizabeth T. H.] Louisiana State Univ, Hlth Sci Ctr, Dept Epidemiol, Sch Publ Hlth, New Orleans, LA USA; [Ruiz, Bernardo] Louisiana State Univ, Hlth Sci Ctr, Dept Pathol, New Orleans, LA USA	Roswell Park Cancer Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Roswell Park Cancer Institute; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Sucheston, LE (corresponding author), Roswell Pk Canc Inst, Dept Canc Prevent & Control, Buffalo, NY 14263 USA.	lara.sucheston@roswellpark.org	taylor, jack a/C-7154-2019; Facility, Biospecimen Processing/AAC-7837-2022	taylor, jack a/0000-0001-5303-6398; xu, zongli/0000-0002-9034-8902	National Institutes of Health (NIH), National Institute of Environmental Health Sciences; NIH National Center on Minority Health and Health Disparities; Department of Defense [DAMD 17-03-2-0052]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049032, ZIAES049033] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH), National Institute of Environmental Health Sciences and the NIH National Center on Minority Health and Health Disparities. The North Carolina Louisiana Prostate Cancer Project (PCaP) is carried out as a collaborative study supported by the Department of Defense contract DAMD 17-03-2-0052. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlbom A, 1997, J NATL CANCER I, V89, P287, DOI 10.1093/jnci/89.4.287; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Barnholtz-Sloan JS, 2008, CANCER EPIDEM BIOMAR, V17, P471, DOI 10.1158/1055-9965.EPI-07-0491; Barnholtz-Sloan JS, 2005, CANCER EPIDEM BIOMAR, V14, P1545, DOI 10.1158/1055-9965.EPI-04-0832; Carpten JD, 2000, GENOMICS, V64, P1, DOI 10.1006/geno.1999.6051; Collins FS, 2003, SCIENCE, V302, P745, DOI 10.1126/science.302.5646.745; Cotter MP, 2002, PROSTATE, V50, P216, DOI 10.1002/pros.10051; Cunningham GR, 2003, PROSTATE, V56, P256, DOI 10.1002/pros.10252; Giri VN, 2009, CANCER PREV RES, V2, P244, DOI 10.1158/1940-6207.CAPR-08-0150; GRONBERG H, 1994, J UROLOGY, V152, P1484, DOI 10.1016/S0022-5347(17)32452-7; Gronberg H, 1994, J UROLOGY, V152, P1487; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Page WF, 1997, PROSTATE, V33, P240; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Rokman A, 2002, AM J HUM GENET, V70, P1299, DOI 10.1086/340450; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Ruiz-Narvaez EA, 2011, AM J EPIDEMIOL, V173, P587, DOI 10.1093/aje/kwq401; Scacheri PC, 1999, AM J MED GENET, V86, P477, DOI 10.1002/(SICI)1096-8628(19991029)86:5<477::AID-AJMG14>3.3.CO;2-1; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Schroeder JC, 2006, PROSTATE, V66, P1162, DOI 10.1002/pros.20449; Sinha M, 2006, NEW ENGL J MED, V354, P421, DOI 10.1056/NEJMc052515; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Tsai HJ, 2005, HUM GENET, V118, P424, DOI 10.1007/s00439-005-0067-z; UMBAS R, 1992, CANCER RES, V52, P5104; Wang HS, 2010, HUM GENET, V128, P165, DOI 10.1007/s00439-010-0841-4; Xu JF, 2002, NAT GENET, V32, P321, DOI 10.1038/ng994; Xu Z, 2010, PROSTATE; Yaeger R, 2008, CANCER EPIDEM BIOMAR, V17, P1329, DOI 10.1158/1055-9965.EPI-07-2505; Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758	33	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e30950	10.1371/journal.pone.0030950	http://dx.doi.org/10.1371/journal.pone.0030950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479307	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900001
J	Meunier, H; Vauclair, J; Fagard, J				Meunier, Helene; Vauclair, Jacques; Fagard, Jacqueline			Human Infants and Baboons Show the Same Pattern of Handedness for a Communicative Gesture	PLOS ONE			English	Article							HAND PREFERENCE; LANGUAGE	To test the role of gestures in the origin of language, we studied hand preferences for grasping or pointing to objects at several spatial positions in human infants and adult baboons. If the roots of language are indeed in gestural communication, we expect that human infants and baboons will present a comparable difference in their pattern of laterality according to task: both should be more right-hand/left-hemisphere specialized when communicating by pointing than when simply grasping objects. Our study is the first to test both human infants and baboons on the same communicative task. Our results show remarkable convergence in the distribution of the two species' hand biases on the two kinds of tasks: In both human infants and baboons, right-hand preference was significantly stronger for the communicative task than for grasping objects. Our findings support the hypothesis that left-lateralized language may be derived from a gestural communication system that was present in the common ancestor of baboons and humans.	[Meunier, Helene] Strasbourg Univ, Primatol Ctr, Ft Foch, Niederhausberge, France; [Meunier, Helene; Vauclair, Jacques] Aix Marseille Univ, Res Ctr Psychol Cognit Language & Emot, Aix En Provence, France; [Fagard, Jacqueline] Univ Paris 05, Lab Psychol Percept, Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite	Meunier, H (corresponding author), Strasbourg Univ, Primatol Ctr, Ft Foch, Niederhausberge, France.	meunier.h@gmail.com			French National Research Agency (ANR Agence Nationale Recherche) [ANR-08-BLAN-0011_01]	French National Research Agency (ANR Agence Nationale Recherche)(French National Research Agency (ANR))	This research was supported by a French National Research Agency (ANR Agence Nationale Recherche) grant reference ANR-08-BLAN-0011_01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates E, 1986, DEV NEUROPSYCHOL, V2, P1, DOI 10.1080/87565648609540323; Bishop DVM, 1996, BRIT J PSYCHOL, V87, P269, DOI 10.1111/j.2044-8295.1996.tb02590.x; Bonvillian JD, 1997, BRAIN LANG, V58, P1, DOI 10.1006/brln.1997.1754; Corballis MC, 2010, BRAIN LANG, V112, P25, DOI 10.1016/j.bandl.2009.02.002; Esseily Rana, LATERALITY IN PRESS; Goldin-Meadow S., 1999, DESCENT MIND, P155; Hopkins WD, 2005, PSYCHOL SCI, V16, P487; Hopkins WD, 1998, J COMP PSYCHOL, V112, P95, DOI 10.1037/0735-7036.112.1.95; Kimura D., 1993, NEUROMOTOR MECH HUMA; Leavens DA, 2004, J COMP PSYCHOL, V118, P48, DOI 10.1037/0735-7036.118.1.48; Liszkowski U, 2004, DEVELOPMENTAL SCI, V7, P297, DOI 10.1111/j.1467-7687.2004.00349.x; Meguerditchian A, 2010, CORTEX, V46, P40, DOI 10.1016/j.cortex.2009.02.013; Meguerditchian A, 2009, BRAIN LANG, V108, P167, DOI 10.1016/j.bandl.2008.10.004; Meunier H, 2011, BEHAV BRAIN RES, V218, P1, DOI 10.1016/j.bbr.2010.11.011; MURPHY CM, 1978, CHILD DEV, V49, P371, DOI 10.1111/j.1467-8624.1978.tb02325.x; Ozcaliskan S, 2005, COGNITION, V96, pB101, DOI 10.1016/j.cognition.2005.01.001; Taglialatela JP, 2006, NEUROREPORT, V17, P923, DOI 10.1097/01.wnr.0000221835.26093.5e; Vauclair J, 2009, DEVELOPMENTAL SCI, V12, P1060, DOI 10.1111/j.1467-7687.2009.00850.x	18	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33959	10.1371/journal.pone.0033959	http://dx.doi.org/10.1371/journal.pone.0033959			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470500	Green Published, gold			2022-12-27	WOS:000303857100062
J	Acar, E; Plopper, GE; Yener, B				Acar, Evrim; Plopper, George E.; Yener, Buelent			Coupled Analysis of In Vitro and Histology Tissue Samples to Quantify Structure-Function Relationship	PLOS ONE			English	Article							CELL-GRAPHS; CANCER; CLASSIFICATION; DIAGNOSIS; TEXTURE; IMAGES	The structure/function relationship is fundamental to our understanding of biological systems at all levels, and drives most, if not all, techniques for detecting, diagnosing, and treating disease. However, at the tissue level of biological complexity we encounter a gap in the structure/function relationship: having accumulated an extraordinary amount of detailed information about biological tissues at the cellular and subcellular level, we cannot assemble it in a way that explains the correspondingly complex biological functions these structures perform. To help close this information gap we define here several quantitative temperospatial features that link tissue structure to its corresponding biological function. Both histological images of human tissue samples and fluorescence images of three-dimensional cultures of human cells are used to compare the accuracy of in vitro culture models with their corresponding human tissues. To the best of our knowledge, there is no prior work on a quantitative comparison of histology and in vitro samples. Features are calculated from graph theoretical representations of tissue structures and the data are analyzed in the form of matrices and higher-order tensors using matrix and tensor factorization methods, with a goal of differentiating between cancerous and healthy states of brain, breast, and bone tissues. We also show that our techniques can differentiate between the structural organization of native tissues and their corresponding in vitro engineered cell culture models.	[Acar, Evrim] Univ Copenhagen, Fac Life Sci, Frederiksberg C, Denmark; [Plopper, George E.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Yener, Buelent] Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA	University of Copenhagen; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Acar, E (corresponding author), Univ Copenhagen, Fac Life Sci, Frederiksberg C, Denmark.	yener@cs.rpi.edu	Acar, Evrim/A-7161-2015	Acar, Evrim/0000-0002-3737-292X	National Institutes of Health [RO1 EB008016]; VILLUM FOUNDATION; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VILLUM FOUNDATION(Villum Fonden); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported in part by National Institutes of Health grant #RO1 EB008016 and in part by the VILLUM FOUNDATION. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilgin C, 2007, P ANN INT IEEE EMBS, P5311, DOI 10.1109/IEMBS.2007.4353540; Bilgin CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012783; Bilgin CC, 2010, I S BIOMED IMAGING, P1427, DOI 10.1109/ISBI.2010.5490267; Bilgin CC, 2010, DATA MIN KNOWL DISC, V20, P416, DOI 10.1007/s10618-009-0153-2; Blekas K., 1998, Journal of Intelligent Systems, V8, P55, DOI 10.1515/JISYS.1998.8.1-2.55; Bro R, 2003, J CHEMOMETR, V17, P274, DOI 10.1002/cem.801; Carroll JD, 1970, PSYCHOMETRIKA, V35, P218; Choi HK, 1997, ANAL CELL PATHOL, V15, P1; Demir C, 2005, IEEE ACM T COMPUT BI, V2, P262, DOI 10.1109/TCBB.2005.42; Demir C, 2005, BIOINFORMATICS, V21, P7, DOI 10.1093/bioinformatics/bti1100; Demir C, 2005, P 4 C MOD SIM BIOL M, P153; Elden L, 2007, FUND ALGORITHMS, V4, pIX, DOI 10.1137/1.9780898718867; Esgiar A N, 1998, IEEE Trans Inf Technol Biomed, V2, P197, DOI 10.1109/4233.735785; Esgiar AN, 2002, IEEE T INF TECHNOL B, V6, P54, DOI 10.1109/4233.992163; Golub GH., 2013, MATRIX COMPUTATIONS; Gunduz C, 2004, BIOINFORMATICS, V20, P145, DOI 10.1093/bioinformatics/bth933; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Hamilton PW, 1997, J PATHOL, V182, P68; Harshman R. A., 1970, FDN PARAFAC PROCEDUR, P1; Keenan SJ, 2000, J PATHOL, V192, P351, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH708>3.0.CO;2-I; Kolda T. G., 2011, P KDD WORKSH MIN LEA; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Lund AW, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/928286; McKeen-Polizzotti L, 2011, BMC MED IMAGING, V11, DOI 10.1186/1471-2342-11-11; Schnorrenberg F, 1996, Technol Health Care, V4, P147; Smolle J, 2000, SKIN RES TECHNOL, V6, P58, DOI 10.1034/j.1600-0846.2000.006002058.x; Spyridonos P, 2001, MED INFORM INTERNET, V26, P179, DOI 10.1080/14639230110065757; STREET WN, 1993, P SOC PHOTO-OPT INS, V1905, P861, DOI 10.1117/12.148698; Tasoulis DK, 2003, LECT NOTES ARTIF INT, V2773, P199; Thiran JP, 1996, IEEE T BIO-MED ENG, V43, P1011, DOI 10.1109/10.536902; Walker DG, 2003, J CLIN NEUROSCI, V10, P1, DOI 10.1016/S0967-5868(02)00261-8; Weyn B, 1999, CYTOMETRY, V35, P23, DOI 10.1002/(SICI)1097-0320(19990101)35:1<23::AID-CYTO4>3.0.CO;2-P; Wiltgen M, 2003, INT J MED INFORM, V69, P17, DOI 10.1016/S1386-5056(02)00049-7; WOLBERG WH, 1995, HUM PATHOL, V26, P792, DOI 10.1016/0046-8177(95)90229-5; Zhou ZH, 2002, ARTIF INTELL MED, V24, P25, DOI 10.1016/S0933-3657(01)00094-X	37	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32227	10.1371/journal.pone.0032227	http://dx.doi.org/10.1371/journal.pone.0032227			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479315	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100006
J	Catry, T; Alves, JA; Gill, JA; Gunnarsson, TG; Granadeiro, JP				Catry, Teresa; Alves, Jose A.; Gill, Jennifer A.; Gunnarsson, Tomas G.; Granadeiro, Jose P.			Sex Promotes Spatial and Dietary Segregation in a Migratory Shorebird during the Non-Breeding Season	PLOS ONE			English	Article							TAILED GODWITS LIMOSA; SIZE DIMORPHISM; LATITUDINAL CLINES; FEEDING ECOLOGY; WADDEN SEA; BILL-SIZE; SELECTION; HABITAT; AGE; SANDPIPERS	Several expressions of sexual segregation have been described in animals, especially in those exhibiting conspicuous dimorphism. Outside the breeding season, segregation has been mostly attributed to size or age-mediated dominance or to trophic niche divergence. Regardless of the recognized implications for population dynamics, the ecological causes and consequences of sexual segregation are still poorly understood. We investigate the foraging habits of a shorebird showing reversed sexual dimorphism, the black-tailed godwit Limosa limosa, during the winter season, and found extensive segregation between sexes in spatial distribution, microhabitat use and dietary composition. Males and females exhibited high site-fidelity but differed in their distributions at estuary-scale. Male godwits (shorter-billed) foraged more frequently in exposed mudflats than in patches with higher water levels, and consumed more bivalves and gastropods and fewer polychaetes than females. Females tended to be more frequently involved and to win more aggressive interactions than males. However, the number of aggressions recorded was low, suggesting that sexual dominance plays a lesser role in segregation, although its importance cannot be ruled out. Dimorphism in the feeding apparatus has been used to explain sex differences in foraging ecology and behaviour of many avian species, but few studies confirmed that morphologic characteristics drive individual differences within each sex. We found a relationship between resource use and bill size when pooling data from males and females. However, this relationship did not hold for either sex separately, suggesting that differences in foraging habits of godwits are primarily a function of sex, rather than bill size. Hence, the exact mechanisms through which this segregation operates are still unknown. The recorded differences in spatial distribution and resource use might expose male and female to distinct threats, thus affecting population dynamics through differential mortality. Therefore, population models and effective conservation strategies should increasingly take sex-specific requirements into consideration.	[Catry, Teresa; Granadeiro, Jose P.] Univ Lisbon, CESAM, Museo Nacl Hist Nat, P-1699 Lisbon, Portugal; [Alves, Jose A.; Gill, Jennifer A.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Gunnarsson, Tomas G.] Univ Iceland, S Iceland Res Ctr, Hella, Iceland	Universidade de Lisboa; University of East Anglia; University of Iceland	Catry, T (corresponding author), Univ Lisbon, CESAM, Museo Nacl Hist Nat, P-1699 Lisbon, Portugal.	teresa_catry@yahoo.com	Granadeiro, José Pedro/E-8060-2011; Alves, José A./U-4674-2018; Catry, Teresa/A-8082-2012; Gill, Jennifer A/A-7759-2008; Gunnarsson, Tomas G/L-9783-2015	Granadeiro, José Pedro/0000-0002-7207-3474; Alves, José A./0000-0001-7182-0936; Catry, Teresa/0000-0003-4047-9995; Gunnarsson, Tomas Gretar/0000-0001-7692-0637	Fundacao para a Ciencia e Tecnologia (FCT) through the Project "MigraTagis" [PTDC/MAR/66319/2006]; NERC [NE/H008527/1] Funding Source: UKRI; Natural Environment Research Council [NE/H008527/1] Funding Source: researchfish	Fundacao para a Ciencia e Tecnologia (FCT) through the Project "MigraTagis"; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by Fundacao para a Ciencia e Tecnologia (FCT-http://www.fct.pt/index.phtml.en) through the Project "MigraTagis" (PTDC/MAR/66319/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 1986, STAT ANAL COMPOSITIO, DOI DOI 10.1007/978-94-009-4109-0; Alves JA, 2012, ANIM CONSERV, V15, P44, DOI 10.1111/j.1469-1795.2011.00485.x; Alves J. A., 2009, THESIS U E ANGLIA NO; Alves JA, 2010, BIRD STUDY, V57, P381, DOI 10.1080/00063651003678475; Ardia DR, 1997, ANIM BEHAV, V53, P1305, DOI 10.1006/anbe.1996.0364; BARRY T W, 1968, Canadian Field-Naturalist, V82, P140; Both C, 2003, ARDEA, V91, P268; Cardoso I, 2010, ESTUAR COAST SHELF S, V86, P580, DOI 10.1016/j.ecss.2009.11.024; Catry P, 2005, SEXUAL SEGREGATION V; Catry T, 2011, BIRD CONSERV INT, V21, P438, DOI 10.1017/S0959270910000626; Conradt L., 2005, SEXUAL SEGREGATION V; CRESSWELL W, 1994, J ANIM ECOL, V63, P589, DOI 10.2307/5225; Delany S., 2009, ATLAS WADER POPULATI; Dias MP, 2006, BIOL CONSERV, V131, P446, DOI 10.1016/j.biocon.2006.02.020; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Durell SEALD, 1996, ARDEA, V84A, P373; Durell SEALD, 2000, BIOL REV, V75, P503; DURELL SEALD, 1993, J ANIM ECOL, V62, P205, DOI 10.2307/5495; ESSELINK P, 1989, MAR ECOL PROG SER, V56, P243, DOI 10.3354/meps056243; Fernandez G, 2006, CONDOR, V108, P547, DOI 10.1650/0010-5422(2006)108[547:SAABSD]2.0.CO;2; Gill JA, 2001, NATURE, V412, P436, DOI 10.1038/35086568; Gill Jennifer A., 1995, Ringing and Migration, V16, P159; Gonzalez-Solis J, 2002, MAR ECOL PROG SER, V244, P257, DOI 10.3354/meps244257; GONZALEZSOLIS J, 2005, SEXUAL SEGREGATION V; GOSSCUSTARD JD, 1983, IBIS, V125, P155, DOI 10.1111/j.1474-919X.1983.tb03096.x; Gunnarsson TG, 2005, P ROY SOC B-BIOL SCI, V272, P2319, DOI 10.1098/rspb.2005.3214; Gunnarsson TG, 2006, BIRD STUDY, V53, P193, DOI 10.1080/00063650609461433; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Jonsson P.E., 1991, Wader Study Group Bulletin, P56; MANLY BFJ, 1974, BIOMETRICS, V30, P281, DOI 10.2307/2529649; Marra PP, 2000, BEHAV ECOL, V11, P299, DOI 10.1093/beheco/11.3.299; Mathot KJ, 2007, ECOLOGY, V88, P781, DOI 10.1890/06-1225; MILLER EH, 1983, CAN J ZOOL, V61, P2880, DOI 10.1139/z83-376; MOREIRA F, 1994, IBIS, V136, P349, DOI 10.1111/j.1474-919X.1994.tb01106.x; Nebel S, 2005, ACTA OECOL, V28, P33, DOI 10.1016/j.actao.2005.02.002; Nebel S, 2011, EVOL ECOL RES, V13, P35; Phillips RA, 2004, P ROY SOC B-BIOL SCI, V271, P1283, DOI 10.1098/rspb.2004.2718; PIERSMA T, 1993, NETH J SEA RES, V31, P503, DOI 10.1016/0077-7579(93)90062-W; Pinheiro J, 2001, MIXED EFFECTS MODELS; PINHEIRO JC, 2011, NLME LINEAR NONLINEA, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0018860; Reimchen TE, 2001, BIOL J LINN SOC, V73, P51, DOI 10.1006/bijl.2001.0523; Rubin ES, 2005, SEXUAL SEGREGATION V; Sandercock Brett K., 2001, Wader Study Group Bulletin, V96, P64; Santiago-Quesada F, 2009, COMP BIOCHEM PHYS A, V152, P565, DOI 10.1016/j.cbpa.2009.01.001; Santos CD, 2005, ARDEOLA, V52, P235; Scheiffarth G, 2001, ARDEA, V89, P481; Schroeder J, 2008, ARDEA, V96, P25, DOI 10.5253/078.096.0104; SMITH P C, 1973, Wildfowl, V24, P135; SUMMERS RW, 1990, BIRD STUDY, V37, P187, DOI 10.1080/00063659009477056; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Szekely T, 2000, EVOLUTION, V54, P1404, DOI 10.1111/j.0014-3820.2000.tb00572.x; Szekely T, 2004, P NATL ACAD SCI USA, V101, P12224, DOI 10.1073/pnas.0404503101; Temeles EJ, 2010, PHILOS T R SOC B, V365, P1053, DOI 10.1098/rstb.2009.0284; van den Boogaart KG, 2010, COMPOSITIONS COMPOSI, P110; WHITFIELD DP, 1990, J ANIM ECOL, V59, P193, DOI 10.2307/5168; Zharikov Y, 2002, CAN J ZOOL, V80, P1918, DOI 10.1139/Z02-178; Zuur Alain F., 2009, P1; ZWARTS L, 1993, NETH J SEA RES, V31, P441, DOI 10.1016/0077-7579(93)90059-2; ZWARTS L, 1988, ARDEA, V76, P42	59	30	32	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33811	10.1371/journal.pone.0033811	http://dx.doi.org/10.1371/journal.pone.0033811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479448	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100072
J	Mariotti, M; Ridge, PG; Zhang, Y; Lobanov, AV; Pringle, TH; Guigo, R; Hatfield, DL; Gladyshev, VN				Mariotti, Marco; Ridge, Perry G.; Zhang, Yan; Lobanov, Alexei V.; Pringle, Thomas H.; Guigo, Roderic; Hatfield, Dolph L.; Gladyshev, Vadim N.			Composition and Evolution of the Vertebrate and Mammalian Selenoproteomes	PLOS ONE			English	Article							MITOCHONDRIAL THIOREDOXIN REDUCTASE; MULTIPLE SEQUENCE ALIGNMENT; 21ST AMINO-ACID; GLUTATHIONE-PEROXIDASE; SELENOCYSTEINE INCORPORATION; FUNCTIONAL-CHARACTERIZATION; SECIS ELEMENT; EXPRESSION; GENE; IDENTIFICATION	Background: Selenium is an essential trace element in mammals due to its presence in proteins in the form of selenocysteine (Sec). Human genome codes for 25 Sec-containing protein genes, and mouse and rat genomes for 24. Methodology/Principal Findings: We characterized the selenoproteomes of 44 sequenced vertebrates by applying gene prediction and phylogenetic reconstruction methods, supplemented with the analyses of gene structures, alternative splicing isoforms, untranslated regions, SECIS elements, and pseudogenes. In total, we detected 45 selenoprotein subfamilies. 28 of them were found in mammals, and 41 in bony fishes. We define the ancestral vertebrate (28 proteins) and mammalian (25 proteins) selenoproteomes, and describe how they evolved along lineages through gene duplication (20 events), gene loss (10 events) and replacement of Sec with cysteine (12 events). We show that an intronless selenophosphate synthetase 2 gene evolved in early mammals and replaced functionally the original multiexon gene in placental mammals, whereas both genes remain in marsupials. Mammalian thioredoxin reductase 1 and thioredoxin-glutathione reductase evolved from an ancestral glutaredoxin-domain containing enzyme, still present in fish. Selenoprotein V and GPx6 evolved specifically in placental mammals from duplications of SelW and GPx3, respectively, and GPx6 lost Sec several times independently. Bony fishes were characterized by duplications of several selenoprotein families (GPx1, GPx3, GPx4, Dio3, MsrB1, SelJ, SelO, SelT, SelU1, and SelW2). Finally, we report identification of new isoforms for several selenoproteins and describe unusually conserved selenoprotein pseudogenes. Conclusions/Significance: This analysis represents the first comprehensive survey of the vertebrate and mammal selenoproteomes, and depicts their evolution along lineages. It also provides a wealth of information on these selenoproteins and their forms.	[Mariotti, Marco; Zhang, Yan; Lobanov, Alexei V.; Gladyshev, Vadim N.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Mariotti, Marco; Zhang, Yan; Lobanov, Alexei V.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Boston, MA USA; [Mariotti, Marco; Guigo, Roderic] Ctr Genom Regulat, Barcelona, Spain; [Mariotti, Marco; Guigo, Roderic] Univ Pompeu Fabra, Barcelona, Spain; [Ridge, Perry G.] Univ Nebraska, Dept Biochem, Lincoln, NE 68583 USA; [Ridge, Perry G.] Univ Nebraska, Redox Biol Ctr, Lincoln, NE 68583 USA; [Zhang, Yan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Pringle, Thomas H.] Sperling Fdn, Eugene, OR USA; [Hatfield, Dolph L.] NCI, Lab Canc Prevent, NIH, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mariotti, M (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/J-6187-2013; Guigo, Roderic/D-1303-2010; Gladyshev, Vadim N/A-9894-2013; Mariotti, Marco/AAB-7136-2019	Guigo, Roderic/0000-0002-5738-4477; Mariotti, Marco/0000-0002-7411-4161; Gladyshev, Vadim/0000-0002-0372-7016	NIH [GM061603, GM065204]; NATIONAL CANCER INSTITUTE [ZIABC005317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061603, R01GM065204, R37GM065204] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH GM061603 and GM065204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bellingham J, 2003, BBA-GENE STRUCT EXPR, V1627, P140, DOI 10.1016/S0167-4781(03)00078-2; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; BIANCO AC, 2006, SELENIUM ITS MOL BIO, P207; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Boschan C, 2002, GENOMICS, V79, P387, DOI 10.1006/geno.2001.6715; Brigelius-Flohe R, 2008, CHEM BIODIVERS, V5, P389, DOI 10.1002/cbdv.200890039; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Castellano S, 2004, EMBO REP, V5, P71, DOI 10.1038/sj.embor.7400036; Castellano S, 2009, MOL BIOL EVOL, V26, P2031, DOI 10.1093/molbev/msp109; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Damdimopoulou PE, 2009, BBA-MOL CELL RES, V1793, P1588, DOI 10.1016/j.bbamcr.2009.07.007; Dammeyer P, 2008, J BIOL CHEM, V283, P2814, DOI 10.1074/jbc.M708939200; DIAMOND AM, 1992, GENE, V122, P377, DOI 10.1016/0378-1119(92)90230-M; Dikiy A, 2007, BIOCHEMISTRY-US, V46, P6871, DOI 10.1021/bi602462q; Ferguson-Smith MA, 2010, RUSS J GENET+, V46, P1160, DOI 10.1134/S1022795410100054; Fomenko DE, 2009, J BIOL CHEM, V284, P5986, DOI 10.1074/jbc.M805770200; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gerashchenko MV, 2010, J BIOL CHEM, V285, P4595, DOI 10.1074/jbc.M109.070532; Gladyshev VN, 2001, BIOFACTORS, V14, P87, DOI 10.1002/biof.5520140112; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Henneberry AL, 1999, BIOCHEM J, V339, P291, DOI 10.1042/0264-6021:3390291; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Horibata Y, 2007, J LIPID RES, V48, P503, DOI 10.1194/jlr.C600019-JLR200; Huerta-Cepas J, 2011, NUCLEIC ACIDS RES, V39, pD556, DOI 10.1093/nar/gkq1109; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Jakupoglu C, 2005, MOL CELL BIOL, V25, P1980, DOI 10.1128/MCB.25.5.1980-1988.2005; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Khil PP, 2005, TRENDS GENET, V21, P3, DOI 10.1016/j.tig.2004.11.005; Koc A, 2007, ANN NY ACAD SCI, V1100, P383, DOI 10.1196/annals.1395.042; Kollmus H, 1996, NUCLEIC ACIDS RES, V24, P1195, DOI 10.1093/nar/24.7.1195; Krol A, 2002, BIOCHIMIE, V84, P765, DOI 10.1016/S0300-9084(02)01405-0; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumaraswamy E, 2000, J BIOL CHEM, V275, P35540, DOI 10.1074/jbc.M004014200; Liang XW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011497; Lobanov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r62; Lobanov AV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r198; Lobanov AV, 2009, BBA-GEN SUBJECTS, V1790, P1424, DOI 10.1016/j.bbagen.2009.05.014; Lothrop AP, 2009, BIOCHEMISTRY-US, V48, P6213, DOI 10.1021/bi802146w; Low SC, 1996, TRENDS BIOCHEM SCI, V21, P203, DOI 10.1016/0968-0004(96)10025-6; Maiorino M, 2003, J BIOL CHEM, V278, P34286, DOI 10.1074/jbc.M305327200; Mariotti M, 2010, BIOINFORMATICS, V26, P2656, DOI 10.1093/bioinformatics/btq516; Martin GW, 1996, RNA, V2, P171; Matsui M, 1996, DEV BIOL, V178, P179, DOI 10.1006/dbio.1996.0208; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Moreno SG, 2003, BIOL CHEM, V384, P635, DOI 10.1515/BC.2003.070; Novoselov SV, 2006, BIOCHEM J, V394, P575, DOI 10.1042/BJ20051569; Novoselov SV, 2003, PROTEIN SCI, V12, P372, DOI 10.1110/ps.0226503; Ohba KI, 2001, MOL CELL ENDOCRINOL, V172, P169, DOI 10.1016/S0303-7207(00)00368-3; Olson GE, 2005, BIOL REPROD, V73, P201, DOI 10.1095/biolreprod.105.040360; Panopoulou G, 2003, GENOME RES, V13, P1056, DOI 10.1101/gr.874803; Peters MM, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-12; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rother M, 2001, MOL MICROBIOL, V40, P900, DOI 10.1046/j.1365-2958.2001.02433.x; Rundlof AK, 2000, BIOCHEM J, V347, P661, DOI 10.1042/0264-6021:3470661; Rundlof AK, 2004, FREE RADICAL BIO MED, V36, P641, DOI 10.1016/j.freeradbiomed.2003.12.004; Salvatore D, 1999, BIOCHIMIE, V81, P535, DOI 10.1016/S0300-9084(99)80106-0; Schomburg L, 2009, BBA-GEN SUBJECTS, V1790, P1453, DOI 10.1016/j.bbagen.2009.03.015; Selenius M, 2010, ANTIOXID REDOX SIGN, V12, P867, DOI 10.1089/ars.2009.2884; Shchedrina VA, 2007, P NATL ACAD SCI USA, V104, P13919, DOI 10.1073/pnas.0703448104; SHEN QC, 1993, J BIOL CHEM, V268, P11463; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; Stillwell RJ, 2005, P NATL ACAD SCI USA, V102, P16123, DOI 10.1073/pnas.0508349102; Su D, 2004, BIOCHEMISTRY-US, V43, P12177, DOI 10.1021/bi048478t; Suppmann S, 1999, EMBO J, V18, P2284, DOI 10.1093/emboj/18.8.2284; Svensson O, 2006, PLOS COMPUT BIOL, V2, P358, DOI 10.1371/journal.pcbi.0020046; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toppo S, 2008, ANTIOXID REDOX SIGN, V10, P1501, DOI 10.1089/ars.2008.2057; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Turanov AA, 2006, J BIOL CHEM, V281, P22953, DOI 10.1074/jbc.M604326200; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Ventura M, 2011, GENOME RES, V21, P1640, DOI 10.1101/gr.124461.111; Wingler K, 1999, BIOFACTORS, V10, P245, DOI 10.1002/biof.5520100223; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Zhang Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r94; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307	88	166	171	6	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33066	10.1371/journal.pone.0033066	http://dx.doi.org/10.1371/journal.pone.0033066			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479358	Green Published, gold			2022-12-27	WOS:000305339100031
J	Zhu, WZ; Cao, M; Wang, SG; Xiao, WF; Li, MH				Zhu, Wan-Ze; Cao, Min; Wang, San-Gen; Xiao, Wen-Fan; Li, Mai-He			Seasonal Dynamics of Mobile Carbon Supply in Quercus aquifolioides at the Upper Elevational Limit	PLOS ONE			English	Article							CARBOHYDRATE RESERVES; PINUS-CEMBRA; STEM PHOTOSYNTHESIS; SINK LIMITATION; COLD-HARDINESS; FOOD RESERVES; WOODY-PLANTS; GROWTH; TREES; STORAGE	Many studies have tried to explain the physiological mechanisms of the alpine treeline phenomenon, but the debate on the alpine treeline formation remains controversial due to opposite results from different studies. The present study explored the carbon-physiology of an alpine shrub species (Quercus aquifolioides) grown at its upper elevational limit compared to lower elevations, to test whether the elevational limit of alpine shrubs (<3 m in height) are determined by carbon limitation or growth limitation. We studied the seasonal variations in non-structural carbohydrate (NSC) and its pool size in Q. aquifolioides grown at 3000 m, 3500 m, and at its elevational limit of 3950 m above sea level (a.s.l.) on Zheduo Mt., SW China. The tissue NSC concentrations along the elevational gradient varied significantly with season, reflecting the season-dependent carbon balance. The NSC levels in tissues were lowest at the beginning of the growing season, indicating that plants used the winter reserve storage for re-growth in the early spring. During the growing season, plants grown at the elevational limit did not show lower NSC concentrations compared to plants at lower elevations, but during the winter season, storage tissues, especially roots, had significantly lower NSC concentrations in plants at the elevational limit compared to lower elevations. The present results suggest the significance of winter reserve in storage tissues, which may determine the winter survival and early-spring re-growth of Q. aquifolioides shrubs at high elevation, leading to the formation of the uppermost distribution limit. This result is consistent with a recent hypothesis for the alpine treeline formation.	[Zhu, Wan-Ze] Chinese Acad Sci, Inst Mt Hazard & Environm, Alpine Ecosyst Observat & Expt Stn Gongga Mt, Chengdu, Peoples R China; [Li, Mai-He] Swiss Fed Res Inst WSL, Tree Physiol Grp, Birmensdorf, Switzerland; [Li, Mai-He] Chinese Acad Sci, State Key Lab Forest & Soil Ecol, Inst Appl Ecol, Shenyang, Peoples R China; [Cao, Min] Chinese Acad Sci, Key Lab Trop Forest Ecol, Xishuangbanna Trop Bot Garden, Mengla, Peoples R China; [Wang, San-Gen] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China; [Xiao, Wen-Fan] Chinese Acad Forestry, State Forestry Adm, Key Lab Forest Ecol & Environm, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Southwest University - China; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF	Zhu, WZ (corresponding author), Chinese Acad Sci, Inst Mt Hazard & Environm, Alpine Ecosyst Observat & Expt Stn Gongga Mt, Chengdu, Peoples R China.	wzzhu@imde.ac.cn; maihe.li@wsl.ch	Li, Mai-He/L-6390-2013	Li, Mai-He/0000-0002-7029-2841	Natural Science Foundation of China [30872017]; Chinese Academy of Sciences [KSCX2-YW-N-066, KZCX2-YW-331]; Key Laboratory of Forest Ecology and Environment, State Forestry Administration, Chinese Academy of Forestry [CAFIFEEPYBB2007001]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Key Laboratory of Forest Ecology and Environment, State Forestry Administration, Chinese Academy of Forestry	This study was supported by the Natural Science Foundation of China (Project No. 30872017), the Knowledge Innovation Priority Project of the Chinese Academy of Sciences (Grant No. KSCX2-YW-N-066 and KZCX2-YW-331), and the Key Laboratory of Forest Ecology and Environment, State Forestry Administration, Chinese Academy of Forestry (Project No. CAFIFEEPYBB2007001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschan G, 2003, FLORA, V198, P81, DOI 10.1078/0367-2530-00080; Bansal S, 2008, OECOLOGIA, V158, P217, DOI 10.1007/s00442-008-1145-4; Barbaroux C, 2003, NEW PHYTOL, V157, P605, DOI 10.1046/j.1469-8137.2003.00681.x; Barbaroux C, 2002, TREE PHYSIOL, V22, P1201, DOI 10.1093/treephys/22.17.1201; Berveiller D, 2007, TREE PHYSIOL, V27, P53, DOI 10.1093/treephys/27.1.53; Birk EM, 1986, TREE PHYSIOL, V2, P17, DOI 10.1093/treephys/2.1-2-3.17; BRADBURY IK, 1977, CAN J BOT, V55, P1121, DOI 10.1139/b77-129; CHAPIN FS, 1980, J ECOL, V68, P189; CHAPIN FS, 1990, ANNU REV ECOL SYST, V21, P423, DOI 10.1146/annurev.ecolsys.21.1.423; Cherbuy B, 2001, TREE PHYSIOL, V21, P9, DOI 10.1093/treephys/21.1.9; CRANSWICK A M, 1987, New Zealand Journal of Forestry Science, V17, P229; Eckstein RL, 1998, OIKOS, V81, P567, DOI 10.2307/3546777; Edwards NT, 1996, TREE PHYSIOL, V16, P433; ERICSSON A, 1978, PHYSIOL PLANTARUM, V43, P351, DOI 10.1111/j.1399-3054.1978.tb01593.x; FISCHER C, 1991, TREES-STRUCT FUNCT, V5, P187, DOI 10.1007/BF00227524; FONDA RW, 1966, B TORREY BOT CLUB, V93, P268, DOI 10.2307/2483955; Gaucher C, 2005, TREE PHYSIOL, V25, P93, DOI 10.1093/treephys/25.1.93; Genet M, 2011, ANN BOT-LONDON, V107, P311, DOI 10.1093/aob/mcq237; Graham EA, 2003, P NATL ACAD SCI USA, V100, P572, DOI 10.1073/pnas.0133045100; Han S. S., 1981, Journal of the Japanese Forestry Society, V63, P242; Handa IT, 2005, ECOLOGY, V86, P1288, DOI 10.1890/04-0711; [何毓蓉 He Yurong], 2005, [山地学报, Journal of Mountain Science], V23, P651; Hoch G, 2003, PLANT CELL ENVIRON, V26, P1067, DOI 10.1046/j.0016-8025.2003.01032.x; Hoch G, 2003, OECOLOGIA, V135, P10, DOI 10.1007/s00442-002-1154-7; Hoch G, 2002, OIKOS, V98, P361, DOI 10.1034/j.1600-0706.2002.980301.x; JONASSON S, 1989, OIKOS, V56, P121, DOI 10.2307/3566095; JONASSON S, 1995, ECOLOGY, V76, P475, DOI 10.2307/1941206; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Korner C, 2003, J ECOL, V91, P4, DOI 10.1046/j.1365-2745.2003.00742.x; Kozlowski T.T., 1991, PHYSL ECOLOGY WOODY, DOI 10.1016/B978-0-12-424160-2.50005-7; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; KRAMER PJ, 1979, PHYSL WOODY PLANTS, P258; KRUEGER KW, 1967, FOREST SCI, V13, P192; Landhausser SM, 2003, TREES-STRUCT FUNCT, V17, P471, DOI 10.1007/s00468-003-0263-1; LARCHER W, 1988, ACTA OECOL-OEC PLANT, V9, P271; Le Roux X, 2001, ANN FOR SCI, V58, P469, DOI 10.1051/forest:2001140; Levitt J, 1956, HARDINESS PLANTS; Li CY, 2006, SILVA FENN, V40, P5, DOI 10.14214/sf.348; Li MH, 2008, PLANT CELL ENVIRON, V31, P1377, DOI 10.1111/j.1365-3040.2008.01848.x; Li MH, 2008, TREE PHYSIOL, V28, P1287, DOI 10.1093/treephys/28.8.1287; Li MH, 2006, TREES-STRUCT FUNCT, V20, P611, DOI 10.1007/s00468-006-0076-0; Li MH, 2002, TREES-STRUCT FUNCT, V16, P331, DOI 10.1007/s00468-002-0172-8; Li MC, 2009, J FOREST RES-JPN, V14, P229, DOI 10.1007/s10310-009-0132-x; LOESCHER WH, 1990, HORTSCIENCE, V25, P274, DOI 10.21273/HORTSCI.25.3.274; Mataa M, 1996, J JPN SOC HORTIC SCI, V65, P513, DOI 10.2503/jjshs.65.513; Morin X, 2007, TREE PHYSIOL, V27, P817, DOI 10.1093/treephys/27.6.817; Newell EA, 2002, OECOLOGIA, V131, P333, DOI 10.1007/s00442-002-0888-6; Ogren E, 1997, PLANT CELL ENVIRON, V20, P247, DOI 10.1046/j.1365-3040.1997.d01-56.x; Oleksyn J, 2000, TREE PHYSIOL, V20, P837; OSAKI M, 1991, SOIL SCI PLANT NUTR, V37, P117, DOI 10.1080/00380768.1991.10415017; Palacio S, 2007, ENVIRON EXP BOT, V59, P34, DOI 10.1016/j.envexpbot.2005.10.003; Patton AJ, 2007, CROP SCI, V47, P2170, DOI 10.2135/cropsci2006.12.0784; Pfanz H, 2001, PROG BOT, V62, P477; Piispanen R, 2001, TREES-STRUCT FUNCT, V15, P444, DOI 10.1007/s004680100125; Piper FI, 2006, PLANT ECOL, V185, P29, DOI 10.1007/s11258-005-9081-4; READER RJ, 1978, CAN J BOT, V56, P1248, DOI 10.1139/b78-139; Regier N, 2010, TREE PHYSIOL, V30, P979, DOI 10.1093/treephys/tpq047; Sakai A, ROLE SUGAR RELATED C; Sakai A, 1987, FROST SURVIVAL PLANT, P151; Schadel C, 2009, TREE PHYSIOL, V29, P901, DOI 10.1093/treephys/tpp034; SCHULZE ED, 1967, ECOLOGY, V48, P1044, DOI 10.2307/1934564; Shi P, 2008, FUNCT ECOL, V22, P213, DOI 10.1111/j.1365-2435.2007.01370.x; Shi PL, 2006, BASIC APPL ECOL, V7, P370, DOI 10.1016/j.baae.2005.06.005; SHIBATA O, 1993, ARCTIC ALPINE RES, V25, P207, DOI 10.2307/1551815; Sichuan Forest Editorial Committee Forests in Sichuan, 1992, SICH FOR, P634; Silpi U, 2007, TREE PHYSIOL, V27, P881, DOI 10.1093/treephys/27.6.881; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Spann TM, 2008, TREE PHYSIOL, V28, P207, DOI 10.1093/treephys/28.2.207; STEVENS GC, 1991, ANNU REV ECOL SYST, V22, P177, DOI 10.1146/annurev.es.22.110191.001141; Strand A, 2003, PLANT CELL ENVIRON, V26, P523, DOI 10.1046/j.1365-3040.2003.00983.x; Susiluoto S, 2010, J ECOL, V98, P1186, DOI 10.1111/j.1365-2745.2010.01684.x; Tolsma AD, 2007, AUST J BOT, V55, P771, DOI 10.1071/BT06216; WARDLE P, 1993, NATO ADV SCI INST SE, V244, P89; Wurth MKR, 2005, OECOLOGIA, V143, P11, DOI 10.1007/s00442-004-1773-2; YEMM EW, 1954, BIOCHEM J, V57, P508, DOI 10.1042/bj0570508; Zhou Zhe-Kun, 1993, Acta Botanica Yunnanica, V15, P21	76	38	52	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34213	10.1371/journal.pone.0034213	http://dx.doi.org/10.1371/journal.pone.0034213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479567	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100137
J	Zschuttig, A; Zimmermann, K; Blom, J; Goesmann, A; Pohlmann, C; Gunzer, F				Zschuettig, Anke; Zimmermann, Kurt; Blom, Jochen; Goesmann, Alexander; Poehlmann, Christoph; Gunzer, Florian			Identification and Characterization of Microcin S, a New Antibacterial Peptide Produced by Probiotic Escherichia coli G3/10	PLOS ONE			English	Article							MOLECULAR-WEIGHT ANTIBIOTICS; GROWTH-PHASE; CELL-LINES; PLASMIDS; BACTERIA; GENOME; ENTEROBACTERIA; TRANSCRIPTION; DETERMINANTS; EXPRESSION	Escherichia coli G3/10 is a component of the probiotic drug Symbioflor 2. In an in vitro assay with human intestinal epithelial cells, E. coli G3/10 is capable of suppressing adherence of enteropathogenic E. coli E2348/69. In this study, we demonstrate that a completely novel class II microcin, produced by probiotic E. coli G3/10, is responsible for this behavior. We named this antibacterial peptide microcin S (MccS). Microcin S is coded on a 50.6 kb megaplasmid of E. coli G3/10, which we have completely sequenced and annotated. The microcin S operon is about 4.7 kb in size and is comprised of four genes. Subcloning of the genes and gene fragments followed by gene expression experiments enabled us to functionally characterize all members of this operon, and to clearly identify the nucleotide sequences encoding the microcin itself (mcsS), its transport apparatus and the gene mcsI conferring self immunity against microcin S. Overexpression of cloned mcsI antagonizes MccS activity, thus protecting indicator strain E. coli E2348/69 in the in vitro adherence assay. Moreover, growth of E. coli transformed with a plasmid containing mcsS under control of an araC PBAD activator-promoter is inhibited upon mcsS induction. Our data provide further mechanistic insight into the probiotic behavior of E. coli G3/10.	[Zschuettig, Anke; Gunzer, Florian] Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany; [Zimmermann, Kurt] SymbioPharm GmbH, Herborn Horbach, Germany; [Blom, Jochen; Goesmann, Alexander] Univ Bielefeld, CeBiTec, D-33615 Bielefeld, Germany; [Poehlmann, Christoph] Robert Bosch Krankenhaus, Abt Lab Med, Stuttgart, Germany	Technische Universitat Dresden; University of Bielefeld; Bosch; Robert Bosch Krankenhaus	Zschuttig, A (corresponding author), Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany.	florian.gunzer@tu-dresden.de		Goesmann, Alexander/0000-0002-7086-2568	Federal Ministry of Education and Research (BMBF GenomikTransfer, PROTumor consortium) [0315590A]; SymbioPharm GmbH [100_2847]	Federal Ministry of Education and Research (BMBF GenomikTransfer, PROTumor consortium); SymbioPharm GmbH	This work has been funded by restricted research grants of the Federal Ministry of Education and Research (BMBF GenomikTransfer, PROTumor consortium, # 0315590A) and of SymbioPharm GmbH(# 100_2847) to FG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASENSIO C, 1976, BIOCHEM BIOPH RES CO, V69, P7, DOI 10.1016/S0006-291X(76)80264-1; BAQUERO F, 1978, J BACTERIOL, V135, P342, DOI 10.1128/JB.135.2.342-347.1978; CHEHADE H, 1988, FEMS MICROBIOL LETT, V52, P177, DOI 10.1111/j.1574-6968.1988.tb02591.x; Chiuchiolo MJ, 2001, J BACTERIOL, V183, P1755, DOI 10.1128/JB.183.5.1755-1764.2001; CONNELL N, 1987, MOL MICROBIOL, V1, P195, DOI 10.1111/j.1365-2958.1987.tb00512.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dicks LMT, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P391, DOI 10.1007/978-1-4419-7692-5_19; DONNENBERG MS, 1992, INFECT IMMUN, V60, P3953, DOI 10.1128/IAI.60.10.3953-3961.1992; DREWINKO B, 1978, J NATL CANCER I, V61, P75, DOI 10.1093/jnci/61.1.75; Drexler H., 2001, DSMZ CATALOGUE HUMAN, Veighth; Duquesne S, 2007, NAT PROD REP, V24, P708, DOI 10.1039/b516237h; Enck P, 2009, Z GASTROENTEROL, V47, P209, DOI 10.1055/s-2008-1027702; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fomenko D, 2001, RES MICROBIOL, V152, P469, DOI 10.1016/S0923-2508(01)01220-7; Gillor O, 2004, ADV APPL MICROBIOL, V54, P129, DOI 10.1016/S0065-2164(04)54005-4; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Guarner F, 1998, INT J FOOD MICROBIOL, V39, P237, DOI 10.1016/S0168-1605(97)00136-0; HAVARSTEIN LS, 1994, MICROBIOL-SGM, V140, P2383, DOI 10.1099/13500872-140-9-2383; HERNANDEZCHICO C, 1986, J BACTERIOL, V167, P1058, DOI 10.1128/jb.167.3.1058-1065.1986; Hetz C, 2002, P NATL ACAD SCI USA, V99, P2696, DOI 10.1073/pnas.052709699; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Kleta S, 2006, J APPL MICROBIOL, V101, P1357, DOI 10.1111/j.1365-2672.2006.03019.x; Kuipers A, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P147, DOI 10.1007/978-1-4419-7692-5_9; Martens U, 2010, Ger Med Sci, V8, pDoc07, DOI 10.3205/000096; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; MILLAN JLS, 1985, J BACTERIOL, V163, P275, DOI 10.1128/JB.163.1.275-281.1985; MILLER HJ, 1992, SHORT COURSE BACTERI; Nissle A., 1916, DEUT MED WOCHENSCHR, V42, P1181, DOI [10.1055/s-0028-1135392, DOI 10.1055/S-0028-1135392]; NOVOA MA, 1986, J BACTERIOL, V168, P1384, DOI 10.1128/jb.168.3.1384-1391.1986; OBRIEN GJ, 1994, PLASMID, V31, P288, DOI 10.1006/plas.1994.1030; Ong CLY, 2009, APPL ENVIRON MICROB, V75, P6783, DOI 10.1128/AEM.00974-09; Patzer SI, 2003, MICROBIOL-SGM, V149, P2557, DOI 10.1099/mic.0.26396-0; Poey ME, 2006, ANTIMICROB AGENTS CH, V50, P1411, DOI 10.1128/AAC.50.4.1411-1418.2006; Pons AM, 2004, ANTIMICROB AGENTS CH, V48, P505, DOI 10.1128/AAC.48.2.505-513.2004; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Posfai G, 1997, J BACTERIOL, V179, P4426, DOI 10.1128/jb.179.13.4426-4428.1997; Rebuffat S, 2011, PROKARYOTIC ANTIMICROBIAL PEPTIDES: FROM GENES TO APPLICATIONS, P55, DOI 10.1007/978-1-4419-7692-5_4; ROUSSET M, 1986, BIOCHIMIE, V68, P1035, DOI 10.1016/S0300-9084(86)80177-8; SALOMON RA, 1992, J BACTERIOL, V174, P7428, DOI 10.1128/jb.174.22.7428-7435.1992; Sanger F, 1992, Biotechnology, V24, P104; WATERS VL, 1991, MICROBIOL REV, V55, P437, DOI 10.1128/MMBR.55.3.437-450.1991; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	43	56	59	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33351	10.1371/journal.pone.0033351	http://dx.doi.org/10.1371/journal.pone.0033351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479389	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100044
J	Kang, W; Tong, JHM; Chan, AWH; Lung, RWM; Chau, SL; Wong, QWL; Wong, N; Yu, J; Cheng, ASL; To, KF				Kang, Wei; Tong, Joanna H. M.; Chan, Anthony W. H.; Lung, Raymond W. M.; Chau, Shuk Ling; Wong, Queenie W. L.; Wong, Nathalie; Yu, Jun; Cheng, Alfred S. L.; To, Ka Fai			Stathmin1 Plays Oncogenic Role and Is a Target of MicroRNA-223 in Gastric Cancer	PLOS ONE			English	Article							POOR-PROGNOSIS; HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; CELL PROLIFERATION; EARLY RECURRENCE; DOWN-REGULATION; EXPRESSION; OVEREXPRESSION; PROGRESSION; P53	Stathmin1 (STMN1) is a candidate oncoprotein and prognosis marker in several kinds of cancers. This study was aimed to analyze its expression and biological functions in gastric cancer. The expression of STMN1 was evaluated by qRT-PCR, western blot and immunohistochemistry. The biological function of STMN1 was determined by MTT proliferation assays, monolayer colony formation and cell invasion assays using small interference RNA technique in gastric cancer cell lines. We also explored the regulation of STMN1 expression by microRNA-223. STMN1 was upregulated in gastric cancer cell lines and primary gastric adenocarcinomas. STMN1-positive tumors were more likely to be found in old age group and associated with p53 nuclear expression. In diffuse type gastric adenocarcinomas, STMN1 expression was correlated with age (p = 0.043), T stage (p = 0.004) and lymph node metastasis (p = 0.046). Expression of STMN1 in diffuse type gastric adenocarcinoma was associated with poor disease specific survival by univariate analysis (p = 0.01). STMN1 knockdown in AGS and MKN7 cell lines suppressed proliferation (p < 0.001), reduced monolayer colony formation (p < 0.001), inhibited cell invasion and migration ability (p<0.001) and induced G1 phase arrest. siSTMN1 could also suppress cell growth in vivo (p < 0. 01). We finally confirmed that STMN1 is a putative downstream target of miR-223 in gastric cancer. Our findings supported an oncogenic role of STMN1 in gastric cancer. STMN1 might serve as a prognostic marker and a potential therapeutic target for gastric cancer.	[Kang, Wei; Tong, Joanna H. M.; Chan, Anthony W. H.; Lung, Raymond W. M.; Chau, Shuk Ling; Wong, Queenie W. L.; Wong, Nathalie; To, Ka Fai] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, State Key Lab Oncol S China, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Kang, Wei; Tong, Joanna H. M.; Lung, Raymond W. M.; Chau, Shuk Ling; Yu, Jun; Cheng, Alfred S. L.; To, Ka Fai] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China; [Yu, Jun; Cheng, Alfred S. L.] Chinese Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong	Kang, W (corresponding author), Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, State Key Lab Oncol S China, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China.	kfto@cuhk.edu.hk	Chan, Anthony/U-7768-2019; KANG, Wei/C-5451-2016; Yu, Jun/D-8569-2015; Ling, Chau Shuk/AAB-5669-2020; Chan, Anthony Wing Hung/HGB-4311-2022; Raymond, Lung/G-3200-2011; Chan, Anthony W.H./N-6719-2016; Cheng, Alfred SL/C-3327-2014; LUNG, Raymond Wai-ming/D-1274-2014	Chan, Anthony/0000-0002-1771-163X; KANG, Wei/0000-0002-4651-677X; Yu, Jun/0000-0001-5008-2153; Ling, Chau Shuk/0000-0001-7407-5767; Chan, Anthony Wing Hung/0000-0002-1771-163X; Raymond, Lung/0000-0002-0813-7429; Chan, Anthony W.H./0000-0002-1771-163X; Cheng, Alfred SL/0000-0003-2345-6951; LUNG, Raymond Wai-ming/0000-0002-0813-7429	UGC [CUHK04/CRF/08]	UGC(University Grants Commission, India)	This study is supported by UGC Collaborated Research Fund (CUHK04/CRF/08) and the funder's website is http://www.ugc.edu.hk/eng/rgc/fund/crf_202011_2012.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 1999, ONCOGENE, V18, P5954, DOI 10.1038/sj.onc.1202986; Alli E, 2007, ONCOGENE, V26, P1003, DOI 10.1038/sj.onc.1209864; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Chan AWH, 2005, ONCOL REP, V13, P937; Cheng YY, 2007, BRIT J CANCER, V97, P895, DOI 10.1038/sj.bjc.6603968; Du Y, 2009, J GASTROENTEROL, V44, P556, DOI 10.1007/s00535-009-0037-7; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; Gan L, 2010, ONCOL REP, V23, P1037, DOI 10.3892/or_00000730; Ghosh R, 2007, PROSTATE, V67, P1038, DOI 10.1002/pros.20601; Golouh R, 2008, BREAST CANCER RES TR, V110, P317, DOI 10.1007/s10549-007-9724-3; Hsieh SY, 2010, MOL CARCINOGEN, V49, P476, DOI 10.1002/mc.20627; Iancu-Rubin C, 2005, TRENDS CELL BIOL, V15, P346, DOI 10.1016/j.tcb.2005.05.008; Jeon TY, 2010, BRIT J CANCER, V102, P710, DOI 10.1038/sj.bjc.6605537; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Johnsen JI, 2000, INT J CANCER, V88, P685, DOI 10.1002/1097-0215(20001201)88:5<685::AID-IJC1>3.0.CO;2-Z; Kang W, 2011, CLIN CANCER RES, V17, P2130, DOI 10.1158/1078-0432.CCR-10-2467; Kim JY, 2007, ANTICANCER RES, V27, P39; Kouzu Y, 2006, BRIT J CANCER, V94, P717, DOI 10.1038/sj.bjc.6602991; Laios A, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-35; Leung WK, 2008, CARCINOGENESIS, V29, P1648, DOI 10.1093/carcin/bgn156; Leung WK, 2004, GUT, V53, P331, DOI 10.1136/gut.2003.021105; Li J, 2009, BRIT J CANCER, V101, P691, DOI 10.1038/sj.bjc.6605202; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Singer S, 2009, CANCER RES, V69, P2234, DOI 10.1158/0008-5472.CAN-08-3338; Smith MG, 2006, WORLD J GASTROENTERO, V12, P2979, DOI 10.3748/wjg.v12.i19.2979; Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335; Sun W, 2010, CELL RES, V20, P1158, DOI 10.1038/cr.2010.134; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Wang Feng, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1552; Wang JF, 2010, BIOCHEM BIOPH RES CO, V394, P184, DOI 10.1016/j.bbrc.2010.02.145; Wang X, 2009, PROTEOMICS, V9, P242, DOI 10.1002/pmic.200800155; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Xi W, 2009, J CANCER RES CLIN, V135, P837, DOI 10.1007/s00432-008-0520-1; Xiao BX, 2009, CLIN CHIM ACTA, V400, P97, DOI 10.1016/j.cca.2008.10.021; Yemelyanova A, 2011, MOD PATHOL; Yu J, 2009, GASTROENTEROLOGY, V136, P640, DOI 10.1053/j.gastro.2008.10.050; Yuan RH, 2006, J PATHOL, V209, P549, DOI 10.1002/path.2011; ZHANG Y, 2009, MED ONCOL; Zheng P, 2010, J PROTEOME RES, V9, P4897, DOI 10.1021/pr100712t	43	81	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33919	10.1371/journal.pone.0033919	http://dx.doi.org/10.1371/journal.pone.0033919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470493	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000044
J	Spencer, AJ; Hill, F; Honeycutt, JD; Cottingham, MG; Bregu, M; Rollier, CS; Furze, J; Draper, SJ; Sogaard, KC; Gilbert, SC; Wyllie, DH; Hill, AVS				Spencer, Alexandra J.; Hill, Fergal; Honeycutt, Jared D.; Cottingham, Matthew G.; Bregu, Migena; Rollier, Christine S.; Furze, Julie; Draper, Simon J.; Sogaard, Karen C.; Gilbert, Sarah C.; Wyllie, David H.; Hill, Adrian V. S.			Fusion of the Mycobacterium tuberculosis Antigen 85A to an Oligomerization Domain Enhances Its Immunogenicity in Both Mice and Non-Human Primates	PLOS ONE			English	Article							T-CELLS; VACCINE; ADJUVANT; MVA85A; MEMORY; EXPRESSION; PROTECTION; ANTIBODIES; EPITOPES; IMMUNITY	To prevent important infectious diseases such as tuberculosis, malaria and HIV, vaccines inducing greater T cell responses are required. In this study, we investigated whether fusion of the M. tuberculosis antigen 85A to recently described adjuvant IMX313, a hybrid avian C4bp oligomerization domain, could increase T cell responses in pre-clinical vaccine model species. In mice, the fused antigen 85A showed consistent increases in CD4(+) and CD8(+) T cell responses after DNA and MVA vaccination. In rhesus macaques, higher IFN-gamma responses were observed in animals vaccinated with MVA-Ag85A IMX313 after both primary and secondary immunizations. In both animal models, fusion to IMX313 induced a quantitative enhancement in the response without altering its quality: multifunctional cytokines were uniformly increased and differentiation into effector and memory T cell subsets was augmented rather than skewed. An extensive in vivo characterization suggests that IMX313 improves the initiation of immune responses as an increase in antigen 85A specific cells was observed as early as day 3 after vaccination. This report demonstrates that antigen multimerization using IMX313 is a simple and effective cross-species method to improve vaccine immunogenicity with potentially broad applicability.	[Spencer, Alexandra J.; Honeycutt, Jared D.; Cottingham, Matthew G.; Bregu, Migena; Rollier, Christine S.; Furze, Julie; Draper, Simon J.; Sogaard, Karen C.; Gilbert, Sarah C.; Wyllie, David H.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Oxford, England; [Hill, Fergal] Imaxio SA, Lyon, France	University of Oxford; Jenner Institute	Spencer, AJ (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	alex.spencer@ndm.ox.ac.uk	Draper, Simon J/F-1758-2011; Spencer, Alexandra/AAE-6494-2019; Hill, Fergal/AAI-1329-2021; Gilbert, Sarah C./H-2857-2019	Draper, Simon J/0000-0002-9415-1357; Spencer, Alexandra/0000-0001-7958-6961; Gilbert, Sarah C./0000-0002-6823-9750; Cottingham, Matthew/0000-0003-0766-6465	Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative; Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; Medical Research Council [G1000527] Funding Source: researchfish; MRC [G1000527] Funding Source: UKRI	Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative with additional funding from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bins AD, 2007, J IMMUNOL, V179, P2126, DOI 10.4049/jimmunol.179.4.2126; Brookes RH, 2003, EUR J IMMUNOL, V33, P3293, DOI 10.1002/eji.200324109; Caruso AM, 1999, J IMMUNOL, V162, P5407; Chambers RS, 2003, NAT BIOTECHNOL, V21, P1088, DOI 10.1038/nbt858; Christiansen D, 2000, J VIROL, V74, P4672, DOI 10.1128/JVI.74.10.4672-4678.2000; D'Souza S, 2003, INFECT IMMUN, V71, P483, DOI 10.1128/IAI.71.1.483-493.2003; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Delamarre L, 2006, J EXP MED, V203, P2049, DOI 10.1084/jem.20052442; Denis O, 1998, INFECT IMMUN, V66, P1527, DOI 10.1128/IAI.66.4.1527-1533.1998; Dervillez X, 2006, CHEMMEDCHEM, V1, P330, DOI 10.1002/cmdc.200500062; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Engel J, 2000, MATRIX BIOL, V19, P283, DOI 10.1016/S0945-053X(00)00075-5; Fazekas de St Groth B, 2004, IMMUNOL CELL BIOL, V82, P260, DOI 10.1111/j.0818-9641.2004.01243.x; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Goonetilleke NP, 2003, J IMMUNOL, V171, P1602, DOI 10.4049/jimmunol.171.3.1602; GRUN JL, 1989, CELL IMMUNOL, V121, P134, DOI 10.1016/0008-8749(89)90011-7; Hawkridge T, 2008, J INFECT DIS, V198, P544, DOI 10.1086/590185; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; Huster KM, 2006, EUR J IMMUNOL, V36, P1453, DOI 10.1002/eji.200635874; Ibango HB, 2006, LANCET INFECT DIS, V6, P522, DOI 10.1016/S1473-3099(06)70552-7; Kask L, 2002, BIOCHEMISTRY-US, V41, P9349, DOI 10.1021/bi025980+; Libyh MT, 1997, BLOOD, V90, P3978, DOI 10.1182/blood.V90.10.3978; Liu JY, 2008, J VIROL, V82, P4844, DOI 10.1128/JVI.02616-07; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; McShane H, 2005, TUBERCULOSIS, V85, P47, DOI 10.1016/j.tube.2004.09.015; McShane H, 2004, NAT MED, V10, P1240, DOI 10.1038/nm1128; McShane H, 2002, INFECT IMMUN, V70, P1623, DOI 10.1128/IAI.70.3.1623-1626.2002; Ogun SA, 2008, INFECT IMMUN, V76, P3817, DOI 10.1128/IAI.01369-07; Oudin S, 2000, J IMMUNOL, V164, P1505, DOI 10.4049/jimmunol.164.3.1505; Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shinya E, 1999, BIOMED PHARMACOTHER, V53, P471, DOI 10.1016/S0753-3322(00)88106-8; Smith A, 2000, IMMUNITY, V13, P783, DOI 10.1016/S1074-7613(00)00076-5; Taracha ELN, 2003, INFECT IMMUN, V71, P6906, DOI 10.1128/IAI.71.12.6906-6914.2003; Ulanova M, 2001, INFECT IMMUN, V69, P1151, DOI 10.1128/IAI.69.2.1151-1159.2001; van Pinxteren LAH, 2000, EUR J IMMUNOL, V30, P3689, DOI 10.1002/1521-4141(200012)30:12<3689::AID-IMMU3689>3.3.CO;2-W; Williams A, 2009, TUBERCULOSIS, V89, P389, DOI 10.1016/j.tube.2009.08.004	41	38	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33555	10.1371/journal.pone.0033555	http://dx.doi.org/10.1371/journal.pone.0033555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470455	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000025
J	Swanson, DL; Thomas, NE; Liknes, ET; Cooper, SJ				Swanson, David L.; Thomas, Nathan E.; Liknes, Eric T.; Cooper, Sheldon J.			Intraspecific Correlations of Basal and Maximal Metabolic Rates in Birds and the Aerobic Capacity Model for the Evolution of Endothermy	PLOS ONE			English	Article							IN-HOUSE FINCHES; SEASONAL ACCLIMATIZATION; THERMOGENIC CAPACITY; PHENOTYPIC FLEXIBILITY; GEOGRAPHIC-VARIATION; OXYGEN-CONSUMPTION; BODY-COMPOSITION; PASSERINE BIRDS; COLD TOLERANCE; SHIVERING THERMOGENESIS	The underlying assumption of the aerobic capacity model for the evolution of endothermy is that basal (BMR) and maximal aerobic metabolic rates are phenotypically linked. However, because BMR is largely a function of central organs whereas maximal metabolic output is largely a function of skeletal muscles, the mechanistic underpinnings for their linkage are not obvious. Interspecific studies in birds generally support a phenotypic correlation between BMR and maximal metabolic output. If the aerobic capacity model is valid, these phenotypic correlations should also extend to intraspecific comparisons. We measured BMR, M-sum (maximum thermoregulatory metabolic rate) and MMR (maximum exercise metabolic rate in a hop-flutter chamber) in winter for dark-eyed juncos (Junco hyemalis), American goldfinches (Carduelis tristis; M-sum and MMR only), and black-capped chickadees (Poecile atricapillus; BMR and M-sum only) and examined correlations among these variables. We also measured BMR and M-sum in individual house sparrows (Passer domesticus) in both summer, winter and spring. For both raw metabolic rates and residuals from allometric regressions, BMR was not significantly correlated with either M-sum or MMR in juncos. Moreover, no significant correlation between M-sum and MMR or their mass-independent residuals occurred for juncos or goldfinches. Raw BMR and M-sum were significantly positively correlated for black-capped chickadees and house sparrows, but mass-independent residuals of BMR and M-sum were not. These data suggest that central organ and exercise organ metabolic levels are not inextricably linked and that muscular capacities for exercise and shivering do not necessarily vary in tandem in individual birds. Why intraspecific and interspecific avian studies show differing results and the significance of these differences to the aerobic capacity model are unknown, and resolution of these questions will require additional studies of potential mechanistic links between minimal and maximal metabolic output.	[Swanson, David L.; Thomas, Nathan E.; Liknes, Eric T.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Liknes, Eric T.] No State Univ, Dept Biol, Aberdeen, SD USA; [Cooper, Sheldon J.] Univ Wisconsin, Dept Biol & Microbiol, Oshkosh, WI 54901 USA	University of South Dakota; Northern State University; University of Wisconsin System	Swanson, DL (corresponding author), Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA.	david.swanson@usd.edu	, nathan/AAE-1393-2020		U.S. National Science Foundation EPSCoR [0091948]; U.S. National Science Foundation [IOS 1021218]	U.S. National Science Foundation EPSCoR(National Science Foundation (NSF)); U.S. National Science Foundation(National Science Foundation (NSF))	U.S. National Science Foundation EPSCoR Award 0091948 and U.S. National Science Foundation Award IOS 1021218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arens JR, 2005, PHYSIOL BIOCHEM ZOOL, V78, P579, DOI 10.1086/430235; BARTHOLOMEW GA, 1981, J EXP BIOL, V90, P17; BENNETT AF, 1979, SCIENCE, V206, P649, DOI 10.1126/science.493968; Broggi J, 2004, J ANIM ECOL, V73, P967, DOI 10.1111/j.0021-8790.2004.00872.x; Buchanan KL, 2001, P ROY SOC B-BIOL SCI, V268, P1337, DOI 10.1098/rspb.2001.1669; Bundle MW, 1999, NATURE, V397, P31, DOI 10.1038/16173; CHAPPELL MA, 1995, PHYSIOL ZOOL, V68, P421, DOI 10.1086/physzool.68.3.30163777; Chappell MA, 1999, J EXP BIOL, V202, P2269; Chappell MA, 2011, J EXP BIOL, V214, P3186, DOI 10.1242/jeb.055046; COOPER SJ, 1994, CONDOR, V96, P638, DOI 10.2307/1369467; DAAN S, 1990, AM J PHYSIOL, V259, pR333, DOI 10.1152/ajpregu.1990.259.2.R333; Dawson W.R., 1986, P427; Dawson William R., 1996, P85; DAWSON WR, 1976, J COMP PHYSIOL, V112, P317, DOI 10.1007/BF00692302; DAWSON WR, 1983, PHYSIOL ZOOL, V56, P353, DOI 10.1086/physzool.56.3.30152600; DAWSON WR, 1983, AM J PHYSIOL, V245, pR755, DOI 10.1152/ajpregu.1983.245.6.R755; Dutenhoffer MS, 1996, PHYSIOL ZOOL, V69, P1232, DOI 10.1086/physzool.69.5.30164255; ELIA M, 1992, ENERGY METABOLISM, P61; GESSAMAN JA, 1988, CONDOR, V90, P662, DOI 10.2307/1368356; GESSAMAN JA, 1991, CONDOR, V93, P546, DOI 10.2307/1368186; HART J. S., 1962, PHYSIOL ZOOL, V35, P224; HAYES JP, 1995, EVOLUTION, V49, P836, DOI 10.1111/j.1558-5646.1995.tb02320.x; HILL RW, 1972, J APPL PHYSIOL, V33, P261, DOI 10.1152/jappl.1972.33.2.261; HOHTOLA E, 1982, COMP BIOCHEM PHYS A, V73, P159, DOI 10.1016/0300-9629(82)90049-4; Holloway JC, 2001, PHYSIOL BIOCHEM ZOOL, V74, P219, DOI 10.1086/319666; JEHL JR, 1994, J AVIAN BIOL, V25, P63, DOI 10.2307/3677295; Jetz W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003261; Lewden A, 2012, J COMP PHYSIOL B, V182, P381, DOI 10.1007/s00360-011-0625-8; Liknes ET, 2011, J THERM BIOL, V36, P430, DOI 10.1016/j.jtherbio.2011.07.011; Liknes ET, 2011, J THERM BIOL, V36, P363, DOI 10.1016/j.jtherbio.2011.06.010; Liknes ET, 2002, CONDOR, V104, P548, DOI 10.1650/0010-5422(2002)104[0548:SAITAG]2.0.CO;2; Marjoniemi K, 1999, PHYSIOL BIOCHEM ZOOL, V72, P484, DOI 10.1086/316676; Marsh R L., 1989, ADV COMP ENV PHYSL, V4, P206; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; McKechnie AE, 2008, J COMP PHYSIOL B, V178, P235, DOI 10.1007/s00360-007-0218-8; Mckechnie AE, 2010, CURR ZOOL, V56, P741, DOI 10.1093/czoolo/56.6.741; OCONNOR TP, 1995, J COMP PHYSIOL B, V165, P298, DOI 10.1007/BF00367313; OConnor TP, 1996, CONDOR, V98, P371, DOI 10.2307/1369155; Olson JR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P263, DOI 10.1086/648395; Pierce BJ, 2005, J EXP BIOL, V208, P1277, DOI 10.1242/jeb.01493; Piersma T, 1996, PHYSIOL ZOOL, V69, P191, DOI 10.1086/physzool.69.1.30164207; Piersma T., 2011, FLEXIBLE PHENOTYPE B; Rezende EL, 2002, J EXP BIOL, V205, P101; ROSENMANN M, 1974, AM J PHYSIOL, V226, P490, DOI 10.1152/ajplegacy.1974.226.3.490; Suarez RK, 2005, J EXP BIOL, V208, P1627, DOI 10.1242/jeb.01503; Swanson DL, 2011, PHYSIOL BIOCHEM ZOOL, V84, P185, DOI 10.1086/658291; Swanson DL, 2010, CURR ORNITHOL, V17, P75, DOI 10.1007/978-1-4419-6421-2_3; Swanson DL, 2009, EVOLUTION, V63, P184, DOI 10.1111/j.1558-5646.2008.00522.x; SWANSON DL, 1991, CONDOR, V93, P538, DOI 10.2307/1368185; SWANSON DL, 1990, AUK, V107, P561; Swanson DL, 2006, J EXP BIOL, V209, P466, DOI 10.1242/jeb.02024; Swanson DL, 1999, J AVIAN BIOL, V30, P245, DOI 10.2307/3677350; Swanson DL, 1995, AUK, V112, P870, DOI 10.2307/4089019; Swanson DL, 1996, J THERM BIOL, V21, P221, DOI 10.1016/0306-4565(96)00005-8; Swanson DL, 1999, PHYSIOL BIOCHEM ZOOL, V72, P566, DOI 10.1086/316696; SWANSON DL, 1993, J THERM BIOL, V18, P275, DOI 10.1016/0306-4565(93)90014-K; Vezina F, 2007, AM J PHYSIOL-REG I, V292, pR1287, DOI 10.1152/ajpregu.00683.2006; Vezina F, 2006, J EXP BIOL, V209, P3141, DOI 10.1242/jeb.02338; WEATHERS WW, 1979, OECOLOGIA, V42, P81, DOI 10.1007/BF00347620; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P20866, DOI 10.1073/pnas.0707683104; Wiersma P, 2007, P NATL ACAD SCI USA, V104, P9340, DOI 10.1073/pnas.0702212104	61	40	40	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34271	10.1371/journal.pone.0034271	http://dx.doi.org/10.1371/journal.pone.0034271			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479584	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900077
J	Bruggemann, H; Lomholt, HB; Tettelin, H; Kilian, M				Bruggemann, Holger; Lomholt, Hans B.; Tettelin, Herve; Kilian, Mogens			CRISPR/cas Loci of Type II Propionibacterium acnes Confer Immunity against Acquisition of Mobile Elements Present in Type I P. acnes	PLOS ONE			English	Article							GENOME SEQUENCE; HORIZONTAL TRANSFER; BACTERIA; GENES; PATHOGENESIS; DEFENSE; SYSTEM; RNA	Propionibacterium acnes is a skin commensal that occasionally acts as an opportunistic pathogen. The population structure of this species shows three main lineages (I-III). While type I strains are mainly associated with sebaceous follicles of human skin and inflammatory acne, types II and III strains are more often associated with deep tissue infections. We investigated the occurrence and distribution of the clustered regularly interspaced short palindromic repeats (CRISPR) in P. acnes, assessed their immunological memory, and addressed the question if such a system could account for type-specific properties of the species. A collection of 108 clinical isolates covering all known phylotypes of P. acnes was screened for the existence of CRISPR/cas loci. We found that CRISPR loci are restricted to type II P. acnes strains. Sequence analyses of the CRISPR spacers revealed that the system confers immunity to P. acnes-specific phages and to two mobile genetic elements. These elements are found almost exclusively in type I P. acnes strains. Genome sequencing of a type I P. acnes isolate revealed that one element, 54 kb in size, encodes a putative secretion/tight adherence (TAD) system. Thus, CRISPR/cas loci in P. acnes recorded the exposure of type II strains to mobile genetic elements of type I strains. The CRISPR/cas locus is deleted in type I strains, which conceivably accounts for their ability to horizontally acquire fitness or virulence traits and might indicate that type I strains constitute a younger subpopulation of P. acnes.	[Bruggemann, Holger; Lomholt, Hans B.; Kilian, Mogens] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Tettelin, Herve] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Tettelin, Herve] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA	Aarhus University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bruggemann, H (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	brueggemann@microbiology.au.dk		Kilian, Mogens/0000-0002-5861-0472; Bruggemann, Holger/0000-0001-7433-0190	European Skin Research Foundation	European Skin Research Foundation	The project was supported by a grant from the European Skin Research Foundation (2011 ESRF New Investigator Award to HB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Bruggemann H, 2004, SCIENCE, V305, P671, DOI 10.1126/science.1100330; Brzuszkiewicz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021581; Butler-Wu SM, 2011, J BACTERIOL, V193, P3678, DOI 10.1128/JB.05036-11; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chakraborty S, 2010, MOL PHYLOGENET EVOL, V56, P878, DOI 10.1016/j.ympev.2010.05.020; Dessinioti C, 2010, CLIN DERMATOL, V28, P2, DOI 10.1016/j.clindermatol.2009.03.012; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Horvath B, 2012, J BACTERIOL, V194, P202, DOI 10.1128/JB.06388-11; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Kilian M, 2012, J CLIN MICROBIO 0118; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; Kong HDH, 2011, TRENDS MOL MED, V17, P320, DOI 10.1016/j.molmed.2011.01.013; Kurokawa I, 2009, EXP DERMATOL, V18, P821, DOI 10.1111/j.1600-0625.2009.00890.x; Lomholt HB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012277; Lood R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-198; Lood R, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-139; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; McDowell A, 2008, J MED MICROBIOL, V57, P218, DOI 10.1099/jmm.0.47489-0; McDowell A, 2011, MICROBIOL-SGM, V157, P1990, DOI 10.1099/mic.0.049676-0; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/ERI.11.137, 10.1586/eri.11.137]; Planet PJ, 2003, NAT GENET, V34, P193, DOI 10.1038/ng1154; Roh H, 2011, J BACTERIOL, V193, P3391, DOI 10.1128/JB.05041-11; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Suzuki K, 1997, APPL ENVIRON MICROB, V63, P2089, DOI 10.1128/AEM.63.5.2089-2091.1997; Takeuchi N, 2012, J BACTERIOL, V194, P1216, DOI 10.1128/JB.06521-11; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomich M, 2007, NAT REV MICROBIOL, V5, P363, DOI 10.1038/nrmicro1636	35	41	45	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34171	10.1371/journal.pone.0034171	http://dx.doi.org/10.1371/journal.pone.0034171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479553	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100131
J	Farinelli, M; Heitz, FD; Grewe, BF; Tyagarajan, SK; Helmchen, F; Mansuy, IM				Farinelli, Melissa; Heitz, Fabrice D.; Grewe, Benjamin F.; Tyagarajan, Shiva K.; Helmchen, Fritjof; Mansuy, Isabelle M.			Selective Regulation of NR2B by Protein Phosphatase-1 for the Control of the NMDA Receptor in Neuroprotection	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; ORGANOTYPIC HIPPOCAMPAL CULTURES; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; KINASE-II; ISCHEMIC BRAIN; CELL-DEATH; CA-2+-INDEPENDENT ACTIVITY; MOLECULAR-MECHANISMS; SYNAPTIC PLASTICITY	An imbalance between pro-survival and pro-death pathways in brain cells can lead to neuronal cell death and neurodegeneration. While such imbalance is known to be associated with alterations in glutamatergic and Ca2+ signaling, the underlying mechanisms remain undefined. We identified the protein Ser/Thr phosphatase protein phosphatase-1 (PP1), an enzyme associated with glutamate receptors, as a key trigger of survival pathways that can prevent neuronal death and neurodegeneration in the adult hippocampus. We show that PP1 alpha overexpression in hippocampal neurons limits NMDA receptor overactivation and Ca2+ overload during an excitotoxic event, while PP1 inhibition favors Ca2+ overload and cell death. The protective effect of PP1 is associated with a selective dephosphorylation on a residue phosphorylated by CaMKII alpha on the NMDA receptor subunit NR2B, which promotes pro-survival pathways and associated transcriptional programs. These results reveal a novel contributor to the mechanisms of neuroprotection and underscore the importance of PP1-dependent dephosphorylation in these mechanisms. They provide a new target for the development of potential therapeutic treatment of neurodegeneration.	[Farinelli, Melissa; Heitz, Fabrice D.; Grewe, Benjamin F.; Helmchen, Fritjof; Mansuy, Isabelle M.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Farinelli, Melissa; Heitz, Fabrice D.; Mansuy, Isabelle M.] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland; [Tyagarajan, Shiva K.] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland	University of Zurich; ETH Zurich; University of Zurich	Farinelli, M (corresponding author), Univ Zurich, Brain Res Inst, Zurich, Switzerland.	mansuy@hifo.uzh.ch	Mansuy, Isabelle M/N-3042-2015; Tyagarajan, Shiva/P-3135-2015; Grewe, Benjamin/E-7044-2017; Helmchen, Fritjof/A-6255-2008	Mansuy, Isabelle M/0000-0001-7785-5371; Tyagarajan, Shiva/0000-0003-0074-1805; Grewe, Benjamin/0000-0001-8560-2120; Helmchen, Fritjof/0000-0002-8867-9569	National Center for Competence in Research "Neural Plasticity and Repair''; University of Zurich; Swiss Federal Institute of Technology; Human Frontier Science Program; Swiss National Foundation; Slack-Gyr Foundation; Bitterlin Foundation	National Center for Competence in Research "Neural Plasticity and Repair''; University of Zurich; Swiss Federal Institute of Technology; Human Frontier Science Program(Human Frontier Science Program); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Slack-Gyr Foundation; Bitterlin Foundation	Funding by the National Center for Competence in Research "Neural Plasticity and Repair'', the University of Zurich, the Swiss Federal Institute of Technology, The Human Frontier Science Program, The Swiss National Foundation, Slack-Gyr Foundation, and Bitterlin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Camacho A, 2007, NEUROSCIENCE, V145, P873, DOI 10.1016/j.neuroscience.2006.12.069; Ceulemans H, 2002, J BIOL CHEM, V277, P47331, DOI 10.1074/jbc.M206838200; Cheng CL, 1999, BRAIN RES, V849, P97, DOI 10.1016/S0006-8993(99)01995-2; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fields RD, 2005, CELL CALCIUM, V37, P433, DOI 10.1016/j.ceca.2005.01.011; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gao J, 2005, NEURON, V48, P635, DOI 10.1016/j.neuron.2005.10.011; Gee CE, 2006, EUR J NEUROSCI, V23, P2595, DOI 10.1111/j.1460-9568.2006.04786.x; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hedou GF, 2008, J NEUROSCI, V28, P154, DOI 10.1523/JNEUROSCI.4109-07.2008; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kitagawa K, 2007, FEBS J, V274, P3210, DOI 10.1111/j.1742-4658.2007.05890.x; Kollen M, 2008, NEUROSCIENCE, V154, P1308, DOI 10.1016/j.neuroscience.2008.04.045; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lennmyr F, 2004, ACTA NEUROL SCAND, V110, P175, DOI 10.1111/j.1600-0404.2004.00306.x; Liao GY, 2001, MOL PHARMACOL, V59, P960, DOI 10.1124/mol.59.5.960; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Martel MA, 2008, NEUROSCIENCE; MILLER SG, 1988, NEURON, V1, P593, DOI 10.1016/0896-6273(88)90109-2; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; NEWELL DW, 1995, J NEUROSCI, V15, P7702; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Raveendran R, 2009, J NEUROCHEM, V110, P92, DOI 10.1111/j.1471-4159.2009.06108.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schubert P, 1994, J Neural Transm Suppl, V44, P73; SCHWORER H, 1988, BRIT J PHARMACOL, V93, P715, DOI 10.1111/j.1476-5381.1988.tb10330.x; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Strack S, 1997, J NEUROCHEM, V68, P2119; STRASSER U, 1995, J NEUROSCI METH, V57, P177, DOI 10.1016/0165-0270(94)00147-9; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tu W, CELL, V140, P222; Walton M, 1996, MOL BRAIN RES, V43, P21, DOI 10.1016/S0169-328X(96)00144-1; WANG LY, 1994, NATURE, V369, P230, DOI 10.1038/369230a0; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	62	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34047	10.1371/journal.pone.0034047	http://dx.doi.org/10.1371/journal.pone.0034047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479519	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100108
J	Magi, S; Lariccia, V; Castaldo, P; Arcangeli, S; Nasti, AA; Giordano, A; Amoroso, S				Magi, Simona; Lariccia, Vincenzo; Castaldo, Pasqualina; Arcangeli, Sara; Nasti, Annamaria Assunta; Giordano, Antonio; Amoroso, Salvatore			Physical and Functional Interaction of NCX1 and EAAC1 Transporters Leading to Glutamate-Enhanced ATP Production in Brain Mitochondria	PLOS ONE			English	Article							THREO-BETA-BENZYLOXYASPARTATE; LACTATE SHUTTLE HYPOTHESIS; HEART-MITOCHONDRIA; ENERGY-METABOLISM; IN-SITU; SUBCELLULAR-LOCALIZATION; MOLECULAR PHARMACOLOGY; OXIDATIVE-METABOLISM; NA+/CA2+ EXCHANGER; NA+-CA2+ EXCHANGER	Glutamate is emerging as a major factor stimulating energy production in CNS. Brain mitochondria can utilize this neurotransmitter as respiratory substrate and specific transporters are required to mediate the glutamate entry into the mitochondrial matrix. Glutamate transporters of the Excitatory Amino Acid Transporters (EAATs) family have been previously well characterized on the cell surface of neuronal and glial cells, representing the primary players for glutamate uptake in mammalian brain. Here, by using western blot, confocal microscopy and immunoelectron microscopy, we report for the first time that the Excitatory Amino Acid Carrier 1 (EAAC1), an EAATs member, is expressed in neuronal and glial mitochondria where it participates in glutamate-stimulated ATP production, evaluated by a luciferase-luciferin system. Mitochondrial metabolic response is counteracted when different EAATs pharmacological blockers or selective EAAC1 antisense oligonucleotides were used. Since EAATs are Na+-dependent proteins, this raised the possibility that other transporters regulating ion gradients across mitochondrial membrane were required for glutamate response. We describe colocalization, mutual activity dependency, physical interaction between EAAC1 and the sodium/calcium exchanger 1 (NCX1) both in neuronal and glial mitochondria, and that NCX1 is an essential modulator of this glutamate transporter. Only NCX1 activity is crucial for such glutamate-stimulated ATP synthesis, as demonstrated by pharmacological blockade and selective knock-down with antisense oligonucleotides. The EAAC1/NCX1-dependent mitochondrial response to glutamate may be a general and alternative mechanism whereby this neurotransmitter sustains ATP production, since we have documented such metabolic response also in mitochondria isolated from heart. The data reported here disclose a new physiological role for mitochondrial NCX1 as the key player in glutamate-induced energy production.	[Magi, Simona; Lariccia, Vincenzo; Castaldo, Pasqualina; Arcangeli, Sara; Nasti, Annamaria Assunta; Amoroso, Salvatore] Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Giordano, Antonio] Univ Politecn Marche, Dept Expt & Clin Med, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University	Magi, S (corresponding author), Univ Politecn Marche, Dept Biomed Sci & Publ Hlth, Ancona, Italy.	s.amoroso@univpm.it	MAGI, Simona/O-4651-2019	MAGI, Simona/0000-0002-8115-8226; LARICCIA, Vincenzo/0000-0002-1518-1495; Giordano, Antonio/0000-0003-1401-5855	"Ricerca Scientifica di Ateneo" (RSA) grant	"Ricerca Scientifica di Ateneo" (RSA) grant	This study was supported by "Ricerca Scientifica di Ateneo" (RSA) grant (2006-2010) to S. Amoroso, PC, SM and VL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 1998, BRAIN RES PROTOC, V2, P209, DOI 10.1016/S1385-299X(97)00044-5; AMOROSO S, 1990, SCIENCE, V247, P852, DOI 10.1126/science.2305257; Anderson CM, 2001, J NEUROCHEM, V79, P1207; Babsky A, 2001, EXP BIOL MED, V226, P543, DOI 10.1177/153537020122600606; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bernardinelli Y, 2006, GLIA, V54, P460, DOI 10.1002/glia.20387; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Castaldo P, 2009, PROG NEUROBIOL, V87, P58, DOI 10.1016/j.pneurobio.2008.09.017; Castaldo P, 2007, NEUROPHARMACOLOGY, V53, P369, DOI 10.1016/j.neuropharm.2007.05.019; Castaldo P, 2010, PHARMACOL RES, V61, P334, DOI 10.1016/j.phrs.2009.11.008; CERVOSNAVARRO J, 1991, CRIT REV NEUROBIOL, V6, P149; Chalmers S, 2008, J CELL SCI, V121, P75, DOI 10.1242/jcs.014522; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; COX DA, 1993, J CARDIOVASC PHARM, V21, P595, DOI 10.1097/00005344-199304000-00013; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dedkova EN, 2005, AM J PHYSIOL-CELL PH, V289, pC836, DOI 10.1152/ajpcell.00011.2005; del Arco A, 1998, J BIOL CHEM, V273, P23327, DOI 10.1074/jbc.273.36.23327; Desagher S, 1997, J NEUROSCI, V17, P9060; Figley CR, 2011, J NEUROSCI, V31, P4768, DOI 10.1523/JNEUROSCI.6612-10.2011; FISKUM G, 1985, CELL CALCIUM, V6, P25, DOI 10.1016/0143-4160(85)90032-6; Frontini A, 2008, BRAIN RES, V1215, P105, DOI 10.1016/j.brainres.2008.03.078; Giordano A, 2005, CELL DEATH DIFFER, V12, P603, DOI 10.1038/sj.cdd.4401636; Gobbi P, 2007, PHARMACOL RES, V56, P556, DOI 10.1016/j.phrs.2007.10.005; Guang HM, 2006, EUR J PHARMACOL, V542, P77, DOI 10.1016/j.ejphar.2006.04.054; Gunter TE, 2004, J NEUROCHEM, V88, P266, DOI 10.1046/j.1471-4159.2003.02122.x; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; Hirrlinger J, 2010, BRAIN RES REV, V63, P177, DOI 10.1016/j.brainresrev.2009.10.003; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; JUNG DW, 1992, AM J PHYSIOL, V262, pC1047, DOI 10.1152/ajpcell.1992.262.4.C1047; KANAI Y, 1993, FASEB J, V7, P1450, DOI 10.1096/fasebj.7.15.7903261; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Lartigue L, 2009, MOL BIOL CELL, V20, P4871, DOI 10.1091/mbc.E09-07-0649; Lee A, 2011, ASIAN J ANDROL, V13, P254, DOI 10.1038/aja.2010.99; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Li S, 2001, NEUROSCIENCE, V107, P675, DOI 10.1016/S0306-4522(01)00385-2; Lomonosova E, 2005, ONCOGENE, V24, P6796, DOI 10.1038/sj.onc.1208836; Magi S, 2005, J PHARMACOL EXP THER, V315, P291, DOI 10.1124/jpet.105.088948; Magistretti PJ, 1999, NEWS PHYSIOL SCI, V14, P177, DOI 10.1152/physiologyonline.1999.14.5.177; Mangia S, 2003, NEUROSCIENCE, V118, P7, DOI 10.1016/S0306-4522(02)00792-3; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; Minelli A, 2007, CELL CALCIUM, V41, P221, DOI 10.1016/j.ceca.2006.06.004; Montiel T, 2005, NEUROSCIENCE, V133, P667, DOI 10.1016/j.neuroscience.2004.11.020; Nehlig A, 2007, GLIA, V55, P1238, DOI 10.1002/glia.20376; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; O'Rourke B, 2007, ANNU REV PHYSIOL, V69, P19, DOI 10.1146/annurev.physiol.69.031905.163804; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Panov A, 2009, J BIOL CHEM, V284, P14448, DOI 10.1074/jbc.M900985200; Pellerin L, 2005, MOL NEUROBIOL, V32, P59, DOI 10.1385/MN:32:1:059; Pellerin L, 1997, J NEUROCHEM, V69, P2132; Perez-Ortiz JM, 2004, J BIOL CHEM, V279, P8976, DOI 10.1074/jbc.M308518200; PISARENKO OI, 1985, BASIC RES CARDIOL, V80, P126, DOI 10.1007/BF01910459; Proper EA, 2002, BRAIN, V125, P32, DOI 10.1093/brain/awf001; Quednau BD, 1997, AM J PHYSIOL-CELL PH, V272, pC1250, DOI 10.1152/ajpcell.1997.272.4.C1250; Ralphe JC, 2004, J MOL CELL CARDIOL, V37, P33, DOI 10.1016/j.yjmcc.2004.04.008; Ralphe JC, 2005, AM J PHYSIOL-HEART C, V288, pH2521, DOI 10.1152/ajpheart.00991.2004; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Shigeri Y, 2004, BRAIN RES REV, V45, P250, DOI 10.1016/j.brainresrev.2004.04.004; Shimamoto K, 2004, MOL PHARMACOL, V65, P1008, DOI 10.1124/mol.65.4.1008; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Smets I, 2004, AM J PHYSIOL-RENAL, V286, pF784, DOI 10.1152/ajprenal.00284.2003; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Van Cuong D, 2005, MITOCHONDRION, V5, P121, DOI 10.1016/j.mito.2004.12.001; Vanzetta I, 1999, SCIENCE, V286, P1555, DOI 10.1126/science.286.5444.1555; Waagepetersen HS, 2001, NEUROCHEM RES, V26, P661, DOI 10.1023/A:1010939304104; Wittig I, 2007, METHOD CELL BIOL, V80, P723, DOI 10.1016/S0091-679X(06)80033-6; YU WH, 1995, J BIOL CHEM, V270, P13998, DOI 10.1074/jbc.270.23.13998; Yu YX, 2006, J CELL SCI, V119, P3776, DOI 10.1242/jcs.03151; YUDKOFF M, 1994, J BIOL CHEM, V269, P27414; Zambonin JL, 2011, BRAIN, V134, P1901, DOI 10.1093/brain/awr110; Zhivotovsky B, 2009, CELL DEATH DIFFER, V16, P1419, DOI 10.1038/cdd.2009.118	79	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34015	10.1371/journal.pone.0034015	http://dx.doi.org/10.1371/journal.pone.0034015			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479505	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100096
J	Magnus, C; Regoes, RR				Magnus, Carsten; Regoes, Roland R.			Analysis of the Subunit Stoichiometries in Viral Entry	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN TRIMERS; IMMUNODEFICIENCY-VIRUS TYPE-1; HIV-1; NEUTRALIZATION; GP120; RECEPTOR; COMPLEMENTATION; DEFECTS; COMPLEX; V1V2	Virions of the Human Immunodeficiency Virus (HIV) infect cells by first attaching with their surface spikes to the CD4 receptor on target cells. This leads to conformational changes in the viral spikes, enabling the virus to engage a coreceptor, commonly CCR5 or CXCR4, and consecutively to insert the fusion peptide into the cellular membrane. Finally, the viral and the cellular membranes fuse. The HIV spike is a trimer consisting of three identical heterodimers composed of the gp120 and gp41 envelope proteins. Each of the gp120 proteins in the trimer is capable of attaching to the CD4 receptor and the coreceptor, and each of the three gp41 units harbors a fusion domain. It is still under debate how many of the envelope subunits within a given trimer have to bind to the CD4 receptors and to the coreceptors, and how many gp41 protein fusion domains are required for fusion. These numbers are referred to as subunit stoichiometries. We present a mathematical framework for estimating these parameters individually by analyzing infectivity assays with pseudotyped viruses. We find that the number of spikes that are engaged in mediating cell entry and the distribution of the spike number play important roles for the estimation of the subunit stoichiometries. Our model framework also shows why it is important to subdivide the question of the number of functional subunits within one trimer into the three different subunit stoichiometries. In a second step, we extend our models to study whether the subunits within one trimer cooperate during receptor binding and fusion. As an example for how our models can be applied, we reanalyze a data set on subunit stoichiometries. We find that two envelope proteins have to engage with CD4-receptors and coreceptors and that two fusion proteins must be revealed within one trimer for viral entry. Our study is motivated by the mechanism of HIV entry but the experimental technique and the model framework can be extended to other viral systems as well.	[Magnus, Carsten; Regoes, Roland R.] Swiss Fed Inst Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Magnus, C (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	carsten.magnus@zoo.ox.ac.uk	Regoes, Roland R/A-6538-2008	Regoes, Roland R/0000-0001-8319-5293; Magnus, Carsten/0000-0003-1125-2783	Swiss National Science Foundation [315200-114148, 315230-130855]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Support was provided by the Swiss National Science Foundation (315200-114148 and 315230-130855). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0; Carlson LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001173; De Beeck AO, 2004, J VIROL, V78, P2994, DOI 10.1128/JVI.78.6.2994-3002.2004; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; DOMS RW, 1990, J VIROL, V64, P3537, DOI 10.1128/JVI.64.7.3537-3540.1990; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; Klasse PJ, 2007, VIROLOGY, V369, P245, DOI 10.1016/j.virol.2007.06.044; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lapham CK, 1996, SCIENCE, V274, P602, DOI 10.1126/science.274.5287.602; Lassen KG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000377; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Louder MK, 2005, VIROLOGY, V339, P226, DOI 10.1016/j.virol.2005.06.003; Magnus C, 2011, J THEOR BIOL, V283, P192, DOI 10.1016/j.jtbi.2011.06.004; Magnus C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000713; Magnus C, 2009, J VIROL, V83, P1523, DOI 10.1128/JVI.01764-08; Mulampaka SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019941; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; ROBEY WG, 1985, SCIENCE, V228, P593, DOI 10.1126/science.2984774; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; Salzwedel K, 2000, P NATL ACAD SCI USA, V97, P12794, DOI 10.1073/pnas.230438497; Salzwedel K, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-75; SATTENTAU QJ, 1991, J EXP MED, V174, P407, DOI 10.1084/jem.174.2.407; Schonning K, 1999, J VIROL, V73, P8364; Sougrat R, 2007, PLOS PATHOG, V3, P1; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; VERONESE FD, 1985, SCIENCE, V229, P1402, DOI 10.1126/science.2994223; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yang XZ, 2006, J VIROL, V80, P4388, DOI 10.1128/JVI.80.9.4388-4395.2006; Yang XZ, 2005, J VIROL, V79, P12132, DOI 10.1128/JVI.79.19.12132-12147.2005; Yang XZ, 2005, J VIROL, V79, P3500, DOI 10.1128/JVI.79.6.3500-3508.2005; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083; Zhu P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000203; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	38	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33441	10.1371/journal.pone.0033441	http://dx.doi.org/10.1371/journal.pone.0033441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479399	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100049
J	Pitti, T; Manoj, N				Pitti, Thejkiran; Manoj, Narayanan			Molecular Evolution of the Neuropeptide S Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; FUNCTIONAL DIVERGENCE; SUSCEPTIBILITY LOCUS; VASOPRESSIN RECEPTOR; EXTRACELLULAR LOOP; OXYTOCIN RECEPTOR; SIGNALING SYSTEM; FOOD-INTAKE; PEPTIDE; BINDING	The neuropeptide S receptor (NPSR) is a recently deorphanized member of the G protein-coupled receptor (GPCR) superfamily and is activated by the neuropeptide S (NPS). NPSR and NPS are widely expressed in central nervous system and are known to have crucial roles in asthma pathogenesis, locomotor activity, wakefulness, anxiety and food intake. The NPS-NPSR system was previously thought to have first evolved in the tetrapods. Here we examine the origin and the molecular evolution of the NPSR using in-silico comparative analyses and document the molecular basis of divergence of the NPSR from its closest vertebrate paralogs. In this study, NPSR-like sequences have been identified in a hemichordate and a cephalochordate, suggesting an earlier emergence of a NPSR-like sequence in the metazoan lineage. Phylogenetic analyses revealed that the NPSR is most closely related to the invertebrate cardioacceleratory peptide receptor (CCAPR) and the group of vasopressin-like receptors. Gene structure features were congruent with the phylogenetic clustering and supported the orthology of NPSR to the invertebrate NPSR-like and CCAPR. A site-specific analysis between the vertebrate NPSR and the well studied paralogous vasopressin-like receptor subtypes revealed several putative amino acid sites that may account for the observed functional divergence between them. The data can facilitate experimental studies aiming at deciphering the common features as well as those related to ligand binding and signal transduction processes specific to the NPSR.	[Pitti, Thejkiran; Manoj, Narayanan] Indian Inst Technol Madras, Dept Biotechnol, Chennai, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Pitti, T (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Chennai, Tamil Nadu, India.	nmanoj@iitm.ac.in	Manoj, Narayanan/W-2301-2019	Manoj, Narayanan/0000-0002-8144-1566	Department of Biotechnology, Government of India [BT/PR11748/BID/07/285/2008]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	We thank the Department of Biotechnology, Government of India, for funding the project BT/PR11748/BID/07/285/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Ahuja S, 2009, TRENDS PHARMACOL SCI, V30, P494, DOI 10.1016/j.tips.2009.06.003; Aikins MJ, 2008, INSECT BIOCHEM MOLEC, V38, P740, DOI 10.1016/j.ibmb.2008.04.006; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Beck B, 2005, BIOCHEM BIOPH RES CO, V332, P859, DOI 10.1016/j.bbrc.2005.05.029; Bernier V, 2006, J BIOL CHEM, V281, P24704, DOI 10.1074/jbc.M603691200; Betts MJ, 2001, EMBO J, V20, P5354, DOI 10.1093/emboj/20.19.5354; BICHET DG, 1994, AM J HUM GENET, V55, P278; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Brendel V, 2004, BIOINFORMATICS, V20, P1157, DOI 10.1093/bioinformatics/bth058; Camarda V, 2009, J PHARMACOL EXP THER, V328, P549, DOI 10.1124/jpet.108.143867; Cazzamali G, 2003, BIOCHEM BIOPH RES CO, V303, P146, DOI 10.1016/S0006-291X(03)00302-4; CHINI B, 1995, EMBO J, V14, P2176, DOI 10.1002/j.1460-2075.1995.tb07211.x; Clark SD, 2010, PEPTIDES, V31, P130, DOI 10.1016/j.peptides.2009.10.015; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; Cotte N, 1998, J BIOL CHEM, V273, P29462, DOI 10.1074/jbc.273.45.29462; D'Amato M, 2007, GASTROENTEROLOGY, V133, P808, DOI 10.1053/j.gastro.2007.06.012; Dreborg S, 2008, P NATL ACAD SCI USA, V105, P15487, DOI 10.1073/pnas.0805590105; Drummond AJ, 2010, GENEIOUS V5 1; Duangdao DM, 2009, BEHAV BRAIN RES, V205, P1, DOI 10.1016/j.bbr.2009.07.024; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elphick MR, 2010, GENE, V458, P20, DOI 10.1016/j.gene.2010.03.004; Erlenbach I, 1998, J BIOL CHEM, V273, P26549, DOI 10.1074/jbc.273.41.26549; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gloriam DE, 2009, J MED CHEM, V52, P4429, DOI 10.1021/jm900319e; Gloriam DEI, 2005, BBA-GEN SUBJECTS, V1722, P235, DOI 10.1016/j.bbagen.2004.12.001; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Gu X, 2006, MOL BIOL EVOL, V23, P1937, DOI 10.1093/molbev/msl056; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Gupte J, 2004, P NATL ACAD SCI USA, V101, P1508, DOI 10.1073/pnas.0308250100; Han RW, 2009, NEUROSCI LETT, V455, P74, DOI 10.1016/j.neulet.2009.03.023; Hansen KK, 2010, J BIOL CHEM, V285, P10736, DOI 10.1074/jbc.M109.045369; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Hoyle CHV, 1999, BRAIN RES, V848, P1, DOI 10.1016/S0006-8993(99)01975-7; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kawada T, 2008, PEPTIDES, V29, P1672, DOI 10.1016/j.peptides.2008.05.030; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laitinen T, 2001, NAT GENET, V28, P87, DOI 10.1038/ng0501-87; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Li W, 2009, REGUL PEPTIDES, V156, P90, DOI 10.1016/j.regpep.2009.03.013; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Macrae AD, 1996, MOL BRAIN RES, V42, P245, DOI 10.1016/S0169-328X(96)00128-3; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Melen E, 2005, AM J RESP CRIT CARE, V171, P1089, DOI 10.1164/rccm.200410-1317OC; MOUILLAC B, 1995, J BIOL CHEM, V270, P25771, DOI 10.1074/jbc.270.43.25771; Nepomuceno D, 2010, EUR J PHARMACOL, V635, P27, DOI 10.1016/j.ejphar.2010.03.008; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Okamura N, 2008, J PHARMACOL EXP THER, V325, P893, DOI 10.1124/jpet.107.135103; Oksche A, 1998, J MOL MED, V76, P326, DOI 10.1007/s001090050224; OLIVEIRA L, 1993, J COMPUT AID MOL DES, V7, P649, DOI 10.1007/BF00125323; Pape HC, 2010, NEUROPHARMACOLOGY, V58, P29, DOI 10.1016/j.neuropharm.2009.06.001; Park JI, 2005, ENDOCRINE, V26, P267, DOI 10.1385/ENDO:26:3:267; Peng YL, 2010, PEPTIDES, V31, P2259, DOI 10.1016/j.peptides.2010.08.015; Postina R, 1996, J BIOL CHEM, V271, P31593, DOI 10.1074/jbc.271.49.31593; Pulkkinen V, 2006, ANN MED, V38, P357, DOI 10.1080/07853890600756453; Qiu WG, 2004, MOL BIOL EVOL, V21, P1252, DOI 10.1093/molbev/msh120; Reinscheid RK, 2007, PEPTIDES, V28, P830, DOI 10.1016/j.peptides.2007.01.008; Reinscheid RK, 2005, J PHARMACOL EXP THER, V315, P1338, DOI 10.1124/jpet.105.093427; Reinscheid RK, 2005, MOL INTERV, V5, P42, DOI 10.1124/mi5.1.8; Roch GJ, 2011, GEN COMP ENDOCR, V171, P1, DOI 10.1016/j.ygcen.2010.12.014; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruzza C, 2010, PEPTIDES, V31, P915, DOI 10.1016/j.peptides.2010.02.012; Sanchez D, 2003, MOL BIOL EVOL, V20, P775, DOI 10.1093/molbev/msg079; Sato S, 2002, World Patent Application, Patent No. [WO 02/ 31145 A1, 0231145]; Scheerer P, 2009, P NATL ACAD SCI USA, V106, P10660, DOI 10.1073/pnas.0900072106; Schertler GFX, 2008, NATURE, V453, P292, DOI 10.1038/453292a; Schwarz DA, 2000, J BIOL CHEM, V275, P32174, DOI 10.1074/jbc.M005333200; Stafflinger E, 2008, P NATL ACAD SCI USA, V105, P3262, DOI 10.1073/pnas.0710897105; Sundstrom G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010512; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Sverdlov AV, 2005, NUCLEIC ACIDS RES, V33, P1741, DOI 10.1093/nar/gki316; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; UFER E, 1995, FEBS LETT, V362, P19, DOI 10.1016/0014-5793(95)00150-8; Ukena Kazuyoshi, 2008, Endocrinology, V149, P5254, DOI 10.1210/en.2008-0607; VANETTI M, 1993, FEBS LETT, V331, P260, DOI 10.1016/0014-5793(93)80349-Y; Vendelin J, 2005, AM J RESP CELL MOL, V33, P262, DOI 10.1165/rcmb.2004-0405OC; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Wang L, 2001, ENDOCRINOLOGY, V142, P4015, DOI 10.1210/en.142.9.4015; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Xu YL, 2007, J COMP NEUROL, V500, P84, DOI 10.1002/cne.21159; Xu YL, 2004, NEURON, V43, P487, DOI 10.1016/j.neuron.2004.08.005; Zingg HH, 1996, BAILLIERE CLIN ENDOC, V10, P75, DOI 10.1016/S0950-351X(96)80314-4	85	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34046	10.1371/journal.pone.0034046	http://dx.doi.org/10.1371/journal.pone.0034046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479518	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100107
J	Yin, J; Feng, HL; Sun, HY; Xi, JH; Cao, YZ; Li, KB				Yin, Jiao; Feng, Honglin; Sun, Hongyan; Xi, Jinghui; Cao, Yazhong; Li, Kebin			Functional Analysis of General Odorant Binding Protein 2 from the Meadow Moth, Loxostege sticticalis L. (Lepidoptera: Pyralidae)	PLOS ONE			English	Article							SEX-PHEROMONE COMPONENTS; DROSOPHILA-MELANOGASTER; OLFACTORY SENSILLA; BOMBYX-MORI; ANTHERAEA-POLYPHEMUS; MAMESTRA-BRASSICAE; ANOPHELES-GAMBIAE; IMMUNOCYTOCHEMICAL LOCALIZATION; BACTERIAL EXPRESSION; MOLECULAR-CLONING	Odorant binding proteins play a crucial role in transporting semiochemicals across the sensillum lymph to olfactory receptors within the insect antennal sensilla. In this study, the general odorant binding protein 2 gene was cloned from the antennae of Loxostege sticticalis, using reverse transcription PCR and rapid amplification of cDNA ends. Recombinant LstiGOBP2 was expressed in Escherichia coli and purified by Ni ion affinity chromatography. Real-time PCR assays indicated that LstiGOBP2 mRNA is expressed mainly in adult antennae, with expression levels differing with developmental age. Ligand-binding experiments using N-phenyl-naphthylamine (1-NPN) as a fluorescent probe demonstrated that the LstiGOBP2 protein has binding affinity to a broad range of odorants. Most importantly, trans-11-tetradecen-1-yl acetate, the pheromone component of Loxostege sticticalis, and trans-2-hexenal and cis-3-hexen-1-ol, the most abundant plant volatiles in essential oils extracted from host plants, had high binding affinities to LstiGOBP2 and elicited strong electrophysiological responses from the antennae of adults.	[Yin, Jiao; Feng, Honglin; Sun, Hongyan; Cao, Yazhong; Li, Kebin] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Xi, Jinghui] Jilin Univ, Coll Plant Sci, Changchun 130023, Jilin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Jilin University	Yin, J (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	jyin@ippcaas.cn	Feng, Honglin/J-1298-2019	Feng, Honglin/0000-0001-6803-3413	Special Fund for Agro-Scientific Research in the Public Interest from the Chinese government [201003079]	Special Fund for Agro-Scientific Research in the Public Interest from the Chinese government	This work was supported by the Special Fund for Agro-Scientific Research in the Public Interest (No. 201003079) from the Chinese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton S, 2007, ENTOMOL EXP APPL, V123, P1, DOI 10.1111/j.1570-7458.2007.00516.x; Benton R, 2007, TRENDS NEUROSCI, V30, P512, DOI 10.1016/j.tins.2007.07.004; Biessmann H, 2002, INSECT MOL BIOL, V11, P123, DOI 10.1046/j.1365-2583.2002.00316.x; BREER H, 1990, INSECT BIOCHEM, V20, P735, DOI 10.1016/0020-1790(90)90088-C; Campanacci V, 2001, J BIOL CHEM, V276, P20078, DOI 10.1074/jbc.M100713200; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Deng SS, 2012, CHEM SENSES, V37, P141, DOI 10.1093/chemse/bjr084; Du YJ, 1998, J CHEM ECOL, V24, P1355, DOI 10.1023/A:1021278816970; Du Yong-Jun, 1994, Acta Entomologica Sinica, V37, P233; Ebbs ML, 2007, PFLUG ARCH EUR J PHY, V454, P735, DOI 10.1007/s00424-007-0246-y; Fan X-J, 2010, J ANHUI AGR SCI, V38, P4636; FEIXAS J, 1995, EUR J BIOCHEM, V234, P521, DOI 10.1111/j.1432-1033.1995.521_b.x; Feng L, 1997, INSECT BIOCHEM MOLEC, V27, P405, DOI 10.1016/S0965-1748(97)00012-X; Gong DP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-332; Gong ZJ, 2009, INSECT MOL BIOL, V18, P405, DOI 10.1111/j.1365-2583.2009.00886.x; Gu SH, 2011, ARCH INSECT BIOCHEM, V77, P81, DOI 10.1002/arch.20427; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; Hammack L, 1996, J MED ENTOMOL, V33, P859, DOI 10.1093/jmedent/33.5.859; He XL, 2010, J CHEM ECOL, V36, P1293, DOI 10.1007/s10886-010-9870-7; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Honson N, 2003, CHEM SENSES, V28, P479, DOI 10.1093/chemse/28.6.479; Jacquin-Joly E, 2000, EUR J BIOCHEM, V267, P6708, DOI 10.1046/j.1432-1327.2000.01772.x; Jiang QY, 2009, INSECT BIOCHEM MOLEC, V39, P440, DOI 10.1016/j.ibmb.2009.04.004; Kim MS, 2001, CHEM SENSES, V26, P195, DOI 10.1093/chemse/26.2.195; KRASNOFF SB, 1989, J CHEM ECOL, V15, P47, DOI 10.1007/BF02027773; Krieger J, 1996, INSECT BIOCHEM MOLEC, V26, P297, DOI 10.1016/0965-1748(95)00096-8; LAUE M, 1994, NATURWISSENSCHAFTEN, V81, P178, DOI 10.1007/BF01134537; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Li S, 2008, BIOCHEM BIOPH RES CO, V372, P464, DOI 10.1016/j.bbrc.2008.05.064; Maibeche-Coisne M, 1998, EUR J BIOCHEM, V258, P768, DOI 10.1046/j.1432-1327.1998.2580768.x; Maida R, 2000, EUR J BIOCHEM, V267, P2899, DOI 10.1046/j.1432-1327.2000.01303.x; Mo S.S., 2006, CHINESE J TROPICAL A, V26, P84; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PRESTWICH GD, 1995, CHEM SENSES, V20, P461, DOI 10.1093/chemse/20.4.461; PRESTWICH GD, 1993, PROTEIN SCI, V2, P420; Qu Xi-Feng, 1999, Entomological Knowledge, V36, P11; Smith DP, 2007, PFLUG ARCH EUR J PHY, V454, P749, DOI 10.1007/s00424-006-0190-2; Steinbrecht RA, 1996, ENTOMOL EXP APPL, V80, P15, DOI 10.1007/BF00194714; STEINBRECHT RA, 1995, CELL TISSUE RES, V282, P203, DOI 10.1007/BF00319112; Steinbrecht RA, 1998, ANN NY ACAD SCI, V855, P323, DOI 10.1111/j.1749-6632.1998.tb10591.x; STRUBLE DL, 1977, CAN ENTOMOL, V109, P261, DOI 10.4039/Ent109261-2; Sun Hong-Yan, 2011, Acta Entomologica Sinica, V54, P381; Tegoni M, 2000, BBA-PROTEIN STRUCT M, V1482, P229, DOI 10.1016/S0167-4838(00)00167-9; TEULON DAJ, 1993, J ECON ENTOMOL, V86, P1405, DOI 10.1093/jee/86.5.1405; VERKERK RHJ, 1994, ANN APPL BIOL, V125, P477, DOI 10.1111/j.1744-7348.1994.tb04985.x; VISSER JH, 1983, ACS SYM SER, V208, P215; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; VOGT RG, 1991, J NEUROSCI, V11, P2972; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Yan S. C., 2003, CHINESE J APPL ECOLO, V4, P310; Yin J, 2004, J PLANT PROTECTION, V31, P173; Yin J, 2010, INT J BIOL SCI, V6, P491; Yin Jiao, 2005, Acta Ecologica Sinica, V25, P1844; Yu F, 2009, BIOCHEM BIOPH RES CO, V385, P369, DOI 10.1016/j.bbrc.2009.05.074; Zhang LX, 2010, CHIN AGR SCI B, V26, P215; Zhang SA, 2011, J CHEM ECOL, V37, P189, DOI 10.1007/s10886-010-9902-3; Zhang TT, 2011, BIOCHEM BIOPH RES CO, V407, P393, DOI 10.1016/j.bbrc.2011.03.032; Zhang ZC, 2009, J CHEM ECOL, V35, P1188, DOI 10.1007/s10886-009-9697-2; [钟涛 Zhong Tao], 2008, [植物保护, Plant Protection], V34, P31; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9; Zhou JJ, 2009, J MOL BIOL, V389, P529, DOI 10.1016/j.jmb.2009.04.015; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007; Zhou JJ, 2004, FEBS LETT, V558, P23, DOI 10.1016/S0014-5793(03)01521-7	66	57	69	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33589	10.1371/journal.pone.0033589	http://dx.doi.org/10.1371/journal.pone.0033589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479417	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100061
J	Carico, C; Nuno, M; Mukherjee, D; Elramsisy, A; Dantis, J; Hu, J; Rudnick, J; Yu, JS; Black, KL; Bannykh, SI; Patil, CG				Carico, Christine; Nuno, Miriam; Mukherjee, Debraj; Elramsisy, Adam; Dantis, Jocelynn; Hu, Jethro; Rudnick, Jeremy; Yu, John S.; Black, Keith L.; Bannykh, Serguei I.; Patil, Chirag G.			Loss of PTEN Is Not Associated with Poor Survival in Newly Diagnosed Glioblastoma Patients of the Temozolomide Era	PLOS ONE			English	Article							PROTEIN-KINASE-B; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; BREAST-CANCER; ANAPLASTIC ASTROCYTOMA; PROGNOSTIC-FACTORS; CELL-SURVIVAL; AKT PATHWAY; ACTIVATION; EXPRESSION	Introduction: Pre-temozoloide studies demonstrated that loss of the tumor suppressor gene PTEN held independent prognostic significance in GBM patients. We investigated whether loss of PTEN predicted shorter survival in the temozolomide era. The role of PTEN in the P13K/Akt pathway is also reviewed. Methods: Patients with histologically proven newly diagnosed GBM were identified from a retrospective database between 2007 and 2010. Cox proportional hazards analysis was used to calculate the independent effects of PTEN expression, age, extent of resection, Karnofsky performance scale (KPS), and treatment on overall survival. Results: Sixty-five percent of patients were men with median age of 63 years, and 70% had KPS >= 80.Most patients (81%) received standard treatment (temozolomide with concurrent radiation). A total of 72 (47%) patients had retained PTEN expression. Median overall survival (OS) was 19.1 months (95% CI: 15.0-22.5). Median survival of 20.0 months (95% CI: 15.0-25.5) and 18.2 months (95% CI: 13.0-25.7) was observed in PTEN retained and PTEN loss patients, respectively (p =.71). PTEN loss patients were also found to have amplifications of EGFR gene more frequently than patients with retained PTEN (70.8% vs. 47.8%, p =.01). Multivariate analysis showed that older age (HR 1.64, CI: 1.02-2.63, p =.04), low KPS (HR 3.57, CI: 2.20-5.79, p <.0001), and lack of standard treatment (HR 3.98, CI: 2.38-6.65, p <.0001) yielded worse survival. PTEN loss was not prognostic of overall survival (HR 1.31, CI: 0.85-2.03, p =.22). Conclusions: Loss of expression of PTEN does not confer poor overall survival in the temozolomide era. These findings imply a complex and non-linear molecular relationship between PTEN, its regulators and effectors in the tumorigenesis of glioblastoma. Additionally, there is evidence that temozolomide may be more effective in eradicating GBM cancer cells with PTEN loss and hence, level the outcomes between the PTEN retained and loss groups.	[Carico, Christine; Nuno, Miriam; Mukherjee, Debraj; Elramsisy, Adam; Dantis, Jocelynn; Hu, Jethro; Rudnick, Jeremy; Yu, John S.; Black, Keith L.; Patil, Chirag G.] Cedars Sinai Med Ctr, Dept Neurosurg, Ctr Neurosurg Outcomes Res, Maxine Dunitz Neurosurg Inst, Los Angeles, CA 90048 USA; [Bannykh, Serguei I.] Cedars Sinai Med Ctr, Dept Pathol, Div Neuropathol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center	Carico, C (corresponding author), Cedars Sinai Med Ctr, Dept Neurosurg, Ctr Neurosurg Outcomes Res, Maxine Dunitz Neurosurg Inst, Los Angeles, CA 90048 USA.	chirag.patil@cshs.org		Patil, Chirag/0000-0001-9068-1898; Yu, John/0000-0003-1230-8494; Black, Keith/0000-0002-0546-4934; Carico, Christine/0000-0001-7426-8200	Maxine Dunitz Neurosurgical Institute	Maxine Dunitz Neurosurgical Institute	This work was supported by the Maxine Dunitz Neurosurgical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	al SVe, 2011, J MOL MED BERL, P123; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Choe G, 2003, CANCER RES, V63, P2742; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Downes CP, 2001, BIOCHEM SOC T, V29, P846, DOI 10.1042/BST0290846; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Duerr EM, 1998, ONCOGENE, V16, P2259, DOI 10.1038/sj.onc.1201756; Edwards LA, 2005, ONCOGENE, V24, P3596, DOI 10.1038/sj.onc.1208427; Ermoian RP, 2002, CLIN CANCER RES, V8, P1100; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Hu XY, 2005, NEOPLASIA, V7, P356, DOI 10.1593/neo.04595; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kirkegaard T, 2005, J PATHOL, V207, P139, DOI 10.1002/path.1829; Knobbe CB, 2002, NEURO-ONCOLOGY, V4, P196; Koul D, 2008, CANCER BIOL THER, V7, P1321, DOI 10.4161/cbt.7.9.6954; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Link W, 2005, J CELL BIOCHEM, V95, P979, DOI 10.1002/jcb.20479; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McEllin B, 2010, CANCER RES, V70, P5457, DOI 10.1158/0008-5472.CAN-09-4295; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nakayama K, 2006, CANCER BIOL THER, V5, P779, DOI 10.4161/cbt.5.7.2751; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nielsen-Preiss SM, 2003, J CELL BIOCHEM, V90, P964, DOI 10.1002/jcb.10709; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Panigrahi AR, 2004, J PATHOL, V204, P93, DOI 10.1002/path.1611; Paramio JM, 1999, ONCOGENE, V18, P7462, DOI 10.1038/sj.onc.1203151; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Pelloski CE, 2006, CLIN CANCER RES, V12, P3935, DOI 10.1158/1078-0432.CCR-05-2202; Pitter KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014545; Robinson JP, 2011, AM J CANCER RES, V1, P155; Sano T, 1999, CANCER RES, V59, P1820; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Slipicevic A, 2005, AM J CLIN PATHOL, V124, P528, DOI 10.1309/YT58WWMTA6YR1PRV; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Sonoda Y, 2001, CANCER RES, V61, P6674; Srividya MR, 2011, NEUROPATHOLOGY, V31, P376, DOI 10.1111/j.1440-1789.2010.01178.x; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Teng DHF, 1997, CANCER RES, V57, P5221; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Xing DY, 2005, P NATL ACAD SCI USA, V102, P6936, DOI 10.1073/pnas.0502256102	50	51	52	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33684	10.1371/journal.pone.0033684	http://dx.doi.org/10.1371/journal.pone.0033684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479427	gold, Green Submitted, Green Published			2022-12-27	WOS:000304523400027
J	Liu, ZX; Yuan, F; Ren, J; Cao, J; Zhou, YH; Yang, Q; Xue, Y				Liu, Zexian; Yuan, Fang; Ren, Jian; Cao, Jun; Zhou, Yanhong; Yang, Qing; Xue, Yu			GPS-ARM: Computational Analysis of the APC/C Recognition Motif by Predicting D-Boxes and KEN-Boxes	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE; UBIQUITIN PATHWAY; LINEAR MOTIFS; CDC20; CDH1; IDENTIFICATION; DESTRUCTION; DEGRADATION; COMPLEX/CYCLOSOME	Anaphase-promoting complex/cyclosome (APC/C), an E3 ubiquitin ligase incorporated with Cdh1 and/or Cdc20 recognizes and interacts with specific substrates, and faithfully orchestrates the proper cell cycle events by targeting proteins for proteasomal degradation. Experimental identification of APC/C substrates is largely dependent on the discovery of APC/C recognition motifs, e.g., the D-box and KEN-box. Although a number of either stringent or loosely defined motifs proposed, these motif patterns are only of limited use due to their insufficient powers of prediction. We report the development of a novel GPS-ARM software package which is useful for the prediction of D-boxes and KEN-boxes in proteins. Using experimentally identified D-boxes and KEN-boxes as the training data sets, a previously developed GPS (Group-based Prediction System) algorithm was adopted. By extensive evaluation and comparison, the GPS-ARM performance was found to be much better than the one using simple motifs. With this powerful tool, we predicted 4,841 potential D-boxes in 3,832 proteins and 1,632 potential KEN-boxes in 1,403 proteins from H. sapiens, while further statistical analysis suggested that both the D-box and KEN-box proteins are involved in a broad spectrum of biological processes beyond the cell cycle. In addition, with the co-localization information, we predicted hundreds of mitosis-specific APC/C substrates with high confidence. As the first computational tool for the prediction of APC/C-mediated degradation, GPS-ARM is a useful tool for information to be used in further experimental investigations. The GPS-ARM is freely accessible for academic researchers at: http://arm.biocuckoo.org.	[Liu, Zexian; Yuan, Fang; Cao, Jun; Zhou, Yanhong; Yang, Qing; Xue, Yu] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Dept Syst Biol, Wuhan 430074, Hubei, Peoples R China; [Liu, Zexian] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Liu, Zexian] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China; [Ren, Jian] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Sun Yat Sen University	Liu, ZX (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Hubei Bioinformat & Mol Imaging Key Lab, Dept Syst Biol, Wuhan 430074, Hubei, Peoples R China.	yangqinghust@mail.hust.edu.cn; xueyu@mail.hust.edu.cn	Ren, Jian/D-3270-2011; Xue, Yu/G-5929-2011; Liu, Zexian/D-1153-2011	Ren, Jian/0000-0002-4161-1292; Xue, Yu/0000-0002-9403-6869; Liu, Zexian/0000-0001-9698-0610	National Basic Research Program (973 project) [2010CB945400, 2012CB911200, 2012CB910101]; Natural Science Foundation of China [90919001, 31071154, 30900835, 30830036, 91019020, 31171263]; Fundamental Research Funds for the Central Universities [HUST: 2010JC049, 2010ZD018, 2011TS085, SYSU: 11lgzd11]	National Basic Research Program (973 project)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported, in whole or in part, by the National Basic Research Program (973 project) (2010CB945400, 2012CB911200, 2012CB910101), Natural Science Foundation of China (90919001, 31071154, 30900835, 30830036, 91019020, 31171263), and Fundamental Research Funds for the Central Universities (HUST: 2010JC049, 2010ZD018, 2011TS085; SYSU: 11lgzd11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, NAT CELL BIOL, V3, pE265; Barford D, 2011, Q REV BIOPHYS, V44, P153, DOI 10.1017/S0033583510000259; Castro A, 2003, MOL CELL BIOL, V23, P4126, DOI 10.1128/MCB.23.12.4126-4138.2003; Colombo SL, 2010, P NATL ACAD SCI USA, V107, P18868, DOI 10.1073/pnas.1012362107; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Davey NE, 2011, NUCLEIC ACIDS RES, V39, pW56, DOI 10.1093/nar/gkr402; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Fang GW, 1999, PHILOS T ROY SOC B, V354, P1583, DOI 10.1098/rstb.1999.0502; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gurden MDJ, 2010, J CELL SCI, V123, P321, DOI 10.1242/jcs.062075; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Kim AH, 2007, MOL CELL NEUROSCI, V34, P281, DOI 10.1016/j.mcn.2006.11.019; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Kurasawa Y, 1999, ONCOGENE, V18, P5131, DOI 10.1038/sj.onc.1203133; Liot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023676; Liu ZX, 2011, MOL BIOSYST, V7, P2737, DOI 10.1039/c1mb05217a; Liu ZX, 2011, MOL BIOSYST, V7, P1197, DOI 10.1039/c0mb00279h; Michael S, 2008, BIOINFORMATICS, V24, P453, DOI 10.1093/bioinformatics/btm624; Naoe H, 2010, MOL CELL BIOL, V30, P3994, DOI 10.1128/MCB.01358-09; Nasmyth K, 2001, CELL, V107, P689, DOI 10.1016/S0092-8674(01)00604-3; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Owens TJ, 2005, MOL CELL, V18, P611, DOI 10.1016/j.molcel.2005.05.019; Pagano M, 1997, FASEB J, V11, P1067, DOI 10.1096/fasebj.11.13.9367342; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Peters JM, 1998, CURR OPIN CELL BIOL, V10, P759, DOI 10.1016/S0955-0674(98)80119-1; Pfleger CM, 2000, GENE DEV, V14, P655; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Ren J, 2010, NUCLEIC ACIDS RES, V38, pD155, DOI 10.1093/nar/gkp784; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Silies M, 2010, NAT NEUROSCI, V13, P1357, DOI 10.1038/nn.2656; SUDAKIN V, 1995, MOL BIOL CELL, V6, P185, DOI 10.1091/mbc.6.2.185; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Tudzarova S, 2011, P NATL ACAD SCI USA, V108, P5278, DOI 10.1073/pnas.1102247108; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200	36	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34370	10.1371/journal.pone.0034370	http://dx.doi.org/10.1371/journal.pone.0034370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479614	gold, Green Published, Green Submitted			2022-12-27	WOS:000304523400078
J	Shin, DW; Cho, J; Kim, YW; Oh, JH; Kim, SW; Chung, KW; Lee, WY; Lee, JE; Guallar, E; Lee, WC				Shin, Dong Wook; Cho, Juhee; Kim, Young Woo; Oh, Jae Hwan; Kim, Seok Won; Chung, Ki-Wook; Lee, Woo-Yong; Lee, Jeong Eon; Guallar, Eliseo; Lee, Won-Chul			Efficacy of an Educational Material on Second Primary Cancer Screening Practice for Cancer Survivors: A Randomized Controlled Trial	PLOS ONE			English	Article							TELEPHONE OUTREACH; NATIONAL-HEALTH; CARE; INTERVENTION; POPULATION; PATIENT; KOREA; METAANALYSIS; PREVENTION; QUALITY	Background: Cancer surivors have limited knowledge about second primary cancer (SPC) screening and suboptimal rates of completion of screening practices for SPC. Our objective was to test the efficacy of an educational material on the knowledge, attitudes, and screening practices for SPC among cancer survivors. Methods: Randomized, controlled trial among 326 cancer survivors from 6 oncology care outpatient clinics in Korea. Patients were randomized to an intervention or an attention control group. The intervention was a photo-novel, culturally tailored to increase knowledge about SPC screening. Knowledge and attitudes regarding SPC screening were assessed two weeks after the intervention, and screening practices were assessed after one year. Results: At two weeks post-intervention, the average knowledge score was significantly higher in the intervention compared to the control group (0.81 vs. 0.75, P<0.01), with no significant difference in their attitude scores (2.64 vs. 2.57, P = 0.18). After 1 year of follow-up, the completion rate of all appropriate cancer screening was 47.2% in both intervention and control groups. Conclusion: While the educatinal material was effective for increasing knowledge of SPC screening, it did not promote cancer screening practice among cancer survivors. More effective interventions are needed to increase SPC screening rates in this population.	[Shin, Dong Wook] Seoul Natl Univ Hosp, Dept Family Med, Seoul 110744, South Korea; [Shin, Dong Wook] Seoul Natl Univ Hosp, Hlth Promot Ctr, Seoul 110744, South Korea; [Shin, Dong Wook] Seoul Natl Univ Hosp, Canc Survivorship Clin, Canc Hosp, Seoul 110744, South Korea; [Cho, Juhee] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Canc Educ Ctr,Samsung Comprehens Canc Ctr, Seoul, South Korea; [Cho, Juhee] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Seoul, South Korea; [Cho, Juhee] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth, Baltimore, MD USA; [Cho, Juhee] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Behav, Baltimore, MD USA; [Cho, Juhee] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Soc & Epidemiol, Baltimore, MD USA; [Kim, Young Woo; Oh, Jae Hwan; Kim, Seok Won; Chung, Ki-Wook] Natl Canc Ctr, Canc Hosp & Res Inst, Goyang, South Korea; [Lee, Woo-Yong; Lee, Jeong Eon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Guallar, Eliseo] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Guallar, Eliseo] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Lee, Won-Chul] Catholic Univ Korea, Dept Prevent Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); Samsung Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Catholic University of Korea	Shin, DW (corresponding author), Seoul Natl Univ Hosp, Dept Family Med, Seoul 110744, South Korea.	jcho@jhsph.edu; leewc@catholic.ac.kr	Guallar, Eliseo/D-3807-2014; Cho, Juhee/ABD-2280-2021	Guallar, Eliseo/0000-0002-4471-9565; Lee, Jeong Eon/0000-0003-0037-2456; Kim, Young-Woo/0000-0002-1559-9672	National Cancer Center [0710422-3]	National Cancer Center	This work was supported by National Cancer Center Grant no. 0710422-3. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Basch CE, 2006, AM J PUBLIC HEALTH, V96, P2246, DOI 10.2105/AJPH.2005.067223; Bellizzi KM, 2005, J CLIN ONCOL, V23, P8884, DOI 10.1200/JCO.2005.02.2343; [Center for Disease Control and Prevention Korean Institute for Health and Social Affairs], 2007, IN DEPTH AN 3 NAT HL; Cheung WY, 2009, J CLIN ONCOL, V27, P2489, DOI 10.1200/JCO.2008.20.3232; Cho J, 2010, CANCER CAUSE CONTROL, V21, P2203, DOI 10.1007/s10552-010-9640-4; Christie J, 2008, J NATL MED ASSOC, V100, P278, DOI 10.1016/S0027-9684(15)31240-2; Cronbach LJ, 2004, EDUC PSYCHOL MEAS, V64, P391, DOI 10.1177/0013164404266386; Curtis R, 2006, NEW MALIGNANCIES CAN; del Carmen MG, 2007, AM J ROENTGENOL, V188, P1147, DOI 10.2214/AJR.06.0619; Earle CC, 2004, CANCER, V101, P1712, DOI 10.1002/cncr.20560; Earle CC, 2003, J CLIN ONCOL, V21, P1447, DOI 10.1200/JCO.2003.03.060; Ferreira MR, 2005, J CLIN ONCOL, V23, P1548, DOI 10.1200/JCO.2005.07.049; Holden DJ, 2010, ANN INTERN MED, V152, P668, DOI 10.7326/0003-4819-152-10-201005180-00239; Horner MJ, 2009, SEER CANC STAT REV 1; Jung KW, 2009, J KOREAN MED SCI, V24, P995, DOI 10.3346/jkms.2009.24.6.995; Juon HS, 2006, CANCER DETECT PREV, V30, P297, DOI 10.1016/j.cdp.2006.03.008; Kim SH, 2000, J KOREAN RADIOL SOC, V42, P1009; Kindree T, 1997, Chronic Dis Can, V18, P168; *KOR AC FAM MED, 2003, LIF HLTH PROM KOR UP; Korea Cancer Association, 2004, SCREEN GUID 7 MAJ CA; MCPHEE SJ, 1991, JAMA-J AM MED ASSOC, V266, P538, DOI 10.1001/jama.266.4.538; National Cancer Center (Korea), 2008, CANC FACTS FIG; National Cancer Center & Ministry of Health and Welfare, 2001, NAT CANC SCREEN GUID; National Cancer Institute (NCI), 2007, DES PRINT MAT COMM G; Oeffinger KC, 2006, J CLIN ONCOL, V24, P5117, DOI 10.1200/JCO.2006.07.0474; Park SM, 2007, J CLIN ONCOL, V25, P4835, DOI 10.1200/JCO.2006.10.3416; Park SM, 2009, WORLD J GASTROENTERO, V15, P3153, DOI 10.3748/wjg.15.3153; Rauscher GH, 2008, CANCER EPIDEM BIOMAR, V17, P748, DOI 10.1158/1055-9965.EPI-07-2629; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Schaapveld M, 2008, J CLIN ONCOL, V26, P1239, DOI 10.1200/JCO.2007.11.9081; Shea S, 1996, J AM MED INFORM ASSN, V3, P399, DOI 10.1136/jamia.1996.97084513; Shin DW, 2011, CANCER; Shin DW, 2010, PATIENT ED COUNS; Simon SR, 2010, ARCH INTERN MED, V170, P264, DOI 10.1001/archinternmed.2009.522; Snyder CF, 2009, J CLIN ONCOL, V27, P1054, DOI 10.1200/JCO.2008.18.0950; Stokamer CL, 2005, J GEN INTERN MED, V20, P278, DOI 10.1111/j.1525-1497.2005.40023.x; SUH J, 2010, KOREA J MED, V79, P237; Trask PC, 2005, AM J PREV MED, V28, P351, DOI 10.1016/j.amepre.2005.01.005; Tu SP, 2006, CANCER-AM CANCER SOC, V107, P959, DOI 10.1002/cncr.22091; Yoo KY, 2008, JPN J CLIN ONCOL, V38, P327, DOI 10.1093/jjco/hyn026; Yu C. H., 2005, ENCY SOCIAL MEASUREM, V3, P777	41	64	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33238	10.1371/journal.pone.0033238	http://dx.doi.org/10.1371/journal.pone.0033238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948SR	22479375				2022-12-27	WOS:000304523400017
J	Sun, L; Edelmann, FT; Kaiser, CJO; Papsdorf, K; Gaiser, AM; Richter, K				Sun, Li; Edelmann, Franziska T.; Kaiser, Christoph J. O.; Papsdorf, Katharina; Gaiser, Andreas M.; Richter, Klaus			The Lid Domain of Caenorhabditis elegans Hsc70 Influences ATP Turnover, Cofactor Binding and Protein Folding Activity	PLOS ONE			English	Article							MOLECULAR CHAPERONE DNAK; ESCHERICHIA-COLI DNAJ; HEAT-SHOCK PROTEINS; INDUCED CONFORMATIONAL-CHANGES; NUCLEOTIDE EXCHANGE FACTOR; HSP70 MULTIGENE FAMILY; SUBSTRATE-BINDING; ALLOSTERIC REGULATION; INTERDOMAIN LINKER; CRYSTAL-STRUCTURE	Hsc70 is a conserved ATP-dependent molecular chaperone, which utilizes the energy of ATP hydrolysis to alter the folding state of its client proteins. In contrast to the Hsc70 systems of bacteria, yeast and humans, the Hsc70 system of C. elegans (CeHsc70) has not been studied to date. We find that CeHsc70 is characterized by a high ATP turnover rate and limited by post-hydrolysis nucleotide exchange. This rate-limiting step is defined by the helical lid domain at the C-terminus. A certain truncation in this domain (CeHsc70-D545) reduces the turnover rate and renders the hydrolysis step rate-limiting. The helical lid domain also affects cofactor affinities as the lidless mutant CeHsc70-D512 binds more strongly to DNJ-13, forming large protein complexes in the presence of ATP. Despite preserving the ability to hydrolyze ATP and interact with its cofactors DNJ-13 and BAG-1, the truncation of the helical lid domain leads to the loss of all protein folding activity, highlighting the requirement of this domain for the functionality of the nematode's Hsc70 protein.	Tech Univ Munich, CIPSM, D-8046 Garching, Germany; Tech Univ Munich, Dept Chem, D-8046 Garching, Germany	Technical University of Munich; Technical University of Munich	Sun, L (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	klaus.richter@ch.tum.de	Richter, Klaus/A-2673-2010; Kaiser, Christoph JO/C-5609-2013	Richter, Klaus/0000-0002-8952-9642; Kaiser, Christoph JO/0000-0002-8481-6845; Papsdorf, Katharina/0000-0001-9873-7585; Edelmann, Franziska/0000-0002-4391-1432	Deutsche Forschungsgemeinschaft (DFG) [RI1873/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by a grant of the Deutsche Forschungsgemeinschaft to KR (DFG-grant RI1873/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Aponte RA, 2010, J MOL BIOL, V399, P154, DOI 10.1016/j.jmb.2010.03.060; Bendz H, 2007, J BIOL CHEM, V282, P31688, DOI 10.1074/jbc.M704129200; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bimston D, 1998, EMBO J, V17, P6871, DOI 10.1093/emboj/17.23.6871; Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Buczynski G, 2001, J BIOL CHEM, V276, P27231, DOI 10.1074/jbc.M100237200; Cajo GC, 2006, J BIOL CHEM, V281, P12436, DOI 10.1074/jbc.M511192200; Chesnokova LS, 2003, BIOCHEMISTRY-US, V42, P9028, DOI 10.1021/bi0346493; CRAIG EA, 1984, CELL, V38, P841, DOI 10.1016/0092-8674(84)90279-4; CRAIG EA, 1989, MOL CELL BIOL, V9, P3000, DOI 10.1128/MCB.9.7.3000; Demeler B, 2010, MACROMOL BIOSCI, V10, P775, DOI 10.1002/mabi.200900481; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; Fernandez-Saiz V, 2006, J BIOL CHEM, V281, P7479, DOI 10.1074/jbc.M512744200; FREEMAN BC, 1995, EMBO J, V14, P2281, DOI 10.1002/j.1460-2075.1995.tb07222.x; Gaiser AM, 2009, J MOL BIOL; Gaiser AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025485; Gaiser AM, 2010, J BIOL CHEM, V285, P40921, DOI 10.1074/jbc.M110.131086; Gassler CS, 1998, P NATL ACAD SCI USA, V95, P15229, DOI 10.1073/pnas.95.26.15229; Gassler CS, 2001, J BIOL CHEM, V276, P32538, DOI 10.1074/jbc.M105328200; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; GuhaThakurta D, 2002, GENOME RES, V12, P701, DOI 10.1101/gr.228902; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Han WJ, 2001, FEBS LETT, V497, P55, DOI 10.1016/S0014-5793(01)02435-8; Harrison CJ, 1997, SCIENCE, V276, P431, DOI 10.1126/science.276.5311.431; Hayes DB, 2010, MACROMOL BIOSCI, V10, P731, DOI 10.1002/mabi.201000075; HESCHL MFP, 1990, COMP BIOCHEM PHYS B, V96, P633, DOI 10.1016/0305-0491(90)90206-9; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Jiang JW, 2007, MOL CELL, V28, P422, DOI 10.1016/j.molcel.2007.08.022; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; JORDAN R, 1995, J BIOL CHEM, V270, P4563, DOI 10.1074/jbc.270.9.4563; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Karzai AW, 1996, J BIOL CHEM, V271, P11236, DOI 10.1074/jbc.271.19.11236; Knarr G, 2002, J MOL BIOL, V318, P611, DOI 10.1016/S0022-2836(02)00166-3; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Lopez-Buesa P, 1998, P NATL ACAD SCI USA, V95, P15253, DOI 10.1073/pnas.95.26.15253; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; MCCARTY JS, 1995, J MOL BIOL, V249, P126, DOI 10.1006/jmbi.1995.0284; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; MORSHAUSER RC, 1995, BIOCHEMISTRY-US, V34, P6261, DOI 10.1021/bi00019a001; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nollen EAA, 2001, J BIOL CHEM, V276, P4677, DOI 10.1074/jbc.M009745200; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; Pierpaoli EV, 1997, J MOL BIOL, V269, P757, DOI 10.1006/jmbi.1997.1072; Popp S, 2005, J MOL BIOL, V347, P1039, DOI 10.1016/j.jmb.2005.02.026; Popp SL, 2009, FEBS LETT, V583, P573, DOI 10.1016/j.febslet.2008.12.062; Rist W, 2006, J BIOL CHEM, V281, P16493, DOI 10.1074/jbc.M600847200; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Russell R, 1999, BIOCHEMISTRY-US, V38, P4165, DOI 10.1021/bi9824036; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHRODER H, 1993, EMBO J, V12, P4137, DOI 10.1002/j.1460-2075.1993.tb06097.x; Sha BD, 2000, STRUCTURE, V8, P799, DOI 10.1016/S0969-2126(00)00170-2; Shi YY, 2005, J BIOL CHEM, V280, P22761, DOI 10.1074/jbc.M503643200; Slepenkov SV, 2003, BIOCHEMISTRY-US, V42, P5867, DOI 10.1021/bi034126v; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Strub A, 2003, J MOL BIOL, V334, P1087, DOI 10.1016/j.jmb.2003.10.023; Stuart JK, 1998, J BIOL CHEM, V273, P22506, DOI 10.1074/jbc.273.35.22506; Su PH, 2010, PLANT CELL, V22, P1516, DOI 10.1105/tpc.109.071415; Suh WC, 1999, J BIOL CHEM, V274, P30534, DOI 10.1074/jbc.274.43.30534; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Symersky J, 2004, ACTA CRYSTALLOGR D, V60, P1606, DOI [10.1107/S0907444904017603, 10.1107/S0907444904017605]; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Vogel M, 2006, J BIOL CHEM, V281, P38705, DOI 10.1074/jbc.M609020200; WALL D, 1994, J BIOL CHEM, V269, P5446; Wang H, 1998, BIOCHEMISTRY-US, V37, P7929, DOI 10.1021/bi9800855; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19307, DOI 10.1074/jbc.270.33.19307; WAWRZYNOW A, 1995, J BIOL CHEM, V270, P19300, DOI 10.1074/jbc.270.33.19300; Wegele H, 2003, J BIOL CHEM, V278, P25970, DOI 10.1074/jbc.M301548200; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; WELCH WJ, 1982, J BIOL CHEM, V257, P4949; WIECH H, 1993, J BIOL CHEM, V268, P7414; Wittung-Stafshede P, 2003, BIOCHEMISTRY-US, V42, P4937, DOI 10.1021/bi027333o; Worrall LJ, 2007, BIOCHEM BIOPH RES CO, V357, P105, DOI 10.1016/j.bbrc.2007.03.107; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606	92	15	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33980	10.1371/journal.pone.0033980	http://dx.doi.org/10.1371/journal.pone.0033980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479492	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400046
J	An, SH; Dong, SZ; Wang, Q; Li, S; Gilbert, LI; Stanley, D; Song, QS				An, Shiheng; Dong, Shengzhang; Wang, Qian; Li, Sheng; Gilbert, Lawrence I.; Stanley, David; Song, Qisheng			Insect Neuropeptide Bursicon Homodimers Induce Innate Immune and Stress Genes during Molting by Activating the NF-kappa B Transcription Factor Relish	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; REGULATED GENES; HOST-DEFENSE; RECEPTOR; HORMONE; IDENTIFICATION	Background: Bursicon is a heterodimer neuropeptide composed of two cystine knot proteins, bursicon alpha (burs alpha) and bursicon beta (burs beta), that elicits cuticle tanning (melanization and sclerotization) through the Drosophila leucine-rich repeats-containing G protein-coupled receptor 2 (DLGR2). Recent studies show that both bursicon subunits also form homodimers. However, biological functions of the homodimers have remained unknown until now. Methodology/Principal Findings: In this report, we show in Drosophila melanogaster that both bursicon homodimers induced expression of genes encoding antimicrobial peptides (AMPs) in neck-ligated adults following recombinant homodimer injection and in larvae fat body after incubation with recombinant homodimers. These AMP genes were also up-regulated in 24 h old unligated flies (when the endogenous bursicon level is low) after injection of recombinant homodimers. Up-regulation of AMP genes by the homodimers was accompanied by reduced bacterial populations in fly assay preparations. The induction of AMP expression is via activation of the NF-kappa B transcription factor Relish in the immune deficiency (Imd) pathway. The influence of bursicon homodimers on immune function does not appear to act through the heterodimer receptor DLGR2, i.e. novel receptors exist for the homodimers. Conclusions/Significance: Our results reveal a mechanism of CNS-regulated prophylactic innate immunity during molting via induced expression of genes encoding AMPs and genes of the Turandot family. Turandot genes are also up-regulated by a broader range of extreme insults. From these data we infer that CNS-generated bursicon homodimers mediate innate prophylactic immunity to both stress and infection during the vulnerable molting cycle.	[An, Shiheng; Dong, Shengzhang; Wang, Qian; Song, Qisheng] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Li, Sheng] Chinese Acad Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Gilbert, Lawrence I.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Stanley, David] USDA ARS, Biol Control Insects Res Lab, Columbia, MO 65205 USA	University of Missouri System; University of Missouri Columbia; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Agriculture (USDA)	An, SH (corresponding author), Henan Agr Univ, Coll Plant Protect, Zhengzhou, Henan, Peoples R China.	songq@missouri.edu		Wang, Qian/0000-0002-7517-7930; Dong, Shengzhang/0000-0002-8218-4688	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	This research was supported by National Science Foundation to QS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-424; Arakane Y, 2008, MECH DEVELOP, V125, P984, DOI 10.1016/j.mod.2008.09.002; Bai H, 2010, DEV BIOL, V344, P248, DOI 10.1016/j.ydbio.2010.05.003; Baker JD, 2002, J EXP BIOL, V205, P2555; Davis MM, 2007, DEVELOPMENT, V134, P4395, DOI 10.1242/dev.009902; Dewey EM, 2004, CURR BIOL, V14, P1208, DOI 10.1016/j.cub.2004.06.051; Ekengren S, 2001, BIOCHEM BIOPH RES CO, V284, P998, DOI 10.1006/bbrc.2001.5067; Ekengren S, 2001, CURR BIOL, V11, P714, DOI 10.1016/S0960-9822(01)00203-2; Honegger HW, 2008, J COMP PHYSIOL A, V194, P989, DOI 10.1007/s00359-008-0386-3; Huang JH, 2007, FEBS LETT, V581, P697, DOI 10.1016/j.febslet.2007.01.034; Kimura KI, 2004, DEVELOPMENT, V131, P1597, DOI 10.1242/dev.01049; LEMAITRE B, 1995, P NATL ACAD SCI USA, V92, P9465, DOI 10.1073/pnas.92.21.9465; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Loveall BJ, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-92; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Mendive FM, 2005, FEBS LETT, V579, P2171, DOI 10.1016/j.febslet.2005.03.006; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Song Q., 2012, INSECT ENDOCRINOLOGY, P93; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Tracey KJ, 2011, SCIENCE, V332, P673, DOI 10.1126/science.1206353; Wang SJ, 2008, ARCH INSECT BIOCHEM, V68, P100, DOI 10.1002/arch.20239	22	44	54	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34510	10.1371/journal.pone.0034510	http://dx.doi.org/10.1371/journal.pone.0034510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470576	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000115
J	Lee, KY; Lee, KH; Park, JW; Kim, DM				Lee, Ka-Young; Lee, Kyung-Ho; Park, Ji-Woong; Kim, Dong-Myung			Flexible Programming of Cell-Free Protein Synthesis Using Magnetic Bead-Immobilized Plasmids	PLOS ONE			English	Article							SYNTHESIS SYSTEM; RECOMBINANT PROTEINS; GENE-EXPRESSION; HIGH-THROUGHPUT; COMBINATORIAL; CONSTRUCTION	The use of magnetic bead-immobilized DNA as movable template for cell-free protein synthesis has been investigated. Magnetic microbeads containing chemically conjugated plasmids were used to direct cell-free protein synthesis, so that protein generation could be readily programmed, reset and reprogrammed. Protein synthesis by using this approach could be ON/OFF-controlled through repeated addition and removal of the microbead-conjugated DNA and employed in sequential expression of different genes in a same reaction mixture. Since the incubation periods of individual template plasmids are freely controllable, relative expression levels of multiple proteins can be tuned to desired levels. We expect that the presented results will find wide application to the flexible design and execution of synthetic pathways in cell-free chassis.	[Lee, Ka-Young; Lee, Kyung-Ho; Kim, Dong-Myung] Chungnam Natl Univ, Dept Fine Chem Engn & Appl Chem, Taejon, South Korea; [Park, Ji-Woong] Gwangju Inst Sci & Technol, Dept Mat Sci & Engn, Kwangju, South Korea	Chungnam National University; Gwangju Institute of Science & Technology (GIST)	Lee, KY (corresponding author), Chungnam Natl Univ, Dept Fine Chem Engn & Appl Chem, Taejon, South Korea.	dmkim@cnu.ac.kr	Park, Ji-Woong/AAH-6097-2021	Park, Ji-Woong/0000-0002-8783-3675; Kim, Dong-Myung/0000-0001-7875-0694	National Research Foundation of Korea [2011-0027629, 2011-0027901]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (grant numbers 2011-0027629 and 2011-0027901). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2008, BIOTECHNOL BIOENG, V101, P422, DOI 10.1002/bit.21884; Ahn JH, 2008, J PROTEOME RES, V7, P2107, DOI 10.1021/pr700856s; Carlini DB, 2001, GENETICS, V159, P623; Chursov A, 2011, NUCL ACIDS IN PRESS; Keum JW, 2006, BIOCHEM BIOPH RES CO, V350, P562, DOI 10.1016/j.bbrc.2006.09.072; Keum JW, 2009, BIOTECHNOL BIOENG, V102, P577, DOI 10.1002/bit.22081; Kigawa Takanori, 2002, Journal of Structural and Functional Genomics, V2, P29, DOI 10.1023/A:1013203532303; Kim HC, 2011, PROCESS BIOCHEM, V46, P1366, DOI 10.1016/j.procbio.2011.03.008; Kim TW, 2007, BIOTECHNOL BIOENG, V97, P1510, DOI 10.1002/bit.21337; Kim TW, 2006, J BIOTECHNOL, V126, P554, DOI 10.1016/j.jbiotec.2006.05.014; Park S, 2010, ACS NANO, V4, P2555, DOI 10.1021/nn100362m; Ramachandran N, 2004, SCIENCE, V305, P86, DOI 10.1126/science.1097639; Rungpragayphan S, 2003, FEBS LETT, V540, P147, DOI 10.1016/S0014-5793(03)00251-5; Scaffidi JP, 2011, ACS NANO, V5, P4679, DOI 10.1021/nn200511m; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Torizawa T, 2004, J BIOMOL NMR, V30, P311, DOI 10.1007/s10858-004-3534-2; Trotta E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021590; Zhang Y, 2001, Nucleic Acids Res, V29, pE66, DOI 10.1093/nar/29.13.e66	18	11	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34429	10.1371/journal.pone.0034429	http://dx.doi.org/10.1371/journal.pone.0034429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470570	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000109
J	Appelbaum, LG; Ales, JM; Norcia, AM				Appelbaum, Lawrence G.; Ales, Justin M.; Norcia, Anthony M.			The Time Course of Segmentation and Cue-Selectivity in the Human Visual Cortex	PLOS ONE			English	Article							FIGURE-GROUND SEGREGATION; CLASSICAL RECEPTIVE-FIELD; TEXTURE SEGREGATION; NEURONAL RESPONSES; SCENE SEGMENTATION; V1 NEURONS; AREA V4; ORIENTATION; ATTENTION; DISCRIMINATION	Texture discontinuities are a fundamental cue by which the visual system segments objects from their background. The neural mechanisms supporting texture-based segmentation are therefore critical to visual perception and cognition. In the present experiment we employ an EEG source-imaging approach in order to study the time course of texture-based segmentation in the human brain. Visual Evoked Potentials were recorded to four types of stimuli in which periodic temporal modulation of a central 3 degrees figure region could either support figure-ground segmentation, or have identical local texture modulations but not produce changes in global image segmentation. The image discontinuities were defined either by orientation or phase differences across image regions. Evoked responses to these four stimuli were analyzed both at the scalp and on the cortical surface in retinotopic and functional regions-of-interest (ROIs) defined separately using fMRI on a subject-by-subject basis. Texture segmentation (tsVEP: segmenting versus non-segmenting) and cue-specific (csVEP: orientation versus phase) responses exhibited distinctive patterns of activity. Alternations between uniform and segmented images produced highly asymmetric responses that were larger after transitions from the uniform to the segmented state. Texture modulations that signaled the appearance of a figure evoked a pattern of increased activity starting at similar to 143 ms that was larger in V1 and LOC ROIs, relative to identical modulations that didn't signal figure-ground segmentation. This segmentation-related activity occurred after an initial response phase that did not depend on the global segmentation structure of the image. The two cue types evoked similar tsVEPs up to 230 ms when they differed in the V4 and LOC ROIs. The evolution of the response proceeded largely in the feed-forward direction, with only weak evidence for feedback-related activity.	[Appelbaum, Lawrence G.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27705 USA; [Appelbaum, Lawrence G.] Duke Univ, Dept Psychiat, Durham, NC 27706 USA; [Ales, Justin M.; Norcia, Anthony M.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Duke University; Duke University; Stanford University	Appelbaum, LG (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27705 USA.	greg@duke.edu		Appelbaum, Lawrence/0000-0002-3184-6725; Ales, Justin/0000-0002-2089-1563	NIH INRSA [EY14536, EY06579]; Pacific Vision Foundation; NATIONAL EYE INSTITUTE [T32EY014536] Funding Source: NIH RePORTER	NIH INRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pacific Vision Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH INRSA awards EY14536 and EY06579, and the Pacific Vision Foundation http://www.pacificvisionfoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaki T, 2002, NEUROSCI RES, V43, P207, DOI 10.1016/S0168-0102(02)00038-X; Ales JM, 2010, NEUROIMAGE, V52, P1401, DOI 10.1016/j.neuroimage.2010.05.016; Ales JM, 2009, J VISION, V9, DOI 10.1167/9.7.8; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Appelbaum LG, 2010, NEUROPSYCHOLOGIA, V48, P3323, DOI 10.1016/j.neuropsychologia.2010.07.016; Appelbaum LG, 2006, J NEUROSCI, V26, P11695, DOI 10.1523/JNEUROSCI.2741-06.2006; Appelbaum LG, 2008, J VISION, V8, DOI 10.1167/8.9.8; Appelbaum LG, 2009, J VISION, V9, DOI 10.1167/9.11.18; Bach M, 1998, DOC OPHTHALMOL, V95, P335, DOI 10.1023/A:1001864625557; Bach M, 1997, VISION RES, V37, P1409, DOI 10.1016/S0042-6989(96)00322-7; BACH M, 1992, VISION RES, V32, P417, DOI 10.1016/0042-6989(92)90233-9; Bair W, 2003, J NEUROSCI, V23, P7690; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; Cao A, 2003, VISUAL NEUROSCI, V20, P77, DOI 10.1017/S0952523803201085; Caputo G, 1999, VISION RES, V39, P31, DOI 10.1016/S0042-6989(98)00015-7; Casco C, 2005, VISION RES, V45, P2384, DOI 10.1016/j.visres.2005.02.022; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cottereau BR, HUM BRAIN MAPP; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DeWeerd P, 1996, VISUAL NEUROSCI, V13, P529, DOI 10.1017/S0952523800008208; El-Shamayleh Y, 2011, J NEUROSCI, V31, P8543, DOI 10.1523/JNEUROSCI.5974-10.2011; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Fahle M, 2003, VISION RES, V43, P7, DOI 10.1016/S0042-6989(02)00265-1; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Fahrenfort JJ, 2008, J VISION, V8, DOI 10.1167/8.1.12; Fitzpatrick D, 2000, CURR OPIN NEUROBIOL, V10, P438, DOI 10.1016/S0959-4388(00)00113-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Heinen K, 2005, NEUROREPORT, V16, P1483, DOI 10.1097/01.wnr.0000175611.26485.c8; Heinrich SP, 2007, J VISION, V7, DOI 10.1167/7.6.6; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; Kandil FI, 2003, VISION RES, V43, P2583, DOI 10.1016/S0042-6989(03)00456-5; Kastner S, 2000, J NEUROPHYSIOL, V83, P2453, DOI 10.1152/jn.2000.83.4.2453; Khoe W, 2006, BRAIN RES, V1078, P101, DOI 10.1016/j.brainres.2005.12.083; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; LAMME VAF, 1992, VISION RES, V32, P797, DOI 10.1016/0042-6989(92)90022-B; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Li ZP, 2000, SPATIAL VISION, V13, P25, DOI 10.1163/156856800741009; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Marcus DS, 2002, J NEUROPHYSIOL, V88, P2648, DOI 10.1152/jn.00916.2001; Maurer U, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-13; Merigan WH, 1996, VISUAL NEUROSCI, V13, P51, DOI 10.1017/S0952523800007124; Merigan WH, 2000, VISUAL NEUROSCI, V17, P949, DOI 10.1017/S095252380017614X; Murray MM, 2004, J NEUROSCI, V24, P6898, DOI 10.1523/JNEUROSCI.1996-04.2004; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; Nothdurft HC, 2000, VISUAL NEUROSCI, V17, P421, DOI 10.1017/S0952523800173092; Pitts MA, 2011, J COGNITIVE NEUROSCI, V23, P880, DOI 10.1162/jocn.2010.21438; Schira MM, 2004, J NEUROPHYSIOL, V91, P1716, DOI 10.1152/jn.00380.2003; Schmid AM, 2008, BRAIN RES, V1238, P59, DOI 10.1016/j.brainres.2008.08.029; Scholte HS, 2008, J COGNITIVE NEUROSCI, V20, P2097, DOI 10.1162/jocn.2008.20142; Scholte HS, 2006, BRAIN RES, V1076, P106, DOI 10.1016/j.brainres.2005.10.051; Schubo A, 2001, COGNITIVE BRAIN RES, V11, P341, DOI 10.1016/S0926-6410(01)00008-8; Shen ZM, 2007, J PHYSIOL-LONDON, V583, P581, DOI 10.1113/jphysiol.2007.130294; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Thielscher A, 2007, J COMPUT NEUROSCI, V22, P255, DOI 10.1007/s10827-006-0011-9; Vinberg J, 2008, J NEUROPHYSIOL, V99, P1380, DOI 10.1152/jn.01223.2007; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; WESTHEIMER G, 1979, INVEST OPHTH VIS SCI, V18, P893; Xu WF, 2005, CEREB CORTEX, V15, P1697, DOI 10.1093/cercor/bhi046; Zhou H, 2000, J NEUROSCI, V20, P6594, DOI 10.1523/JNEUROSCI.20-17-06594.2000	67	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34205	10.1371/journal.pone.0034205	http://dx.doi.org/10.1371/journal.pone.0034205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479566	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900070
J	Baumeister, MA; Zhang, N; Beas, H; Brooks, JR; Canchola, JA; Cosenza, C; Kleshik, F; Rampersad, V; Surtihadi, J; Battersby, TR				Baumeister, Mark A.; Zhang, Nan; Beas, Hilda; Brooks, Jesse R.; Canchola, Jesse A.; Cosenza, Carlo; Kleshik, Felix; Rampersad, Vinod; Surtihadi, Johan; Battersby, Thomas R.			A Sensitive Branched DNA HIV-1 Signal Amplification Viral Load Assay with Single Day Turnaround	PLOS ONE			English	Article							RNA; QUANTIFICATION; PCR	Branched DNA (bDNA) is a signal amplification technology used in clinical and research laboratories to quantitatively detect nucleic acids. An overnight incubation is a significant drawback of highly sensitive bDNA assays. The VERSANT (R) HIV-1 RNA 3.0 Assay (bDNA) ("Versant Assay") currently used in clinical laboratories was modified to allow shorter target incubation, enabling the viral load assay to be run in a single day. To dramatically reduce the target incubation from 16-18 h to 2.5 h, composition of only the "Lysis Diluent" solution was modified. Nucleic acid probes in the assay were unchanged. Performance of the modified assay (assay in development; not commercially available) was evaluated and compared to the Versant Assay. Dilution series replicates (>950 results) were used to demonstrate that analytical sensitivity, linearity, accuracy, and precision for the shorter modified assay are comparable to the Versant Assay. HIV RNA-positive clinical specimens (n = 135) showed no significant difference in quantification between the modified assay and the Versant Assay. Equivalent relative quantification of samples of eight genotypes was demonstrated for the two assays. Elevated levels of several potentially interfering endogenous substances had no effect on quantification or specificity of the modified assay. The modified assay with drastically improved turnaround time demonstrates the viability of signal-amplifying technology, such as bDNA, as an alternative to the PCR-based assays dominating viral load monitoring in clinical laboratories. Highly sensitive bDNA assays with a single day turnaround may be ideal for laboratories with especially stringent cost, contamination, or reliability requirements.	[Baumeister, Mark A.; Zhang, Nan; Beas, Hilda; Brooks, Jesse R.; Canchola, Jesse A.; Cosenza, Carlo; Kleshik, Felix; Rampersad, Vinod; Surtihadi, Johan; Battersby, Thomas R.] Siemens Healthcare Diagnost Inc, Berkeley, CA USA	Siemens AG	Baumeister, MA (corresponding author), Siemens Healthcare Diagnost Inc, Berkeley, CA USA.	thomas.battersby@siemens.com			Siemens Healthcare Diagnostics	Siemens Healthcare Diagnostics	Siemens Healthcare Diagnostics was the sole source of funding for this work. As the authors are all employees of Siemens Healthcare Diagnostics, and the authors performed all of the work, Siemens Healthcare Diagnostics was involved in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Aslanzadeh J, 2004, ANN CLIN LAB SCI, V34, P389; Collins ML, 1997, NUCLEIC ACIDS RES, V25, P2979, DOI 10.1093/nar/25.15.2979; COLLINS ML, 1995, ANAL BIOCHEM, V226, P120, DOI 10.1006/abio.1995.1199; CORNBLEET PJ, 1979, CLIN CHEM, V25, P432; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; Gleaves CA, 2002, J CLIN VIROL, V25, P205, DOI 10.1016/S1386-6532(02)00011-2; HORN T, 1989, NUCLEIC ACIDS RES, V17, P6959, DOI 10.1093/nar/17.17.6959; Knudsen BS, 2008, J MOL DIAGN, V10, P169, DOI 10.2353/jmoldx.2008.070127; Korn K, 2009, J CLIN MICROBIOL, V47, P1238, DOI 10.1128/JCM.02204-08; Lubelchek RJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006008; McEnroe RJ, 2005, EP7A2 CLSI; Murphy DG, 2000, J CLIN MICROBIOL, V38, P4034, DOI 10.1128/JCM.38.11.4034-4041.2000; Petrie III CR, 1998, Patent US, Patent No. [5,853,986, 5853986]	13	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33295	10.1371/journal.pone.0033295	http://dx.doi.org/10.1371/journal.pone.0033295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479381	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900022
J	Mous, K; Jennes, W; Camara, M; Seydi, M; Daneau, G; Mboup, S; Kestens, L; Van Ostade, X				Mous, Kim; Jennes, Wim; Camara, Makhtar; Seydi, Moussa; Daneau, Geraldine; Mboup, Souleymane; Kestens, Luc; Van Ostade, Xaveer			Expression Analysis of LEDGF/p75, APOBEC3G, TRIM5alpha, and Tetherin in a Senegalese Cohort of HIV-1-Exposed Seronegative Individuals	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MESSENGER-RNA LEVELS; HIV-1 INFECTION; HUMAN TRIM5-ALPHA; CELL SPREAD; RESTRICTION; ALPHA; GENE; SUSCEPTIBILITY; MACROPHAGES	Background: HIV-1 replication depends on a delicate balance between cellular co-factors and antiviral restriction factors. Lens epithelium-derived growth factor (LEDGF/p75) benefits HIV, whereas apolipoprotein B mRNA-editing catalytic polypeptide-like 3G (APOBEC3G), tripartite motif 5alpha (TRIM5 alpha), and tetherin exert anti-HIV activity. Expression levels of these proteins possibly contribute to HIV-1 resistance in HIV-1-exposed populations. Methodology/Principal Findings: We used real-time PCR and flow cytometry to study mRNA and protein levels respectively in PBMC and PBMC subsets. We observed significantly reduced LEDGF/p75 protein levels in CD4+ lymphocytes of HIV-1-exposed seronegative subjects relative to healthy controls, whereas we found no differences in APOBEC3G, TRIM5 alpha, or tetherin expression. Untreated HIV-1-infected patients generally expressed higher mRNA and protein levels than healthy controls. Increased tetherin levels, in particular, correlated with markers of disease progression: directly with the viral load and T cell activation and inversely with the CD4 count. Conclusions/Significance: Our data suggest that reduced LEDGF/p75 levels may play a role in resistance to HIV-1 infection, while increased tetherin levels could be a marker of advanced HIV disease. Host factors that influence HIV-1 infection and disease could be important targets for new antiviral therapies.	[Mous, Kim; Van Ostade, Xaveer] Univ Antwerp, Dept Biomed Sci, Lab Proteinsci Prote & Epigenet Signaling, Antwerp, Belgium; [Mous, Kim; Jennes, Wim; Daneau, Geraldine; Kestens, Luc] Inst Trop Med, Dept Microbiol, Immunol Lab, B-2000 Antwerp, Belgium; [Camara, Makhtar; Mboup, Souleymane] Cheikh Anta Diop Univ, Ctr Hosp Univ Le Dantec, Dept Bacteriol Virol, Immunol Lab, Dakar, Senegal; [Seydi, Moussa] Cheikh Anta Diop Univ, Ctr Hosp Univ Fann, Dept Infect Dis, Dakar, Senegal	University of Antwerp; Institute of Tropical Medicine (ITM); University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar	Mous, K (corresponding author), Univ Antwerp, Dept Biomed Sci, Lab Proteinsci Prote & Epigenet Signaling, Antwerp, Belgium.	xaveer.vanostade@ua.ac.be	Van Ostade, Xaveer/AAG-9587-2020; Jennes, Wim/M-2523-2013; Van Ostade, Xaveer WMP/D-1702-2015	Jennes, Wim/0000-0002-3125-6389; Van Ostade, Xaveer WMP/0000-0003-4078-3014; Daneau, Geraldine/0000-0002-2570-0893	fund for Scientific Research (FWO) Flanders [G.0660.06]; FWO doctoral fellowship	fund for Scientific Research (FWO) Flanders(FWO); FWO doctoral fellowship	This work is supported by the fund for Scientific Research (FWO) Flanders (www.fwo.be) (grant G.0660.06) and an FWO doctoral fellowship to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaoka K, 2005, BIOCHEM BIOPH RES CO, V338, P1950, DOI 10.1016/j.bbrc.2005.10.173; Biasin M, 2007, J INFECT DIS, V195, P960, DOI 10.1086/511988; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Camara M, 2010, J INFECT DIS, V201, P835, DOI 10.1086/651000; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chiu YL, 2006, TRENDS IMMUNOL, V27, P291, DOI 10.1016/j.it.2006.04.003; Cho SJ, 2006, J VIROL, V80, P2069, DOI 10.1128/JVI.80.4.2069-2072.2006; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Coleman CM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-26; Gandhi SK, 2008, J VIROL, V82, P3125, DOI 10.1128/JVI.01533-07; Gummuluru S, 2000, J VIROL, V74, P10882, DOI 10.1128/JVI.74.23.10882-10891.2000; Jennes W, 2008, J VIROL, V82, P8619, DOI 10.1128/JVI.00027-08; Jin X, 2005, J VIROL, V79, P11513, DOI 10.1128/JVI.79.17.11513-11516.2005; Jolly C, 2010, J VIROL, V84, P12185, DOI 10.1128/JVI.01447-10; Kawai S, 2008, CANCER SCI, V99, P2461, DOI 10.1111/j.1349-7006.2008.00968.x; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; MacPherson JI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000863; Madlala P, 2011, AIDS, V25, P1711, DOI 10.1097/QAD.0b013e328349c693; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Miyazawa M, 2009, AIDS, V23, P161, DOI 10.1097/QAD.0b013e3283196a80; Mous K, 2011, J IMMUNOL METHODS, V372, P52, DOI 10.1016/j.jim.2011.06.028; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Reddy K, 2010, AIDS, V24, P195, DOI 10.1097/QAD.0b013e3283353bba; Sakuma R, 2007, J VIROL, V81, P10201, DOI 10.1128/JVI.00419-07; Sewram S, 2009, J INFECT DIS, V199, P1657, DOI 10.1086/598861; Sharma P, 2000, BIOCHEM BIOPH RES CO, V276, P1320, DOI 10.1006/bbrc.2000.3606; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; Strebel K, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-48; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Takamura Y, 2006, AM J PHYSIOL-CELL PH, V290, pC554, DOI 10.1152/ajpcell.00398.2005; Tokarev A, 2009, AIDS RES HUM RETROV, V25, P1197, DOI 10.1089/aid.2009.0253; Ulenga NK, 2008, J INFECT DIS, V198, P486, DOI 10.1086/590212; Van Maele B, 2006, TRENDS BIOCHEM SCI, V31, P98, DOI 10.1016/j.tibs.2005.12.002; Vazquez-Perez JA, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-23; Zhang XF, 2010, MICROBES INFECT, V12, P768, DOI 10.1016/j.micinf.2010.05.004; Zheng YF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-68; Zielske SP, 2006, J VIROL, V80, P7275, DOI 10.1128/JVI.02470-05	45	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33934	10.1371/journal.pone.0033934	http://dx.doi.org/10.1371/journal.pone.0033934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479480	gold, Green Published, Green Submitted			2022-12-27	WOS:000303894900051
J	Yan, XH; Zhang, L; Chen, B; Xiong, ZY; Chen, CL; Wang, LJ; Yu, JY; Lu, CM; Wei, WH				Yan, Xiaohong; Zhang, Lei; Chen, Bo; Xiong, Zhiyong; Chen, Chunli; Wang, Lijun; Yu, Jingyin; Lu, Changming; Wei, Wenhui			Functional Identification and Characterization of the Brassica Napus Transcription Factor Gene BnAP2, the Ortholog of Arabidopsis Thaliana APETALA2	PLOS ONE			English	Article							FLORAL ORGAN ABSCISSION; DOUBLE-STRANDED-RNA; INFLORESCENCE-DEFICIENT; ARABIDOPSIS-THALIANA; FLOWER DEVELOPMENT; AGROBACTERIUM-TUMEFACIENS; MEDIATED TRANSFORMATION; SEED DEVELOPMENT; CELL-SEPARATION; HOMEOTIC GENES	BnAP2, an APETALA2 (AP2)-like gene, has been isolated from Brassica napus cultivar Zhongshuang 9. The cDNA of BnAP2, with 1, 299 bp in length, encoded a transcription factor comprising of 432 amino acid residues. Results from complementary experiment indicated that BnAP2 was completely capable of restoring the phenotype of Arabidopsis ap2-11 mutant. Together with the sequence and expression data, the complementation data suggested that BnAP2 encodes the ortholog of AtAP2. To address the transcriptional activation of BnAP2, we performed transactivation assays in yeast. Fusion protein of BnAP2 with GAL4 DNA binding domain strongly activated transcription in yeast, and the transactivating activity of BnAP2 was localized to the N-terminal 100 amino acids. To further study the function of BnAP2 involved in the phenotype of B. napus, we used a transgenic approach that involved targeted RNA interference (RNAi) repression induced by ihp-RNA. Floral various phenotype defectives and reduced female fertility were observed in B. napus BnAP2-RNAi lines. Loss of the function of BnAP2 gene also resulted in delayed sepal abscission and senescence with the ethylene-independent pathway. In the strong BnAP2-RNAi lines, seeds showed defects in shape, structure and development and larger size. Strong BnAP2-RNAi and wild-type seeds initially did not display a significant difference in morphology at 10 DAF, but the development of BnAP2-RNAi seeds was slower than that of wild type at 20 DAF, and further at 30 DAF, wild-type seeds were essentially at their final size, whereas BnAP2-RNAi seeds stopped growing and developing and gradually withered.	[Yan, Xiaohong; Chen, Bo; Wang, Lijun; Yu, Jingyin; Lu, Changming; Wei, Wenhui] Chinese Acad Agr Sci, Inst Oil Crops, Minist Agr, Key Lab Oil Crop Biol & Genet Breeding, Wuhan, Peoples R China; [Xiong, Zhiyong] Univ Missouri Columbia, Div Biol Sci, Columbia, MO USA; [Zhang, Lei] Wuhan Univ, Sch Life Sci, Wuhan 430072, Peoples R China; [Chen, Chunli] Huazhong Agr Univ, Sch Life Sci & Technol, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; University of Missouri System; University of Missouri Columbia; Wuhan University; Huazhong Agricultural University	Yan, XH (corresponding author), Chinese Acad Agr Sci, Inst Oil Crops, Minist Agr, Key Lab Oil Crop Biol & Genet Breeding, Wuhan, Peoples R China.	cmlu@oilcrops.cn; whwei@oilcrops.cn	Xiong, Zhiyong/AAO-8735-2021	Xiong, Zhiyong/0000-0003-1894-7588; Chen, Chunli/0000-0002-6464-4580	National Natural Science Foundation of China [30671312]; Natural Science Foundation of Hubei Province [2008CDA083, 2009CDB191]; Chenguang Program of Wuhan City [201050231022]; National Nonprofit Institute [1610172008004]; Key Laboratory of Oil Crop Biology, Ministry of Agriculture [201003, 201004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Chenguang Program of Wuhan City; National Nonprofit Institute; Key Laboratory of Oil Crop Biology, Ministry of Agriculture	This work was supported by the National Natural Science Foundation of China (grant no. 30671312), the Natural Science Foundation of Hubei Province (grants no. 2008CDA083 and 2009CDB191), the Chenguang Program of Wuhan City (grant no. 201050231022), the National Nonprofit Institute Research Grant (grant no. 1610172008004), and the Open Program of the Key Laboratory of Oil Crop Biology, Ministry of Agriculture (grants no. 201003 and 201004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Bechtold N, 1998, METH MOL B, V82, P259; Bewley J. D., 2013, SEEDS, DOI [10.1017/S0960258513000287, DOI 10.1007/978-1-4614-4693-4_1]; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1991, PLANT CELL, V3, P749, DOI 10.1105/tpc.3.8.749; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Brown RC, 1999, SEX PLANT REPROD, V12, P32, DOI 10.1007/s004970050169; Butenko MA, 2003, PLANT CELL, V15, P2296, DOI 10.1105/tpc.014365; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; DEBLOCK M, 1989, PLANT PHYSIOL, V91, P694, DOI 10.1104/pp.91.2.694; DREWS GN, 1991, CELL, V65, P991, DOI 10.1016/0092-8674(91)90551-9; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; Fernandez DE, 2000, PLANT CELL, V12, P183, DOI 10.1105/tpc.12.2.183; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fujii S, 2005, THEOR APPL GENET, V111, P696, DOI 10.1007/s00122-005-2054-0; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; GOLDBERG RB, 1994, SCIENCE, V266, P605, DOI 10.1126/science.266.5185.605; Harada JJ, 1997, ADV CELL MOL BIOL PL, V4, P545; Helliwell CA, 2005, METHOD ENZYMOL, V392, P24, DOI 10.1016/S0076-6879(04)92002-2; Higgins JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010065; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; Iida K, 2005, DNA RES, V12, P247, DOI 10.1093/dnares/dsi011; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jofuku KD, 2005, P NATL ACAD SCI USA, V102, P3117, DOI 10.1073/pnas.0409893102; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kandasamy MK, 2005, PLANT PHYSIOL, V138, P2019, DOI 10.1104/pp.105.065326; Kandasamy MK, 2005, PLANT J, V41, P845, DOI 10.1111/j.1365-313X.2005.02345.x; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Keck E, 2003, EMBO J, V22, P1058, DOI 10.1093/emboj/cdg097; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; KOMAKI MK, 1988, DEVELOPMENT, V104, P195; Koornneef J, 1980, ARABIDOPSIS INFORMAT, V17, P11; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; KUNST L, 1989, PLANT CELL, V1, P1195, DOI 10.1105/tpc.1.12.1195; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le BH, 2010, P NATL ACAD SCI USA, V107, P8063, DOI 10.1073/pnas.1003530107; Lewis MW, 2006, CURR OPIN PLANT BIOL, V9, P59, DOI 10.1016/j.pbi.2005.11.009; Lohmann JU, 2002, DEV CELL, V2, P135, DOI 10.1016/S1534-5807(02)00122-3; Maes T, 2001, PLANT CELL, V13, P229, DOI 10.1105/tpc.13.2.229; Marathe R, 2000, PLANT MOL BIOL, V43, P295, DOI 10.1023/A:1006456000564; Mckim SM, 2008, DEVELOPMENT, V135, P1537, DOI 10.1242/dev.012807; NAITO S, 1988, PLANT MOL BIOL, V11, P109, DOI 10.1007/BF00015664; Nizampatnam NR, 2011, PLANT MOL BIOL, V76, P557, DOI 10.1007/s11103-011-9789-6; Ohad N, 1996, P NATL ACAD SCI USA, V93, P5319, DOI 10.1073/pnas.93.11.5319; Ohto M, 2005, P NATL ACAD SCI USA, V102, P3123, DOI 10.1073/pnas.0409858102; Ohto MA, 2009, SEX PLANT REPROD, V22, P277, DOI 10.1007/s00497-009-0116-1; OKAMURO JK, 1993, PLANT CELL, V5, P1183, DOI 10.1105/tpc.5.10.1183; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; Raghavan V, DOUBLE FERTILIZATION; RAO GU, 1992, ANN BOT-LONDON, V69, P193, DOI 10.1093/oxfordjournals.aob.a088329; Roberts JA, 2002, ANNU REV PLANT BIOL, V53, P131, DOI 10.1146/annurev.arplant.53.092701.180236; Roberts JA, 2007, HDB PLANT SCI, V1, P512; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SCHULTZ EA, 1993, DEVELOPMENT, V119, P745; SHANNON S, 1993, PLANT CELL, V5, P639, DOI 10.1105/tpc.5.6.639; Shinjyo C, 1975, SCI B COLL AGR U RYU, V22, P1; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Stenvik GE, 2008, PLANT CELL, V20, P1805, DOI 10.1105/tpc.108.059139; Stenvik GE, 2006, PLANT CELL, V18, P1467, DOI 10.1105/tpc.106.042036; Takagi K, 2011, PLANT CELL REP, V30, P1835, DOI 10.1007/s00299-011-1091-1; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JE, 2001, NEW PHYTOL, V151, P323, DOI 10.1046/j.0028-646x.2001.00194.x; U. N., 1935, Japanese Journal of Botany, V7, P389; Van Eldik GJ, 1998, NUCLEIC ACIDS RES, V26, P5176, DOI 10.1093/nar/26.22.5176; Vicente-Carbajosa J, 2005, INT J DEV BIOL, V49, P645, DOI 10.1387/ijdb.052046jc; Wang EM, 2003, PLANTA, V216, P686, DOI 10.1007/s00425-002-0904-4; Wang MB, 2000, MOL PLANT PATHOL, V1, P347, DOI 10.1046/j.1364-3703.2000.00038.x; Wang P, 2008, J BIOSCIENCES, V33, P177, DOI 10.1007/s12038-008-0035-6; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Watson JM, 2005, FEBS LETT, V579, P5982, DOI 10.1016/j.febslet.2005.08.014; Wei WH, 2010, THEOR APPL GENET, V120, P1089, DOI 10.1007/s00122-009-1236-6; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wurschum T, 2006, PLANT CELL, V18, P295, DOI 10.1105/tpc.105.038398; Yu B, 2007, PLANT CELL TISS ORG, V90, P265, DOI 10.1007/s11240-007-9265-9	80	22	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33890	10.1371/journal.pone.0033890	http://dx.doi.org/10.1371/journal.pone.0033890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479468	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900048
J	Ahmed, SSU; Ersboll, AK; Biswas, PK; Christensen, JP; Hannan, ASMA; Toft, N				Ahmed, Syed S. U.; Ersboll, Annette K.; Biswas, Paritosh K.; Christensen, Jens P.; Hannan, Abu S. M. A.; Toft, Nils			Ecological Determinants of Highly Pathogenic Avian Influenza (H5N1) Outbreaks in Bangladesh	PLOS ONE			English	Article							A VIRUS H5N1; RISK-FACTORS; THAILAND; SURVEILLANCE; INFECTION; MIGRATION; CLUSTERS; NIGERIA; DUCKS	Background: The agro-ecology and poultry husbandry of the south Asian and south-east Asian countries share common features, however, with noticeable differences. Hence, the ecological determinants associated with risk of highly pathogenic avian influenza (HPAI-H5N1) outbreaks are expected to differ between Bangladesh and e. g., Thailand and Vietnam. The primary aim of the current study was to establish ecological determinants associated with the risk of HPAI-H5N1 outbreaks at subdistrict level in Bangladesh. The secondary aim was to explore the performance of two different statistical modeling approaches for unmeasured spatially correlated variation. Methodology/Principal Findings: An ecological study at subdistrict level in Bangladesh was performed with 138 subdistricts with HPAI-H5N1 outbreaks during 2007-2008, and 326 subdistricts with no outbreaks. The association between ecological determinants and HPAI-H5N1 outbreaks was examined using a generalized linear mixed model. Spatial clustering of the ecological data was modeled using 1) an intrinsic conditional autoregressive (ICAR) model at subdistrict level considering their first order neighbors, and 2) a multilevel (ML) model with subdistricts nested within districts. Ecological determinants significantly associated with risk of HPAI-H5N1 outbreaks at subdistrict level were migratory birds' staging areas, river network, household density, literacy rate, poultry density, live bird markets, and highway network. Predictive risk maps were derived based on the resulting models. The resulting models indicate that the ML model absorbed some of the covariate effect of the ICAR model because of the neighbor structure implied in the two different models. Conclusions/Significance: The study identified a new set of ecological determinants related to river networks, migratory birds' staging areas and literacy rate in addition to already known risk factors, and clarified that the generalized concept of free grazing duck and duck-rice cultivation interacted ecology are not significant determinants for Bangladesh. These findings will refine current understanding of the HPAI-H5N1 epidemiology in Bangladesh.	[Ahmed, Syed S. U.; Toft, Nils] Univ Copenhagen, Fac Life Sci, Dept Large Anim Sci, Copenhagen, Denmark; [Ahmed, Syed S. U.] Chittagong Vet & Anim Sci Univ, Fac Vet Med, Dept Med & Surg, Chittagong, Bangladesh; [Ersboll, Annette K.] Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Biswas, Paritosh K.] Chittagong Vet & Anim Sci Univ, Fac Vet Med, Dept Microbiol, Chittagong, Bangladesh; [Christensen, Jens P.] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Copenhagen, Denmark; [Hannan, Abu S. M. A.] Dept Livestock Serv, Epidemiol Unit, Dhaka, Bangladesh	University of Copenhagen; University of Southern Denmark; University of Copenhagen	Ahmed, SSU (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Large Anim Sci, Copenhagen, Denmark.	ssua@life.ku.dk	Ahmed, Syed Sayeem Uddin/AAL-5160-2021; Syed, Ahmed/B-5030-2009	Syed, Ahmed/0000-0002-5394-3227; Toft, Nils/0000-0002-0265-3764; Christensen, Jens Peter/0000-0002-6430-9010; Ersboll, Annette Kjaer/0000-0002-9407-3387				Ahmed SSU, 2010, EPIDEMIOL INFECT, V138, P843, DOI 10.1017/S0950268810000178; Ahmed SSU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024324; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Bin Muzaffar S, 2008, FORKTAIL, P100; Bird Life International, 2010, IMP BIRD AR FACTSH B; Biswas PK, 2009, VET REC, V164, P743, DOI 10.1136/vr.164.24.743; Biswas PK, 2009, EMERG INFECT DIS, V15, P1931, DOI 10.3201/eid1512.090643; Brooks WA, 2009, EMERG INFECT DIS, V15, P1311, DOI 10.3201/eid1508.090283; Chriel M, 1999, PREV VET MED, V40, P1, DOI 10.1016/S0167-5877(99)00016-1; Dohoo I., 2003, VET EPIDEMIOLOGY RES; Dolberg F., 2009, POULTRY SECTOR COUNT; FAO, 2011, FAOSTAT; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Gilbert M, 2007, AGR ECOSYST ENVIRON, V119, P409, DOI 10.1016/j.agee.2006.09.001; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Gilbert M, 2010, ECOHEALTH, V7, P448, DOI 10.1007/s10393-010-0672-8; Gregory NG, 2010, OUTLOOK AGR, V39, P115, DOI 10.5367/000000010791745367; GRIFFITH D. A., 1996, PRACTICAL HDB SPATIA, P65; ICDDR B, 2008, LIF CHICK BANGL BACK; International water management institute (IWMI), 2009, BANGL INTR; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Loth L, 2010, PREV VET MED, V96, P104, DOI 10.1016/j.prevetmed.2010.05.013; McCulloch E.C., 2001, GEN LINEAR MIXED MOD; Minh PQ, 2009, PREV VET MED, V89, P16, DOI 10.1016/j.prevetmed.2009.01.004; Ministry of Fisheries and livestock(MOFL), 2010, DAIL BIRD FLUE SIT; Mitra and Associates, 2007, AV INFL KNOWL ATT PR; Paul M, 2010, VET RES, V41, DOI 10.1051/vetres/2009076; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Ralston B.A., 1994, J TRANSP GEOGR, V2, P101; Rasmussen S, 2004, COMPUT METH PROG BIO, V76, P83, DOI 10.1016/j.cmpb.2004.03.003; Razzaque M.A., 1997, INT J PHYS DISTR LOG, V27, P18; Rivas AL, 2010, EPIDEMIOL INFECT, V138, P192, DOI 10.1017/S0950268809990495; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; Suarez David L., 2010, Animal Health Research Reviews, V11, P19, DOI 10.1017/S1466252310000095; Tiensin T, 2007, AVIAN DIS, V51, P182, DOI 10.1637/7635-042806R.1; Tiensin T, 2009, J INFECT DIS, V199, P1735, DOI 10.1086/599207; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Universite ' Libre de Bruxelles, 2010, AGR BIRD FLU HPAI H5; Waller L.A., 2004, APPL SPATIAL STAT PU; Ward M, 2008, VET RES COMMUN, V32, P627, DOI 10.1007/s11259-008-9064-8; Williams RAJ, 2008, T ROY SOC TROP MED H, V102, P471, DOI 10.1016/j.trstmh.2008.01.016; World Organization for Animal Health (OIE), 2011, UPD HIGHL PATH AV IN	43	33	33	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33938	10.1371/journal.pone.0033938	http://dx.doi.org/10.1371/journal.pone.0033938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470496	Green Published, Green Submitted, gold			2022-12-27	WOS:000303857100060
J	Damon, M; Wyszynska-Koko, J; Vincent, A; Herault, F; Lebret, B				Damon, Marie; Wyszynska-Koko, Joanna; Vincent, Annie; Herault, Frederic; Lebret, Benedicte			Comparison of Muscle Transcriptome between Pigs with Divergent Meat Quality Phenotypes Identifies Genes Related to Muscle Metabolism and Structure	PLOS ONE			English	Article							SKELETAL-MUSCLE; CARCASS TRAITS; CANDIDATE GENES; EATING QUALITY; PORK QUALITY; GROWTH; EXPRESSION; MICE; NORMALIZATION; TENDERNESS	Background: Meat quality depends on physiological processes taking place in muscle tissue, which could involve a large pattern of genes associated with both muscle structural and metabolic features. Understanding the biological phenomena underlying muscle phenotype at slaughter is necessary to uncover meat quality development. Therefore, a muscle transcriptome analysis was undertaken to compare gene expression profiles between two highly contrasted pig breeds, Large White (LW) and Basque (B), reared in two different housing systems themselves influencing meat quality. LW is the most predominant breed used in pig industry, which exhibits standard meat quality attributes. B is an indigenous breed with low lean meat and high fat contents, high meat quality characteristics, and is genetically distant from other European pig breeds. Methodology/Principal Findings: Transcriptome analysis undertaken using a custom 15 K microarray, highlighted 1233 genes differentially expressed between breeds (multiple-test adjusted P-value<0.05), out of which 635 were highly expressed in the B and 598 highly expressed in the LW pigs. No difference in gene expression was found between housing systems. Besides, expression level of 12 differentially expressed genes quantified by real-time RT-PCR validated microarray data. Functional annotation clustering emphasized four main clusters associated to transcriptome breed differences: metabolic processes, skeletal muscle structure and organization, extracellular matrix, lysosome, and proteolysis, thereby highlighting many genes involved in muscle physiology and meat quality development. Conclusions/Significance: Altogether, these results will contribute to a better understanding of muscle physiology and of the biological and molecular processes underlying meat quality. Besides, this study is a first step towards the identification of molecular markers of pork quality and the subsequent development of control tools.	[Damon, Marie; Wyszynska-Koko, Joanna; Vincent, Annie; Herault, Frederic; Lebret, Benedicte] INRA, Physiol Environm & Genet Anim & Syst Elevage PEGA, St Gilles, France; [Damon, Marie; Wyszynska-Koko, Joanna; Vincent, Annie; Herault, Frederic; Lebret, Benedicte] Agrocampus Ouest, Physiol Environm & Genet Anim & Syst Elevage PEGA, Rennes, France	INRAE; Institut Agro; Agrocampus Ouest	Damon, M (corresponding author), INRA, Physiol Environm & Genet Anim & Syst Elevage PEGA, St Gilles, France.	Marie.Damon@rennes.inra.fr		Herault, Frederic/0000-0001-5824-4081	European Community [FOOD-CT-2007- 036245]	European Community(European Commission)	The authors gratefully acknowledge from the European Community financial participation under the Sixth Framework Programme for Research, Technological Development and Demonstration Activities, for the Integrated Project Q-PORKCHAINS FOOD-CT-2007- 036245. The views expressed in this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use, which might be made of the information. The information in this document is provided as is and no guarantee or warranty is given that the information is fit for any particular purpose. The user thereof uses the information at its sole risk and liability. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso L, 2005, ANIM RES, V54, P33, DOI 10.1051/animres:2005001; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arnyasi M, 2006, J ANIM BREED GENET, V123, P198, DOI 10.1111/j.1439-0388.2006.00588.x; Bao Y, 1996, GENOMICS, V38, P155, DOI 10.1006/geno.1996.0611; Barrientos T, 2007, J BIOL CHEM, V282, P8393, DOI 10.1074/jbc.M607549200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonneau M, 2010, MEAT SCI, V84, P293, DOI 10.1016/j.meatsci.2009.03.013; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Chai J, 2010, MOL BIOL REP, V37, P613, DOI 10.1007/s11033-009-9872-0; Champigny MJ, 2005, EXP CELL RES, V311, P157, DOI 10.1016/j.yexcr.2005.08.023; Dalpe G, 1999, DEV BIOL, V210, P367, DOI 10.1006/dbio.1999.9263; Damon M., 2011, NATURE PRECEDINGS, DOI DOI 10.1038/NPRE.2011.5730.1; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Davoli Roberta, 2007, Briefings in Functional Genomics & Proteomics, V6, P313, DOI 10.1093/bfgp/elm036; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Finbow ME, 1997, BIOCHEM J, V324, P697, DOI 10.1042/bj3240697; Fontanesi L, 2010, J ANIM SCI, V88, P2235, DOI 10.2527/jas.2009-2560; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Gerbens F, 2001, J ANIM SCI, V79, P347; Hackstadt AJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-11; Honikel KO, 1998, MEAT SCI, V49, P447, DOI 10.1016/S0309-1740(98)00034-5; HONIKEL KO, 1986, MEAT SCI, V16, P267, DOI 10.1016/0309-1740(86)90038-0; Hopkins DL, 2009, APPLIED MUSCLE BIOLOGY AND MEAT SCIENCE, P149; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ibrahim RM, 2008, J ANIM SCI, V86, P1426, DOI 10.2527/jas.2007-0618; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim NK, 2010, MAMM GENOME, V21, P307, DOI 10.1007/s00335-010-9264-8; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Labeit S, 2011, FASEB J, V25, P822, DOI 10.1096/fj.10-157412; Labroue F., 2000, Journees de la Recherche Porcine en France, V32, P403; Lamon S, 2009, J PHYSIOL-LONDON, V587, P1795, DOI 10.1113/jphysiol.2009.168674; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Lebret B, 2008, ANIMAL, V2, P1548, DOI 10.1017/S1751731108002796; Lebret B, 2007, ANIMAL, V1, P849, DOI 10.1017/S1751731107000201; Lebret B, 2006, J ANIM SCI, V84, P2436, DOI 10.2527/jas.2005-689; Lee SH, 2008, BMB REP, V41, P846, DOI 10.5483/BMBRep.2008.41.12.846; Lefaucheur L, 2010, MEAT SCI, V84, P257, DOI 10.1016/j.meatsci.2009.05.004; Li XH, 2008, DOMEST ANIM ENDOCRIN, V35, P263, DOI 10.1016/j.domaniend.2008.06.002; Lin CS, 2005, J ANIM SCI, V83, P2075; MACBEATH JRE, 1993, J BIOL CHEM, V268, P19826; Meyers SN, 2008, ANIM GENET, V39, P531, DOI 10.1111/j.1365-2052.2008.01765.x; Ponsuksili S, 2009, FUNCT INTEGR GENOMIC, V9, P455, DOI 10.1007/s10142-009-0131-1; Ponsuksili S, 2008, J AGR FOOD CHEM, V56, P10311, DOI 10.1021/jf800881y; Purslow PP, 2005, MEAT SCI, V70, P435, DOI 10.1016/j.meatsci.2004.06.028; R Core Team, 2018, R LANG ENV STAT COMP; Rosenvold K, 2003, MEAT SCI, V64, P219, DOI 10.1016/S0309-1740(02)00186-9; Sakuma K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/721219; Samaras SE, 2006, J INVEST DERM SYMP P, V11, P124, DOI 10.1038/sj.jidsymp.5650014; Sayd T, 2006, J AGR FOOD CHEM, V54, P2732, DOI 10.1021/jf052569v; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Schwab CR, 2006, J ANIM SCI, V84, P1577, DOI 10.2527/2006.8461577x; Sentandreu MA, 2002, TRENDS FOOD SCI TECH, V13, P400, DOI 10.1016/S0924-2244(02)00188-7; Shan T, 2009, ANIM GENET, V40, P863, DOI 10.1111/j.1365-2052.2009.01927.x; Smith MA, 2010, DEV CELL, V19, P365, DOI 10.1016/j.devcel.2010.08.008; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; STEWART TS, 1991, J ANIM SCI, V69, P3882, DOI 10.2527/1991.6993882x; Tomsig JL, 2009, BIOCHEM J, V419, P611, DOI 10.1042/BJ20081888; Torrado Mario, 2005, J Mol Cell Cardiol, V38, P353, DOI 10.1016/j.yjmcc.2004.11.034; Tribout T, 2010, J ANIM SCI, V88, P2856, DOI 10.2527/jas.2009-2356; Tsukada T, 2010, J CELL SCI, V123, P3136, DOI 10.1242/jcs.071837; van de Wiel DFM, 2007, MEAT SCI, V77, P46, DOI 10.1016/j.meatsci.2007.04.017; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wheeler TL, 2000, J ANIM SCI, V78, P958; Wimmers K, 2010, ANIM SCI PAP REP, V28, P115; WullrichSchmoll A, 1996, EUR J BIOCHEM, V238, P374, DOI 10.1111/j.1432-1033.1996.0374z.x; Zanoteli E, 2010, BBA-MOL BASIS DIS, V1802, P659, DOI 10.1016/j.bbadis.2010.04.002; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]	69	66	67	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33763	10.1371/journal.pone.0033763	http://dx.doi.org/10.1371/journal.pone.0033763			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470472	Green Published, gold			2022-12-27	WOS:000303857100047
J	Guilford, T; Wynn, R; McMinn, M; Rodriguez, A; Fayet, A; Maurice, L; Jones, A; Meier, R				Guilford, Tim; Wynn, Russell; McMinn, Miguel; Rodriguez, Ana; Fayet, Annette; Maurice, Lou; Jones, Alice; Meier, Rhiannon			Geolocators Reveal Migration and Pre-Breeding Behaviour of the Critically Endangered Balearic Shearwater Puffinus mauretanicus	PLOS ONE			English	Article							NORTHEAST ATLANTIC WATERS; RANGE EXPANSION; CLIMATE-CHANGE; TOP PREDATOR; SEABIRD; DISCARDS; SUMMER	Using combined miniature archival light and salt-water immersion loggers, we characterise the year-round individual at-sea movements of Europe's only critically endangered seabird, the Balearic shearwater Puffinus mauretanicus, for the first time. Focusing on the non-breeding period, we show that all of the 26 breeding birds tracked from their breeding site on Mallorca in the Mediterranean Sea successfully made a 2-4 month migration into the Atlantic Ocean, where they utilised well-defined core areas off Portuguese and French coasts. As well as identifying high-risk areas in the Atlantic, our results confirm that breeding birds spend most of the year concentrated around productive waters of the Iberian shelf in the western Mediterranean. Migration phenology appeared largely unrelated to the subsequent (distinctly synchronous) breeding attempt, suggesting that any carry-over effects were compensated for during a long pre-laying period spent over winter in the Mediterranean. Using the light and salt-water immersion data alone we were also able to characterise the pattern of pre-laying visits to the colony in considerable detail, demonstrating that breeding pairs appear to coordinate their over-day visits using a high frequency of night-time visits throughout the winter. Our study shows that geolocation technology is a valuable tool for assessing the spatial distribution of risks to this critically endangered species, and also provides a low-impact method for remotely observing the detailed behaviour of seabird species that may be sensitive to disturbance from traditional study methods.	[Guilford, Tim; Fayet, Annette] Univ Oxford, Dept Zool, Oxford, Oxon, England; [Wynn, Russell; Jones, Alice; Meier, Rhiannon] Natl Oceanog Ctr, Marine Geosci Grp, Southampton, Hants, England; [McMinn, Miguel; Rodriguez, Ana] Skua Gabinete Estudios Ambient Soc Ltd Profess, Conservat Dept, Palma De Mallorca, Balearic Island, Spain; [Maurice, Lou] British Geol Survey, Nat Environm Res Council, Crowmarsh Gifford, Oxon, England	University of Oxford; NERC National Oceanography Centre; Met Office - UK; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey	Guilford, T (corresponding author), Univ Oxford, Dept Zool, Oxford, Oxon, England.	tim.guilford@zoo.ox.ac.uk		Fayet, Annette/0000-0001-6373-0500; Jones, Alice/0000-0002-6157-2024; Austin, Rhiannon/0000-0002-7411-6191	NERC [bgs05007, noc010009] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1095480] Funding Source: researchfish; Natural Environment Research Council [bgs05007, noc010009] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Arcos J. M, 2011, INT SPECIES ACTION P; Arcos JM, 2002, MAR ECOL PROG SER, V239, P209, DOI 10.3354/meps239209; BROOKE M, 1990, MANX SHEARWATER; Darlaston M, BRIT BIRDS IN PRESS; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Fevrier Y, 2011, LE FOU, V83, P39; Frederiksen M, DIVERS DIST IN PRESS; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Guilford T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021336; Gutierrez Ricard, 1995, Ardeola, V42, P161; Le Mao P, 1993, STATUS CONSERVATION, P135; Louzao M, 2011, MAR ECOL PROG SER, V429, P291, DOI 10.3354/meps09126; Louzao M, 2006, MAR ECOL PROG SER, V318, P247, DOI 10.3354/meps318247; Luczak C, 2011, BIOL LETTERS, V7, P702, DOI 10.1098/rsbl.2011.0225; Mourino J, 2003, SCI MAR, V67, P135, DOI 10.3989/scimar.2003.67s2135; Navarro J, 2009, MAR BIOL, V156, P2571, DOI 10.1007/s00227-009-1281-3; Oro D, 2004, BIOL CONSERV, V116, P93, DOI 10.1016/S0006-3207(03)00180-0; Poot Martin, 2005, Airo, V15, P43; Powell CDL, 2007, EMU, V107, P275, DOI 10.1071/MU07005; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; Rodriguez Molina Ana, 2002, Boletin SEDECK, V3, P128; Ruiz A, 2004, PARDELA BALEAR; Serventy D. L., 1963, P INT ORN C, V1, P338; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Votier SC, 2008, BIOL LETTERS, V4, P204, DOI 10.1098/rsbl.2007.0558; Wynn Russell B., 2007, British Birds, V100, P392; Wynn RB, 2007, BIOL LETTERS, V3, P529, DOI 10.1098/rsbl.2007.0162; Yesou P, 2003, SCI MAR, V67, P143, DOI 10.3989/scimar.2003.67s2143	28	57	58	2	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33753	10.1371/journal.pone.0033753	http://dx.doi.org/10.1371/journal.pone.0033753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470471	Green Published, gold, Green Accepted			2022-12-27	WOS:000303857100046
J	Bellesi, M; Vyazovskiy, VV; Tononi, G; Cirelli, C; Conti, F				Bellesi, Michele; Vyazovskiy, Vladyslav V.; Tononi, Giulio; Cirelli, Chiara; Conti, Fiorenzo			Reduction of EEG Theta Power and Changes in Motor Activity in Rats Treated with Ceftriaxone	PLOS ONE			English	Article							GLUTAMATE TRANSPORTER GLT-1; HIPPOCAMPAL THETA; UP-REGULATION; PREPULSE INHIBITION; NEURODEGENERATIVE DISEASES; SYNAPTIC LOCALIZATION; GAMMA OSCILLATIONS; STARTLE REFLEX; AXON TERMINALS; RHYTHM	The glutamate transporter GLT-1 is responsible for the largest proportion of total glutamate transport. Recently, it has been demonstrated that ceftriaxone (CEF) robustly increases GLT-1 expression. In addition, physiological studies have shown that GLT-1 up-regulation strongly affects synaptic plasticity, and leads to an impairment of the prepulse inhibition, a simple form of information processing, thus suggesting that GLT-1 over-expression may lead to dysfunctions of large populations of neurons. To test this possibility, we assessed whether CEF affects cortical electrical activity by using chronic electroencephalographic (EEG) recordings in male WKY rats. Spectral analysis showed that 8 days of CEF treatment resulted in a delayed reduction in EEG theta power (7-9 Hz) in both frontal and parietal derivations. This decrease peaked at day 10, i.e., 2 days after the end of treatment, and disappeared by day 16. In addition, we found that the same CEF treatment increased motor activity, especially when EEG changes are more prominent. Taken together, these data indicate that GLT-1 up-regulation, by modulating glutamatergic transmission, impairs the activity of widespread neural circuits. In addition, the increased motor activity and prepulse inhibition alterations previously described suggest that neural circuits involved in sensorimotor control are particularly sensitive to GLT-1 up-regulation.	[Bellesi, Michele; Conti, Fiorenzo] Univ Politecn Marche, Sect Neurosci & Cell Biol, Dept Expt & Clin Med, Ancona, Italy; [Vyazovskiy, Vladyslav V.; Tononi, Giulio; Cirelli, Chiara] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Conti, Fiorenzo] Univ Politecn Marche, Fdn Med Mol, Ancona, Italy	Marche Polytechnic University; University of Wisconsin System; University of Wisconsin Madison; Marche Polytechnic University	Bellesi, M (corresponding author), Univ Politecn Marche, Sect Neurosci & Cell Biol, Dept Expt & Clin Med, Ancona, Italy.	f.conti@univpm.it	Conti, Fiorenzo/J-9853-2018	Vyazovskiy, Vladyslav/0000-0002-4336-6681; Bellesi, Michele/0000-0002-3922-0188	Universita Politecnica delle Marche	Universita Politecnica delle Marche	This work was supported by funds from Universita Politecnica delle Marche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGLETON JP, 1995, BEHAV BRAIN RES, V68, P91, DOI 10.1016/0166-4328(94)00163-A; Bast T, 2003, PROG NEUROBIOL, V70, P319, DOI 10.1016/S0301-0082(03)00112-6; Beart PM, 2007, BRIT J PHARMACOL, V150, P5, DOI 10.1038/sj.bjp.0706949; Bellesi M, 2010, NEUROPSYCHOPHARMACOL, V35, P1253, DOI 10.1038/npp.2009.225; Bellesi M, 2009, GLIA, V57, P703, DOI 10.1002/glia.20798; BERRY SD, 1978, SCIENCE, V200, P1298, DOI 10.1126/science.663612; Bikbaev A, 2008, FRONT NEUROSCI-SWITZ, V2, P56, DOI 10.3389/neuro.01.010.2008; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; BORBELY AA, 1984, BEHAV BRAIN RES, V14, P171, DOI 10.1016/0166-4328(84)90186-4; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Chen WZ, 2004, J NEUROSCI, V24, P1136, DOI 10.1523/JNEUROSCI.1586-03.2004; Chu K, 2007, STROKE, V38, P177, DOI 10.1161/01.STR.0000252091.36912.65; Conti F, 1999, TRENDS NEUROSCI, V22, P451, DOI 10.1016/S0166-2236(99)01445-9; Conti F, 1996, EXCITATORY AMINO ACI; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DANBOLT NC, 1992, NEUROSCIENCE, V51, P295, DOI 10.1016/0306-4522(92)90316-T; Dash MB, 2012, SLEEP IN PRESS; de Vivo L, 2010, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.031.2009; Ennaceur A, 1996, BEHAV BRAIN RES, V80, P9, DOI 10.1016/0166-4328(96)00006-X; Furness DN, 2008, NEUROSCIENCE, V157, P80, DOI 10.1016/j.neuroscience.2008.08.043; Garcia-Garcia F, 1998, BRAIN RES BULL, V47, P317, DOI 10.1016/S0361-9230(98)00071-9; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; GIVENS BS, 1990, BEHAV NEUROSCI, V104, P849, DOI 10.1037/0735-7044.104.6.849; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Kanai Y, 2004, PFLUG ARCH EUR J PHY, V447, P469, DOI 10.1007/s00424-003-1146-4; Kopp C, 2003, EUR J NEUROSCI, V17, P2226, DOI 10.1046/j.1460-9568.2003.02651.x; Lauriat TL, 2007, MOL PSYCHIATR, V12, P1065, DOI 10.1038/sj.mp.4002065; Lazarewicz MT, 2010, J COGNITIVE NEUROSCI, V22, P1452, DOI 10.1162/jocn.2009.21305; LEUNG LWS, 1984, ELECTROEN CLIN NEURO, V58, P553, DOI 10.1016/0013-4694(84)90045-2; MACRIDES F, 1982, J NEUROSCI, V2, P1705; MAREN S, 1994, BEHAV NEUROSCI, V108, P44, DOI 10.1037/0735-7044.108.1.44; MCFARLAND WL, 1975, J COMP PHYSIOL PSYCH, V88, P324, DOI 10.1037/h0076177; Melone M, 2011, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00151; Melone M, 2009, GLIA, V57, P108, DOI 10.1002/glia.20744; Miller BR, 2008, NEUROSCIENCE, V153, P329, DOI 10.1016/j.neuroscience.2008.02.004; Miller TM, 2005, SCIENCE, V307, P361, DOI 10.1126/science.1109027; Minelli A, 2001, NEUROSCIENCE, V108, P51, DOI 10.1016/S0306-4522(01)00375-X; Neymotin SA, 2011, J NEUROSCI, V31, P11733, DOI 10.1523/JNEUROSCI.0501-11.2011; Oddie SD, 1998, NEUROSCI BIOBEHAV R, V22, P221, DOI 10.1016/S0149-7634(97)00003-1; Omrani A, 2009, J PHYSIOL-LONDON, V587, P4575, DOI 10.1113/jphysiol.2009.177881; Ramos KM, 2010, NEUROSCIENCE, V169, P1888, DOI 10.1016/j.neuroscience.2010.06.014; RAWLINS JNP, 1979, EXP BRAIN RES, V37, P49, DOI 10.1007/BF01474253; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Rusakov DA, 1999, TRENDS NEUROSCI, V22, P382, DOI 10.1016/S0166-2236(99)01425-3; SEMBA K, 1984, NEUROSCIENCE, V12, P761, DOI 10.1016/0306-4522(84)90168-4; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Slawinska U, 1998, BRAIN RES, V796, P327, DOI 10.1016/S0006-8993(98)00390-4; Steriade M, 2000, NEUROSCIENCE, V101, P243, DOI 10.1016/S0306-4522(00)00353-5; Swerdlow NR, 2000, BEHAV PHARMACOL, V11, P185, DOI 10.1097/00008877-200006000-00002; SWERDLOW NR, 1986, PHARMACOL BIOCHEM BE, V25, P233, DOI 10.1016/0091-3057(86)90261-3; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; Torres GE, 2007, CURR OPIN NEUROBIOL, V17, P304, DOI 10.1016/j.conb.2007.05.002; Tsanov M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005850; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Vertes RP, 1997, NEUROSCIENCE, V81, P893; WHISHAW IQ, 1973, BEHAV BIOL, V8, P461, DOI 10.1016/S0091-6773(73)80041-0; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Yamamoto M, 1997, PHARMACOL BIOCHEM BE, V57, P361, DOI 10.1016/S0091-3057(96)00304-8	65	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34139	10.1371/journal.pone.0034139	http://dx.doi.org/10.1371/journal.pone.0034139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479544	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339100122
J	Silvestroff, L; Franco, PG; Pasquini, JM				Silvestroff, Lucas; Gabriela Franco, Paula; Maria Pasquini, Juana			ApoTransferrin: Dual Role on Adult Subventricular Zone-Derived Neurospheres	PLOS ONE			English	Article							CUPRIZONE-INDUCED DEMYELINATION; TRANSFERRIN GENE-EXPRESSION; NG2 CELLS; MULTIPLE-SCLEROSIS; PROGENITOR CELLS; GLIA GENERATE; OLIGODENDROCYTES; BRAIN; RAT; OLIGODENDROGENESIS	Neural stem and progenitor cells (NSC/NPCs) are multipotent self-renewing cells that are able to generate neurons, astrocytes and oligodendrocytes (OLs) within the adult central nervous system. We cultured NSC/NPCs from the rat subventricular zone as neurospheres (NS) and studied apoTransferrin (aTf) effects on oligodendroglial specification and maturation. Our findings suggest that aTf acts at different stages during progression from NSC to mature oligodendrocytes. On the one hand, an early event associated with the activation of NSC/NPCs proliferation and commitment toward the oligodendroglial fate, as indicated by increased BrdU incorporation, larger neurospheres production, and higher ability to generate OL precursors (OPCs) from undifferentiated cultures. On the other hand, aTf exposure during differentiating conditions favours OL maturation from OPCs by promoting OL morphological development. This evidence supports a key role of Tf on the generation of OL from NSC/NPCs and highlights its potential in demyelinating disorder treatment.	[Silvestroff, Lucas] Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, Consejo Nacl Invest Cient & Tecn CONICET, RA-1113 Buenos Aires, DF, Argentina; Univ Buenos Aires, Fac Farm & Bioquim, Inst Quim & Fisicoquim Biol IQUIFIB, Consejo Nacl Invest Cient & Tecn CONICET, RA-1113 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Silvestroff, L (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Dept Quim Biol, Consejo Nacl Invest Cient & Tecn CONICET, Junin 956,C1113AAD, RA-1113 Buenos Aires, DF, Argentina.	jpasquin@qb.ffyb.uba.ar		Franco, Paula/0000-0002-0551-791X	CONICET (National Science and Technology Research Council) [PIP 112-200801-01767, Prestamo BID-PICT 0791]; UBACyT (Buenos Aires University Science and Technology Program) [20020090200481]	CONICET (National Science and Technology Research Council); UBACyT (Buenos Aires University Science and Technology Program)	Financial support was provided by the following: CONICET (National Science and Technology Research Council) PIP 112-200801-01767 to PGF, Prestamo BID-PICT 0791 to JMP, and UBACyT (Buenos Aires University Science and Technology Program) 20020090200481 to PGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo AM, 2006, EXP NEUROL, V198, P519, DOI 10.1016/j.expneurol.2005.12.027; ALDRED AR, 1987, J BIOL CHEM, V262, P5293; Badaracco ME, 2008, J NEUROSCI RES, V86, P2663, DOI 10.1002/jnr.21709; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Belachew S, 2002, J NEUROSCI, V22, P8553; BLOCH B, 1985, P NATL ACAD SCI USA, V82, P6706, DOI 10.1073/pnas.82.19.6706; CABRERA OEE, 1994, DEV NEUROSCI-BASEL, V16, P248, DOI 10.1159/000112116; Cabrera OEE, 1997, J NEUROSCI RES, V47, P603; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; DELOSMONTEROS AE, 1988, INT J DEV NEUROSCI, V6, P167, DOI 10.1016/0736-5748(88)90042-1; DELOSMONTEROS AE, 1989, J NEUROSCI RES, V24, P125, DOI 10.1002/jnr.490240202; Erickson RI, 2008, J NEUROSCI RES, V86, P1884, DOI 10.1002/jnr.21631; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Imitola J, 2003, PHYSIOL GENOMICS, V14, P171, DOI 10.1152/physiolgenomics.00021.2002; Komitova M, 2009, J COMP NEUROL, V512, P702, DOI 10.1002/cne.21917; Levine JM, 2001, TRENDS NEUROSCI, V24, P39, DOI 10.1016/S0166-2236(00)01691-X; Liu XX, 2006, GLIA, V54, P394, DOI 10.1002/glia.20392; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Marta CB, 2003, NEUROCHEM RES, V28, P101, DOI 10.1023/A:1021604413737; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Moos T, 2000, CELL MOL NEUROBIOL, V20, P77, DOI 10.1023/A:1006948027674; Nait-Oumesmar B, 2008, J NEUROL SCI, V265, P26, DOI 10.1016/j.jns.2007.09.032; Nait-Oumesmar B, 2007, P NATL ACAD SCI USA, V104, P4694, DOI 10.1073/pnas.0606835104; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Paez PM, 2006, NEUROCHEM INT, V49, P359, DOI 10.1016/j.neuint.2006.02.009; Paez PM, 2004, GLIA, V46, P207, DOI 10.1002/glia.20001; Paez PM, 2002, DEV NEUROSCI-BASEL, V24, P47, DOI 10.1159/000064945; Pevny L, 2003, TRENDS NEUROSCI, V26, P351, DOI 10.1016/S0166-2236(03)00169-3; Picard-Riera N, 2002, P NATL ACAD SCI USA, V99, P13211, DOI 10.1073/pnas.192314199; Qian ZM, 1999, EXP BRAIN RES, V129, P473, DOI 10.1007/s002210050916; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Rosato-Siri MV, 2010, J NEUROSCI RES, V88, P1695, DOI 10.1002/jnr.22348; Saleh MC, 2003, J NEUROSCI RES, V72, P587, DOI 10.1002/jnr.10619; Silvestroff L, 2010, J COMP NEUROL, V518, P2261, DOI 10.1002/cne.22330; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Tripathi RB, 2010, J NEUROSCI, V30, P16383, DOI 10.1523/JNEUROSCI.3411-10.2010; TSUTSUMI M, 1989, J BIOL CHEM, V264, P9626; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Weiss S, 1996, J NEUROSCI, V16, P7599; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Zhao C, 2008, J NEUROL SCI, V265, P12, DOI 10.1016/j.jns.2007.05.008; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	46	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33937	10.1371/journal.pone.0033937	http://dx.doi.org/10.1371/journal.pone.0033937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479482	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339100086
J	Urbanek, M; Hayes, MG; Lee, H; Freathy, RM; Lowe, LP; Ackerman, C; Jafari, N; Dyer, AR; Cox, NJ; Dunger, DB; Hattersley, AT; Metzger, BE; Lowe, WL				Urbanek, Margrit; Hayes, M. Geoffrey; Lee, Hoon; Freathy, Rachel M.; Lowe, Lynn P.; Ackerman, Christine; Jafari, Nadereh; Dyer, Alan R.; Cox, Nancy J.; Dunger, David B.; Hattersley, Andrew T.; Metzger, Boyd E.; Lowe, William L., Jr.			The Role of Inflammatory Pathway Genetic Variation on Maternal Metabolic Phenotypes during Pregnancy	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; INDUCED INSULIN-RESISTANCE; INDIVIDUAL PARTICIPANTS DATA; PLASMA ADIPONECTIN LEVELS; TYPE-2 DIABETES-MELLITUS; INTERLEUKIN-6 IL-6; ADIPOSE-TISSUE; PROMOTER POLYMORPHISMS	Background: Since mediators of inflammation are associated with insulin resistance, and the risk of developing diabetes mellitus and gestational diabetes, we hypothesized that genetic variation in members of the inflammatory gene pathway impact glucose levels and related phenotypes in pregnancy. We evaluated this hypothesis by testing for association between genetic variants in 31 inflammatory pathway genes in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) cohort, a large multiethnic multicenter study designed to address the impact of glycemia less than overt diabetes on pregnancy outcome. Results: Fasting, 1-hour, and 2-hour glucose, fasting and 1-hour C-peptide, and HbA1c levels were measured in blood samples obtained from HAPO participants during an oral glucose tolerance test at 24-32 weeks gestation. We tested for association between 458 SNPs mapping to 31 genes in the inflammatory pathway and metabolic phenotypes in 3836 European ancestry and 1713 Thai pregnant women. The strongest evidence for association was observed with TNF alpha and HbA1c (rs1052248; 0.04% increase per allele C; p-value = 4.4 x 10(-5)), RETN and fasting plasma glucose (rs1423096; 0.7 mg/dl decrease per allele A; p-value = 1.1 x 10(-4)), IL8 and 1 hr plasma glucose (rs2886920; 2.6 mg/dl decrease per allele T; p-value = 1.3 x 10(-4)), ADIPOR2 and fasting C-peptide (rs2041139; 0.55 ug/L decrease per allele A; p-value = 1.4 x 10(-4)), LEPR and 1-hour C-peptide (rs1171278; 0.62 ug/L decrease per allele T; p-value = 2.4 x 10(-4)), and IL6 and 1-hour plasma glucose (rs6954897; -2.29 mg/dl decrease per allele G, p-value = 4.3 x 10(-4)). Conclusions: Based on the genes surveyed in this study the inflammatory pathway is unlikely to have a strong impact on maternal metabolic phenotypes in pregnancy although variation in individual members of the pathway (e. g. RETN, IL8, ADIPOR2, LEPR, IL6, and TNF alpha,) may contribute to metabolic phenotypes in pregnant women.	[Urbanek, Margrit; Hayes, M. Geoffrey; Lee, Hoon; Ackerman, Christine; Metzger, Boyd E.; Lowe, William L., Jr.] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Freathy, Rachel M.; Hattersley, Andrew T.] Univ Exeter, Peninsula Coll Med & Dent, Exeter, Devon, England; [Lowe, Lynn P.; Dyer, Alan R.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Jafari, Nadereh] Northwestern Univ, Genom Core, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Dunger, David B.] Univ Cambridge, Dept Paediat, Cambridge, England; [Lowe, Lynn P.; Dyer, Alan R.; Metzger, Boyd E.] HAPO Study Cooperat Res Grp, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; University of Exeter; University of Plymouth; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Chicago; University of Cambridge	Urbanek, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA.	m-urbanek@northwestern.edu		Hayes, M Geoffrey/0000-0002-4617-3981; Freathy, Rachel/0000-0003-4152-2238; Hattersley, Andrew/0000-0001-5620-473X; Dunger, Professor David/0000-0002-2566-9304; Urbanek, Margrit/0000-0001-6994-7110	Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01 DK067459, R01-HD34242, R01-HD34243]; National Institute of Diabetes, Digestive, and Kidney Diseases; National Center for Research Resources [M01-RR00048, M01-RR00080]; American Diabetes Association; Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust) [085541/Z/08/Z]; Diabetes UK [RD04/0002756]; Kaiser Permanente Medical Center; KK Women's and Children's Hospital; Mater Mother's Hospital; Novo Nordisk; Myre Sim Fund of the Royal College of Physicians of Edinburgh; Howard and Carol Bernick Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057450] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034242, R01HD034243] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000048, M01RR000080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067459] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Diabetes Association(American Diabetes Association); Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust); Diabetes UK(Diabetes UK); Kaiser Permanente Medical Center; KK Women's and Children's Hospital; Mater Mother's Hospital; Novo Nordisk(Novo Nordisk); Myre Sim Fund of the Royal College of Physicians of Edinburgh; Howard and Carol Bernick Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study is funded by grants R01 DK067459, R01-HD34242 and R01-HD34243 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Diabetes, Digestive, and Kidney Diseases, by the National Center for Research Resources (M01-RR00048, M01-RR00080), and by the American Diabetes Association. RMF is funded by a Sir Henry Wellcome Postdoctoral Fellowship (Wellcome Trust grant: 085541/Z/08/Z). ATH is employed as a core member of the Peninsula NIHR Clinical Research Facility. Support has also been provided to local field centers by Diabetes UK (RD04/0002756), Kaiser Permanente Medical Center, KK Women's and Children's Hospital, Mater Mother's Hospital, Novo Nordisk, the Myre Sim Fund of the Royal College of Physicians of Edinburgh, and the Howard and Carol Bernick Family Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminkeng F, 2009, HUM IMMUNOL, V70, P706, DOI 10.1016/j.humimm.2009.06.013; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Berthier MT, 2003, J HUM GENET, V48, P1; Bo S, 2005, J ENDOCRINOL INVEST, V28, P779, DOI 10.1007/BF03347566; Boraska V, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-69; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Bouhaha R, 2010, CLIN BIOCHEM, V43, P549, DOI 10.1016/j.clinbiochem.2010.01.008; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carrol ED, 2011, J IMMUNOL, V186, P2329, DOI 10.4049/jimmunol.1002402; Cochery-Nouvellon E, 2009, BIOL REPROD, V80, P1115, DOI 10.1095/biolreprod.108.072215; Dong ZM, 1997, P NATL ACAD SCI USA, V94, P7526, DOI 10.1073/pnas.94.14.7526; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Escobar-Morreale HF, 2003, OBES RES, V11, P987, DOI 10.1038/oby.2003.136; Esposito K, 2003, AM J CLIN NUTR, V78, P1135, DOI 10.1093/ajcn/78.6.1135; Esposito K, 2003, J CLIN ENDOCR METAB, V88, P1055, DOI 10.1210/jc.2002-021437; Esposito K, 2002, J CLIN ENDOCR METAB, V87, P3864, DOI 10.1210/jc.2002-????; Fasshauer M, 2004, FEBS LETT, V560, P153, DOI 10.1016/S0014-5793(04)00096-1; Fernandez-Real JM, 2000, DIABETES, V49, P517, DOI 10.2337/diabetes.49.3.517; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; Forte GI, 2010, CURR PHARM DESIGN, V16, P898, DOI 10.2174/138161210790883642; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frayling TM, 2007, J GERONTOL A-BIOL, V62, P73, DOI 10.1093/gerona/62.1.73; Freathy RM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-51; Hamid YH, 2005, DIABETOLOGIA, V48, P251, DOI 10.1007/s00125-004-1623-0; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hivert MF, 2009, DIABETES, V58, P750, DOI 10.2337/db08-1339; Hivert MF, 2008, DIABETES, V57, P3353, DOI 10.2337/db08-0700; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Howson JMM, 2009, GENES IMMUN, V10, pS74, DOI 10.1038/gene.2009.96; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Huth C, 2006, DIABETES, V55, P2915, DOI 10.2337/db06-0600; Huth C, 2009, ANN MED, V41, P128, DOI 10.1080/07853890802337037; Illig T, 2004, J CLIN ENDOCR METAB, V89, P5053, DOI 10.1210/jc.2004-0355; Jermendy A, 2010, DIABETOLOGIA, V53, P98, DOI 10.1007/s00125-009-1561-y; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kathiresan S, 2005, CIRCULATION, V112, P1728, DOI 10.1161/CIRCULATIONAHA.105.547836; Kawazoe Y, 2001, J EXP MED, V193, P263, DOI 10.1084/jem.193.2.263; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kinalski M, 2005, HORM METAB RES, V37, P450, DOI 10.1055/s-2005-870238; Kyriakou T, 2008, J HUM GENET, V53, P718, DOI 10.1007/s10038-008-0303-1; Lagathu C, 2003, BIOCHEM BIOPH RES CO, V311, P372, DOI 10.1016/j.bbrc.2003.10.013; Laumen H, 2009, DIABETES, V58, P984, DOI 10.2337/db07-1646; Lin FH, 2011, INT J OBESITY, V35, P587, DOI 10.1038/ijo.2010.195; Liu CY, 2008, MOL MED, V14, P575, DOI 10.2119/2008-00056.Liu; Liu S, 2009, HUM MOL GENET, V18, P358, DOI 10.1093/hmg/ddn342; Lowe LP, 2010, J CLIN ENDOCR METAB, V95, P5427, DOI 10.1210/jc.2010-1662; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Martinez-Calatrava MJ, 2007, THROMB HAEMOSTASIS, V98, P1088, DOI 10.1160/TH07-03-0231; Matsuki T, 2003, J EXP MED, V198, P877, DOI 10.1084/jem.20030299; Melistas L, 2009, EUR J ENDOCRINOL, V161, P845, DOI 10.1530/EJE-09-0492; Menzaghi C, 2010, J INTERN MED, V267, P287, DOI 10.1111/j.1365-2796.2009.02141.x; Metzger BE, 2010, BJOG-INT J OBSTET GY, V117, P575, DOI 10.1111/j.1471-0528.2009.02486.x; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Moriwaki Y, 2003, METABOLISM, V52, P605, DOI 10.1053/meta.2003.50096; Muller S, 2002, DIABETOLOGIA, V45, P805, DOI 10.1007/s00125-002-0829-2; Nesbitt GS, 2006, CLIN TRIALS, V3, P397, DOI 10.1177/174077450607695; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Nilsson J, 1998, ARTERIOSCL THROM VAS, V18, P1199, DOI 10.1161/01.ATV.18.8.1199; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Owecki M, 2007, HORM METAB RES, V39, P25, DOI 10.1055/s-2007-957343; Perreault M, 2001, NAT MED, V7, P1138, DOI 10.1038/nm1001-1138; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Pollin TI, 2005, DIABETES, V54, P268, DOI 10.2337/diabetes.54.1.268; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2007, J CLIN ENDOCR METAB, V92, P3618, DOI 10.1210/jc.2007-0877; Qi L, 2006, HUM MOL GENET, V15, P1914, DOI 10.1093/hmg/ddl113; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qu HQ, 2008, DIABETOLOGIA, V51, P473, DOI 10.1007/s00125-007-0895-6; Rafiq S, 2008, DIABETOLOGIA, V51, P2205, DOI 10.1007/s00125-008-1160-3; Rafiq S, 2007, GENES IMMUN, V8, P552, DOI 10.1038/sj.gene.6364414; Rafiq S, 2007, GENES IMMUN, V8, P344, DOI 10.1038/sj.gene.6364393; Reiner AP, 2008, ARTERIOSCL THROM VAS, V28, P1407, DOI 10.1161/ATVBAHA.108.167437; Richardson DK, 2006, DIABETOLOGIA, V49, P2317, DOI 10.1007/s00125-006-0384-3; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shoelson SE, 2003, INT J OBESITY, V27, pS49, DOI 10.1038/sj.ijo.0802501; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study, 2002, INT J GYNAECOLOGY OB, V78, P69; Tsai FJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000847; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; van Eijk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017791; Velez DR, 2008, HUM MOL GENET, V17, P1619, DOI 10.1093/hmg/ddn049; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang YB, 2009, J GENET GENOMICS, V36, P417, DOI 10.1016/S1673-8527(08)60131-9; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wen WQ, 2008, CANCER-AM CANCER SOC, V112, P2409, DOI 10.1002/cncr.23453; Williams MA, 2004, J CLIN ENDOCR METAB, V89, P2306, DOI 10.1210/jc.2003-031201; Yamauchi S, 2010, P NATL ACAD SCI USA, V107, P11924, DOI 10.1073/pnas.0913179107; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zee RYL, 2008, ATHEROSCLEROSIS, V197, P931, DOI 10.1016/j.atherosclerosis.2007.08.013; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	111	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32958	10.1371/journal.pone.0032958	http://dx.doi.org/10.1371/journal.pone.0032958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479352	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100026
J	Zhuang, X; Wu, ZY; Poundstone, K; Yang, CQ; Zhong, YQ; Jiang, SY				Zhuang, Xun; Wu, Zunyou; Poundstone, Katharine; Yang, Changqing; Zhong, Yaqin; Jiang, Shengyang			HIV-Related High-Risk Behaviors among Chinese Migrant Construction Laborers in Nantong, Jiangsu	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASE; TO-URBAN MIGRANTS; TRANSMISSION; INFECTION; MIGRATION; SYPHILIS; WORKERS	Background: HIV transmission in rural areas of China is being fueled in part by migrant workers who acquire HIV outside of their hometowns. Recent surveillance statistics indicate that HIV prevalence among returning migrants has increased significantly. Methods: We conducted a community-based cross-sectional study to assess HIV-related knowledge, attitudes and behaviors among migrant returnees in Nantong, Jiangsu Province, one of the largest exporters of migrant laborers. Results: A total of 1625 subjects were enrolled with a response rate of 89%. All participants were male and of the majority Han ethnicity. The mean age was 39.0 years (SD = 6.7; range: 18 to 63), and most had a stable partner (N = 1533, 94.3%). Most correctly identified the major modes of HIV transmission (68.9%-82.0%), but fewer were able to identify ways that HIV cannot be transmitted. Nearly one-third of participants held positive attitudes toward having multiple sex partners, and nearly half believed that sex work should be legalized. Multiple logistic regression analysis indicated that risky sexual behavior (defined as sex with a casual or commercial sex partner) was associated with no stable partner; working abroad; correct condom use; age <22 at first sex; higher coital frequency; and having a positive attitude towards multiple sex partners. Conclusions: We found high levels of reported sex with a casual or commercial sex partner and low levels of consistent condom use. HIV prevention interventions among migrant workers need to focus on younger migrants, migrants without stable partners, and migrants who travel abroad for work.	[Zhuang, Xun; Wu, Zunyou; Poundstone, Katharine] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Zhuang, Xun; Yang, Changqing; Zhong, Yaqin; Jiang, Shengyang] Nantong Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Nantong, Jiangsu, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Nantong University	Zhuang, X (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wuzy@263.net			Multidisciplinary HIV and TB Implementation Sciences Training in China [U2R TW 006918]; US National Institutes of Health; Fogarty International Center; National Institute of Drug Abuse	Multidisciplinary HIV and TB Implementation Sciences Training in China; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	This study was supported by the Multidisciplinary HIV and TB Implementation Sciences Training in China with grant number U2R TW 006918, funded by the US National Institutes of Health, the Fogarty International Center and the National Institute of Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDS Data Hub, 2009, HIV MIGR REG PROF AS; Anderson AF, 2003, AIDS CARE, V15, P177, DOI 10.1080/0954012031000068326; Apostolopoulos Yorghos, 2006, J Immigr Minor Health, V8, P291, DOI 10.1007/s10903-006-9334-2; Bechtel G A, 1995, J Community Health Nurs, V12, P15, DOI 10.1207/s15327655jchn1201_2; Colvin M, 1998, INT J STD AIDS, V9, P548, DOI 10.1258/0956462981922683; Detels R, 2003, SEX TRANSM DIS, V30, P803, DOI 10.1097/01.OLQ.0000086607.82667.CF; GREENBERG J, 1992, SEX TRANSM DIS, V19, P331, DOI 10.1097/00007435-199211000-00006; He N, 2006, AIDS EDUC PREV, V18, P176, DOI 10.1521/aeap.2006.18.2.176; Hesketh T, 2006, SEX TRANSM INFECT, V82, P11, DOI 10.1136/sti.2004.014043; Hu Z, 2006, PUBLIC HEALTH, V120, P339, DOI 10.1016/j.puhe.2005.10.016; Li L, 2007, AIDS CARE, V19, P1288, DOI 10.1080/09540120701402855; Li XM, 2004, AIDS EDUC PREV, V16, P538, DOI 10.1521/aeap.16.6.538.53787; Liu HJ, 2005, AIDS PATIENT CARE ST, V19, P49, DOI 10.1089/apc.2005.19.49; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Mardh P A, 2000, Eur J Contracept Reprod Health Care, V5, P177, DOI 10.1080/13625180008500396; MELLANBY A, 1993, BRIT MED J, V307, P25, DOI 10.1136/bmj.307.6895.25; Nantong Center for Disease Control and Prevention, 2009, 2008 HIV STDS SURV R; National Bureau of Statistics, 2009, TOT RUR MIGR LAB REA; National Center for AIDS/STD Control and Prevention of China CDC, 2009, NAT HIV SURV SURV RE; PISON G, 1993, J ACQ IMMUN DEF SYND, V6, P196; Poudel KC, 2003, TROP MED INT HEALTH, V8, P933, DOI 10.1046/j.1365-3156.2003.01110.x; Scheineson A., 2009, CHINAS INTERNAL MIGR; Shi L, 2008, 89 POL INT STAT DEP; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yang Hongmei, 2005, Health Care Women Int, V26, P134, DOI 10.1080/07399330590905585; Zhang M, 2005, J PREVENTIVE MED INF, V21, P268	26	19	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e31986	10.1371/journal.pone.0031986	http://dx.doi.org/10.1371/journal.pone.0031986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UC	22479313	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100004
J	Huang, T; Zhang, M; Wei, ZG; Wang, P; Sun, Y; Hu, XX; Ren, LM; Meng, QY; Zhang, R; Guo, Y; Hammarstrom, L; Li, N; Zhao, YF				Huang, Tian; Zhang, Min; Wei, Zhiguo; Wang, Ping; Sun, Yi; Hu, Xiaoxiang; Ren, Liming; Meng, Qingyong; Zhang, Ran; Guo, Ying; Hammarstrom, Lennart; Li, Ning; Zhao, Yaofeng			Analysis of Immunoglobulin Transcripts in the Ostrich Struthio camelus, a Primitive Avian Species	PLOS ONE			English	Article							HEAVY-CHAIN LOCUS; CONSTANT-REGION GENES; LIGHT-CHAIN; GENOMIC ORGANIZATION; ANAS-PLATYRHYNCHOS; XENOPUS-TROPICALIS; JAWED VERTEBRATES; RAINBOW-TROUT; TELEOST FISH; DUCK	Previous studies on the immunoglobulin (Ig) genes in avian species are limited (mainly to galliformes and anseriformes) but have revealed several interesting features, including the absence of the Ig kappa and Igk encoding genes, inversion of the IgA encoding gene and the use of gene conversion as the primary mechanism to generate an antibody repertoire. To better understand the Ig genes and their evolutionary development in birds, we analyzed the Ig genes in the ostrich (Struthio camelus), which is one of the most primitive birds. Similar to the chicken and duck, the ostrich expressed only three IgH chain isotypes (IgM, IgA and IgY) and lambda light chains. The IgM and IgY constant domains are similar to their counterparts described in other vertebrates. Although conventional IgM, IgA and IgY cDNAs were identified in the ostrich, we also detected a transcript encoding a short membrane-bound form of IgA (lacking the last two CH exons) that was undetectable at the protein level. No Ig kappa or kappa encoding genes were identified. The presence of a single leader peptide in the expressed heavy chain and light chain V regions indicates that gene conversion also plays a major role in the generation of antibody diversity in the ostrich. Because the ostrich is one of the most primitive living aves, this study suggests that the distinct features of the bird Ig genes appeared very early during the divergence of the avian species and are thus shared by most, if not all, avian species.	[Huang, Tian; Zhang, Min; Wang, Ping; Sun, Yi; Hu, Xiaoxiang; Ren, Liming; Meng, Qingyong; Zhang, Ran; Guo, Ying; Li, Ning; Zhao, Yaofeng] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China; [Wei, Zhiguo] Henan Univ Sci & Technol, Coll Anim Sci & Technol, Luoyang, Henan, Peoples R China; [Hammarstrom, Lennart] Karolinska Univ Hosp Huddinge, Dept Lab Med, Div Clin Immunol, Stockholm, Sweden; [Zhao, Yaofeng] Qingdao Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Reprod & Germplasm Enhancement, Shandong Univ, Qingdao, Peoples R China	China Agricultural University; Henan University of Science & Technology; Karolinska Institutet; Karolinska University Hospital; Qingdao Agricultural University; Shandong University	Huang, T (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Natl Engn Lab Anim Breeding, Beijing 100094, Peoples R China.	yaofengzhao@cau.edu.cn	Meng, Qingyong/AAS-4335-2021		National Science Fund for Distinguished Young Scholars [30725029]; Taishan Scholar Foundation of Shandong Province; National Basic Research Program of China (973 Program) [2010CB945300]	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Taishan Scholar Foundation of Shandong Province; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Science Fund for Distinguished Young Scholars (30725029), the Taishan Scholar Foundation of Shandong Province, and the National Basic Research Program of China (973 Program-2010CB945300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bengten E, 2000, CURR TOP MICROBIOL, V248, P189; Choi JW, 2010, VET IMMUNOL IMMUNOP, V136, P248, DOI 10.1016/j.vetimm.2010.03.014; Criscitiello MF, 2007, EUR J IMMUNOL, V37, P2683, DOI 10.1002/eji.200737263; Danilova N, 2005, NAT IMMUNOL, V6, P295, DOI 10.1038/ni1166; Das S, 2008, P NATL ACAD SCI USA, V105, P16647, DOI 10.1073/pnas.0808800105; Das S, 2010, MOL BIOL EVOL, V27, P113, DOI 10.1093/molbev/msp212; de Lalla C, 1998, MOL IMMUNOL, V35, P837, DOI 10.1016/S0161-5890(98)00073-X; Flajnik MF, 2002, NAT REV IMMUNOL, V2, P688, DOI 10.1038/nri889; Fleurant M, 2004, J IMMUNOL, V173, P5574, DOI 10.4049/jimmunol.173.9.5574; Gerdes T, 2002, IMMUNOGENETICS, V54, P62, DOI 10.1007/s00251-002-0435-y; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; Guo YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016889; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Haire RN, 2000, IMMUNOGENETICS, V51, P915, DOI 10.1007/s002510000229; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; HSU E, 1985, J IMMUNOL, V135, P1998; Janke A, 1997, MOL BIOL EVOL, V14, P1266, DOI 10.1093/oxfordjournals.molbev.a025736; Kawasaki K, 2001, EUR J IMMUNOL, V31, P1017, DOI 10.1002/1521-4141(200104)31:4<1017::AID-IMMU1017>3.3.CO;2-V; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Lundqvist ML, 2006, DEV COMP IMMUNOL, V30, P93, DOI 10.1016/j.dci.2005.06.019; Lundqvist ML, 2001, J BIOL CHEM, V276, P46729, DOI 10.1074/jbc.M106221200; Magor KE, 1999, IMMUNOGENETICS, V49, P692, DOI 10.1007/s002510050666; MAGOR KE, 1994, J IMMUNOL, V153, P5549; MAGOR KE, 1992, J IMMUNOL, V149, P2627; MAGOR KE, 1994, DEV COMP IMMUNOL, V18, P523, DOI 10.1016/S0145-305X(06)80006-6; MCCORMACK WT, 1990, GENE DEV, V4, P548, DOI 10.1101/gad.4.4.548; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Ohta Y, 2006, P NATL ACAD SCI USA, V103, P10723, DOI 10.1073/pnas.0601407103; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; PARVARI R, 1987, EMBO J, V6, P97, DOI 10.1002/j.1460-2075.1987.tb04724.x; Patel HM, 1997, J IMMUNOL, V159, P3391; Pereira SL, 2006, MOL BIOL EVOL, V23, P1731, DOI 10.1093/molbev/msl038; Qin T, 2008, DEV COMP IMMUNOL, V32, P156, DOI 10.1016/j.dci.2007.05.007; ROMAN T, 1995, EUR J IMMUNOL, V25, P269, DOI 10.1002/eji.1830250144; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ros F, 2004, GENE, V330, P49, DOI 10.1016/j.gene.2003.12.037; SANDERS BG, 1975, BIOCHEM GENET, V13, P779, DOI 10.1007/BF00484409; Sorensen V, 2000, INT IMMUNOL, V12, P19, DOI 10.1093/intimm/12.1.19; Sun Y, 2011, DEV COMP IMMUNOL, V35, P975, DOI 10.1016/j.dci.2010.12.010; van Tuinen M, 2001, MOL BIOL EVOL, V18, P206, DOI 10.1093/oxfordjournals.molbev.a003794; Wang XX, 2009, IMMUNOGENETICS, V61, P581, DOI 10.1007/s00251-009-0385-8; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; Wei ZG, 2009, J IMMUNOL, V183, P3858, DOI 10.4049/jimmunol.0803251; Wilson M, 1997, P NATL ACAD SCI USA, V94, P4593, DOI 10.1073/pnas.94.9.4593; Woof JM, 2006, J PATHOL, V208, P270, DOI 10.1002/path.1877; Wu Q, 2010, DEV COMP IMMUNOL, V34, P579, DOI 10.1016/j.dci.2009.12.019; Xu Z, 2009, MOL IMMUNOL, V46, P2124, DOI 10.1016/j.molimm.2009.03.028; Zhao Y, 2000, IMMUNOLOGY, V101, P348, DOI 10.1046/j.1365-2567.2000.00106.x; Zhao YF, 2006, P NATL ACAD SCI USA, V103, P12087, DOI 10.1073/pnas.0600291103; Zhao YF, 2009, J IMMUNOL, V183, P3285, DOI 10.4049/jimmunol.0900469; Zhao YF, 2002, J IMMUNOL, V169, P4408, DOI 10.4049/jimmunol.169.8.4408; Zhao ZH, 2007, DEV COMP IMMUNOL, V31, P1034, DOI 10.1016/j.dci.2007.01.002	52	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34346	10.1371/journal.pone.0034346	http://dx.doi.org/10.1371/journal.pone.0034346			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479606	gold, Green Published, Green Submitted			2022-12-27	WOS:000304523400075
J	Van Belle, VMCA; Van Calster, B; Timmerman, D; Bourne, T; Bottomley, C; Valentin, L; Neven, P; Van Huffel, S; Suykens, JAK; Boyd, S				Van Belle, Vanya M. C. A.; Van Calster, Ben; Timmerman, Dirk; Bourne, Tom; Bottomley, Cecilia; Valentin, Lil; Neven, Patrick; Van Huffel, Sabine; Suykens, Johan A. K.; Boyd, Stephen			A Mathematical Model for Interpretable Clinical Decision Support with Applications in Gynecology	PLOS ONE			English	Article							PREOPERATIVE DIAGNOSIS; PROSTATE-CANCER; OVARIAN-TUMORS; BREAST-CANCER; PREDICTION; REGRESSION; RISK; NOMOGRAM; VALIDATION; ULTRASOUND	Background: Over time, methods for the development of clinical decision support (CDS) systems have evolved from interpretable and easy-to-use scoring systems to very complex and non-interpretable mathematical models. In order to accomplish effective decision support, CDS systems should provide information on how the model arrives at a certain decision. To address the issue of incompatibility between performance, interpretability and applicability of CDS systems, this paper proposes an innovative model structure, automatically leading to interpretable and easily applicable models. The resulting models can be used to guide clinicians when deciding upon the appropriate treatment, estimating patient-specific risks and to improve communication with patients. Methods and Findings: We propose the interval coded scoring (ICS) system, which imposes that the effect of each variable on the estimated risk is constant within consecutive intervals. The number and position of the intervals are automatically obtained by solving an optimization problem, which additionally performs variable selection. The resulting model can be visualised by means of appealing scoring tables and color bars. ICS models can be used within software packages, in smartphone applications, or on paper, which is particularly useful for bedside medicine and home-monitoring. The ICS approach is illustrated on two gynecological problems: diagnosis of malignancy of ovarian tumors using a dataset containing 3,511 patients, and prediction of first trimester viability of pregnancies using a dataset of 1,435 women. Comparison of the performance of the ICS approach with a range of prediction models proposed in the literature illustrates the ability of ICS to combine optimal performance with the interpretability of simple scoring systems. Conclusions: The ICS approach can improve patient-clinician communication and will provide additional insights in the importance and influence of available variables. Future challenges include extensions of the proposed methodology towards automated detection of interaction effects, multi-class decision support systems, prognosis and high-dimensional data.	[Van Belle, Vanya M. C. A.; Van Calster, Ben; Van Huffel, Sabine; Suykens, Johan A. K.] Katholieke Univ Leuven, Dept Elect Engn ESAT SCD, Louvain, Belgium; [Van Belle, Vanya M. C. A.; Van Calster, Ben; Van Huffel, Sabine; Suykens, Johan A. K.] Katholieke Univ Leuven, IBBT Future Hlth Dept, Louvain, Belgium; [Van Calster, Ben; Timmerman, Dirk; Bourne, Tom] Univ Hosp Leuven, Dept Dev & Regenerat, Louvain, Belgium; [Bourne, Tom] Univ London Imperial Coll Sci Technol & Med, Dept Obstet & Gynaecol, London, England; [Bottomley, Cecilia] Chelsea & Westminster Hosp, London, England; [Valentin, Lil] Lund Univ, Dept Obstet & Gynecol, Skane Univ Hosp Malmo, Malmo, Sweden; [Neven, Patrick] Univ Hosp Leuven, Multidisciplinary Breast Ctr MBC, Louvain, Belgium; [Neven, Patrick] Univ Hosp Leuven, Dept Gynaecol Oncol, Louvain, Belgium; [Boyd, Stephen] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA	KU Leuven; KU Leuven; KU Leuven; University Hospital Leuven; Imperial College London; Imperial College London; Lund University; Skane University Hospital; KU Leuven; University Hospital Leuven; KU Leuven; University Hospital Leuven; Stanford University	Van Belle, VMCA (corresponding author), Katholieke Univ Leuven, Dept Elect Engn ESAT SCD, Louvain, Belgium.	vanya.vanbelle@esat.kuleuven.be	Suykens, Johan A.K./C-9781-2014; Timmerman, Dirk/AAD-2363-2019; Bourne, Tom/I-6478-2012; Van Calster, Ben/F-9150-2010	Suykens, Johan A.K./0000-0002-8846-6352; Timmerman, Dirk/0000-0002-3707-6645; Bourne, Tom/0000-0003-1421-6059; Van Calster, Ben/0000-0003-1613-7450; Valentin, Lil/0000-0002-3830-6414	Research Council KUL: GOA (Geconcerteerde onderzoeksacties); Ambiorics; GOA MaNet; OPTEC [CoE EF/05/006]; FWO [G.0302.07, G0226.06]; IWT [TBM070706-IOTA3]; IBBT (Interdisciplinair Instituut voor Breedband Technologie), Belgian Federal Science Policy Office [P6/04]; IWT Vlaanderen; Katholieke Universiteit Leuven; Research Foundation - Flanders (FWO)	Research Council KUL: GOA (Geconcerteerde onderzoeksacties); Ambiorics; GOA MaNet; OPTEC; FWO(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); IBBT (Interdisciplinair Instituut voor Breedband Technologie), Belgian Federal Science Policy Office; IWT Vlaanderen(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Katholieke Universiteit Leuven(KU Leuven); Research Foundation - Flanders (FWO)(FWO)	This research was supported by Research Council KUL: GOA (Geconcerteerde onderzoeksacties), Ambiorics, GOA MaNet (Mathematical engineering tools for Networks: Data driven mining, identification, control and optimization), CoE EF/05/006 Optimization in Engineering (OPTEC), projects: FWO (Fonds Wetenschappelijk Onderzoek), SVM (Support Vector Machines) G.0302.07 (Support Vector Machines/Kernel), G0226.06 (cooperative systems and optimization); IWT (Agentschap voor Innovatie door Wetenschap en Technologie): TBM070706-IOTA3; IBBT (Interdisciplinair Instituut voor Breedband Technologie), Belgian Federal Science Policy Office: IUAP (Interuniversitaire Actractiepolen) P6/04 (DYSCO, 'Dynamical systems, control and optimization', 2007-2011). V. Van Belle is supported by a grant of the IWT Vlaanderen (Agentschap voor Innovatie door Wetenschap en Technologie) and a post-doctoral grant (BOF-PDM) from the Katholieke Universiteit Leuven. B. Van Calster is a post-doctoral researcher from the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barakat N, 2010, NEUROCOMPUTING, V74, P178, DOI 10.1016/j.neucom.2010.02.016; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Boyd S., 2004, CONVEX OPTIMIZATION; Brabanter J.D., 2002, LEAST SQUARES SUPPOR, DOI DOI 10.1142/9789812776655; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Candes EJ, 2008, J FOURIER ANAL APPL, V14, P877, DOI 10.1007/s00041-008-9045-x; Choong S, 2003, ULTRASOUND OBST GYN, V22, P571, DOI 10.1002/uog.909; Chun FKH, 2007, EUR UROL, V51, P1236, DOI 10.1016/j.eururo.2006.07.021; Chun FKH, 2007, BJU INT, V99, P794, DOI 10.1111/j.1464-410X.2006.06694.x; Daemen A, 2009, IEEE ENG MED BIO, P5913, DOI 10.1109/IEMBS.2009.5334847; de Boor C., 2001, APPL MATH SCI, V27; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Falco P, 1996, ULTRASOUND OBST GYN, V7, P165, DOI 10.1046/j.1469-0705.1996.07030165.x; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Harrell FE, 2001, REGRESSION MODELING; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Karakiewicz PI, 2005, J UROLOGY, V173, P1930, DOI 10.1097/01.ju.0000158039.94467.5d; Kattan MW, 2005, NAT CLIN PRACT UROL, V2, P183, DOI 10.1038/ncpuro0144; Kattan MW, 2003, J UROLOGY, V170, pS6, DOI 10.1097/01.ju.0000094764.56269.2d; Kattan MW, 2003, CURR OPIN UROL, V13, P111, DOI 10.1097/00042307-200303000-00005; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; LEDLEY RS, 1960, OPER RES, V8, P299, DOI 10.1287/opre.8.3.299; MILLER RA, 1994, J AM MED INFORM ASSN, V1, P8, DOI 10.1136/jamia.1994.95236141; Musen MA, 2006, BIOMEDICAL INFORM CO, P698, DOI DOI 10.1007/0-387-36278-920; Osheroff JA., 2009, IMPROVING MEDICATION; Pelckmans K, 2005, NEURAL PROCESS LETT, V22, P171, DOI 10.1007/s11063-005-5264-l; Purcell GP, 2005, BRIT MED J, V330, P740, DOI 10.1136/bmj.330.7494.740; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Shariat SF, 2008, CLIN CANCER RES, V14, P4400, DOI 10.1158/1078-0432.CCR-07-4713; Smaletz O, 2002, J CLIN ONCOL, V20, P3972, DOI 10.1200/JCO.2002.11.021; Specht MC, 2005, ANN SURG ONCOL, V12, P654, DOI 10.1245/ASO.2005.06.037; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742; Timmerman D, 2010, ULTRASOUND OBST GYN, V36, P226, DOI 10.1002/uog.7636; Timmerman D, 2000, ULTRASOUND OBST GYN, V16, P500, DOI 10.1046/j.1469-0705.2000.00287.x; Van Belle V, 2011, J MACH LEARN RES, V12, P819; Van Calster B, 2007, ULTRASOUND OBST GYN, V29, P496, DOI 10.1002/uog.3996; Van Calster B, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-96; Van Zee KJ, 2003, ANN SURG ONCOL, V10, P1140, DOI 10.1245/ASO.2003.03.015; Vapnik V., 1998, STAT LEARNING THEORY; Wears RL, 2005, JAMA-J AM MED ASSOC, V293, P1261, DOI 10.1001/jama.293.10.1261; WYATT JC, 1995, BMJ-BRIT MED J, V311, P1539, DOI 10.1136/bmj.311.7019.1539	45	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34312	10.1371/journal.pone.0034312	http://dx.doi.org/10.1371/journal.pone.0034312			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479598	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400072
J	Binks, MJ; Temple, B; Kirkham, LA; Wiertsema, SP; Dunne, EM; Richmond, PC; Marsh, RL; Leach, AJ; Smith-Vaughan, HC				Binks, Michael J.; Temple, Beth; Kirkham, Lea-Ann; Wiertsema, Selma P.; Dunne, Eileen M.; Richmond, Peter C.; Marsh, Robyn L.; Leach, Amanda J.; Smith-Vaughan, Heidi C.			Molecular Surveillance of True Nontypeable Haemophilus influenzae: An Evaluation of PCR Screening Assays	PLOS ONE			English	Article							OTITIS-MEDIA; STREPTOCOCCUS-PNEUMONIAE; HAEMOLYTICUS; CARRIAGE; CHILDREN; STRAINS; DISEASE	Background: Unambiguous identification of nontypeable Haemophilus influenzae (NTHi) is not possible by conventional microbiology. Molecular characterisation of phenotypically defined NTHi isolates suggests that up to 40% are Haemophilus haemolyticus (Hh); however, the genetic similarity of NTHi and Hh limits the power of simple molecular techniques such as PCR for species discrimination. Methodology/Principal Findings: Here we assess the ability of previously published and novel PCR-based assays to identify true NTHi. Sixty phenotypic NTHi isolates, classified by a dual 16S rRNA gene PCR algorithm as NTHi (n = 22), Hh (n = 27) or equivocal (n = 11), were further characterised by sequencing of the 16S rRNA and recA genes then interrogated by PCRbased assays targeting the omp P2, omp P6, lgtC, hpd, 16S rRNA, fucK and iga genes. The sequencing data and PCR results were used to define NTHi for this study. Two hpd real time PCR assays (hpd#1 and hpd#3) and the conventional iga PCR assay were equally efficient at differentiating study-defined NTHi from Hh, each with a receiver operator characteristic curve area of 0.90 [0.83; 0.98]. The hpd#1 and hpd#3 assays were completely specific against a panel of common respiratory bacteria, unlike the iga PCR, and the hpd#3 assay was able to detect below 10 copies per reaction. Conclusions/Significance: Our data suggest an evolutionary continuum between NTHi and Hh and therefore no single gene target could completely differentiate NTHi from Hh. The hpd#3 real time PCR assay proved to be the superior method for discrimination of NTHi from closely related Haemophilus species with the added potential for quantification of H. influenzae directly from specimens. We suggest the hpd#3 assay would be suitable for routine NTHi surveillance and to assess the impact of antibiotics and vaccines, on H. influenzae carriage rates, carriage density, and disease.	[Binks, Michael J.; Temple, Beth; Marsh, Robyn L.; Leach, Amanda J.; Smith-Vaughan, Heidi C.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia; [Kirkham, Lea-Ann; Wiertsema, Selma P.; Richmond, Peter C.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Kirkham, Lea-Ann; Wiertsema, Selma P.; Richmond, Peter C.] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Dunne, Eileen M.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Charles Darwin University; Menzies School of Health Research; University of Western Australia; Telethon Kids Institute; University of Western Australia; Murdoch Children's Research Institute	Binks, MJ (corresponding author), Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia.	michael.binks@menzies.edu.au	Kirkham, Lea-Ann S/A-5847-2013; Temple, Beth/ABC-6583-2020; Richmond, Peter C/G-3379-2012; Dunne, Eileen M/M-3203-2019	Kirkham, Lea-Ann S/0000-0001-5421-8126; Temple, Beth/0000-0002-4885-9848; Richmond, Peter C/0000-0001-7562-7228; Dunne, Eileen M/0000-0001-5542-0780; Marsh, Robyn/0000-0002-8507-6586	National Health and Medical Research Council of Australia (NHRMC) [1011172, 545232]	National Health and Medical Research Council of Australia (NHRMC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia (NHRMC project grants 1011172 and 545232). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeldaim GMK, 2009, DIAGN MICR INFEC DIS, V64, P366, DOI 10.1016/j.diagmicrobio.2009.03.030; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Binks MJ, 2011, RECENT ADV OTITIS ME; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Hare KM, 2010, J PEDIAT; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Jordan IK, 2011, J BACTERIOL, V193, P5879, DOI 10.1128/JB.05863-11; KILIAN M, 1976, J GEN MICROBIOL, V93, P9, DOI 10.1099/00221287-93-1-9; Kirkham LAS, 2010, J CLIN MICROBIOL, V48, P2557, DOI 10.1128/JCM.00069-10; Leach A, 2008, PEDIATR INFECT DIS J, V27, P692, DOI 10.1097/INF.0b013e31816fca9d; Lilliebridge RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019749; McCrea KW, 2008, J CLIN MICROBIOL, V46, P406, DOI 10.1128/JCM.01832-07; Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003; Morris P, 2005, BMC PEDIATR, V5, P27; Murphy TF, 2003, CURR OPIN INFECT DIS, V16, P129, DOI 10.1097/00001432-200304000-00009; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Norskov-Lauritsen N, 2009, J CLIN MICROBIOL, V47, P2590, DOI 10.1128/JCM.00013-09; Norskov-Lauritsen N, 2009, J BACTERIOL, V191, P822, DOI 10.1128/JB.00782-08; O'Grady KAF, 2010, CLIN INFECT DIS, V50, P970, DOI 10.1086/651079; Pichichero ME, 2008, CLIN PEDIATR, V47, P901, DOI 10.1177/0009922808319966; Prymula R, 2009, VACCINE, V28, P71, DOI 10.1016/j.vaccine.2009.09.113; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; Stubbs E, 2005, PEDIATR INFECT DIS J, V24, P423, DOI 10.1097/01.inf.0000160945.87356.ca; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vitovski S, 2002, JAMA-J AM MED ASSOC, V287, P1699, DOI 10.1001/jama.287.13.1699; Wang X, 2011, INT J MED MICROBIOL, V301, P303, DOI 10.1016/j.ijmm.2010.11.004; Wiertsema SP, 2011, VACCINE, V29, P5163, DOI 10.1016/j.vaccine.2011.05.035; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0	28	62	65	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34083	10.1371/journal.pone.0034083	http://dx.doi.org/10.1371/journal.pone.0034083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470516	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000060
J	Carneiro, P; Duarte, M; Videira, A				Carneiro, Patricia; Duarte, Margarida; Videira, Arnaldo			Characterization of Apoptosis-Related Oxidoreductases from Neurospora crassa	PLOS ONE			English	Article							ALTERNATIVE NAD(P)H DEHYDROGENASE; COMPLEX-I; SUPRAMOLECULAR ORGANIZATION; ELECTRON-TRANSPORT; NADH DEHYDROGENASE; RESPIRATORY-CHAIN; AIF; GENE; IDENTIFICATION; MITOCHONDRIA	The genome from Neurospora crassa presented three open reading frames homologous to the genes coding for human AIF and AMID proteins, which are flavoproteins with oxidoreductase activities implicated in caspase-independent apoptosis. To investigate the role of these proteins, namely within the mitochondrial respiratory chain, we studied their cellular localization and characterized the respective null mutant strains. Efficiency of the respiratory chain was analyzed by oxygen consumption studies and supramolecular organization of the OXPHOS system was assessed through BN-PAGE analysis in the respective null mutant strains. The results demonstrate that, unlike in mammalian systems, disruption of AIF in Neurospora does not affect either complex I assembly or function. Furthermore, the mitochondrial respiratory chain complexes of the mutant strains display a similar supramolecular organization to that observed in the wild type strain. Further characterization revealed that N. crassa AIF appears localized to both the mitochondria and the cytoplasm, whereas AMID was found exclusively in the cytoplasm. AMID2 was detected in both mitochondria and cytoplasm of the amid mutant strain, but was barely discernible in wild type extracts, suggesting overlapping functions for the two proteins.	[Carneiro, Patricia; Duarte, Margarida; Videira, Arnaldo] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Videira, Arnaldo] Univ Porto, ICBAS, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Carneiro, P (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	carneiro@ibmc.up.pt; avideira@ibmc.up.pt	Videira, Arnaldo/H-8150-2013; Carneiro, Patrícia/J-6801-2013; Duarte, Margarida/K-1424-2013	Carneiro, Patrícia/0000-0003-4404-9343; Duarte, Margarida/0000-0002-8933-2487; Videira, Arnaldo/0000-0001-7267-4459	Fundacao para a Ciencia e a Tecnologia from Portugal; Quadro Comunitario de Apoio III (QCA III)	Fundacao para a Ciencia e a Tecnologia from Portugal(Portuguese Foundation for Science and Technology); Quadro Comunitario de Apoio III (QCA III)	The work was supported by the following: Fundacao para a Ciencia e a Tecnologia from Portugal for financial support through research grants to AV and a fellowship awarded to PC during the Research Program Operacional Ciencia, Tecnologia, Inovacao (POCTI) from Quadro Comunitario de Apoio III (QCA III) (co-participated by Fundo Europeu de Desenvolvimento Regional - FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Bilyy R, 2008, APOPTOSIS, V13, P729, DOI 10.1007/s10495-008-0198-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Brust D, 2010, CURR GENET, V56, P225, DOI 10.1007/s00294-010-0295-1; Carneiro P, 2004, BBA-BIOENERGETICS, V1608, P45, DOI 10.1016/j.bbabio.2003.10.004; Carneiro P, 2007, J MOL BIOL, V368, P1114, DOI 10.1016/j.jmb.2007.02.080; Carneiro P, 2012, FREE RADICAL BIO MED, V52, P402, DOI 10.1016/j.freeradbiomed.2011.10.492; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Castro A, 2008, J BIOL CHEM, V283, P19314, DOI 10.1074/jbc.M802112200; Cho YM, 2007, DIABETES RES CLIN PR, V77, pS172, DOI 10.1016/j.diabres.2007.01.052; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; Dinamarco TM, 2010, FUNGAL GENET BIOL, V47, P1055, DOI 10.1016/j.fgb.2010.07.006; Duarte M, 1997, BBA-BIOENERGETICS, V1322, P237, DOI 10.1016/S0005-2728(97)00084-4; Duarte M, 2003, BIOCHEM J, V371, P1005, DOI 10.1042/BJ20021374; Duarte M, 2007, MITOCHONDRIAL NADPH, P54; Duarte M, 2009, MOL MICROBIOL, V72, P246, DOI 10.1111/j.1365-2958.2009.06643.x; Hangen E, 2010, TRENDS BIOCHEM SCI, V35, P278, DOI 10.1016/j.tibs.2009.12.008; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Joseph-Horne T, 2001, BBA-BIOENERGETICS, V1504, P179, DOI 10.1016/S0005-2728(00)00251-6; Joza N, 2009, ANN NY ACAD SCI, V1171, P2, DOI 10.1111/j.1749-6632.2009.04681.x; Keeping A, 2011, FUNGAL GENET BIOL, V48, P526, DOI 10.1016/j.fgb.2010.11.011; Krause F, 2004, J BIOL CHEM, V279, P26453, DOI 10.1074/jbc.M402756200; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; Lakshminarasimhan M, 2011, EXP GERONTOL, V46, P174, DOI 10.1016/j.exger.2010.08.024; Li W, 2006, MOL BIOL CELL, V17, P1802, DOI 10.1091/mbc.E05-04-0333; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Marques I, 2005, BBA-BIOENERGETICS, V1707, P211, DOI 10.1016/j.bbabio.2004.12.003; Marques I, 2007, EUKARYOT CELL, V6, P2391, DOI 10.1128/EC.00149-07; Marshall KR, 2005, J BIOL CHEM, V280, P30735, DOI 10.1074/jbc.M414018200; McCluskey K, 2003, ADV APPL MICROBIOL, V52, P245, DOI 10.1016/S0065-2164(03)01010-4; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Melo AMP, 1999, BBA-BIOENERGETICS, V1412, P282, DOI 10.1016/S0005-2728(99)00072-9; Melo AMP, 2001, J BIOL CHEM, V276, P3947, DOI 10.1074/jbc.M008199200; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Ohiro Y, 2002, FEBS LETT, V524, P163, DOI 10.1016/S0014-5793(02)03049-1; Pinto D, 2008, FUNGAL GENET BIOL, V45, P1600, DOI 10.1016/j.fgb.2008.09.011; Raffaello A, 2011, BBA-MOL CELL RES, V1813, P260, DOI 10.1016/j.bbamcr.2010.10.007; Ralph SJ, 2010, MOL ASPECTS MED, V31, P29, DOI 10.1016/j.mam.2009.12.006; Rasmusson AG, 2008, MITOCHONDRION, V8, P47, DOI 10.1016/j.mito.2007.10.004; Sambrook J., 2001, MOL CLONING LAB MANU; Savoldi M, 2008, MOL MICROBIOL, V70, P44, DOI 10.1111/j.1365-2958.2008.06385.x; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Solscheid B, 2000, FEBS LETT, V480, P118, DOI 10.1016/S0014-5793(00)01901-3; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Varecha M, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-59; VIDEIRA A, 1989, EUR J BIOCHEM, V181, P493, DOI 10.1111/j.1432-1033.1989.tb14751.x; Videira A, 2002, BBA-BIOENERGETICS, V1555, P187, DOI 10.1016/S0005-2728(02)00276-1; Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138; Wu M, 2004, ONCOGENE, V23, P6815, DOI 10.1038/sj.onc.1207909; Wu M, 2002, J BIOL CHEM, V277, P25617, DOI 10.1074/jbc.M202285200; Xie Q, 2005, J BIOL CHEM, V280, P19673, DOI 10.1074/jbc.M409517200; ZAUNER R, 1985, EUR J BIOCHEM, V150, P447, DOI 10.1111/j.1432-1033.1985.tb09042.x; Zickermann V, 2009, BBA-BIOENERGETICS, V1787, P574, DOI 10.1016/j.bbabio.2009.01.012	60	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34270	10.1371/journal.pone.0034270	http://dx.doi.org/10.1371/journal.pone.0034270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470547	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000086
J	Curtin, CD; Borneman, AR; Chambers, PJ; Pretorius, IS				Curtin, Chris D.; Borneman, Anthony R.; Chambers, Paul J.; Pretorius, Isak S.			De-Novo Assembly and Analysis of the Heterozygous Triploid Genome of the Wine Spoilage Yeast Dekkera bruxellensis AWRI1499	PLOS ONE			English	Article							VINYLPHENOL REDUCTASE; HYDROXYCINNAMIC ACIDS; POPULATION-DYNAMICS; ALCOHOL PRODUCTION; WEB SERVER; SACCHAROMYCES; GENE; EVOLUTION; GROWTH; SSU1	Despite its industrial importance, the yeast species Dekkera (Brettanomyces) bruxellensis has remained poorly understood at the genetic level. In this study we describe whole genome sequencing and analysis for a prevalent wine spoilage strain, AWRI1499. The 12.7 Mb assembly, consisting of 324 contigs in 99 scaffolds (super-contigs) at 26-fold coverage, exhibits a relatively high density of single nucleotide polymorphisms (SNPs). Haplotype sampling for 1.2% of open reading frames suggested that the D. bruxellensis AWRI1499 genome is comprised of a moderately heterozygous diploid genome, in combination with a divergent haploid genome. Gene content analysis revealed enrichment in membrane proteins, particularly transporters, along with oxidoreductase enzymes. Availability of this assembly and annotation provides a resource for further investigation of genomic organization in this species, and functional characterization of genes that may confer important phenotypic traits.	[Curtin, Chris D.; Borneman, Anthony R.; Chambers, Paul J.; Pretorius, Isak S.] Australian Wine Res Inst, Adelaide, SA, Australia; [Pretorius, Isak S.] Univ S Australia, Adelaide, SA 5001, Australia	Australian Wine Research Institute; University of South Australia	Curtin, CD (corresponding author), Australian Wine Res Inst, Adelaide, SA, Australia.	chris.curtin@awri.com.au	Curtin, Chris/H-6589-2014; Pretorius, Isak/C-1213-2012	Borneman, Anthony/0000-0001-8491-7235; Pretorius, Isak/0000-0001-9127-3175	Australia's grapegrowers and winemakers; Australian government; South Australian State Government; National Collaborative Research Infrastructure Strategy (NCRIS)	Australia's grapegrowers and winemakers; Australian government(Australian GovernmentCGIAR); South Australian State Government; National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science)	Research at the Australian Wine Research Institute is funded by Australia's grapegrowers and winemakers through their not-for-profit investment body, The Grape and Wine Research Development Corporation, with matching funding from the Australian government. Omics and Systems biology research at the AWRI uses resources provided as part of the National Collaborative Research Infrastructure Strategy (NCRIS), an initiative of the Australian Governement, in addition to funds from the South Australian State Government. AWRI's collaborating partners within this NCRIS-funded initiative which is overseen by Bioplatforms Australia-are Genomics Australia, Proteomics Australia, Metabolomics Australia (of which the Microbial Metabolomics unit is housed at the AWRI) and Bioinformatics Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aa E, 2006, FEMS YEAST RES, V6, P702, DOI 10.1111/j.1567-1364.2006.00059.x; Antunovics Z, 2005, FEMS YEAST RES, V5, P1141, DOI 10.1016/j.femsyr.2005.04.008; Avram D, 1997, J BACTERIOL, V179, P5971, DOI 10.1128/jb.179.18.5971-5974.1997; Barata A, 2006, AM J ENOL VITICULT, V57, P133; BetesSaura C, 1996, J AGR FOOD CHEM, V44, P3040, DOI 10.1021/jf9601628; Blomqvist J, 2011, LETT APPL MICROBIOL, V53, P73, DOI 10.1111/j.1472-765X.2011.03067.x; Boido E, 2011, AUST J GRAPE WINE R, V17, P383, DOI 10.1111/j.1755-0238.2011.00164.x; CARRASCOSA JM, 1981, A VAN LEEUW J MICROB, V47, P209, DOI 10.1007/BF00403392; CHATONNET P, 1992, J SCI FOOD AGR, V60, P165, DOI 10.1002/jsfa.2740600205; Chevreux B, 2005, THESIS RUPRECHT KARL; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Curtin CD, 2007, FEMS YEAST RES, V7, P471, DOI 10.1111/j.1567-1364.2006.00183.x; Delneri D, 2003, NATURE, V422, P68, DOI 10.1038/nature01418; Fugelsang KC, 2003, AM J ENOL VITICULT, V54, P294; Galafassi S, 2011, J IND MICROBIOL BIOT, V38, P1079, DOI 10.1007/s10295-010-0885-4; Godoy L, 2008, INT J FOOD MICROBIOL, V127, P6, DOI 10.1016/j.ijfoodmicro.2008.05.011; Goto-Yamamoto N, 1998, J FERMENT BIOENG, V86, P427, DOI 10.1016/S0922-338X(98)80146-3; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Harris V, 2009, APPL MICROBIOL BIOT, V81, P1117, DOI 10.1007/s00253-008-1708-7; Harris V, 2008, APPL MICROBIOL BIOT, V78, P997, DOI 10.1007/s00253-007-1328-7; Harris V, 2010, APPL MICROBIOL BIOT, V86, P721, DOI 10.1007/s00253-009-2352-6; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Hellborg L, 2009, EUKARYOT CELL, V8, P1739, DOI 10.1128/EC.00115-09; Huang HK, 2012, J IND MICROBIOL BIOT, V39, P55, DOI 10.1007/s10295-011-0998-4; Joseph CML, 2007, AM J ENOL VITICULT, V58, P373; Larcher R, 2008, ANAL CHIM ACTA, V609, P235, DOI 10.1016/j.aca.2007.12.038; Lattey KA, 2010, AUST J GRAPE WINE R, V16, P189, DOI 10.1111/j.1755-0238.2009.00069.x; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lilly M, 2006, YEAST, V23, P641, DOI 10.1002/yea.1382; Loureiro V, 2003, INT J FOOD MICROBIOL, V86, P23, DOI 10.1016/S0168-1605(03)00246-0; Meroth CB, 2003, APPL ENVIRON MICROB, V69, P7453, DOI 10.1128/AEM.69.12.7453-7461.2003; Morrissey WF, 2004, J APPL MICROBIOL, V97, P647, DOI 10.1111/j.1365-2672.2004.02354.x; NAGEL CW, 1979, AM J ENOL VITICULT, V30, P198; Nakao Y, 2009, DNA RES, V16, P115, DOI 10.1093/dnares/dsp003; Nardi T, 2010, MICROBIOL-SGM, V156, P1686, DOI 10.1099/mic.0.036723-0; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Passoth V, 2007, APPL ENVIRON MICROB, V73, P4354, DOI 10.1128/AEM.00437-07; Prochazka E, 2010, FEMS YEAST RES, V10, P545, DOI 10.1111/j.1567-1364.2010.00644.x; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Romano A, 2008, J APPL MICROBIOL, V104, P1577, DOI 10.1111/j.1365-2672.2007.03693.x; Rozpedowska E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1305; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Tchobanov I, 2008, FEMS MICROBIOL LETT, V284, P213, DOI 10.1111/j.1574-6968.2008.01192.x; Teoh AL, 2004, INT J FOOD MICROBIOL, V95, P119, DOI 10.1016/j.ijfoodmicro.2003.12.020; Vanbeneden N, 2008, FOOD CHEM, V107, P221, DOI 10.1016/j.foodchem.2007.08.008; VANDERWALT JP, 1964, ANTON VAN LEE J M S, V30, P273, DOI 10.1007/BF02046733; Woolfit M, 2007, EUKARYOT CELL, V6, P721, DOI 10.1128/EC.00338-06; Yao ZY, 2012, APPL MICROBIOL BIOT, V93, P1999, DOI 10.1007/s00253-011-3541-7	51	98	98	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33840	10.1371/journal.pone.0033840	http://dx.doi.org/10.1371/journal.pone.0033840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470482	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000304489000038
J	Eisenhauer, N; Scheu, S; Jousset, A				Eisenhauer, Nico; Scheu, Stefan; Jousset, Alexandre			Bacterial Diversity Stabilizes Community Productivity	PLOS ONE			English	Article							SPECIES RICHNESS; PLANT DIVERSITY; BIODIVERSITY; ECOSYSTEMS; RELIABILITY; PREDICTABILITY; HYPOTHESIS; INVASION; ECOLOGY; SYSTEMS	Background: Stability is a crucial ecosystem feature gaining particular importance in face of increasing anthropogenic stressors. Biodiversity is considered to be a driving biotic force maintaining stability, and in this study we investigate how different indices of biodiversity affect the stability of communities in varied abiotic (composition of available resources) and biotic (invasion) contexts. Methodology/Principal Findings: We set up microbial microcosms to study the effects of genotypic diversity on the reliability of community productivity, defined as the inverse of the coefficient of variation of across-treatment productivity, in different environmental contexts. We established a bacterial diversity gradient ranging from 1 to 8 Pseudomonas fluorescens genotypes and grew the communities in different resource environments or in the presence of model invasive species. Biodiversity significantly stabilized community productivity across treatments in both experiments. Path analyses revealed that different aspects of diversity determined stability: genotypic richness stabilized community productivity across resource environments, whereas functional diversity determined stability when subjected to invasion. Conclusions/Significance: Biodiversity increases the stability of microbial communities against both biotic and abiotic environmental perturbations. Depending on stressor type, varying aspects of biodiversity contribute to the stability of ecosystem functions. The results suggest that both genetic and functional diversity need to be preserved to ensure buffering of communities against abiotic and biotic stresses.	[Eisenhauer, Nico; Scheu, Stefan; Jousset, Alexandre] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Eisenhauer, Nico] Univ Minnesota, Dept Forest Resources, St Paul, MN USA	University of Gottingen; University of Minnesota System; University of Minnesota Twin Cities	Eisenhauer, N (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany.	nico.eisenhauer@web.de	Eisenhauer, Nico/I-5932-2012; Jousset, Alexandre/C-7607-2011; Eisenhauer, Nico/I-3191-2019; Scheu, Stefan/H-7049-2015	Eisenhauer, Nico/0000-0002-0371-6720; Eisenhauer, Nico/0000-0002-0371-6720; 	German Research Foundation [Ei 862/1-1]	German Research Foundation(German Research Foundation (DFG))	This work was supported by the German Research Foundation (Ei 862/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cadotte MW, 2008, P NATL ACAD SCI USA, V105, P17012, DOI 10.1073/pnas.0805962105; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Campbell V, 2011, OIKOS, V120, P399, DOI 10.1111/j.1600-0706.2010.18768.x; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Doak DF, 1998, AM NAT, V151, P264, DOI 10.1086/286117; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Eisenhauer N, 2011, J ECOL, V99, P572, DOI 10.1111/j.1365-2745.2010.01783.x; Fargione JE, 2005, ECOL LETT, V8, P604, DOI 10.1111/j.1461-0248.2005.00753.x; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Flynn DFB, 2008, J PLANT ECOL, V1, P59, DOI 10.1093/jpe/rtm004; Grace JB., 2015, STRUCTURAL EQUATION; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; Hodgson DJ, 2002, P ROY SOC B-BIOL SCI, V269, P2277, DOI 10.1098/rspb.2002.2146; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jessup CM, 2005, ADV ECOL RES, V37, P273, DOI 10.1016/S0065-2504(04)37009-1; Jiang L, 2009, AM NAT, V174, P651, DOI 10.1086/605961; Jousset A, 2011, ECOL LETT, V14, P537, DOI 10.1111/j.1461-0248.2011.01613.x; Jousset A, 2011, ISME J, V5, P1108, DOI 10.1038/ismej.2011.9; Koch B, 2001, J MICROBIOL METH, V45, P187, DOI 10.1016/S0167-7012(01)00246-9; Loreau M, 2010, PHILOS T R SOC B, V365, P49, DOI 10.1098/rstb.2009.0155; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Milcu A, 2010, SOIL BIOL BIOCHEM, V42, P2102, DOI 10.1016/j.soilbio.2010.08.005; Morin PJ, 2004, OIKOS, V104, P458, DOI 10.1111/j.0030-1299.2004.13256.x; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Proulx R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013382; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; Schuhegger R, 2006, PLANT CELL ENVIRON, V29, P909, DOI 10.1111/j.1365-3040.2005.01471.x; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Vogt RJ, 2006, OIKOS, V113, P55, DOI 10.1111/j.0030-1299.2006.14494.x; Weigelt A, 2008, ECOL LETT, V11, P338, DOI 10.1111/j.1461-0248.2007.01145.x; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	45	81	112	11	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34517	10.1371/journal.pone.0034517	http://dx.doi.org/10.1371/journal.pone.0034517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470577	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000116
J	Bhatter, P; Chatterjee, A; D'souza, D; Tolani, M; Mistry, N				Bhatter, Purva; Chatterjee, Anirvan; D'souza, Desiree; Tolani, Monica; Mistry, Nerges			Estimating Fitness by Competition Assays between Drug Susceptible and Resistant Mycobacterium tuberculosis of Predominant Lineages in Mumbai, India	PLOS ONE			English	Article							SPREAD; STRAIN; COST	Background: Multi Drug Resistant Tuberculosis (MDR TB) is a threat to global tuberculosis control. A significant fitness cost has been associated with DR strains from specific lineages. Evaluation of the influence of the competing drug susceptible strains on fitness of drug resistant strains may have an important bearing on understanding the spread of MDR TB. The aim of this study was to evaluate the fitness of MDR TB strains, from a TB endemic region of western India: Mumbai, belonging to 3 predominant lineages namely CAS, Beijing and MANU in the presence of drug susceptible strains from the same lineages. Methodology: Drug susceptible strains from a single lineage were mixed with drug resistant strain, bearing particular non synonymous mutation (rpoB D516V; inhA, A16G; katG, S315T1/T2) from the same or different lineages. Fitness of M. tuberculosis (M.tb) strains was evaluated using the difference in growth rates obtained by using the CFU assay system. Conclusion/Significance: While MANU were most fit amongst the drug susceptible strains of the 3 lineages, only Beijing MDR strains were found to grow in the presence of any of the competing drug susceptible strains. A disproportionate increase in Beijing MDR could be an alarm for an impending epidemic in this locale. In addition to particular non synonymous substitutions, the competing strains in an environment may impact the fitness of circulating drug resistant strains.	[Bhatter, Purva; Chatterjee, Anirvan; D'souza, Desiree; Tolani, Monica; Mistry, Nerges] Fdn Med Res, Mumbai, Maharashtra, India		Bhatter, P (corresponding author), Fdn Med Res, Mumbai, Maharashtra, India.	fmr@fmrindia.org		Chatterjee, Anirvan/0000-0002-7113-9718; Bhatter, Purva/0000-0001-7589-4801	Department of Biotechnology, Government of India [BT/01/COE/05/06/01]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The study was funded by the Department of Biotechnology, Government of India, through grant: BT/01/COE/05/06/01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-41; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Be'er A, 2009, P NATL ACAD SCI USA, V106, P428, DOI 10.1073/pnas.0811816106; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Chatterjee A, 2010, J CLIN MICROBIOL, V48, P3593, DOI 10.1128/JCM.00430-10; Chowgule R V, 1998, Indian J Chest Dis Allied Sci, V40, P23; Cohen T, 2008, P NATL ACAD SCI USA, V105, P16302, DOI 10.1073/pnas.0808746105; D'souza DTB, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-211; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Groll AV, 2010, PLOS ONE, V5; Hanekom M, 2007, J CLIN MICROBIOL, V45, P2263, DOI 10.1128/JCM.02354-06; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Kulkarni S, 2005, RES MICROBIOL, V156, P588, DOI 10.1016/j.resmic.2005.01.005; Mariam DH, 2004, ANTIMICROB AGENTS CH, V48, P1289, DOI 10.1128/AAC.48.4.1289-1294.2004; Mistry NF, 2002, J CLIN MICROBIOL, V40, P2677, DOI 10.1128/JCM.40.7.2677-2680.2002; Normark BH, 2002, J INTERN MED, V252, P91, DOI 10.1046/j.1365-2796.2002.01026.x; Rodrigues C, 2006, INT J TUBERC LUNG D, V10, P1421; SAITO H, 1983, J BACTERIOL, V153, P1294, DOI 10.1128/JB.153.3.1294-1300.1983; Sergeev R, 2011, J THEOR BIOL, V280, P88, DOI 10.1016/j.jtbi.2011.04.011; Siddiqi N, 2002, ANTIMICROB AGENTS CH, V46, P443, DOI 10.1128/AAC.46.2.443-450.2002; Strauss OJ, 2008, J CLIN MICROBIOL, V46, P1514, DOI 10.1128/JCM.01938-07; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Wagner A, 2005, FEBS LETT, V579, P1772, DOI 10.1016/j.febslet.2005.01.063	24	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33507	10.1371/journal.pone.0033507	http://dx.doi.org/10.1371/journal.pone.0033507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479407	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900029
J	Chen, XP; Hermansen, K; Xiao, JZ; Bystrup, SK; O'Driscoll, L; Jeppesen, PB				Chen, Xiaoping; Hermansen, Kjeld; Xiao, Jianzhong; Bystrup, Sara Kjaergaard; O'Driscoll, Lorraine; Jeppesen, Per Bendix			Isosteviol Has Beneficial Effects on Palmitate-Induced alpha-Cell Dysfunction and Gene Expression	PLOS ONE			English	Article							SECRETION IN-VIVO; GLUCAGON-SECRETION; INSULIN-RECEPTOR; DIABETES-MELLITUS; FATTY-ACIDS; BETA-CELLS; GLUCOSE; STEVIOSIDE; MOUSE; HYPERGLYCEMIA	Background: Long-term exposure to high levels of fatty acids impairs insulin secretion and exaggerates glucagon secretion. The aim of this study was to explore if the antihyperglycemic agent, Isosteviol (ISV), is able to counteract palmitate-induced alpha-cell dysfunction and to influence alpha-cell gene expression. Methodology/Principal Findings: Long-term incubation studies with clonal alpha-TC1-6 cells were performed in the presence of 0.5 mM palmitate with or without ISV. We investigated effects on glucagon secretion, glucagon content, cellular triglyceride (TG) content, cell proliferation, and expression of genes involved in controlling glucagon synthesis, fatty acid metabolism, and insulin signal transduction. Furthermore, we studied effects of ISV on palmitate-induced glucagon secretion from isolated mouse islets. Culturing alpha-cells for 72-h with 0.5 mM palmitate in the presence of 18 mM glucose resulted in a 56% (p < 0.01) increase in glucagon secretion. Concomitantly, the TG content of alpha-cells increased by 78% (p < 0.01) and cell proliferation decreased by 19% (p < 0.05). At 18 mM glucose, ISV (10(-8) and 10(-6) M) reduced palmitate-stimulated glucagon release by 27% (p < 0.05) and 27% (p < 0.05), respectively. ISV (10(-6) M) also counteracted the palmitate-induced hypersecretion of glucagon in mouse islets. ISV (10(-6) M) reduced alpha-TC1-6 cell proliferation rate by 25% (p < 0.05), but ISV (10(-8) and 10(-6) M) had no effect on TG content in the presence of palmitate. Palmitate (0.5 mM) increased Pcsk2 (p < 0.001), Irs2 (p < 0.001), Fasn (p < 0.001), Srebf2 (p < 0.001), Acaca (p < 0.01), Pax6 (p < 0.05) and Gcg mRNA expression (p < 0.05). ISV significantly (p < 0.05) up-regulated Insr, Irs1, Irs2, Pik3r1 and Akt1 gene expression in the presence of palmitate. Conclusions/Significance: ISV counteracts alpha-cell hypersecretion and apparently contributes to changes in expression of key genes resulting from long-term exposure to palmitate. ISV apparently acts as a glucagonostatic drug with potential as a new anti-diabetic drug for the treatment of type 2 diabetes.	[Chen, Xiaoping; Hermansen, Kjeld; Bystrup, Sara Kjaergaard; Jeppesen, Per Bendix] Aarhus Univ Hosp, Dept Endocrinol & Metab MEA, DK-8000 Aarhus, Denmark; [Chen, Xiaoping; Xiao, Jianzhong] China Japan Friendship Hosp, Dept Endocrinol, Beijing, Peoples R China; [O'Driscoll, Lorraine] Univ Dublin Trinity Coll, Sch Pharm & Pharmaceut Sci, Dublin 2, Ireland	Aarhus University; China-Japan Friendship Hospital; Trinity College Dublin	Chen, XP (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Metab MEA, DK-8000 Aarhus, Denmark.	per.bendix.jeppesen@ki.au.dk	hermansen, kjeld/AAY-4241-2021	O'Driscoll, Lorraine/0000-0002-9860-8262; Bystrup, Sara/0000-0001-9029-1734	Faculty of Health Sciences, Aarhus University, Toyota Foundation; Research Foundation of Aarhus University; A. P. Moller foundation for the Advancement of Medical Science, Aarhus Sygehus THG; Danish Council for Strategic Research-Health, Food and Welfare (MAXVEG) [09-067129]	Faculty of Health Sciences, Aarhus University, Toyota Foundation; Research Foundation of Aarhus University; A. P. Moller foundation for the Advancement of Medical Science, Aarhus Sygehus THG; Danish Council for Strategic Research-Health, Food and Welfare (MAXVEG)	This study was supported by the Faculty of Health Sciences, Aarhus University, Toyota Foundation, The Research Foundation of Aarhus University, The A. P. Moller foundation for the Advancement of Medical Science, Aarhus Sygehus THG and The Danish Council for Strategic Research-Health, Food and Welfare (MAXVEG 09-067129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPLIN CM, 1981, J CLIN INVEST, V68, P314, DOI 10.1172/JCI110251; Bansal P, 2008, AM J PHYSIOL-ENDOC M, V295, pE751, DOI 10.1152/ajpendo.90295.2008; BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Boden G, 2004, DIABETES CARE, V27, P2253, DOI 10.2337/diacare.27.9.2253; Bollheimer LC, 2004, METABOLISM, V53, P1443, DOI 10.1016/j.metabol.2004.06.011; Chen Jianguo, 2006, Rev Diabet Stud, V3, P178, DOI 10.1900/RDS.2006.3.178; Diao JY, 2005, J BIOL CHEM, V280, P33487, DOI 10.1074/jbc.M506276200; Dunning BE, 2007, ENDOCR REV, V28, P253, DOI 10.1210/er.2006-0026; Franklin I, 2005, DIABETES, V54, P1808, DOI 10.2337/diabetes.54.6.1808; Furuta M, 2001, J BIOL CHEM, V276, P27197, DOI 10.1074/jbc.M103362200; Gonzalez M, 2008, DIABETOLOGIA, V51, P2012, DOI 10.1007/s00125-008-1134-5; Gosmain Y, 2010, J BIOL CHEM, V285, P33381, DOI 10.1074/jbc.M110.147215; Gregersen S, 2004, METABOLISM, V53, P73, DOI 10.1016/j.metabol.2003.07.013; Gremlich S, 1997, J BIOL CHEM, V272, P30261, DOI 10.1074/jbc.272.48.30261; Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007; Gromada J, 2009, CELL METAB, V9, P303, DOI 10.1016/j.cmet.2009.03.008; HAMAGUCHI K, 1990, DIABETES, V39, P415, DOI 10.2337/diabetes.39.4.415; Hong J, 2006, AM J PHYSIOL-ENDOC M, V290, pE416, DOI 10.1152/ajpendo.00331.2005; Hong J, 2005, METABOLISM, V54, P1329, DOI 10.1016/j.metabol.2005.04.022; Hong J, 2007, DIABETES-METAB RES, V23, P202, DOI 10.1002/dmrr.663; Jeppesen PB, 2003, METABOLISM, V52, P372, DOI 10.1053/meta.2003.50058; Jeppesen PB, 2002, PHYTOMEDICINE, V9, P9, DOI 10.1078/0944-7113-00081; Jeppesen PB, 2000, METABOLISM, V49, P208, DOI 10.1016/S0026-0495(00)91325-8; Kaneko K, 1999, DIABETES RES CLIN PR, V44, P83, DOI 10.1016/S0168-8227(99)00021-2; Katz LS, 2009, MOL CELL BIOL, V29, P2322, DOI 10.1128/MCB.01543-08; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; KISANUKI K, 1995, DIABETOLOGIA, V38, P422, DOI 10.1007/BF00410279; Leung YM, 2006, ENDOCRINOLOGY, V147, P2155, DOI 10.1210/en.2005-1249; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016096; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mizushina Y, 2005, LIFE SCI, V77, P2127, DOI 10.1016/j.lfs.2005.03.022; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Nordentoft I, 2008, DIABETES OBES METAB, V10, P939, DOI 10.1111/j.1463-1326.2007.00836.x; Olofsson CS, 2004, DIABETES, V53, P2836, DOI 10.2337/diabetes.53.11.2836; Paranjape SA, 2010, DIABETES, V59, P1521, DOI 10.2337/db10-0014; Piro S, 2010, ENDOCRINOLOGY, V151, P4197, DOI 10.1210/en.2009-1472; RANDLE PJ, 1963, LANCET, V1, P785; Ravier MA, 2005, DIABETES, V54, P1789, DOI 10.2337/diabetes.54.6.1789; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; ROTHENBERG PL, 1995, DIABETES, V44, P802, DOI 10.2337/diabetes.44.7.802; ROUILLE Y, 1994, P NATL ACAD SCI USA, V91, P3242, DOI 10.1073/pnas.91.8.3242; Tahrani AA, 2011, LANCET, V378, P182, DOI 10.1016/S0140-6736(11)60207-9; UNGER RH, 1975, LANCET, V1, P14; UNGER RH, 1977, ANNU REV MED, V28, P119, DOI 10.1146/annurev.me.28.020177.001003; Unger RH, 2010, P NATL ACAD SCI USA, V107, P16009, DOI 10.1073/pnas.1006639107; Xiao JZ, 2002, METABOLISM, V51, P155, DOI 10.1053/meta.2002.29977; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015	48	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34361	10.1371/journal.pone.0034361	http://dx.doi.org/10.1371/journal.pone.0034361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479612	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900084
J	Wang, LY; Pedroja, BS; Meyers, EE; Garcia, AL; Twining, SS; Bernstein, AM				Wang, Lingyan; Pedroja, Benjamin S.; Meyers, Erin E.; Garcia, Angelo L.; Twining, Sally S.; Bernstein, Audrey M.			Degradation of Internalized alpha v beta 5 Integrin Is Controlled by uPAR Bound uPA: Effect on beta 1 Integrin Activity and alpha-SMA Stress Fiber Assembly	PLOS ONE			English	Article							MICROVASCULAR ENDOTHELIAL-CELLS; PLASMINOGEN-ACTIVATOR RECEPTOR; UROKINASE RECEPTOR; SYSTEMIC-SCLEROSIS; GROWTH-FACTOR; MEDIATED ACTIVATION; MYOFIBROBLAST; CLEAVAGE; MIGRATION; TISSUE	Myofibroblasts (Mfs) that persist in a healing wound promote extracellular matrix (ECM) accumulation and excessive tissue contraction. Increased levels of integrin alpha v beta 5 promote the Mf phenotype and other fibrotic markers. Previously we reported that maintaining uPA (urokinase plasminogen activator) bound to its cell-surface receptor, uPAR prevented TGF beta-induced Mf differentiation. We now demonstrate that uPA/uPAR controls integrin beta 5 protein levels and in turn, the Mf phenotype. When cell-surface uPA was increased, integrin b5 levels were reduced (61%). In contrast, when uPA/uPAR was silenced, integrin beta 5 total and cell-surface levels were increased (2-4 fold). Integrin beta 5 accumulation resulted from a significant decrease in beta 5 ubiquitination leading to a decrease in the degradation rate of internalized beta 5. uPA-silencing also induced alpha-SMA stress fiber organization in cells that were seeded on collagen, increased cell area (1.7 fold), and increased integrin beta 1 binding to the collagen matrix, with reduced activation of beta 1. Elevated cell-surface integrin beta 5 was necessary for these changes after uPA-silencing since blocking alpha v beta 5 function reversed these effects. Our data support a novel mechanism by which downregulation of uPA/uPAR results in increased integrin alpha v beta 5 cell-surface protein levels that regulate the activity of beta 1 integrins, promoting characteristics of the persistent Mf.	[Wang, Lingyan; Pedroja, Benjamin S.; Meyers, Erin E.; Garcia, Angelo L.; Bernstein, Audrey M.] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA; [Twining, Sally S.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Icahn School of Medicine at Mount Sinai; Medical College of Wisconsin	Wang, LY (corresponding author), Mt Sinai Sch Med, Dept Ophthalmol, New York, NY 10029 USA.	audrey.bernstein@mssm.edu		Bernstein, Audrey/0000-0002-2537-2594	NIH-NEI [R01s EY017030, EY09414, E_12731, 5R24CA095823-04]; NEI [P30-EY01867]; Research to Prevent Blindness; NIH [5U42RR006042, 1S10RR09145-01]; NSF [DBI-9724504]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145, U42RR006042] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001867, R56EY009414, R01EY009414, R01EY021152, R01EY017030] Funding Source: NIH RePORTER	NIH-NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by NIH-NEI Grants R01s EY017030 (AMB), EY09414 (S. K. Masur, PI), E_12731 (SST), NEI Core Grant P30-EY01867, and a Research to Prevent Blindness grant. The authors acknowledge use of human tissues provided by the National Disease Research Interchange (NDRI), with support from NIH grant 5U42RR006042. Microscopy was performed at the MSSM-Microscopy Shared Resource Facility, supported with funding from NIH-NCI shared resources grant (5R24CA095823-04), a NSF Major Research Instrumentation grant (DBI-9724504), and a NIH shared instrumentation grant (1S10RR09145-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Asano Y, 2006, AM J PATHOL, V168, P499, DOI 10.2353/ajpath.2006.041306; Asano Y, 2005, ARTHRITIS RHEUM-US, V52, P2897, DOI 10.1002/art.21246; Asano Y, 2006, J INVEST DERMATOL, V126, P1761, DOI 10.1038/sj.jid.5700331; Bandinelli F, 2005, CLIN EXP RHEUMATOL, V23, P671; Bernstein AM, 2007, MOL BIOL CELL, V18, P2716, DOI 10.1091/mbc.E06-10-0912; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Carracedo S, 2010, J BIOL CHEM, V285, P10434, DOI 10.1074/jbc.M109.078766; Carriero MV, 1999, CANCER RES, V59, P5307; Chandhoke SK, 2004, J CELL SCI, V117, P1431, DOI 10.1242/jcs.00987; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Crawford LJ, 2011, J CELL COMMUN SIGNAL, V5, P101, DOI 10.1007/s12079-011-0121-7; Czekay RP, 2003, J CELL BIOL, V160, P781, DOI 10.1083/jcb.200208117; Czekay RP, 2001, MOL BIOL CELL, V12, P1467, DOI 10.1091/mbc.12.5.1467; D'Alessio S, 2004, ARTHRITIS RHEUM-US, V50, P3275, DOI 10.1002/art.20562; DALTON SL, 1995, MOL BIOL CELL, V6, P1781, DOI 10.1091/mbc.6.12.1781; Defilles C, 2009, EXP CELL RES, V315, P1840, DOI 10.1016/j.yexcr.2009.03.014; Deng HX, 2011, NATURE; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; DESMOULIERE A, 1995, AM J PATHOL, V146, P56; Franco P, 2006, J CELL SCI, V119, P3424, DOI 10.1242/jcs.03067; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Horan GS, 2008, AM J RESP CRIT CARE, V177, P56, DOI 10.1164/rccm.200706-805OC; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Kang LI, 2011, CURR PHARM BIOTECHNO; Kanno Y, 2008, J INVEST DERMATOL, V128, P2792, DOI 10.1038/jid.2008.157; Koukoulis GK, 2001, HUM PATHOL, V32, P1356, DOI 10.1053/hupa.2001.29675; Leifheit-Nestler M, 2010, ARTERIOSCL THROM VAS, V30, P1398, DOI 10.1161/ATVBAHA.110.206086; Lijnen HR, 2001, ANN NY ACAD SCI, V936, P226; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Margheri F, 2006, ARTHRITIS RHEUM-US, V54, P3926, DOI 10.1002/art.22263; Mazzieri R, 2006, MOL BIOL CELL, V17, P367, DOI 10.1091/mbc.E05-07-0635; Memmo LM, 1998, J CELL SCI, V111, P425; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Montuori N, 2009, FRONT BIOSCI-LANDMRK, V14, P2494, DOI 10.2741/3392; Nieves EC, 2010, J BIOL CHEM, V285, P12595, DOI 10.1074/jbc.M109.008581; Norambuena A, 2011, MOL BIOL CELL, V22, P3456, DOI 10.1091/mbc.E11-04-0361; Pawar SC, 2007, EXP CELL RES, V313, P1080, DOI 10.1016/j.yexcr.2007.01.006; Postglione L, 2010, INT J IMMUNOPATH PH, V23, P891, DOI 10.1177/039463201002300325; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Riederer BM, 2011, EXP BIOL MED, V236, P268, DOI 10.1258/ebm.2010.010327; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vassilieva EV, 2008, AM J PHYSIOL-GASTR L, V295, pG965, DOI 10.1152/ajpgi.00082.2008; Vocca I, 2009, INT J CANCER, V124, P316, DOI 10.1002/ijc.23933; Warejcka D, 2005, MOL VIS, V11, P859; Weber GF, 2011, J CELL SCI, V124, P1183, DOI 10.1242/jcs.064618; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wipff PJ, 2009, J BODYW MOV THER, V13, P121, DOI 10.1016/j.jbmt.2008.04.031; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	58	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33915	10.1371/journal.pone.0033915	http://dx.doi.org/10.1371/journal.pone.0033915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470492	gold, Green Published, Green Submitted			2022-12-27	WOS:000303857100057
J	Berberian, B; Sarrazin, JC; Le Blaye, P; Haggard, P				Berberian, Bruno; Sarrazin, Jean-Christophe; Le Blaye, Patrick; Haggard, Patrick			Automation Technology and Sense of Control: A Window on Human Agency	PLOS ONE			English	Article							APPARENT MENTAL CAUSATION; BINDING; SELF; AWARENESS; ILLUSION	Previous studies have shown that the perceived times of voluntary actions and their effects are perceived as shifted towards each other, so that the interval between action and outcome seems shortened. This has been referred to as 'intentional binding' (IB). However, the generality of this effect remains unclear. Here we demonstrate that Intentional Binding also occurs in complex control situations. Using an aircraft supervision task with different autopilot settings, our results first indicated a strong relation between measures of IB and different levels of system automation. Second, measures of IB were related to explicit agency judgement in this applied setting. We discuss the implications for the underlying mechanisms, and for sense of agency in automated environments.	[Berberian, Bruno; Sarrazin, Jean-Christophe; Le Blaye, Patrick] Off Natl Etud & Rech Aerosp, Syst Control & Flight Dynam Dept, Toulouse, France; [Haggard, Patrick] UCL, Inst Cognit Neurosci, London WC1E 6BT, England	National Office for Aerospace Studies & Research (ONERA); University of London; University College London	Berberian, B (corresponding author), Off Natl Etud & Rech Aerosp, Syst Control & Flight Dynam Dept, Toulouse, France.	bruno.berberian@onera.fr		Haggard, Patrick/0000-0001-7798-793X; Berberian, Bruno/0000-0002-3908-4358				Aarts H, 2005, CONSCIOUS COGN, V14, P439, DOI 10.1016/j.concog.2004.11.001; Anderson J, LEVELS AUTOMATION US; Andersson J, VTT S VALTION TEKNIL, V258, P107; Baron S., 1988, HUMAN FACTORS AVIATI, P347; Buehner MJ, 2009, PSYCHOL SCI, V20, P1221, DOI 10.1111/j.1467-9280.2009.02435.x; Cravo AM, 2009, EXP BRAIN RES, V199, P95, DOI 10.1007/s00221-009-1969-0; Daprati E, 1997, COGNITION, V65, P71, DOI 10.1016/S0010-0277(97)00039-5; Ebert JP, 2010, CONSCIOUS COGN, V19, P481, DOI 10.1016/j.concog.2009.10.002; Engbert K, 2008, COGNITION, V107, P693, DOI 10.1016/j.cognition.2007.07.021; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Garcia J, 1966, PSYCHON SCI, V5, P121, DOI DOI 10.3758/BF03328311; Haggard P, 2002, ATTENTION PERFORM, V19, P266; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Humphreys GR, 2009, J EXP PSYCHOL HUMAN, V35, P1542, DOI 10.1037/a0014492; MOORE J, CONSCIOUSNE IN PRESS; Moore JW, 2009, CONSCIOUS COGN, V18, P1056, DOI 10.1016/j.concog.2009.05.004; Norman DA, 1990, PHILOS T ROYAL SOC B, V327; Pronin E, 2006, J PERS SOC PSYCHOL, V91, P218, DOI 10.1037/0022-3514.91.2.218; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; Sheridan T., 1978, HUMAN COMPUTER CONTR, DOI [10.21236/ada057655, DOI 10.21236/ADA057655]; Tsakiris M, 2003, EXP BRAIN RES, V149, P439, DOI 10.1007/s00221-003-1386-8; Wegner DM, 2002, BRADFORD BOOKS, P1; Wegner DM, 2004, BEHAV BRAIN SCI, V27, P649, DOI 10.1017/S0140525X04000159; Wegner DM, 1999, AM PSYCHOL, V54, P480, DOI 10.1037/0003-066X.54.7.480; Wegner DM, 2004, J PERS SOC PSYCHOL, V86, P838, DOI 10.1037/0022-3514.86.6.838; Wenke D, 2010, COGNITION, V115, P26, DOI 10.1016/j.cognition.2009.10.016; Wenke D, 2009, EXP BRAIN RES, V196, P311, DOI 10.1007/s00221-009-1848-8; Young ME, 2005, MEM COGNITION, V33, P320, DOI 10.3758/BF03195320	29	68	68	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34075	10.1371/journal.pone.0034075	http://dx.doi.org/10.1371/journal.pone.0034075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UC	22479528	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100114
J	Eglington, SM; Pearce-Higgins, JW				Eglington, Sarah M.; Pearce-Higgins, James W.			Disentangling the Relative Importance of Changes in Climate and Land-Use Intensity in Driving Recent Bird Population Trends	PLOS ONE			English	Article							AGRICULTURAL INTENSIFICATION; FARMLAND BIRDS; BIODIVERSITY; HABITAT; ENGLAND; CONSERVATION; EXTINCTION; WEATHER; IMPACT; INDICATORS	Threats to biodiversity resulting from habitat destruction and deterioration have been documented for many species, whilst climate change is regarded as increasingly impacting upon species' distribution and abundance. However, few studies have disentangled the relative importance of these two drivers in causing recent population declines. We quantify the relative importance of both processes by modelling annual variation in population growth of 18 farmland bird species in the UK as a function of measures of land-use intensity and weather. Modelled together, both had similar explanatory power in accounting for annual fluctuations in population growth. When these models were used to retrodict population trends for each species as a function of annual variation in land-use intensity and weather combined, and separately, retrodictions incorporating land-use intensity were more closely linked to observed population trends than retrodictions based only on weather, and closely matched the UK farmland bird index from 1970 onwards. Despite more stable land-use intensity in recent years, climate change (inferred from weather trends) has not overtaken land-use intensity as the dominant driver of bird populations.	[Eglington, Sarah M.; Pearce-Higgins, James W.] British Trust Ornithol, Thetford, Norfolk, England	British Trust for Ornithology	Eglington, SM (corresponding author), British Trust Ornithol, Thetford, Norfolk, England.	james.pearce-higgins@bto.org	Eglington, Sarah/H-8264-2012		Department for Environment, Food and Rural Affairs; Countryside Council for Wales; Northern Ireland Environment Agency; Natural England; Scottish Natural Heritage	Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Countryside Council for Wales; Northern Ireland Environment Agency; Natural England; Scottish Natural Heritage	This work was funded by the Department for Environment, Food and Rural Affairs (www.defra.gov.uk), the Countryside Council for Wales (www.ccw.gov.uk), the Northern Ireland Environment Agency(www.doeni.gov.uk/niea), Natural England(www.naturalengland.org.uk) and Scottish Natural Heritage(www.snh.gov.uk) and overseen by a steering group which included individuals from the funding organisations. The steering group provided high-level input to the overall project, but did not play a direct role in the design, analysis or decision to publish this piece of work, but were given the opportunity to comment on a pre-submission manuscript.	Bradbury RB, 2003, IBIS, V145, P295, DOI 10.1046/j.1474-919X.2003.00142.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Davey CM, 2010, IBIS, V152, P459, DOI 10.1111/j.1474-919X.2009.01001.x; de Chazal J, 2009, GLOBAL ENVIRON CHANG, V19, P306, DOI 10.1016/j.gloenvcha.2008.09.007; DEFRA, 2011, WILD BIRD POP UK; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Freeman SN, 2007, BIRD STUDY, V54, P61, DOI 10.1080/00063650709461457; Fuller RM, 2005, GLOBAL ECOL BIOGEOGR, V14, P223, DOI 10.1111/j.1466-822X.2005.00145.x; Gaston KJ, 2003, P ROY SOC B-BIOL SCI, V270, P1293, DOI 10.1098/rspb.2002.2303; GREENWOOD JJD, 1991, IBIS, V133, P121, DOI 10.1111/j.1474-919X.1991.tb07675.x; Gregory RD, 2004, IBIS, V146, P1, DOI 10.1111/j.1474-919X.2004.00358.x; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Gregory RD, 1996, BREED BIRD SURV 1994; Gregory RD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004678; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jiguet F, 2007, GLOBAL CHANGE BIOL, V13, P1672, DOI 10.1111/j.1365-2486.2007.01386.x; Jiguet F, 2010, P ROY SOC B-BIOL SCI, V277, P3601, DOI 10.1098/rspb.2010.0796; Jones PD, 1997, INT J CLIMATOL, V17, P427, DOI [10.1002/(SICI)1097-0088(19970330)17:4<427::AID-JOC139>3.0.CO;2-Q, 10.1002/(SICI)1097-0088(19970330)17:4<427::AID-JOC139>3.3.CO;2-H]; Keep M., 2009, SNSG3339 HOUS COMM L; Lucas R, 2007, ISPRS J PHOTOGRAMM, V62, P165, DOI 10.1016/j.isprsjprs.2007.03.003; Mac Nally R, 2002, BIODIVERS CONSERV, V11, P1397, DOI 10.1023/A:1016250716679; Marchant J., 1990, POPULATION TRENDS BR; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Murray K, 2009, ECOLOGY, V90, P348, DOI 10.1890/07-1929.1; Newson SE, 2010, J APPL ECOL, V47, P244, DOI 10.1111/j.1365-2664.2010.01771.x; Olesen JE, 2002, EUR J AGRON, V16, P239, DOI 10.1016/S1161-0301(02)00004-7; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PEACH W, 1991, IBIS, V133, P300, DOI 10.1111/j.1474-919X.1991.tb04573.x; Pearce-Higgins JW, 2011, IBIS, V153, P207, DOI 10.1111/j.1474-919X.2010.01086.x; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Rands MRW, 2010, SCIENCE, V329, P1298, DOI 10.1126/science.1189138; Robinson RA, 2007, IBIS, V149, P357, DOI 10.1111/j.1474-919X.2006.00648.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SAS Institute Inc, 2008, SAS 9 2 ENH LOGG FAC; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Wilson A, 2007, BIOL CONSERV, V136, P128, DOI 10.1016/j.biocon.2006.11.010; Wilson JD, 2009, ECOL BIODIVERS CONS, P1; [No title captured]	47	94	100	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e30407	10.1371/journal.pone.0030407	http://dx.doi.org/10.1371/journal.pone.0030407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479304	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100001
J	Eppinger, M; Radnedge, L; Andersen, G; Vietri, N; Severson, G; Mou, S; Ravel, J; Worsham, PL				Eppinger, Mark; Radnedge, Lyndsay; Andersen, Gary; Vietri, Nicholas; Severson, Grant; Mou, Sherry; Ravel, Jacques; Worsham, Patricia L.			Novel Plasmids and Resistance Phenotypes in Yersinia pestis: Unique Plasmid Inventory of Strain Java 9 Mediates High Levels of Arsenic Resistance	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; LACTOSE TRANSPOSON TN951; ESCHERICHIA-COLI; ARS OPERON; SMALL MAMMALS; DNA-SEQUENCE; WEST JAVA; PLAGUE; VIRULENCE; EVOLUTION	Growing evidence suggests that the plasmid repertoire of Yersinia pestis is not restricted to the three classical virulence plasmids. The Java 9 strain of Y. pestis is a biovar Orientalis isolate obtained from a rat in Indonesia. Although it lacks the Y. pestis-specific plasmid pMT, which encodes the F1 capsule, it retains virulence in mouse and non-human primate animal models. While comparing diverse Y. pestis strains using subtractive hybridization, we identified sequences in Java 9 that were homologous to a Y. enterocolitica strain carrying the transposon Tn2502, which is known to encode arsenic resistance. Here we demonstrate that Java 9 exhibits high levels of arsenic and arsenite resistance mediated by a novel promiscuous class II transposon, named Tn2503. Arsenic resistance was self-transmissible from Java 9 to other Y. pestis strains via conjugation. Genomic analysis of the atypical plasmid inventory of Java 9 identified pCD and pPCP plasmids of atypical size and two previously uncharacterized cryptic plasmids. Unlike the Tn2502-mediated arsenic resistance encoded on the Y. enterocolitica virulence plasmid; the resistance loci in Java 9 are found on all four indigenous plasmids, including the two novel cryptic plasmids. This unique mobilome introduces more than 105 genes into the species gene pool. The majority of these are encoded by the two entirely novel self-transmissible plasmids, which show partial homology and synteny to other enterics. In contrast to the reductive evolution in Y. pestis, this study underlines the major impact of a dynamic mobilome and lateral acquisition in the genome evolution of the plague bacterium.	[Eppinger, Mark; Ravel, Jacques] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Eppinger, Mark; Ravel, Jacques] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Radnedge, Lyndsay; Andersen, Gary] Lawrence Livermore Natl Lab, Livermore, CA USA; [Vietri, Nicholas; Severson, Grant; Mou, Sherry; Worsham, Patricia L.] USA, Med Res Inst Infect Dis, Bacteriol Div, Ft Detrick, MD 21702 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Eppinger, M (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA.	jravel@som.umaryland.edu; patricia.worsham@us.army.mil	Ravel, Jacques/D-2530-2009	Ravel, Jacques/0000-0002-0851-2233	Defense Threat Reduction Agency [05-4-5A-0AC]; Department of the Army [TB1-5A]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900007C]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Department of the Army; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part with federal funds from the Defense Threat Reduction Agency (Project 05-4-5A-0AC), the Department of the Army (Project number TB1-5A) and from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under contract number HHSN272200900007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Adair DM, 2000, J CLIN MICROBIOL, V38, P1516, DOI 10.1128/JCM.38.4.1516-1519.2000; Avila P, 1996, J MOL BIOL, V261, P135, DOI 10.1006/jmbi.1996.0447; Bansal N, 2000, CAN J MICROBIOL, V46, P481, DOI 10.1139/cjm-46-5-481; Bistue AJCS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001800; Butcher BG, 2000, APPL ENVIRON MICROB, V66, P1826, DOI 10.1128/AEM.66.5.1826-1833.2000; Butcher BG, 2002, MICROBIOL-SGM, V148, P3983, DOI 10.1099/00221287-148-12-3983; Cantwell AM, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-29; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chu MC, 1998, AM J TROP MED HYG, V59, P679, DOI 10.4269/ajtmh.1998.59.679; Cornelis GR, 1998, MICROBIOL MOL BIOL R, V62, P1315, DOI 10.1128/MMBR.62.4.1315-1352.1998; Davis KJ, 1996, ARCH PATHOL LAB MED, V120, P156; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; Derbise A, 2010, INFECT IMMUN; Dong XQ, 2000, PLASMID, V43, P144, DOI 10.1006/plas.1999.1432; Eppinger M, 2007, PLOS GENET, V3, P1508, DOI 10.1371/journal.pgen.0030142; Eppinger M, 2011, P NATL ACAD SCI USA, V108, P20142, DOI 10.1073/pnas.1107176108; Eppinger M, 2010, J BACTERIOL, V192, P1685, DOI 10.1128/JB.01518-09; Eppinger M, 2009, J BACTERIOL, V191, P7628, DOI 10.1128/JB.01227-09; Filippov AA, 1990, FEMS MICROBIOL LETT, V55, P45; FRIEDLANDER AM, 1995, CLIN INFECT DIS, V21, pS178, DOI 10.1093/clinids/21.Supplement_2.S178; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Golubov A, 2004, INFECT IMMUN, V72, P5613, DOI 10.1128/IAI.72.10.5613-5621.2004; Hinnebusch BJ, 2002, SCIENCE, V296, P733, DOI 10.1126/science.1069972; Holden MTG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000346; HUDSON BW, 1973, AM J TROP MED HYG, V22, P642, DOI 10.4269/ajtmh.1973.22.642; Huson D H, 2001, Bioinformatics, V17 Suppl 1, pS132; Ibrahim Ima Nurisa, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P932; Joshua GWP, 2003, MICROBIOL-SGM, V149, P3221, DOI 10.1099/mic.0.26475-0; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; KUSHARYONO C, 1980, INT J ZOONOSES, V7, P1; Lemaitre N, 2006, INFECT IMMUN, V74, P5126, DOI 10.1128/IAI.00219-06; LIAT L B, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P71; LINK V B, 1953, Bull World Health Organ, V9, P585; MICHIELS T, 1989, PLASMID, V22, P249, DOI 10.1016/0147-619X(89)90008-5; MICHIELS T, 1987, J BACTERIOL, V169, P624, DOI 10.1128/jb.169.2.624-631.1987; MICHIELS T, 1984, J BACTERIOL, V158, P866, DOI 10.1128/JB.158.3.866-871.1984; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Mukhopadhyay R, 2002, ENVIRON HEALTH PERSP, V110, P745, DOI 10.1289/ehp.02110s5745; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Neyt C, 1997, J BACTERIOL, V179, P612, DOI 10.1128/jb.179.3.612-619.1997; Nunez B, 1997, MOL MICROBIOL, V24, P1157, DOI 10.1046/j.1365-2958.1997.4111778.x; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; PHILLIPS AP, 1988, EPIDEMIOL INFECT, V101, P59, DOI 10.1017/S0950268800029228; Radnedge L, 2002, MICROBIOL-SGM, V148, P1687, DOI 10.1099/00221287-148-6-1687; Rangrez AY, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000115; Rasko DA, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-2; Ryan D, 2002, PLASMID, V47, P234, DOI 10.1016/S0147-619X(02)00012-4; Singleton G. R., 1994, ACIAR TECHNICAL REPO; Singleton GR, 1998, CROP PROT, V17, P55, DOI 10.1016/S0261-2194(98)80013-6; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Sun YC, 2008, P NATL ACAD SCI USA, V105, P8097, DOI 10.1073/pnas.0803525105; Sun YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019267; SUSTRIAYU N, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P108; Tuffin IM, 2006, APPL ENVIRON MICROB, V72, P2247, DOI 10.1128/AEM.72.3.2247-2253.2006; Tuffin IM, 2005, MICROBIOL-SGM, V151, P3027, DOI 10.1099/mic.0.28131-0; TURNER AK, 1987, NUCLEIC ACIDS RES, V15, P10049, DOI 10.1093/nar/15.23.10049; TURNER AK, 1990, J GEN MICROBIOL, V136, P65, DOI 10.1099/00221287-136-1-65; van Peenen P.F.D., 1976, Southeast Asian Journal of Tropical Medicine and Public Health, V7, P411; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Wilkinson P, 2010, FEMS MICROBIOL LETT; WILLIAMS JE, 1980, B WORLD HEALTH ORGAN, V58, P459; WILLIAMS JE, 1978, AM J PUBLIC HEALTH, V68, P262, DOI 10.2105/AJPH.68.3.262; WINTER C C, 1960, Bull World Health Organ, V23, P408; Worsham PL, 1995, CONTRIB TO MICROBIOL, V13, P325; Worsham PLL, 2001, ANN M AM SOC MICR; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730	69	15	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32911	10.1371/journal.pone.0032911	http://dx.doi.org/10.1371/journal.pone.0032911			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479347	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339100023
J	Pan, SY; Wang, F; Huang, PJ; Xu, T; Zhang, LX; Xu, J; Li, Q; Xia, WY; Sun, RH; Huang, L; Peng, Y; Qin, XJ; Shu, YQ; Hu, ZB; Shen, HB				Pan, Shiyang; Wang, Fang; Huang, Peijun; Xu, Ting; Zhang, Lixia; Xu, Jian; Li, Qing; Xia, Wenying; Sun, Ruihong; Huang, Lei; Peng, Ying; Qin, Xuejun; Shu, Yongqian; Hu, Zhibin; Shen, Hongbing			The Study on Newly Developed McAb NJ001 Specific to Non-Small Cell Lung Cancer and Its Biological Characteristics	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; GROWTH; THERAPY; GENERATION; ANTIGEN; ANGIOGENESIS; PACLITAXEL; DOCETAXEL; MARKER; TRENDS	Monoclonal antibody (McAb) is the key tool for cancer immunodiagnosis and immunotherapy. McAb-based immunotherapy that targets tumor antigens has had great achivement. In this study, a cell clone which kept secreting high-titer IgG1-type McAb named NJ001 against human non-small cell lung cancer (NSCLC) cells was obtained. The titer of purified NJ001 was 2 x 10(6). The antigen named SP70 of NSCLC specifically identified by NJ001 was proved to be a protein with the relative molecular mass (Mr) of 70 kDa. The results of immunohistochemical staining indicated that NJ001 could positively react to NSCLC, but weak positively or negatively react to human small-cell lung cancer (SCLC), pulmonary pseudotumor and other epithelial tumors. In soft agar assay, the colony formation efficiency in NJ001 groups decreased in a dose-dependent manner. For the concentration of 100 mu g/ml, 200 mu g/ml and 400 mu g/ml, the inhibition ratio of colony formation was 23.4%, 62.5% and 100% respectively. Meanwhile, NJ001 caused significant reduction in tumor volume and tumor weight compared to control mice in lung cancer xenograft model. The tumor growth inhibition ratio in 200 mu g, 400 mu g and 800 mu g NJ001 groups was 10.44%, 37.29% and 44.04%, respectively. NJ001 also led to cytomorphological changes and induced the apoptosis of human lung adenocarcinoma cell line SPC-A1 significantly. The newly developed NJ001 selectively reacted to NSCLC and exhibited anti-tumor activity both in vitro and in vivo. NJ001 is of great value concerning immunodiagnostics and immunotherapy for NSCLC and holds promise for further research regarding the mechanism underlying tumor progression of NSCLC.	[Pan, Shiyang; Wang, Fang; Huang, Peijun; Xu, Ting; Zhang, Lixia; Xu, Jian; Li, Qing; Xia, Wenying; Sun, Ruihong; Huang, Lei; Peng, Ying; Qin, Xuejun] Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Shu, Yongqian] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Jiangsu, Peoples R China; [Pan, Shiyang; Wang, Fang; Huang, Peijun; Xu, Ting; Zhang, Lixia; Xu, Jian; Li, Qing; Xia, Wenying; Sun, Ruihong; Huang, Lei; Peng, Ying; Qin, Xuejun] Natl Key Clin Dept Lab Med, Nanjing, Jiangsu, Peoples R China; [Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Ctr Canc, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Pan, SY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Lab Med, Nanjing, Jiangsu, Peoples R China.	sypan@njmu.edu.cn	Shu, Yongqian/ABD-5698-2021		National Natural Science Foundation of China [30972821, 30901344, 30901262]; Key Laboratory Medicine of Jiangsu Province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory Medicine of Jiangsu Province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by National Natural Science Foundation of China (30972821, 30901344 and 30901262), Key Laboratory Medicine of Jiangsu Province of China, Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argyriou AA, 2009, MOL MED, V15, P183, DOI 10.2119/molmed.2009.00007; Carter P, 2001, NAT REV CANCER, V1, P118, DOI 10.1038/35101072; Catanzaro JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019096; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Ferris RL, 2010, J CLIN ONCOL, V28, P4390, DOI 10.1200/JCO.2009.27.6360; Gao JN, 2006, PROTEOMICS, V6, P427, DOI 10.1002/pmic.200500409; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gridelli C, 2009, ONCOLOGIST, V14, P601, DOI 10.1634/theoncologist.2008-0153; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Hollmen M, 2009, ONCOGENE, V28, P1309, DOI 10.1038/onc.2008.481; Hong KW, 2010, J BIOTECHNOL, V145, P84, DOI 10.1016/j.jbiotec.2009.09.023; Jain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023344; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Jin ZY, 2005, CANCER BIOL THER, V4, P139, DOI 10.4161/cbt.4.2.1508; Kollmannsberger C, 2006, ANN ONCOL, V17, P1007, DOI 10.1093/annonc/mdl042; Krug LM, 2005, CANCER, V104, P2149, DOI 10.1002/cncr.21428; Kunitoh H, 2007, BRIT J CANCER, V96, P1498, DOI 10.1038/sj.bjc.6603751; Kuroda K, 2010, PROSTATE, V70, P1286, DOI 10.1002/pros.21164; Lin MZ, 2005, CLIN CANCER RES, V11, P129; Lu ZJ, 2009, BMC CANCER, V14, P9; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Ning YS, 2006, PROTEOMICS, V6, P438, DOI 10.1002/pmic.200500327; Oldham RK, 2008, J CLIN ONCOL, V26, P1774, DOI 10.1200/JCO.2007.15.7438; Pal SK, 2010, MOL CANCER THER, V9, P1931, DOI 10.1158/1535-7163.MCT-10-0239; Reck M, 2009, LUNG CANCER, V63, P1, DOI 10.1016/j.lungcan.2008.05.015; Reichert JM, 2007, NAT REV DRUG DISCOV, V6, P349, DOI 10.1038/nrd2241; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; Rinderknecht M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011941; Saito S, 2008, INT J CANCER, V123, P633, DOI 10.1002/ijc.23490; Salgia R, 2011, CANCER-AM CANCER SOC, V117, P3889, DOI 10.1002/cncr.25935; Sawada R, 2011, CLIN CANCER RES, V17, P1024, DOI 10.1158/1078-0432.CCR-10-2640; Schofield DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r254; Schultz H, 2011, BRIT J CANCER, V105, P673, DOI 10.1038/bjc.2011.281; Stern M, 2005, CRIT REV ONCOL HEMAT, V54, P11, DOI 10.1016/j.critrevonc.2004.10.011; Tran PLCHB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-276; Vansteenkiste JF, 2004, HEMATOL ONCOL CLIN N, V18, P269, DOI 10.1016/S0889-8588(03)00152-7; Wang DD, 2010, J PROTEOME RES, V9, P1834, DOI 10.1021/pr900997z; Welinder C, 2011, GLYCOBIOLOGY, V21, P1097, DOI 10.1093/glycob/cwr048; Yu YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009072; Zhao WM, 2010, CLIN CANCER RES, V16, P5750, DOI 10.1158/1078-0432.CCR-10-0531	41	9	25	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33009	10.1371/journal.pone.0033009	http://dx.doi.org/10.1371/journal.pone.0033009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479355	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100029
J	Jimenez-Ortega, L; Martin-Loeches, M; Casado, P; Sel, A; Fondevila, S; de Tejada, PH; Schacht, A; Sommer, W				Jimenez-Ortega, Laura; Martin-Loeches, Manuel; Casado, Pilar; Sel, Alejandra; Fondevila, Sabela; Herreros de Tejada, Pilar; Schacht, Annekathrin; Sommer, Werner			How the Emotional Content of Discourse Affects Language Comprehension	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SENTENCE COMPREHENSION; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; BRAIN POTENTIALS; SPOKEN SENTENCES; CAPACITY THEORY; POSITIVE AFFECT; NEGATIVE MOOD; SYNTAX	Emotion effects on cognition have often been reported. However, only few studies investigated emotional effects on subsequent language processing, and in most cases these effects were induced by non-linguistic stimuli such as films, faces, or pictures. Here, we investigated how a paragraph of positive, negative, or neutral emotional valence affects the processing of a subsequent emotionally neutral sentence, which contained either semantic, syntactic, or no violation, respectively, by means of event-related brain potentials (ERPs). Behavioral data revealed strong effects of emotion; error rates and reaction times increased significantly in sentences preceded by a positive paragraph relative to negative and neutral ones. In ERPs, the N400 to semantic violations was not affected by emotion. In the syntactic experiment, however, clear emotion effects were observed on ERPs. The left anterior negativity (LAN) to syntactic violations, which was not visible in the neutral condition, was present in the negative and positive conditions. This is interpreted as reflecting modulatory effects of prior emotions on syntactic processing, which is discussed in the light of three alternative or complementary explanations based on emotion-induced cognitive styles, working memory, and arousal models. The present effects of emotion on the LAN are especially remarkable considering that syntactic processing has often been regarded as encapsulated and autonomous.	[Jimenez-Ortega, Laura; Martin-Loeches, Manuel; Casado, Pilar; Sel, Alejandra; Fondevila, Sabela] UCM ISCIII, Ctr Human Evolut & Behav, Madrid, Spain; [Jimenez-Ortega, Laura; Martin-Loeches, Manuel; Casado, Pilar; Herreros de Tejada, Pilar] Univ Complutense Madrid, Dept Psychobiol, Madrid, Spain; [Schacht, Annekathrin; Sommer, Werner] Humboldt Univ, Dept Psychobiol, D-10099 Berlin, Germany; [Schacht, Annekathrin] Univ Gottingen, CRC Text Struct, Gottingen, Germany	Complutense University of Madrid; Humboldt University of Berlin; University of Gottingen	Jimenez-Ortega, L (corresponding author), UCM ISCIII, Ctr Human Evolut & Behav, Madrid, Spain.	laura.jimenez.ortega@psi.ucm.es	Martin-Loeches, Manuel/G-4288-2017; Sommer, Werner/H-4672-2011; Casado, Pilar/GPX-1002-2022; Schacht, Annekathrin/B-2521-2014; Sommer, Werner/N-1945-2019; Jimenez-Ortega, Laura/F-5590-2016	Martin-Loeches, Manuel/0000-0002-3487-8423; Sommer, Werner/0000-0001-5266-3445; Sommer, Werner/0000-0001-5266-3445; Sel, Alex/0000-0002-1601-8833; Casado, PILAR/0000-0002-3991-4155; Schacht, Anne/0000-0001-9471-3842; Jimenez-Ortega, Laura/0000-0001-8002-5563	Ministerio de Ciencia e Innovacion, Spain (MICINN) [SEJ2007-60485/PSIC, PSI2010-19619]	Ministerio de Ciencia e Innovacion, Spain (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This research was funded by grants Ref. SEJ2007-60485/PSIC and PSI2010-19619 from Ministerio de Ciencia e Innovacion, Spain (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashby FG, 1999, PSYCHOL REV, V106, P529, DOI 10.1037/0033-295X.106.3.529; Ben Shalom D, 2008, NEUROSCIENTIST, V14, P119, DOI 10.1177/1073858407305726; Blanchette I, 2010, COGNITION EMOTION, V24, P561, DOI 10.1080/02699930903132496; Bockler A, 2011, EXP PSYCHOL, V58, P102, DOI 10.1027/1618-3169/a000073; Bolte A, 2003, PSYCHOL SCI, V14, P416, DOI 10.1111/1467-9280.01456; Caplan D, 1999, NEURON, V24, P292, DOI 10.1016/S0896-6273(00)80843-0; Chung G, 1996, PSYCHOPHYSIOLOGY, V33, P218, DOI 10.1111/j.1469-8986.1996.tb00419.x; CHWILLA DJ, 1995, PSYCHOPHYSIOLOGY, V32, P274, DOI 10.1111/j.1469-8986.1995.tb02956.x; Costa VD, 2010, HUM BRAIN MAPP, V31, P1446, DOI 10.1002/hbm.20948; DANEMAN M, 1980, J VERB LEARN VERB BE, V19, P450, DOI 10.1016/S0022-5371(80)90312-6; Dillon DG, 2006, BRAIN COGNITION, V62, P43, DOI 10.1016/j.bandc.2006.03.008; Federmeier KD, 2001, NEUROSCI LETT, V305, P149, DOI 10.1016/S0304-3940(01)01843-2; Fedorenko E, 2008, J MEM LANG, V54, P541; Fischer R, 2010, EXP PSYCHOL, V57, P89, DOI 10.1027/1618-3169/a000012; Fodor J. A, 1983, MODULARITY MIND; Friederici A, 2002, COGNITION; Friederici AD, 2001, COGNITIVE BRAIN RES, V11, P305, DOI 10.1016/S0926-6410(00)00065-3; Friederici AD, 2009, TRENDS COGN SCI; Gibbons H, 2009, CONSCIOUS COGN, V18, P383, DOI 10.1016/j.concog.2009.02.007; Gouvea AC, 1999, LANG COGNITIVE PROC, V25, P149; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Grodner D, 2005, COGNITION, V95, P275, DOI 10.1016/j.cognition.2004.01.007; Gunter TC, 1997, PSYCHOPHYSIOLOGY, V34, P660, DOI 10.1111/j.1469-8986.1997.tb02142.x; Hagoort P, 2003, NEUROIMAGE, V20, pS18, DOI 10.1016/j.neuroimage.2003.09.013; Hagoort P, 2003, J COGNITIVE NEUROSCI, V15, P883, DOI 10.1162/089892903322370807; Hagoort P, 2000, NEUROPSYCHOLOGIA, V38, P1531, DOI 10.1016/S0028-3932(00)00053-1; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Ihssen N, 2007, J COGNITIVE NEUROSCI, V19, P1932, DOI 10.1162/jocn.2007.19.12.1932; ISEN AM, 1985, J PERS SOC PSYCHOL, V48, P1413, DOI 10.1037/0022-3514.48.6.1413; Jackendoff R, 2007, BRAIN RES, V1146, P2, DOI 10.1016/j.brainres.2006.08.111; JUST MA, 1992, PSYCHOL REV, V99, P122, DOI 10.1037/0033-295X.99.1.122; Keil A, 2006, PROG BRAIN RES, V156, P217, DOI 10.1016/S0079-6123(06)56011-X; Keil A, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-23; Kemmerer D, 2007, BRAIN LANG, V100, P238, DOI 10.1016/j.bandl.2005.12.002; Kensinger EA, 2006, COGN AFFECT BEHAV NE, V6, P110, DOI 10.3758/CABN.6.2.110; Kiefer M, 2001, TRENDS COGN SCI, V5, P469, DOI 10.1016/S1364-6613(00)01798-8; Kuperberg GR, 2000, J COGNITIVE NEUROSCI, V12, P321, DOI 10.1162/089892900562138; KUTAS M, 1980, BIOL PSYCHOL, V11, P99, DOI 10.1016/0301-0511(80)90046-0; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Lee CU, 2002, ARCH GEN PSYCHIAT, V59, P775, DOI 10.1001/archpsyc.59.9.775; Lee Gregory P, 2004, Cogn Behav Neurol, V17, P9, DOI 10.1097/00146965-200403000-00002; MacDonald MC, 2002, PSYCHOL REV, V109, P35, DOI 10.1037//0033-295X.109.1.35; Martin-Loeches M, 2005, PSYCHOPHYSIOLOGY, V42, P508, DOI 10.1111/j.1469-8986.2005.00308.x; Martin-Loeches M, 2006, BRAIN RES, V1093, P178, DOI 10.1016/j.brainres.2006.03.094; Martin-Loeches M, 2009, J COGNITIVE NEUROSCI, V21, P1365, DOI 10.1162/jocn.2009.21106; Mitchell RLC, 2007, NEUROPSYCHOLOGIA, V45, P617, DOI 10.1016/j.neuropsychologia.2006.06.030; MUNTE TF, 1994, ARCH NEUROL-CHICAGO, V51, P482, DOI 10.1001/archneur.1994.00540170058017; Munte TF, 1993, COGNITIVE ELECTROPHY; Nevins A, 2007, BRAIN RES, V1164, P81, DOI 10.1016/j.brainres.2007.05.058; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Stowe LA, 2004, BRAIN LANG, V89, P290, DOI 10.1016/S0093-934X(03)00359-6; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; van Herten M, 2005, COGNITIVE BRAIN RES, V22, P241, DOI 10.1016/j.cogbrainres.2004.09.002; Vissers CTWM, 2010, NEUROPSYCHOLOGIA, V48, P3521, DOI 10.1016/j.neuropsychologia.2010.08.001; Vos SH, 2001, PSYCHOPHYSIOLOGY, V38, P41, DOI 10.1111/1469-8986.3810041; Waters GS, 1996, PSYCHOL REV, V103, P761, DOI 10.1037/0033-295X.103.4.761; Weckerly J, 1999, PSYCHOPHYSIOLOGY, V36, P559, DOI 10.1017/S0048577299971202; WESENSTEN NJ, 1992, BIOL PSYCHOL, V33, P173, DOI 10.1016/0301-0511(92)90030-X; Wiswede D, 2009, SOC COGN AFFECT NEUR, V4, P227, DOI 10.1093/scan/nsp015; Wiswede D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005754	64	29	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33718	10.1371/journal.pone.0033718	http://dx.doi.org/10.1371/journal.pone.0033718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948SR	22479432	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000304523400030
J	Kastenberger, I; Lutsch, C; Herzog, H; Schwarzer, C				Kastenberger, Iris; Lutsch, Christian; Herzog, Herbert; Schwarzer, Christoph			Influence of Sex and Genetic Background on Anxiety-Related and Stress-Induced Behaviour of Prodynorphin-Deficient Mice	PLOS ONE			English	Article							KAPPA-OPIOID RECEPTORS; BASOLATERAL AMYGDALA; KNOCKOUT MICE; SOCIAL-STATUS; ACTIVATION; DYNORPHIN; SYSTEM; MOUSE; MU; RESPONSES	The role of dynorphin/kappa opioid receptors in epilepsy and addiction are well accepted, but their function in emotional control is not yet fully understood. Data obtained from different strains of prodynorphin (Pdyn)- and kappa opioid receptor (KOP)-deficient mice do not provide a consistent picture of the functions of Dyn/KOP in anxiety, suggesting the influence of testing conditions and/or genetic background. Therefore, we investigated the behaviour and neurochemistry of male and female Pdyn KO mice on the balb/c and C57Bl/6N background. Consistent with our results obtained from male mice on the C57bl/6N background, we observed a less anxious phenotype in the elevated plus maze, open-field and light-dark test in male mice on the balb/c background. Female mice on the balb/c background also displayed less anxiety like behaviour; however these data reflect high trait anxiety and inter-individual differences. In contrast, female mice on the C57Bl/6N background displayed low trait anxiety and a paradigm-dependent reduction of anxiety. No differences were observed in the forced swim test, while balb/c Pdyn KO mice displayed prolonged immobility in the tail suspension test. In line with our previous results, we observed reduced CRH mRNA in the central amygdala in all groups of mice. In contrast, the recently observed CRH mRNA reduction in the hypothalamic paraventricular nucleus appears restricted to male, but not female mice. Our data support previous data suggesting a pronounced impact of endogenous prodynorphin-derived peptides on anxiety. Moreover, our data support the idea that the less anxious phenotype manifests only at elevated stress levels.	[Kastenberger, Iris; Lutsch, Christian; Schwarzer, Christoph] Innsbruck Med Univ, Dept Pharmacol, Innsbruck, Austria; [Herzog, Herbert] St Vincents Hosp, Garvan Inst Med Res, Neurosci Program, Darlinghurst, NSW 2010, Australia	Medical University of Innsbruck; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Kastenberger, I (corresponding author), Innsbruck Med Univ, Dept Pharmacol, Innsbruck, Austria.	Schwarzer.Christoph@i-med.ac.at	Herzog, Herbert/B-8294-2008	Schwarzer, Christoph/0000-0002-6373-3717; , Herbert/0000-0002-1713-1029	Austrian Science Fund Project [P20107-B05]	Austrian Science Fund Project(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund Project P20107-B05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilkei-Gorzo A, 2008, PSYCHONEUROENDOCRINO; Bilkei-Gorzo A, 2008, PSYCHONEUROENDOCRINO, V33, P425, DOI 10.1016/j.psyneuen.2007.12.010; Bruchas MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008528; Chapman JC, 1998, PHYSIOL BEHAV, V64, P529, DOI 10.1016/S0031-9384(98)00115-2; Clarke S, 2003, NEUROSCIENCE, V122, P479, DOI 10.1016/j.neuroscience.2003.07.011; DAMATO FR, 1988, J COMP PSYCHOL, V102, P146, DOI 10.1037/0735-7036.102.2.146; Femenia T, 2010, J PSYCHOPHARMACOL; Ferrari PF, 1997, PSYCHOPHARMACOLOGY, V134, P258, DOI 10.1007/s002130050448; Hardy MP, 2002, BIOL REPROD, V67, P1750, DOI 10.1095/biolreprod.102.006312; HEILIG M, 1994, TRENDS NEUROSCI, V17, P80, DOI 10.1016/0166-2236(94)90079-5; Huge V, 2009, EUR J PAIN, V13, P124, DOI 10.1016/j.ejpain.2008.03.010; JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q; Kudryavtseva NN, 2004, PEPTIDES, V25, P1355, DOI 10.1016/j.peptides.2004.05.005; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Lathe R, 2004, GENES BRAIN BEHAV, V3, P317, DOI 10.1111/j.1601-183X.2004.00083.x; Loacker S, 2007, BRAIN, V130, P1017, DOI 10.1093/brain/awl384; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; Morgan MA, 2001, HORM BEHAV, V40, P472, DOI 10.1006/hbeh.2001.1716; Morgan MA, 2002, BEHAV BRAIN RES, V132, P85, DOI 10.1016/S0166-4328(01)00398-9; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; Slowe SJ, 1999, BRAIN RES, V818, P335, DOI 10.1016/S0006-8993(98)01201-3; Starec M, 1996, PHYSIOL RES, V45, P433; STEENBERGEN HL, 1990, PHYSIOL BEHAV, V48, P571, DOI 10.1016/0031-9384(90)90302-K; Ter Horst GJ, 2009, PHYSIOL BEHAV, V97, P239, DOI 10.1016/j.physbeh.2009.02.036; Wittmann W, 2009, NEUROPSYCHOPHARMACOL, V34, P775, DOI 10.1038/npp.2008.142	25	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34251	10.1371/journal.pone.0034251	http://dx.doi.org/10.1371/journal.pone.0034251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479578	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400065
J	Restivo, M; van de Rijt, A				Restivo, Michael; van de Rijt, Arnout			Experimental Study of Informal Rewards in Peer Production	PLOS ONE			English	Article								We test the effects of informal rewards in online peer production. Using a randomized, experimental design, we assigned editing awards or "barnstars'' to a subset of the 1% most productive Wikipedia contributors. Comparison with the control group shows that receiving a barnstar increases productivity by 60% and makes contributors six times more likely to receive additional barnstars from other community members, revealing that informal rewards significantly impact individual effort.	[Restivo, Michael; van de Rijt, Arnout] SUNY Stony Brook, Dept Sociol, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Restivo, M (corresponding author), SUNY Stony Brook, Dept Sociol, New York, NY USA.	michael.restivo@stonybrook.edu		van de Rijt, Arnout/0000-0002-4208-3452				[Anonymous], 1965, LOGIC COLLECTIVE ACT; Benkler Y, 2002, YALE LAW J, V112, P369, DOI 10.2307/1562247; Demil B, 2006, ORGAN STUD, V27, P1447, DOI 10.1177/0170840606067250; DiPrete TA, 2006, ANNU REV SOCIOL, V32, P271, DOI 10.1146/annurev.soc.32.061604.123127; Ellingsen T, 2008, AM ECON REV, V98, P990, DOI 10.1257/aer.98.3.990; Forte A, 2005, GROUP 05 SUSTAINING; Hilbe C, 2010, P ROY SOC B-BIOL SCI, V277, P2427, DOI 10.1098/rspb.2010.0065; MERTON RK, 1968, SCIENCE, V159, P56, DOI 10.1126/science.159.3810.56; Raymond Eric, 1999, CATHEDRAL BAZAAR, DOI DOI 10.1007/S12130-999-1026-0; Stewart D, 2005, AM SOCIOL REV, V70, P823, DOI 10.1177/000312240507000505; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; von Krogh G, 2006, MANAGE SCI, V52, P975, DOI 10.1287/mnsc.1060.0560; Voss J., 2005, P 10 INT C INT SOC S; Wikimedia Foundation, 2011, WIK ED STUD RES ED S; Willer R, 2009, AM SOCIOL REV, V74, P23, DOI 10.1177/000312240907400102	15	33	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34358	10.1371/journal.pone.0034358	http://dx.doi.org/10.1371/journal.pone.0034358			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948SR	22479610	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400077
J	Gravningen, K; Christerson, L; Furberg, AS; Simonsen, GS; Odman, K; Stahlsten, A; Herrmann, B				Gravningen, Kirsten; Christerson, Linus; Furberg, Anne-Sofie; Simonsen, Gunnar Skov; Odman, Kristina; Stahlsten, Anna; Herrmann, Bjorn			Multilocus Sequence Typing of Genital Chlamydia trachomatis in Norway Reveals Multiple New Sequence Types and a Large Genetic Diversity	PLOS ONE			English	Article							IDENTIFICATION; INFECTIONS; VALIDATION; VARIANT; REAL; DNA	Background: The Chlamydia trachomatis incidence rate in Finnmark, the most northern and sparsely populated county in Norway, has been twice the national average. This population based cross-sectional study among Finnmark high school students had the following aims: i) to examine distribution of multilocus sequence types (STs) of C. trachomatis in a previously unmapped area, ii) to compare chlamydia genetic diversity in Finnmark with that of two urban regions, and iii) to compare discriminatory capacity of multilocus sequence typing (MLST) with conventional ompA sequencing in a large number of chlamydia specimens. Methodology: ompA sequencing and a high-resolution MLST system based on PCR amplification and DNA sequencing of five highly variable genetic regions were used. Eighty chlamydia specimens from adolescents aged 15-20 years in Finnmark were collected in five high schools (n = 60) and from routine clinical samples in the laboratory (n = 20). These were compared to routine clinical samples from adolescents in Tromso (n = 80) and Trondheim (n = 88), capitals of North and Central Norway, respectively. Principal Findings: ompA sequencing detected 11 genotypes in 248 specimens from all three areas. MLST displayed 50 STs providing a five-fold higher resolution. Two-thirds of all STs were novel. The common ompA E/Bour genotype comprised 46% and resolved into 24 different STs. MLST identified the Swedish new variant of C. trachomatis not discriminated by ompA sequencing. Simpson's discriminatory index (D) was 0.93 for MLST, while a corrected D-c was 0.97. There were no statistically significant differences in ST genetic diversity between geographic areas. Finnmark had an atypical genovar distribution with G being predominant. This was mainly due to expansion of specific STs of which the novel ST161 was unique for Finnmark. Conclusions/Significance: MLST revealed multiple new STs and a larger genetic diversity in comparison to ompA sequencing and proved to be a useful tool in molecular epidemiology of chlamydia infections.	[Gravningen, Kirsten; Furberg, Anne-Sofie; Simonsen, Gunnar Skov] Univ Hosp N Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Gravningen, Kirsten; Furberg, Anne-Sofie; Simonsen, Gunnar Skov] Univ Tromso, Fac Hlth Sci, Tromso, Norway; [Christerson, Linus; Odman, Kristina; Stahlsten, Anna; Herrmann, Bjorn] Uppsala Univ, Dept Med Sci, Sect Clin Bacteriol, Uppsala, Sweden	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; Uppsala University	Gravningen, K (corresponding author), Univ Hosp N Norway, Dept Microbiol & Infect Control, Tromso, Norway.	kirsten.gravningen@unn.no		Gravningen, Kirsten/0000-0002-8194-3208	North Norway Savings Bank 1 [SNN1 29052008]	North Norway Savings Bank 1	The Norwegian Directorate of Health, State Budget 2009, chap. 719, p. 70. Ref. No: 2009001019. URL: http://www.helsedirektoratet.no/portal/page?_pageid = 134,112387&_dad = portal&_schema = PORTAL&language = english. 2. Sparebank1 Nord Norges Medical Research Grant 2008, i.e. The North Norway Savings Bank 1 Research Grant. Grant number: SNN129052008. URL: https://www2.sparebank1.no/portal/4702/3_privat?_nfpb = true&_pageLabel = page_privat_forside&_nfls = false. 3. The North Norway Regional Health Authority, 2009. Grant number: HST949-10. URL: http://www.helse-nord.no/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The medical research grant from the commercial funder North Norway Savings Bank 1 (no: SNN1 29052008) is awarded on application by an independent board of medical scientists/doctors and in collaboration with the North Norway Saving Bank 1 to research projects with a focus on the population in North Norway. None of the authors are employed by or do collaborate with this commercial funder. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The authors have declared that no competing interests exist.	Bom RJM, 2011, J CLIN MICROBIOL, V49, P2844, DOI 10.1128/JCM.00128-11; Borkowf CB, 2006, STAT MED, V25, P3679, DOI 10.1002/sim.2469; Christerson L, 2011, MULTILOCUS SEQUENCE; Christerson L, 2011, J CLIN MICROBIOL, V49, P2838, DOI 10.1128/JCM.00883-11; Christerson L, 2010, EMERG INFECT DIS, V16, P1777, DOI 10.3201/eid1611.100379; Dean D, 2009, EMERG INFECT DIS, V15, P1385, DOI 10.3201/eid1509.090272; Harding-Esch EM, 2010, CHLAMYDIAL INFECT, P55; Herrmann B, 2008, EMERG INFECT DIS, V14, P1462, DOI 10.3201/eid1409.080153; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Ikryannikova LN, 2010, FEMS IMMUNOL MED MIC, V59, P188, DOI 10.1111/j.1574-695X.2010.00678.x; Jalal H, 2006, J CLIN MICROBIOL, V44, P206, DOI 10.1128/JCM.44.1.206-213.2006; Jonsdottir K, 2003, SEX TRANSM DIS, V30, P249, DOI 10.1097/00007435-200303000-00015; Jurstrand M, 2010, SEX TRANSM INFECT, V86, P56, DOI 10.1136/sti.2009.037572; Klint M, 2011, CLIN MICROBIOL INFEC, V17, P683, DOI 10.1111/j.1469-0691.2010.03305.x; Klint M, 2007, J CLIN MICROBIOL, V45, P1410, DOI 10.1128/JCM.02301-06; Klovstad H, 2010, 10 NORW I PUBL HLTH; Klovstad H, 2009, SEX TRANSM DIS, V36, P17, DOI 10.1097/OLQ.0b013e31818653b0; Lysen M, 2004, J CLIN MICROBIOL, V42, P1641, DOI 10.1128/JCM.42.4.1641-1647.2004; Pannekoek Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-42; Pedersen LN, 2008, CLIN MICROBIOL INFEC, V14, P644, DOI 10.1111/j.1469-0691.2008.02011.x; Pedersen LN, 2009, FEMS IMMUNOL MED MIC, V55, P120, DOI 10.1111/j.1574-695X.2008.00526.x; Reinton Nils, 2010, Tidsskr Nor Laegeforen, V130, P380, DOI 10.4045/tidsskr.09.0051; Ripa T, 2007, SEX TRANSM DIS, V34, P255, DOI 10.1097/OLQ.0b013e31805ce2b9; Savage E J, 2007, Euro Surveill, V12, pE3; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; TRAEEN B, 1992, J COMMUNITY APPL SOC, V2, P227, DOI 10.1002/casp.2450020402; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016971	29	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34452	10.1371/journal.pone.0034452	http://dx.doi.org/10.1371/journal.pone.0034452			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470572	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000111
J	He, WX; Porsov, E; Kemp, D; Nuttall, AL; Ren, TY				He, Wenxuan; Porsov, Edward; Kemp, David; Nuttall, Alfred L.; Ren, Tianying			The Group Delay and Suppression Pattern of the Cochlear Microphonic Potential Recorded at the Round Window	PLOS ONE			English	Article							OUTER HAIR-CELLS; BASILAR-MEMBRANE; TECTORIAL MEMBRANE; MAMMALIAN COCHLEA; REVERSE PROPAGATION; MONGOLIAN GERBIL; GUINEA-PIG; MOUSE; VIBRATION; PRESTIN	Background: It is commonly assumed that the cochlear microphonic potential (CM) recorded from the round window (RW) is generated at the cochlear base. Based on this assumption, the low-frequency RW CM has been measured for evaluating the integrity of mechanoelectrical transduction of outer hair cells at the cochlear base and for studying sound propagation inside the cochlea. However, the group delay and the origin of the low-frequency RW CM have not been demonstrated experimentally. Methodology/Principal Findings: This study quantified the intra-cochlear group delay of the RW CM by measuring RW CM and vibrations at the stapes and basilar membrane in gerbils. At low sound levels, the RW CM showed a significant group delay and a nonlinear growth at frequencies below 2 kHz. However, at high sound levels or at frequencies above 2 kHz, the RW CM magnitude increased proportionally with sound pressure, and the CM phase in respect to the stapes showed no significant group delay. After the local application of tetrodotoxin the RW CM below 2 kHz became linear and showed a negligible group delay. In contrast to RW CM phase, the BM vibration measured at location,2.5 mm from the base showed high sensitivity, sharp tuning, and nonlinearity with a frequency-dependent group delay. At low or intermediate sound levels, low-frequency RW CMs were suppressed by an additional tone near the probe-tone frequency while, at high sound levels, they were partially suppressed only at high frequencies. Conclusions/Significance: We conclude that the group delay of the RW CM provides no temporal information on the wave propagation inside the cochlea, and that significant group delay of low-frequency CMs results from the auditory nerve neurophonic potential. Suppression data demonstrate that the generation site of the low-frequency RW CM shifts from apex to base as the probe-tone level increases.	[He, Wenxuan; Porsov, Edward; Nuttall, Alfred L.; Ren, Tianying] Oregon Hlth & Sci Univ, Dept Otolaryngol & Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Kemp, David] UCL, UCL Ear Inst, London, England	Oregon Health & Science University; University of London; University College London	He, WX (corresponding author), Oregon Hlth & Sci Univ, Dept Otolaryngol & Head & Neck Surg, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	rent@ohsu.edu			National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004554, R01DC000141, P30DC005983] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by the National Institutes of Health (NIH)/National Institute on Deafness and Other Communication Disorders (NIDCD) (http://www.nidcd.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian L, 2001, J ACOUST SOC AM, V109, P671, DOI 10.1121/1.1340644; BROWN AM, 1985, HEARING RES, V19, P191, DOI 10.1016/0378-5955(85)90138-8; Cheatham MA, 2007, AUDIOL NEURO-OTOL, V12, P378, DOI 10.1159/000106481; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; Cheatham MA, 2006, NONLINEAR RESPONSES; Cheatham MA, 2011, JARO-J ASSOC RES OTO, V12, P113, DOI 10.1007/s10162-010-0240-5; DALLOS P, 1971, J ACOUST SOC AM, V49, P1140, DOI 10.1121/1.1912475; DALLOS P, 1976, J ACOUST SOC AM, V60, P510, DOI 10.1121/1.381086; DALLOS P, 1973, BASIC MECHANISMS HEA, P335, DOI DOI 10.1016/B978-0-12-504250-5.50017-5; DOLAN DF, 1989, J ACOUST SOC AM, V86, P2167, DOI 10.1121/1.398477; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; Fridberger A, 2004, J NEUROSCI, V24, P10057, DOI 10.1523/JNEUROSCI.2711-04.2004; GREENWOOD D, 1961, J ACOUST SOC AM, V33, P1344, DOI 10.1121/1.1908437; He WX, 2008, P NATL ACAD SCI USA, V105, P2729, DOI 10.1073/pnas.0708103105; He WX, 2007, HEARING RES, V228, P112, DOI 10.1016/j.heares.2007.01.026; He WX, 2010, BIOPHYS J, V98, P2497, DOI 10.1016/j.bpj.2010.03.003; HENRY KR, 1995, HEARING RES, V90, P176, DOI 10.1016/0378-5955(95)00162-6; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; Kirk DL, 1997, HEARING RES, V112, P69, DOI 10.1016/S0378-5955(97)00104-4; Lagarde MMM, 2008, CURR BIOL, V18, P200, DOI 10.1016/j.cub.2008.01.006; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Legan PK, 2005, NAT NEUROSCI, V8, P1035, DOI 10.1038/nn1496; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lukashkin AN, 2007, CURR BIOL, V17, P1340, DOI 10.1016/j.cub.2007.06.061; Meenderink SWF, 2010, J NEUROPHYSIOL, V103, P1448, DOI 10.1152/jn.00899.2009; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; PATUZZI RB, 1989, HEARING RES, V39, P189, DOI 10.1016/0378-5955(89)90090-7; PATUZZI RB, 1989, HEARING RES, V42, P47, DOI 10.1016/0378-5955(89)90117-2; PATUZZI RB, 1989, HEARING RES, V39, P177, DOI 10.1016/0378-5955(89)90089-0; Ren TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020149; Ren TY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1226; Ren TY, 2004, NAT NEUROSCI, V7, P333, DOI 10.1038/nn1216; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; Rhode WS, 2007, J ACOUST SOC AM, V121, P2792, DOI 10.1121/1.2718397; RHODE WS, 1971, J ACOUST SOC AM, V49, P1218, DOI 10.1121/1.1912485; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Russell IJ, 2007, NAT NEUROSCI, V10, P215, DOI 10.1038/nn1828; RUSSELL IJ, 1986, HEARING RES, V22, P199, DOI 10.1016/0378-5955(86)90096-1; RUSSELL IJ, 1983, NATURE, V301, P334, DOI 10.1038/301334a0; Teudt IU, 2011, IEEE T BIO-MED ENG, V58, P1648, DOI 10.1109/TBME.2011.2108297; vonBekesy G., 1960, EXPT HEARING; WILSON JP, 1980, HEARING RES, V2, P527, DOI 10.1016/0378-5955(80)90090-8; Zou Y, 2006, J ACOUST SOC AM, V119, P2232, DOI 10.1121/1.2173517	43	22	22	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34356	10.1371/journal.pone.0034356	http://dx.doi.org/10.1371/journal.pone.0034356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470560	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000099
J	Jung, M; Leye, N; Vidal, N; Fargette, D; Diop, H; Kane, CT; Gascuel, O; Peeters, M				Jung, Matthieu; Leye, Nafissatou; Vidal, Nicole; Fargette, Denis; Diop, Halimatou; Kane, Coumba Toure; Gascuel, Olivier; Peeters, Martine			The Origin and Evolutionary History of HIV-1 Subtype C in Senegal	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DRUG-RESISTANCE MUTATIONS; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; INTERPRETATION ALGORITHMS; TYPE-1; STRAINS; NAIVE; SEX; MEN	Background: The classification of HIV-1 strains in subtypes and Circulating Recombinant Forms (CRFs) has helped in tracking the course of the HIV pandemic. In Senegal, which is located at the tip of West Africa, CRF02_AG predominates in the general population and Female Sex Workers (FSWs). In contrast, 40% of Men having Sex with Men (MSM) in Senegal are infected with subtype C. In this study we analyzed the geographical origins and introduction dates of HIV-1 C in Senegal in order to better understand the evolutionary history of this subtype, which predominates today in the MSM population Methodology/Principal Findings: We used a combination of phylogenetic analyses and a Bayesian coalescent-based approach, to study the phylogenetic relationships in pol of 56 subtype C isolates from Senegal with 3,025 subtype C strains that were sampled worldwide. Our analysis shows a significantly well supported cluster which contains all subtype C strains that circulate among MSM in Senegal. The MSM cluster and other strains from Senegal are widely dispersed among the different subclusters of African HIV-1 C strains, suggesting multiple introductions of subtype C in Senegal from many different southern and east African countries. More detailed analyses show that HIV-1 C strains from MSM are more closely related to those from southern Africa. The estimated date of the MRCA of subtype C in the MSM population in Senegal is estimated to be in the early 80's. Conclusions/Significance: Our evolutionary reconstructions suggest that multiple subtype C viruses with a common ancestor originating in the early 1970s entered Senegal. There was only one efficient spread in the MSM population, which most likely resulted from a single introduction, underlining the importance of high-risk behavior in spread of viruses.	[Jung, Matthieu; Leye, Nafissatou; Vidal, Nicole; Peeters, Martine] IRD, TransVIHMI, UMI233, Montpellier, France; [Jung, Matthieu; Fargette, Denis; Gascuel, Olivier] Univ Montpellier 2, Montpellier, France; [Jung, Matthieu; Gascuel, Olivier] CNRS, Lab Informat Robot & Microelectron Montpellier, UMR 5506, Montpellier, France; [Jung, Matthieu; Leye, Nafissatou; Vidal, Nicole; Peeters, Martine] Univ Montpellier I, Montpellier, France; [Leye, Nafissatou; Diop, Halimatou; Kane, Coumba Toure] Dantec Univ, Teaching Hosp, Lab Bacteriol & Virol, Dakar, Senegal; [Fargette, Denis] Inst Rech Dev, UMR RPB, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier; Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Jung, M (corresponding author), IRD, TransVIHMI, UMI233, Montpellier, France.	gascuel@lirmm.fr; martine.peeters@ird.fr	Vidal, Nicole/L-4130-2017	Vidal, Nicole/0000-0001-7022-2643; DIOP-NDIAYE, Halimatou/0000-0001-5885-5448	Region Languedoc-Roussillon; University of Montpellier 2, France; S.C.A.C. (Service de Cooperation et d'Action Culturelle) of the French Embassy in Senegal	Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France); University of Montpellier 2, France; S.C.A.C. (Service de Cooperation et d'Action Culturelle) of the French Embassy in Senegal	MJ was supported by a PhD grant from the Region Languedoc-Roussillon and from the University of Montpellier 2, France. Nafissatou Leye has a PhD grant from S.C.A.C. (Service de Cooperation et d'Action Culturelle) of the French Embassy in Senegal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha A, 2009, J VIROL, V83, P5592, DOI 10.1128/JVI.02051-08; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Ayouba A, 2009, AIDS RES HUM RETROV, V25, P1193, DOI 10.1089/aid.2009.0142; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; BARIN F, 1985, LANCET, V2, P1387; Bello G, 2008, AIDS, V22, P1993, DOI 10.1097/QAD.0b013e328315e0aa; Bennett DE, 2008, ANTIVIR THER, V13, P1; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Veras NMC, 2011, J GEN VIROL, V92, P1698, DOI 10.1099/vir.0.028951-0; Dalai SC, 2009, AIDS, V23, P2523, DOI 10.1097/QAD.0b013e3283320ef3; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; de Oliveira T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009311; Diop-Ndiaye H, 2010, AIDS RES HUM RETROV, V26, P1133, DOI 10.1089/aid.2009.0295; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fontella R, 2008, AIDS, V22, P2001, DOI 10.1097/QAD.0b013e3283108f69; Gamble LJ, 2010, DRUG DES DEV THER, V5, P9, DOI 10.2147/DDDT.S6959; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hamel DJ, 2007, AIDS RES HUM RETROV, V23, P1189, DOI 10.1089/aid.2007.0037; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; John-Stewart GC, 2005, J INFECT DIS, V192, P492, DOI 10.1086/431514; Alcantara LCJ, 2009, NUCLEIC ACIDS RES, V37, pW634, DOI 10.1093/nar/gkp455; KANE F, 1993, AIDS, V7, P1261, DOI 10.1097/00002030-199309000-00017; Kanki P J, 1997, AIDS, V11 Suppl B, pS33; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Martinez-Cajas JL, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-11; McDaid LM, 2010, CURR OPIN HIV AIDS, V5, P311, DOI 10.1097/COH.0b013e32833a0b86; Minin VN, 2008, MOL BIOL EVOL, V25, P1459, DOI 10.1093/molbev/msn090; Ndiaye HD, 2009, JAIDS-J ACQ IMM DEF, V52, P249, DOI 10.1097/QAI.0b013e3181af70a4; Neilson JR, 1999, J VIROL, V73, P4393, DOI 10.1128/JVI.73.5.4393-4403.1999; Peeters M, 2010, CLIN MICROBIOL INFEC, V16, P1525, DOI 10.1111/j.1469-0691.2010.03300.x; Posada D, 2001, MOL BIOL EVOL, V18, P897, DOI 10.1093/oxfordjournals.molbev.a003890; Rambaut A, 2001, NATURE, V410, P1047, DOI 10.1038/35074179; Renjifo B, 2004, AIDS, V18, P1629, DOI 10.1097/01.aids.0000131392.68597.34; Snoeck J, 2006, ANTIMICROB AGENTS CH, V50, P694, DOI 10.1128/AAC.50.2.694-701.2006; Soares EAJM, 2005, AIDS, V19, pS81, DOI 10.1097/01.aids.0000191497.00928.e4; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tebit DM, 2011, LANCET INFECT DIS, V11, P45, DOI 10.1016/S1473-3099(10)70186-9; Thomson MM, 2011, VIROLOGY, V415, P30, DOI 10.1016/j.virol.2011.03.021; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; Toure-Kane C, 2000, AIDS RES HUM RETROV, V16, P603, DOI 10.1089/088922200309025; Travers SAA, 2004, J VIROL, V78, P10501, DOI 10.1128/JVI.78.19.10501-10506.2004; Tully DC, 2010, AIDS, V24, P1577, DOI 10.1097/QAD.0b013e32833999e1; Vergne L, 2003, AIDS, V17, pS31, DOI 10.1097/00002030-200317003-00005; Vergne L, 2000, J CLIN MICROBIOL, V38, P3919, DOI 10.1128/JCM.38.11.3919-3925.2000; Vergne L, 2006, FEMS IMMUNOL MED MIC, V46, P53, DOI 10.1111/j.1574-695X.2005.00011.x; Vergne L, 2006, ANTIVIR THER, V11, P575; Vidal N, 2000, J VIROL, V74, P10498, DOI 10.1128/JVI.74.22.10498-10507.2000; Wade AS, 2005, AIDS, V19, P2133, DOI 10.1097/01.aids.0000194128.97640.07; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390	54	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33579	10.1371/journal.pone.0033579	http://dx.doi.org/10.1371/journal.pone.0033579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470456	Green Published, gold			2022-12-27	WOS:000304489000026
J	Partinen, M; Saarenpaa-Heikkila, O; Ilveskoski, I; Hublin, C; Linna, M; Olsen, P; Nokelainen, P; Alen, R; Wallden, T; Espo, M; Rusanen, H; Olme, J; Satila, H; Arikka, H; Kaipainen, P; Julkunen, I; Kirjavainen, T				Partinen, Markku; Saarenpaa-Heikkila, Outi; Ilveskoski, Ismo; Hublin, Christer; Linna, Miika; Olsen, Paivi; Nokelainen, Pekka; Alen, Reija; Wallden, Tiina; Espo, Merimaaria; Rusanen, Harri; Olme, Jan; Satila, Heli; Arikka, Harri; Kaipainen, Pekka; Julkunen, Ilkka; Kirjavainen, Turkka			Increased Incidence and Clinical Picture of Childhood Narcolepsy following the 2009 H1N1 Pandemic Vaccination Campaign in Finland	PLOS ONE			English	Article							INFLUENZA-A H1N1; GENOME-WIDE ASSOCIATION; RISK-FACTORS; CATAPLEXY; HYPERSOMNIA; POPULATION; INFECTIONS; ONSET; AUTOANTIBODIES; SUSCEPTIBILITY	Background: Narcolepsy is a rare neurological sleep disorder especially in children who are younger than 10 years. In the beginning of 2010, an exceptionally large number of Finnish children suffered from an abrupt onset of excessive daytime sleepiness (EDS) and cataplexy. Therefore, we carried out a systematic analysis of the incidence of narcolepsy in Finland between the years 2002-2010. Methods: All Finnish hospitals and sleep clinics were contacted to find out the incidence of narcolepsy in 2010. The national hospital discharge register from 2002 to 2009 was used as a reference. Findings: Altogether 335 cases (all ages) of narcolepsy were diagnosed in Finland during 2002-2009 giving an annual incidence of 0.79 per 100 000 inhabitants (95% confidence interval 0.62-0.96). The average annual incidence among subjects under 17 years of age was 0.31 (0.12-0.51) per 100 000 inhabitants. In 2010, 54 children under age 17 were diagnosed with narcolepsy (5.3/100 000; 17-fold increase). Among adults >= 20 years of age the incidence rate in 2010 was 0.87/100 000, which equals that in 2002-2009. Thirty-four of the 54 children were HLA-typed, and they were all positive for narcolepsy risk allele DQB1*0602/DRB1*15. 50/54 children had received Pandemrix vaccination 0 to 242 days (median 42) before onset. All 50 had EDS with abnormal multiple sleep latency test (sleep latency <8 min and >= 2 sleep onset REM periods). The symptoms started abruptly. Forty-seven (94%) had cataplexy, which started at the same time or soon after the onset of EDS. Psychiatric symptoms were common. Otherwise the clinical picture was similar to that described in childhood narcolepsy. Interpretation: A sudden increase in the incidence of abrupt childhood narcolepsy was observed in Finland in 2010. We consider it likely that Pandemrix vaccination contributed, perhaps together with other environmental factors, to this increase in genetically susceptible children.	[Partinen, Markku] Vitalmed Res Ctr, Finnish Narcolepsy Res Ctr, Helsinki Sleep Clin, Helsinki, Finland; [Partinen, Markku] Univ Helsinki, Dept Clin Neurosci, Helsinki, Finland; [Saarenpaa-Heikkila, Outi] Tampere Univ Hosp, Dept Paediat, Unit Child Neurol, Tampere, Finland; [Ilveskoski, Ismo] Univ Helsinki, Cent Hosp, Childrens Hosp, Dept Child Neurol, Helsinki, Finland; [Hublin, Christer] Finnish Inst Occupat Hlth, Helsinki, Finland; [Linna, Miika] Natl Inst Hlth & Welf THL, Dept Stat & Registers, Helsinki, Finland; [Olsen, Paivi] Oulu Univ Hosp, Dept Child Neurol, Oulu, Finland; [Nokelainen, Pekka] Kuopio Univ Hosp, Dept Child Neurol, SF-70210 Kuopio, Finland; [Alen, Reija] Jyvaskyla Cent Hosp, Dept Child Neurol, Jyvaskyla, Finland; [Wallden, Tiina; Espo, Merimaaria] Cent Hosp Kymenlaakso, Dept Child Neurol, Kotka, Finland; [Rusanen, Harri] Oulu Univ Hosp, Dept Neurol, Oulu, Finland; [Olme, Jan] Vaasa Cent Hosp, Dept Child Neurol, Vaasa, Finland; [Satila, Heli] Kanta Hame Cent Hosp, Dept Child Neurol, Hameenlinna, Finland; [Arikka, Harri] Turku Univ Hosp, Dept Child Neurol, FIN-20520 Turku, Finland; [Partinen, Markku; Kaipainen, Pekka] Rinnekoti Res Ctr, Espoo, Finland; [Julkunen, Ilkka] Natl Inst Hlth & Welf THL, Dept Vaccinat & Immune Protect, Helsinki, Finland; [Kirjavainen, Turkka] Univ Helsinki, Cent Hosp, Childrens Hosp, Dept Paediat, Helsinki, Finland	University of Helsinki; Tampere University; Tampere University Hospital; University of Helsinki; Helsinki University Central Hospital; Finnish Institute of Occupational Health; Finland National Institute for Health & Welfare; University of Oulu; Kuopio University Hospital; University of Eastern Finland; Central Finland Central Hospital; University of Oulu; Vaasa Central Hospital; University of Turku; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Partinen, M (corresponding author), Vitalmed Res Ctr, Finnish Narcolepsy Res Ctr, Helsinki Sleep Clin, Helsinki, Finland.	markku.partinen@helsinki.fi	Hublin, Christer/AAM-7105-2021; Sätilä, Heli/ABA-7179-2020	Partinen, Markku/0000-0002-8182-9368; Kirjavainen, Turkka/0000-0002-0043-5093; Julkunen, Ilkka/0000-0003-0165-2564	THL	THL	The authors have no external support or funding to report. The collection of data from the registries and from different hospitals was funded by THL. The study group had freedom for the study design, data collection, data analysis, data interpretation, and writing of the report. The authors had access to all the data, take responsibility for the integrity of the data and the accuracy of the analysis, and had final responsibility for the reporting of the data.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; [Anonymous], 2011, PRINCIPLES PRACTICE; Aran A, 2010, SLEEP, V33, P1457, DOI 10.1093/sleep/33.11.1457; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Cvetkovic-Lopes V, 2010, J CLIN INVEST, V120, P713, DOI 10.1172/JCI41366; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; Dauvilliers Y, 2010, SLEEP, V33, P1428, DOI 10.1093/sleep/33.11.1428; Deloumeau A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013320; Fontana A, 2010, BRAIN, V133, P1300, DOI 10.1093/brain/awq086; Hallmayer J, 2009, NAT GENET, V41, P708, DOI 10.1038/ng.372; Han F, 2001, SLEEP, V24, P321, DOI 10.1093/sleep/24.3.321; Han F, 2012, SLEEP MED, V13, P269, DOI 10.1016/j.sleep.2011.06.020; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Honda M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004254; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; HUBLIN C, 1994, ANN NEUROL, V35, P709, DOI 10.1002/ana.410350612; Ikonen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013329; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kawashima M, 2010, SLEEP, V33, P869, DOI 10.1093/sleep/33.7.869; Knudsen S, 2010, SLEEP, V33, P169, DOI 10.1093/sleep/33.2.169; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; Kornum BR, 2011, CURR OPIN NEUROBIOL, V21, P897, DOI 10.1016/j.conb.2011.09.003; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; Lareb, 2011, DUTCH CAS NARC ASS P; Longstreth WT, 2007, SLEEP, V30, P13, DOI 10.1093/sleep/30.1.13; Longstreth WT, 2009, SLEEP, V32, P1548, DOI 10.1093/sleep/32.12.1548; Medical Products Agency (Lakemedelsverket), 2011, OCC NARC CAT CHILDR; Medical Products Agency (Lakemedelsverket), 2010, MPA INV REP NARC PAT; Medicare Payment Advisory Commission, 2011, REG BAS COMP COH STU, P1; Mereckiene J, 2012, EURO SURVEILL, V17; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Miyagawa T, 2010, J HUM GENET, V55, P63, DOI 10.1038/jhg.2009.118; Montastruc JL, 2011, VACCINE, V29, P2010, DOI 10.1016/j.vaccine.2010.12.092; Nevsimalova S, 2011, EUR J PAEDIATR NEURO, V15, P320, DOI 10.1016/j.ejpn.2011.01.008; Nishino S, 2005, SLEEP MED REV, V9, P269, DOI 10.1016/j.smrv.2005.03.004; Nohynek H, 2012, PLOS ONE IN PRESS; Overeem S, 2008, SLEEP MED REV, V12, P95, DOI 10.1016/j.smrv.2007.07.010; Picchioni D, 2007, NEUROEPIDEMIOLOGY, V29, P185, DOI 10.1159/000111581; Coelho FMS, 2011, HUM IMMUNOL, V72, P817, DOI 10.1016/j.humimm.2011.05.024; Shimada M, 2010, HUM GENET, V128, P433, DOI 10.1007/s00439-010-0862-z; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; Talk about sleep, 2010, POSS LINK H1N1 NARC; Tanaka S, 2008, SLEEP, V31, P749, DOI 10.1093/sleep/31.5.749; Tanaka S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009555; THL, 2010, NAT I HLTH WELF REC; THL, 2011, ASS PAND NARC CONF F; Toyoda H, 2010, SLEEP, V33, P875, DOI 10.1093/sleep/33.7.875; Tsai TF, 2011, SCAND J INFECT DIS, V43, P702, DOI 10.3109/00365548.2011.580777; Webster RI, 2010, NEUROLOGY, V74, P1077, DOI 10.1212/WNL.0b013e3181d6b113; WHO, 2010, PAND VACC CAS NARC; Wijnans L, 2011, VACCINE, V29, P7559, DOI 10.1016/j.vaccine.2011.08.016	56	274	276	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33723	10.1371/journal.pone.0033723	http://dx.doi.org/10.1371/journal.pone.0033723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470463	Green Published, gold			2022-12-27	WOS:000304489000030
J	Diamantopoulou, A; Raftogianni, A; Stamatakis, A; Alikaridis, F; Oitzl, MS; Stylianopoulou, F				Diamantopoulou, Anastasia; Raftogianni, Androniki; Stamatakis, Antonios; Alikaridis, Filaretos; Oitzl, Melly S.; Stylianopoulou, Fotini			Denial of Reward in the Neonate Shapes Sociability and Serotonergic Activity in the Adult Rat	PLOS ONE			English	Article							EARLY-LIFE STRESS; LONG-EVANS RATS; KNOCK-OUT MICE; MATERNAL SEPARATION; AGGRESSIVE-BEHAVIOR; CORTICOSTERONE LEVELS; SOCIAL DEPRIVATION; CHILDHOOD TRAUMA; RHESUS-MONKEYS; COPING STYLES	Background: Manipulations of the early environment are linked to long-lasting alterations of emotionality and social capabilities. Denial of rewarding mother-pup interactions in early life of rats could serve as model for child neglect. Negative consequences for social competence in later life, accompanied by changes in the serotonergic system would be expected. In contrast, rewarding mother-pup contact should promote adequate social abilities. Methodology/Principal Findings: Male Wistar rats trained in a T-maze during postnatal days 10-13 under denial (DER) or permission (RER) of maternal contact were tested for play behavior in adolescence and for coping with defeat in adulthood. We estimated serotonin (5-HT) levels in the brain under basal conditions and following defeat, as well as serotonin receptor 1A (5-HT1A) and serotonin transporter (SERT) expression. DER rats exhibited increased aggressive-like play behavior in adolescence (i.e. increased nape attacks, p<0.0001) and selected a proactive coping style during defeat in adulthood (higher sum of proactive behaviors: number of attacks, flights, rearings and defensive upright posture; p = 0.011, p<0.05 vs RER, non-handled-NH). In adulthood, they had lower 5-HT levels in both the prefrontal cortex (p<0.05 vs RER) and the amygdala (p<0.05 vs NH), increased 5-HT levels following defeat (PFC p<0.0001) and decreased serotonin turnover (amygdala p = 0.008). The number of 5-HT1A immunopositive cells in the CA1 hippocampal area was increased (p<0.05 DER, vs RER, NH); SERT levels in the amygdala were elevated (p<0.05 vs RER, NH), but were lower in the prefrontal cortex (p<0.05 vs NH). Conclusions/Significance: Denial of expected maternal reward early in life negatively affects sociability and the serotonergic system in a complex manner. We propose that our animal model could contribute to the identification of the neurobiological correlates of early neglect effects on social behavior and coping with challenges, but also in parallel with the effects of a rewarding early-life environment.	[Diamantopoulou, Anastasia; Raftogianni, Androniki; Stamatakis, Antonios; Stylianopoulou, Fotini] Univ Athens, Sch Hlth Sci, Lab Biol Biochem, Athens, Greece; [Alikaridis, Filaretos] Univ Athens, Sch Med, Dept Biol Chem, Athens, Greece; [Oitzl, Melly S.] Leiden Univ, Div Med Pharmacol, Leiden, Netherlands	National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; Leiden University; Leiden University - Excl LUMC	Diamantopoulou, A (corresponding author), Univ Athens, Sch Hlth Sci, Lab Biol Biochem, Athens, Greece.	fstilian@nurs.uoa.gr	Stamatakis, A./J-5294-2019; STYLIANOPOULOU, FOTINI/B-1403-2008	Stamatakis, A./0000-0003-2480-5578; Raftogianni, Androniki/0000-0002-1850-8916	European Union; Heracleitus II. Investing in knowledge society [10947]; IRTG-NWO [DN-95-420]; NWO [433-09-251]; IRTG (International Research Training Group)	European Union(European Commission); Heracleitus II. Investing in knowledge society; IRTG-NWO; NWO(Netherlands Organization for Scientific Research (NWO)); IRTG (International Research Training Group)	This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund, Scholarship #10947 to AD. MSO supported by - IRTG-NWO DN-95-420 and NWO 433-09-251. AD also supported by IRTG (International Research Training Group). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova E, 2009, BIOL PSYCHIAT, V66, P627, DOI 10.1016/j.biopsych.2009.03.012; Amat J, 1998, BRAIN RES, V797, P12, DOI 10.1016/S0006-8993(98)00368-0; Arborelius L, 2004, PSYCHOPHARMACOLOGY, V176, P248, DOI 10.1007/s00213-004-1883-x; Arnold JL, 2002, DEV PSYCHOBIOL, V41, P205, DOI 10.1002/dev.10069; Bachevalier J, 2006, BEHAV NEUROSCI, V120, P989, DOI 10.1037/0735-7044.120.4.989; Barr CS, 2004, BIOL PSYCHIAT, V55, P733, DOI 10.1016/j.biopsych.2003.12.008; Barr CS, 2003, GENES BRAIN BEHAV, V2, P336, DOI 10.1046/j.1601-1848.2003.00051.x; Bartolomucci A, 2010, DIS MODEL MECH, V3, P459, DOI 10.1242/dmm.004614; Beauregard M, 1995, NEUROREPORT, V6, P2521, DOI 10.1097/00001756-199512150-00018; Belsky J, 1997, CHILD DEV, V68, P598, DOI 10.2307/1132110; Belsky J, 2009, MOL PSYCHIATR, V14, P746, DOI 10.1038/mp.2009.44; BLANCHARD RJ, 1977, BEHAV BIOL, V21, P197, DOI 10.1016/S0091-6773(77)90308-X; Bolhuis JE, 2004, BEHAV BRAIN RES, V152, P351, DOI 10.1016/j.bbr.2003.10.024; Caramaschi D, 2007, PHYSIOL BEHAV, V90, P590, DOI 10.1016/j.physbeh.2006.11.010; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cicchetti D, 2007, DEV PSYCHOPATHOL, V19, P1161, DOI 10.1017/S0954579407000600; Collier DA, 1996, MOL PSYCHIATR, V1, P453; Cools R, 2005, PSYCHOPHARMACOLOGY, V180, P670, DOI 10.1007/s00213-005-2215-5; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; de Boer SF, 2005, EUR J PHARMACOL, V526, P125, DOI 10.1016/j.ejphar.2005.09.065; de Boer SF, 2003, BEHAV GENET, V33, P485, DOI 10.1023/A:1025766415159; Diamantopoulou A, 2011, NEUROSCIENCE, V181, P89, DOI 10.1016/j.neuroscience.2011.03.002; DODGE KA, 1990, SCIENCE, V250, P1678, DOI 10.1126/science.2270481; Domes G, 2007, BIOL PSYCHIAT, V62, P1187, DOI 10.1016/j.biopsych.2007.03.025; Dori IE, 1998, EXP NEUROL, V154, P113, DOI 10.1006/exnr.1998.6937; Ethier LS, 2004, CHILD ABUSE NEGLECT, V28, P1265, DOI 10.1016/j.chiabu.2004.07.006; Fonagy P, 2004, ANN NY ACAD SCI, V1036, P181, DOI 10.1196/annals.1330.012; Gardner KL, 2005, NEUROSCIENCE, V136, P181, DOI 10.1016/j.neuroscience.2005.07.042; Gartside SE, 2003, EUR J NEUROSCI, V17, P2401, DOI 10.1046/j.1460-9568.2003.02668.x; Heim C, 2001, BIOL PSYCHIAT, V49, P1023, DOI 10.1016/S0006-3223(01)01157-X; Higley JD, 1996, NEUROPSYCHOPHARMACOL, V14, P67, DOI 10.1016/S0893-133X(96)80060-1; Homberg JR, 2007, NEUROSCIENCE, V146, P1662, DOI 10.1016/j.neuroscience.2007.03.030; Homberg JR, 2007, EUR J NEUROSCI, V26, P2066, DOI 10.1111/j.1460-9568.2007.05839.x; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; Ichise M, 2006, J NEUROSCI, V26, P4638, DOI 10.1523/JNEUROSCI.5199-05.2006; Kalin NH, 2008, MOL PSYCHIATR, V13, P1021, DOI 10.1038/mp.2008.37; Kalinichev M, 2002, PHARMACOL BIOCHEM BE, V73, P131, DOI 10.1016/S0091-3057(02)00781-5; Kasper Siegfried, 2002, World J Biol Psychiatry, V3, P133, DOI 10.3109/15622970209150614; Keeney A, 2006, J NEUROENDOCRINOL, V18, P330, DOI 10.1111/j.1365-2826.2006.01422.x; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kotch JB, 2008, PEDIATRICS, V121, P725, DOI 10.1542/peds.2006-3622; Ladd CO, 2000, PROG BRAIN RES, V122, P81; LAUDER JM, 1988, DEVELOPMENT, V102, P709; Lee JH, 2007, NEUROSCI RES, V58, P32, DOI 10.1016/j.neures.2007.01.008; Lesch KP, 2007, EMBO REP, V8, pS24, DOI 10.1038/sj.embor.7401008; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lesch KP, 2000, BEHAV SCI LAW, V18, P581, DOI 10.1002/1099-0798(200010)18:5<581::AID-BSL411>3.0.CO;2-L; Levitt P, 1997, TRENDS NEUROSCI, V20, P269, DOI 10.1016/S0166-2236(96)01028-4; LEWIS DO, 1992, J AM ACAD CHILD PSY, V31, P383, DOI 10.1097/00004583-199205000-00001; Li Q, 2000, J NEUROSCI, V20, P7888; Linthorst ACE, 2000, EUR J NEUROSCI, V12, P283, DOI 10.1046/j.1460-9568.2000.00878.x; LIPTON SA, 1989, TRENDS NEUROSCI, V12, P265, DOI 10.1016/0166-2236(89)90026-X; Machado CJ, 2006, BEHAV NEUROSCI, V120, P761, DOI 10.1037/0735-7044.120.4.761; McEwen BS, 2003, MENT RETARD DEV D R, V9, P149, DOI 10.1002/mrdd.10074; Meerlo P, 2001, BEHAV NEUROSCI, V115, P1111, DOI 10.1037//0735-7044.115.5.1111; Miczek KA, 2002, PSYCHOPHARMACOLOGY, V163, P434, DOI 10.1007/s00213-002-1139-6; Miczek KA, 2004, NEUROSCI BIOBEHAV R, V27, P787, DOI 10.1016/j.neubiorev.2003.11.005; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Nemeroff CB, 2004, J CLIN PSYCHIAT, V65, P18; Oler JA, 2009, J NEUROSCI, V29, P9961, DOI 10.1523/JNEUROSCI.0795-09.2009; Panagiotaropoulos T, 2004, NEUROENDOCRINOLOGY, V80, P181, DOI 10.1159/000082516; Panagiotaropoulos T, 2009, NEUROBIOL LEARN MEM, V91, P2, DOI 10.1016/j.nlm.2008.09.007; PANKSEPP J, 1980, BEHAV NEURAL BIOL, V30, P197, DOI 10.1016/S0163-1047(80)91077-8; Papaioannou A, 2002, NEUROSCIENCE, V114, P195, DOI 10.1016/S0306-4522(02)00129-X; Paxinos G., 2005, RAT BRAIN STEREOTAXI, Vxliii; PELLIS SM, 1990, DEV PSYCHOBIOL, V23, P215, DOI 10.1002/dev.420230303; PELLIS SM, 1995, BEHAV BRAIN RES, V68, P65, DOI 10.1016/0166-4328(94)00161-8; Pellis SM, 1998, NEUROSCI BIOBEHAV R, V23, P87, DOI 10.1016/S0149-7634(97)00071-7; Roy A, 2002, PSYCHIAT RES, V112, P69, DOI 10.1016/S0165-1781(02)00176-2; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; Sarchiapone A, 2009, EUR PSYCHIAT, V24, P57, DOI 10.1016/j.eurpsy.2008.07.005; Siever LJ, 2008, AM J PSYCHIAT, V165, P429, DOI 10.1176/appi.ajp.2008.07111774; Stamatakis A, 2006, NEUROSCIENCE, V140, P1, DOI 10.1016/j.neuroscience.2006.01.035; Suomi Stephen J, 2005, Novartis Found Symp, V268, P216; TORNATZKY W, 1994, PSYCHOPHARMACOLOGY, V116, P346, DOI 10.1007/BF02245339; Toth M, 2008, BEHAV NEUROSCI, V122, P849, DOI 10.1037/0735-7044.122.4.849; van den Berg CL, 1999, DEV PSYCHOBIOL, V34, P129, DOI 10.1002/(SICI)1098-2302(199903)34:2<129::AID-DEV6>3.3.CO;2-C; van der Vegt BJ, 2003, BEHAV NEUROSCI, V117, P667, DOI 10.1037/0735-7044.117.4.667; van der Vegt BJ, 2001, PHYSIOL BEHAV, V74, P205, DOI 10.1016/S0031-9384(01)00565-0; van Erp AMM, 2000, J NEUROSCI, V20, P9320; van Honk J, 2010, J PERS, V78, P67, DOI 10.1111/j.1467-6494.2009.00609.x; Vanderschuren LJMJ, 1997, NEUROSCI BIOBEHAV R, V21, P309, DOI 10.1016/S0149-7634(96)00020-6; Vazquez DM, 2000, BRAIN RES, V855, P76, DOI 10.1016/S0006-8993(99)02307-0; Veenema AH, 2006, EUR J NEUROSCI, V24, P1711, DOI 10.1111/j.1460-9568.2006.05045.x; Veenema AH, 2009, FRONT NEUROENDOCRIN, V30, P497, DOI 10.1016/j.yfrne.2009.03.003; Veenema AH, 2009, PSYCHONEUROENDOCRINO, V34, P463, DOI 10.1016/j.psyneuen.2008.10.017; Venerosi A, 2003, PHARMACOL BIOCHEM BE, V74, P671, DOI 10.1016/S0091-3057(02)01068-7; Vicentic A, 2006, NEUROSCIENCE, V140, P355, DOI 10.1016/j.neuroscience.2006.02.008; Vitalis T, 2003, DEV NEUROSCI-BASEL, V25, P245, DOI 10.1159/000072272; Vitiello B, 1997, J AM ACAD CHILD PSY, V36, P307, DOI 10.1097/00004583-199703000-00008; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007; WIDOM CS, 1989, AM J ORTHOPSYCHIAT, V59, P355, DOI 10.1111/j.1939-0025.1989.tb01671.x; Wigger A, 1999, PHYSIOL BEHAV, V66, P293, DOI 10.1016/S0031-9384(98)00300-X; Witte AV, 2009, HUM BRAIN MAPP, V30, P2558, DOI 10.1002/hbm.20687; Ziabreva I, 2003, J NEUROSCI, V23, P5329	98	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33793	10.1371/journal.pone.0033793	http://dx.doi.org/10.1371/journal.pone.0033793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479443	gold, Green Published, Green Submitted			2022-12-27	WOS:000303894900038
J	Lin, YT; Liu, CJ; Chen, TJ; Fung, CP				Lin, Yi-Tsung; Liu, Chia-Jen; Chen, Tzeng-Ji; Fung, Chang-Phone			Long-Term Mortality of Patients with Septic Ocular or Central Nervous System Complications from Pyogenic Liver Abscess: A Population-Based Study	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE BACTEREMIA; EMERGING DISEASE; RISK-FACTORS; SEROTYPE K1; ENDOPHTHALMITIS; TAIWAN; INFECTION; PATHOGEN	Background: Taiwan is endemic for pyogenic liver abscess (PLA). Septic ocular or central nervous system (CNS) complications derived from PLA can result in catastrophic disability. We investigated the epidemiology and long-term prognosis of PLA patients with septic ocular or CNS complications over an 8-year period. Methodology/Principal Findings: We extracted 21,307 patients with newly diagnosed PLA from a nationwide health registry in Taiwan between 2000 and 2007. The frequency of and risk factors for PLA with septic ocular or CNS complications were determined. The 2-year survival of these patients was compared between those with and without septic ocular or CNS complications. Septic ocular or CNS complications accounted for 2.1% of all PLA patients. Age and the Charlson comorbidity index were significantly lower in PLA patients with ocular or CNS complications than those without. Diabetes and age <65 years were independent predictors of septic ocular or CNS complications. The 2-year mortality of patients with septic ocular or CNS complications was similar to those without complications (24.8% vs. 27.5%, p = 0.502). However, among patients <65 years old and a Charlson index <= 1, the 2-year mortality was significantly higher in those with than without complications (18.6% vs. 11.8%, p = 0.001). Conclusions/Significance: Physicians should recognize that catastrophic disability due to ocular or neurological complications from PLA could lead to a poor long-term prognosis, and should follow-up these patients more closely.	[Lin, Yi-Tsung; Fung, Chang-Phone] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan; [Liu, Chia-Jen] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan; [Lin, Yi-Tsung; Liu, Chia-Jen; Chen, Tzeng-Ji; Fung, Chang-Phone] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Tzeng-Ji] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Fung, CP (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan.	cpfung@vghtpe.gov.tw	Chen, TJ/AAH-8430-2021		Taipei Veterans General Hospital [V100D-002-3]	Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work was supported partly by grants from Taipei Veterans General Hospital (V100D-002-3). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahmood Ammar M., 2011, International Ophthalmology, V31, P145, DOI 10.1007/s10792-011-9429-9; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHENG D-L, 1991, Archives of Internal Medicine, V151, P1557, DOI 10.1001/archinte.151.8.1557; Chou FF, 1996, J AM COLL SURGEONS, V182, P33; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Jepsen P, 2005, ALIMENT PHARM THER, V21, P1185, DOI 10.1111/j.1365-2036.2005.02487.x; Kaplan GG, 2004, CLIN GASTROENTEROL H, V2, P1032, DOI 10.1016/S1542-3565(04)00459-8; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Laupland KB, 2011, INFECTION, V39, P405, DOI 10.1007/s15010-011-0149-x; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Lee SSJ, 2008, CLIN INFECT DIS, V47, P642, DOI 10.1086/590932; LEIBOVICI L, 1995, JAMA-J AM MED ASSOC, V274, P807, DOI 10.1001/jama.274.10.807; Lin YT, 2011, AM J MED, V124, P1158, DOI 10.1016/j.amjmed.2011.08.012; LIU YC, 1986, ARCH INTERN MED, V146, P1913, DOI 10.1001/archinte.146.10.1913; Lok KH, 2008, J MICROBIOL IMMUNOL, V41, P483; Meddings L, 2010, AM J GASTROENTEROL, V105, P117, DOI 10.1038/ajg.2009.614; Sheu SJ, 2011, RETINA-J RET VIT DIS, V31, P2026, DOI 10.1097/IAE.0b013e31820d3f9e; Tan YM, 2004, WORLD J SURG, V28, P38, DOI 10.1007/s00268-003-6963-2; Tsai FC, 2008, EMERG INFECT DIS, V14, P1592, DOI 10.3201/eid1410.071254; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Yang CS, 2007, OPHTHALMOLOGY, V114, P876, DOI 10.1016/j.ophtha.2006.12.035; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06	25	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33978	10.1371/journal.pone.0033978	http://dx.doi.org/10.1371/journal.pone.0033978			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479491	gold, Green Submitted, Green Published			2022-12-27	WOS:000303894900054
J	Saravia, LA; Giorgi, A; Momo, F				Saravia, Leonardo Ariel; Giorgi, Adonis; Momo, Fernando			Multifractal Spatial Patterns and Diversity in an Ecological Succession	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; LIQUID WATER DISTRIBUTIONS; MARINE STRATOCUMULUS; SCALE-INVARIANCE; RAIN-FORESTS; INTERMITTENCY; COMPETITION; VEGETATION; HETEROGENEITY; BIODIVERSITY	We analyzed the relationship between biodiversity and spatial biomass heterogeneity along an ecological succession developed in the laboratory. Periphyton (attached microalgae) biomass spatial patterns at several successional stages were obtained using digital image analysis and at the same time we estimated the species composition and abundance. We show that the spatial pattern was self-similar and as the community developed in an homogeneous environment the pattern is self-organized. To characterize it we estimated the multifractal spectrum of generalized dimensions D-q. Using D-q we analyze the existence of cycles of heterogeneity during succession and the use of the information dimension D-1 as an index of successional stage. We did not find cycles but the values of D-1 showed an increasing trend as the succession developed and the biomass was higher. D-1 was also negatively correlated with Shannon's diversity. Several studies have found this relationship in different ecosystems but here we prove that the community self-organizes and generates its own spatial heterogeneity influencing diversity. If this is confirmed with more experimental and theoretical evidence D-1 could be used as an index, easily calculated from remote sensing data, to detect high or low diversity areas.	[Saravia, Leonardo Ariel; Momo, Fernando] Univ Nacl Gen Sarmiento, Inst Ciencias, Buenos Aires, DF, Argentina; [Giorgi, Adonis] Univ Nacl Lujan, Dept Ciencias Basicas, CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Lujan	Saravia, LA (corresponding author), Univ Nacl Gen Sarmiento, Inst Ciencias, Buenos Aires, DF, Argentina.	lsaravia@ungs.edu.ar	Momo, Fernando/A-5984-2015; Saravia, Leonardo A./AAM-3461-2021; Momo, Fernando R/E-3426-2012	Saravia, Leonardo A./0000-0002-7911-4398; Momo, Fernando R/0000-0003-0710-1149	Universidad Nacional de Lujan	Universidad Nacional de Lujan	This work was supported by the Universidad Nacional de Lujan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alados CL, 2007, ECOL MODEL, V201, P233, DOI 10.1016/j.ecolmodel.2006.09.014; Alados CL, 2006, BIOL J LINN SOC, V87, P103, DOI 10.1111/j.1095-8312.2006.00559.x; Alados CL, 2004, ECOL MODEL, V180, P523, DOI 10.1016/j.ecolmodel.2003.10.034; Alados CL, 2003, ECOL MODEL, V163, P1, DOI 10.1016/S0304-3800(02)00294-6; Saravia LA, 2012, OIKOS, V121, P1810, DOI 10.1111/j.1600-0706.2011.20423.x; Armesto JJ, 1991, ECOLOGICAL HETEROGEN, P256; Biggs BJF, 1998, ARCH HYDROBIOL, V143, P21; Biggs BJF, 2002, LIMNOL OCEANOGR, V47, P1175, DOI 10.4319/lo.2002.47.4.1175; Borda-de-Agua L, 2002, AM NAT, V159, P138, DOI 10.1086/324787; Brown JH, 2002, PHILOS T R SOC B, V357, P619, DOI 10.1098/rstb.2001.0993; Buttel LA, 2002, THEOR POPUL BIOL, V61, P265, DOI 10.1006/tpbi.2001.1569; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Chave J, 2003, J ECOL, V91, P240, DOI 10.1046/j.1365-2745.2003.00757.x; CROWLEY PH, 1992, ANNU REV ECOL SYST, V23, P405, DOI 10.1146/annurev.es.23.110192.002201; Davis A, 1996, J ATMOS SCI, V53, P1538, DOI 10.1175/1520-0469(1996)053<1538:SIOLWD>2.0.CO;2; DAVIS A, 1994, J GEOPHYS RES-ATMOS, V99, P8055, DOI 10.1029/94JD00219; Dodds WK, 1999, J PHYCOL, V35, P42, DOI 10.1046/j.1529-8817.1999.3510042.x; Dufour A, 2006, ECOGRAPHY, V29, P573, DOI 10.1111/j.0906-7590.2006.04605.x; Economo EP, 2008, ECOL LETT, V11, P52, DOI 10.1111/j.1461-0248.2007.01126.x; Everstz C. J. G., 1992, CHAOS FRACTALS NEW F, P921; GRASSBERGER P, 1983, PHYS LETT A, V97, P227, DOI 10.1016/0375-9601(83)90753-3; HASTINGS HM, 1982, BIOSYSTEMS, V15, P281, DOI 10.1016/0303-2647(82)90043-0; Hastings HM, 1993, FRACTALS USERS GUIDE; HOLM S, 1979, SCAND J STAT, V6, P65; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; Klausmeier CA, 1999, SCIENCE, V284, P1826, DOI 10.1126/science.284.5421.1826; Lavallee D., 1993, FRACTALS GEOGRAPHY, P158; Li BL, 2000, ECOL MODEL, V132, P33, DOI 10.1016/S0304-3800(00)00303-3; Loehle C, 1996, ECOL APPL, V6, P784, DOI 10.2307/2269483; Loehle C, 1996, ECOL MODEL, V85, P271, DOI 10.1016/0304-3800(94)00177-4; Lowe Rex L., 1996, P57, DOI 10.1016/B978-012668450-6/50032-1; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Manrubia SC, 1996, CHAOS SOLITON FRACT, V7, P523, DOI 10.1016/0960-0779(95)00091-7; MARGALEF R, 1979, OIKOS, V33, P152, DOI 10.2307/3543992; Marshak A, 1997, J ATMOS SCI, V54, P1423, DOI 10.1175/1520-0469(1997)054<1423:SIILWD>2.0.CO;2; MELTZER MI, 1992, J APPL ECOL, V29, P635, DOI 10.2307/2404471; PASCUAL M, 1995, J PLANKTON RES, V17, P1209, DOI 10.1093/plankt/17.6.1209; Plotnick RE, 2001, PALEOBIOLOGY, V27, P126, DOI 10.1666/0094-8373(2001)027<0126:AMMMFO>2.0.CO;2; REJMANEK M, 1992, ECOLOGY, V73, P2329, DOI 10.2307/1941478; Renshaw E, 1997, FOREST ECOL MANAG, V94, P165, DOI 10.1016/S0378-1127(96)03977-1; Renyi A., 1970, PROBABILITY THEORY; Ricotta C, 2000, ECOL MODEL, V125, P245, DOI 10.1016/S0304-3800(99)00185-4; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Saravia Leonardo A., 1999, Aquatic Ecology, V33, P325, DOI 10.1023/A:1009934626188; Seuront L, 2002, PHYSICA A, V313, P513, DOI 10.1016/S0378-4371(02)00989-5; Seuront L, 1999, J PLANKTON RES, V21, P877, DOI 10.1093/plankt/21.5.877; Smyth G., 2011, STATMOD STAT MODELIN; SOLE RV, 1995, PHYS REV E, V51, P6250, DOI 10.1103/PhysRevE.51.6250; SOLE RV, 1995, J THEOR BIOL, V173, P31, DOI 10.1006/jtbi.1995.0040; SOLE RV, 2006, SELF ORG COMPLEX ECO; SUGIHARA G, 1990, TRENDS ECOL EVOL, V5, P79, DOI 10.1016/0169-5347(90)90235-6; Thomaz SM, 2008, FRESHWATER BIOL, V53, P358, DOI 10.1111/j.1365-2427.2007.01898.x; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Vadeboncoeur Y, 2001, ECOLOGY, V82, P1065, DOI 10.1890/0012-9658(2001)082[1065:WLFEOD]2.0.CO;2; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952; Weigelt A, 2008, ECOL LETT, V11, P338, DOI 10.1111/j.1461-0248.2007.01145.x; Wetzel R.G., 1983, LIMNOLOGY, V2nd; Yakimov BN, 2008, OIKOS, V117, P33, DOI 10.1111/j.2007.0030-1299.16121.x; YARRANTON GA, 1974, J ECOL, V62, P417, DOI 10.2307/2258988	61	9	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e34096	10.1371/journal.pone.0034096	http://dx.doi.org/10.1371/journal.pone.0034096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470522	Green Submitted, Green Published, gold			2022-12-27	WOS:000303857100066
J	Chang, EM; Shi, SQ; Liu, JF; Cheng, TL; Xue, L; Yang, XY; Yang, WJ; Lan, Q; Jiang, ZP				Chang, Ermei; Shi, Shengqing; Liu, Jianfeng; Cheng, Tielong; Xue, Liang; Yang, Xiuyan; Yang, Wenjuan; Lan, Qian; Jiang, Zeping			Selection of Reference Genes for Quantitative Gene Expression Studies in Platycladus orientalis (Cupressaceae) Using Real-Time PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; INTERNAL CONTROL GENES; HOUSEKEEPING GENES; RT-PCR; NORMALIZATION; IDENTIFICATION; RNA; VALIDATION; RICE	Platycladus orientalis is a tree species that is highly resistant, widely adaptable, and long-lived, with lifespans of even thousands of years. To explore the mechanisms underlying these characteristics, gene expressions have been investigated at the transcriptome level by RNA-seq combined with a digital gene expression (DGE) technique. So, it is crucial to have a reliable set of reference genes to normalize the expressions of genes in P. orientalis under various conditions using the most accurate and sensitive method of quantitative real-time PCR (qRT-PCR). In this study, we selected 10 reference gene candidates from transcriptome data of P. orientalis, and examined their expression profiles by qRT-PCR using 29 different samples of P. orientalis, which were collected from plants of different ages, different tissues, and plants subjected to different treatments including cold, heat, salinity, polyethylene glycol (PEG), and abscisic acid (ABA). Three analytical software packages (geNorm, Bestkeeper, and NormFinder) were used to assess the stability of gene expression. The results showed that ubiquitin-conjugating enzyme E2 (UBC) and alpha-tubulin (aTUB) were the optimum pair of reference genes at all developmental stages and under all stress conditions. ACT7 was the most stable gene across different tissues and cold-treated samples, while UBQ was the most stably expressed reference gene for NaCl-and ABA-treated samples. In parallel, aTUB and UBC were used singly or in combination as reference genes to examine the expression levels of NAC (a homolog of AtNAC2) in plants subjected to various treatments with qRT-PCR. The results further proved the reliability of the two selected reference genes. Our study will benefit future research on the expression of genes in response to stress/senescence in P. orientalis and other members of the Cupressaceae.	[Chang, Ermei; Shi, Shengqing; Liu, Jianfeng; Xue, Liang; Yang, Xiuyan; Yang, Wenjuan; Lan, Qian; Jiang, Zeping] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Cheng, Tielong] Chinese Acad Forestry, Sci Tech Management Div, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Chinese Academy of Forestry	Jiang, ZP (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	jiangzp@caf.ac.cn		xue, liang/0000-0001-8188-073X; Liu, Jianfeng/0000-0002-5502-0872	Grant for National Non-profit Research Institutions of CAF [RIF2010-10]; National Natural Science Foundation of China [31100490]	Grant for National Non-profit Research Institutions of CAF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a Grant for National Non-profit Research Institutions of CAF (RIF2010-10) and National Natural Science Foundation of China (31100490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Balazadeh S, 2010, PLANT J, V62, P250, DOI 10.1111/j.1365-313X.2010.04151.x; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Everaert BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023793; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Faccioli P, 2007, PLANT MOL BIOL, V63, P679, DOI 10.1007/s11103-006-9116-9; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hoenemann C, 2011, ELECTRON J BIOTECHN, V14, DOI 10.2225/vol14-issue1-fulltext-8; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Ishimaru T, 2005, PLANT CELL PHYSIOL, V46, P620, DOI 10.1093/pcp/pci066; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jiang P, 2009, J SHIHEZI U NATURAL, V27, P30; Kanegae H, 2005, PLANT PHYSIOL BIOCH, V43, P669, DOI 10.1016/j.plaphy.2005.06.004; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kim JH, 2009, SCIENCE, V323, P1053, DOI 10.1126/science.1166386; Kwon MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006162; Lanner RM, 2002, AGEING RES REV, V1, P653, DOI 10.1016/S1568-1637(02)00025-9; Li Xin-ping, 2011, Forest Research, V24, P91; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Lovdal T, 2009, ANAL BIOCHEM, V387, P238, DOI 10.1016/j.ab.2009.01.024; Luo HL, 2010, ANAL BIOCHEM, V404, P100, DOI 10.1016/j.ab.2010.05.002; Maess MB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-90; Mahoney DJ, 2004, PHYSIOL GENOMICS, V18, P226, DOI 10.1152/physiolgenomics.00067.2004; McCurley AT, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-102; Migocka M, 2011, MOL BREEDING, V28, P343, DOI 10.1007/s11032-010-9487-0; Narayanan NN, 2007, PLANT PHYSIOL BIOCH, V45, P277, DOI 10.1016/j.plaphy.2007.03.021; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Penuelas J, 2005, NATURE, V437, P965, DOI 10.1038/437965a; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Remans T, 2008, PLANTA, V227, P1343, DOI 10.1007/s00425-008-0706-4; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Yan HZ, 2006, FUNGAL GENET BIOL, V43, P430, DOI 10.1016/j.fgb.2006.01.010; Yang LT, 2005, J AGR FOOD CHEM, V53, P183, DOI 10.1021/jf0493730; Yoo WG, 2009, PARASITOL RES, V104, P321, DOI 10.1007/s00436-008-1195-x; Zhang YanJie, 2010, Scientia Silvae Sinicae, V46, P134; Zhao WJ, 2011, J IND MICROBIOL BIOT, V38, P1279, DOI 10.1007/s10295-010-0906-3	57	120	139	6	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33278	10.1371/journal.pone.0033278	http://dx.doi.org/10.1371/journal.pone.0033278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479379	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100039
J	Kim, J; Li, Y; Buckett, PD; Bohlke, M; Thompson, KJ; Takahashi, M; Maher, TJ; Wessling-Resnick, M				Kim, Jonghan; Li, Yuan; Buckett, Peter D.; Boehlke, Mark; Thompson, Khristy J.; Takahashi, Masaya; Maher, Timothy J.; Wessling-Resnick, Marianne			Iron-Responsive Olfactory Uptake of Manganese Improves Motor Function Deficits Associated with Iron Deficiency	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT-BRAIN; IN-VIVO; DOPAMINE; TRANSPORTER; METABOLISM; REGIONS; ACCUMULATION; AMPHETAMINE; ABSORPTION	Iron-responsive manganese uptake is increased in iron-deficient rats, suggesting that toxicity related to manganese exposure could be modified by iron status. To explore possible interactions, the distribution of intranasally-instilled manganese in control and iron-deficient rat brain was characterized by quantitative image analysis using T1-weighted magnetic resonance imaging (MRI). Manganese accumulation in the brain of iron-deficient rats was doubled after intranasal administration of MnCl2 for 1-or 3-week. Enhanced manganese level was observed in specific brain regions of iron-deficient rats, including the striatum, hippocampus, and prefrontal cortex. Iron-deficient rats spent reduced time on a standard accelerating rotarod bar before falling and with lower peak speed compared to controls; unexpectedly, these measures of motor function significantly improved in iron-deficient rats intranasally-instilled with MnCl2. Although tissue dopamine concentrations were similar in the striatum, dopamine transporter (DAT) and dopamine receptor D-1 (D1R) levels were reduced and dopamine receptor D-2 (D2R) levels were increased in manganese-instilled rats, suggesting that manganese-induced changes in post-synaptic dopaminergic signaling contribute to the compensatory effect. Enhanced olfactory manganese uptake during iron deficiency appears to be a programmed "rescue response" with beneficial influence on motor impairment due to low iron status.	[Kim, Jonghan; Li, Yuan; Buckett, Peter D.; Thompson, Khristy J.; Wessling-Resnick, Marianne] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Boehlke, Mark; Maher, Timothy J.] Massachusetts Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Boston, MA USA; [Takahashi, Masaya] Harvard Inst Med, Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kim, J (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	wessling@hsph.harvard.edu			NIH [R90 DK071507, K99 ES17781, R03 DA027030, R01 ES014638]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014638, K99ES017781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027030] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported NIH Roadmap Training Grant R90 DK071507 (JK), by NIH grant K99 ES17781 (JK), and by National Institutes of Health grants R03 DA027030 and R01 ES014638 (MWR). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIEHS (National Institute of Environmental Health Sciences (NIEHS)). NIEHS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JG, 2007, ENVIRON TOXICOL PHAR, V23, P179, DOI 10.1016/j.etap.2006.08.006; Aschner M, 2005, CRIT REV TOXICOL, V35, P1, DOI 10.1080/10408440590905920; AUTISSIER N, 1982, TOXICOLOGY, V24, P175, DOI 10.1016/0300-483X(82)90055-5; BEARD JL, 1994, PHARMACOL BIOCHEM BE, V48, P621, DOI 10.1016/0091-3057(94)90323-9; BONILLA E, 1984, EXP NEUROL, V84, P696, DOI 10.1016/0014-4886(84)90216-4; Brenneman KA, 2000, TOXICOL APPL PHARM, V169, P238, DOI 10.1006/taap.2000.9073; Canonne-Hergaux F, 1999, BLOOD, V93, P4406, DOI 10.1182/blood.V93.12.4406.412k21_4406_4417; Chen MK, 2006, NEUROTOXICOLOGY, V27, P229, DOI 10.1016/j.neuro.2005.10.008; CHEN Q, 1995, J NUTR BIOCHEM, V6, P486, DOI 10.1016/0955-2863(95)00074-A; COTZIAS GC, 1958, PHYSIOL REV, V38, P503, DOI 10.1152/physrev.1958.38.3.503; EPA, 2010, 7439965 EPA CASRN; Erikson KA, 2002, BIOL TRACE ELEM RES, V87, P143, DOI 10.1385/BTER:87:1-3:143; Erikson KM, 2000, J NUTR, V130, P2831, DOI 10.1093/jn/130.11.2831; Ferguson SA, 2003, PHYSIOL BEHAV, V80, P109, DOI 10.1016/S0031-9384(03)00214-2; Fitsanakis VA, 2008, TOXICOL SCI, V103, P116, DOI 10.1093/toxsci/kfn019; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; GAMACHE P, 1993, J CHROMATOGR-BIOMED, V614, P213, DOI 10.1016/0378-4347(93)80311-Q; Guilarte TR, 2008, J NEUROCHEM, V107, P1236, DOI 10.1111/j.1471-4159.2008.05695.x; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Heilig E, 2005, AM J PHYSIOL-LUNG C, V288, pL887, DOI 10.1152/ajplung.00382.2004; HUNT JR, 1994, AM J CLIN NUTR, V59, P413, DOI 10.1093/ajcn/59.2.413; Ingersoll RT, 1999, NEUROTOXICOLOGY, V20, P467; Kankaanpaa A, 2001, J CHROMATOGR B, V753, P413, DOI 10.1016/S0378-4347(00)00553-3; Kern CH, 2011, SYNAPSE, V65, P532, DOI 10.1002/syn.20873; Kern CH, 2010, SYNAPSE, V64, P363, DOI 10.1002/syn.20736; Lozoff B, 2011, J NUTR, V141, p740S, DOI 10.3945/jn.110.131169; McEwan AG, 2009, MOL MICROBIOL, V72, P812, DOI 10.1111/j.1365-2958.2009.06700.x; McNaughton RL, 2010, P NATL ACAD SCI USA, V107, P15335, DOI 10.1073/pnas.1009648107; NACHTMAN JP, 1986, NEUROTOXICOL TERATOL, V8, P711; Nelson C, 1997, J NUTR, V127, P2282, DOI 10.1093/jn/127.12.2282; Nong A, 2008, J TOXICOL ENV HEAL A, V71, P413, DOI 10.1080/15287390701838697; SUBHASH MN, 1991, FOOD CHEM TOXICOL, V29, P579, DOI 10.1016/0278-6915(91)90051-8; TAKEDA A, 1995, BRAIN RES, V695, P53, DOI 10.1016/0006-8993(95)00916-E; Takeda A, 1998, BRAIN RES BULL, V45, P149, DOI 10.1016/S0361-9230(97)00330-4; Thompson K, 2006, TOXICOL APPL PHARM, V210, P17, DOI 10.1016/j.taap.2005.05.014; Thompson K, 2007, FASEB J, V21, P223, DOI 10.1096/fj.06-6710com; Thompson KJ, 2011, TOXICOL SCI, V120, P163, DOI 10.1093/toxsci/kfq387; Tjalve H, 1996, PHARMACOL TOXICOL, V79, P347; Vidal L, 2005, NEUROCHEM RES, V30, P1147, DOI 10.1007/s11064-005-7775-6; Williams JM, 2010, TOXICOL SCI, V114, P310, DOI 10.1093/toxsci/kfq002; Yamamoto K, 2001, PLANT CELL PHYSIOL, V42, P969, DOI 10.1093/pcp/pce125; YOUDIM MBH, 1989, AM J CLIN NUTR, V50, P607, DOI 10.1093/ajcn/50.3.607	42	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33533	10.1371/journal.pone.0033533	http://dx.doi.org/10.1371/journal.pone.0033533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479410	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100055
J	Lau, EMT; Iyer, N; Ilsar, R; Bailey, BP; Adams, MR; Celermajer, DS				Lau, Edmund M. T.; Iyer, Nithin; Ilsar, Rahn; Bailey, Brian P.; Adams, Mark R.; Celermajer, David S.			Abnormal Pulmonary Artery Stiffness in Pulmonary Arterial Hypertension: In Vivo Study with Intravascular Ultrasound	PLOS ONE			English	Article							MAGNETIC-RESONANCE; CLINICAL-APPLICATIONS; VASCULAR-RESISTANCE; DISTENSIBILITY; PRESSURE; FLOW; CAPACITANCE; MORTALITY; IMPEDANCE; DISEASE	Background: There is increasing recognition that pulmonary artery stiffness is an important determinant of right ventricular (RV) afterload in pulmonary arterial hypertension (PAH). We used intravascular ultrasound (IVUS) to evaluate the mechanical properties of the elastic pulmonary arteries (PA) in subjects with PAH, and assessed the effects of PAH-specific therapy on indices of arterial stiffness. Method: Using IVUS and simultaneous right heart catheterisation, 20 pulmonary segments in 8 PAH subjects and 12 pulmonary segments in 8 controls were studied to determine their compliance, distensibility, elastic modulus and stiffness index beta. PAH subjects underwent repeat IVUS examinations after 6-months of bosentan therapy. Results: At baseline, PAH subjects demonstrated greater stiffness in all measured indices compared to controls: compliance (1.50 +/- 0.11 x 10(-2) mm(2)/mmHg vs 4.49 +/- 0.43 x 10(-2) mm(2)/mmHg, p<0.0001), distensibility (0.32 +/- 0.03%/mmHg vs 1.18 +/- 0.13%/mmHg, p<0.0001), elastic modulus (720 +/- 64 mmHg vs 198 +/- 19 mmHg, p<0.0001), and stiffness index b (15.0 +/- 1.4 vs 11.0 +/- 0.7, p = 0.046). Strong inverse exponential associations existed between mean pulmonary artery pressure and compliance (r(2) = 0.82, p<0.0001), and also between mean PAP and distensibility (r(2) = 0.79, p = 0.002). Bosentan therapy, for 6-months, was not associated with any significant changes in all indices of PA stiffness. Conclusion: Increased stiffness occurs in the proximal elastic PA in patients with PAH and contributes to the pathogenesis RV failure. Bosentan therapy may not be effective at improving PA stiffness.	[Lau, Edmund M. T.; Ilsar, Rahn; Bailey, Brian P.; Adams, Mark R.; Celermajer, David S.] Royal Prince Alfred Hosp, Dept Cardiol, Camperdown, NSW 2050, Australia; [Lau, Edmund M. T.] Royal Prince Alfred Hosp, Dept Resp & Sleep Med, Camperdown, NSW 2050, Australia; [Lau, Edmund M. T.; Iyer, Nithin; Adams, Mark R.; Celermajer, David S.] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia	University of Sydney; University of Sydney; University of Sydney	Lau, EMT (corresponding author), Royal Prince Alfred Hosp, Dept Cardiol, Camperdown, NSW 2050, Australia.	david.celermajer@email.cs.nsw.gov.au		Celermajer, David/0000-0001-7640-0439	National Health and Medical Research Council of Australia [633136]; Actelion Pharmaceuticals Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Actelion Pharmaceuticals Australia	This work was funded by National Health and Medical Research Council of Australia (Postgraduate Scholarship No. 633136) and by a grant from Actelion Pharmaceuticals Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOGREN HG, 1989, AM HEART J, V118, P990, DOI 10.1016/0002-8703(89)90235-4; Borges AC, 1997, EUR HEART J, V18, P1988; Bressollette E, 2001, CHEST, V120, P809, DOI 10.1378/chest.120.3.809; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Gan CTJ, 2007, CHEST, V132, P1906, DOI 10.1378/chest.07-1246; Grignola JC, 2011, INT J CARDIOL; HIRAI T, 1989, CIRCULATION, V80, P78, DOI 10.1161/01.CIR.80.1.78; Huez S, 2004, CHEST, V125, P2121, DOI 10.1378/chest.125.6.2121; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Hunter KS, 2008, AM HEART J, V155, P166, DOI 10.1016/j.ahj.2007.08.014; Ilsar R, 2010, EUR RESPIR J, V36, P1483, DOI 10.1183/09031936.00083910; ISHII M, 1995, J AM COLL CARDIOL, V26, P272, DOI 10.1016/0735-1097(95)00154-R; Jardim C, 2007, EUR RESPIR J, V29, P476, DOI 10.1183/09031936.00016806; Lankhaar JW, 2008, EUR HEART J, V29, P1688, DOI 10.1093/eurheartj/ehn103; Lankhaar JW, 2006, AM J PHYSIOL-HEART C, V291, pH1731, DOI 10.1152/ajpheart.00336.2006; Lau EM, 2011, EUR HEART J; Mahapatra S, 2006, J AM COLL CARDIOL, V47, P799, DOI 10.1016/j.jacc.2005.09.054; Mahapatra S, 2006, J AM SOC ECHOCARDIOG, V19, P1045, DOI 10.1016/j.echo.2006.03.008; O'Rourke MF, 2002, AM J HYPERTENS, V15, P426, DOI 10.1016/S0895-7061(01)02319-6; PANDIAN NG, 1990, CIRCULATION, V81, P2007, DOI 10.1161/01.CIR.81.6.2007; PAZ R, 1993, EUR HEART J, V14, P1524, DOI 10.1093/eurheartj/14.11.1524; Pini R, 2008, J AM COLL CARDIOL, V51, P2432, DOI 10.1016/j.jacc.2008.03.031; PORTER TR, 1994, CHEST, V106, P1551, DOI 10.1378/chest.106.5.1551; Rodes-Cabau J, 2003, HEART, V89, P311, DOI 10.1136/heart.89.3.311; Sanz J, 2009, JACC-CARDIOVASC IMAG, V2, P286, DOI 10.1016/j.jcmg.2008.08.007; Saouti N, 2010, EUR RESPIR REV, V19, P197, DOI 10.1183/09059180.00002210; Saouti N, 2010, AM J RESP CRIT CARE, V182, P1315, DOI 10.1164/rccm.200910-1643OC; Tuchscherer HA, 2007, J BIOMECH, V40, P993, DOI 10.1016/j.jbiomech.2006.03.023; Tuder RM, 2009, SEMIN RESP CRIT CARE, V30, P376, DOI 10.1055/s-0029-1233307; Vanderpool RR, 2011, J APPL PHYSIOL, V110, P188, DOI 10.1152/japplphysiol.00533.2010; WESTERHOF N, 1971, J APPL PHYSIOL, V31, P776, DOI 10.1152/jappl.1971.31.5.776; Westerhof N, 2009, MED BIOL ENG COMPUT, V47, P131, DOI 10.1007/s11517-008-0359-2	32	27	30	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33331	10.1371/journal.pone.0033331	http://dx.doi.org/10.1371/journal.pone.0033331			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479385	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100042
J	Liang, XX; Zhou, DD; Wei, C; Luo, HS; Liu, JL; Fu, R; Cui, S				Liang, Xiaoxuan; Zhou, Doudou; Wei, Chao; Luo, Haoshu; Liu, Jiali; Fu, Rui; Cui, Sheng			MicroRNA-34c Enhances Murine Male Germ Cell Apoptosis through Targeting ATF1	PLOS ONE			English	Article							TESTIS; BCL-2; EXPRESSION; MICE; ELECTROPORATION; ACTIVATION; MECHANISMS; MICROARRAY; SYSTEM	Background: MicroRNAs (miRNAs) play vital regulatory roles in many cellular processes. The expression of miRNA (miR)-34c is highly enriched in adult mouse testis, but its roles and underlying mechanisms of action are not well understood. Methodology/Principal Findings: In the present study, we show that miR-34c is detected in mouse pachytene spermatocytes and continues to be highly expressed in spermatids. To explore the specific functions of miR-34c, we have established an in vivo model by transfecting miR-34c inhibitors into primary spermatocytes to study the loss-of-function of miR-34c. The results show that silencing of miR-34c significantly increases the Bcl-2/Bax ratio and prevents germ cell from apoptosis induced by deprivation of testosterone. Moreover, ectopic expression of the miR-34c in GC-2 cell trigger the cell apoptosis with a decreased Bcl-2/Bax ratio and miR-34c inhibition lead to a low spontaneous apoptotic ratio and an increased Bcl-2/Bax ratio. Furthermore, ectopic expression of miR-34c reduces ATF1 protein expression without affecting ATF1 mRNA level via directly binding to ATF1's 3'UTR, indicating that ATF1 is one of miR-34c's target genes. Meanwhile, the knockdown of ATF1 significantly decreases the Bcl-2/Bax ratio and triggers GC-2 cell apoptosis. Inhibition of miR-34c does not decrease the GC-2 cell apoptosis ratio in ATF1 knockdown cells. Conclusions/Significance: Our study shows for the first time that miR-34c functions, at least partially, by targeting the ATF1 gene in germ cell apoptosis, providing a novel mechanism with involvement of miRNA in the regulation of germ cell apoptosis.	[Liang, Xiaoxuan; Zhou, Doudou; Wei, Chao; Luo, Haoshu; Liu, Jiali; Fu, Rui; Cui, Sheng] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China	China Agricultural University	Liang, XX (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	cuisheng@cau.edu.cn			National Basic Research Program of China [2009CB941702]; National Science Foundation of China [30871846]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants to SC from the National Basic Research Program of China (2009CB941702) and the National Science Foundation of China (30871846). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Lopez JA, 2011, BIOCHEM BIOPH RES CO, V409, P513, DOI 10.1016/j.bbrc.2011.05.036; Antonini D, 2010, J INVEST DERMATOL, V130, P1249, DOI 10.1038/jid.2009.438; Beumer TL, 2000, MOL REPROD DEV, V56, P353, DOI 10.1002/1098-2795(200007)56:3&lt;353::AID-MRD4&gt;3.0.CO;2-3; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Bouhallier F, 2010, RNA, V16, P720, DOI 10.1261/rna.1963810; Bozec A, 2004, J ENDOCRINOL, V183, P79, DOI 10.1677/joe.1.05771; Cannell IG, 2010, CELL CYCLE, V9, P2726, DOI 10.4161/cc.9.14.12182; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chandrasekaran Y, 2006, BIOL REPROD, V74, P560, DOI 10.1095/biolreprod.105.045146; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; Dong LA, 1999, J BIOL CHEM, V274, P32099, DOI 10.1074/jbc.274.45.32099; Fabbri M, 2011, JAMA-J AM MED ASSOC, V305, P59, DOI 10.1001/jama.2010.1919; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Furuchi T, 1996, DEVELOPMENT, V122, P1703; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hagman Z, 2010, INT J CANCER, V127, P2768, DOI 10.1002/ijc.25269; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hibbitt O, 2006, BIOL REPROD, V74, P95, DOI 10.1095/biolreprod.105.042267; Hikim APS, 1997, BIOL REPROD, V57, P1193, DOI 10.1095/biolreprod57.5.1193; Hikim APS, 1999, REV REPROD, V4, P38; Hisaoka M, 2008, AM J SURG PATHOL, V32, P452, DOI 10.1097/PAS.0b013e31814b18fb; HOFMANN MC, 1994, P NATL ACAD SCI USA, V91, P5533, DOI 10.1073/pnas.91.12.5533; Idler RK, 2011, J ANDROL; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jin XL, 2010, BIOL REPROD, V82, P459, DOI 10.1095/biolreprod.109.078758; Klemm DJ, 1998, J BIOL CHEM, V273, P917, DOI 10.1074/jbc.273.2.917; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Korhonen HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024821; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081; Liu KD, 2011, J BIOL CHEM, V286, P2057, DOI 10.1074/jbc.M110.147306; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Maatouk DM, 2008, BIOL REPROD, V79, P696, DOI 10.1095/biolreprod.108.067827; Mackey TJ, 1998, UROLOGY, V52, P1085, DOI 10.1016/S0090-4295(98)00360-4; Meikar O, 2011, REPRODUCTION, V142, P195, DOI 10.1530/REP-11-0057; Oldereid NB, 2001, MOL HUM REPROD, V7, P403, DOI 10.1093/molehr/7.5.403; Papaioannou MD, 2010, J ANDROL, V31, P26, DOI 10.2164/jandrol.109.008128; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; Rokhlin OW, 2008, CANCER BIOL THER, V7, P1288, DOI 10.4161/cbt.7.8.6284; Skinner M.K., 2005, SERTOLI CELL BIOL; Song R, 2009, NAT GENET, V41, P488, DOI 10.1038/ng.338; Widlak W, 2003, MOL REPROD DEV, V65, P382, DOI 10.1002/mrd.10305; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yan NH, 2007, REPRODUCTION, V134, P73, DOI 10.1530/REP-07-0056; Yan NH, 2009, J ASSIST REPROD GEN, V26, P179, DOI 10.1007/s10815-009-9305-y; Yan W, 2000, MOL CELL ENDOCRINOL, V165, P115, DOI 10.1016/S0303-7207(00)00257-4; Yomgogida K, 2008, DEV GROWTH DIFFER, V50, P513, DOI [10.1111/j.1440-169x.2008.01042.x, 10.1111/j.1440-169X.2008.01042.x]; Yu XZ, 2001, TOXICOL APPL PHARM, V174, P35, DOI 10.1006/taap.2001.9187; Zhang KY, 2007, BIOCHEM BIOPH RES CO, V360, P327, DOI 10.1016/j.bbrc.2007.06.071	55	132	143	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33861	10.1371/journal.pone.0033861	http://dx.doi.org/10.1371/journal.pone.0033861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479460	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100076
J	Rosas, U; Zhou, RW; Castillo, G; Collazo-Ortega, M				Rosas, Ulises; Zhou, Royce W.; Castillo, Guillermo; Collazo-Ortega, Margarita			Developmental Reaction Norms for Water Stressed Seedlings of Succulent Cacti	PLOS ONE			English	Article							OPUNTIA-FICUS-INDICA; PHOTOSYNTHETIC METABOLISM; CACTACEAE; EVOLUTION; DROUGHT; CHLORENCHYMA; GERMINATION; PARENCHYMA; SHAPE	Succulent cacti are remarkable plants with capabilities to withstand long periods of drought. However, their adult success is contingent on the early seedling stages, when plants are highly susceptible to the environment. To better understand their early coping strategies in a challenging environment, two developmental aspects (anatomy and morphology) in Polaskia chichipe and Echinocactus platyacanthus were studied in the context of developmental reaction norms under drought conditions. The morphology was evaluated using landmark based morphometrics and Principal Component Analysis, which gave three main trends of the variation in each species. The anatomy was quantified as number and area of xylem vessels. The quantitative relationship between morphology and anatomy in early stages of development, as a response to drought was revealed in these two species. Qualitatively, collapsible cells and collapsible parenchyma tissue were observed in seedlings of both species, more often in those subjected to water stress. These tissues were located inside the epidermis, resembling a web of collapsible-cell groups surrounding turgid cells, vascular bundles, and spanned across the pith. Occasionally the groups formed a continuum stretching from the epidermis towards the vasculature. Integrating the morphology and the anatomy in a developmental context as a response to environmental conditions provides a better understanding of the organism's dynamics, adaptation, and plasticity.	[Rosas, Ulises; Zhou, Royce W.] NYU, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Castillo, Guillermo] Univ Nacl Autonoma Mexico, Inst Ecol, Mexico City 04510, DF, Mexico; [Collazo-Ortega, Margarita] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City 04510, DF, Mexico	New York University; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Rosas, U (corresponding author), NYU, Ctr Genom & Syst Biol, New York, NY 10003 USA.	ur6@nyu.edu		Castillo, Guillermo/0000-0003-1344-8819; Zhou, Royce/0000-0002-1585-4784; Rosas, Ulises/0000-0001-5088-2679	Fundacion Telmex scholarship; PROBETEL-UNAM grant; Human Frontier Science Program Postdoctoral Fellowship	Fundacion Telmex scholarship; PROBETEL-UNAM grant; Human Frontier Science Program Postdoctoral Fellowship(Human Frontier Science Program)	This work was supported by a Fundacion Telmex scholarship, a PROBETEL-UNAM grant, and a Human Frontier Science Program Postdoctoral Fellowship for UR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTESOR A, 1994, BOT J LINN SOC, V114, P283, DOI 10.1111/j.1095-8339.1994.tb01937.x; Arber A, 1910, NEW PHYTOL, V9, P333; Arias M.S, 1997, FLORA VALLE TEHUACAN; Ayala-Cordero G, 2006, J EXP BOT, V57, P3165, DOI 10.1093/jxb/erl078; Backhaus A, 2010, NEW PHYTOL, V187, P251, DOI 10.1111/j.1469-8137.2010.03266.x; Bensmihen S, 2008, HFSP J, V2, P110, DOI 10.2976/1.2836738; Bravo-Hollis H, 1991, CACTACEAS MEXICO, VII; Cruz-Gonzalez Y, 2002, CARACTERIZACION MORF; De Fraine E, 1910, ANN BOT-LONDON, V24, P125, DOI 10.1093/oxfordjournals.aob.a089252; Dubrovsky JG, 1996, AM J BOT, V83, P624, DOI 10.2307/2445922; Gibson A.C., 1986, CACTUS PRIMER, DOI DOI 10.4159/HARVARD.9780674281714; GOLDSTEIN G, 1991, AUST J PLANT PHYSIOL, V18, P95, DOI 10.1071/PP9910095; HAGEMANN W, 1992, INT J PLANT SCI, V153, pS38, DOI 10.1086/297062; Langlade NB, 2005, P NATL ACAD SCI USA, V102, P10221, DOI 10.1073/pnas.0504210102; Lee K, 2006, PLANT CELL, V18, P2145, DOI 10.1105/tpc.106.043042; Loza-Cornejo S, 2003, INTERCIENCIA, V28, P83; Loza-Cornejo S., 1996, BOT SCI, V59, P13, DOI [10.17129/botsci.1502, DOI 10.17129/BOTSCI.1502]; Mauseth JD, 2006, ANN BOT-LONDON, V98, P901, DOI 10.1093/aob/mcl133; MAUSETH JD, 1995, B TORREY BOT CLUB, V122, P145, DOI 10.2307/2996453; Mauseth JD, 2004, INT J PLANT SCI, V165, P359, DOI 10.1086/382808; Mauseth JD, 1982, CACTUS SUCCULENT J, V54, P263; Mauseth JD, 1984, CACTUS SUCULENT J, V56, P131; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; Nobel PS, 2006, ANN BOT-LONDON, V97, P469, DOI 10.1093/aob/mcj054; NORTH GB, 1992, NEW PHYTOL, V120, P9, DOI 10.1111/j.1469-8137.1992.tb01053.x; Pigliucci Massomo, 1996, Plant Species Biology, V11, P69, DOI 10.1111/j.1442-1984.1996.tb00110.x; Pimienta-Barrios E, 2002, ENVIRON EXP BOT, V47, P77, DOI 10.1016/S0098-8472(01)00114-9; Rojas-Arechiga M, 2000, J ARID ENVIRON, V44, P85, DOI 10.1006/jare.1999.0582; RojasArechiga M, 1997, J ARID ENVIRON, V36, P571, DOI 10.1006/jare.1996.0218; Rosas U, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000429; Rosas-Lopez U, 2004, PHYTON, P213; Terrazas Salgado T, 2002, CACTI BIOL USES, P23; Valiente-Banuet A, 2002, CACTI BIOL USES, P91; Winter K, 2011, J EXPT BOT; Woltereck R., 1909, VERH DTSCH ZOOL GES, V19, P110, DOI DOI 10.1007/BF01876686	35	9	10	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33936	10.1371/journal.pone.0033936	http://dx.doi.org/10.1371/journal.pone.0033936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479481	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100085
J	Venkatesan, N; Barre, L; Bourhim, M; Magdalou, J; Mainard, D; Netter, P; Fournel-Gigleux, S; Ouzzine, M				Venkatesan, Narayanan; Barre, Lydia; Bourhim, Mustapha; Magdalou, Jacques; Mainard, Didier; Netter, Patrick; Fournel-Gigleux, Sylvie; Ouzzine, Mohamed			Xylosyltransferase-I Regulates Glycosaminoglycan Synthesis during the Pathogenic Process of Human Osteoarthritis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HUMAN ARTICULAR CHONDROCYTES; ARTHRITIC HUMAN HIPS; GENE-EXPRESSION; PROTEOGLYCAN TURNOVER; METABOLIC ABNORMALITIES; CARTILAGE METABOLISM; INTERLEUKIN-1; COLLAGEN; AGGRECAN	Loss of glycosaminoglycan (GAG) chains of proteoglycans (PGs) is an early event of osteoarthritis (OA) resulting in cartilage degradation that has been previously demonstrated in both huma and experimental OA models. However, the mechanism of GAG loss and the role of xylosyltransferase-I (XT-I) that initiates GAG biosynthesis onto PG molecules in the pathogenic process of human OA are unknown. In this study, we have characterized XT-I expression and activity together with GAG synthesis in human OA cartilage obtained from different regions of the same joint, defined as "normal", "late-stage" or adjacent to "late-stage". The results showed that GAG synthesis and content increased in cartilage from areas flanking OA lesions compared to cartilage from macroscopically "normal" unaffected regions, while decreased in "late-stage" OA cartilage lesions. This increase in anabolic state was associated with a marked upregulation of XT-I expression and activity in cartilage "next to lesion" while a decrease in the "late-stage" OA cartilage. Importantly, XT-I inhibition by shRNA or forced-expression with a pCMV-XT-I construct correlated with the modulation of GAG anabolism in human cartilage explants. The observation that XT-I gene expression was down-regulated by IL-1 beta and up-regulated by TGF-beta 1 indicates that these cytokines may play a role in regulating GAG content in human OA. Noteworthy, expression of IL-1 beta receptor (IL-1R1) was down-regulated whereas that of TGF-beta 1 was up-regulated in early OA cartilage. Theses observations may account for upregulation of XT-I and sustained GAG synthesis prior to the development of cartilage lesions during the pathogenic process of OA.	[Venkatesan, Narayanan; Barre, Lydia; Bourhim, Mustapha; Magdalou, Jacques; Mainard, Didier; Netter, Patrick; Fournel-Gigleux, Sylvie; Ouzzine, Mohamed] Univ Nancy 1, UMR 7561, CNRS, Fac Med, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Venkatesan, N (corresponding author), Univ Nancy 1, UMR 7561, CNRS, Fac Med, Vandoeuvre Les Nancy, France.	ouzzine@medecine.uhp-nancy.fr	Ouzzine, Mohamed/G-4368-2013	OUZZINE, Mohamed/0000-0003-0058-4950	Fondation pour la Recherche Medicale (Vieillissement Osteoarticulaire) [DVO20081013491]; Agence Nationale de la Recherche (GlycoCart) [ANR-BLAN-0163-01]	Fondation pour la Recherche Medicale (Vieillissement Osteoarticulaire); Agence Nationale de la Recherche (GlycoCart)(French National Research Agency (ANR))	Fondation pour la Recherche Medicale (DVO20081013491, Vieillissement Osteoarticulaire) and the Agence Nationale de la Recherche (ANR-BLAN-0163-01, GlycoCart). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Aurich M, 2006, ARTHRITIS RHEUM-US, V54, P244, DOI 10.1002/art.21535; BIRD TA, 1986, NATURE, V324, P263, DOI 10.1038/324263a0; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Boumediene K, 1998, OSTEOARTHR CARTILAGE, V6, P146, DOI 10.1053/joca.1997.0104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; Davidson ENB, 2007, OSTEOARTHR CARTILAGE, V15, P597, DOI 10.1016/j.joca.2007.02.005; DEVRIES BJ, 1986, RHEUMATOL INT, V6, P273, DOI 10.1007/BF00541319; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Glansbeek HL, 1998, LAB INVEST, V78, P133; Goldring MB, 2011, EUR CELLS MATER, V21, P202, DOI 10.22203/eCM.v021a16; HARDINGHAM TE, 1992, BRIT J RHEUMATOL, V31, P1; Hardingham TE, 1994, REV RHUM ED FR, V6, p93S; Heinegard D, 2011, NAT REV RHEUMATOL, V7, P50, DOI 10.1038/nrrheum.2010.198; Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200; Hickery MS, 1998, BBA-GEN SUBJECTS, V1425, P282, DOI 10.1016/S0304-4165(98)00080-4; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kuettner KE, 2005, OSTEOARTHR CARTILAGE, V13, P93, DOI 10.1016/j.joca.2004.11.006; LARSSON SE, 1974, CALC TISS RES, V14, P49, DOI 10.1007/BF02060282; MANKIN HJ, 1970, J BONE JOINT SURG AM, VA 52, P424, DOI 10.2106/00004623-197052030-00002; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Mastbergen SC, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1846; Nelson F, 1998, J CLIN INVEST, V102, P2115, DOI 10.1172/JCI4853; Pelletier JP, 1996, OSTEOARTHR CARTILAGE, V4, P77, DOI 10.1016/S1063-4584(96)80009-4; Prante C, 2007, J BIOL CHEM, V282, P26441, DOI 10.1074/jbc.M702299200; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; Pujol JP, 2008, CONNECT TISSUE RES, V49, P293, DOI 10.1080/03008200802148355; Radons J, 2006, INT J MOL MED, V17, P661; RAYAN V, 1994, MATRIX BIOL, V14, P263; RIZKALLA G, 1992, J CLIN INVEST, V90, P2268, DOI 10.1172/JCI116113; Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; Squires GR, 2003, ARTHRITIS RHEUM-US, V48, P1261, DOI 10.1002/art.10976; Susarla BTS, 2011, J NEUROCHEM, V119, P868, DOI 10.1111/j.1471-4159.2011.07470.x; THOMPSON RC, 1979, J BONE JOINT SURG AM, V61, P407, DOI 10.2106/00004623-197961030-00017; TYLER JA, 1985, BIOCHEM J, V227, P869, DOI 10.1042/bj2270869; VANLENT PLEM, 1995, J RHEUMATOL, V22, P2250; Venkatesan N, 2009, FASEB J, V23, P813, DOI 10.1096/fj.08-118166; Vincourt JB, 2006, MOL CELL PROTEOMICS, V5, P1984, DOI 10.1074/mcp.T600007-MCP200; Weilke C, 1997, CLIN CHEM, V43, P45; Yagi R, 2005, J ORTHOP RES, V23, P1128, DOI 10.1016/j.orthres.2004.12.016; Young AA, 2005, ARTHRITIS RES THER, V7, pR852, DOI 10.1186/ar1756	45	22	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34020	10.1371/journal.pone.0034020	http://dx.doi.org/10.1371/journal.pone.0034020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479506	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100097
J	Zhou, XH; Evans, SL; Han, X; Liu, YY; Yu, XF				Zhou, Xiaohong; Evans, Sean L.; Han, Xue; Liu, Yayan; Yu, Xiao-Fang			Characterization of the Interaction of Full-Length HIV-1 Vif Protein with its Key Regulator CBF beta and CRL5 E3 Ubiquitin Ligase Components	PLOS ONE			English	Article							VIRUS TYPE-1 VIF; APOBEC3 CYTIDINE DEAMINASES; VIRAL INFECTIVITY FACTOR; REVERSE TRANSCRIPTION; URACIL-DNA; SOCS-BOX; I VIF; BIOPHYSICAL CHARACTERIZATION; BINDING-PROPERTIES; HOST RESTRICTION	Human immunodeficiency virus-1 (HIV-1) viral infectivity factor (Vif) is essential for viral replication because of its ability to eliminate the host's antiviral response to HIV-1 that is mediated by the APOBEC3 family of cellular cytidine deaminases. Vif targets these proteins, including APOBEC3G, for polyubiquitination and subsequent proteasome-mediated degradation via the formation of a Cullin5-ElonginB/C-based E3 ubiquitin ligase. Determining how the cellular components of this E3 ligase complex interact with Vif is critical to the intelligent design of new antiviral drugs. However, structural studies of Vif, both alone and in complex with cellular partners, have been hampered by an inability to express soluble full-length Vif protein. Here we demonstrate that a newly identified host regulator of Vif, core-binding factor-beta (CBF beta), interacts directly with Vif, including various isoforms and a truncated form of this regulator. In addition, carboxyl-terminal truncations of Vif lacking the BC-box and cullin box motifs were sufficient for CBFb interaction. Furthermore, association of Vif with CBF beta, alone or in combination with Elongin B/C (EloB/C), greatly increased the solubility of full-length Vif. Finally, a stable complex containing Vif-CBF beta-EloB/C was purified in large quantity and shown to bind purified Cullin5 (Cul5). This efficient strategy for purifying Vif-Cul5-CBF beta-EloB/C complexes will facilitate future structural and biochemical studies of Vif function and may provide the basis for useful screening approaches for identifying novel anti-HIV drug candidates.	[Zhou, Xiaohong; Han, Xue; Yu, Xiao-Fang] Jilin Univ, Affiliated Hosp 1, Inst Virol & AIDS Res, Jilin, Jilin, Peoples R China; [Zhou, Xiaohong; Evans, Sean L.; Han, Xue; Liu, Yayan; Yu, Xiao-Fang] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA	Jilin University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhou, XH (corresponding author), Jilin Univ, Affiliated Hosp 1, Inst Virol & AIDS Res, Jilin, Jilin, Peoples R China.	xfyu@jhsph.edu	Zhou, Xiaohong/B-3416-2012	Zhou, Xiaohong/0000-0003-0519-2550	Major State Basic Research Development Program from the Ministry of Science and Technology [2012CB9111]; Program for Changjiang Scholars and Innovative Research Team in University from The Ministry of Education of China [IRT1016]; NIH grants [F31 AI091326]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI091326] Funding Source: NIH RePORTER	Major State Basic Research Development Program from the Ministry of Science and Technology(National Basic Research Program of China); Program for Changjiang Scholars and Innovative Research Team in University from The Ministry of Education of China; NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Major State Basic Research Development Program from the Ministry of Science and Technology (no. 2012CB9111) and the Program for Changjiang Scholars and Innovative Research Team in University from The Ministry of Education (no. IRT1016) of China. This work was supported by NIH grants F31 AI091326 (to SLE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Auclair JR, 2007, PROTEINS, V69, P270, DOI 10.1002/prot.21471; Barraud P, 2008, CURR HIV RES, V6, P91, DOI 10.2174/157016208783885056; Bergeron JRC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000925; Bernacchi S, 2007, J BIOL CHEM, V282, P26361, DOI 10.1074/jbc.M703122200; Bernacchi S, 2011, NUCLEIC ACIDS RES, V39, P2404, DOI 10.1093/nar/gkq979; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chen G, 2009, J VIROL; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Cullen BR, 2006, J VIROL, V80, P1067, DOI 10.1128/JVI.80.3.1067-1076.2006; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; Dettenhofer M, 2000, J VIROL, V74, P8938, DOI 10.1128/JVI.74.19.8938-8945.2000; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; Gallerano D, 2011, AMINO ACIDS, V40, P981, DOI 10.1007/s00726-010-0725-x; Giri K, 2009, BIOPOLYMERS, V92, P417, DOI 10.1002/bip.21209; Giri K, 2009, BIOCHEMISTRY-US, V48, P7969, DOI 10.1021/bi900677w; Goila-Gaur R, 2008, J VIROL; Goila-Gaur R, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-51; Golla-Gaur R, 2008, VIROLOGY, V372, P136, DOI 10.1016/j.virol.2007.10.017; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Hache G, 2006, AIDS REV, V8, P148; HAJRA A, 1995, GENOMICS, V26, P571, DOI 10.1016/0888-7543(95)80177-N; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; He ZW, 2008, J MOL BIOL, V381, P1000, DOI 10.1016/j.jmb.2008.06.061; Huang XM, 1998, J BIOL CHEM, V273, P2480, DOI 10.1074/jbc.273.4.2480; Hultquist JF, 2011, J VIROL; Hwang BJ, 1996, MUTAT RES-DNA REPAIR, V362, P105, DOI 10.1016/0921-8777(95)00040-2; Ito Y, 2008, ADV CANCER RES, V99, P33, DOI 10.1016/S0065-230X(07)99002-8; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Kaiser SM, 2006, J VIROL, V80, P875, DOI 10.1128/JVI.80.2.875-882.2006; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Khan MA, 2001, J VIROL, V75, P7252, DOI 10.1128/JVI.75.16.7252-7265.2001; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Liu BD, 2004, J VIROL, V78, P2072, DOI 10.1128/JVI.78.4.2072-2081.2004; Luo K, 2005, P NATL ACAD SCI USA, V102, P11444, DOI 10.1073/pnas.0502440102; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; Luo K, 2007, J VIROL, V81, P7238, DOI 10.1128/JVI.02584-06; Luo K, 2007, FASEB J, V21, P1742, DOI 10.1096/fj.06-7241com; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marcsisin SR, 2011, J MOL BIOL, V410, P1008, DOI 10.1016/j.jmb.2011.04.053; Marcsisin SR, 2010, J MOL BIOL, V402, P892, DOI 10.1016/j.jmb.2010.08.026; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mbisa JL, 2007, J VIROL, V81, P7099, DOI 10.1128/JVI.00272-07; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2007, J VIROL, V81, P13235, DOI 10.1128/JVI.00204-07; Mehle A, 2006, J BIOL CHEM, V281, P17259, DOI 10.1074/jbc.M602413200; Miller JH, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-81; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Niewiadomska AM, 2009, CURR TOP MICROBIOL, V339, P1, DOI 10.1007/978-3-642-02175-6_1; Reingewertz TH, 2010, PROTEIN PEPTIDE LETT, V17, P988; Reingewertz TH, 2009, PROTEIN ENG DES SEL, V22, P281, DOI 10.1093/protein/gzp004; Russell RA, 2007, J VIROL, V81, P8201, DOI 10.1128/JVI.00395-07; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schrofelbauer B, 2005, J VIROL, V79, P10978, DOI 10.1128/JVI.79.17.10978-10987.2005; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon V, 2005, PLOS PATHOG, V1, P20, DOI 10.1371/journal.ppat.0010006; Sorensen HP, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-1; Stanley BJ, 2008, J VIROL, V82, P8656, DOI 10.1128/JVI.00767-08; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Tian CJ, 2006, J VIROL, V80, P3112, DOI 10.1128/JVI.80.6.3112-3115.2006; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Wolfe LS, 2010, J VIROL, V84, P7135, DOI 10.1128/JVI.00031-10; Xiao Z, 2007, J MOL BIOL, V373, P541, DOI 10.1016/j.jmb.2007.07.029; Xiao ZX, 2006, VIROLOGY, V349, P290, DOI 10.1016/j.virol.2006.02.002; Yang B, 2003, J BIOL CHEM, V278, P6596, DOI 10.1074/jbc.M210164200; Yang B, 2007, J BIOL CHEM, V282, P11667, DOI 10.1074/jbc.M606864200; Yang SC, 2001, J BIOL CHEM, V276, P4889, DOI 10.1074/jbc.M004895200; Yang X, 1996, J BIOL CHEM, V271, P10121, DOI 10.1074/jbc.271.17.10121; Yang YL, 2007, VIROLOGY, V365, P92, DOI 10.1016/j.virol.2007.03.022; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zhang H, 2000, J VIROL, V74, P8252, DOI 10.1128/JVI.74.18.8252-8261.2000; Zhang WY, 2008, CELL MICROBIOL, V10, P1662, DOI 10.1111/j.1462-5822.2008.01157.x; Zhang WY, 2012, NATURE, V481, P376, DOI 10.1038/nature10718; Zhang WY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003963	90	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33495	10.1371/journal.pone.0033495	http://dx.doi.org/10.1371/journal.pone.0033495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479405	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339100053
J	Balasubramanian, D; Schneper, L; Merighi, M; Smith, R; Narasimhan, G; Lory, S; Mathee, K				Balasubramanian, Deepak; Schneper, Lisa; Merighi, Massimo; Smith, Roger; Narasimhan, Giri; Lory, Stephen; Mathee, Kalai			The Regulatory Repertoire of Pseudomonas aeruginosa AmpC beta-Lactamase Regulator AmpR Includes Virulence Genes	PLOS ONE			English	Article							MULTIDRUG EFFLUX SYSTEM; MEXE-MEXF-OPRN; III SECRETION SYSTEM; CAENORHABDITIS-ELEGANS; SIGMA-FACTOR; TRANSCRIPTIONAL REGULATION; ANTIBIOTIC-RESISTANCE; GALACTOPHILIC LECTIN; BIOFILM FORMATION; ESCHERICHIA-COLI	In Enterobacteriaceae, the transcriptional regulator AmpR, a member of the LysR family, regulates the expression of a chromosomal beta-lactamase AmpC. The regulatory repertoire of AmpR is broader in Pseudomonas aeruginosa, an opportunistic pathogen responsible for numerous acute and chronic infections including cystic fibrosis. In addition to regulating ampC, P. aeruginosa AmpR regulates the sigma factor AlgT/ U and production of some quorum sensing ( QS)regulated virulence factors. In order to better understand the ampR regulon, we compared the transcriptional profile generated using DNA microarrays of the prototypic P. aeruginosa PAO1 strain with its isogenic ampR deletion mutant, PAODampR. Transcriptome analysis demonstrates that the AmpR regulon is much more extensive than previously thought, with the deletion of ampR influencing the differential expression of over 500 genes. In addition to regulating resistance to blactam antibiotics via AmpC, AmpR also regulates non-beta-lactam antibiotic resistance by modulating the MexEF-OprN efflux pump. Other virulence mechanisms including biofilm formation and QS-regulated acute virulence factors are AmpRregulated. Real-time PCR and phenotypic assays confirmed the microarray data. Further, using a Caenorhabditis elegans model, we demonstrate that a functional AmpR is required for P. aeruginosa pathogenicity. AmpR, a member of the core genome, also regulates genes in the regions of genome plasticity that are acquired by horizontal gene transfer. Further, we show differential regulation of other transcriptional regulators and sigma factors by AmpR, accounting for the extensive AmpR regulon. The data demonstrates that AmpR functions as a global regulator in P. aeruginosa and is a positive regulator of acute virulence while negatively regulating biofilm formation, a chronic infection phenotype. Unraveling this complex regulatory circuit will provide a better understanding of the bacterial response to antibiotics and how the organism coordinately regulates a myriad of virulence factors in response to antibiotic exposure.	[Balasubramanian, Deepak] Florida Int Univ, Dept Biol Sci, Coll Arts & Sci, Miami, FL 33199 USA; [Schneper, Lisa; Mathee, Kalai] Florida Int Univ, Herbert Werthiem Coll Med, Miami, FL 33199 USA; [Merighi, Massimo; Smith, Roger; Lory, Stephen] Harvard Univ, Sch Med, Boston, MA USA; [Narasimhan, Giri] Florida Int Univ, Coll Engn & Comp, Sch Comp & Informat Sci, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University; Harvard University; Harvard Medical School; State University System of Florida; Florida International University	Balasubramanian, D (corresponding author), Florida Int Univ, Dept Biol Sci, Coll Arts & Sci, Miami, FL 33199 USA.	Kalai.Mathee@fiu.edu	Mathee, Kalai/AAE-2085-2021; Narasimhan, Giri/M-9419-2019; Balasubramanian, Deepak/J-2723-2013	Balasubramanian, Deepak/0000-0002-6066-0030; Mathee, Kalai/0000-0003-4569-5419; Narasimhan, Giri/0000-0003-0535-4871	National Institutes of Health SCORE [S06 GM08205, 5SC1AI081376]; Florida International University (FIU); FIU (Herbert Werthiem College of Medicine); Cystic Fibrosis Foundation [BALASU08H0]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI081376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008205] Funding Source: NIH RePORTER	National Institutes of Health SCORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida International University (FIU); FIU (Herbert Werthiem College of Medicine); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by National Institutes of Health-Minority Biomedical Research Support SCORE (S06 GM08205 and 5SC1AI081376; to KM), Florida International University (FIU) Teaching Assistantship (Biological Sciences; to DB), FIU Research Assistantship (Herbert Werthiem College of Medicine; to DB) and the Cystic Fibrosis Foundation Student Traineeship Award (BALASU08H0; to DB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adonizio A, 2008, J MED MICROBIOL, V57, P809, DOI 10.1099/jmm.0.47802-0; Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Asgarali A, 2009, ANTIMICROB AGENTS CH, V53, P2274, DOI 10.1128/AAC.01617-08; Avison MB, 2004, J ANTIMICROB CHEMOTH, V53, P197, DOI 10.1093/jac/dkh077; Avison MB, 2001, J BIOL CHEM, V276, P26955, DOI 10.1074/jbc.M011186200; Bakkal S, 2010, MICROBIOL-SGM, V156, P2058, DOI 10.1099/mic.0.036848-0; Balasubramanian D, 2011, J MED MICROBIOL, V60, P147, DOI 10.1099/jmm.0.021600-0; Balasubramanian Deepak, 2009, Human Genomics, V3, P349; Bonfiglio G, 1998, J ANTIMICROB CHEMOTH, V42, P697, DOI 10.1093/jac/42.6.697; Bouza E, 2002, CLIN MICROBIOL INFEC, V8, P265, DOI 10.1046/j.1469-0691.2002.00385.x; Brazas MD, 2005, ANTIMICROB AGENTS CH, V49, P3222, DOI 10.1128/AAC.49.8.3222-3227.2005; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; Carterson AJ, 2004, J BACTERIOL, V186, P6837, DOI 10.1128/JB.186.20.6837-6844.2004; Chang W, 2005, BMC GENOMICS, V6, P1, DOI 10.1186/1471-2164-6-115; CHEN HY, 1995, J MED MICROBIOL, V43, P300, DOI 10.1099/00222615-43-4-300; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE, V7; Collin BA, 2001, CLIN INFECT DIS, V33, P947, DOI 10.1086/322604; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dam P, 2007, NUCLEIC ACIDS RES, V35, P288, DOI 10.1093/nar/gkl1018; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Davies Jane C, 2002, Paediatr Respir Rev, V3, P128, DOI 10.1016/S1526-0550(02)00003-3; De Kievit TR, 2001, ANTIMICROB AGENTS CH, V45, P1761, DOI 10.1128/AAC.45.6.1761-1770.2001; DEVRIES CA, 1994, J BACTERIOL, V176, P6677, DOI 10.1128/JB.176.21.6677-6687.1994; Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001; Dietrich LEP, 2008, SCIENCE, V321, P1203, DOI 10.1126/science.1160619; Diggle SP, 2006, ENVIRON MICROBIOL, V8, P1095, DOI 10.1111/j.1462-2920.2006.001001.x; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; GALLAGHER PG, 1989, REV INFECT DIS, V11, P846; Hanson ND, 1999, CURR PHARM DESIGN, V5, P881; Harmsen M, 2010, FEMS IMMUNOL MED MIC, V59, P253, DOI 10.1111/j.1574-695X.2010.00690.x; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Heeb S, 2005, FEMS MICROBIOL LETT, V243, P251, DOI 10.1016/j.femsle.2004.12.008; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; HENNESSEY TD, 1967, J GEN MICROBIOL, V49, P277, DOI 10.1099/00221287-49-2-277; Holder IA, 2001, BURNS, V27, P129, DOI 10.1016/S0305-4179(00)00142-X; HONORE N, 1986, EMBO J, V5, P3709, DOI 10.1002/j.1460-2075.1986.tb04704.x; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; Jacobs C, 1997, CELL, V88, P823, DOI 10.1016/S0092-8674(00)81928-5; Journet L, 2005, MOL MEMBR BIOL, V22, P41, DOI 10.1080/09687860500041858; Juan C, 2006, ANTIMICROB AGENTS CH, V50, P1780, DOI 10.1128/AAC.50.5.1780-1787.2006; Kamath S, 1998, MOL MICROBIOL, V30, P933, DOI 10.1046/j.1365-2958.1998.01121.x; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI 10.1016/j.jhin.2009.04.020; KESSLER B, 1992, MOL GEN GENET, V233, P293, DOI 10.1007/BF00587591; KESSLER E, 1993, J BIOL CHEM, V268, P7503; Kirkeby S, 2006, MICROB PATHOGENESIS, V40, P191, DOI 10.1016/j.micpath.2006.01.006; Klausen M, 2003, MOL MICROBIOL, V50, P61, DOI 10.1046/j.1365-2958.2003.03677.x; Kohler T, 2009, P NATL ACAD SCI USA, V106, P6339, DOI 10.1073/pnas.0811741106; Kohler T, 1999, J BACTERIOL, V181, P6300; Kohler T, 1997, MOL MICROBIOL, V23, P345, DOI 10.1046/j.1365-2958.1997.2281594.x; Kong KF, 2005, ANTIMICROB AGENTS CH, V49, P4567, DOI 10.1128/AAC.49.11.4567-4575.2005; Kong KF, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-328; Kong KF, 2010, APMIS, V118, P1, DOI 10.1111/j.1600-0463.2009.02563.x; Kumar A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0018759, 10.1371/journal.pone.0026520, 10.1371/journal.pone.0020701]; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Laughlin RS, 2000, ANN SURG, V232, P133, DOI 10.1097/00000658-200007000-00019; Li XZ, 2000, J ANTIMICROB CHEMOTH, V46, P885, DOI 10.1093/jac/46.6.885; LINDBERG F, 1986, J ANTIMICROB CHEMOTH, V18, P43, DOI 10.1093/jac/18.Supplement_C.43; LINDBERG F, 1986, REV INFECT DIS, V8, pS292; LINDBERG F, 1988, REV INFECT DIS, V10, P782; LINDBERG F, 1987, J BACTERIOL, V169, P1923, DOI 10.1128/jb.169.5.1923-1928.1987; LINDQUIST S, 1989, J BACTERIOL, V171, P3746, DOI 10.1128/jb.171.7.3746-3753.1989; Lister PD, 2009, CLIN MICROBIOL REV, V22, P582, DOI 10.1128/CMR.00040-09; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; LIU PV, 1974, J INFECT DIS, V130, pS94, DOI 10.1093/infdis/130.Supplement.S94; LODGE J, 1993, FEMS MICROBIOL LETT, V111, P315, DOI 10.1016/0378-1097(93)90399-M; LODGE JM, 1990, BIOCHEM J, V272, P627, DOI 10.1042/bj2720627; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Manfredi R, 2000, EUR J EPIDEMIOL, V16, P111, DOI 10.1023/A:1007626410724; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; MARTIN DW, 1993, P NATL ACAD SCI USA, V90, P8377, DOI 10.1073/pnas.90.18.8377; MARTIN DW, 1994, J BACTERIOL, V176, P6688, DOI 10.1128/JB.176.21.6688-6696.1994; Maseda H, 2000, FEMS MICROBIOL LETT, V192, P107, DOI 10.1016/S0378-1097(00)00419-5; Maseda H, 2010, FEMS MICROBIOL LETT, V311, P36, DOI 10.1111/j.1574-6968.2010.02063.x; Masuda N, 1999, ANTIMICROB AGENTS CH, V43, P400, DOI 10.1128/AAC.43.2.400; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; MATSUI H, 1993, J BACTERIOL, V175, P1257, DOI 10.1128/JB.175.5.1257-1263.1993; Matsumoto K, 2004, BIOL CHEM, V385, P1007, DOI 10.1515/BC.2004.131; MICHEAHAMZEHPOUR M, 1987, ANTIMICROB AGENTS CH, V31, P1803, DOI 10.1128/AAC.31.11.1803; Michel-Briand Y, 2002, BIOCHIMIE, V84, P499, DOI 10.1016/S0300-9084(02)01422-0; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Moya B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000353; Mulcahy H, 2006, INFECT IMMUN, V74, P3012, DOI 10.1128/IAI.74.5.3012-3015.2006; Mulcahy H, 2008, INFECT IMMUN, V76, P632, DOI 10.1128/IAI.01132-07; Nakae T, 1999, ANTIMICROB AGENTS CH, V43, P1301, DOI 10.1128/AAC.43.5.1301; Nakayama K, 2000, MOL MICROBIOL, V38, P213, DOI 10.1046/j.1365-2958.2000.02135.x; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; NICAS TI, 1985, CAN J MICROBIOL, V31, P387, DOI 10.1139/m85-074; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; NORMARK S, 1986, SCAND J INFECT DIS, P38; Obritsch MD, 2004, ANTIMICROB AGENTS CH, V48, P4606, DOI 10.1128/AAC.48.12.4606-4610.2004; Ochs MM, 1999, ANTIMICROB AGENTS CH, V43, P1085, DOI 10.1128/AAC.43.5.1085; OHMAN DE, 1980, J BACTERIOL, V142, P836, DOI 10.1128/JB.142.3.836-842.1980; Okazaki A, 2008, ANTIMICROB AGENTS CH, V52, P1525, DOI 10.1128/AAC.01485-07; OLSSON O, 1983, P NATL ACAD SCI-BIOL, V80, P7556, DOI 10.1073/pnas.80.24.7556; Poirel L, 1999, ANTIMICROB AGENTS CH, V43, P769, DOI 10.1128/AAC.43.4.769; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; PROENCA R, 1993, ANTIMICROB AGENTS CH, V37, P667, DOI 10.1128/AAC.37.4.667; Qiu XY, 2006, P NATL ACAD SCI USA, V103, P19830, DOI 10.1073/pnas.0606810104; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Schmidtke AJ, 2008, ANTIMICROB AGENTS CH, V52, P3922, DOI 10.1128/AAC.00341-08; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; Schuster M, 2004, MOL MICROBIOL, V51, P973, DOI 10.1046/j.1365-2958.2003.03886.x; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; SEOANE A, 1992, ANTIMICROB AGENTS CH, V36, P1049, DOI 10.1128/AAC.36.5.1049; Sivaneson M, 2011, MOL MICROBIOL, V79, P1353, DOI 10.1111/j.1365-2958.2010.07527.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Suh SJ, 1999, J BACTERIOL, V181, P3890, DOI 10.1128/JB.181.13.3890-3897.1999; TAMURA Y, 1992, J VET MED SCI, V54, P597, DOI 10.1292/jvms.54.597; TAMURA Y, 1992, MICROB PATHOGENESIS, V12, P237, DOI 10.1016/0882-4010(92)90058-V; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; TRIAS J, 1990, ANTIMICROB AGENTS CH, V34, P52, DOI 10.1128/AAC.34.1.52; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x; Vento S, 2008, LANCET ONCOL, V9, P982, DOI 10.1016/S1470-2045(08)70255-9; Vettoretti L, 2009, ANTIMICROB AGENTS CH, V53, P1987, DOI 10.1128/AAC.01024-08; Westfall LW, 2006, FEMS MICROBIOL LETT, V255, P247, DOI 10.1111/j.1574-6968.2005.00075.x; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Winzer K, 2000, J BACTERIOL, V182, P6401, DOI 10.1128/JB.182.22.6401-6411.2000; Wolfgang MC, 2004, P NATL ACAD SCI USA, V101, P6664, DOI 10.1073/pnas.0307553101; Wood LF, 2009, MOL MICROBIOL, V72, P183, DOI 10.1111/j.1365-2958.2009.06635.x; WOZNIAK DJ, 1994, J BACTERIOL, V176, P6007, DOI 10.1128/jb.176.19.6007-6014.1994; Wu WH, 2005, J BACTERIOL, V187, P6058, DOI 10.1128/JB.187.17.6058-6068.2005; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x; Yeung ATY, 2011, J BACTERIOL, V193, P918, DOI 10.1128/JB.00911-10; Zamorano L, 2010, ANTIMICROB AGENTS CH, V54, P3557, DOI 10.1128/AAC.00385-10; Zeng Erliang, 2007, Comput Syst Bioinformatics Conf, V6, P227, DOI 10.1142/9781860948732_0025; Zhang L, 2008, J BACTERIOL, V190, P4447, DOI 10.1128/JB.01655-07; Zhang Y, 2010, ANTIMICROB AGENTS CH, V54, P4772, DOI 10.1128/AAC.00009-10	142	80	85	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34067	10.1371/journal.pone.0034067	http://dx.doi.org/10.1371/journal.pone.0034067			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479525	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400054
J	Das, S; Tucker, JA; Khullar, S; Samant, RS; Shevde, LA				Das, Shamik; Tucker, J. Allan; Khullar, Shikha; Samant, Rajeev S.; Shevde, Lalita A.			Hedgehog Signaling in Tumor Cells Facilitates Osteoblast-Enhanced Osteolytic Metastases	PLOS ONE			English	Article							BREAST-CANCER CELLS; HORMONE-RELATED PEPTIDE; THERAPEUTIC TARGET; ALKALINE-PHOSPHATASE; BONE; EXPRESSION; DIFFERENTIATION; OSTEOPONTIN; PATHWAY; PROTEINS	The remodeling process in bone yields numerous cytokines and chemokines that mediate crosstalk between osteoblasts and osteoclasts and also serve to attract and support metastatic tumor cells. The metastatic tumor cells disturb the equilibrium in bone that manifests as skeletal complications. The Hedgehog (Hh) pathway plays an important role in skeletogenesis. We hypothesized that the Hh pathway mediates an interaction between tumor cells and osteoblasts and influences osteoblast differentiation in response to tumor cells. We have determined that breast tumor cells have an activated Hh pathway characterized by upregulation of the ligand, IHH and transcription factor GLI1. Breast cancer cells interact with osteoblasts and cause an enhanced differentiation of pre-osteoblasts to osteoblasts that express increased levels of the osteoclastogenesis factors, RANKL and PTHrP. There is sustained expression of osteoclast-promoting factors, RANKL and PTHrP, even after the osteoblast differentiation ceases and apoptosis sets in. Moreover, tumor cells that are deficient in Hh signaling are compromised in their ability to induce osteoblast differentiation and consequently are inefficient in causing osteolysis. The stimulation of osteoblast differentiation sets the stage for osteoclast differentiation and overall promotes osteolysis. Thus, in the process of developing newer therapeutic strategies against breast cancer metastasis to bone it would worthwhile to keep in mind the role of the Hh pathway in osteoblast differentiation in an otherwise predominant osteolytic phenomenon.	[Das, Shamik; Khullar, Shikha; Samant, Rajeev S.; Shevde, Lalita A.] Univ S Alabama, Dept Oncol Sci, USA Mitchell Canc Inst, Mobile, AL 36688 USA; [Tucker, J. Allan] Univ S Alabama, Dept Pathol, Mobile, AL 36688 USA; [Khullar, Shikha] Univ S Alabama, Dept Radiol, Mobile, AL 36688 USA	University of South Alabama; University of South Alabama; University of South Alabama	Das, S (corresponding author), Univ S Alabama, Dept Oncol Sci, USA Mitchell Canc Inst, Mobile, AL 36688 USA.	lsamant@usouthal.edu		Samant, Rajeev/0000-0001-5681-4976	Department of Defense [07-1-0400]; Mayer Mitchell Award; National Institutes of Health (NIH) [1R01CA140472-01A1]; USA Mitchell Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA140472] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Mayer Mitchell Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USA Mitchell Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge funding from the Department of Defense (IDEA Award 07-1-0400 to Dr. Shevde), Mayer Mitchell Award (to Dr. Shevde), National Institutes of Health (NIH) (1R01CA140472-01A1 to Dr. Samant), and support from the USA Mitchell Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussard KM, 2008, CANCER METAST REV, V27, P41, DOI 10.1007/s10555-007-9109-4; Carvalho RS, 2003, MATRIX BIOL, V22, P241, DOI 10.1016/S0945-053X(03)00038-6; Carvalho RS, 1998, J CELL BIOCHEM, V70, P376, DOI 10.1002/(SICI)1097-4644(19980901)70:3<376::AID-JCB11>3.0.CO;2-J; Casimiro S, 2009, MOL CELL ENDOCRINOL, V310, P71, DOI 10.1016/j.mce.2009.07.004; Chen YC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2781; COLLIN P, 1992, CALCIFIED TISSUE INT, V50, P175, DOI 10.1007/BF00298797; Das S, 2010, J BIOL CHEM; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; Ehlen Harald W. A., 2006, Birth Defects Research, V78, P267, DOI 10.1002/bdrc.20076; Enomoto-Iwamoto M, 2000, J BONE MINER RES, V15, P1659, DOI 10.1359/jbmr.2000.15.9.1659; Harms JF, 2004, CLIN EXP METASTAS, V21, P119, DOI 10.1023/B:CLIN.0000024763.69809.64; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; Jemtland R, 2003, BONE, V32, P611, DOI 10.1016/S8756-3282(03)00092-9; Kameda C, 2009, ANTICANCER RES, V29, P871; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kasper M, 2009, CARCINOGENESIS, V30, P903, DOI 10.1093/carcin/bgp048; Katano M, 2005, CANCER LETT, V227, P99, DOI 10.1016/j.canlet.2004.11.030; Kesper DA, 2010, DEV DYNAM, V239, P1818, DOI 10.1002/dvdy.22301; Kiuru M, 2009, J BONE MINER RES, V24, P1598, DOI [10.1359/JBMR.090313, 10.1359/jbmr.090313]; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Liu YK, 1997, FEBS LETT, V420, P112, DOI 10.1016/S0014-5793(97)01498-1; Martin TJ, 2005, J CLIN INVEST, V115, P2322, DOI 10.1172/JCI26239; Mastro AM, 2004, J CELL BIOCHEM, V91, P265, DOI 10.1002/jcb.10746; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; McKee MD, 1996, CONNECT TISSUE RES, V35, P197, DOI 10.3109/03008209609029192; Mercer RR, 2005, EXP CELL RES, V310, P270, DOI 10.1016/j.yexcr.2005.07.029; Mercer RR, 2004, CLIN EXP METASTAS, V21, P427, DOI 10.1007/s10585-004-1867-6; Miao DS, 2004, ENDOCRINOLOGY, V145, P3554, DOI 10.1210/en.2003-1695; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; Mukherjee S, 2006, CANCER BIOL THER, V5, P674, DOI 10.4161/cbt.5.6.2906; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakamura T, 1997, BIOCHEM BIOPH RES CO, V237, P465, DOI 10.1006/bbrc.1997.7156; Nefussi JR, 1997, J HISTOCHEM CYTOCHEM, V45, P493, DOI 10.1177/002215549704500402; O'Toole SA, 2011, CANCER RES, V71, P4002, DOI 10.1158/0008-5472.CAN-10-3738; Shevde LA, 2006, CLIN EXP METASTAS, V23, P123, DOI 10.1007/s10585-006-9013-2; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Singh S, 2011, CANCER RES, V71, P4454, DOI 10.1158/0008-5472.CAN-10-2313; Souzaki M, 2011, CANCER SCI, V102, P373, DOI 10.1111/j.1349-7006.2010.01779.x; Sterling JA, 2006, CANCER RES, V66, P7548, DOI 10.1158/0008-5472.CAN-06-0452; Xuan YH, 2009, J CANCER RES CLIN, V135, P235, DOI 10.1007/s00432-008-0451-x	40	29	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34374	10.1371/journal.pone.0034374	http://dx.doi.org/10.1371/journal.pone.0034374			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479615	gold, Green Submitted, Green Published			2022-12-27	WOS:000304523400079
J	Kitami, T; Logan, DJ; Negri, J; Hasaka, T; Tolliday, NJ; Carpenter, AE; Spiegelman, BM; Mootha, VK				Kitami, Toshimori; Logan, David J.; Negri, Joseph; Hasaka, Thomas; Tolliday, Nicola J.; Carpenter, Anne E.; Spiegelman, Bruce M.; Mootha, Vamsi K.			A Chemical Screen Probing the Relationship between Mitochondrial Content and Cell Size	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; SKELETAL-MUSCLE; GENE-EXPRESSION; RECEPTOR-ALPHA; ERR-ALPHA; BIOGENESIS; KINASE; COACTIVATOR; PGC-1-ALPHA; INHIBITORS	The cellular content of mitochondria changes dynamically during development and in response to external stimuli, but the underlying mechanisms remain obscure. To systematically identify molecular probes and pathways that control mitochondrial abundance, we developed a high-throughput imaging assay that tracks both the per cell mitochondrial content and the cell size in confluent human umbilical vein endothelial cells. We screened 28,786 small molecules and observed that hundreds of small molecules are capable of increasing or decreasing the cellular content of mitochondria in a manner proportionate to cell size, revealing stereotyped control of these parameters. However, only a handful of compounds dissociate this relationship. We focus on one such compound, BRD6897, and demonstrate through secondary assays that it increases the cellular content of mitochondria as evidenced by fluorescence microscopy, mitochondrial protein content, and respiration, even after rigorous correction for cell size, cell volume, or total protein content. BRD6897 increases uncoupled respiration 1.6-fold in two different, non-dividing cell types. Based on electron microscopy, BRD6897 does not alter the percent of cytoplasmic area occupied by mitochondria, but instead, induces a striking increase in the electron density of existing mitochondria. The mechanism is independent of known transcriptional programs and is likely to be related to a blockade in the turnover of mitochondrial proteins. At present the molecular target of BRD6897 remains to be elucidated, but if identified, could reveal an important additional mechanism that governs mitochondrial biogenesis and turnover.	[Kitami, Toshimori; Logan, David J.; Negri, Joseph; Hasaka, Thomas; Tolliday, Nicola J.; Carpenter, Anne E.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA USA; [Kitami, Toshimori; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Kitami, Toshimori; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kitami, T (corresponding author), Broad Inst, Cambridge, MA USA.	vamsi@hms.harvard.edu	Carpenter, Anne/C-4982-2008; Kitami, Toshimori/N-7460-2019	Carpenter, Anne/0000-0003-1555-8261; Kitami, Toshimori/0000-0001-8418-5230	National Institutes of Health (NIH) [R24DK080261]; Richard and Susan Smith Family Foundation; Nestle Research Center [R01GM089652]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089652] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard and Susan Smith Family Foundation; Nestle Research Center(Nestle SA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the National Institutes of Health (NIH) (R24DK080261) to Dr. Spiegelman and Dr. Mootha, Richard and Susan Smith Family Foundation and Nestle Research Center award to Dr. Mootha, and a grant from NIH (R01GM089652) to Dr. Carpenter. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Echave P, 2009, J CELL SCI, V122, P4516, DOI 10.1242/jcs.049734; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jones TR, 2005, LECT NOTES COMPUT SC, V3765, P535; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; KLEIBER M, 1947, PHYSIOL REV, V27, P511, DOI 10.1152/physrev.1947.27.4.511; LAMARCO KL, 1989, GENE DEV, V3, P1372, DOI 10.1101/gad.3.9.1372; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; McGehee AM, 2009, J IMMUNOL, V183, P3690, DOI 10.4049/jimmunol.0900953; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Seiler KP, 2008, NUCLEIC ACIDS RES, V36, pD351, DOI 10.1093/nar/gkm843; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; VIRBASIUS CMA, 1993, GENE DEV, V7, P2431, DOI 10.1101/gad.7.12a.2431; Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387; Wright GL, 2008, FASEB J, V22, P3264, DOI 10.1096/fj.08-106468; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	30	42	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33755	10.1371/journal.pone.0033755	http://dx.doi.org/10.1371/journal.pone.0033755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479437	Green Published, gold			2022-12-27	WOS:000304523400032
J	Marchal, C; Vinatier, G; Sanial, M; Plessis, A; Pret, AM; Limbourg-Bouchon, B; Theodore, L; Netter, S				Marchal, Christelle; Vinatier, Gerald; Sanial, Matthieu; Plessis, Anne; Pret, Anne-Marie; Limbourg-Bouchon, Bernadette; Theodore, Laurent; Netter, Sophie			The HIV-1 Vpu Protein Induces Apoptosis in Drosophila via Activation of JNK Signaling	PLOS ONE			English	Article							N-TERMINAL KINASE; DEPENDENT IMMUNE-RESPONSES; CELL-DEATH; BETA-TRCP; GENE-EXPRESSION; ACCESSORY PROTEIN; DORSAL CLOSURE; KAPPA-B; MEDIATED DEGRADATION; TNF SUPERFAMILY	The genome of the human immunodeficiency virus type 1 (HIV-1) encodes the canonical retroviral proteins, as well as additional accessory proteins that enhance the expression of viral genes, the infectivity of the virus and the production of virions. The accessory Viral Protein U (Vpu), in particular, enhances viral particle production, while also promoting apoptosis of HIV-infected human T lymphocytes. Some Vpu effects rely on its interaction with the ubiquitin-proteasome protein degradation system, but the mechanisms responsible for its pro-apoptotic effects in vivo are complex and remain largely to be elucidated. We took advantage of the Drosophila model to study the effects of Vpu activity in vivo. Expression of Vpu in the developing Drosophila wing provoked tissue loss due to caspase-dependent apoptosis. Moreover, Vpu induced expression of the pro-apoptotic gene reaper, known to down-regulate Inhibitor of Apoptosis Proteins (IAPs) which are caspase-antagonizing E3 ubiquitin ligases. Indeed, Vpu also reduced accumulation of Drosophila IAP1 (DIAP1). Though our results demonstrate a physical interaction between Vpu and the proteasome-addressing SLIMB/beta-TrCP protein, as in mammals, both SLIMB/beta TrCP-dependent and -independent Vpu effects were observed in the Drosophila wing. Lastly, the pro-apoptotic effect of Vpu in this tissue was abrogated upon inactivation of the c-Jun N-terminal Kinase (JNK) pathway. Our results in the fly thus provide the first functional evidence linking Vpu pro-apoptotic effects to activation of the conserved JNK pathway.	[Marchal, Christelle; Vinatier, Gerald; Limbourg-Bouchon, Bernadette; Theodore, Laurent; Netter, Sophie] Univ Versailles St Quentin En Yvelines, EA4589, Lab Genet & Biol Cellulaire, Versailles, France; [Pret, Anne-Marie] Univ Versailles St Quentin En Yvelines, UFR Sci, Versailles, France; [Sanial, Matthieu; Plessis, Anne] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, Paris, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Marchal, C (corresponding author), Univ Bordeaux, CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, Bordeaux, France.	sophie.netter@uvsq.fr	Plessis, Anne/AAC-4935-2020	Plessis, Anne/0000-0001-9193-7031; sanial, matthieu/0000-0002-0301-4710	Agence Nationale de la Recherche sur le Sida (ANRS); Centre National de la Recherche Scientifique (CNRS); Universite de Versailles/Saint-Quentin en Yvelines (UVSQ); Association pour la Recherche contre le Cancer (ARC) [1799, 7919]	Agence Nationale de la Recherche sur le Sida (ANRS)(ANRSFrench National Research Agency (ANR)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite de Versailles/Saint-Quentin en Yvelines (UVSQ); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR))	Funding was provided by Agence Nationale de la Recherche sur le Sida (ANRS), http://www.anrs.fr; Centre National de la Recherche Scientifique (CNRS), http://www.cnrs.fr; Universite de Versailles/Saint-Quentin en Yvelines (UVSQ), http://www.uvsq.fr; Association pour la Recherche contre le Cancer (ARC, # no 1799 et # no7919), http://www.arc-cancer.net; and Action Thematique et Incitative sur Programme (ATIP) CNRS grant, http://www.cnrs.fr/infoslabos/atip/vivant.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; Adamson AL, 2005, GENETICS, V171, P1125, DOI 10.1534/genetics.105.042572; Agnes F, 1999, DEVELOPMENT, V126, P5453; Akari H, 2001, J EXP MED, V194, P1299, DOI 10.1084/jem.194.9.1299; Battaglia PA, 2001, J CELL SCI, V114, P2787; Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Besnard-Guerin C, 2004, J BIOL CHEM, V279, P788, DOI 10.1074/jbc.M308068200; Binette J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-75; BLACKMAN RK, 1991, DEVELOPMENT, V111, P657; Bour S, 2003, MICROBES INFECT, V5, P1029, DOI 10.1016/S1286-4579(03)00191-6; Bour S, 2001, J BIOL CHEM, V276, P15920, DOI 10.1074/jbc.M010533200; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Casella CR, 1999, J VIROL, V73, P92, DOI 10.1128/JVI.73.1.92-100.1999; Cha GH, 2003, MOL CELL BIOL, V23, P7982, DOI 10.1128/MCB.23.22.7982-7991.2003; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-114; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Estrabaud E, 2007, PLOS PATHOG, V3, P995, DOI 10.1371/journal.ppat.0030104; Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145; Geuking P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007709; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Hsu K, 2004, MOL CELL, V14, P259, DOI 10.1016/S1097-2765(04)00183-2; Huh JR, 2004, CURR BIOL, V14, P1262, DOI 10.1016/j.cub.2004.06.015; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kanda H, 2002, J BIOL CHEM, V277, P28372, DOI 10.1074/jbc.C200324200; Kauppila S, 2003, ONCOGENE, V22, P4860, DOI 10.1038/sj.onc.1206715; Kotadia S, 2008, ONCOGENE, V27, P6334, DOI 10.1038/onc.2008.254; Kuranaga E, 2002, NAT CELL BIOL, V4, P705, DOI 10.1038/ncb842; Lee JH, 2006, CELL DEATH DIFFER, V13, P1110, DOI 10.1038/sj.cdd.4401790; Lee SB, 2005, J CELL SCI, V118, P1851, DOI 10.1242/jcs.02312; Leulier F, 2006, CELL DEATH DIFFER, V13, P1663, DOI 10.1038/sj.cdd.4401868; Leulier F, 2003, EMBO REP, V4, P976, DOI 10.1038/sj.embor.embor936; Magadan JG, 2012, J VIROL, V86, P757, DOI 10.1128/JVI.05933-11; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Martin FA, 2009, INT J DEV BIOL, V53, P1341, DOI 10.1387/ijdb.072447fm; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McEwen DG, 2005, DEVELOPMENT, V132, P3935, DOI 10.1242/dev.01949; Meusser B, 2004, MOL CELL, V14, P247, DOI 10.1016/S1097-2765(04)00212-6; Miletich I, 2000, MECH DEVELOP, V93, P15, DOI 10.1016/S0925-4773(00)00256-2; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Monnier V, 1998, CURR BIOL, V8, P583, DOI 10.1016/S0960-9822(98)70227-1; Monnier V, 2002, GENESIS, V34, P76, DOI 10.1002/gene.10130; Morata G, 2011, DEV GROWTH DIFFER, V53, P168, DOI 10.1111/j.1440-169X.2010.01225.x; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Murphy TD, 2003, J CELL SCI, V116, P2321, DOI 10.1242/jcs.00463; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neisch AL, 2010, J CELL BIOL, V189, P311, DOI 10.1083/jcb.200912010; Netter S, 2001, DNA CELL BIOL, V20, P483, DOI 10.1089/104454901316976118; Nomaguchi M, 2008, MICROBES INFECT, V10, P960, DOI 10.1016/j.micinf.2008.07.006; Nordstrom W, 1996, DEV BIOL, V180, P213, DOI 10.1006/dbio.1996.0296; Perez-Garijo A, 2004, DEVELOPMENT, V131, P5591, DOI 10.1242/dev.01432; Perez-Garijo A, 2009, DEVELOPMENT, V136, P1169, DOI 10.1242/dev.034017; Ponti D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-32; Rallis A, 2010, DEV BIOL, V339, P65, DOI 10.1016/j.ydbio.2009.12.016; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Sathyanarayana P, 2003, BBA-MOL CELL RES, V1640, P77, DOI 10.1016/S0167-4889(03)00022-3; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Singh J, 2010, ONCOGENE, V29, P4033, DOI 10.1038/onc.2010.155; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Speigelman VS, 2001, J BIOL CHEM, V276, P27152, DOI 10.1074/jbc.M100031200; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; Steinberg R, 2008, TRANSGENIC RES, V17, P105, DOI 10.1007/s11248-007-9136-5; Stronach B, 2002, GENE DEV, V16, P377, DOI 10.1101/gad.953002; Su YC, 1998, GENE DEV, V12, P2371, DOI 10.1101/gad.12.15.2371; Takatsu Y, 2000, MOL CELL BIOL, V20, P3015, DOI 10.1128/MCB.20.9.3015-3026.2000; Tervo HM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-9; Theodosiou NA, 1998, DEVELOPMENT, V125, P3411; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Verma S, 2011, BLOOD, V117, P6600, DOI 10.1182/blood-2011-01-333427; Vidal M, 2006, DEV CELL, V10, P33, DOI 10.1016/j.devcel.2005.11.007; Wang X, 2010, MOL CELL BIOCHEM, V337, P175, DOI 10.1007/s11010-009-0297-9; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Xu D, 2006, CELL DEATH DIFFER, V13, P1697, DOI 10.1038/sj.cdd.4401920; Xu DB, 2005, DEVELOPMENT, V132, P2125, DOI 10.1242/dev.01790; Xu DB, 2009, FLY, V3, P78, DOI 10.4161/fly.3.1.7800; Xue L, 2007, DEV CELL, V13, P446, DOI 10.1016/j.devcel.2007.07.012; Yan N, 2004, NAT STRUCT MOL BIOL, V11, P420, DOI 10.1038/nsmb764; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793	92	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34310	10.1371/journal.pone.0034310	http://dx.doi.org/10.1371/journal.pone.0034310			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479597	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400071
J	Upadhyay, AK; Murmu, A; Singh, A; Panda, AK				Upadhyay, Arun K.; Murmu, Aruna; Singh, Anupam; Panda, Amulya K.			Kinetics of Inclusion Body Formation and Its Correlation with the Characteristics of Protein Aggregates in Escherichia coli	PLOS ONE			English	Article							SECONDARY STRUCTURE; AMYLOID FIBRILS; CONGO RED; BODIES; SOLUBILIZATION; QUALITY; SIZE	The objective of the research was to understand the structural determinants governing protein aggregation into inclusion bodies during expression of recombinant proteins in Escherichia coli. Recombinant human growth hormone (hGH) and asparaginase were expressed as inclusion bodies in E. coli and the kinetics of aggregate formation was analyzed in details. Asparaginase inclusion bodies were of smaller size (200 nm) and the size of the aggregates did not increase with induction time. In contrast, the seeding and growth behavior of hGH inclusion bodies were found to be sequential, kinetically stable and the aggregate size increased from 200 to 800 nm with induction time. Human growth hormone inclusion bodies showed higher resistance to denaturants and proteinase K degradation in comparison to those of asparaginase inclusion bodies. Asparaginase inclusion bodies were completely solubilized at 2-3 M urea concentration and could be refolded into active protein, whereas 7 M urea was required for complete solubilization of hGH inclusion bodies. Both hGH and asparaginase inclusion bodies showed binding with amyloid specific dyes. In spite of its low b-sheet content, binding with dyes was more prominent in case of hGH inclusion bodies than that of asparaginase. Arrangements of protein molecules present in the surface as well as in the core of inclusion bodies were similar. Hydrophobic interactions between partially folded amphiphillic and hydrophobic alpha-helices were found to be one of the main determinants of hGH inclusion body formation. Aggregation behavior of the protein molecules decides the nature and properties of inclusion bodies.	[Upadhyay, Arun K.; Murmu, Aruna; Singh, Anupam; Panda, Amulya K.] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Upadhyay, AK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	amulya@nii.res.in	Upadhyay, Arun/D-4510-2014	Singh, Anupam/0000-0003-0092-5102; Panda, Amulya K/0000-0002-3648-1390	Department of Biotechnology Core funding to National Institutue of Immunology, new Delhi	Department of Biotechnology Core funding to National Institutue of Immunology, new Delhi	This work is funded by Department of Biotechnology Core funding to National Institutue of Immunology, new Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami D, 2005, FEBS LETT, V579, P3433, DOI 10.1016/j.febslet.2005.04.085; Carrio M, 2005, J MOL BIOL, V347, P1025, DOI 10.1016/j.jmb.2005.02.030; Carrio MM, 2001, FEBS LETT, V489, P29, DOI 10.1016/S0014-5793(01)02073-7; Carrio MM, 2000, FEBS LETT, V471, P7, DOI 10.1016/S0014-5793(00)01357-0; Carvajal P, 2011, BIOTECHNOL PROGR, V27, P232, DOI 10.1002/btpr.538; COOPER JH, 1974, LAB INVEST, V31, P232; DELELLIS RA, 1968, J HISTOCHEM CYTOCHEM, V16, P663, DOI 10.1177/16.10.663-a; Doglia Silvia Maria, 2008, Biotechnol J, V3, P193, DOI 10.1002/biot.200700238; Fahnert B, 2004, ADV BIOCHEM ENG BIOT, V89, P93; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Garcia-Fruitos E, 2005, BIOTECHNOL BIOENG, V90, P869, DOI 10.1002/bit.20496; Garcia-Fruitos E, 2012, TRENDS BIOTECHNOL, V30, P65, DOI 10.1016/j.tibtech.2011.09.003; Georgiou G, 1999, METHOD ENZYMOL, V309, P48; GLENNER GG, 1972, J HISTOCHEM CYTOCHEM, V20, P821, DOI 10.1177/20.10.821; Ignatova Z, 2007, BIOPOLYMERS, V88, P157, DOI 10.1002/bip.20665; Jevsevar S, 2005, BIOTECHNOL PROGR, V21, P632, DOI 10.1021/bp0497839; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; LeVine H, 1997, ARCH BIOCHEM BIOPHYS, V342, P306, DOI 10.1006/abbi.1997.0137; Margreiter G, 2008, J BIOTECHNOL, V138, P67, DOI 10.1016/j.jbiotec.2008.07.1995; Margreiter Gerd, 2008, Biotechnology Journal, V3, P1245, DOI 10.1002/biot.200800072; Morell M, 2008, BBA-MOL CELL RES, V1783, P1815, DOI 10.1016/j.bbamcr.2008.06.007; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; OBERG K, 1994, BIOCHEMISTRY-US, V33, P2628, DOI 10.1021/bi00175a035; Panda AK, 2003, ADV BIOCHEM ENG BIOT, V85, P43; Patra AK, 2000, EUR J BIOCHEM, V267, P7075, DOI 10.1046/j.1432-1327.2000.01808.x; Peternel S, 2011, INT J MOL SCI, V12, P8275, DOI 10.3390/ijms12118275; Peternel S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-34; PRZYBYCIEN TM, 1994, PROTEIN ENG, V7, P131, DOI 10.1093/protein/7.1.131; RINAS U, 1992, APPL MICROBIOL BIOT, V37, P609; Rudolph R, 1996, PROTEIN ENG PRINCIPL, P293; Salnikova MS, 2008, INT J PHARM, V358, P108, DOI 10.1016/j.ijpharm.2008.02.022; Singh SM, 2005, J BIOSCI BIOENG, V99, P303, DOI 10.1263/jbb.99.303; Singh SM, 2012, PROTEIN EXPRES PURIF, V81, P75, DOI 10.1016/j.pep.2011.09.004; Speed MA, 1996, NAT BIOTECHNOL, V14, P1283, DOI 10.1038/nbt1096-1283; TAYLOR G, 1986, BIO-TECHNOL, V4, P553, DOI 10.1038/nbt0686-553; Umetsu M, 2005, BIOCHEM BIOPH RES CO, V328, P189, DOI 10.1016/j.bbrc.2004.12.156; Vallejo LF, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-11; Ventura S, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-11; Ventura S, 2006, TRENDS BIOTECHNOL, V24, P179, DOI 10.1016/j.tibtech.2006.02.007; Villaverde A, 2003, BIOTECHNOL LETT, V25, P1385, DOI 10.1023/A:1025024104862; Wang L, 2008, PLOS BIOL, V6, P1791, DOI 10.1371/journal.pbio.0060195; Ward KR, 1999, INT J PHARM, V187, P153, DOI 10.1016/S0378-5173(99)00163-5; Worrall D M, 1989, Aust J Biotechnol, V3, P28; WRISTON JC, 1985, METHOD ENZYMOL, V113, P608	44	78	82	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33951	10.1371/journal.pone.0033951	http://dx.doi.org/10.1371/journal.pone.0033951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479486	Green Submitted, gold, Green Published			2022-12-27	WOS:000304523400045
J	Sancho, A; Duran, J; Garcia-Espana, A; Mauvezin, C; Alemu, EA; Lamark, T; Macias, MJ; DeSalle, R; Royo, M; Sala, D; Chicote, JU; Palacin, M; Johansen, T; Zorzano, A				Sancho, Ana; Duran, Jordi; Garcia-Espana, Antonio; Mauvezin, Caroline; Alemu, Endalkachew A.; Lamark, Trond; Macias, Maria J.; DeSalle, Rob; Royo, Miriam; Sala, David; Chicote, Javier U.; Palacin, Manuel; Johansen, Terje; Zorzano, Antonio			DOR/Tp53inp2 and Tp53inp1 Constitute a Metazoan Gene Family Encoding Dual Regulators of Autophagy and Transcription	PLOS ONE			English	Article							MALIGNANT GLIOMA-CELLS; NUCLEAR EXPORT SIGNAL; SELECTIVE AUTOPHAGY; STRUCTURAL BASIS; PROTEINS; DEGRADATION; P62/SQSTM1; EXPRESSION; EVOLUTION; APOPTOSIS	Human DOR/TP53INP2 displays a unique bifunctional role as a modulator of autophagy and gene transcription. However, the domains or regions of DOR that participate in those functions have not been identified. Here we have performed structure/function analyses of DOR guided by identification of conserved regions in the DOR gene family by phylogenetic reconstructions. We show that DOR is present in metazoan species. Invertebrates harbor only one gene, DOR/Tp53inp2, and in the common ancestor of vertebrates Tp53inp1 may have arisen by gene duplication. In keeping with these data, we show that human TP53INP1 regulates autophagy and that different DOR/TP53INP2 and TP53INP1 proteins display transcriptional activity. The use of molecular evolutionary information has been instrumental to determine the regions that participate in DOR functions. DOR and TP53INP1 proteins share two highly conserved regions (region 1, aa residues 28-42; region 2, 66112 in human DOR). Mutation of conserved hydrophobic residues in region 1 of DOR (that are part of a nuclear export signal, NES) reduces transcriptional activity, and blocks nuclear exit and autophagic activity under autophagy-activated conditions. We also identify a functional and conserved LC3-interacting motif (LIR) in region 1 of DOR and TP53INP1 proteins. Mutation of conserved acidic residues in region 2 of DOR reduces transcriptional activity, impairs nuclear exit in response to autophagy activation, and disrupts autophagy. Taken together, our data reveal DOR and TP53INP1 as dual regulators of transcription and autophagy, and identify two conserved regions in the DOR family that concentrate multiple functions crucial for autophagy and transcription.	[Sancho, Ana; Duran, Jordi; Mauvezin, Caroline; Macias, Maria J.; Sala, David; Palacin, Manuel; Zorzano, Antonio] IRB Barcelona, Barcelona, Spain; [Sancho, Ana; Duran, Jordi; Mauvezin, Caroline; Sala, David; Palacin, Manuel; Zorzano, Antonio] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Sancho, Ana; Duran, Jordi; Mauvezin, Caroline; Sala, David; Zorzano, Antonio] Inst Salud Carlos III, CIBER Diabet & Enfermedades Metabol Asociadas CIB, Madrid, Spain; [Garcia-Espana, Antonio; Chicote, Javier U.] Univ Rovira & Virgili, Inst Invest Sanitaria Rovira & Virgili IISPV, Hosp Joan XXIII, Unitat Recerca, Tarragona, Spain; [Alemu, Endalkachew A.; Lamark, Trond; Johansen, Terje] Univ Tromso, Inst Med Biol, Mol Canc Res Grp, Tromso, Norway; [Macias, Maria J.] ICREA, Barcelona, Spain; [DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Gen, New York, NY 10024 USA; [Royo, Miriam] Combinatorial Chem Unit, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV); UiT The Arctic University of Tromso; ICREA; American Museum of Natural History (AMNH)	Sancho, A (corresponding author), IRB Barcelona, Barcelona, Spain.	antonio.zorzano@irbbarcelona.org	Royo, Miriam/AAH-4918-2019; Macias, Maria J/K-3898-2014; Palacín, Manuel/G-9786-2015; Zorzano, Antonio/R-5479-2018; garcia-españa, antonio/I-4756-2015; Johansen, Terje/AAY-1753-2021; Duran, Jordi/AGP-2068-2022; Royo, Miriam/B-1665-2013; Johansen, Terje/N-2971-2015; Mauvezin, Caroline/B-5803-2016; Duran, Jordi/J-7298-2017	Royo, Miriam/0000-0001-5292-0819; Macias, Maria J/0000-0002-6915-963X; garcia-españa, antonio/0000-0002-9957-3161; Johansen, Terje/0000-0003-1451-9578; Duran, Jordi/0000-0002-8342-4882; Royo, Miriam/0000-0001-5292-0819; Johansen, Terje/0000-0003-1451-9578; Mauvezin, Caroline/0000-0003-4220-7272; Palacin, Manuel/0000-0002-8670-293X; UGARTE CHICOTE, JAVIER/0000-0001-6771-8584; Lamark, Trond/0000-0001-6338-3342	MEC "Ministerio de Educacion y Ciencia'' [SAF2008-03803]; "Generalitat de Catalunya'', CIBERDEM ("Instituto de Salud Carlos III'') [2009SGR915, SOE1/P1/E178]; COST [BM0602]; Norwegian Research Council; Norwegian Cancer Society; "Instituto de Salud Carlos III'' [PI070789]; Instituto de Salud Carlos III-Institut Catala de la Salut in Catalonia; University of Barcelona; ICREA Funding Source: Custom	MEC "Ministerio de Educacion y Ciencia''(Spanish GovernmentEuropean Commission); "Generalitat de Catalunya'', CIBERDEM ("Instituto de Salud Carlos III'')(Instituto de Salud Carlos IIIGeneralitat de Catalunya); COST(European Cooperation in Science and Technology (COST)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); "Instituto de Salud Carlos III''(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III-Institut Catala de la Salut in Catalonia; University of Barcelona; ICREA(ICREA)	JD was an FPI Fellow and AS is an FIS Fellow at the "Instituto de Salud Carlos III'', Spain. This study was supported by research grants from the MEC "Ministerio de Educacion y Ciencia'' (SAF2008-03803), Grant 2009SGR915 from the "Generalitat de Catalunya'', CIBERDEM ("Instituto de Salud Carlos III''), (INTERREG IV-B-SUDOE-FEDER (DIOMED, SOE1/P1/E178), and COST Action BM0602 to A.Z., from the Norwegian Research Council and Norwegian Cancer Society to T.J, and PI070789 from "Instituto de Salud Carlos III'' to AGE. AGE is supported by the Research Stabilization Program of the Instituto de Salud Carlos III-Institut Catala de la Salut in Catalonia. AZ is the recipient of a Science Intensification Award from the University of Barcelona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner BG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001183; Bennetts JS, 2007, DEV DYNAM, V236, P843, DOI 10.1002/dvdy.21064; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Carrier A, 1999, IMMUNOGENETICS, V50, P255, DOI 10.1007/s002510050601; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dong XH, 2009, NATURE, V458, P1136, DOI 10.1038/nature07975; Drake KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009806; Enrique-Tarancon G, 2000, BIOCHEM J, V350, P171, DOI 10.1042/0264-6021:3500171; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Francis VA, 2010, CURR BIOL, V20, P1799, DOI 10.1016/j.cub.2010.08.055; Garcia-Espana A, 2008, GENOMICS, V91, P326, DOI 10.1016/j.ygeno.2007.12.005; Garcia-Espana A, 2006, MOL PHYLOGENET EVOL, V41, P355, DOI 10.1016/j.ympev.2006.04.023; Garcia-Espana A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004680; Hedges SB, 2002, SCIENCE, V297, P1283; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; Liang XH, 2001, CANCER RES, V61, P3443; Mauvezin C, 2010, EMBO REP, V11, P37, DOI 10.1038/embor.2009.242; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; N'Guessan P, 2011, ANTIOXID REDOX SIGNA; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Nowak J, 2009, MOL BIOL CELL, V20, P870, DOI 10.1091/mbc.E08-07-0671; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Paglin S, 2001, CANCER RES, V61, P439; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J BIOL CHEM, V285, P5941, DOI 10.1074/jbc.M109.039925; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Shvets E, 2008, J CELL SCI, V121, P2685, DOI 10.1242/jcs.026005; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Tomasini R, 2003, J BIOL CHEM, V278, P37722, DOI 10.1074/jbc.M301979200; Tomasini R, 2005, ONCOGENE, V24, P8093, DOI 10.1038/sj.onc.1208951	38	48	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34034	10.1371/journal.pone.0034034	http://dx.doi.org/10.1371/journal.pone.0034034			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470510	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000054
J	Palkola, NV; Pakkanen, SH; Kantele, JM; Rossi, N; Puohiniemi, R; Kantele, A				Palkola, Nina V.; Pakkanen, Sari H.; Kantele, Jussi M.; Rossi, Niina; Puohiniemi, Ritvaleena; Kantele, Anu			Pathogen-Specific Circulating Plasmablasts in Patients with Pneumonia	PLOS ONE			English	Article							ANTIBODY-SECRETING CELLS; MUCOSAL IMMUNE-SYSTEM; INVASIVE PNEUMOCOCCAL DISEASE; URINARY-TRACT-INFECTION; LYMPHOID-TISSUE BALT; HUMAN B-CELLS; STREPTOCOCCUS-PNEUMONIAE; HOMING RECEPTORS; SALMONELLA-TYPHI; IMMUNOGLOBULIN-A	Lower respiratory tract infections (LRTI) are the leading cause of death world-wide, with Streptococcus pneumoniae (Pnc) as the most prevalent pathogen. Local immune mechanisms appear central to protection against the disease, yet they are poorly characterized. Infections at other, non-respiratory mucosal sites are associated with a transient circulation of mucosa-originating lymphocytes from the mucosal site to blood and back to the mucosa. The present study explored whether pathogen-specific plasmablasts appear in the circulation also in patients with infection of the lower respiratory tract. 16 patients with bacteremic Pnc pneumonia and 14 healthy volunteers were explored for circulating plasmablasts secreting antibodies against their own pathogenic Pnc strain isolated in blood cultures (patients) or against several pathogenic strains from pneumonia patients (14 controls) or a mixture of nine different purified pneumococcal polysaccharides (8 controls). Both patients and volunteers were studied for all plasmablasts. The cells were identified with ELISPOT as Pnc-specific antibody-secreting cells (ASC) and as all immunoglobulin-secreting cells (ISC). High numbers of circulating Pnc-specific ASC were found in the acute phase of the disease in all patients with pneumonia (median 97 ASC/10(6) PBMC), but in none of the controls. IgG isotype predominated in 9/16 patients. The numbers of ISC were significantly higher in the patients than in the healthy controls, yet Pnc-specific ASC only accounted for 0.7% of all the patients' ISC. The present study is the first to show that antigen-specific plasmablasts appear in the circulation in pneumonia, suggesting that pulmonary lypmhocytes recirculate in humans. Assessing these cells provides a novel tool for studying immune response to antigens encountered at the LRT.	[Palkola, Nina V.; Pakkanen, Sari H.; Rossi, Niina; Kantele, Anu] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland; [Palkola, Nina V.; Pakkanen, Sari H.; Rossi, Niina; Kantele, Anu] Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki, Finland; [Kantele, Jussi M.] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Puohiniemi, Ritvaleena] Helsinki Univ Hosp Lab HUSLAB, Dept Bacteriol, Helsinki, Finland; [Kantele, Anu] Univ Helsinki, Dept Med, Inst Clin Med, Helsinki, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Palkola, NV (corresponding author), Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, Helsinki, Finland.	anu.kantele@hus.fi	Kantele, Anu/AAS-4131-2021	Kantele, Anu/0000-0002-0004-1000; Pakkanen, Sari/0000-0003-4522-5337	Finnish Medical Association; Finnish government; Finnish Tuberculosis foundation; Pulmonary Association Heli; Paulo foundation	Finnish Medical Association; Finnish government; Finnish Tuberculosis foundation; Pulmonary Association Heli; Paulo foundation	The study was supported by the Finnish Medical Association (AK, NP, SP), by the specific Finnish governmental subsidy for health science research (AK, SP), by the Finnish Tuberculosis foundation (NP), the Pulmonary Association Heli (NP) and by the Paulo foundation (AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Bienenstock J, 2005, IMMUNOL REV, V206, P22, DOI 10.1111/j.0105-2896.2005.00299.x; BIENENSTOCK J, 1983, ANN NY ACAD SCI, V409, P164, DOI 10.1111/j.1749-6632.1983.tb26866.x; BIENENSTOCK J, 1980, IMMUNOLOGY, V41, P249; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Brandtzaeg P, 1999, IMMUNOL TODAY, V20, P267, DOI 10.1016/S0167-5699(99)01468-1; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Jambo KC, 2010, TRENDS MICROBIOL, V18, P81, DOI 10.1016/j.tim.2009.12.001; Johansen FE, 2005, BLOOD, V106, P593, DOI 10.1182/blood-2004-12-4630; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kantele A, 1997, J IMMUNOL, V158, P574; KANTELE A, 1986, J INFECT DIS, V153, P1126, DOI 10.1093/infdis/153.6.1126; Kantele A, 1998, INFECT IMMUN, V66, P5630, DOI 10.1128/IAI.66.12.5630-5635.1998; KANTELE A, 1994, J INFECT DIS, V169, P1023, DOI 10.1093/infdis/169.5.1023; KANTELE A, 1990, VACCINE, V8, P321, DOI 10.1016/0264-410X(90)90088-4; KANTELE AM, 1988, J INFECT DIS, V158, P1011, DOI 10.1093/infdis/158.5.1011; Kantele A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/279206; Kantele AM, 2008, CLIN IMMUNOL, V128, P427, DOI 10.1016/j.clim.2008.05.003; Kantele JM, 1996, GASTROENTEROLOGY, V110, P1061, DOI 10.1053/gast.1996.v110.pm8612994; King MD, 2003, CLIN INFECT DIS, V37, P1029, DOI 10.1086/377736; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; Macpherson AJ, 2008, MUCOSAL IMMUNOL, V1, P11, DOI 10.1038/mi.2007.6; MAKELA MJ, 1995, J MED VIROL, V47, P416, DOI 10.1002/jmv.1890470420; Mason EO, 2007, PEDIATR INFECT DIS J, V26, P480, DOI 10.1097/INF.0b013e31805ce277; McEllistrem MC, 2002, J INFECT DIS, V185, P1364, DOI 10.1086/339882; MERRILL WW, 1985, AM REV RESPIR DIS, V131, P584, DOI 10.1164/arrd.1985.131.4.584; MESTECKY J, 1987, J CLIN IMMUNOL, V7, P265, DOI 10.1007/BF00915547; Mestecky J, MUCOSAL IMMUNOLOGY U, P153; Pakkanen SH, 2010, CLIN VACCINE IMMUNOL, V17, P393, DOI 10.1128/CVI.00475-09; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; QUIDINGJARBRINK M, 1995, EUR J IMMUNOL, V25, P322, DOI 10.1002/eji.1830250203; SMINIA T, 1989, CRIT REV IMMUNOL, V9, P119; Twigg 3rd HL, 2005, P AM THORAC SOC, V2, P41; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; VANDERBRUGGEGAMELKOORN GJ, 1985, J IMMUNOL, V134, P3746; Woof JM, 2005, IMMUNOL REV, V206, P64, DOI 10.1111/j.0105-2896.2005.00290.x; World Health Organization, 2008, 10 LEAD CAUS DEATH B	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34334	10.1371/journal.pone.0034334	http://dx.doi.org/10.1371/journal.pone.0034334			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479603	Green Submitted, Green Published, gold			2022-12-27	WOS:000303894900081
J	Silber, J; Jacobsen, A; Ozawa, T; Harinath, G; Pedraza, A; Sander, C; Holland, EC; Huse, JT				Silber, Joachim; Jacobsen, Anders; Ozawa, Tatsuya; Harinath, Girish; Pedraza, Alicia; Sander, Chris; Holland, Eric C.; Huse, Jason T.			miR-34a Repression in Proneural Malignant Gliomas Upregulates Expression of Its Target PDGFRA and Promotes Tumorigenesis	PLOS ONE			English	Article							STEM-CELLS; P53; APOPTOSIS; MICRORNAS; SUBCLASSES; MICROARRAY; SITES	Glioblastoma (GBM) and other malignant gliomas are aggressive primary neoplasms of the brain that exhibit notable refractivity to standard treatment regimens. Recent large-scale molecular profiling has revealed distinct disease subclasses within malignant gliomas whose defining genomic features highlight dysregulated molecular networks as potential targets for therapeutic development. The "proneural" designation represents the largest and most heterogeneous of these subclasses, and includes both a large fraction of GBMs along with most of their lower-grade astrocytic and oligodendroglial counterparts. The pathogenesis of proneural gliomas has been repeatedly associated with dysregulated PDGF signaling. Nevertheless, genomic amplification or activating mutations involving the PDGF receptor (PDGFRA) characterize only a subset of proneural GBMs, while the mechanisms driving dysregulated PDGF signaling and downstream oncogenic networks in remaining tumors are unclear. MicroRNAs (miRNAs) are a class of small, noncoding RNAs that regulate gene expression by binding loosely complimentary sequences in target mRNAs. The role of miRNA biology in numerous cancer variants is well established. In an analysis of miRNA involvement in the phenotypic expression and regulation of oncogenic PDGF signaling, we found that miR-34a is downregulated by PDGF pathway activation in vitro. Similarly, analysis of data from the Cancer Genome Atlas (TCGA) revealed that miR-34a expression is significantly lower in proneural gliomas compared to other tumor subtypes. Using primary GBM cells maintained under neurosphere conditions, we then demonstrated that miR-34a specifically affects growth of proneural glioma cells in vitro and in vivo. Further bioinformatic analysis identified PDGFRA as a direct target of miR-34a and this interaction was experimentally validated. Finally, we found that PDGF-driven miR-34a repression is unlikely to operate solely through a p53-dependent mechanism. Taken together, our data support the existence of reciprocal negative feedback regulation involving miR-34 and PDGFRA expression in proneural gliomas and, as such, identify a subtype specific therapeutic potential for miR-34a.	[Harinath, Girish; Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Silber, Joachim; Harinath, Girish; Pedraza, Alicia; Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Jacobsen, Anders; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Ozawa, Tatsuya; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Silber, J (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	husej@mskcc.org	Skanderup, Anders Jacobsen/K-1081-2013	Skanderup, Anders Jacobsen/0000-0001-6847-4980	The Society of MSKCC; MSKCC Brain Tumor Center; Leon Levy Foundation; Lundbeck Foundation; Augustinus Fonden; Christian og Ottilia Brorsons Rejselegat for Yngre Videnskabsmaend og -kvinder; Dagmar Marshalls Fond; Direktor Jacob Madsen og Hustru Olga Madsens Fond; Fabrikant Einar Willumsens Mindelegat; Familien Hede Nielsens Fond; Fhv. Direktor Leo Nielsen og Hustru Karen Margrethe Nielsens Legat; Folketingsmand J. Christensen og hustru K. Christensens Fond; Fonden til Laegevidenskabens Fremme; Generalkonsul Friedrich Bohm og datter Else Bohms Fond; Harboefonden; Poul og Ellen Hertz's Fond; Aage og Johanne Louis-Hansens Fond	The Society of MSKCC; MSKCC Brain Tumor Center; Leon Levy Foundation; Lundbeck Foundation(Lundbeckfonden); Augustinus Fonden; Christian og Ottilia Brorsons Rejselegat for Yngre Videnskabsmaend og -kvinder; Dagmar Marshalls Fond; Direktor Jacob Madsen og Hustru Olga Madsens Fond; Fabrikant Einar Willumsens Mindelegat; Familien Hede Nielsens Fond; Fhv. Direktor Leo Nielsen og Hustru Karen Margrethe Nielsens Legat; Folketingsmand J. Christensen og hustru K. Christensens Fond; Fonden til Laegevidenskabens Fremme; Generalkonsul Friedrich Bohm og datter Else Bohms Fond; Harboefonden; Poul og Ellen Hertz's Fond; Aage og Johanne Louis-Hansens Fond	This work was supported by The Society of MSKCC (www.thesocietyofmskcc.org), the MSKCC Brain Tumor Center, the Leon Levy Foundation (www.leonlevyfoundation.org), the Lundbeck Foundation (www.lundbeckfonden.dk), Augustinus Fonden (www.augustinusfonden.dk), Christian og Ottilia Brorsons Rejselegat for Yngre Videnskabsmaend og -kvinder, Dagmar Marshalls Fond, Direktor Jacob Madsen og Hustru Olga Madsens Fond, Fabrikant Einar Willumsens Mindelegat, Familien Hede Nielsens Fond (www.hedenielsensfond.dk), Fhv. Direktor Leo Nielsen og Hustru Karen Margrethe Nielsens Legat, Folketingsmand J. Christensen og hustru K. Christensens Fond, Fonden til Laegevidenskabens Fremme (www.apmollerfonde.dk), Generalkonsul Friedrich Bohm og datter Else Bohms Fond, Harboefonden (www.harboefonden.dk), Poul og Ellen Hertz's Fond, and Aage og Johanne Louis-Hansens Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Huse JT, 2009, CELL CYCLE, V8, P3611, DOI 10.4161/cc.8.22.9893; Jacobsen A, 2010, GENOME RES, V20, P1010, DOI 10.1101/gr.103259.109; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Li Y, 2009, CANC RES, P0008; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Ozawa T, 2010, GENE DEV, V24, P2205, DOI 10.1101/gad.1972310; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Silber J, 2009, NEUROMOL MED, V11, P208, DOI 10.1007/s12017-009-8087-9; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126	23	91	96	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33844	10.1371/journal.pone.0033844	http://dx.doi.org/10.1371/journal.pone.0033844			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479456	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900041
J	Charusanti, P; Fong, NL; Nagarajan, H; Pereira, AR; Li, HJ; Abate, EA; Su, YX; Gerwick, WH; Palsson, BO				Charusanti, Pep; Fong, Nicole L.; Nagarajan, Harish; Pereira, Alban R.; Li, Howard J.; Abate, Elisa A.; Su, Yongxuan; Gerwick, William H.; Palsson, Bernhard O.			Exploiting Adaptive Laboratory Evolution of Streptomyces clavuligerus for Antibiotic Discovery and Overproduction	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; SECONDARY METABOLIC PATHWAYS; COMPLETE GENOME SEQUENCE; LONG-TERM EXPERIMENT; WD-REPEAT PROTEINS; ESCHERICHIA-COLI; GENE-CLUSTER; BIOSYNTHESIS PATHWAY; ASPERGILLUS-NIDULANS; ADENYLATION DOMAINS	Adaptation is normally viewed as the enemy of the antibiotic discovery and development process because adaptation among pathogens to antibiotic exposure leads to resistance. We present a method here that, in contrast, exploits the power of adaptation among antibiotic producers to accelerate the discovery of antibiotics. A competition-based adaptive laboratory evolution scheme is presented whereby an antibiotic-producing microorganism is competed against a target pathogen and serially passed over time until the producer evolves the ability to synthesize a chemical entity that inhibits growth of the pathogen. When multiple Streptomyces clavuligerus replicates were adaptively evolved against methicillin-resistant Staphylococcus aureus N315 in this manner, a strain emerged that acquired the ability to constitutively produce holomycin. In contrast, no holomycin could be detected from the unevolved wild-type strain. Moreover, genome resequencing revealed that the evolved strain had lost pSCL4, a large 1.8 Mbp plasmid, and acquired several single nucleotide polymorphisms in genes that have been shown to affect secondary metabolite biosynthesis. These results demonstrate that competition-based adaptive laboratory evolution can constitute a platform to create mutants that overproduce known antibiotics and possibly to discover new compounds as well.	[Charusanti, Pep; Fong, Nicole L.; Nagarajan, Harish; Li, Howard J.; Abate, Elisa A.; Palsson, Bernhard O.] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Nagarajan, Harish] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Pereira, Alban R.; Gerwick, William H.] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA 92093 USA; [Pereira, Alban R.; Gerwick, William H.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Su, Yongxuan] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; University of California System; University of California San Diego	Charusanti, P (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	palsson@ucsd.edu		Charusanti, Pep/0000-0003-0009-6615; Palsson, Bernhard/0000-0003-2357-6785	National Institutes of Health [GM062791, GM071808]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071808, R01GM062791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM062791 and GM071808. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony C, 2000, Subcell Biochem, V35, P73; Auriol C, 2011, P NATL ACAD SCI USA, V108, P1278, DOI 10.1073/pnas.1010431108; Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P657, DOI 10.1007/s10295-010-0934-z; Baneriee R, 2008, ANTIMICROB AGENTS CH, V52, P2089, DOI 10.1128/AAC.01403-07; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BERGERBACHI B, 1989, J ANTIMICROB CHEMOTH, V23, P179, DOI 10.1093/jac/23.2.179; Bergmann S, 2010, APPL ENVIRON MICROB, V76, P8143, DOI 10.1128/AEM.00683-10; Bills G, 2009, MYCOLOGY S, P257; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Challis GL, 2003, P NATL ACAD SCI USA, V100, P14555, DOI 10.1073/pnas.1934677100; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Charusanti P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001186; Conrad TM, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r118; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Cozier GE, 1995, BIOCHEM J, V312, P679, DOI 10.1042/bj3120679; de la Fuente A, 2002, J BACTERIOL, V184, P6559, DOI 10.1128/JB.184.23.6559-6565.2002; Friedman L, 2006, ANTIMICROB AGENTS CH, V50, P2137, DOI 10.1128/AAC.00039-06; Garbeva P, 2011, ISME J; Gause GF, 1932, J EXP BIOL, V9, P389; Gilbert DN, 2001, ANTIMICROB AGENTS CH, V45, P883, DOI 10.1128/AAC.45.3.883-892.2001; Gottelt M, 2010, MICROBIOL-SGM, V156, P2343, DOI 10.1099/mic.0.038281-0; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Herring CD, 2006, NAT GENET, V38, P1406, DOI 10.1038/ng1906; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Hosaka T, 2009, NAT BIOTECHNOL, V27, P462, DOI 10.1038/nbt.1538; Hu HB, 2010, BIOCHEM BIOPH RES CO, V391, P1033, DOI 10.1016/j.bbrc.2009.12.013; Hughes GJ, 2002, J GEN VIROL, V83, P1907, DOI 10.1099/0022-1317-83-8-1907; Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820; KENIG M, 1979, J ANTIBIOT, V32, P549, DOI 10.7164/antibiotics.32.549; Khare A, 2009, NATURE, V461, P980, DOI 10.1038/nature08472; KIRBY R, 1978, FEMS MICROBIOL LETT, V3, P283, DOI 10.1016/0378-1097(78)90119-2; Kontnik R, 2010, ACS CHEM BIOL, V5, P659, DOI 10.1021/cb100117k; Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Kurosawa K, 2008, J AM CHEM SOC, V130, P1126, DOI 10.1021/ja077821p; Laskaris P, 2010, ENVIRON MICROBIOL, V12, P783, DOI 10.1111/j.1462-2920.2009.02125.x; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Li B, 2010, P NATL ACAD SCI USA, V107, P19731, DOI 10.1073/pnas.1014140107; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Liras P, 2009, METHOD ENZYMOL, V458, P401, DOI 10.1016/S0076-6879(09)04816-2; Locher CP, 2003, J VIROL, V77, P77, DOI 10.1128/JVI.77.1.77-83.2003; Locke JB, 2009, ANTIMICROB AGENTS CH, V53, P5265, DOI 10.1128/AAC.00871-09; MAPLESTONE RA, 1992, GENE, V115, P151, DOI 10.1016/0378-1119(92)90553-2; Medema MH, 2010, GENOME BIOL EVOL, V2, P212, DOI 10.1093/gbe/evq013; Mutka SC, 2006, BIOCHEMISTRY-US, V45, P1321, DOI 10.1021/bi052075r; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nowak-Thompson B, 1999, J BACTERIOL, V181, P2166, DOI 10.1128/JB.181.7.2166-2174.1999; Oh DC, 2007, J NAT PROD, V70, P515, DOI 10.1021/np060381f; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; OKAMURA K, 1977, J ANTIBIOT, V30, P334, DOI 10.7164/antibiotics.30.334; Oliva B, 2001, ANTIMICROB AGENTS CH, V45, P532, DOI 10.1128/AAC.45.2.532-539.2001; Peiru S, 2005, APPL ENVIRON MICROB, V71, P2539, DOI 10.1128/AEM.71.5.2539-2547.2005; PERRY MJ, 1984, J GEN MICROBIOL, V130, P319; Puehringer Sandra, 2008, BMC Biochemistry, V9, P8, DOI 10.1186/1471-2091-9-8; Sanchez S, 2010, J ANTIBIOT, V63, P442, DOI 10.1038/ja.2010.78; Scherlach K, 2010, J ANTIBIOT, V63, P375, DOI 10.1038/ja.2010.46; Slattery M, 2001, MICROBIAL ECOL, V41, P90; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Song JY, 2010, J BACTERIOL, V192, P6317, DOI 10.1128/JB.00859-10; SONNENBICHLER J, 1983, PHYTOCHEMISTRY, V22, P1489, DOI 10.1016/S0031-9422(00)84043-1; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Stanley D, 2010, J IND MICROBIOL BIOT, V37, P139, DOI 10.1007/s10295-009-0655-3; Stoebel DM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000671; Tremblay PL, 2011, ENVIRON MICROBIOL, V13, P13, DOI 10.1111/j.1462-2920.2010.02302.x; Trinh CT, 2009, APPL ENVIRON MICROB, V75, P6696, DOI 10.1128/AEM.00670-09; Wang ES, 2011, J VIROL, V85, P5606, DOI 10.1128/JVI.01502-10; Wang YZ, 2011, J IND MICROBIOL BIOT, V38, P1371, DOI 10.1007/s10295-010-0920-5; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Wiener P, 1996, EVOL ECOL, V10, P405, DOI 10.1007/BF01237726; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103	72	62	68	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33727	10.1371/journal.pone.0033727	http://dx.doi.org/10.1371/journal.pone.0033727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470465	Green Published, gold			2022-12-27	WOS:000303857100042
J	Muthuraman, M; Tamas, G; Hellriegel, H; Deuschl, G; Raethjen, J				Muthuraman, Muthuraman; Tamas, Gertrud; Hellriegel, Helge; Deuschl, Guenther; Raethjen, Jan			Source Analysis of Beta-Synchronisation and Cortico-Muscular Coherence after Movement Termination Based on High Resolution Electroencephalography	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; PARKINSONS-DISEASE; OSCILLATORY ACTIVITY; PATHOLOGICAL SYNCHRONIZATION; SENSORIMOTOR CORTEX; FINGER MOVEMENT; HAND MOVEMENTS; HUMAN BRAIN; MUSCLE; EEG	We hypothesized that post-movement beta synchronization (PMBS) and cortico-muscular coherence (CMC) during movement termination relate to each other and have similar role in sensorimotor integration. We calculated the parameters and estimated the sources of these phenomena. We measured 64-channel EEG simultaneously with surface EMG of the right first dorsal interosseus muscle in 11 healthy volunteers. In Task1, subjects kept a medium-strength contraction continuously; in Task2, superimposed on this movement, they performed repetitive self-paced short contractions. In Task3 short contractions were executed alone. Time-frequency analysis of the EEG and CMC was performed with respect to the offset of brisk movements and averaged in each subject. Sources of PMBS and CMC were also calculated. High beta power in Task1, PMBS in Task2-3, and CMC in Task1-2 could be observed in the same individual frequency bands. While beta synchronization in Task1 and PMBS in Task2-3 appeared bilateral with contralateral predominance, CMC in Task1-2 was strictly a unilateral phenomenon; their main sources did not differ contralateral to the movement in the primary sensorimotor cortex in 7 of 11 subjects in Task1, and in 6 of 9 subjects in Task2. In Task2, CMC and PMBS had the same latency but their amplitudes did not correlate with each other. In Task2, weaker PMBS source was found bilaterally within the secondary sensory cortex, while the second source of CMC was detected in the premotor cortex, contralateral to the movement. In Task3, weaker sources of PMBS could be estimated in bilateral supplementary motor cortex and in the thalamus. PMBS and CMC appear simultaneously at the end of a phasic movement possibly suggesting similar antikinetic effects, but they may be separate processes with different active functions. Whereas PMBS seems to reset the supraspinal sensorimotor network, cortico-muscular coherence may represent the recalibration of cortico-motoneuronal and spinal systems.	[Muthuraman, Muthuraman; Hellriegel, Helge; Deuschl, Guenther; Raethjen, Jan] Univ Kiel, Dept Neurol, D-2300 Kiel, Germany; [Tamas, Gertrud] Semmelweis Univ, Dept Neurol, Budapest, Hungary	University of Kiel; Semmelweis University	Muthuraman, M (corresponding author), Univ Kiel, Dept Neurol, D-2300 Kiel, Germany.	m.muthuraman@neurologie.uni-kiel.de	Deuschl, Gunther/A-7986-2010; Tamas, Gertrud/X-9756-2019; Muthuraman, Muthuraman/ABD-2021-2020	Deuschl, Gunther/0000-0002-4176-9196; Tamas, Gertrud/0000-0001-8054-3678; Muthuraman, Muthuraman/0000-0001-6158-2663	German Research Council (Deutsche Forschungsgemeinschaft, DFG) [SFB 855]; TAMOP [4.2.1.B-09/1/KMR]	German Research Council (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); TAMOP	MM was supported from the German Research Council (Deutsche Forschungsgemeinschaft, DFG, SFB 855, Project D2). GT was supported by a TAMOP 4.2.1.B-09/1/KMR grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre M, 2004, CLIN NEUROPHYSIOL, V115, P124, DOI 10.1016/S1388-2457(03)00311-0; Baker SN, 2007, CURR OPIN NEUROBIOL, V17, P649, DOI 10.1016/j.conb.2008.01.007; Brown P, 2007, CURR OPIN NEUROBIOL, V17, P656, DOI 10.1016/j.conb.2007.12.001; Brown P, 2000, PROG NEUROBIOL, V60, P97, DOI 10.1016/S0301-0082(99)00029-5; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Della Penna S, 2004, NEUROIMAGE, V22, P1438, DOI 10.1016/j.neuroimage.2004.03.045; Doyle LMF, 2005, EUR J NEUROSCI, V21, P1403, DOI 10.1111/j.1460-9568.2005.03969.x; DUM RP, 1991, J NEUROSCI, V11, P667; Erbil N, 2007, BRAIN RES, V1169, P44, DOI 10.1016/j.brainres.2007.07.014; Eusebio A, 2011, J NEUROL NEUROSUR PS, V82, P569, DOI 10.1136/jnnp.2010.217489; Evans A C, 1992, Neuroimage, V1, P43, DOI 10.1016/1053-8119(92)90006-9; Feige B, 2000, J NEUROPHYSIOL, V84, P2622, DOI 10.1152/jn.2000.84.5.2622; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Gertrtud T, 2011, NEUROSCI LETT, V494, P240, DOI 10.1016/j.neulet.2011.03.024; Gilbertson T, 2005, J NEUROSCI, V25, P7771, DOI 10.1523/JNEUROSCI.1762-05.2005; Gourab K, 2010, CLIN NEUROPHYSIOL, V121, P2017, DOI 10.1016/j.clinph.2010.05.012; Gross J, 1999, PHYS MED BIOL, V44, P2081, DOI 10.1088/0031-9155/44/8/317; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Halliday DM, 1998, NEUROSCI LETT, V241, P5, DOI 10.1016/S0304-3940(97)00964-6; Houdayer E, 2006, CLIN NEUROPHYSIOL, V117, P628, DOI 10.1016/j.clinph.2005.12.001; Huttunen J, 1996, NEUROREPORT, V7, P1009, DOI 10.1097/00001756-199604100-00011; Jarvis MR, 2001, NEURAL COMPUT, V13, P717, DOI 10.1162/089976601300014312; JOURNEE HL, 1983, IEEE T BIO-MED ENG, V30, P304, DOI 10.1109/TBME.1983.325120; Jurkiewicz MT, 2006, NEUROIMAGE, V32, P1281, DOI 10.1016/j.neuroimage.2006.06.005; Kilner JM, 2003, NEUROIMAGE, V18, P67, DOI 10.1006/nimg.2002.1322; Kilner JM, 2000, J NEUROSCI, V20, P8838; Kuhn AA, 2009, EXP NEUROL, V215, P380, DOI 10.1016/j.expneurol.2008.11.008; Kuhn AA, 2006, BRAIN, V129, P695, DOI 10.1093/brain/awh715; Mima T, 1998, J NEUROPHYSIOL, V80, P2215, DOI 10.1152/jn.1998.80.4.2215; Mima T, 1999, J CLIN NEUROPHYSIOL, V16, P501, DOI 10.1097/00004691-199911000-00002; Mima T, 1999, NEUROSCI LETT, V275, P77, DOI 10.1016/S0304-3940(99)00734-X; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Muller-Putz GR, 2007, BRAIN RES, V1137, P84, DOI 10.1016/j.brainres.2006.12.052; Murayama N, 2001, NEUROIMAGE, V14, P1206, DOI 10.1006/nimg.2001.0907; Muthuraman M, 2012, NEUROIMAGE, V60, P1331, DOI 10.1016/j.neuroimage.2012.01.088; Muthuraman M, 2010, BIOMED SIGNAL PROCES, V5, P205, DOI 10.1016/j.bspc.2010.02.006; Muthuraman M, 2008, IEEE ENG MED BIO, P4716, DOI 10.1109/IEMBS.2008.4650266; Ohara S, 2000, BRAIN, V123, P1203, DOI 10.1093/brain/123.6.1203; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Parkes LM, 2006, NEUROIMAGE, V29, P685, DOI 10.1016/j.neuroimage.2005.08.018; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Pfurtscheller G, 1998, ELECTROMYOGR MOTOR C, V109, P154, DOI 10.1016/S0924-980X(97)00070-2; Pfurtscheller G, 2003, NEUROSCI LETT, V339, P111, DOI 10.1016/S0304-3940(02)01479-9; Pfurtscheller G, 2009, CLIN NEUROPHYSIOL, V120, P24, DOI 10.1016/j.clinph.2008.09.027; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; PFURTSCHELLER G, 1981, ELECTROEN CLIN NEURO, V51, P253, DOI 10.1016/0013-4694(81)90139-5; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Reyns N, 2008, CLIN NEUROPHYSIOL, V119, P1335, DOI 10.1016/j.clinph.2008.02.020; Salenius S, 2002, BRAIN, V125, P491, DOI 10.1093/brain/awf042; Salenius S, 2003, CURR OPIN NEUROBIOL, V13, P678, DOI 10.1016/j.conb.2003.10.008; Salmelin R, 1995, ELECTROEN CLIN NEURO, V95, P444, DOI 10.1016/0013-4694(95)00193-X; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; SLEPIAN D, 1961, BELL SYST TECH J, V40, P43, DOI 10.1002/j.1538-7305.1961.tb03976.x; Stancak A, 1997, J CLIN NEUROPHYSIOL, V14, P419, DOI 10.1097/00004691-199709000-00008; Stancak A, 2006, PROG BRAIN RES, V159, P237, DOI 10.1016/S0079-6123(06)59016-8; Szurhaj W, 2003, CLIN NEUROPHYSIOL, V114, P107, DOI 10.1016/S1388-2457(02)00333-4; Tamas G, 2003, CLIN NEUROPHYSIOL, V114, P614, DOI 10.1016/S1388-2457(02)00424-8; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; van Burik M, 1999, J CLIN NEUROPHYSIOL, V16, P383, DOI 10.1097/00004691-199907000-00011; vanDrongelen W, 1996, BRAIN TOPOGR, V9, P39, DOI 10.1007/BF01191641; Weinstein D, 2000, ANN BIOMED ENG, V28, P1059, DOI 10.1114/1.1310220; ZHANG Z, 1995, PHYS MED BIOL, V40, P335, DOI 10.1088/0031-9155/40/3/001	64	18	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33928	10.1371/journal.pone.0033928	http://dx.doi.org/10.1371/journal.pone.0033928			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470495	gold, Green Published, Green Submitted			2022-12-27	WOS:000303857100059
J	Sutejo, R; Yeo, DS; Myaing, MZ; Hui, C; Xia, JJ; Ko, D; Cheung, PCF; Tan, BH; Sugrue, RJ				Sutejo, Richard; Yeo, Dawn S.; Myaing, Myint Zu; Hui, Chen; Xia, Jiajia; Ko, Debbie; Cheung, Peter C. F.; Tan, Boon-Huan; Sugrue, Richard J.			Activation of Type I and III Interferon Signalling Pathways Occurs in Lung Epithelial Cells Infected with Low Pathogenic Avian Influenza Viruses	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; A VIRUS; RIG-I; ANTIVIRAL RESPONSES; HOST-RESPONSES; PROTEIN-KINASE; GENE-EXPRESSION; H5N1; APOPTOSIS; XIAP	The host response to the low pathogenic avian influenza (LPAI) H5N2, H5N3 and H9N2 viruses were examined in A549, MDCK, and CEF cells using a systems-based approach. The H5N2 and H5N3 viruses replicated efficiently in A549 and MDCK cells, while the H9N2 virus replicated least efficiently in these cell types. However, all LPAI viruses exhibited similar and higher replication efficiencies in CEF cells. A comparison of the host responses of these viruses and the H1N1/WSN virus and low passage pH1N1 clinical isolates was performed in A549 cells. The H9N2 and H5N2 virus subtypes exhibited a robust induction of Type I and Type III interferon (IFN) expression, sustained STAT1 activation from between 3 and 6 hpi, which correlated with large increases in IFN-stimulated gene (ISG) expression by 10 hpi. In contrast, cells infected with the pH1N1 or H1N1/WSN virus showed only small increases in Type III IFN signalling, low levels of ISG expression, and down-regulated expression of the IFN type I receptor. JNK activation and increased expression of the pro-apoptotic XAF1 protein was observed in A549 cells infected with all viruses except the H1N1/WSN virus, while MAPK p38 activation was only observed in cells infected with the pH1N1 and the H5 virus subtypes. No IFN expression and low ISG expression levels were generally observed in CEF cells infected with either AIV, while increased IFN and ISG expression was observed in response to the H1N1/WSN infection. These data suggest differences in the replication characteristics and antivirus signalling responses both among the different LPAI viruses, and between these viruses and the H1N1 viruses examined. These virus-specific differences in host cell signalling highlight the importance of examining the host response to avian influenza viruses that have not been extensively adapted to mammalian tissue culture.	[Sutejo, Richard; Yeo, Dawn S.; Myaing, Myint Zu; Hui, Chen; Xia, Jiajia; Ko, Debbie; Cheung, Peter C. F.; Sugrue, Richard J.] Nanyang Technol Univ, Sch Biol Sci, Div Mol & Cell Biol, Singapore, Singapore; [Yeo, Dawn S.; Tan, Boon-Huan] DSO Natl Labs, Detect & Diagnost Lab, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Sutejo, R (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Mol & Cell Biol, Singapore, Singapore.	rjsugrue@ntu.edu.sg	Cheung, Peter/A-2213-2011; Tan, Boon Huan/ABB-8381-2021; Sugrue, Richard J/A-2214-2011	Tan, Boon Huan/0000-0002-4976-7988; 	Defence Science and Technology Agency; National Medical Research Council of Singapore	Defence Science and Technology Agency(Defence Science and Technology Agency); National Medical Research Council of Singapore(National Medical Research Council, Singapore)	The authors acknowledge the Defence Science and Technology Agency and National Medical Research Council of Singapore for funding this current study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; Brand S, 2005, AM J PHYSIOL-GASTR L, V289, pG960, DOI 10.1152/ajpgi.00126.2005; Brand S, 2005, BIOCHEM BIOPH RES CO, V331, P543, DOI 10.1016/j.bbrc.2005.04.004; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Chakrabarti AK, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-219; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Cong YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012591; Daidoji T, 2008, J VIROL, V82, P11294, DOI 10.1128/JVI.01192-08; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Doyle SE, 2006, HEPATOLOGY, V44, P896, DOI 10.1002/hep.21312; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Holcik M, 2001, APOPTOSIS, V6, P253, DOI 10.1023/A:1011379307472; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; Holzinger D, 2007, J VIROL, V81, P7776, DOI 10.1128/JVI.00546-06; HORIMOTO T, 1995, VIROLOGY, V213, P223, DOI 10.1006/viro.1995.1562; Iordanov MS, 2000, MOL CELL BIOL, V20, P617, DOI 10.1128/MCB.20.2.617-627.2000; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Kochs G, 1999, J BIOL CHEM, V274, P4370, DOI 10.1074/jbc.274.7.4370; Kochs G, 1999, P NATL ACAD SCI USA, V96, P2082, DOI 10.1073/pnas.96.5.2082; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Koerner I, 2007, J VIROL, V81, P2025, DOI 10.1128/JVI.01718-06; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Kujime K, 2000, J IMMUNOL, V164, P3222, DOI 10.4049/jimmunol.164.6.3222; Lee CW, 2005, J VIROL, V79, P11412, DOI 10.1128/JVI.79.17.11412-11421.2005; Lee DCW, 2005, J VIROL, V79, P10147, DOI 10.1128/JVI.79.16.10147-10154.2005; Lee SMY, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-147; Lee SMY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008072; Lee VJ, 2010, NEW ENGL J MED, V362, P2166, DOI 10.1056/NEJMoa0908482; Li GQ, 2004, J BIOL CHEM, V279, P1123, DOI 10.1074/jbc.M305893200; Li W, 2008, CELL PROLIFERAT, V41, P960, DOI 10.1111/j.1365-2184.2008.00558.x; Li Y, 2010, J VIROL, V84, P3023, DOI 10.1128/JVI.02203-09; Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Moncorge O, 2010, J VIROL, V84, P9978, DOI 10.1128/JVI.01134-10; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Ogata T, 2008, J EPIDEMIOL, V18, P160, DOI 10.2188/jea.JE2007446; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; PLOTCH SJ, 1981, CELL, V23, P847, DOI 10.1016/0092-8674(81)90449-9; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Reemers SS, 2010, MOL IMMUNOL, V47, P1675, DOI 10.1016/j.molimm.2010.03.008; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Soda K, 2011, J VET MED SCI, V73, P767, DOI 10.1292/jvms.10-0532; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Sun YP, 2011, P NATL ACAD SCI USA, V108, P4164, DOI 10.1073/pnas.1019109108; Turan K, 2004, NUCLEIC ACIDS RES, V32, P643, DOI 10.1093/nar/gkh192; Wang J, 2009, CARCINOGENESIS, V30, P222, DOI 10.1093/carcin/bgn271; Wang M, 2009, NEW ENGL J MED, V360, P2583, DOI 10.1056/NEJMc0900358; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xing Z, 2008, J GEN VIROL, V89, P1288, DOI 10.1099/vir.0.83362-0; Yamazaki Y, 2009, ARCH VIROL, V154, P421, DOI 10.1007/s00705-009-0319-7; Yeo DSY, 2009, VET MICROBIOL, V138, P304, DOI 10.1016/j.vetmic.2009.04.025; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zhang CF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-51; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	68	50	51	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33732	10.1371/journal.pone.0033732	http://dx.doi.org/10.1371/journal.pone.0033732			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470468	gold, Green Published			2022-12-27	WOS:000303857100045
J	Chen, HC; Ziemba, BP; Landgraf, KE; Corbin, JA; Falke, JJ				Chen, Huai-Chun; Ziemba, Brian P.; Landgraf, Kyle E.; Corbin, John A.; Falke, Joseph J.			Membrane Docking Geometry of GRP1 PH Domain Bound to a Target Lipid Bilayer: An EPR Site-Directed Spin-Labeling and Relaxation Study	PLOS ONE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; C2 DOMAIN; ORIENTATION; POSITION; AKT1; PIP2; DYNAMICS; MUTATION; BINDING; INTERFACE	The second messenger lipid PIP3 (phosphatidylinositol-3,4,5-trisphosphate) is generated by the lipid kinase PI3K (phosphoinositide-3-kinase) in the inner leaflet of the plasma membrane, where it regulates a broad array of cell processes by recruiting multiple signaling proteins containing PIP3-specific pleckstrin homology (PH) domains to the membrane surface. Despite the broad importance of PIP3-specific PH domains, the membrane docking geometry of a PH domain bound to its target PIP3 lipid on a bilayer surface has not yet been experimentally determined. The present study employs EPR site-directed spin labeling and relaxation methods to elucidate the membrane docking geometry of GRP1 PH domain bound to bilayer-embedded PIP3. The model target bilayer contains the neutral background lipid PC and both essential targeting lipids: (i) PIP3 target lipid that provides specificity and affinity, and (ii) PS facilitator lipid that enhances the PIP3 on-rate via an electrostatic search mechanism. The EPR approach measures membrane depth parameters for 18 function-retaining spin labels coupled to the PH domain, and for calibration spin labels coupled to phospholipids. The resulting depth parameters, together with the known high resolution structure of the co-complex between GRP1 PH domain and the PIP3 headgroup, provide sufficient constraints to define an optimized, self-consistent membrane docking geometry. In this optimized geometry the PH domain engulfs the PIP3 headgroup with minimal bilayer penetration, yielding the shallowest membrane position yet described for a lipid binding domain. This binding interaction displaces the PIP3 headgroup from its lowest energy position and orientation in the bilayer, but the headgroup remains within its energetically accessible depth and angular ranges. Finally, the optimized docking geometry explains previous biophysical findings including mutations observed to disrupt membrane binding, and the rapid lateral diffusion observed for PIP3-bound GRP1 PH domain on supported lipid bilayers.	[Chen, Huai-Chun] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Univ Colorado, Mol Biophys Program, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Chen, HC (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	falke@colorado.edu		ZIEMBA, BRIAN/0000-0002-0508-6830	National Institutes of Health [NIH R01 GM-063235, NIH T32 GM-065103]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103, R01GM063235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from the National Institutes of Health, grant no. NIH R01 GM-063235 (to JJF) and NIH T32 GM-065103 (to KEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; Ball A, 1999, P NATL ACAD SCI USA, V96, P6637, DOI 10.1073/pnas.96.12.6637; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Calleja Veronique, 2009, J Chem Biol, V2, P11, DOI 10.1007/s12154-009-0016-8; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Corbin JA, 2004, BIOCHEMISTRY-US, V43, P16161, DOI 10.1021/bi049017a; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; DiNitto Jonathan P, 2003, Sci STKE, V2003, pre16, DOI 10.1126/stke.2132003re16; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Frazier AA, 2003, BIOCHEMISTRY-US, V42, P96, DOI 10.1021/bi0268145; Frazier AA, 2002, BIOCHEMISTRY-US, V41, P6282, DOI 10.1021/bi0160821; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Hoff B, 2005, BIOPHYS J, V88, P1818, DOI 10.1529/biophysj.104.052399; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Insall RH, 2001, DEV CELL, V1, P743, DOI 10.1016/S1534-5807(01)00086-7; Jackson TR, 2000, TRENDS BIOCHEM SCI, V25, P489, DOI 10.1016/S0968-0004(00)01644-3; Jaud S, 2007, BIOPHYS J, V92, P517, DOI 10.1529/biophysj.106.090704; Knight JD, 2010, BIOPHYS J, V99, P2879, DOI 10.1016/j.bpj.2010.08.046; Knight JD, 2009, BIOPHYS J, V96, P566, DOI 10.1016/j.bpj.2008.10.020; Kuo WW, 2011, BIOCHEMISTRY-US, V50, P2633, DOI 10.1021/bi200049c; Kuo WW, 2009, J MOL BIOL, V387, P284, DOI 10.1016/j.jmb.2009.01.064; Lai CL, 2010, J MOL BIOL, V402, P301, DOI 10.1016/j.jmb.2010.07.037; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P12260, DOI 10.1021/bi801683k; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P8301, DOI 10.1021/bi800711t; Langen R, 2000, BIOCHEMISTRY-US, V39, P8396, DOI 10.1021/bi000604f; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Li Z, 2009, BIOPHYS J, V97, P155, DOI 10.1016/j.bpj.2009.04.037; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Lumb CN, 2011, STRUCTURE, V19, P1338, DOI 10.1016/j.str.2011.04.010; Malmberg NJ, 2005, ANNU REV BIOPH BIOM, V34, P71, DOI 10.1146/annurev.biophys.34.040204.144534; Malmberg NJ, 2003, BIOCHEMISTRY-US, V42, P13227, DOI 10.1021/bi035119+; Newton AC, 2009, J LIPID RES, V50, pS266, DOI 10.1194/jlr.R800064-JLR200; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Pilling C, 2011, BIOCHEMISTRY-US, V50, P9845, DOI 10.1021/bi2011306; Rufener E, 2005, BIOCHEMISTRY-US, V44, P18, DOI 10.1021/bi048370d; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; WIENER MC, 1992, BIOPHYS J, V61, P434, DOI 10.1016/S0006-3495(92)81849-0; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; YU YG, 1994, BIOCHEMISTRY-US, V33, P14221, DOI 10.1021/bi00251a034; Ziemba BP, 2012, BIOCHEMISTR IN PRESS	50	50	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33640	10.1371/journal.pone.0033640	http://dx.doi.org/10.1371/journal.pone.0033640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479423	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100063
J	Fattorini, S; Cardoso, P; Rigal, F; Borges, PAV				Fattorini, Simone; Cardoso, Pedro; Rigal, Francois; Borges, Paulo A. V.			Use of Arthropod Rarity for Area Prioritisation: Insights from the Azorean Islands	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; SPECIES DISTRIBUTION; PROTECTED AREAS; RICHNESS; BUTTERFLIES; PREDICTION; ABUNDANCE; ENDEMISM; BIRDS	We investigated the conservation concern of Azorean forest fragments and the entire Terceira Island surface using arthropod species vulnerability as defined by the Kattan index, which is based on species rarity. Species rarity was evaluated according to geographical distribution (endemic vs. non endemic species), habitat specialization (distribution across biotopes) and population size (individuals collected in standardized samples). Geographical rarity was considered at 'global' scale (species endemic to the Azorean islands) and 'regional' scale (single island endemics). Measures of species vulnerability were combined into two indices of conservation concern for each forest fragment: (1) the Biodiversity Conservation Concern index, BCC, which reflects the average rarity score of the species present in a site, and (2) one proposed here and termed Biodiversity Conservation Weight, BCW, which reflects the sum of rarity scores of the same species assemblage. BCW was preferable to prioritise the areas with highest number of vulnerable species, whereas BCC helped the identification of areas with few, but highly threatened species due to a combination of different types of rarity. A novel approach is introduced in which BCC and BCW indices were also adapted to deal with probabilities of occurrence instead of presence/absence data. The new probabilistic indices, termed pBCC and pBCW, were applied to Terceira Island for which we modelled species distributions to reconstruct species occurrence with different degree of probability also in areas from which data were not available. The application of the probabilistic indices revealed that some island sectors occupied by secondary vegetation, and hence not included in the current set of protected areas, may in fact host some rare species. This result suggests that protecting marginal non-natural areas which are however reservoirs of vulnerable species may also be important, especially when areas with well preserved primary habitats are scarce.	[Fattorini, Simone; Cardoso, Pedro; Rigal, Francois; Borges, Paulo A. V.] Univ Acores, Azorean Biodivers Grp, Dept Ciencias Agr CITA A, Pico Da Urze, Angra Do Herois, Portugal; [Fattorini, Simone] Univ Milano Bicocca, Dept Biotechnol & Biosci, Water Ecol Team, Milan, Italy; [Cardoso, Pedro] Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20560 USA	Universidade dos Acores; University of Milano-Bicocca; Smithsonian Institution; Smithsonian National Museum of Natural History	Fattorini, S (corresponding author), Univ Acores, Azorean Biodivers Grp, Dept Ciencias Agr CITA A, Pico Da Urze, Angra Do Herois, Portugal.	simone_fattorini@virgilio.it	Fattorini, Simone/AAR-8028-2020; Cardoso, Pedro/AAY-9650-2020; Borges, Paulo/H-5153-2019; Borges, Paulo/B-2780-2008; Fattorini, Simone/E-7075-2012; Cardoso, Pedro/A-8820-2008	Fattorini, Simone/0000-0002-4517-2135; Cardoso, Pedro/0000-0001-8119-9960; Borges, Paulo/0000-0002-8448-7623; Borges, Paulo/0000-0002-8448-7623; Fattorini, Simone/0000-0002-4517-2135; Cardoso, Pedro/0000-0001-8119-9960; Rigal, Francois/0000-0001-6882-1591	Direccao Regional dos Recursos Florestais [17.01-080203]; Direccao Regional da Ciencia e Tecnologia (Project: "Consequences of land-use change on Azorean fauna and flora) [M.2.1.2/I/003/2008]; Fundacao Ciencia e Tecnologia [SFRH/BPD/40688/2007, PTDC/BIA-BEC/100182/2008]; Azorean Biodiversity Group (CITA-A)	Direccao Regional dos Recursos Florestais; Direccao Regional da Ciencia e Tecnologia (Project: "Consequences of land-use change on Azorean fauna and flora); Fundacao Ciencia e Tecnologia(Portuguese Foundation for Science and Technology); Azorean Biodiversity Group (CITA-A)	Data used in this manuscript were obtained in the projects funded by Direccao Regional dos Recursos Florestais (Project: 17.01-080203, 1999-2004) and Direccao Regional da Ciencia e Tecnologia (Project: "Consequences of land-use change on Azorean fauna and flora - the 2010 Target, M.2.1.2/I/003/2008). Grants and fellowships to the authors were provided by Fundacao Ciencia e Tecnologia (SFRH/BPD/40688/2007 and PTDC/BIA-BEC/100182/2008 for PC and FR, respectively) and Azorean Biodiversity Group (CITA-A) (Summer 2010 and Summer 2011 grants to SF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arponen A, 2008, J APPL ECOL, V45, P1436, DOI 10.1111/j.1365-2664.2008.01513.x; Assing V, 2010, LIST TERRESTRIAL MAR; Bergerot B, 2008, BIODIVERS CONSERV, V17, P2247, DOI 10.1007/s10531-008-9331-6; Bhagwat SA, 2008, TRENDS ECOL EVOL, V23, P261, DOI 10.1016/j.tree.2008.01.005; Borges P. A. V., 2008, INSECT ECOLOGY CONSE, P47; Borges PAV, 2006, J BIOGEOGR, V33, P169, DOI 10.1111/j.1365-2699.2005.01324.x; Borges PAV, 2005, BIODIVERS CONSERV, V14, P2029, DOI 10.1007/s10531-004-4283-y; Brown J. H., 1995, MACROECOLOGY; Cardoso P, 2007, BIODIVERS CONSERV, V16, P2883, DOI 10.1007/s10531-006-9078-x; Cardoso P, 2012, INT J SPELEOL, V41, P83, DOI 10.5038/1827-806X.41.1.9; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Cardoso P, 2011, BIOL CONSERV, V144, P2432, DOI 10.1016/j.biocon.2011.06.020; Cardoso P, 2009, ACTA OECOL, V35, P590, DOI 10.1016/j.actao.2009.05.005; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Cook JA, 2001, BIOL CONSERV, V97, P207, DOI 10.1016/S0006-3207(00)00113-0; Dapporto L, 2008, J INSECT CONSERV, V12, P237, DOI 10.1007/s10841-008-9150-9; de Azevedo EB, 1999, AGR WATER MANAGE, V40, P393, DOI 10.1016/S0378-3774(99)00012-8; Dennis RLH, 2006, BIODIVERS CONSERV, V15, P1943, DOI 10.1007/s10531-005-4314-3; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Dias E, 2004, BIODIVERS CONSERV, V13, P1519, DOI 10.1023/B:BIOC.0000021326.50170.66; DOBSON FS, 1993, CONSERV BIOL, V7, P586, DOI 10.1046/j.1523-1739.1993.07030586.x; DROTRH, 2007, CART OC SOL REG AUT; Dunn RR, 2005, CONSERV BIOL, V19, P1030, DOI 10.1111/j.1523-1739.2005.00078.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J., 2009, SPATIAL CONSERVATION, P70; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ervin J, 2003, BIOSCIENCE, V53, P819, DOI 10.1641/0006-3568(2003)053[0819:PAAIP]2.0.CO;2; Fattorini S, 2006, ANIM CONSERV, V9, P75, DOI 10.1111/j.1469-1795.2005.00009.x; Fattorini S, 2009, ANIM CONSERV, V12, P313, DOI 10.1111/j.1469-1795.2009.00251.x; Fattorini S, 2008, J INSECT CONSERV, V12, P251, DOI 10.1007/s10841-007-9080-y; Fattorini S, 2006, CONSERV BIOL, V20, P1169, DOI 10.1111/j.1523-1739.2006.00418.x; Fattorini S, 2011, INSECT CONSERV DIVER, V4, P307, DOI 10.1111/j.1752-4598.2010.00129.x; Fattorini S, 2010, BIODIVERS CONSERV, V19, P3413, DOI 10.1007/s10531-010-9903-0; Fattorini S, 2010, J INSECT CONSERV, V14, P367, DOI 10.1007/s10841-010-9266-6; Franklin JF, 2009, P NATL ACAD SCI USA, V106, P349, DOI 10.1073/pnas.0812016105; Gabriel R, 2011, A OREANA, V7, P149; Gaspar C, 2011, J INSECT CONSERV, V15, P671, DOI 10.1007/s10841-010-9365-4; Gaspar Clara, 2008, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, P1; Gaston K.J., 1994, RARITY, P1; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gaston KJ, 2006, J ANIM ECOL, V75, P646, DOI 10.1111/j.1365-2656.2006.01085.x; Hartley S, 2003, CONSERV BIOL, V17, P1559, DOI 10.1111/j.1523-1739.2003.00015.x; Hopkins MJG, 2007, J BIOGEOGR, V34, P1400, DOI 10.1111/j.1365-2699.2007.01737.x; Hughes JB, 2002, ECOL LETT, V5, P121, DOI 10.1046/j.1461-0248.2002.00294.x; KATTAN GH, 1992, CONSERV BIOL, V6, P64, DOI 10.1046/j.1523-1739.1992.610064.x; Koomen P, 1996, NATURE ENV, V77; Leroy B, 2012, INSECT CONSERV DIVER, V5, P159, DOI 10.1111/j.1752-4598.2011.00148.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lomolino MV, 2004, FRONTIERS OF BIOGEOGRAPHY: NEW DIRECTIONS IN THE GEOGRAPHY OF NATURE, P1; Manne LL, 2001, ANIM CONSERV, V4, P221, DOI 10.1017/S1367943001001263; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Martin JL, 2010, BIODIVERS CONSERV, V19, P1659, DOI 10.1007/s10531-010-9795-z; McDonald RI, 2011, BIOL CONSERV, V144, P383, DOI 10.1016/j.biocon.2010.09.016; Meijer SS, 2011, J INSECT CONSERV, V15, P505, DOI 10.1007/s10841-010-9330-2; Moilanen A., 2009, SPATIAL CONSERVATION; Mokany K, 2011, DIVERS DISTRIB, V17, P374, DOI 10.1111/j.1472-4642.2010.00735.x; Myers AA, 2000, VIE MILIEU, V50, P195; New T. R., 2011, Journal of Threatened Taxa, V3, P2033; New TR, 2009, ECOL BIODIVERS CONS, P1, DOI 10.1017/CBO9780511626876; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pineda E, 2009, J ANIM ECOL, V78, P182, DOI 10.1111/j.1365-2656.2008.01471.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Primack R.B., 2006, ESSENTIALS CONSERVAT; Rabinowitz D., 1986, CONSERVATION BIOL SC, P182; Rabinowitz D., 1981, 7 FORMS RARITY BIOLO; RAMOS JA, 1995, BIOL CONSERV, V71, P237, DOI 10.1016/0006-3207(94)00033-M; Ricketts TH, 2001, CONSERV BIOL, V15, P378, DOI 10.1046/j.1523-1739.2001.015002378.x; Rodrigues ASL, 1999, P ROY SOC B-BIOL SCI, V266, P1453, DOI 10.1098/rspb.1999.0800; Sarkar S, 1999, BIOSCIENCE, V49, P405, DOI 10.2307/1313633; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Solomon M, 2003, BIODIVERS CONSERV, V12, P2435, DOI 10.1023/A:1025805731366; WallisDeVries MF, 2002, BIOL CONSERV, V104, P265, DOI 10.1016/S0006-3207(01)00191-4; Zhu HG, 2004, BIODIVERS CONSERV, V13, P1335, DOI 10.1023/B:BIOC.0000019401.52391.a9	75	21	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33995	10.1371/journal.pone.0033995	http://dx.doi.org/10.1371/journal.pone.0033995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479498	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100092
J	Jin, X; Chen, YP; Yang, YD; Li, YM; Zheng, L; Xu, CQ				Jin, Xi; Chen, Yi-peng; Yang, Yi-da; Li, You-ming; Zheng, Lin; Xu, Chuan-qing			Association between Hepatic Steatosis and Entecavir Treatment Failure in Chinese Patients with Chronic Hepatitis B	PLOS ONE			English	Article							FATTY LIVER-DISEASE; NATURAL-HISTORY; EPIDEMIOLOGY; REDUCTION	Background: The coexistence of HBV infection and nonalcoholic fatty liver disease (NAFLD) becomes characteristic of liver disease in China, with unknown bilateral influence. We aimed to investigate the effect of hepatic steatosis, a common hepatocyte change in NAFLD, on antiviral therapy in patients with chronic hepatitis B (CHB). Methods and Findings: We carried out a prospective nested case control study in CHB patients receiving Entecavir for initial antiviral therapy, by recording demographic, anthropometric and clinical data at baseline, 24(wk), 48(wk) and 96(wk). Univariate analysis and multivariate logistic regression were applied to find out independent factors of hepatic steatosis and Entecavir treatment failure. The rates of HBV-DNA clearance, HBeAg seroconversion and ALT normalization were compared between CHB patients with and without steatosis by post hoc analysis. A total of 267 Chinese patients with CHB entered final analysis, with overall percentages of hepatic steatosis and HBeAg positive as 30.5% and 62.4%. Multivariate analysis showed waist circumference, serum TG and uric acid levels were independent factors of hepatic steatosis. The response rates to Entecavir were 54.9%, 63.8%, 74.2% at 24(wk), 48(wk) and 96(wk). Hepatic steatosis was revealed as an independent factor of Entecavir treatment failure by multivariate logistic regression at 24(wk), 48(wk) and 96(wk). In CHB patients with hepatic steatosis, HBV-DNA clearance and HBeAg seroconversion were both lower throughout the follow-up, but only the former reached statistical significance. Besides, ALT normalization was also significantly lower at 24(wk) and 48(wk). Conclusion: Hepatic steatosis is significantly associated with Entecavir treatment failure and metabolic factors are independent factors of hepatic steatosis in CHB patients, which called for a specified antiviral strategy in CHB patients with NAFLD.	[Jin, Xi; Chen, Yi-peng; Li, You-ming; Xu, Chuan-qing] Zhejiang Univ, Dept Gastroenterol, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Yang, Yi-da; Zheng, Lin] Zhejiang Univ, Dept Infect Dis, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Jin, X (corresponding author), Zhejiang Univ, Dept Gastroenterol, Coll Med, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China.	jxfl007@hotmail.com		Ma, Han/0000-0001-9985-3035	National Natural Science Foundation of China [81000169]; Excellent Young Investigator Foundation of Health Bureau of Zhejiang Province [2010QNA011]; Excellent Young Investigator Natural Science Foundation of Zhejiang province [R2110159]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Young Investigator Foundation of Health Bureau of Zhejiang Province; Excellent Young Investigator Natural Science Foundation of Zhejiang province	This study is sponsored by the 2010 National Natural Science Foundation of China (Project 81000169), 2010 Excellent Young Investigator Foundation of Health Bureau of Zhejiang Province (Project 2010QNA011) and 2011 Excellent Young Investigator Natural Science Foundation of Zhejiang province (Project R2110159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altiparmak E, 2005, WORLD J GASTROENTERO, V11, P3056, DOI 10.3748/wjg.v11.i20.3056; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bellentani S, 2009, ANN HEPATOL, V8, pS4, DOI 10.1016/S1665-2681(19)31820-4; Bjornsson E, 2007, ARCH MED RES, V38, P621, DOI 10.1016/j.arcmed.2006.09.001; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P13, DOI 10.3760/cma.j.issn.1007-3418.2011.01.007; Cindoruk M, 2007, J CLIN GASTROENTEROL, V41, P513, DOI 10.1097/01.mcg.0000225586.78330.60; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Fan JG, 2009, J HEPATOL, V50, P204, DOI 10.1016/j.jhep.2008.10.010; Giannini E, 2001, J HEPATOL, V35, P432, DOI 10.1016/S0168-8278(01)00107-6; Lai CL, 2007, ANN INTERN MED, V147, P58, DOI 10.7326/0003-4819-147-1-200707030-00010; Leclercq I, 1998, J HEPATOL, V28, P410, DOI 10.1016/S0168-8278(98)80314-0; Li You-ming, 2003, Zhonghua Gan Zang Bing Za Zhi, V11, P647; Li YM, 2009, J HEPATOL, V50, P1029, DOI 10.1016/j.jhep.2008.11.021; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; MCGILL DB, 1990, GASTROENTEROLOGY, V99, P1396, DOI 10.1016/0016-5085(90)91167-5; Minakari M, 2009, EUR J GASTROEN HEPAT, V21, P512, DOI 10.1097/MEG.0b013e328326792e; Peng DD, 2008, J GASTROEN HEPATOL, V23, P1082, DOI 10.1111/j.1440-1746.2008.05478.x; Rocha R, 2005, J HUM NUTR DIET, V18, P365, DOI 10.1111/j.1365-277X.2005.00634.x; Romero-Gomez M, 2005, GASTROENTEROLOGY, V128, P636, DOI 10.1053/j.gastro.2004.12.049; Sass DA, 2005, DIGEST DIS SCI, V50, P171, DOI 10.1007/s10620-005-1267-z; Shepherd J, 2009, HEALTH TECHNOL ASSES, V13, P31, DOI 10.3310/hta13suppl3/05; Siegelman ES, 2001, SEMIN LIVER DIS, V21, P71, DOI 10.1055/s-2001-12930; TALIANI G, 1995, HEPATOLOGY, V21, P1760, DOI 10.1002/hep.1840210646; Tchelepi H, 2002, J ULTRAS MED, V21, P1023, DOI 10.7863/jum.2002.21.9.1023; Thomopoulos KC, 2006, EUR J GASTROEN HEPAT, V18, P233, DOI 10.1097/00042737-200603000-00002; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Williams R, 2006, HEPATOLOGY, V44, P521, DOI 10.1002/hep.21347; YAJIMA Y, 1983, TOHOKU J EXP MED, V139, P43, DOI 10.1620/tjem.139.43	29	56	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34198	10.1371/journal.pone.0034198	http://dx.doi.org/10.1371/journal.pone.0034198			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479562	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100136
J	Lin, YH; Wang, YY; Chen, HI; Kuo, YC; Chiou, YW; Lin, HH; Wu, CM; Hsu, CC; Chiang, HS; Kuo, PL				Lin, Ying-Hung; Wang, Ya-Yun; Chen, Hau-Inh; Kuo, Yung-Che; Chiou, Yu-Wei; Lin, Hsi-Hui; Wu, Ching-Ming; Hsu, Chao-Chin; Chiang, Han-Sun; Kuo, Pao-Lin			SEPTIN12 Genetic Variants Confer Susceptibility to Teratozoospermia	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; CELL-DIVISION CYCLE; FUSION PARTNER GENE; MAMMALIAN SEPTINS; HUMAN ASTHENOZOOSPERMIA; INTERCELLULAR BRIDGES; SPLICING MUTATIONS; DISEASE PENETRANCE; FUSES MLL; SPERM	It is estimated that 10-15% of couples are infertile and male factors account for about half of these cases. With the advent of intracytoplasmic sperm injection (ICSI), many infertile men have been able to father offspring. However, teratozoospermia still remains a big challenge to tackle. Septins belong to a family of cytoskeletal proteins with GTPase activity and are involved in various biological processes e. g. morphogenesis, compartmentalization, apoptosis and cytokinesis. SEPTIN12, identified by c-DNA microarray analysis of infertile men, is exclusively expressed in the post meiotic male germ cells. Septin12(+/+)/Septin12(+/-) chimeric mice have multiple reproductive defects including the presence of immature sperm in the semen, and sperm with bent neck (defect of the annulus) and nuclear DNA damage. These facts make SEPTIN12 a potential sterile gene in humans. In this study, we sequenced the entire coding region of SEPTIN12 in infertile men (n = 160) and fertile controls (n = 200) and identified ten variants. Among them is the c. 474 G. A variant within exon 5 that encodes part of the GTP binding domain. The variant creates a novel splice donor site that causes skipping of a portion of exon 5, resulting in a truncated protein lacking the C-terminal half of SEPTIN12. Most individuals homozygous for the c. 474 A allele had teratozoospermia (abnormal sperm <14%) and their sperm showed bent tail and de-condensed nucleus with significant DNA damage. Ex vivo experiment showed truncated SEPT12 inhibits filament formation in a dose-dependent manner. This study provides the first causal link between SEPTIN12 genetic variant and male infertility with distinctive sperm pathology. Our finding also suggests vital roles of SEPT12 in sperm nuclear integrity and tail development.	[Lin, Ying-Hung; Chiang, Han-Sun] Fu Jen Catholic Univ, Coll Med, Grad Inst Basic Med, Taipei, Taiwan; [Wang, Ya-Yun; Kuo, Pao-Lin] Natl Cheng Kung Univ, Coll Med, Dept Obstet & Gynecol, Tainan 70101, Taiwan; [Wang, Ya-Yun] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan; [Chen, Hau-Inh; Kuo, Pao-Lin] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Kuo, Yung-Che; Kuo, Pao-Lin] Natl Cheng Kung Univ, Coll Med, Grad Inst Basic Med Sci, Tainan 70101, Taiwan; [Chiou, Yu-Wei] Natl Cheng Kung Univ, Coll Engn, Dept Biomed Engn, Tainan 70101, Taiwan; [Lin, Hsi-Hui] Natl Cheng Kung Univ, Coll Med, Dept Physiol, Tainan 70101, Taiwan; [Wu, Ching-Ming] Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan 70101, Taiwan; [Hsu, Chao-Chin] China Med Univ, Dept Obstet & Gynecol, Taichung, Taiwan	Fu Jen Catholic University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; China Medical University Taiwan	Lin, YH (corresponding author), Fu Jen Catholic Univ, Coll Med, Grad Inst Basic Med, Taipei, Taiwan.	paolink@mail.ncku.edu.tw	Lin, Ying-Hung/AAC-6327-2019	Lin, Ying-Hung/0000-0002-1574-1579; Kuo, Yung-Che/0000-0002-9425-7389; Lin, Hsi-Hui/0000-0002-4880-3481				Auger J, 2001, HUM REPROD, V16, P2710, DOI 10.1093/humrep/16.12.2710; Baccetti B, 2005, HUM REPROD, V20, P2790, DOI 10.1093/humrep/dei126; Basel-Vanagaite L, 2007, EUR J HUM GENET, V15, P242, DOI 10.1038/sj.ejhg.5201733; Bonnet C, 2008, J MED GENET, V45, P438, DOI 10.1136/jmg.2007.056895; Borkhardt A, 2001, GENE CHROMOSOME CANC, V32, P82, DOI 10.1002/gcc.1169; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Burrows JF, 2003, J PATHOL, V201, P581, DOI 10.1002/path.1484; Cerveira N, 2006, ONCOGENE, V25, P6147, DOI 10.1038/sj.onc.1209626; de Souza JE, 2011, NUCL ACIDS RES; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Ding XM, 2008, MOL CELLS, V25, P385; Ding XM, 2007, J BIOCHEM MOL BIOL, V40, P973; Estey MP, 2010, J CELL BIOL, V191, P741, DOI 10.1083/jcb.201006031; Frio TR, 2008, HUM MOL GENET, V17, P3154, DOI 10.1093/hmg/ddn212; Frio TR, 2009, HUM MUTAT, V30, P1340, DOI 10.1002/humu.21071; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gonzalez ME, 2007, CANCER RES, V67, P8554, DOI 10.1158/0008-5472.CAN-07-1474; Graveley BR, 2008, TRENDS GENET, V24, P5, DOI 10.1016/j.tig.2007.10.004; Greenbaum MP, 2007, DEV BIOL, V305, P389, DOI 10.1016/j.ydbio.2007.02.025; Greenbaum MP, 2006, P NATL ACAD SCI USA, V103, P4982, DOI 10.1073/pnas.0505123103; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; Hime GR, 1996, J CELL SCI, V109, P2779; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Javed M, 2010, REPROD BIOMED ONLINE, V20, P56, DOI 10.1016/j.rbmo.2009.10.010; Joo E, 2007, DEV CELL, V13, P677, DOI 10.1016/j.devcel.2007.09.001; Kartmann B, 2001, J CELL SCI, V114, P839; Kinoshita A, 1998, AM J PATHOL, V153, P1551, DOI 10.1016/S0002-9440(10)65743-4; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Kojima K, 2004, LEUKEMIA, V18, P998, DOI 10.1038/sj.leu.2403334; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Krishnan R, 2000, GENETICS, V156, P489; KRUGER TF, 1986, FERTIL STERIL, V46, P1118; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Lee JD, 1997, BIOL REPROD, V56, P42, DOI 10.1095/biolreprod56.1.42; Lhuillier P, 2009, HUM REPROD, V24, P1296, DOI 10.1093/humrep/dep020; Lin YH, 2010, INT J ANDROL; Lin YH, 2006, FERTIL STERIL, V86, P1650, DOI 10.1016/j.fertnstert.2006.04.039; Lin YH, 2011, FERTIL STERIL, V95, P363, DOI 10.1016/j.fertnstert.2010.07.1064; Lin YH, 2009, AM J PATHOL, V174, P1857, DOI 10.2353/ajpath.2009.080955; Liu HX, 2001, NAT GENET, V27, P55, DOI 10.1038/83762; Martinez C, 2004, BIOCHEM J, V382, P783, DOI 10.1042/BJ20040372; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Megonigal MD, 1998, P NATL ACAD SCI USA, V95, P6413, DOI 10.1073/pnas.95.11.6413; Miyamoto T, 2011, J ANDROL; Moolman JA, 2000, CIRCULATION, V101, P1396, DOI 10.1161/01.CIR.101.12.1396; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Nissim-Rafinia M, 2002, TRENDS GENET, V18, P123, DOI 10.1016/S0168-9525(01)02619-1; Oliveira JBA, 2009, REPROD BIOMED ONLINE, V18, P320, DOI 10.1016/S1472-6483(10)60088-0; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Ono R, 2002, CANCER RES, V62, P333; Osaka M, 1999, P NATL ACAD SCI USA, V96, P6428, DOI 10.1073/pnas.96.11.6428; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Peterson EA, 2010, CLIN GENET, V77, P511, DOI 10.1111/j.1399-0004.2010.01392.x; Peterson EA, 2007, MAMM GENOME, V18, P796, DOI 10.1007/s00335-007-9065-x; Quaye L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005983; RaveHarel N, 1997, AM J HUM GENET, V60, P87; Russell SEH, 2000, CANCER RES, V60, P4729; Smolka MB, 2006, J CELL BIOL, V175, P743, DOI 10.1083/jcb.200605081; Son JH, 2005, J NEUROCHEM, V94, P1040, DOI 10.1111/j.1471-4159.2005.03257.x; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; Steels JD, 2007, CELL MOTIL CYTOSKEL, V64, P794, DOI 10.1002/cm.20224; Sugino Y, 2008, J UROLOGY, V180, P2706, DOI 10.1016/j.juro.2008.08.005; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Tarnasky H, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-67; Teng YN, 2007, FERTIL STERIL, V87, P1291, DOI 10.1016/j.fertnstert.2006.11.050; Tsang CW, 2008, MOL CELL BIOL, V28, P7012, DOI 10.1128/MCB.00035-08; *WHO, 1998, WHO LAB MAN EX HUM S; Xue J, 2004, J NEUROCHEM, V91, P579, DOI 10.1111/j.1471-4159.2004.02755.x; Yan W, 2009, MOL CELL ENDOCRINOL, V306, P24, DOI 10.1016/j.mce.2009.03.003; Yeh YC, 2005, REPROD FERT DEVELOP, V17, P447, DOI 10.1071/RD04077; Yeung CH, 2009, HUM REPROD, V24, P1288, DOI 10.1093/humrep/dep017; Zhu M, 2008, J BIOL CHEM, V283, P18916, DOI 10.1074/jbc.M710591200	80	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34011	10.1371/journal.pone.0034011	http://dx.doi.org/10.1371/journal.pone.0034011			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479503	gold, Green Submitted, Green Published			2022-12-27	WOS:000305339100095
J	Valenzuela, LO; Chesson, LA; Bowen, GJ; Cerling, TE; Ehleringer, JR				Valenzuela, Luciano O.; Chesson, Lesley A.; Bowen, Gabriel J.; Cerling, Thure E.; Ehleringer, James R.			Dietary Heterogeneity among Western Industrialized Countries Reflected in the Stable Isotope Ratios of Human Hair	PLOS ONE			English	Article							NUTRITION EPIC PROJECT; PREHISTORIC HUMAN DIET; ANOREXIA-NERVOSA; FISH CONSUMPTION; CARBON ISOTOPES; S-34 ANALYSIS; AMINO-ACIDS; LAMB MEAT; NITROGEN; EUROPE	Although the globalization of food production is often assumed to result in a homogenization of consumption patterns with a convergence towards a Western style diet, the resources used to make global food products may still be locally produced (glocalization). Stable isotope ratios of human hair can quantify the extent to which residents of industrialized nations have converged on a standardized diet or whether there is persistent heterogeneity and glocalization among countries as a result of different dietary patterns and the use of local food products. Here we report isotopic differences among carbon, nitrogen and sulfur isotope ratios of human hair collected in thirteen Western European countries and in the USA. European hair samples had significantly lower delta C-13 values (-22.7 to -18.3 parts per thousand, and significantly higher delta N-15 (7.8 to 10.3 parts per thousand) and delta S-34 (4.8 to 8.3 parts per thousand) values than samples from the USA (delta C-13: -21.9 to -15.0 parts per thousand, delta N-15: 6.7 to 9.9 parts per thousand, delta S-34: -1.2 to 9.9 parts per thousand). Within Europe, we detected differences in hair delta C-13 and delta S-34 values among countries and covariation of isotope ratios with latitude and longitude. This geographic structuring of isotopic data suggests heterogeneity in the food resources used by citizens of industrialized nations and supports the presence of different dietary patterns within Western Europe despite globalization trends. Here we showed the potential of stable isotope analysis as a population-wide tool for dietary screening, particularly as a complement of dietary surveys, that can provide additional information on assimilated macronutrients and independent verification of data obtained by those self-reporting instruments.	[Valenzuela, Luciano O.; Chesson, Lesley A.; Cerling, Thure E.; Ehleringer, James R.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Chesson, Lesley A.; Cerling, Thure E.; Ehleringer, James R.] IsoForensics Inc, Salt Lake City, UT USA; [Bowen, Gabriel J.] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA; [Cerling, Thure E.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Utah System of Higher Education; University of Utah	Valenzuela, LO (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	valenzuela@biology.utah.edu	Bowen, Gabriel J/C-1708-2008; Ehleringer, James/G-1780-2010	Cerling, Thure/0000-0002-3590-294X; Valenzuela, Luciano/0000-0002-5024-6581	University of Utah; United States National Science Foundation [DBI-0743543]; Purdue University; IsoForensics, Inc.	University of Utah; United States National Science Foundation(National Science Foundation (NSF)); Purdue University; IsoForensics, Inc.	L.O.V. was funded by the University of Utah. G.J.B. was supported by United States National Science Foundation grant DBI-0743543 and Purdue University. L.A.C., T.E.C. and J.R.E. were funded by IsoForensics, Inc., and the University of Utah. IsoForensics, Inc., is a for-profit scientific research company based in Salt Lake City, UT, and provided funds for sample acquisition, sample processing, and sample analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar B, 2005, RAPID COMMUN MASS SP, V19, P1937, DOI 10.1002/rcm.2007; Balanza R, 2007, PUBLIC HEALTH NUTR, V10, P168, DOI 10.1017/S1368980007246592; Bol R, 2002, RAPID COMMUN MASS SP, V16, P2195, DOI 10.1002/rcm.706; Bol R, 2007, RAPID COMMUN MASS SP, V21, P2951, DOI 10.1002/rcm.3168; BOUTTON TW, 1991, CRIT REV FOOD SCI, V30, P373, DOI 10.1080/10408399109527548; Buchardt B, 2007, CHEM GEOL, V244, P316, DOI 10.1016/j.chemgeo.2007.06.022; Camin F, 2007, ANAL BIOANAL CHEM, V389, P309, DOI 10.1007/s00216-007-1302-3; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chesson L, 2009, P NATL ACAD SCI USA, V106, pE8, DOI 10.1073/pnas.0811787106; Chesson LA, 2008, J AGR FOOD CHEM, V56, P4084, DOI 10.1021/jf0733618; Coplen TB, 2011, RAPID COMMUN MASS SP, V25, P2538, DOI 10.1002/rcm.5129; Crosson ER, 2002, ANAL CHEM, V74, P2003, DOI 10.1021/ac025511d; Cruz JAA, 2000, EUR J CLIN NUTR, V54, pS29, DOI 10.1038/sj.ejcn.1600981; FAO, 2010, SUSTAINABLE DIETS BI, V91, P1; Fry B, 2002, RAPID COMMUN MASS SP, V16, P854, DOI 10.1002/rcm.651; Fuller BT, 2005, RAPID COMMUN MASS SP, V19, P2497, DOI 10.1002/rcm.2090; GRIGG D, 1995, GEOFORUM, V26, P1, DOI 10.1016/0016-7185(94)00020-8; Halkjaer J, 2009, EUR J CLIN NUTR, V63, pS16, DOI 10.1038/ejcn.2009.73; Hatch KA, 2006, RAPID COMMUN MASS SP, V20, P3367, DOI 10.1002/rcm.2740; Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; Hill MJ, 1997, EUR J CANCER PREV, V6, pS11, DOI 10.1097/00008469-199703001-00003; Hu FB, 2008, CIRCULATION, V118, P1913, DOI 10.1161/CIRCULATIONAHA.108.808493; Jahren AH, 2008, P NATL ACAD SCI USA, V105, P17855, DOI 10.1073/pnas.0809870105; Kellner CM, 2007, AM J PHYS ANTHROPOL, V133, P1112, DOI 10.1002/ajpa.20618; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kennedy G., 2004, FAO Food and Nutrition Paper, P1; Knobbe N, 2006, ANAL BIOANAL CHEM, V386, P104, DOI 10.1007/s00216-006-0644-6; Macko SA, 1999, PHILOS T ROY SOC B, V354, P65, DOI 10.1098/rstb.1999.0360; Margetts BM, 2009, EUR J CLIN NUTR, V63, pS1, DOI 10.1038/ejcn.2009.122; Martinelli LA, 2011, FOOD CHEM, V127, P1712, DOI 10.1016/j.foodchem.2011.02.046; Masud Z, 1999, J AGR FOOD CHEM, V47, P4693, DOI 10.1021/jf9900027; McCullagh JSO, 2005, RAPID COMMUN MASS SP, V19, P3227, DOI 10.1002/rcm.2150; Mekota AM, 2006, RAPID COMMUN MASS SP, V20, P1604, DOI 10.1002/rcm.2477; Mutzel E, 2009, INT J LEGAL MED, V123, P35, DOI 10.1007/s00414-008-0286-7; NAKAMURA K, 1982, BIOMED MASS SPECTROM, V9, P390, DOI 10.1002/bms.1200090906; Nardoto GB, 2006, AM J PHYS ANTHROPOL, V131, P137, DOI 10.1002/ajpa.20409; O'Connell T, 2005, ISS TOXICOL, P175; O'Connell TC, 2001, J ARCHAEOL SCI, V28, P1247, DOI 10.1006/jasc.2001.0698; Parizkova J, 2000, EUR J CLIN NUTR, V54, pS36, DOI 10.1038/sj.ejcn.1600982; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Petzke KJ, 2005, J NUTR, V135, P1515; Petzke KJ, 2005, RAPID COMMUN MASS SP, V19, P1392, DOI 10.1002/rcm.1925; Petzke KJ, 2006, RAPID COMMUN MASS SP, V20, P2973, DOI 10.1002/rcm.2695; Petzke KJ, 2010, CURR OPIN CLIN NUTR, V13, P532, DOI 10.1097/MCO.0b013e32833c3c84; Phillips L, 2006, ANNU REV ANTHROPOL, V35, P37, DOI 10.1146/annurev.anthro.35.081705.123214; Piasentier E, 2003, MEAT SCI, V64, P239, DOI 10.1016/S0309-1740(02)00183-3; Pollan Michael, 2006, OMNIVORES DILEMMA NA; R Core Team, 2018, R LANG ENV STAT COMP; Richards MP, 2001, EARTH PLANET SC LETT, V191, P185, DOI 10.1016/S0012-821X(01)00427-7; Rolland-Cachera MF, 2000, EUR J CLIN NUTR, V54, pS41, DOI 10.1038/sj.ejcn.1600983; Roos G, 2001, PUBLIC HEALTH NUTR, V4, P35, DOI 10.1079/PHN200048; Rumm-Kreuter D, 2001, INT J VITAM NUTR RES, V71, P141, DOI 10.1024/0300-9831.71.3.141; SALONEN JT, 1995, CIRCULATION, V91, P645, DOI 10.1161/01.CIR.91.3.645; Samuelson G, 2000, EUR J CLIN NUTR, V54, pS21, DOI 10.1038/sj.ejcn.1600980; Schmidt O, 2005, FOOD CHEM, V91, P545, DOI 10.1016/j.foodchem.2004.08.036; SCHOELLER DA, 1986, ECOL FOOD NUTR, V18, P159, DOI 10.1080/03670244.1986.9990922; Sieri S, 2002, PUBLIC HEALTH NUTR, V5, P1287, DOI 10.1079/PHN2002405; Slimani N, 2002, PUBLIC HEALTH NUTR, V5, P1311, DOI 10.1079/PHN2002407; Slimani N, 2009, EUR J CLIN NUTR, V63, pS206, DOI 10.1038/ejcn.2009.82; Still CJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001807; Thompson AH, 2010, AM J PHYS ANTHROPOL, V141, P440, DOI 10.1002/ajpa.21162; Trichopoulou A, 2001, Nutr Metab Cardiovasc Dis, V11, P1; Turner BS, 2003, AM BEHAV SCI, V47, P137, DOI 10.1177/0002764203256180; Valenzuela LO, 2011, RAPID COMMUN MASS SP, V25, P861, DOI 10.1002/rcm.4934; Vitoria L, 2004, ENVIRON SCI TECHNOL, V38, P3254, DOI 10.1021/es0348187; Welch AA, 2002, PUBLIC HEALTH NUTR, V5, P1273, DOI 10.1079/PHN2002404; WHITE CD, 1994, AM J PHYS ANTHROPOL, V93, P165, DOI 10.1002/ajpa.1330930203; WHO, 2007, WHO TECH REP SER, V935, P1; York R, 2004, ECOL ECON, V48, P293, DOI 10.1016/j.ecolecon.2003.10.009; Zazzo A, 2011, RAPID COMMUN MASS SP, V25, P2371, DOI 10.1002/rcm.5131	71	55	58	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34234	10.1371/journal.pone.0034234	http://dx.doi.org/10.1371/journal.pone.0034234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479574	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100139
J	Boraska, V; Day-Williams, A; Franklin, CS; Elliott, KS; Panoutsopoulou, K; Tachmazidou, I; Albrecht, E; Bandinelli, S; Beilin, LJ; Bochud, M; Cadby, G; Ernst, F; Evans, DM; Hayward, C; Hicks, AA; Huffman, J; Huth, C; James, AL; Klopp, N; Kolcic, I; Kutalik, Z; Lawlor, DA; Musk, AW; Pehlic, M; Pennell, CE; Perry, JRB; Peters, A; Polasek, O; St Pourcain, B; Ring, SM; Salvi, E; Schipf, S; Staessen, JA; Teumer, A; Timpson, N; Vitart, V; Warrington, NM; Yaghootkar, H; Zemunik, T; Zgaga, L; An, P; Anttila, V; Borecki, IB; Holmen, J; Ntalla, I; Palotie, A; Pietilainen, KH; Wedenoja, J; Winsvold, BS; Dedoussis, GV; Kaprio, J; Province, MA; Zwart, JA; Burnier, M; Campbell, H; Cusi, D; Smith, GD; Frayling, TM; Gieger, C; Palmer, LJ; Pramstaller, PP; Rudan, I; Volzke, H; Wichmann, HE; Wright, AF; Zeggini, E				Boraska, Vesna; Day-Williams, Aaron; Franklin, Christopher S.; Elliott, Katherine S.; Panoutsopoulou, Kalliope; Tachmazidou, Ioanna; Albrecht, Eva; Bandinelli, Stefania; Beilin, Lawrence J.; Bochud, Murielle; Cadby, Gemma; Ernst, Florian; Evans, David M.; Hayward, Caroline; Hicks, Andrew A.; Huffman, Jennifer; Huth, Cornelia; James, Alan L.; Klopp, Norman; Kolcic, Ivana; Kutalik, Zoltan; Lawlor, Debbie A.; Musk, Arthur W.; Pehlic, Marina; Pennell, Craig E.; Perry, John R. B.; Peters, Annette; Polasek, Ozren; St Pourcain, Beate; Ring, Susan M.; Salvi, Erika; Schipf, Sabine; Staessen, Jan A.; Teumer, Alexander; Timpson, Nicholas; Vitart, Veronique; Warrington, Nicole M.; Yaghootkar, Hanieh; Zemunik, Tatijana; Zgaga, Lina; An, Ping; Anttila, Verneri; Borecki, Ingrid B.; Holmen, Jostein; Ntalla, Ioanna; Palotie, Aarno; Pietilainen, Kirsi H.; Wedenoja, Juho; Winsvold, Bendik S.; Dedoussis, George V.; Kaprio, Jaakko; Province, Michael A.; Zwart, John-Anker; Burnier, Michel; Campbell, Harry; Cusi, Daniele; Smith, George Davey; Frayling, Timothy M.; Gieger, Christian; Palmer, Lyle J.; Pramstaller, Peter P.; Rudan, Igor; Voelzke, Henry; Wichmann, H. Erich; Wright, Alan F.; Zeggini, Eleftheria			Genome-Wide Association Study to Identify Common Variants Associated with Brachial Circumference: A Meta-Analysis of 14 Cohorts	PLOS ONE			English	Article							BODY-FAT; MUSCLE QUALITY; FTO GENE; ARM; STRENGTH; SEX; MEN; AGE; FAMILIES; MALES	Brachial circumference (BC), also known as upper arm or mid arm circumference, can be used as an indicator of muscle mass and fat tissue, which are distributed differently in men and women. Analysis of anthropometric measures of peripheral fat distribution such as BC could help in understanding the complex pathophysiology behind overweight and obesity. The purpose of this study is to identify genetic variants associated with BC through a large-scale genome-wide association scan (GWAS) meta-analysis. We used fixed-effects meta-analysis to synthesise summary results across 14 GWAS discovery and 4 replication cohorts comprising overall 22,376 individuals (12,031 women and 10,345 men) of European ancestry. Individual analyses were carried out for men, women, and combined across sexes using linear regression and an additive genetic model: adjusted for age and adjusted for age and BMI. We prioritised signals for follow-up in two-stages. We did not detect any signals reaching genome-wide significance. The FTO rs9939609 SNP showed nominal evidence for association (p<0.05) in the age-adjusted strata for men and across both sexes. In this first GWAS meta-analysis for BC to date, we have not identified any genome-wide significant signals and do not observe robust association of previously established obesity loci with BC. Large-scale collaborations will be necessary to achieve higher power to detect loci underlying BC.	[Boraska, Vesna; Day-Williams, Aaron; Franklin, Christopher S.; Panoutsopoulou, Kalliope; Tachmazidou, Ioanna; Anttila, Verneri; Palotie, Aarno; Winsvold, Bendik S.; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Cambridge, England; [Boraska, Vesna; Pehlic, Marina; Zemunik, Tatijana] Univ Split, Sch Med, Dept Med Biol, Split, Croatia; [Elliott, Katherine S.; Perry, John R. B.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Albrecht, Eva; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Genet Epidemiol, Neuherberg, Germany; [Bandinelli, Stefania] Azienda Sanit Firenze, Geriatr Unit, Florence, Italy; [Beilin, Lawrence J.; James, Alan L.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Bochud, Murielle] CHU Vaudois, Inst Social & Prevent Med, CH-1011 Lausanne, Switzerland; [Bochud, Murielle] Univ Lausanne, Lausanne, Switzerland; [Cadby, Gemma; Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Ernst, Florian; Teumer, Alexander] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Evans, David M.; Lawlor, Debbie A.; Ring, Susan M.; Timpson, Nicholas; Smith, George Davey] Univ Bristol, Sch Social & Community Med, MRC CAiTE Ctr, Bristol, Avon, England; [Hayward, Caroline; Huffman, Jennifer; Vitart, Veronique; Wright, Alan F.] Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh, Midlothian, Scotland; [Hicks, Andrew A.; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Ctr Biomed, Bolzano, Italy; [Hicks, Andrew A.; Pramstaller, Peter P.] Med Univ Lubeck, Affiliated Inst, D-23538 Lubeck, Germany; [Huth, Cornelia; Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 2, Neuherberg, Germany; [James, Alan L.; Musk, Arthur W.] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn, Nedlands, WA 6009, Australia; [James, Alan L.] Sir Charles Gairdner Hosp, Dept Pulm Physiol, W Australian Sleep Disorders Res Inst, Nedlands, WA 6009, Australia; [Klopp, Norman] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Unit Mol Epidemiol, Neuherberg, Germany; [Kolcic, Ivana; Polasek, Ozren; Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Kutalik, Zoltan] Univ Lausanne, Dept Med Genet, Lausanne, Switzerland; [Musk, Arthur W.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia; [Musk, Arthur W.] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Musk, Arthur W.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Pennell, Craig E.; Warrington, Nicole M.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Perry, John R. B.; Yaghootkar, Hanieh; Frayling, Timothy M.] Univ Exeter, Peninsula Med Sch, Exeter, Devon, England; [Salvi, Erika] Univ Milan, Dept Med Surg & Dent, Milan, Italy; [Salvi, Erika; Cusi, Daniele] Univ Milan, Fdn Filarete, Milan, Italy; [Schipf, Sabine; Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med SHIP Clin Epidemiol Res, Greifswald, Germany; [Staessen, Jan A.] Univ Louvain, Studies Coordinating Ctr, Div Hypertens & Cardiovasc Rehabil, Dept Cardiovasc Dis, Louvain, Belgium; [Staessen, Jan A.] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands; [Zgaga, Lina; Campbell, Harry; Rudan, Igor] Univ Edinburgh, Ctr Populat Hlth Sci, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland; [Zgaga, Lina; Campbell, Harry; Rudan, Igor] Univ Edinburgh, Inst Genet & Mol Med, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland; [Zgaga, Lina] Univ Zagreb, Sch Med, Andrija Stampar Sch Publ Hlth, Zagreb 41001, Croatia; [An, Ping; Borecki, Ingrid B.; Province, Michael A.] Washington Univ, Sch Med, Div Stat Genom, St Louis, MO USA; [An, Ping; Borecki, Ingrid B.; Province, Michael A.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Anttila, Verneri; Palotie, Aarno; Pietilainen, Kirsi H.; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Holmen, Jostein] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, Levanger, Norway; [Ntalla, Ioanna; Dedoussis, George V.] Harokopio Univ Athens, Dept Nutr & Dietet, Athens, Greece; [Palotie, Aarno] Univ Cent Hosp Helsinki, Helsinki, Finland; [Palotie, Aarno] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Palotie, Aarno] Broad Inst MIT & Harvard, Cambridge, MA USA; [Pietilainen, Kirsi H.] Univ Helsinki, Cent Hosp, Obes Res Unit, Dept Med,Div Internal Med, Helsinki, Finland; [Pietilainen, Kirsi H.; Wedenoja, Juho; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Winsvold, Bendik S.; Zwart, John-Anker] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Winsvold, Bendik S.; Zwart, John-Anker] Univ Oslo, Oslo, Norway; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth & Subst Abuse Serv, Helsinki, Finland; [Burnier, Michel] Univ Hosp Lausanne CHUV, Serv Nephrol, Lausanne, Switzerland; [Cusi, Daniele] San Paolo Hosp, Div Nephrol, Milan, Italy; [Palmer, Lyle J.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Prosserman Ctr Hlth Res, Toronto, ON M5G 1X5, Canada; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, Bolzano, Italy; [Pramstaller, Peter P.] Med Univ Lubeck, Dept Neurol, D-23538 Lubeck, Germany; [Wichmann, H. Erich] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany; [Wichmann, H. Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Epidemiol, Munich, Germany; [Wichmann, H. Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany	Wellcome Trust Sanger Institute; University of Split; University of Oxford; Wellcome Centre for Human Genetics; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Azienda Sanitaria di Firenze; University of Western Australia; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Ernst Moritz Arndt Universitat Greifswald; University of Bristol; University of Edinburgh; European Academy of Bozen-Bolzano; University of Lubeck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Western Australia; University of Western Australia; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Split; University of Lausanne; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Exeter; University of Milan; University of Milan; Ernst Moritz Arndt Universitat Greifswald; Maastricht University; University of Edinburgh; University of Edinburgh; University of Zagreb; Washington University (WUSTL); Washington University (WUSTL); University of Helsinki; Norwegian University of Science & Technology (NTNU); Harokopio University Athens; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oslo; University of Oslo; Finland National Institute for Health & Welfare; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); San Paolo-Polo Universitaria Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Krankenhaus Bozen; University of Lubeck; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich	Boraska, V (corresponding author), Wellcome Trust Sanger Inst, Morgan Bldg,Wellcome Trust Genome Campus, Cambridge, England.	vb2@sanger.ac.uk; ez1@sanger.ac.uk	Evans, David M/H-6325-2013; Timpson, Nicholas John/O-7548-2015; Study, Raine/K-4517-2013; Davey Smith, George/A-7407-2013; Peters, Annette/A-6117-2011; Perica, Vesna Boraska/D-8230-2017; Huth, Cornelia/B-5350-2014; Campbell, Harry/E-2959-2010; Bochud, Murielle/A-3981-2010; Colaus, PsyColaus/K-6607-2013; Teumer, Alexander/S-7438-2019; Zgaga, Lina/Q-9415-2018; Palmer, Lyle John/K-3196-2014; Staessen, Jan A/A-1065-2011; Kutalik, Zoltan/HHZ-5697-2022; Rudan, Igor/I-1467-2012; Hicks, Andrew Anthony/E-9518-2017; Study, Raine/G-9547-2015; Pennell, Craig/ABD-6902-2020; Cadby, Gemma/AAE-3849-2022; bandinelli, stefania/AAL-4570-2020; Kolcic, Ivana/E-2713-2017; Wichmann, Heinz Erich/AAA-5695-2022; Salvi, Erika/AAA-1415-2019; Wedenoja, Juho/AAX-7008-2020; Dedoussis, George/AAN-7252-2021; Salvi, Erika/C-1033-2015; Pramstaller, Peter P/C-2357-2008; Winsvold, Bendik/ABF-7839-2021; Fox, Laura J/C-6249-2016; Polasek, Ozren/B-6002-2011; Kaprio, Jaakko/A-1820-2008; Attrill, Lauren/V-1688-2018; Warrington, Nicole/P-4868-2014; Zemunik, Tatijana/D-8584-2017; Palmer, Lyle John/N-1948-2019; Hayward, Caroline/M-8818-2016	Evans, David M/0000-0003-0663-4621; Timpson, Nicholas John/0000-0002-7141-9189; Davey Smith, George/0000-0002-1407-8314; Peters, Annette/0000-0001-6645-0985; Perica, Vesna Boraska/0000-0003-3999-1529; Huth, Cornelia/0000-0003-2421-433X; Campbell, Harry/0000-0002-6169-6262; Bochud, Murielle/0000-0002-5727-0218; Teumer, Alexander/0000-0002-8309-094X; Zgaga, Lina/0000-0003-4089-9703; Palmer, Lyle John/0000-0002-1628-3055; Staessen, Jan A/0000-0002-3026-1637; Kutalik, Zoltan/0000-0001-8285-7523; Rudan, Igor/0000-0001-6993-6884; Hicks, Andrew Anthony/0000-0001-6320-0411; Pennell, Craig/0000-0002-0937-6165; Kolcic, Ivana/0000-0001-7918-6052; Salvi, Erika/0000-0002-2724-2291; Wedenoja, Juho/0000-0002-6155-0378; Dedoussis, George/0000-0002-7798-6221; Salvi, Erika/0000-0002-2724-2291; Winsvold, Bendik/0000-0003-4171-8919; Polasek, Ozren/0000-0002-5765-1862; Kaprio, Jaakko/0000-0002-3716-2455; Warrington, Nicole/0000-0003-4195-775X; Zemunik, Tatijana/0000-0001-8120-2891; Palmer, Lyle John/0000-0002-1628-3055; Hayward, Caroline/0000-0002-9405-9550; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Palotie, Aarno/0000-0002-2527-5874; Pramstaller, Peter P/0000-0002-9831-8302; Anttila, Verneri/0000-0002-0073-4675; Zeggini, Eleftheria/0000-0003-4238-659X; St Pourcain, Beate/0000-0002-4680-3517; Gieger, Christian/0000-0001-6986-9554; Pietilainen, Kirsi/0000-0002-8522-1288; Panoutsopoulou, Kalliope/0000-0002-5460-8025; s, hema/0000-0002-3440-9475; Lawlor, Debbie A/0000-0002-6793-2262; , Hanieh/0000-0001-9672-9477	Unity Through Knowledge Fund CONNECTIVITY PROGRAM; The National Foundation for Science, Higher Education and Technological Development of the Republic of Croatia; Wellcome Trust [098051, WT092731, WT089062]; University of Bristol; MRC [G9815508]; Healthway, Western Australia; The Great Wine Estates of the Margaret River region of Western Australia; The Ark at UWA; GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation [33CSCO-122661]; Swiss School of Public Health Plus; Medical Research Council (UK); Republic of Croatia Ministry of Science, Education and Sports research [108-1080315-0302]; European Commission [LSHG-CT-2006-018947]; NIH [R01-HL-087700, R01-HL-088215]; National Heart, Lung, and Blood Institute (NHLBI); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01-DK-8925601, R01-DK-075681]; South-Eastern Norway Regional Health Authority, Norway; Finnish Cultural Foundation; EU [HEALTH-F4-2007-201550]; Italian Ministry of Health [ICS110.1/RF97.71]; U.S. National Institute on Aging [263 MD 9164, 263 MD 821336, N.1-AG-1-1, N.1-AG-1-2111, N01-AG-5-0002]; National Institute on Aging, National Institutes of Health, Baltimore, Maryland; Sir Henry Wellcome Postdoctoral Fellowship [092447/Z/10/Z]; Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany; German Federal Ministry of Education and Research (BMBF); German National Genome Research Network (NGFNPlus) [NGFN-2, 01GS0823, 01GS0834]; Munich Center of Health Sciences (MC Health) LMUinnovativ; Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; National Health and Medical Research Council of Australia [572613, 403981, 353514]; Western Australian Health Promotion Foundation; Canadian Institutes of Health Research [MOP-82893]; NHMRC; Telethon Institute for Child Health Research; University of Western Australia (UWA); Raine Medical Research Foundation; UWA Faculty of Medicine; Dentistry and Health Sciences; Women and Infants Research Foundation and Curtin University; Federal Ministry of Education and Research [01ZZ9603, 01ZZ0103, 01ZZ0403, 03ZIK012]; Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany; Federal State of Mecklenburg-West Pomerania; European Union (European Social Fund - ESF); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund; Novo Nordisk; Gyllenberg; Biomedicum Helsinki; Jalmari; Rauha Ahokas Foundation; Finnish Foundation for Cardiovascular Research; Academy of Finland Centre of Excellence in Complex Disease Genetics; European Community; ENGAGE Consortium [HEALTH-F4-2007-201413]; Medical Research Council [G0800582, G0600705, MC_PC_U127561128, G9815508, MC_U127561128] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088215, R01HL087700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075681, R01DK089256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012111] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009164] Funding Source: NIH RePORTER; MRC [MC_U127561128, MC_PC_U127561128, G0800582, G0600705] Funding Source: UKRI	Unity Through Knowledge Fund CONNECTIVITY PROGRAM; The National Foundation for Science, Higher Education and Technological Development of the Republic of Croatia; Wellcome Trust(Wellcome Trust); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Healthway, Western Australia; The Great Wine Estates of the Margaret River region of Western Australia; The Ark at UWA; GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss School of Public Health Plus; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Republic of Croatia Ministry of Science, Education and Sports research; European Commission(European CommissionEuropean Commission Joint Research Centre); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); South-Eastern Norway Regional Health Authority, Norway; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); EU(European Commission); Italian Ministry of Health(Ministry of Health, Italy); U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging, National Institutes of Health, Baltimore, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Sir Henry Wellcome Postdoctoral Fellowship; Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network (NGFNPlus); Munich Center of Health Sciences (MC Health) LMUinnovativ; Ministry of Health and Department of Educational Assistance; University and Research of the Autonomous Province of Bolzano; South Tyrolean Sparkasse Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Western Australian Health Promotion Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Telethon Institute for Child Health Research; University of Western Australia (UWA); Raine Medical Research Foundation; UWA Faculty of Medicine; Dentistry and Health Sciences; Women and Infants Research Foundation and Curtin University; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry of Cultural Affairs; Social Ministry of the Federal State of Mecklenburg-West Pomerania; Siemens Healthcare, Erlangen, Germany(Siemens AG); Federal State of Mecklenburg-West Pomerania; European Union (European Social Fund - ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund; Novo Nordisk(Novo Nordisk); Gyllenberg; Biomedicum Helsinki; Jalmari; Rauha Ahokas Foundation; Finnish Foundation for Cardiovascular Research; Academy of Finland Centre of Excellence in Complex Disease Genetics(Academy of Finland); European Community(European Commission); ENGAGE Consortium; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Vesna Boraska is supported by Unity Through Knowledge Fund CONNECTIVITY PROGRAM ("Gaining Experience'' Grant 2A), The National Foundation for Science, Higher Education and Technological Development of the Republic of Croatia (BRAIN GAIN-Postdoc fellowship) and the Wellcome Trust (098051). Eleftheria Zeggini is supported by the Wellcome Trust (098051). ALSPAC: ALSPAC is jointly funded by the University of Bristol, Wellcome Trust and MRC. Current renewal grant numbers: WT092731 and G9815508. BUSSELTON: The Busselton Health Study acknowledges the generous support for the 1994/5 follow-up study from Healthway, Western Australia. The Busselton Health Study is supported by The Great Wine Estates of the Margaret River region of Western Australia. The study gratefully acknowledges the assistance of the Western Australian DNA Bank (National Health and Medical Research Council (NHMRC) Enabling Facility) with DNA samples and the support provided by the The Ark at UWA for this study. CoLaus-Hercules: The CoLaus study received financial contributions from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661). Murielle Bochud is supported by the Swiss School of Public Health Plus. CROATIA-Korcula: The CROATIA-Korcula study was funded by grants from the Medical Research Council (UK), and Republic of Croatia Ministry of Science, Education and Sports research (108-1080315-0302). The SNP genotyping for the CROATIA-Korcula cohort was performed in Helmholtz Zentrum Munchen, Neuherberg, Germany. CROATIA-Split: The CROATIA- Split study is funded by grants from the Medical Research Council (UK) and Republic of Croatia Ministry of Science, Education and Sports research grants to I.R. (108-1080315-0302). The SNP genotyping for the CROATIA-Split cohort was performed by AROS Applied Biotechnology, Aarhus, Denmark. CROATIA-Vis: The CROATIA-Vis study was funded by grants from the Medical Research Council (UK), European Commission Framework 6 project EUROSPAN (Contract No. LSHG-CT-2006-018947) and Republic of Croatia Ministry of Science, Education and Sports research grants (108-1080315-0302). The SNP genotyping for the CROATIA-Vis cohort was performed in the core genotyping laboratory of the Wellcome Trust Clinical Research Facility at the Western General Hospital, Edinburgh, Scotland, UK. FamHS: The Family Heart Study (FamHS) was supported by NIH grants R01-HL-087700, R01-HL-088215 (Michael A. Province) from the National Heart, Lung, and Blood Institute (NHLBI), and R01-DK-8925601, R01-DK-075681 (Ingrid B. Borecki) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). HUNT: Bendik S. Winsvold is funded from the South-Eastern Norway Regional Health Authority, Norway. Vemeri Anttila is funded from the Wellcome Trust (grant number WT089062; www.wellcome.ac.uk) and the Finnish Cultural Foundation (www.skr.fi). HYPERGENES: HYPERGENES (European Network for Genetic-Epidemiological Studies: Building a method to dissect complex genetic traits, using essential hypertension as a disease model) is a Large Cooperative Project funded by EU within the FP7 (HEALTH-F4-2007-201550). InCHIANTI: The InCHIANTI study baseline (1998-2000) was supported as a "targeted project'' (ICS110.1/RF97.71) by the Italian Ministry of Health and in part by the U.S. National Institute on Aging (Contracts: 263 MD 9164 and 263 MD 821336); the InCHIANTI Follow-up 1 (2001-2003) was funded by the U.S. National Institute on Aging (Contracts: N.1-AG-1-1 and N.; 1-AG-1-2111); the InCHIANTI Follow-ups 2 and 3 studies (2004-2010) were financed by the U.S. National Institute on Aging (Contract: N01-AG-5-0002); supported in part by the Intramural research program of the National Institute on Aging, National Institutes of Health, Baltimore, Maryland. JRBP is funded by a Sir Henry Wellcome Postdoctoral Fellowship (092447/Z/10/Z). KORA: The KORA Augsburg studies were financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, Neuherberg, Germany (http://www.helmholtz-muenchen.de) and supported by grants from the German Federal Ministry of Education and Research (BMBF) (http://www.bmbf.de). Part of this work was financed by the German National Genome Research Network (NGFN-2, NGFNPlus 01GS0823 and 01GS0834) (http://www.ngfn.de). Our research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ (http://www.mc-health.uni-muenchen.de). Cornelia Huth was supported by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). MICROS: In South Tyrol, the study was supported by the Ministry of Health and Department of Educational Assistance, University and Research of the Autonomous Province of Bolzano, and the South Tyrolean Sparkasse Foundation. RAINE: The National Health and Medical Research Council of Australia (Grant ID 572613, ID 403981 and ID 353514; URL: http://www.nhmrc.gov.au/), The Western Australian Health Promotion Foundation (URL: http://www.healthway.wa.gov.au/) and the Canadian Institutes of Health Research (MOP-82893; URL: http://www.cihr-irsc.gc.ca/e/193.html). The authors gratefully acknowledge the NH&MRC for their long term contribution to funding the study over the last 20 years and also the Telethon Institute for Child Health Research for long term support of the study. The following Institutions are acknowledged for providing funding for Core Management of the Raine Study: The University of Western Australia (UWA), Raine Medical Research Foundation, UWA Faculty of Medicine, Dentistry and Health Sciences, The Telethon Institute for Child Health Research, Women and Infants Research Foundation and Curtin University. SHIP: SHIP (BMBF), Henry Volzke (public funding from Federal Ministry of Education and Research). SHIP is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (grants no. 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania. Genome-wide data have been supported by the Federal Ministry of Education and Research (grant no. 03ZIK012) and a joint grant from Siemens Healthcare, Erlangen, Germany and the Federal State of Mecklenburg-West Pomerania. The University of Greifswald is a member of the "Center of Knowledge Interchange'' program of the Siemens AG. TEENAGE: This research has been co-financed by the European Union (European Social Fund - ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund. TwinFat: Helsinki University Hospital Research Funds, grants from Novo Nordisk, Gyllenberg, Biomedicum Helsinki, Jalmari and Rauha Ahokas Foundation, and Finnish Foundation for Cardiovascular Research.; Academy of Finland Centre of Excellence in Complex Disease Genetics. The European Community's Seventh Framework Programme (FP7/2007-2013), ENGAGE Consortium, grant agreement HEALTH-F4-2007-201413. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartali B, 2002, SOZ PRAVENTIV MED, V47, P336, DOI 10.1007/PL00012644; Berkley J, 2005, JAMA-J AM MED ASSOC, V294, P591, DOI 10.1001/jama.294.5.591; Canoy D, 2008, CURR OPIN CARDIOL, V23, P591, DOI 10.1097/HCO.0b013e328313133a; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Chomtho S, 2006, PEDIATR RES, V59, P860, DOI 10.1203/01.pdr.0000219395.83159.91; Drieschner N, 2006, THYROID, V16, P1091, DOI 10.1089/thy.2006.16.1091; EVANS WJ, 1993, J NUTR, V123, P465, DOI 10.1093/jn/123.suppl_2.465; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; FRONTERA WR, 1991, J APPL PHYSIOL, V71, P644, DOI 10.1152/jappl.1991.71.2.644; Gauderman WJ, 2003, GENET EPIDEMIOL, V25, P327, DOI 10.1002/gepi.10262; Ha L, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-75; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Heyeard VH, 2004, APPL BODY COMPOSITIO; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins M, 1996, AM J EPIDEMIOL, V143, P1219, DOI 10.1093/oxfordjournals.aje.a008709; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Hughes VA, 2004, AM J CLIN NUTR, V80, P475, DOI 10.1093/ajcn/80.2.475; JAMES WPT, 1994, EUR J CLIN NUTR, V48, P883; Kaprio J, 2006, TWIN RES HUM GENET, V9, P772, DOI 10.1375/twin.9.6.772; LEY CJ, 1992, AM J CLIN NUTR, V55, P950, DOI 10.1093/ajcn/55.5.950; Lynch NA, 1999, J APPL PHYSIOL, V86, P188, DOI 10.1152/jappl.1999.86.1.188; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mazicioglu M Mumtaz, 2010, J Clin Res Pediatr Endocrinol, V2, P144, DOI 10.4274/jcrpe.v2i4.144; Miljkovic-Gacic I, 2008, METABOLISM, V57, P819, DOI 10.1016/j.metabol.2008.01.022; MILLER AEJ, 1993, EUR J APPL PHYSIOL O, V66, P254, DOI 10.1007/BF00235103; Nyirandutiye DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014818; Pezzolesi MG, 2006, AM J HUM GENET, V79, P923, DOI 10.1086/508943; Pietilainen KH, 2009, OBESITY, V17, P1208, DOI 10.1038/oby.2008.675; Poveda A, 2010, COLLEGIUM ANTROPOL, V34, P515; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SHIMOKATA H, 1989, J GERONTOL, V44, pM66, DOI 10.1093/geronj/44.2.M66; Smith FW, 2002, SPORTS MED ARTHROSC, V10, P98, DOI 10.1097/00132585-200210010-00014; Stuebe AM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.069; Tanton LC, 2009, CLIN MED INSIGHTS-AR, V2, P9; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	38	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e31369	10.1371/journal.pone.0031369	http://dx.doi.org/10.1371/journal.pone.0031369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479309	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000304523400002
J	Abarrategi, A; Moreno-Vicente, C; Martinez-Vazquez, FJ; Civantos, A; Ramos, V; Sanz-Casado, JV; Martinez-Corria, R; Perera, FH; Mulero, F; Miranda, P; Lopez-Lacomba, JL				Abarrategi, Ander; Moreno-Vicente, Carolina; Javier Martinez-Vazquez, Francisco; Civantos, Ana; Ramos, Viviana; Vicente Sanz-Casado, Jose; Martinez-Corria, Ramon; Hugo Perera, Fidel; Mulero, Francisca; Miranda, Pedro; Luis Lopez-Lacomba, Jose			Biological Properties of Solid Free Form Designed Ceramic Scaffolds with BMP-2: In Vitro and In Vivo Evaluation	PLOS ONE			English	Article							CALCIUM-PHOSPHATE SCAFFOLDS; BETA-TRICALCIUM PHOSPHATE; BONE MORPHOGENETIC PROTEIN-2; MECHANICAL-PROPERTIES; HYDROXYAPATITE; OSTEOINDUCTION; RHBMP-2; TRANSLATION; BIOCERAMICS; BIOMATERIAL	Porous ceramic scaffolds are widely studied in the tissue engineering field due to their potential in medical applications as bone substitutes or as bone-filling materials. Solid free form (SFF) fabrication methods allow fabrication of ceramic scaffolds with fully controlled pore architecture, which opens new perspectives in bone tissue regeneration materials. However, little experimentation has been performed about real biological properties and possible applications of SFF designed 3D ceramic scaffolds. Thus, here the biological properties of a specific SFF scaffold are evaluated first, both in vitro and in vivo, and later scaffolds are also implanted in pig maxillary defect, which is a model for a possible application in maxillofacial surgery. In vitro results show good biocompatibility of the scaffolds, promoting cell ingrowth. In vivo results indicate that material on its own conducts surrounding tissue and allow cell ingrowth, thanks to the designed pore size. Additional osteoinductive properties were obtained with BMP-2, which was loaded on scaffolds, and optimal bone formation was observed in pig implantation model. Collectively, data show that SFF scaffolds have real application possibilities for bone tissue engineering purposes, with the main advantage of being fully customizable 3D structures.	[Abarrategi, Ander; Moreno-Vicente, Carolina; Civantos, Ana; Luis Lopez-Lacomba, Jose] Univ Complutense, Inst Estudios Biofuncionales, E-28040 Madrid, Spain; [Abarrategi, Ander] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Javier Martinez-Vazquez, Francisco; Hugo Perera, Fidel; Miranda, Pedro] Univ Extremadura, Dept Ingn Mecan Energet & Mat, Badajoz, Extremadura, Spain; [Ramos, Viviana] Noricum SL, Dept I D, Madrid, Spain; [Vicente Sanz-Casado, Jose; Martinez-Corria, Ramon] Univ Complutense, Fac Med, E-28040 Madrid, Spain; [Mulero, Francisca] Ctr Nacl Invest Oncol, Mol Imaging Core Unit, Madrid, Spain	Complutense University of Madrid; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Universidad de Extremadura; Complutense University of Madrid	Abarrategi, A (corresponding author), Univ Complutense, Inst Estudios Biofuncionales, E-28040 Madrid, Spain.	pmiranda@unex.es; lacomba@farm.ucm.es	Miranda, Pedro/C-4465-2008; Fernandez, Ana Fatima Civantos/G-9452-2019; Miranda, Pedro/M-6188-2019; Abarrategi, Ander/ABF-2373-2020; Mulero, Francisca/R-2387-2019; Mulero, Francisca M/M-3289-2014	Miranda, Pedro/0000-0003-4348-110X; Fernandez, Ana Fatima Civantos/0000-0002-5349-7183; Miranda, Pedro/0000-0003-4348-110X; Abarrategi, Ander/0000-0002-6510-2337; Mulero, Francisca/0000-0001-9584-4211; Mulero, Francisca M/0000-0001-9584-4211; Martinez-Vazquez, Francisco Javier/0000-0003-2418-2067; Perera Martinez, Fidel Hugo/0000-0001-5042-0028	Ministerio de Ciencia e Innovacion [PET2008-0168, CSD2009-00088]; Ministerio de Educacion y Ciencia y Fondo Social Europeo [PTQ05-02-02498, MAT 2006-08720]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Educacion y Ciencia y Fondo Social Europeo(Spanish Government)	This work was supported by Ministerio de Ciencia e Innovacion (PET2008-0168, CSD2009-00088), and Ministerio de Educacion y Ciencia y Fondo Social Europeo (PTQ05-02-02498 and Fundacion PCM, MAT 2006-08720). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Escherichia-coli-produced recombinant human BMP-2 (rhBMP-2) was generously supplied by Noricum S. L. (Spain). We thank Alba Cuenca-Moya (Noricum S.L.) and Virginia Gutierrez (Pharmakine) for their technical support.	Abarrategi A, 2008, TISSUE ENG PT A, V14, P1305, DOI 10.1089/ten.tea.2007.0229; Abarrategi A, 2008, BIOMACROMOLECULES, V9, P711, DOI 10.1021/bm701049g; Abarrategi A, 2009, ACTA BIOMATER, V5, P2633, DOI 10.1016/j.actbio.2009.02.031; Becker ST, 2009, ORAL ONCOL, V45, pE181, DOI 10.1016/j.oraloncology.2009.07.004; Cesarano J, 1998, CERAMIC IND, V148; Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5; Daculsi G, 2008, KEY ENG MATER, V361-363, P1139, DOI 10.4028/www.scientific.net/KEM.361-363.1139; Dorozhkin SV, 2007, J MATER SCI, V42, P1061, DOI 10.1007/s10853-006-1467-8; Evans CH, 2011, TISSUE ENG PART B-RE, V17, P437, DOI [10.1089/ten.teb.2011.0228, 10.1089/ten.TEB.2011.0228]; Habibovic P, 2008, BIOMATERIALS, V29, P944, DOI 10.1016/j.biomaterials.2007.10.023; Hall J, 2007, J CLIN PERIODONTOL, V34, P444, DOI 10.1111/j.1600-051X.2007.01064.x; Heini PF, 2001, EUR SPINE J, V10, pS205, DOI 10.1007/s005860100308; HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x; Hollister SJ, 2011, TISSUE ENG PART B-RE, V17, P459, DOI [10.1089/ten.teb.2011.0251, 10.1089/ten.TEB.2011.0251]; Hollister SJ, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/1/012001; Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977; Hoshino M, 2006, BIOMATERIALS, V27, P4934, DOI 10.1016/j.biomaterials.2006.04.044; Jingushi Seiya, 2002, J Orthop Sci, V7, P490, DOI 10.1007/s007760200085; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Kim JY, 2010, TISSUE ENG PT A, V16, P2229, DOI [10.1089/ten.tea.2009.0644, 10.1089/ten.TEA.2009.0644]; Kong SW, 2011, BONE, V48, P298, DOI 10.1016/j.bone.2010.09.029; Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105; Kwon SH, 2002, J AM CERAM SOC, V85, P3129, DOI 10.1111/j.1151-2916.2002.tb00599.x; LeGeros Racquel Z., 2008, P153, DOI 10.1007/978-1-59745-239-7_8; Levengood SKL, 2010, ACTA BIOMATER, V6, P3283, DOI 10.1016/j.actbio.2010.02.026; Liang G, 2005, BIOMATERIALS, V26, P4265, DOI 10.1016/j.biomaterials.2004.10.035; Lopez-Lacomba JL, 2006, BIOMACROMOLECULES, V7, P792, DOI 10.1021/bm050859e; Lopiz-Morales Y, 2010, EUR CELLS MATER, V20, P367; Metsger DS, 1999, J MATER SCI-MATER M, V10, P9, DOI 10.1023/A:1008883809160; Miranda P, 2006, ACTA BIOMATER, V2, P457, DOI 10.1016/j.actbio.2006.02.004; Miranda P, 2008, J BIOMED MATER RES A, V85A, P218, DOI 10.1002/jbm.a.31587; Miranda P, 2007, J BIOMED MATER RES A, V83A, P646, DOI 10.1002/jbm.a.31272; Miranda P, 2008, ACTA BIOMATER, V4, P1715, DOI 10.1016/j.actbio.2008.05.020; Mourino V, 2010, J R SOC INTERFACE, V7, P209, DOI 10.1098/rsif.2009.0379; Nakamura Y, 2003, J BONE MINER RES, V18, P1854, DOI 10.1359/jbmr.2003.18.10.1854; O'Keefe RJ, 2011, TISSUE ENG PART B-RE, V17, P389, DOI [10.1089/ten.teb.2011.0475, 10.1089/ten.TEB.2011.0475]; Perera FH, 2010, CERAM INT, V36, P1929, DOI 10.1016/j.ceramint.2010.03.015; Pham D. T., 2000, RAPID MANUFACTURING, P19; Rauch C, 2002, AM J PHYSIOL-CELL PH, V283, pC235, DOI 10.1152/ajpcell.00234.2001; Ripamonti U, 1999, S AFR J SCI, V95, P335; Sachlos E., 2003, European Cells & Materials, V5, P29; Saiz E, 2007, MAT SCI ENG C-BIO S, V27, P546, DOI 10.1016/j.msec.2006.05.038; Sanchez-Salcedo S, 2006, TISSUE ENG, V12, P279, DOI 10.1089/ten.2006.12.279; Shim JH, 2011, BIOFABRICATION, V3, DOI 10.1088/1758-5082/3/3/034102; Simon JL, 2007, J BIOMED MATER RES A, V83A, P747, DOI 10.1002/jbm.a.31329; Smay JE, 2002, LANGMUIR, V18, P5429, DOI 10.1021/la0257135; Smith E, 2005, BIOMATERIALS, V26, P7329, DOI 10.1016/j.biomaterials.2005.05.060; Tay BY, 2003, INT MATER REV, V48, P341, DOI 10.1179/095066003225010263; Warnke PH, 2010, J BIOMED MATER RES B, V93B, P212, DOI 10.1002/jbm.b.31577; Yamamoto M, 1998, J BIOMAT SCI-POLYM E, V9, P439, DOI 10.1163/156856298X00550; Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004; Yuan HP, 2001, J MATER SCI-MATER M, V12, P761, DOI 10.1023/A:1013957431372; Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047; Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015	55	62	69	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34117	10.1371/journal.pone.0034117	http://dx.doi.org/10.1371/journal.pone.0034117			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470527	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000067
J	Buchheim, A; Viviani, R; Kessler, H; Kachele, H; Cierpka, M; Roth, G; George, C; Kernberg, OF; Bruns, G; Taubner, S				Buchheim, Anna; Viviani, Roberto; Kessler, Henrik; Kaechele, Horst; Cierpka, Manfred; Roth, Gerhard; George, Carol; Kernberg, Otto F.; Bruns, Georg; Taubner, Svenja			Changes in Prefrontal-Limbic Function in Major Depression after 15 Months of Long-Term Psychotherapy	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; COGNITIVE-BEHAVIOR THERAPY; HAPPY FACIAL EXPRESSIONS; PSYCHODYNAMIC PSYCHOTHERAPY; NEURAL RESPONSE; HUMAN AMYGDALA; ANTIDEPRESSANT TREATMENT; UNIPOLAR DEPRESSION; EMOTION REGULATION; BRAIN ACTIVATION	Neuroimaging studies of depression have demonstrated treatment-specific changes involving the limbic system and regulatory regions in the prefrontal cortex. While these studies have examined the effect of short-term, interpersonal or cognitive-behavioural psychotherapy, the effect of long-term, psychodynamic intervention has never been assessed. Here, we investigated recurrently depressed (DSM-IV) unmedicated outpatients (N = 16) and control participants matched for sex, age, and education (N = 17) before and after 15 months of psychodynamic psychotherapy. Participants were scanned at two time points, during which presentations of attachment-related scenes with neutral descriptions alternated with descriptions containing personal core sentences previously extracted from an attachment interview. Outcome measure was the interaction of the signal difference between personal and neutral presentations with group and time, and its association with symptom improvement during therapy. Signal associated with processing personalized attachment material varied in patients from baseline to endpoint, but not in healthy controls. Patients showed a higher activation in the left anterior hippocampus/amygdala, subgenual cingulate, and medial prefrontal cortex before treatment and a reduction in these areas after 15 months. This reduction was associated with improvement in depressiveness specifically, and in the medial prefrontal cortex with symptom improvement more generally. This is the first study documenting neurobiological changes in circuits implicated in emotional reactivity and control after long-term psychodynamic psychotherapy.	[Buchheim, Anna; Viviani, Roberto] Univ Innsbruck, Inst Psychol, A-6020 Innsbruck, Austria; [Viviani, Roberto] Univ Ulm, Dept Psychiat & Psychotherapy 3, Ulm, Germany; [Kessler, Henrik; Taubner, Svenja] Hanse Inst Adv Study, Delmenhorst, Germany; [Kessler, Henrik; Kaechele, Horst] Univ Ulm, Dept Psychosomat Med & Psychotherapy, Ulm, Germany; [Kessler, Henrik] Univ Bonn, Dept Psychiat, Bonn, Germany; [Kaechele, Horst; Taubner, Svenja] Int Psychoanalyt Univ, Berlin, Germany; [Cierpka, Manfred] Heidelberg Univ, Inst Psychosomat Cooperat Res & Family Therapy, Heidelberg, Germany; [Roth, Gerhard] Univ Bremen, Brain Res Inst, D-28359 Bremen, Germany; [George, Carol] Mills Coll, Dept Psychol, Oakland, CA 94613 USA; [Kernberg, Otto F.] Weill Med Coll, New York, NY USA; [Bruns, Georg] Univ Bremen, D-28359 Bremen, Germany; [Taubner, Svenja] Univ Kassel, Dept Psychol, Kassel, Germany	University of Innsbruck; Ulm University; Ulm University; University of Bonn; Ruprecht Karls University Heidelberg; University of Bremen; Cornell University; University of Bremen; Universitat Kassel	Buchheim, A (corresponding author), Univ Innsbruck, Inst Psychol, A-6020 Innsbruck, Austria.	anna.buchheim@uibk.ac.at	Viviani, Roberto/A-8787-2015; Taubner, Svenja/AAY-5144-2020	Taubner, Svenja/0000-0001-8058-762X; Buchheim, Anna/0000-0002-1339-5246; Viviani, Roberto/0000-0002-7517-6006	International Psychoanalytic Association	International Psychoanalytic Association	This study was supported by a research grant of the International Psychoanalytic Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts K, 2005, ANAT EMBRYOL, V210, P343, DOI 10.1007/s00429-005-0025-5; Beck A, 1979, COGNITIVE THERAPY DE; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Beck AT, 1996, PSYCHOL ASSESS; Bermpohl F, 2009, NEUROSCI LETT, V463, P108, DOI 10.1016/j.neulet.2009.07.061; Beutel ME, 2010, PSYCHIAT RES-NEUROIM, V184, P96, DOI 10.1016/j.pscychresns.2010.06.005; Bowlby J., 1969, ATTACHMENT LOSS ATTA, DOI [10.2307/588279, DOI 10.2307/588279]; Brody AL, 2001, ARCH GEN PSYCHIAT, V58, P631, DOI 10.1001/archpsyc.58.7.631; Buchheim A, 2006, PSYCHOPATHOLOGY, V39, P144, DOI 10.1159/000091800; Buchheim A, 2008, PSYCHIAT RES-NEUROIM, V163, P223, DOI 10.1016/j.pscychresns.2007.07.001; Buchsbaum MS, 1997, BIOL PSYCHIAT, V41, P15, DOI 10.1016/S0006-3223(96)00097-2; Carhart-Harris Robin L, 2008, Ann Gen Psychiatry, V7, P9, DOI 10.1186/1744-859X-7-9; Davidson RJ, 2003, AM J PSYCHIAT, V160, P64, DOI 10.1176/appi.ajp.160.1.64; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Derogatis LR, 1993, BSI BRIEF SYMPTOM IN; DeRubeis RJ, 2008, NAT REV NEUROSCI, V9, P788, DOI 10.1038/nrn2345; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Erk S, 2010, J NEUROSCI, V30, P15726, DOI 10.1523/JNEUROSCI.1856-10.2010; Fan Y, 2011, PSYCHOL MED, V41, P1641, DOI 10.1017/S003329171000228X; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Fitzgerald PB, 2006, PSYCHIAT RES-NEUROIM, V148, P33, DOI 10.1016/j.pscychresns.2006.04.006; Fonagy P., 2009, NEW OXFORD TXB PSYCH, V2, P1337, DOI DOI 10.1093/MED/9780199696758.001.0001; Franke G. H., 1995, SCL90R; Frewen PA, 2008, CLIN PSYCHOL REV, V28, P228, DOI 10.1016/j.cpr.2007.05.002; Fu CHY, 2004, ARCH GEN PSYCHIAT, V61, P877, DOI 10.1001/archpsyc.61.9.877; Fu CHY, 2008, BIOL PSYCHIAT, V64, P505, DOI 10.1016/j.biopsych.2008.04.033; George C, 2001, Attach Hum Dev, V3, P30; Gillath O, 2005, NEUROIMAGE, V28, P835, DOI 10.1016/j.neuroimage.2005.06.048; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Goldin PR, 2005, NEUROIMAGE, V27, P26, DOI 10.1016/j.neuroimage.2005.03.018; Grimm S, 2009, NEUROPSYCHOPHARMACOL, V34, P932, DOI 10.1038/npp.2008.81; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Keller F., 1992, BECK DEPRESSION INVE; Leichsenring F, 2008, JAMA-J AM MED ASSOC, V300, P1551, DOI 10.1001/jama.300.13.1551; Leichsenring F, 2011, BRIT J PSYCHIAT, V199, P15, DOI 10.1192/bjp.bp.110.082776; Levy KN, 2005, DEV PSYCHOPATHOL, V17, P959, DOI 10.1017/S0954579405050455; Linden DEJ, 2006, MOL PSYCHIATR, V11, P528, DOI 10.1038/sj.mp.4001816; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; Mayberg HS, 2003, NEUROIMAG CLIN N AM, V13, P805, DOI 10.1016/S1052-5149(03)00104-7; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Navarro V, 2002, NEUROIMAGE, V16, P781, DOI 10.1006/nimg.2002.1051; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Roffman JL, 2005, PSYCHOL MED, V35, P1385, DOI 10.1017/S0033291705005064; Shedler J, 2010, AM PSYCHOL, V65, P98, DOI 10.1037/a0018378; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Siegle GJ, 2006, AM J PSYCHIAT, V163, P735, DOI 10.1176/appi.ajp.163.4.735; Siegle GJ, 2002, BIOL PSYCHIAT, V51, P693, DOI 10.1016/S0006-3223(02)01314-8; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Taylor D., 2008, ADV PSYCHIAT TREATME, V14, P401, DOI [10.1192/apt.bp.107.004382, DOI 10.1192/APT.BP.107.004382]; Taylor SF, 2007, TRENDS COGN SCI, V11, P413, DOI 10.1016/j.tics.2007.08.006; Thomas EJ, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.030.2009; Whalen Paul J, 2002, Semin Clin Neuropsychiatry, V7, P234, DOI 10.1053/scnp.2002.35219; WITTCHEN HU, 1997, SKID 1 STRUCTURED CL	63	105	109	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33745	10.1371/journal.pone.0033745	http://dx.doi.org/10.1371/journal.pone.0033745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470470	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000032
J	Djonlagic, I; Saboisky, J; Carusona, A; Stickgold, R; Malhotra, A				Djonlagic, Ina; Saboisky, Julian; Carusona, Andrea; Stickgold, Robert; Malhotra, Atul			Increased Sleep Fragmentation Leads to Impaired Off-Line Consolidation of Motor Memories in Humans	PLOS ONE			English	Article							DEPRIVATION; DEFICITS; SKILLS; APNEA	A growing literature supports a role for sleep after training in long-term memory consolidation and enhancement. Consequently, interrupted sleep should result in cognitive deficits. Recent evidence from an animal study indeed showed that optimal memory consolidation during sleep requires a certain amount of uninterrupted sleep. Sleep continuity is disrupted in various medical disorders. We compared performance on a motor sequence learning task (MST) in relatively young subjects with obstructive sleep apnea (n = 16; apnea-hypopnea index 17.1 +/- 2.6/h [SEM]) to a carefully matched control group (n = 15, apnea-hypopnea index 3.7 +/- 0.4/h, p<0.001. Apart from AHI, oxygen nadir and arousal index, there were no significant differences between groups in total sleep time, sleep efficiency and sleep architecture as well as subjective measures of sleepiness based on standard questionnaires. In addition performance on the psychomotor vigilance task (reaction time and lapses), which is highly sensitive to sleep deprivation showed no differences as well as initial learning performance during the training phase. However there was a significant difference in the primary outcome of immediate overnight improvement on the MST between the two groups (controls = 14.7 +/- 4%, patients = 1.1 +/- 3.6%; P = 0.023) as well as plateau performance (controls = 24.0 +/- 5.3%, patients = 10.1 +/- 2.0%; P = 0.017) and this difference was predicted by the arousal index (p = 0.02) rather than oxygen saturation (nadir and time below 90% saturation. Taken together, this outcome provides evidence that there is a clear minimum requirement of sleep continuity in humans to ensure optimal sleep dependent memory processes. It also provides important new information about the cognitive impact of obstructive sleep apnea and challenges its current definitions.	[Djonlagic, Ina; Saboisky, Julian; Carusona, Andrea; Malhotra, Atul] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [Djonlagic, Ina; Stickgold, Robert] Beth Israel Deaconess Med Ctr, Dept Psychiat, Boston, MA 02215 USA; [Djonlagic, Ina; Saboisky, Julian; Carusona, Andrea; Stickgold, Robert; Malhotra, Atul] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Djonlagic, I (corresponding author), Brigham & Womens Hosp, Div Sleep Med, 75 Francis St, Boston, MA 02115 USA.	idonlagic@partners.org	Saboisky, Julian/P-5782-2014	Saboisky, Julian/0000-0002-9450-6023	American Board of Sleep Medicine [54-JF-1-10, P01 HL 095491, K24 HL 093218, R01 HL090897, AHA 0840159N, R01 HL085188];  [K23 HL103850-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090897, P01HL095491, R01HL085188, K24HL093218, K23HL103850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092638, R01MH048832] Funding Source: NIH RePORTER	American Board of Sleep Medicine; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by K23 HL103850-01, American Board of Sleep Medicine Junior Faculty Research Award # 54-JF-1-10, P01 HL 095491, K24 HL 093218, R01 HL090897, AHA 0840159N, R01 HL085188. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Doyon J, 2005, CURR OPIN NEUROBIOL, V15, P161, DOI 10.1016/j.conb.2005.03.004; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Halasz P, 2004, J SLEEP RES, V13, P1, DOI 10.1111/j.1365-2869.2004.00388.x; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Iber C., 2007, AASM MANUAL SCORING; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kim HC, 1997, AM J RESP CRIT CARE, V156, P1813, DOI 10.1164/ajrccm.156.6.9610026; Kloepfer C, 2009, J CLIN SLEEP MED, V5, P540; Kuriyama K, 2004, LEARN MEMORY, V11, P705, DOI 10.1101/lm.76304; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Rolls A, 2011, P NATL ACAD SCI USA, V108, P13305, DOI 10.1073/pnas.1015633108; Saper CB, 2001, TRENDS NEUROSCI, V24, P726, DOI 10.1016/S0166-2236(00)02002-6; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Twigg GL, 2010, AM J RESP CRIT CARE, V182, P98, DOI 10.1164/rccm.200901-0065OC; Van Der Werf YD, 2009, NAT NEUROSCI, V12, P122, DOI 10.1038/nn.2253; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Yoo SS, 2007, NAT NEUROSCI, V10, P385, DOI 10.1038/nn1851	23	83	86	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34106	10.1371/journal.pone.0034106	http://dx.doi.org/10.1371/journal.pone.0034106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470524	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000065
J	Diambra, L; Malta, CP				Diambra, Luis; Malta, Coraci P.			Modeling the Emergence of Circadian Rhythms in a Clock Neuron Network	PLOS ONE			English	Article							INTERCELLULAR SYNCHRONIZATION; BEHAVIORAL RHYTHMS; DROSOPHILA; PERIOD; NEUROPEPTIDE; GENE; OSCILLATIONS; EXPRESSION; ENTRAINMENT; VRILLE	Circadian rhythms in pacemaker cells persist for weeks in constant darkness, while in other types of cells the molecular oscillations that underlie circadian rhythms damp rapidly under the same conditions. Although much progress has been made in understanding the biochemical and cellular basis of circadian rhythms, the mechanisms leading to damped or self-sustained oscillations remain largely unknown. There exist many mathematical models that reproduce the circadian rhythms in the case of a single cell of the Drosophila fly. However, not much is known about the mechanisms leading to coherent circadian oscillation in clock neuron networks. In this work we have implemented a model for a network of interacting clock neurons to describe the emergence (or damping) of circadian rhythms in Drosophila fly, in the absence of zeitgebers. Our model consists of an array of pacemakers that interact through the modulation of some parameters by a network feedback. The individual pacemakers are described by a well-known biochemical model for circadian oscillation, to which we have added degradation of PER protein by light and multiplicative noise. The network feedback is the PER protein level averaged over the whole network. In particular, we have investigated the effect of modulation of the parameters associated with (i) the control of net entrance of PER into the nucleus and (ii) the non-photic degradation of PER. Our results indicate that the modulation of PER entrance into the nucleus allows the synchronization of clock neurons, leading to coherent circadian oscillations under constant dark condition. On the other hand, the modulation of non-photic degradation cannot reset the phases of individual clocks subjected to intrinsic biochemical noise.	[Diambra, Luis] Univ Nacl La Plata, Ctr Reg Estudios Genomicos, Buenos Aires, DF, Argentina; [Malta, Coraci P.] Univ Sao Paulo, Inst Fis, BR-01498 Sao Paulo, Brazil	National University of La Plata; Universidade de Sao Paulo	Diambra, L (corresponding author), Univ Nacl La Plata, Ctr Reg Estudios Genomicos, Buenos Aires, DF, Argentina.	ldiambra@creg.org.ar	L, Diambra/F-6319-2015	L, Diambra/0000-0001-8052-4880	CNPq (Brazil) [311022/2009-0]	CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CM has received financial support from CNPq (Brazil), grant #311022/2009-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Bagheri N, 2008, J R SOC INTERFACE, V5, pS17, DOI 10.1098/rsif.2008.0045.focus; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Bernard S, 2007, PLOS COMPUT BIOL, V3, P667, DOI 10.1371/journal.pcbi.0030068; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Forger DB, 2003, P NATL ACAD SCI USA, V100, P14806, DOI 10.1073/pnas.2036281100; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; Glossop NRJ, 2003, NEURON, V37, P249, DOI 10.1016/S0896-6273(03)00002-3; GOLDBETER A, 1995, P ROY SOC B-BIOL SCI, V261, P319, DOI 10.1098/rspb.1995.0153; Gonze D, 2004, PHYSICA A, V342, P221, DOI 10.1016/j.physa.2004.04.082; HARDIN PE, 1994, MOL CELL BIOL, V14, P7211, DOI 10.1128/MCB.14.11.7211; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Lema MA, 2000, J THEOR BIOL, V204, P565, DOI 10.1006/jtbi.2000.2038; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Scheper TO, 1999, J NEUROSCI, V19, P40, DOI 10.1523/JNEUROSCI.19-01-00040.1999; Smolen P, 2004, BIOPHYS J, V86, P2786, DOI 10.1016/S0006-3495(04)74332-5; To TL, 2007, BIOPHYS J, V92, P3792, DOI 10.1529/biophysj.106.094086; Ueda HR, 2002, J THEOR BIOL, V216, P501, DOI 10.1006/jtbi.2002.3000; Ullner E, 2009, BIOPHYS J, V96, P3573, DOI 10.1016/j.bpj.2009.02.031; Vasalou C, 2011, BIOPHYS J, V101, P12, DOI 10.1016/j.bpj.2011.04.051; Vasalou C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000706; VOSSHALL LB, 1995, NEURON, V15, P345, DOI 10.1016/0896-6273(95)90039-X; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135	31	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33912	10.1371/journal.pone.0033912	http://dx.doi.org/10.1371/journal.pone.0033912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479474	Green Published, gold, Green Submitted			2022-12-27	WOS:000303894900050
J	Kothandan, G; Gadhe, CG; Cho, SJ				Kothandan, Gugan; Gadhe, Changdev G.; Cho, Seung Joo			Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study	PLOS ONE			English	Article							CHEMOKINE RECEPTOR ANTAGONISTS; SMALL-MOLECULE INHIBITOR; HIV-1 INFECTION; POTENT; ENTRY; RESISTANCE; DISCOVERY; DOCKING; SITES; MUTAGENESIS	Chemokine receptors are G protein-coupled receptors that contain seven transmembrane domains. In particular, CCR2 and CCR5 and their ligands have been implicated in the pathophysiology of a number of diseases, including rheumatoid arthritis and multiple sclerosis. Based on their roles in disease, they have been attractive targets for the pharmaceutical industry, and furthermore, targeting both CCR2 and CCR5 can be a useful strategy. Owing to the importance of these receptors, information regarding the binding site is of prime importance. Structural studies have been hampered due to the lack of Xray crystal structures, and templates with close homologs for comparative modeling. Most of the previous models were based on the bovine rhodopsin and beta 2-adrenergic receptor. In this study, based on a closer homolog with higher resolution (CXCR4, PDB code: 3ODU 2.5 angstrom), we constructed three-dimensional models. The main aim of this study was to provide relevant information on binding sites of these receptors. Molecular dynamics simulation was done to refine the homology models and PROCHECK results indicated that the models were reasonable. Here, binding poses were checked with some established inhibitors of high pharmaceutical importance against the modeled receptors. Analysis of interaction modes gave an integrated interpretation with detailed structural information. The binding poses confirmed that the acidic residues Glu291 (CCR2) and Glu283 (CCR5) are important, and we also found some additional residues. Comparisons of binding sites of CCR2/CCR5 were done sequentially and also by docking a potent dual antagonist. Our results can be a starting point for further structure-based drug design.	[Kothandan, Gugan; Gadhe, Changdev G.; Cho, Seung Joo] Chosun Univ, Dept Bionew Drug Dev, Coll Med, Kwangju, South Korea; [Cho, Seung Joo] Chosun Univ, Dept Cellular Mol Med, Coll Med, Res Ctr Resistant Cells, Kwangju, South Korea	Chosun University; Chosun University	Kothandan, G (corresponding author), Chosun Univ, Dept Bionew Drug Dev, Coll Med, Kwangju, South Korea.	chosj@chosun.ac.kr	Gorakshnath, Gadhe Changdev/AAR-5175-2020		Korea Science and Engineering Foundation (KOSEF); Korea government (MEST) through Research Center for Resistant Cells [R13-2003-009]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Korea government (MEST) through Research Center for Resistant Cells	This work was supported by the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korea government (MEST) through the Research Center for Resistant Cells (R13-2003-009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1985, MATH METHODS PHYS; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Berkhout TA, 2003, J MED CHEM, V46, P4070, DOI 10.1021/jm030862l; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Butora G, 2006, BIOORG MED CHEM LETT, V16, P4715, DOI 10.1016/j.bmcl.2006.07.011; Castonguay LA, 2003, BIOCHEMISTRY-US, V42, P1544, DOI 10.1021/bi026639s; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Charo IF, 2003, MICROCIRCULATION, V10, P259, DOI 10.1038/sj.mn.7800191; Cherney RJ, 2008, BIOORG MED CHEM LETT, V18, P5063, DOI 10.1016/j.bmcl.2008.07.123; Chowdhuri S, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2357117; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 2000, P NATL ACAD SCI USA, V97, P5639, DOI 10.1073/pnas.090576697; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fano A, 2006, J CHEM INF MODEL, V46, P1223, DOI 10.1021/ci050490k; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gadhe CG, 2010, B KOREAN CHEM SOC, V31, P2761, DOI 10.5012/bkcs.2010.31.10.2761; Gavrilin MA, 2005, BIOCHEM BIOPH RES CO, V327, P533, DOI 10.1016/j.bbrc.2004.12.037; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; Hall SE, 2009, MOL PHARMACOL, V75, P1325, DOI 10.1124/mol.108.053470; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Hunt JS, 2009, PHARMACOTHERAPY, V29, P295, DOI 10.1592/phco.29.3.295; Kim JH, 2011, J MOL MODEL IN PRESS; Kimura SR, 2008, PROTEINS, V71, P1919, DOI 10.1002/prot.21906; Kondru R, 2008, MOL PHARMACOL, V73, P789, DOI 10.1124/mol.107.042101; Kothandan G, 2011, CHEM BIOL DRUG DES, V78, P161, DOI 10.1111/j.1747-0285.2011.01095.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li G, 2009, J CHEM INF MODEL, V49, P120, DOI 10.1021/ci800356a; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Mirzadegan T, 2000, J BIOL CHEM, V275, P25562, DOI 10.1074/jbc.M000692200; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moree WJ, 2008, BIOORG MED CHEM LETT, V18, P1869, DOI 10.1016/j.bmcl.2008.02.015; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murphy PM, 2002, PHARMACOL REV, V54, P227, DOI 10.1124/pr.54.2.227; Ness TL, 2006, EXPERT OPIN THER PAT, V16, P1051, DOI 10.1517/13543776.16.8.1051; Nishikawa M, 2005, ANTIMICROB AGENTS CH, V49, P4708, DOI 10.1128/AAC.49.11.4708-4715.2005; Pasternak A, 2010, ACS MED CHEM LETT, V1, P14, DOI 10.1021/ml900009d; Paterlini MG, 2002, BIOPHYS J, V83, P3012, DOI 10.1016/S0006-3495(02)75307-1; Pease JE, 2009, EXPERT OPIN THER PAT, V19, P199, DOI 10.1517/13543770802641353; Pease JE, 2009, EXPERT OPIN THER PAT, V19, P39, DOI 10.1517/13543770802641346; Pinkerton AB, 2007, BIOORG MED CHEM LETT, V17, P807, DOI 10.1016/j.bmcl.2006.10.060; Rolland C, 2005, J MED CHEM, V48, P6563, DOI 10.1021/jm0500673; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Seibert C, 2006, VIROLOGY, V349, P41, DOI 10.1016/j.virol.2006.01.018; Shahlaei M, 2011, BBA-BIOMEMBRANES, V1808, P802, DOI 10.1016/j.bbamem.2010.12.004; Shi XF, 2002, J MOL MODEL, V8, P217, DOI 10.1007/s00894-002-0089-6; Strizki JM, 2001, P NATL ACAD SCI USA, V98, P12718, DOI 10.1073/pnas.221375398; Strizki JM, 2005, ANTIMICROB AGENTS CH, V49, P4911, DOI 10.1128/AAC.49.12.4911-4919.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsamis F, 2003, J VIROL, V77, P5201, DOI 10.1128/JVI.77.9.5201-5208.2003; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wagstaff AJ, 2009, DRUGS, V69, P319, DOI 10.2165/00003495-200969030-00007; Wang T, 2008, J MOL GRAPH MODEL, V26, P1287, DOI 10.1016/j.jmgm.2007.12.003; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Xu Y, 2004, BIOORGAN MED CHEM, V12, P6193, DOI 10.1016/j.bmc.2004.08.045; Yang LH, 2006, BIOORG MED CHEM LETT, V16, P3735, DOI 10.1016/j.bmcl.2006.04.045; Zheng CS, 2011, BIOORG MED CHEM LETT, V21, P1442, DOI 10.1016/j.bmcl.2011.01.015; Zimmerman PA, 1997, MOL MED, V3, P23, DOI 10.1007/BF03401665	67	41	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e32864	10.1371/journal.pone.0032864	http://dx.doi.org/10.1371/journal.pone.0032864			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479344	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900014
J	Schonkeren, D; Swings, G; Roberts, D; Claas, F; de Heer, E; Scherjon, S				Schonkeren, Dorrith; Swings, Godelieve; Roberts, Drucilla; Claas, Frans; de Heer, Emile; Scherjon, Sicco			Pregnancy Close to the Edge: An Immunosuppressive Infiltrate in the Chorionic Plate of Placentas from Uncomplicated Egg Cell Donation	PLOS ONE			English	Article							REGULATORY T-CELLS; DECIDUAL MACROPHAGES; REACTION PATTERNS; PREECLAMPSIA; DONOR; HLA; REPRODUCIBILITY; EXPRESSION; PHENOTYPE; NOSOLOGY	In pregnancies achieved after egg donation (ED) tolerance towards a completely allogeneic fetus is mediated by several complex immunoregulatory mechanisms, of which numerous aspects are still unknown. A distinct lesion not described previously in the literature, was repeatedly found in the chorionic plate in a substantial portion of placentas from ED pregnancies, but never in placentas from normal term pregnancies. The aim of this study was to assess its origin and its cellular composition. The relation between the lesion, the clinical and histological parameters were assessed. In addition we investigated the relation with the number of HLA-mismatches and KIR genotype of mother and child. In ten out of twenty-six (38.5%) placentas from ED pregnancies an inflammatory lesion was present in the chorionic plate. A significantly lower incidence of pre-eclampsia was found in the group with the lesion; 0% versus 45.5%. A significant relation was found between this lesion and the presence of intervillositis, chronic deciduitis, presence of plasma cells and fibrin deposition in the decidua. Fluorescent in situ hybridisation with X/Y-chromosome probes showed that the majority of cells present in the lesion are of maternal origin. The expression of the macrophage marker CD14+ and of the type 2 macrophage (M2) marker CD163+ was significantly higher in the lesion. The incidence of a fetal HLA-C2 genotype was significantly higher in cases with a lesion compared to the group without the lesion. In conclusion, a striking relationship was observed between the presence of a not previously described inflammatory lesion in the chorionic plate and the absence of pre-eclampsia in ED pregnancies. The lesion consists of mainly maternal cells with a higher expression of the macrophage marker CD14+ and the M2 marker CD163+. These findings suggest a protective immune mechanism which might contribute to the prevention of severe clinical complications like pre-eclampsia.	[Schonkeren, Dorrith; Swings, Godelieve; Scherjon, Sicco] Leiden Univ, Dept Obstet, Med Ctr, Leiden, Netherlands; [Roberts, Drucilla] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Claas, Frans] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands; [de Heer, Emile] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Massachusetts General Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Schonkeren, D (corresponding author), Leiden Univ, Dept Obstet, Med Ctr, Leiden, Netherlands.	C.M.C.Schonkeren@lumc.nl	Roberts, Drucilla/AAB-6379-2022					Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Alves LGT, 2009, TISSUE ANTIGENS, V73, P188, DOI 10.1111/j.1399-0039.2008.01184.x; Apps R, 2009, IMMUNOLOGY, V127, P26, DOI 10.1111/j.1365-2567.2008.03019.x; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gundogan F, 2010, FERTIL STERIL, V93, P397, DOI 10.1016/j.fertnstert.2008.12.144; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Henne MB, 2007, J REPROD MED, V52, P585; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998; Knuist M, 1998, OBSTET GYNECOL, V92, P174, DOI 10.1016/S0029-7844(98)00143-4; Koelman CA, 2000, J REPROD IMMUNOL, V46, P155, DOI 10.1016/S0165-0378(99)00062-5; Moffett A, 2004, PLACENTA, V25, P1, DOI 10.1016/S0143-4004(03)00167-X; Perni SC, 2005, J PERINAT MED, V33, P27, DOI 10.1515/JPM.2005.004; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Redline RW, 2004, PEDIATR DEVEL PATHOL, V7, P237, DOI 10.1007/s10024-003-8083-2; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Robinson J, 2005, NUCLEIC ACIDS RES, V33, pD523, DOI 10.1093/nar/gki032; Schonkeren D, 2011, AM J PATHOL, V178, P709, DOI 10.1016/j.ajpath.2010.10.011; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Styer AK, 2003, AM J OBSTET GYNECOL, V189, P1184, DOI 10.1067/S0002-9378(03)00577-5; Tilburgs T, 2010, PLACENTA, V31, pS82, DOI 10.1016/j.placenta.2010.01.007; Tilburgs T, 2008, J IMMUNOL, V180, P5737, DOI 10.4049/jimmunol.180.8.5737; Tilburgs T, 2009, J REPROD IMMUNOL, V82, P148, DOI 10.1016/j.jri.2009.05.003; van der Hoorn MLP, 2010, HUM REPROD UPDATE, V16, P704, DOI 10.1093/humupd/dmq017	26	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e32347	10.1371/journal.pone.0032347	http://dx.doi.org/10.1371/journal.pone.0032347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479322	Green Submitted, Green Published, gold			2022-12-27	WOS:000303894900007
J	Duftner, C; Dejaco, C; Hengster, P; Bijuklic, K; Joannidis, M; Margreiter, R; Schirmer, M				Duftner, Christina; Dejaco, Christian; Hengster, Paul; Bijuklic, Klaudija; Joannidis, Michael; Margreiter, Raimund; Schirmer, Michael			Apoptotic Effects of Antilymphocyte Globulins on Human Pro-inflammatory CD4(+)CD28(-) T-cells	PLOS ONE			English	Article							POLYCLONAL ANTITHYMOCYTE GLOBULINS; RHEUMATOID-ARTHRITIS PATIENTS; ACUTE CORONARY SYNDROMES; SEVERE APLASTIC-ANEMIA; DEPENDENT APOPTOSIS; PERIPHERAL-BLOOD; CD28 EXPRESSION; UNSTABLE ANGINA; LYMPHOCYTES; ATG	Background: Pro-inflammatory, cytotoxic CD4(+) CD28(-) T-cells with known defects in apoptosis have been investigated as markers of premature immuno-senescence in various immune-mediated diseases. In this study we evaluated the influence of polyclonal antilymphocyte globulins (ATG-Fresenius, ATG-F) on CD4(+)CD28(-) T-cells in vivo and in vitro. Principal Findings: Surface and intracellular three colour fluorescence activated cell sorting analyses of peripheral blood mononuclear cells from 16 consecutive transplant recipients and short-term cell lines were performed. In vivo, peripheral levels of CD3(+)CD4(+)CD28(-) T-cells decreased from 3.767.1% before to 060% six hours after ATG-F application (P = 0.043) in 5 ATG-F treated but not in 11 control patients (2.962.9% vs. 3.963.0%). In vitro, ATG-F induced apoptosis even in CD4(+)CD28(-) T-cells, which was 4.3-times higher than in CD4(+)CD28(+) T-cells. ATG-F evoked apoptosis was partially reversed by the broad-spectrum caspase inhibitor benzyloxycarbonyl (Cbz)-Val-Ala-Asp(OMe)-fluoromethylketone (zVAD-fmk) and prednisolon-21-hydrogensuccinate. ATG-F triggered CD25 expression and production of pro-inflammatory cytokines, and induced down-regulation of the type 1 chemokine receptors CXCR-3, CCR-5, CX3CR-1 and the central memory adhesion molecule CD62L predominately in CD4(+)CD28(-) T-cells. Conclusion: In summary, in vivo depletion of peripheral CD3(+)CD4(+)CD28(-) T-cells by ATG-F in transplant recipients was paralleled in vitro by ATG-F induced apoptosis. CD25 expression and chemokine receptor down-regulation in CD4(+)CD28(-) T-cells only partly explain the underlying mechanism.	[Duftner, Christina; Bijuklic, Klaudija; Joannidis, Michael; Schirmer, Michael] Innsbruck Med Univ, Dept Internal Med, Clin Internal Med 1, Innsbruck, Austria; [Dejaco, Christian] Med Univ Graz, Dept Rheumatol, Graz, Austria; [Duftner, Christina] Gen Hosp Kufstein, Dept Internal Med, Kufstein, Austria; [Hengster, Paul; Margreiter, Raimund] Innsbruck Med Univ, Dept Operat Med, Clin Visceral Transplant & Thorac Surg, Innsbruck, Austria	Medical University of Innsbruck; Medical University of Graz; Medical University of Innsbruck	Duftner, C (corresponding author), Innsbruck Med Univ, Dept Internal Med, Clin Internal Med 1, Innsbruck, Austria.	schirmer@live.at	Joannidis, Michael/AAZ-8790-2020; Schirmer, Michael/B-1893-2012	Schirmer, Michael/0000-0001-9208-7809; Dejaco, Christian/0000-0002-0173-0668	Innsbruck Medical University, Tyrolean Research Funds; Verein zur Forderung der wissenschaftlichen Ausbildung und Tatigkeit von Sudtirolern an der Universitat Innsbruck; Verein zur Forderung der Hamatologie, Onkologie und Immunologie, Innsbruck	Innsbruck Medical University, Tyrolean Research Funds; Verein zur Forderung der wissenschaftlichen Ausbildung und Tatigkeit von Sudtirolern an der Universitat Innsbruck; Verein zur Forderung der Hamatologie, Onkologie und Immunologie, Innsbruck	This study was supported by the Innsbruck Medical University, Tyrolean Research Funds (to C. Duftner), "Verein zur Forderung der wissenschaftlichen Ausbildung und Tatigkeit von Sudtirolern an der Universitat Innsbruck" (to C. Dejaco) as well as "Verein zur Forderung der Hamatologie, Onkologie und Immunologie, Innsbruck". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayuk FA, 2005, EXP HEMATOL, V33, P1531, DOI 10.1016/j.exphem.2005.08.004; Beiras-Fernandez A, 2004, TRANSPL IMMUNOL, V13, P9, DOI 10.1016/j.trim.2004.01.002; BonnefoyBerard N, 1996, J HEART LUNG TRANSPL, V15, P435; BONNEFOYBERARD N, 1991, TRANSPLANTATION, V51, P669, DOI 10.1097/00007890-199103000-00024; Brugaletta S, 2006, HEART, V92, P249, DOI 10.1136/hrt.2004.052282; Bryl E, 2005, ARTHRITIS RHEUM-US, V52, P2996, DOI 10.1002/art.21353; Dubey S, 2003, ANN HEMATOL, V82, P496, DOI 10.1007/s00277-003-0645-x; Duftner C, 2005, ARTERIOSCL THROM VAS, V25, P1347, DOI 10.1161/01.ATV.0000167520.41436.c0; Duftner C, 2003, ARTHRITIS RES THER, V5, pR292, DOI 10.1186/ar793; Feng XM, 2008, BLOOD, V111, P3675, DOI 10.1182/blood-2008-01-130146; Genestier L, 1998, BLOOD, V91, P2360, DOI 10.1182/blood.V91.7.2360.2360_2360_2368; Gerli R, 2004, CIRCULATION, V109, P2744, DOI 10.1161/01.CIR.0000131450.66017.B3; Goronzy JJ, 2004, ARTHRITIS RHEUM-US, V50, P43, DOI 10.1002/art.11445; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; Han DM, 2004, DIABETES, V53, P2281, DOI 10.2337/diabetes.53.9.2281; Joannidis M, 2004, CELL PHYSIOL BIOCHEM, V14, P101, DOI 10.1159/000076931; Lamprecht P, 2001, THORAX, V56, P751, DOI 10.1136/thorax.56.10.751; Liuzzo G, 2000, CIRCULATION, V101, P2883, DOI 10.1161/01.CIR.101.25.2883; Lowsky R, 2005, NEW ENGL J MED, V353, P1321, DOI 10.1056/NEJMoa050642; Markovic-Plese S, 2001, J CLIN INVEST, V108, P1185, DOI 10.1172/JCI12516; Marsh J, 1999, BLOOD, V93, P2191, DOI 10.1182/blood.V93.7.2191.407a03_2191_2195; Martens PB, 1997, ARTHRITIS RHEUM, V40, P1106, DOI 10.1002/art.1780400615; Mengel M, 2004, TRANSPL INT, V17, P293, DOI 10.1111/j.1432-2277.2004.tb00446.x; Michallet MC, 2003, TRANSPLANTATION, V75, P657, DOI 10.1097/01.TP.0000053198.99206.E6; Michallet MC, 2003, BLOOD, V102, P3719, DOI 10.1182/blood-2003-04-1075; Mohty M, 2007, LEUKEMIA, V21, P1387, DOI 10.1038/sj.leu.2404683; Moosig F, 1998, CLIN EXP IMMUNOL, V114, P113; MUELLER TF, 2003, CURR OPIN ORGAN TRAN, V8, P305; Nadareishvili ZG, 2004, NEUROLOGY, V63, P1446; Nakajima T, 2002, CIRCULATION, V105, P570, DOI 10.1161/hc0502.103348; Pawlik A, 2004, RHEUMATOL INT, V24, P351, DOI 10.1007/s00296-003-0374-4; Pawlik A, 2003, TRANSPL P, V35, P2902, DOI 10.1016/j.transproceed.2003.10.061; Pawlik Andrzej, 2003, Ann Transplant, V8, P54; Penack O, 2007, TRANSPL IMMUNOL, V18, P85, DOI 10.1016/j.trim.2007.05.001; RAEFSKY EL, 1986, BLOOD, V68, P712; REBELLATO LM, 1994, TRANSPLANTATION, V57, P685, DOI 10.1097/00007890-199403150-00010; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Rizzello V, 2006, CIRCULATION, V113, P2272, DOI 10.1161/CIRCULATIONAHA.105.588533; Schirmer M, 1998, J IMMUNOL, V161, P1018; Schmidt D, 1996, J CLIN INVEST, V97, P2027, DOI 10.1172/JCI118638; Studer SM, 2008, AM J RESP CRIT CARE, V178, P765, DOI 10.1164/rccm.200701-013OC; TARKOWSKI A, 1993, SCAND J RHEUMATOL, V22, P261, DOI 10.3109/03009749309095136; TARKOWSKI A, 1994, TRANSPLANT P, V26, P3197; Terasako K, 2010, HEMATOLOGY, V15, P165, DOI 10.1179/102453309X12583347113852; Vallejo AN, 2000, J IMMUNOL, V165, P6301, DOI 10.4049/jimmunol.165.11.6301; Vallejo AN, 1998, J BIOL CHEM, V273, P8119, DOI 10.1074/jbc.273.14.8119; Warrington KJ, 2005, ARTHRITIS RES THER, V7, pR984, DOI 10.1186/ar1775; Weimer R, 2005, TRANSPL INT, V18, P226, DOI 10.1111/j.1432-2277.2004.00047.x; Yen JH, 2001, J EXP MED, V193, P1159, DOI 10.1084/jem.193.10.1159; Zhang XY, 2005, ARTHRITIS RHEUM-US, V52, P3839, DOI 10.1002/art.21482	50	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33939	10.1371/journal.pone.0033939	http://dx.doi.org/10.1371/journal.pone.0033939			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479483	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100087
J	Koch, TM; Munster, S; Bonakdar, N; Butler, JP; Fabry, B				Koch, Thorsten M.; Muenster, Stefan; Bonakdar, Navid; Butler, James P.; Fabry, Ben			3D Traction Forces in Cancer Cell Invasion	PLOS ONE			English	Article							MATRIX INTERACTIONS; MIGRATION; MICROSCOPY; FIBROBLASTS; LOCOMOTION	Cell invasion through a dense three-dimensional (3D) matrix is believed to depend on the ability of cells to generate traction forces. To quantify the role of cell tractions during invasion in 3D, we present a technique to measure the elastic strain energy stored in the matrix due to traction-induced deformations. The matrix deformations around a cell were measured by tracking the 3D positions of fluorescent beads tightly embedded in the matrix. The bead positions served as nodes for a finite element tessellation. From the strain in each element and the known matrix elasticity, we computed the local strain energy in the matrix surrounding the cell. We applied the technique to measure the strain energy of highly invasive MDA-MB-231 breast carcinoma and A-125 lung carcinoma cells in collagen gels. The results were compared to the strain energy generated by non-invasive MCF-7 breast and A-549 lung carcinoma cells. In all cases, cells locally contracted the matrix. Invasive breast and lung carcinoma cells showed a significantly higher contractility compared to non-invasive cells. Higher contractility, however, was not universally associated with higher invasiveness. For instance, non-invasive A-431 vulva carcinoma cells were the most contractile cells among all cell lines tested. As a universal feature, however, we found that invasive cells assumed an elongated spindle-like morphology as opposed to a more spherical shape of non-invasive cells. Accordingly, the distribution of strain energy density around invasive cells followed patterns of increased complexity and anisotropy. These results suggest that not so much the magnitude of traction generation but their directionality is important for cancer cell invasion.	[Koch, Thorsten M.; Muenster, Stefan; Bonakdar, Navid; Fabry, Ben] Univ Erlangen Nurnberg, Dept Phys, D-91054 Erlangen, Germany; [Butler, James P.] Harvard Univ, Sch Publ Hlth, Mol Integrat Physiol Sci Program, Boston, MA 02115 USA; [Butler, James P.] Harvard Univ, Sch Med, Dept Med, Div Sleep Med, Boston, MA USA; [Butler, James P.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of Erlangen Nuremberg; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Koch, TM (corresponding author), Univ Erlangen Nurnberg, Dept Phys, D-91054 Erlangen, Germany.	tkoch@biomed.uni-erlangen.de	Fabry, Ben/C-5496-2013; Fabry, Ben/AAT-5717-2020	Fabry, Ben/0000-0003-1737-0465; Fabry, Ben/0000-0003-1737-0465; Munster, Stefan/0000-0002-8697-0344	Deutsche Forschungsgemeinschaft (DFG) [FA336/2-1]; National Institutes of Health - Bioengineering Research Partnerships NIH-BRP [HL65960]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065960] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Institutes of Health - Bioengineering Research Partnerships NIH-BRP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by the following: Deutsche Forschungsgemeinschaft (DFG): FA336/2-1; National Institutes of Health - Bioengineering Research Partnerships NIH-BRP: HL65960. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; del Alamo JC, 2007, P NATL ACAD SCI USA, V104, P13343, DOI 10.1073/pnas.0705815104; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Fraley SI, 2010, NAT CELL BIOL; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Maskarinec SA, 2009, P NATL ACAD SCI USA, V106, P22108, DOI 10.1073/pnas.0904565106; Merkel R, 2007, BIOPHYS J, V93, P3314, DOI 10.1529/biophysj.107.111328; Mickel W, 2008, BIOPHYS J, V95, P6072, DOI 10.1529/biophysj.108.135939; Mierke CT, 2008, BIOPHYS J, V94, P2832, DOI 10.1529/biophysj.107.113613; Petroll WM, 2003, CELL MOTIL CYTOSKEL, V55, P254, DOI 10.1002/cm.10126; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217; SCHMIDT CE, 1993, J CELL BIOL, V123, P977, DOI 10.1083/jcb.123.4.977; Sun Y, 2004, MICROSC RES TECHNIQ, V65, P139, DOI 10.1002/jemt.20118; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	24	210	216	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33476	10.1371/journal.pone.0033476	http://dx.doi.org/10.1371/journal.pone.0033476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479403	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100051
J	Lu, HK; Mitchell, A; Endoh, Y; Hampartzoumian, T; Huynh, O; Borges, L; Geczy, C; Bryant, K; Tedla, N				Lu, Hao K.; Mitchell, Ainslie; Endoh, Yasumi; Hampartzoumian, Taline; Huynh, Owen; Borges, Luis; Geczy, Carolyn; Bryant, Katherine; Tedla, Nicodemus			LILRA2 Selectively Modulates LPS-Mediated Cytokine Production and Inhibits Phagocytosis by Monocytes	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; CLASS-I MOLECULES; TUMOR NECROSIS FACTOR; FC-GAMMA-RII; DENDRITIC CELLS; RHEUMATOID-ARTHRITIS; CROSS-LINKING; MYELOID CELLS; ACTIVATION; EXPRESSION	The activating immunoglobulin-like receptor, subfamily A, member 2 (LILRA2) is primarily expressed on the surface of cells of the innate immunity including monocytes, macrophages, neutrophils, basophils and eosinophils but not on lymphocytes and NK cells. LILRA2 cross-linking on monocytes induces pro-inflammatory cytokines while inhibiting dendritic cell differentiation and antigen presentation. A similar activating receptor, LILRA4, has been shown to modulate functions of TLR7/9 in dendritic cells. These suggest a selective immune regulatory role for LILRAs during innate immune responses. However, whether LILRA2 has functions distinct from other receptors of the innate immunity including Toll-like receptor (TLR) 4 and Fc gamma RI remains unknown. Moreover, the effects of LILRA2 on TLR4 and Fc gamma RI-mediated monocyte functions are not elucidated. Here, we show activation of monocytes via LILRA2 cross-linking selectively increased GM-CSF production but failed to induce IL-12 and MCP-1 production that were strongly up-regulated by LPS, suggesting functions distinct from TLR4. Interestingly, LILRA2 cross-linking on monocytes induced similar amounts of IL-6, IL-8, G-CSF and MIP-1 alpha but lower levels of TNF alpha, IL-1 beta, IL-10 and IFN gamma compared to those stimulated with LPS. Furthermore, cross-linking of LILRA2 on monocytes significantly decreased phagocytosis of IgG-coated micro-beads and serum opsonized Escherichia coli but had limited effect on phagocytosis of non-opsonized bacteria. Simultaneous co-stimulation of monocytes through LILRA2 and LPS or sequential activation of monocytes through LILRA2 followed by LPS led lower levels of TNF alpha, IL-1 beta and IL-12 production compared to LPS alone, but had additive effect on levels of IL-10 and IFN gamma but not on IL-6. Interestingly, LILRA2 cross-linking on monocytes caused significant inhibition of TLR4 mRNA and protein, suggesting LILRA2-mediated suppression of LPS responses might be partly via regulation of this receptor. Taken together, we provide evidence that LILRA2-mediated activation of monocytes is significantly different to LPS and that LILRA2 selectively modulates LPS-mediated monocyte activation and Fc gamma RI-dependent phagocytosis.	[Lu, Hao K.; Mitchell, Ainslie; Endoh, Yasumi; Hampartzoumian, Taline; Huynh, Owen; Geczy, Carolyn; Bryant, Katherine; Tedla, Nicodemus] Univ New S Wales, Dept Pathol, Sch Med Sci, Inflammat & Infect Res Ctr, Kensington, NSW, Australia; [Bryant, Katherine] Liverpool Hosp, S Western Sydney Clin Sch, Sydney, NSW, Australia; [Borges, Luis] Amgen Seattle, Seattle, WA USA	University of New South Wales Sydney; Liverpool Hospital	Lu, HK (corresponding author), Univ New S Wales, Dept Pathol, Sch Med Sci, Inflammat & Infect Res Ctr, Kensington, NSW, Australia.	N.Tedla@unsw.edu.au	Bryant, Katherine/E-8574-2010	Bryant, Katherine/0000-0002-8686-623X; Lu, Hao/0000-0002-3940-3283	National Health and Medical Research Council of Australia project [568711]	National Health and Medical Research Council of Australia project(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia project grants number 568711. Luis Borges from Amgen has supplied us with anti-LILRA2 mAb and provided some intellectual input during writing of the manuscript. NHMRC had no role in the study design, data collection and analysis, decision to publish or preparation of manuscript.	An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Billadeau DD, 2002, J CLIN INVEST, V109, P161, DOI 10.1172/JCI14843; Blank U, 2009, IMMUNOL REV, V232, P59, DOI 10.1111/j.1600-065X.2009.00832.x; Bleharski JR, 2003, SCIENCE, V301, P1527, DOI 10.1126/science.1087785; Borges L, 1997, J IMMUNOL, V159, P5192; Borges L, 2000, CYTOKINE GROWTH F R, V11, P209, DOI 10.1016/S1359-6101(00)00007-1; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Conti L, 2008, EUR J IMMUNOL, V38, P750, DOI 10.1002/eji.200737395; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEBETS JMH, 1988, J IMMUNOL, V141, P1197; DEBETS JMH, 1990, J IMMUNOL, V144, P1304; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Endoh Y, 2009, J IMMUNOL, V182, P2258, DOI 10.4049/jimmunol.0802683; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Feng GJ, 1999, J IMMUNOL, V163, P6403; Fitzgerald KA, 2004, MICROBES INFECT, V6, P1361, DOI 10.1016/j.micinf.2004.08.015; GRAZIANO RF, 1987, J IMMUNOL, V139, P3536; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Hornell TMC, 2003, J IMMUNOL, V171, P2374, DOI 10.4049/jimmunol.171.5.2374; Huang JH, 2010, J VIROL, V84, P9463, DOI 10.1128/JVI.01009-10; Huynh OA, 2007, RHEUMATOLOGY, V46, P742, DOI 10.1093/rheumatology/kel405; Ibeagha-Awemu EM, 2008, VET RES, V39, DOI 10.1051/vetres:2007047; Lee DJ, 2007, J IMMUNOL, V179, P8128, DOI 10.4049/jimmunol.179.12.8128; Lu HK, 2009, J BIOL CHEM, V284, P34839, DOI 10.1074/jbc.M109.035683; Mitchell A, 2008, EUR J IMMUNOL, V38, P3459, DOI 10.1002/eji.200838415; Nakajima H, 1999, J IMMUNOL, V162, P5; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; PELTZ G, 1988, MOL IMMUNOL, V25, P243, DOI 10.1016/0161-5890(88)90015-6; POJDA Z, 1994, LANCET, V343, P1100, DOI 10.1016/S0140-6736(94)90211-9; SIELING PA, 1994, J IMMUNOL, V153, P3639; Sloane DE, 2004, BLOOD, V104, P2832, DOI 10.1182/blood-2004-01-0268; STEVENS P, 1983, IMMUNOLOGY, V50, P497; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tedla N, 2003, P NATL ACAD SCI USA, V100, P1174, DOI 10.1073/pnas.0337567100; Tedla N, 2002, AM J PATHOL, V160, P425, DOI 10.1016/S0002-9440(10)64861-4; Tedla N, 2008, J LEUKOCYTE BIOL, V83, P334, DOI 10.1189/jlb.0507314; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Wang L, 2010, IMMUNITY, V32, P518, DOI 10.1016/j.immuni.2010.03.014; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	45	20	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33478	10.1371/journal.pone.0033478	http://dx.doi.org/10.1371/journal.pone.0033478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479404	Green Published, gold			2022-12-27	WOS:000305339100052
J	Marchal, J; Blanc, S; Epelbaum, J; Aujard, F; Pifferi, F				Marchal, Julia; Blanc, Stephane; Epelbaum, Jacques; Aujard, Fabienne; Pifferi, Fabien			Effects of Chronic Calorie Restriction or Dietary Resveratrol Supplementation on Insulin Sensitivity Markers in a Primate, Microcebus murinus	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; RESTING METABOLIC-RATE; GRAPE SEED EXTRACT; HIGH-FAT DIET; RHESUS-MONKEYS; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; OXIDATIVE STRESS; NONHUMAN PRIMATE; BODY-WEIGHT	The prevalence of diabetes and hyperinsulinemia increases with age, inducing metabolic failure and limiting lifespan. Calorie restriction (CR) without malnutrition delays the aging process, but its long-term application to humans seems difficult. Resveratrol (RSV), a dietary polyphenol, appears to be a promising CR mimetic that can be easily administered in humans. In this work, we hypothesized that both CR and RSV impact insulin sensitivity in a non-human primate compared to standard-fed control (CTL) animals. Four-to five-year-old male grey mouse lemurs (Microcebus murinus) were assigned to three dietary groups: a CTL group, a CR group receiving 30% fewer calories than the CTL and a RSV group receiving the CTL diet supplemented with RSV (200 mg.day(-1).kg(-1)). Insulin sensitivity and glycemia were assessed using an oral glucose tolerance test (OGTT) and the homeostasis model assessment of insulin resistance (HOMA-IR index) evaluation after 21 or 33 months of chronic treatment. Resting metabolic rate was also measured to assess the potential relationships between this energy expenditure parameter and insulin sensitivity markers. No differences were found after a 21-month period of treatment, except for lower glucose levels 30 min after glucose loading in CR animals. After 33 months, CR and RSV decreased glycemia after the oral glucose loading without decreasing fasting blood insulin. A general effect of treatment was observed on the HOMA-IR index, with an 81% reduction in CR animals and 53% in RSV animals after 33 months of treatment compared to CTL. Chronic CR and dietary supplementation with RSV affected insulin sensitivity by improving the glucose tolerance of animals without disturbing their baseline insulin secretion. These results suggest that both CR and RSV have beneficial effects on metabolic alterations, although these effects are different in amplitude between the two anti-aging treatments and potentially rely on different metabolic changes.	[Marchal, Julia; Aujard, Fabienne; Pifferi, Fabien] Museum Natl Hist Nat, UMR Ctr Natl Rech Sci 7179, Brunoy, France; [Blanc, Stephane] Univ Strasbourg, Dept Ecol, Ethol UMR CNRS 7178, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Epelbaum, Jacques] Univ Paris 05, Fac Med, Ctr Psychiat & Neurosci, UMR Inserm 894, Paris, France	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Marchal, J (corresponding author), Museum Natl Hist Nat, UMR Ctr Natl Rech Sci 7179, Brunoy, France.	aujard@mnhn.fr	Epelbaum, Jacques/B-2263-2013	Pifferi, Fabien/0000-0001-9316-1935	French National Research Agency [ANR-06-PNRA-010-01]; Foundation for French Medical Research	French National Research Agency(French National Research Agency (ANR)); Foundation for French Medical Research	This study was conducted with the financial support of the French National Research Agency (project ANR-06-PNRA-010-01) and the Foundation for French Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2010, TRENDS ENDOCRIN MET, V21, P134, DOI 10.1016/j.tem.2009.11.005; Anderson SR, 2008, METABOLISM, V57, P347, DOI 10.1016/j.metabol.2007.10.009; Aubin MC, 2008, J PHARMACOL EXP THER, V325, P961, DOI 10.1124/jpet.107.135061; Aujard F, 1998, J COMP PHYSIOL B, V168, P540, DOI 10.1007/s003600050175; Barrett K, 2006, MOL CELL BIOCHEM, V293, P9, DOI 10.1007/s11010-006-0387-x; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2010, MECH AGEING DEV, V131, P261, DOI 10.1016/j.mad.2010.02.007; Blanc SP, 2003, J CLIN ENDOCR METAB, V88, P3454, DOI 10.1210/jc.2003-030547; BODKIN NL, 1995, J GERONTOL A-BIOL, V50, pB142, DOI 10.1093/gerona/50A.3.B142; CARTEE GD, 1994, AM J PHYSIOL, V266, pR1443, DOI 10.1152/ajpregu.1994.266.5.R1443; CEFALU WT, 1995, J GERONTOL A-BIOL, V50, pB337, DOI 10.1093/gerona/50A.6.B337; Chen WP, 2007, EUR J PHARMACOL, V568, P269, DOI 10.1016/j.ejphar.2007.04.062; Chi TC, 2007, LIFE SCI, V80, P1713, DOI 10.1016/j.lfs.2007.02.002; CLORE JN, 1992, J CLIN ENDOCR METAB, V74, P660, DOI 10.1210/jc.74.3.660; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cox LS, 2009, AGING CELL, V8, P607, DOI 10.1111/j.1474-9726.2009.00509.x; Dal-Pan A, 2011, AGE, V33, P15, DOI 10.1007/s11357-010-9156-6; Dal-Pan A, 2009, COMP BIOCHEM PHYS A, V153A, pS147, DOI 10.1016/j.cbpa.2009.04.282; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Fujimoto S, 2010, LIFE SCI, V87, P679, DOI 10.1016/j.lfs.2010.10.001; FUKUDA M, 1989, DIABETES RES CLIN PR, V7, P61, DOI 10.1016/0168-8227(89)90047-8; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P2482; HOLLENBECK C, 1987, J CLIN ENDOCR METAB, V64, P1169, DOI 10.1210/jcem-64-6-1169; Ingram DK, 2006, BIOGERONTOLOGY, V7, P143, DOI 10.1007/s10522-006-9013-2; Jacobson P, 2006, AM J CLIN NUTR, V84, P1527, DOI 10.1093/ajcn/84.6.1527; Kar P, 2009, DIABETIC MED, V26, P526, DOI 10.1111/j.1464-5491.2009.02727.x; KEMNITZ JW, 1994, AM J PHYSIOL, V266, pE540, DOI 10.1152/ajpendo.1994.266.4.E540; Keskin M, 2005, PEDIATRICS, V115, pE500, DOI 10.1542/peds.2004-1921; Kirk E, 2009, GASTROENTEROLOGY, V136, P1552, DOI 10.1053/j.gastro.2009.01.048; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lane MA, 1999, TOXICOL SCI, V52, P41, DOI 10.1093/toxsci/52.suppl_1.41; LANE MA, 1995, AM J PHYSIOL-ENDOC M, V268, pE941, DOI 10.1152/ajpendo.1995.268.5.E941; Languille S, 2012, AGEING RES REV, V11, P150, DOI 10.1016/j.arr.2011.07.001; Llado I, 1999, J NUTR BIOCHEM, V10, P609, DOI 10.1016/S0955-2863(99)00050-9; Masoro EJ, 2000, HUM ECOL RISK ASSESS, V6, P273, DOI 10.1080/10807030009380062; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mattson MP, 2008, AGEING RES REV, V7, P43, DOI 10.1016/j.arr.2007.08.004; Motero-Conejo E, 2003, ARCH LATINOAM NUTR, V53, P39; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pi-Sunyer FX, 2007, NUTR REV, V65, P101, DOI [10.1301/nr.2007.mar.101-110, 10.1111/j.1753-4887.2007.tb00287.x]; Piper MDW, 2008, CELL METAB, V8, P99, DOI 10.1016/j.cmet.2008.06.012; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; REAVEN E, 1983, DIABETES, V32, P175, DOI 10.2337/diabetes.32.2.175; Reaven G, 2006, AM J CLIN NUTR, V84, P1252, DOI 10.1093/ajcn/84.5.1252; REAVEN GM, 1991, AM HEART J, V121, P1283, DOI 10.1016/0002-8703(91)90434-J; ROWE JW, 1983, J CLIN INVEST, V71, P1581, DOI 10.1172/JCI110914; Schindler TH, 2006, J AM COLL CARDIOL, V47, P1188, DOI 10.1016/j.jacc.2005.10.062; Stuart JA, 2010, MECH AGEING DEV, V131, P591, DOI 10.1016/j.mad.2010.08.005; Suwannaphet W, 2010, FOOD CHEM TOXICOL, V48, P1853, DOI 10.1016/j.fct.2010.04.021; Szkudelski T, 2008, LIFE SCI, V82, P430, DOI 10.1016/j.lfs.2007.12.008; Szkudelski T, 2006, EUR J PHARMACOL, V552, P176, DOI 10.1016/j.ejphar.2006.09.046; Thompson WG, 2006, DIABETES RES CLIN PR, V74, P129, DOI 10.1016/j.diabres.2006.03.017; Walder K, 1998, METABOLISM, V47, P125, DOI 10.1016/S0026-0495(98)90206-2; Weatherall FRS D, 2006, USE NONHUMAN PRIMATE; Weindruch R, 2003, CLIN NEUROSCI RES, V2, P279, DOI 10.1016/S1566-2772(03)00004-5; Weiss R, 2004, DIABETES, V53, pA419; WING RR, 1994, AM J MED, V97, P354, DOI 10.1016/0002-9343(94)90302-6	57	60	60	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34289	10.1371/journal.pone.0034289	http://dx.doi.org/10.1371/journal.pone.0034289			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479589	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100144
J	Potts, JR; Harris, S; Giuggioli, L				Potts, Jonathan R.; Harris, Stephen; Giuggioli, Luca			Territorial Dynamics and Stable Home Range Formation for Central Place Foragers	PLOS ONE			English	Article							DIFFUSION; VULPES	Uncovering the mechanisms behind territory formation is a fundamental problem in behavioural ecology. The broad nature of the underlying conspecific avoidance processes are well documented across a wide range of taxa. Scent marking in particular is common to a large range of terrestrial mammals and is known to be fundamental for communication. However, despite its importance, exact quantification of the time-scales over which scent cues and messages persist remains elusive. Recent work by the present authors has begun to shed light on this problem by modelling animals as random walkers with scent-mediated interaction processes. Territories emerge as dynamic objects that continually change shape and slowly move without settling to a fixed location. As a consequence, the utilisation distribution of such an animal results in a slowly increasing home range, as shown for urban foxes (Vulpes vulpes). For certain other species, however, home ranges reach a stable state. The present work shows that stable home ranges arise when, in addition to scent-mediated conspecific avoidance, each animal moves as a central place forager. That is, the animal's movement has a random aspect but is also biased towards a fixed location, such as a den or nest site. Dynamic territories emerge but the probability distribution of the territory border locations reaches a steady state, causing stable home ranges to emerge from the territorial dynamics. Approximate analytic expressions for the animal's probability density function are derived. A programme is given for using these expressions to quantify both the strength of the animal's movement bias towards the central place and the time-scale over which scent messages persist. Comparisons are made with previous theoretical work modelling central place foragers with conspecific avoidance. Some insights into the mechanisms behind allometric scaling laws of animal space use are also given.	[Potts, Jonathan R.; Giuggioli, Luca] Univ Bristol, Bristol Ctr Complex Sci, Bristol, Avon, England; [Potts, Jonathan R.; Harris, Stephen; Giuggioli, Luca] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Giuggioli, Luca] Univ Bristol, Dept Engn Math, Bristol, Avon, England	University of Bristol; University of Bristol; University of Bristol	Potts, JR (corresponding author), Univ Bristol, Bristol Ctr Complex Sci, Bristol, Avon, England.	jonathan.potts.08@bristol.ac.uk	Giuggioli, Luca/J-2881-2012	Potts, Jonathan/0000-0002-8564-2904; Giuggioli, Luca/0000-0002-2325-4682	EPSRC [EP/E501214/1]; Dulverton Trust	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Dulverton Trust	This work was partially supported by the EPSRC grant number EP/E501214/1 http://www.epsrc.ac.uk (LG and JRP) and the Dulverton Trust http://www.dulverton.org/ (SH). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams ES, 2001, ANNU REV ECOL SYST, V32, P277, DOI 10.1146/annurev.ecolsys.32.081501.114034; BARLOW GW, 1974, ANIM BEHAV, V22, P876, DOI 10.1016/0003-3472(74)90010-4; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; Briscoe BK, 2002, B MATH BIOL, V64, P261, DOI 10.1006/bulm.2001.0273; Brown J.L., 1970, ANNU REV ECOL SYST, V1, P239; DURRETT R, 1994, THEOR POPUL BIOL, V46, P363, DOI 10.1006/tpbi.1994.1032; Foerster CR, 2002, BIOTROPICA, V34, P423, DOI 10.1111/j.1744-7429.2002.tb00556.x; Frank T, 1996, FOKKER PLANCK EQUATI; Gautestad AO, 2005, AM NAT, V165, P44, DOI 10.1086/426673; Giuggioli L, 2005, B MATH BIOL, V67, P1135, DOI 10.1016/j.bulm.2005.01.003; Giuggioli L, 2012, J R SOC INTERFACE, V9, P1529, DOI 10.1098/rsif.2011.0797; Giuggioli L, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061138; Giuggioli L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002008; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Harris T. E., 1965, J APPL PROBAB, V2, P323, DOI [DOI 10.2307/3212197, 10.2307/3212197]; Holgate P., 1971, SAMPLING MODELING BI, V2, P1; Hurst Jane L., 2006, P219; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kac M, 1947, AM MATH MONTHLY, V54; KANG K, 1985, PHYS REV A, V32, P435, DOI 10.1103/PhysRevA.32.435; Kenkre VM, 2007, EUR PHYS J B, V55, P461, DOI 10.1140/epjb/e2007-00074-x; LANDIM C, 1992, ANN PROBAB, V20, P206, DOI 10.1214/aop/1176989925; LEWIS MA, 1993, NATURE, V366, P738, DOI 10.1038/366738a0; Maude G., 2010, THESIS U BRISTOL; McKane AJ, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041902; Montroll E. W., 1987, Fluctuation phenomena, P61; Moon P, 1969, PARTIAL DIFFERENTIAL; Moorcroft P.R., 2006, MECHANISTIC HOME RAN; Moorcroft PR, 2006, P ROY SOC B, V273; Okubo A., 2002, DIFFUSION ECOLOGICAL; Potts JR, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/48/485003; Soulsbury CD, 2011, J MAMMAL, V92, P190, DOI 10.1644/09-MAMM-A-187.1; SPENCER SR, 1990, ECOLOGY, V71, P1817, DOI 10.2307/1937590; van Kampen N. G., 1981, STOCHASTIC PROCESSES; Van Moorter B, 2009, OIKOS, V118, P641, DOI 10.1111/j.1600-0706.2008.17003.x; WHITE PCL, 1994, J ANIM ECOL, V63, P315, DOI 10.2307/5550	36	30	30	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34033	10.1371/journal.pone.0034033	http://dx.doi.org/10.1371/journal.pone.0034033			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479510	Green Submitted, Green Published, gold			2022-12-27	WOS:000305339100101
J	Sawyer, S; Krause, J; Guschanski, K; Savolainen, V; Paabo, S				Sawyer, Susanna; Krause, Johannes; Guschanski, Katerina; Savolainen, Vincent; Paeaebo, Svante			Temporal Patterns of Nucleotide Misincorporations and DNA Fragmentation in Ancient DNA	PLOS ONE			English	Article							NEANDERTHAL; SEQUENCE; EXTRACTION	DNA that survives in museum specimens, bones and other tissues recovered by archaeologists is invariably fragmented and chemically modified. The extent to which such modifications accumulate over time is largely unknown but could potentially be used to differentiate between endogenous old DNA and present-day DNA contaminating specimens and experiments. Here we examine mitochondrial DNA sequences from tissue remains that vary in age between 18 and 60,000 years with respect to three molecular features: fragment length, base composition at strand breaks, and apparent C to T substitutions. We find that fragment length does not decrease consistently over time and that strand breaks occur preferentially before purine residues by what may be at least two different molecular mechanisms that are not yet understood. In contrast, the frequency of apparent C to T substitutions towards the 5'-ends of molecules tends to increase over time. These nucleotide misincorporations are thus a useful tool to distinguish recent from ancient DNA sources in specimens that have not been subjected to unusual or harsh treatments.	[Sawyer, Susanna; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Krause, Johannes] Univ Tubingen, Inst Archaeol Sci, Tubingen, Germany; [Guschanski, Katerina] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Savolainen, Vincent] Univ London Imperial Coll Sci Technol & Med, Ascot, Berks, England	Max Planck Society; Eberhard Karls University of Tubingen; University of Lausanne; Imperial College London	Sawyer, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	susanna_sawyer@eva.mpg.de	Krause, Johannes/AFP-2642-2022; Krause, Johannes/E-6640-2015	Krause, Johannes/0000-0001-9144-3920; Krause, Johannes/0000-0001-5475-4690; Savolainen, Vincent/0000-0001-5350-9984; Sawyer, Susanna/0000-0002-8477-6089; Guschanski, Katerina/0000-0002-8493-5457	Max Planck Society; European Research Council; Royal Society; Natural Environment Research Council	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by the Max Planck Society, the European Research Council, Royal Society, and the Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Brotherton P, 2007, NUCLEIC ACIDS RES, V35, P5717, DOI 10.1093/nar/gkm588; Caramelli D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002700; Ermini L, 2008, CURR BIOL, V18, P1687, DOI 10.1016/j.cub.2008.09.028; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fortea J, 2008, J HUM EVOL, V55, P353, DOI 10.1016/j.jhevol.2008.03.005; Garcia-Garcera M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024161; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Hoss M, 1996, P NATL ACAD SCI USA, V93, P181, DOI 10.1073/pnas.93.1.181; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Malmstrom H, 2005, MOL BIOL EVOL, V22, P2040, DOI 10.1093/molbev/msi195; Maricic T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014004; Meyer M, 2010, COLD SPRING HARB PRO, V2010, DOI DOI 10.1101/PDB.PROT5448; Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Serre D, 2004, PLOS BIOL, V2, P313, DOI 10.1371/journal.pbio.0020057; Team RDC, 2010, R LANG ENV STAT COMP	26	278	283	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34131	10.1371/journal.pone.0034131	http://dx.doi.org/10.1371/journal.pone.0034131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479540	Green Published, gold			2022-12-27	WOS:000305339100120
J	Song, B; Niu, SL; Zhang, Z; Yang, HJ; Li, LH; Wan, SQ				Song, Bing; Niu, Shuli; Zhang, Zhe; Yang, Haijun; Li, Linghao; Wan, Shiqiang			Light and Heavy Fractions of Soil Organic Matter in Response to Climate Warming and Increased Precipitation in a Temperate Steppe	PLOS ONE			English	Article							DOUBLED PRECIPITATION; EXTRACTION METHOD; CARBON; ECOSYSTEM; WATER; DECOMPOSITION; TURNOVER; NITROGEN; CO2; RESPIRATION	Soil is one of the most important carbon (C) and nitrogen (N) pools and plays a crucial role in ecosystem C and N cycling. Climate change profoundly affects soil C and N storage via changing C and N inputs and outputs. However, the influences of climate warming and changing precipitation regime on labile and recalcitrant fractions of soil organic C and N remain unclear. Here, we investigated soil labile and recalcitrant C and N under 6 years' treatments of experimental warming and increased precipitation in a temperate steppe in Northern China. We measured soil light fraction C (LFC) and N (LFN), microbial biomass C (MBC) and N (MBN), dissolved organic C (DOC) and heavy fraction C (HFC) and N (HFN). The results showed that increased precipitation significantly stimulated soil LFC and LFN by 16.1% and 18.5%, respectively, and increased LFC: HFC ratio and LFN: HFN ratio, suggesting that increased precipitation transferred more soil organic carbon into the quick-decayed carbon pool. Experimental warming reduced soil labile C (LFC, MBC, and DOC). In contrast, soil heavy fraction C and N, and total C and N were not significantly impacted by increased precipitation or warming. Soil labile C significantly correlated with gross ecosystem productivity, ecosystem respiration and soil respiration, but not with soil moisture and temperature, suggesting that biotic processes rather than abiotic factors determine variations in soil labile C. Our results indicate that certain soil carbon fraction is sensitive to climate change in the temperate steppe, which may in turn impact ecosystem carbon fluxes in response and feedback to climate change.	[Song, Bing; Niu, Shuli; Zhang, Zhe; Yang, Haijun; Li, Linghao] Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China; [Song, Bing; Zhang, Zhe; Yang, Haijun] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Wan, Shiqiang] Henan Univ, Coll Life Sci, Key Lab Plant Stress Biol, Kaifeng, Henan, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Henan University	Song, B (corresponding author), Chinese Acad Sci, State Key Lab Vegetat & Environm Change, Inst Bot, Beijing, Peoples R China.	niushuli@ibcas.ac.cn	Wan, Shiqiang/L-9166-2019; Wan, Shiqiang/B-5799-2009; Yang, Haijun/E-7186-2012	Wan, Shiqiang/0000-0003-0631-1232; Wan, Shiqiang/0000-0003-0631-1232; Yang, Haijun/0000-0002-9596-4907; Niu, Shuli/0000-0002-2394-2864	Institute of Botany, Chinese Academy of Sciences	Institute of Botany, Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was conducted as part of a comprehensive research project (Global Change Multifactor Experiment - Duolun) sponsored by Institute of Botany, Chinese Academy of Sciences. The authors thank Naili Zhang, Changhui Wang, Weixing Liu and Wendong Zhang for their help in instrument support and laboratory analysis. We thank the staff of Duolun Restoration Ecology Experimentation and Demonstration Station.	Aanderud ZT, 2010, ECOSYSTEMS, V13, P673, DOI 10.1007/s10021-010-9346-1; Bai WM, 2010, GLOBAL CHANGE BIOL, V16, P1306, DOI 10.1111/j.1365-2486.2009.02019.x; Belay-Tedla A, 2009, SOIL BIOL BIOCHEM, V41, P110, DOI 10.1016/j.soilbio.2008.10.003; Bell C, 2008, MICROB ECOL, V56, P153, DOI 10.1007/s00248-007-9333-z; Biasi C, 2005, RAPID COMMUN MASS SP, V19, P1401, DOI 10.1002/rcm.1911; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Crow SE, 2007, BIOGEOCHEMISTRY, V85, P69, DOI 10.1007/s10533-007-9100-8; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dore MHI, 2005, ENVIRON INT, V31, P1167, DOI 10.1016/j.envint.2005.03.004; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Froberg M, 2008, BIOGEOCHEMISTRY, V89, P151, DOI 10.1007/s10533-008-9205-8; Giardina CP, 2000, NATURE, V404, P858, DOI 10.1038/35009076; Goidts E, 2007, GEODERMA, V141, P341, DOI 10.1016/j.geoderma.2007.06.013; Gregorich E.G., 2020, STRUCTURE ORGANIC MA, P167; GREGORICH EG, 1994, CAN J SOIL SCI, V74, P367, DOI 10.4141/cjss94-051; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Lal R, 2004, GEODERMA, V123, P1, DOI 10.1016/j.geoderma.2004.01.032; Landesman WJ, 2010, SOIL BIOL BIOCHEM, V42, P1751, DOI 10.1016/j.soilbio.2010.06.012; Liski J, 1999, AMBIO, V28, P171; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Luo YQ, 2009, GCB BIOENERGY, V1, P62, DOI 10.1111/j.1757-1707.2008.01005.x; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Niu SL, 2008, NEW PHYTOL, V177, P209, DOI 10.1111/j.1469-8137.2007.02237.x; Niu SL, 2011, GLOBAL CHANGE BIOL, V17, P1073, DOI 10.1111/j.1365-2486.2010.02280.x; Norton U, 2008, SOIL BIOL BIOCHEM, V40, P1421, DOI 10.1016/j.soilbio.2007.12.021; OCIO JA, 1990, SOIL BIOL BIOCHEM, V22, P999, DOI 10.1016/0038-0717(90)90144-O; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Schlesinger WH., 1997, BIOGEOCHEMISTRY; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Sherry RA, 2008, GLOBAL CHANGE BIOL, V14, P2923, DOI 10.1111/j.1365-2486.2008.01703.x; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; SKOPP J, 1990, SOIL SCI SOC AM J, V54, P1619, DOI 10.2136/sssaj1990.03615995005400060018x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SPARLING GP, 1992, AUST J SOIL RES, V30, P195, DOI 10.1071/SR9920195; Sponseller RA, 2007, GLOBAL CHANGE BIOL, V13, P426, DOI 10.1111/j.1365-2486.2006.01307.x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; von Lutzow M, 2007, SOIL BIOL BIOCHEM, V39, P2183, DOI 10.1016/j.soilbio.2007.03.007; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Xu ZF, 2010, PLANT SOIL, V336, P183, DOI 10.1007/s11104-010-0461-8; Yan LM, 2011, GLOBAL CHANGE BIOL, V17, P1990, DOI 10.1111/j.1365-2486.2010.02365.x; Zhou G, 2002, J VEG SCI, V13, P361, DOI 10.1111/j.1654-1103.2002.tb02060.x; Zhou XH, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002526; Zhou XH, 2009, ECOSYSTEMS, V12, P1369, DOI 10.1007/s10021-009-9296-7	48	69	77	26	215	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33217	10.1371/journal.pone.0033217	http://dx.doi.org/10.1371/journal.pone.0033217			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479373	gold, Green Published, Green Submitted			2022-12-27	WOS:000305339100038
J	Zhao, LX; Huang, YL; Tian, CH; Taylor, L; Curthoys, N; Wang, Y; Vernon, H; Zheng, JL				Zhao, Lixia; Huang, Yunlong; Tian, Changhai; Taylor, Lynn; Curthoys, Norman; Wang, Yi; Vernon, Hamilton; Zheng, Jialin			Interferon-alpha Regulates Glutaminase 1 Promoter through STAT1 Phosphorylation: Relevance to HIV-1 Associated Neurocognitive Disorders	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS-FACTOR-ALPHA; MITOCHONDRIAL GLUTAMINASE; HIV-1-INFECTED MACROPHAGES; TYROSINE PHOSPHORYLATION; EXTRACELLULAR GLUTAMATE; MESSENGER-RNA; IFN-ALPHA; GENE; NEUROTOXICITY	HIV-1 associated neurocognitive disorders (HAND) develop during progressive HIV-1 infection and affect up to 50% of infected individuals. Activated microglia and macrophages are critical cell populations that are involved in the pathogenesis of HAND, which is specifically related to the production and release of various soluble neurotoxic factors including glutamate. In the central nervous system (CNS), glutamate is typically derived from glutamine by mitochondrial enzyme glutaminase. Our previous study has shown that glutaminase is upregulated in HIV-1 infected monocyte-derived-macrophages (MDM) and microglia. However, how HIV-1 leads to glutaminase upregulation, or how glutaminase expression is regulated in general, remains unclear. In this study, using a dual-luciferase reporter assay system, we demonstrated that interferon (IFN) alpha specifically activated the glutaminase 1 (GLS1) promoter. Furthermore, IFN-alpha treatment increased signal transducer and activator of transcription 1 (STAT1) phosphorylation and glutaminase mRNA and protein levels. IFN-alpha stimulation of GLS1 promoter activity correlated to STAT1 phosphorylation and was reduced by fludarabine, a chemical that inhibits STAT1 phosphorylation. Interestingly, STAT1 was found to directly bind to the GLS1 promoter in MDM, an effect that was dependent on STAT1 phosphorylation and significantly enhanced by IFN-alpha treatment. More importantly, HIV-1 infection increased STAT1 phosphorylation and STAT1 binding to the GLS1 promoter, which was associated with increased glutamate levels. The clinical relevance of these findings was further corroborated with investigation of post-mortem brain tissues. The glutaminase C (GAC, one isoform of GLS1) mRNA levels in HIV associated-dementia (HAD) individuals correlate with STAT1 (p<0.01), IFN-alpha (p<0.05) and IFN-beta (p<0.01). Together, these data indicate that both HIV-1 infection and IFN-alpha treatment increase glutaminase expression through STAT1 phosphorylation and by binding to the GLS1 promoter. Since glutaminase is a potential component of elevated glutamate production during the pathogenesis of HAND, our data will help to identify additional therapeutic targets for the treatment of HAND.	[Zhao, Lixia; Huang, Yunlong; Tian, Changhai; Wang, Yi; Vernon, Hamilton; Zheng, Jialin] Univ Nebraska Med Ctr, Lab Neuroimmunol & Regenerat Therapy, Omaha, NE 68198 USA; [Zhao, Lixia; Huang, Yunlong; Tian, Changhai; Wang, Yi; Vernon, Hamilton; Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pharmacol, Omaha, NE USA; [Zhao, Lixia; Huang, Yunlong; Tian, Changhai; Wang, Yi; Vernon, Hamilton; Zheng, Jialin] Univ Nebraska Med Ctr, Dept Expt Neurosci, Omaha, NE USA; [Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE USA; [Zheng, Jialin] Univ Nebraska Med Ctr, Dept Microbiol, Omaha, NE USA; [Taylor, Lynn; Curthoys, Norman] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Colorado State University	Zhao, LX (corresponding author), Univ Nebraska Med Ctr, Lab Neuroimmunol & Regenerat Therapy, Omaha, NE 68198 USA.	yhuan1@unmc.edu; jzheng@unmc.edu	Huang, Yunlong/J-6554-2015; Tian, Changhai/AAY-1601-2021; Tian, Changhai/AAD-4856-2019	Huang, Yunlong/0000-0002-3328-1924; Tian, Changhai/0000-0002-7056-1802; 	National Institutes of Health [R01 NS 41858-01, R01 NS 061642-01, 3R01NS61642-2S1, R21 MH 083525-01, P01 NS043985, P20 RR15635-01]; National Natural Science Foundation of China (NSFC) [81028007]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH083525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061642, R01NS041858, P01NS043985] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by research grants by the National Institutes of Health: R01 NS 41858-01, R01 NS 061642-01, 3R01NS61642-2S1, R21 MH 083525-01, P01 NS043985, and P20 RR15635-01 (JZ) and National Natural Science Foundation of China (NSFC) # 81028007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ABRAMOVICH C, 1994, EMBO J, V13, P5871, DOI 10.1002/j.1460-2075.1994.tb06932.x; Andratsch M, 2007, AM J PHYSIOL-RENAL, V293, pF846, DOI 10.1152/ajprenal.00139.2007; Andrianifahanana M, 2007, ONCOGENE, V26, P7251, DOI 10.1038/sj.onc.1210532; Barber SA, 2004, J NEUROVIROL, V10, P15, DOI 10.1080/13550280490268179; Canaff L, 2008, J BIOL CHEM, V283, P13586, DOI 10.1074/jbc.M708087200; Chaudhuri A, 2008, BLOOD, V111, P2062, DOI 10.1182/blood-2007-05-091207; Constantino AA, 2011, NEUROTOX RES, V20, P277, DOI 10.1007/s12640-011-9241-3; de la Rosa V, 2009, NEUROCHEM INT, V55, P76, DOI 10.1016/j.neuint.2009.02.021; DROGE W, 1987, IMMUNOBIOLOGY, V174, P473, DOI 10.1016/S0171-2985(87)80019-0; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Erdmann N, 2007, J NEUROCHEM, V102, P539, DOI 10.1111/j.1471-4159.2007.04594.x; Erdmann N, 2009, J NEUROCHEM, V109, P551, DOI 10.1111/j.1471-4159.2009.05989.x; Frank DA, 1999, NAT MED, V5, P444, DOI 10.1038/7445; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; GENDELMAN HE, 1988, J EXP MED, V167, P1428, DOI 10.1084/jem.167.4.1428; GIULIAN D, 1990, SCIENCE, V250, P1593, DOI 10.1126/science.2148832; Gupta S, 1996, EMBO J, V15, P1075, DOI 10.1002/j.1460-2075.1996.tb00445.x; Huang YL, 2011, J NEUROSCI, V31, P15195, DOI 10.1523/JNEUROSCI.2051-11.2011; Huang YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005397; Jiang ZG, 2001, J NEUROIMMUNOL, V117, P97, DOI 10.1016/S0165-5728(01)00315-0; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kim DY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-25; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; Kraft-Terry SD, 2009, NEURON, V64, P133, DOI 10.1016/j.neuron.2009.09.042; LARNER AC, 1993, SCIENCE, V261, P1730, DOI 10.1126/science.8378773; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Maezawa I, 2010, J NEUROSCI, V30, P5346, DOI 10.1523/JNEUROSCI.5966-09.2010; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mizuno T, 2008, FASEB J, V22, P1797, DOI 10.1096/fj.07-099499; MOCK B, 1989, GENOMICS, V5, P291, DOI 10.1016/0888-7543(89)90060-8; Mogensen KE, 1999, J INTERF CYTOK RES, V19, P1069, DOI 10.1089/107999099313019; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; Newcomb R, 1997, J BIOL CHEM, V272, P11276; OLLENSCHLAGER G, 1988, CLIN CHEM, V34, P1787; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; Perez-Gomez C, 2003, BIOCHEM J, V370, P771, DOI 10.1042/BJ20021445; Porter LD, 2002, PHYSIOL GENOMICS, V9, P157, DOI 10.1152/physiolgenomics.00017.2002; Ricciarelli R, 2004, IUBMB LIFE, V56, P349, DOI 10.1080/15216540412331286002; Romero-Gomez M, 2010, ANN INTERN MED, V153, P281, DOI 10.7326/0003-4819-153-5-201009070-00002; Schroeder JM, 2003, AM J PHYSIOL-RENAL, V285, pF258, DOI 10.1152/ajprenal.00422.2002; Szeliga M, 2008, NEUROCHEM RES, V33, P808, DOI 10.1007/s11064-007-9507-6; Szutkowska M, 2009, KIDNEY INT, V76, P730, DOI 10.1038/ki.2009.265; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Taylor L, 2001, BBA-GENE STRUCT EXPR, V1518, P132, DOI 10.1016/S0167-4781(01)00183-X; Tian CH, 2008, J NEUROCHEM, V105, P994, DOI 10.1111/j.1471-4159.2007.05197.x; VANDENBROECKE C, 1988, J INTERFERON RES, V8, P803; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; Yadav A, 2009, J NEUROIMMUNE PHARM, V4, P430, DOI 10.1007/s11481-009-9174-2; ZHANG XK, 1995, SCIENCE, V267, P1990, DOI 10.1126/science.7701321; Zhao JX, 2004, J NEUROCHEM, V88, P169, DOI 10.1046/j.1471-4159.2003.02146.x; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	52	34	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32995	10.1371/journal.pone.0032995	http://dx.doi.org/10.1371/journal.pone.0032995			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479354	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100028
J	Choisy, SC; Cheng, HW; Smith, GL; James, AF; Hancox, JC				Choisy, Stephanie C.; Cheng, Hongwei; Smith, Godfrey L.; James, Andrew F.; Hancox, Jules C.			Modulation by Endothelin-1 of Spontaneous Activity and Membrane Currents of Atrioventricular Node Myocytes from the Rabbit Heart	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; RECTIFIER POTASSIUM CURRENT; ISOLATED SINOATRIAL NODE; CORONARY-ARTERY-DISEASE; VENTRICULAR MYOCYTES; ELECTROPHYSIOLOGICAL PROPERTIES; ANTAGONIST BOSENTAN; ATRIAL MYOCYTES; ETA-RECEPTOR; K+ CHANNELS	Background: The atrioventricular node (AVN) is a key component of the cardiac pacemaker-conduction system. Although it is known that receptors for the peptide hormone endothelin-1 (ET-1) are expressed in the AVN, there is very little information available on the modulatory effects of ET-1 on AVN electrophysiology. This study characterises for the first time acute modulatory effects of ET-1 on AVN cellular electrophysiology. Methods: Electrophysiological experiments were conducted in which recordings were made from rabbit isolated AVN cells at 35-37 degrees C using the whole-cell patch clamp recording technique. Results: Application of ET-1 (10 nM) to spontaneously active AVN cells led rapidly (within similar to 13 s) to membrane potential hyperpolarisation and cessation of spontaneous action potentials (APs). This effect was prevented by pre-application of the ETA receptor inhibitor BQ-123 (1 mu M) and was not mimicked by the ETB receptor agonist IRL-1620 (300 nM). In whole-cell voltage-clamp experiments, ET-1 partially inhibited L-type calcium current (I-Ca,I-L) and rapid delayed rectifier K+ current (I-Kr), whilst it transiently activated the hyperpolarisation-activated current (I-f) at voltages negative to the pacemaking range, and activated an inwardly rectifying current that was inhibited by both tertiapin-Q (300 nM) and Ba2+ ions (2 mM); each of these effects was sensitive to ETA receptor inhibition. In cells exposed to tertiapin-Q, ET-1 application did not produce membrane potential hyperpolarisation or immediate cessation of spontaneous activity; instead, there was a progressive decline in AP amplitude and depolarisation of maximum diastolic potential. Conclusions: Acutely applied ET-1 exerts a direct modulatory effect on AVN cell electrophysiology. The dominant effect of ET-1 in this study was activation of a tertiapin-Q sensitive inwardly rectifying K+ current via ETA receptors, which led rapidly to cell quiescence.	[Choisy, Stephanie C.; Cheng, Hongwei; James, Andrew F.; Hancox, Jules C.] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Smith, Godfrey L.] Univ Glasgow, Glasgow, Lanark, Scotland	University of Bristol; University of Glasgow	Choisy, SC (corresponding author), Univ Bristol, Sch Physiol & Pharmacol, Med Sci Bldg, Bristol, Avon, England.	a.james@bristol.ac.uk; jules.hancox@bristol.ac.uk	Hancox, Jules C./Z-1550-2019	Cheng, Hongwei/0000-0002-3986-299X	British Heart Foundation [PG/08/104]; British Heart Foundation [PG/08/104/26137] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was funded by a project grant from the British Heart Foundation (PG/08/104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RH, 1974, CIRC RES, V35, P909, DOI 10.1161/01.RES.35.6.909; Ballard C, 1996, J MOL CELL CARDIOL, V28, P11, DOI 10.1006/jmcc.1996.0002; Bolter CP, 2008, EXP PHYSIOL, V93, P53, DOI 10.1113/expphysiol.2007.038901; BOYETT MR, 1987, J PHYSIOL-LONDON, V393, P171, DOI 10.1113/jphysiol.1987.sp016818; Cheng HW, 2011, CELL CALCIUM, V49, P56, DOI 10.1016/j.ceca.2010.11.008; Cheng HW, 2009, J MOL CELL CARDIOL, V46, P75, DOI 10.1016/j.yjmcc.2008.09.709; CHILDERS R, 1977, PROG CARDIOVASC DIS, V19, P361, DOI 10.1016/0033-0620(77)90016-0; Cho H, 2005, P NATL ACAD SCI USA, V102, P4643, DOI 10.1073/pnas.0408844102; Cho H, 2010, KOREAN J PHYSIOL PHA, V14, P145, DOI 10.4196/kjpp.2010.14.3.145; Drici MD, 2000, BRIT J PHARMACOL, V131, P569, DOI 10.1038/sj.bjp.0703611; Duru F, 2001, CARDIOVASC RES, V49, P272, DOI 10.1016/S0008-6363(00)00263-7; Efimov IR, 2004, ANAT REC PART A, V280A, P952, DOI 10.1002/ar.a.20108; Gelzer ARM, 2004, J CARDIOVASC PHARM, V44, P564, DOI 10.1097/00005344-200411000-00008; Habuchi Y, 1995, HEART VESSELS S, VS9, P203; HANCOX J, 1994, PFLUG ARCH EUR J PHY, V427, P121, DOI 10.1007/BF00585950; HANCOX JC, 1993, AM J PHYSIOL, V265, pH755, DOI 10.1152/ajpheart.1993.265.2.H755; Hancox JC, 2003, INT J BIFURCAT CHAOS, V13, P3675, DOI 10.1142/S021812740300879X; HARADA K, 1993, BRIT J PHARMACOL, V109, P679, DOI 10.1111/j.1476-5381.1993.tb13627.x; HilalDandan R, 1997, J PHARMACOL EXP THER, V281, P267; HONJO H, 1992, AM J PHYSIOL, V263, pH1779, DOI 10.1152/ajpheart.1992.263.6.H1779; HORKAY F, 1995, J CARDIOVASC PHARM, V26, pS502; Howarth FC, 1996, PFLUG ARCH EUR J PHY, V431, P713, DOI 10.1007/BF02253834; IHARA M, 1992, LIFE SCI, V50, P247, DOI 10.1016/0024-3205(92)90331-I; Inada S, 2009, BIOPHYS J, V97, P2117, DOI 10.1016/j.bpj.2009.06.056; ISENBERG G, 1982, PFLUG ARCH EUR J PHY, V395, P6, DOI 10.1007/BF00584963; Ju YK, 2011, CIRC RES, V109, P848, DOI 10.1161/CIRCRESAHA.111.243824; KASKI JC, 1995, BRIT HEART J, V74, P620; Kawanabe Y, 2011, CELL MOL LIFE SCI, V68, P195, DOI 10.1007/s00018-010-0518-0; KIM D, 1991, CIRC RES, V69, P250, DOI 10.1161/01.RES.69.1.250; Kolettis TM, 2003, J INTERV CARD ELECTR, V8, P173, DOI 10.1023/A:1023961004016; LANGENDORF R, 1956, CIRCULATION, V13, P381, DOI 10.1161/01.CIR.13.3.381; Lei M, 2002, CARDIOVASC RES, V53, P68, DOI 10.1016/S0008-6363(01)00459-X; Levi AJ, 1996, PFLUG ARCH EUR J PHY, V432, P930, DOI 10.1007/s004240050217; Loffler B-M, 1993, J MOL CELL CARDIOL, V24, P407; MacCarthy PA, 2000, CIRCULATION, V101, P142, DOI 10.1161/01.CIR.101.2.142; Mackenzie L, 2004, J CELL SCI, V117, P6327, DOI 10.1242/jcs.01559; Mackenzie L, 2004, BIOL RES, V37, P553, DOI 10.4067/S0716-97602004000400008; Mackenzie L, 2002, J PHYSIOL-LONDON, V541, P395, DOI 10.1113/jphysiol.2001.013411; Magyar J, 2000, PFLUG ARCH EUR J PHY, V441, P144, DOI 10.1007/s004240000400; Mangoni ME, 2008, PHYSIOL REV, V88, P919, DOI 10.1152/physrev.00018.2007; Martynyuk AE, 1995, CARDIOVASC RES, V30, P668, DOI 10.1016/0008-6363(95)00078-X; MEBAZAA A, 1993, AM J PHYSIOL, V265, pH1841, DOI 10.1152/ajpheart.1993.265.5.H1841; MEIJLER FL, 1988, PHYSIOL REV, V68, P608, DOI 10.1152/physrev.1988.68.2.608; Mitani H, 2000, EUR J PHARMACOL, V387, P313, DOI 10.1016/S0014-2999(99)00808-0; Mitcheson JS, 1997, PFLUG ARCH EUR J PHY, V434, P855, DOI 10.1007/s004240050476; Mitcheson JS, 1999, PFLUG ARCH EUR J PHY, V438, P843, DOI 10.1007/s004240051114; MOLENAAR P, 1993, CIRC RES, V72, P526, DOI 10.1161/01.RES.72.3.526; Munk AA, 1996, J PHYSIOL-LONDON, V493, P801, DOI 10.1113/jphysiol.1996.sp021424; MURAMATSU K-H, 1991, Heart and Vessels, V6, P191, DOI 10.1007/BF02125096; Nikmaram MR, 2008, PROG BIOPHYS MOL BIO, V96, P452, DOI 10.1016/j.pbiomolbio.2007.07.003; ONO K, 1994, NATURE, V370, P301, DOI 10.1038/370301a0; Ono K, 2001, J PHYSIOL-LONDON, V537, P467, DOI 10.1111/j.1469-7793.2001.00467.x; Rankin AC, 1997, CAN J CARDIOL, V13, P1183; Ren FX, 2006, CHINESE MED J-PEKING, V119, P2075, DOI 10.1097/00029330-200612020-00009; Ridley JM, 2008, CELL CALCIUM, V44, P580, DOI 10.1016/j.ceca.2008.04.004; RUBANYI GM, 1994, PHARMACOL REV, V46, P325; Russell FD, 2000, TRENDS PHARMACOL SCI, V21, P353, DOI 10.1016/S0165-6147(00)01524-8; Sato N, 2000, EUR J PHARMACOL, V404, P281, DOI 10.1016/S0014-2999(00)00603-8; Spiers JP, 1996, BRIT J PHARMACOL, V119, P1427, DOI 10.1111/j.1476-5381.1996.tb16055.x; Sutsch G, 1997, CARDIOVASC DRUG THER, V10, P717, DOI 10.1007/BF00053029; TAKAI M, 1992, BIOCHEM BIOPH RES CO, V184, P953, DOI 10.1016/0006-291X(92)90683-C; Tanaka H, 1998, J CARDIOVASC PHARM, V31, pS440, DOI 10.1097/00005344-199800001-00126; Tanaka H, 1997, BRIT J PHARMACOL, V122, P321, DOI 10.1038/sj.bjp.0701370; Tawara S., 1906, REIZLEITUNGSSYSTEM S; Wainwright Cherry L., 2005, Current Vascular Pharmacology, V3, P333, DOI 10.2174/157016105774329417; Watanabe T, 1999, N-S ARCH PHARMACOL, V360, P654; Wenzel RR, 1998, CIRCULATION, V98, P2235, DOI 10.1161/01.CIR.98.21.2235; Xie LH, 1996, PFLUG ARCH EUR J PHY, V431, P533, DOI 10.1007/BF02191900; Yamada M, 2002, J PHARMACOL EXP THER, V300, P681, DOI 10.1124/jpet.300.2.681; YAMASAKI H, 1989, EUR J PHARMACOL, V168, P247; Yang ZK, 1996, J PHYSIOL-LONDON, V492, P789, DOI 10.1113/jphysiol.1996.sp021346; Zhang YH, 2001, CELL CALCIUM, V30, P351, DOI 10.1054/ceca.2001.0244	72	40	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33448	10.1371/journal.pone.0033448	http://dx.doi.org/10.1371/journal.pone.0033448			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479400				2022-12-27	WOS:000304523400023
J	Olotu, A; Fegan, G; Wambua, J; Nyangweso, G; Ogada, E; Drakeley, C; Marsh, K; Bejon, P				Olotu, Ally; Fegan, Gregory; Wambua, Juliana; Nyangweso, George; Ogada, Edna; Drakeley, Chris; Marsh, Kevin; Bejon, Philip			Estimating Individual Exposure to Malaria Using Local Prevalence of Malaria Infection in the Field	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; ENTOMOLOGICAL INOCULATION RATE; VACCINE EFFICACY; ANTIBODY-RESPONSES; TRANSMISSION; HETEROGENEITY; AREA; CHILDREN; MOSQUITOS; ANTIGENS	Background: Heterogeneity in malaria exposure complicates survival analyses of vaccine efficacy trials and confounds the association between immune correlates of protection and malaria infection in longitudinal studies. Analysis may be facilitated by taking into account the variability in individual exposure levels, but it is unclear how exposure can be estimated at an individual level. Method and Findings: We studied three cohorts (Chonyi, Junju and Ngerenya) in Kilifi District, Kenya to assess measures of malaria exposure. Prospective data were available on malaria episodes, geospatial coordinates, proximity to infected and uninfected individuals and residence in predefined malaria hotspots for 2,425 individuals. Antibody levels to the malaria antigens AMA1 and MSP1(142) were available for 291 children from Junju. We calculated distance-weighted local prevalence of malaria infection within 1 km radius as a marker of individual's malaria exposure. We used multivariable modified Poisson regression model to assess the discriminatory power of these markers for malaria infection (i.e. asymptomatic parasitaemia or clinical malaria). The area under the receiver operating characteristic (ROC) curve was used to assess the discriminatory power of the models. Local malaria prevalence within 1 km radius and AMA1 and MSP1(142) antibodies levels were independently associated with malaria infection. Weighted local malaria prevalence had an area under ROC curve of 0.72 (95%CI: 0.66-0.73), 0.71 (95%CI: 0.69-0.73) and 0.82 (95%CI: 0.80-0.83) among cohorts in Chonyi, Junju and Ngerenya respectively. In a small subset of children from Junju, a model incorporating weighted local malaria prevalence with AMA1 and MSP1(142) antibody levels provided an AUC of 0.83 (95%CI: 0.79-0.88). Conclusion: We have proposed an approach to estimating the intensity of an individual's malaria exposure in the field. The weighted local malaria prevalence can be used as individual marker of malaria exposure in malaria vaccine trials and longitudinal studies of natural immunity to malaria.	[Olotu, Ally; Fegan, Gregory; Wambua, Juliana; Nyangweso, George; Ogada, Edna; Marsh, Kevin; Bejon, Philip] Ctr Geog Med Res, Wellcome Trust Res Programme, Kenya Med Res Inst, Kilifi, Kenya; [Fegan, Gregory; Marsh, Kevin; Bejon, Philip] Univ Oxford, Ctr Clin Vaccinol & Trop Med, Nuffield Dept Med, Oxford, England; [Drakeley, Chris] London Sch Hyg & Trop Med, London WC1, England; [Ogada, Edna] Populat Serv Int, Nairobi, Kenya	Kenya Medical Research Institute; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Olotu, A (corresponding author), Ctr Geog Med Res, Wellcome Trust Res Programme, Kenya Med Res Inst, Kilifi, Kenya.	Aolotu@kilifi.kemri-wellcome.org	Fegan, Greg W/O-8079-2018	Fegan, Greg W/0000-0002-2663-2765; Ogada, Edna/0000-0003-0181-2505	Wellcome Trust [084538, 077176]; Medical Research Council(UK); MRC [G1002624] Funding Source: UKRI; Medical Research Council [G1002624] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Olotu was supported by Wellcome Trust Strategic Award (084538) which funded the study. Dr. Bejon is funded by the Medical Research Council(UK). Dr. Marsh is supported by Wellcome Trust Programme grants (077176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bejon P, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010029; Bejon P, 2011, J INFECT DIS, V204, P9, DOI 10.1093/infdis/jir222; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Drakeley C, 2003, TROP MED INT HEALTH, V8, P767, DOI 10.1046/j.1365-3156.2003.01100.x; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Halloran ME, 1996, AM J EPIDEMIOL, V144, P83, DOI 10.1093/oxfordjournals.aje.a008858; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Kinyanjui SM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-242; Knols BGJ, 1995, T ROY SOC TROP MED H, V89, P604, DOI 10.1016/0035-9203(95)90406-9; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Mbogo CM, 2003, AM J TROP MED HYG, V68, P734; Mirghani SE, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-172; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Olotu A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015569; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Shepard D., 1968, P 1968 23 ACM NATL C, P517, DOI [10.1145/800186.810616, DOI 10.1145/800186.810616]; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Slutsker L, 1996, AM J TROP MED HYG, V55, P71, DOI 10.4269/ajtmh.1996.55.71; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Smith T, 2006, AM J TROP MED HYG, V75, P11, DOI 10.4269/ajtmh.2006.75.2_suppl.0750011; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Thompson R, 1997, AM J TROP MED HYG, V57, P550, DOI 10.4269/ajtmh.1997.57.550; Valim C, 2008, PHILOS T R SOC A, V366, P2347, DOI 10.1098/rsta.2008.0044; Watson B, 2000, PEDIATRICS, V105, P84, DOI 10.1542/peds.105.1.84; White MT, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-82; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	40	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32929					8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479349	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000304523400010
J	Everard, A; Geurts, L; Van Roye, M; Delzenne, NM; Cani, PD				Everard, Amandine; Geurts, Lucie; Van Roye, Marie; Delzenne, Nathalie M.; Cani, Patrice D.			Tetrahydro iso-Alpha Acids from Hops Improve Glucose Homeostasis and Reduce Body Weight Gain and Metabolic Endotoxemia in High-Fat Diet-Fed Mice	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; GUT MICROBIOTA; ALKALINE-PHOSPHATASE; TIGHT JUNCTIONS; INDUCED OBESITY; INFLAMMATION; LIPOPOLYSACCHARIDE; MECHANISM; ISOHUMULONES; PERMEABILITY	Obesity and related metabolic disorders such as insulin resistance and type 2 diabetes are associated with a low-grade inflammatory state possibly through changes in gut microbiota composition and the development of higher plasma lipopolysaccharide (LPS) levels, i.e. metabolic endotoxemia. Various phytochemical compounds have been investigated as potential tools to regulate these metabolic features. Humulus lupulus L. (hops) contains several classes of compounds with anti-inflammatory potential. Recent evidence suggests that hops-derived compounds positively impact adipocyte metabolism and glucose tolerance in obese and diabetic rodents via undefined mechanisms. In this study, we found that administration of tetrahydro iso-alpha acids (termed META060) to high-fat diet (HFD)-fed obese and diabetic mice for 8 weeks reduced body weight gain, the development of fat mass, glucose intolerance, and fasted hyperinsulinemia, and normalized insulin sensitivity markers. This was associated with reduced portal plasma LPS levels, gut permeability, and higher intestinal tight junction proteins Zonula occludens-1 and occludin. Moreover, META060 treatment increased the plasma level of the anti-inflammatory cytokine interleukin-10 and decreased the plasma level of the pro-inflammatory cytokine granulocyte colony-stimulating factor. In conclusion, this research allows us to decipher a novel mechanism contributing to the positive effects of META060 treatment, and supports the need to investigate such compounds in obese and type 2 diabetic patients.	[Everard, Amandine; Geurts, Lucie; Van Roye, Marie; Delzenne, Nathalie M.; Cani, Patrice D.] Catholic Univ Louvain, Metab & Nutr Res Grp, Louvain Drug Res Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain	Everard, A (corresponding author), Catholic Univ Louvain, Metab & Nutr Res Grp, Louvain Drug Res Inst, B-1200 Brussels, Belgium.	patrice.cani@uclouvain.be	Delzenne, Nathalie/AAC-4628-2019; D., Cani Patrice/M-8055-2016	Delzenne, Nathalie/0000-0003-2115-6082; D., Cani Patrice/0000-0003-2040-2448; Everard, Amandine/0000-0001-8925-8144	Societe francophone du Diabete, France; Metagenics, Inc., United States of America	Societe francophone du Diabete, France; Metagenics, Inc., United States of America	NMD and PDC are recipients of Fonds speciaux de recherches, UCL, Belgium and Fonds de la recherche scientifique medicale, Belgium grants. PDC is a recipient of grants from the Societe francophone du Diabete, France. This study was supported by Metagenics, Inc., United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2011, J CELL MOL MED, V15, P970, DOI 10.1111/j.1582-4934.2010.01065.x; Al-Sadi R, 2010, AM J PATHOL, V177, P2310, DOI 10.2353/ajpath.2010.100371; Basu S, 2011, OBESITY, V19, P476, DOI 10.1038/oby.2010.215; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Deopurkar R, 2010, DIABETES CARE, V33, P991, DOI 10.2337/dc09-1630; Desai A, 2009, INFLAMM RES, V58, P229, DOI 10.1007/s00011-008-8162-y; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Geurts L, 2012, J AGR FOOD CHEM, V60, P2063, DOI 10.1021/jf204916x; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Hall AJ, 2008, PHYTOCHEMISTRY, V69, P1534, DOI 10.1016/j.phytochem.2008.02.001; Hall D, 2010, J BIOL CHEM, V285, P31011, DOI 10.1074/jbc.M110.127159; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Kimura H, 1997, J CELL PHYSIOL, V171, P284, DOI 10.1002/(SICI)1097-4652(199706)171:3<284::AID-JCP6>3.0.CO;2-K; Konda VR, 2010, ARTHRITIS RHEUM-US, V62, P1683, DOI 10.1002/art.27441; Lalles JP, 2010, NUTR REV, V68, P323, DOI 10.1111/j.1753-4887.2010.00292.x; Minich DM, 2010, J NUTR METAB, V2010, DOI 10.1155/2010/467316; Moroi S, 1998, AM J PHYSIOL-CELL PH, V274, pC1708, DOI 10.1152/ajpcell.1998.274.6.C1708; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Nusrat A, 2000, AM J PHYSIOL-GASTR L, V279, pG851, DOI 10.1152/ajpgi.2000.279.5.G851; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Plomgaard P, 2005, DIABETES, V54, P2939, DOI 10.2337/diabetes.54.10.2939; Pussinen PJ, 2011, DIABETES CARE, V34, P392, DOI 10.2337/dc10-1676; Sheth P, 2007, AM J PHYSIOL-GASTR L, V293, pG308, DOI 10.1152/ajpgi.00582.2006; Straczkowski M, 2005, DIABETES CARE, V28, P2036, DOI 10.2337/diacare.28.8.2036; Vaishnava S, 2007, CELL HOST MICROBE, V2, P365, DOI 10.1016/j.chom.2007.11.004; VAN CM, 2009, MOL NUTR FOOD RES, V53, P1143; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yajima H, 2005, INT J OBESITY, V29, P991, DOI 10.1038/sj.ijo.0802965; Yajima H, 2004, J BIOL CHEM, V279, P33456, DOI 10.1074/jbc.M403456200; Zanoli P, 2008, J ETHNOPHARMACOL, V116, P383, DOI 10.1016/j.jep.2008.01.011	42	51	53	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33858	10.1371/journal.pone.0033858	http://dx.doi.org/10.1371/journal.pone.0033858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470484	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000040
J	Grant, EHC; Lynch, HJ; Muneepeerakul, R; Arunachalam, M; Rodriguez-Iturbe, I; Fagan, WF				Grant, Evan H. Campbell; Lynch, Heather J.; Muneepeerakul, Rachata; Arunachalam, Muthukumarasamy; Rodriguez-Iturbe, Ignacio; Fagan, William F.			Interbasin Water Transfer, Riverine Connectivity, and Spatial Controls on Fish Biodiversity	PLOS ONE			English	Article							NETWORK STRUCTURE; DISPERSAL; DIVERSITY; PATTERNS; THREATS; WORLD	Background: Large-scale inter-basin water transfer (IBWT) projects are commonly proposed as solutions to water distribution and supply problems. These problems are likely to intensify under future population growth and climate change scenarios. Scarce data on the distribution of freshwater fishes frequently limits the ability to assess the potential implications of an IBWT project on freshwater fish communities. Because connectivity in habitat networks is expected to be critical to species' biogeography, consideration of changes in the relative isolation of riverine networks may provide a strategy for controlling impacts of IBWTs on freshwater fish communities. Methods/Principal Findings: Using empirical data on the current patterns of freshwater fish biodiversity for rivers of peninsular India, we show here how the spatial changes alone under an archetypal IBWT project will (1) reduce freshwater fish biodiversity system-wide, (2) alter patterns of local species richness, (3) expand distributions of widespread species throughout peninsular rivers, and (4) decrease community richness by increasing inter-basin similarity (a mechanism for the observed decrease in biodiversity). Given the complexity of the IBWT, many paths to partial or full completion of the project are possible. We evaluate two strategies for step-wise implementation of the 11 canals, based on economic or ecological considerations. We find that for each step in the project, the impacts on freshwater fish communities are sensitive to which canal is added to the network. Conclusions/Significance: Importantly, ecological impacts can be reduced by associating the sequence in which canals are added to characteristics of the links, except for the case when all 11 canals are implemented simultaneously (at which point the sequence of canal addition is inconsequential). By identifying the fundamental relationship between the geometry of riverine networks and freshwater fish biodiversity, our results will aid in assessing impacts of IBWT projects and balancing ecosystem and societal demands for freshwater, even in cases where biodiversity data are limited.	[Grant, Evan H. Campbell] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA; [Lynch, Heather J.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Muneepeerakul, Rachata] Arizona State Univ, Sch Sustainabil, Tempe, AZ USA; [Muneepeerakul, Rachata] Arizona State Univ, Math Computat & Modeling Sci Ctr, Tempe, AZ USA; [Arunachalam, Muthukumarasamy] Manonmaniam Sundaranar Univ, Sri Paramakalyani Ctr Environm Sci, Tirunelveli, Tamil Nadu, India; [Rodriguez-Iturbe, Ignacio] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Fagan, William F.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	United States Department of the Interior; United States Geological Survey; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Manonmaniam Sundaranar University; Princeton University; University System of Maryland; University of Maryland College Park	Grant, EHC (corresponding author), US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD 20708 USA.	ehgrant@usgs.gov	Arunachalam, muthukumarasamy/AAU-9940-2021; Grant, Evan/N-5160-2014; Arunachalam, Muthukumarasamy/AAU-8723-2021	Grant, Evan/0000-0003-4401-6496; Arunachalam, Muthukumarasamy/0000-0003-3979-2829	James S. McDonnell Foundation	James S. McDonnell Foundation	HJL, RM, IR-I and WFF acknowledge the support of the James S. McDonnell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Chaput-Bardy A, 2009, ECOL MODEL, V220, P3589, DOI 10.1016/j.ecolmodel.2009.06.027; Charles S, 2000, ECOL MODEL, V133, P15, DOI 10.1016/S0304-3800(00)00277-5; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; DAVIES BR, 1992, AQUAT CONSERV, V2, P325, DOI 10.1002/aqc.3270020404; Dunne JA, 2002, ECOL LETT, V5, P558, DOI 10.1046/j.1461-0248.2002.00354.x; Economo EP, 2008, ECOL LETT, V11, P52, DOI 10.1111/j.1461-0248.2007.01126.x; Fairless D, 2008, NATURE, V452, P278, DOI 10.1038/452278a; Fekete B., 2002, GLOBAL COMPOSITE RUN; Ghassemi F, INTERBASIN WATER TRA; Gleick PH, 1998, ECOL APPL, V8, P571, DOI 10.1890/1051-0761(1998)008[0571:WICPTS]2.0.CO;2; Grant EHC, 2010, P NATL ACAD SCI USA, V107, P6936, DOI 10.1073/pnas.1000266107; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill MF, 2002, AM NAT, V160, P389, DOI 10.1086/341526; Holland MD, 2008, NATURE, V456, P792, DOI 10.1038/nature07395; Hubbell Stephen P., 2001, V32, pi; Jackson RB, 2001, ECOL APPL, V11, P1027, DOI 10.1890/1051-0761(2001)011[1027:WIACW]2.0.CO;2; Leuven RSEW, 2009, BIOL INVASIONS, V11, P1989, DOI 10.1007/s10530-009-9491-7; Lynch HJ, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010330; McDonald RI, 2011, P NATL ACAD SCI USA, V108, P6312, DOI 10.1073/pnas.1011615108; Muneepeerakul R, 2008, NATURE, V453, P220, DOI 10.1038/nature06813; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NCAER, 2008, NAT COUNC EC RES EC; Oberdorff T, 1995, ECOGRAPHY, V18, P345, DOI 10.1111/j.1600-0587.1995.tb00137.x; Palmer M, 2004, SCIENCE, V304, P1251, DOI 10.1126/science.1095780; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Postel S, RIVERS LIFE MANAGING; Ranta E, 2008, P ROY SOC B-BIOL SCI, V275, P435, DOI 10.1098/rspb.2007.1546; Rosindell J, 2011, TRENDS ECOL EVOL, V26, P340, DOI 10.1016/j.tree.2011.03.024; Shiva V, 2003, LIVING WATERS IMPACT; Smakhtin VA, 2007, 114 IWMI; Strahler A.N., 1957, EOS T AM GEOPHYS UN, V38, P913, DOI [DOI 10.1029/TR038I006P00913, 10.1029/TR038i006p00913]; Veech JA, 2010, ECOLOGY, V91, P1964, DOI 10.1890/08-1727.1; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440	34	54	57	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34170	10.1371/journal.pone.0034170	http://dx.doi.org/10.1371/journal.pone.0034170			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470533	gold, Green Submitted, Green Published			2022-12-27	WOS:000304489000072
J	Grimm, MOW; Zinser, EG; Grosgen, S; Hundsdorfer, B; Rothhaar, TL; Burg, VK; Kaestner, L; Bayer, TA; Lipp, P; Muller, U; Grimm, HS; Hartmann, T				Grimm, Marcus O. W.; Zinser, Eva G.; Groesgen, Sven; Hundsdoerfer, Benjamin; Rothhaar, Tatjana L.; Burg, Verena K.; Kaestner, Lars; Bayer, Thomas A.; Lipp, Peter; Mueller, Ulrike; Grimm, Heike S.; Hartmann, Tobias			Amyloid Precursor Protein (APP) Mediated Regulation of Ganglioside Homeostasis Linking Alzheimer's Disease Pathology with Ganglioside Metabolism	PLOS ONE			English	Article							GAMMA-SECRETASE CLEAVAGE; BETA-PROTEIN; GM1 GANGLIOSIDE; INTRAMEMBRANE PROTEOLYSIS; HUMAN BRAIN; INTRACELLULAR DOMAIN; TARGETING SIGNAL; CELL BIOLOGY; IN-VIVO; CHOLESTEROL	Gangliosides are important players for controlling neuronal function and are directly involved in AD pathology. They are among the most potent stimulators of A beta production, are enriched in amyloid plaques and bind amyloid beta (A beta). However, the molecular mechanisms linking gangliosides with AD are unknown. Here we identified the previously unknown function of the amyloid precursor protein (APP), specifically its cleavage products A beta and the APP intracellular domain (AICD), of regulating GD3-synthase (GD3S). Since GD3S is the key enzyme converting a-to b-series gangliosides, it therefore plays a major role in controlling the levels of major brain gangliosides. This regulation occurs by two separate and additive mechanisms. The first mechanism directly targets the enzymatic activity of GD3S: Upon binding of A beta to the ganglioside GM3, the immediate substrate of the GD3S, enzymatic turnover of GM3 by GD3S was strongly reduced. The second mechanism targets GD3S expression. APP cleavage results, in addition to A beta release, in the release of AICD, a known candidate for gene transcriptional regulation. AICD strongly down regulated GD3S transcription and knock-in of an AICD deletion mutant of APP in vivo, or knock-down of Fe65 in neuroblastoma cells, was sufficient to abrogate normal GD3S functionality. Equally, knock-out of the presenilin genes, presenilin 1 and presenilin 2, essential for A beta and AICD production, or of APP itself, increased GD3S activity and expression and consequently resulted in a major shift of a- to b-series gangliosides. In addition to GD3S regulation by APP processing, gangliosides in turn altered APP cleavage. GM3 decreased, whereas the ganglioside GD3, the GD3S product, increased A beta production, resulting in a regulatory feedback cycle, directly linking ganglioside metabolism with APP processing and A beta generation. A central aspect of this homeostatic control is the reduction of GD3S activity via an A beta-GM3 complex and AICD-mediated repression of GD3S transcription.	[Grimm, Marcus O. W.; Hartmann, Tobias] Univ Saarland, DIDP, D-6650 Homburg, Germany; [Bayer, Thomas A.] Univ Gottingen, Dept Psychiat, Gottingen, Germany; [Mueller, Ulrike] Heidelberg Univ, IPMB, Heidelberg, Germany	Saarland University; University of Gottingen; Ruprecht Karls University Heidelberg	Grimm, MOW (corresponding author), Univ Saarland, DIDP, D-6650 Homburg, Germany.	marcus.grimm@uks.eu; Tobias.Hartmann@uniklinikum-saarland.de	Grimm, Marcus O. W./F-8134-2011; Kaestner, Lars/P-6988-2016; Hartmann, Tobias/AAB-8297-2022	Grimm, Marcus O. W./0000-0002-4160-6506; Kaestner, Lars/0000-0001-6796-9535; Hartmann, Tobias/0000-0001-7481-6430	EU [211696]; Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung, Forschung, Wissenschaft und Technologie via NGFNplus; Kompetenznetz degenerative Demenzen; HOMFOR; Homburger Forschungsforderungsprogramm (Saarland University)	EU(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung, Forschung, Wissenschaft und Technologie via NGFNplus(Federal Ministry of Education & Research (BMBF)); Kompetenznetz degenerative Demenzen; HOMFOR; Homburger Forschungsforderungsprogramm (Saarland University)	The research leading to these results has received funding from the EU FP7 project LipiDiDiet, Grant Agreement No 211696 (TH), the Deutsche Forschungsgemeinschaft (TH), the Bundesministerium fur Bildung, Forschung, Wissenschaft und Technologie via NGFNplus and Kompetenznetz degenerative Demenzen (TH), the HOMFOR 2008 (MG) and Homburger Forschungsforderungsprogramm 2009 (MG, TH) (Saarland University research grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga T, 2001, ARCH BIOCHEM BIOPHYS, V388, P225, DOI 10.1006/abbi.2001.2304; Barrier L, 2007, NEUROBIOL AGING, V28, P1863, DOI 10.1016/j.neurobiolaging.2006.08.002; Bernardo A, 2009, NEUROBIOL AGING, V30, P1777, DOI 10.1016/j.neurobiolaging.2007.12.022; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buckland AG, 1998, BBA-LIPID LIPID MET, V1391, P367, DOI 10.1016/S0005-2760(98)00026-5; BUSAM K, 1986, EUR J BIOCHEM, V160, P23, DOI 10.1111/j.1432-1033.1986.tb09934.x; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Christie WW, 2003, ANAL PHOSPHOLIPIDS G, P137; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; Dhanushkodi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029285; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Grimm HS, 2003, J BIOL CHEM, V278, P13077, DOI 10.1074/jbc.M210380200; Grimm MOW, 2008, J BIOL CHEM, V283, P11302, DOI 10.1074/jbc.M801520200; Grimm MOW, 2011, J BIOL CHEM, V286, P14028, DOI 10.1074/jbc.M110.182329; Grimm MOW, 2005, NAT CELL BIOL, V7, P1118, DOI 10.1038/ncb1313; HAASS C, 1994, P NATL ACAD SCI USA, V91, P1564, DOI 10.1073/pnas.91.4.1564; Harris JR, 2008, MICRON, V39, P1192, DOI 10.1016/j.micron.2008.05.001; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Heber S, 2000, J NEUROSCI, V20, P7951; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kouchi Z, 1998, EUR J BIOCHEM, V258, P291, DOI 10.1046/j.1432-1327.1998.2580291.x; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; KRACUN I, 1991, International Journal of Developmental Biology, V35, P289; Kreutz F, 2011, NEUROCHEM INT, V59, P648, DOI 10.1016/j.neuint.2011.06.007; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lichtenthaler SF, 1999, FEBS LETT, V453, P288, DOI 10.1016/S0014-5793(99)00730-9; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Matsuzaki K, 2011, INT J ALZHEIMERS DIS, DOI DOI 10.4061/2011/956104; Molander-Melin M, 2005, J NEUROCHEM, V92, P171, DOI 10.1111/j.1471-4159.2004.02849.x; Oikawa N, 2009, NEUROREPORT, V20, P1043, DOI 10.1097/WNR.0b013e32832e4b9d; Okada T, 2007, J MOL BIOL, V371, P481, DOI 10.1016/j.jmb.2007.05.069; Ono Y, 1997, J BIOCHEM-TOKYO, V121, P585; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; OSHIMA H, 1993, INT IMMUNOL, V5, P1349, DOI 10.1093/intimm/5.10.1349; PALESTINI P, 1995, CHEM PHYS LIPIDS, V77, P253, DOI 10.1016/0009-3084(95)02474-W; Radzimanowski J, 2008, EMBO REP, V9, P1134, DOI 10.1038/embor.2008.188; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; SVENNERHOLM L, 1994, J NEUROCHEM, V63, P1802; SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2; Tamboli IY, 2005, J BIOL CHEM, V280, P28110, DOI 10.1074/jbc.M414525200; van der Gun BTF, 2007, J CONTROL RELEASE, V123, P228, DOI 10.1016/j.jconrel.2007.08.014; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wakabayashi M, 2005, BIOCHEM BIOPH RES CO, V328, P1019, DOI 10.1016/j.bbrc.2005.01.060; Wakabayashi T, 2008, PHYSIOLOGY, V23, P194, DOI 10.1152/physiol.00009.2008; Whitfield P, 2000, ACTA NEUROPATHOL, V100, P409, DOI 10.1007/s004010000187; Wolozin B, 2004, NEURON, V41, P7, DOI 10.1016/S0896-6273(03)00840-7; Wu GS, 2005, J NEUROSCI, V25, P11014, DOI 10.1523/JNEUROSCI.3635-05.2005; Yamamoto N, 2008, BBA-BIOMEMBRANES, V1778, P2717, DOI 10.1016/j.bbamem.2008.07.028; Yanagisawa K, 2005, NEUROSCIENTIST, V11, P250, DOI 10.1177/1073858405275177; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yanagisawa K, 2011, J NEUROCHEM; YOHE HC, 1972, CHEM PHYS LIPIDS, V9, P279, DOI 10.1016/0009-3084(72)90015-1; Zha Q, 2004, MOL PSYCHIATR, V9, P946, DOI 10.1038/sj.mp.4001509; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3	72	43	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34095	10.1371/journal.pone.0034095	http://dx.doi.org/10.1371/journal.pone.0034095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470521	Green Published, Green Submitted, gold			2022-12-27	WOS:000304489000064
J	Gurarie, D; Karl, S; Zimmerman, PA; King, CH; Pierre, TGS; Davis, TME				Gurarie, David; Karl, Stephan; Zimmerman, Peter A.; King, Charles H.; Pierre, Timothy G. St.; Davis, Timothy M. E.			Mathematical Modeling of Malaria Infection with Innate and Adaptive Immunity in Individuals and Agent-Based Communities	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; TROPHOZOITE-INDUCED INFECTIONS; ASEXUAL BLOOD-STAGES; ANTIGENIC VARIATION; RETROSPECTIVE EXAMINATION; CLINICAL IMMUNITY; VAR GENES; DYNAMICS; GAMETOCYTES; RECRUDESCENCE	Background: Agent-based modeling of Plasmodium falciparum infection offers an attractive alternative to the conventional Ross-Macdonald methodology, as it allows simulation of heterogeneous communities subjected to realistic transmission (inoculation patterns). Methodology/Principal Findings: We developed a new, agent based model that accounts for the essential in-host processes: parasite replication and its regulation by innate and adaptive immunity. The model also incorporates a simplified version of antigenic variation by Plasmodium falciparum. We calibrated the model using data from malaria-therapy (MT) studies, and developed a novel calibration procedure that accounts for a deterministic and a pseudo-random component in the observed parasite density patterns. Using the parasite density patterns of 122 MT patients, we generated a large number of calibrated parameters. The resulting data set served as a basis for constructing and simulating heterogeneous agent-based (AB) communities of MT-like hosts. We conducted several numerical experiments subjecting AB communities to realistic inoculation patterns reported from previous field studies, and compared the model output to the observed malaria prevalence in the field. There was overall consistency, supporting the potential of this agent-based methodology to represent transmission in realistic communities. Conclusions/Significance: Our approach represents a novel, convenient and versatile method to model Plasmodium falciparum infection.	[Gurarie, David] Case Western Reserve Univ, Dept Math, Cleveland, OH 44106 USA; [Karl, Stephan; Pierre, Timothy G. St.] Univ Western Australia, Sch Phys, Crawley, WA, Australia; [Zimmerman, Peter A.; King, Charles H.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Karl, Stephan; Davis, Timothy M. E.] Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Fremantle, WA, Australia	Case Western Reserve University; University of Western Australia; Case Western Reserve University; University of Western Australia	Gurarie, D (corresponding author), Case Western Reserve Univ, Dept Math, Cleveland, OH 44106 USA.	stephan.karl@physics.uwa.edu.au	Davis, Timothy ME/M-5144-2014; Karl, Stephan/A-2365-2012; Gurarie, David/AAA-2096-2021; St Pierre, Timothy G/A-5509-2008	St Pierre, Timothy G/0000-0003-4682-4972; King, Charles/0000-0001-8349-9270; Davis, Timothy/0000-0003-0749-7411; Gurarie, David/0000-0002-5314-7888; Zimmerman, Peter/0000-0002-5349-4513	National Institutes of Health [R01TW008067, R01TW007872]; Fogarty International Center; NHMRC; FOGARTY INTERNATIONAL CENTER [R01TW007872, R01TW008067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	DG was supported by National Institutes of Health Research Grants R01TW008067 and R01TW007872 funded by the Ecology of Infectious Diseases Program of the Fogarty International Center. TMED is supported by an NHMRC practitioner fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1989, PARASITOLOGY, V99, pS59, DOI 10.1017/S0031182000083426; Austin DJ, 1998, J THEOR BIOL, V194, P313, DOI 10.1006/jtbi.1997.0438; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Carneiro IA, 2006, AM J TROP MED HYG, V75, P82, DOI 10.4269/ajtmh.2006.75.82; Chookajorn T, 2008, TRENDS PARASITOL, V24, P455, DOI 10.1016/j.pt.2008.07.005; Collins WE, 1999, AM J TROP MED HYG, V61, P44, DOI 10.4269/tropmed.1999.61-044; Collins WE, 1999, AM J TROP MED HYG, V61, P4, DOI 10.4269/tropmed.1999.61-04; Collins WE, 1999, AM J TROP MED HYG, V61, P20, DOI 10.4269/tropmed.1999.61-020; Collins WE, 1999, AM J TROP MED HYG, V61, P36, DOI 10.4269/tropmed.1999.61-036; Diebner HH, 2000, J THEOR BIOL, V202, P113, DOI 10.1006/jtbi.1999.1041; Dietz K, 2006, AM J TROP MED HYG, V75, P46, DOI 10.4269/ajtmh.2006.75.46; Eichner M, 2001, T ROY SOC TROP MED H, V95, P497, DOI 10.1016/S0035-9203(01)90016-1; Gatton ML, 2004, INFECT IMMUN, V72, P6538, DOI 10.1128/IAI.72.11.6538-6545.2004; GAZIN P, 1988, T ROY SOC TROP MED H, V82, P50, DOI 10.1016/0035-9203(88)90261-1; Gurarie D, 2006, J THEOR BIOL, V240, P185, DOI 10.1016/j.jtbi.2005.09.015; Gurarie D, 2007, MATH BIOSCI, V210, P576, DOI 10.1016/j.mbs.2007.07.001; Gurarie D, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-86; HOWARD RJ, 1983, P NATL ACAD SCI-BIOL, V80, P4129, DOI 10.1073/pnas.80.13.4129; Karl S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020805; Karl S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-66; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Maire N, 2006, AM J TROP MED HYG, V75, P19, DOI 10.4269/ajtmh.2006.75.19; Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202; Mason DP, 1999, J THEOR BIOL, V198, P549, DOI 10.1006/jtbi.1999.0932; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; McKenzie FE, 2005, J THEOR BIOL, V232, P411, DOI 10.1016/j.jtbi.2004.08.021; McKenzie FE, 2004, AM J TROP MED HYG, V71, P94, DOI 10.4269/ajtmh.2004.71.94; Metcalf CJ, SCIENCE, V333, P984; Molineaux L, 2001, PARASITOLOGY, V122, P379, DOI 10.1017/S0031182001007533; Molineaux L, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P221; Paget-McNicol S, 2002, PARASITOLOGY, V124, P225, DOI 10.1017/S0031182001001160; Phillips RS, 1997, PARASITE IMMUNOL, V19, P427, DOI 10.1046/j.1365-3024.1997.d01-239.x; Recker M, 2004, NATURE, V429, P555, DOI 10.1038/nature02486; Ross A, 2006, AM J TROP MED HYG, V75, P63, DOI 10.4269/ajtmh.2006.75.63; Ross R., 1911, PREVENTION MALARIA; Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Sutherland CJ, 1998, PARASITOL TODAY, V14, P329, DOI 10.1016/S0169-4758(98)01276-9; VERCRUYSSE J, 1983, B WORLD HEALTH ORGAN, V61, P821; Yazdani SS, 2006, CURR MOL MED, V6, P187, DOI 10.2174/156652406776055212	41	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34040	10.1371/journal.pone.0034040	http://dx.doi.org/10.1371/journal.pone.0034040			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470511	Green Published, gold			2022-12-27	WOS:000304489000055
J	Xin, LJ; Shelite, TR; Gong, B; Mendell, NL; Soong, L; Fang, R; Walker, DH				Xin, Lijun; Shelite, Thomas R.; Gong, Bin; Mendell, Nicole L.; Soong, Lynn; Fang, Rong; Walker, David H.			Systemic Treatment with CpG-B after Sublethal Rickettsial Infection Induces Mouse Death through Indoleamine 2,3-Dioxygenase (IDO)	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; BACTERIAL-DNA; NITRIC-OXIDE; SPOTTED-FEVER; LISTERIA-MONOCYTOGENES; EXPERIMENTAL ASTHMA; INTERFERON-GAMMA; TH1 RESPONSES; CUTTING EDGE	Due to its strong immune stimulatory effects through TLR9, CpG-containing oligodeoxynucleotides (CpG ODN) have been tested in multiple clinical trials as vaccine adjuvant for infectious diseases and cancer. However, immune suppression induced by systemic administration of CpGs has been reported recently. In this study, we evaluated the impact of CpGs in an acute rickettsiosis model. We found that systemic treatment with type B CpG (CpG-B), but not type A CpG (CpG-A), at 2 days after sublethal R. australis infection induced mouse death. Although wild-type (WT) B6 and IDO-/- mice showed similar survival rates with three different doses of R. australis infection, treatment with CpG-B after sublethal infection consistently induced higher mortality with greater tissue bacterial loads in WT but not IDO-/- mice. Also, CpG-B treatment promoted the development of higher serum concentrations of proinflammatory cytokines/chemokines through IDO. Furthermore, while T cell-mediated immune responses enhanced by CpG-B were independent of IDO, treatment with CpG-B promoted T cell activation, PD-1 expression and cell apoptosis partially through IDO. A depletion study using anti-mPDCA-1 mAb indicated that plasmacytoid dendritic cells (pDC) were not required for CpG-B-induced death of R. australis-infected mice. Additionally, the results in iNOS(-/-) mice suggested that nitric oxide (NO) was partially involved in CpG-B-induced death of R. australis-infected mice. Surprisingly, pre-treatment with CpG-B before administration of a lethal dose of R. australis provided effective immunity in WT, IDO-/- and iNOS(-/-) mice. Taken together, our study provides evidence that CpGs exert complex immunological effects by both IDO-dependent and -independent mechanisms, and that systemic treatment with CpGs before or after infection has a significant and distinct impact on disease outcomes.	[Xin, Lijun; Shelite, Thomas R.; Gong, Bin; Mendell, Nicole L.; Soong, Lynn; Fang, Rong; Walker, David H.] Univ Texas Galveston, Med Branch, Dept Pathol, Galveston, TX 77550 USA; [Xin, Lijun; Shelite, Thomas R.; Gong, Bin; Mendell, Nicole L.; Soong, Lynn; Fang, Rong; Walker, David H.] Univ Texas Galveston, Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77550 USA; [Soong, Lynn] Univ Texas Galveston, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Xin, LJ (corresponding author), Univ Texas Galveston, Med Branch, Dept Pathol, Galveston, TX 77550 USA.	dwalker@utmb.edu	Fang, Rong/ABD-6123-2020		National Institute of Allergy and Infectious Diseases [AI021242]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021242] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a grant from the National Institute of Allergy and Infectious Diseases (AI021242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baban B, 2011, J IMMUNOL, V187, P2329, DOI 10.4049/jimmunol.1100276; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Cowdery J, 1996, J IMMUNOL, V156, P4570; Dow SW, 1999, J IMMUNOL, V163, P1552; Elkins KL, 1999, J IMMUNOL, V162, P2291; Ertelt JM, 2011, J IMMUNOL, V187, P2569, DOI 10.4049/jimmunol.1100374; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Fang R, 2009, INFECT IMMUN, V77, P3838, DOI 10.1128/IAI.00349-09; FENG HM, 1993, AM J PATHOL, V142, P1471; Feng HM, 1997, J IMMUNOL, V158, P5314; FENG HM, 1993, AM J PATHOL, V143, P1016; Hayashi T, 2004, J CLIN INVEST, V114, P270, DOI 10.1172/JCI200421275; Hayashi T, 2007, P NATL ACAD SCI USA, V104, P18619, DOI 10.1073/pnas.0709261104; Huttunen R, 2010, SHOCK, V33, P149, DOI 10.1097/SHK.0b013e3181ad3195; Ito S, 2005, INFECT IMMUN, V73, P3803, DOI 10.1128/IAI.73.6.3803-3805.2005; Johnson BA, 2009, IMMUNOTHERAPY-UK, V1, P645, DOI 10.2217/IMT.09.21; Jordan JM, 2008, INFECT IMMUN, V76, P3717, DOI 10.1128/IAI.00311-08; Jung ID, 2009, J IMMUNOL, V182, P3146, DOI 10.4049/jimmunol.0803104; Klinman DM, 1999, INFECT IMMUN, V67, P5658, DOI 10.1128/IAI.67.11.5658-5663.1999; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krieg AM, 1998, J IMMUNOL, V161, P2428; Krieg AM, 2007, J CLIN INVEST, V117, P1184, DOI 10.1172/JCI31414; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Labruna MB, 2004, J CLIN MICROBIOL, V42, P90, DOI 10.1128/JCM.42.1.90-98.2004; Mellor AL, 2005, J IMMUNOL, V175, P5601, DOI 10.4049/jimmunol.175.9.5601; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Minton K, 2010, NAT REV IMMUNOL, V10, DOI 10.1038/nri2872; Muller AJ, 2010, IMMUNOTHERAPY-UK, V2, P293, DOI 10.2217/IMT.10.22; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Navarini AA, 2009, P NATL ACAD SCI USA, V106, P7107, DOI 10.1073/pnas.0901162106; Nierkens S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008368; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Scott GN, 2009, J IMMUNOL, V182, P7509, DOI 10.4049/jimmunol.0804328; Scumpia PO, 2006, J IMMUNOL, V177, P7943, DOI 10.4049/jimmunol.177.11.7943; Serebrisky D, 2000, J IMMUNOL, V165, P5906, DOI 10.4049/jimmunol.165.10.5906; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Sparwasser T, 1997, NATURE, V386, P336, DOI 10.1038/386336a0; TAKIKAWA O, 1988, J BIOL CHEM, V263, P2041; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Walker DH, 1997, LAB INVEST, V76, P129; Walker DH, 2001, INFECT IMMUN, V69, P1841, DOI 10.1128/IAI.69.3.1841-1846.2001; Wingender G, 2006, EUR J IMMUNOL, V36, P12, DOI 10.1002/eji.200535602; Xu H, 2008, IMMUNOL LETT, V121, P1, DOI 10.1016/j.imlet.2008.08.008; Yi AK, 2001, INT IMMUNOL, V13, P1391, DOI 10.1093/intimm/13.11.1391; Zimmermann S, 1998, J IMMUNOL, V160, P3627	47	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34062	10.1371/journal.pone.0034062	http://dx.doi.org/10.1371/journal.pone.0034062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470514	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000058
J	Romero, MD; Fernandez-Lopez, JA; Remesar, X; Alemany, M				del Mar Romero, Maria; Antonio Fernandez-Lopez, Jose; Remesar, Xavier; Alemany, Maria			Effect of Sex and Prior Exposure to a Cafeteria Diet on the Distribution of Sex Hormones between Plasma and Blood Cells	PLOS ONE			English	Article							CORTICOSTEROID-BINDING GLOBULIN; HIGH-DENSITY-LIPOPROTEIN; ADIPOSE-TISSUE; ERYTHROCYTE DEFORMABILITY; METABOLIC SYNDROME; FREE TESTOSTERONE; OLEOYL-ESTRONE; HUMAN SERUM; PROTEIN; RAT	It is generally assumed that steroid hormones are carried in the blood free and/or bound to plasma proteins. We investigated whether blood cells were also able to bind/carry sex-related hormones: estrone, estradiol, DHEA and testosterone. Wistar male and female rats were fed a cafeteria diet for 30 days, which induced overweight. The rats were fed the standard rat diet for 15 additional days to minimize the immediate effects of excess ingested energy. Controls were always kept on standard diet. After the rats were killed, their blood was used for 1) measuring plasma hormone levels, 2) determining the binding of labeled hormones to washed red blood cells (RBC), 3) incubating whole blood with labeled hormones and determining the distribution of label between plasma and packed cells, discounting the trapped plasma volume, 4) determining free plasma hormone using labeled hormones, both through membrane ultrafiltration and dextran-charcoal removal. The results were computed individually for each rat. Cells retained up to 32% estrone, and down to 10% of testosterone, with marked differences due to sex and diet (the latter only for estrogens, not for DHEA and testosterone). Sex and diet also affected the concentrations of all hormones, with no significant diet effects for estradiol and DHEA, but with considerable interaction between both factors. Binding to RBC was non-specific for all hormones. Estrogen distribution in plasma compartments was affected by sex and diet. In conclusion: a) there is a large non-specific RBC-carried compartment for estrone, estradiol, DHEA and testosterone deeply affected by sex; b) Prior exposure to a cafeteria (hyperlipidic) diet induced hormone distribution changes, affected by sex, which hint at sex-related structural differences in RBC membranes; c) We postulate that the RBC compartment may contribute to maintain free (i.e., fully active) sex hormone levels in a way similar to plasma proteins non-specific binding.	[del Mar Romero, Maria; Antonio Fernandez-Lopez, Jose; Remesar, Xavier; Alemany, Maria] Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain; [del Mar Romero, Maria; Antonio Fernandez-Lopez, Jose; Remesar, Xavier; Alemany, Maria] Univ Barcelona, Inst Biomed, Barcelona, Spain; [del Mar Romero, Maria; Antonio Fernandez-Lopez, Jose; Remesar, Xavier; Alemany, Maria] Natl Inst Hlth Carlos III, CIBER Ctr Invest Biomed Red Physiopathol Obes & N, Madrid, Spain	University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Romero, MD (corresponding author), Univ Barcelona, Fac Biol, Dept Nutr & Food Sci, Barcelona, Spain.	malemany@ub.edu	Alemany, Marià/H-5224-2011; del Mar Romero, Maria/K-9004-2017; López, José Antonio Fernández/C-5467-2017; Remesar, Xavier/G-5703-2013; Remesar, Xavier/L-4555-2019	Alemany, Marià/0000-0002-9783-8293; del Mar Romero, Maria/0000-0001-6274-5743; López, José Antonio Fernández/0000-0002-2856-7223; Remesar, Xavier/0000-0002-9707-7287; Remesar, Xavier/0000-0002-9707-7287	Government of Spain [SAF2009 11739, AGL2010 19740]	Government of Spain(Spanish Government)	The study was supported by grants SAF2009 11739 of the Plan Nacional de Investigacion en Biomedicina and AGL2010 19740 of the Plan Nacional de Investigacion en Ciencia y Tecnologia de los Alimentos of the Government of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnet F, 2009, EUR J ENDOCRINOL, V161, P81, DOI 10.1530/EJE-09-0202; CHADER GJ, 1968, J BIOL CHEM, V243, P928; Chen Y, 2010, CLIN BIOCHEM, V43, P490, DOI 10.1016/j.clinbiochem.2009.12.005; Davenport A.P., 1996, CURRENT DIRECTIONS R, P169, DOI DOI 10.1007/978-94-009-1768-2_11; Doucet DR, 2010, J TRAUMA, V68, P35, DOI 10.1097/TA.0b013e3181bbbddb; DUFAU ML, 1972, CLIN CHIM ACTA, V37, P109, DOI 10.1016/0009-8981(72)90421-4; Egleston BL, 2010, ANN CLIN BIOCHEM, V47, P233, DOI 10.1258/acb.2010.009112; FARESE RV, 1962, J CLIN INVEST, V41, P53, DOI 10.1172/JCI104466; FERRANDO A, 1981, COMP BIOCHEM PHYS A, V70, P611, DOI 10.1016/0300-9629(81)92586-X; Ferrer-Lorente R, 2005, LIFE SCI, V77, P2051, DOI 10.1016/j.lfs.2005.04.008; FOLCH J, 1957, J BIOL CHEM, V226, P497; GARNIER M, 1990, METABOLISM, V39, P794, DOI 10.1016/0026-0495(90)90121-R; GEIGER JM, 1980, BIOL REPROD, V22, P837, DOI 10.1095/biolreprod22.4.837; Grasa MM, 2001, HORM METAB RES, V33, P407, DOI 10.1055/s-2001-16228; Hackbarth JS, 2011, STEROIDS, V76, P48, DOI 10.1016/j.steroids.2010.08.008; HIRAMATSU R, 1988, ANN NY ACAD SCI, V538, P159; Hockerstedt A, 2006, ATHEROSCLEROSIS, V185, P264, DOI 10.1016/j.atherosclerosis.2005.06.032; Hockerstedt A, 2004, J CLIN ENDOCR METAB, V89, P5088, DOI 10.1210/jc.2004-0141; Ibarrola I, 1996, BBA-BIOMEMBRANES, V1284, P41, DOI 10.1016/0005-2736(96)00110-1; JACOBSOHN MK, 1994, BBA-BIOMEMBRANES, V1195, P131, DOI 10.1016/0005-2736(94)90019-1; JOSEPH DR, 1985, J ANDROL, V6, P392; Katan MB, 1997, J LIPID RES, V38, P2012; KUHN RW, 1988, ANN NY ACAD SCI, V538, P146; LEA OA, 1972, J STEROID BIOCHEMIST, V3, P409, DOI 10.1016/0022-4731(72)90087-8; LEPETITTHEVENIN J, 1991, AM J PHYSIOL, V261, pC423, DOI 10.1152/ajpcell.1991.261.3.C423; LESZCZYNSKI DE, 1989, BIOCHIM BIOPHYS ACTA, V1014, P90, DOI 10.1016/0167-4889(89)90245-0; Lovejoy JC, 2009, OBES REV, V10, P154, DOI 10.1111/j.1467-789X.2008.00529.x; Ly LP, 2005, EUR J ENDOCRINOL, V152, P471, DOI 10.1530/eje.1.01844; Melanson EL, 2009, ANN NUTR METAB, V55, P229, DOI 10.1159/000229004; MENDEL CM, 1990, J STEROID BIOCHEM, V37, P245, DOI 10.1016/0960-0760(90)90333-G; MICKELSON KE, 1975, BIOCHEMISTRY-US, V14, P957, DOI 10.1021/bi00676a013; MIGEON CJ, 1962, J CLIN INVEST, V41, P2025, DOI 10.1172/JCI104661; Moolman JA, 2006, CARDIOVASC RES, V69, P777, DOI 10.1016/j.cardiores.2006.01.001; NEQUIN LG, 1979, BIOL REPROD, V20, P659, DOI 10.1095/biolreprod20.3.659; PALOU A, 1980, DIABETES METAB, V6, P271; PARDRIDGE WM, 1979, J CLIN INVEST, V64, P145, DOI 10.1172/JCI109433; PEARLMAN WH, 1967, J BIOL CHEM, V242, P182; Peri A, 2011, NEUROSCIENCE, V191, P107, DOI 10.1016/j.neuroscience.2011.03.011; PRATS E, 1989, PHYSIOL BEHAV, V45, P263, DOI 10.1016/0031-9384(89)90128-5; PROENZA AM, 1994, BIOCHEM MOL BIOL INT, V34, P971; Prokai L, 2005, DRUG DEVELOP RES, V66, P118, DOI 10.1002/ddr.20050; RAFECAS I, 1994, BRIT J NUTR, V72, P199, DOI 10.1079/BJN19940024; RITZEN EM, 1971, ENDOCRINOLOGY, V89, P143; Roberts CK, 2006, METABOLISM, V55, P928, DOI 10.1016/j.metabol.2006.02.022; Romero MM, 2006, INT J OBESITY, V30, P1149, DOI 10.1038/sj.ijo.0803224; Scheidt HA, 2010, CHEM PHYS LIPIDS, V163, P356, DOI 10.1016/j.chemphyslip.2010.02.001; SODERGARD R, 1982, J STEROID BIOCHEM, V16, P801, DOI 10.1016/0022-4731(82)90038-3; Tchoukalova YD, 2010, OBESITY, V18, P1875, DOI 10.1038/oby.2010.56; Vanbillemont G, 2010, J CLIN ENDOCR METAB, V95, P1579, DOI 10.1210/jc.2009-2189; Vaya A, 2010, CLIN HEMORHEOL MICRO, V46, P313, DOI 10.3233/CH-2010-1357; Vidgren HM, 1997, LIPIDS, V32, P697, DOI 10.1007/s11745-997-0089-x; Vihma V, 2011, J STEROID BIOCHEM, V124, P65, DOI 10.1016/j.jsbmb.2011.01.011; WATTS RP, 1979, LIFE SCI, V25, P1577, DOI 10.1016/0024-3205(79)90440-5; Xing DQ, 2009, ARTERIOSCL THROM VAS, V29, P289, DOI 10.1161/ATVBAHA.108.182279	54	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e34381	10.1371/journal.pone.0034381	http://dx.doi.org/10.1371/journal.pone.0034381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479617	gold, Green Published, Green Submitted			2022-12-27	WOS:000303894900087
J	Matozzo, V; Chinellato, A; Munari, M; Finos, L; Bressan, M; Marin, MG				Matozzo, Valerio; Chinellato, Andrea; Munari, Marco; Finos, Livio; Bressan, Monica; Marin, Maria Gabriella			First Evidence of Immunomodulation in Bivalves under Seawater Acidification and Increased Temperature	PLOS ONE			English	Article							MUSSEL MYTILUS-GALLOPROVINCIALIS; INVERTEBRATE SIPUNCULUS-NUDUS; CLAM TAPES-PHILIPPINARUM; OCEAN ACIDIFICATION; FUNCTIONAL-RESPONSES; IMMUNE-RESPONSE; CLIMATE-CHANGE; ENVIRONMENTAL HYPERCAPNIA; PROTEIN-SYNTHESIS; CHAMELEA-GALLINA	Water acidification, temperature increases and changes in seawater salinity are predicted to occur in the near future. In such a global climate change (GCC) scenario, there is growing concern for the health status of both wild and farmed organisms. Bivalve molluscs, an important component of coastal marine ecosystems, are at risk. At the immunological level, the ability of an organism to maintain its immunosurveillance unaltered under adverse environmental conditions may enhance its survival capability. To our knowledge, only a few studies have investigated the effects of changing environmental parameters (as predicted in a GCC scenario) on the immune responses of bivalves. In the present study, the effects of both decreased pH values and increased temperature on the important immune parameters of two bivalve species were evaluated for the first time. The clam Chamelea gallina and the mussel Mytilus galloprovincialis, widespread along the coast of the Northwestern Adriatic Sea, were chosen as model organisms. Bivalves were exposed for 7 days to three pH values (8.1, 7.7 and 7.4) at two temperatures (22 and 28 degrees C). Three independent experiments were carried out at salinities of 28, 34 and 40 PSU. The total haemocyte count, Neutral Red uptake, haemolymph lysozyme activity and total protein levels were measured. The results obtained demonstrated that tested experimental conditions affected significantly most of the immune parameters measured in bivalves, even if the variation pattern of haemocyte responses was not always linear. Between the two species, C. gallina appeared more vulnerable to changing pH and temperature than M. galloprovincialis. Overall, this study demonstrated that climate changes can strongly affect haemocyte functionality in bivalves. However, further studies are needed to clarify better the mechanisms of action of changing environmental parameters, both individually and in combination, on bivalve haemocytes.	[Matozzo, Valerio; Chinellato, Andrea; Munari, Marco; Bressan, Monica; Marin, Maria Gabriella] Univ Padua, Dept Biol, Padua, Italy; [Finos, Livio] Univ Padua, Dept Stat Sci, Padua, Italy	University of Padua; University of Padua	Matozzo, V (corresponding author), Univ Padua, Dept Biol, Via Trieste 75, Padua, Italy.	mgmar@bio.unipd.it	Munari, Marco/ABI-7729-2020; Finos, Livio/AAQ-6411-2020; Matozzo, Valerio/D-6999-2017; Munari, Marco/M-2952-2016	Finos, Livio/0000-0003-3181-8078; Matozzo, Valerio/0000-0001-9935-0366; Munari, Marco/0000-0002-2702-5393; MARIN, MARIA/0000-0002-1479-5428	Italian Ministry for Environment, Land and Sea (IMELS) [DEC/RAS/649/2008]; Foundation for Science and Technology of Portugal; Regional Ministry of Innovation and Industry of the Galician Government (European Commission)	Italian Ministry for Environment, Land and Sea (IMELS); Foundation for Science and Technology of Portugal(Portuguese Foundation for Science and Technology); Regional Ministry of Innovation and Industry of the Galician Government (European Commission)	This work is a contribution of the project "The integrated impacts of marine acidification, temperature and precipitation changes on bivalve coastal biodiversity and fisheries: how to adapt (ACIDBIV)", which is part of the CIRCLE Med projects, funded by the Italian Ministry for Environment, Land and Sea (IMELS) (DEC/RAS/649/2008), the Foundation for Science and Technology of Portugal, and the Regional Ministry of Innovation and Industry of the Galician Government, in the framework of the Circle ERA Net project (which is funded by the European Commission 6th Framework Programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibby R, 2008, AQUAT BIOL, V2, P67, DOI 10.3354/ab00037; Binelli A, 2009, COMP BIOCHEM PHYS C, V150, P50, DOI 10.1016/j.cbpc.2009.02.005; Booij MJ, 2005, J HYDROL, V303, P176, DOI 10.1016/j.jhydrol.2004.07.013; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bussell JA, 2008, J EXP MAR BIOL ECOL, V358, P78, DOI 10.1016/j.jembe.2008.01.018; Cajaraville MP, 1996, ECOTOX ENVIRON SAFE, V35, P253, DOI 10.1006/eesa.1996.0108; Caldeira K, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002671; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; Canesi L, 2007, COMP BIOCHEM PHYS C, V145, P464, DOI 10.1016/j.cbpc.2007.02.002; Cheng T.C., 1981, INVERTEBRATE BLOOD C, V1, P233; CHENG TC, 1975, J INVERTEBR PATHOL, V25, P261, DOI 10.1016/0022-2011(75)90076-2; Cima F, 2000, FISH SHELLFISH IMMUN, V10, P677, DOI 10.1006/fsim.2000.0282; COLES JA, 1995, DIS AQUAT ORGAN, V22, P59, DOI 10.3354/dao022059; Donaghy L, 2009, AQUACULTURE, V297, P10, DOI 10.1016/j.aquaculture.2009.09.003; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Fenoglio S, 2010, ITAL J ZOOL, V77, P374, DOI 10.1080/11250000903176497; Fisher W.S., 1996, J SHELLFISH RES, V15, P554; Galloway TS, 2001, ECOTOXICOLOGY, V10, P5, DOI 10.1023/A:1008939520263; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Hauton C, 1998, COMP BIOCHEM PHYS B, V119, P619, DOI 10.1016/S0305-0491(98)00036-4; Hernroth B, 2011, AQUAT TOXICOL, V103, P222, DOI 10.1016/j.aquatox.2011.03.001; Hine PM, 1999, FISH SHELLFISH IMMUN, V9, P367, DOI 10.1006/fsim.1998.0205; IPCC, 2007, CLIM CHANG 2007 PHYS; Kay AL, 2006, J HYDROL, V318, P163, DOI 10.1016/j.jhydrol.2005.06.013; Langenbuch M, 2006, COMP BIOCHEM PHYS A, V144, P479, DOI 10.1016/j.cbpa.2006.04.017; Langenbuch M, 2003, J EXP BIOL, V206, P3895, DOI 10.1242/jeb.00620; Langenbuch M, 2002, J EXP BIOL, V205, P1153; Leclerc M, 1996, INVERTEBRATE IMMUNOL, P1; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Martin LB, 2010, ANN NY ACAD SCI, V1195, P129, DOI 10.1111/j.1749-6632.2010.05454.x; Martinez-Sanchez A, 2007, ENTOMOL EXP APPL, V122, P93, DOI 10.1111/j.1570-7458.2006.00497.x; Matozzo V, 2002, APPL ORGANOMET CHEM, V16, P169, DOI 10.1002/aoc.278; Matozzo V, 2001, ARCH ENVIRON CON TOX, V41, P163; Matozzo V, 2007, MAR BIOL, V151, P1051, DOI 10.1007/s00227-006-0543-6; Mitta G, 1999, EUR J BIOCHEM, V265, P71, DOI 10.1046/j.1432-1327.1999.00654.x; Monari M, 2007, FISH SHELLFISH IMMUN, V22, P98, DOI 10.1016/j.fsi.2006.03.016; Morgan ER, 2009, TRENDS PARASITOL, V25, P308, DOI 10.1016/j.pt.2009.03.012; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Munari M, 2011, FISH SHELLFISH IMMUN, V30, P1024, DOI 10.1016/j.fsi.2011.01.025; Nirchio T. Mauro, 1998, Boletin del Instituto Oceanografico de Venezuela Universidad de Oriente, V36, P31; O'Connor LJ, 2006, VET PARASITOL, V142, P1, DOI 10.1016/j.vetpar.2006.08.035; Oliver LM, 1999, BIOMARKERS, V4, P510, DOI 10.1080/135475099230679; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; PIPE RK, 1995, FISH SHELLFISH IMMUN, V5, P581, DOI 10.1016/S1050-4648(95)80043-3; Poulin R, 2006, PARASITOLOGY, V132, P143, DOI 10.1017/S0031182005008693; Prieur G, 1990, OCEANOGRAPHY MARINE, V28, P277; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Raven J, 2005, OCEAN ACIDIFICATION; Reid HI, 2003, DIS AQUAT ORGAN, V56, P249, DOI 10.3354/dao056249; Reid SD, 1997, CAN J FISH AQUAT SCI, V54, P2014, DOI 10.1139/cjfas-54-9-2014; SANTAREM MM, 1994, DIS AQUAT ORGAN, V18, P217, DOI 10.3354/dao018217; Wikfors GH, 2009, J SHELLFISH RES, V28, P658; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343	54	102	109	3	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33820	10.1371/journal.pone.0033820	http://dx.doi.org/10.1371/journal.pone.0033820			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479452	gold, Green Published, Green Submitted			2022-12-27	WOS:000303894900040
J	Tan, YW; Ding, KQ; Su, J; Trinh, X; Peng, ZH; Gong, YH; Chen, L; Cui, Q; Lei, N; Chen, X; Yu, RB				Tan, Youwen; Ding, Keqin; Su, Jing; Trinh, Xuan; Peng, Zhihang; Gong, Yuhua; Chen, Li; Cui, Qian; Lei, Na; Chen, Xin; Yu, Rongbin			The Naturally Occurring YMDD Mutation among Patients Chronically Infected HBV and Untreated with Lamivudine: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HEPATITIS-B-VIRUS; RESISTANCE; MUTANTS; GENOTYPES	Background: Several recent reports have demonstrated that tyrosine (Y)-methionine (M)-aspartic acid (D)-aspartic acid (D) (YMDD) motif mutations can naturally occur in chronic HBV patients without antiviral treatment such as lamivudine therapy. This paper aims to assess the overall spontaneous incidence and related risk factors of YMDD-motif mutations among lamivudine-naive chronic HBV carriers, so as to provide some clue for clinical treatment of hepatitis B. Methodology/Principal Findings: Chinese and English literatures were searched for studies reporting natural YMDD mutations among untreated chronic HBV patients from 2001 to 2010. The incidence estimates were summarized and analyzed by meta-analyses. Forty-seven eligible articles from eight countries were selected in this review (13 in English and 34 in Chinese). The pooled incidence of YMDD-motif mutation among untreated chronic HBV patients from eight countries was 12.21% (95% CI: 9.69%-14.95%). China had an incidence of 13.38% (95% CI: 10.90%-16.07%) and seven other countries had an incidence of 9.90% (95% CI: 3.28%-19.55%), respectively. Lamivudine therapy would increase the risk of mutations 5.23 times higher than the untreated patients. A higher HBV DNA copy number was associated with increased incidence of natural YMDD mutation. No significant difference was found in YMDD mutation incidence between groups of different gender, age, HBeAg status, patients' ALT (alanine aminotransferase) level, and between the groups of HBV genotype B and C. Conclusions: The YMDD-motif mutations can occur spontaneously with a relatively high incidence in CHB patients untreated with lamivudine. These mutations might be the consequence of accumulated base mismatch due to the nature of viral polymerase. More fundamental and clinical studies are needed to clarify the influence of YMDD mutations in hepatitis B progression and antiviral treatment.	[Tan, Youwen; Ding, Keqin; Su, Jing; Peng, Zhihang; Cui, Qian; Lei, Na; Chen, Xin; Yu, Rongbin] Nanjing Med Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Tan, Youwen; Gong, Yuhua; Chen, Li] Third Peoples Hosp Zhenjiang City, Dept Hepatosis, Zhenjiang, Peoples R China; [Trinh, Xuan] Univ Gothenburg, Dept Pharmacol, Gothenburg, Sweden	Nanjing Medical University; University of Gothenburg	Tan, YW (corresponding author), Nanjing Med Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China.	rongbinyu@njmu.edu.cn			National Science and Technology Major Project [2012ZX10001-001, 2011ZX10004-902]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Jiangsu Province, China [BK2010079]; Social Development Project of Zhenjiang City [SH2009016]	National Science and Technology Major Project; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Social Development Project of Zhenjiang City	This work was supported by the National Science and Technology Major Project (2012ZX10001-001,2011ZX10004-902) (http://www.nmp.gov.cn/), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (http://202.119.175.131/pages/index.aspx), the Natural Science Foundation Key Project of Jiangsu Province, China (BK2010079) (http://www.jstd.gov.cn/) and the Social Development Project of Zhenjiang City (SH2009016) (http://kjj.zhenjiang.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarsu M, 2006, J GASTROEN HEPATOL, V21, P1783, DOI 10.1111/j.1440-1746.2006.04567.x; Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Amini-Bavil-Olyaee S, 2008, INT J INFECT DIS, V12, P83, DOI 10.1016/j.ijid.2007.05.001; Atkins M, 1998, HEPATOLOGY, V28, p319A; Chen NL, 2008, CHINESE J CLIN PHYS, V2, P1123; Cheng FJ, 2006, ZHEJIANG J PREVENTIV, V18, P11; [郭海波 Guo Haibo], 2004, [中国生物工程杂志, Journal of Chinese Biotechnology], V24, P107; Heo J, 2004, J KOREAN MED SCI, V19, P541, DOI 10.3346/jkms.2004.19.4.541; Huang ZM, 2005, WORLD J GASTROENTERO, V11, P867, DOI 10.3748/wjg.v11.i6.867; Huo H, 2006, CHIN HEPATOL, V11, P232; Kao JH, 2002, LANCET INFECT DIS, V2, P395, DOI 10.1016/S1473-3099(02)00315-8; Kobayashi S, 2001, J HEPATOL, V34, P584, DOI 10.1016/S0168-8278(00)00023-4; Li CM, 2003, CHINESE J INTEGRATED, V13, P137; [李玲 Li Ling], 2005, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V27, P167; Liu JH, 2008, J CHINESE TROPICAL M, V8, P1483; Liu TH, 2004, CHINESE PHARM, V13, P29; Masaadeh HA, 2008, WORLD J GASTROENTERO, V14, P7231, DOI 10.3748/wjg.14.7231; Matsuda M, 2004, J MED VIROL, V74, P361, DOI 10.1002/jmv.20185; Min Xiao-chun, 2009, Zhonghua Gan Zang Bing Za Zhi, V17, P887; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Pan HQ, 2010, MED INFORM, V23, P2094; [齐青松 Qi Qingsong], 2005, [江西医学院学报, Acta Academiae Medicinae Jiangxi], V45, P42; [钱健帮 Qian Jianbang], 2002, [江苏医药, Jiangsu medical Journal], V28, P408; Qian YQ, 2005, J CHINESE PHYS, V7, P1551; Qiu YW, 2008, CLIN FOCUS, V23, P350; Qu JX, 2008, CHINESE J CLIN HEPAT, V24, P116; Qu JX, 2010, WORLD CHINESE J DIGE, V18, P2604; Qu YY, 2006, J TROPICAL MED, V6, P791; Amitis RA, 2008, INT J INFECT DIS, V12, P252, DOI 10.1016/j.ijid.2007.08.003; Ren YQ, 2004, J CLIN HEPATOLOGY, V7, P83; Selabe SG, 2007, J MED VIROL, V79, P1650, DOI 10.1002/jmv.20974; Seta T, 2000, J MED VIROL, V60, P8, DOI 10.1002/(SICI)1096-9071(200001)60:1&lt;8::AID-JMV2&gt;3.0.CO;2-U; Shi M, 2006, CLIN CHIM ACTA, V373, P172, DOI 10.1016/j.cca.2006.05.023; Stuyver LJ, 2001, HEPATOLOGY, V33, P751, DOI 10.1053/jhep.2001.22166; [唐孝亮 TANG Xiaoliang], 2009, [中国现代医学杂志, China Journal of Modern Medicine], V19, P1544; Tipples GA, 1996, HEPATOLOGY, V24, P714, DOI 10.1053/jhep.1996.v24.pm0008781348; Tsubota A, 2006, J GASTROEN HEPATOL, V21, P1783; Villa E, 2009, ANTIVIR THER, V14, P1081, DOI 10.3851/IMP1465; Wang JF, 2003, WORLD J INFECT, V3, P405; Wang YingQiu, 2009, China Tropical Medicine, V9, P652; [隗佳 Wei Jia], 2010, [中华肝脏病杂志, Chinese Journal of Hepatology], V18, P855; Wu C, 2007, MED LAB SCI CLIN, V18, P46; Wu Jie, 2009, Journal of Hainan Medical College, V15, P714; Xiang T, 2010, J HUBEI U NATL, V27, P47; Xiong Y, 2005, J BEIHUA U, V6, P421; Yan Ming-he, 2003, Zhonghua Gan Zang Bing Za Zhi, V11, P430; Yu HZ, 2009, MED INFORM, V1, P19; Yu J, 2007, INT MED HLTH GUIDANC, V13, P63; Zhang JM, 2004, J SHANGDONG MED, V44, P22; Zhang Xin-hua, 2003, Zhonghua Yi Xue Za Zhi, V83, P459; Zhang Y, 2005, MILITARY MED J S CHI, V19, P13; [郑建敏 Zheng Jianmin], 2003, [上海医学检验杂志, Shanghai Journal of Medical Laboratory Sciences], V18, P261; Zheng NH, 2007, CHINESE J CLIN HEPAT, V23, P213; 何煦, 2007, [四川大学学报. 医学版, Journal of Sichuan University. Medical Science Edition], V38, P895	55	28	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e32789	10.1371/journal.pone.0032789	http://dx.doi.org/10.1371/journal.pone.0032789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479339	Green Submitted, Green Published, gold			2022-12-27	WOS:000303894900012
J	Marshall, KE; Robinson, EW; Hengel, SM; Pasa-Tolic, L; Roesijadi, G				Marshall, Kathryn E.; Robinson, Errol W.; Hengel, Shawna M.; Pasa-Tolic, Ljiljana; Roesijadi, Guritno			FRET Imaging of Diatoms Expressing a Biosilica-Localized Ribose Sensor	PLOS ONE			English	Article							SILICA IMMOBILIZATION; ENZYME IMMOBILIZATION; PORE ARCHITECTURE; MEMBRANES	Future materials are envisioned to include bio-assembled, hybrid, three-dimensional nanosystems that incorporate functional proteins. Diatoms are amenable to genetic modification for localization of recombinant proteins in the biosilica cell wall. However, the full range of protein functionalities that can be accommodated by the modified porous biosilica has yet to be described. Our objective was to functionalize diatom biosilica with a reagent-less sensor dependent on ligand-binding and conformational change to drive FRET-based signaling capabilities. A fusion protein designed to confer such properties included a bacterial periplasmic ribose binding protein (R) flanked by CyPet (C) and YPet (Y), cyan and yellow fluorescent proteins that act as a FRET pair. The structure and function of the CRY recombinant chimeric protein was confirmed by expression in E. coli prior to transformation of the diatom Thalassiosira pseudonana. Mass spectrometry of the recombinant CRY showed 97% identity with the deduced amino acid sequence. CRY with and without an N-terminal Sil3 tag for biosilica localization exhibited characteristic ribose-dependent changes in FRET, with similar dissociation constants of 123.3 mu M and 142.8 mu M, respectively. The addition of the Sil3 tag did not alter the affinity of CRY for the ribose substrate. Subsequent transformation of T. pseudonana with a vector encoding Sil3-CRY resulted in fluorescence localization in the biosilica and changes in FRET in both living cells and isolated frustules in response to ribose. This work demonstrated that the nano-architecture of the genetically modified biosilica cell wall was able to support the functionality of the relatively complex Sil3-CyPet-RBP-YPet fusion protein with its requirement for ligand-binding and conformational change for FRET-signal generation.	[Marshall, Kathryn E.; Roesijadi, Guritno] Pacific NW Natl Lab, Marine Sci Lab, Sequim, WA USA; [Robinson, Errol W.; Hengel, Shawna M.; Pasa-Tolic, Ljiljana] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Marshall, KE (corresponding author), Pacific NW Natl Lab, Marine Sci Lab, Sequim, WA USA.	g.roesijadi@pnnl.gov	Robinson, Errol/I-3148-2012	Robinson, Errol/0000-0003-0696-6239	Office of Naval Research [N0001409IP20071]; American Reinvestment and Recovery Act; U.S. Department of Energy (DOE) Office of Biological and Environmental Research; Science Undergraduate Laboratory through the U.S. Department of Energy	Office of Naval Research(Office of Naval Research); American Reinvestment and Recovery Act; U.S. Department of Energy (DOE) Office of Biological and Environmental Research(United States Department of Energy (DOE)); Science Undergraduate Laboratory through the U.S. Department of Energy	This study was supported, in part, by the Office of Naval Research, award number N0001409IP20071 (http://www.onr.navy.mil/).Research using mass spectroscopy was partially supported by the American Reinvestment and Recovery Act of 2009 and the U.S. Department of Energy (DOE) Office of Biological and Environmental Research. Student participation was partially funded by the Science Undergraduate Laboratory Internship program through the U.S. Department of Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao ZH, 2007, NATURE, V446, P172, DOI 10.1038/nature05570; Carlson HJ, 2009, CURR OPIN BIOTECH, V20, P19, DOI 10.1016/j.copbio.2009.01.003; Chen J, 2007, NAT NAN IN WORKSH RE; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Gordon R, 2005, J NANOSCI NANOTECHNO, V5, P35, DOI 10.1166/jnn.2005.002; Hildebrand M, 2006, J MATER RES, V21, P2689, DOI 10.1557/JMR.2006.0333; Jeffryes C, 2008, ACS NANO, V2, P2103, DOI 10.1021/nn800470x; Jeffryes C, 2008, MAT SCI ENG C-BIO S, V28, P107, DOI 10.1016/j.msec.2007.01.002; Kent MS, 2009, MATER RES SOC SYMP P, V1187, P95; Kroger N, 2010, MRS BULL, V35, P122, DOI 10.1557/mrs2010.631; Kroger N, 2008, ANNU REV GENET, V42, P83, DOI 10.1146/annurev.genet.41.110306.130109; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Lager I, 2003, FEBS LETT, V553, P85, DOI 10.1016/S0014-5793(03)00976-1; Li L, 2009, MAT SCI ENG C-MATER, V29, P2029, DOI 10.1016/j.msec.2009.03.020; Losic D, 2006, J NANOSCI NANOTECHNO, V6, P982, DOI 10.1166/jnn.2006.174; Luckarift HR, 2006, J CHROMATOGR B, V843, P310, DOI 10.1016/j.jchromb.2006.06.036; Luckarift HR, 2004, NAT BIOTECHNOL, V22, P211, DOI 10.1038/nbt931; Marner WD, 2009, BIOTECHNOL PROGR, V25, P417, DOI 10.1002/btpr.136; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; Naik RR, 2004, CHEM COMMUN, P1684, DOI 10.1039/b404586f; Newman RH, 2011, CHEM REV, V111, P3614, DOI 10.1021/cr100002u; Nguyen AW, 2005, NAT BIOTECHNOL, V23, P355, DOI 10.1038/nbt1066; Patwardhan SV, 2011, CHEM COMMUN, V47, P7567, DOI 10.1039/c0cc05648k; Poulsen N, 2007, ANGEW CHEM INT EDIT, V46, P1843, DOI 10.1002/anie.200603928; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Scheffel A, 2011, P NATL ACAD SCI USA, V108, P3175, DOI 10.1073/pnas.1012842108; Shen YF, 2008, ANAL CHEM, V80, P7742, DOI 10.1021/ac801123p; Sheppard VC, 2012, APPL ENVIRON MICROB, V78, P211, DOI 10.1128/AEM.06698-11; Vrieling EG, 2000, J PHYCOL, V36, P146, DOI 10.1046/j.1529-8817.2000.99120.x; Wang W, 2009, J AM CHEM SOC, V131, P4178, DOI 10.1021/ja809079n; Wieneke R, 2011, ORG BIOMOL CHEM, V9, P5482, DOI 10.1039/c1ob05406f	31	18	20	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2012	7	3							e33771	10.1371/journal.pone.0033771	http://dx.doi.org/10.1371/journal.pone.0033771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939YN	22470473	Green Published, gold, Green Submitted			2022-12-27	WOS:000303857100048
J	Neuhofer, D; Ronacher, B				Neuhofer, Daniela; Ronacher, Bernhard			Influence of Different Envelope Maskers on Signal Recognition and Neuronal Representation in the Auditory System of a Grasshopper	PLOS ONE			English	Article							CHORTHIPPUS-BIGUTTULUS; ACOUSTIC COMMUNICATION; AMPLITUDE MODULATIONS; METATHORACIC GANGLION; ANIMAL COMMUNICATION; PATTERN-RECOGNITION; NOISE; SONG; ORTHOPTERA; EVOLUTION	Background: Animals that communicate by sound face the problem that the signals arriving at the receiver often are degraded and masked by noise. Frequency filters in the receiver's auditory system may improve the signal-to-noise ratio (SNR) by excluding parts of the spectrum which are not occupied by the species-specific signals. This solution, however, is hardly amenable to species that produce broad band signals or have ears with broad frequency tuning. In mammals auditory filters exist that work in the temporal domain of amplitude modulations (AM). Do insects also use this type of filtering? Principal Findings: Combining behavioural and neurophysiological experiments we investigated whether AM filters may improve the recognition of masked communication signals in grasshoppers. The AM pattern of the sound, its envelope, is crucial for signal recognition in these animals. We degraded the species-specific song by adding random fluctuations to its envelope. Six noise bands were used that differed in their overlap with the spectral content of the song envelope. If AM filters contribute to reduced masking, signal recognition should depend on the degree of overlap between the song envelope spectrum and the noise spectra. Contrary to this prediction, the resistance against signal degradation was the same for five of six masker bands. Most remarkably, the band with the strongest frequency overlap to the natural song envelope (0-100 Hz) impaired acceptance of degraded signals the least. To assess the noise filter capacities of single auditory neurons, the changes of spike trains as a function of the masking level were assessed. Increasing levels of signal degradation in different frequency bands led to similar changes in the spike trains in most neurones. Conclusions: There is no indication that auditory neurones of grasshoppers are specialized to improve the SNR with respect to the pattern of amplitude modulations.	[Neuhofer, Daniela] Humboldt Univ, Dept Biol, Berlin, Germany; [Ronacher, Bernhard] Bernstein Ctr Computat Neurosci Berlin, Berlin, Germany	Humboldt University of Berlin	Neuhofer, D (corresponding author), Humboldt Univ, Dept Biol, Berlin, Germany.	neu.dani@gmx.at		Neuhofer, Daniela/0000-0001-5726-7855	Federal Ministry of Education and Research, Germany, through the Bernstein Center for Computational Neuroscience [01GQ1001A]; Deutsche Forschungsgemeinschaft [SFB618]; Austrian Academy of Science	Federal Ministry of Education and Research, Germany, through the Bernstein Center for Computational Neuroscience; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Academy of Science	This work was funded by grants from the Federal Ministry of Education and Research, Germany, through the Bernstein Center for Computational Neuroscience (01GQ1001A) and the Deutsche Forschungsgemeinschaft (SFB618), grants to BR, and a grant (Doc-FFORTE) from the Austrian Academy of Science to DN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan R, 2001, J COMP PHYSIOL A, V187, P255, DOI 10.1007/s003590100197; Bee MA, 2008, ANIM BEHAV, V75, P1781, DOI 10.1016/j.anbehav.2007.10.032; Bee MA, 2009, J ACOUST SOC AM, V126, P2788, DOI 10.1121/1.3224707; Bradbury J.W., 1998, PRINCIPLES ANIMAL CO; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; Buus S, 1998, HANDBOOK OF ACOUSTICS, P1147; Clemens J, 2010, J COMP PHYSIOL A, V196, P285, DOI 10.1007/s00359-010-0515-7; Einhaupl A, 2011, BEHAV ECOL, V22, P791, DOI 10.1093/beheco/arr064; Hennig RM, 2004, MICROSC RES TECHNIQ, V63, P351, DOI 10.1002/jemt.20052; Joris PX, 2004, PHYSIOL REV, V84, P541, DOI 10.1152/physrev.00029.2003; Klump Georg M., 1996, P321; KLUMP GM, 1990, NATURWISSENSCHAFTEN, V77, P545, DOI 10.1007/BF01139270; Kostarakos K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-22; KRIEGBAUM H, 1989, NATURWISSENSCHAFTEN, V76, P81, DOI 10.1007/BF00396715; Lang Friederike, 2000, Bioacoustics, V10, P233; LANGNER G, 1992, HEARING RES, V60, P115, DOI 10.1016/0378-5955(92)90015-F; LANGNER G, 1988, J NEUROPHYSIOL, V60, P1799, DOI 10.1152/jn.1988.60.6.1799; Machens CK, 2003, NAT NEUROSCI, V6, P341, DOI 10.1038/nn1036; Machens CK, 2001, J NEUROSCI, V21, P3215, DOI 10.1523/JNEUROSCI.21-09-03215.2001; Michelsen A., 1983, P321; Neuhofer D, 2008, P ROY SOC B-BIOL SCI, V275, P1965, DOI 10.1098/rspb.2008.0527; Neuhofer D, 2011, J COMP PHYSIOL A, V197, P251, DOI 10.1007/s00359-010-0606-5; RICHARDS DG, 1980, AM NAT, V115, P381, DOI 10.1086/283568; ROMER H, 1976, J COMP PHYSIOL, V109, P101; ROMER H, 1992, BEHAV ECOL SOCIOBIOL, V29, P437, DOI 10.1007/BF00170174; Romer H, 2000, J COMP PHYSIOL A, V186, P181, DOI 10.1007/s003590050018; Romer H, 1998, J EXP BIOL, V201, P1023; ROMER H, 1989, J COMP PHYSIOL A, V164, P609, DOI 10.1007/BF00614503; ROMER H, 1984, J COMP PHYSIOL, V155, P249, DOI 10.1007/BF00612642; Romer H., 2001, ECOLOGY SENSING, P59, DOI [10.1007/978-3-662-22644-5_4, DOI 10.1007/978-3-662-22644-5_4]; Ronacher B, 1998, J COMP PHYSIOL A, V183, P729, DOI 10.1007/s003590050295; RONACHER B, 1988, J COMP PHYSIOL A, V163, P517, DOI 10.1007/BF00604905; Ronacher B, 2003, J COMP PHYSIOL A, V189, P419, DOI 10.1007/s00359-003-0417-z; Ronacher B, 2000, J COMP PHYSIOL A, V186, P1065, DOI 10.1007/s003590000153; Schmidt A, 2008, J COMP PHYSIOL A, V194, P221, DOI 10.1007/s00359-007-0295-x; Schmidt AKD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028593; Stumpner A, 2001, NATURWISSENSCHAFTEN, V88, P159, DOI 10.1007/s001140100223; STUMPNER A, 1991, J EXP BIOL, V158, P391; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Vogel A, 2007, J NEUROPHYSIOL, V97, P3376, DOI 10.1152/jn.00796.2006; von Helversen D, 1998, BIOL CYBERN, V79, P467, DOI 10.1007/s004220050496; von Helversen D, 1994, FORTSCHR ZOOL, V39, P253; vonHelversen D, 1997, J COMP PHYSIOL A, V180, P373, DOI 10.1007/s003590050056; Weschke G, 2008, J COMP PHYSIOL A, V194, P255, DOI 10.1007/s00359-007-0303-1; Wiley RH, 2006, ADV STUD BEHAV, V36, P217, DOI 10.1016/S0065-3454(06)36005-6; Wohlgemuth S, 2007, J NEUROPHYSIOL, V97, P3082, DOI 10.1152/jn.01235.2006; Wohlgemuth S, 2011, J COMP PHYSIOL A, V197, P61, DOI 10.1007/s00359-010-0587-4	48	6	6	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34384	10.1371/journal.pone.0034384	http://dx.doi.org/10.1371/journal.pone.0034384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479619	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100154
J	Thiyagarajan, D; Fismen, S; Seredkina, N; Jacobsen, S; Elung-Jensen, T; Kamper, AL; Fenton, CG; Rekvig, OP; Mortensen, ES				Thiyagarajan, Dhivya; Fismen, Silje; Seredkina, Natalya; Jacobsen, Soren; Elung-Jensen, Thomas; Kamper, Anne-Lise; Fenton, Christopher Graham; Rekvig, Ole Petter; Mortensen, Elin Synnove			Silencing of Renal DNaseI in Murine Lupus Nephritis Imposes Exposure of Large Chromatin Fragments and Activation of Toll Like Receptors and the Clec4e	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; APOPTOTIC CELLS; METALLOPROTEINASE ACTIVITY; AUTOANTIBODY PRODUCTION; DYING CELLS; ERYTHEMATOSUS; EXPRESSION; TOLL-LIKE-RECEPTOR-9; GLOMERULONEPHRITIS; CLASSIFICATION	Recent studies demonstrate that transformation of mild lupus nephritis into end-stage disease is imposed by silencing of renal DNaseI gene expression in (NZBxNZW)F1 mice. Down-regulation of DNaseI results in reduced chromatin fragmentation, and in deposition of extracellular chromatin-IgG complexes in glomerular basement membranes in individuals that produce IgG anti-chromatin antibodies. The main focus of the present study is to describe the biological consequences of renal DNaseI shut-down and reduced chromatin fragmentation with a particular focus on whether exposed large chromatin fragments activate Toll like receptors and the necrosis-related Clec4e receptor in murine and human lupus nephritis. Furthermore, analyses where performed to determine if matrix metalloproteases are up-regulated as a consequence of chromatin-mediated Toll like receptors/Clec4e stimulation. Mouse and human mRNA expression levels of DNaseI, Toll like receptors 7-9, Clec4e, pro-inflammatory cytokines and MMP2/MMP9 were determined and compared with in situ protein expression profiles and clinical data. We demonstrate that exposure of chromatin significantly up-regulate Toll like receptors and Clec4e in mice, and also but less pronounced in patients with lupus nephritis treated with immunosuppresants. In conclusion, silencing of renal DNaseI gene expression initiates a cascade of inflammatory signals leading to progression of both murine and human lupus nephritis. Principal component analyses biplot of data from murine and human lupus nephrits demonstrate the importance of DNaseI gene shut down for progression of the organ disease.	[Thiyagarajan, Dhivya; Fismen, Silje; Seredkina, Natalya; Rekvig, Ole Petter; Mortensen, Elin Synnove] Univ Tromso, Fac Med, Mol Pathol Res Grp, Tromso, Norway; [Jacobsen, Soren] Copenhagen Univ Hosp, Dept Rheumatol, Copenhagen, Denmark; [Elung-Jensen, Thomas; Kamper, Anne-Lise] Copenhagen Univ Hosp, Dept Nephrol, Copenhagen, Denmark; [Fenton, Christopher Graham] Univ Tromso, Fac Med, Microarray Platform, Tromso, Norway	UiT The Arctic University of Tromso; University of Copenhagen; University of Copenhagen; UiT The Arctic University of Tromso	Thiyagarajan, D (corresponding author), Univ Tromso, Fac Med, Mol Pathol Res Grp, Tromso, Norway.	olepr@fagmed.uit.no	Rekvig, Ole Petter/V-7113-2019; Jacobsen, Søren/T-2491-2019	Jacobsen, Søren/0000-0002-5654-4993; Kamper, Anne-Lise/0000-0001-7523-6569	Foundation for Health and Rehabilitation through the Norwegian Rheumatology Organization [2004/2/0250]; Northern Norway Regional Health Authority Medical Research Program [SFP-100-04, SFP-101-04]; University of Tromso; Novo Nordisk Foundation; Danish Rheumatism Association	Foundation for Health and Rehabilitation through the Norwegian Rheumatology Organization; Northern Norway Regional Health Authority Medical Research Program; University of Tromso; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Rheumatism Association	This work was supported by Foundation for Health and Rehabilitation through the Norwegian Rheumatology Organization (project 2004/2/0250), from Northern Norway Regional Health Authority Medical Research Program (Grants # SFP-100-04, SFP-101-04), and from University of Tromso as a Milieu support given to OPR, and The Novo Nordisk Foundation and Danish Rheumatism Association supported SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aringer M, 2002, LUPUS, V11, P102, DOI 10.1191/0961203302lu160oa; Balow JE, 1999, SYSTEMIC LUPUS ERYTH, P657; Basnakian AG, 2005, J AM SOC NEPHROL, V16, P697, DOI 10.1681/ASN.2004060494; Ben David D, 2008, HISTOCHEM CELL BIOL, V129, P589, DOI 10.1007/s00418-008-0391-1; Benigni A, 2007, ARTHRITIS RHEUM, V56, P1569, DOI 10.1002/art.22524; Berden JHM, 2002, J NEPHROL, V15, pS1; Brown GD, 2008, NAT IMMUNOL, V9, P1099, DOI 10.1038/ni1008-1099; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Cherfils-Vicini J, 2010, J CLIN INVEST, V120, P1285, DOI 10.1172/JCI36551; Christensen SR, 2007, SEMIN IMMUNOL, V19, P11, DOI 10.1016/j.smim.2006.12.005; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Ciferska H, 2008, LUPUS, V17, P580, DOI 10.1177/0961203307088130; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Dieker JWC, 2004, NEPHROL DIAL TRANSPL, V19, P282, DOI 10.1093/ndt/gfg485; Fenton K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008474; Fismen S, 2010, IMMUNOL CELL BIOL; Frisoni L, 2007, J IMMUNOL, V179, P7959, DOI 10.4049/jimmunol.179.11.7959; Gaipl US, 2006, CURR DIRECT AUTOIMMU, V9, P173; Gaipl US, 2006, CURR TOP MICROBIOL, V305, P161, DOI 10.1007/3-540-29714-6_8; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Haas C, 1997, J IMMUNOL, V158, P5484; Haas C, 1996, J INFLAMM, V47, P206; Han YP, 2001, J CELL SCI, V114, P131; Hedberg A, 2010, ARTHRITIS RHEUM; Jacob C O, 1992, Semin Immunol, V4, P147; JACOB CO, 1988, NATURE, V331, P356, DOI 10.1038/331356a0; Kalaaji M, 2007, KIDNEY INT, V71, P664, DOI 10.1038/sj.ki.5002133; Kalaaji M, 2006, AM J PATHOL, V168, P1779, DOI 10.2353/ajpath.2006.051329; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kawane K, 2008, METHOD ENZYMOL, V442, P271, DOI 10.1016/S0076-6879(08)01414-6; Kim S, 2008, MOLECULES, V13, P2975, DOI 10.3390/molecules13122975; Kossakowska AE, 1999, BLOOD, V94, P2080, DOI 10.1182/blood.V94.6.2080.418k30_2080_2089; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Kruse K, 2010, APOPTOSIS; Licht R, 2004, J AUTOIMMUN, V22, P139, DOI 10.1016/j.jaut.2003.11.003; Lim EJ, 2006, FEBS LETT, V580, P4533, DOI 10.1016/j.febslet.2006.06.100; Lim EJ, 2007, EXP MOL MED, V39, P239, DOI 10.1038/emm.2007.27; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Napirei M, 2006, INT J BIOCHEM CELL B, V38, P297, DOI 10.1016/j.biocel.2005.10.023; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Pawar RD, 2006, J AM SOC NEPHROL, V17, P3365, DOI 10.1681/ASN.2006030263; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; SBARRA AJ, 1963, NATURE, V198, P159, DOI 10.1038/198159a0; Seredkina N, 2009, AM J PATHOL IN PRESS; Seredkina S, 2011, AM J PATHOL; Smits ELJM, 2008, ONCOLOGIST, V13, P859, DOI 10.1634/theoncologist.2008-0097; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Triantafyllopoulou A, 2010, P NATL ACAD SCI USA, V107, P3012, DOI 10.1073/pnas.0914902107; Tveita AA, 2009, LUPUS, V18, P355, DOI 10.1177/0961203308100842; Tveita A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2532; Tveita AA, 2008, KIDNEY INT, V74, P1150, DOI 10.1038/ki.2008.308; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Zhang Q, 2008, ANN RHEUM DIS, V67, P1633, DOI 10.1136/ard.2007.079574; Zykova SN, 2008, ARTHRITIS RHEUM-US, V58, P813, DOI 10.1002/art.23276; Zykova SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012096	63	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34080	10.1371/journal.pone.0034080	http://dx.doi.org/10.1371/journal.pone.0034080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479529	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100115
J	Wang, QS; Xiang, YZ; Cui, YL; Lin, KM; Zhang, XF				Wang, Qiang-Song; Xiang, Yaozu; Cui, Yuan-Lu; Lin, Ke-Ming; Zhang, Xin-Fang			Dietary Blue Pigments Derived from Genipin, Attenuate Inflammation by Inhibiting LPS-Induced iNOS and COX-2 Expression via the NF-kappa B Inactivation	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RAW 264.7 MACROPHAGES; STIMULATED RAW264.7 MACROPHAGES; THERAPEUTIC TARGET; ALPHA PRODUCTION; GARDENIA FRUITS; GENE-EXPRESSION; L-ARGININE; TNF-ALPHA; CELLS	Background and Purpose: The edible blue pigments produced by gardenia fruits have been used as value-added colorants for foods in East Asia for 20 years. However, the biological activity of the blue pigments derived from genipin has not been reported. Methodology/Principal Findings: The anti-inflammatory effect of blue pigments was studied in lipopolysaccharide (LPS) stimulated RAW 264.7 macrophage in vitro. The secretions of nitric oxide (NO) and prostaglandin E-2 (PGE(2)) were inhibited in concentration-dependent manner by blue pigments. Real-time reverse-transcription polymerase chain reaction (Real-time RT-PCR) analyses demonstrated that the mRNA expression of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), interleukin (IL)-6, and tumor necrosis factor alpha (TNF-alpha) was inhibited, moreover, ELISA results showed that the productions of IL-6 and TNF-alpha were inhibited. Cell-based ELISA revealed the COX-2 protein expression was inhibited. The proteome profiler array showed that 12 cytokines and chemokines involved in the inflammatory process were down-regulated by blue pigments. Blue pigments inhibited the nuclear transcription factor kappa-B (NF-kappa B) activation induced by LPS, and this was associated with decreasing the DNA-binding activity of p65 and p50. Furthermore, blue pigments suppressed the degradation of inhibitor of kappa B (I kappa B) alpha, Inhibitor of NF-kappa B Kinase (IKK) alpha, IKK-beta, and phosphorylation of I kappa B-alpha. The anti-inflammatory effect of blue pigments in vivo was studied in carrageenan-induced paw edema and LPS-injecting ICR mice. Finally, blue pigments significantly inhibited paw swelling and reduced plasma TNF-alpha and IL-6 production in vivo. Conclusions and Implications: These results suggest that the anti-inflammatory properties of blue pigments might be the results from the inhibition of iNOS, COX-2, IL-6, IL-1 beta, and TNF-alpha expression through the down-regulation of NF-kappa B activation, which will provide strong scientific evidence for the edible blue pigments to be developed as a new healthenhancing nutritional food for the prevention and treatment of inflammatory diseases.	[Wang, Qiang-Song; Cui, Yuan-Lu; Lin, Ke-Ming; Zhang, Xin-Fang] Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China; [Xiang, Yaozu] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England	Tianjin University of Traditional Chinese Medicine; Imperial College London	Cui, YL (corresponding author), Tianjin Univ Tradit Chinese Med, Tianjin State Key Lab Modern Chinese Med, Tianjin, Peoples R China.	cuiyl@tju.edu.cn	Cui, Yuan-Lu/A-3705-2013	Cui, Yuan-Lu/0000-0003-4392-3713; /0000-0002-1452-6455	National Natural Science Foundation of China [30973967, 81173469]; Program for New Century Excellent Talents in University [NCET-09-0899]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT); Specialized Research Fund for the Doctoral Program of Higher Education [20091210110003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Natural Science Foundation of China (No. 30973967, 81173469), Program for New Century Excellent Talents in University (NCET-09-0899), Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) and the Specialized Research Fund for the Doctoral Program of Higher Education (No. 20091210110003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avni D, 2010, MOL IMMUNOL, V47, P1396, DOI 10.1016/j.molimm.2010.02.015; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Burger D, 2006, BEST PRACT RES CL RH, V20, P879, DOI 10.1016/j.berh.2006.06.004; Chang WH, 2003, J BIOMAT SCI-POLYM E, V14, P481, DOI 10.1163/156856203766652084; Cho JY, 2000, J ETHNOPHARMACOL, V70, P127, DOI 10.1016/S0378-8741(99)00154-3; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Feron M, 2009, AM J PATHOL, V174, P1459, DOI 10.2353/ajpath.2009.080460; FUJIKAWA S, 1987, TETRAHEDRON LETT, V28, P4699, DOI 10.1016/S0040-4039(00)96601-2; FUJIKAWA S, 1987, J FERMENT BIOENG, V65, P419, DOI 10.1016/0385-6380(87)90138-5; Fukuzawa M, 1997, IMMUNOPHARMACOLOGY, V36, P49, DOI 10.1016/S0162-3109(96)00160-9; GODAMBE SA, 1994, J IMMUNOL, V153, P143; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; Hinz B, 2000, BIOCHEM BIOPH RES CO, V272, P744, DOI 10.1006/bbrc.2000.2859; Hinz B, 2000, BIOCHEM BIOPH RES CO, V271, P353, DOI 10.1006/bbrc.2000.2632; Jeon YJ, 2000, IMMUNOPHARMACOLOGY, V48, P173, DOI 10.1016/S0162-3109(00)00199-5; Kang HG, 2007, CANCER RES, V67, P3094, DOI 10.1158/0008-5472.CAN-06-3259; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Koo HJ, 2004, EUR J PHARMACOL, V495, P201, DOI 10.1016/j.ejphar.2004.05.031; Korhonen Riku, 2005, Current Drug Targets - Inflammation and Allergy, V4, P471, DOI 10.2174/1568010054526359; Lappas M, 2002, BIOL REPROD, V67, P668, DOI 10.1095/biolreprod67.2.668; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Levinton-Shamuilov G, 2005, J FORENSIC SCI, V50, P1367; Liu BS, 2003, J BIOMED MATER RES A, V67A, P1163, DOI 10.1002/jbm.a.20017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lowenstein CJ, 1996, J CLIN INVEST, V97, P1837, DOI 10.1172/JCI118613; Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1; Marcondes AM, 2008, P NATL ACAD SCI USA, V105, P2865, DOI 10.1073/pnas.0712391105; MARLETTA MA, 1993, J BIOL CHEM, V268, P12231; MASFERRER JL, 1994, P NATL ACAD SCI USA, V91, P3228, DOI 10.1073/pnas.91.8.3228; May MJ, 1999, SCIENCE, V284, P271, DOI 10.1126/science.284.5412.271; Mehta VB, 2001, J BIOL CHEM, V276, P3820, DOI 10.1074/jbc.M006814200; MONCADA S, 1991, PHARMACOL REV, V43, P109; Paik YS, 2001, J AGR FOOD CHEM, V49, P430, DOI 10.1021/jf000978f; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Park JE, 2002, J AGR FOOD CHEM, V50, P6511, DOI 10.1021/jf020499b; Rafi MM, 2007, MOL NUTR FOOD RES, V51, P333, DOI 10.1002/mnfr.200600170; Raspotnig G, 1999, ANAL BIOCHEM, V275, P74, DOI 10.1006/abio.1999.4309; Renard P, 1999, CELL BIOL TOXICOL, V15, P341, DOI 10.1023/A:1007652414175; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; Rose-John S, 2007, EXPERT OPIN THER TAR, V11, P613, DOI 10.1517/14728222.11.5.613; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Seo WG, 2001, J ETHNOPHARMACOL, V76, P119, DOI 10.1016/S0378-8741(01)00220-3; Shin EM, 2008, INT IMMUNOPHARMACOL, V8, P1524, DOI 10.1016/j.intimp.2008.06.008; Suh N, 1998, CANCER RES, V58, P717; Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P751, DOI 10.1163/156856299X00621; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Takeuchi S, 2005, HEPATOL RES, V33, P298, DOI 10.1016/j.hepres.2005.08.009; Tanaka M, 2009, BIOL PHARM BULL, V32, P1220, DOI 10.1248/bpb.32.1220; Tsai CC, 2001, BIOMATERIALS, V22, P523, DOI 10.1016/S0142-9612(00)00206-4; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; Versteeg HH, 2000, BIOCHEM J, V350, P717, DOI 10.1042/0264-6021:3500717; Wang QS, 2011, J ETHNOPHARMACOL, V136, P480, DOI 10.1016/j.jep.2010.06.008; Zhang C. H., 2006, FOOD COLORANTS DATA	61	140	143	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34122	10.1371/journal.pone.0034122	http://dx.doi.org/10.1371/journal.pone.0034122			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479539	Green Published, gold, Green Submitted			2022-12-27	WOS:000305339100119
J	Mondal, S; Bhattacharya, K; Mallick, A; Sangwan, R; Mandal, C				Mondal, Susmita; Bhattacharya, Kaushik; Mallick, Asish; Sangwan, Rajender; Mandal, Chitra			Bak Compensated for Bax in p53-null Cells to Release Cytochrome c for the Initiation of Mitochondrial Signaling during Withanolide D-Induced Apoptosis	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; WITHANIA-SOMNIFERA; LEUKEMIC-CELLS; P53 NETWORK; DNA-DAMAGE; DEATH; CANCER; GENE; ASHWAGANDHA; SUPPRESSION	The goal of cancer chemotherapy to induce multi-directional apoptosis as targeting a single pathway is unable to decrease all the downstream effect arises from crosstalk. Present study reports that Withanolide D (WithaD), a steroidal lactone isolated from Withania somnifera, induced cellular apoptosis in which mitochondria and p53 were intricately involved. In MOLT-3 and HCT116p53+/+ cells, WithaD induced crosstalk between intrinsic and extrinsic signaling through Bid, whereas in K562 and HCT116p53-/- cells, only intrinsic pathway was activated where Bid remain unaltered. WithaD showed pronounced activation of p53 in cancer cells. Moreover, lowered apoptogenic effect of HCT116p53-/- over HCT116p53+/+ established a strong correlation between WithaD-mediated apoptosis and p53. WithaD induced Bax and Bak upregulation in HCT116p53+/+, whereas increase only Bak expression in HCT116p53-/- cells, which was coordinated with augmented p53 expression. p53 inhibition substantially reduced Bax level and failed to inhibit Bak upregulation in HCT116p53+/+ cells confirming p53-dependent Bax and p53-independent Bak activation. Additionally, in HCT116p53+/+ cells, combined loss of Bax and Bak (HCT116Bax2Bak2) reduced WithaD-induced apoptosis and completely blocked cytochrome c release whereas single loss of Bax or Bak (HCT116Bax2Bak+/HCT116Bax+Bak-) was only marginally effective after WithaD treatment. In HCT116p53-/- cells, though Bax translocation to mitochondria was abrogated, Bak oligomerization helped the cells to release cytochrome c even before the disruption of mitochondrial membrane potential. WithaD also showed in vitro growth-inhibitory activity against an array of p53 wild type and null cancer cells and K562 xenograft in vivo. Taken together, WithaD elicited apoptosis in malignant cells through Bax/Bak dependent pathway in p53-wild type cells, whereas Bak compensated against loss of Bax in p53-null cells.	[Mondal, Susmita; Bhattacharya, Kaushik; Mallick, Asish; Mandal, Chitra] Indian Inst Chem Biol, Canc & Cell Biol Div, Council Sci & Ind Res, Kolkata, W Bengal, India; [Sangwan, Rajender] Cent Inst Med & Aromat Plants, Council Sci & Ind Res, Metab & Struct Biol Div, Lucknow 226016, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Mondal, S (corresponding author), Sammilani Mahavidyalaya, Dept Microbiol, Kolkata, India.	chitra_mandal@yahoo.com		Sangwan, Rajender Singh/0000-0003-1708-4151	Council of Scientific and Industrial Research (CSIR) [IAP-0001]; New Millennium Indian Technology leadership Initiative (NMITLI) [TLP-004, HCP004]; CSIR - Indian Institute of Chemical Biology (IICB), Department of Biotechnology (DBT), Government of India [GAP 235]	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); New Millennium Indian Technology leadership Initiative (NMITLI); CSIR - Indian Institute of Chemical Biology (IICB), Department of Biotechnology (DBT), Government of India	Council of Scientific and Industrial Research (CSIR) under IAP-0001, Systems Biology (HCP004), New Millennium Indian Technology leadership Initiative (NMITLI, TLP-004), CSIR - Indian Institute of Chemical Biology (IICB), Department of Biotechnology (DBT) under cancer Biology (GAP 235), Government of India supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 1999, J ETHNOPHARMACOL, V67, P27, DOI 10.1016/S0378-8741(99)00065-3; Bhattacharya K, 2010, BIOCHEM PHARMACOL, V79, P361, DOI 10.1016/j.bcp.2009.09.007; Billen LP, 2008, ONCOGENE, V27, pS93, DOI 10.1038/onc.2009.47; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Das Chaurasiya N, 2008, PHYTOCHEM ANALYSIS, V19, P148, DOI 10.1002/pca.1029; Degenhardt K, 2002, CANCER CELL, V2, P193, DOI 10.1016/S1535-6108(02)00126-5; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Gogvadze V, 2009, SEMIN CANCER BIOL, V19, P57, DOI 10.1016/j.semcancer.2008.11.007; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; Hoffman WH, 2002, J BIOL CHEM, V277, P3247, DOI 10.1074/jbc.M106643200; Iuvone T, 2003, LIFE SCI, V72, P1617, DOI 10.1016/S0024-3205(02)02472-4; Jayaprakasam B, 2003, LIFE SCI, V74, P125, DOI 10.1016/j.lfs.2003.07.007; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Madesh M, 2002, J BIOL CHEM, V277, P5651, DOI 10.1074/jbc.M108171200; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Mandal C, 2008, APOPTOSIS, V13, P1450, DOI 10.1007/s10495-008-0271-0; Mandal C, 2010, INT J CANCER, V126, P337, DOI 10.1002/ijc.24733; MIYASHITA T, 1994, CANCER RES, V54, P3131; Mondal S, 2012, ANTI-CANCER AGENT ME, V12, P49, DOI 10.2174/187152012798764697; Mondal S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-239; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; O'Connor L, 2000, CANCER RES, V60, P1217; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200; Rasool M, 2007, FUND CLIN PHARMACOL, V21, P157, DOI 10.1111/j.1472-8206.2006.00461.x; Sugars KL, 2001, NUCLEIC ACIDS RES, V29, P4530, DOI 10.1093/nar/29.22.4530; Tokino T, 2000, CRIT REV ONCOL HEMAT, V33, P1, DOI 10.1016/S1040-8428(99)00051-7; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Ziauddin M, 1996, J ETHNOPHARMACOL, V50, P69, DOI 10.1016/0378-8741(95)01318-0	39	31	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34277	10.1371/journal.pone.0034277	http://dx.doi.org/10.1371/journal.pone.0034277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479585	Green Published, gold			2022-12-27	WOS:000304523400066
J	Rousk, J; Ackermann, K; Curling, SF; Jones, DL				Rousk, Johannes; Ackermann, Kathrin; Curling, Simon F.; Jones, Davey L.			Comparative Toxicity of Nanoparticulate CuO and ZnO to Soil Bacterial Communities	PLOS ONE			English	Article							METAL-OXIDE NANOPARTICLES; COPPER BIOAVAILABILITY; LEUCINE INCORPORATION; MICROBIAL PROCESSES; TOLERANCE; GROWTH; NANOMATERIALS; STABILITY; THYMIDINE; FUNGAL	The increasing industrial application of metal oxide Engineered Nano-Particles (ENPs) is likely to increase their environmental release to soils. While the potential of metal oxide ENPs as environmental toxicants has been shown, lack of suitable control treatments have compromised the power of many previous assessments. We evaluated the ecotoxicity of ENP (nano) forms of Zn and Cu oxides in two different soils by measuring their ability to inhibit bacterial growth. We could show a direct acute toxicity of nano-CuO acting on soil bacteria while the macroparticulate (bulk) form of CuO was not toxic. In comparison, CuSO4 was more toxic than either oxide form. Unlike Cu, all forms of Zn were toxic to soil bacteria, and the bulk-ZnO was more toxic than the nano-ZnO. The ZnSO4 addition was not consistently more toxic than the oxide forms. Consistently, we found a tight link between the dissolved concentration of metal in solution and the inhibition of bacterial growth. The inconsistent toxicological response between soils could be explained by different resulting concentrations of metals in soil solution. Our findings suggested that the principal mechanism of toxicity was dissolution of metal oxides and sulphates into a metal ion form known to be highly toxic to bacteria, and not a direct effect of nano-sized particles acting on bacteria. We propose that integrated efforts toward directly assessing bioavailable metal concentrations are more valuable than spending resources to reassess ecotoxicology of ENPs separately from general metal toxicity.	[Rousk, Johannes; Ackermann, Kathrin; Jones, Davey L.] Bangor Univ, Environm Ctr Wales, Bangor, Gwynedd, Wales; [Rousk, Johannes] Lund Univ, Dept Biol, Sect Microbial Ecol, Lund, Sweden; [Curling, Simon F.] Bangor Univ, BioComposites Ctr, Bangor, Gwynedd, Wales	Bangor University; Lund University; Bangor University	Rousk, J (corresponding author), Bangor Univ, Environm Ctr Wales, Bangor, Gwynedd, Wales.	johannes.rousk@biol.lu.se	Rousk, Kathrin/H-8836-2013; Jones, Davey L/C-7411-2011; jones, davey/AAN-5606-2020; Rousk, Johannes/E-9741-2010; Jones, Davey/AAD-6037-2020	Rousk, Kathrin/0000-0003-3140-9864; Jones, Davey L/0000-0002-1482-4209; Rousk, Johannes/0000-0002-4985-7262; Jones, Davey/0000-0002-1482-4209; Curling, Simon/0000-0002-3486-0311	Swedish research council [2009-7343, 2011-5719]	Swedish research council(Swedish Research CouncilEuropean Commission)	JR was funded by the Swedish research council (www.vr.se) grants nos 2009-7343 and 2011-5719. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen KN, 2011, ENVIRON TOXICOL CHEM, V30, P588, DOI 10.1002/etc.420; Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004; Auffan M, 2009, NAT NANOTECHNOL, V4, P634, DOI 10.1038/nnano.2009.242; Auffan M, 2009, ENVIRON POLLUT, V157, P1127, DOI 10.1016/j.envpol.2008.10.002; BAATH E, 1994, BIOL FERT SOILS, V17, P147, DOI 10.1007/BF00337747; Baath E, 2001, SOIL BIOL BIOCHEM, V33, P1571, DOI 10.1016/S0038-0717(01)00073-6; Baldock J., 1999, SOIL ANAL INTERPRETA, P159; Brandt KK, 2008, ENVIRON SCI TECHNOL, V42, P3102, DOI 10.1021/es071916+; Brandt KK, 2009, ENVIRON SCI TECHNOL, V43, P2963, DOI 10.1021/es803546y; Broos K, 2007, ENVIRON TOXICOL CHEM, V26, P583, DOI 10.1897/06-302R.1; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Demoling LA, 2008, ENVIRON SCI TECHNOL, V42, P6917, DOI 10.1021/es8004706; Demoling LA, 2008, ENVIRON TOXICOL CHEM, V27, P334, DOI 10.1897/07-289R.1; DIAZRAVINA M, 1994, APPL ENVIRON MICROB, V60, P2238; Fernandez-Calvino D, 2008, EUR J SOIL SCI, V59, P315, DOI 10.1111/j.1365-2389.2007.01004.x; Fernandez-Calvino D, 2011, SOIL BIOL BIOCHEM, V43, P1569, DOI 10.1016/j.soilbio.2011.04.007; Ge YG, 2011, ENVIRON SCI TECHNOL, V45, P1659, DOI 10.1021/es103040t; Giller KE, 1998, SOIL BIOL BIOCHEM, V30, P1389, DOI 10.1016/S0038-0717(97)00270-8; Giller KE, 2009, SOIL BIOL BIOCHEM, V41, P2031, DOI 10.1016/j.soilbio.2009.04.026; Godwin HA, 2009, ENVIRON SCI TECHNOL, V43, P6453, DOI 10.1021/es8034544; Hanley C, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295103; Jiang X, 2002, NANO LETT, V71, P1308; Kakinen A, 2011, SENSORS-BASEL, V11, P10502, DOI 10.3390/s111110502; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kirchman D, 1985, APPL ENVIRON MICROB, V59, P3605; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Li HF, 2009, CHEMOSPHERE, V75, P979, DOI 10.1016/j.chemosphere.2008.12.068; Li M, 2011, ENVIRON SCI TECHNOL, V45, P1977, DOI 10.1021/es102624t; Lin DH, 2010, J ENVIRON QUAL, V39, P1896, DOI 10.2134/jeq2009.0423; Lofts S, 2004, ENVIRON SCI TECHNOL, V38, P3623, DOI 10.1021/es030155h; Mertens J, 2007, ENVIRON SCI TECHNOL, V41, P2992, DOI 10.1021/es061995+; Miller RJ, 2010, ENVIRON SCI TECHNOL, V44, P7329, DOI 10.1021/es100247x; Ore S, 2010, ENVIRON SCI TECHNOL, V44, P9201, DOI 10.1021/es1026294; Pan B, 2008, ENVIRON SCI TECHNOL, V42, P9005, DOI 10.1021/es801777n; Rajapaksha RMCP, 2004, APPL ENVIRON MICROB, V70, P2966, DOI 10.1128/AEM.70.5.2966-2973.2004; Rooney CP, 2006, ENVIRON TOXICOL CHEM, V25, P726, DOI 10.1897/04-602R.1; Rousk J, 2011, SOIL BIOL BIOCHEM, V43, P1881, DOI 10.1016/j.soilbio.2011.05.007; Rousk J, 2011, FEMS MICROBIOL ECOL, V78, P17, DOI 10.1111/j.1574-6941.2011.01106.x; Rousk J, 2011, APPL ENVIRON MICROB, V77, P2791, DOI 10.1128/AEM.02870-10; Rousk J, 2010, SOIL BIOL BIOCHEM, V42, P2331, DOI 10.1016/j.soilbio.2010.08.017; Rousk J, 2009, MICROB ECOL, V58, P75, DOI 10.1007/s00248-008-9444-1; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Saleh NB, 2010, ENVIRON SCI TECHNOL, V44, P2412, DOI 10.1021/es903059t; Smolders E, 2009, ENVIRON TOXICOL CHEM, V28, P1633, DOI 10.1897/08-592.1; Speir TW, 1999, SOIL BIOL BIOCHEM, V31, P1953, DOI 10.1016/S0038-0717(99)00115-7; Thakali S, 2006, ENVIRON SCI TECHNOL, V40, P7094, DOI 10.1021/es061173c; Wang ZY, 2011, ENVIRON SCI TECHNOL, V45, P6032, DOI 10.1021/es2010573; Zhao FJ, 2006, ENVIRON TOXICOL CHEM, V25, P733, DOI 10.1897/04-603R.1	49	88	91	3	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34197	10.1371/journal.pone.0034197	http://dx.doi.org/10.1371/journal.pone.0034197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479561	Green Published, gold, Green Submitted			2022-12-27	WOS:000304523400059
J	Veleri, S; Bishop, K; Nogare, DED; English, MA; Foskett, TJ; Chitnis, A; Sood, R; Liu, P; Swaroop, A				Veleri, Shobi; Bishop, Kevin; Nogare, Damian E. Dalle; English, Milton A.; Foskett, Trevor J.; Chitnis, Ajay; Sood, Raman; Liu, Paul; Swaroop, Anand			Knockdown of Bardet-Biedl Syndrome Gene BBS9/PTHB1 Leads to Cilia Defects	PLOS ONE			English	Article							PLANAR CELL POLARITY; RESPONSIVE B1 GENE; WPK RAT; DISEASE; PROTEIN; DISSECTION; GENOMICS; COMPLEX; FAMILY; MODEL	Bardet-Biedl Syndrome (BBS, MIM#209900) is a genetically heterogeneous disorder with pleiotropic phenotypes that include retinopathy, mental retardation, obesity and renal abnormalities. Of the 15 genes identified so far, seven encode core proteins that form a stable complex called BBSome, which is implicated in trafficking of proteins to cilia. Though BBS9 (also known as PTHB1) is reportedly a component of BBSome, its direct function has not yet been elucidated. Using zebrafish as a model, we show that knockdown of bbs9 with specific antisense morpholinos leads to developmental abnormalities in retina and brain including hydrocephaly that are consistent with the core phenotypes observed in syndromic ciliopathies. Knockdown of bbs9 also causes reduced number and length of cilia in Kupffer's vesicle. We also demonstrate that an orthologous human BBS9 mRNA, but not one carrying a missense mutation identified in BBS patients, can rescue the bbs9 morphant phenotype. Consistent with these findings, knockdown of Bbs9 in mouse IMCD3 cells results in the absence of cilia. Our studies suggest a key conserved role of BBS9 in biogenesis and/or function of cilia in zebrafish and mammals.	[Veleri, Shobi; English, Milton A.; Foskett, Trevor J.; Swaroop, Anand] NEI, N NRL, NIH, Bethesda, MD 20892 USA; [Bishop, Kevin; English, Milton A.; Sood, Raman; Liu, Paul] NHGRI, NIH, Bethesda, MD 20892 USA; [Nogare, Damian E. Dalle; Chitnis, Ajay] NICHHD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Veleri, S (corresponding author), NEI, N NRL, NIH, Bethesda, MD 20892 USA.	swaroopa@nei.nih.gov	Veleri, Shobi/ABD-9406-2020; Liu, Paul/A-7976-2012; Bishop, Kevin H/C-7816-2012	Liu, Paul/0000-0002-6779-025X; Bishop, Kevin H/0000-0002-8057-1051; Swaroop, Anand/0000-0002-1975-1141	National Eye Institute, National Human Genome Research Institute; National Institute of Child Health and Development, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001012] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000450] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000102, ZIGHG200351] Funding Source: NIH RePORTER	National Eye Institute, National Human Genome Research Institute; National Institute of Child Health and Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The study was supported by intramural funds of the National Eye Institute, National Human Genome Research Institute and National Institute of Child Health and Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AE, 1999, BONE, V24, P305, DOI 10.1016/S8756-3282(98)00188-4; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Beales PL, 1999, J MED GENET, V36, P437; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Craige B, J CELL BIOL, V190, P927; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Ghosh AK, HUM MOL GENET, V19, P90; GREEN JS, 1989, NEW ENGL J MED, V321, P1002, DOI 10.1056/NEJM198910123211503; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Hurd TW, NEPHRON EXP NEPHROL, V118, pe9; Jin H, CELL, V141, P1208; Johnson ET, 2008, DEV DYNAM, V237, P2053, DOI 10.1002/dvdy.21612; Kang H, 2008, HUM REPROD, V23, P1457, DOI 10.1093/humrep/den086; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim SK, SCIENCE, V329, P1337; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Lyons SE, 2001, BLOOD, V97, P2611, DOI 10.1182/blood.V97.9.2611; May-Simera HL, DEV BIOL, V345, P215; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nishimura DY, 2005, AM J HUM GENET, V77, P1021, DOI 10.1086/498323; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Shu X, HUM MOL GENET, V19, P657; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Tissir F, NAT NEUROSCI, V13, P700; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Vernon EG, 2003, ONCOGENE, V22, P1371, DOI 10.1038/sj.onc.1206332; Vieira JP, 2012, J CHILD NEUROLOGY; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041; Zhou W, AM J PHYSL RENAL PHY	41	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34389	10.1371/journal.pone.0034389	http://dx.doi.org/10.1371/journal.pone.0034389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479622	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400080
J	Koizumi, I; Usio, N; Kawai, T; Azuma, N; Masuda, R				Koizumi, Itsuro; Usio, Nisikawa; Kawai, Tadashi; Azuma, Noriko; Masuda, Ryuichi			Loss of Genetic Diversity Means Loss of Geological Information: The Endangered Japanese Crayfish Exhibits Remarkable Historical Footprints	PLOS ONE			English	Article							NESTED CLADE ANALYSIS; SEA-LEVEL CHANGE; FRESH-WATER; CAMBAROIDES-JAPONICUS; PHYLOGEOGRAPHY; MITOCHONDRIAL; DECAPODA; POPULATION; DNA; EVOLUTION	Intra-specific genetic diversity is important not only because it influences population persistence and evolutionary potential, but also because it contains past geological, climatic and environmental information. In this paper, we show unusually clear genetic structure of the endangered Japanese crayfish that, as a sedentary species, provides many insights into lesser-known past environments in northern Japan. Over the native range, most populations consisted of unique 16S mtDNA haplotypes, resulting in significant genetic divergence (overall F-ST = 0.96). Owing to the simple and clear structure, a new graphic approach unraveled a detailed evolutionary history; regional crayfish populations were comprised of two distinct lineages that had experienced contrasting demographic processes (i.e. rapid expansion vs. slow stepwise range expansion) following differential drainage topologies and past climate events. Nuclear DNA sequences also showed deep separation between the lineages. Current ocean barriers to dispersal did not significantly affect the genetic structure of the freshwater crayfish, indicating the formation of relatively recent land bridges. This study provides one of the best examples of how phylogeographic analysis can unravel a detailed evolutionary history of a species and how this history contributes to the understanding of the past environment in the region. Ongoing local extinctions of the crayfish lead not only to loss of biodiversity but also to the loss of a significant information regarding past geological and climatic events.	[Koizumi, Itsuro] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido, Japan; [Koizumi, Itsuro] Hokkaido Univ, Grad Sch Environm Earth Sci, Sapporo, Hokkaido 060, Japan; [Usio, Nisikawa] Niigata Univ, Niigata, Japan; [Usio, Nisikawa] Niigata Univ, Ctr Toki & Ecol Restorat, Sado, Japan; [Kawai, Tadashi] Wakkanai Fisheries Res Inst, Fisheries Res Dept, Wakkanai, Hokkaido, Japan; [Azuma, Noriko] Tokyo Univ Agr, Nodai Bioresource Inst, Abashiri, Japan; [Masuda, Ryuichi] Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 060, Japan	Hokkaido University; Hokkaido University; Niigata University; Niigata University; Tokyo University of Agriculture; Hokkaido University	Koizumi, I (corresponding author), Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido, Japan.	itsuro@cris.hokudai.ac.jp	MASUDA, RYUICHI/G-5223-2012; Koizumi, Itsuro/D-4222-2009; Usio, Nisikawa/G-3778-2010	Usio, Nisikawa/0000-0003-3417-6533; Usio, Nisikawa/0000-0002-5906-184X	National Institute for Environmental Studies; JSPS; Grants-in-Aid for Scientific Research [23770013] Funding Source: KAKEN	National Institute for Environmental Studies; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Funding to Promote Creative Research (Shorei Kenkyu) at National Institute for Environmental Studies to NU. I.K. was financially supported by the JSPS Postdoctoral Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn DH, 2006, KOREAN J GENETIC, V28, P185; Aizawa M, 2007, MOL ECOL, V16, P3393, DOI 10.1111/j.1365-294X.2007.03391.x; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Bennett KD, 2008, QUATERNARY SCI REV, V27, P2449, DOI 10.1016/j.quascirev.2008.08.019; Biebach I, 2009, MOL ECOL, V18, P5046, DOI 10.1111/j.1365-294X.2009.04420.x; Bishop P, 1995, PROG PHYS GEOG, V19, P449, DOI 10.1177/030913339501900402; BOILEAU MG, 1992, J EVOLUTION BIOL, V5, P25, DOI 10.1046/j.1420-9101.1992.5010025.x; Braband A, 2006, J ZOOL SYST EVOL RES, V44, P17, DOI 10.1111/j.1439-0469.2005.00338.x; Buhay JE, 2005, MOL ECOL, V14, P4259, DOI 10.1111/j.1365-294X.2005.02755.x; Buhay JE, 2007, MOL PHYLOGENET EVOL, V42, P435, DOI 10.1016/j.ympev.2006.07.014; Burridge CP, 2008, EVOLUTION, V62, P1484, DOI 10.1111/j.1558-5646.2008.00377.x; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Castric V, 2001, EVOLUTION, V55, P1016, DOI 10.1554/0014-3820(2001)055[1016:LSAHGD]2.0.CO;2; Crandall KA, 1996, SYST BIOL, V45, P1; CRANDALL KA, 1993, GENETICS, V134, P959; Crandall KA, 2008, HYDROBIOLOGIA, V595, P295, DOI 10.1007/s10750-007-9120-3; Depraz A, 2008, MOL ECOL, V17, P2449, DOI 10.1111/j.1365-294X.2008.03760.x; DOBSON, 1998, QUATERNARY RES, V37, P385; Edmonds CA, 2004, P NATL ACAD SCI USA, V101, P975, DOI 10.1073/pnas.0308064100; Epperson BK, 2010, MOL ECOL, V19, P3549, DOI 10.1111/j.1365-294X.2010.04678.x; Fetzner JW, 2003, EVOLUTION, V57, P2101; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Fratini S, 2005, HEREDITY, V94, P108, DOI 10.1038/sj.hdy.6800581; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guo QF, 2003, ECOGRAPHY, V26, P129, DOI 10.1034/j.1600-0587.2003.03379.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hansen MM, 2009, MOL ECOL, V18, P2549, DOI 10.1111/j.1365-294X.2009.04198.x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Hughes JM, 2009, BIOSCIENCE, V59, P573, DOI 10.1525/bio.2009.59.7.8; Hurwood DA, 2001, MOL ECOL, V10, P113, DOI 10.1046/j.1365-294X.2001.01175.x; Ikeda H, 2006, MOL ECOL, V15, P3731, DOI 10.1111/j.1365-294X.2006.03054.x; Kawai T, 2004, P BIOL SOC WASH, V117, P23; Kawai T, 1997, B MAR SCI, V61, P147; Kawamura Yoshinari, 2007, Quaternary Research (Tokyo), V46, P171; Kitamura A, 2006, PALAEOGEOGR PALAEOCL, V236, P355, DOI 10.1016/j.palaeo.2005.11.015; Koaze T, REGIONAL GEOMORPHOLO, V2; Koskinen MT, 2002, MOL ECOL, V11, P2599, DOI 10.1046/j.1365-294X.2002.01642.x; Kurose N, 1999, ZOOL SCI, V16, P971, DOI 10.2108/zsj.16.971; Lambeck K, 2001, SCIENCE, V292, P679, DOI 10.1126/science.1059549; Lee E, 2008, QUATERN INT, V176, P3, DOI 10.1016/j.quaint.2007.03.021; Letcher BH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001139; Lorenzen ED, 2008, MOL ECOL, V17, P2812, DOI 10.1111/j.1365-294X.2008.03781.x; Marthinsen G, 2009, CONSERV GENET, V10, P923, DOI 10.1007/s10592-008-9581-6; Millien-Parra V, 1999, J BIOGEOGR, V26, P959, DOI 10.1046/j.1365-2699.1999.00346.x; Ministry of the Environmental Government of Japan, 2006, THREAT WILDL JAP RED; Morjan CL, 2004, MOL ECOL, V13, P1341, DOI 10.1111/j.1365-294X.2004.02164.x; Nagata J, 1998, MOL ECOL, V7, P871, DOI 10.1046/j.1365-294x.1998.00404.x; Nakata K, 2004, AQUACULTURE, V242, P335, DOI 10.1016/j.aquaculture.2004.08.043; Nakata K, 2006, J CRUSTACEAN BIOL, V26, P134, DOI 10.1651/S-2652.1; Nguyen TTT, 2004, BIOL J LINN SOC, V83, P539, DOI 10.1111/j.1095-8312.2004.00410.x; Ohshima K, 1990, QUATERNARY RES, V29, P193, DOI DOI 10.4116/JAQUA.29.193; Ohta T, 2002, P NATL ACAD SCI USA, V99, P16134, DOI 10.1073/pnas.252626899; Ozawa H, 2005, MAR MICROPALEONTOL, V54, P167, DOI 10.1016/j.marmicro.2004.10.002; Pannell JR, 2000, PHILOS T R SOC B, V355, P1851, DOI 10.1098/rstb.2000.0740; Pongratz N, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-23; Ponniah M, 2004, EVOLUTION, V58, P1073; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schneider S, ARLEQUIN VERSION 2 0; Scholtz G, 2002, ACTA ZOOL-STOCKHOLM, V83, P203, DOI 10.1046/j.1463-6395.2002.00113.x; Schubart CD, 1998, NATURE, V393, P363, DOI 10.1038/30724; Schultz MB, 2008, MOL ECOL, V17, P5291, DOI 10.1111/j.1365-294X.2008.03996.x; Shull HC, 2005, MOL PHYLOGENET EVOL, V37, P249, DOI 10.1016/j.ympev.2005.04.034; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Sota T, 2007, J BIOGEOGR, V34, P977, DOI 10.1111/j.1365-2699.2006.01672.x; Suzuki H, 2004, GENES GENET SYST, V79, P165, DOI 10.1266/ggs.79.165; Suzuki T, 1992, MEM GEOL SOC JAPAN, V37, P25; TEMPLETON AR, 1993, GENETICS, V134, P659; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Turgeon J, 2001, EVOLUTION, V55, P2274; Usio N, 2007, BIOL CONSERV, V134, P517, DOI 10.1016/j.biocon.2006.09.002; Watanabe Katsutoshi, 2006, Japanese Journal of Ichthyology, V53, P1; Wegener A, 1966, ORIGIN CONTINENTS OC; Yamaguchi Takao, 1993, P15; Yamazaki Y, 2003, J FISH BIOL, V62, P591, DOI 10.1046/j.1095-8649.2003.00050.x; Yokoyama R, 2002, ICHTHYOL RES, V49, P147, DOI 10.1007/s102280200019; Yonekura N, REGIONAL GEOMORPHOLO, V1	85	33	35	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33986	10.1371/journal.pone.0033986	http://dx.doi.org/10.1371/journal.pone.0033986			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470505	Green Published, gold			2022-12-27	WOS:000304489000050
J	Nohynek, H; Jokinen, J; Partinen, M; Vaarala, O; Kirjavainen, T; Sundman, J; Himanen, SL; Hublin, C; Julkunen, I; Olsen, P; Saarenpaa-Heikkila, O; Kilpi, T				Nohynek, Hanna; Jokinen, Jukka; Partinen, Markku; Vaarala, Outi; Kirjavainen, Turkka; Sundman, Jonas; Himanen, Sari-Leena; Hublin, Christer; Julkunen, Ilkka; Olsen, Paivi; Saarenpaa-Heikkila, Outi; Kilpi, Terhi			AS03 Adjuvanted AH1N1 Vaccine Associated with an Abrupt Increase in the Incidence of Childhood Narcolepsy in Finland	PLOS ONE			English	Article							AUTOIMMUNITY; CATAPLEXY; ACTIVATION; INDUCTION; CHILDREN; COMPLEX; ADULTS; TYPE-1; ONSET	Background: Narcolepsy is a chronic sleep disorder with strong genetic predisposition causing excessive daytime sleepiness and cataplexy. A sudden increase in childhood narcolepsy was observed in Finland soon after pandemic influenza epidemic and vaccination with ASO3-adjuvanted Pandemrix. No increase was observed in other age groups. Methods: Retrospective cohort study. From January 1, 2009 to December 31, 2010 we retrospectively followed the cohort of all children living in Finland and born from January 1991 through December 2005. Vaccination data of the whole population was obtained from primary health care databases. All new cases with assigned ICD-10 code of narcolepsy were identified and the medical records reviewed by two experts to classify the diagnosis of narcolepsy according to the Brighton collaboration criteria. Onset of narcolepsy was defined as the first documented contact to health care because of excessive daytime sleepiness. The primary follow-up period was restricted to August 15, 2010, the day before media attention on post-vaccination narcolepsy started. Findings: Vaccination coverage in the cohort was 75%. Of the 67 confirmed cases of narcolepsy, 46 vaccinated and 7 unvaccinated were included in the primary analysis. The incidence of narcolepsy was 9.0 in the vaccinated as compared to 0.7/100,000 person years in the unvaccinated individuals, the rate ratio being 12.7 (95% confidence interval 6.1-30.8). The vaccine-attributable risk of developing narcolepsy was 1:16,000 vaccinated 4 to 19-year-olds (95% confidence interval 1:13,000-1:21,000). Conclusions: Pandemrix vaccine contributed to the onset of narcolepsy among those 4 to 19 years old during the pandemic influenza in 2009-2010 in Finland. Further studies are needed to determine whether this observation exists in other populations and to elucidate potential underlying immunological mechanism. The role of the adjuvant in particular warrants further research before drawing conclusions about the use of adjuvanted pandemic vaccines in the future.	[Nohynek, Hanna; Jokinen, Jukka; Vaarala, Outi; Sundman, Jonas; Kilpi, Terhi] Natl Inst Hlth & Welf, Dept Vaccines & Immune Protect, Helsinki, Finland; [Partinen, Markku] Vitalmed Res Ctr, Helsinki Sleep Clin, Helsinki, Finland; [Kirjavainen, Turkka] Helsinki Univ Hosp, Childrens Hosp, Dept Pediat, Helsinki, Finland; [Himanen, Sari-Leena] Tampere Univ Hosp, Dept Clin Neurophysiol, Tampere, Finland; [Hublin, Christer] Finnish Inst Occupat Hlth, Helsinki, Finland; [Julkunen, Ilkka] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Olsen, Paivi] Oulu Univ Hosp, Dept Child Neurol, Oulu, Finland; [Saarenpaa-Heikkila, Outi] Tampere Univ Hosp, Dept Pediat, Tampere, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University Hospital; Finnish Institute of Occupational Health; Finland National Institute for Health & Welfare; University of Oulu; Tampere University; Tampere University Hospital	Nohynek, H (corresponding author), Natl Inst Hlth & Welf, Dept Vaccines & Immune Protect, Helsinki, Finland.	hanna.nohynek@thl.fi	Hublin, Christer/AAM-7105-2021	Partinen, Markku/0000-0002-8182-9368; Himanen, Sari-Leena/0000-0003-0175-590X; Kirjavainen, Turkka/0000-0002-0043-5093; Julkunen, Ilkka/0000-0003-0165-2564	National Institute for Health and Welfare (THL); Ministry of Social Affairs and Health, Finland	National Institute for Health and Welfare (THL); Ministry of Social Affairs and Health, Finland	The following organizations funded the study: National Institute for Health and Welfare (THL) and Ministry of Social Affairs and Health, Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agence francaise de securite sanitaire des produits de sante, 2011, VACC PAND GRIPP A H1; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; BECK FWJ, 1976, P SOC EXP BIOL MED, V151, P615; Billiard M, 1989, SLEEP RES, V18, P201; Blewett MM, 2010, MED HYPOTHESES, V74, P433, DOI 10.1016/j.mehy.2009.10.003; Carmona A, 2010, VACCINE, V28, P5837, DOI 10.1016/j.vaccine.2010.06.065; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; Dauvilliers Y, 2010, SLEEP, V33, P1428, DOI 10.1093/sleep/33.11.1428; Fontana A, 2010, BRAIN, V133, P1300, DOI 10.1093/brain/awq086; Fujinami RS, 2006, CLIN MICROBIOL REV, V19, P80, DOI 10.1128/CMR.19.1.80-94.2006; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Guo JP, 2008, ARTHRITIS RHEUM, V58, P1343, DOI 10.1002/art.23434; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Health Service Executive of Ireland, 2011, STAT NARC PAND; Hor H, 2010, NAT GENET, V42, P786, DOI 10.1038/ng.647; KARJALAINEN J, 1989, NEW ENGL J MED, V320, P881, DOI 10.1056/NEJM198904063201401; Lammi N, 2007, DIABETOLOGIA, V50, P1393, DOI 10.1007/s00125-007-0690-4; Longstreth WT, 2007, SLEEP, V30, P13, DOI 10.1093/sleep/30.1.13; Mignot E, 1997, SLEEP, V20, P1012; Montplaisir J., 1989, SLEEP RES, V18, P271; Munz C, 2009, NAT REV IMMUNOL, V9, P246, DOI 10.1038/nri2527; National Narcolepsy Task Force, 2011, INT REP ASS NARC PAN; Overeem S, 2008, SLEEP MED REV, V12, P95, DOI 10.1016/j.smrv.2007.07.010; Partinen M, 2012, PLOS ONE IN PRESS; Picchioni D, 2007, NEUROEPIDEMIOLOGY, V29, P185, DOI 10.1159/000111581; Satoh M, 2003, J AUTOIMMUN, V21, P1, DOI 10.1016/S0896-8411(03)00083-0; Sweden Medical Products Agency, 2011, OCC NARC CAT CHILDR; Thunander M, 2008, DIABETES RES CLIN PR, V82, P247, DOI 10.1016/j.diabres.2008.07.022; Wucherpfennig KW, 2001, J CLIN INVEST, V108, P1097, DOI 10.1172/JCI200114235	29	342	345	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33536	10.1371/journal.pone.0033536	http://dx.doi.org/10.1371/journal.pone.0033536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470453	Green Submitted, Green Published, gold			2022-12-27	WOS:000304489000023
J	Volz, MS; Mendonca, M; Pinheiro, FS; Cui, HS; Santana, M; Fregni, F				Volz, Magdalena S.; Mendonca, Mariana; Pinheiro, Fernando S.; Cui, Huashun; Santana, Marcus; Fregni, Felipe			Dissociation of Motor Task-Induced Cortical Excitability and Pain Perception Changes in Healthy Volunteers	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; ADULT SQUIRREL-MONKEYS; SILENT PERIOD; INTRACORTICAL INHIBITION; CORTEX STIMULATION; MOVEMENT REPRESENTATIONS; THALAMIC PAIN; PLASTICITY; MUSCLE; HAND	Background: There is evidence that interventions aiming at modulation of the motor cortex activity lead to pain reduction. In order to understand further the role of the motor cortex on pain modulation, we aimed to compare the behavioral (pressure pain threshold) and neurophysiological effects (transcranial magnetic stimulation (TMS) induced cortical excitability) across three different motor tasks. Methodology/Principal Findings: Fifteen healthy male subjects were enrolled in this randomized, controlled, blinded, cross-over designed study. Three different tasks were tested including motor learning with and without visual feedback, and simple hand movements. Cortical excitability was assessed using single and paired-pulse TMS measures such as resting motor threshold (RMT), motor-evoked potential (MEP), intracortical facilitation (ICF), short intracortical inhibition (SICI), and cortical silent period (CSP). All tasks showed significant reduction in pain perception represented by an increase in pressure pain threshold compared to the control condition (untrained hand). ANOVA indicated a difference among the three tasks regarding motor cortex excitability change. There was a significant increase in motor cortex excitability (as indexed by MEP increase and CSP shortening) for the simple hand movements. Conclusions/Significance: Although different motor tasks involving motor learning with and without visual feedback and simple hand movements appear to change pain perception similarly, it is likely that the neural mechanisms might not be the same as evidenced by differential effects in motor cortex excitability induced by these tasks. In addition, TMS-indexed motor excitability measures are not likely good markers to index the effects of motor-based tasks on pain perception in healthy subjects as other neural networks besides primary motor cortex might be involved with pain modulation during motor training.	[Volz, Magdalena S.; Mendonca, Mariana; Pinheiro, Fernando S.; Cui, Huashun; Santana, Marcus; Fregni, Felipe] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Lab Neuromodulat,Spaulding Rehabil Hosp, Boston, MA 02115 USA; [Volz, Magdalena S.; Mendonca, Mariana; Pinheiro, Fernando S.; Cui, Huashun; Santana, Marcus; Fregni, Felipe] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Volz, Magdalena S.] Charite, Charite Ctr Neurol Neurosurg & Psychiat, Campus Charite Mitte, D-13353 Berlin, Germany	Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Volz, MS (corresponding author), Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Lab Neuromodulat,Spaulding Rehabil Hosp, Boston, MA 02115 USA.	fregni.felipe@mgh.harvard.edu		Fregni, Felipe/0000-0001-9359-8643; Pruss, Magdalena Sarah/0000-0002-4522-7482	German Academic Exchange Service (DAAD); National Institutes of Heatlh [R21 DK081773-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK081773] Funding Source: NIH RePORTER	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); National Institutes of Heatlh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Volz MS was funded by a grant scholarship from the German Academic Exchange Service (DAAD). This work was partially supported by a National Institutes of Heatlh grant (R21 DK081773-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahmed MA, 2011, NEUROL RES, V33, P953, DOI 10.1179/1743132811Y.0000000045; Bermpohl F, 2006, PSYCHIAT RES, V141, P1, DOI 10.1016/j.psychres.2005.07.018; Boggio PS, 2008, EUR J NEUROL, V15, P1124, DOI 10.1111/j.1468-1331.2008.02270.x; BONICA JJ, 1979, PAIN, V6, P247, DOI 10.1016/0304-3959(79)90046-0; Boudreau SA, 2010, MANUAL THER, V15, P410, DOI 10.1016/j.math.2010.05.008; Busch A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003786.pub2; Chen R, 1999, EXP BRAIN RES, V128, P539, DOI 10.1007/s002210050878; Conte A, 2007, EXP BRAIN RES, V182, P109, DOI 10.1007/s00221-007-0975-3; Cui RQ, 2000, EXP BRAIN RES, V134, P49, DOI 10.1007/s002210000449; Delvendahl I, 2011, BRAIN STIMUL, V4, P156, DOI 10.1016/j.brs.2010.10.002; Eisenberg E, 2005, PAIN, V113, P99, DOI 10.1016/j.pain.2004.09.030; Fransen M, 2003, COCHRANE DB SYST REV; Fregni F, 2006, ARTHRITIS RHEUM-US, V54, P3988, DOI 10.1002/art.22195; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Garcia-Larrea L, 1999, PAIN, V83, P259, DOI 10.1016/S0304-3959(99)00114-1; Garcia-Larrea L, 1997, STEREOT FUNCT NEUROS, V68, P141, DOI 10.1159/000099915; Garry MI, 2004, J NEUROPHYSIOL, V91, P1570, DOI 10.1152/jn.00595.2003; Gopin CB, 2011, BIPOLAR DISORD, V13, P164, DOI 10.1111/j.1399-5618.2011.00906.x; Grafton ST, 1998, J NEUROSCI, V18, P9420; Hattemer K, 2007, CLIN ENDOCRINOL, V66, P387, DOI 10.1111/j.1365-2265.2007.02744.x; INGHILLERI M, 1993, J PHYSIOL-LONDON, V466, P521; KARNI A, 1995, NATURE, V377, P155; Kwakkel G, 2008, NEUROREHAB NEURAL RE, V22, P111, DOI 10.1177/1545968307305457; Lefaucheur JP, 2006, NEUROLOGY, V67, P1568, DOI 10.1212/01.wnl.0000242731.10074.3c; Liepert J, 2004, BRAIN RES, V1003, P68, DOI 10.1016/j.brainres.2003.12.039; Liepert J, 1998, EXP BRAIN RES, V118, P421, DOI 10.1007/s002210050296; Loscher W, 2009, NEUROTHERAPEUTICS, V6, P258, DOI 10.1016/j.nurt.2009.01.014; Mercier C, 2009, NEUROREHAB NEURAL RE, V23, P587, DOI 10.1177/1545968308328717; Mhalla A, 2011, PAIN; Mhalla A, 2010, PAIN, V149, P495, DOI 10.1016/j.pain.2010.03.009; Moller B, 2007, NEUROREPORT, V18, P1503; Muellbacher W, 2001, EXP BRAIN RES, V136, P431, DOI 10.1007/s002210000614; Nosek BA, 2011, SOC COGNITION, V19, P625; Nudo RJ, 1996, J NEUROPHYSIOL, V75, P2144, DOI 10.1152/jn.1996.75.5.2144; Nudo RJ, 1996, J NEUROSCI, V16, P785; O'Connell NE, 2011, EUR J PHYS REHABIL M; Ostry DJ, 2010, J NEUROSCI, V30, P5384, DOI 10.1523/JNEUROSCI.4571-09.2010; Park JW, 2010, NEUROREHABILITATION, V26, P95, DOI 10.3233/NRE-2010-0540; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037, DOI 10.1152/jn.1995.74.3.1037; Roosink M, 2010, BEHAV BRAIN RES, V213, P35, DOI 10.1016/j.bbr.2010.04.027; Rosenkranz K, 2006, EUR J NEUROSCI, V23, P822, DOI 10.1111/j.1460-9568.2006.04605.x; Sadato N, 1996, J NEUROSCI, V16, P2693; Sainburg RL, 2004, J NEUROPHYSIOL, V92, P1374, DOI 10.1152/jn.00181.2004; Schwenkreis P, 2003, NEUROLOGY, V61, P515, DOI 10.1212/WNL.61.4.515; Seidel S, 2011, ROFO-FORTSCHR RONTG, V183, P1051, DOI 10.1055/s-0031-1281768; Smith MJ, 1999, NEUROLOGY, V53, P2069, DOI 10.1212/WNL.53.9.2069; Strafella AP, 2004, EUR J NEUROSCI, V20, P2245, DOI 10.1111/j.1460-9568.2004.03669.x; Strom V, 2009, EUR J PAIN, V13, P843, DOI 10.1016/j.ejpain.2008.11.003; Strom V, 2009, PAIN, V144, P147, DOI 10.1016/j.pain.2009.04.002; Tazoe T, 2007, EXP BRAIN RES, V177, P419, DOI 10.1007/s00221-006-0686-1; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; Timmermans AAA, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-1; TSUBOKAWA T, 1993, J NEUROSURG, V78, P393, DOI 10.3171/jns.1993.78.3.0393; Tsubokawa T, 1991, Acta Neurochir Suppl (Wien), V52, P137; TSUBOKAWA T, 1991, PACE, V14, P131, DOI 10.1111/j.1540-8159.1991.tb04058.x; van Vliet PM, 2006, MANUAL THER, V11, P208, DOI 10.1016/j.math.2006.03.009; WILSON SA, 1993, J NEUROL SCI, V114, P216, DOI 10.1016/0022-510X(93)90301-E; Zaghi S, 2011, RESTOR NEUROL NEUROS; Zhang W, 2006, NEUROSCI LETT, V409, P200, DOI 10.1016/j.neulet.2006.09.048; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004; ZIEMANN U, 1993, NEUROSCI LETT, V156, P167, DOI 10.1016/0304-3940(93)90464-V; Ziemann U, 2001, BRAIN, V124, P1171, DOI 10.1093/brain/124.6.1171; Zimerman M, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00149	65	12	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34273	10.1371/journal.pone.0034273	http://dx.doi.org/10.1371/journal.pone.0034273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470548	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000087
J	Dawson, JC; Bruche, S; Spence, HJ; Braga, VMM; Machesky, LM				Dawson, John C.; Bruche, Susann; Spence, Heather J.; Braga, Vania M. M.; Machesky, Laura M.			Mtss1 Promotes Cell-Cell Junction Assembly and Stability through the Small GTPase Rac1	PLOS ONE			English	Article							SUPPRESSOR 1 MTSS1; SMALL G-PROTEINS; ADHERENS JUNCTIONS; E-CADHERIN; ADHESION; METASTASIS; CANCER; MIM; ENDOCYTOSIS; ACTIVATION	Cell-cell junctions are an integral part of epithelia and are often disrupted in cancer cells during epithelial-to-mesenchymal transition (EMT), which is a main driver of metastatic spread. We show here that Metastasis suppressor-1 (Mtss1; Missing in Metastasis, MIM), a member of the IMD-family of proteins, inhibits cell-cell junction disassembly in wound healing or HGF-induced scatter assays by enhancing cell-cell junction strength. Mtss1 not only makes cells more resistant to cell-cell junction disassembly, but also accelerates the kinetics of adherens junction assembly. Mtss1 drives enhanced junction formation specifically by elevating Rac-GTP. Lastly, we show that Mtss1 depletion reduces recruitment of F-actin at cell-cell junctions. We thus propose that Mtss1 promotes Rac1 activation and actin recruitment driving junction maintenance. We suggest that the observed loss of Mtss1 in cancers may compromise junction stability and thus promote EMT and metastasis.	[Dawson, John C.; Spence, Heather J.; Machesky, Laura M.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Bruche, Susann; Braga, Vania M. M.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London, England	Beatson Institute; Imperial College London	Dawson, JC (corresponding author), Beatson Inst Canc Res, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	john.c.dawson@ed.ac.uk; l.machesky@beatson.gla.ac.uk	Machesky, Laura/Z-4554-2019; Dawson, John/HDM-6702-2022; Braga, Vania MM/C-7345-2008	Machesky, Laura/0000-0002-7592-9856; Dawson, John/0000-0001-5713-1026; Braga, Vania/0000-0003-0546-7163; Bruche, Susann/0000-0002-5814-7166	Association for International Cancer Research [07-0438]; Cancer Research UK; MRC [G0600791, G117/569] Funding Source: UKRI; Cancer Research UK [11980, 15673] Funding Source: researchfish; Medical Research Council [G117/569, G0600791] Funding Source: researchfish	Association for International Cancer Research; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JCD was funded by a grant to LMM from the Association for International Cancer Research (07-0438). LMM was also funded by Cancer Research UK core funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2001, MOL BIOL CELL, V12, P847, DOI 10.1091/mbc.12.4.847; Betson M, 2002, J BIOL CHEM, V277, P36962, DOI 10.1074/jbc.M207358200; Boissan M, 2010, CANCER RES, V70, P7710, DOI 10.1158/0008-5472.CAN-10-1887; Bompard G, 2005, J CELL SCI, V118, P5393, DOI 10.1242/jcs.02640; Braga VMM, 1999, MOL BIOL CELL, V10, P9, DOI 10.1091/mbc.10.1.9; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Dawson JC, 2011, ONCOGENE; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Lampugnani MG, 2002, MOL BIOL CELL, V13, P1175, DOI 10.1091/mbc.01-07-0368; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Lin JX, 2005, ONCOGENE, V24, P2059, DOI 10.1038/sj.onc.1208412; Liu K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-428; Loberg RD, 2005, INT J ONCOL, V26, P1699; Machesky LM, 2007, J MOL MED-JMM, V85, P569, DOI 10.1007/s00109-007-0207-0; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Millard TH, 2007, J CELL SCI, V120, P1663, DOI 10.1242/jcs.001776; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Quinones GA, 2010, J CELL BIOL, V189, P353, DOI 10.1083/jcb.200910136; Saarikangas J, 2008, J CELL SCI, V121, P1444, DOI 10.1242/jcs.027466; Saarikangas J, 2011, J CELL SCI, V124, P1245, DOI 10.1242/jcs.082610; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Uhlenbrock K, 2004, J CELL SCI, V117, P4863, DOI 10.1242/jcs.01367; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058	35	25	31	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e31141	10.1371/journal.pone.0031141	http://dx.doi.org/10.1371/journal.pone.0031141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479308	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000303894900002
J	Shanmugasundaram, R; Selvaraj, RK				Shanmugasundaram, Revathi; Selvaraj, Ramesh K.			CD4(+)CD25(+) Regulatory T Cell Ontogeny and Preferential Migration to the Cecal Tonsils in Chickens	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; IN-VIVO; PCR DATA; THYMUS; RECEPTOR; SUBPOPULATION; AUTOIMMUNITY; GAMMA/DELTA; THYMECTOMY; EXPRESSION	Thymic CD4(+)CD25(+) cells have regulatory-T-cell-like properties in chickens. This study examined the ontogeny of CD4(+)CD25(+) cells in the thymus and in peripheral compartments in chickens. CD4(+)CD25(+) cells started to appear in the thymus at day 15 of incubation (E15), although at low percentages. Expressed as a percentage of CD4(+) cells, CD4(+)CD25(+) cells increased (P < 0.01) from 1.7% at E20 to 7.3% at 0 d post-hatch (D0). CD4(+)CD25(+) cells did not appear in the spleen or cecal tonsils of embryos. Expressed as a percentage of CD4(+) cells, CD4(+)CD25(+) cells increased (P < 0.01) from 0% at D0 to 27% at D1 in cecal tonsils and from 0% at D0 to 11% at D1 in the spleen. Expressed as a percentage of all mononuclear cells, cecal tonsils at D1 had approximately 3.5-fold higher percentage of CD4(+)CD25(+) cells than the spleen at D1. CD4(+)CD25(+) cells from cecal tonsils of chicks at D1 were suppressive. CD4(+)CD25(+) cells from D0 thymus, when injected back into MHC-compatible chicks, migrated to cecal tonsils and lungs and were detected until 10 d post-injection. CD4(+)CD25(+) cells from cecal tonsils had a higher (P = 0.01) relative amount of CCR9 mRNA than CD4(+)CD25(+) cells from the thymus. It could be concluded that in chickens CD4(+)CD25(+) cells migrate from the thymus immediately post-hatch and preferentially colonize the gut associated lymphoid tissues. CD4(+)CD25(+) cells' preferential migration to cecal tonsils is likely directed through the CCR9 pathway in chickens.	[Shanmugasundaram, Revathi; Selvaraj, Ramesh K.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Anim Sci, Wooster, OH 44691 USA	University System of Ohio; Ohio State University	Shanmugasundaram, R (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Anim Sci, Wooster, OH 44691 USA.	selvaraj.7@osu.edu		/0000-0003-0546-6902	OARDC (Ohio Agricultural Research and Development Center); George and Edna Jaap funding; state fund; federal fund	OARDC (Ohio Agricultural Research and Development Center); George and Edna Jaap funding; state fund; federal fund	This research was supported by an OARDC (Ohio Agricultural Research and Development Center) SEEDS grant and George and Edna Jaap funding awarded to RKS. Salaries and research support were provided by state and federal funds appropriated to The Ohio State University, Ohio Agricultural Research and Development Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Annamalai T, 2010, POULTRY SCI, V89, P2419, DOI 10.3382/ps.2010-00968; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bar-Shira E, 2003, DEV COMP IMMUNOL, V27, P147, DOI 10.1016/S0145-305X(02)00076-9; CHAR D, 1990, J IMMUNOL, V145, P3547; COLTEY M, 1989, J EXP MED, V170, P543, DOI 10.1084/jem.170.2.543; COLTEY M, 1987, CELL DIFFER DEV, V22, P71, DOI 10.1016/0045-6039(87)90414-3; Couper KN, 2007, INFECT IMMUN, V75, P5806, DOI 10.1128/IAI.01005-07; De Boever S, 2008, VET IMMUNOL IMMUNOP, V122, P312, DOI 10.1016/j.vetimm.2007.12.002; Dujardin HC, 2004, P NATL ACAD SCI USA, V101, P14473, DOI 10.1073/pnas.0403303101; DUNON D, 1990, EMBO J, V9, P3315, DOI 10.1002/j.1460-2075.1990.tb07531.x; DUNON D, 1993, EUR J IMMUNOL, V23, P2545, DOI 10.1002/eji.1830231025; DUNON D, 1994, EMBO J, V13, P808, DOI 10.1002/j.1460-2075.1994.tb06323.x; Dunon D, 1996, CURR TOP MICROBIOL, V212, P79; Dunon D, 1997, J EXP MED, V186, P977, DOI 10.1084/jem.186.7.977; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Gagnerault MC, 2009, J IMMUNOL, V183, P4913, DOI 10.4049/jimmunol.0901954; Guo Z, 2008, INT IMMUNOL, V20, P307, DOI 10.1093/intimm/dxm143; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Itoh M, 1999, J IMMUNOL, V162, P5317; Izcue A, 2008, IMMUNOLOGY, V123, P6, DOI 10.1111/j.1365-2567.2007.02778.x; Li S, 2008, J VIROL, V82, P21, DOI 10.1128/JVI.01768-07; Loudon AH, 2011, POULTRY SCI, V90, P2041, DOI 10.3382/ps.2011-01347; NISHIZUK.Y, 1969, SCIENCE, V166, P753, DOI 10.1126/science.166.3906.753; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shanmugasundaram R, 2012, VET IMMUNOL IMMUNOP, DOI [10.1016/j.vetimm.2011.1008.1016, DOI 10.1016/J.VETIMM.2011.1008.1016]; Shanmugasundaram R, 2012, DEV COMP IMMUNOL, V36, P578, DOI 10.1016/j.dci.2011.09.015; Shanmugasundaram R, 2011, J IMMUNOL, V186, P1997, DOI 10.4049/jimmunol.1002040; Shanmugasundaram R, 2010, VET IMMUNOL IMMUNOP, V137, P161, DOI 10.1016/j.vetimm.2010.04.017; SOWDER JT, 1988, J EXP MED, V167, P315, DOI 10.1084/jem.167.2.315; Spence PJ, 2008, P NATL ACAD SCI USA, V105, P973, DOI 10.1073/pnas.0709071105; Wendland M, 2007, P NATL ACAD SCI USA, V104, P6347, DOI 10.1073/pnas.0609180104; Wermers JD, 2011, GASTROENTEROLOGY, V140, P1526, DOI 10.1053/j.gastro.2011.01.044; Westermann J, 2003, LAB INVEST, V83, P459, DOI 10.1097/01.LAB.0000062852.80567.90	36	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 27	2012	7	3							e33970	10.1371/journal.pone.0033970	http://dx.doi.org/10.1371/journal.pone.0033970			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940MY	22479489	Green Published, Green Submitted, gold			2022-12-27	WOS:000303894900053
J	Mirshahvalad, A; Lindholm, J; Derlen, M; Rosvall, M				Mirshahvalad, Atieh; Lindholm, Johan; Derlen, Mattias; Rosvall, Martin			Significant Communities in Large Sparse Networks	PLOS ONE			English	Article							COMPLEX NETWORKS; PREDICTION	Researchers use community-detection algorithms to reveal large-scale organization in biological and social networks, but community detection is useful only if the communities are significant and not a result of noisy data. To assess the statistical significance of the network communities, or the robustness of the detected structure, one approach is to perturb the network structure by removing links and measure how much the communities change. However, perturbing sparse networks is challenging because they are inherently sensitive; they shatter easily if links are removed. Here we propose a simple method to perturb sparse networks and assess the significance of their communities. We generate resampled networks by adding extra links based on local information, then we aggregate the information from multiple resampled networks to find a coarse-grained description of significant clusters. In addition to testing our method on benchmark networks, we use our method on the sparse network of the European Court of Justice (ECJ) case law, to detect significant and insignificant areas of law. We use our significance analysis to draw a map of the ECJ case law network that reveals the relations between the areas of law.	[Mirshahvalad, Atieh; Rosvall, Martin] Umea Univ, Dept Phys, Integrated Sci Lab, Umea, Sweden; [Lindholm, Johan; Derlen, Mattias] Umea Univ, Dept Law, Umea, Sweden	Umea University; Umea University	Mirshahvalad, A (corresponding author), Umea Univ, Dept Phys, Integrated Sci Lab, Umea, Sweden.	atieh.mirshahvalad@physics.umu.se	Rosvall, Martin/ABD-6411-2020; Rosvall, Martin/A-9488-2015	Rosvall, Martin/0000-0002-7181-9940; Lindholm, Johan/0000-0001-6009-7412	Swedish Research Council [2009-5344]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	MR was supported by Swedish Research Council grant 2009-5344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bommarito MJ, 2010, PHYSICA A, V389, P4201, DOI 10.1016/j.physa.2010.06.003; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Danon L, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/11/P11010; Gfeller D, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.056135; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Hastings MB, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.035102; Hu YQ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.066106; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Karrer B, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046119; Lancichinetti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018961; Lancichinetti A, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046110; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Leicht EA, 2007, EUR PHYS J B, V59, P75, DOI 10.1140/epjb/e2007-00271-7; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lorrain F., 1971, J MATH SOCIOL, V1, P49, DOI [10.1080/0022250X.1971.9989788, DOI 10.1080/0022250X.1971.9989788, 10.1080/0022250x.1971.9989788]; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Reichardt J, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.078701; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Rosvall M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008694; Spirin V, 2003, P NATL ACAD SCI USA, V100, P12123, DOI 10.1073/pnas.2032324100	27	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33721	10.1371/journal.pone.0033721	http://dx.doi.org/10.1371/journal.pone.0033721			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479433	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100067
J	Reda, AA; Moges, A; Biadgilign, S; Wondmagegn, BY				Reda, Ayalu A.; Moges, Asmamaw; Biadgilign, Sibhatu; Wondmagegn, Berhanu Y.			Prevalence and Determinants of Khat (Catha edulis) Chewing among High School Students in Eastern Ethiopia: A Cross-Sectional Study	PLOS ONE			English	Article							UNIVERSITY-STUDENTS; PEER	Background: Use of psychoactive drugs such as khat leaves (Catha edulis) alter moods and emotional state and lead to adverse effects on the health and social life of users. Ethiopia is a major producer and exporter of khat in east Africa and the majority of the khat comes from the eastern part of the country, however, no studies have been conducted to investigate the habit in this area. This study was conducted to assess the prevalence and predictors of khat chewing among high school students in Harar, eastern Ethiopia. Methodology: The study was conducted among 1,890 secondary school students in Harar town in April 2010. A structured self-administered questionnaire was used for data collection. Descriptive statistics and logistic regression were performed to examine the prevalence and predictors of khat chewing. Result: The overall prevalence of khat chewing among the sample was 24.2% (95% CI 22.2%-26.2%). About 28.5% of females and 71.5% of males had chewed khat. Older age (OR 1.31; 95% CI 1.16-1.49), male gender (OR 2.10; 95% CI 1.50-2.93), Muslim religion (OR 1.88; 95% CI 1.17-3.04), having friends who chewed khat (OR 7.93; 95% CI 5.40-11.64), and availability of someone with a similar habit in the family (OR 1.50; 95% CI 1.07-2.11) were found to be independent predictors of chewing. Conclusion: A significant proportion of students chew khat. The use of khat is significantly associated with age, gender, Muslim religion, peer influence and habit of family and other relatives among students. Measures such as educational campaigns need to be instituted to create awareness among school adolescents and their parents in order to reduce the prevalence of the habit and its adverse social and health consequences.	[Reda, Ayalu A.; Moges, Asmamaw] Haramaya Univ, Coll Hlth Sci, Dept Publ Hlth, Harar, Ethiopia; [Moges, Asmamaw] Univ Addis Ababa, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Biadgilign, Sibhatu] Jimma Univ, Coll Med & Hlth Sci, Dept Epidemiol & Biostat, Jimma, Ethiopia; [Wondmagegn, Berhanu Y.] Haramaya Univ, Coll Hlth Sci, Dept Environm Hlth Sci, Harar, Ethiopia	Haramaya University; Addis Ababa University; Jimma University; Haramaya University	Reda, AA (corresponding author), Haramaya Univ, Coll Hlth Sci, Dept Publ Hlth, Harar, Ethiopia.	ayaluaklilu@yahoo.com		Biadgilign, Sibhatu/0000-0002-7582-5977	Haramaya University	Haramaya University	Haramaya University provided funds for the study (www.haramaya.edu.et). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADUGNA F, 1994, ETHIOPIAN MED J, V32, P161; Ageely HM, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-11; Al-Motarreb A, 2002, PHYTOTHER RES, V16, P403, DOI 10.1002/ptr.1106; Al-Mugahed L, 2008, B WORLD HEALTH ORGAN, V86, P741, DOI 10.2471/BLT.08.011008; Alem A, 1999, ACTA PSYCHIAT SCAND, V100, P84, DOI 10.1111/j.1600-0447.1999.tb10699.x; Ayana AM, 2004, ETHIOPIAN MED J, V42, P125; Azale T, 2007, PREVALENCE RISK FACT; Belew M, 2000, ETHIOPIAN MED J, V38, P11; Corkery JM, 2011, DRUG-EDUC PREV POLIC, V18, P408, DOI 10.3109/09687637.2010.504200; Cox G, 2003, ADV PSYCHIAT TREAT, V9, P456, DOI [10.1192/apt.9.6.456, DOI 10.1192/APT.9.6.456]; Dawit Abebe, 2005, Ethiopian Journal of Health Development, V19, P174; Dawson DA, 2003, ALCOHOL RES HEALTH, V27, P18; Global Youth Tobacco Survey, 2001, GLOBAL YOUTH TOBACCO; Griffiths P, 1997, BRIT J PSYCHIAT, V170, P281, DOI 10.1192/bjp.170.3.281; Hassan NAGM, 2000, TROP DOCT, V30, P107, DOI 10.1177/004947550003000219; KALIX P, 1984, B WORLD HEALTH ORGAN, V62, P681; KALIX P, 1987, BRIT J ADDICT, V82, P47; Kebede D, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-109; Kssaye M, ETHIOP J HLTH DEV, V13, P101; Li CY, 2002, ADDICTION, V97, P1537, DOI 10.1046/j.1360-0443.2002.00238.x; Odenwald M, 2007, PLOS MED; OMOLO OE, 1987, BRIT J ADDICT, V82, P97; Selassie S. Gebre, 1996, Bulletin on Narcotics, V48, P53; Stanton B, 2002, J URBAN HEALTH, V79, P536, DOI 10.1093/jurban/79.4.536; STEINBERG L, 1994, PEDIATRICS, V93, P1060; Tesfaye F, 2008, PUBLIC HLTH RES PRAC, V5, P1; WIDLER P, 1994, CLIN PHARMACOL THER, V55, P556, DOI 10.1038/clpt.1994.69; Yared K, 2002, E AFR MED J, V79, P274; Yigzaw Kebede, 2002, Ethiopian Journal of Health Development, V16, P9; ZEIN ZA, 1988, J TROP MED HYG, V91, P71	30	62	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e33946	10.1371/journal.pone.0033946	http://dx.doi.org/10.1371/journal.pone.0033946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479484	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100088
J	Stacey, KB; Breen, E; Jefferies, CA				Stacey, Kevin B.; Breen, Eamon; Jefferies, Caroline A.			Tyrosine Phosphorylation of the E3 Ubiquitin Ligase TRIM21 Positively Regulates Interaction with IRF3 and Hence TRIM21 Activity	PLOS ONE			English	Article							NF-KAPPA-B; CYTOKINE EXPRESSION; AUTOANTIGEN RO52; C-CBL; ACTIVATION; PROTEIN; KINASE; MACROPHAGES; DOMAIN; LIPOPOLYSACCHARIDE	Patients suffering from Systemic Lupus Erythematous (SLE) have elevated type I interferon (IFN) levels which correlate with disease activity and severity. TRIM21, an autoantigen associated with SLE, has been identified as an ubiquitin E3 ligase that targets the transcription factor IRF3 in order to turn off and limit type I IFN production following detection of viral and bacterial infection by Toll Like Receptors (TLRs). However, how the activity of TRIM21 is regulated downstream of TLRs is unknown. In this study we demonstrate that TRIM21 is tyrosine phosphorylated following TLR3 and TLR4 stimulation, suggesting that its activity is potentially regulated by tyrosine phosphorylation. Using Netphos, we have identified three key tyrosines that are strongly predicted to be phosphorylated, two of which are conserved between the human and murine forms of TRIM21, at residues 343, 388, and 393, all of which have been mutated from tyrosine to phenylalanine (Y343F, Y388F, and Y393F). We have observed that tyrosine phosphorylation of TRIM21 only occurs in the substrate binding PRY/SPRY domain, and that Y393, and to a lesser extent, Y388 are required for TRIM21 to function as a negative regulator of IFN-beta promoter activity. Further studies revealed that mutating Y393 to phenylalanine inhibits the ability of TRIM21 to interact with its substrate, IRF3, thus providing a molecular explanation for the lack of activity of Y393 on the IFN-beta promoter. Our data demonstrates a novel role for tyrosine phosphorylation in regulating the activity of TRIM21 downstream of TLR3 and TLR4. Given the pathogenic role of TRIM21 in systemic autoimmunity, these findings have important implications for the development of novel therapeutics.	[Stacey, Kevin B.; Breen, Eamon; Jefferies, Caroline A.] Royal Coll Surgeons Ireland, Res Inst, Dept Mol & Cellular Therapeut, Dublin 2, Ireland; [Breen, Eamon] Centenary Inst, Camperdown, NSW, Australia; [Breen, Eamon] Arthur William AW Morrow Gastroenterol & Liver Ct, Camperdown, NSW, Australia	Royal College of Surgeons - Ireland; University of Sydney; Centenary Institute	Stacey, KB (corresponding author), Royal Coll Surgeons Ireland, Res Inst, Dept Mol & Cellular Therapeut, Dublin 2, Ireland.	cjefferies@rcsi.ie	Stacey, Kevin/F-6921-2015; Jefferies, Caroline/AAI-1543-2021	Stacey, Kevin/0000-0001-9500-7165; Jefferies, Caroline/0000-0002-8879-6722	Science Foundation Ireland through the National Biophotonics and Imaging Platform, Ireland (NBIP) [05/PICA/B815, 08/IN.1/B2091]; Irish Government's Programme for Research in Third Level Institutions, Cycle 4; Ireland's EU Structural Funds Programmes [1101Q]; Alliance Lupus Research (ALR) under the TIL program [187805]	Science Foundation Ireland through the National Biophotonics and Imaging Platform, Ireland (NBIP)(Science Foundation Ireland); Irish Government's Programme for Research in Third Level Institutions, Cycle 4; Ireland's EU Structural Funds Programmes; Alliance Lupus Research (ALR) under the TIL program	This work was supported by funding from Science Foundation Ireland under grant no. [05/PICA/B815] and [08/IN.1/B2091], through the National Biophotonics and Imaging Platform, Ireland (NBIP), and funded by the Irish Government's Programme for Research in Third Level Institutions, Cycle 4, Ireland's EU Structural Funds Programmes 2007-2013, Grant no. [1101Q], and from the Alliance Lupus Research (ALR) under the TIL program [proposal number 187805]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; BOULET I, 1992, ONCOGENE, V7, P703; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Doyle SL, 2007, J BIOL CHEM, V282, P36953, DOI 10.1074/jbc.M707682200; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Espinosa A, 2011, J BIOL CHEM; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Espinosa A, 2008, EXP CELL RES, V314, P3605, DOI 10.1016/j.yexcr.2008.09.011; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2008, BIOCHEM SOC T, V36, P453, DOI 10.1042/BST0360453; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Rhodes DA, 2007, MOL IMMUNOL, V44, P2406, DOI 10.1016/j.molimm.2006.10.013; Ryan PE, 2010, J BIOL CHEM, V285, P23687, DOI 10.1074/jbc.M109.091157; Smith S, 2011, ARTHRITIS RHEUMATISM; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xiao H, 2008, J BIOL CHEM, V283, P14654, DOI 10.1074/jbc.M706931200; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	32	27	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e34041	10.1371/journal.pone.0034041	http://dx.doi.org/10.1371/journal.pone.0034041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479513	Green Published, Green Submitted, gold			2022-12-27	WOS:000305339100104
J	Tsai-Morris, CH; Sato, H; Gutti, R; Dufau, ML				Tsai-Morris, Chon-Hwa; Sato, Hisashi; Gutti, Ravi; Dufau, Maria L.			Role of Gonadotropin Regulated Testicular RNA Helicase (GRTH/DDX25) on Polysomal Associated mRNAs in Mouse Testis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GENE-EXPRESSION; HUMAN SPERM; HISTONE UBIQUITINATION; HAPLOID SPERMATIDS; CHROMATOID BODY; LEYDIG-CELLS; RAT TESTIS; ZETA 1; SPERMATOGENESIS	Gonadotropin Regulated Testicular RNA Helicase (GRTH/Ddx25) is a testis-specific multifunctional RNA helicase and an essential post-transcriptional regulator of spermatogenesis. GRTH transports relevant mRNAs from nucleus to cytoplasmic sites of meiotic and haploid germ cells and associates with actively translating polyribosomes. It is also a negative regulator of steroidogenesis in Leydig cells. To obtain a genome-wide perspective of GRTH regulated genes, in particularly those associated with polyribosomes, microarray differential gene expression analysis was performed using polysome-bound RNA isolated from testes of wild type (WT) and GRTH KO mice. 792 genes among the entire mouse genome were found to be polysomal GRTH-linked in WT. Among these 186 were down-regulated and 7 up-regulated genes in GRTH null mice. A similar analysis was performed using total RNA extracted from purified germ cell populations to address GRTH action in individual target cells. The down-regulation of known genes concerned with spermatogenesis at polysomal sites in GRTH KO and their association with GRTH in WT coupled with early findings of minor or unchanged total mRNAs and abolition of their protein expression in KO underscore the relevance of GRTH in translation. Ingenuity pathway analysis predicted association of GRTH bound polysome genes with the ubiquitin-proteasome-heat shock protein signaling network pathway and NF kappa B/TP53/TGFB1 signaling networks were derived from the differentially expressed gene analysis. This study has revealed known and unexplored factors in the genome and regulatory pathways underlying GRTH action in male reproduction.	[Tsai-Morris, Chon-Hwa; Sato, Hisashi; Gutti, Ravi; Dufau, Maria L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Endocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Tsai-Morris, CH (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Mol Endocrinol, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20814 USA.	morrisch@mail.nih.gov		Tsai Morris, Chon Hwa/0000-0002-8113-0979; Gutti, Ravi Kumar/0000-0002-0912-5796	National Institutes of Health Intramural Program through the Eunice Kennedy Shriver National Institutes of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000150] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program through the Eunice Kennedy Shriver National Institutes of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health Intramural Program through the Eunice Kennedy Shriver National Institutes of Child Health and Human Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMON E, 1993, DEV BIOL, V156, P107, DOI 10.1006/dbio.1993.1062; AQUILANO DR, 1984, ANN NY ACAD SCI, V438, P237, DOI 10.1111/j.1749-6632.1984.tb38290.x; Avallet O, 1997, BIOCHEM BIOPH RES CO, V238, P905, DOI 10.1006/bbrc.1997.7275; Baarends WM, 1999, DEV BIOL, V207, P322, DOI 10.1006/dbio.1998.9155; Bagu ET, 2010, REPROD DOMEST ANIM, V45, P348, DOI 10.1111/j.1439-0531.2008.01326.x; BUCCI LR, 1986, BIOL REPROD, V34, P195, DOI 10.1095/biolreprod34.1.195; Carvalho LR, 2010, MOL ENDOCRINOL, V24, P754, DOI 10.1210/me.2008-0359; Collins LL, 2003, CYTOGENET GENOME RES, V103, P299, DOI 10.1159/000076816; Cooney MA, 2010, BIOL REPROD, V83, P92, DOI 10.1095/biolreprod.109.079814; De Bortoli M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-223; Dufau ML, 2007, TRENDS ENDOCRIN MET, V18, P314, DOI 10.1016/j.tem.2007.09.001; Dufau ML, 1998, ANNU REV PHYSIOL, V60, P461, DOI 10.1146/annurev.physiol.60.1.461; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Frebel K, 2006, BIOCHEM SOC T, V34, P1287, DOI 10.1042/BST0341287; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Fukushima M, 2011, J BIOL CHEM, V286, P29932, DOI 10.1074/jbc.M111.236083; Gomes C, 2005, BIOL REPROD, V72, P651, DOI 10.1095/biolreprod.104.032672; Guo B, 2001, J BIOL CHEM, V276, P2780, DOI 10.1074/jbc.M005889200; Gutti RK, 2008, J BIOL CHEM, V283, P17055, DOI 10.1074/jbc.M708449200; Hasegawa T, 2000, BIOCHEM J, V352, P795, DOI 10.1042/0264-6021:3520795; Hawthorne SK, 2006, GENOMICS, V87, P382, DOI 10.1016/j.ygeno.2005.09.010; Holdcraft RW, 2004, INT J ANDROL, V27, P335, DOI 10.1111/j.1365-2605.2004.00502.x; Iguchi N, 2004, BIOL REPROD, V70, P1239, DOI 10.1095/biolreprod.103.024760; Ishii H, 2004, ONCOGENE, V23, P8040, DOI 10.1038/sj.onc.1207974; Jimenez A, 2002, MOL HUM REPROD, V8, P710, DOI 10.1093/molehr/8.8.710; Kitamura K, 2003, J BIOL CHEM, V278, P44417, DOI 10.1074/jbc.M304306200; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Krebber H, 1996, GENE, V180, P7, DOI 10.1016/S0378-1119(96)00389-7; Li YH, 2011, MOL HUM REPROD, V17, P42, DOI 10.1093/molehr/gaq071; LIEBERMANN DA, 1994, STEM CELLS, V12, P352, DOI 10.1002/stem.5530120402; Louie SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004310; Lue YH, 2010, ENDOCRINOLOGY, V151, P350, DOI 10.1210/en.2009-0577; Ma T, 2011, ACTA BIOCH BIOPH SIN, V43, P339, DOI 10.1093/abbs/gmr016; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Mullenbach E, 2006, GENE, V372, P53, DOI 10.1016/j.gene.2005.12.004; Naaby-Hansen S, 2010, J REPROD IMMUNOL, V84, P32, DOI 10.1016/j.jri.2009.09.006; Nayernia K, 2002, MOL CELL BIOL, V22, P3046, DOI 10.1128/MCB.22.9.3046-3052.2002; Ozguden-Akkoc C, 2011, BIOTECH HISTOCHEM; Parvinen M, 2005, INT J ANDROL, V28, P189, DOI 10.1111/j.1365-2605.2005.00542.x; Pei ZT, 2006, J BIOL CHEM, V281, P6632, DOI 10.1074/jbc.M511558200; Platta HW, 2009, MOL CELL BIOL, V29, P5505, DOI 10.1128/MCB.00388-09; Rathke C, 2007, J CELL SCI, V120, P1689, DOI 10.1242/jcs.004663; Richards JS, 2002, RECENT PROG HORM RES, V57, P195, DOI 10.1210/rp.57.1.195; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Rozhkova AV, 2011, GENE, V481, P65, DOI 10.1016/j.gene.2011.04.010; Sato H, 2010, BBA-MOL CELL RES, V1803, P534, DOI 10.1016/j.bbamcr.2010.02.004; Sheng Y, 2003, J BIOL CHEM, V278, P27796, DOI 10.1074/jbc.M302411200; Sheng Y, 2006, J BIOL CHEM, V281, P35048, DOI 10.1074/jbc.M605086200; Shetty G, 2008, ENDOCRINOLOGY, V149, P2773, DOI 10.1210/en.2007-1338; SHYJAN AW, 1991, GENOMICS, V11, P435, DOI 10.1016/0888-7543(91)90152-5; Soupene E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-21; Spiridonov NA, 2005, MOL CELL BIOL, V25, P4250, DOI 10.1128/MCB.25.10.4250-4261.2005; Steger K, 1999, ANAT EMBRYOL, V199, P471, DOI 10.1007/s004290050245; Steger K, 2001, ANAT EMBRYOL, V203, P323, DOI 10.1007/s004290100176; Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319; Tan KAL, 2005, BIOL REPROD, V72, P1151, DOI 10.1095/biolreprod.104.037689; Tanaka H, 2006, INT J ANDROL, V29, P353, DOI 10.1111/j.1365-2605.2005.00600.x; Tang PZ, 1999, J BIOL CHEM, V274, P37932, DOI 10.1074/jbc.274.53.37932; Teesalu T, 1998, DEV GENET, V23, P317, DOI 10.1002/(SICI)1520-6408(1998)23:4<317::AID-DVG6>3.0.CO;2-O; Tsai-Morris CH, 2004, P NATL ACAD SCI USA, V101, P6373, DOI 10.1073/pnas.0401855101; Tsai-Morris CH, 2010, J ANDROL, V31, P45, DOI 10.2164/jandrol.109.008219; Wang XJ, 2004, J BIOL CHEM, V279, P51370, DOI 10.1074/jbc.M410471200; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Xue Y, 2011, P NATL ACAD SCI USA, V108, P16229, DOI 10.1073/pnas.1103407108; Yano M, 2011, J BIOL CHEM, V286, P3992, DOI 10.1074/jbc.M110.179176; Yoon SY, 2008, J CLIN INVEST, V118, P3671, DOI 10.1172/JCI36942; Zuercher G, 2000, MECH DEVELOP, V93, P175, DOI 10.1016/S0925-4773(00)00255-0	67	18	18	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 30	2012	7	3							e32470	10.1371/journal.pone.0032470	http://dx.doi.org/10.1371/journal.pone.0032470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UC	22479328	Green Submitted, gold, Green Published			2022-12-27	WOS:000305339100011
J	Brandt, JP; Aziz-Zaman, S; Juozaityte, V; Martinez-Velazquez, LA; Petersen, JG; Pocock, R; Ringstad, N				Brandt, Julia P.; Aziz-Zaman, Sonya; Juozaityte, Vaida; Martinez-Velazquez, Luis A.; Petersen, Jakob Gramstrup; Pocock, Roger; Ringstad, Niels			A Single Gene Target of an ETS-Family Transcription Factor Determines Neuronal CO2-Chemosensitivity	PLOS ONE			English	Article							CARBON-DIOXIDE AVOIDANCE; C-ELEGANS; GUANYLATE-CYCLASE; SENSING NEURONS; BRAIN-STEM; DOMAIN; OXYGEN; DIFFERENTIATION; TEMPERATURE; SEROTONIN	Many animals possess neurons specialized for the detection of carbon dioxide (CO2), which acts as a cue to elicit behavioral responses and is also an internally generated product of respiration that regulates animal physiology. In many organisms how such neurons detect CO2 is poorly understood. We report here a mechanism that endows C. elegans neurons with the ability to detect CO2. The ETS-5 transcription factor is necessary for the specification of CO2-sensing BAG neurons. Expression of a single ETS-5 target gene, gcy-9, which encodes a receptor-type guanylate cyclase, is sufficient to bypass a requirement for ets-5 in CO2-detection and transforms neurons into CO2-sensing neurons. Because ETS-5 and GCY-9 are members of gene families that are conserved between nematodes and vertebrates, a similar mechanism might act in the specification of CO2-sensing neurons in other phyla.	[Brandt, Julia P.; Aziz-Zaman, Sonya; Martinez-Velazquez, Luis A.; Ringstad, Niels] NYU, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, Mol Neurobiol Program,Langone Med Ctr, New York, NY 10003 USA; [Brandt, Julia P.; Aziz-Zaman, Sonya; Martinez-Velazquez, Luis A.; Ringstad, Niels] NYU, Langone Med Ctr, Dept Cell Biol, New York, NY USA; [Juozaityte, Vaida; Petersen, Jakob Gramstrup; Pocock, Roger] Univ Copenhagen, BRIC, Copenhagen, Denmark	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Copenhagen	Brandt, JP (corresponding author), NYU, Helen L & Martin S Kimmel Ctr Biol & Med, Skirball Inst Biomol Med, Mol Neurobiol Program,Langone Med Ctr, New York, NY 10003 USA.	Roger.Pocock@bric.ku.dk; Niels.Ringstad@med.nyu.edu	Pocock, Roger/AAQ-8526-2020	Pocock, Roger/0000-0002-5515-3608; Juozaityte, Vaida/0000-0003-3403-6143	Edward Mallinckrodt Jr. Foundation; NIGMS [R01-GM098320]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098320] Funding Source: NIH RePORTER	Edward Mallinckrodt Jr. Foundation; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Edward Mallinckrodt Jr. Foundation and NIGMS R01-GM098320 (to NR). NR is a Pew Scholar in the Biomedical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2003, NAT GENET, V33, P459, DOI 10.1038/ng1130; Bretscher AJ, 2008, P NATL ACAD SCI USA, V105, P8044, DOI 10.1073/pnas.0707607105; Bretscher AJ, 2011, NEURON, V69, P1099, DOI 10.1016/j.neuron.2011.02.023; Chao Y-C, 2010, BIOCH J; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Duda T, 2010, BIOCHEM BIOPH RES CO, V391, P1379, DOI 10.1016/j.bbrc.2009.12.068; Ercan S, 2007, NAT GENET, V39, P403, DOI 10.1038/ng1983; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Guerenstein PG, 2008, ANNU REV ENTOMOL, V53, P161, DOI 10.1146/annurev.ento.53.103106.093402; Guillermin ML, 2011, GENETICS, V189, P1327, DOI 10.1534/genetics.111.133835; Guo BQ, 2006, MOL CELL BIOL, V26, P4529, DOI 10.1128/MCB.01667-05; Guo DG, 2009, BIOCHEMISTRY-US, V48, P4417, DOI 10.1021/bi900441v; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hallem EA, 2011, P NATL ACAD SCI USA, V108, P254, DOI 10.1073/pnas.1017354108; Hendricks TJ, 2003, NEURON, V37, P233, DOI 10.1016/S0896-6273(02)01167-4; Hodges MR, 2008, J NEUROSCI, V28, P2495, DOI 10.1523/JNEUROSCI.4729-07.2008; Hu J, 2007, SCIENCE, V317, P953, DOI 10.1126/science.1144233; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Kinney HC, 2009, ANNU REV PATHOL-MECH, V4, P517, DOI 10.1146/annurev.pathol.4.110807.092322; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Munger SD, 2010, CURR BIOL, V20, P1438, DOI 10.1016/j.cub.2010.06.021; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Ray RS, 2011, SCIENCE, V333, P637, DOI 10.1126/science.1205295; Ryu WS, 2002, J NEUROSCI, V22, P5727; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Spyer KM, 2009, PHILOS T R SOC B, V364, P2603, DOI 10.1098/rstb.2009.0082; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Sun LM, 2009, P NATL ACAD SCI USA, V106, P2041, DOI 10.1073/pnas.0812220106; TREIER M, 1995, CELL, V83, P753, DOI 10.1016/0092-8674(95)90188-4; van den Akker F, 2000, NATURE, V406, P101, DOI 10.1038/35017602; Wedel BJ, 2001, ANNU REV PHYSIOL, V63, P215, DOI 10.1146/annurev.physiol.63.1.215; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Yuasa Y, 2003, DEVELOPMENT, V130, P2419, DOI 10.1242/dev.00468; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	40	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34014	10.1371/journal.pone.0034014	http://dx.doi.org/10.1371/journal.pone.0034014			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479504	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400051
J	Kossenkov, AV; Dawany, N; Evans, TL; Kucharczuk, JC; Albelda, SM; Showe, LC; Showe, MK; Vachani, A				Kossenkov, Andrew V.; Dawany, Noor; Evans, Tracey L.; Kucharczuk, John C.; Albelda, Steven M.; Showe, Louise C.; Showe, Michael K.; Vachani, Anil			Peripheral Immune Cell Gene Expression Predicts Survival of Patients with Non-Small Cell Lung Cancer	PLOS ONE			English	Article							MICRORNA SIGNATURES; CXCR4 EXPRESSION; SUPPRESSOR-CELLS; BLOOD; NEUTROPHILS; SYSTEM; STAGE	Prediction of cancer recurrence in patients with non-small cell lung cancer (NSCLC) currently relies on the assessment of clinical characteristics including age, tumor stage, and smoking history. A better prediction of early stage cancer patients with poorer survival and late stage patients with better survival is needed to design patient-tailored treatment protocols. We analyzed gene expression in RNA from peripheral blood mononuclear cells (PBMC) of NSCLC patients to identify signatures predictive of overall patient survival. We find that PBMC gene expression patterns from NSCLC patients, like patterns from tumors, have information predictive of patient outcomes. We identify and validate a 26 gene prognostic panel that is independent of clinical stage. Many additional prognostic genes are specific to myeloid cells and are more highly expressed in patients with shorter survival. We also observe that significant numbers of prognostic genes change expression levels in PBMC collected after tumor resection. These post-surgery gene expression profiles may provide a means to re-evaluate prognosis over time. These studies further suggest that patient outcomes are not solely determined by tumor gene expression profiles but can also be influenced by the immune response as reflected in peripheral immune cells.	[Kossenkov, Andrew V.; Dawany, Noor; Showe, Louise C.; Showe, Michael K.] Wistar Inst Anat & Biol, Philadelphia, PA USA; [Evans, Tracey L.] Univ Penn, Sch Med, Dept Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Kucharczuk, John C.] Univ Penn, Sch Med, Dept Surg, Div Thorac Surg, Philadelphia, PA 19104 USA; [Albelda, Steven M.; Vachani, Anil] Univ Penn, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Kossenkov, AV (corresponding author), Wistar Inst Anat & Biol, Philadelphia, PA USA.	lshowe@wistar.org			Pennsylvania Department of Health [SAP 4100020718]; Wistar Cancer Center [P30 CA010815]; National Institutes of Health [K07 CA111952, T32 CA 09171]; NATIONAL CANCER INSTITUTE [T32CA009171, K07CA111952, P30CA010815] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024693] Funding Source: NIH RePORTER	Pennsylvania Department of Health; Wistar Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Pennsylvania Department of Health Tobacco Settlement grant (SAP 4100020718); the Pennsylvania Department of Health Commonwealth Universal Research Enhancement Program; the Wistar Cancer Center Support Grant (P30 CA010815); National Institutes of Health (K07 CA111952) to A. V. and (T32 CA 09171) to A. V. K. The project used the Wistar Institute Genomics and Bioinformatics facilities supported by the Wistar Cancer Center Support Grant (P30 CA010815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006098; Abbas AR, 2005, GENES IMMUN, V6, P319, DOI 10.1038/sj.gene.6364173; ACS, 2010, CANC FACTS FIG 2010; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Chen AL, 2008, BIOTECHNOL LETT, V30, P2045, DOI 10.1007/s10529-008-9800-8; Chen G, 2011, WORLD J SURG, V35, P56, DOI 10.1007/s00268-010-0784-x; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Dubey S, 2008, AM J RESP CRIT CARE, V177, P941, DOI 10.1164/rccm.200801-107UP; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; GONEN M, 2005, CONCORDANCE PROBABIL; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Hu ZB, 2010, J CLIN ONCOL, V28, P1721, DOI 10.1200/JCO.2009.24.9342; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Kadara H, 2011, CLIN CANCER RES, V17, P1490, DOI 10.1158/1078-0432.CCR-10-2703; Kossenkov AV, 2011, CLIN CANC RES; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Leone V, 2011, J CLIN ENDOCRINOL ME; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Pardoll D, 2003, ANNU REV IMMUNOL, V21, P807, DOI 10.1146/annurev.immunol.21.120601.141135; Schmielau J, 2001, CANCER RES, V61, P4756; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Showe MK, 2009, CANCER RES, V69, P9202, DOI 10.1158/0008-5472.CAN-09-1378; Stachon A, 2001, CLIN CHEM LAB MED, V39, P239, DOI 10.1515/CCLM.2001.038; Storey John D, 2003, Methods Mol Biol, V224, P149; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Trellakis S, 2011, INT J CA; van den Akker E, 2010, HAEMATOL-HEMATOL J, V95, P1594, DOI 10.3324/haematol.2009.019828; Varlotto J, 2005, INT J RADIAT ONCOL, V63, P25, DOI 10.1016/j.ijrobp.2005.04.049; Yamada M, 2011, CELL MOL IMMUNOL, V8, P305, DOI 10.1038/cmi.2011.8	32	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34392	10.1371/journal.pone.0034392	http://dx.doi.org/10.1371/journal.pone.0034392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479623	gold, Green Submitted, Green Published			2022-12-27	WOS:000304523400081
J	Ma, Y; Yuan, X; Wyatt, WR; Pomerening, JR				Ma, Yan; Yuan, Xi; Wyatt, William R.; Pomerening, Joseph R.			Expression of Constitutively Active CDK1 Stabilizes APC-Cwdh1 Substrates and Potentiates Premature Spindle Assembly and Checkpoint Function in G1 Cells	PLOS ONE			English	Article							CHROMOSOME SEGREGATION; PROTEIN-KINASE; AURORA-B; GENOMIC STABILITY; TUMOR SUPPRESSION; CYCLE REGULATION; MITOTIC SPINDLE; SOMATIC WEE1; DNA-DAMAGE; PHOSPHORYLATION	Mitotic progression in eukaryotic cells depends upon the activation of cyclin-dependent kinase 1 (CDK1), followed by its inactivation through the anaphase-promoting complex (APC)/cyclosome-mediated degradation of M-phase cyclins. Previous work revealed that expression of a constitutively active CDK1 (CDK1AF) in HeLa cells permitted their division, but yielded G1 daughter cells that underwent premature S-phase and early mitotic events. While CDK1AF was found to impede the sustained activity of APC-Cdh1, it was unknown if this defect improperly stabilized mitotic substrates and contributed to the occurrence of these premature M phases. Here, we show that CDK1AF expression in HeLa cells improperly stabilized APC-Cdh1 substrates in G1-phase daughter cells, including mitotic kinases and the APC adaptor, Cdc20. Division of CDK1AF-expressing cells produced G1 daughters with an accelerated S-phase onset, interrupted by the formation of premature bipolar spindles capable of spindle assembly checkpoint function. Further characterization of these phenotypes induced by CDK1AF expression revealed that this early spindle formation depended upon premature CDK1 and Aurora B activities, and their inhibition induced rapid spindle disassembly. Following its normal M-phase degradation, we found that the absence of Wee1 in these prematurely cycling daughter cells permitted the endogenous CDK1 to contribute to these premature mitotic events, since expression of a non-degradable Wee1 reduced the number of cells that exhibited premature cyclin B1oscillations. Lastly, we discovered that Cdh1-ablated cells could not be forced into a premature M phase, despite cyclin B1 overexpression and proteasome inhibition. Together, these results demonstrate that expression of constitutively active CDK1AF hampers the destruction of critical APC-Cdh1 targets, and that this type of condition could prevent newly divided cells from properly maintaining a prolonged interphase state. We propose that this more subtle type of defect in activity of the APC-driven negative-feedback loop may have implications for triggering genome instability and tumorigenesis.	[Ma, Yan; Yuan, Xi; Pomerening, Joseph R.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Wyatt, William R.] Indiana Univ, Dept Stat, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Ma, Y (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	jpomeren@indiana.edu		Pomerening, Joseph/0000-0003-4120-9081	IU Light Microscopy Imaging Center; National Institutes of Health (NIH) [S10RR025033-01, GM086526]; Pew Scholars Program in the Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086526] Funding Source: NIH RePORTER	IU Light Microscopy Imaging Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program in the Biomedical Sciences; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to the IU Light Microscopy Imaging Center (National Institutes of Health (NIH) S10RR025033-01), and to Dr. Pomerening from the National Institutes of Health (GM086526) and the Pew Scholars Program in the Biomedical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud L, 1998, CHROMOSOMA, V107, P424, DOI 10.1007/s004120050326; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Blasina A, 1997, MOL BIOL CELL, V8, P1013, DOI 10.1091/mbc.8.6.1013; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Chen RH, 1996, SCIENCE, V274, P242, DOI 10.1126/science.274.5285.242; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; D'Angiolella V, 2003, GENE DEV, V17, P2520, DOI 10.1101/gad.267603; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; Floyd S, 2008, CURR BIOL, V18, P1649, DOI 10.1016/j.cub.2008.09.058; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; GERACE L, 1982, J CELL BIOL, V95, P826, DOI 10.1083/jcb.95.3.826; Hagting A, 2002, J CELL BIOL, V157, P1125, DOI 10.1083/jcb.200111001; HANKS SK, 1983, EXP CELL RES, V148, P293, DOI 10.1016/0014-4827(83)90153-2; Hannak E, 2001, J CELL BIOL, V155, P1109, DOI 10.1083/jcb.200108051; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Jin P, 1996, J CELL BIOL, V134, P963, DOI 10.1083/jcb.134.4.963; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kang YH, 2006, MOL CELL, V24, P409, DOI 10.1016/j.molcel.2006.10.016; Kimura M, 1997, J BIOL CHEM, V272, P13766, DOI 10.1074/jbc.272.21.13766; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lehman NL, 2007, AM J PATHOL, V170, P1793, DOI 10.2353/ajpath.2007.060767; Listovsky T, 2004, EMBO J, V23, P1619, DOI 10.1038/sj.emboj.7600149; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; MUELLER PR, 1995, MOL BIOL CELL, V6, P119, DOI 10.1091/mbc.6.1.119; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Myers JW, 2005, METH MOL B, V309, P93; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; O'Connell CB, 2008, J CELL BIOL, V183, P29, DOI 10.1083/jcb.200801038; Parker L, 1955, INACTIVATION P34CDC2; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Pfleger CM, 2001, GENE DEV, V15, P1759, DOI 10.1101/gad.897901; Planchais S, 1997, PLANT J, V12, P191, DOI 10.1046/j.1365-313X.1997.12010191.x; Pomerening JR, 2008, MOL BIOL CELL, V19, P3426, DOI 10.1091/mbc.E08-02-0172; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Robbins JA, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-23; Roberts K, 1971, Microsc Acta, V71, P102; Roghi C, 1998, J CELL SCI, V111, P557; SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x; Sigl R, 2009, J CELL SCI, V122, P4208, DOI 10.1242/jcs.054197; Smith A, 2007, CELL CYCLE, V6, P2795, DOI 10.4161/cc.6.22.4919; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; TANG ZH, 1993, EMBO J, V12, P3427, DOI 10.1002/j.1460-2075.1993.tb06017.x; Wasch R, 2010, ONCOGENE, V29, P1, DOI 10.1038/onc.2009.325; Wang YL, 2000, CELL GROWTH DIFFER, V11, P211; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Watanabe N, 2005, P NATL ACAD SCI USA, V102, P11663, DOI 10.1073/pnas.0500410102; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x	55	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33835	10.1371/journal.pone.0033835	http://dx.doi.org/10.1371/journal.pone.0033835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479455	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400040
J	Perez-Gonzalez, D; Hernandez, O; Covey, E; Malmierca, MS				Perez-Gonzalez, David; Hernandez, Olga; Covey, Ellen; Malmierca, Manuel S.			GABA(A)-Mediated Inhibition Modulates Stimulus-Specific Adaptation in the Inferior Colliculus	PLOS ONE			English	Article							FREQUENCY-RESPONSE AREAS; BRAIN-STEM; IN-VIVO; GLYCINERGIC INHIBITION; SYNAPTIC MECHANISMS; NEURONAL RESPONSES; GABA(B) RECEPTORS; CENTRAL NUCLEUS; SOUND DURATION; RAT	The ability to detect novel sounds in a complex acoustic context is crucial for survival. Neurons from midbrain through cortical levels adapt to repetitive stimuli, while maintaining responsiveness to rare stimuli, a phenomenon called stimulus-specific adaptation (SSA). The site of origin and mechanism of SSA are currently unknown. We used microiontophoretic application of gabazine to examine the role of GABA(A)-mediated inhibition in SSA in the inferior colliculus, the midbrain center for auditory processing. We found that gabazine slowed down the process of adaptation to high probability stimuli but did not abolish it, with response magnitude and latency still depending on the probability of the stimulus. Blocking GABA(A) receptors increased the firing rate to high and low probability stimuli, but did not completely equalize the responses. Together, these findings suggest that GABA(A)-mediated inhibition acts as a gain control mechanism that enhances SSA by modifying the responsiveness of the neuron.	[Perez-Gonzalez, David; Hernandez, Olga; Covey, Ellen; Malmierca, Manuel S.] Univ Salamanca, Inst Neurosci Castilla & Leon, Auditory Neurophysiol Unit, E-37008 Salamanca, Spain; [Hernandez, Olga; Malmierca, Manuel S.] Univ Salamanca, Fac Med, Dept Cell Biol & Pathol, E-37008 Salamanca, Spain; [Covey, Ellen] Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Salamanca; University of Salamanca; University of Washington; University of Washington Seattle	Perez-Gonzalez, D (corresponding author), Univ Salamanca, Inst Neurosci Castilla & Leon, Auditory Neurophysiol Unit, E-37008 Salamanca, Spain.	msm@usal.es	Perez-Gonzalez, David/E-9188-2011; Malmierca, Manuel S./K-9285-2014	Perez-Gonzalez, David/0000-0001-6288-2692; Malmierca, Manuel S./0000-0003-0168-7572	Spanish MEC [BFU2009-07286]; Spanish MICINN [EUI2009-04083]; JCYL-UE [GR221]	Spanish MEC(Spanish Government); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); JCYL-UE(Junta de Castilla y Leon)	Financial support was provided by the Spanish MEC (BFU2009-07286), Spanish MICINN (EUI2009-04083) in the frame of the ERA-NET NEURON, and JCYL-UE (GR221) to Dr. Malmierca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Anderson LA, 2009, J NEUROSCI, V29, P7359, DOI 10.1523/JNEUROSCI.0793-09.2009; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Best AR, 2004, J NEUROSCI, V24, P652, DOI 10.1523/JNEUROSCI.4220-03.2004; Binns KE, 1997, J PHYSIOL-LONDON, V504, P629, DOI 10.1111/j.1469-7793.1997.629bd.x; BINNS KE, 1995, VISUAL NEUROSCI, V12, P563, DOI 10.1017/S0952523800008452; CANDY JM, 1974, NEUROPHARMACOLOGY, V13, P423, DOI 10.1016/0028-3908(74)90130-0; Carandini M, 2000, CURR BIOL, V10, pR605, DOI 10.1016/S0960-9822(00)00637-0; Caspary DM, 2002, HEARING RES, V168, P163, DOI 10.1016/S0378-5955(02)00363-5; CASSEDAY JH, 1994, SCIENCE, V264, P847, DOI 10.1126/science.8171341; Casseday JH, 2000, J NEUROPHYSIOL, V84, P1475, DOI 10.1152/jn.2000.84.3.1475; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Covey E, 1996, J NEUROSCI, V16, P3009; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Eytan D, 2003, J NEUROSCI, V23, P9349; Faure PA, 2003, J NEUROSCI, V23, P3052; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Fuzessery ZA, 2003, JARO, V4, P60, DOI 10.1007/s10162-002-2054-6; Garagnani M, 2011, NEUROIMAGE, V54, P170, DOI 10.1016/j.neuroimage.2010.08.031; Grimm S, 2011, PSYCHOPHYSIOLOGY, V48, P377, DOI 10.1111/j.1469-8986.2010.01073.x; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Hernandez O, 2005, NEUROSCIENCE, V132, P203, DOI 10.1016/j.neuroscience.2005.01.001; Hernandez O, 2006, NEUROREPORT, V17, P1611, DOI 10.1097/01.wnr.0000236857.70715.be; Ingham NJ, 2005, J NEUROSCI, V25, P6187, DOI 10.1523/JNEUROSCI.0146-05.2005; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jaaskelainen IP, 2007, TRENDS NEUROSCI, V30, P653, DOI 10.1016/j.tins.2007.09.003; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Katzner S, 2011, J NEUROSCI, V31, P5931, DOI 10.1523/JNEUROSCI.5753-10.2011; Kelly JB, 2005, INFERIOR COLLICULUS, P248, DOI 10.1007/0-387-27083-3_9; Koch U, 1998, J NEUROPHYSIOL, V80, P71, DOI 10.1152/jn.1998.80.1.71; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kurt S, 2006, HEARING RES, V212, P224, DOI 10.1016/j.heares.2005.12.002; Kuwada S, 1997, J NEUROSCI, V17, P7565; LeBeau FEN, 2001, J NEUROSCI, V21, P7303, DOI 10.1523/JNEUROSCI.21-18-07303.2001; LeBeau FEN, 1996, J NEUROPHYSIOL, V75, P902, DOI 10.1152/jn.1996.75.2.902; Loftus WC, 2008, NEUROSCIENCE, V154, P196, DOI 10.1016/j.neuroscience.2008.01.019; Malmierca MS, 2008, J NEUROSCI, V28, P4767, DOI 10.1523/JNEUROSCI.0238-08.2008; Malmierca MS, 2011, HEARING RES, V274, P13, DOI 10.1016/j.heares.2010.06.011; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; MALMIERCA MS, 1993, J COMP NEUROL, V333, P1, DOI 10.1002/cne.903330102; Malmierca MS, 2005, NEUROSCIENCE, V136, P883, DOI 10.1016/j.neuroscience.2005.04.040; Malmierca MS, 2005, EUR J NEUROSCI, V21, P2701, DOI 10.1111/j.1460-9568.2005.04103.x; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; Malmierca MS, 2003, EXP BRAIN RES, V153, P522, DOI 10.1007/s00221-003-1615-1; MALMIERCA MS, 1995, ANAT EMBRYOL, V191, P343, DOI 10.1007/BF00534687; MALMIERCA MS, 1995, J COMP NEUROL, V357, P124, DOI 10.1002/cne.903570112; Malmierca MS, 2010, AUDITORY BRAIN; Merchan M, 2005, NEUROSCIENCE, V136, P907, DOI 10.1016/j.neuroscience.2004.12.030; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; Mill R, 2011, NEURAL COMPUT, V23, P435, DOI 10.1162/NECO_a_00077; Naatanen R., 2018, ATTENTION BRAIN FUNC; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Oliver D. L., 1991, NEUROBIOLOGY HEARING, P195; Palombi PS, 1996, J NEUROPHYSIOL, V75, P2211, DOI 10.1152/jn.1996.75.6.2211; Perez-Gonzalez D, 2006, J NEUROPHYSIOL, V95, P823, DOI 10.1152/jn.00741.2005; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; Pollak GD, 2002, HEARING RES, V168, P60, DOI 10.1016/S0378-5955(02)00362-3; Razak KA, 2009, J NEUROPHYSIOL, V102, P1366, DOI 10.1152/jn.00334.2009; Reches A, 2008, J NEUROSCI, V28, P1523, DOI 10.1523/JNEUROSCI.3785-07.2008; Rees A, 1997, J NEUROPHYSIOL, V77, P2945, DOI 10.1152/jn.1997.77.6.2945; REES A, 1990, J PHYSIOL-LONDON, V430, pP6; Reetz G, 1999, BRAIN RES, V816, P527, DOI 10.1016/S0006-8993(98)01230-X; ROSE D, 1974, NATURE, V249, P375, DOI 10.1038/249375a0; Sivaramakrishnan S, 2004, J NEUROSCI, V24, P5031, DOI 10.1523/JNEUROSCI.0357-04.2004; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; Sun H, 2009, NEUROSCIENCE, V160, P198, DOI 10.1016/j.neuroscience.2009.02.011; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; Wu SH, 2004, J NEUROSCI, V24, P4625, DOI 10.1523/JNEUROSCI.0318-04.2004; YANG LC, 1992, J NEUROPHYSIOL, V68, P1760, DOI 10.1152/jn.1992.68.5.1760; Yin SK, 2008, HEARING RES, V237, P32, DOI 10.1016/j.heares.2007.12.008; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhao L, 2011, NEUROSCIENCE, V181, P163, DOI 10.1016/j.neuroscience.2011.01.060	80	69	70	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34297	10.1371/journal.pone.0034297	http://dx.doi.org/10.1371/journal.pone.0034297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479591	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400068
J	Bhattachan, A; Tatlhego, M; Dintwe, K; O'Donnell, F; Caylor, KK; Okin, GS; Perrot, DO; Ringrose, S; D'Odorico, P				Bhattachan, Abinash; Tatlhego, Mokganedi; Dintwe, Kebonye; O'Donnell, Frances; Caylor, Kelly K.; Okin, Gregory S.; Perrot, Danielle O.; Ringrose, Susan; D'Odorico, Paolo			Evaluating Ecohydrological Theories of Woody Root Distribution in the Kalahari	PLOS ONE			English	Article							TREE-GRASS COEXISTENCE; NICHE DIFFERENTIATION; ARIDITY GRADIENT; VEGETATION COVER; SOIL-MOISTURE; GLOBAL CHANGE; WATER; DYNAMICS; PATTERNS; MODEL	The contribution of savannas to global carbon storage is poorly understood, in part due to lack of knowledge of the amount of belowground biomass. In these ecosystems, the coexistence of woody and herbaceous life forms is often explained on the basis of belowground interactions among roots. However, the distribution of root biomass in savannas has seldom been investigated, and the dependence of root biomass on rainfall regime remains unclear, particularly for woody plants. Here we investigate patterns of belowground woody biomass along a rainfall gradient in the Kalahari of southern Africa, a region with consistent sandy soils. We test the hypotheses that (1) the root depth increases with mean annual precipitation (root optimality and plant hydrotropism hypothesis), and (2) the root-to-shoot ratio increases with decreasing mean annual rainfall (functional equilibrium hypothesis). Both hypotheses have been previously assessed for herbaceous vegetation using global root data sets. Our data do not support these hypotheses for the case of woody plants in savannas. We find that in the Kalahari, the root profiles of woody plants do not become deeper with increasing mean annual precipitation, whereas the root-to-shoot ratios decrease along a gradient of increasing aridity.	[Bhattachan, Abinash; D'Odorico, Paolo] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Tatlhego, Mokganedi; Ringrose, Susan] Univ Botswana, Okavango Res Inst, Maun, Botswana; [Dintwe, Kebonye; Okin, Gregory S.] Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90024 USA; [Dintwe, Kebonye] Dept Forestry & Range Resources, Gaborone, Botswana; [O'Donnell, Frances; Caylor, Kelly K.] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Perrot, Danielle O.] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [D'Odorico, Paolo] Ecole Polytech Fed Lausanne, Sch Architecture Civil & Environm Engn, Lausanne, Switzerland	University of Virginia; University of Botswana; University of California System; University of California Los Angeles; Princeton University; University of Colorado System; University of Colorado Boulder; Ecole Polytechnique Federale de Lausanne	Bhattachan, A (corresponding author), Univ Virginia, Dept Environm Sci, Clark Hall, Charlottesville, VA 22903 USA.	paolo@virginia.edu	D'Odorico, Paolo/A-5836-2008; Caylor, Kelly/B-7734-2008; Okin, Greg/D-3226-2019; Caylor, Kelly/ABF-2818-2020; Dintwe, Kebonye/P-8938-2019	D'Odorico, Paolo/0000-0002-0007-5833; Caylor, Kelly/0000-0002-6466-6448; Caylor, Kelly/0000-0002-6466-6448; Dintwe, Kebonye/0000-0001-5512-2361; O'Donnell, Frances/0000-0002-5886-8270; Okin, Gregory/0000-0002-0484-3537; Ringrose, Susan/0000-0003-4788-4133	National Science Foundation DEB [0717360]	National Science Foundation DEB(National Science Foundation (NSF))	Funding for this study came from the National Science Foundation DEB #0717360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, ECOLOGICAL CLIMATOLO; Barbier N, 2008, ECOLOGY, V89, P1521, DOI 10.1890/07-0365.1; Boutraa T., 2010, Research Journal of Agriculture and Biological Sciences, V6, P20; Breshears DD, 1999, LANDSCAPE ECOL, V14, P465, DOI 10.1023/A:1008040327508; BROUWER R., 1962, NETHERLANDS JOUR AGRIC SCI, V10, P361; Burgess SSO, 1998, OECOLOGIA, V115, P306, DOI 10.1007/s004420050521; Butnor JR, 2001, TREE PHYSIOL, V21, P1269, DOI 10.1093/treephys/21.17.1269; Canadell J, 1996, OECOLOGIA, V108, P583, DOI 10.1007/BF00329030; Casper BB, 2003, ECOLOGY, V84, P2313, DOI 10.1890/02-0287; Caylor KK, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004683; Caylor KK, 2005, ECOSYSTEMS, V8, P17, DOI 10.1007/s10021-004-0027-9; Caylor KK, 2003, J ARID ENVIRON, V54, P281, DOI 10.1006/jare.2002.1090; CHENG W, 1990, J APPL ECOL, V27, P592, DOI 10.2307/2404304; Collins DBG, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005541; D'Odorico P, 2006, AM NAT, V167, pE79, DOI 10.1086/500617; D'Odorico P, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000379; DOdorico P., 2006, DRYLAND ECOHYDROLOGY; du Toit J.T., 2003, KRUGER EXPERIENCE EC; Fan JW, 2009, J ARID ENVIRON, V73, P521, DOI 10.1016/j.jaridenv.2008.12.004; Feddes RA, 2001, B AM METEOROL SOC, V82, P2797, DOI 10.1175/1520-0477(2001)082<2797:MRWUIH>2.3.CO;2; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Gottlicher SG, 2008, FOREST ECOL MANAG, V255, P75, DOI 10.1016/j.foreco.2007.08.032; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; GREENE RSB, 1992, AUST J SOIL RES, V30, P55, DOI 10.1071/SR9920055; Guswa AJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009122; Guswa AJ, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006384; Hartle RT, 2006, J ARID ENVIRON, V64, P586, DOI 10.1016/j.jaridenv.2005.06.021; Hely C, 2007, ECOSYSTEMS, V10, P1116, DOI 10.1007/s10021-007-9082-3; Hipondoka MHT, 2006, ECOL INDIC, V6, P516, DOI 10.1016/j.ecolind.2005.07.004; Hipondoka MHT, 2003, J ARID ENVIRON, V54, P319, DOI 10.1006/jare.2002.1093; Horton JL, 1998, TRENDS ECOL EVOL, V13, P232, DOI 10.1016/S0169-5347(98)01328-7; House JI, 2003, J BIOGEOGR, V30, P1763, DOI 10.1046/j.1365-2699.2003.00873.x; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; Jackson RB, 1997, P NATL ACAD SCI USA, V94, P7362, DOI 10.1073/pnas.94.14.7362; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Kimmins J.P., 2004, FOREST ECOLOGY FDN S, V3rd; Klepper B., 1991, PLANT ROOTS HIDDEN H, P265; Koch GW, 1995, VEGETATIO, V121, P53, DOI 10.1007/BF00044672; Kulmatiski A, 2010, NEW PHYTOL, V188, P199, DOI 10.1111/j.1469-8137.2010.03338.x; Laio F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027331; LEROUX X, 1995, OECOLOGIA, V104, P147, DOI 10.1007/BF00328579; Ludwig F, 2003, OECOLOGIA, V134, P293, DOI 10.1007/s00442-002-1119-x; Mommer L, 2010, J ECOL, V98, P1117, DOI 10.1111/j.1365-2745.2010.01702.x; Nadezhdina N, 2003, J EXP BOT, V54, P1511, DOI 10.1093/jxb/erg154; Norby RJ, 2000, NEW PHYTOL, V147, P3, DOI 10.1046/j.1469-8137.2000.00676.x; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Porporato A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002448; Preti F, 2010, ECOL ENG, V36, P305, DOI 10.1016/j.ecoleng.2009.07.010; Ringrose S, 2003, J ARID ENVIRON, V54, P297, DOI 10.1006/jare.2002.1092; Roy DP, 2008, REMOTE SENS ENVIRON, V112, P3690, DOI 10.1016/j.rse.2008.05.013; Saari SK, 2005, NEW PHYTOL, V165, P295, DOI 10.1111/j.1469-8137.2004.01213.x; Sala O.E., 1997, PLANT FUNCTIONAL TYP, P217; Sankaran M, 2004, ECOL LETT, V7, P480, DOI 10.1111/j.1461-0248.2004.00596.x; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Schenk HJ, 2008, VADOSE ZONE J, V7, P1119, DOI 10.2136/vzj2007.0119; Schenk HJ, 2005, GEODERMA, V126, P129, DOI 10.1016/j.geoderma.2004.11.018; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Scholes R.J., 1993, AFRICAN SAVANNA SYNT; Scholes RJ, 2002, J VEG SCI, V13, P419, DOI 10.1111/j.1654-1103.2002.tb02066.x; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Schulze ED, 1996, OECOLOGIA, V108, P503, DOI 10.1007/BF00333727; Schutz AEN, 2009, OECOLOGIA, V160, P235, DOI 10.1007/s00442-009-1293-1; Shugart HH, 2004, GLOBAL CHANGE BIOL, V10, P273, DOI 10.1111/j.1365-2486.2004.00732.x; SKARPE C, 1992, J VEG SCI, V3, P293, DOI 10.2307/3235754; van Wijk MT, 2011, GLOBAL ECOL BIOGEOGR, V20, P331, DOI 10.1111/j.1466-8238.2010.00601.x; van Wijk MT, 2001, HYDROL EARTH SYST SC, V5, P629, DOI 10.5194/hess-5-629-2001; Waisel Y, 1991, PLANT ROOTS HIDDEN H; Walter H., 1971, ECOLOGY TROPICAL SUB; Wang L, 2009, J ARID ENVIRON, V73, P480, DOI 10.1016/j.jaridenv.2008.11.010; Wang L, 2007, J ARID ENVIRON, V71, P259, DOI 10.1016/j.jaridenv.2007.03.016	72	26	27	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e33996	10.1371/journal.pone.0033996	http://dx.doi.org/10.1371/journal.pone.0033996			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470506	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000051
J	Brydges, CR; Clunies-Ross, K; Clohessy, M; Lo, ZL; Nguyen, A; Rousset, C; Whitelaw, P; Yeap, YJ; Fox, AM				Brydges, Christopher R.; Clunies-Ross, Karen; Clohessy, Madeleine; Lo, Zhao Li; An Nguyen; Rousset, Claire; Whitelaw, Patrick; Yeap, Yit Jing; Fox, Allison M.			Dissociable Components of Cognitive Control: An Event-Related Potential (ERP) Study of Response Inhibition and Interference Suppression	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; EXECUTIVE FUNCTIONS; STOP-SIGNAL; PREFRONTAL CORTEX; STROOP; TASK; FLANKER; PSYCHOPATHOLOGY; PERFORMANCE; MECHANISMS	Background: Cognitive control refers to the ability to selectively attend and respond to task-relevant events while resisting interference from distracting stimuli or prepotent automatic responses. The current study aimed to determine whether interference suppression and response inhibition are separable component processes of cognitive control. Methodology/Principal Findings: Fourteen young adults completed a hybrid Go/Nogo flanker task and continuous EEG data were recorded concurrently. The incongruous flanker condition (that required interference suppression) elicited a more centrally distributed topography with a later N2 peak than the Nogo condition (that required response inhibition). Conclusions/Significance: These results provide evidence for the dissociability of interference suppression and response inhibition, indicating that taxonomy of inhibition is warranted with the integration of research evidence from neuroscience.	[Brydges, Christopher R.; Clunies-Ross, Karen; Clohessy, Madeleine; Lo, Zhao Li; An Nguyen; Rousset, Claire; Whitelaw, Patrick; Yeap, Yit Jing; Fox, Allison M.] Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia; [Brydges, Christopher R.; Fox, Allison M.] Univ Western Australia, Neurocognit Dev Unit, Perth, WA 6009, Australia	University of Western Australia; University of Western Australia	Brydges, CR (corresponding author), Univ Western Australia, Sch Psychol, Perth, WA 6009, Australia.	brydgc01@student.uwa.edu.au	Fox, Allison M/H-9218-2014	Fox, Allison M/0000-0001-5189-6271; Brydges, Christopher/0000-0001-5901-638X	Australian Research Council [DP0665616]; School of Psychology, University of Western Australia	Australian Research Council(Australian Research Council); School of Psychology, University of Western Australia	Funding support was provided for equipment by the Australian Research Council DP0665616 (http://www.arc.gov.au/) and the School of Psychology, University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Blasi G, 2006, EUR J NEUROSCI, V23, P1658, DOI 10.1111/j.1460-9568.2006.04680.x; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Christ SE, 2007, J AUTISM DEV DISORD, V37, P1155, DOI 10.1007/s10803-006-0259-y; Cragg L, 2009, DEV PSYCHOBIOL, V51, P533, DOI 10.1002/dev.20391; Dagenbach D, INHIBITORY PROCESSES; DEMPSTER FN, 1991, INTELLIGENCE, V15, P157, DOI 10.1016/0160-2896(91)90028-C; Dempster FN, 1993, EMERGING THEMES COGN; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Forster SE, 2011, J COGNITIVE NEUROSCI, V23, P923, DOI 10.1162/jocn.2010.21458; Fox AM, 2000, CLIN NEUROPHYSIOL, V111, P1045, DOI 10.1016/S1388-2457(00)00257-1; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; GEHRING WJ, 1992, J EXP PSYCHOL HUMAN, V18, P198, DOI 10.1037/0096-1523.18.1.198; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Harnishfeger Katherine Kipp, 1995, P175, DOI 10.1016/B978-012208930-5/50007-6; Karayanidis F, 1997, ELECTROEN CLIN NEURO, V103, P282, DOI 10.1016/S0013-4694(97)96077-6; Kooijmans R, 2000, CHILD NEUROPSYCHOL, V6, P175, DOI 10.1076/chin.6.3.175.3154; Kramer UM, 2011, J COGNITIVE NEUROSCI, V23, P2481, DOI 10.1162/jocn.2010.21573; LOGAN GD, 1986, J EXP PSYCHOL HUMAN, V12, P549, DOI 10.1037/0096-1523.12.4.549; Michel F, 2009, DEVELOPMENTAL SCI, V12, P272, DOI 10.1111/j.1467-7687.2008.00759.x; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mostofsky SH, 2008, J COGNITIVE NEUROSCI, V20, P751, DOI 10.1162/jocn.2008.20500; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Richardson C, 2011, DEV PSYCHOBIOL, V53, P256, DOI 10.1002/dev.20518; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Roche RAP, 2005, EXP BRAIN RES, V160, P60, DOI 10.1007/s00221-004-1985-z; Rueda MR, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-39; Swick D, 2002, NEUROPSYCHOLOGIA, V40, P1240, DOI 10.1016/S0028-3932(01)00226-3; Tanji J, 2008, PHYSIOL REV, V88, P37, DOI 10.1152/physrev.00014.2007; Tillman CM, 2011, PSYCHOPHYSIOLOGY, V48, P1405, DOI 10.1111/j.1469-8986.2011.01203.x; van Boxtel GJM, 2001, BIOL PSYCHOL, V58, P229, DOI 10.1016/S0301-0511(01)00117-X; van Mourik R, 2005, J CHILD PSYCHOL PSYC, V46, P150, DOI 10.1111/j.1469-7610.2004.00345.x; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Verbruggen F, 2004, ACTA PSYCHOL, V116, P21, DOI 10.1016/j.actpsy.2003.12.011; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; White CN, 2011, COGNITIVE PSYCHOL, V63, P210, DOI 10.1016/j.cogpsych.2011.08.001	44	64	78	4	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34482	10.1371/journal.pone.0034482	http://dx.doi.org/10.1371/journal.pone.0034482			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	948FM	22470574	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000113
J	Butler, RJ; Barrett, PM; Gower, DJ				Butler, Richard J.; Barrett, Paul M.; Gower, David J.			Reassessment of the Evidence for Postcranial Skeletal Pneumaticity in Triassic Archosaurs, and the Early Evolution of the Avian Respiratory System	PLOS ONE			English	Article							NEW-MEXICO; AIR-SACS; EUCOELOPHYSIS-BALDWINI; VERTEBRAL PNEUMATICITY; BODY PLANS; DINOSAUR; ORIGIN; REPTILIA; DIAPSIDA; ANATOMY	Uniquely among extant vertebrates, birds possess complex respiratory systems characterised by the combination of small, rigid lungs, extensive pulmonary air sacs that possess diverticula that invade (pneumatise) the postcranial skeleton, unidirectional ventilation of the lungs, and efficient crosscurrent gas exchange. Crocodilians, the only other living archosaurs, also possess unidirectional lung ventilation, but lack true air sacs and postcranial skeletal pneumaticity (PSP). PSP can be used to infer the presence of avian-like pulmonary air sacs in several extinct archosaur clades (non-avian theropod dinosaurs, sauropod dinosaurs and pterosaurs). However, the evolution of respiratory systems in other archosaurs, especially in the lineage leading to crocodilians, is poorly documented. Here, we use mu CT-scanning to investigate the vertebral anatomy of Triassic archosaur taxa, from both the avian and crocodilian lineages as well as non-archosaurian diapsid outgroups. Our results confirm previous suggestions that unambiguous evidence of PSP (presence of internal pneumatic cavities linked to the exterior by foramina) is found only in bird-line (ornithodiran) archosaurs. We propose that pulmonary air sacs were present in the common ancestor of Ornithodira and may have been subsequently lost or reduced in some members of the clade (notably in ornithischian dinosaurs). The development of these avian-like respiratory features might have been linked to inferred increases in activity levels among ornithodirans. By contrast, no crocodile-line archosaur (pseudosuchian) exhibits evidence for unambiguous PSP, but many of these taxa possess the complex array of vertebral laminae and fossae that always accompany the presence of air sacs in ornithodirans. These laminae and fossae are likely homologous with those in ornithodirans, which suggests the need for further investigation of the hypothesis that a reduced, or non-invasive, system of pulmonary air sacs may be have been present in these taxa (and secondarily lost in extant crocodilians) and was potentially primitive for Archosauria as a whole.	[Butler, Richard J.] Univ Munich, GeoBioctr, Munich, Germany; [Butler, Richard J.; Barrett, Paul M.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Gower, David J.] Nat Hist Museum, Dept Zool, London SW7 5BD, England	University of Munich; Natural History Museum London; Natural History Museum London	Butler, RJ (corresponding author), Univ Munich, GeoBioctr, Munich, Germany.	butler.richard.j@gmail.com	Barrett, Paul M/A-2648-2010; Butler, Richard J./A-5239-2011	Barrett, Paul M/0000-0003-0412-3000; Butler, Richard J./0000-0003-2136-7541	United Kingdom Natural Environment Research Council [NE/F/009933/1]; NERC [NE/F009933/1] Funding Source: UKRI; Natural Environment Research Council [NE/F009933/1] Funding Source: researchfish	United Kingdom Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by the United Kingdom Natural Environment Research Council (NE/F/009933/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcober O, 1997, J VERTEBR PALEONTOL, V17, P548, DOI 10.1080/02724634.1997.10011001; ARCUCCI A, 1987, Ameghiniana, V24, P89; ARCUCCI A, 1990, Ameghiniana, V27, P365; Barrett Paul M., 2008, Zitteliana Reihe B, V28, P61; Bennett SC, 1996, ZOOL J LINN SOC-LOND, V118, P261, DOI 10.1111/j.1096-3642.1996.tb01267.x; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Benton MJ, 2004, DINOSAURIA, 2ND EDITION, P7; BENTON MJ, 1983, PHILOS T ROY SOC B, V302, P605, DOI 10.1098/rstb.1983.0079; BENTON MJ, 1990, PHILOS T ROY SOC B, V328, P213, DOI 10.1098/rstb.1990.0114; Benton MJ, 1997, J VERTEBR PALEONTOL, V17, P74, DOI 10.1080/02724634.1997.10010955; Benton MJ, 1999, PHILOS T ROY SOC B, V354, P1423, DOI 10.1098/rstb.1999.0489; Bittencourt JD, 2009, ZOOTAXA, P1; Bonde Niels, 2003, Geological Society Special Publication, V217, P217, DOI 10.1144/GSL.SP.2003.217.01.13; Borsuk-Bialynicka Magdalena, 2009, PALAEONTOLOGIA POLONICA, P283; Britt B., 1997, ENCY DINOSAURS, P590; Britt BB, 1998, NATURE, V395, P374, DOI 10.1038/26469; BRITT BB, 1993, THESIS U CALGARY CAN; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Brusatte SL, 2010, J SYST PALAEONTOL, V8, P3, DOI 10.1080/14772010903537732; Butler RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025693; Butler RJ, 2009, J VERTEBR PALEONTOL, V29, P1022, DOI 10.1671/039.029.0404; Butler RJ, 2009, BIOL LETTERS, V5, P557, DOI 10.1098/rsbl.2009.0139; Campione NE, 2010, J VERTEBR PALEONTOL, V30, P724, DOI 10.1080/02724631003762914; Charig AJ, 1976, HDB PALAOHERPETOLOGI, V13, P11; CHATERJEE S, 1993, RES EXPLOR, V9, P274; CHATTERJEE S, 1985, PHILOS T ROY SOC B, V309, P395, DOI 10.1098/rstb.1985.0092; CHATTERJEE S, 1984, NATURWISSENSCHAFTEN, V71, P630, DOI 10.1007/BF00377897; Christiansen P, 2000, P ROY SOC B-BIOL SCI, V267, P2501, DOI 10.1098/rspb.2000.1311; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; Cruickshank A.R.I., 1972, P89; de Ricqles A, 2008, ANN PALEONTOL, V94, P57, DOI 10.1016/j.annpal.2008.03.002; Dilkes D, 2009, J VERTEBR PALEONTOL, V29, P58, DOI 10.1080/02724634.2009.10010362; DILKES DW, 1995, PALAEONTOLOGY, V38, P665; Dumont ER, 2010, P ROY SOC B-BIOL SCI, V277, P2193, DOI 10.1098/rspb.2010.0117; Duncker H.-R., 1978, P2; Duncker H.-R., 1971, ADV ANAT EMBRYOL CEL, V45, P1; Dzik J, 2003, J VERTEBR PALEONTOL, V23, P556, DOI 10.1671/A1097; EWER RF, 1965, PHILOS T ROY SOC B, V248, P379, DOI 10.1098/rstb.1965.0003; Ezcurra MD, 2006, GEODIVERSITAS, V28, P649; Farmer CG, 2006, RESP PHYSIOL NEUROBI, V154, P89, DOI 10.1016/j.resp.2006.04.014; Farmer CG, 2010, SCIENCE, V327, P338, DOI 10.1126/science.1180219; Ferigolo J., 2006, HIST BIOL, V19, P1, DOI DOI 10.1080/08912960600845767; Fostowicz-Frelik L, 2010, LETHAIA, V43, P137, DOI 10.1111/j.1502-3931.2009.00179.x; Galton Peter M., 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V201, P303; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Gower D, 2009, J VERTEBR PALEONTOL, V29, p108A; Gower David J., 2000, P140; Gower DJ, 2009, J VERTEBR PALEONTOL, V29, P103, DOI 10.1080/02724634.2009.10010365; Gower David John, 2003, Annals of the South African Museum, V110, P1; Gower DJ, 2006, J VERTEBR PALEONTOL, V26, P79, DOI 10.1671/0272-4634(2006)26[79:TBOABE]2.0.CO;2; Gower DJ, 2000, NEUES JAHRB GEOL P-A, V218, P447, DOI 10.1127/njgpa/218/2000/447; Gower DJ, 2001, NATURWISSENSCHAFTEN, V88, P119, DOI 10.1007/s001140100206; Gower DJ, 1996, P ROY SOC B-BIOL SCI, V263, P1399, DOI 10.1098/rspb.1996.0205; Irmis RB, 2007, SCIENCE, V317, P358, DOI 10.1126/science.1143325; Juul Lars, 1994, Palaeontologia Africana, V31, P1; King A. S., 1966, International Review of General and Experimental Zoology, V2, P171; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Long R.A., 1995, NEW MEXICO MUSEUM NA, V4, P1; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Mundil R, 2010, GEOL SOC SPEC PUBL, V334, P41, DOI 10.1144/SP334.3; Nesbitt SJ, 2006, P ROY SOC B-BIOL SCI, V273, P1045, DOI 10.1098/rspb.2005.3426; Nesbitt S, 2007, B AM MUS NAT HIST, P1; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Nesbitt SJ, 2011, B AM MUS NAT HIST, P1, DOI 10.1206/352.1; Nesbitt SJ, 2010, NATURE, V464, P95, DOI 10.1038/nature08718; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Nesbitt SJ, 2009, ZOOL J LINN SOC-LOND, V157, P814, DOI 10.1111/j.1096-3642.2009.00530.x; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; O'Connor PM, 2009, J EXP ZOOL PART A, V311A, P629, DOI 10.1002/jez.548; O'Connor PM, 2004, J MORPHOL, V261, P141, DOI 10.1002/jmor.10190; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Parker William G., 2008, Paleobios, V28, P1; PERRY SF, 1983, ADV ANAT EMBRYOL CEL, V79, P1; Perry Steven F., 2011, P83; Perry Steven F., 1998, V19, P1; Peters D, 2000, RIV ITAL PALEONTOL S, V106, P293, DOI 10.13130/2039-4942/6148; Piechowski R, 2010, J VERTEBR PALEONTOL, V30, P1127, DOI 10.1080/02724634.2010.483547; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Renesto S, 2006, RIV ITAL PALEONTOL S, V112, P77, DOI 10.13130/2039-4942/5851; Romer A.S., 1972, Breviora, VNo. 385, P1; Romer A.S., 1972, Breviora, VNo. 390, P1; Romer A. S., 1940, GEOLOGICAL SOC AM SP, V28, P1, DOI DOI 10.1130/SPE28-P1; Sanders RK, 2012, ANAT REC, V295, P699, DOI 10.1002/ar.22427; Schachner ER, 2011, ANAT REC, V294, P1532, DOI 10.1002/ar.21439; Schwarz D, 2007, ACTA PALAEONTOL POL, V52, P167; Schwarz D, 2006, ECLOGAE GEOL HELV, V99, P65, DOI 10.1007/s00015-006-1177-x; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P1; Sereno Paul C., 2007, Historical Biology, V19, P145, DOI 10.1080/08912960601167435; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P385; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; SERENO PC, 1994, J VERTEBR PALEONTOL, V14, P53, DOI 10.1080/02724634.1994.10011538; Smith ND, 2012, EVOLUTION, V66, P1059, DOI 10.1111/j.1558-5646.2011.01494.x; Sullivan RM, 1999, J VERTEBR PALEONTOL, V19, P81, DOI 10.1080/02724634.1999.10011124; Torday JS, 2007, INTEGR COMP BIOL, V47, P601, DOI 10.1093/icb/icm069; Wedel M, 2007, SPEC PAP PALAEONTOL, P207; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel MJ, 2006, INTEGR ZOOL, V1, P80, DOI 10.1111/j.1749-4877.2006.00019.x; Wedel MJ, 2009, J EXP ZOOL PART A, V311A, P611, DOI 10.1002/jez.513; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Werning S, 2011, ANN M SOC VERT PAL; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007; Yates AM, 2012, ACTA PALAEONTOL POL, V57, P85, DOI 10.4202/app.2010.0075; Young C. C., 1936, Bulletin of the Geological Society of China, V15, P291; Young C. C., 1963, Vertebrata Palasiatica, V7, P215; Zhou ZH, 2003, NATURWISSENSCHAFTEN, V90, P220, DOI 10.1007/s00114-003-0416-5	118	54	54	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34094	10.1371/journal.pone.0034094	http://dx.doi.org/10.1371/journal.pone.0034094			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470520	gold, Green Published, Green Submitted			2022-12-27	WOS:000304489000063
J	Chouteau, M; Angers, B				Chouteau, Mathieu; Angers, Bernard			Wright's Shifting Balance Theory and the Diversification of Aposematic Signals	PLOS ONE			English	Article							MULLERIAN MIMICRY; WARNING-COLOR; POISON FROGS; POPULATION BOTTLENECKS; GENE FLOW; EVOLUTION; SELECTION; PERSPECTIVE; DIVERSITY; DIFFERENTIATION	Despite accumulating evidence for selection within natural systems, the importance of random genetic drift opposing Wright's and Fisher's views of evolution continue to be a subject of controversy. The geographical diversification of aposematic signals appears to be a suitable system to assess the factors involved in the process of adaptation since both theories were independently proposed to explain this phenomenon. In the present study, the effects of drift and selection were assessed from population genetics and predation experiments on poison-dart frogs, Ranitomaya imitator, of Northern Peru. We specifically focus on the transient zone between two distinct aposematic signals. In contrast to regions where high predation maintains a monomorphic aposematic signal, the transient zones are characterized by lowered selection and a high phenotypic diversity. As a result, the diversification of phenotypes may occur via genetic drift without a significant loss of fitness. These new phenotypes may then colonize alternative habitats if successfully recognized and avoided by predators. This study highlights the interplay between drift and selection as determinant processes in the adaptive diversification of aposematic signals. Results are consistent with the expectations of the Wright's shifting balance theory and represent, to our knowledge, the first empirical demonstration of this highly contested theory in a natural system.	[Chouteau, Mathieu] Univ Montreal, Grp Interuniv Res Limnol & Aquat Environm GRIL, Montreal, PQ, Canada; Univ Montreal, Dept Biol Sci, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	Chouteau, M (corresponding author), Univ Montreal, Grp Interuniv Res Limnol & Aquat Environm GRIL, Montreal, PQ, Canada.	mathieu.chouteau@umontreal.ca	Angers, Bernard/U-9340-2019	Angers, Bernard/0000-0002-0992-140X; Chouteau, Mathieu/0000-0003-2043-0895	Natural Sciences and Engineering Research Council (NSERC); Group of Interuniversity research in limnology and aquatic environment (GRIL)	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Group of Interuniversity research in limnology and aquatic environment (GRIL)	Funding was provided by the Natural Sciences and Engineering Research Council scholarship (NSERC) and the Group of Interuniversity research in limnology and aquatic environment (GRIL) to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Balogh ACV, 2005, P ROY SOC B-BIOL SCI, V272, P2269, DOI 10.1098/rspb.2005.3227; BARTON NH, 1992, EVOLUTION, V46, P551, DOI 10.1111/j.1558-5646.1992.tb02058.x; Belkhir K, 1996, 5171 CNRS UMR U MONT; Benson W.W., 1982, P608; BENSON WW, 1972, SCIENCE, V176, P936, DOI 10.1126/science.176.4037.936; Bocak L, 2010, EVOLUTION, V64, P39, DOI 10.1111/j.1558-5646.2009.00812.x; Borer M, 2010, EVOLUTION, V64, P3629, DOI 10.1111/j.1558-5646.2010.01137.x; Brown JL, 2008, ZOOTAXA, P1; Brown JL, 2009, CONSERV GENET RESOUR, V1, P149, DOI 10.1007/s12686-009-9036-5; Brown JL, 2009, ANIM BEHAV, V77, P547, DOI 10.1016/j.anbehav.2008.10.002; BROWN KS, 1974, PROC R SOC SER B-BIO, V187, P369, DOI 10.1098/rspb.1974.0082; Bryant EH, 1996, EVOLUTION, V50, P935, DOI [10.2307/2410867, 10.1111/j.1558-5646.1996.tb03904.x]; Bryant EH, 1996, HEREDITY, V77, P168, DOI 10.1038/hdy.1996.121; Chouteau M, 2011, AM NAT, V178, P810, DOI 10.1086/662667; Chouteau M, 2011, BIOL LETTERS, V7, P796, DOI 10.1098/rsbl.2011.0039; Cornuet JM, 1996, GENETICS, V144, P2001; Coyne JA, 2000, EVOLUTION, V54, P306, DOI 10.1111/j.0014-3820.2000.tb00033.x; Coyne JA, 1997, EVOLUTION, V51, P643, DOI [10.2307/2411143, 10.1111/j.1558-5646.1997.tb03650.x]; Endler J.A., 1982, P641; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fisher RA, 1930, GENETICAL THEORY NAT; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Jiggins CD, 1997, HEREDITY, V79, P495, DOI 10.1038/sj.hdy.6882230; Joron M, 1998, TRENDS ECOL EVOL, V13, P461, DOI 10.1016/S0169-5347(98)01483-9; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Langham GM, 2004, EVOLUTION, V58, P2783; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li W. H, 1997, MOL EVOLUTION; MALLET J, 1990, GENETICS, V124, P921; MALLET J, 1987, BIOL J LINN SOC, V32, P337, DOI 10.1111/j.1095-8312.1987.tb00435.x; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mallet J, 1999, EVOL ECOL, V13, P777, DOI 10.1023/A:1011060330515; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; MALLET J, 1986, HEREDITY, V56, P191, DOI 10.1038/hdy.1986.31; Mallet J, 2010, ECOL ENTOMOL, V35, P90, DOI 10.1111/j.1365-2311.2009.01137.x; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Marek PE, 2009, P NATL ACAD SCI USA, V106, P9755, DOI 10.1073/pnas.0810408106; Merchan HA, 2005, BIOTROPICA, V37, P119, DOI 10.1111/j.1744-7429.2005.03140.x; Noonan BP, 2006, MOL ECOL, V15, P4425, DOI 10.1111/j.1365-294X.2006.03074.x; Noonan BP, 2009, BIOL LETTERS, V5, P51, DOI 10.1098/rsbl.2008.0586; Pinheiro CEG, 2003, BIOTROPICA, V35, P356, DOI 10.1646/02128; Pray LA, 1997, EVOLUTION, V51, P308, DOI 10.1111/j.1558-5646.1997.tb02414.x; PRAY LA, 1995, EVOLUTION, V49, P176, DOI 10.2307/2410303; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roberts JL, 2006, HERPETOL J, V16, P377; Robertson JM, 2008, J BIOGEOGR, V35, P830, DOI 10.1111/j.1365-2699.2007.01824.x; Rousset F, 1997, GENETICS, V145, P1219; Rudh A, 2007, MOL ECOL, V16, P4284, DOI 10.1111/j.1365-294X.2007.03479.x; Ruxton GD, 2004, AVOIDING ATTACK EVOL; SCHULTE R, 1999, PFEILGIFTFROSCHE, V2; SHEPPARD PM, 1985, PHILOS T R SOC B, V308, P433, DOI 10.1098/rstb.1985.0066; Sherratt TN, 2008, NATURWISSENSCHAFTEN, V95, P681, DOI 10.1007/s00114-008-0403-y; Sherratt TN, 2006, J THEOR BIOL, V240, P165, DOI 10.1016/j.jtbi.2005.09.017; Symula R, 2003, MOL PHYLOGENET EVOL, V26, P452, DOI 10.1016/S1055-7903(02)00367-6; Symula R, 2001, P ROY SOC B-BIOL SCI, V268, P2415, DOI 10.1098/rspb.2001.1812; Turner J.R.G., 1971, ECOLOGICAL GENETICS, P224; Wade MJ, 1998, EVOLUTION, V52, P1537, DOI 10.1111/j.1558-5646.1998.tb02235.x; WADE MJ, 1991, SCIENCE, V253, P1015, DOI 10.1126/science.1887214; Wang IJ, 2008, EVOLUTION, V62, P2742, DOI 10.1111/j.1558-5646.2008.00507.x; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WHITLOCK MC, 1995, THEOR POPUL BIOL, V48, P44, DOI 10.1006/tpbi.1995.1021; Wright S, 1943, GENETICS, V28, P114; Wright S., 1978, EVOLUTION GENETICS P; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	68	32	33	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34028	10.1371/journal.pone.0034028	http://dx.doi.org/10.1371/journal.pone.0034028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470509	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000053
J	Miller, RJ; Bennett, S; Keller, AA; Pease, S; Lenihan, HS				Miller, Robert J.; Bennett, Samuel; Keller, Arturo A.; Pease, Scott; Lenihan, Hunter S.			TiO2 Nanoparticles Are Phototoxic to Marine Phytoplankton	PLOS ONE			English	Article							METAL-OXIDE NANOPARTICLES; ENGINEERED NANOPARTICLES; ULTRAVIOLET-RADIATION; STRESS; NANOMATERIALS; BIOCHEMISTRY; ENVIRONMENT; MECHANISMS; BEHAVIOR; SURFACE	Nanoparticulate titanium dioxide (TiO2) is highly photoactive, and its function as a photocatalyst drives much of the application demand for TiO2. Because TiO2 generates reactive oxygen species (ROS) when exposed to ultraviolet radiation (UVR), nanoparticulate TiO2 has been used in antibacterial coatings and wastewater disinfection, and has been investigated as an anti-cancer agent. Oxidative stress mediated by photoactive TiO2 is the likely mechanism of its toxicity, and experiments demonstrating cytotoxicity of TiO2 have used exposure to strong artificial sources of ultraviolet radiation (UVR). In vivo tests of TiO2 toxicity with aquatic organisms have typically shown low toxicity, and results across studies have been variable. No work has demonstrated that photoactivity causes environmental toxicity of TiO2 under natural levels of UVR. Here we show that relatively low levels of ultraviolet light, consistent with those found in nature, can induce toxicity of TiO2 nanoparticles to marine phytoplankton, the most important primary producers on Earth. No effect of TiO2 on phytoplankton was found in treatments where UV light was blocked. Under low intensity UVR, ROS in seawater increased with increasing nano-TiO2 concentration. These increases may lead to increased overall oxidative stress in seawater contaminated by TiO2, and cause decreased resiliency of marine ecosystems. Phototoxicity must be considered when evaluating environmental impacts of nanomaterials, many of which are photoactive.	[Miller, Robert J.; Bennett, Samuel; Keller, Arturo A.; Pease, Scott; Lenihan, Hunter S.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Miller, Robert J.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Miller, Robert J.; Bennett, Samuel; Keller, Arturo A.; Lenihan, Hunter S.] Univ Calif Santa Barbara, Univ Calif Ctr Environm Implicat Nanotechnol, Santa Barbara, CA 93106 USA; [Pease, Scott] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Washington; University of Washington Seattle	Miller, RJ (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA.	miller@msi.ucsb.edu		Miller, Robert/0000-0002-8350-3759; Hocevar, John/0000-0002-8346-1341	National Science Foundation [EF-0742521]; United States Environmental Protection Agency [NSF-EF0830117]	National Science Foundation(National Science Foundation (NSF)); United States Environmental Protection Agency(United States Environmental Protection Agency)	This work was supported by the National Science Foundation and the United States Environmental Protection Agency under Cooperative Agreement # NSF-EF0830117, and by National Science Foundation grant EF-0742521. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angel DL, 1999, HELGOLAND MAR RES, V53, P209; Battin TJ, 2009, ENVIRON SCI TECHNOL, V43, P8098, DOI 10.1021/es9017046; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Bennett SW, 2011, APPL CATAL B-ENVIRON, V102, P600, DOI 10.1016/j.apcatb.2010.12.045; Berliner LJ, 2001, FREE RADICAL BIO MED, V30, P489, DOI 10.1016/S0891-5849(00)00491-3; Brunet L, 2009, ENVIRON SCI TECHNOL, V43, P4355, DOI 10.1021/es803093t; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Carp O, 2004, PROG SOLID STATE CH, V32, P33, DOI 10.1016/j.progsolidstchem.2004.08.001; CHAMULITRAT W, 1992, ARCH BIOCHEM BIOPHYS, V296, P645, DOI 10.1016/0003-9861(92)90621-3; Collen J, 1999, PLANT CELL ENVIRON, V22, P1143, DOI 10.1046/j.1365-3040.1999.00477.x; Czili H, 2008, APPL CATAL B-ENVIRON, V81, P295, DOI 10.1016/j.apcatb.2008.01.001; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Farre M, 2009, ANAL BIOANAL CHEM, V393, P81, DOI 10.1007/s00216-008-2458-1; Fridovich I, 1998, J EXP BIOL, V201, P1203; Godwin HA, 2009, ENVIRON SCI TECHNOL, V43, P6453, DOI 10.1021/es8034544; Gopal NO, 2010, J AM CHEM SOC, V132, P10982, DOI 10.1021/ja909901f; Gottschalk F, 2010, ENVIRON TOXICOL CHEM, V29, P1036, DOI 10.1002/etc.135; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; He ZM, 2011, NANOSCALE, V3, P4977, DOI 10.1039/c1nr11126d; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hund-Rinke K, 2006, ENVIRON SCI POLLUT R, V13, P225, DOI 10.1065/espr2006.06.311; Johnston HJ, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-33; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Kim J, 2010, AQUAT TOXICOL, V97, P116, DOI 10.1016/j.aquatox.2009.12.022; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Konstantinou IK, 2004, APPL CATAL B-ENVIRON, V49, P1, DOI 10.1016/j.apcatb.2003.11.010; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; McKenzie RL, 2007, PHOTOCH PHOTOBIO SCI, V6, P218, DOI 10.1039/b700017k; Menard A, 2011, ENVIRON POLLUT, V159, P677, DOI 10.1016/j.envpol.2010.11.027; Miller RJ, 2010, ENVIRON SCI TECHNOL, V44, P7329, DOI 10.1021/es100247x; MOPPER K, 1990, SCIENCE, V250, P661, DOI 10.1126/science.250.4981.661; Musee N, 2011, J ENVIRON MONITOR, V13, P1164, DOI 10.1039/c1em10023h; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; ODA T, 1992, MAR BIOL, V112, P505, DOI 10.1007/BF00356297; Rozhkova EA, 2009, NANO LETT, V9, P3337, DOI 10.1021/nl901610f; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; Theron J, 2008, CRIT REV MICROBIOL, V34, P43, DOI [10.1080/10408410701710442, 10.1080/10408410701710442 ]; YANG CZ, 1995, DIS AQUAT ORGAN, V23, P101, DOI 10.3354/dao023101; Zhang DQ, 2010, J MATER CHEM, V20, P4529, DOI 10.1039/b925342d; Zubia M, 2007, J APPL PHYCOL, V19, P449, DOI 10.1007/s10811-006-9152-5	44	231	242	7	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30321	10.1371/journal.pone.0030321	http://dx.doi.org/10.1371/journal.pone.0030321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	909MH	22470486	Green Submitted, Green Published, gold			2022-12-27	WOS:000301568100035
J	Sejdic, E; Steele, CM; Chau, T				Sejdic, Ervin; Steele, Catriona M.; Chau, Tom			A Method for Removal of Low Frequency Components Associated with Head Movements from Dual-Axis Swallowing Accelerometry Signals	PLOS ONE			English	Article							ACCELERATION; DYSPHAGIA; CHARACTERIZE; ASPIRATION; DIAGNOSIS; DESIGN; PHASE	Head movements can greatly affect swallowing accelerometry signals. In this paper, we implement a spline-based approach to remove low frequency components associated with these motions. Our approach was tested using both synthetic and real data. Synthetic signals were used to perform a comparative analysis of the spline-based approach with other similar techniques. Real data, obtained data from 408 healthy participants during various swallowing tasks, was used to analyze the processing accuracy with and without the spline-based head motions removal scheme. Specifically, we analyzed the segmentation accuracy and the effects of the scheme on statistical properties of these signals, as measured by the scaling analysis. The results of the numerical analysis showed that the spline-based technique achieves a superior performance in comparison to other existing techniques. Additionally, when applied to real data, we improved the accuracy of the segmentation process by achieving a 27% drop in the number of false negatives and a 30% drop in the number of false positives. Furthermore, the anthropometric trends in the statistical properties of these signals remained unaltered as shown by the scaling analysis, but the strength of statistical persistence was significantly reduced. These results clearly indicate that any future medical devices based on swallowing accelerometry signals should remove head motions from these signals in order to increase segmentation accuracy.	[Sejdic, Ervin] Univ Pittsburgh, Dept Elect & Comp Engn, Pittsburgh, PA 15260 USA; [Steele, Catriona M.] Univ Toronto, Dept Speech Language Pathol, Toronto, ON, Canada; [Steele, Catriona M.] Univ Toronto, Toronto Rehabil Inst, Toronto, ON, Canada; [Steele, Catriona M.; Chau, Tom] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Steele, Catriona M.; Chau, Tom] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital	Sejdic, E (corresponding author), Univ Pittsburgh, Dept Elect & Comp Engn, Pittsburgh, PA 15260 USA.	esejdic@ieee.org	Chau, Tom TK/C-8426-2009	Chau, Tom TK/0000-0002-7486-0316; Steele, Catriona/0000-0002-4294-6561; Sejdic, Ervin/0000-0003-4987-8298	Ontario Centres of Excellence; Toronto Rehabilitation Institute; Bloorview Kids Rehab; Canada Research Chairs	Ontario Centres of Excellence; Toronto Rehabilitation Institute(University of Toronto); Bloorview Kids Rehab; Canada Research Chairs(Canada Research ChairsCGIAR)	This research was funded in part by the Ontario Centres of Excellence, the Toronto Rehabilitation Institute, Bloorview Kids Rehab, and the Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chau T, 2005, IEEE T NEUR SYS REH, V13, P99, DOI 10.1109/TNSRE.2004.841384; Das A, 2001, COMPUT METH PROG BIO, V64, P87, DOI 10.1016/S0169-2607(00)00099-7; Ekberg O, 2002, DYSPHAGIA, V17, P139, DOI 10.1007/s00455-001-0113-5; Ghaffari A, 2009, COMPUTER METHODS BIO; Hung D, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-25; Ishida R, 2002, DYSPHAGIA, V17, P262, DOI 10.1007/s00455-002-0064-5; Karczewicz M, 1997, SIGNAL PROCESS, V59, P43, DOI 10.1016/S0165-1684(97)00037-6; Kim YS, 2008, DYSPHAGIA, V23, P274, DOI 10.1007/s00455-007-9135-y; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lee J, 2008, PHYSIOL MEAS, V29, P1105, DOI 10.1088/0967-3334/29/9/008; Lee J, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-14; Liang HL, 2005, IEEE T BIO-MED ENG, V52, P1692, DOI 10.1109/TBME.2005.855719; Logemann J., 1998, EVALUATION TREATMENT, V2nd, DOI DOI 10.1097/00020840-199812000-00008; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Miller A.J., 1999, NEUROSCIENTIFIC PRIN; Ramsey DJC, 2006, STROKE, V37, P2984, DOI 10.1161/01.STR.0000248758.32627.3b; REDDY NP, 1991, J BIOMED ENG, V13, P379, DOI 10.1016/0141-5425(91)90018-3; Reddy NP, 2000, MED ENG PHYS, V22, P405, DOI 10.1016/S1350-4533(00)00047-3; REDDY NP, 1990, IEEE T BIO-MED ENG, V37, P392, DOI 10.1109/10.52346; REDDY NP, 1988, IEEE ENG MED BIOL, V7, P16, DOI 10.1109/51.7929; Sejdic E., 2010, BMC RES, V3, DOI DOI 10.1186/1756-0500-3-269; Sejdic E, 2011, COMPUT METH PROG BIO, V103, P113, DOI 10.1016/j.cmpb.2010.06.010; Sejdic E, 2010, COMPUT BIOL MED, V40, P839, DOI 10.1016/j.compbiomed.2010.09.002; Sejdic E, 2010, MED ENG PHYS, V32, P668, DOI 10.1016/j.medengphy.2010.04.008; Sejdic E, 2010, PHYSIOL MEAS, V31, pN1, DOI 10.1088/0967-3334/31/1/N01; Sejdic E, 2009, IEEE T BIO-MED ENG, V56, P1090, DOI 10.1109/TBME.2008.2010504; Smithard DG, 1996, STROKE, V27, P1200, DOI 10.1161/01.STR.27.7.1200; Steele CM, 2007, CAN J SPEECH-LANG PA, V31, P166; Tarvainen MP, 2002, IEEE T BIO-MED ENG, V49, P172, DOI 10.1109/10.979357; UNSER M, 1991, IEEE T PATTERN ANAL, V13, P277, DOI 10.1109/34.75515; UNSER M, 1992, IEEE T INFORM THEORY, V38, P95, DOI 10.1109/18.108253; Unser M, 2002, PROC SPIE, V4684, P225, DOI 10.1117/12.467162; UNSER M, 1993, IEEE T SIGNAL PROCES, V41, P834, DOI 10.1109/78.193221; UNSER M, 1993, IEEE T SIGNAL PROCES, V41, P821, DOI 10.1109/78.193220; Unser M, 1999, IEEE SIGNAL PROC MAG, V16, P22, DOI 10.1109/79.799930	35	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e33464	10.1371/journal.pone.0033464	http://dx.doi.org/10.1371/journal.pone.0033464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22479402	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000304523400024
J	Yang, HC; Liang, YJ; Chen, JW; Chiang, KM; Chung, CM; Ho, HY; Ting, CT; Lin, TH; Sheu, SH; Tsai, WC; Chen, JH; Leu, HB; Yin, WH; Chiu, TY; Chern, CI; Lin, SJ; Tomlinson, B; Guo, YL; Sham, PC; Cherny, SS; Lam, TH; Thomas, N; Pan, WH				Yang, Hsin-Chou; Liang, Yu-Jen; Chen, Jaw-Wen; Chiang, Kuang-Mao; Chung, Chia-Min; Ho, Hung-Yun; Ting, Chih-Tai; Lin, Tsung-Hsien; Sheu, Sheng-Hsiung; Tsai, Wei-Chuan; Chen, Jyh-Hong; Leu, Hsin-Bang; Yin, Wei-Hsian; Chiu, Ting-Yu; Chern, Ching-Iuan; Lin, Shing-Jong; Tomlinson, Brian; Guo, Youling; Sham, Pak C.; Cherny, Stacey S.; Lam, Tai Hing; Thomas, Neil; Pan, Wen-Harn			Identification of IGF1, SLC4A4, WWOX, and SFMBT1 as Hypertension Susceptibility Genes in Han Chinese with a Genome-Wide Gene-Based Association Study	PLOS ONE			English	Article							FACTOR-I GENE; BLOOD-PRESSURE; PROMOTER REGION; GLUCOSE-HOMEOSTASIS; TUMOR-SUPPRESSOR; GROWTH; POLYMORPHISM; LINKAGE; MICE; LOCUS	Hypertension is a complex disorder with high prevalence rates all over the world. We conducted the first genome-wide gene-based association scan for hypertension in a Han Chinese population. By analyzing genome-wide single-nucleotide-polymorphism data of 400 matched pairs of young-onset hypertensive patients and normotensive controls genotyped with the Illumina HumanHap550-Duo BeadChip, 100 susceptibility genes for hypertension were identified and also validated with permutation tests. Seventeen of the 100 genes exhibited differential allelic and expression distributions between patient and control groups. These genes provided a good molecular signature for classifying hypertensive patients and normotensive controls. Among the 17 genes, IGF1, SLC4A4, WWOX, and SFMBT1 were not only identified by our gene-based association scan and gene expression analysis but were also replicated by a gene-based association analysis of the Hong Kong Hypertension Study. Moreover, cis-acting expression quantitative trait loci associated with the differentially expressed genes were found and linked to hypertension. IGF1, which encodes insulin-like growth factor 1, is associated with cardiovascular disorders, metabolic syndrome, decreased body weight/size, and changes of insulin levels in mice. SLC4A4, which encodes the electrogenic sodium bicarbonate cotransporter 1, is associated with decreased body weight/size and abnormal ion homeostasis in mice. WWOX, which encodes the WW domain-containing protein, is related to hypoglycemia and hyperphosphatemia. SFMBT1, which encodes the scm-like with four MBT domains protein 1, is a novel hypertension gene. GRB14, TMEM56 and KIAA1797 exhibited highly significant differential allelic and expressed distributions between hypertensive patients and normotensive controls. GRB14 was also found relevant to blood pressure in a previous genetic association study in East Asian populations. TMEM56 and KIAA1797 may be specific to Taiwanese populations, because they were not validated by the two replication studies. Identification of these genes enriches the collection of hypertension susceptibility genes, thereby shedding light on the etiology of hypertension in Han Chinese populations.	[Yang, Hsin-Chou; Liang, Yu-Jen] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Chiang, Kuang-Mao; Chung, Chia-Min; Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Liang, Yu-Jen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Chen, Jaw-Wen; Leu, Hsin-Bang; Lin, Shing-Jong] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Jaw-Wen; Leu, Hsin-Bang; Lin, Shing-Jong] Taipei Vet Gen Hosp, Taipei, Taiwan; [Chiang, Kuang-Mao] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Ho, Hung-Yun; Ting, Chih-Tai] Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung, Taiwan; [Lin, Tsung-Hsien; Sheu, Sheng-Hsiung] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Wei-Chuan; Chen, Jyh-Hong] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70101, Taiwan; [Yin, Wei-Hsian] Cheng Hsin Rehabil Med Ctr, Div Cardiol, Taipei, Taiwan; [Chiu, Ting-Yu; Chern, Ching-Iuan] Min Sheng Gen Hosp, Div Cardiol, Tao Yuan, Taiwan; [Tomlinson, Brian] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Guo, Youling; Sham, Pak C.; Cherny, Stacey S.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak C.; Cherny, Stacey S.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Thomas, Neil] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Pan, Wen-Harn] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Prevent Med & Hlth Serv Res, Miaoli, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Defense Medical Center; Taichung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Cheng Kung University; Chinese University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Birmingham; National Health Research Institutes - Taiwan	Yang, HC (corresponding author), Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan.	pan@ibms.sinica.edu.tw	Thomas, G. Neil/A-1879-2013; Cherny, Stacey S/B-3315-2008; Yang, Hsin-Chou/AAP-2547-2021; Pan, Wen-Harn/F-9972-2010; Tomlinson, Brian/P-5365-2015; Tomlinson, Brian/AAD-9404-2019	Thomas, G. Neil/0000-0002-2777-1847; Cherny, Stacey S/0000-0002-0269-3352; Yang, Hsin-Chou/0000-0001-6853-7881; Pan, Wen-Harn/0000-0001-9136-0658; Tomlinson, Brian/0000-0001-6717-5444; Chiang, Kuang-Mao/0000-0002-8745-2004; Lin, Tsung-Hsien/0000-0002-7226-8730	National Research Program for Genomic Medicine [NSC 97-3112-B-001-027, NSC 98-3112-B-001-013, NSC 99-3112-B001-009, NSC 99-3112-B-001-029]; National Science Council of Taiwan [NSC 97-2314-B-001-006-MY3, NSC 100-2314-B-001-005-MY3, NSC 100-2319-B-010002]; Career Development Award of Academia Sinica [AS-100-CDA-M03]; Academia Sinica Genomics and Proteomics Program [521023-92-81, 521023-93-81, 521023-94-19, 30-34-GSK]; Academia Sinica Genomic Medicine Multicenter Studies [40-05-GMM]; Wellcome Trust Funding Source: Medline	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Career Development Award of Academia Sinica; Academia Sinica Genomics and Proteomics Program; Academia Sinica Genomic Medicine Multicenter Studies; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the National Research Program for Genomic Medicine (NSC 97-3112-B-001-027, NSC 98-3112-B-001-013, NSC 99-3112-B001-009, and NSC 99-3112-B-001-029), National Science Council grants (NSC 97-2314-B-001-006-MY3, NSC 100-2314-B-001-005-MY3, and NSC 100-2319-B-010002) of Taiwan, the Career Development Award of Academia Sinica (AS-100-CDA-M03), the Academia Sinica Genomics and Proteomics Program (2003-2006) (521023-92-81, 521023-93-81, 521023-94-19 and 30-34-GSK), and the Academia Sinica Genomic Medicine Multicenter Studies (2007-present) (40-05-GMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Angius A, 2002, AM J HUM GENET, V71, P893, DOI 10.1086/342929; Aqeilan RI, 2008, J BIOL CHEM, V283, P21629, DOI 10.1074/jbc.M800855200; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BONNARDEAUX A, 1994, HYPERTENSION, V24, P63, DOI 10.1161/01.HYP.24.1.63; Buil Alfonso, 2009, BMC Proc, V3 Suppl 7, pS130; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fang YJ, 2010, J HYPERTENS, V28, P1203, DOI 10.1097/HJH.0b013e3283384b07; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Funke-Kaiser H, 2003, HUM MOL GENET, V12, P423, DOI 10.1093/hmg/ddg040; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; Goenaga D, 2009, MOL ENDOCRINOL, V23, P1043, DOI 10.1210/me.2008-0360; Gong ML, 2003, HUM MOL GENET, V12, P1273, DOI 10.1093/hmg/ddg135; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Guzman B, 2006, HYPERTENSION, V48, P883, DOI 10.1161/01.HYP.0000244085.52918.a0; Hanasaki H, 2009, HYPERTENS RES, V32, P261, DOI 10.1038/hr.2009.2; Hiura Y, 2010, CIRC J, V74, P2353, DOI 10.1253/circj.CJ-10-0353; Hong KW, 2011, J HUM GENET, V56, P205, DOI 10.1038/jhg.2010.167; Horio T, 2010, J HUM HYPERTENS, V24, P320, DOI 10.1038/jhh.2009.73; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunt SC, 2006, HYPERTENSION, V47, P532, DOI 10.1161/01.HYP.0000196949.26088.3c; Jakobsson J, 2004, PHARMACOGENOMICS J, V4, P245, DOI 10.1038/sj.tpj.6500236; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Julier C, 1997, HUM MOL GENET, V6, P2077, DOI 10.1093/hmg/6.12.2077; Kato N, 2008, HUM MOL GENET, V17, P617, DOI 10.1093/hmg/ddm335; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Knight J, 2006, BEHAV GENET, V36, P665, DOI 10.1007/s10519-005-9016-9; Koivukoski L, 2004, HUM MOL GENET, V13, P2325, DOI 10.1093/hmg/ddh237; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Landmann E, 2006, PEDIATRICS, V118, P2374, DOI 10.1542/peds.2006-0146; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Org E, 2009, HUM MOL GENET, V18, P2288, DOI 10.1093/hmg/ddp135; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Pan WH, 2001, J HUM HYPERTENS, V15, P793, DOI 10.1038/sj.jhh.1001268; Peterson AJ, 2004, GENETICS, V167, P1225, DOI 10.1534/genetics.104.027474; PICKERING G, 1978, AM J MED, V65, P561, DOI 10.1016/0002-9343(78)90839-2; Pineda LL, 2003, PATHOL INT, V53, P390, DOI 10.1046/j.1440-1827.2003.01486.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Puig O, 2010, PHYSIOL GENOMICS, V42A, P24, DOI 10.1152/physiolgenomics.00010.2010; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rietveld I, 2006, EUR J ENDOCRINOL, V154, P715, DOI 10.1530/eje.1.02144; Rietveld I, 2004, CLIN ENDOCRINOL, V61, P195, DOI 10.1111/j.1365-2265.2004.02078.x; Riva A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-33; Roy D, 2011, BLOOD, V118, pE32, DOI 10.1182/blood-2010-12-323659; Ruigrok YM, 2005, J NEUROL, V252, P417, DOI 10.1007/s00415-005-0661-y; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; San Millan JL, 2004, J CLIN ENDOCR METAB, V89, P2640, DOI 10.1210/jc.2003-031252; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schut AFC, 2003, STROKE, V34, P1623, DOI 10.1161/01.STR.0000076013.00240.B0; Slavin TP, 2011, HUM GENET, V130, P725, DOI 10.1007/s00439-011-1009-6; Stratikopoulos E, 2008, P NATL ACAD SCI USA, V105, P19378, DOI 10.1073/pnas.0809223105; Sweeney C, 2005, CANCER EPIDEM BIOMAR, V14, P1802, DOI 10.1158/1055-9965.EPI-05-0149; t Hart LM, 2004, DIABETES, V53, pS26, DOI 10.2337/diabetes.53.2007.S26; Taylor JY, 2009, BIOL RES NURS, V11, P53, DOI 10.1177/1099800409334817; te Velde Saskia J, 2005, BMC Endocr Disord, V5, P5, DOI 10.1186/1472-6823-5-5; Telgmann R, 2009, FASEB J, V23, P1303, DOI 10.1096/fj.08-116863; Ueki I, 2000, P NATL ACAD SCI USA, V97, P6868, DOI 10.1073/pnas.120172697; Voorhoeve PG, 2006, EUR J ENDOCRINOL, V154, P379, DOI 10.1530/eje.1.02101; Wallace C, 2006, AM J HUM GENET, V79, P323, DOI 10.1086/506370; Wang K, 2011, PLOS ONE, V6; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Wiemuth D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012163; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Xu XP, 1999, AM J HUM GENET, V64, P1694, DOI 10.1086/302405; Yang HC, 2008, GENETICS, V179, P1057, DOI 10.1534/genetics.107.084616; Yang Hsin-Chou, 2009, BMC Proc, V3 Suppl 7, pS135; Yang HC, 2006, GENET EPIDEMIOL, V30, P531, DOI 10.1002/gepi.20165; Yang HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005459; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yazdanpanah M, 2006, AM J CARDIOL, V97, P1274, DOI 10.1016/j.amjcard.2005.11.069; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zhang MC, 2008, IMMUNOGENETICS, V60, P599, DOI 10.1007/s00251-008-0320-4	96	210	224	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32907	10.1371/journal.pone.0032907	http://dx.doi.org/10.1371/journal.pone.0032907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	23029496	gold, Green Published			2022-12-27	WOS:000304523400009
J	Yang, HY; Zhang, W; Pan, H; Feldser, HG; Lainez, E; Miller, C; Leung, S; Zhong, Z; Zhao, HZ; Sweitzer, S; Considine, T; Riera, T; Suri, V; White, B; Ellis, JL; Vlasuk, GP; Loh, C				Yang, Hongying; Zhang, Wei; Pan, Heng; Feldser, Heidi G.; Lainez, Elden; Miller, Christine; Leung, Stewart; Zhong, Zhong; Zhao, Huizhen; Sweitzer, Sharon; Considine, Thomas; Riera, Thomas; Suri, Vipin; White, Brian; Ellis, James L.; Vlasuk, George P.; Loh, Christine			SIRT1 Activators Suppress Inflammatory Responses through Promotion of p65 Deacetylation and Inhibition of NF-kappa B Activity	PLOS ONE			English	Article							SMALL-MOLECULE ACTIVATORS; DEPENDENT GENE-EXPRESSION; CELL-SURVIVAL; NEGATIVE REGULATION; CYTOKINE RELEASE; IN-VIVO; ACETYLATION; PHOSPHORYLATION; P53; RESVERATROL	Chronic inflammation is a major contributing factor in the pathogenesis of many age-associated diseases. One central protein that regulates inflammation is NF-kappa B, the activity of which is modulated by post-translational modifications as well as by association with co-activator and co-repressor proteins. SIRT1, an NAD+-dependent protein deacetylase, has been shown to suppress NF-kappa B signaling through deacetylation of the p65 subunit of NF-kappa B resulting in the reduction of the inflammatory responses mediated by this transcription factor. The role of SIRT1 in the regulation of NF-kappa B provides the necessary validation for the development of pharmacological strategies for activating SIRT1 as an approach for the development of a new class of anti-inflammatory therapeutics. We report herein the development of a quantitative assay to assess compound effects on acetylated p65 protein in the cell. We demonstrate that small molecule activators of SIRT1 (STACs) enhance deacetylation of cellular p65 protein, which results in the suppression of TNF alpha-induced NF-kappa B transcriptional activation and reduction of LPS-stimulated TNF alpha secretion in a SIRT1-dependent manner. In an acute mouse model of LPS-induced inflammation, the STAC SRTCX1003 decreased the production of the proinflammatory cytokines TNF alpha and IL-12. Our studies indicate that increasing SIRT1-mediated NF-kappa B deacetylation using small molecule activating compounds is a novel approach to the development of a new class of therapeutic anti-inflammatory agents.	[Yang, Hongying; Feldser, Heidi G.; Lainez, Elden; Miller, Christine; Considine, Thomas; Riera, Thomas; Suri, Vipin; White, Brian; Ellis, James L.; Vlasuk, George P.; Loh, Christine] Sirtris, Cambridge, MA USA; [Zhang, Wei; Pan, Heng; Leung, Stewart; Zhong, Zhong] GlaxoSmithKline R&D China, Shanghai, Peoples R China; [Zhao, Huizhen; Sweitzer, Sharon] GlaxoSmithKline, Collegeville, PA USA	GlaxoSmithKline; GlaxoSmithKline	Yang, HY (corresponding author), Sirtris, Cambridge, MA USA.	Hongying.2.yang@gsk.com	Thomas, G. Neil/A-1879-2013; Cherny, Stacey S/B-3315-2008; Yang, Hsin-Chou/AAP-2547-2021; Pan, Wen-Harn/F-9972-2010; Tomlinson, Brian/P-5365-2015; Tomlinson, Brian/AAD-9404-2019	Thomas, G. Neil/0000-0002-2777-1847; Cherny, Stacey S/0000-0002-0269-3352; Yang, Hsin-Chou/0000-0001-6853-7881; Pan, Wen-Harn/0000-0001-9136-0658; Tomlinson, Brian/0000-0001-6717-5444; Chiang, Kuang-Mao/0000-0002-8745-2004; Lin, Tsung-Hsien/0000-0002-7226-8730	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aulakh R, 2008, INDIAN J PEDIATR, V75, P1067, DOI 10.1007/s12098-008-0211-6; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Baur JA, 2010, MECH AGEING DEV, V131, P261, DOI 10.1016/j.mad.2010.02.007; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Camu F, 1996, Acta Anaesthesiol Belg, V47, P143; Chen J, 2005, J BIOL CHEM; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794; Disch JS, 2010, 240 ACS NAT M MEDI, P70; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Ghizzoni M, 2011, DRUG DISCOV TODAY, V16, P504, DOI 10.1016/j.drudis.2011.03.009; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Lysko PG, 1999, J PHARMACOL EXP THER, V289, P1277; Manabe I, 2011, CIRC J, V75, P2739, DOI 10.1253/circj.CJ-11-1184; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Robers MB, 2011, MOL BIOSYST, V7, P59, DOI 10.1039/c0mb00026d; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Satoh A, 2012, HDB EXP PHARM, V206, P125; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tang BL, 2011, TRANSL RES, V157, P276, DOI 10.1016/j.trsl.2010.11.006; van der Meer AJ, 2011, INFLAMM RES, V60, P82; vanderPoll T, 1997, J IMMUNOL, V158, P1971; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Vu C. B., 2010, Patent Appl., Patent No. [PCT WO 2010/003048, 2010003048]; Vu C. B., 2010, WO Patent, Patent No. [2010037129A1, 2010037129, PCT WO 2010/037129]; YAMAZAKI Y, 2009, AM J PHYSL ENDOCRINO; Yang Baichun, 2008, BMC Pharmacology, V8, P7, DOI 10.1186/1471-2210-8-7; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	65	210	224	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46364	10.1371/journal.pone.0046364	http://dx.doi.org/10.1371/journal.pone.0046364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029496	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900143
J	Zhang, X; Lynch, AI; Davis, BR; Ford, CE; Boerwinkle, E; Eckfeldt, JH; Leiendecker-Foster, C; Arnett, DK				Zhang, Xue; Lynch, Amy I.; Davis, Barry R.; Ford, Charles E.; Boerwinkle, Eric; Eckfeldt, John H.; Leiendecker-Foster, Catherine; Arnett, Donna K.			Pharmacogenetic Association of NOS3 Variants with Cardiovascular Disease in Patients with Hypertension: The GenHAT Study	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CORONARY-ARTERY-DISEASE; STAGE RENAL-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; GENE POLYMORPHISM; GLU298ASP POLYMORPHISM; COMMON VARIANT; RISK-FACTOR; ENOS; SUSCEPTIBILITY	Nitric oxide synthase 3 (NOS3) catalyzes production of NO in the endothelium and may play a role in cardiovascular disease (CVD). We assessed the pharmacogenetic associations of three NOS3 polymorphisms and three antihypertensive drugs with CVD outcomes. Hypertensive subjects (n = 30,280) from a multi-center, double-blind clinical trial were randomized to chlorthalidone, amlodipine, or lisinopril treatment (mean follow up, 4.9 years). Outcomes included coronary heart disease (CHD: fatal CHD and nonfatal myocardial infarction); stroke; heart failure (fatal, requiring hospitalization, or outpatient treatment); all-cause mortality; and end-stage renal disease (ESRD). Main effects of NOS3 variants on outcome and genotype-treatment interactions were tested. For NOS3 2690 C>T (rs3918226), a higher hazard ratio (HR) was found in minor allele carriers for CHD (CC = 1.00, CT+TT = 1.12 (95% confidence interval (CI) = 1.00-1.26), P = 0.048). For NOS3 2922 A>G (rs1800779), a higher HR was found in minor allele carriers for heart failure (AA = 1.00, AG+GG = 1.10 (CI = 1.00-1.21), P = 0.046). Significant pharmacogenetic findings were observed for stroke and all-cause mortality. For 2690 C>T, a lower HR was observed for stroke in minor allele carriers when treated with amlodipine versus lisinopril (CC = 0.85 (CI = 0.73-0.99), CT+TT = 0.49 (CI = 0.31-0.80), P = 0.04). For glu298asp G>T (rs1799983), a lower HR was observed for all-cause mortality in minor allele carriers when treated with amlodipine versus lisinopril (GG = 1.01 (CI = 0.91-1.13), GT+TT = 0.85 (CI = 0.75-0.97), P = 0.04). We observed significant associations with NOS3 variants and CHD and heart failure and significant pharmacogenetic effects for stroke and all cause mortality. This suggests that NOS3 variants may potentially provide useful clinical information with respect to treatment decisions in the future.	[Zhang, Xue] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Lynch, Amy I.; Eckfeldt, John H.; Leiendecker-Foster, Catherine] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Davis, Barry R.; Ford, Charles E.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Boerwinkle, Eric] Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX USA; [Arnett, Donna K.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA	Cincinnati Children's Hospital Medical Center; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Alabama System; University of Alabama Birmingham	Zhang, X (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA.	arnett@uab.edu		Haile, Colin/0000-0001-8293-7291	National Heart, Lung and Blood Institute [HL63082, N01-HC-35130]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083498, R01HL063082] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung and Blood Institute grants HL63082 (GenHAT - Genetics of Hypertension Associated Treatments: ClinicalTrials.gov, NCT00006294, http://clinicaltrials.gov/ct2/show/NCT00006294) and N01-HC-35130 (ALLHAT - Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: ClinicalTrials.gov, NCT00000542, http://clinicaltrials.gov/ct2/show/NCT00000542). The National Heart, Lung, and Blood Institute had a contributing role in the analysis and interpretation of the ALLHAT data.	Arnett D. K., 2002, Pharmacogenomics Journal, V2, P309; Arnett DK, 2006, VASC PHARMACOL, V44, P107, DOI 10.1016/j.vph.2005.09.010; Asakimori Y, 2004, AM J KIDNEY DIS, V44, P112, DOI 10.1053/j.ajkd.2004.03.034; Augeri Amanda L, 2009, Atherosclerosis, V204, pe28, DOI 10.1016/j.atherosclerosis.2008.12.015; Benjafield AV, 2000, AM J HYPERTENS, V13, P994, DOI 10.1016/S0895-7061(00)00282-X; Bhandary UV, 2008, NEPHROLOGY, V13, P348, DOI 10.1111/j.1440-1797.2008.00925.x; Burns JC, 2005, GENES IMMUN, V6, P438, DOI 10.1038/sj.gene.6364225; Chang KY, 2003, CORONARY ARTERY DIS, V14, P293, DOI 10.1097/01.mca.0000073080.69657.71; Cherney DZI, 2009, KIDNEY INT, V75, P327, DOI 10.1038/ki.2008.574; Chobanian AV, 2001, NEW ENGL J MED, V345, P534, DOI 10.1056/NEJM200108163450709; Colombo MG, 2003, CLIN CHEM, V49, P389, DOI 10.1373/49.3.389; Colombo MG, 2002, HEART, V87, P525, DOI 10.1136/heart.87.6.525; Cooke GE, 2007, PHARMACOGENOMICS, V8, P1723, DOI 10.2217/14622416.8.12.1723; Davis BR, 1996, AM J HYPERTENS, V9, P342, DOI 10.1016/0895-7061(96)00037-4; de Simone G, 2002, J HYPERTENS, V20, P323, DOI 10.1097/00004872-200202000-00024; Dell'Omo G, 2007, J HYPERTENS, V25, P1389, DOI 10.1097/HJH.0b013e3281268548; Fischmann TO, 1999, NAT STRUCT BIOL, V6, P233, DOI 10.1038/6675; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Hibi K, 1998, HYPERTENSION, V32, P521, DOI 10.1161/01.HYP.32.3.521; Hingorani AD, 2003, CURR HYPERTENS REP, V5, P19, DOI 10.1007/s11906-003-0006-0; Hingorani AD, 1999, CIRCULATION, V100, P1515, DOI 10.1161/01.CIR.100.14.1515; Howard TD, 2005, STROKE, V36, P1848, DOI 10.1161/01.STR.0000177978.97428.53; Jachymova M, 2001, BIOCHEM BIOPH RES CO, V284, P426, DOI 10.1006/bbrc.2001.5007; Joshi MS, 2008, ACTA BIOCH BIOPH SIN, V40, P47, DOI 10.1111/j.1745-7270.2008.00369.x; Kullo IJ, 2008, ATHEROSCLEROSIS, V196, P905, DOI 10.1016/j.atherosclerosis.2007.02.008; Leeson CPM, 2002, CIRC RES, V90, P1153, DOI 10.1161/01.RES.0000020562.07492.D4; Lenasi H, 2003, CARDIOVASC RES, V59, P844, DOI 10.1016/S0008-6363(03)00505-4; Lynch AI, 2008, JAMA-J AM MED ASSOC, V299, P296, DOI 10.1001/jama.299.3.296; Markus HS, 1998, STROKE, V29, P1908, DOI 10.1161/01.STR.29.9.1908; Miyamoto Y, 1998, HYPERTENSION, V32, P3, DOI 10.1161/01.HYP.32.1.3; Moe KT, 2006, J HUM HYPERTENS, V20, P956, DOI 10.1038/sj.jhh.1002096; Mollsten A, 2006, ANN MED, V38, P522, DOI 10.1080/07853890600969213; Nagase S, 2003, MOL CELL BIOCHEM, V244, P113, DOI 10.1023/A:1022473405275; Noiri E, 2002, HYPERTENSION, V40, P535, DOI 10.1161/01.HYP.0000033974.57407.82; Oemar BS, 1998, CIRCULATION, V97, P2494, DOI 10.1161/01.CIR.97.25.2494; Persu A, 2002, HUM MOL GENET, V11, P229, DOI 10.1093/hmg/11.3.229; Rossi GP, 2006, J AM COLL CARDIOL, V48, P1166, DOI 10.1016/j.jacc.2006.05.046; Salvi E, 2012, HYPERTENSION, V59, P248, DOI 10.1161/HYPERTENSIONAHA.111.181990; Savvidou MD, 2001, HYPERTENSION, V38, P1289, DOI 10.1161/hy1201.097305; Suzuki H, 2000, CLIN CHEM, V46, P1858; Tangurek B, 2006, HEART VESSELS, V21, P285, DOI 10.1007/s00380-005-0902-0; Tesauro M, 2000, P NATL ACAD SCI USA, V97, P2832, DOI 10.1073/pnas.97.6.2832; Thaha M, 2008, CLIN NEPHROL, V70, P144; Wang XL, 2000, MOL GENET METAB, V70, P241, DOI 10.1006/mgme.2000.3033; Xin Y, 2009, CLIN SCI, V117, P67, DOI 10.1042/CS20080476	45	42	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2012	7	3							e34217	10.1371/journal.pone.0034217	http://dx.doi.org/10.1371/journal.pone.0034217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948FM	22470539	Green Published, gold, Green Submitted			2022-12-27	WOS:000304489000078
J	Wang, YX; Zeng, X; Iyer, NJ; Bryant, DW; Mockler, TC; Mahalingam, R				Wang, Yixing; Zeng, Xin; Iyer, Niranjani J.; Bryant, Douglas W.; Mockler, Todd C.; Mahalingam, Ramamurthy			Exploring the Switchgrass Transcriptome Using Second-Generation Sequencing Technology	PLOS ONE			English	Article							MICROSATELLITE MARKERS; COMPARATIVE GENOMICS; MESSENGER-RNA; GENE; ARABIDOPSIS; PLANT; GERMINATION; RICE; IDENTIFICATION; ANNOTATION	Background: Switchgrass (Panicum virgatum L.) is a C4 perennial grass and widely popular as an important bioenergy crop. To accelerate the pace of developing high yielding switchgrass cultivars adapted to diverse environmental niches, the generation of genomic resources for this plant is necessary. The large genome size and polyploid nature of switchgrass makes whole genome sequencing a daunting task even with current technologies. Exploring the transcriptional landscape using next generation sequencing technologies provides a viable alternative to whole genome sequencing in switchgrass. Principal Findings: Switchgrass cDNA libraries from germinating seedlings, emerging tillers, flowers, and dormant seeds were sequenced using Roche 454 GS-FLX Titanium technology, generating 980,000 reads with an average read length of 367 bp. De novo assembly generated 243,600 contigs with an average length of 535 bp. Using the foxtail millet genome as a reference greatly improved the assembly and annotation of switchgrass ESTs. Comparative analysis of the 454-derived switchgrass EST reads with other sequenced monocots including Brachypodium, sorghum, rice and maize indicated a 70-80% overlap. RPKM analysis demonstrated unique transcriptional signatures of the four tissues analyzed in this study. More than 24,000 ESTs were identified in the dormant seed library. In silico analysis indicated that there are more than 2000 EST-SSRs in this collection. Expression of several orphan ESTs was confirmed by RT-PCR. Significance: We estimate that about 90% of the switchgrass gene space has been covered in this analysis. This study nearly doubles the amount of EST information for switchgrass currently in the public domain. The celerity and economical nature of second-generation sequencing technologies provide an in-depth view of the gene space of complex genomes like switchgrass. Sequence analysis of closely related members of the NAD(+)-malic enzyme type C4 grasses such as the model system Setaria viridis can serve as a viable proxy for the switchgrass genome.	[Wang, Yixing; Zeng, Xin; Iyer, Niranjani J.; Mahalingam, Ramamurthy] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Bryant, Douglas W.; Mockler, Todd C.] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Oklahoma State University System; Oklahoma State University - Stillwater; Donald Danforth Plant Science Center	Wang, YX (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	ramamurthy.mahalingam@okstate.edu	Mahalingam, Ramamurthy/AAP-5463-2020; Mockler, Todd C/L-2609-2013	Mockler, Todd C/0000-0002-0462-5775; Sung, Wen-Wei/0000-0002-2375-0029	National Science Foundation [EPS-0814361]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation under Grant No. EPS-0814361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Barbazuk WB, 2007, SNP MINING MAIZE 454; Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Boe A, 2008, CROP SCI, V48, P1306, DOI 10.2135/cropsci2007.08.0482; Bouton Joe, 2008, P295, DOI 10.1007/978-0-387-70805-8_11; Bouton JH, 2007, CURR OPIN GENET DEV, V17, P553, DOI 10.1016/j.gde.2007.08.012; Brutnell TP, 2010, PLANT CELL, V22, P2537, DOI 10.1105/tpc.110.075309; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Chi KR, 2008, NAT METHODS, V5, P11, DOI 10.1038/NMETH1154; Christin PA, 2009, PLANT PHYSIOL, V149, P82, DOI 10.1104/pp.108.128553; Der JP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-99; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Furumoto T, 2011, NATURE, V476, P472, DOI 10.1038/nature10250; Hale MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-203; Hopkins AA, 1996, CROP SCI, V36, P1192, DOI 10.2135/cropsci1996.0011183X003600050021x; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kantety RV, 2002, PLANT MOL BIOL, V48, P501, DOI 10.1023/A:1014875206165; Kaur S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-265; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Keshwani DR, 2009, BIORESOURCE TECHNOL, V100, P1515, DOI 10.1016/j.biortech.2008.09.035; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mahalingam R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r20; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Masumoto C, 2010, P NATL ACAD SCI USA, V107, P5226, DOI 10.1073/pnas.0913127107; Matts J, 2010, J PLANT PHYSIOL, V167, P896, DOI 10.1016/j.jplph.2010.02.001; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Muthukumar B, 2004, MOL GENET GENOMICS, V271, P308, DOI 10.1007/s00438-004-0980-1; Nakabayashi K, 2005, PLANT J, V41, P697, DOI 10.1111/j.1365-313X.2005.02337.x; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Palmer NA, 2012, BIOENERG RES, V5, P649, DOI 10.1007/s12155-011-9171-1; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Puckette M, 2009, J PLANT PHYSIOL, V166, P1284, DOI 10.1016/j.jplph.2009.01.009; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; SCHULZESIEBERT D, 1984, PLANT PHYSIOL, V76, P465, DOI 10.1104/pp.76.2.465; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Schwender J, 2004, CURR OPIN PLANT BIOL, V7, P309, DOI 10.1016/j.pbi.2004.03.016; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tangphatsornruang S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-137; TANIGUCHI M, 1995, ARCH BIOCHEM BIOPHYS, V318, P295, DOI 10.1006/abbi.1995.1233; Tobias CM, 2008, PLANT GENOME-US, V1, P111, DOI 10.3835/plantgenome2008.08.0003; Tobias CM, 2006, MOL ECOL NOTES, V6, P185, DOI 10.1111/j.1471-8286.2006.01187.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vicentini A, 2008, GLOBAL CHANGE BIOL, V14, P2963, DOI 10.1111/j.1365-2486.2008.01688.x; Wall PK, 2008, NUCLEIC ACIDS RES, V36, pD970, DOI 10.1093/nar/gkm972; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang YW, 2011, THEOR APPL GENET, V122, P677, DOI 10.1007/s00122-010-1477-4; Zalapa JE, 2012, AM J BOT, V99, P193, DOI 10.3732/ajb.1100394	67	72	77	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e34225	10.1371/journal.pone.0034225	http://dx.doi.org/10.1371/journal.pone.0034225			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22848356	Green Submitted, Green Published, gold			2022-12-27	WOS:000304523400061
J	Wang, XM; Zhu, CF; Bao, WG; Zhao, K; Niu, JQ; Yu, XF; Zhang, WY				Wang, Xiaomei; Zhu, Chunfeng; Bao, Wanguo; Zhao, Ke; Niu, Junqi; Yu, Xiao-Fang; Zhang, Wenyan			Characterization of Full-Length Enterovirus 71 Strains from Severe and Mild Disease Patients in Northeastern China	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; FOOT; HAND; TAIWAN; RECOMBINATION; INFECTION; EVOLUTION; OUTBREAK	Human enterovirus 71 (EV71)-associated hand, foot, and mouth disease (HFMD) has been a leading cause of childhood infection in China since 2008. Epidemic and molecular characteristics of HFMD have been examined in many areas of China, including the central and southern regions. However, clinical and genetic characterization of EV71 in the northeastern region of China is scarce. In this study, a series of analyses were performed on seven full-length EV71 sequences from HFMD patients who had either severe or mild disease. We have determined that these seven circulating EV71 viruses from Changchun, China are actually complex recombinant viruses involving multiple type A human enterovirus (HEV). Classified as EV71 subtype C4 (EV71 C4), these Changchun EV71 viruses contain genetic recombination events between the CA4, CA5, EV71B4 and EV71C1 strains. Most of the structural protein region (P1) of these viruses resembled that of the prototype EV71 C1 strains. The non-structural protein domains (P2 and P3) showed a high degree of similarity with CA4, CA5 and EV71 B4 in different regions. The 5'UTR had unclassified recombination, while partial 3D region of these viruses showed a high degree of similarity to CA16. Phylogenetic analysis of full-length or partial sequences of isolates from severe or mild disease patients in Changchun always formed a single cluster in various phylogenetic analyses of different genomic regions, suggesting that all seven strains originated from one single common ancestor. There was no correlation between viral genomic sequence and virulence. Thus, we found that circulating recombinant forms of EV71 are prevalent among HFMD patients in Northeastern China. The existence of a unique cluster of EV71 related viruses in Northeast China has important implications for vaccine development that would address the increasing prevalence of HFMD.	[Wang, Xiaomei; Zhu, Chunfeng; Zhao, Ke; Yu, Xiao-Fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China; [Wang, Xiaomei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin Province, Peoples R China; [Bao, Wanguo] Jilin Univ, Hosp 1, Dept Infect Dis, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, XM (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China.	junqiniu@yahoo.com.cn; xfyu@jhsph.edu; zhangwenyan@jlu.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	Specialized Research Fund for the Doctoral Program of Higher Education; Jilin University [200903258]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jilin University(Jilin University); Key Laboratory of Molecular Virology, Jilin Province, China; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by funding from the Specialized Research Fund for the Doctoral Program of Higher Education and Jilin University (No200903258) to Wenyan Zhang, and a grant from the Key Laboratory of Molecular Virology, Jilin Province (20102209), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026237; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shi XD, 2011, CENT EUR J MED, V6, P220, DOI 10.2478/s11536-010-0075-9; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	22	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32405	10.1371/journal.pone.0050575	http://dx.doi.org/10.1371/journal.pone.0050575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	22558416	gold, Green Submitted, Green Published			2022-12-27	WOS:000304523400005
J	Wang, XX; Huang, M; Wang, YZ				Wang, Xinxia; Huang, Ming; Wang, Yizhen			The Effect of Insulin, TNF alpha and DHA on the Proliferation, Differentiation and Lipolysis of Preadipocytes Isolated from Large Yellow Croaker (Pseudosciaena Crocea R.)	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TROUT ONCORHYNCHUS-MYKISS; FATTY-ACID SYNTHASE; INHIBITS ADIPOCYTE DIFFERENTIATION; ADIPOSE TRIGLYCERIDE LIPASE; ACTIVATED RECEPTORS ALPHA; SIGNAL-RELATED KINASE; LPL GENE-EXPRESSION; RAINBOW-TROUT; LIPOPROTEIN-LIPASE	Fish final product can be affected by excessive lipid accumulation. Therefore, it is important to develop strategies to control obesity in cultivated fish to strengthen the sustainability of the aquaculture industry. As in mammals, the development of adiposity in fish depends on hormonal, cytokine and dietary factors. In this study, we investigated the proliferation and differentiation of preadipocytes isolated from the large yellow croaker and examined the effects of critical factors such as insulin, TNF alpha and DHA on the proliferation, differentiation and lipolysis of adipocytes. Preadipocytes were isolated by collagenase digestion, after which their proliferation was evaluated. The differentiation process was optimized by assaying glycerol-3-phosphate dehydrogenase (GPDH) activity. Oil red O staining and electron microscopy were performed to visualize the accumulated triacylglycerol. Gene transcript levels were measured using SYBR green quantitative real-time PCR. Insulin promoted preadipocytes proliferation, stimulated cell differentiation and decreased lipolysis of mature adipocytes. TNF alpha and DHA inhibited cell proliferation and differentiation. While TNF alpha stimulated mature adipocyte lipolysis, DHA showed no lipolytic effect on adipocytes. The expressions of adipose triglyceride lipase (ATGL), fatty acid synthase (FAS), lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor alpha, gamma (PPAR alpha, PPAR gamma) were quantified during preadipocytes differentiation and adipocytes lipolysis to partly explain the regulation mechanisms. In summary, the results of this study indicated that although preadipocytes proliferation and the differentiation process in large yellow croaker are similar to these processes in mammals, the effects of critical factors such as insulin, TNF alpha and DHA on fish adipocytes development are not exactly the same. Our findings fill in the gaps in the basic data regarding the effects of critical factors on adiposity development in fish and will facilitate the further study of molecular mechanism by which these factors act in fish and the application of this knowledge to eventually control obesity in cultured species.	[Wang, Xinxia; Huang, Ming; Wang, Yizhen] Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, YZ (corresponding author), Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yzwang@zju.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	NSFC (National Natural Science Foundation of China) [30901104]; China Postdoctoral Science Foundation [2009046138]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by grants from the NSFC (National Natural Science Foundation of China, grant # 30901104), and the China Postdoctoral Science Foundation (grant # 2009046138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2007, COMP BIOCHEM PHYS B, V148, P151, DOI 10.1016/j.cbpb.2007.05.004; Albalat A, 2005, COMP BIOCHEM PHYS A, V142, P347, DOI 10.1016/j.cbpa.2005.08.006; Albalat A, 2005, AM J PHYSIOL-REG I, V289, pR259, DOI 10.1152/ajpregu.00574.2004; Albalat A, 2005, J ENDOCRINOL, V184, P527, DOI 10.1677/joe.1.05940; Albalat A, 2006, GEN COMP ENDOCR, V146, P226, DOI 10.1016/j.ygcen.2005.11.011; [Anonymous], 2011, CHIN FISH STAT YB; Awad AB, 2000, J NUTR BIOCHEM, V11, P153, DOI 10.1016/S0955-2863(99)00087-X; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Boone C, 2000, REPROD NUTR DEV, V40, P325, DOI 10.1051/rnd:2000103; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; Bouraoui L, 2012, COMP BIOCHEM PHYS A, V161, P83, DOI 10.1016/j.cbpa.2011.09.008; Bouraoui L, 2010, AM J PHYSIOL-REG I, V299, pR33, DOI 10.1152/ajpregu.00457.2009; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Capilla E, 2011, GEN COMP ENDOCR, V172, P107, DOI 10.1016/j.ygcen.2011.03.020; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cersosimo E, 2012, AM J PHYSIOL-CELL PH, V302, pC652, DOI 10.1152/ajpcell.00022.2011; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Claycombe KJ, 1998, AM J PHYSIOL-REG I, V274, pR1253, DOI 10.1152/ajpregu.1998.274.5.R1253; CORNELIUS P, 1990, J BIOL CHEM, V265, P20506; DANI C, 1990, J CELL BIOCHEM, V43, P103, DOI 10.1002/jcb.240430202; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; Deiuliis JA, 2008, LIPIDS, V43, P215, DOI 10.1007/s11745-007-3146-1; DOERRLER W, 1994, CYTOKINE, V6, P478, DOI 10.1016/1043-4666(94)90074-4; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FRANSEN L, 1986, CELL IMMUNOL, V100, P260, DOI 10.1016/0008-8749(86)90025-0; Garcia-Castillo J, 2004, CELL MOL LIFE SCI, V61, P1331, DOI 10.1007/s00018-004-4068-1; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Glosli H, 2005, BBA-MOL CELL BIOL L, V1734, P235, DOI 10.1016/j.bbalip.2005.02.011; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grohmann M, 2005, J LIPID RES, V46, P93, DOI 10.1194/jlr.M400295-JLR200; GRUNFELD C, 1988, J LIPID RES, V29, P1327; Hansen JO, 2008, AQUACULTURE, V284, P159, DOI 10.1016/j.aquaculture.2008.07.043; HARMON JS, 1992, GEN COMP ENDOCR, V87, P214, DOI 10.1016/0016-6480(92)90025-F; Hensler M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-128; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Khan S, 2002, J LIPID RES, V43, P979; Kim HK, 2006, J NUTR, V136, P409, DOI 10.1093/jn/136.2.409; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Kras KM, 2000, OBES RES, V8, P186, DOI 10.1038/oby.2000.20; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezSoriano J, 1997, MOL CELL ENDOCRINOL, V132, P93, DOI 10.1016/S0303-7207(97)00125-1; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Montserrat N, 2007, GEN COMP ENDOCR, V150, P462, DOI 10.1016/j.ygcen.2006.11.009; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Niemela SM, 2007, J CRANIOFAC SURG, V18, P325, DOI 10.1097/scs.0b013e3180333b6a; Oku H, 2006, COMP BIOCHEM PHYS B, V144, P326, DOI 10.1016/j.cbpb.2006.03.008; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; PALOMBELLA VJ, 1989, J BIOL CHEM, V264, P18128; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ramsay TG, 2003, COMP BIOCHEM PHYS B, V136, P245, DOI 10.1016/S1096-4959(02)00261-0; Rieusset J, 1999, DIABETES, V48, P699, DOI 10.2337/diabetes.48.4.699; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; SMITH RA, 1986, J BIOL CHEM, V261, P4871; Sottile V, 2001, ANAL BIOCHEM, V293, P124, DOI 10.1006/abio.2001.5121; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Sun C, 2011, MOL BIOL REP, V38, P731, DOI 10.1007/s11033-010-0160-9; Suryawan A, 1997, J ANIM SCI, V75, P105; Todorcevic M, 2008, BBA-MOL CELL BIOL L, V1781, P326, DOI 10.1016/j.bbalip.2008.04.014; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Vegusdal A, 2003, LIPIDS, V38, P289, DOI 10.1007/s11745-003-1063-3; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wang XX, 2012, AQUAC RES, V43, P281, DOI 10.1111/j.1365-2109.2011.02826.x; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhang F, 2004, DRUG NEWS PERSPECT, V17, P661, DOI 10.1358/dnp.2004.17.10.873918; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhao ZY, 2008, J FOOD LIPIDS, V15, P534, DOI 10.1111/j.1745-4522.2008.00138.x; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	87	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48069	10.1371/journal.pone.0048069	http://dx.doi.org/10.1371/journal.pone.0048069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	22558416	Green Published, gold, Green Submitted			2022-12-27	WOS:000310262500033
J	Wang, XG; Comita, LS; Hao, ZQ; Davies, SJ; Ye, J; Lin, F; Yuan, ZQ				Wang, Xugao; Comita, Liza S.; Hao, Zhanqing; Davies, Stuart J.; Ye, Ji; Lin, Fei; Yuan, Zuoqiang			Local-Scale Drivers of Tree Survival in a Temperate Forest	PLOS ONE			English	Article							TROPICAL TREE; DENSITY-DEPENDENCE; HABITAT ASSOCIATIONS; SHADE TOLERANCE; SPATIAL DISTRIBUTIONS; SIZE DISTRIBUTIONS; SOIL INTERACTIONS; INDIVIDUAL TREES; LONG-TERM; GROWTH	Tree survival plays a central role in forest ecosystems. Although many factors such as tree size, abiotic and biotic neighborhoods have been proposed as being important in explaining patterns of tree survival, their contributions are still subject to debate. We used generalized linear mixed models to examine the relative importance of tree size, local abiotic conditions and the density and identity of neighbors on tree survival in an old-growth temperate forest in northeastern China at three levels (community, guild and species). Tree size and both abiotic and biotic neighborhood variables influenced tree survival under current forest conditions, but their relative importance varied dramatically within and among the community, guild and species levels. Of the variables tested, tree size was typically the most important predictor of tree survival, followed by biotic and then abiotic variables. The effect of tree size on survival varied from strongly positive for small trees (1-20 cm dbh) and medium trees (20-40 cm dbh), to slightly negative for large trees (>40 cm dbh). Among the biotic factors, we found strong evidence for negative density and frequency dependence in this temperate forest, as indicated by negative effects of both total basal area of neighbors and the frequency of conspecific neighbors. Among the abiotic factors tested, soil nutrients tended to be more important in affecting tree survival than topographic variables. Abiotic factors generally influenced survival for species with relatively high abundance, for individuals in smaller size classes and for shade-tolerant species. Our study demonstrates that the relative importance of variables driving patterns of tree survival differs greatly among size classes, species guilds and abundance classes in temperate forest, which can further understanding of forest dynamics and offer important insights into forest management.	[Wang, Xugao; Hao, Zhanqing; Ye, Ji; Lin, Fei; Yuan, Zuoqiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China; [Comita, Liza S.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Comita, Liza S.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Davies, Stuart J.] Harvard Univ, Ctr Trop Forest Sci, Boston, MA 02115 USA; [Davies, Stuart J.] Smithsonian Trop Res Inst, Boston, MA USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Smithsonian Institution; Smithsonian Tropical Research Institute	Wang, XG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China.	hzq@iae.ac.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	Chinese Academy of Sciences [KSCX2-EW-Z-5, KZCX2-YW-QN402]; National Natural Science Foundation of China [40971286, 31011120470, 31061160188]; Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF [EF-0553768]; University of California, Santa Barbara; State of California; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This study was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-5 and KZCX2-YW-QN402) and the National Natural Science Foundation of China (40971286, 31011120470 and 31061160188). XW acknowledges the support of a fellowship from the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute and the HSBC Climate Partnership. LSC acknowledges the support of a fellowship from the National Center for Ecological Analysis and Synthesis, a center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2009, LME4 LINEAR MIXED EF; Blundell AG, 2001, J ECOL, V89, P608, DOI 10.1046/j.0022-0477.2001.00581.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Castagneri D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009111; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONNELL J H, 1971, P298; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; FILIP GM, 1982, PLANT DIS, V66, P240, DOI 10.1094/PD-66-240; Finzi AC, 1998, ECOL APPL, V8, P447, DOI 10.2307/2641084; Finzi AC, 1998, ECOL APPL, V8, P440, DOI 10.2307/2641083; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Gelman A, DATA ANAL USING REGR; [郝占庆 HAO ZhanQing], 2008, [植物生态学报, Acta Phytoecologica Sinica], V32, P238; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harrell FE, 2001, REGRESSION MODELING; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; HIBBS DE, 1983, ECOLOGY, V64, P1394, DOI 10.2307/1937493; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Imaji A, 2010, OECOLOGIA, V162, P273, DOI 10.1007/s00442-009-1453-3; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Keane RE, 2001, CLIMATIC CHANGE, V51, P509, DOI 10.1023/A:1012539409854; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; Maloney PE, 2008, CAN J FOREST RES, V38, P3011, DOI 10.1139/X08-141; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; NORBERG RA, 1988, AM NAT, V131, P220, DOI 10.1086/284787; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Packer A, 2003, ECOLOGY, V84, P108, DOI 10.1890/0012-9658(2003)084[0108:SPAPSS]2.0.CO;2; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; R Core Team, 2020, R LANG ENV STAT COMP; Reinhart KO, 2009, ECOLOGY, V90, P2984, DOI 10.1890/08-1380.1; Runkle JR, 2000, ECOLOGY, V81, P554, DOI 10.1890/0012-9658(2000)081[0554:CTTIOG]2.0.CO;2; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Shibata M, 2010, ECOSCIENCE, V17, P137, DOI 10.2980/17-2-3163; Slik JW, 2001, OECOLOGIA, V141, P114; SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wang LiWei, 2011, Biodiversity Science, V19, P260, DOI 10.3724/SP.J.1003.2011.11279; Wang XG, 2008, ACTA OECOL, V33, P345, DOI 10.1016/j.actao.2008.01.005; Wang XG, 2010, CAN J FOREST RES, V40, P1011, DOI 10.1139/X10-056; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; Woods KD, 2000, ECOLOGY, V81, P110, DOI 10.2307/177138; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yao XH, 2001, CAN J FOREST RES, V31, P283, DOI 10.1139/cjfr-31-2-283; Zhang J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008086; Zhao DH, 2006, ECOL MODEL, V196, P90, DOI 10.1016/j.ecolmodel.2006.02.002; Zuur Alain F., 2009, P1	83	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e29469	10.1371/journal.pone.0029469	http://dx.doi.org/10.1371/journal.pone.0029469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	22558416	gold, Green Published, Green Submitted			2022-12-27	WOS:000302733900002
J	Wang, XM; Yang, R; Feng, SF; Hou, XQ; Zhang, YQ; Li, Y; Ren, Y				Wang, Xumei; Yang, Rui; Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Li, Yan; Ren, Yi			Genetic Variation in Rheum palmatum and Rheum tanguticum (Polygonaceae), Two Medicinally and Endemic Species in China Using ISSR Markers	PLOS ONE			English	Article							CHLOROPLAST DNA; DIVERSITY; SEQUENCE; EVOLUTION; RHUBARB; DIFFERENTIATION; POPULATIONS; RADIATION; PLATEAU; NUMBER	Aims: Both Rheum palmatum and R. tanguticum are important but endangered medicinal plants endemic to China. In this study, we aimed to (i) investigate the level and pattern of genetic variability within/among populations of those species; (ii) evaluate genetic differentiation between both species and its relationships and ascertain whether both species are consistent with their current taxonomical treatment as separate species; and (iii) discuss the implications for the effective conservation of two species. Methods: Total 574 individuals from 30 populations of R. palmatum and R. tanguticum were collected, covering the entire distribution range of two species in China. The genetic variation within and among 30 populations was evaluated using inter-simple sequence repeat (ISSR) markers. Important Findings: Twelve selected ISSR primers generated a total of 175 fragments, 173 (98.86%) of which were polymorphic. The Nei's gene diversity (H) and Shannon's index (I) of both species were high at species level (H = 0.3107, I = 0.4677 for R. palmatum; H = 0.2848, I = 0.4333 for R. tanguticum). But for both species, the genetic diversity was low at population level, and average within-population diversity of R. palmatum was H = 0.1438, I = 0.2151, and that of R. tanguticum was H = 0.1415, I = 0.2126. The hierarchical AMOVA revealed high levels of among-population genetic differentiation in both species, in line with the gene differentiation coefficient and the limited among-population gene flow (R. palmatum: Phi(st) = 0.592, G(st) = 0.537, N-m = 0.432; R. tanguticum: Phi(st) = 0.567, G(st) = 0.497, N-m = 0.507). By contrast, only 6.52% of the total genetic variance was partitioned between R. palmatum and R. tanguticum. Bayesian analysis, UPGMA cluster analysis, and PCoA analysis all demonstrated the similar results. A significant isolation-by-distance pattern was revealed in R. palmatum (r = 0.547, P = 0.010), but not in R. tanguticum (r = 0.241, P = 0.100). Based on these results, effective conservation strategies were proposed for these two species. The small molecular variance between R. palmatum and R. tanguticum revealed that they had a common ancestor, and we considered that these two species might not be good species.	[Wang, Xumei; Yang, Rui; Li, Yan] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China; [Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Ren, Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Shaanxi Normal University	Wang, XM (corresponding author), Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China.	wangxumei@mail.xjtu.edu.cn	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	National Nature Science Foundation of China [81001602]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Nature Science Foundation of China (No. 81001602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amel SH, 2004, GENET RESOUR CROP EV, V51, P269, DOI 10.1023/B:GRES.0000024012.59828.6b; [Anonymous], 1984, GARTENFLORA, V23, P305; Bao BJ., 2003, FLORA CHINA, V5, P341; BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Chen Da-Xia, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2309; Chen FJ, 2009, BIOCHEM SYST ECOL, V37, P613, DOI 10.1016/j.bse.2009.08.004; Chennaoui-Kourda H, 2007, BIOCHEM SYST ECOL, V35, P682, DOI 10.1016/j.bse.2007.05.005; Chinese Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, P22; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Doyle J. J., 1987, PHYTOCHEM B, P11; Esselman EJ, 1999, MOL ECOL, V8, P443, DOI 10.1046/j.1365-294X.1999.00585.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Freeland J. R., 2011, MOL ECOLOGY; Ge XJ, 2005, BIODIVERS CONSERV, V14, P849, DOI 10.1007/s10531-004-0655-6; Ge XJ, 1999, MOL ECOL, V8, P2061, DOI 10.1046/j.1365-294x.1999.00821.x; Goropashnaya AV, 2001, MOL ECOL, V10, P2807, DOI 10.1046/j.1365-294X.2001.t01-1-01410.x; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hogbin PM, 1999, CONSERV BIOL, V13, P514, DOI 10.1046/j.1523-1739.1999.98182.x; Hu YP, 2010, BIOCHEM SYST ECOL, V38, P264, DOI 10.1016/j.bse.2010.01.006; KARRON JD, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P87; Knuth P, 1906, HDB FLOWER POLLINATI, V3; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Li EX, 2008, MOL PHYLOGENET EVOL, V49, P702, DOI 10.1016/j.ympev.2008.09.012; Li JM, 2007, PLANT SCI, V172, P1048, DOI 10.1016/j.plantsci.2007.02.009; Li PQ, 2010, LIAONING J TRAD CHIN, V37, P136; Lu Jian-ying, 2008, Xibei Shifan Daxue Xuebao (Ziran Kexue Ban), V44, P66; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Miller MP, 1997, TOOLS POPULATION GEN; Moreira RG, 2010, CONSERV GENET, V11, P1247, DOI 10.1007/s10592-009-9953-6; Moreno S, 1998, EUPHYTICA, V101, P117, DOI 10.1023/A:1018379805873; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; NEI M, 1974, GENETICS, V76, P379; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rajesh PN, 2003, EUPHYTICA, V129, P15, DOI 10.1023/A:1021567821141; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Song ZQ, 2010, GENETICA, V138, P241, DOI 10.1007/s10709-009-9416-5; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Suo FengMei, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P292; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang A. T., 2009, THESIS LANZHOU U; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang XM, 2012, INT J MOL SCI, V13, P3900, DOI 10.3390/ijms13033900; Wang XM, 2010, J MED PLANTS RES, V4, P1865; Wang XM, 2010, J MED PLANTS RES, V4, P904; Wright S, 1931, GENETICS, V16, P0097; Wu JK, 1992, ACTA BOT BOREALI-OCC, V12, P309; Xia T, 2005, BIOCHEM GENET, V43, P87, DOI 10.1007/s10528-005-1502-5; Xiao Su-ping, 2007, Zhongguo Zhong Yao Za Zhi, V32, P195; Yang DY, 2004, BIOL PHARM BULL, V27, P375, DOI 10.1248/bpb.27.375; Yeh F.C., 1997, POPGENE VERSION 1 31	55	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51667	10.1371/journal.pone.0051667	http://dx.doi.org/10.1371/journal.pone.0051667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	22558416	Green Published, Green Submitted, gold			2022-12-27	WOS:000312483300022
J	Wang, XH; Fiorini, Z; Smith, C; Zhang, YN; Li, J; Watkins, LR; Yin, H				Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Zhang, Yingning; Li, Jing; Watkins, Linda R.; Yin, Hang			Repositioning Antimicrobial Agent Pentamidine as a Disruptor of the Lateral Interactions of Transmembrane Domain 5 of EBV Latent Membrane Protein 1	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN CYCLIN A(2); ENDOTHELIAL-CELLS; P-GLYCOPROTEIN; EXPRESSION; BRAIN; ACTIVATION; RESISTANCE; STABILITY; APOPTOSIS	The lateral transmembrane protein-protein interactions (PPI) have been regarded as "undruggable" despite their importance in many essential biological processes. The homo-trimerization of transmembrane domain 5 (TMD-5) of latent membrane protein 1 (LMP-1) is critical for the constitutive oncogenic activation of the Epstein-Barr virus (EBV). Herein we repurpose the antimicrobial agent pentamidine as a regulator of LMP-1 TMD-5 lateral interactions. The results of ToxR assay, tryptophan fluorescence assay, courmarin fluorescence dequenching assay, and Bis-Tris sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) consistently show pentamidine disrupts LMP-1 TMD-5 lateral interactions. Furthermore, pentamidine inhibits LMP-1 signaling, inducing cellular apoptosis and suppressing cell proliferation in the EBV infected B cells. In contrast, EBV negative cells are less susceptible to pentamidine. This study provides a novel non-peptide small molecule agent for regulating LMP-1 TMD-5 lateral interactions.	[Li, Jing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Li, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China.	lijing6515@pumch.cn; hubert.yin@colorado.edu	Li, Yang/GWM-7879-2022; Wang, Xiaohui/B-8126-2011; Li, Yuan/GXV-1310-2022; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; Wang, Xugao/B-1111-2015; Pausch, Hubert/U-5934-2019; Pausch, Hubert/B-7637-2018; li, yong/HDN-3885-2022	Wang, Xiaohui/0000-0002-3415-5612; YIN, HANG/0000-0002-9762-4818; Wang, Xugao/0000-0003-1207-8852; Pausch, Hubert/0000-0002-0501-6760; Wang, Jing/0000-0002-2806-6517; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629; Comita, Liza/0000-0002-9169-1331; Fiorini, Zeno/0000-0001-5218-2502; wang, yizhen/0000-0002-3908-7102	National Institutes of Health [R21CA138373, DA024044]; Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research [SKF-08-101]; Stand Up to Cancer Innovative Research Award [SU2C]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research; Stand Up to Cancer Innovative Research Award; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank the National Institutes of Health (R21CA138373, DA024044), Cancer League of Colorado for financial supports of this work. H.Y. is also grateful for the 2009 Elion Award from the American Association of Cancer Research, a Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research (SKF-08-101) and a Stand Up to Cancer (SU2C) Innovative Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1988, CANCER RES, V48, P589; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Beaulieu E, 1997, BIOCHEM J, V326, P539, DOI 10.1042/bj3260539; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Grigoriev MY, 2002, CELL CYCLE, V1, P337, DOI 10.4161/cc.1.5.152; Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10; Joce C, 2011, JOVE-J VIS EXP, DOI 10.3791/2721; Joce C, 2011, BBA-BIOMEMBRANES, V1808, P2948, DOI 10.1016/j.bbamem.2011.07.008; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Long HM, 2011, CURR OPIN IMMUNOL, V23, P258, DOI 10.1016/j.coi.2010.12.014; Maeda E, 2009, JPN J RADIOL, V27, P4, DOI 10.1007/s11604-008-0291-2; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Quintana FJ, 2007, BIOCHEMISTRY-US, V46, P2317, DOI 10.1021/bi061849g; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sackett DL, 2009, NAT CHEM, V1, P596, DOI 10.1038/nchem.427; Sammond DW, 2011, BIOPOLYMERS, V95, P772, DOI 10.1002/bip.21672; Sheikh MS, 2003, CELL CYCLE, V2, P550, DOI 10.4161/cc.2.6.566; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sun BH, 2000, WORLD J GASTROENTERO, V6, P356; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Vereide D, 2009, SEMIN CANCER BIOL, V19, P389, DOI 10.1016/j.semcancer.2009.07.006; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XH, 2008, J PHYS CHEM B, V112, P8346, DOI 10.1021/jp712026m; Wang X, 2007, PROTEIN EXPRES PURIF, V56, P27, DOI 10.1016/j.pep.2007.05.011; Wang XH, 2012, BBA-BIOMEMBRANES, V1818, P2282, DOI 10.1016/j.bbamem.2012.05.013; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006665; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Yin H, 2008, ANGEW CHEM INT EDIT, V47, P2744, DOI 10.1002/anie.200704780; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zhao TX, 2010, CURR PHARM DESIGN, V16, P1055, DOI 10.2174/138161210790963878	38	319	351	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47703	10.1371/journal.pone.0047703	http://dx.doi.org/10.1371/journal.pone.0047703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	22558416	Green Submitted, gold, Green Published			2022-12-27	WOS:000310050200040
